PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lewicki, MS				Lewicki, MS			Efficient coding of natural sounds	NATURE NEUROSCIENCE			English	Article							INDEPENDENT COMPONENT ANALYSIS; AUDITORY-NERVE FIBERS; INFORMATION-TRANSMISSION; REPRESENTATIONS; SEPARATION; FRAMEWORK; FILTERS; SPARSE	The auditory system encodes sound by decomposing the amplitude signal arriving at the ear into multiple frequency bands whose center frequencies and bandwidths are approximately exponential functions of the distance from the stapes. This organization is thought to result from the adaptation of cochlear mechanisms to the animal's auditory environment. Here we report that several basic auditory nerve fiber tuning properties can be accounted for by adapting a population of filter shapes to encode natural sounds efficiently. The form of the code depends on sound class, resembling a Fourier transformation when optimized for animal vocalizations and a wavelet transformation when optimized for non-biological environmental sounds. Only for the combined set does the optimal code follow scaling characteristics of physiological data. These results suggest that auditory nerve fibers encode a broad set of natural sounds in a manner consistent with information theoretic principles.	Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lewicki, MS (corresponding author), Carnegie Mellon Univ, Dept Comp Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.							Amari S, 1996, ADV NEUR IN, V8, P757; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI 10.3109/0954898X.2011.638888; ATTIAS H, 1997, ADV NEURAL INFORMATI, V9; Barlow H., 1961, SENSORY COMMUNICATIO, P217; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bell AJ, 1996, NETWORK-COMP NEURAL, V7, P261, DOI 10.1088/0954-898X/7/2/005; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Box GEP., 1973, BAYESIAN INFERENCE S; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; CARDOSO JF, 1997, IEEE SIGNAL PROCESS, V4, P109; CARNEY LH, 1988, J NEUROPHYSIOL, V60, P1653, DOI 10.1152/jn.1988.60.5.1653; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; DEBOER E, 1978, J ACOUST SOC AM, V63, P115, DOI 10.1121/1.381704; Emmons LH, 1997, SOUNDS NEOTROPICAL R; EVANS EF, 1977, PSYCHOPHYSICS PHYSL, P185; EVANS EF, 1975, HDB SENSORY PHYSIOLO, V5, P1; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; FURTH PM, 1995, IEEE T CIRCUITS-I, V42, P966, DOI 10.1109/81.477209; Irino T, 1997, J ACOUST SOC AM, V101, P412, DOI 10.1121/1.417975; Kiang NYS, 1965, DISCHARGE PATTERNS S; Laughlin S.B., 1983, PHYS BIOLOGICAL PROC, P42; Lewicki MS, 1999, ADV NEUR IN, V11, P730; Lewicki MS, 1999, J OPT SOC AM A, V16, P1587, DOI 10.1364/JOSAA.16.001587; Lewicki MS, 2000, NEURAL COMPUT, V12, P337, DOI 10.1162/089976600300015826; LINSKER R, 1990, ANNU REV NEUROSCI, V13, P257, DOI 10.1146/annurev.ne.13.030190.001353; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Moore B, 1986, FREQUENCY SELECTIVIT; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Pearlmutter B. A., 1996, Progress in Neural Information Processing. Proceedings of the International Conference on Neural Information Processing, P151; RHODE WS, 1985, HEARING RES, V18, P159, DOI 10.1016/0378-5955(85)90008-5; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; SIMONS J, 1979, THEOR CHEM ADV PERSP, V3, P1; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P2315, DOI 10.1098/rspb.1998.0577; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; ZOHARIAN AS, 1981, J ACOUST SOC AM, V69, P832	38	417	423	3	37	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					356	363		10.1038/nn831	http://dx.doi.org/10.1038/nn831			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11896400	Green Submitted			2022-12-17	WOS:000174606900016
J	Churchland, AK; Kiani, R; Shadlen, MN				Churchland, Anne K.; Kiani, Roozbeh; Shadlen, Michael N.			Decision-making with multiple alternatives	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; MACAQUE AREA LIP; PERCEPTUAL DECISION; VISUAL-MOTION; DISCRIMINATION TASK; SUPERIOR COLLICULUS; TIME; MICROSTIMULATION; REPRESENTATION; RESPONSES	Simple perceptual tasks have laid the groundwork for understanding the neurobiology of decision-making. Here, we examined this foundation to explain how decision-making circuitry adjusts in the face of a more difficult task. We measured behavioral and physiological responses of monkeys on a two-and four-choice direction-discrimination decision task. For both tasks, firing rates in the lateral intraparietal area appeared to reflect the accumulation of evidence for or against each choice. Evidence accumulation began at a lower firing rate for the four-choice task, but reached a common level by the end of the decision process. The larger excursion suggests that the subjects required more evidence before making a choice. Furthermore, on both tasks, we observed a time-dependent rise in firing rates that may impose a deadline for deciding. These physiological observations constitute an effective strategy for handling increased task difficulty. The differences appear to explain subjects' accuracy and reaction times.	[Churchland, Anne K.; Kiani, Roozbeh; Shadlen, Michael N.] Univ Washington, Sch Med, Dept Physiol & Biophys, Natl Primate Res Ctr,Howard Hughes Med Inst, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Churchland, AK (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Natl Primate Res Ctr,Howard Hughes Med Inst, Seattle, WA 98195 USA.	anne99@u.washington.edu	Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210	Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [P51 RR000166, RR00166] Funding Source: Medline; NEI NIH HHS [R01 EY011378, R01 EY011378-11A1, EY011378] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arai K, 2004, J NEUROPHYSIOL, V91, P890, DOI 10.1152/jn.00818.2003; Basso MA, 1998, J NEUROSCI, V18, P7519; Bogacz R, 2007, PHILOS T R SOC B, V362, P1655, DOI 10.1098/rstb.2007.2059; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Churchland AK, 2003, NEURON, V37, P1001, DOI 10.1016/S0896-6273(03)00145-4; COLD JI, 2007, ANNU REV NEUROSCI, V30, P535; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Ditterich J, 2006, NEURAL NETWORKS, V19, P981, DOI 10.1016/j.neunet.2006.05.042; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Hamed SB, 2002, CEREB CORTEX, V12, P234, DOI 10.1093/cercor/12.3.234; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Jazayeri M, 2007, NATURE, V446, P912, DOI 10.1038/nature05739; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Laming D. R. J., 1968, INFORM THEORY CHOICE; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; LINK SW, 1975, PSYCHOMETRIKA, V40, P77, DOI 10.1007/BF02291481; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Luce RD, 1986, RESPONSE TIMES; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Maimon G, 2006, NAT NEUROSCI, V9, P948, DOI 10.1038/nn1716; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; McMillen T, 2006, J MATH PSYCHOL, V50, P30, DOI 10.1016/j.jmp.2005.10.003; Nichols MJ, 2002, J NEUROSCI, V22, P9530; Niwa M, 2008, J NEUROSCI, V28, P4435, DOI 10.1523/JNEUROSCI.5564-07.2008; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Platt ML, 1998, EXP BRAIN RES, V121, P65, DOI 10.1007/s002210050438; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; Ratcliff R, 2007, J NEUROPHYSIOL, V97, P1756, DOI 10.1152/jn.00393.2006; Reddi BAJ, 2003, J NEUROPHYSIOL, V90, P3538, DOI 10.1152/jn.00689.2002; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Risken H., 1989, FOKKER PLANCK EQUATI, DOI DOI 10.1007/978-3-642-61544-3; Roitman JD, 2002, J NEUROSCI, V22, P9475; SALZMAN CD, 1994, SCIENCE, V264, P231, DOI 10.1126/science.8146653; Sato T, 2001, EXP BRAIN RES, V139, P53, DOI 10.1007/s002210100750; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Thier P, 1996, P NATL ACAD SCI USA, V93, P4962, DOI 10.1073/pnas.93.10.4962; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Van Essen DC, 2004, NEUROIMAGE, V23, pS97, DOI 10.1016/j.neuroimage.2004.07.024; Vickers D., 1979, DECISION PROCESSES V; Walker R, 1997, J NEUROPHYSIOL, V78, P1108, DOI 10.1152/jn.1997.78.2.1108	50	416	419	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					693	702		10.1038/nn.2123	http://dx.doi.org/10.1038/nn.2123			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18488024	Green Accepted			2022-12-17	WOS:000256133700016
J	Desai, NS; Cudmore, RH; Nelson, SB; Turrigiano, GG				Desai, NS; Cudmore, RH; Nelson, SB; Turrigiano, GG			Critical periods for experience-dependent synaptic scaling in visual cortex	NATURE NEUROSCIENCE			English	Article							MONOCULAR DEPRIVATION; QUANTAL AMPLITUDE; NMDA-RECEPTOR; PLASTICITY; RAT; EXPRESSION; SYNAPSES; AMPA; MECHANISMS; ZIF268	The mechanisms underlying experience-dependent plasticity and refinement of central circuits are not yet fully understood. A non-Hebbian form of synaptic plasticity, which scales synaptic strengths up or down to stabilize firing rates, has recently been discovered in cultured neuronal networks. Here we demonstrate the existence of a similar mechanism in the intact rodent visual cortex. The frequency of miniature excitatory postsynaptic currents (mEPSCs) in principal neurons increased steeply between post-natal days 12 and 23. There was a concomitant decrease in mEPSC amplitude, which was prevented by rearing rats in complete darkness from 12 days of age. In addition, as little as two days of monocular deprivation scaled up mEPSC amplitude in a layer- and age-dependent manner. These data indicate that mEPSC amplitudes can be globally scaled up or down as a function of development and sensory experience, and suggest that synaptic scaling may be involved in the activity-dependent refinement of cortical connectivity.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Turrigiano, GG (corresponding author), Brandeis Univ, Dept Biol, MS 008,415 South St, Waltham, MA 02454 USA.	turrigiano@brandeis.edu		Cudmore, Robert/0000-0002-0440-1704; Nelson, Sacha/0000-0002-0108-8599	NATIONAL EYE INSTITUTE [R01EY011116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036853] Funding Source: NIH RePORTER; NEI NIH HHS [EY 11116] Funding Source: Medline; NINDS NIH HHS [R01 NS 36853] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2001, NAT NEUROSCI, V4, P115, DOI 10.1038/83920; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BLUE ME, 1983, J NEUROCYTOL, V12, P599, DOI 10.1007/BF01181526; Caleo M, 1999, NEUROSCIENCE, V91, P1017, DOI 10.1016/S0306-4522(98)00682-4; Caleo M, 1999, EUR J NEUROSCI, V11, P2979, DOI 10.1046/j.1460-9568.1999.00737.x; CHANGNACAMITAI Y, 1989, J NEUROPHYSIOL, V62, P1149; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; Davis GW, 1998, CURR OPIN NEUROBIOL, V8, P149, DOI 10.1016/S0959-4388(98)80018-4; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; FOX K, 1992, J NEUROSCI, V12, P1826; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Gordon JA, 1996, J NEUROSCI, V16, P3274; Guire ES, 1999, J NEUROPHYSIOL, V81, P121, DOI 10.1152/jn.1999.81.1.121; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; Leslie KR, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-19-j0005.2001; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; McCormick DA, 1999, SCIENCE, V285, P541, DOI 10.1126/science.285.5427.541; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; REID SNM, 1991, BRAIN RES, V563, P293, DOI 10.1016/0006-8993(91)91549-G; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Varela JA, 1999, J NEUROSCI, V19, P4293; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; WORLEY PF, 1991, P NATL ACAD SCI USA, V88, P5106, DOI 10.1073/pnas.88.12.5106; ZILLES K, 1984, J COMP NEUROL, V226, P391, DOI 10.1002/cne.902260308	49	416	428	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					783	789		10.1038/nn878	http://dx.doi.org/10.1038/nn878			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12080341				2022-12-17	WOS:000177088900022
J	Miki, T; Liss, B; Minami, K; Shiuchi, T; Saraya, A; Kashima, Y; Horiuchi, M; Ashcroft, F; Minokoshi, Y; Roeper, J; Seino, S				Miki, T; Liss, B; Minami, K; Shiuchi, T; Saraya, A; Kashima, Y; Horiuchi, M; Ashcroft, F; Minokoshi, Y; Roeper, J; Seino, S			ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis	NATURE NEUROSCIENCE			English	Article							POTASSIUM CHANNELS; VENTROMEDIAL HYPOTHALAMUS; SULFONYLUREA RECEPTOR; BODY-WEIGHT; FOOD-INTAKE; GLUCAGON-SECRETION; HORMONE-RELEASE; SKELETAL-MUSCLE; RAT-BRAIN; NEURONS	Glucose-responsive (GR) neurons in the hypothalamus are thought to be critical in glucose homeostasis, but it is not known how they function in this context. Kir6.2 is the pore-forming subunit of K-ATP channels in many cell types, including pancreatic beta -cells and heart. Here we show the complete absence of both functional ATP-sensitive K+ (K-ATP) channels and glucose responsiveness in the neurons of the ventromedial hypothalamus (VMH) in Kir6.2(-/-) mice. Although pancreatic alpha -cells were functional in Kir6.2(-/-), the mice exhibited a severe defect in glucagon secretion in response to systemic hypoglycemia. In addition, they showed a complete loss of glucagon secretion, together with reduced food intake in response to neuroglycopenia. Thus, our results demonstrate that K-ATP channels are important in glucose sensing in VMH GR neurons, and are essential for the maintenance of glucose homeostasis.	Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba 2608670, Japan; Univ Oxford, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England; Ehime Univ, Sch Med, Dept Biochem Med, Matsuyama, Ehime 7910295, Japan; Univ Oxford, Univ Lab Physiol, Oxford OX1 3TH, England	Chiba University; University of Oxford; Ehime University; University of Oxford	Seino, S (corresponding author), Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba 2608670, Japan.		Shiuchi, Tetsuya/AAG-7620-2020; MIKI, Takashi/ABD-3995-2020	Shiuchi, Tetsuya/0000-0002-3027-5465; MIKI, Takashi/0000-0001-5741-1626; liss, Birgit/0000-0002-6733-9207; Roeper, Jochen/0000-0003-2145-8742; Minami, Kohtaro/0000-0003-4698-6250; Minokoshi, Yasuhiko/0000-0002-7119-4805				Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; AMOROSO S, 1990, SCIENCE, V247, P852, DOI 10.1126/science.2305257; Ashcroft FM, 1998, TRENDS NEUROSCI, V21, P288, DOI 10.1016/S0166-2236(98)01225-9; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; ASHFORD MLJ, 1988, PFLUG ARCH EUR J PHY, V412, P297, DOI 10.1007/BF00582512; ASHFORD MLJ, 1990, PFLUG ARCH EUR J PHY, V415, P479, DOI 10.1007/BF00373626; ASHFORD MLJ, 1990, BRIT J PHARMACOL, V101, P531, DOI 10.1111/j.1476-5381.1990.tb14116.x; Bergen HT, 1996, BRAIN RES, V734, P332, DOI 10.1016/0006-8993(96)00887-6; BERNARDI H, 1993, P NATL ACAD SCI USA, V90, P1340, DOI 10.1073/pnas.90.4.1340; Bokvist K, 1999, PFLUG ARCH EUR J PHY, V438, P428, DOI 10.1007/s004240051058; Borg MA, 1999, DIABETES, V48, P584, DOI 10.2337/diabetes.48.3.584; Borg MA, 1997, J CLIN INVEST, V99, P361, DOI 10.1172/JCI119165; BORG WP, 1994, J CLIN INVEST, V93, P1677, DOI 10.1172/JCI117150; BORG WP, 1995, DIABETES, V44, P180, DOI 10.2337/diabetes.44.2.180; Chutkow WA, 1999, J BIOL CHEM, V274, P13656, DOI 10.1074/jbc.274.19.13656; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; Dunn-Meynell AA, 1998, BRAIN RES, V814, P41, DOI 10.1016/S0006-8993(98)00956-1; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Gribble FM, 1998, DIABETES, V47, P1412, DOI 10.2337/diabetes.47.9.1412; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Karschin A, 1998, J PHYSIOL-LONDON, V509, P339, DOI 10.1111/j.1469-7793.1998.339bn.x; Karschin C, 1997, FEBS LETT, V401, P59, DOI 10.1016/S0014-5793(96)01438-X; LAMBOLEZ B, 1992, NEURON, V9, P247, DOI 10.1016/0896-6273(92)90164-9; Lee K, 1999, J PHYSIOL-LONDON, V515, P439, DOI 10.1111/j.1469-7793.1999.439ac.x; LELOUP C, 1994, BRAIN RES, V638, P221, DOI 10.1016/0006-8993(94)90653-X; Levin BE, 1999, AM J PHYSIOL-REG I, V276, pR1223; Liss B, 1999, EMBO J, V18, P833, DOI 10.1093/emboj/18.4.833; Lynch RM, 2000, DIABETES, V49, P693, DOI 10.2337/diabetes.49.5.693; Matschinsky FM, 1998, DIABETES, V47, P307, DOI 10.2337/diabetes.47.3.307; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; MINAMI T, 1986, J PHYSIOL-LONDON, V380, P127, DOI 10.1113/jphysiol.1986.sp016276; MULLER EE, 1971, LIFE SCI, V10, P1057, DOI 10.1016/0024-3205(71)90180-9; OHNOSHOSAKU T, 1992, PFLUG ARCH EUR J PHY, V422, P260, DOI 10.1007/BF00376211; OOMURA Y, 1969, NATURE, V222, P282, DOI 10.1038/222282a0; PESSIN JE, 1992, ANNU REV PHYSIOL, V54, P911, DOI 10.1146/annurev.ph.54.030192.004403; ROPER J, 1995, PFLUG ARCH EUR J PHY, V430, P44, DOI 10.1007/BF00373838; Sakura H, 1995, FEBS LETT, V377, P338, DOI 10.1016/0014-5793(95)01369-5; Salehi A, 1999, J PHYSIOL-LONDON, V514, P579, DOI 10.1111/j.1469-7793.1999.579ae.x; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Silver IA, 1998, J NEUROPHYSIOL, V79, P1733, DOI 10.1152/jn.1998.79.4.1733; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; SPRUCE AE, 1985, NATURE, V316, P736, DOI 10.1038/316736a0; STEFFENS AB, 1990, NEUROSCI BIOBEHAV R, V14, P305, DOI 10.1016/S0149-7634(05)80040-5; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Suzuki M, 1997, DIABETES, V46, P1440, DOI 10.2337/diabetes.46.9.1440; Taborsky GJ, 1998, DIABETES, V47, P995, DOI 10.2337/diabetes.47.7.995; TERZIC A, 1995, AM J PHYSIOL-CELL PH, V269, pC525, DOI 10.1152/ajpcell.1995.269.3.C525; Yang XJ, 1999, DIABETES, V48, P1763, DOI 10.2337/diabetes.48.9.1763; Zawar C, 1999, J PHYSIOL-LONDON, V514, P327	50	415	426	0	21	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2001	4	5					507	512		10.1038/87455	http://dx.doi.org/10.1038/87455			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NN	11319559				2022-12-17	WOS:000168412600014
J	Hardingham, GE; Arnold, FJL; Bading, H				Hardingham, GE; Arnold, FJL; Bading, H			Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity	NATURE NEUROSCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; HIPPOCAMPAL-NEURONS; DIFFERENTIAL ACTIVATION; CYTOPLASMIC CALCIUM; PYRAMIDAL NEURONS; ACTION-POTENTIALS; TERNARY COMPLEX; TRANSCRIPTION; PHOSPHORYLATION; GROWTH	Information storage in the nervous system requires transcription triggered by synaptically evoked calcium signals. It has been suggested that translocation of calmodulin into the nucleus, initiated by submembranous calcium transients, relays synaptic signals to CREB. Here we show that in hippocampal neurons, signaling to CREB can be activated by nuclear calcium alone and does not require import of cytoplasmic proteins into the nucleus. The nucleus is particularly suited to integrate neuronal firing patterns, and specifies the transcriptional outputs through a burst frequency-to-nuclear calcium amplitude conversion. Calcium release from intracellular stores promotes calcium wave propagation into the nucleus, which is critical for CREB-mediated transcription by synaptic NMDA receptors. Pharmacological or genetic modulation of nuclear calcium may directly affect transcription-dependent memory and cognitive functions.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Bading, H (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.			Hardingham, Giles/0000-0002-7629-5314				Adams JP, 2000, ACTA NEUROBIOL EXP, V60, P377; Ahn S, 2000, ANNU REV PHYSIOL, V62, P803, DOI 10.1146/annurev.physiol.62.1.803; Bading H, 2000, EUR J BIOCHEM, V267, P5280, DOI 10.1046/j.1432-1327.2000.01565.x; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; CRUZALEGUI FH, 1993, J BIOL CHEM, V268, P26171; Cruzalegui FH, 1999, EMBO J, V18, P1335, DOI 10.1093/emboj/18.5.1335; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DEYO RA, 1989, SCIENCE, V243, P809, DOI 10.1126/science.2916127; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Fields RD, 1997, J NEUROSCI, V17, P7252; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; Goodman RH, 2000, GENE DEV, V14, P1553; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Hardingham GE, 1999, MICROSC RES TECHNIQ, V46, P348, DOI 10.1002/(SICI)1097-0029(19990915)46:6<348::AID-JEMT3>3.3.CO;2-1; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Johnson CM, 1997, J NEUROSCI, V17, P6189; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; LEREA LS, 1992, J NEUROSCI, V12, P2973, DOI 10.1523/JNEUROSCI.12-08-02973.1992; LEVERE TE, 1991, NEUROBIOL AGING, V13, P63; Lipp P, 1997, EMBO J, V16, P7166, DOI 10.1093/emboj/16.23.7166; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Morich FJ, 1996, CLIN DRUG INVEST, V11, P185, DOI 10.2165/00044011-199611040-00001; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Nakazawa H, 1999, J NEUROCHEM, V73, P1075, DOI 10.1046/j.1471-4159.1999.0731075.x; OLWIN BB, 1984, J BIOL CHEM, V259, P949; PRUSCHY M, 1994, J CELL BIOL, V127, P1527, DOI 10.1083/jcb.127.6.1527; SANDIN M, 1990, NEUROBIOL AGING, V11, P573, DOI 10.1016/0197-4580(90)90120-O; SCHILLER J, 1995, J PHYSIOL-LONDON, V487, P583, DOI 10.1113/jphysiol.1995.sp020902; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	50	415	422	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					261	267		10.1038/85109	http://dx.doi.org/10.1038/85109			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224542				2022-12-17	WOS:000167178300013
J	Hefft, S; Jonas, P				Hefft, S; Jonas, P			Asynchronous GABA release generates long-lasting inhibition at a hippocampal interneuron-principal neuron synapse	NATURE NEUROSCIENCE			English	Article							TRANSMITTER RELEASE; RAT HIPPOCAMPUS; NEUROMUSCULAR-JUNCTION; SHUNTING INHIBITION; NERVE-TERMINALS; GRANULE CELLS; TIME-COURSE; IN-VITRO; TRANSMISSION; PARVALBUMIN	Hippocampal GABAergic interneurons show diverse molecular and morphological properties. The functional significance of this diversity for information processing is poorly understood. Here we show that cholecystokinin (CCK)-expressing interneurons in rat dentate gyrus release GABA in a highly asynchronous manner, in contrast to parvalbumin (PV) interneurons. With a gamma-frequency burst of ten action potentials, the ratio of asynchronous to synchronous release is 3: 1 in CCK interneurons but is 1: 5 in parvalbumin interneurons. N-type channels trigger synchronous and asynchronous release in CCK interneuron synapses, whereas P/Q-type Ca2+ channels mediate release at PV interneuron synapses. Effects of Ca2+ chelators suggest that both a long-lasting presynaptic Ca2+ transient and a large distance between Ca2+ source and sensor of exocytosis contribute to the higher ratio of asynchronous to synchronous release in CCK interneuron synapses. Asynchronous release occurs at physiological temperature and with behaviorally relevant stimulation patterns, thus generating long-lasting inhibition in the brain.	Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany	University of Freiburg	Jonas, P (corresponding author), Univ Freiburg, Inst Physiol, Hermann Herder Str 7, D-79104 Freiburg, Germany.	peter.jonas@physiologie.uni-freiburg.de		Jonas, Peter/0000-0001-5001-4804				Atluri PP, 1998, J NEUROSCI, V18, P8214; Atluri PP, 1996, J NEUROSCI, V16, P5661; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brickley SG, 1999, J NEUROSCI, V19, P2960; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Collin T, 2005, J NEUROSCI, V25, P96, DOI 10.1523/JNEUROSCI.3748-04.2005; DATYNER NB, 1980, J PHYSIOL-LONDON, V303, P299, DOI 10.1113/jphysiol.1980.sp013286; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; Hefft S, 2002, J PHYSIOL-LONDON, V539, P201, DOI 10.1113/jphysiol.2001.013455; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Holt GR, 1997, NEURAL COMPUT, V9, P1001, DOI 10.1162/neco.1997.9.5.1001; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; ISAACSON JS, 1995, NEURON, V15, P875, DOI 10.1016/0896-6273(95)90178-7; Jensen K, 2000, BRAIN RES, V880, P198, DOI 10.1016/S0006-8993(00)02746-3; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Losonczy A, 2004, P NATL ACAD SCI USA, V101, P1362, DOI 10.1073/pnas.0304752101; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; Matsui K, 2004, J NEUROSCI, V24, P8932, DOI 10.1523/JNEUROSCI.2650-04.2004; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Morozov YM, 2003, NEUROSCIENCE, V120, P923, DOI 10.1016/S0306-4522(03)00409-3; Neher E, 2001, J NEUROSCI, V21, P9638, DOI 10.1523/JNEUROSCI.21-24-09638.2001; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; Poncer JC, 1997, NEURON, V18, P463, DOI 10.1016/S0896-6273(00)81246-5; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; RANDALL A, 1995, J NEUROSCI, V15, P2995; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Rumpel E, 1999, J PHYSIOL-LONDON, V514, P447, DOI 10.1111/j.1469-7793.1999.447ae.x; Schmidt H, 2003, J PHYSIOL-LONDON, V551, P13, DOI 10.1113/jphysiol.2002.035824; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; VANDERKLOOT W, 1988, J PHYSIOL-LONDON, V402, P595, DOI 10.1113/jphysiol.1988.sp017224; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wu LG, 1999, J NEUROSCI, V19, P726; Xu-Friedman MA, 1999, BIOPHYS J, V76, P2029, DOI 10.1016/S0006-3495(99)77360-1; ZHANG L, 1995, J PHYSIOL-LONDON, V488, P661, DOI 10.1113/jphysiol.1995.sp020998	50	414	418	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1319	1328		10.1038/nn1542	http://dx.doi.org/10.1038/nn1542			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16158066				2022-12-17	WOS:000232145900015
J	Elmquist, JK; Maratos-Flier, E; Saper, CB; Flier, JS				Elmquist, JK; Maratos-Flier, E; Saper, CB; Flier, JS			Unraveling the central nervous system pathways underlying responses to leptin	NATURE NEUROSCIENCE			English	Review							OBESE GENE-PRODUCT; RECEPTOR MESSENGER-RNA; FORM SPLICE VARIANT; NORMAL FEMALE MICE; NEUROPEPTIDE-Y; OB/OB MICE; ARCUATE NUCLEUS; OB-R; VENTROMEDIAL HYPOTHALAMUS; DORSOMEDIAL HYPOTHALAMUS	Here we summarize recent progress in the biology of leptin, concentrating on its central nervous system (CNS) actions. The product of the ob gene, leptin is a circulating hormone produced by white adipose tissue that has potent effects on feeding behavior, thermogenesis and neuroendocrine responses. Leptin regulates energy homeostasis, as its absence in rodents and humans causes severe obesity. We consider the physiological mechanisms underlying leptin action, along with several novel hypothalamic neuropeptides that affect food intake and body weight. The molecular causes of several other obesity syndromes are discussed to illuminate how the CNS regulates body weight. We describe neural circuits that are downstream of leptin receptors and propose a model linking populations of leptin-responsive neurons with effector neurons underlying leptin's endocrine, autonomic and behavioral effects.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Endocrinol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02215 USA; Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Elmquist, JK (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Endocrinol, 325 Res N,99 Brookline Ave, Boston, MA 02215 USA.	jelmquis@bidmc.harvard.edu	Flier, jeffrey/AAG-6223-2019					Ahima RS, 1997, J CLIN INVEST, V99, P391, DOI 10.1172/JCI119172; Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; Barash IA, 1996, ENDOCRINOLOGY, V137, P3144, DOI 10.1210/en.137.7.3144; Barrachina MD, 1997, P NATL ACAD SCI USA, V94, P10455, DOI 10.1073/pnas.94.19.10455; BELLINGER LL, 1976, NEUROENDOCRINOLOGY, V22, P216, DOI 10.1159/000122628; Bernardis LL, 1996, NEUROSCI BIOBEHAV R, V20, P189, DOI 10.1016/0149-7634(95)00015-1; BERNARDIS LL, 1987, BRAIN RES REV, V12, P321, DOI 10.1016/0165-0173(87)90004-X; Bi S, 1997, J BIOL CHEM, V272, P30583, DOI 10.1074/jbc.272.48.30583; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Bjorbaek C, 1998, ENDOCRINOLOGY, V139, P3485, DOI 10.1210/en.139.8.3485; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; BROADWELL RD, 1976, J COMP NEUROL, V166, P257, DOI 10.1002/cne.901660302; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Caro JF, 1996, LANCET, V348, P159, DOI 10.1016/S0140-6736(96)03173-X; Carro E, 1997, ENDOCRINOLOGY, V138, P2203, DOI 10.1210/en.138.5.2203; Casto RM, 1998, NEUROSCI LETT, V246, P29, DOI 10.1016/S0304-3940(98)00223-7; Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; Chehab FF, 1997, SCIENCE, V275, P88, DOI 10.1126/science.275.5296.88; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489; Cheung CC, 1997, ENDOCRINOLOGY, V138, P855, DOI 10.1210/en.138.2.855; Choi SJ, 1996, J NEUROSCI, V16, P8170; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Couce ME, 1997, NEUROENDOCRINOLOGY, V66, P145, DOI 10.1159/000127232; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; DiMicco JA, 1996, CLIN EXP PHARMACOL P, V23, P171, DOI 10.1111/j.1440-1681.1996.tb02592.x; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; Elmquist JK, 1997, ENDOCRINOLOGY, V138, P839, DOI 10.1210/en.138.2.839; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Elmquist JK, 1998, P NATL ACAD SCI USA, V95, P741, DOI 10.1073/pnas.95.2.741; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Flier JS, 1998, J CLIN ENDOCR METAB, V83, P1407, DOI 10.1210/jc.83.5.1407; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; FROHMAN LA, 1971, AM J PHYSIOL, V221, P1596, DOI 10.1152/ajplegacy.1971.221.6.1596; FULWILER CE, 1985, NEUROSCI LETT, V53, P289, DOI 10.1016/0304-3940(85)90553-1; Gerald C, 1996, NATURE, V382, P168, DOI 10.1038/382168a0; Glaum SR, 1996, MOL PHARMACOL, V50, P230; GOLD RM, 1973, SCIENCE, V182, P488, DOI 10.1126/science.182.4111.488; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Hakansson ML, 1998, J NEUROSCI, V18, P559; Hakansson ML, 1996, NEUROREPORT, V7, P3087, DOI 10.1097/00001756-199611250-00059; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Hetherington AW, 1940, ANAT REC, V78, P149, DOI 10.1002/ar.1090780203; Huang QL, 1998, ENDOCRINOLOGY, V139, P1524, DOI 10.1210/en.139.4.1524; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kalsbeek A, 1996, NEUROENDOCRINOLOGY, V63, P69, DOI 10.1159/000126937; Kesterson RA, 1997, MOL ENDOCRINOL, V11, P630, DOI 10.1210/me.11.5.630; Koylu EO, 1997, J NEUROENDOCRINOL, V9, P823, DOI 10.1046/j.1365-2826.1997.00651.x; Koylu EO, 1998, J COMP NEUROL, V391, P115; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Lambert PD, 1998, SYNAPSE, V29, P293, DOI 10.1002/(SICI)1098-2396(199808)29:4<293::AID-SYN1>3.0.CO;2-0; Lambert R., 1997, NEUROPEPTIDES, V31, P620; Laughlin GA, 1997, J CLIN ENDOCR METAB, V82, P318, DOI 10.1210/jc.82.1.318; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Legradi G, 1997, ENDOCRINOLOGY, V138, P2569, DOI 10.1210/en.138.6.2569; LEIBOWITZ SF, 1994, ANN NY ACAD SCI, V739, P12, DOI 10.1111/j.1749-6632.1994.tb19804.x; Licinio J, 1997, NAT MED, V3, P575, DOI 10.1038/nm0597-575; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Mercer JG, 1996, J NEUROENDOCRINOL, V8, P733, DOI 10.1046/j.1365-2826.1996.05161.x; Mercer JG, 1998, ENDOCRINOLOGY, V139, P29, DOI 10.1210/en.139.1.29; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Mizuno TM, 1998, DIABETES, V47, P294, DOI 10.2337/diabetes.47.2.294; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Ravussin E, 1997, NAT MED, V3, P238, DOI 10.1038/nm0297-238; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; SAPER CB, 1985, J COMP NEUROL, V237, P21, DOI 10.1002/cne.902370103; Satoh N, 1997, ENDOCRINOLOGY, V138, P947, DOI 10.1210/en.138.3.947; Savioz A, 1997, NEUROREPORT, V8, P3123, DOI 10.1097/00001756-199709290-00023; SCHWARTZ MW, 1995, AM J PHYSIOL-REG I, V269, pR949, DOI 10.1152/ajpregu.1995.269.5.R949; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Smedh U, 1998, NEUROREPORT, V9, P297, DOI 10.1097/00001756-199801260-00022; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; SUEMARU S, 1995, NEUROENDOCRINOLOGY, V61, P453, DOI 10.1159/000126868; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Thornton JE, 1997, ENDOCRINOLOGY, V138, P5063, DOI 10.1210/en.138.11.5063; TRTOS NA, IN PRESS ENDOCRINOLO, V139; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; vanDijk G, 1996, AM J PHYSIOL-REG I, V271, pR1096, DOI 10.1152/ajpregu.1996.271.4.R1096; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; WATTS AG, 1987, J COMP NEUROL, V258, P204, DOI 10.1002/cne.902580204; Watts AG, 1991, SUPRACHIASMATIC NUCL, P75; White DW, 1997, J BIOL CHEM, V272, P4065, DOI 10.1074/jbc.272.7.4065; White DW, 1997, P NATL ACAD SCI USA, V94, P10657, DOI 10.1073/pnas.94.20.10657; Woods AJ, 1996, NATURE, V381, P745, DOI 10.1038/381745a0; YOSHIMATSU H, 1984, BRAIN RES, V303, P147, DOI 10.1016/0006-8993(84)90222-1; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	107	414	425	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	1998	1	6					445	450		10.1038/2164	http://dx.doi.org/10.1038/2164			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	128LE	10196541				2022-12-17	WOS:000076406900008
J	Rotshtein, P; Henson, RNA; Treves, A; Driver, J; Dolan, RJ				Rotshtein, P; Henson, RNA; Treves, A; Driver, J; Dolan, RJ			Morphing Marilyn into Maggie dissociates physical and identity face representations in the brain	NATURE NEUROSCIENCE			English	Article							FAMOUS FACES; PERCEPTION; RECOGNITION; FMRI; RESPONSES; NEURONS; ACCOUNT; AREA; ACTIVATION; EXPRESSION	How the brain represents different aspects of faces remains controversial. Here we presented subjects with stimuli drawn from morph continua between pairs of famous faces. In the paired presentations, a second face could be identical to the first, could share perceived identity but differ physically (30% along the morph continuum), or could differ physically by the same distance along the continuum (30%) but in the other direction. We show that, behaviorally, subjects are more likely to classify face pairs in the third paired presentation as different and that this effect is more pronounced for subjects who are more familiar with the faces. In functional magnetic resonance imaging (fMRI), inferior occipital gyrus (IOG) shows sensitivity to physical rather than to identity changes, whereas right fusiform gyrus (FFG) shows sensitivity to identity rather than to physical changes. Bilateral anterior temporal regions show sensitivity to identity change that varies with the subjects' pre-experimental familiarity with the faces. These findings provide neurobiological support for a hierarchical model of face perception.	UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London, England; UCL, Dept Psychol, London WC1N 3BG, England; UCL, Inst Cognit Neurosci, London WC1N 3BG, England; SISSA, Program Neurosci, I-34013 Trieste, Italy	University of London; University College London; University of London; University College London; University of London; University College London; International School for Advanced Studies (SISSA)	Rotshtein, P (corresponding author), UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, 12 Queen Sq, London, England.	p.rotshtein@fil.ion.ucl.ac.uk	Treves, Alessandro/B-2318-2009; Henson, Richard/H-8822-2019; Driver, Jon/A-4779-2010	Henson, Richard/0000-0002-0712-2639; Rotshtein, Pia/0000-0002-0301-9511; TREVES, Alessandro/0000-0001-7246-5673; Dolan, Ray/0000-0001-9356-761X				Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Barton JJS, 2003, NEUROLOGY, V61, P220, DOI 10.1212/01.WNL.0000071229.11658.F8; BEALE JM, 1995, COGNITION, V57, P217, DOI 10.1016/0010-0277(95)00669-X; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Campanella S, 2000, PSYCHOPHYSIOLOGY, V37, P796, DOI 10.1017/S0048577200991728; de Gelder B, 2001, ACTA PSYCHOL, V107, P183, DOI 10.1016/S0001-6918(01)00024-5; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; DERENZI E, 1986, NEUROPSYCHOLOGIA, V24, P385; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; George N, 1999, NAT NEUROSCI, V2, P574, DOI 10.1038/9230; Glosser G, 2003, NEUROLOGY, V61, P81, DOI 10.1212/01.WNL.0000073621.18013.E1; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Harnad S., 1987, CATEGORICAL PERCEPTI, P29; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RN, 2003, CEREB CORTEX, V13, P793, DOI 10.1093/cercor/13.7.793; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Ishai A, 2002, NEUROIMAGE, V17, P1729, DOI 10.1006/nimg.2002.1330; Josephs O., 2000, NEUROIMAGE, V11, pS543; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; LEONARD CM, 1985, BEHAV BRAIN RES, V15, P159, DOI 10.1016/0166-4328(85)90062-2; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; Mundel T, 2003, J CLIN NEUROPHYSIOL, V20, P102, DOI 10.1097/00004691-200304000-00003; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; PENNY W, 2003, HUMAN BRAIN FUNCTION, V2, P851; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Posamentier MT, 2003, NEUROPSYCHOL REV, V13, P113, DOI 10.1023/A:1025519712569; Rajah MN, 1999, COGNITIVE BRAIN RES, V8, P259, DOI 10.1016/S0926-6410(99)00030-0; Rolls ET, 1997, J COMPUT NEUROSCI, V4, P309, DOI 10.1023/A:1008899916425; Seeck M, 2001, EPILEPSY BEHAV, V2, P545, DOI 10.1006/ebeh.2001.0266; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; SIROVICH L, 1987, J OPT SOC AM A, V4, P519, DOI 10.1364/JOSAA.4.000519; Sugiura M, 2001, NEUROIMAGE, V13, P877, DOI 10.1006/nimg.2001.0747; Tanaka J, 1998, COGNITION, V68, P199, DOI 10.1016/S0010-0277(98)00048-1; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Tranel D, 1997, NEUROPSYCHOLOGIA, V35, P1319, DOI 10.1016/S0028-3932(97)00085-7; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Winston JS, 2003, NEUROIMAGE, V20, P84, DOI 10.1016/S1053-8119(03)00303-3; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004	50	412	416	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					107	113		10.1038/nn1370	http://dx.doi.org/10.1038/nn1370			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15592463	Green Published			2022-12-17	WOS:000225967600023
J	Finney, EM; Fine, I; Dobkins, KR				Finney, EM; Fine, I; Dobkins, KR			Visual stimuli activate auditory cortex in the deaf	NATURE NEUROSCIENCE			English	Article							SPATIAL ATTENTION; LANGUAGE; BLIND		Univ Calif San Diego, Psychol Dept 0109, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Dobkins, KR (corresponding author), Univ Calif San Diego, Psychol Dept 0109, La Jolla, CA 92093 USA.	kdobkins@ucsd.edu						Baumgart F, 1999, NATURE, V400, P724, DOI 10.1038/23390; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Christman S, 1997, CEREBRAL ASYMMETRIES; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Kujala T, 2000, TRENDS NEUROSCI, V23, P115, DOI 10.1016/S0166-2236(99)01504-0; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; NEVILLE HJ, 1990, ANN NY ACAD SCI, V608, P71, DOI 10.1111/j.1749-6632.1990.tb48892.x; Nishimura H, 1999, NATURE, V397, P116, DOI 10.1038/16376; Petitto LA, 2000, P NATL ACAD SCI USA, V97, P13961, DOI 10.1073/pnas.97.25.13961; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Talairach J., 1988, COPLANAR STEREOTAXIC; Weeks R, 2000, J NEUROSCI, V20, P2664; Westbury CF, 1999, CEREB CORTEX, V9, P392, DOI 10.1093/cercor/9.4.392	15	411	426	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1171	1173		10.1038/nn763	http://dx.doi.org/10.1038/nn763			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11704763				2022-12-17	WOS:000172525000011
J	Zhou, FM; Liang, Y; Dani, JA				Zhou, FM; Liang, Y; Dani, JA			Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum	NATURE NEUROSCIENCE			English	Article							ACETYLCHOLINE-RECEPTORS; NUCLEUS-ACCUMBENS; CIGARETTE-SMOKING; BRAIN; SCHIZOPHRENIA; MICRODIALYSIS; DIVERSITY; NEURONS; REWARD; PHARMACOLOGY	Dopamine is vital for coordinated motion and for association learning linked to behavioral reinforcement. Here we show that the precise overlap of striatal dopaminergic and cholinergic fibers underlies potent control of dopamine release by ongoing nicotinic receptor activity. In mouse striatal slices, nicotinic antagonists or depletion of endogenous acetylcholine decreased evoked dopamine release by 90%. Nicotine at the concentration experienced by smokers also regulated dopamine release. In mutant mice lacking the beta2 nicotinic subunit, evoked dopamine release was dramatically suppressed, and those mice did not show cholinergic regulation of dopamine release. The results offer new perspectives when considering nicotine addiction and the high prevalence of smoking in schizophrenics.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	Baylor College of Medicine	Dani, JA (corresponding author), Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R23NS021229, R01NS021229, R37NS021229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012661, R01DA009411] Funding Source: NIH RePORTER; NIDA NIH HHS [DA12661, DA09411] Funding Source: Medline; NINDS NIH HHS [NS21229] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; Adler LE, 1998, SCHIZOPHRENIA BULL, V24, P189, DOI 10.1093/oxfordjournals.schbul.a033320; ADLER LE, 1993, AM J PSYCHIAT, V150, P1856; ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455; ANDEN NE, 1966, ACTA PHYSIOL SCAND, V67, P306, DOI 10.1111/j.1748-1716.1966.tb03317.x; AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; Balfour DJK, 2000, BEHAV BRAIN RES, V113, P73, DOI 10.1016/S0166-4328(00)00202-3; Bennett BD, 1999, J NEUROSCI, V19, P5586; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; BJORKLUND A, 1984, CLASSICAL TRANSMIT 1, P55; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; BUTCHER LL, 1984, CLASSICAL TRANSMITTE, P1; CHANG HT, 1988, BRAIN RES BULL, V21, P295, DOI 10.1016/0361-9230(88)90244-4; Colquhoun L M, 1997, Adv Pharmacol, V39, P191, DOI 10.1016/S1054-3589(08)60072-1; Dalack GW, 1998, AM J PSYCHIAT, V155, P1490, DOI 10.1176/ajp.155.11.1490; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; Dani JA, 2001, NEURON, V31, P349, DOI 10.1016/S0896-6273(01)00379-8; Descarries L, 1997, PROG NEUROBIOL, V53, P603, DOI 10.1016/S0301-0082(97)00050-6; Di Chiara G, 2000, EUR J PHARMACOL, V393, P295, DOI 10.1016/S0014-2999(00)00122-9; Fenster CP, 1997, J NEUROSCI, V17, P5747; Garris PA, 1999, NATURE, V398, P67, DOI 10.1038/18019; Grace AA, 2000, BRAIN RES REV, V31, P330, DOI 10.1016/S0165-0173(99)00049-1; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; HENNINGFIELD JE, 1993, DRUG ALCOHOL DEPEN, V33, P23, DOI 10.1016/0376-8716(93)90030-T; HILL JA, 1993, J NEUROSCI, V13, P1551; HODGE AS, 1992, MOL PHARMACOL, V41, P937; Johnson JH, 2000, BRAIN RES BULL, V51, P249, DOI 10.1016/S0361-9230(99)00226-9; Jones IW, 2001, J COMP NEUROL, V439, P235, DOI 10.1002/cne.1345; Kalivas PW, 1999, CURR OPIN NEUROBIOL, V9, P223, DOI 10.1016/S0959-4388(99)80031-2; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; KOELLE GB, 1949, P SOC EXP BIOL MED, V70, P617; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Marshall DL, 1997, J NEUROCHEM, V68, P1511; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; PARSONS LH, 1992, J NEUROCHEM, V58, P212, DOI 10.1111/j.1471-4159.1992.tb09298.x; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; PRIOR C, 1992, GEN PHARMACOL, V23, P1017, DOI 10.1016/0306-3623(92)90280-W; Rezvani AH, 2001, BIOL PSYCHIAT, V49, P258, DOI 10.1016/S0006-3223(00)01094-5; SACAAN AI, 1995, J PHARMACOL EXP THER, V274, P224; SCHENK JO, 1982, BRAIN RES, V277, P1; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHWARTZ ML, 1993, J COMP NEUROL, V327, P48, DOI 10.1002/cne.903270105; SCHWARTZ RD, 1984, J NEUROCHEM, V42, P1495, DOI 10.1111/j.1471-4159.1984.tb02818.x; Vinson PN, 1997, J NEUROSCI METH, V73, P61, DOI 10.1016/S0165-0270(96)02213-3; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; Wu Y, 2000, NEUROSCIENCE, V96, P65, DOI 10.1016/S0306-4522(99)00539-4; Xu W, 1999, J NEUROSCI, V19, P9298	48	411	416	1	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1224	1229		10.1038/nn769	http://dx.doi.org/10.1038/nn769			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11713470				2022-12-17	WOS:000172525000019
J	Orenstein, SJ; Kuo, SH; Tasset, I; Arias, E; Koga, H; Fernandez-Carasa, I; Cortes, E; Honig, LS; Dauer, W; Consiglio, A; Raya, A; Sulzer, D; Cuervo, AM				Orenstein, Samantha J.; Kuo, Sheng-Han; Tasset, Inmaculada; Arias, Esperanza; Koga, Hiroshi; Fernandez-Carasa, Irene; Cortes, Etty; Honig, Lawrence S.; Dauer, William; Consiglio, Antonella; Raya, Angel; Sulzer, David; Cuervo, Ana Maria			Interplay of LRRK2 with chaperone-mediated autophagy	NATURE NEUROSCIENCE			English	Article							ALPHA-SYNUCLEIN; LYSOSOMAL DEGRADATION; PEPTIDE SEQUENCES; DISEASE; MUTANT; PROTEINS; LOCALIZATION; RECEPTOR; MICRODOMAINS; MUTATIONS	Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of familial Parkinson's disease. We found LRRK2 to be degraded in lysosomes by chaperone-mediated autophagy (CMA), whereas the most common pathogenic mutant form of LRRK2, G2019S, was poorly degraded by this pathway. In contrast to the behavior of typical CMA substrates, lysosomal binding of both wild-type and several pathogenic mutant LRRK2 proteins was enhanced in the presence of other CMA substrates, which interfered with the organization of the CMA translocation complex, resulting in defective CMA. Cells responded to such LRRK2-mediated CMA compromise by increasing levels of the CMA lysosomal receptor, as seen in neuronal cultures and brains of LRRK2 transgenic mice, induced pluripotent stem cell-derived dopaminergic neurons and brains of Parkinson's disease patients with LRRK2 mutations. This newly described LRRK2 self-perpetuating inhibitory effect on CMA could underlie toxicity in Parkinson's disease by compromising the degradation of alpha-synuclein, another Parkinson's disease-related protein degraded by this pathway.	[Orenstein, Samantha J.; Tasset, Inmaculada; Arias, Esperanza; Koga, Hiroshi; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Orenstein, Samantha J.; Tasset, Inmaculada; Arias, Esperanza; Koga, Hiroshi; Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Studies, Bronx, NY 10467 USA; [Kuo, Sheng-Han; Cortes, Etty; Honig, Lawrence S.; Sulzer, David] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA; [Fernandez-Carasa, Irene; Consiglio, Antonella] Univ Barcelona, Institute Biomed IBUB, Barcelona, Spain; [Cortes, Etty; Honig, Lawrence S.] Columbia Univ, Sch Med, Taub Inst, New York, NY USA; [Dauer, William] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Consiglio, Antonella] Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Raya, Angel] Inst Bioengn Catalonia IBEC, Control Stem Cell Potency Grp, Barcelona, Spain; [Raya, Angel] ICREA, Barcelona, Spain; [Raya, Angel] Ctr Networked Biomed Res Bioengn Biomat & Nanomed, Barcelona, Spain; [Sulzer, David] Columbia Univ, Dept Psychiat, Sch Med, New York, NY USA; [Sulzer, David] Columbia Univ, Dept Pharmacol, Med Ctr, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Columbia University; University of Barcelona; Columbia University; University of Michigan System; University of Michigan; University of Brescia; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; ICREA; Columbia University; Columbia University	Cuervo, AM (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA.	ds43@columbia.edu; ana-maria.cuervo@einstein.yu.edu	Cuevas, Inmaculada Tasset/R-4509-2019; Fernandez-Carasa, Irene/R-4421-2018; consiglio, antonella/G-1815-2016; consiglio, antonella/AAA-5864-2019; Raya, Angel/E-6205-2010	Cuevas, Inmaculada Tasset/0000-0003-0730-6750; Fernandez-Carasa, Irene/0000-0002-8195-3510; consiglio, antonella/0000-0002-3988-6254; consiglio, antonella/0000-0002-3988-6254; Raya, Angel/0000-0003-2189-9775; Cuervo, Ana Maria/0000-0002-0771-700X; Kuo, Sheng-Han/0000-0002-9412-931X; Arias, Esperanza/0000-0002-7836-5072; Dauer, William/0000-0003-1775-7504	US National Institutes of Health National Institute on Aging [AG031782, AG038072, AG08702, T32AG023475]; MINECO [SAF2012-33526, PLE2009-0144, ACI2010-1117, RyC-2008-02772, BFU2010-21823]; Beatrice and Roy Backus Foundation; Rainwaters Foundation; Robert and Renee Belfer gift; JPB Foundation; Parkinson's Disease Foundation; Fondazione Guido Berlucchi; CIBERNED Cooperative Project; US National Institute of Neurological Disorders and Stroke Udall Center of Excellence; Hirschl/Weill-Caulier Career Scientist Award; American Academy of Neurology Research Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS083738, P50NS038370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031782, P30AG038072, R37AG021904, P50AG008702, R01AG021904, T32AG023475] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	US National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MINECO(Spanish Government); Beatrice and Roy Backus Foundation; Rainwaters Foundation; Robert and Renee Belfer gift; JPB Foundation; Parkinson's Disease Foundation; Fondazione Guido Berlucchi; CIBERNED Cooperative Project; US National Institute of Neurological Disorders and Stroke Udall Center of Excellence; Hirschl/Weill-Caulier Career Scientist Award; American Academy of Neurology Research Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ICREA(ICREA)	We thank the Michael J. Fox Foundation for kindly providing some of the LRRK2 antibodies, C. Calatayud for help with neuronal differentiation of iPSC, D. Arduino and B. Caballero for their help with the generation of the LRRK2 knockdown cells, J.P. Vonsattel and R. Alcalay for assistance with human tissue and A. Diaz and B. Patel for technical assistance in several aspects of this work. This work was supported by grants from the US National Institutes of Health National Institute on Aging (AG031782 and AG038072 (A.M.C.) and AG08702 (Alzheimer's Disease Research Center at Columbia University)), MINECO (SAF2012-33526, PLE2009-0144 and ACI2010-1117 (A.R.); RyC-2008-02772 and BFU2010-21823 (A.C.)), the Beatrice and Roy Backus Foundation (A.M.C.), the Rainwaters Foundation (A.M.C.), a Robert and Renee Belfer gift (A.M.C.), the JPB Foundation (D.S.), the Parkinson's Disease Foundation (D.S. and S.-H.K.), Fondazione Guido Berlucchi (A.C.), a CIBERNED Cooperative Project (A.R.), a US National Institute of Neurological Disorders and Stroke Udall Center of Excellence (A.M.C. and D.S.) and a Hirschl/Weill-Caulier Career Scientist Award (A.M.C.). S.J.O. was supported by US National Institutes of Health National Institute on Aging training grant T32AG023475 and S.-H.K. by an American Academy of Neurology Research Fellowship.	Alegre-Abarrategui J, 2009, HUM MOL GENET, V18, P4022, DOI 10.1093/hmg/ddp346; Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneurol.2010.198; Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07; Berger Z, 2010, BIOCHEMISTRY-US, V49, P5511, DOI 10.1021/bi100157u; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; CHIANG HL, 1988, J BIOL CHEM, V263, P6797; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; CUERVO AM, 1994, J BIOL CHEM, V269, P26374; Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2003, EMBO J, V22, P47, DOI 10.1093/emboj/cdg002; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Cuervo AM, 2010, TRENDS ENDOCRIN MET, V21, P142, DOI 10.1016/j.tem.2009.10.003; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; Dodson MW, 2012, HUM MOL GENET, V21, P1350, DOI 10.1093/hmg/ddr573; Gomez-Suaga P, 2012, HUM MOL GENET, V21, P511, DOI 10.1093/hmg/ddr481; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kaushik S, 2006, EMBO J, V25, P3921, DOI 10.1038/sj.emboj.7601283; Kaushik S, 2009, METHOD ENZYMOL, V452, P297, DOI 10.1016/S0076-6879(08)03619-7; Kett LR, 2012, HUM MOL GENET, V21, P890, DOI 10.1093/hmg/ddr526; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Koga H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1393; Kon M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003182; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; LOWRY CC, 1951, AM J SURG, V81, P676, DOI 10.1016/0002-9610(51)90161-4; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Michael A.C., 2007, ELECTROCHEMICAL METH; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Orenstein SJ, 2010, SEMIN CELL DEV BIOL, V21, P719, DOI 10.1016/j.semcdb.2010.02.005; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Poulopoulos M, 2012, J MOL NEUROSCI, V47, P139, DOI 10.1007/s12031-011-9696-y; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Sulzer D, 2013, MOVEMENT DISORD, V28, P41, DOI 10.1002/mds.25095; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851; Zhu JH, 2003, BRAIN PATHOL, V13, P473	54	410	421	6	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					394	U52		10.1038/nn.3350	http://dx.doi.org/10.1038/nn.3350			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23455607	Green Accepted			2022-12-17	WOS:000316723700009
J	Fujisawa, S; Amarasingham, A; Harrison, MT; Buzsaki, G				Fujisawa, Shigeyoshi; Amarasingham, Asohan; Harrison, Matthew T.; Buzsaki, Gyoergy			Behavior-dependent short-term assembly dynamics in the medial prefrontal cortex	NATURE NEUROSCIENCE			English	Article							WORKING-MEMORY; GABAERGIC INTERNEURONS; FEEDFORWARD INHIBITION; SYNAPTIC PLASTICITY; UNIT-ACTIVITY; IN-VIVO; NEURONS; RAT; CELLS; HIPPOCAMPUS	Although short-term plasticity is believed to play a fundamental role in cortical computation, empirical evidence bearing on its role during behavior is scarce. Here we looked for the signature of short-term plasticity in the fine-timescale spiking relationships of a simultaneously recorded population of physiologically identified pyramidal cells and interneurons, in the medial prefrontal cortex of the rat, in a working memory task. On broader timescales, sequentially organized and transiently active neurons reliably differentiated between different trajectories of the rat in the maze. On finer timescales, putative monosynaptic interactions reflected short-term plasticity in their dynamic and predictable modulation across various aspects of the task, beyond a statistical accounting for the effect of the neurons' co-varying firing rates. Seeking potential mechanisms for such effects, we found evidence for both firing pattern-dependent facilitation and depression, as well as for a supralinear effect of presynaptic coincidence on the firing of postsynaptic targets.	[Fujisawa, Shigeyoshi; Amarasingham, Asohan; Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Harrison, Matthew T.] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Carnegie Mellon University	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	Fujisawa, Shigeyoshi/N-6439-2015	Fujisawa, Shigeyoshi/0000-0003-3963-4281; Buzsaki, Gyorgy/0000-0002-3100-4800	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064537, R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH054671, R01 MH054671-10, MH54671, MH064537, R01 MH064537] Funding Source: Medline; NINDS NIH HHS [R01 NS034994-11, NS34994, R01 NS034994] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; [Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Baeg EH, 2007, J NEUROSCI, V27, P909, DOI 10.1523/JNEUROSCI.4759-06.2007; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; BATUEV AS, 1990, BEHAV BRAIN RES, V41, P95, DOI 10.1016/0166-4328(90)90145-5; BEAULIEU C, 1993, BRAIN RES, V609, P284, DOI 10.1016/0006-8993(93)90884-P; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; EICHENBAUM H, 1983, EXP NEUROL, V79, P434, DOI 10.1016/0014-4886(83)90224-8; Euston DR, 2006, J NEUROSCI, V26, P13143, DOI 10.1523/JNEUROSCI.3803-06.2006; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Good PI, 2005, PERMUTATION PARAMETR; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hatsopoulos N, 2003, NEUROCOMPUTING, V52-4, P25, DOI 10.1016/S0925-2312(02)00773-7; Hempel CM, 2000, J NEUROPHYSIOL, V83, P3031, DOI 10.1152/jn.2000.83.5.3031; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Hirabayashi T, 2005, J NEUROSCI, V25, P10299, DOI 10.1523/JNEUROSCI.3036-05.2005; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jung MW, 1998, CEREB CORTEX, V8, P437, DOI 10.1093/cercor/8.5.437; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kargo WJ, 2007, J NEUROSCI, V27, P3548, DOI 10.1523/JNEUROSCI.3604-06.2007; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Marshall L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0001.2002; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; PERKEL DH, 1967, BIOPHYS J, V7, P391, DOI 10.1016/S0006-3495(67)86596-2; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Sussillo D, 2007, J NEUROPHYSIOL, V97, P4079, DOI 10.1152/jn.01357.2006; Swadlow HA, 2002, PHILOS T R SOC B, V357, P1717, DOI 10.1098/rstb.2002.1156; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Ventura V, 2005, J NEUROPHYSIOL, V94, P2928, DOI 10.1152/jn.00644.2004; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; Westfall P.H., 1993, RESAMPLING BASED MUL; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	50	410	412	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					823	833		10.1038/nn.2134	http://dx.doi.org/10.1038/nn.2134			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18516033	Green Accepted			2022-12-17	WOS:000257089400020
J	Fujisaki, W; Shimojo, S; Kashino, M; Nishida, S				Fujisaki, W; Shimojo, S; Kashino, M; Nishida, S			Recalibration of audiovisual simultaneity	NATURE NEUROSCIENCE			English	Article							VISUAL-MOTION PERCEPTION; TEMPORAL-ORDER JUDGMENT; MULTISENSORY INTEGRATION; AUDITORY LOCALIZATION; SUPERIOR COLLICULUS; SOUND LOCALIZATION; TIME; ADAPTATION; PLASTICITY; VISION	To perceive the auditory and visual aspects of a physical event as occurring simultaneously, the brain must adjust for differences between the two modalities in both physical transmission time and sensory processing time. One possible strategy to overcome this difficulty is to adaptively recalibrate the simultaneity point from daily experience of audiovisual events. Here we report that after exposure to a fixed audiovisual time lag for several minutes, human participants showed shifts in their subjective simultaneity responses toward that particular lag. This 'lag adaptation' also altered the temporal tuning of an auditory-induced visual illusion, suggesting that adaptation occurred via changes in sensory processing, rather than as a result of a cognitive shift while making task responses. Our findings suggest that the brain attempts to adjust subjective simultaneity across different modalities by detecting and reducing time lags between inputs that likely arise from the same physical events.	NTT Corp, NTT Commun Sci Labs, Kanagawa 2430198, Japan; CALTECH, Div Biol, Pasadena, CA 91125 USA	Nippon Telegraph & Telephone Corporation; California Institute of Technology	Nishida, S (corresponding author), NTT Corp, NTT Commun Sci Labs, 3-1 Morinosato Wakamiya, Kanagawa 2430198, Japan.	nishida@brl.ntt.co.jp	Fujisaki, Waka/N-6151-2016	Fujisaki, Waka/0000-0003-3844-5235				BARLOW H, 1989, COMP NEUR S, P54; BARLOW HB, 1963, NATURE, V200, P1345, DOI 10.1038/2001345a0; BENNETT RG, 1985, VISION RES, V25, P565, DOI 10.1016/0042-6989(85)90161-0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bushara KO, 2003, NAT NEUROSCI, V6, P190, DOI 10.1038/nn993; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; CANON LK, 1970, J EXP PSYCHOL, V84, P141, DOI 10.1037/h0028925; Corneil BD, 2002, J NEUROPHYSIOL, V88, P438, DOI 10.1152/jn.2002.88.1.438; Cunningham DW, 2001, J VISION, V1, P88, DOI 10.1167/1.2.3; Cunningham DW, 2001, PSYCHOL SCI, V12, P532, DOI 10.1111/1467-9280.00398; DENNETT DC, 1992, BEHAV BRAIN SCI, V15, P183, DOI 10.1017/S0140525X00068229; Dolezal H., 1982, LIVING WORLD TRANSFO; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; Foder J. A., 1983, MODULARITY MIND; James W., 1890, PRINCIPLES PSYCHOL, V2; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Kashino M, 1998, J ACOUST SOC AM, V103, P3597, DOI 10.1121/1.423064; KING AJ, 1985, EXP BRAIN RES, V60, P492; Kitagawa N, 2002, NATURE, V416, P172, DOI 10.1038/416172a; KNUDSEN EI, 1985, SCIENCE, V230, P545, DOI 10.1126/science.4048948; Lewald J, 2004, NEUROSCI LETT, V357, P119, DOI 10.1016/j.neulet.2003.12.045; Lu ZL, 2001, J OPT SOC AM A, V18, P2331, DOI 10.1364/JOSAA.18.002331; Mather G., 1998, MOTION AFTEREFFECT M; McAlpine D, 2003, TRENDS NEUROSCI, V26, P347, DOI 10.1016/S0166-2236(03)00140-1; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Nishida S, 2002, CURR BIOL, V12, P359, DOI 10.1016/S0960-9822(02)00698-X; Okada M, 2003, NEUROREPORT, V14, P261, DOI 10.1097/00001756-200302100-00021; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Poppel E., 1985, GRENZEN BEWUSSTSEINS; Recanzone GH, 2003, J NEUROPHYSIOL, V89, P1078, DOI 10.1152/jn.00706.2002; Recanzone GH, 1998, P NATL ACAD SCI USA, V95, P869, DOI 10.1073/pnas.95.3.869; Regan D., 1989, HUMAN BRAIN ELECTROP; Reichardt W, 1961, SENS COMMUN, P303; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Shimojo S, 2001, CURR OPIN NEUROBIOL, V11, P505, DOI 10.1016/S0959-4388(00)00241-5; Spence C, 2003, CURR BIOL, V13, pR519, DOI 10.1016/S0960-9822(03)00445-7; Spence C, 2001, J EXP PSYCHOL GEN, V130, P799, DOI 10.1037//0096-3445.130.4.799; Stone JV, 2001, P ROY SOC B-BIOL SCI, V268, P31, DOI 10.1098/rspb.2000.1326; Sugita Y, 2003, NATURE, V421, P911, DOI 10.1038/421911a; TAPPE T, 1994, PERCEPTION, V23, P335, DOI 10.1068/p230335; Watanabe K, 2001, PSYCHOL SCI, V12, P109, DOI 10.1111/1467-9280.00319; WATSON AB, 1979, VISION RES, V19, P515, DOI 10.1016/0042-6989(79)90136-6; Zwiers MP, 2003, NAT NEUROSCI, V6, P175, DOI 10.1038/nn999	44	410	419	2	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					773	778		10.1038/nn1268	http://dx.doi.org/10.1038/nn1268			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15195098				2022-12-17	WOS:000222274400020
J	Okun, M; Lampl, I				Okun, Michael; Lampl, Ilan			Instantaneous correlation of excitation and inhibition during ongoing and sensory-evoked activities	NATURE NEUROSCIENCE			English	Article							MEMBRANE-POTENTIAL DYNAMICS; AUDITORY-CORTEX; BARREL CORTEX; INFORMATION; NEURONS; SYSTEM; AWAKE	Temporal and quantitative relations between excitatory and inhibitory inputs in the cortex are central to its activity, yet they remain poorly understood. In particular, a controversy exists regarding the extent of correlation between cortical excitation and inhibition. Using simultaneous intracellular recordings in pairs of nearby neurons in vivo, we found that excitatory and inhibitory inputs are continuously synchronized and correlated in strength during spontaneous and sensory-evoked activities in the rat somatosensory cortex.	[Okun, Michael; Lampl, Ilan] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Lampl, I (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	ilan.lampl@weizmann.ac.il		Lampl, Ilan/0000-0002-9380-0730; Okun, Michael/0000-0002-7795-5513				Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; DeWeese MR, 2006, J NEUROSCI, V26, P12206, DOI 10.1523/JNEUROSCI.2813-06.2006; Deweese MR, 2004, J NEUROPHYSIOL, V92, P1840, DOI 10.1152/jn.00197.2004; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Las L, 2005, J NEUROSCI, V25, P1503, DOI 10.1523/JNEUROSCI.4007-04.2005; Lestienne R, 2001, PROG NEUROBIOL, V65, P545, DOI 10.1016/S0301-0082(01)00019-3; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Pinto DJ, 2003, CEREB CORTEX, V13, P33, DOI 10.1093/cercor/13.1.33; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116	15	408	416	3	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					535	537		10.1038/nn.2105	http://dx.doi.org/10.1038/nn.2105			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18376400				2022-12-17	WOS:000255327300009
J	Coricelli, G; Critchley, HD; Joffily, M; O'Doherty, JP; Sirigu, A; Dolan, RJ				Coricelli, G; Critchley, HD; Joffily, M; O'Doherty, JP; Sirigu, A; Dolan, RJ			Regret and its avoidance: a neuroimaging study of choice behavior	NATURE NEUROSCIENCE			English	Article							ROSTRAL ANTERIOR CINGULATE; ORBITOFRONTAL CORTEX; DECISION-MAKING; NEURAL RESPONSES; REWARD VALUE; ERROR; EMOTION; FMRI; DISAPPOINTMENT; PREDICTION	Human decisions can be shaped by predictions of emotions that ensue after choosing advantageously or disadvantageously. Indeed, anticipating regret is a powerful predictor of future choices. We measured brain activity using functional magnetic resonance imaging ( fMRI) while subjects selected between two gambles wherein regret was induced by providing information about the outcome of the unchosen gamble. Increasing regret enhanced activity in the medial orbitofrontal region, the anterior cingulate cortex and the hippocampus. Notably, across the experiment, subjects became increasingly regret-aversive, a cumulative effect reflected in enhanced activity within medial orbitofrontal cortex and amygdala. This pattern of activity reoccurred just before making a choice, suggesting that the same neural circuitry mediates direct experience of regret and its anticipation. These results demonstrate that medial orbitofrontal cortex modulates the gain of adaptive emotions in a manner that may provide a substrate for the influence of high-level emotions on decision making.	Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; CNRS, Inst Cognit Sci, Neuropsychol Grp, F-69675 Bron, France	University of London; University College London; Centre National de la Recherche Scientifique (CNRS)	Sirigu, A (corresponding author), Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	sirigu@isc.cnrs.fr; rdolan@fil.ion.ucl.ac.uk	O'Doherty, John P/F-1204-2013; Joffily, Mateus/H-7457-2017; Sirigu, Angela/L-4683-2017; critchley, hugo d/G-9267-2011	Joffily, Mateus/0000-0003-4073-4562; critchley, hugo d/0000-0002-2445-9284; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BELL DE, 1985, OPER RES, V33, P1, DOI 10.1287/opre.33.1.1; BELL DE, 1982, OPER RES, V30, P961, DOI 10.1287/opre.30.5.961; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Byrne RMJ, 2002, TRENDS COGN SCI, V6, P426, DOI 10.1016/S1364-6613(02)01974-5; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Cartei G, 1999, ANN ONCOL, V10, P57, DOI 10.1023/A:1008368624555; Corlett PR, 2004, NEURON, V44, P877, DOI 10.1016/j.neuron.2004.11.022; Critchley HD, 2005, NEUROIMAGE, V24, P751, DOI 10.1016/j.neuroimage.2004.10.013; Critchley HD, 2004, P NATL ACAD SCI USA, V101, P6333, DOI 10.1073/pnas.0401510101; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; DREHER JC, IN PRESS CEREB CORTE; Elliott R, 2003, J NEUROSCI, V23, P303; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Gobel SM, 2004, J COGNITIVE NEUROSCI, V16, P1536, DOI 10.1162/0898929042568442; Gottfried JA, 2004, NAT NEUROSCI, V7, P1145, DOI 10.1038/nn1314; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; KAHNEMAN D, 1986, PSYCHOL REV, V93, P136, DOI 10.1037/0033-295X.93.2.136; KAHNEMAN D, 1982, SCI AM, V246, P160, DOI 10.1038/scientificamerican0182-160; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1017/S0048577200990231; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lane RD, 1998, J COGNITIVE NEUROSCI, V10, P525, DOI 10.1162/089892998562924; LOOMES G, 1986, REV ECON STUD, V53, P271, DOI 10.2307/2297651; LOOMES G, 1982, ECON J, V92, P805, DOI 10.2307/2232669; Mellers B, 1999, J EXP PSYCHOL GEN, V128, P332, DOI 10.1037/0096-3445.128.3.332; Miceli M, 2002, THEOR PSYCHOL, V12, P335, DOI 10.1177/0959354302012003015; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Phan KL, 2003, NEUROPSYCHOPHARMACOL, V28, P1344, DOI 10.1038/sj.npp.1300186; ROESE NJ, 1995, WHAT MIGHT BEEN SOCI; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Zeelenberg M, 1996, ORGAN BEHAV HUM DEC, V65, P148, DOI 10.1006/obhd.1996.0013; ZEELENBERG M, 2005, PSYCHOL COUNTERFACTU, P147	46	408	422	4	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1255	1262		10.1038/nn1514	http://dx.doi.org/10.1038/nn1514			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116457				2022-12-17	WOS:000231483800027
J	Nery, S; Fishell, G; Corbin, JG				Nery, S; Fishell, G; Corbin, JG			The caudal ganglionic eminence is a source of distinct cortical and subcortical cell populations	NATURE NEUROSCIENCE			English	Article							IN-SITU HYBRIDIZATION; GABAERGIC NEURONS; BASAL FOREBRAIN; MAMMALIAN FOREBRAIN; PROJECTION NEURONS; CEREBRAL-CORTEX; HOMEOBOX GENE; TELENCEPHALON; MIGRATION; ORIGIN	During development, the mammalian ventral telencephalon is comprised of three major proliferative zones: the medial (MGE), lateral (LGE) and caudal (CGE) ganglionic eminences. Through gene expression studies, in vitro migration assays, genetic mutant analysis and in vivo fate mapping in mice, we found that the CGE is a progenitor region that is distinct from both the MGE and LGE. Notably, CGE cells showed a unique in vivo pattern of migration, and the CGE contributed cells to nuclei distinct from those populated by the MGE and LGE. Moreover, we report that the migratory fate of cells from the CGE is intrinsically determined by embryonic day 13.5 (E13.5). Together, these results provide the first insights into the development and fate of the CGE.	NYU, Med Ctr, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; NYU, Med Ctr, Skirball Inst Biomol Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	Fishell, G (corresponding author), NYU, Med Ctr, Skirball Inst Biomol Med, Dev Genet Program, 540 1st Ave, New York, NY 10016 USA.	fishell@saturn.med.nyu.edu	Nery, Susana Vaz/P-4518-2014	Fishell, Gordon/0000-0002-9640-9278; Vaz Nery, Susana/0000-0002-2399-7785	NINDS NIH HHS [NS10962-03, R01 NS39007-03] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039007] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2001, DEVELOPMENT, V128, P353; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Casarosa S, 1999, DEVELOPMENT, V126, P525; Corbin JG, 2000, DEVELOPMENT, V127, P5007; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; DEFELIPE J, 1993, CEREB CORTEX, V3, P273, DOI 10.1093/cercor/3.4.273; Deprimo SE, 1996, TRANSGENIC RES, V5, P459, DOI 10.1007/BF01980211; FENTRESS JC, 1981, ANAT EMBRYOL, V163, P275, DOI 10.1007/BF00315705; Gaiano N, 1999, NAT NEUROSCI, V2, P812, DOI 10.1038/12186; Garel S, 1999, DEVELOPMENT, V126, P5285; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; He WL, 2001, J NEUROSCI, V21, P8854, DOI 10.1523/JNEUROSCI.21-22-08854.2001; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Kim AS, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-05-j0002.2001; KUBOTA Y, 1994, BRAIN RES, V649, P159, DOI 10.1016/0006-8993(94)91060-X; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Marin O, 2000, J NEUROSCI, V20, P6063; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Martin J., 1989, NEUROANATOMY TEXT AT; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; Nery S, 2001, DEVELOPMENT, V128, P527; Olivier C, 2001, DEVELOPMENT, V128, P1757; Olsson M, 1998, NEUROSCIENCE, V84, P867, DOI 10.1016/S0306-4522(97)00532-0; OLSSON M, 1995, NEUROSCIENCE, V69, P1169, DOI 10.1016/0306-4522(95)00325-D; OUIMET CC, 1984, J NEUROSCI, V4, P111; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; Paxinos G, 1995, RAT NERVOUS SYSTEM; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; SMART IHM, 1979, NEOSTRIATUM, P127; Spassky N, 1998, J NEUROSCI, V18, P8331; Sussel L, 1999, DEVELOPMENT, V126, P3359; Szucsik JC, 1997, DEV BIOL, V191, P230, DOI 10.1006/dbio.1997.8733; Tamamaki N, 1997, J NEUROSCI, V17, P8313; Toresson H, 2000, DEVELOPMENT, V127, P4361; Toresson H, 1999, DEVELOPMENT, V126, P1317; Villegas EMP, 1999, DEV BIOL, V216, P98, DOI 10.1006/dbio.1999.9438; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Yun K, 2001, DEVELOPMENT, V128, P193	47	408	417	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1279	1287		10.1038/nn971	http://dx.doi.org/10.1038/nn971			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12411960				2022-12-17	WOS:000179447500010
J	D'Amelio, M; Cavallucci, V; Middei, S; Marchetti, C; Pacioni, S; Ferri, A; Diamantini, A; De Zio, D; Carrara, P; Battistini, L; Moreno, S; Bacci, A; Ammassari-Teule, M; Marie, H; Cecconi, F				D'Amelio, Marcello; Cavallucci, Virve; Middei, Silvia; Marchetti, Cristina; Pacioni, Simone; Ferri, Alberto; Diamantini, Adamo; De Zio, Daniela; Carrara, Paolo; Battistini, Luca; Moreno, Sandra; Bacci, Alberto; Ammassari-Teule, Martine; Marie, Helene; Cecconi, Francesco			Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease	NATURE NEUROSCIENCE			English	Article							MILD COGNITIVE IMPAIRMENT; AMYLOID-BETA PROTEIN; LONG-TERM DEPRESSION; DENDRITIC SPINE LOSS; A-BETA; TRANSGENIC MICE; CELL-DEATH; PRECURSOR PROTEIN; IN-VIVO; ACTIVATION	Synaptic loss is the best pathological correlate of the cognitive decline in Alzheimer's disease; however, the molecular mechanisms underlying synaptic failure are unknown. We found a non-apoptotic baseline caspase-3 activity in hippocampal dendritic spines and an enhancement of this activity at the onset of memory decline in the Tg2576-APPswe mouse model of Alzheimer's disease. In spines, caspase-3 activated calcineurin, which in turn triggered dephosphorylation and removal of the GluR1 subunit of AMPA-type receptor from postsynaptic sites. These molecular modifications led to alterations of glutamatergic synaptic transmission and plasticity and correlated with spine degeneration and a deficit in hippocampal-dependent memory. Notably, pharmacological inhibition of caspase-3 activity in Tg2576 mice rescued the observed Alzheimer-like phenotypes. Our results identify a previously unknown caspase-3-dependent mechanism that drives synaptic failure and contributes to cognitive dysfunction in Alzheimer's disease. These findings indicate that caspase-3 is a potential target for pharmacological therapy during early disease stages.	[D'Amelio, Marcello; Cavallucci, Virve; Cecconi, Francesco] Fdn Santa Lucia, IRCCS, Dulbecco Telethon Inst, Lab Mol Neuroembryol, Rome, Italy; [D'Amelio, Marcello] Univ Campus Biomed, Lab Mol Neurosci, Rome, Italy; [Middei, Silvia; Ammassari-Teule, Martine] Fdn Santa Lucia, IRCCS, CNR, Inst Neurosci, Rome, Italy; [Marchetti, Cristina; Marie, Helene] European Brain Res Inst, Lab Mol Mech Synapt Plast, Rome, Italy; [Pacioni, Simone; Bacci, Alberto] European Brain Res Inst, Lab Cellular Physiol Cort Microcircuits, Rome, Italy; [Ferri, Alberto] CNR, Inst Neurosci, Dept Psychobiol & Psychopharmacol, Rome, Italy; [Diamantini, Adamo; Battistini, Luca] Fdn Santa Lucia, IRCCS, Lab Neuroimmunol, Rome, Italy; [De Zio, Daniela; Cecconi, Francesco] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [Carrara, Paolo; Moreno, Sandra] Univ Roma Tre, Dept Biol Interdept, Lab Electron Microscopy LIME, Rome, Italy	Fondazione Telethon; Dulbecco Telethon Institute (DTI); IRCCS Santa Lucia; University Campus Bio-Medico - Rome Italy; Consiglio Nazionale delle Ricerche (CNR); IRCCS Santa Lucia; Consiglio Nazionale delle Ricerche (CNR); IRCCS Santa Lucia; University of Rome Tor Vergata; Roma Tre University	Cecconi, F (corresponding author), Fdn Santa Lucia, IRCCS, Dulbecco Telethon Inst, Lab Mol Neuroembryol, Rome, Italy.	francesco.cecconi@uniroma2.it	Cecconi, Francesco/K-3969-2016; Battistini, Luca/D-6920-2014; Marie, Hélène/F-1404-2011; Battistini, luca/ABE-1882-2021; Marchetti, Cristina/G-7220-2012; FERRI, ALBERTO/B-7660-2015; Moreno, Sandra/D-4254-2014	Cecconi, Francesco/0000-0002-5614-4359; Battistini, Luca/0000-0002-6488-4891; Marie, Hélène/0000-0003-2310-6097; FERRI, ALBERTO/0000-0002-4097-0605; Bacci, Alberto/0000-0002-3355-5892; D'Amelio, Marcello/0000-0001-6526-1832; Cavallucci, Virve/0000-0003-3082-6359; Ammassari-Teule, Martine/0000-0003-1987-5723; De Zio, Daniela/0000-0002-9454-402X; moreno, sandra/0000-0002-1079-3222; middei, silvia/0000-0002-0488-323X	Telethon Foundation; Italian Ministry of Health; Italian Ministry of University; Research and Compagnia di San Paolo	Telethon Foundation(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); Research and Compagnia di San Paolo(Compagnia di San Paolo)	We thank the Animal Facility of the IRCCS Fondazione Santa Lucia/EBRI/CNR for the mouse work, Taconic for the Tg2576 mice, M. Acuna-Villa and M.W. Bennett for editorial and secretarial work, R. Nardacci, F. Fanelli and M. Nencini for research assistance and help with image processing, and A. Roberto and A. Pignataro for help with Neurolucida measurements. We are grateful to E. Perez-Paya for providing us with the apoptosome inhibitor QM56. This work was supported in part by grants from the Telethon Foundation, Ricerca Corrente and Ricerca Finalizzata from the Italian Ministry of Health, the Italian Ministry of University and Research and Compagnia di San Paolo.	Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Bravarenko NI, 2006, EUR J NEUROSCI, V23, P129, DOI 10.1111/j.1460-9568.2005.04549.x; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; FERRER I, 1990, NEUROSCI LETT, V114, P11, DOI 10.1016/0304-3940(90)90420-E; Ferri A, 2000, J NEUROCHEM, V75, P606, DOI 10.1046/j.1471-4159.2000.0750606.x; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gylys KH, 2004, NEUROCHEM INT, V44, P125, DOI 10.1016/S0197-0186(03)00146-3; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Huesmann GR, 2006, NEURON, V52, P1061, DOI 10.1016/j.neuron.2006.10.033; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lajtha A, 2008, HDB NEUROCHEMISTRY M; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee I, 2004, HIPPOCAMPUS, V14, P301, DOI 10.1002/hipo.10177; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Louneva N, 2008, AM J PATHOL, V173, P1488, DOI 10.2353/ajpath.2008.080434; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Marin N, 2000, MECH AGEING DEV, V119, P63, DOI 10.1016/S0047-6374(00)00172-X; Mattson MP, 1998, EXP NEUROL, V153, P35, DOI 10.1006/exnr.1998.6863; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Mukerjee N, 2000, ARCH BIOCHEM BIOPHYS, V379, P337, DOI 10.1006/abbi.2000.1889; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Santamaria B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006634; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Stadelmann C, 1999, AM J PATHOL, V155, P1459, DOI 10.1016/S0002-9440(10)65460-0; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Vicent MJ, 2006, J MED CHEM, V49, P3763, DOI 10.1021/jm060458x; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Zhou YX, 2008, ALZHEIMERS DEMENT, V4, P265, DOI 10.1016/j.jalz.2008.04.006	50	407	416	0	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					69	U97		10.1038/nn.2709	http://dx.doi.org/10.1038/nn.2709			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21151119	Green Submitted			2022-12-17	WOS:000285684900016
J	Glowatzki, E; Fuchs, PA				Glowatzki, E; Fuchs, PA			Transmitter release at the hair cell ribbon synapse	NATURE NEUROSCIENCE			English	Article							EXCITATORY POSTSYNAPTIC CURRENTS; GUINEA-PIG COCHLEA; AUDITORY-NERVE; MOUSE COCHLEA; TRANSMISSION; FIBERS; POTENTIALS; ENDOCYTOSIS; EXOCYTOSIS; RECEPTORS	Neurotransmitters are released continuously at ribbon synapses in the retina and cochlea. Notably, a single ribbon synapse of inner hair cells provides the entire input to each cochlear afferent fiber. We investigated hair cell transmitter release in the postnatal rat cochlea by recording excitatory postsynaptic currents (EPSCs) from afferent boutons directly abutting the ribbon synapse. EPSCs were carried by rapidly gating AMPA receptors. EPSCs were clustered in time, indicating the possibility of coordinate release. Amplitude distributions of spontaneous EPSCs were highly skewed, peaking at 0.4 nS and ranging up to 20 times larger. Hair cell depolarization increased EPSC frequency up to 150 Hz without altering the amplitude distribution. We propose that the ribbon synapse operates by multivesicular release, possibly to achieve high-frequency transmission.	Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Ctr Hearing & Balance, Baltimore, MD 21205 USA	Johns Hopkins University	Glowatzki, E (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Ctr Hearing & Balance, Traylor 521,720 Rutland Ave, Baltimore, MD 21205 USA.			Glowatzki, Elisabeth/0000-0003-3135-658X	PHS HHS [00276] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Auger C, 1998, J NEUROSCI, V18, P4532; Auger C, 2000, J PHYSIOL-LONDON, V526, P3, DOI 10.1111/j.1469-7793.2000.t01-3-00003.x; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Beutner D, 2001, J NEUROSCI, V21, P4593, DOI 10.1523/JNEUROSCI.21-13-04593.2001; ECHTELER SM, 1992, P NATL ACAD SCI USA, V89, P6324, DOI 10.1073/pnas.89.14.6324; EMMERLING MR, 1990, J ELECTRON MICR TECH, V15, P123, DOI 10.1002/jemt.1060150205; Forti L, 1997, NATURE, V388, P874, DOI 10.1038/42251; FURUKAWA T, 1978, J PHYSIOL-LONDON, V276, P211, DOI 10.1113/jphysiol.1978.sp012229; GEISLER CD, 1998, FROM SOUND SYNAPSE, P177; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Isaacson JS, 1996, J NEUROPHYSIOL, V76, P1566, DOI 10.1152/jn.1996.76.3.1566; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Lenzi D, 1999, J NEUROSCI, V19, P119, DOI 10.1523/JNEUROSCI.19-01-00119.1999; LIBERMAN MC, 1982, SCIENCE, V216, P1239, DOI 10.1126/science.7079757; LIBERMAN MC, 1980, HEARING RES, V3, P45, DOI 10.1016/0378-5955(80)90007-6; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; Locke R, 1999, ANN NY ACAD SCI, V871, P35, DOI 10.1111/j.1749-6632.1999.tb09174.x; MAPLE BR, 1994, VISION RES, V34, P2357, DOI 10.1016/0042-6989(94)90281-X; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Muller M, 1996, HEARING RES, V94, P148, DOI 10.1016/0378-5955(95)00230-8; NAKAGAWA T, 1991, J NEUROPHYSIOL, V65, P715, DOI 10.1152/jn.1991.65.3.715; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Ottersen OP, 1998, PROG NEUROBIOL, V54, P127, DOI 10.1016/S0301-0082(97)00054-3; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; Puel JL, 1995, PROG NEUROBIOL, V47, P449, DOI 10.1016/0301-0082(95)00028-3; ROSSI ML, 1994, J PHYSIOL-LONDON, V478, P17, DOI 10.1113/jphysiol.1994.sp020227; Ruel J, 1999, J PHYSIOL-LONDON, V518, P667, DOI 10.1111/j.1469-7793.1999.0667p.x; Sahara Y, 2001, J PHYSIOL-LONDON, V536, P189, DOI 10.1111/j.1469-7793.2001.00189.x; SIEGEL JH, 1992, HEARING RES, V59, P85, DOI 10.1016/0378-5955(92)90105-V; SOBKOWICZ HM, 1982, J NEUROSCI, V2, P942; Spassova M, 2001, J PHYSIOL-LONDON, V535, P689, DOI 10.1111/j.1469-7793.2001.00689.x; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; UZIEL A, 1981, AUDIOLOGY, V20, P89; von Gersdorff H, 1999, ANNU REV PHYSIOL, V61, P725, DOI 10.1146/annurev.physiol.61.1.725; von Gersdorff H, 2001, NEURON, V29, P7, DOI 10.1016/S0896-6273(01)00175-1; ZHANG S, 1994, J PHYSIOL-LONDON, V480, P123, DOI 10.1113/jphysiol.1994.sp020346	41	407	421	0	42	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					147	154		10.1038/nn796	http://dx.doi.org/10.1038/nn796			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11802170				2022-12-17	WOS:000173558400017
J	Logothetis, NK; Guggenberger, H; Peled, S; Pauls, J				Logothetis, NK; Guggenberger, H; Peled, S; Pauls, J			Functional imaging of the monkey brain	NATURE NEUROSCIENCE			English	Article							HUMAN VISUAL-CORTEX; SOMATOSENSORY STIMULATION; SENSORY STIMULATION; ELECTRICAL-ACTIVITY; INTRINSIC SIGNALS; MRI; ACTIVATION; CONTRAST; FMRI; RAT	Functional magnetic resonance imaging (fMRI) has become an essential tool for studying human brain function. Here we describe the application of this technique to anesthetized monkeys. We present spatially resolved functional images of the monkey cortex based on blood oxygenation level dependent (BOLD) contrast. Checkerboard patterns or pictures of primates were used to study stimulus-induced activation of the visual cortex, in a 4.7-Tesla magnetic field, using optimized multi-slice, gradient-recalled, echo-planar imaging (EPI) sequences to image the entire brain. Under our anesthesia protocol, visual stimulation yielded robust, reproducible, focal activation of the lateral geniculate nucleus (LGN), the primary visual area (V1) and a number of extrastriate visual areas, including areas in the superior temporal sulcus. Similar responses were obtained in alert, behaving monkeys performing a discrimination task.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Univ Tubingen Hosp, Dept Anesthesiol, D-72076 Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Logothetis, NK (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	nikos.logothetis@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019; Peled, Sharon/ABD-7732-2021; Peled, Sharon/F-8590-2015					BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; BINDER JR, 1995, INT J IMAG SYST TECH, V6, P280, DOI 10.1002/ima.1850060219; Bock C, 1998, MAGNET RESON MED, V39, P457, DOI 10.1002/mrm.1910390316; Buckner RL, 1996, SEMIN NEUROSCI, V8, P47, DOI 10.1006/smns.1996.0007; Courtney SM, 1997, CURR OPIN NEUROBIOL, V7, P554, DOI 10.1016/S0959-4388(97)80036-0; CRYER PE, 1980, NEW ENGL J MED, V303, P436; DEYOE EA, 1994, J NEUROSCI METH, V54, P171, DOI 10.1016/0165-0270(94)90191-0; Donoho DL, 1995, J AM STAT ASSOC, V90, P1200, DOI 10.1080/01621459.1995.10476626; Dubowitz DJ, 1998, NEUROREPORT, V9, P2213, DOI 10.1097/00001756-199807130-00012; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; FOX PT, 1986, NATURE, V323, P806, DOI 10.1038/323806a0; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; FRAHM J, 1993, MAGNET RESON MED, V29, P139, DOI 10.1002/mrm.1910290126; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Gyngell ML, 1996, MAGNET RESON MED, V36, P13, DOI 10.1002/mrm.1910360104; HAASE A, 1986, J MAGN RESON, V67, P258, DOI 10.1016/0022-2364(86)90433-6; HOCHMANN J, 1980, J MAGN RESON, V38, P23, DOI 10.1016/0022-2364(80)90174-2; Hu XP, 1997, MAGNET RESON MED, V37, P877, DOI 10.1002/mrm.1910370612; Huang W, 1996, P NATL ACAD SCI USA, V93, P6037, DOI 10.1073/pnas.93.12.6037; Jezzard P, 1997, MAGNET RESON MED, V38, P699, DOI 10.1002/mrm.1910380504; Kindermann SS, 1997, SCHIZOPHR RES, V27, P143, DOI 10.1016/S0920-9964(97)00063-7; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; LEE JH, 1995, MAGN RESON MED, V34, P308, DOI 10.1002/mrm.1910340305; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; MANSFIELD P, 1977, J PHYS C SOLID STATE, V10, pL55, DOI 10.1088/0022-3719/10/3/004; MENON RS, 1992, INVEST RADIOL, V27, pS47, DOI 10.1097/00004424-199212002-00009; Menon RS, 1997, J NEUROPHYSIOL, V77, P2780, DOI 10.1152/jn.1997.77.5.2780; MENON RS, 1995, MAGNET RESON MED, V33, P453, DOI 10.1002/mrm.1910330323; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Posner MI, 1998, P NATL ACAD SCI USA, V95, P763, DOI 10.1073/pnas.95.3.763; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Stefanacci L, 1998, NEURON, V20, P1051, DOI 10.1016/S0896-6273(00)80485-7; TURNER R, 1993, MAGNET RESON MED, V29, P277, DOI 10.1002/mrm.1910290221; UGURBIL K, 1993, MAGN RESON QUART, V9, P259; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Yang XJ, 1996, P NATL ACAD SCI USA, V93, P475, DOI 10.1073/pnas.93.1.475; Yang XJ, 1997, MAGNET RESON MED, V38, P874, DOI 10.1002/mrm.1910380604	44	406	416	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					555	562		10.1038/9210	http://dx.doi.org/10.1038/9210			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273YA	10448221				2022-12-17	WOS:000084735900016
J	Brennan, AM; Suh, SW; Won, SJ; Narasimhan, P; Kauppinen, TM; Lee, H; Edling, Y; Chan, PH; Swanson, RA				Brennan, Angela M.; Suh, Sang Won; Won, Seok Joon; Narasimhan, Purnima; Kauppinen, Tiina M.; Lee, Hokyou; Edling, Ylva; Chan, Pak H.; Swanson, Raymond A.			NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; NEUTROPHIL RESPIRATORY BURST; CEREBELLAR GRANULE NEURONS; OXYGEN-FREE-RADICALS; CORTICAL-NEURONS; CELL-DEATH; GLUTAMATE EXCITOTOXICITY; CALCIUM-CONCENTRATION; OXIDATIVE STRESS; NITRIC-OXIDE	Neuronal NMDA receptor (NMDAR) activation leads to the formation of superoxide, which normally acts in cell signaling. With extensive NMDAR activation, the resulting superoxide production leads to neuronal death. It is widely held that NMDA-induced superoxide production originates from the mitochondria, but definitive evidence for this is lacking. We evaluated the role of the cytoplasmic enzyme NADPH oxidase in NMDA-induced superoxide production. Neurons in culture and in mouse hippocampus responded to NMDA with a rapid increase in superoxide production, followed by neuronal death. These events were blocked by the NADPH oxidase inhibitor apocynin and in neurons lacking the p47(phox) subunit, which is required for NADPH oxidase assembly. Superoxide production was also blocked by inhibiting the hexose monophosphate shunt, which regenerates the NADPH substrate, and by inhibiting protein kinase C zeta, which activates the NADPH oxidase complex. These findings identify NADPH oxidase as the primary source of NMDA-induced superoxide production.	[Brennan, Angela M.; Suh, Sang Won; Won, Seok Joon; Kauppinen, Tiina M.; Lee, Hokyou; Edling, Ylva; Swanson, Raymond A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Brennan, Angela M.; Suh, Sang Won; Won, Seok Joon; Kauppinen, Tiina M.; Lee, Hokyou; Edling, Ylva; Swanson, Raymond A.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Narasimhan, Purnima; Chan, Pak H.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Narasimhan, Purnima; Chan, Pak H.] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA; [Narasimhan, Purnima; Chan, Pak H.] Stanford Univ, Sch Med, Dept Neurol Sci, Stanford, CA 94305 USA; [Narasimhan, Purnima; Chan, Pak H.] Stanford Univ, Sch Med, Program Neurosci, Stanford, CA 94305 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Stanford University; Stanford University; Stanford University; Stanford University	Swanson, RA (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	Raymond.swanson@ucsf.edu	Kauppinen, Tiina/I-1009-2019	Kauppinen, Tiina/0000-0001-7219-9862; Swanson, Raymond/0000-0002-3664-5359	Department of Veterans Affairs Merit Review program; US National Institutes of Health [NS14543, NS051855]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS014543, P01NS014543, R01NS051855] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit Review program(US Department of Veterans Affairs); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Mochly-Rosen for advice with the TAT-conjugated peptides, C. Alano and C. Escartin for their careful reviews of the manuscript, and C. Hefner for technical assistance. This work was supported by the Department of Veterans Affairs Merit Review program (R. A. S.) and by the US National Institutes of Health (grants NS14543 to P. H. C. and NS051855 and NS051855 to R. A. S.).	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; AIZENMAN E, 1990, NEURON, V5, P841, DOI 10.1016/0896-6273(90)90343-E; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Atlante A, 1997, J NEUROCHEM, V68, P2038, DOI 10.1046/j.1471-4159.1997.68052038.x; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BENDSOE MP, 1985, OPTIM CONTR APPL MET, V6, P191, DOI 10.1002/oca.4660060302; Bey EA, 2004, J IMMUNOL, V173, P5730, DOI 10.4049/jimmunol.173.9.5730; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Brandes RP, 2005, HYPERTENSION, V45, P847, DOI 10.1161/01.HYP.0000165019.32059.b2; Bright R, 2004, J NEUROSCI, V24, P6880, DOI 10.1523/JNEUROSCI.4474-03.2004; Budd SL, 1996, J NEUROCHEM, V67, P2282; Chan PH, 1998, J NEUROSCI, V18, P8292, DOI 10.1523/jneurosci.18-20-08292.1998; CHENG Y, 1994, NEUROCHEM RES, V19, P1557, DOI 10.1007/BF00969006; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; Crisanti P, 2005, J NEUROCHEM, V93, P1587, DOI 10.1111/j.1471-4159.2005.03157.x; Dang PMC, 2001, J IMMUNOL, V166, P1206, DOI 10.4049/jimmunol.166.2.1206; Duan YT, 2007, J PHYSIOL-LONDON, V585, P741, DOI 10.1113/jphysiol.2007.145409; DUGAN LL, 1995, J NEUROSCI, V15, P6377; DYKENS JA, 1994, J NEUROCHEM, V63, P584; FAVARON M, 1990, P NATL ACAD SCI USA, V87, P1983, DOI 10.1073/pnas.87.5.1983; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Gupte SA, 2006, J MOL CELL CARDIOL, V41, P340, DOI 10.1016/j.yjmcc.2006.05.003; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hyrc K, 1997, J NEUROSCI, V17, P6669; Inanami O, 1998, J BIOL CHEM, V273, P9539, DOI 10.1074/jbc.273.16.9539; Johnson-Cadwell LI, 2007, J NEUROCHEM, V101, P1619, DOI 10.1111/j.1471-4159.2007.04516.x; Klann E, 1998, J NEUROPHYSIOL, V80, P452, DOI 10.1152/jn.1998.80.1.452; Koponen S, 2003, J NEUROCHEM, V86, P442, DOI 10.1046/j.1471-4159.2003.01846.x; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Lai B, 2005, EXP NEUROL, V194, P484, DOI 10.1016/j.expneurol.2005.03.005; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MacDonald John F., 2006, Critical Reviews in Neurobiology, V18, P71; Mandir AS, 2000, J NEUROSCI, V20, P8005; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5; Porasuphatana S, 2003, COMP BIOCHEM PHYS C, V134, P281, DOI 10.1016/S1532-0456(02)00271-5; Raineri I, 2001, FREE RADICAL BIO MED, V31, P1018, DOI 10.1016/S0891-5849(01)00686-4; REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Sacktor TC, 2008, PROG BRAIN RES, V169, P27, DOI 10.1016/S0079-6123(07)00002-7; STOLK J, 1994, AM J RESP CELL MOL, V11, P95, DOI 10.1165/ajrcmb.11.1.8018341; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2008, ANN NEUROL, V64, P654, DOI 10.1002/ana.21511; Tejada-Simon MV, 2005, MOL CELL NEUROSCI, V29, P97, DOI 10.1016/j.mcn.2005.01.007; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; White RJ, 1996, J NEUROSCI, V16, P5688; Ying WH, 2000, J CEREBR BLOOD F MET, V20, P359, DOI 10.1097/00004647-200002000-00018; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	49	404	420	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2009	12	7					857	U57		10.1038/nn.2334	http://dx.doi.org/10.1038/nn.2334			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	462OA	19503084	Green Accepted			2022-12-17	WOS:000267362900012
J	Doya, K				Doya, Kenji			Modulators of decision making	NATURE NEUROSCIENCE			English	Review							ORBITAL PREFRONTAL CORTEX; INTER-TEMPORAL CHOICE; NUCLEUS-ACCUMBENS CORE; IMPULSIVE-CHOICE; BASAL GANGLIA; ORBITOFRONTAL CORTEX; QUANTITATIVE-ANALYSIS; PROBABILISTIC REINFORCEMENT; CORTICOSTRIATAL SYNAPSES; COGNITIVE INFLEXIBILITY	Human and animal decisions are modulated by a variety of environmental and intrinsic contexts. Here I consider computational factors that can affect decision making and review anatomical structures and neurochemical systems that are related to contextual modulation of decision making. Expectation of a high reward can motivate a subject to go for an action despite a large cost, a decision that is influenced by dopamine in the anterior cingulate cortex. Uncertainty of action outcomes can promote risk taking and exploratory choices, in which norepinephrine and the orbitofrontal cortex appear to be involved. Predictable environments should facilitate consideration of longer-delayed rewards, which depends on serotonin in the dorsal striatum and dorsal prefrontal cortex. This article aims to sort out factors that affect the process of decision making from the viewpoint of reinforcement learning theory and to bridge between such computational needs and their neurophysiological substrates.	[Doya, Kenji] Okinawa Inst Sci & Technol, Neural Computat Unit, Okinawa 9042234, Japan; [Doya, Kenji] Computat Neurosci Labs, ATR, Kyoto 6190288, Japan	Okinawa Institute of Science & Technology Graduate University	Doya, K (corresponding author), Okinawa Inst Sci & Technol, Neural Computat Unit, 12-22 Suzaki, Okinawa 9042234, Japan.	doya@oist.jp	Doya, Kenji/B-5841-2015	Doya, Kenji/0000-0002-2446-6820				Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Balleine BW, 2005, PHYSIOL BEHAV, V86, P717, DOI 10.1016/j.physbeh.2005.08.061; BAUM WM, 1981, J EXP ANAL BEHAV, V36, P387, DOI 10.1901/jeab.1981.36-387; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Berns GS, 2007, TRENDS COGN SCI, V11, P482, DOI 10.1016/j.tics.2007.08.011; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Cardinal RN, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-37; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Cardinal RN, 2006, NEURAL NETWORKS, V19, P1277, DOI 10.1016/j.neunet.2006.03.004; Chamberlain SR, 2006, SCIENCE, V311, P861, DOI 10.1126/science.1121218; Clarke HF, 2007, CEREB CORTEX, V17, P18, DOI 10.1093/cercor/bhj120; Clarke HF, 2004, SCIENCE, V304, P878, DOI 10.1126/science.1094987; Corbit LH, 2003, BEHAV BRAIN RES, V146, P145, DOI 10.1016/j.bbr.2003.09.023; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Dayan P, 2006, NETWORK-COMP NEURAL, V17, P335, DOI 10.1080/09548980601004024; Denk F, 2005, PSYCHOPHARMACOLOGY, V179, P587, DOI 10.1007/s00213-004-2059-4; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Doya K., 2007, BAYESIAN BRAIN PROBA; Doya K, 2007, HFSP J, V1, P30, DOI [10.2976/1.2732246, 10.2976/1.2732246/10.2976/1]; Floresco SB, 2008, NEUROPSYCHOPHARMACOL, V33, P1966, DOI 10.1038/sj.npp.1301565; Hariri AR, 2006, J NEUROSCI, V26, P13213, DOI 10.1523/JNEUROSCI.3446-06.2006; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Ho MY, 1999, PSYCHOPHARMACOLOGY, V146, P362, DOI 10.1007/PL00005482; Ishii S, 2002, NEURAL NETWORKS, V15, P665, DOI 10.1016/S0893-6080(02)00056-4; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kakade S, 2002, PSYCHOL REV, V109, P533, DOI 10.1037//0033-295X.109.3.533; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kheramin S, 2004, PSYCHOPHARMACOLOGY, V175, P206, DOI 10.1007/s00213-004-1813-y; Kheramin S, 2005, BEHAV BRAIN RES, V156, P145, DOI 10.1016/j.bbr.2004.05.017; Kheramin S, 2002, PSYCHOPHARMACOLOGY, V165, P9, DOI 10.1007/s00213-002-1228-6; Komura Y, 2005, NAT NEUROSCI, V8, P1203, DOI 10.1038/nn1528; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Minamimoto T, 2005, SCIENCE, V308, P1798, DOI 10.1126/science.1109154; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Pasquereau B, 2007, J NEUROSCI, V27, P1176, DOI 10.1523/JNEUROSCI.3745-06.2007; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Pothuizen HHJ, 2005, EUR J NEUROSCI, V22, P2605, DOI 10.1111/j.1460-9568.2005.04388.x; Puterman M., 1994, MARKOV DECISION PROC, DOI [10.1002/9780470316887, DOI 10.1002/9780470316887]; RACHLIN H, 1991, J EXP ANAL BEHAV, V55, P233, DOI 10.1901/jeab.1991.55-233; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; Robinson ESJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1028, DOI 10.1038/sj.npp.1301487; Rogers RD, 1999, PSYCHOPHARMACOLOGY, V146, P482, DOI 10.1007/PL00005494; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Rogers RD, 2004, PSYCHOPHARMACOLOGY, V172, P157, DOI 10.1007/s00213-003-1641-5; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Rudebeck PH, 2006, NAT NEUROSCI, V9, P1161, DOI 10.1038/nn1756; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Schweighofer N, 2006, PLOS COMPUT BIOL, V2, P1349, DOI 10.1371/journal.pcbi.0020152; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Seymour B, 2007, J NEUROSCI, V27, P4826, DOI 10.1523/JNEUROSCI.0400-07.2007; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Tanaka SC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001333; Tanaka SC, 2006, NEURAL NETWORKS, V19, P1233, DOI 10.1016/j.neunet.2006.05.039; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; van der Plasse G, 2007, PSYCHOPHARMACOLOGY, V195, P435, DOI 10.1007/s00213-007-0917-6; van Gaalen MM, 2006, BIOL PSYCHIAT, V60, P66, DOI 10.1016/j.biopsych.2005.06.005; Walton ME, 2002, J NEUROSCI, V22, P10996; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Wickens JR, 1996, NEUROSCIENCE, V70, P1, DOI 10.1016/0306-4522(95)00436-M; Winstanley CA, 2004, NEUROPSYCHOPHARMACOL, V29, P1331, DOI 10.1038/sj.npp.1300434; Winstanley CA, 2006, CEREB CORTEX, V16, P106, DOI 10.1093/cercor/bhi088; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	88	404	408	0	148	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					410	416		10.1038/nn2077	http://dx.doi.org/10.1038/nn2077			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18368048				2022-12-17	WOS:000254359300010
J	Anagnostaras, SG; Murphy, GG; Hamilton, SE; Mitchell, SL; Rahnama, NP; Nathanson, NM; Silva, AJ				Anagnostaras, SG; Murphy, GG; Hamilton, SE; Mitchell, SL; Rahnama, NP; Nathanson, NM; Silva, AJ			Selective cognitive dysfunction in acetylcholine M-1 muscarinic receptor mutant mice	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; CONTEXTUAL FEAR; CHOLINERGIC MODULATION; RETROGRADE-AMNESIA; DORSAL HIPPOCAMPUS; RATS; SCOPOLAMINE; LESIONS; ACQUISITION; BRAIN	Blockade of cholinergic neurotransmission by muscarinic receptor antagonists produces profound deficits in attention and memory. However, the antagonists used in previous studies bind to more than one of the five muscarinic receptor subtypes. Here we examined memory in mice with a null mutation of the gene coding the M, receptor, the most densely distributed muscarinic receptor in the hippocampus and forebrain. In contrast with previous studies using nonselective pharmacological antagonists, the M-1 receptor deletion produced a selective phenotype that included both enhancements and deficits in memory. Long-term potentiation (LTP) in response to theta burst stimulation in the hippocampus was also reduced in mutant mice. M-1 null mutant mice showed normal or enhanced memory for tasks that involved matching-to-sample problems, but they were severely impaired in nonmatching-to-sample working memory as well as consolidation. Our results suggest that the M-1 receptor is specifically involved in memory processes for which the cortex and hippocampus interact.	Univ Calif Los Angeles, Inst Brain Res, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Dept Psychiat, Los Angeles, CA 90095 USA; Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; Ctr Behav Neurosci, Atlanta, GA 30322 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Emory University; University of Washington; University of Washington Seattle	Silva, AJ (corresponding author), Univ Calif Los Angeles, Inst Brain Res, Dept Neurobiol, 2554 Gonda Ctr,Box 951761, Los Angeles, CA 90095 USA.		Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Anagnostaras, Stephan/0000-0002-6906-1181; Nathanson, Neil/0000-0002-9216-121X; Silva, Alcino/0000-0001-5525-0494	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010932, R01NS026920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG005858, R01AG017499] Funding Source: NIH RePORTER; NIA NIH HHS [F32 AG5858, R01 AG17499] Funding Source: Medline; NINDS NIH HHS [F32 NS10932, R01 NS26920] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alreja M, 2000, J NEUROSCI, V20, P8103; Anagnostaras SG, 1999, NEUROPSYCHOPHARMACOL, V21, P731, DOI 10.1016/S0893-133X(99)00083-4; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Bussiere T, 2002, NEUROSCIENCE, V112, P75, DOI 10.1016/S0306-4522(02)00056-8; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cain DP, 1998, NEUROSCI BIOBEHAV R, V22, P181, DOI 10.1016/S0149-7634(97)00005-5; Caulfield MP, 1998, PHARMACOL REV, V50, P279; D'Esposito M, 1999, NEUROPSYCHOLOGIA, V37, P1303, DOI 10.1016/S0028-3932(99)00021-4; Dias R, 2000, EUR J NEUROSCI, V12, P4457, DOI 10.1046/j.0953-816X.2000.01323.x; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Fornari RV, 2000, LEARN MEMORY, V7, P287, DOI 10.1101/lm.34900; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Fransen E, 2002, J NEUROSCI, V22, P1081, DOI 10.1523/JNEUROSCI.22-03-01081.2002; Gale GD, 2001, HIPPOCAMPUS, V11, P371, DOI 10.1002/hipo.1051.abs; Gerber DJ, 2001, P NATL ACAD SCI USA, V98, P15312, DOI 10.1073/pnas.261583798; HAGEN JJ, 1986, BEHAV NEUROSCI, V100, P483; Hamilton SE, 2001, LIFE SCI, V68, P2489, DOI 10.1016/S0024-3205(01)01043-8; Hamilton SE, 2001, J BIOL CHEM, V276, P15850, DOI 10.1074/jbc.M011563200; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Konorski J., 1967, INTEGRATIVE ACTIVITY; LEVEY AI, 1991, J NEUROSCI, V11, P3218; LEVEY AI, 1995, J NEUROSCI, V15, P4077; LEVY A, 1983, BEHAV NEURAL BIOL, V39, P229, DOI 10.1016/S0163-1047(83)90893-2; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Maren S, 1998, TRENDS COGN SCI, V2, P39, DOI 10.1016/S1364-6613(98)01123-1; Marino MJ, 1998, P NATL ACAD SCI USA, V95, P11465, DOI 10.1073/pnas.95.19.11465; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; OLTON DS, 1972, PHYSIOL BEHAV, V9, P353, DOI 10.1016/0031-9384(72)90158-8; PHILLIPS RG, 1994, LEARN MEMORY, V1, P34; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rudy JW, 1996, NEUROBIOL LEARN MEM, V65, P73, DOI 10.1006/nlme.1996.0008; Shiozaki K, 2001, J NEUROL SCI, V193, P23, DOI 10.1016/S0022-510X(01)00638-4; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Wallenstein GV, 2001, NEUROBIOL LEARN MEM, V75, P245, DOI 10.1006/nlme.2001.4005; Wallis RM, 1999, LIFE SCI, V64, P395, DOI 10.1016/S0024-3205(98)00585-2; WEI J, 1994, J NEUROCHEM, V63, P815; WINSLOW JT, 1995, PSYCHOPHARMACOLOGY, V121, P164, DOI 10.1007/BF02245626	50	404	414	0	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					51	58		10.1038/nn992	http://dx.doi.org/10.1038/nn992			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12483218				2022-12-17	WOS:000180089300015
J	Chun, MM; Phelps, EA				Chun, MM; Phelps, EA			Memory deficits for implicit contextual information in amnesic subjects with hippocampal damage	NATURE NEUROSCIENCE			English	Article							EXPLICIT MEMORY; ASSOCIATIONS; MONKEYS; MODEL; DISSOCIATION; IMPAIRMENT; SYSTEMS	The role of the hippocampus and adjacent medial temporal lobe structures in memory systems has long been debated. Here we show in humans that these neural structures are important for encoding implicit contextual information from the environment. We used a contextual cuing task in which repeated visual context facilitates visual search for embedded target objects. An important feature of our task is that memory traces for contextual information were not accessible to conscious awareness, and hence could be classified as implicit. Amnesic patients with medial temporal system damage showed normal implicit perceptual/skill learning but were impaired on implicit contextual learning. Our results demonstrate that the human medial temporal memory system is important for learning contextual information, which requires the binding of multiple cues.	Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Yale University	Chun, MM (corresponding author), Vanderbilt Univ, Dept Psychol, 531 Wilson Hall, Nashville, TN 37240 USA.			Chun, Marvin/0000-0003-1070-7993	NIMH NIH HHS [MH50812] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH050812] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BIEDERMA.I, 1972, SCIENCE, V177, P77, DOI 10.1126/science.177.4043.77; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Cohen N.J., 1993, MEMORY AMNESIA HIPPO, DOI DOI 10.1136/JNNP.58.1.128-A; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; CORKIN S, 1968, NEUROPSYCHOLOGIA, V6, P255, DOI 10.1016/0028-3932(68)90024-9; Dore FY, 1998, HIPPOCAMPUS, V8, P323, DOI 10.1002/(SICI)1098-1063(1998)8:4<323::AID-HIPO2>3.0.CO;2-I; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; Gabrieli JDE, 1997, PSYCHOL SCI, V8, P326, DOI 10.1111/j.1467-9280.1997.tb00447.x; GAFFAN D, 1994, J COGNITIVE NEUROSCI, V6, P305, DOI 10.1162/jocn.1994.6.4.305; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P501, DOI 10.1037/0278-7393.11.3.501; HIRSH R, 1974, BEHAV BIOL, V12, P421, DOI 10.1016/S0091-6773(74)92231-7; Johnson Marcia K., 1994, P311; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; KNOWLTON BJ, 1992, PSYCHOL SCI, V3, P172, DOI 10.1111/j.1467-9280.1992.tb00021.x; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; MAYES AR, 1995, BEHAV BRAIN RES, V66, P29, DOI 10.1016/0166-4328(94)00120-5; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; MUSEN G, 1993, J EXP PSYCHOL LEARN, V19, P789, DOI 10.1037/0278-7393.19.4.789; Musen G., 1993, NEUROPSYCHOLOGY, V7, P119, DOI DOI 10.1037/0894-4105.7.2.119; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; SCHACTER DL, 1995, PSYCHOL SCI, V6, P20, DOI 10.1111/j.1467-9280.1995.tb00299.x; SCHACTER DL, 1987, J EXP PSYCHOL LEARN, V13, P501, DOI 10.1037/0278-7393.13.3.501; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SHIMAMURA AP, 1989, J EXP PSYCHOL LEARN, V15, P721, DOI 10.1037/0278-7393.15.4.721; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SQUIRE LR, 1993, ANNU REV PSYCHOL, V44, P453, DOI 10.1146/annurev.ps.44.020193.002321; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; SUTHERLAND RJ, 1989, PSYCHOBIOLOGY, V17, P129; TREISMAN A, 1992, AM J PSYCHOL, V105, P341, DOI 10.2307/1423032; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; WARRINGTON EK, 1968, NATURE, V217, P972, DOI 10.1038/217972a0; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419	34	404	410	2	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	1999	2	9					844	847		10.1038/12222	http://dx.doi.org/10.1038/12222			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	259FB	10461225				2022-12-17	WOS:000083882900017
J	Rice, ME; Cragg, SJ				Rice, ME; Cragg, SJ			Nicotine amplifies reward-related dopamine signals in striatum	NATURE NEUROSCIENCE			English	Article							BETA-2 SUBUNIT; RELEASE; NEURONS; RAT	Reward-seeking behaviors depend critically on dopamine signaling-dopamine neurons encode reward-related information by switching from tonic to phasic (burst-like) activity. Using guinea pig brain slices, we show that nicotine, like cocaine and amphetamine, acts directly in striatum where it enhances dopamine release during phasic but not tonic activity. This amplification provides a mechanism for nicotine facilitation of reward-related dopamine signals, including responses to other primary reinforcers that govern nicotine dependence in smokers.	Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA	University of Oxford; New York University	Cragg, SJ (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	cragg@pharm.ox.ac.uk		Cragg, Stephanie/0000-0001-9677-2256; Rice, Margaret/0000-0003-1793-2798				Caggiula AR, 2001, PHARMACOL BIOCHEM BE, V70, P515, DOI 10.1016/S0091-3057(01)00676-1; Cragg SJ, 2003, J NEUROSCI, V23, P4378; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; GRENHOFF J, 1986, ACTA PHYSIOL SCAND, V128, P351, DOI 10.1111/j.1748-1716.1986.tb07988.x; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Jones IW, 2001, J COMP NEUROL, V439, P235, DOI 10.1002/cne.1345; Mansvelder HD, 2002, NEURON, V33, P905, DOI 10.1016/S0896-6273(02)00625-6; NISELL M, 1994, PHARMACOL TOXICOL, V75, P348, DOI 10.1111/j.1600-0773.1994.tb00373.x; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; SCHULTZ W, 1986, J NEUROPHYSIOL, V56, P1439, DOI 10.1152/jn.1986.56.5.1439; Thomson AM, 2000, PROG NEUROBIOL, V62, P159, DOI 10.1016/S0301-0082(00)00008-3; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	15	403	406	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					583	584		10.1038/nn1244	http://dx.doi.org/10.1038/nn1244			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15146188				2022-12-17	WOS:000221640300009
J	Roche, KW; Standley, S; McCallum, J; Ly, CD; Ehlers, MD; Wenthold, RJ				Roche, KW; Standley, S; McCallum, J; Ly, CD; Ehlers, MD; Wenthold, RJ			Molecular determinants of NMDA receptor internalization	NATURE NEUROSCIENCE			English	Article							AMPA RECEPTORS; GLUTAMATE RECEPTORS; K+ CHANNELS; EXPRESSION; SUBUNITS; DISTINCT; ENDOCYTOSIS; PSD-95; REDISTRIBUTION; PROTEINS	Although synaptic AMPA receptors have been shown to rapidly internalize, synaptic NMDA receptors are reported to be static. It is not certain whether NMDA receptor stability at synaptic sites is an inherent property of the receptor, or is due to stabilization by scaffolding proteins. In this study, we demonstrate that NMDA receptors are internalized in both heterologous cells and neurons, and we define an internalization motif, YEKL, on the distal C-terminus of NR2B. In addition, we show that the synaptic protein PSD-95 inhibits NR2B-mediated internalization, and that deletion of the PDZ-binding domain of NR2B increases internalization in neurons. This suggests an involvement for PSD-95 in NMDA receptor regulation and an explanation for NMDA receptor stability at synaptic sites.	Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Bethesda, MD 20892 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Duke University	Roche, KW (corresponding author), Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Bldg 36,Room 5B25, Bethesda, MD 20892 USA.	rochek@nidcd.nih.gov	Roche, Katherine/W-9893-2019	Roche, Katherine/0000-0001-7282-6539	NINDS NIH HHS [R01-NS39402] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000003] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Craven SE, 2000, J BIOL CHEM, V275, P20045, DOI 10.1074/jbc.M910153199; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Hawkins LM, 1999, J BIOL CHEM, V274, P27211, DOI 10.1074/jbc.274.38.27211; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hsueh YP, 1998, PROG BRAIN RES, V116, P123, DOI 10.1016/S0079-6123(08)60434-3; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jugloff DGM, 2000, J BIOL CHEM, V275, P1357, DOI 10.1074/jbc.275.2.1357; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; Mammen AL, 1997, J NEUROSCI, V17, P7351; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Rao A, 1998, J NEUROSCI, V18, P1217; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Roche KW, 1999, J NEUROSCI, V19, P3926; ROCHE KW, 1995, NEUROSCIENCE, V69, P383, DOI 10.1016/0306-4522(95)00253-F; Rumbaugh G, 1999, J NEUROSCI, V19, P10603, DOI 10.1523/JNEUROSCI.19-24-10603.1999; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Takagi N, 2000, J NEUROCHEM, V74, P169, DOI 10.1046/j.1471-4159.2000.0740169.x; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; VICARIOABEJON C, 1997, CURRENT PROTOCOLS NE; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501	50	403	420	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2001	4	8					794	802		10.1038/90498	http://dx.doi.org/10.1038/90498			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	457KY	11477425				2022-12-17	WOS:000170137300012
J	Tucker, KL; Meyer, M; Barde, YA				Tucker, KL; Meyer, M; Barde, YA			Neurotrophins are required for nerve growth during development	NATURE NEUROSCIENCE			English	Article							SENSORY NEURONS; MICE LEADS; CELL-DEATH; EXPRESSION; NGF; SURVIVAL; GANGLIA; TRK; OVEREXPRESSION; INNERVATION	Although the requirement of neurotrophins for the prevention of cell death in the peripheral nervous system is well established, their physiological involvement in nerve growth is still unclear. To address this question, we generated a mouse that expresses the green fluorescent protein in post-mitotic neurons, allowing the repeated visualization of all motor and sensory axons during development. We imaged the growth of these axons into the limb bud of day 10.5 embryos. Sensory axons, but rarely motor axons, were targeted to ectopically placed beads containing any of the neurotrophins NGF, BDNF, NT-3 or NT-4/5. Conversely, a combination of function-blocking monoclonal antibodies to NGF, BDNF and NT-3 dramatically inhibited elongation of both sensory and motor axons in the limb bud, indicating that the growth of mixed nerves is dependent upon neurotrophins during development.	Max Planck Inst Neurobiol, Dept Neurobiochem, D-82152 Martinsried, Germany	Max Planck Society	Barde, YA (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	yves.barde@fmi.ch	Barde, Yves/F-6019-2011	Barde, Yves/0000-0002-7627-461X				ALBERS KM, 1994, J NEUROSCI, V14, P1422, DOI 10.1523/JNEUROSCI.14-03-01422.1994; Albers KM, 1996, J CELL BIOL, V134, P487, DOI 10.1083/jcb.134.2.487; BANDTLOW CE, 1987, EMBO J, V6, P891, DOI 10.1002/j.1460-2075.1987.tb04835.x; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; CHEN MGM, 1978, ARCH ITAL BIOL, V116, P53; COHEN S, 1954, P NATL ACAD SCI USA, V40, P1014, DOI 10.1073/pnas.40.10.1014; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; Dechant G, 1997, CURR OPIN NEUROBIOL, V7, P413, DOI 10.1016/S0959-4388(97)80071-2; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; EDWARDS RH, 1989, CELL, V58, P161, DOI 10.1016/0092-8674(89)90412-1; Elshamy WM, 1996, DEVELOPMENT, V122, P491; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Fagan AM, 1996, J NEUROSCI, V16, P6208; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; Frade JM, 1999, DEVELOPMENT, V126, P683; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; GAESE F, 1994, DEVELOPMENT, V120, P1613; Gallo G, 1997, J NEUROSCI, V17, P5445; GOTZ R, 1992, EUR J BIOCHEM, V204, P745, DOI 10.1111/j.1432-1033.1992.tb16689.x; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; HASSANKHANI A, 1995, DEV BIOL, V169, P309, DOI 10.1006/dbio.1995.1146; HOGAN B, 1994, MANIPULATING MOUSE E; Hotary KB, 1996, METHOD CELL BIOL, V51, P109, DOI 10.1016/S0091-679X(08)60625-1; HOYLE GW, 1993, NEURON, V10, P1019, DOI 10.1016/0896-6273(93)90051-R; KATZ LC, 1987, J NEUROSCI, V7, P1223; Kolbeck R, 1999, J NEUROCHEM, V72, P1930, DOI 10.1046/j.1471-4159.1999.0721930.x; KORSCHING S, 1987, METHOD ENZYMOL, V147, P167; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Maina F, 1997, GENE DEV, V11, P3341, DOI 10.1101/gad.11.24.3341; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; Ming GL, 1997, J NEUROSCI, V17, P7860; MOODY SA, 1989, J COMP NEUROL, V279, P567, DOI 10.1002/cne.902790406; MORRISKAY GM, 1993, ESSENTIAL DEV BIOL P, P55; NOSRAT CA, 1995, J COMP NEUROL, V360, P698, DOI 10.1002/cne.903600413; O'Connor R, 1999, NEURON, V24, P165, DOI 10.1016/S0896-6273(00)80830-2; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Phillips HS, 1996, PHILOS T ROY SOC B, V351, P413, DOI 10.1098/rstb.1996.0036; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Theiler K, 1972, HOUSE MOUSE DEV NORM; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; White FA, 1996, J NEUROSCI, V16, P4662; WRIGHT EM, 1992, NEURON, V9, P139, DOI 10.1016/0896-6273(92)90229-7; Xue Y, 1999, J COMP NEUROL, V408, P299, DOI 10.1002/(SICI)1096-9861(19990607)408:3<299::AID-CNE1>3.0.CO;2-N; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9	50	403	411	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2001	4	1					29	37		10.1038/82868	http://dx.doi.org/10.1038/82868			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UB	11135642				2022-12-17	WOS:000167178000011
J	Boemio, A; Fromm, S; Braun, A; Poeppel, D				Boemio, A; Fromm, S; Braun, A; Poeppel, D			Hierarchical and asymmetric temporal sensitivity in human auditory cortices	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; SPEECH-PERCEPTION; CORTEX; SOUNDS; FMRI; REPRESENTATIONS; INTEGRATION; TIME; IDENTIFICATION; ORGANIZATION	Lateralization of function in auditory cortex has remained a persistent puzzle. Previous studies using signals with differing spectrotemporal characteristics support a model in which the left hemisphere is more sensitive to temporal and the right more sensitive to spectral stimulus attributes. Here we use single-trial sparse-acquisition fMRI and a stimulus with parametrically varying segmental structure affecting primarily temporal properties. We show that both left and right auditory cortices are remarkably sensitive to temporal structure. Crucially, beyond bilateral sensitivity to timing information, we uncover two functionally significant interactions. First, local spectrotemporal signal structure is differentially processed in the superior temporal gyrus. Second, lateralized responses emerge in the higher-order superior temporal sulcus, where more slowly modulated signals preferentially drive the right hemisphere. The data support a model in which sounds are analyzed on two distinct timescales, 25-50 ms and 200-300 ms.	Univ Maryland, Dept Linguist, College Pk, MD 20742 USA; NIMH, Brain & Cognit Lab, NIH, Bethesda, MD 20892 USA; Natl Inst Deafness & Other Commun Disorders, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Poeppel, D (corresponding author), Univ Maryland, Dept Linguist, College Pk, MD 20742 USA.	dpoeppel@deans.umd.edu			NIDCD NIH HHS [R01 DC05660] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005660, ZIADC000031, Z01DC000031] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; DIVENYI PL, 1989, BRAIN LANG, V37, P290, DOI 10.1016/0093-934X(89)90020-5; Edmister WB, 1999, HUM BRAIN MAPP, V7, P89, DOI 10.1002/(SICI)1097-0193(1999)7:2<89::AID-HBM2>3.3.CO;2-E; Galuske RAW, 2000, SCIENCE, V289, P1946, DOI 10.1126/science.289.5486.1946; Gandour J, 2002, J COGNITIVE NEUROSCI, V14, P1076, DOI 10.1162/089892902320474526; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; Giraud AL, 2000, J NEUROPHYSIOL, V84, P1588, DOI 10.1152/jn.2000.84.3.1588; Griffiths TD, 1998, NAT NEUROSCI, V1, P422, DOI 10.1038/1637; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Hall DA, 2003, AUDIOL NEURO-OTOL, V8, P1, DOI 10.1159/000067894; Hall DA, 2002, CEREB CORTEX, V12, P140, DOI 10.1093/cercor/12.2.140; Harms MP, 2002, J NEUROPHYSIOL, V88, P1433, DOI 10.1152/jn.2002.88.3.1433; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Ivry RB, 1997, 2 SIDES PERCEPTION; Jancke L, 2002, NEUROIMAGE, V15, P733, DOI 10.1006/nimg.2001.1027; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Meyer M, 2002, HUM BRAIN MAPP, V17, P73, DOI 10.1002/hbm.10042; MOORE BCJ, 1993, HUMAN PSYCHOPHYSICS; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Palva S, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-04-j0003.2002; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; SCHWARTZ J, 1980, SCIENCE, V207, P1380, DOI 10.1126/science.7355297; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Shamma S, 2001, TRENDS COGN SCI, V5, P340, DOI 10.1016/S1364-6613(00)01704-6; Smith ZM, 2002, NATURE, V416, P87, DOI 10.1038/416087a; Stevens Kenneth, 1998, ACOUSTIC PHONETICS, V30; Sussman E, 1999, NEUROSCI LETT, V264, P161, DOI 10.1016/S0304-3940(99)00214-1; Wang XQ, 2003, SPEECH COMMUN, V41, P107, DOI 10.1016/S0167-6393(02)00097-3; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; WINKLER I, 1993, PERCEPT PSYCHOPHYS, V53, P443, DOI 10.3758/BF03206788; Yabe H, 2001, BRAIN RES, V897, P222, DOI 10.1016/S0006-8993(01)02224-7; YOST WA, 1991, HEARING RES, V56, P8, DOI 10.1016/0378-5955(91)90148-3; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; ZWISLOCKI J, 1960, J ACOUST SOC AM, V32, P1046, DOI 10.1121/1.1908276	39	402	408	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					389	395		10.1038/nn1409	http://dx.doi.org/10.1038/nn1409			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15723061				2022-12-17	WOS:000227354600025
J	Aston-Jones, G; Chen, S; Zhu, Y; Oshinsky, ML				Aston-Jones, G; Chen, S; Zhu, Y; Oshinsky, ML			A neural circuit for circadian regulation of arousal	NATURE NEUROSCIENCE			English	Article							NUCLEUS LOCUS-CERULEUS; SUPRACHIASMATIC NUCLEUS; EFFERENT PROJECTIONS; PSEUDORABIES VIRUS; COERULEUS; SLEEP; ACTIVATION; RAT; RETROGRADE; TRANSPORT	An unknown aspect of behavioral state regulation is how the circadian oscillator of the suprachiasmatic nucleus (SCN) regulates sleep and waking. In this report, we describe the necessary elements for a circuit that provides circadian regulation of arousal. Trans-synaptic retrograde tracing revealed a prominent indirect projection from the SCN to the noradrenergic nucleus locus coeruleus (LC), a brain arousal system. Double-labeling experiments revealed several possible links between the SCN and the LC, including the dorsomedial (DMH) and paraventricular hypothalamic nuclei (PVN), as well as medial and ventrolateral pre-optic areas. Lesion studies confirmed that the DMH is a substantial relay in this circuit. Next, neurophysiology experiments revealed circadian variations in LC impulse activity. Lesions of the DMH eliminated these circadian changes in LC activity, confirming the functionality of the SCN-DMH-LC circuit. These results reveal mechanisms for regulation of circadian and sleep-waking functions.	Univ Penn, Sch Med, Dept Psychiat, VAMC, Philadelphia, PA 19104 USA	University of Pennsylvania	Aston-Jones, G (corresponding author), Univ Penn, Sch Med, Dept Psychiat, VAMC, 151,Univ & Woodland Ave, Philadelphia, PA 19104 USA.	gaj@mail.med.upenn.edu		Oshinsky, Michael/0000-0002-0976-1047	NINDS NIH HHS [NS24698] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024698] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACHERMANN P, 1994, BIOL CYBERN, V71, P115, DOI 10.1007/BF00197314; AGHAJANIAN GK, 1975, BRAIN RES, V88, P221, DOI 10.1016/0006-8993(75)90386-8; Aston-Jones G, 2000, J NEUROSCI METH, V103, P51, DOI 10.1016/S0165-0270(00)00295-8; Aston-Jones G, 2000, PROG BRAIN RES, V126, P165; Aston-Jones Gary, 1995, P183; ASTONJONES G, 1986, SCIENCE, V234, P734, DOI 10.1126/science.3775363; ASTONJONES G, 1981, J NEUROSCI, V1, P876; BERNARDIS LL, 1985, BRAIN RES BULL, V14, P537, DOI 10.1016/0361-9230(85)90103-0; Bernardis LL, 1998, P SOC EXP BIOL MED, V218, P284; BERRIDGE CW, 1991, J NEUROSCI, V11, P3135; Berridge CW, 2000, NEUROSCIENCE, V99, P495, DOI 10.1016/S0306-4522(00)00215-3; Berry MW, 1999, COMPUT SCI ENG, V1, P16, DOI 10.1109/MCISE.1999.774836; Billig I, 1999, BRAIN RES, V820, P31, DOI 10.1016/S0006-8993(98)01320-1; Buijs RM, 1996, PROG BRAIN RES, V111, P229, DOI 10.1016/S0079-6123(08)60411-2; Card JP, 1998, J VIROL, V72, P4434, DOI 10.1128/JVI.72.5.4434-4441.1998; CARD JP, 1993, J NEUROSCI, V13, P2515, DOI 10.1523/JNEUROSCI.13-06-02515.1993; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chen S, 1999, BRAIN RES, V838, P171, DOI 10.1016/S0006-8993(99)01680-7; Chen S, 1996, NEUROSCIENCE, V71, P443, DOI 10.1016/0306-4522(95)00437-8; DEVAUGES V, 1991, BEHAV BRAIN RES, V43, P93, DOI 10.1016/S0166-4328(05)80056-7; EDGAR DM, 1993, J NEUROSCI, V13, P1065; ENNIS M, 1988, J NEUROSCI, V8, P3644; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; Gillette MU, 1999, RECENT PROG HORM RES, V54, P33; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; Horvath TL, 1999, J COMP NEUROL, V415, P145; Ivanov A, 2000, NEUROREPORT, V11, P1755, DOI 10.1097/00001756-200006050-00031; Jasmin L, 1997, J NEUROSCI, V17, P3751; Jodo E, 1998, NEUROSCIENCE, V83, P63, DOI 10.1016/S0306-4522(97)00372-2; Johnson M P, 1992, J Sleep Res, V1, P24; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; LOEWY AD, 1991, PROG BRAIN RES, V87, P253; LUPPI PH, 1995, NEUROSCIENCE, V65, P119, DOI 10.1016/0306-4522(94)00481-J; MORIN LP, 1994, NEUROSCIENCE, V61, P391, DOI 10.1016/0306-4522(94)90240-2; ODonnell P, 1997, J NEUROSCI, V17, P2143; Peyron C, 1998, J NEUROSCI, V18, P9996; Robbins Trevor W., 1995, P363; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; SEMBA J, 1984, SLEEP, V7, P211, DOI 10.1093/sleep/7.3.211; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260, DOI 10.1152/jn.1987.57.1.260; Swanson L., 1992, BRAIN MAPS STRUCTURE; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549; WATTS AG, 1987, J COMP NEUROL, V258, P204, DOI 10.1002/cne.902580204; WEITZMAN ED, 1981, ANNU REV NEUROSCI, V4, P381, DOI 10.1146/annurev.ne.04.030181.002121; Wirz-Justice A, 1999, BIOL PSYCHIAT, V46, P445, DOI 10.1016/S0006-3223(99)00125-0	48	402	411	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					732	738		10.1038/89522	http://dx.doi.org/10.1038/89522			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	448HK	11426230				2022-12-17	WOS:000169621300019
J	Spanswick, D; Smith, MA; Mirshamsi, S; Routh, VH; Ashford, MLJ				Spanswick, D; Smith, MA; Mirshamsi, S; Routh, VH; Ashford, MLJ			Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats	NATURE NEUROSCIENCE			English	Article							REDUCES FOOD-INTAKE; LEPTIN RECEPTOR; FATTY MUTATION; BODY-WEIGHT; ZUCKER RATS; EXPRESSION		Univ Aberdeen, Aberdeen Ctr Energy Regulat & Obes, Inst Med Sci, Dept Biomed Sci, Aberdeen AB25 2ZD, Scotland	University of Aberdeen	Ashford, MLJ (corresponding author), Univ Aberdeen, Aberdeen Ctr Energy Regulat & Obes, Inst Med Sci, Dept Biomed Sci, Aberdeen AB25 2ZD, Scotland.		Smith, Mark/K-5792-2017	Smith, Mark/0000-0003-1474-5225; Ashford, Michael/0000-0002-0861-7676				Anai M, 1998, DIABETES, V47, P13, DOI 10.2337/diabetes.47.1.13; ASHFORD MLJ, 1990, PFLUG ARCH EUR J PHY, V415, P479, DOI 10.1007/BF00373626; ASHFORD MLJ, 1990, BRIT J PHARMACOL, V101, P531, DOI 10.1111/j.1476-5381.1990.tb14116.x; Crouse JA, 1998, J BIOL CHEM, V273, P18365, DOI 10.1074/jbc.273.29.18365; da Silva BA, 1998, ENDOCRINOLOGY, V139, P3681, DOI 10.1210/en.139.9.3681; Harvey J, 2000, J BIOL CHEM, V275, P4660, DOI 10.1074/jbc.275.7.4660; IKEDA H, 1986, APPETITE, V7, P381, DOI 10.1016/S0195-6663(86)80006-X; Jiang ZY, 1999, J CLIN INVEST, V104, P447, DOI 10.1172/JCI5971; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; SCHWARTZ MW, 1992, ENDOCR REV, V13, P387, DOI 10.1210/er.13.3.387; Seeley RJ, 1996, HORM METAB RES, V28, P664, DOI 10.1055/s-2007-979874; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; White DW, 1997, P NATL ACAD SCI USA, V94, P10657, DOI 10.1073/pnas.94.20.10657; Yamashita T, 1997, DIABETES, V46, P1077, DOI 10.2337/diabetes.46.6.1077	15	402	430	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					757	758		10.1038/77660	http://dx.doi.org/10.1038/77660			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903566				2022-12-17	WOS:000167177300008
J	Huys, QJM; Maia, TV; Frank, MJ				Huys, Quentin J. M.; Maia, Tiago V.; Frank, Michael J.			Computational psychiatry as a bridge from neuroscience to clinical applications	NATURE NEUROSCIENCE			English	Review							ISPOT-D; ANTIDEPRESSANT TREATMENT; STRIATAL DOPAMINE; MENTAL-DISORDERS; NEURAL SYSTEMS; REINFORCEMENT; DEPRESSION; PREDICTION; ADDICTION; PATTERN	Translating advances in neuroscience into benefits for patients with mental illness presents enormous challenges because it involves both the most complex organ, the brain, and its interaction with a similarly complex environment. Dealing with such complexities demands powerful techniques. Computational psychiatry combines multiple levels and types of computation with multiple types of data in an effort to improve understanding, prediction and treatment of mental illness. Computational psychiatry, broadly defined, encompasses two complementary approaches: data driven and theory driven. Data-driven approaches apply machine-learning methods to high-dimensional data to improve classification of disease, predict treatment outcomes or improve treatment selection. These approaches are generally agnostic as to the underlying mechanisms. Theory-driven approaches, in contrast, use models that instantiate prior knowledge of, or explicit hypotheses about, such mechanisms, possibly at multiple levels of analysis and abstraction. We review recent advances in both approaches, with an emphasis on clinical applications, and highlight the utility of combining them.	[Huys, Quentin J. M.] Univ Zurich, Inst Biomed Engn, Translat Neuromodeling Unit, Zurich, Switzerland; [Huys, Quentin J. M.] Swiss Fed Inst Technol ETH Zuich, Zurich, Switzerland; [Huys, Quentin J. M.] Univ Zurich, Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Ctr Addict Disorders, Zurich, Switzerland; [Maia, Tiago V.] Univ Lisbon, Sch Med, P-1699 Lisbon, Portugal; [Maia, Tiago V.] Univ Lisbon, Inst Mol Med, P-1699 Lisbon, Portugal; [Frank, Michael J.] Brown Univ, Brown Inst Brain Sci Psychiat & Human Behav, Computat Brain & Mind, Providence, RI 02912 USA	University of Zurich; University of Zurich; Universidade de Lisboa; Universidade de Lisboa; Brown University	Huys, QJM (corresponding author), Univ Zurich, Inst Biomed Engn, Translat Neuromodeling Unit, Zurich, Switzerland.; Huys, QJM (corresponding author), Swiss Fed Inst Technol ETH Zuich, Zurich, Switzerland.; Huys, QJM (corresponding author), Univ Zurich, Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Ctr Addict Disorders, Zurich, Switzerland.	qhuys@cantab.net		Maia, Tiago/0000-0002-5254-0389; Frank, Michael/0000-0001-8451-0523	Swiss National Science Foundation [320030L_153449/1]; NSF [1460604]; NIMH [R01 MH080066-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080066] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NSF(National Science Foundation (NSF)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Q.J.M.H. was supported by a project grant from the Swiss National Science Foundation (320030L_153449/1) and M. F. by NSF grant 1460604 and NIMH R01 MH080066-01.	Abid MR, 2014, IEEE INT CONF COMP, P12, DOI 10.1109/CIVEMSA.2014.6841431; American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, V5th, DOI 10.1176/appi.books.9780890425596; Anderson I., 2010, DEPRESSION TREATMENT; Anticevic A, 2012, P NATL ACAD SCI USA, V109, P16720, DOI 10.1073/pnas.1208494109; Arns M, 2016, CLIN NEUROPHYSIOL, V127, P509, DOI 10.1016/j.clinph.2015.05.032; Arns M, 2015, EUR NEUROPSYCHOPHARM, V25, P1190, DOI 10.1016/j.euroneuro.2015.03.007; Borsboom D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027407; Boureau YL, 2015, TRENDS COGN SCI, V19, P700, DOI 10.1016/j.tics.2015.08.013; Bringmann LF, 2015, PSYCHOL MED, V45, P747, DOI 10.1017/S0033291714001809; Bringmann LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060188; Brodersen KH, 2014, NEUROIMAGE-CLIN, V4, P98, DOI 10.1016/j.nicl.2013.11.002; Browning M, 2015, NAT NEUROSCI, V18, P590, DOI 10.1038/nn.3961; Candy M, 2008, COCHRANE DB SYST REV; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Caspi A, 2014, CLIN PSYCHOL SCI, V2, P119, DOI 10.1177/2167702613497473; Cavanagh JF, 2011, NAT NEUROSCI, V14, P1462, DOI 10.1038/nn.2925; Chekroud AM, 2016, LANCET PSYCHIAT, V3, P243, DOI 10.1016/S2215-0366(15)00471-X; Collins AGE, 2014, PSYCHOL REV, V121, P337, DOI 10.1037/a0037015; Collins AGE, 2013, PSYCHOL REV, V120, P190, DOI 10.1037/a0030852; Costafreda SG, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-18; Cramer AOJ, 2010, BEHAV BRAIN SCI, V33, P137, DOI 10.1017/S0140525X09991567; Cunningham JP, 2014, NAT NEUROSCI, V17, P1500, DOI 10.1038/nn.3776; Cushman F, 2015, P NATL ACAD SCI USA, V112, P13817, DOI 10.1073/pnas.1506367112; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Daw N., 2009, DECISION MAKING AFFE, P1; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; DeBattista C, 2011, J PSYCHIATR RES, V45, P64, DOI 10.1016/j.jpsychires.2010.05.009; Deco G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000092; DeRubeis RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083875; Deserno L, 2015, P NATL ACAD SCI USA, V112, P1595, DOI 10.1073/pnas.1417219112; Dolan RJ, 2013, NEURON, V80, P312, DOI 10.1016/j.neuron.2013.09.007; Dunlop BW, 2012, J PSYCHIATR RES, V46, P708, DOI 10.1016/j.jpsychires.2012.03.002; Eshel N, 2015, NATURE, V525, P243, DOI 10.1038/nature14855; Etkin A, 2015, NAT REV NEUROSCI, V16, P693, DOI 10.1038/nrn4044; Etkin A, 2015, NEUROPSYCHOPHARMACOL, V40, P1332, DOI 10.1038/npp.2014.333; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fairburn CG, 2005, BEHAV RES THER, V43, P691, DOI 10.1016/j.brat.2004.06.011; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Frank M. J., 2015, INTRO MODEL BASED CO, P159; Frank MJ, 2015, J NEUROSCI, V35, P485, DOI 10.1523/JNEUROSCI.2036-14.2015; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Freedman R, 2013, AM J PSYCHIAT, V170, P1, DOI 10.1176/appi.ajp.2012.12091189; Friedel E, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00587; Garbusow M, 2016, ADDICT BIOL, V21, P719, DOI 10.1111/adb.12243; Gershman SJ, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00164; Gershman SJ, 2010, PSYCHOL REV, V117, P197, DOI 10.1037/a0017808; Gillan CM, 2015, AM J PSYCHIAT, V172, P284, DOI 10.1176/appi.ajp.2014.14040525; Gold JM, 2012, ARCH GEN PSYCHIAT, V69, P129, DOI 10.1001/archgenpsychiatry.2011.1269; Gordon E, 2015, NEUROPSYCH DIS TREAT, V11, P517, DOI 10.2147/NDT.S75975; Guitart-Masip M, 2012, NEUROIMAGE, V62, P154, DOI 10.1016/j.neuroimage.2012.04.024; Gurney KN, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002034; Hahn T, 2011, ARCH GEN PSYCHIAT, V68, P361, DOI 10.1001/archgenpsychiatry.2010.178; Harle KM, 2015, BRAIN, V138, DOI 10.1093/brain/awv246; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Horga G, 2015, HUM BRAIN MAPP, V36, P793, DOI 10.1002/hbm.22665; Huys Q. J. M., PSYCHOL MED IN PRESS; Huys QJM, 2015, CLIN PSYCHOL SCI, V3, P400, DOI 10.1177/2167702614562040; Huys QJM, 2015, ANNU REV NEUROSCI, V38, P1, DOI 10.1146/annurev-neuro-071714-033928; Huys QJM, 2015, P NATL ACAD SCI USA, V112, P3098, DOI 10.1073/pnas.1414219112; Huys QJM, 2014, PROG BRAIN RES, V211, P31, DOI 10.1016/B978-0-444-63425-2.00003-9; Huys QJM, 2013, BIOL MOOD ANXIETY DI, V3, DOI 10.1186/2045-5380-3-12; Huys QJM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002410; Huys QJM, 2011, NEURAL NETWORKS, V24, P544, DOI 10.1016/j.neunet.2011.03.001; Huys QJM, 2009, COGNITION, V113, P314, DOI 10.1016/j.cognition.2009.01.008; Hyman SE, 2010, ANNU REV CLIN PSYCHO, V6, P155, DOI 10.1146/annurev.clinpsy.3.022806.091532; Iacoviello BM, 2010, J ABNORM PSYCHOL, V119, P459, DOI 10.1037/a0020114; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Iosifescu DV, 2009, EUR NEUROPSYCHOPHARM, V19, P772, DOI 10.1016/j.euroneuro.2009.06.001; Iosifescu DV, 2011, HARVARD REV PSYCHIAT, V19, P144, DOI 10.3109/10673229.2011.586549; Kapur S, 2012, MOL PSYCHIATR, V17, P1174, DOI 10.1038/mp.2012.105; Keramati M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002055; Kessler RC, 1996, BRIT J PSYCHIAT, V168, P17, DOI 10.1192/S0007125000298371; Kessler RC, 1997, J AFFECT DISORDERS, V45, P19, DOI 10.1016/S0165-0327(97)00056-6; Khodayari-Rostamabad A, 2013, CLIN NEUROPHYSIOL, V124, P1975, DOI 10.1016/j.clinph.2013.04.010; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Kim J, 2016, NEUROIMAGE, V124, P127, DOI 10.1016/j.neuroimage.2015.05.018; Kohavi R., 1995, INT JOINT C ART INT, V14, P1137, DOI DOI 10.1067/MOD.2000.109031; Korgaonkar MS, 2015, EBIOMEDICINE, V2, P37, DOI 10.1016/j.ebiom.2014.12.002; Koutsouleris N, 2009, ARCH GEN PSYCHIAT, V66, P700, DOI 10.1001/archgenpsychiatry.2009.62; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Lesaint F, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003466; Leuchter A F, 1994, Neuroimage, V1, P208, DOI 10.1006/nimg.1994.1006; Lisman JE, 2008, TRENDS NEUROSCI, V31, P234, DOI 10.1016/j.tins.2008.02.005; Lubke GH, 2007, J AM ACAD CHILD PSY, V46, P1584, DOI 10.1097/chi.0b013e31815750dd; MacKay David JC, 2003, INFORM THEORY INFERE; MACKAY DJC, 1992, NEURAL COMPUT, V4, P415, DOI 10.1162/neco.1992.4.3.448; Maia TV, 2015, CLIN PSYCHOL SCI, V3, P460, DOI 10.1177/2167702614566809; Maia TV, 2015, CLIN PSYCHOL SCI, V3, P374, DOI 10.1177/2167702614567350; Maia TV, 2012, TRENDS COGN SCI, V16, P14, DOI 10.1016/j.tics.2011.11.011; Maia TV, 2011, NAT NEUROSCI, V14, P154, DOI 10.1038/nn.2723; Maia TV, 2009, COGN AFFECT BEHAV NE, V9, P343, DOI 10.3758/CABN.9.4.343; Maia TV, 2009, COGNITIVE SCI, V33, P1232, DOI 10.1111/j.1551-6709.2009.01054.x; Maroco Joao, 2011, BMC Res Notes, V4, P299, DOI 10.1186/1756-0500-4-299; Marr D., 1982, VISION; McGrath CL, 2013, JAMA PSYCHIAT, V70, P821, DOI 10.1001/jamapsychiatry.2013.143; Mennes M, 2013, NEUROIMAGE, V82, P683, DOI 10.1016/j.neuroimage.2012.10.064; Montague PR, 2012, TRENDS COGN SCI, V16, P72, DOI 10.1016/j.tics.2011.11.018; Murray JD, 2014, CEREB CORTEX, V24, P859, DOI 10.1093/cercor/bhs370; Mwangi B, 2014, NEUROINFORMATICS, V12, P229, DOI 10.1007/s12021-013-9204-3; Nelson A, 2006, J NEUROSCI, V26, P3805, DOI 10.1523/JNEUROSCI.4305-05.2006; Niculescu AB, 2015, MOL PSYCHIATR, V20, P1266, DOI 10.1038/mp.2015.112; Nutt DJ, 2015, NAT REV NEUROSCI, V16, P305, DOI 10.1038/nrn3939; Olbrich S, 2013, INT REV PSYCHIATR, V25, P604, DOI 10.3109/09540261.2013.816269; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Otto AR, 2013, P NATL ACAD SCI USA, V110, P20941, DOI 10.1073/pnas.1312011110; Otto AR, 2013, PSYCHOL SCI, V24, P751, DOI 10.1177/0956797612463080; Panlilio LV, 2007, PHARMACOL BIOCHEM BE, V86, P774, DOI 10.1016/j.pbb.2007.03.005; Peng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079476; Pereira Francisco, 2009, Neuroimage, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Rifkin R, 2004, J MACH LEARN RES, V5, P101; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; Roiser JP, 2009, PSYCHOL MED, V39, P199, DOI 10.1017/S0033291708003863; Ruiz FJR, 2014, J MACH LEARN RES, V15, P1215; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Sabuncu MR, 2015, NEUROINFORMATICS, V13, P31, DOI 10.1007/s12021-014-9238-1; Schad DJ, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01450; Schlagenhauf F, 2014, NEUROIMAGE, V89, P171, DOI 10.1016/j.neuroimage.2013.11.034; Schmaal L, 2015, BIOL PSYCHIAT, V78, P278, DOI 10.1016/j.biopsych.2014.11.018; Sebold M, 2014, NEUROPSYCHOBIOLOGY, V70, P122, DOI 10.1159/000362840; Segal ZV, 2010, ARCH GEN PSYCHIAT, V67, P1256, DOI 10.1001/archgenpsychiatry.2010.168; Shenoy P, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00048; Sjoerds Z, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.107; Solimando A, 2014, LECT NOTES COMPUT SC, V8797, P1, DOI 10.1007/978-3-319-11915-1_1; Stephan KE, 2016, LANCET PSYCHIAT, V3, P77, DOI 10.1016/S2215-0366(15)00361-2; Stephan KE, 2015, NEURON, V87, P716, DOI 10.1016/j.neuron.2015.07.008; Stephan KE, 2014, CURR OPIN NEUROBIOL, V25, P85, DOI 10.1016/j.conb.2013.12.007; Stringaris A, 2015, AM J PSYCHIAT, V172, P1215, DOI 10.1176/appi.ajp.2015.14101298; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Telford C, 2012, PSYCHOL MED, V42, P1119, DOI 10.1017/S0033291711002200; van de Leemput IA, 2014, P NATL ACAD SCI USA, V111, P87, DOI 10.1073/pnas.1312114110; van Dinteren R, 2015, EUR NEUROPSYCHOPHARM, V25, P1981, DOI 10.1016/j.euroneuro.2015.07.022; Voon V, 2015, MOL PSYCHIATR, V20, P345, DOI 10.1038/mp.2014.44; Wang XJ, 2014, NEURON, V84, P638, DOI 10.1016/j.neuron.2014.10.018; Watanabe T, 2014, NEUROIMAGE, V96, P183, DOI 10.1016/j.neuroimage.2014.03.067; Whelan R, 2014, NATURE, V512, P185, DOI 10.1038/nature13402; Whelan R, 2014, BIOL PSYCHIAT, V75, P746, DOI 10.1016/j.biopsych.2013.05.014; Wiecki T. V., PLOS ONE IN PRESS; Wiecki TV, 2015, CLIN PSYCHOL SCI, V3, P378, DOI 10.1177/2167702614565359; Wig GS, 2014, CEREB CORTEX, V24, P2036, DOI 10.1093/cercor/bht056; Wigman JTW, 2015, PSYCHOL MED, V45, P2375, DOI 10.1017/S0033291715000331; Williams LM, 2015, NEUROPSYCHOPHARMACOL, V40, P2398, DOI 10.1038/npp.2015.89; Williams LM, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-4; Wolfers T, 2015, NEUROSCI BIOBEHAV R, V57, P328, DOI 10.1016/j.neubiorev.2015.08.001; World Health Organization, 1990, INT CLASS DIS; Wunderlich K, 2012, NEURON, V75, P418, DOI 10.1016/j.neuron.2012.03.042	148	401	408	13	156	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2016	19	3					404	413		10.1038/nn.4238	http://dx.doi.org/10.1038/nn.4238			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DE7MU	26906507	Green Accepted			2022-12-17	WOS:000370822200009
J	Bale, TL; Epperson, CN				Bale, Tracy L.; Epperson, C. Neill			Sex differences and stress across the lifespan	NATURE NEUROSCIENCE			English	Review							CORTICOTROPIN-RELEASING-FACTOR; PITUITARY-ADRENAL AXIS; GLUCOCORTICOID-RECEPTOR SYSTEM; MESSENGER-RNA EXPRESSION; RAT LIMBIC BRAIN; PRENATAL STRESS; PSYCHOSOCIAL STRESS; GENE-EXPRESSION; GENDER-DIFFERENCES; ANXIETY DISORDERS	Sex differences in stress responses can be found at all stages of life and are related to both the organizational and activational effects of gonadal hormones and to genes on the sex chromosomes. As stress dysregulation is the most common feature across neuropsychiatric diseases, sex differences in how these pathways develop and mature may predict sex-specific periods of vulnerability to disruption and increased disease risk or resilience across the lifespan. The aging brain is also at risk to the effects of stress, where the rapid decline of gonadal hormones in women combined with cellular aging processes promote sex biases in stress dysregulation. In this Review, we discuss potential underlying mechanisms driving sex differences in stress responses and their relevance to disease. Although stress is involved in a much broader range of diseases than neuropsychiatric ones, we highlight here this area and its examples across the lifespan.	[Bale, Tracy L.; Epperson, C. Neill] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bale, Tracy L.] Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA; [Bale, Tracy L.; Epperson, C. Neill] Univ Penn, Penn Ctr Study Sex & Gender Hlth, Philadelphia, PA 19104 USA; [Epperson, C. Neill] Univ Penn, Dept Obstet & Gynecol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Bale, TL (corresponding author), Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA.	tbale@vet.upenn.edu	Epperson, Cynthia Neill/ABE-9424-2021		US National Institutes of Health [MH073030, MH091258, MH087597, MH104184, MH108286, MH099910, AG048839, DA030301]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091258, R37MH108286, P50MH099910, R01MH073030, R01MH087597, R33MH104184, R21MH104184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG048839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA030301, R01DA037289] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work discussed in this Review was Funded a part by US National Institutes of Health grants MH073030 (T.L.B.), MH091258 (T.L.B.), MH087597 (T.L.B.), MH104184 (T.L.B.), MH108286 (T.L.B.), MH099910 (C.N.E. and T.L.B.), AG048839 (C.N.E.), DA030301 (C.N.E.). We thank T. Tillakos for editorial assistance with the manuscript.	Ahmed EI, 2008, NAT NEUROSCI, V11, P995, DOI 10.1038/nn.2178; Albert K, 2015, PSYCHONEUROENDOCRINO, V59, P14, DOI 10.1016/j.psyneuen.2015.04.022; Amin Z, 2006, NEUROIMAGE, V32, P457, DOI 10.1016/j.neuroimage.2006.03.013; Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; Araujo AB, 2011, BEST PRACT RES CL EN, V25, P303, DOI 10.1016/j.beem.2010.11.004; Arborelius L, 1999, J ENDOCRINOL, V160, P1, DOI 10.1677/joe.0.1600001; Arnold AP, 2009, HORM BEHAV, V55, P570, DOI 10.1016/j.yhbeh.2009.03.011; Bale TL, 2015, NAT REV NEUROSCI, V16, P332, DOI 10.1038/nrn3818; Bale TL, 2011, STRESS, V14, P348, DOI 10.3109/10253890.2011.586447; Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028; Bangasser DA, 2014, FRONT NEUROENDOCRIN, V35, P303, DOI 10.1016/j.yfrne.2014.03.008; Barha CK, 2007, PHYSIOL BEHAV, V92, P939, DOI 10.1016/j.physbeh.2007.06.022; Barha CK, 2011, HIPPOCAMPUS, V21, P1216, DOI 10.1002/hipo.20829; Baron-Cohen S, 2015, MOL PSYCHIATR, V20, P369, DOI 10.1038/mp.2014.48; Bethea CL, 2010, MOL PSYCHIATR, V15, P1034, DOI 10.1038/mp.2009.78; Bethea CL, 2009, FRONT NEUROENDOCRIN, V30, P212, DOI 10.1016/j.yfrne.2009.04.003; Bethea CL, 2009, GENE EXPR PATTERNS, V9, P94, DOI 10.1016/j.gep.2008.10.002; Beversdorf DQ, 2005, J AUTISM DEV DISORD, V35, P471, DOI 10.1007/s10803-005-5037-8; Bingham B, 2008, ENDOCRINOLOGY, V149, P3581, DOI 10.1210/en.2007-1796; Bloss EB, 2013, NEUROBIOL AGING, V34, P200, DOI 10.1016/j.neurobiolaging.2012.05.014; Bowman RE, 2006, BRAIN RES, V1126, P156, DOI 10.1016/j.brainres.2006.07.047; Brunton PJ, 2010, J NEUROENDOCRINOL, V22, P258, DOI 10.1111/j.1365-2826.2010.01969.x; Brydges NM, 2014, HIPPOCAMPUS, V24, P684, DOI 10.1002/hipo.22259; Capel B, 1998, ANNU REV PHYSIOL, V60, P497, DOI 10.1146/annurev.physiol.60.1.497; CLARKE AS, 1993, DEV PSYCHOBIOL, V26, P293, DOI 10.1002/dev.420260506; Cottrell EC, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.019.2009; Cowell PE, 1996, AM J PSYCHIAT, V153, P799; Davis EP, 2014, PSYCHONEUROENDOCRINO, V49, P11, DOI 10.1016/j.psyneuen.2014.06.014; De Bellis MD, 2001, CEREB CORTEX, V11, P552, DOI 10.1093/cercor/11.6.552; Donner N, 2009, NEUROSCIENCE, V163, P705, DOI 10.1016/j.neuroscience.2009.06.046; Dumas JA, 2012, AM J GERIAT PSYCHIAT, V20, P734, DOI 10.1097/JGP.0b013e31825c0a14; Ege Margaret A, 2015, Am J Geriatr Psychiatry, V23, P110, DOI 10.1016/j.jagp.2014.08.014; Erskine HE, 2013, J CHILD PSYCHOL PSYC, V54, P1263, DOI 10.1111/jcpp.12144; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Freeman EW, 2014, JAMA PSYCHIAT, V71, P36, DOI 10.1001/jamapsychiatry.2013.2819; Freeman EW, 2006, ARCH GEN PSYCHIAT, V63, P375, DOI 10.1001/archpsyc.63.4.375; Freeman EW, 2004, ARCH GEN PSYCHIAT, V61, P62, DOI 10.1001/archpsyc.61.1.62; Galea LAN, 2001, BEHAV BRAIN RES, V122, P1, DOI 10.1016/S0166-4328(01)00170-X; Gerardin P, 2011, J CLIN PSYCHIAT, V72, P378, DOI 10.4088/JCP.09m05724blu; Gillespie CF, 2009, DEPRESS ANXIETY, V26, P984, DOI 10.1002/da.20605; Godar SC, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00071; Goel N, 2007, ENDOCRINOLOGY, V148, P4585, DOI 10.1210/en.2007-0479; Goel N, 2011, ENDOCRINOLOGY, V152, P2001, DOI 10.1210/en.2010-0964; Goel N, 2010, ENDOCRINOLOGY, V151, P1784, DOI 10.1210/en.2009-1180; Goel N, 2008, ENDOCRINOLOGY, V149, P6399, DOI 10.1210/en.2008-0433; Goldstein JM, 2013, AM J MED GENET B, V162, P698, DOI 10.1002/ajmg.b.32159; Goldstein JM, 2010, J NEUROSCI, V30, P431, DOI 10.1523/JNEUROSCI.3021-09.2010; Goldstein JM, 2002, ARCH GEN PSYCHIAT, V59, P154, DOI 10.1001/archpsyc.59.2.154; Gomez F, 2004, ENDOCRINOLOGY, V145, P59, DOI 10.1210/en.2003-0565; Gore AC, 2014, ENDOCR REV, V35, P961, DOI 10.1210/er.2013-1122; Gur RE, 2004, BIOL PSYCHIAT, V55, P512, DOI 10.1016/j.biopsych.2003.10.009; HANDA RJ, 1994, HORM BEHAV, V28, P464, DOI 10.1006/hbeh.1994.1044; Hanninen V, 1996, SOC SCI MED, V43, P1453, DOI 10.1016/0277-9536(96)00045-7; Harsh Veronica, 2007, Expert Rev Neurother, V7, pS7, DOI 10.1586/14737175.7.11s.S7; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Heim C, 1999, BIOL PSYCHIAT, V46, P1509, DOI 10.1016/S0006-3223(99)00224-3; Heim C, 2012, EXP NEUROL, V233, P102, DOI 10.1016/j.expneurol.2011.10.032; Heim C, 2010, DEV PSYCHOBIOL, V52, P671, DOI 10.1002/dev.20494; Heim C, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.041.2009; Hiroi R, 2006, BIOL PSYCHIAT, V60, P288, DOI 10.1016/j.biopsych.2005.10.019; Hong DS, 2014, J NEUROSCI, V34, P3509, DOI 10.1523/JNEUROSCI.2790-13.2014; Hong DS, 2014, SOC COGN AFFECT NEUR, V9, P255, DOI 10.1093/scan/nss133; Ivy AS, 2008, NEUROSCIENCE, V154, P1132, DOI 10.1016/j.neuroscience.2008.04.019; Ivy AS, 2010, J NEUROSCI, V30, P13005, DOI 10.1523/JNEUROSCI.1784-10.2010; Kajantie E, 2006, PSYCHONEUROENDOCRINO, V31, P151, DOI 10.1016/j.psyneuen.2005.07.002; Kapoor A, 2005, J PHYSIOL-LONDON, V566, P967, DOI 10.1113/jphysiol.2005.090191; Kapoor A, 2009, BEHAV BRAIN RES, V197, P144, DOI 10.1016/j.bbr.2008.08.018; Karatsoreos Ilia N, 2013, F1000Prime Rep, V5, P13, DOI 10.12703/P5-13; Kelly SD, 2014, PHYSIOL BEHAV, V126, P39, DOI 10.1016/j.physbeh.2013.12.002; Kendler KS, 2001, AM J PSYCHIAT, V158, P587, DOI 10.1176/appi.ajp.158.4.587; Kessler R.C., 2015, EPIDEMIOL PSYCHIAT S, P1, DOI [10.1017/s2045796015000189, DOI 10.10:17,/]; Kessler RC, 2003, J AFFECT DISORDERS, V74, P5, DOI 10.1016/S0165-0327(02)00426-3; Khan A, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00042; Khashan AS, 2008, ARCH GEN PSYCHIAT, V65, P146, DOI 10.1001/archgenpsychiatry.2007.20; Kim DR, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0546-9; Kirby LG, 2000, NEUROPSYCHOPHARMACOL, V22, P148, DOI 10.1016/S0893-133X(99)00093-7; Kornstein SG, 1997, J CLIN PSYCHIAT, V58, P12; Korosi A, 2010, J NEUROSCI, V30, P703, DOI 10.1523/JNEUROSCI.4214-09.2010; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P83, DOI 10.1016/S0306-4530(02)00146-4; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Lima FB, 2010, MOL PSYCHIATR, V15, P657, DOI 10.1038/mp.2009.97; Lombardo MV, 2012, J NEUROSCI, V32, P674, DOI 10.1523/JNEUROSCI.4389-11.2012; Lund TD, 2006, J NEUROSCI, V26, P1448, DOI 10.1523/JNEUROSCI.3777-05.2006; Lyons DM, 2010, DEV PSYCHOBIOL, V52, P616, DOI 10.1002/dev.20500; Lyons DM, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.032.2009; Maki PM, 2010, MENOPAUSE, V17, P815, DOI 10.1097/gme.0b013e3181d763d2; Martin EI, 2010, CLIN LAB MED, V30, P865, DOI 10.1016/j.cll.2010.07.006; McCarthy MM, 2013, J NEUROENDOCRINOL, V25, P1133, DOI 10.1111/jne.12072; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; McEwen BS, 2013, NEURON, V79, P16, DOI 10.1016/j.neuron.2013.06.028; McEwen BS, 2001, J APPL PHYSIOL, V91, P2785, DOI 10.1152/jappl.2001.91.6.2785; MEANEY MJ, 1985, DEV BRAIN RES, V18, P159, DOI 10.1016/0165-3806(85)90259-7; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; MEANEY MJ, 1993, ANN NY ACAD SCI, V697, P70, DOI 10.1111/j.1749-6632.1993.tb49924.x; Morgan CP, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-22; Morrison KE, 2014, NEUROSCIENCE, V264, P17, DOI 10.1016/j.neuroscience.2013.11.014; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Mueller BR, 2007, PHYSIOL BEHAV, V91, P55, DOI 10.1016/j.physbeh.2007.01.017; Mueller BR, 2006, PHYSIOL BEHAV, V88, P605, DOI 10.1016/j.physbeh.2006.05.019; Nemeroff Charles B, 2007, Expert Rev Neurother, V7, pS11, DOI 10.1586/14737175.7.11s.S11; Newhouse PA, 2010, MENOPAUSE, V17, P860, DOI 10.1097/gme.0b013e3181e15df4; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Nugent BM, 2015, NAT NEUROSCI, V18, P690, DOI 10.1038/nn.3988; Nuruddin S, 2013, PSYCHONEUROENDOCRINO, V38, P3115, DOI 10.1016/j.psyneuen.2013.09.011; O'Connor TG, 2002, BRIT J PSYCHIAT, V180, P502, DOI 10.1192/bjp.180.6.502; Otte C, 2005, PSYCHONEUROENDOCRINO, V30, P80, DOI 10.1016/j.psyneuen.2004.06.002; Pechtel P, 2014, NEUROIMAGE, V97, P236, DOI 10.1016/j.neuroimage.2014.04.025; Pembrey M, 2014, J MED GENET, V51, P563, DOI 10.1136/jmedgenet-2014-102577; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Plant TM, 2004, HUM REPROD UPDATE, V10, P67, DOI 10.1093/humupd/dmh001; Protopopescu X, 2005, P NATL ACAD SCI USA, V102, P16060, DOI 10.1073/pnas.0502818102; Putnam K, 2005, J CLIN ENDOCR METAB, V90, P4224, DOI 10.1210/jc.2004-2525; Rabinowitz J, 2006, SCHIZOPHR RES, V88, P96, DOI 10.1016/j.schres.2006.07.007; Rice CJ, 2008, ENDOCRINOLOGY, V149, P4892, DOI 10.1210/en.2008-0633; Richardson HN, 2006, ENDOCRINOLOGY, V147, P2506, DOI 10.1210/en.2005-1054; RIVIER C, 1983, NATURE, V305, P325, DOI 10.1038/305325a0; RIVIER C, 1985, FED PROC, V44, P189; Rodgers AB, 2015, BIOL PSYCHIAT, V78, P307, DOI 10.1016/j.biopsych.2015.03.018; Rohleder N, 2001, PSYCHOSOM MED, V63, P966, DOI 10.1097/00006842-200111000-00016; Romeo RD, 2003, J NEUROENDOCRINOL, V15, P1185, DOI 10.1111/j.1365-2826.2003.01106.x; Romeo RD, 2006, ANN NY ACAD SCI, V1094, P202, DOI 10.1196/annals.1376.022; Romeo RD, 2010, FRONT NEUROENDOCRIN, V31, P232, DOI 10.1016/j.yfrne.2010.02.004; Rose AB, 2004, ANN NY ACAD SCI, V1032, P231, DOI 10.1196/annals.1314.027; Rubinow DR, 2005, NEUROPSYCHOPHARMACOL, V30, P1906, DOI 10.1038/sj.npp.1300742; Ruta L, 2011, PSYCHONEUROENDOCRINO, V36, P1154, DOI 10.1016/j.psyneuen.2011.02.007; Sandman CA, 2013, J PSYCHOSOM RES, V75, P327, DOI 10.1016/j.jpsychores.2013.07.009; SAPOLSKY RM, 1985, DEV BRAIN RES, V18, P169, DOI 10.1016/0165-3806(85)90261-5; SAWCHENKO PE, 1993, CIBA F SYMP, V172, P5; Schmitt A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00019; Schmitt JE, 2014, P NATL ACAD SCI USA, V111, P6774, DOI 10.1073/pnas.1311630111; Schneider ML, 2002, PSYCHONEUROENDOCRINO, V27, P285, DOI 10.1016/S0306-4530(01)00050-6; Seeman TE, 2001, PSYCHONEUROENDOCRINO, V26, P225, DOI 10.1016/S0306-4530(00)00043-3; Shanmugan S, 2014, HUM BRAIN MAPP, V35, P847, DOI 10.1002/hbm.22218; Shively CA, 2006, ARCH GEN PSYCHIAT, V63, P396, DOI 10.1001/archpsyc.63.4.396; Stoffel EC, 2004, PHYSIOL BEHAV, V83, P505, DOI 10.1016/j.physbeh.2004.08.033; Suda S, 2008, BIOL PSYCHIAT, V64, P311, DOI 10.1016/j.biopsych.2008.03.029; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; van der Knaap LJ, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.22; van Os J, 1998, BRIT J PSYCHIAT, V172, P324, DOI 10.1192/bjp.172.4.324; Viau V, 2002, J NEUROENDOCRINOL, V14, P506, DOI 10.1046/j.1365-2826.2002.00798.x; WALKER CD, 1986, ENDOCRINOLOGY, V118, P1445, DOI 10.1210/endo-118-4-1445; Weinstock M, 2001, PROG NEUROBIOL, V65, P427, DOI 10.1016/S0301-0082(01)00018-1; Weiser MJ, 2009, NEUROSCIENCE, V159, P883, DOI 10.1016/j.neuroscience.2008.12.058; Weiser MJ, 2008, EXP NEUROL, V214, P62, DOI 10.1016/j.expneurol.2008.07.013; Woolley CS, 2007, ANNU REV PHARMACOL, V47, P657, DOI 10.1146/annurev.pharmtox.47.120505.105219	146	401	405	8	167	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2015	18	10					1413	1420		10.1038/nn.4112	http://dx.doi.org/10.1038/nn.4112			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CS2OK	26404716	Green Accepted			2022-12-17	WOS:000361910600010
J	Gray, PA; Janczewski, WA; Mellen, N; McCrimmon, DR; Feldman, JL				Gray, PA; Janczewski, WA; Mellen, N; McCrimmon, DR; Feldman, JL			Normal breathing requires preBotzinger complex neurokinin-1 receptor-expressing neurons	NATURE NEUROSCIENCE			English	Article							RESPIRATORY RHYTHM; SPINAL NEURONS; GENERATION; HYPOVENTILATION	The normal breathing rhythm in mammals is hypothesized to be generated by neurokinin-1 receptor(NK1R)-expressing neurons in the preBotzinger complex (preBotc), a medullary region proposed to contain the kernel of the circuits generating respiration. If this hypothesis is correct, then complete destruction of preBotC NK1R neurons should severely perturb and perhaps even fatally arrest breathing. Here we show that specific and near complete bilateral (but not unilateral) destruction of preBotC NK1R neurons results in both an ataxic breathing pattern with markedly altered blood gases and pH, and pathological responses to challenges such as hyperoxia, hypoxia and anesthesia. Thus, these similar to 600 neurons seem necessary for the generation of normal breathing in rats.	Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Interdepartmental PhD Program Neurosci, Los Angeles, CA 90095 USA; Northwestern Univ, Sch Med, Dept Physiol, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, NW Inst Neurosci, Chicago, IL 60611 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Northwestern University; Northwestern University	Feldman, JL (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Box 951763, Los Angeles, CA 90095 USA.	feldman@ucla.edu	feldman, jack/AAO-7505-2021; McCrimmon, Donald R/F-9271-2013	feldman, jack/0000-0003-3692-9412; McCrimmon, Donald/0000-0001-5339-6043	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040959] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL40959, R01 HL040959, R01 HL040959-12] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ballanyi K, 1999, PROG NEUROBIOL, V59, P583, DOI 10.1016/S0301-0082(99)00009-X; Champagnat J, 1997, TRENDS NEUROSCI, V20, P119, DOI 10.1016/S0166-2236(96)10078-3; DOBBINS EG, 1994, J COMP NEUROL, V347, P64, DOI 10.1002/cne.903470106; Gdovin MJ, 1999, COMP BIOCHEM PHYS A, V124, P275, DOI 10.1016/S1095-6433(99)00116-6; Gozal D, 1998, PEDIATR PULM, V26, P273; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Guilleminault C, 1996, NEUROL CLIN, V14, P611, DOI 10.1016/S0733-8619(05)70276-0; Guilleminault C, 1996, Curr Opin Pulm Med, V2, P492; Guyenet PG, 2001, J NEUROPHYSIOL, V86, P438, DOI 10.1152/jn.2001.86.1.438; Habre W, 1997, PAEDIATR ANAESTH, V7, P251, DOI 10.1046/j.1460-9592.1997.d01-65.x; Lieske SP, 2000, NAT NEUROSCI, V3, P600, DOI 10.1038/75776; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; MANTYH PW, 1995, SCIENCE, V268, P1629, DOI 10.1126/science.7539937; Maria BL, 1999, J CHILD NEUROL, V14, P583, DOI 10.1177/088307389901400906; McCrimmon DR, 2000, CLIN EXP PHARMACOL P, V27, P126, DOI 10.1046/j.1440-1681.2000.03193.x; NATTIE EE, 1975, AM REV RESPIR DIS, V112, P259; Rekling JC, 1998, ANNU REV PHYSIOL, V60, P385, DOI 10.1146/annurev.physiol.60.1.385; Remmers JE, 1999, LUNG BIOL HEALTH DIS, V135, P1; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; SPECK DF, 1982, J NEUROSCI, V2, P744; Thalhofer S, 1997, RESPIRATION, V64, P2; Wang H, 2001, J COMP NEUROL, V434, P128, DOI 10.1002/cne.1169	22	400	411	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					927	930		10.1038/nn0901-927	http://dx.doi.org/10.1038/nn0901-927			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528424	Green Accepted			2022-12-17	WOS:000170698600019
J	Jovicic, A; Mertens, J; Boeynaems, S; Bogaert, E; Chai, N; Yamada, SB; Paul, JW; Sun, SY; Herdy, JR; Bieri, G; Kramer, NJ; Gage, FH; Van den Bosch, L; Robberecht, W; Gitler, AD				Jovicic, Ana; Mertens, Jerome; Boeynaems, Steven; Bogaert, Elke; Chai, Noori; Yamada, Shizuka B.; Paul, Joseph W., III; Sun, Shuying; Herdy, Joseph R.; Bieri, Gregor; Kramer, Nicholas J.; Gage, Fred H.; Van den Bosch, Ludo; Robberecht, Wim; Gitler, Aaron D.			Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS	NATURE NEUROSCIENCE			English	Article							HEXANUCLEOTIDE REPEAT; RNA FOCI; PROTEINS; ALS; EXPANSIONS; PATHOLOGY	C9orf72 mutations are the most common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Dipeptide repeat proteins (DPRs) produced by unconventional translation of the C9orf72 repeat expansions cause neurodegeneration in cell culture and in animal models. We performed two unbiased screens in Saccharomyces cerevisiae and identified potent modifiers of DPR toxicity, including karyopherins and effectors of Ran-mediated nucleocytoplasmic transport, providing insight into potential disease mechanisms and therapeutic targets.	[Jovicic, Ana; Chai, Noori; Yamada, Shizuka B.; Paul, Joseph W., III; Bieri, Gregor; Kramer, Nicholas J.; Gitler, Aaron D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Mertens, Jerome; Herdy, Joseph R.; Gage, Fred H.] Salk Inst Biol Studies, Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA; [Boeynaems, Steven; Bogaert, Elke; Van den Bosch, Ludo; Robberecht, Wim] Univ Leuven, KU Leuven, Dept Neurosci, Expt Neurol, Leuven, Belgium; [Boeynaems, Steven; Bogaert, Elke; Van den Bosch, Ludo; Robberecht, Wim] Leuven Res Inst Neurosci & Dis LIND, Leuven, Belgium; [Boeynaems, Steven; Bogaert, Elke; Van den Bosch, Ludo; Robberecht, Wim] VIB, Vesalius Res Ctr, Neurobiol Lab, Leuven, Belgium; [Chai, Noori; Bieri, Gregor; Kramer, Nicholas J.] Stanford Univ, Sch Med, Neurosci Grad Program, Stanford, CA 94305 USA; [Yamada, Shizuka B.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Sun, Shuying] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Sun, Shuying] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Neurosci, La Jolla, CA 92093 USA; [Robberecht, Wim] Univ Hosp Leuven, Dept Neurol, Leuven, Belgium	Stanford University; Salk Institute; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Stanford University; Stanford University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; KU Leuven; University Hospital Leuven	Gitler, AD (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	agitler@stanford.edu	Mertens, Jerome/P-1931-2015	Mertens, Jerome/0000-0002-4291-4121; Gitler, Aaron/0000-0001-8603-1526; Van Den Bosch, Ludo/0000-0003-0104-4067; Boeynaems, Steven/0000-0003-3758-8410; Kramer, Nicholas/0000-0003-4557-8343; Boeynaems, Steven/0000-0002-9705-9871; Sun, Shuying/0000-0002-8449-7370	US National Institutes of Health (NIH) [NS069375]; NIH [1R01NS065317, 1R01NS073660, K99/R00, NS091538]; Packard Center for ALS Research at Johns Hopkins; Stanford University; Target ALS; Target ALS Springboard Fellowship; JPB Foundation; Helmsley Foundation; Mathers Foundation; KU Leuven; European Research Council (ERC) [340429]; Fund for Scientific Research Flanders (FWO-Vlaanderen) [G.0983.14N]; Interuniversity Attraction Poles Programme [P7/16]; Belgian Science Policy Office; Association Belge contre les Maladies Neuro-Musculaires (ABMM); ALS Liga (Belgium); Opening the Future fund; Agency for Innovation by Science and Technology IWT; FWO-Vlaanderen; E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065317, R01NS073660, R00NS091538, P30NS069375, K99NS091538] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Center for ALS Research at Johns Hopkins; Stanford University(Stanford University); Target ALS; Target ALS Springboard Fellowship; JPB Foundation; Helmsley Foundation; Mathers Foundation; KU Leuven(KU Leuven); European Research Council (ERC)(European Research Council (ERC)European Commission); Fund for Scientific Research Flanders (FWO-Vlaanderen)(FWO); Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Belgian Science Policy Office(Belgian Federal Science Policy Office); Association Belge contre les Maladies Neuro-Musculaires (ABMM); ALS Liga (Belgium); Opening the Future fund; Agency for Innovation by Science and Technology IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); FWO-Vlaanderen(FWO); E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Ravits and C. Lagier-Tourenne (University of California, San Diego) for sharing the control and C9orf72 ALS patient fibroblasts used in this study. We acknowledge microscopy assistance from the Stanford Neuroscience Microscopy Service, supported by US National Institutes of Health (NIH) grant NS069375. This work was supported by NIH grants 1R01NS065317 and 1R01NS073660 (A.D.G.). A.D.G. is supported by the Packard Center for ALS Research at Johns Hopkins and Target ALS. A. J. is supported by the Dean's Postdoctoral Fellowship from Stanford University. S.S. is a recipient of NIH K99/R00 Award (NS091538) and Target ALS Springboard Fellowship. J.M. and F.H.G. are supported by JPB Foundation, the Helmsley Foundation and the Mathers Foundation. Additional research funding was provided by the KU Leuven, the European Research Council in the context of the European's Seventh Framework Programme (FP7/2007-2013 and ERC grant agreement 340429), the Fund for Scientific Research Flanders (FWO-Vlaanderen) G.0983.14N, the Interuniversity Attraction Poles Programme P7/16 initiated by the Belgian Science Policy Office, the Association Belge contre les Maladies Neuro-Musculaires (ABMM), the ALS Liga (Belgium) and the Opening the Future fund. S.B. received a fellowship from the Agency for Innovation by Science and Technology IWT. E.B. holds a postdoctoral fellowship from FWO-Vlaanderen. W.R. is supported through the E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders.	Armakola M, 2012, NAT GENET, V44, P1302, DOI 10.1038/ng.2434; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Bardy C, 2015, P NATL ACAD SCI USA, V112, pE2725, DOI 10.1073/pnas.1504393112; Chew J, 2015, SCIENCE, V348, P1151, DOI 10.1126/science.aaa9344; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Hu YH, 2007, GENOME RES, V17, P536, DOI 10.1101/gr.6037607; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Krebber H, 1999, GENE DEV, V13, P1994, DOI 10.1101/gad.13.15.1994; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/NMETH.1972, 10.1038/nmeth.1972]; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; May S, 2014, ACTA NEUROPATHOL, V128, P485, DOI 10.1007/s00401-014-1329-4; Mertens J, 2013, AM J PATHOL, V182, P1769, DOI 10.1016/j.ajpath.2013.01.043; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Wen XM, 2014, NEURON, V84, P1213, DOI 10.1016/j.neuron.2014.12.010; Yamakawa M, 2015, HUM MOL GENET, V24, P1630, DOI 10.1093/hmg/ddu576; Zhang YJ, 2014, ACTA NEUROPATHOL, V128, P505, DOI 10.1007/s00401-014-1336-5; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110	27	399	402	1	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2015	18	9					1226	+		10.1038/nn.4085	http://dx.doi.org/10.1038/nn.4085			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CQ0NI	26308983	Green Accepted			2022-12-17	WOS:000360292600009
J	Hadjikhani, N; Liu, AK; Dale, AM; Cavanagh, P; Tootell, RBH				Hadjikhani, N; Liu, AK; Dale, AM; Cavanagh, P; Tootell, RBH			Retinotopy and color sensitivity in human visual cortical area V8	NATURE NEUROSCIENCE			English	Article							STRIATE CORTEX; CEREBRAL-ACHROMATOPSIA; FUNCTIONAL-ANATOMY; SELECTIVE CELLS; RHESUS-MONKEY; MACAQUE; ORGANIZATION; MT; ORIENTATION; PERCEPTION	Prior studies suggest the presence of a color-selective area in the inferior occipital-temporal region of human visual cortex. It has been proposed that this human area is homologous to macaque area V4, which is arguably color selective, but this has never been tested directly. To test this model, we compared the location of the human color-selective region to the retinotopic area boundaries in the same subjects, using functional magnetic resonance imaging (fMRI), cortical flattening and retinotopic mapping techniques. The human color-selective region did not match the location of area V4 (neither its dorsal nor ventral subdivisions), as extrapolated from macaque maps. Instead this region coincides with a new retinotopic area that we call 'V8', which includes a distinct representation of the fovea and both upper and lower visual fields. We also tested the response to stimuli that produce color afterimages and found that these stimuli, like real colors, caused preferential activation of V8 but not V4.	Massachusetts Gen Hosp, Nucl Magnet Resonance Ctr, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Hadjikhani, N (corresponding author), Massachusetts Gen Hosp, Nucl Magnet Resonance Ctr, 149 13th St, Charlestown, MA 02129 USA.	nouchine@nmr.mgh.harvard.edu	Hadjikhani, Nouchine/C-2018-2008; Dale, Anders M/A-5180-2010	Hadjikhani, Nouchine/0000-0003-4075-3106; 	NEI NIH HHS [EY07980, EY09258] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007980, R01EY009258] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; BRINDLEY GS, 1962, J PHYSIOL-LONDON, V164, P168, DOI 10.1113/jphysiol.1962.sp007011; Cornsweet T., 1970, VISUAL PERCEPTION; Cowey A, 1995, BEHAV BRAIN RES, V71, P89, DOI 10.1016/0166-4328(95)00046-1; Craik KJW, 1940, NATURE, V145, P512, DOI 10.1038/145512a0; DAMASIO A, 1980, NEUROLOGY, V30, P1064, DOI 10.1212/WNL.30.10.1064; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DEYOE EA, 1994, NATURE, V371, P151, DOI 10.1038/371151a0; DOW BM, 1974, J NEUROPHYSIOL, V37, P927, DOI 10.1152/jn.1974.37.5.927; Engel S, 1997, NATURE, V388, P68, DOI 10.1038/40398; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Galletti C, 1996, EUR J NEUROSCI, V8, P30, DOI 10.1111/j.1460-9568.1996.tb01165.x; Gegenfurtner KR, 1996, VISUAL NEUROSCI, V13, P161, DOI 10.1017/S0952523800007203; HEYWOOD CA, 1995, EUR J NEUROSCI, V7, P1064, DOI 10.1111/j.1460-9568.1995.tb01093.x; HEYWOOD CA, 1992, J NEUROSCI, V12, P4056; HUBEL DH, 1987, J NEUROSCI, V7, P3378; Jacobs GH, 1997, VISUAL NEUROSCI, V14, P921, DOI 10.1017/S0952523800011639; JAMESON D, 1979, P NATL ACAD SCI USA, V76, P3034, DOI 10.1073/pnas.76.6.3034; Judd D. B., 1975, COLOR BUSINESS SCI I, P388; KENNARD C, 1995, P ROY SOC B-BIOL SCI, V260, P169, DOI 10.1098/rspb.1995.0076; Kleinschmidt A, 1996, EXP BRAIN RES, V110, P279; LENNIE P, 1990, J NEUROSCI, V10, P649; LEVENTHAL AG, 1995, J NEUROSCI, V15, P1808, DOI 10.1523/JNEUROSCI.15-03-01808.1995; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; MAGUIRE WM, 1984, J NEUROSCI, V4, P1690; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; PEARLMAN AL, 1979, ANN NEUROL, V5, P253, DOI 10.1002/ana.410050307; SAKAI K, 1995, P ROY SOC B-BIOL SCI, V261, P89, DOI 10.1098/rspb.1995.0121; SCHEIN SJ, 1982, J NEUROPHYSIOL, V47, P193, DOI 10.1152/jn.1982.47.2.193; SCHILLER PH, 1994, VISUAL NEUROSCI, V11, P643, DOI 10.1017/S0952523800002960; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; TOOTELL RBH, 1989, J NEUROSCI, V9, P2620; TOOTELL RBH, 1988, J NEUROSCI, V8, P1569; Tootell RBH, 1996, TRENDS NEUROSCI, V19, P481, DOI 10.1016/S0166-2236(96)10053-9; TOOTELL RBH, 1995, CEREB CORTEX, V5, P39, DOI 10.1093/cercor/5.1.39; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; TOOTELL RBH, 1997, J NEUROSCI, V17, P7076; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; VANESSEN DC, 1981, J COMP NEUROL, V199, P293, DOI 10.1002/cne.901990302; ZEKI S, 1991, J NEUROSCI, V11, P641; Zeki S, 1996, P ROY SOC B-BIOL SCI, V263, P1539, DOI 10.1098/rspb.1996.0225; ZEKI S, 1983, PROC R SOC SER B-BIO, V217, P449, DOI 10.1098/rspb.1983.0020; ZEKI S, 1990, BRAIN, V113, P1721, DOI 10.1093/brain/113.6.1721; ZEKI SM, 1973, BRAIN RES, V53, P422, DOI 10.1016/0006-8993(73)90227-8; ZEKI SM, 1978, J PHYSIOL-LONDON, V277, P273, DOI 10.1113/jphysiol.1978.sp012272; ZEKI SM, 1977, PROC R SOC SER B-BIO, V197, P195, DOI 10.1098/rspb.1977.0065	50	399	408	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	1998	1	3					235	241		10.1038/681	http://dx.doi.org/10.1038/681			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QC	10195149				2022-12-17	WOS:000076361200015
J	Papadia, S; Soriano, FX; Leveille, F; Martel, MA; Dakin, KA; Hansen, HH; Kaindl, A; Sifringer, M; Fowler, J; Stefovska, V; Mckenzie, G; Craigon, M; Corriveau, R; Ghazal, P; Horsburgh, K; Yankner, BA; Wyllie, DJA; Ikonomidou, C; Hardingham, GE				Papadia, Sofia; Soriano, Francesc X.; Leveille, Frederic; Martel, Marc-Andre; Dakin, Kelly A.; Hansen, Henrik H.; Kaindl, Angela; Sifringer, Marco; Fowler, Jill; Stefovska, Vanya; Mckenzie, Grahame; Craigon, Marie; Corriveau, Roderick; Ghazal, Peter; Horsburgh, Karen; Yankner, Bruce A.; Wyllie, David J. A.; Ikonomidou, Chrysanthy; Hardingham, Giles E.			Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses	NATURE NEUROSCIENCE			English	Article							CYSTEINE-SULFINIC ACID; PROMOTES OXIDATIVE STRESS; CELL-DEATH; APOPTOTIC NEURODEGENERATION; ALZHEIMERS-DISEASE; RESPONSE ELEMENT; GENE-EXPRESSION; NEURONAL DEATH; THIOREDOXIN; PROTEIN	Intrinsic antioxidant defenses are important for neuronal longevity. We found that in rat neurons, synaptic activity, acting via NMDA receptor (NMDAR) signaling, boosted antioxidant defenses by making changes to the thioredoxin-peroxiredoxin (Prx) system. Synaptic activity enhanced thioredoxin activity, facilitated the reduction of overoxidized Prxs and promoted resistance to oxidative stress. Resistance was mediated by coordinated transcriptional changes; synaptic NMDAR activity inactivated a previously unknown Forkhead box O target gene, the thioredoxin inhibitor Txnip. Conversely, NMDAR blockade upregulated Txnip in vivo and in vitro, where it bound thioredoxin and promoted vulnerability to oxidative damage. Synaptic activity also upregulated the Prx reactivating genes Sesn2 (sestrin 2) and Srxn1 (sulfiredoxin), via C/EBP beta and AP-1, respectively. Mimicking these expression changes was sufficient to strengthen antioxidant defenses. Trans-synaptic stimulation of synaptic NMDARs was crucial for boosting antioxidant defenses; chronic bath activation of all (synaptic and extrasynaptic) NMDARs induced no antioxidative effects. Thus, synaptic NMDAR activity may influence the progression of pathological processes associated with oxidative damage.	[Papadia, Sofia; Soriano, Francesc X.; Leveille, Frederic; Martel, Marc-Andre; Fowler, Jill; Horsburgh, Karen; Wyllie, David J. A.; Hardingham, Giles E.] Univ Edinburgh, Neurosci Res Ctr, Edinburgh EH8 9XD, Midlothian, Scotland; [Dakin, Kelly A.; Yankner, Bruce A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Hansen, Henrik H.; Sifringer, Marco; Stefovska, Vanya; Ikonomidou, Chrysanthy] Tech Univ Dresden, Dept Pediat Neurol, D-01307 Dresden, Germany; [Kaindl, Angela] Charite, Dept Pediat Neurol, D-13353 Berlin, Germany; [Kaindl, Angela] Hop Robert Debre, Lab Neurol Dev, INSERM, U676, F-75019 Paris, France; [Mckenzie, Grahame] Hutchison MRC Res Ctr, MRC Canc Cell Unit, Cambridge CB2 0XZ, England; [Craigon, Marie; Ghazal, Peter] Univ Edinburgh, Div Pathway Med, Edinburgh EH16 4SB, Midlothian, Scotland; [Corriveau, Roderick] Coriell Inst Med Res, Camden, NJ 08103 USA; [Hardingham, Giles E.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland	University of Edinburgh; Harvard University; Harvard Medical School; Technische Universitat Dresden; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Edinburgh; Coriell Institute for Medical Research; University of Edinburgh	Hardingham, GE (corresponding author), Univ Edinburgh, Neurosci Res Ctr, Hugh Robson Bldg George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.	giles.hardingham@ed.ac.uk	Wyllie, David J A/AAK-4678-2021; Soriano, Francesc X/U-7552-2017	Wyllie, David J A/0000-0002-4957-6049; Soriano, Francesc X/0000-0003-1678-7162; Hardingham, Giles/0000-0002-7629-5314; Horsburgh, Karen/0000-0002-9620-3691; Kaindl, Angela/0000-0001-9454-206X; Ghazal, Peter/0000-0003-0035-2228	Biotechnology and Biological Sciences Research Council [BB/D011388/1] Funding Source: Medline; NIA NIH HHS [P30 AG010161, P30AG10161] Funding Source: Medline; Wellcome Trust [078178] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG010161] Funding Source: NIH RePORTER; BBSRC [BB/D011388/1] Funding Source: UKRI; Medical Research Council [G0700704B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Adams SM, 2004, J NEUROSCI, V24, P9441, DOI 10.1523/JNEUROSCI.3290-04.2004; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Boulos S, 2007, J NEUROSCI RES, V85, P3089, DOI 10.1002/jnr.21429; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chen HSV, 2006, J NEUROCHEM, V97, P1611, DOI 10.1111/j.1471-4159.2006.03991.x; ELNASR MS, 1990, EUR J PHARMACOL, V185, P19, DOI 10.1016/0014-2999(90)90206-L; Fang JG, 2007, P NATL ACAD SCI USA, V104, P18742, DOI 10.1073/pnas.0705904104; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hattori F, 2003, J NEUROCHEM, V86, P860, DOI 10.1046/j.1471-4159.2003.01918.x; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Jin MH, 2005, NEUROSCI LETT, V381, P252, DOI 10.1016/j.neulet.2005.02.048; Kapinya K, 2000, BRAIN RES, V872, P282, DOI 10.1016/S0006-8993(00)02503-8; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; Mennerick S, 2000, MOL NEUROBIOL, V22, P41; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nakayama K, 2005, J NEUROSCI, V25, P4040, DOI 10.1523/JNEUROSCI.4115-04.2005; Niehof M, 1997, MOL CELL BIOL, V17, P3600, DOI 10.1128/MCB.17.7.3600; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; Olive M, 1996, J BIOL CHEM, V271, P2040, DOI 10.1074/jbc.271.4.2040; Olney JW, 2002, BRAIN PATHOL, V12, P488, DOI 10.1111/j.1750-3639.2002.tb00467.x; Osada S, 1996, J BIOL CHEM, V271, P3891; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Papadia S, 2007, NEUROSCIENTIST, V13, P572, DOI 10.1177/1073858407305833; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; Rhee SG, 2007, KIDNEY INT, V72, pS3, DOI 10.1038/sj.ki.5002380; Sanchez-Font MF, 2003, CELL MOL LIFE SCI, V60, P1513, DOI 10.1007/s00018-003-3048-1; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Spires TL, 2005, FEBS J, V272, P2347, DOI 10.1111/j.1742-4658.2005.04677.x; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Tovar KR, 1999, J NEUROSCI, V19, P4180; WESEMANN W, 1982, ARZNEIMITTEL-FORSCH, V32-2, P1243; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yao J, 2007, MOL CELL NEUROSCI, V35, P377, DOI 10.1016/j.mcn.2007.03.013; Yoshida T, 2005, ANN NY ACAD SCI, V1055, P1, DOI 10.1196/annals.1323.002; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	50	398	411	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					476	487		10.1038/nn2071	http://dx.doi.org/10.1038/nn2071			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18344994	Green Accepted			2022-12-17	WOS:000254359300020
J	Kleim, JA; Chan, S; Pringle, E; Schallert, K; Procaccio, V; Jimenez, R; Cramer, SC				Kleim, Jeffrey A.; Chan, Sheila; Pringle, Erin; Schallert, Kellan; Procaccio, Vincent; Jimenez, Richard; Cramer, Steven C.			BDNF val66met polymorphism is associated with modified experience-dependent plasticity in human motor cortex	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN-MEMORY	Motor training can induce profound physiological plasticity within primary motor cortex, including changes in corticospinal output and motor map topography. Using transcranial magnetic stimulation, we show that training-dependent increases in the amplitude of motor-evoked potentials and motor map reorganization are reduced in healthy subjects with a val66met polymorphism in the brain-derived neurotrophic factor gene ( BDNF), as compared to subjects without the polymorphism. The results suggest that BDNF is involved in mediating experience-dependent plasticity of human motor cortex.	Malcorn Randall VA Hosp, Brain Res Rehabil Ctr, Gainesville, FL 32608 USA; Univ Florida, Dept Neurosci, Mcknight Brain Inst, Gainesville, FL 32610 USA; Univ Calif Irvine, Ctr Med, Dept Neurol, Orange, CA 92868 USA; Univ Calif Irvine, Ctr Med, Dept Anat & Neurobiol, Orange, CA 92868 USA; Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA	State University System of Florida; University of Florida; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Kleim, JA (corresponding author), Malcorn Randall VA Hosp, Brain Res Rehabil Ctr, 1601 SW Archer Rd, Gainesville, FL 32608 USA.	jkleim@ufl.edu		procaccio, Vincent/0000-0002-1537-4684	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T35NS045563] Funding Source: NIH RePORTER; NCRR NIH HHS [5M01RR 00827-29] Funding Source: Medline; NINDS NIH HHS [NS-45563] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Dempster E, 2005, AM J MED GENET B, V134B, P73, DOI 10.1002/ajmg.b.30150; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Kleim JA, 2003, NEUROCHEM RES, V28, P1757, DOI 10.1023/A:1026025408742; Klintsova AY, 2004, BRAIN RES, V1028, P92, DOI 10.1016/j.brainres.2004.09.003; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Monfils MH, 2005, NEUROSCIENTIST, V11, P471, DOI 10.1177/1073858405278015; OEFNER PJ, 1998, CURRENT PROTOCOLS HU; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Sen S, 2003, NEUROPSYCHOPHARMACOL, V28, P397, DOI 10.1038/sj.npp.1300053; Wolf SL, 2004, CLIN NEUROPHYSIOL, V115, P1740, DOI 10.1016/j.clinph.2004.02.027; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9	14	398	402	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					735	737		10.1038/nn1699	http://dx.doi.org/10.1038/nn1699			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16680163	Green Published			2022-12-17	WOS:000237895200011
J	Vuilleumier, P; Henson, RN; Driver, J; Dolan, RJ				Vuilleumier, P; Henson, RN; Driver, J; Dolan, RJ			Multiple levels of visual object constancy revealed by event-related fMRI of repetition priming	NATURE NEUROSCIENCE			English	Article							LATERAL OCCIPITAL COMPLEX; INFEROTEMPORAL CORTEX; 3-DIMENSIONAL OBJECTS; VIEWPOINT INVARIANCE; TEMPORAL CORTEX; TIME-COURSE; RECOGNITION; MEMORY; BRAIN; SPECIFICITY	We conducted two event-related functional magnetic resonance imaging (fMRI) experiments to investigate the neural substrates of visual object recognition in humans. We used a repetition-priming method with visual stimuli recurring at unpredictable intervals, either with the same appearance or with changes in size, viewpoint or exemplar. Lateral occipital and posterior inferior temporal cortex showed lower activity for repetitions of both real and non-sense objects; fusiform and left inferior frontal regions showed decreases for repetitions of only real objects. Repetition of different exemplars with the same name affected only the left inferior frontal cortex. Crucially, priming-induced decreases in activity of the right fusiform cortex depended on whether the three-dimensional objects were repeated with the same viewpoint, regardless of whether retinal image size changed; left fusiform decreases were independent of both viewpoint and size. These data show that dissociable subsystems in ventral visual cortex maintain distinct view-dependent and view-invariant object representations.	UCL, Inst Cognit Neurosci, London WC1N 3AR, England; Wellcome Dept Cognit Neurol, Funct Imaging Lab, London WC1N 3BG, England; Royal Free Hosp & Univ Coll Sch Med, London NW3 2PF, England	University of London; University College London; University of London; University College London; University of London; University College London	Vuilleumier, P (corresponding author), UCL, Inst Cognit Neurosci, Alexandra House,17 Queen Sq, London WC1N 3AR, England.	p.vuilleumier@ucl.ac.uk	Vuilleumier, Patrik/AAJ-1839-2021; Driver, Jon/A-4779-2010; Henson, Richard/H-8822-2019	Vuilleumier, Patrik/0000-0002-8198-9214; Henson, Richard/0000-0002-0712-2639; Dolan, Ray/0000-0001-9356-761X				Ashbridge E, 2000, COGN NEUROPSYCHOL, V17, P13, DOI 10.1080/026432900380463; BENTIN S, 1988, J EXP PSYCHOL GEN, V117, P148, DOI 10.1037/0096-3445.117.2.148; Biederman I, 1999, VISION RES, V39, P2885, DOI 10.1016/S0042-6989(98)00309-5; BIEDERMAN I, 1991, PERCEPTION, V20, P585, DOI 10.1068/p200585; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; BIEDERMAN I, 1993, J EXP PSYCHOL HUMAN, V19, P1162, DOI 10.1037/0096-1523.19.6.1162; Blaxton TA, 1996, CAN J EXP PSYCHOL, V50, P42, DOI 10.1037/1196-1961.50.1.42; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Buckner RL, 2000, BRAIN, V123, P620, DOI 10.1093/brain/123.3.620; BULTHOFF HH, 1995, CEREB CORTEX, V5, P247, DOI 10.1093/cercor/5.3.247; Cave CB, 1996, J EXP PSYCHOL LEARN, V22, P639, DOI 10.1037/0278-7393.22.3.639; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; ELLIS R, 1989, Q J EXP PSYCHOL-A, V41, P775, DOI 10.1080/14640748908402393; FARAH MJ, 1990, DISORDERS OBJECT REC; Fiser J, 2001, VISION RES, V41, P221, DOI 10.1016/S0042-6989(00)00234-0; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Furmanski CS, 2000, VISION RES, V40, P473, DOI 10.1016/S0042-6989(99)00134-0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grusser O. J., 1991, VISUAL AGNOSIA OTHER; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; James TW, 1999, NEUROREPORT, V10, P1019, DOI 10.1097/00001756-199904060-00023; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Koutstaal W, 2001, NEUROPSYCHOLOGIA, V39, P184, DOI 10.1016/S0028-3932(00)00087-7; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; LOGOTHETIS NK, 1994, CURR BIOL, V4, P401, DOI 10.1016/S0960-9822(00)00089-0; LUESCHOW A, 1994, CEREB CORTEX, V4, P523, DOI 10.1093/cercor/4.5.523; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Marr D., 1982, VISION; NAGY ME, 1989, PSYCHOPHYSIOLOGY, V26, P431, DOI 10.1111/j.1469-8986.1989.tb01946.x; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; SCHACTER DL, 1995, NATURE, V376, P587, DOI 10.1038/376587a0; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tarr MJ, 1998, NAT NEUROSCI, V1, P275, DOI 10.1038/1089; Tarr MJ, 1998, COGNITION, V67, P1, DOI 10.1016/S0010-0277(98)00026-2; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Turnbull O H, 1997, J Int Neuropsychol Soc, V3, P288; van Turennout M, 2000, NAT NEUROSCI, V3, P1329, DOI 10.1038/81873; Wagner AD, 2000, CEREB CORTEX, V10, P1176, DOI 10.1093/cercor/10.12.1176; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Wallis G, 1999, TRENDS COGN SCI, V3, P22, DOI 10.1016/S1364-6613(98)01261-3; WARRINGTON EK, 1978, PERCEPTION, V7, P695, DOI 10.1068/p070695; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	50	398	402	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					491	499		10.1038/nn839	http://dx.doi.org/10.1038/nn839			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11967545	Green Published			2022-12-17	WOS:000175272000022
J	Uchida, N; Takahashi, YK; Tanifuji, M; Mori, K				Uchida, N; Takahashi, YK; Tanifuji, M; Mori, K			Odor maps in the mammalian olfactory bulb: domain organization and odorant structural features	NATURE NEUROSCIENCE			English	Article							MITRAL TUFTED CELLS; FUNCTIONAL EXPRESSION; 2-DEOXYGLUCOSE UPTAKE; HOMOLOGOUS SERIES; RECEPTOR; RABBIT; COMBINATORIAL; REPRESENTATIONS; IDENTIFICATION; PROJECTIONS	Psychophysical studies indicate that structural features of odorants differentially influence their perceived odor. In the olfactory bulb (OB), odorants are represented by ensembles of activated glomeruli. Here we used optical imaging of intrinsic signals to examine how these structural features are represented spatially in the sensory map of the rat OB. We found that the dorsal OB contained two topographically fixed domains; constituent glomeruli in each domain could be activated by odorants with particular functional groups. Within each domain, other structural features such as carbon chain length and branching were represented by local differences in patterns. These results suggest that structural features are categorized into two classes, primary features (functional groups) that characterize each domain, and secondary features that are represented by local positions within each domain. Such hierarchical representations of different structural features correlate well with psychophysical structure-odor relationships.	RIKEN, Brain Sci Inst, Lab Integrat Neural Syst, Wako, Saitama 3510198, Japan; Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo 1130033, Japan; RIKEN, Brain Sci Inst, Lab Neuronal Recognit Mol, Wako, Saitama 3510198, Japan	RIKEN; University of Tokyo; RIKEN	Uchida, N (corresponding author), Cold Spring Harbor Lab, POB 100,1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	uchida@cshl.org	Tanifuji, Manabu/H-1744-2019	Tanifuji, Manabu/0000-0001-7754-7774; Uchida, Naoshige/0000-0002-5755-9409; Mori, Kensaku/0000-0001-7853-9370				AMOORE JE, 1964, SCI AM, V210, P42, DOI 10.1038/scientificamerican0264-42; BEETS MGJ, 1970, PHARMACOL REV, V22, P1; BONHOEFFER T, 1995, BRAIN MAPPING METHOD, P55; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; GUTHRIE KM, 1995, CHEM SENSES, V20, P271, DOI 10.1093/chemse/20.2.271; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; Johnson BA, 1999, J COMP NEUROL, V409, P529; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; JOURDAN F, 1980, BRAIN RES, V188, P139, DOI 10.1016/0006-8993(80)90563-6; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; KATOH K, 1993, J NEUROPHYSIOL, V70, P2161, DOI 10.1152/jn.1993.70.5.2161; KLOPPING HL, 1971, J AGR FOOD CHEM, V19, P999, DOI 10.1021/jf60177a002; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Laska M, 1999, CHEM SENSES, V24, P263, DOI 10.1093/chemse/24.3.263; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; LIDE DR, 1996, CRC HDB CHEM PHYSICS; MACLEOD AJ, 1980, S ZOOL SOC LOND, V45, P15; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; Moncrieff R.W., 1967, CHEM SENSES, V3rd; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; MORI K, 1992, J NEUROPHYSIOL, V67, P786, DOI 10.1152/jn.1992.67.3.786; POLAK EH, 1973, J THEOR BIOL, V40, P469, DOI 10.1016/0022-5193(73)90005-2; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Rupe H, 1900, BER DTSCH CHEM GES, V33, P3401, DOI 10.1002/cber.190003303120; SALLAZ M, 1993, NEUROREPORT, V4, P55, DOI 10.1097/00001756-199301000-00014; SHARP FR, 1975, BRAIN RES, V98, P596, DOI 10.1016/0006-8993(75)90377-7; SHARP FR, 1977, J NEUROPHYSIOL, V40, P800, DOI 10.1152/jn.1977.40.4.800; SKEEN LC, 1977, J COMP NEUROL, V172, P1, DOI 10.1002/cne.901720102; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Tsuboi A, 1999, J NEUROSCI, V19, P8409; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	44	398	404	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					1035	1043		10.1038/79857	http://dx.doi.org/10.1038/79857			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017177				2022-12-17	WOS:000167177500022
J	Lagali, PS; Balya, D; Awatramani, GB; Munch, TA; Kim, DS; Busskamp, V; Cepko, CL; Roska, B				Lagali, Pamela S.; Balya, David; Awatramani, Gautam B.; Muench, Thomas A.; Kim, Douglas S.; Busskamp, Volker; Cepko, Constance L.; Roska, Botond			Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration	NATURE NEUROSCIENCE			English	Article							GANGLION-CELLS; MAMMALIAN RETINA; INNER RETINA; LATERAL INHIBITION; WILD-TYPE; MOUSE; VISION; RESPONSES; MICE; NEURONS	Genetically encoded optical neuromodulators create an opportunity for circuit-specific intervention in neurological diseases. One of the diseases most amenable to this approach is retinal degeneration, where the loss of photoreceptors leads to complete blindness. To restore photosensitivity, we genetically targeted a light-activated cation channel, channelrhodopsin-2, to second-order neurons, ON bipolar cells, of degenerated retinas in vivo in the Pde6b(rd1) (also known as rd1) mouse model. In the absence of 'classical' photoreceptors, we found that ON bipolar cells that were engineered to be photosensitive induced light-evoked spiking activity in ganglion cells. The rescue of light sensitivity was selective to the ON circuits that would naturally respond to increases in brightness. Despite degeneration of the outer retina, our intervention restored transient responses and center-surround organization of ganglion cells. The resulting signals were relayed to the visual cortex and were sufficient for the animals to successfully perform optomotor behavioral tasks.	[Lagali, Pamela S.; Balya, David; Awatramani, Gautam B.; Muench, Thomas A.; Busskamp, Volker; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, CH-4058 Basel, Switzerland; [Kim, Douglas S.; Cepko, Constance L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Kim, Douglas S.; Cepko, Constance L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Friedrich Miescher Institute for Biomedical Research; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Maulbeerstr 66, CH-4058 Basel, Switzerland.	botond.roska@fmi.ch	Roska, Botond/AAD-7268-2021; Busskamp, Volker/E-6339-2015	Busskamp, Volker/0000-0001-7517-8944; Kim, Douglas/0000-0001-9029-314X; Munch, Thomas/0000-0002-8884-6961	NEI NIH HHS [R01 EY008064] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008064] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Awatramani GB, 2000, J NEUROSCI, V20, P7087, DOI 10.1523/JNEUROSCI.20-18-07087.2000; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; BELGUM JH, 1987, J PHYSIOL-LONDON, V388, P233, DOI 10.1113/jphysiol.1987.sp016612; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; COLLINS RD, 1995, J NEUROSCI METH, V60, P95, DOI 10.1016/0165-0270(94)00224-5; Cook PB, 1998, NAT NEUROSCI, V1, P714, DOI 10.1038/3714; Dedek K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001714; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; FARBER DB, 1994, PROG RETIN EYE RES, V13, P31, DOI 10.1016/1350-9462(94)90004-3; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Gianfranceschi L, 1999, VISION RES, V39, P569, DOI 10.1016/S0042-6989(98)00169-2; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Jones BW, 2003, J COMP NEUROL, V464, P1, DOI 10.1002/cne.10703; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Ma YP, 2005, VISUAL NEUROSCI, V22, P119, DOI 10.1017/S0952523805222010; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Mao BQ, 1998, VISUAL NEUROSCI, V15, P425; Marc RE, 2007, INVEST OPHTH VIS SCI, V48, P3364, DOI 10.1167/iovs.07-0032; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsui K, 1998, J NEUROSCI, V18, P4500; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Pang JJ, 2004, J PHYSIOL-LONDON, V558, P249, DOI 10.1113/jphysiol.2004.063503; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Renteria RC, 2006, J NEUROSCI, V26, P11857, DOI 10.1523/JNEUROSCI.1718-06.2006; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Shields CR, 2003, J NEUROPHYSIOL, V89, P2449, DOI 10.1152/jn.00916.2002; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; Strettoi E, 2002, J NEUROSCI, V22, P5492; Strettoi E, 2003, VISION RES, V43, P867, DOI 10.1016/S0042-6989(02)00594-1; Taylor WR, 1999, VISUAL NEUROSCI, V16, P285, DOI 10.1017/S0952523899162096; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Weiland JD, 2005, ANNU REV BIOMED ENG, V7, P361, DOI 10.1146/annurev.bioeng.7.060804.100435; Wong AA, 2006, GENES BRAIN BEHAV, V5, P389, DOI 10.1111/j.1601-183X.2005.00173.x; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zrenner E, 2002, SCIENCE, V295, P1022, DOI 10.1126/science.1067996	50	397	431	1	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					667	675		10.1038/nn.2117	http://dx.doi.org/10.1038/nn.2117			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18432197				2022-12-17	WOS:000256133700013
J	Huber, R; Ghilardi, MF; Massimini, M; Ferrarelli, F; Riedner, BA; Peterson, MJ; Tononi, G				Huber, Reto; Ghilardi, M. Felice; Massimini, Marcello; Ferrarelli, Fabio; Riedner, Brady A.; Peterson, Michael J.; Tononi, Giulio			Arm immobilization causes cortical plastic changes and locally decreases sleep slow wave activity	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; EEG; STIMULATION; MEMORY; OSCILLATIONS; EXCITABILITY; MECHANISM; RAT	Sleep slow wave activity (SWA) is thought to reflect sleep need, increasing after wakefulness and decreasing after sleep. We showed recently that a learning task involving a circumscribed brain region produces a local increase in sleep SWA. We hypothesized that increases in cortical SWA reflect synaptic potentiation triggered by learning. To further investigate the link between synaptic plasticity and sleep, we asked whether a procedure leading to synaptic depression would cause instead a decrease in sleep SWA. We show here that if a subject's arm is immobilized during the day, motor performance deteriorates and both somatosensory and motor evoked potentials decrease over contralateral sensorimotor cortex, indicative of local synaptic depression. Notably, during subsequent sleep, SWA over the same cortical area is markedly reduced. Thus, cortical plasticity is linked to local sleep regulation without learning in the classical sense. Moreover, when synaptic strength is reduced, local sleep need is also reduced.	CUNY City Coll, Sch Med, Dept Physiol & Pharmacol, New York, NY 10031 USA; Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA; Univ Wisconsin, Neurosci Training Program, Madison, WI 53719 USA	City University of New York (CUNY) System; City College of New York (CUNY); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Tononi, G (corresponding author), CUNY City Coll, Sch Med, Dept Physiol & Pharmacol, New York, NY 10031 USA.	mg79@columbia.edu; gtononi@wisc.edu	Ferrarelli, Fabio/D-3219-2019; ferrarelli, fabio/C-2945-2011; Tononi, Giulio/B-8387-2009; Peterson, Michael J./A-8834-2009; Massimini, Marcello/T-8115-2017	Ferrarelli, Fabio/0000-0003-0560-0227; Peterson, Michael J./0000-0001-9181-1009; Massimini, Marcello/0000-0003-2271-957X	NINDS NIH HHS [1R01 NS 055 185-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055185] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Borbely A. A., 2000, PRINCIPLES PRACTICE, P377; Candia V, 2003, P NATL ACAD SCI USA, V100, P7942, DOI 10.1073/pnas.1231193100; Cirelli C, 2005, J NEUROSCI, V25, P4503, DOI 10.1523/JNEUROSCI.4845-04.2005; CONTRERAS D, 1995, J NEUROSCI, V15, P604; Datta S, 2000, J NEUROSCI, V20, P8607, DOI 10.1523/JNEUROSCI.20-22-08607.2000; Dinse HR, 2003, SCIENCE, V301, P91, DOI 10.1126/science.1085423; Esser SK, 2006, BRAIN RES BULL, V69, P86, DOI 10.1016/j.brainresbull.2005.11.003; Facchini S, 2002, CLIN NEUROPHYSIOL, V113, P367, DOI 10.1016/S1388-2457(02)00009-3; Finelli LA, 2001, EUR J NEUROSCI, V13, P2282, DOI 10.1046/j.0953-816x.2001.01597.x; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Froc DJ, 2000, J NEUROSCI, V20, P438, DOI 10.1523/JNEUROSCI.20-01-00438.2000; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Ghilardi MF, 2000, BRAIN RES, V871, P127, DOI 10.1016/S0006-8993(00)02365-9; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Huber R, 2000, NEUROREPORT, V11, P3321, DOI 10.1097/00001756-200010200-00012; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Jha SK, 2005, J NEUROSCI, V25, P9266, DOI 10.1523/JNEUROSCI.2722-05.2005; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; KATTLER H, 1994, J SLEEP RES, V3, P159, DOI 10.1111/j.1365-2869.1994.tb00123.x; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; KRYGER MH, 2006, PRINCIPLES PRACTICE; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Marshall L, 2004, J NEUROSCI, V24, P9985, DOI 10.1523/JNEUROSCI.2725-04.2004; Mauguiere F, 1999, EEG CL N SU, P255; Miyamoto H, 2003, NAT NEUROSCI, V6, P553, DOI 10.1038/nn1064; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Molle M, 2002, J NEUROSCI, V22, P10941; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Rechtschaffen A., 1968, MANUAL STANDARDIZED, V20, P246; ROUILLER EM, 1994, EXP BRAIN RES, V102, P227; SAINBURG RL, 1995, J NEUROPHYSIOL, V73, P820, DOI 10.1152/jn.1995.73.2.820; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; TOBLER I, 1986, ELECTROEN CLIN NEURO, V64, P74, DOI 10.1016/0013-4694(86)90044-1; TOBLER I, 2000, PRINCIPLES PRACTICE, P72; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Vyazovskiy V, 2000, J SLEEP RES, V9, P367, DOI 10.1046/j.1365-2869.2000.00230.x; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; WALKER MP, 2005, ANN REV PSYCHOL; Werhahn KJ, 2002, BRAIN, V125, P1402, DOI 10.1093/brain/awf140; Werth E, 1996, AM J PHYSIOL-REG I, V271, pR501, DOI 10.1152/ajpregu.1996.271.3.R501; Werth E, 1997, J SLEEP RES, V6, P102, DOI 10.1046/j.1365-2869.1997.d01-36.x; Ziemann U, 2004, REV NEUROSCIENCE, V15, P253; Ziemann U, 2002, J NEUROSCI, V22, P5563	49	397	406	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1169	1176		10.1038/nn1758	http://dx.doi.org/10.1038/nn1758			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16936722				2022-12-17	WOS:000240080800019
J	Janssen, P; Shadlen, MN				Janssen, P; Shadlen, MN			A representation of the hazard rate of elapsed time in macaque area LIP	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; LATERAL INTRAPARIETAL AREA; SACCADIC EYE-MOVEMENTS; NEURONAL-ACTIVITY; NEURAL REPRESENTATION; SUPERIOR COLLICULUS; PREFRONTAL CORTEX; WORKING-MEMORY; MONKEY; ATTENTION	The capacity to anticipate the timing of environmental cues allows us to allocate sensory resources at the right time and prepare actions. Such anticipation requires knowledge of elapsed time and of the probability that an event will occur. Here we show that neurons in the parietal cortex represent the probability, as a function of time, that a salient event is likely to occur. Rhesus monkeys were trained to make eye movements to peripheral targets after a light dimmed. Within a block of trials, the 'go' times were drawn from either a bimodal or unimodal distribution of random numbers. Neurons in the lateral intraparietal area showed anticipatory activity that revealed an internal representation of both elapsed time and the probability that the 'go' signal was about to occur (termed the hazard rate). The results indicate that the parietal cortex contains circuitry for representing the time structure of environmental cues over a range of seconds.	Univ Washington, Howard Hughes Med Inst, Natl Primate Res Ctr, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Shadlen, MN (corresponding author), KU Leuven Med Sch, Lab Neuroen Psychofysiol, Herestr 49, B-3000 Louvain, Belgium.	shadlen@u.washington.edu	Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210	NCRR NIH HHS [RR00166] Funding Source: Medline; NEI NIH HHS [EY11378] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLISTEL CR, 2000, PSYCHOL REV, V107, P289; Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Anderson T. W, 1984, INTRO MULTIVARIATE S; Bagdonavicius V., 2002, MODELLING STAT ANAL; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bracewell RM, 1996, J NEUROPHYSIOL, V76, P1457, DOI 10.1152/jn.1996.76.3.1457; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Coull JT, 1998, J NEUROSCI, V18, P7426; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Dorris MC, 1998, J NEUROSCI, V18, P7015; Dorris MC, 1997, J NEUROSCI, V17, P8566; Durstewitz D, 2004, NEUROREPORT, V15, P745, DOI 10.1097/00001756-200404090-00001; Eskandar EN, 1999, NAT NEUROSCI, V2, P88, DOI 10.1038/4594; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; GNADT JW, 1988, EXP BRAIN RES, V70, P216; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; KARLIN L, 1966, J EXP PSYCHOL, V72, P505, DOI 10.1037/h0023748; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Loveless N E, 1974, Biol Psychol, V1, P303, DOI 10.1016/0301-0511(74)90005-2; LUC RD, 1986, RESPONSE TIMES THEIR; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Meck W.H., 1988, QUANTITATIVE ANAL BE, P121; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Onoe H, 2001, NEUROIMAGE, V13, P37, DOI 10.1006/nimg.2000.0670; Pare M, 1997, J NEUROPHYSIOL, V78, P3493, DOI 10.1152/jn.1997.78.6.3493; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rakitin BC, 1998, J EXP PSYCHOL-ANIM B, V24, P15, DOI 10.1037/0097-7403.24.1.15; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Reutimann J, 2004, J NEUROSCI, V24, P3295, DOI 10.1523/JNEUROSCI.4098-03.2004; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Roux S, 2003, EUR J NEUROSCI, V18, P1011, DOI 10.1046/j.1460-9568.2003.02792.x; SCHALL JD, 1993, BEHAV BRAIN SCI, V16, P588, DOI 10.1017/S0140525X00031812; Schall JD, 2003, CURR OPIN NEUROBIOL, V13, P182, DOI 10.1016/S0959-4388(03)00039-4; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Tanji J, 2001, CURR OPIN NEUROBIOL, V11, P164, DOI 10.1016/S0959-4388(00)00192-6; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a	50	397	398	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					234	241		10.1038/nn1386	http://dx.doi.org/10.1038/nn1386			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15657597	Green Published			2022-12-17	WOS:000226638200024
J	Bialas, AR; Stevens, B				Bialas, Allison R.; Stevens, Beth			TGF-beta signaling regulates neuronal Clq expression and developmental synaptic refinement	NATURE NEUROSCIENCE			English	Article							CLASS-I MHC; RETINOGENICULATE AXONS; NEURITE OUTGROWTH; RETINAL GANGLION; GENE-EXPRESSION; GROWTH; CNS; C1Q; PROTEINS; GLIA	Immune molecules, including complement proteins Clq and C3, have emerged as critical mediators of synaptic refinement and plasticity. Complement localizes to synapses and refines the developing visual system through C3-dependent microglial phagocytosis of synapses. Retinal ganglion cells (RGCs) express Clq, the initiating protein of the classical complement cascade, during retinogeniculate refinement; however, the signals controlling Clq expression and function remain elusive. Previous work implicated an astrocyte-derived factor in regulating neuronal Clq expression. Here we identify retinal transforming growth factor (TGF)-beta as a key regulator of neuronal Clq expression and synaptic pruning in the developing visual system. Mice lacking TGF-beta receptor II (TGF beta R11) in retinal neurons had reduced Clq expression in RGCs and reduced synaptic localization of complement, and phenocopied refinement defects observed in complement-deficient mice, including reduced eye-specific segregation and microglial engulfment of RGC inputs. These data implicate TGF-beta in regulating neuronal Clq expression to initiate complement- and microglia-mediated synaptic pruning.	[Bialas, Allison R.; Stevens, Beth] Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Boston Childrens Hosp, Boston, MA 02115 USA; [Bialas, Allison R.; Stevens, Beth] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Bialas, AR (corresponding author), Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Boston Childrens Hosp, Boston, MA 02115 USA.	beth.stevens@childrens.harvard.edu			Smith Family Foundation; Dana Foundation; Ellison Foundation; John Merck Scholars Program; NINDS [R01-NS-07100801]; NIDA [R01-DA-15043]; NIH [P30-HD-18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015043] Funding Source: NIH RePORTER	Smith Family Foundation; Dana Foundation; Ellison Foundation(Lawrence Ellison Foundation); John Merck Scholars Program; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank C. Chen, L. Benowitz, D.P. Schafer and M. Buckwalter for comments on the manuscript and critical discussion. In addition we thank A. Stephan, B. Barres and A. Tenner for assistance with anti-Clq antibody production and characterization. We also thank M. Rasband (Baylor College of Medicine) for the 13IV spectrin antibody. Thank you to D.P. Schafer and E.K. Lehrman for technical expertise on the microglial engulfment assay and Imaris image analysis, T. Nelson for technical assistance, and the imaging core at Boston Children's Hospital, including T. Hill, for technical support. This work was supported by grants from the Smith Family Foundation (B.S.), Dana Foundation (B.S.), Ellison Foundation (B.S.), John Merck Scholars Program (B.S.), NINDS (R01-NS-07100801; B.S.), NIDA (R01-DA-15043; B.A. Barres) and NIH (P30-HD-18655; MRDDRC Imaging Core).	Afagh A, 1996, EXP NEUROL, V138, P22, DOI 10.1006/exnr.1996.0043; Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Awasaki T, 2011, NAT NEUROSCI, V14, P821, DOI 10.1038/nn.2833; Ball RW, 2010, NEURON, V66, P536, DOI 10.1016/j.neuron.2010.04.011; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Beier M, 2006, NEUROSCI RES, V56, P193, DOI 10.1016/j.neures.2006.07.002; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; CAMPBELL G, 1992, J NEUROSCI, V12, P1847; Chin J, 2002, J NEUROSCI, V22; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; de Melo J, 2003, J COMP NEUROL, V461, P187, DOI 10.1002/cne.10674; Diniz LP, 2012, J BIOL CHEM, V287, P41432, DOI 10.1074/jbc.M112.380824; Feng Z, 2008, J NEUROSCI, V28, P9599, DOI 10.1523/JNEUROSCI.2589-08.2008; Fonseca MI, 2004, J NEUROSCI, V24, P6457, DOI 10.1523/JNEUROSCI.0901-04.2004; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Fuentes-Medel Y, 2012, CURR BIOL, V22, P1831, DOI 10.1016/j.cub.2012.07.063; Heupel K, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-25; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Huang LC, 2007, DEVELOPMENT, V134, P2925, DOI 10.1242/dev.001925; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Lu CC, 2011, J NEUROSCI, V31, P10903, DOI 10.1523/JNEUROSCI.2358-11.2011; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Peterziel H, 2002, J CELL BIOL, V159, P157, DOI 10.1083/jcb.200203115; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Schafer DP, 2013, GLIA, V61, P24, DOI 10.1002/glia.22389; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; SRETAVAN D, 1984, NATURE, V308, P845, DOI 10.1038/308845a0; Stephan AH, 2013, J NEUROSCI, V33, P13460, DOI 10.1523/JNEUROSCI.1333-13.2013; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Tsui CC, 1996, J NEUROSCI, V16, P2463; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; WyssCoray T, 1997, NATURE, V389, P603, DOI 10.1038/39321; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Yu XMM, 2013, NEURON, V78, P456, DOI 10.1016/j.neuron.2013.03.004; Yuzaki M, 2010, EUR J NEUROSCI, V32, P191, DOI 10.1111/j.1460-9568.2010.07346.x	43	395	403	3	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1773	1782		10.1038/nn.3560	http://dx.doi.org/10.1038/nn.3560			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24162655	Green Accepted, Green Submitted			2022-12-17	WOS:000327416800015
J	Ress, D; Backus, BT; Heeger, DJ				Ress, D; Backus, BT; Heeger, DJ			Activity in primary visual cortex predicts performance in a visual detection task	NATURE NEUROSCIENCE			English	Article							STATE DEPENDENT ACTIVITY; SPATIAL ATTENTION; CORTICAL AREAS; SELECTIVE ATTENTION; SENSORY STIMULATION; NEURAL MECHANISMS; MACAQUE MONKEY; BRAIN ACTIVITY; COLOR SIGNALS; V4	Visual attention can affect both neural activity and behavior in humans. To quantify possible links between the two, we measured activity in early visual cortex (V1, V2 and V3) during a challenging pattern-detection task. Activity was dominated by a large response that was independent of the presence or absence of the stimulus pattern. The measured activity quantitatively predicted the subject's pattern-detection performance: when activity was greater, the subject was more likely to correctly discern the presence or absence of the pattern. This stimulus-independent activity had several characteristics of visual attention, suggesting that attentional mechanisms modulate activity in early visual cortex, and that this attention-related activity strongly influences performance.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Heeger, DJ (corresponding author), Stanford Univ, Dept Psychol, 450 Serra Mall,Bldg 420-400, Stanford, CA 94305 USA.				NEI NIH HHS [R01-EY11794, F32-EY06952, F32-EY06899] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY006899, F32EY006952, R01EY011794] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; BELLIVEAU JW, 1991, SCIENCE, V254, P716, DOI 10.1126/science.1948051; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Carandini M, 1997, J NEUROSCI, V17, P8621; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; DEMB J, 1997, J NEUROSCI, V17, P8621; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Efron B., 1993, INTRO BOOTSTRAP; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Glover GH, 1999, MAGNET RESON MED, V42, P412, DOI 10.1002/(SICI)1522-2594(199908)42:2<412::AID-MRM25>3.0.CO;2-U; Graham N., 1989, VISUAL PATTERN ANAL; GREEN DM, 1988, SIGNAL DETECTION THE; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; PASHLER HE, 1998, PSYCHOL ATTENTION; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Seidemann E, 1999, NEURON, V24, P911, DOI 10.1016/S0896-6273(00)81038-7; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shulman GL, 1999, J NEUROSCI, V19, P9480; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Wandell BA, 1999, NEURON, V24, P901, DOI 10.1016/S0896-6273(00)81037-5	49	395	401	1	25	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					940	945		10.1038/78856	http://dx.doi.org/10.1038/78856			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966626				2022-12-17	WOS:000167177400022
J	Lin, JHC; Weigel, H; Cotrina, ML; Liu, SJ; Bueno, E; Hansen, AJ; Hansen, TW; Goldman, S; Nedergaard, M				Lin, JHC; Weigel, H; Cotrina, ML; Liu, SJ; Bueno, E; Hansen, AJ; Hansen, TW; Goldman, S; Nedergaard, M			Gap-junction-mediated propagation and amplification of cell injury	NATURE NEUROSCIENCE			English	Article							CEREBRAL BLOOD-FLOW; FOCAL ISCHEMIA; INFARCT VOLUME; CALCIUM; BCL-2; EXPRESSION; BRAIN; COMMUNICATION; DEATH; RAT	Gap junctions are conductive channels that connect the interiors of coupled cells. We determined whether gap junctions propagate transcellular signals during metabolic stress and whether such signaling exacerbates cell injury. Although overexpression of the human proto-oncogene bcl2 in C6 glioma cells normally increased their resistance to injury, the relative resistance of bcl2(+) cells to calcium overload, oxidative stress and metabolic inhibition was compromised when they formed gap junctions with more vulnerable cells. The likelihood of death was in direct proportion to the number and density of gap junctions with their less resistant neighbors. Thus, dying glia killed neighboring cells that would otherwise have escaped injury. This process of glial 'fratricide' may provide a basis for the secondary propagation of brain injury in cerebral ischemia.	New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA; New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; New York Med Coll, Dept Neurosurg, Valhalla, NY 10595 USA; Cornell Univ, Med Ctr, Dept Neurol & Neurosci, New York, NY 10021 USA; Novo Nordisk AS, DK-2750 Malev, Denmark	New York Medical College; New York Medical College; New York Medical College; Cornell University; Novo Nordisk	Lin, JHC (corresponding author), New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA.				PHS HHS [R0135011, R0130007] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Cotrina ML, 1998, J NEUROSCI, V18, P2520; Dermietzel R, 1998, GLIA, V24, P1, DOI 10.1002/(SICI)1098-1136(199809)24:1<1::AID-GLIA1>3.0.CO;2-A; DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148, DOI 10.1073/pnas.86.24.10148; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; GINSBERG MD, 1995, NEUROSCIENTIST, V1, P95; GOLDBERG GS, 1995, BIOTECHNIQUES, V18, P490; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Graham D.I., 1992, GREENFIELDS NEUROPAT, P153; Haugland R.P, 1996, HDB FLUORESCENT PROB, V6th; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOEHNBERLAGE M, 1995, J CEREBR BLOOD F MET, V15, P1002, DOI 10.1038/jcbfm.1995.126; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; LAM M, 1994, P NATL ACAD SCI USA, V91, P6569, DOI 10.1073/pnas.91.14.6569; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mesnil M, 1996, P NATL ACAD SCI USA, V93, P1831, DOI 10.1073/pnas.93.5.1831; MIRABELLI F, 1988, BIOCHEM PHARMACOL, V37, P3423, DOI 10.1016/0006-2952(88)90691-0; Nadarajah B, 1996, J COMP NEUROL, V376, P326, DOI 10.1002/(SICI)1096-9861(19961209)376:2<326::AID-CNE13>3.0.CO;2-J; NEDERGAARD M, 1991, J NEUROSCI, V11, P2489; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; NEDERGAARD M, 1996, CELLULAR MOL MECH IS, P301; PREHN JHM, 1994, P NATL ACAD SCI USA, V91, P12599, DOI 10.1073/pnas.91.26.12599; Rawanduzy A, 1997, J NEUROSURG, V87, P916, DOI 10.3171/jns.1997.87.6.0916; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Rohlmann A., 1996, GAP JUNCTIONS NERVOU, P175, DOI DOI 10.1007/978-3-662-21935-5_10; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; Saito R, 1997, J CEREBR BLOOD F MET, V17, P857, DOI 10.1097/00004647-199708000-00004; SIESJO BK, 1995, ANN THORAC SURG, V59, P1316, DOI 10.1016/0003-4975(95)00077-X; SULLIVAN R, 1995, J CELL BIOL, V130, P419, DOI 10.1083/jcb.130.2.419; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Venance L, 1997, J NEUROSCI, V17, P1981; WADE MH, 1986, SCIENCE, V232, P525, DOI 10.1126/science.3961495; WARNER DS, 1995, ANESTHESIOLOGY, V82, P1237, DOI 10.1097/00000542-199505000-00019; ZHONG LT, 1993, P NATL ACAD SCI USA, V90, P4533, DOI 10.1073/pnas.90.10.4533; ZHU D, 1991, P NATL ACAD SCI USA, V88, P1883, DOI 10.1073/pnas.88.5.1883	36	395	423	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1998	1	6					494	500		10.1038/2210	http://dx.doi.org/10.1038/2210			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	128LE	10196547				2022-12-17	WOS:000076406900014
J	Wilson, SR; Gerhold, KA; Bifolck-Fisher, A; Liu, Q; Patel, KN; Dong, XZ; Bautista, DM				Wilson, Sarah R.; Gerhold, Kristin A.; Bifolck-Fisher, Amber; Liu, Qin; Patel, Kush N.; Dong, Xinzhong; Bautista, Diana M.			TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch	NATURE NEUROSCIENCE			English	Article							G-BETA-GAMMA; ION-CHANNEL TRPA1; SPINOTHALAMIC TRACT NEURONS; ALLERGIC RHINITIS; ACTIVATED RECEPTOR-2; SPINAL-CORD; PAIN; PRURITUS; MICE; PATHWAY	Itch, the unpleasant sensation that evokes a desire to scratch, accompanies numerous skin and nervous system disorders. In many cases, pathological itch is insensitive to antihistamine treatment. Recent studies have identified members of the Mas-related G protein-coupled receptor (Mrgpr) family that are activated by mast cell mediators and promote histamine-independent itch. MrgprA3 and MrgprC11 act as receptors for the pruritogens chloroquine and BAM8-22, respectively. However, the signaling pathways and transduction channels activated downstream of these pruritogens are largely unknown. We found that TRPA1 is the downstream target of both MrgprA3 and MrgprC11 in cultured sensory neurons and heterologous cells. TRPA1 is required for Mrgpr-mediated signaling, as sensory neurons from TRPA1-deficient mice exhibited markedly diminished responses to chloroquine and BAM8-22. Similarly, TRPA1-deficient mice displayed little to no scratching in response to these pruritogens. Our findings indicate that TRPA1 is an essential component of the signaling pathways that promote histamine-independent itch.	[Wilson, Sarah R.; Gerhold, Kristin A.; Bifolck-Fisher, Amber; Bautista, Diana M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Liu, Qin; Patel, Kush N.; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Liu, Qin; Patel, Kush N.; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	University of California System; University of California Berkeley; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Bautista, DM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	dbautista@berkeley.edu			US National Institutes of Health [DOD007123A]; Pew Scholars Program; Rita Allen Foundation; McKnight Scholars Fund; National Science Foundation; US National Institutes of Health; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059385] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007123] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Program; Rita Allen Foundation; McKnight Scholars Fund; National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Kollarik for advice on PCR, R. Brem for use of equipment, T. Morita for technical support, and R. Brem, J. Ngai, J. Sack, M. Tsunozaki, P. Aryal and M. Pellegrino for helpful discussions and critical reading of the manuscript. This study was supported by a US National Institutes of Health Innovator Award (DOD007123A), the Pew Scholars Program, the Rita Allen Foundation, and the McKnight Scholars Fund (D. M. B.), the National Science Foundation (S. R. W.), and a US National Institutes of Health grant (X.D.).	Abila B, 1994, Afr J Med Med Sci, V23, P139; AJAYI AA, 1989, EUR J CLIN PHARMACOL, V37, P539, DOI 10.1007/BF00558141; Andriantsoanirina V, 2010, SCAND J INFECT DIS, V42, P22, DOI 10.3109/00365540903289670; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bianchi E, 2009, J NEUROCHEM, V111, P171, DOI 10.1111/j.1471-4159.2009.06308.x; Dascal N, 2001, TRENDS ENDOCRIN MET, V12, P391, DOI 10.1016/S1043-2760(01)00475-1; Davidson S, 2007, J NEUROSCI, V27, P10007, DOI 10.1523/JNEUROSCI.2862-07.2007; Davidson S, 2009, NAT NEUROSCI, V12, P544, DOI 10.1038/nn.2292; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; Guan Y, 2010, P NATL ACAD SCI USA, V107, P15933, DOI 10.1073/pnas.1011221107; Han SK, 2006, NEURON, V52, P691, DOI 10.1016/j.neuron.2006.09.036; Han SK, 2002, P NATL ACAD SCI USA, V99, P14740, DOI 10.1073/pnas.192565799; Howarth PH, 2000, ALLERGY, V55, P7, DOI 10.1034/j.1398-9995.2000.00802.x; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Johanek LM, 2008, J NEUROSCI, V28, P7659, DOI 10.1523/JNEUROSCI.1760-08.2008; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; Kerstein PC, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-19; Kim BM, 2004, NEUROSCI LETT, V361, P159, DOI 10.1016/j.neulet.2004.01.019; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Lee MG, 2008, J IMMUNOL, V180, P2251, DOI 10.4049/jimmunol.180.4.2251; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Ma QF, 2010, J CLIN INVEST, V120, P3773, DOI 10.1172/JCI43426; Mathews JL, 2008, J NEUROSCI, V28, P12183, DOI 10.1523/JNEUROSCI.2326-08.2008; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Montell C, 2008, NEURON, V58, P825, DOI 10.1016/j.neuron.2008.06.006; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; Nathan RA, 2009, SOUTH MED J, V102, P935, DOI 10.1097/SMJ.0b013e3181b01c68; Parsons ME, 2006, BRIT J PHARMACOL, V147, pS127, DOI 10.1038/sj.bjp.0706440; Reddy VB, 2008, J NEUROSCI, V28, P4331, DOI 10.1523/JNEUROSCI.0716-08.2008; Rishal I, 2005, J BIOL CHEM, V280, P16685, DOI 10.1074/jbc.M412196200; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Rousset M, 2004, J BIOL CHEM, V279, P14619, DOI 10.1074/jbc.M313284200; Rukwied R, 2000, BRIT J DERMATOL, V142, P1114, DOI 10.1046/j.1365-2133.2000.03535.x; Sardana N, 2010, ALLERGY ASTHMA PROC, V31, P5, DOI 10.2500/aap.2010.31.3308; Schmelz M, 2003, J NEUROPHYSIOL, V89, P2441, DOI 10.1152/jn.01139.2002; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Shimada SG, 2008, PAIN, V139, P681, DOI 10.1016/j.pain.2008.08.002; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Tsujii K, 2009, J PHARMACOL SCI, V109, P388, DOI 10.1254/jphs.08332FP; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Yosipovitch G, 2003, AM J CLIN DERMATOL, V4, P617, DOI 10.2165/00128071-200304090-00004; Zhou YX, 2008, BIOCHEMISTRY-US, V47, P4410, DOI 10.1021/bi800044n; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	50	394	414	3	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					595	U82		10.1038/nn.2789	http://dx.doi.org/10.1038/nn.2789			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21460831	Green Accepted, Green Submitted			2022-12-17	WOS:000289886600015
J	Araneda, RC; Kini, AD; Firestein, S				Araneda, RC; Kini, AD; Firestein, S			The molecular receptive range of an odorant receptor	NATURE NEUROSCIENCE			English	Article							OLFACTORY RECEPTOR; RECOMBINANT ADENOVIRUS; RESPONSE PROPERTIES; NEURONS; EXPRESSION; IDENTIFICATION; PROTEINS; SYSTEM; CELLS; BULB	An odor perception is the brain's interpretation of the activation pattern of many peripheral sensory neurons that are differentially sensitive to a wide variety of odors. The sensitivity of these neurons is determined by which of the thousand or so odor receptor proteins they express on their surface. Understanding the odor code thus requires mapping the receptive range of odorant receptors. We have adopted a pharmacological approach that uses a large and diverse pool of odorous compounds to characterize the molecular receptive field of an odor receptor. We found a high specificity for certain molecular features, but high tolerance for others-a strategy that enables the olfactory apparatus to be both highly discriminating, and able to recognize several thousand odorous compounds.	Columbia Univ, Dept Biol Sci, New York, NY 10032 USA	Columbia University	Firestein, S (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10032 USA.		Araneda, Ricardo/AAN-1051-2020	Araneda, Ricardo/0000-0001-8728-3063				Beets M. G. J., 1978, STRUCTURE ACTIVITY R; Bikker JA, 1998, J MED CHEM, V41, P2911, DOI 10.1021/jm970767a; Bozza TC, 1998, J NEUROSCI, V18, P4560; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; DuchampViret P, 1997, PROG NEUROBIOL, V53, P561, DOI 10.1016/S0301-0082(97)00049-X; FIRESTEIN S, 1993, J PHYSIOL-LONDON, V468, P1; Hashimoto M, 1996, HUM GENE THER, V7, P149, DOI 10.1089/hum.1996.7.2-149; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; MACKAYSIM A, 1994, J NEUROPHYSIOL, V71, P150, DOI 10.1152/jn.1994.71.1.150; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Marriott DP, 1999, J MED CHEM, V42, P3210, DOI 10.1021/jm980409n; MOHAMADI F, 1990, J COMPUT CHEM, V11, P44; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OTTOSON D, 1971, HDB SENSORY PHYSL; Pilpel Y, 1999, PROTEIN SCI, V8, P969, DOI 10.1110/ps.8.5.969; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Singer MS, 2000, CHEM SENSES, V25, P155, DOI 10.1093/chemse/25.2.155; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; YUSTE R, 2000, IMAGING NEURONS LAB; ZHAO H, 1998, SCIENCE, V279, P327; Zhao HQ, 1996, J NEUROBIOL, V30, P521, DOI 10.1002/(SICI)1097-4695(199608)30:4<521::AID-NEU7>3.0.CO;2-5	28	394	401	1	52	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1248	1255		10.1038/81774	http://dx.doi.org/10.1038/81774			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100145	Bronze			2022-12-17	WOS:000167177900010
J	Conover, JC; Doetsch, F; Garcia-Verdugo, JM; Gale, NW; Yancopoulos, GD; Alvarez-Buylla, A				Conover, JC; Doetsch, F; Garcia-Verdugo, JM; Gale, NW; Yancopoulos, GD; Alvarez-Buylla, A			Disruption of Eph/ephrin signaling affects migration and proliferation in the adult subventricular zone	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; RECEPTOR TYROSINE KINASES; NEURAL CREST MIGRATION; EPH RECEPTORS; NEURONAL MIGRATION; MAMMALIAN BRAIN; STEM-CELLS; TRANSMEMBRANE LIGANDS; GROWTH-FACTOR; POLYSIALIC ACID	The subventricular zone (SVZ) of the lateral ventricles, the largest remaining germinal zone of the adult mammalian brain, contains an extensive network of neuroblasts migrating rostrally to the olfactory bulb. Little is known about the endogenous proliferation signals for SVZ neural stem cells or guidance cues along the migration pathway. Here we show that the receptor tyrosine kinases EphB1-3 and EphA4 and their transmembrane ligands, ephrins-B2/3, are expressed by cells of the SVZ. Electron microscopy revealed ephrin-B ligands associated with SVZ astrocytes, which function as stem cells in this germinal zone. A three-day infusion of the ectodomain of either EphB2 or ephrin-B2 into the lateral ventricle disrupted migration of neuroblasts and increased cell proliferation. These results suggest that Eph/ephrin signaling is involved in the migration of neuroblasts in the adult SVZ and in either direct or indirect regulation of cell proliferation.	Rockefeller Univ, New York, NY 10021 USA; Ecole Normale Super, CNRS, URA 1414, Paris, France; Univ Valencia, Valencia, Spain; Regeneron Pharmaceut Inc, Tarrytown, NY 10804 USA	Rockefeller University; Centre National de la Recherche Scientifique (CNRS); University of Valencia; Regeneron	Conover, JC (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.		García-Verdugo, José Manuel/L-8421-2017	García-Verdugo, José Manuel/0000-0001-9872-6499; Alvarez-Buylla, Arturo/0000-0003-4426-8925				ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Alvarez-Buylla A, 1998, J NEUROSCI, V18, P1020; ALVAREZBUYLLA A, 1988, J NEUROSCI METH, V25, P165, DOI 10.1016/0165-0270(88)90155-0; BRAMBILLA R, 1995, EMBO J, V14, P3116, DOI 10.1002/j.1460-2075.1995.tb07314.x; Bruce V, 1999, BRAIN RES, V821, P169, DOI 10.1016/S0006-8993(99)01112-9; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Chazal G, 2000, J NEUROSCI, V20, P1446; Craig CG, 1996, J NEUROSCI, V16, P2649; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; DRESCHER U, 1997, CURR BIOL, V7, P799; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Gale NW, 1997, CELL TISSUE RES, V290, P227, DOI 10.1007/s004410050927; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holder N, 1999, DEVELOPMENT, V126, P2033; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Krull CE, 1997, CURR BIOL, V7, P571, DOI 10.1016/S0960-9822(06)00256-9; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Orioli D, 1997, TRENDS GENET, V13, P354, DOI 10.1016/S0168-9525(97)01220-1; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Smith A, 1997, CURR BIOL, V7, P561, DOI 10.1016/S0960-9822(06)00255-7; Stein E, 1996, J BIOL CHEM, V271, P23588, DOI 10.1074/jbc.271.38.23588; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tropepe V, 1997, J NEUROSCI, V17, P7850; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; WINSLOW JW, 1995, NEURON, V14, P973, DOI 10.1016/0896-6273(95)90335-6; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9	50	394	424	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1091	1097		10.1038/80606	http://dx.doi.org/10.1038/80606			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036265				2022-12-17	WOS:000167177600013
J	Kemp, JA; McKernan, RM				Kemp, JA; McKernan, RM			NMDA receptor pathways as drug targets	NATURE NEUROSCIENCE			English	Review							D-SERINE; GLYCINE ANTAGONIST; ACUTE STROKE; IFENPRODIL; NEUROPROTECTION; DYSFUNCTION; MECHANISMS; SUBUNIT; SITE	Since the mid 1980s, there has been a great deal of enthusiasm within both academia and industry about the therapeutic potential of drugs targeting the NMDA subtype of glutamate receptors. That early promise is just beginning to translate into approvable drugs. Here we review the reasons for this slow progress and critically assess the future prospects for drugs that act on NMDA receptor pathways, including potential treatments for some major disorders such as stroke and Alzheimer's disease, for which effective therapies are still lacking.	Merck Sharp & Dohme Ltd, Neurosci Res Ctr, Merck Res Labs, Harlow CM20 2QR, Essex, England; EVOTEC Neurosci GmbH, D-22525 Hamburg, Germany	Merck & Company; Evotec	McKernan, RM (corresponding author), Merck Sharp & Dohme Ltd, Neurosci Res Ctr, Merck Res Labs, Terlings Pk,Eastwick Rd, Harlow CM20 2QR, Essex, England.	ruth_mckernan@merck.com						Boyce S, 1999, NEUROPHARMACOLOGY, V38, P611, DOI 10.1016/S0028-3908(98)00218-4; Chase TN, 2000, J NEUROL, V247, P36, DOI 10.1007/PL00007759; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Chizh BA, 2001, TRENDS PHARMACOL SCI, V22, P636, DOI 10.1016/S0165-6147(00)01863-0; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Davis M, 2002, EUR J NEUROSCI, V16, P395, DOI 10.1046/j.1460-9568.2002.02138.x; Del Dotto P, 2001, MOVEMENT DISORD, V16, P515, DOI 10.1002/mds.1112; Gill R, 2002, J PHARMACOL EXP THER, V302, P940, DOI 10.1124/jpet.102.034322; GOTTI B, 1988, J PHARMACOL EXP THER, V247, P1211; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Heresco-Levy U, 2002, AM J PSYCHIAT, V159, P480, DOI 10.1176/appi.ajp.159.3.480; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kemp JA, 1999, HANDB EXP PHARM, V141, P495; KEMP JA, 1998, DRUGS PHARM SCI, V89, P297; Kew JNC, 1996, J PHYSIOL-LONDON, V497, P761, DOI 10.1113/jphysiol.1996.sp021807; Krystal JH, 1999, HARVARD REV PSYCHIAT, V7, P125, DOI 10.1093/hrp/7.3.125; LEDERER R, 1993, BEHAV NEURAL BIOL, V60, P220, DOI 10.1016/0163-1047(93)90409-B; Lees KR, 2000, LANCET, V355, P1949, DOI 10.1016/S0140-6736(00)02326-6; LEESON PD, 1994, J MED CHEM, V37, P4053, DOI 10.1021/jm00050a001; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Malayev A, 2002, BRIT J PHARMACOL, V135, P901, DOI 10.1038/sj.bjp.0704543; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MONDADORI C, 1989, EXP BRAIN RES, V75, P449; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Parsons CG, 2001, EUR J PHARMACOL, V429, P71, DOI 10.1016/S0014-2999(01)01307-3; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; Sacco RL, 2001, JAMA-J AM MED ASSOC, V285, P1719, DOI 10.1001/jama.285.13.1719; SCHWARCZ RJ, 2001, PHARM EXP THER, V296, P659; Sheng M, 2001, J CELL SCI, V114, P1251; Tamminga CA, 1998, CRIT REV NEUROBIOL, V12, P21, DOI 10.1615/CritRevNeurobiol.v12.i1-2.20; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tranquillini, 1999, Expert Opin Investig Drugs, V8, P1837, DOI 10.1517/13543784.8.11.1837; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; Tsai GC, 1998, BIOL PSYCHIAT, V44, P1081, DOI 10.1016/S0006-3223(98)00279-0; WATKINS JC, 1994, NMDA RECEPTOR, P1; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409	37	393	428	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1039	1042		10.1038/nn936	http://dx.doi.org/10.1038/nn936			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403981				2022-12-17	WOS:000179041300009
J	Cheour, M; Ceponiene, R; Lehtokoski, A; Luuk, A; Allik, J; Alho, K; Naatanen, R				Cheour, M; Ceponiene, R; Lehtokoski, A; Luuk, A; Allik, J; Alho, K; Naatanen, R			Development of language-specific phoneme representations in the infant brain	NATURE NEUROSCIENCE			English	Article							PERCEPTION; DISCRIMINATION; CONTRASTS; RESPONSES; CHILDREN; ENGLISH; ADULTS		Univ Helsinki, Dept Psychol, Cognit Brain Res Unit, FIN-00014 Helsinki, Finland; Tartu State Univ, Dept Psychol, EE-202400 Tartu, Estonia	University of Helsinki; University of Tartu	Cheour, M (corresponding author), Univ Helsinki, Dept Psychol, Cognit Brain Res Unit, FIN-00014 Helsinki, Finland.	Marie.Cheour@Helsinki.fi	Alho, Kimmo/G-2997-2013; Allik, Jüri/N-3038-2019; Allik, Jüri/D-5609-2009	Alho, Kimmo/0000-0001-8563-2792; Allik, Jüri/0000-0002-8358-4747; Allik, Jüri/0000-0002-8358-4747				BEST CT, 1988, J EXP PSYCHOL HUMAN, V14, P345, DOI 10.1037/0096-1523.14.3.345; Cheour M, 1997, NEUROREPORT, V8, P1785, DOI 10.1097/00001756-199705060-00043; CheourLuhtanen M, 1996, PSYCHOPHYSIOLOGY, V33, P478, DOI 10.1111/j.1469-8986.1996.tb01074.x; IIVONEN A, 1995, PHONETICA, V52, P221, DOI 10.1159/000262174; Kraus N, 1996, SCIENCE, V273, P971, DOI 10.1126/science.273.5277.971; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Naatanen R., 1992, ATTENTION BRAIN FUNC; POLKA L, 1994, J EXP PSYCHOL HUMAN, V20, P421, DOI 10.1037/0096-1523.20.2.421; STRANGE W, 1984, PERCEPT PSYCHOPHYS, V36, P131, DOI 10.3758/BF03202673; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0; Werker J. F., 1994, DEV SPEECH PERCEPTIO; WERKER JF, 1988, DEV PSYCHOL, V24, P672, DOI 10.1037/0012-1649.24.5.672	14	393	397	2	79	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					351	353		10.1038/1561	http://dx.doi.org/10.1038/1561			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology	127QE	10196522				2022-12-17	WOS:000076361400010
J	Plant, K; Pelkey, KA; Bortolotto, ZA; Morita, D; Terashima, A; McBain, CJ; Collingridge, GL; Isaac, JTR				Plant, K; Pelkey, KA; Bortolotto, ZA; Morita, D; Terashima, A; McBain, CJ; Collingridge, GL; Isaac, JTR			Transient incorporation of native GluR2-lacking AMPA receptors during hippocampal long-term potentiation	NATURE NEUROSCIENCE			English	Article							CALCIUM-PERMEABLE AMPA; SUBUNIT COMPOSITION; PYRAMIDAL NEURONS; RECTIFICATION; SWITCH; TRAFFICKING; SYNAPSES; SUBTYPE; BLOCK; LTP	Postnatal glutamatergic principal neuron synapses are typically presumed to express only calcium-impermeable (CI), GluR2-containing AMPARs under physiological conditions. Here, however, we demonstrate that long-term potentiation (LTP) in CA1 hippocampal pyramidal neurons causes rapid incorporation of GluR2-lackingcalcium-permeable (CP)AMPARs: CP-AMPARs are present transiently, being replaced by GluR2-containing AMPARs similar to 25 min after LTP induction. Thus, CP-AMPARs are physiologically expressed at CA1 pyramidal cell synapses during LTP, and may be required for LTP consolidation.	Univ Bristol, Sch Med Sci, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA; NINDS, Dev Synapt Plast Unit, NIH, Bethesda, MD 20892 USA	University of Bristol; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Isaac, JTR (corresponding author), Univ Bristol, Sch Med Sci, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England.	isaacj@ninds.nih.gov	Collingridge, Graham L/C-4605-2015; collingridge, graham/AAI-8362-2020	Collingridge, Graham L/0000-0002-9572-5359; 	Intramural NIH HHS Funding Source: Medline; Medical Research Council [G9532377] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G9532377] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003011, Z01NS003011] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bagal AA, 2005, P NATL ACAD SCI USA, V102, P14434, DOI 10.1073/pnas.0501956102; Bellone C, 2005, EUR J NEUROSCI, V21, P1280, DOI 10.1111/j.1460-9568.2005.03979.x; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000	15	392	406	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					602	604		10.1038/nn1678	http://dx.doi.org/10.1038/nn1678			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16582904				2022-12-17	WOS:000237417200008
J	Andrew, D; Craig, AD				Andrew, D; Craig, AD			Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch	NATURE NEUROSCIENCE			English	Article							DORSAL-HORN NEURONS; HUMAN SKIN; EPIDURAL MORPHINE; CAT; CAPSAICIN; FIBERS; NOCICEPTORS; PROJECTIONS; SENSATION; RESPONSES	We found a class of lamina I spinothalamic tract (STT) neurons selectively excited by iontophoretic histamine. The responses of this class of neurons parallel the pure itching sensation this stimulus elicits in humans, and match the responses of peripheral C-fibers that have similar selectivity. These neurons have distinct central conduction velocities and thalamic projections, indicating that they constitute a unique subset of STT neurons. These findings can explain why a lesion of the lateral STT disrupts itch along with pain and temperature sensations. Our findings provide strong evidence that itch is subserved by specific neural elements both peripherally and centrally.	Barrow Neurol Inst, Div Neurosurg, Atkinson Pain Res Lab, Phoenix, AZ 85013 USA	Barrow Neurological Institute	Andrew, D (corresponding author), Barrow Neurol Inst, Div Neurosurg, Atkinson Pain Res Lab, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	dandrew@chw.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025616] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 25616] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALLANTYNE JC, 1988, PAIN, V33, P149, DOI 10.1016/0304-3959(88)90085-1; Bickford RG, 1938, CLIN SCI, V3, P377; Carstens E, 1997, J NEUROPHYSIOL, V77, P2499, DOI 10.1152/jn.1997.77.5.2499; CRAIG AD, 1991, J COMP NEUROL, V313, P377, DOI 10.1002/cne.903130212; CRAIG AD, 1985, J PHYSIOL-LONDON, V365, P197, DOI 10.1113/jphysiol.1985.sp015767; CRAIG AD, 1994, BRAIN RES, V636, P233, DOI 10.1016/0006-8993(94)91022-7; CRAIG AD, 1991, BRAIN RES, V558, P93, DOI 10.1016/0006-8993(91)90719-C; Craig AD, 1995, FRONTIER PAIN RES, P13; CRAIG AD, 1994, SCIENCE, V265, P252, DOI 10.1126/science.8023144; DUFFY BL, 1981, ANAESTHESIA, V36, P67, DOI 10.1111/j.1365-2044.1981.tb08609.x; GRAHAM DT, 1951, J CLIN INVEST, V30, P37, DOI 10.1172/JCI102414; GREEN BG, 1990, PERCEPT PSYCHOPHYS, V48, P12, DOI 10.3758/BF03205007; HALES P, 1980, LANCET, V2, P204; Han ZS, 1998, NAT NEUROSCI, V1, P218, DOI 10.1038/665; HANDWERKER HO, 1991, J NEUROPHYSIOL, V66, P307, DOI 10.1152/jn.1991.66.1.307; HSIEH JC, 1994, J NEUROPHYSIOL, V72, P3004, DOI 10.1152/jn.1994.72.6.3004; Hyndman OR, 1943, ARCH NEURO PSYCHIATR, V50, P129, DOI 10.1001/archneurpsyc.1943.02290200029002; Jinks SL, 2000, J NEUROPHYSIOL, V84, P616, DOI 10.1152/jn.2000.84.2.616; Keele C., 1964, SUBSTANCES PRODUCING; KRESS M, 1996, NEUROBIOLOGY NOCICEP, P284; LAMOTTE RH, 1991, J NEUROPHYSIOL, V66, P190, DOI 10.1152/jn.1991.66.1.190; LaMotte RH, 1996, NEUROBIOLOGY NOCICEP, P390; MAGERL W, 1990, J INVEST DERMATOL, V94, P347, DOI 10.1111/1523-1747.ep12874474; MCMAHON SB, 1992, TRENDS NEUROSCI, V15, P497, DOI 10.1016/0166-2236(92)90102-E; MUSIL SY, 1988, J COMP NEUROL, V272, P203, DOI 10.1002/cne.902720205; NATHAN PW, 1990, J NEUROL NEUROSUR PS, V53, P935, DOI 10.1136/jnnp.53.11.935; REEH PW, 1986, BRAIN RES, V384, P42, DOI 10.1016/0006-8993(86)91217-5; Schmelz M, 2000, BRAIN, V123, P560, DOI 10.1093/brain/123.3.560; Schmelz M, 1997, J NEUROSCI, V17, P8003; SCHMIDT R, 1995, J NEUROSCI, V15, P333; SCOTT DW, 1989, CORNELL BOOK CATS, P177; SIMONE DA, 1987, SOMATOSENS MOT RES, V5, P81, DOI 10.3109/07367228709144620; SIMONE DA, 1991, SOMATOSENS MOT RES, V8, P271, DOI 10.3109/08990229109144750; TUCKETT RP, 1987, BRAIN RES, V413, P95, DOI 10.1016/0006-8993(87)90157-0; YASUI Y, 1988, J COMP NEUROL, V274, P91, DOI 10.1002/cne.902740109; Zhang ET, 1996, J COMP NEUROL, V367, P537	36	392	412	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2001	4	1					72	77		10.1038/82924	http://dx.doi.org/10.1038/82924			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UB	11135647				2022-12-17	WOS:000167178000016
J	Crestani, F; Lorez, M; Baer, K; Essrich, C; Benke, D; Laurent, JP; Belzung, C; Fritschy, JM; Luscher, B; Mohler, H				Crestani, F; Lorez, M; Baer, K; Essrich, C; Benke, D; Laurent, JP; Belzung, C; Fritschy, JM; Luscher, B; Mohler, H			Decreased GABA(A)-receptor clustering results in enhanced anxiety and a bias for threat cues	NATURE NEUROSCIENCE			English	Article							BENZODIAZEPINE RECEPTOR-BINDING; PANIC DISORDER; IOMAZENIL-SPECT; MICE; BEHAVIOR; HIPPOCAMPUS; PLASTICITY; SUBTYPES; EMOTION; SUBUNIT	Patients with panic disorders show a deficit of GABA(A) receptors in the hippocampus, parahippocampus and orbitofrontal cortex. Synaptic clustering of GABA(A) receptors in mice heterozygous for the gamma 2 subunit was reduced, mainly in hippocampus and cerebral cortex. The gamma 2(+/-) mice showed enhanced behavioral inhibition toward natural aversive stimuli and heightened responsiveness in trace fear conditioning and ambiguous cue discrimination learning. Implicit and spatial memory as well as long-term potentiation in hippocampus were unchanged. Thus gamma 2(+/-) mice represent a model of anxiety characterized by harm avoidance behavior and an explicit memory bias for threat cues, resulting in heightened sensitivity to negative associations. This model implicates GABA(A)-receptor dysfunction in patients as a causal predisposition to anxiety disorders.	Swiss Fed Inst Technol, Inst Pharmacol, CH-8057 Zurich, Switzerland; Univ Zurich, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Mohler, H (corresponding author), Swiss Fed Inst Technol, Inst Pharmacol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.		Belzung, Catherine/P-6512-2016; Luscher, Bernhard/C-3528-2009	Belzung, Catherine/0000-0001-6095-5974; Luscher, Bernhard/0000-0003-1375-1906; Fritschy, Jean-Marc/0000-0002-8552-3702				Abadie P, 1999, EUR J NEUROSCI, V11, P1470, DOI 10.1046/j.1460-9568.1999.00556.x; ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; Beracochea D J, 1990, J Cogn Neurosci, V2, P133, DOI 10.1162/jocn.1990.2.2.133; BEUZEN A, 1995, PHYSIOL BEHAV, V58, P111, DOI 10.1016/0031-9384(95)00013-9; BLANCHARD DC, 1988, ANNU REV PSYCHOL, V39, P43, DOI 10.1146/annurev.ps.39.020188.000355; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Carlson S, 1996, HEARING RES, V99, P168, DOI 10.1016/S0378-5955(96)00098-6; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; EYSENCK MW, 1992, HDB INDIVIDUAL DIFFE, P157; Fritschy JM, 1998, J COMP NEUROL, V390, P194; GLUE P, 1995, J ANXIETY DISORD, V9, P33, DOI 10.1016/0887-6185(94)00026-7; Gray J A, 1996, Nebr Symp Motiv, V43, P61; GRIEBEL G, 1993, BEHAV PHARMACOL, V4, P637; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; HAEFELY WE, 1994, CHALLENGE NEUROPHARM, P15; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; Holland PC, 1997, ANIM LEARN BEHAV, V25, P373, DOI 10.3758/BF03209846; Holland PC, 1983, QUANTITATIVE ANAL BE, V4, P183; KASCHKA W, 1995, J PSYCHIAT RES, V29, P427, DOI 10.1016/0022-3956(95)00019-2; KIM JJ, 1995, BEHAV NEUROSCI, V109, P195, DOI 10.1037/0735-7044.109.2.195; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Ledoux Joseph E., 1995, P1049; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.ne.17.030194.003033; Malizia AL, 1998, ARCH GEN PSYCHIAT, V55, P715, DOI 10.1001/archpsyc.55.8.715; MCGAUGH JL, 1990, PSYCHOL SCI, V1, P15, DOI 10.1111/j.1467-9280.1990.tb00060.x; McNally R J, 1996, Nebr Symp Motiv, V43, P211; McNaughton N, 1997, PHARMACOL BIOCHEM BE, V56, P603, DOI 10.1016/S0091-3057(96)00419-4; MISSLIN R, 1989, BEHAV PROCESS, V18, P119, DOI 10.1016/S0376-6357(89)80010-5; NORDAHL TE, 1990, NEUROPSYCHOPHARMACOL, V3, P261; OBOYLE CA, 1986, PSYCHOPHARMACOLOGY, V88, P226, DOI 10.1007/BF00652245; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; REIMAN EM, 1984, NATURE, V310, P683, DOI 10.1038/310683a0; Rogan MT, 1996, CELL, V85, P469, DOI 10.1016/S0092-8674(00)81247-7; SCHLEGEL S, 1994, EUR ARCH PSY CLIN N, V244, P49, DOI 10.1007/BF02279812; Tiihonen J, 1997, MOL PSYCHIATR, V2, P463, DOI 10.1038/sj.mp.4000329; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; [No title captured]	39	392	402	3	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	1999	2	9					833	839		10.1038/12207	http://dx.doi.org/10.1038/12207			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	259FB	10461223				2022-12-17	WOS:000083882900015
J	Cruikshank, SJ; Lewis, TJ; Connors, BW				Cruikshank, Scott J.; Lewis, Timothy J.; Connors, Barry W.			Synaptic basis for intense thalamocortical activation of feedforward inhibitory cells in neocortex	NATURE NEUROSCIENCE			English	Article							INTERNEURON DIVERSITY SERIES; SOMATOSENSORY BARREL CORTEX; CORTICAL RECEPTIVE-FIELDS; SPINY STELLATE NEURONS; PRIMARY VISUAL-CORTEX; LAYER-IV; RESPONSES; SYNAPSES; NETWORKS; GABA	The thalamus provides fundamental input to the neocortex. This input activates inhibitory interneurons more strongly than excitatory neurons, triggering powerful feedforward inhibition. We studied the mechanisms of this selective neuronal activation using a mouse somatosensory thalamocortical preparation. Notably, the greater responsiveness of inhibitory interneurons was not caused by their distinctive intrinsic properties but was instead produced by synaptic mechanisms. Axons from the thalamus made stronger and more frequent excitatory connections onto inhibitory interneurons than onto excitatory cells. Furthermore, circuit dynamics allowed feedforward inhibition to suppress responses in excitatory cells more effectively than in interneurons. Thalamocortical excitatory currents rose quickly in interneurons, allowing them to fire action potentials before significant feedforward inhibition emerged. In contrast, thalamocortical excitatory currents rose slowly in excitatory cells, overlapping with feedforward inhibitory currents that suppress action potentials. These results demonstrate the importance of selective synaptic targeting and precise timing in the initial stages of neocortical processing.	Brown Univ, Dept Neurosci, Div Biol & Med, Providence, RI 02912 USA; Univ Calif Davis, Dept Math, Davis, CA 95616 USA	Brown University; University of California System; University of California Davis	Connors, BW (corresponding author), Brown Univ, Dept Neurosci, Div Biol & Med, Box G-LN, Providence, RI 02912 USA.	barry_connors@brown.edu	Connors, Barry/AAX-1975-2020	Connors, Barry/0000-0002-3739-3157				AGMON A, 1992, J NEUROSCI, V12, P319; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Ahmed B, 1997, J COMP NEUROL, V380, P230; AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; Alonso JM, 2005, J NEUROPHYSIOL, V94, P26, DOI 10.1152/jn.01281.2004; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; BENSHALOM G, 1986, J COMP NEUROL, V253, P303, DOI 10.1002/cne.902530303; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Bruno RM, 2002, J NEUROSCI, V22, P10966; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gil Z, 1996, J NEUROSCI, V16, P6567; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; Higley MJ, 2006, J NEUROSCI, V26, P448, DOI 10.1523/JNEUROSCI.3506-05.2006; Inoue T, 2006, J NEUROPHYSIOL, V96, P1746, DOI 10.1152/jn.00301.2006; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; KELLER A, 1987, J COMP NEUROL, V262, P1, DOI 10.1002/cne.902620102; Lambolez B, 1996, P NATL ACAD SCI USA, V93, P1797, DOI 10.1073/pnas.93.5.1797; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Martina M, 2001, J NEUROPHYSIOL, V86, P2887, DOI 10.1152/jn.2001.86.6.2887; MCNAUGHTON BL, 1981, J NEUROPHYSIOL, V46, P952, DOI 10.1152/jn.1981.46.5.952; MILLER W, 1988, CABIOS, V4, P11; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; MOUNTCASTLE VM, 1989, PERPETUAL NEUROSCIEN; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; Staiger JF, 1996, EUR J NEUROSCI, V8, P2273, DOI 10.1111/j.1460-9568.1996.tb01191.x; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Swadlow HA, 2002, PHILOS T R SOC B, V357, P1717, DOI 10.1098/rstb.2002.1156; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Walker HC, 2002, NEURON, V35, P161, DOI 10.1016/S0896-6273(02)00734-1; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Zhou FM, 1998, BRAIN RES, V780, P166, DOI 10.1016/S0006-8993(97)01311-5	41	391	397	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					462	468		10.1038/nn1861	http://dx.doi.org/10.1038/nn1861			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17334362	Green Published			2022-12-17	WOS:000245228600017
J	Beauchamp, MS; Argall, BD; Bodurka, J; Duyn, JH; Martin, A				Beauchamp, MS; Argall, BD; Bodurka, J; Duyn, JH; Martin, A			Unraveling multisensory integration: patchy organization within human STS multisensory cortex	NATURE NEUROSCIENCE			English	Article							SUPERIOR TEMPORAL SULCUS; OCULAR DOMINANCE; MACAQUE MONKEY; RHESUS-MONKEY; HUMAN BRAIN; PROJECTIONS; OBJECTS; SIGNAL; TRACER; SPEECH	Although early sensory cortex is organized along dimensions encoded by receptor organs, little is known about the organization of higher areas in which different modalities are integrated. We investigated multisensory integration in human superior temporal sulcus using recent advances in parallel imaging to perform functional magnetic resonance imaging (fMRI) at very high resolution. These studies suggest a functional architecture in which information from different modalities is brought into close proximity via a patchy distribution of inputs, followed by integration in the intervening cortex.	NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA; NINDS, Sect Adv MRI, Lab Funct & Mol Imaging, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Beauchamp, MS (corresponding author), NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA.	mbeauchamp@nih.gov	Argall, Brenna/G-2543-2011; Duyn, Jozef H/F-2483-2010; Beauchamp, Michael/AAK-9813-2020; martin, alex/B-6176-2009	Beauchamp, Michael/0000-0002-7599-9934; 	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002588, Z01MH002588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002990, Z01NS002990] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beauchamp MS, 2002, NEURON, V34, P149, DOI 10.1016/S0896-6273(02)00642-6; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; BENEVENTO LA, 1977, EXP NEUROL, V57, P849, DOI 10.1016/0014-4886(77)90112-1; Bodurka J, 2004, MAGNET RESON MED, V51, P165, DOI 10.1002/mrm.10693; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Cheng K, 2001, NEURON, V32, P359, DOI 10.1016/S0896-6273(01)00477-9; de Zwart JA, 2004, MAGNET RESON MED, V51, P22, DOI 10.1002/mrm.10678; Goodyear BG, 2001, HUM BRAIN MAPP, V14, P210, DOI 10.1002/hbm.1053; HIKOSAKA K, 1988, J NEUROPHYSIOL, V60, P1615, DOI 10.1152/jn.1988.60.5.1615; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Seltzer B, 1996, J COMP NEUROL, V370, P173, DOI 10.1002/(SICI)1096-9861(19960624)370:2<173::AID-CNE4>3.0.CO;2-#; SELTZER B, 1994, J COMP NEUROL, V343, P445, DOI 10.1002/cne.903430308; van Atteveldt N, 2004, NEURON, V43, P271, DOI 10.1016/j.neuron.2004.06.025; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Wright TM, 2003, CEREB CORTEX, V13, P1034, DOI 10.1093/cercor/13.10.1034	15	391	391	4	45	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1190	1192		10.1038/nn1333	http://dx.doi.org/10.1038/nn1333			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15475952				2022-12-17	WOS:000224749400010
J	Ullman, S; Vidal-Naquet, M; Sali, E				Ullman, S; Vidal-Naquet, M; Sali, E			Visual features of intermediate complexity and their use in classification	NATURE NEUROSCIENCE			English	Article							OBJECT RECOGNITION; FACE RECOGNITION; NATURAL SCENES; CORTEX; SELECTIVITY; EIGENFACES; IMAGES; SHAPE	The human visual system analyzes shapes and objects in a series of stages in which stimulus features of increasing complexity are extracted and analyzed. The first stages use simple local features, and the image is subsequently represented in terms of larger and more complex features. These include features of intermediate complexity and partial object views. The nature and use of these higher-order representations remains an open question in the study of visual processing by the primate cortex. Here we show that intermediate complexity (IC) features are optimal for the basic visual task of classification. Moderately complex features are more informative for classification than very simple or very complex ones, and so they emerge naturally by the simple coding principle of information maximization with respect to a class of images. Our findings suggest a specific role for IC features in visual processing and a principle for their extraction.	Weizmann Inst Sci, Dept Appl Math & Comp Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Ullman, S (corresponding author), Weizmann Inst Sci, Dept Appl Math & Comp Sci, POB 26, IL-76100 Rehovot, Israel.	shimon.ullman@weizmann.ac.il						ATICK JJ, 1992, NEURAL COMPUT, V4, P196, DOI 10.1162/neco.1992.4.2.196; Ballard D.H., 1982, COMPUTER VISION; BARLOW H, 1989, COMP NEUR S, P54; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Bhat DN, 1998, IEEE T PATTERN ANAL, V20, P415, DOI 10.1109/34.677275; BRUNELLI R, 1993, IEEE T PATTERN ANAL, V15, P1042, DOI 10.1109/34.254061; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Mel BW, 1997, NEURAL COMPUT, V9, P777, DOI 10.1162/neco.1997.9.4.777; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; ROLLS ET, 1991, CURR OPIN NEUROBIOL, V1, P275; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; TANAKA K, 1993, SCIENCE, V262, P685, DOI 10.1126/science.8235589; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Ullman S, 1999, NEURAL NETWORKS, V12, P1021, DOI 10.1016/S0893-6080(99)00048-9; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Vogels R, 1999, NEUROREPORT, V10, P1811, DOI 10.1097/00001756-199906230-00002; Wiskott L, 1997, IEEE T PATTERN ANAL, V19, P775, DOI 10.1109/34.598235; Yang MH, 2002, IEEE T PATTERN ANAL, V24, P34, DOI 10.1109/34.982883	28	391	396	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					682	687		10.1038/nn870	http://dx.doi.org/10.1038/nn870			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12055634				2022-12-17	WOS:000176414300019
J	Petralia, RS; Esteban, JA; Wang, YX; Partridge, JG; Zhao, HM; Wenthold, RJ; Malinow, R				Petralia, RS; Esteban, JA; Wang, YX; Partridge, JG; Zhao, HM; Wenthold, RJ; Malinow, R			Selective acquisition of AMPA receptors over postnatal development suggests a molecular basis for silent synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; GLUTAMATE RECEPTORS; HIPPOCAMPAL SLICES; RAT-BRAIN; NEURONS; SUBUNITS; LIGHT; LTP; LOCALIZATION; EXPRESSION	Early in postnatal development, glutamatergic synapses transmit primarily through NMDA receptors. As development progresses, synapses acquire AMPA receptor function. The molecular basis of these physiological observations is not known. Here we examined single excitatory synapses with immunogold electron-microscopic analysis of AMPA and NMDA receptors along with electrophysiological measurements. Early in postnatal development, a significant fraction of excitatory synapses had NMDA receptors and lacked AMPA receptors. As development progressed, synapses acquired AMPA receptors with little change in NMDA receptor number. Thus, synapses with NMDA receptors but no AMPA receptors can account for the electrophysiologically observed 'silent synapse'.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; NIDCD, Neurochem Lab, NIH, Bethesda, MD 20892 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Cold Spring Harbor Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Vanderbilt University	Malinow, R (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.		Esteban, Jose/L-4944-2014	Esteban, Jose/0000-0002-3759-3300	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000003, ZIADC000003] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Desmond NL, 1998, NEUROREPORT, V9, P857, DOI 10.1097/00001756-199803300-00017; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; FOX K, 1995, NEURON, V15, P485, DOI 10.1016/0896-6273(95)90136-1; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; JOHNSON ML, 1992, METHOD ENZYMOL, V210, P1; KATZ LC, 1996, SCIENCE, V274, P1132; Kharazia VN, 1996, NEUROSCI LETT, V210, P37, DOI 10.1016/0304-3940(96)12658-6; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Liao DZ, 1996, LEARN MEMORY, V3, P138, DOI 10.1101/lm.3.2-3.138; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Matsubara A, 1996, J NEUROSCI, V16, P4457; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; PETRALIA RS, 1994, J NEUROSCI, V14, P667; Rusakov DA, 1998, J NEUROSCI, V18, P3158; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; STRAUME M, 1992, METHOD ENZYMOL, V210, P117; WANG BL, 1985, HISTOCHEMISTRY, V83, P47, DOI 10.1007/BF00495299; Wang YX, 1998, J NEUROSCI, V18, P1148; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhao HM, 1998, J NEUROSCI, V18, P5517, DOI 10.1523/JNEUROSCI.18-14-05517.1998	32	391	406	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					31	36		10.1038/4532	http://dx.doi.org/10.1038/4532			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195177				2022-12-17	WOS:000078409300010
J	Royer, S; Zemelman, BV; Losonczy, A; Kim, J; Chance, F; Magee, JC; Buzsaki, G				Royer, Sebastien; Zemelman, Boris V.; Losonczy, Attila; Kim, Jinhyun; Chance, Frances; Magee, Jeffrey C.; Buzsaki, Gyoergy			Control of timing, rate and bursts of hippocampal place cells by dendritic and somatic inhibition	NATURE NEUROSCIENCE			English	Article							CA1 PYRAMIDAL NEURONS; PHASE-PRECESSION; THETA OSCILLATIONS; IN-VIVO; SYNAPTIC PLASTICITY; INTERNEURONS; DYNAMICS; MECHANISMS; SEQUENCES; CORTEX	A consortium of inhibitory neurons control the firing patterns of pyramidal cells, but their specific roles in the behaving animal are largely unknown. We performed simultaneous physiological recordings and optogenetic silencing of either perisomatic (parvalbumin (PV) expressing) or dendrite-targeting (somatostatin (SOM) expressing) interneurons in hippocampal area CA1 of head-fixed mice actively moving a treadmill belt rich with visual-tactile stimuli. Silencing of either PV or SOM interneurons increased the firing rates of pyramidal cells selectively in their place fields, with PV and SOM interneurons having their largest effect during the rising and decaying parts of the place field, respectively. SOM interneuron silencing powerfully increased burst firing without altering the theta phase of spikes. In contrast, PV interneuron silencing had no effect on burst firing, but instead shifted the spikes' theta phase toward the trough of theta. These findings indicate that perisomatic and dendritic inhibition have distinct roles in controlling the rate, burst and timing of hippocampal pyramidal cells.	[Royer, Sebastien; Zemelman, Boris V.; Losonczy, Attila; Kim, Jinhyun; Chance, Frances; Magee, Jeffrey C.; Buzsaki, Gyoergy] Howard Hughes Med Inst, Ashburn, VA USA; [Royer, Sebastien; Kim, Jinhyun] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul, South Korea; [Losonczy, Attila] Columbia Univ, Dept Neurosci, New York, NY USA; [Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Howard Hughes Medical Institute; Korea Institute of Science & Technology (KIST); Columbia University; Rutgers State University Newark; Rutgers State University New Brunswick	Magee, JC (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	mageej@janelia.hhmi.org; gyorgy.buzsaki@nyumc.org		Chance, Frances/0000-0003-1420-4664; Zemelman, Boris/0000-0003-2463-4887; Buzsaki, Gyorgy/0000-0002-3100-4800	Howard Hughes Medical Institute; US National Institutes of Health [NS34994, MH54671]; James S. McDonnell Foundation; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology of Korea (NRF) [WCI 2009-003]; Kavli and Searle Foundations; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology of Korea (NRF)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Kavli and Searle Foundations; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G.F. Turi, T. Adelman and T. Tabachnik for technical contributions, and D. Huber for useful advice. This work was supported by the Howard Hughes Medical Institute, the US National Institutes of Health (NS34994, MH54671), the James S. McDonnell Foundation and the World Class Institute (WCI) Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology of Korea (NRF grant number: WCI 2009-003). A.L. was supported by the Kavli and Searle Foundations.	Azouz R, 1996, J PHYSIOL-LONDON, V492, P211, DOI 10.1113/jphysiol.1996.sp021302; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Buzsaki G, 1996, P NATL ACAD SCI USA, V93, P9921, DOI 10.1073/pnas.93.18.9921; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Geisler C, 2010, P NATL ACAD SCI USA, V107, P7957, DOI 10.1073/pnas.0912478107; Hangya B, 2010, J PHYSIOL-LONDON, V588, P4165, DOI 10.1113/jphysiol.2010.194274; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hirase H, 1999, EUR J NEUROSCI, V11, P4373, DOI 10.1046/j.1460-9568.1999.00853.x; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Huxter JR, 2008, NAT NEUROSCI, V11, P587, DOI 10.1038/nn.2106; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kullmann DM, 2007, NAT REV NEUROSCI, V8, P687, DOI 10.1038/nrn2207; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Losonczy A, 2010, NAT NEUROSCI, V13, P967, DOI 10.1038/nn.2597; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Magee JC, 2001, J NEUROPHYSIOL, V86, P528, DOI 10.1152/jn.2001.86.1.528; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Maurer AP, 2006, J NEUROSCI, V26, P13485, DOI 10.1523/JNEUROSCI.2882-06.2006; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; O'Connor DH, 2009, NATURE, V461, P923, DOI 10.1038/nature08539; O'Keefe J, 2006, NEUROSCIENCE, P475; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Royer S, 2010, EUR J NEUROSCI, V31, P2279, DOI 10.1111/j.1460-9568.2010.07250.x; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116	48	390	392	6	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					769	775		10.1038/nn.3077	http://dx.doi.org/10.1038/nn.3077			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22446878	Green Accepted			2022-12-17	WOS:000303270200022
J	Jazayeri, M; Shadlen, MN				Jazayeri, Mehrdad; Shadlen, Michael N.			Temporal context calibrates interval timing	NATURE NEUROSCIENCE			English	Article							FRONTAL-CORTEX; NEURAL BASIS; TIME; REPRESENTATION; DECISION; CUES; DISCRIMINATION; INTEGRATION; PERCEPTION; JUDGMENT	We use our sense of time to identify temporal relationships between events and to anticipate actions. The degree to which we can exploit temporal contingencies depends on the variability of our measurements of time. We asked humans to reproduce time intervals drawn from different underlying distributions. As expected, production times were more variable for longer intervals. However, production times exhibited a systematic regression toward the mean. Consequently, estimates for a sample interval differed depending on the distribution from which it was drawn. A performance-optimizing Bayesian model that takes the underlying distribution of samples into account provided an accurate description of subjects' performance, variability and bias. This finding suggests that the CNS incorporates knowledge about temporal uncertainty to adapt internal timing mechanisms to the temporal statistics of the environment.	[Jazayeri, Mehrdad] Helen Hay Whitney Fdn, New York, NY USA; [Jazayeri, Mehrdad; Shadlen, Michael N.] Univ Washington, Dept Physiol & Biophys, Natl Primate Res Ctr, Howard Hughes Med Inst, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Jazayeri, M (corresponding author), Helen Hay Whitney Fdn, New York, NY USA.	mjaz@u.washington.edu	Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210	Helen Hay Whitney Foundation; Howard Hughes Medical Institute; US National Institutes of Health [EY11378, RR000166]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to G. Horwitz for sharing resources and to both G. Horwitz and V. de Lafuente for their feedback on the manuscript. This work was supported by a fellowship from Helen Hay Whitney Foundation, the Howard Hughes Medical Institute and research grants EY11378 and RR000166 from the US National Institutes of Health.	AHRENS M, 2008, ADV NEURAL INFORM PR; ALLAN LG, 1979, PERCEPT PSYCHOPHYS, V26, P340, DOI 10.3758/BF03204158; Bernardo J. M., 1994, BAYESIAN THEORY; Brannon EM, 2008, J COGNITIVE NEUROSCI, V20, P193, DOI 10.1162/jocn.2008.20016; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; CREELMAN CD, 1962, J ACOUST SOC AM, V34, P582, DOI 10.1121/1.1918172; Cui X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000167; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; GIBBON J, 1992, J EXP ANAL BEHAV, V57, P393, DOI 10.1901/jeab.1992.57-393; Gold JI, 2008, J NEUROPHYSIOL, V100, P2653, DOI 10.1152/jn.90629.2008; Graf EW, 2005, VISION RES, V45, P3050, DOI 10.1016/j.visres.2005.08.007; HELSON H, 1948, PSYCHOL REV, V55, P297, DOI 10.1037/h0056721; HOLLINGWORTH HL, 1913, ARCH PSYCHOL, V4, P44; Hudson TE, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000130; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Knill DC, 1996, PERCEPTION BAYESIAN; Kording KP, 2004, P NATL ACAD SCI USA, V101, P9839, DOI 10.1073/pnas.0308394101; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Lauwereyns J, 2002, NEURON, V33, P463, DOI 10.1016/S0896-6273(02)00571-8; Lee IH, 2003, J NEUROPHYSIOL, V89, P2528, DOI 10.1152/jn.01055.2002; Lewis PA, 2009, PHILOS T R SOC B, V364, P1897, DOI 10.1098/rstb.2009.0020; Maimon G, 2006, NAT NEUROSCI, V9, P948, DOI 10.1038/nn1716; Mamassian P, 2002, NEU INF PRO, P13; Mamassian P, 2008, PSYCHOL SCI, V19, P601, DOI 10.1111/j.1467-9280.2008.02129.x; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; Mita A, 2009, NAT NEUROSCI, V12, P502, DOI 10.1038/nn.2272; Miyazaki M, 2005, J NEUROPHYSIOL, V94, P395, DOI 10.1152/jn.01168.2004; Nobrel AC, 2007, CURR OPIN NEUROBIOL, V17, P465, DOI 10.1016/j.conb.2007.07.006; OKANO K, 1987, EXP BRAIN RES, V66, P155; PARDUCCI A, 1965, PSYCHOL REV, V72, P407, DOI 10.1037/h0022602; Rakitin BC, 1998, J EXP PSYCHOL-ANIM B, V24, P15, DOI 10.1037/0097-7403.24.1.15; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Raphan M., 2006, NEURAL INFORM PROCES, V19, P1145; Reutimann J, 2004, J NEUROSCI, V24, P3295, DOI 10.1523/JNEUROSCI.4098-03.2004; SCHULTZ W, 1992, EXP BRAIN RES, V91, P363; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Tanaka M, 2006, NAT NEUROSCI, V9, P20, DOI 10.1038/nn1617; Tanaka M, 2007, J NEUROSCI, V27, P12109, DOI 10.1523/JNEUROSCI.1873-07.2007; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Trommershauser J, 2003, J OPT SOC AM A, V20, P1419, DOI 10.1364/JOSAA.20.001419	48	390	392	4	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					1020	U152		10.1038/nn.2590	http://dx.doi.org/10.1038/nn.2590			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20581842	Green Accepted			2022-12-17	WOS:000280400600022
J	Li, YP; Liu, WC; Oo, TF; Wang, L; Tang, Y; Jackson-Lewis, V; Zhou, C; Geghman, K; Bogdanov, M; Przedborski, S; Beal, MF; Burke, RE; Li, CJ				Li, Yanping; Liu, Wencheng; Oo, Tinmarla F.; Wang, Lei; Tang, Yi; Jackson-Lewis, Vernice; Zhou, Chun; Geghman, Kindiya; Bogdanov, Mikhail; Przedborski, Serge; Beal, M. Flint; Burke, Robert E.; Li, Chenjian			Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease	NATURE NEUROSCIENCE			English	Article							MUTATION; GENE; ACTIVATION; EXPRESSION; PATHOLOGY; REGION	Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease. We created a LRRK2 transgenic mouse model that recapitulates cardinal features of the disease: an age-dependent and levodopa-responsive slowness of movement associated with diminished dopamine release and axonal pathology of nigrostriatal dopaminergic projection. These mice provide a valid model of Parkinson's disease and are a resource for the investigation of pathogenesis and therapeutics.	[Li, Yanping; Liu, Wencheng; Wang, Lei; Tang, Yi; Geghman, Kindiya; Bogdanov, Mikhail; Beal, M. Flint; Li, Chenjian] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA; [Oo, Tinmarla F.; Jackson-Lewis, Vernice; Zhou, Chun; Przedborski, Serge; Burke, Robert E.] Columbia Univ, Dept Neurol, New York, NY USA; [Oo, Tinmarla F.; Jackson-Lewis, Vernice; Zhou, Chun; Przedborski, Serge; Burke, Robert E.] Columbia Univ, Dept Pathol, New York, NY USA; [Wang, Lei; Bogdanov, Mikhail] Bedford Vet Adm Med Ctr, Bedford, MA USA	Cornell University; Columbia University; Columbia University	Li, CJ (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA.	chl2011@med.cornell.edu	li, yan/GTI-4638-2022; Burke, Robert/B-7226-2011	Burke, Robert/0000-0002-4760-8553	Michael J. Fox Foundation; US National Institutes of Health; Department of Defense; Parkinson's Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038370, R01NS026836] Funding Source: NIH RePORTER	Michael J. Fox Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Parkinson's Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We wish to thank K. Merchant and her team at Eli Lilly and Company for generating the immunoblot data that facilitated selection of transgenic lines, S. Fleming and M.- F. Chesselet for advice on behavioral studies, and X. William Yang and A. Yamamoto for insightful discussions. This work was supported in part by grants from the Michael J. Fox Foundation and the US National Institutes of Health to C. L., from the Department of Defense to M. F. B., and from US National Institutes of Health and the Parkinson's Disease Foundation to R. E. B. and T. F. O.	Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; Buki A, 2000, J NEUROSCI, V20, P2825; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Di Fonzo A, 2005, LANCET, V365, P412; Duda JE, 2002, ANN NEUROL, V52, P205, DOI 10.1002/ana.10279; El-Khodor BF, 2002, J COMP NEUROL, V452, P65, DOI 10.1002/cne.10367; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Melrose HL, 2007, NEUROSCIENCE, V147, P1047, DOI 10.1016/j.neuroscience.2007.05.027; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Saunders-Pullman R, 2006, NEUROSCI LETT, V402, P92, DOI 10.1016/j.neulet.2006.03.044; Tobin JE, 2008, NEUROLOGY, V71, P28, DOI 10.1212/01.wnl.0000304051.01650.23; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	15	390	402	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2009	12	7					826	828		10.1038/nn.2349	http://dx.doi.org/10.1038/nn.2349			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	462OA	19503083	Green Accepted			2022-12-17	WOS:000267362900008
J	Huang, ZL; Qu, WM; Eguchi, N; Chen, JF; Schwarzschild, MA; Fredholm, BB; Urade, Y; Hayaishi, O				Huang, ZL; Qu, WM; Eguchi, N; Chen, JF; Schwarzschild, MA; Fredholm, BB; Urade, Y; Hayaishi, O			Adenosine A2(A), but not A(1), receptors mediate the arousal effect of caffeine	NATURE NEUROSCIENCE			English	Article							HOMEOSTATIC REGULATION; SLEEP; RATS	Caffeine, a component of tea, coffee and cola, induces wakefulness. It binds to adenosine A(1) and A(2A) receptors as an antagonist, but the receptor subtype mediating caffeine-induced wakefulness remains unclear. Here we report that caffeine at 5, 10 and 15 mg kg(-1) increased wakefulness in both wild-type mice and A(1) receptor knockout mice, but not in A(2A) receptor knockout mice. Thus, caffeine-induced wakefulness depends on adenosine A(2A) receptors.	Osaka Biosci Inst, Dept Mol Behav Biol, Osaka 5650874, Japan; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Massachusetts Gen Hosp, Mol Neurobiol Lab, Boston, MA 02129 USA; Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden	Boston University; Harvard University; Massachusetts General Hospital; Karolinska Institutet	Hayaishi, O (corresponding author), Osaka Biosci Inst, Dept Mol Behav Biol, Osaka 5650874, Japan.	hayaishi@obi.or.jp		Huang, Zhi-Li/0000-0001-9359-1150; Chen, Jiang-Fan/0000-0002-0446-3956				Basheer R, 2004, PROG NEUROBIOL, V73, P379, DOI 10.1016/j.pneurobio.2004.06.004; El Yacoubi M, 2003, NEUROPHARMACOLOGY, V45, P977, DOI 10.1016/S0028-3908(03)00254-5; Fisone G, 2004, CELL MOL LIFE SCI, V61, P857, DOI 10.1007/s00018-003-3269-3; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Fredholm BB, 2005, ANNU REV PHARMACOL, V45, P385, DOI 10.1146/annurev.pharmtox.45.120403.095731; Hayaishi O, 2004, ARCH ITAL BIOL, V142, P533; Hong ZY, 2005, J NEUROCHEM, V92, P1542, DOI 10.1111/j.1471-4159.2004.02991.x; Mignot E, 2002, NAT NEUROSCI, V5, P1071, DOI 10.1038/nn944; Porkka-Heiskanen T, 2002, SLEEP MED REV, V6, P321, DOI 10.1053/smrv.2001.0201; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; RAINNIE DG, 1994, SCIENCE, V263, P689, DOI 10.1126/science.8303279; Satoh S, 1996, P NATL ACAD SCI USA, V93, P5980, DOI 10.1073/pnas.93.12.5980; Scammell TE, 2001, NEUROSCIENCE, V107, P653, DOI 10.1016/S0306-4522(01)00383-9; Stenberg D, 2003, J SLEEP RES, V12, P283, DOI 10.1046/j.0962-1105.2003.00367.x	15	390	422	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					858	859		10.1038/nn1491	http://dx.doi.org/10.1038/nn1491			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15965471				2022-12-17	WOS:000230137100010
J	Storkebaum, E; Lambrechts, D; Dewerchin, M; Moreno-Murciano, MP; Appelmans, S; Oh, H; Van Damme, P; Rutten, B; Man, WY; De Mol, M; Wyns, S; Manka, D; Vermeulen, K; Van den Bosch, L; Mertens, N; Schmitz, C; Robberecht, W; Conway, EM; Collen, D; Moons, L; Carmeliet, P				Storkebaum, E; Lambrechts, D; Dewerchin, M; Moreno-Murciano, MP; Appelmans, S; Oh, H; Van Damme, P; Rutten, B; Man, WY; De Mol, M; Wyns, S; Manka, D; Vermeulen, K; Van den Bosch, L; Mertens, N; Schmitz, C; Robberecht, W; Conway, EM; Collen, D; Moons, L; Carmeliet, P			Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; LEUKEMIA INHIBITORY FACTOR; MOTOR-NEURON DEGENERATION; CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; PROLONGS SURVIVAL; GROWTH-FACTORS; MOUSE; MICE; GENE	Neurotrophin treatment has so far failed to prolong the survival of individuals affected with amyotrophic lateral sclerosis (ALS), an incurable motoneuron degenerative disorder. Here we show that intracerebroventricular (i.c.v.) delivery of recombinant vascular endothelial growth factor (Vegf) in a SOD1(G93A) rat model of ALS delays onset of paralysis by 17 d, improves motor performance and prolongs survival by 22 d, representing the largest effects in animal models of ALS achieved by protein delivery. By protecting cervical motoneurons, i.c.v. delivery of Vegf is particularly effective in rats with the most severe form of ALS with forelimb onset. Vegf has direct neuroprotective effects on motoneurons in vivo, because neuronal expression of a transgene expressing the Vegf receptor prolongs the survival of SOD1(G93A) mice. On i.c.v. delivery, Vegf is anterogradely transported and preserves neuromuscular junctions in SOD1(G93A) rats. Our findings in preclinical rodent models of ALS may have implications for treatment of neurodegenerative disease in general.	Katholieke Univ Leuven VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Leuven, Belgium; Katholieke Univ Leuven, Fac Med, Dept Neurol, B-3000 Leuven, Belgium; Maastricht Univ, Dept Psychiat & Neuropsychol, Div Cellular Neurosci, NL-6200 MD Maastricht, Netherlands; European Grad Sch Neurosci EURON, NL-6200 MD Maastricht, Netherlands; State Univ Ghent VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Maastricht University; Maastricht University; Flanders Institute for Biotechnology (VIB); Ghent University	Carmeliet, P (corresponding author), Katholieke Univ Leuven VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Leuven, Belgium.	peter.carmeliet@med.kuleuven.ac.be	Moreno, Paz/K-6870-2012; Carmeliet, Peter/AAQ-5140-2020; Moreno-Murciano, Paz/D-7871-2018; Storkebaum, Erik/B-5389-2017; Lambrechts, Diether/AAJ-3167-2020; Van Damme, Philip/A-6464-2009; Van Den Bosch, Ludo/B-7258-2012; Verdrengh, Evelien/H-4571-2012	Carmeliet, Peter/0000-0001-7961-1821; Storkebaum, Erik/0000-0002-9519-5642; Lambrechts, Diether/0000-0002-3429-302X; Van Damme, Philip/0000-0002-4010-2357; Rutten, Bart/0000-0002-9834-6346; Conway, Edward/0000-0003-0081-0305; Van Den Bosch, Ludo/0000-0003-0104-4067; Moons, Lieve (Godelieve)/0000-0003-0186-1411				Aebischer P, 2004, GENE THER, V11, P429, DOI 10.1038/sj.gt.3302204; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Azari MF, 2003, BRAIN RES, V982, P92, DOI 10.1016/S0006-8993(03)02989-5; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Brown RH, 2001, SEMIN NEUROL, V21, P131; CARONI P, 1994, J CELL BIOL, V125, P893, DOI 10.1083/jcb.125.4.893; D'Ercole AJ, 2002, NEUROPEPTIDES, V36, P209, DOI 10.1054/npep.2002.0893; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Feeney SJ, 2003, CYTOKINE, V23, P108, DOI 10.1016/S1043-4666(03)00217-5; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gao WQ, 1999, J NEUROBIOL, V39, P142, DOI 10.1002/(SICI)1097-4695(199904)39:1<142::AID-NEU11>3.0.CO;2-H; Giess R, 2002, AM J HUM GENET, V70, P1277, DOI 10.1086/340427; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Heerssen HM, 2002, TRENDS NEUROSCI, V25, P160, DOI 10.1016/S0166-2236(02)02144-6; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; ORRELL RW, 1995, J NEUROL SCI, V132, P126, DOI 10.1016/0022-510X(95)00129-P; Ouary S, 2000, NEUROSCIENCE, V97, P521, DOI 10.1016/S0306-4522(00)00020-8; Przedborski Serge, 2003, Curr Neurol Neurosci Rep, V3, P70, DOI 10.1007/s11910-003-0041-x; Ramer MS, 2003, EUR J NEUROSCI, V18, P2713, DOI 10.1111/j.1460-9568.2003.03012.x; Rothstein JD, 2003, ANN NEUROL, V53, P423, DOI 10.1002/ana.10561; Russell FD, 2000, NEUROSCIENCE, V97, P575, DOI 10.1016/S0306-4522(00)00079-8; Schafers M, 2002, J NEUROSCI, V22, P536, DOI 10.1523/JNEUROSCI.22-02-00536.2002; Storkebaum E, 2004, J CLIN INVEST, V113, P14, DOI 10.1172/JCI200420682; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; Thorne RG, 2001, CLIN PHARMACOKINET, V40, P907, DOI 10.2165/00003088-200140120-00003; Watson FL, 1999, J NEUROSCI, V19, P7889; WINDEBANK AJ, 1995, ADV NEUROL, V68, P229	33	390	437	1	26	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					85	92		10.1038/nn1360	http://dx.doi.org/10.1038/nn1360			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15568021	Green Published			2022-12-17	WOS:000225967600020
J	Yonelinas, AP; Kroll, NEA; Quamme, JR; Lazzara, MM; Sauve, MJ; Widaman, KF; Knight, RT				Yonelinas, AP; Kroll, NEA; Quamme, JR; Lazzara, MM; Sauve, MJ; Widaman, KF; Knight, RT			Effects of extensive temporal lobe damage or mild hypoxia on recollection and familiarity	NATURE NEUROSCIENCE			English	Article							ENDURING MEMORY IMPAIRMENT; RECOGNITION MEMORY; EPISODIC MEMORY; IMPLICIT MEMORY; HIPPOCAMPAL; AMNESIA; EXPLICIT; LESIONS; BASES; ITEM	Memory for past events can be based on recollection or on assessments of familiarity. These two forms of human memory have been studied extensively by philosophers and psychologists, but their neuroanatomical substrates are largely unknown. Here we examined the brain regions that are involved in these two forms of memory by studying patients with damage to different temporal lobe regions. Our results come from (i) structural covariance modeling of recall and recognition, (ii) introspective reports during recognition and (iii) analysis of receiver operating characteristics. In sum, we found that the regions disrupted in mild hypoxia, such as the hippocampus, are centrally involved in conscious recollection, whereas the surrounding temporal lobe supports familiarity-based memory discrimination.	Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; Vet Adm Res Serv, Martinez, CA 94553 USA; Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Yonelinas, AP (corresponding author), Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA.	apyonelinas@ucdavis.edu	Widaman, Keith/Y-3051-2019	Yonelinas, Andrew/0000-0002-9580-4997; Widaman, Keith/0000-0002-6424-3998	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021135, P01NS040813] Funding Source: NIH RePORTER; NIMH NIH HHS [MH59352] Funding Source: Medline; NINDS NIH HHS [NS21135, NS40813] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Aggleton JP, 1996, NEUROPSYCHOLOGIA, V34, P51, DOI 10.1016/0028-3932(95)00150-6; Amaral DG, 1999, HIPPOCAMPUS, V9, P1; Baddeley AD, 2001, J COGNITIVE NEUROSCI, V13, P357, DOI 10.1162/08989290151137403; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Caine D, 2000, J INT NEUROPSYCH SOC, V6, P86, DOI 10.1017/S1355617700611116; CUMMINGS JL, 1984, NEUROLOGY, V34, P679, DOI 10.1212/WNL.34.5.679; Duvernoy HM, 1998, HUMAN HIPPOCAMPUS FU; Duzel E, 2001, P NATL ACAD SCI USA, V98, P8101, DOI 10.1073/pnas.131205798; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; Gadian DG, 2000, BRAIN, V123, P499, DOI 10.1093/brain/123.3.499; Hamann SB, 1997, BEHAV NEUROSCI, V111, P850, DOI 10.1037/0735-7044.111.4.850; Henson RNA, 1999, J NEUROSCI, V19, P3962; HOPKINS RO, 1995, BRAIN COGNITION, V27, P180, DOI 10.1006/brcg.1995.1016; JANOWSKY JS, 1989, BEHAV NEUROSCI, V103, P548, DOI 10.1037/0735-7044.103.3.548; JENNINGS JM, 1993, PSYCHOL AGING, V8, P283, DOI 10.1037/0882-7974.8.2.283; JORESKOG KG, 1974, MULTIVAR BEHAV RES, V9, P498; KARTSOUNIS LD, 1995, J NEUROL NEUROSUR PS, V59, P95, DOI 10.1136/jnnp.59.1.95; KUWERT T, 1993, J NEUROL SCI, V118, P10, DOI 10.1016/0022-510X(93)90238-T; Macmillan N.A., 1991, DETECTION THEORY USE, P407; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; Markowitsch HJ, 1997, EUR J NEUROL, V4, P178, DOI 10.1111/j.1468-1331.1997.tb00324.x; Mishkin M, 1998, HIPPOCAMPUS, V8, P212; Nunally J.C., 1994, PSYCHOMETRIC THEORY; NYBERG L, 1994, J EXP PSYCHOL LEARN, V20, P485, DOI 10.1037/0278-7393.20.2.485; Parkin AJ, 1993, NEUROPSYCHOLOGY AMNE; PRESS GA, 1998, NATURE, V7, P54; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Rey A., 1964, EXAMEN CLIN PSYCHOL; Sauve M J, 1996, Am J Crit Care, V5, P127; SCHACTER DL, 1993, ANNU REV NEUROSCI, V16, P159, DOI 10.1146/annurev.ne.16.030193.001111; Schacter DL, 1996, P NATL ACAD SCI USA, V93, P321, DOI 10.1073/pnas.93.1.321; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Squire LR, 1998, HIPPOCAMPUS, V8, P205, DOI 10.1002/(SICI)1098-1063(1998)8:3<205::AID-HIPO3>3.0.CO;2-I; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Wagner AD, 1997, J EXP PSYCHOL LEARN, V23, P305, DOI 10.1037/0278-7393.23.2.305; Wechsler D., 1987, WECHSLER MEMORY SCAL; Yonelinas AP, 1998, NEUROPSYCHOLOGY, V12, P323, DOI 10.1037/0894-4105.12.3.323; Yonelinas AP, 2001, NEUROREPORT, V12, P359, DOI 10.1097/00001756-200102120-00035; YONELINAS AP, 1995, J MEM LANG, V34, P622, DOI 10.1006/jmla.1995.1028; Zola S.M., 2000, OXFORD HDB MEMORY, P485; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	48	390	395	3	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1236	1241		10.1038/nn961	http://dx.doi.org/10.1038/nn961			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12379865				2022-12-17	WOS:000178884600028
J	Gooley, JJ; Lu, J; Chou, TC; Scammell, TE; Saper, CB				Gooley, JJ; Lu, J; Chou, TC; Scammell, TE; Saper, CB			Melanopsin in cells of origin of the retinohypothalamic tract	NATURE NEUROSCIENCE			English	Article							CIRCADIAN-RHYTHMS; SPECTRAL SENSITIVITY; PHOTORECEPTORS; CONE; MICE		Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Program Neurosci, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Saper, CB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NHLBI NIH HHS [HL07901, HL60292] Funding Source: Medline; NIMH NIH HHS [MH62589] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062589] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; MOORE RY, 1995, J COMP NEUROL, V352, P351, DOI 10.1002/cne.903520304; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; PROVENCIO I, 1995, BRAIN RES, V694, P183, DOI 10.1016/0006-8993(95)00694-L; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; Yoshimura T, 1996, J COMP PHYSIOL A, V178, P797	7	390	406	1	61	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1165	1165		10.1038/nn768	http://dx.doi.org/10.1038/nn768			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11713469				2022-12-17	WOS:000172525000007
J	Zhang, LI; Poo, MM				Zhang, LI; Poo, MM			Electrical activity and development of neural circuits	NATURE NEUROSCIENCE			English	Review							RAT BARREL CORTEX; CLASS-I MHC; VISUAL-CORTEX; SYNAPTIC PLASTICITY; RECEPTOR ACTIVATION; NEURONAL-ACTIVITY; HIPPOCAMPAL-NEURONS; ACTION-POTENTIALS; ADENYLYL-CYCLASE; DENDRITIC SPINES	A distinct feature of the nervous system is the intricate network of synaptic connections among neurons of diverse phenotypes. Although initial connections are formed largely through molecular mechanisms that depend on intrinsic developmental programs, spontaneous and experience-cl riven electrical activities in the developing brain exert critical epigenetic influence on synaptic maturation and refinement of neural circuits. Selective findings discussed here illustrate some of our current understanding of the effects of electrical activity on circuit development and highlight areas that await further study.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco	Poo, MM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mpoo@uclink.berkeley.edu						Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Aamodt S M, 1999, Adv Neurol, V79, P133; Aamodt SM, 2000, J NEUROPHYSIOL, V83, P1580, DOI 10.1152/jn.2000.83.3.1580; [Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; Boulanger L, 1999, NAT NEUROSCI, V2, P346, DOI 10.1038/7258; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Catalano SM, 1998, SCIENCE, V281, P559, DOI 10.1126/science.281.5376.559; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Cooper DMF, 1998, J BIOL CHEM, V273, P27703, DOI 10.1074/jbc.273.42.27703; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Craig AM, 2001, NAT NEUROSCI, V4, P569, DOI 10.1038/88388; DAN Y, 1992, SCIENCE, V256, P1570, DOI 10.1126/science.1317971; Dantzker JL, 1998, J NEUROSCI, V18, P4145; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; Ganguly K, 2000, NAT NEUROSCI, V3, P1018, DOI 10.1038/79838; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; HAHM JO, 1991, NATURE, V351, P568, DOI 10.1038/351568a0; Hensch TK, 1998, J NEUROSCI, V18, P2108; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Kempter R, 2001, P NATL ACAD SCI USA, V98, P4166, DOI 10.1073/pnas.061369698; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Lee SH, 2000, CURR OPIN NEUROBIOL, V10, P125, DOI 10.1016/S0959-4388(99)00046-X; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Lin SY, 1998, J NEUROSCI, V18, P3725; Lohof AM, 1996, REV NEUROSCIENCE, V7, P85; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; Miller KD, 1999, J NEUROBIOL, V41, P44, DOI 10.1002/(SICI)1097-4695(199910)41:1<44::AID-NEU7>3.0.CO;2-V; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; MOONEY R, 1993, NEURON, V10, P815, DOI 10.1016/0896-6273(93)90198-Z; Nedivi E, 1999, J NEUROBIOL, V41, P135, DOI 10.1002/(SICI)1097-4695(199910)41:1<135::AID-NEU17>3.0.CO;2-F; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; NESTLER EJ, 1983, NATURE, V305, P583, DOI 10.1038/305583a0; O'Donovan MJ, 1998, J NEUROBIOL, V37, P131, DOI 10.1002/(SICI)1097-4695(199810)37:1<131::AID-NEU10>3.0.CO;2-H; Penn AA, 1999, PEDIATR RES, V45, P447, DOI 10.1203/00006450-199904010-00001; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; POO MM, 1990, J NEUROBIOL, V21, P157, DOI 10.1002/neu.480210111; POO MM, 1981, ANNU REV BIOPHYS BIO, V10, P245, DOI 10.1146/annurev.bb.10.060181.001333; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; RANCK JB, 1964, SCIENCE, V144, P187, DOI 10.1126/science.144.3615.187; Rao RPN, 2001, NOVART FDN SYMP, V239, P208; REDDY R, 1995, J BIOL CHEM, V270, P14340, DOI 10.1074/jbc.270.24.14340; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; ROSEN KM, 1992, P NATL ACAD SCI USA, V89, P5437, DOI 10.1073/pnas.89.12.5437; Saitoe M, 2001, SCIENCE, V293, P514, DOI 10.1126/science.1061270; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCHMIDT JT, 1985, NEUROSCIENCE, V14, P535, DOI 10.1016/0306-4522(85)90308-2; Schuman EM, 1999, CURR OPIN NEUROBIOL, V9, P105, DOI 10.1016/S0959-4388(99)80013-0; Sharma J, 2000, NATURE, V404, P841, DOI 10.1038/35009043; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shi J, 2001, J NEUROSCI, V21, P6233, DOI 10.1523/JNEUROSCI.21-16-06233.2001; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Spitzer NC, 2000, BIOESSAYS, V22, P811; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; Sur M, 2001, NAT REV NEUROSCI, V2, P251, DOI 10.1038/35067562; Tao HZW, 2001, NEURON, V31, P569, DOI 10.1016/S0896-6273(01)00393-2; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wang X, 1998, WORLD J GASTROENTERO, V4, P18, DOI 10.3748/wjg.v4.i1.18; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; WIESEL TN, 1974, J COMP NEUROL, V158, P307, DOI 10.1002/cne.901580306; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; XIE ZP, 1986, P NATL ACAD SCI USA, V83, P7069, DOI 10.1073/pnas.83.18.7069; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	105	390	397	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4			S			1207	1214		10.1038/nn753	http://dx.doi.org/10.1038/nn753			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	490GF	11687831				2022-12-17	WOS:000172041500013
J	Murray, JD; Bernacchia, A; Freedman, DJ; Romo, R; Wallis, JD; Cai, XY; Padoa-Schioppa, C; Pasternak, T; Seo, H; Lee, D; Wang, XJ				Murray, John D.; Bernacchia, Alberto; Freedman, David J.; Romo, Ranulfo; Wallis, Jonathan D.; Cai, Xinying; Padoa-Schioppa, Camillo; Pasternak, Tatiana; Seo, Hyojung; Lee, Daeyeol; Wang, Xiao-Jing			A hierarchy of intrinsic timescales across primate cortex	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; DECISION-MAKING; NEURONS; VARIABILITY	Specialization and hierarchy are organizing principles for primate cortex, yet there is little direct evidence for how cortical areas are specialized in the temporal domain. We measured timescales of intrinsic fluctuations in spiking activity across areas and found a hierarchical ordering, with sensory and prefrontal areas exhibiting shorter and longer timescales, respectively. On the basis of our findings, we suggest that intrinsic timescales reflect areal specialization for task-relevant computations over multiple temporal ranges.	[Murray, John D.; Wang, Xiao-Jing] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Murray, John D.; Bernacchia, Alberto; Seo, Hyojung; Lee, Daeyeol; Wang, Xiao-Jing] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Bernacchia, Alberto] Jacobs Univ Bremen, Sch Engn & Sci, D-28759 Bremen, Germany; [Freedman, David J.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Romo, Ranulfo] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Romo, Ranulfo] El Colegio Nacl, Mexico City, DF, Mexico; [Wallis, Jonathan D.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Wallis, Jonathan D.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Cai, Xinying; Wang, Xiao-Jing] NYU Shanghai, NYU ECNU Inst Brain & Cognit Sci, Shanghai, Peoples R China; [Cai, Xinying; Padoa-Schioppa, Camillo] Washington Univ, Dept Anat & Neurobiol, St Louis, MO USA; [Pasternak, Tatiana] Univ Rochester, Dept Neurobiol & Anat, Rochester, NY USA; [Pasternak, Tatiana] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA	New York University; Yale University; Jacobs University; University of Chicago; Universidad Nacional Autonoma de Mexico; University of California System; University of California Berkeley; University of California System; University of California Berkeley; NYU Shanghai; Washington University (WUSTL); University of Rochester; University of Rochester	Wang, XJ (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	xjwang@nyu.edu	Murray, John D./B-2835-2009; Lee, Daeyeol/A-6794-2008	Murray, John D./0000-0003-4115-8181; Lee, Daeyeol/0000-0003-3474-019X; romo, ranulfo/0000-0003-3529-3635; Wallis, Joni/0000-0001-7262-7417; Padoa-Schioppa, Camillo/0000-0002-7519-8790	US Office of Naval Research grant [N00014-13-1-0297]; US National Institutes of Health (NIH) [R01MH062349]; NIH [R01EY11749, T32EY07125, R01DA032758, R01DA029330, R01DA19028, P01NS040813, R01EY019041]; Whitehall Foundation [2010-12-13]; Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico; Consejo Nacional de Ciencia y Tecnologia Mexico; NATIONAL EYE INSTITUTE [R01EY019041, P30EY001319, T32EY007125, R01EY011749, F32EY015340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019028, R01DA032758, R01DA029330] Funding Source: NIH RePORTER	US Office of Naval Research grant(Office of Naval Research); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Chaudhuri and H.F. Song for discussions, and W Chaisangmongkon and A. Ponce-Alvarez for assistance with data sets. Funding was provided by US Office of Naval Research grant N00014-13-1-0297 and US National Institutes of Health (NIH) grant R01MH062349 (X.-J.W.); NIH grant R01DA029330 (DL.); NIH grants R01EY11749 and T32EY07125 (T.P.); NIH grant R01DA032758 and Whitehall Foundation grant 2010-12-13 (C.P.-S.); NIH grants R01DA19028 and P01NS040813 (J.D.W.); grants from Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico and Consejo Nacional de Ciencia y Tecnologia Mexico (R.R.); and NIH grant R01EY019041 (D.J.F.).	Amatrudo JM, 2012, J NEUROSCI, V32, P13644, DOI 10.1523/JNEUROSCI.2581-12.2012; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Barbas H, 1997, CEREB CORTEX, V7, P635, DOI 10.1093/cercor/7.7.635; Bernacchia A, 2011, NAT NEUROSCI, V14, P366, DOI 10.1038/nn.2752; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; Churchland AK, 2011, NEURON, V69, P818, DOI 10.1016/j.neuron.2010.12.037; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Elston GN, 2003, CEREB CORTEX, V13, P1124, DOI 10.1093/cercor/bhg093; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Goldman M. S, 2008, ENCY NEUROSCIENCE, P165; Goris RLT, 2014, NAT NEUROSCI, V17, P858, DOI 10.1038/nn.3711; Hasson U, 2008, J NEUROSCI, V28, P2539, DOI 10.1523/JNEUROSCI.5487-07.2008; Honey CJ, 2012, NEURON, V76, P423, DOI 10.1016/j.neuron.2012.08.011; Lennie P, 1998, PERCEPTION, V27, P889, DOI 10.1068/p270889; Maimon G, 2009, NEURON, V62, P426, DOI 10.1016/j.neuron.2009.03.021; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Wang HX, 2008, P NATL ACAD SCI USA, V105, P16791, DOI 10.1073/pnas.0804318105; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670	20	389	390	3	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2014	17	12					1661	1663		10.1038/nn.3862	http://dx.doi.org/10.1038/nn.3862			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AU2ZY	25383900	Green Accepted			2022-12-17	WOS:000345484000012
J	Riedel, G; Micheau, J; Lam, AGM; Roloff, EV; Martin, SJ; Bridge, H; de Hoz, L; Poeschel, B; McCulloch, J; Morris, RGM				Riedel, G; Micheau, J; Lam, AGM; Roloff, EV; Martin, SJ; Bridge, H; de Hoz, L; Poeschel, B; McCulloch, J; Morris, RGM			Reversible neural inactivation reveals hippocampal participation in several memory processes	NATURE NEUROSCIENCE			English	Article							CEREBRAL GLUCOSE-UTILIZATION; RETROGRADE-AMNESIA; RECEPTOR ANTAGONISTS; WATER MAZE; AMPA; RAT; SYSTEMS; LESIONS; BRAIN; MODEL	Studies of patients and animals with brain lesions have implicated the hippocampal formation in spatial, declarative/relational and episodic types of memory. These and other types of memory consist of a series of interdependent but potentially dissociable memory processes-encoding, storage, consolidation and retrieval. To identify whether hippocampal activity contributes to these processes independently, we used a novel method of inactivating synaptic transmission using a water-soluble antagonist of AM PA/kainate glutamate receptors. Once calibrated using electrophysiological and two-deoxyglucose techniques in vivo, drug or vehicle was infused chronically or acutely into the dorsal hippocampus of rats at appropriate times during or after training in a water maze. Our findings indicate that hippocampal neural activity is necessary for both encoding and retrieval of spatial memory and for either trace consolidation or long-term storage.	Univ Edinburgh, Sch Med, Dept Neurosci, Edinburgh EH8 9LE, Midlothian, Scotland; Univ Edinburgh, Sch Med, Ctr Neurosci, Edinburgh EH8 9LE, Midlothian, Scotland; Univ Aberdeen, Dept Biomed Sci, Aberdeen AB25 2ZD, Scotland; Univ Bordeaux 1, Lab Neurosci Comportementales & Cognit, CNRS, UMR 5807, F-33405 Talence, France; Univ Glasgow, Wellcome Surg Inst, Dept Neurosci, Glasgow G61 1QH, Lanark, Scotland	University of Edinburgh; University of Edinburgh; University of Aberdeen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; University of Glasgow	Morris, RGM (corresponding author), Univ Edinburgh, Sch Med, Dept Neurosci, Crichton St, Edinburgh EH8 9LE, Midlothian, Scotland.			Bridge, Holly/0000-0002-8089-6198; Martin, Stephen/0000-0003-0805-8541; de Hoz, Livia/0000-0002-5782-1120	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; [Anonymous], 1983, CANADIAN PSYCHOL; ASTRUP J, 1981, STROKE, V12, P726, DOI 10.1161/01.STR.12.6.726; Bleakman D, 1998, NEUROPHARMACOLOGY, V37, P1187, DOI 10.1016/S0028-3908(98)00139-7; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bohbot V, 1996, P NATL ACAD SCI USA, V93, P4016, DOI 10.1073/pnas.93.9.4016; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; BROWNE SE, 1994, BRAIN RES, V641, P10, DOI 10.1016/0006-8993(94)91809-0; BUSZAKI G, 1989, NEUROSCIENCE, V31, P551; Cohen N.J., 1993, MEMORY AMNESIA HIPPO, DOI DOI 10.1136/JNNP.58.1.128-A; CRANE PD, 1978, STROKE, V9, P12, DOI 10.1161/01.STR.9.1.12; Dolan RJ, 1997, NATURE, V388, P582, DOI 10.1038/41561; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Frackowiak RS., 1997, HUMAN BRAIN FUNCTION; GAFFAN D, 1994, J COGNITIVE NEUROSCI, V6, P305, DOI 10.1162/jocn.1994.6.4.305; HASSELMO M, 1994, BEHAV BRAIN RES, V67, P1; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; Izquierdo I, 1998, NATURE, V393, P635, DOI 10.1038/31371; Izquierdo I, 1997, NEUROBIOL LEARN MEM, V68, P285, DOI 10.1006/nlme.1997.3799; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Lepage M, 1998, HIPPOCAMPUS, V8, P313, DOI 10.1002/(SICI)1098-1063(1998)8:4<313::AID-HIPO1>3.0.CO;2-I; Lorenzini CGA, 1999, NEUROBIOL LEARN MEM, V71, P1; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; MCCARTHY RA, 1990, COGNITIVE NEUROPSYCH; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCGAUGH JL, 1973, ANNU REV PHARMACOL, V13, P229, DOI 10.1146/annurev.pa.13.040173.001305; MCGAUGH JL, 1976, NEURAL MECHANISMS LE, P549; Milner B., 1966, AMNESIA, P109; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; NYBERG L, 1996, NATURE, V380, P714; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; PACKARD MG, 1989, J NEUROSCI, V9, P1465; Ramos JMJ, 1998, EUR J NEUROSCI, V10, P3295, DOI 10.1046/j.1460-9568.1998.00388.x; Reed JM, 1998, J NEUROSCI, V18, P3943; SCHOEPP DD, 1995, NEUROPHARMACOLOGY, V34, P1159, DOI 10.1016/0028-3908(95)00099-R; SCHWARTZ WJ, 1979, SCIENCE, V205, P723, DOI 10.1126/science.462184; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Spooner R I, 1994, Learn Mem, V1, P203; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; STAUBLI U, 1989, BEHAV NEUROSCI, V103, P54, DOI 10.1037/0735-7044.103.1.54; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Turrigiano GG, 1998, NEURON, V21, P933, DOI 10.1016/S0896-6273(00)80607-8; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; WINOCUR G, 1990, BEHAV BRAIN RES, V38, P145, DOI 10.1016/0166-4328(90)90012-4; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	50	389	396	0	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1999	2	10					898	905		10.1038/13202	http://dx.doi.org/10.1038/13202			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	259FE	10491611				2022-12-17	WOS:000083883200016
J	Ju, W; Morishita, W; Tsui, J; Gaietta, G; Deerinck, TJ; Adams, SR; Garner, CC; Tsien, RY; Ellisman, MH; Malenka, RC				Ju, W; Morishita, W; Tsui, J; Gaietta, G; Deerinck, TJ; Adams, SR; Garner, CC; Tsien, RY; Ellisman, MH; Malenka, RC			Activity-dependent regulation of dendritic synthesis and trafficking of AMPA receptors	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; MESSENGER-RNA; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; ENDOPLASMIC-RETICULUM; MEMBRANE; SPINES; GLUR2; RAT	Regulation of AMPA receptor (AMPAR) trafficking is important for neural plasticity. Here we examined the trafficking and synthesis of the GluR1 and GluR2 subunits using ReAsH-EDT2 and FlAsH-EDT2 staining. Activity blockade of rat cultured neurons increased dendritic GluR1, but not GluR2, levels. Examination of transected dendrites revealed that both AMPAR subunits were synthesized in dendrites and that activity blockade enhanced dendritic synthesis of GluR1 but not GluR2. In contrast, acute pharmacological manipulations increased dendritic synthesis of both subunits. AMPARs synthesized in dendrites were inserted into synaptic plasma membranes and, after activity blockade, the electrophysiological properties of native synaptic AMPARs changed in the manner predicted by the imaging experiments. In addition to providing a novel mechanism for synaptic modifications, these results point out the advantages of using FlAsH-EDT2 and ReAsH-EDT2 for studying the trafficking of newly synthesized proteins in local cellular compartments such as dendrites.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, Palo Alto, CA 94304 USA; Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Dept Neurosci 0608, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, Dept Pharmacol, La Jolla, CA 92093 USA	Stanford University; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, 1201 Welch Rd, Palo Alto, CA 94304 USA.	malenka@stanford.edu		Garner, Craig/0000-0003-1970-5417	NCRR NIH HHS [P41-RR04050] Funding Source: Medline; NIMH NIH HHS [MH63394] Funding Source: Medline; NINDS NIH HHS [NS27177] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063394, R37MH063394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027177, R37NS027177] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Benson DL, 1997, NEUROREPORT, V8, P823, DOI 10.1097/00001756-199703030-00004; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Braithwaite SP, 2000, NEUROPHARMACOLOGY, V39, P919, DOI 10.1016/S0028-3908(99)00171-9; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; Horton AC, 2003, J NEUROSCI, V23, P6188; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Kacharmina JE, 2000, P NATL ACAD SCI USA, V97, P11545, DOI 10.1073/pnas.97.21.11545; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marek KW, 2002, NEURON, V36, P805, DOI 10.1016/S0896-6273(02)01068-1; Martone ME, 1996, J NEUROSCI, V16, P7437; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pickard L, 2001, NEUROPHARMACOLOGY, V41, P700, DOI 10.1016/S0028-3908(01)00127-7; Pierce JP, 2000, NAT NEUROSCI, V3, P311, DOI 10.1038/73868; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Steward O, 2002, NEURON, V36, P338, DOI 10.1016/S0896-6273(02)01006-1; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Torre ER, 1996, J NEUROSCI, V16, P5967; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Washburn MS, 1997, J NEUROSCI, V17, P9393; WEILER IJ, 1993, P NATL ACAD SCI USA, V90, P7168, DOI 10.1073/pnas.90.15.7168; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	37	388	405	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					244	253		10.1038/nn1189	http://dx.doi.org/10.1038/nn1189			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14770185				2022-12-17	WOS:000189197900014
J	Lin, JW; Ju, W; Foster, K; Lee, SH; Ahmadian, G; Wyszynski, M; Wang, YT; Sheng, M				Lin, JW; Ju, W; Foster, K; Lee, SH; Ahmadian, G; Wyszynski, M; Wang, YT; Sheng, M			Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptors internalization	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; DOMAIN-CONTAINING PROTEIN; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; SURFACE EXPRESSION; MEMBRANE-FUSION; SYNAPTIC AMPA; C-TERMINUS; IN-VITRO; EEA1	Internalization of postsynaptic AMPA receptors depresses excitatory transmission, but the underlying dynamics and mechanisms of this process are unclear. Using immunofluorescence and surface biotinylation, we characterized and quantified basal and regulated AMPA receptor endocytosis in cultured hippocampal neurons, in response to synaptic activity, AMPA and insulin. AMPA-induced AMPA receptor internalization is mediated in part by secondary activation of voltage-dependent calcium channels, and in part by ligand binding independent of receptor activation. Although both require dynamin, insulin- and AMPA-induced AMPA receptor internalization are differentially dependent on protein phosphatases and sequence determinants within the cytoplasmic tails of GluR1 and GluR2 subunits. AMPA receptors internalized in response to AMPA stimulation enter a recycling endosome system, whereas those internalized in response to insulin diverge into a distinct compartment. Thus, the molecular mechanisms and intracellular sorting of AMPA receptors are diverse, and depend on the internalizing stimulus.	Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Hosp Sick Children, Programme Brain & Behav, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Pathol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X8, Canada	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Lin, JW (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Wellman 423,50 Blossom St, Boston, MA 02114 USA.		Wang, Yu Tian/A-4729-2008; Lee, Sang/R-7518-2019; Wang, Yu Tian/J-8255-2015	Lee, Sang H./0000-0001-5467-0331	NINDS NIH HHS [NS35050] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035050] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Advani RJ, 1998, J BIOL CHEM, V273, P10317, DOI 10.1074/jbc.273.17.10317; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Mammen AL, 1997, J NEUROSCI, V17, P7351; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MERLIN LR, 1993, BRAIN RES, V627, P330, DOI 10.1016/0006-8993(93)90338-N; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; Semsarian C, 1999, NATURE, V400, P576, DOI 10.1038/23054; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Willins DL, 1999, NEUROSCIENCE, V91, P599, DOI 10.1016/S0306-4522(98)00653-8; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8	50	388	406	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1282	1290		10.1038/81814	http://dx.doi.org/10.1038/81814			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100149	Bronze			2022-12-17	WOS:000167177900014
J	O'Connell, RG; Dockree, PM; Kelly, SP				O'Connell, Redmond G.; Dockree, Paul M.; Kelly, Simon P.			A supramodal accumulation-to-bound signal that determines perceptual decisions in humans	NATURE NEUROSCIENCE			English	Article							GENERAL MECHANISM; NEURAL BASIS; REPRESENTATION; INTEGRATION; RESPONSES; COMPONENT; DYNAMICS; NEURONS; P3	In theoretical accounts of perceptual decision-making, a decision variable integrates noisy sensory evidence and determines action through a boundary-crossing criterion. Signals bearing these very properties have been characterized in single neurons in monkeys, but have yet to be directly identified in humans. Using a gradual target detection task, we isolated a freely evolving decision variable signal in human subjects that exhibited every aspect of the dynamics observed in its single-neuron counterparts. This signal could be continuously tracked in parallel with fully dissociable sensory encoding and motor preparation signals, and could be systematically perturbed mid-flight during decision formation. Furthermore, we found that the signal was completely domain general: it exhibited the same decision-predictive dynamics regardless of sensory modality and stimulus features and tracked cumulative evidence even in the absence of overt action. These findings provide a uniquely clear view on the neural determinants of simple perceptual decisions in humans.	[Kelly, Simon P.] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA; [O'Connell, Redmond G.; Dockree, Paul M.] Trinity Coll Dublin, Trin Coll Inst Neurosci, Dublin, Ireland; [O'Connell, Redmond G.; Dockree, Paul M.] Trinity Coll Dublin, Sch Psychol, Dublin, Ireland	City University of New York (CUNY) System; City College of New York (CUNY); Trinity College Dublin; Trinity College Dublin	Kelly, SP (corresponding author), CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA.	skelly2@ccny.cuny.edu		O'Connell, Redmond/0000-0001-6949-2793; Kelly, Simon/0000-0001-9983-3595; Kelly, Simon/0000-0003-4981-3099	Irish Research Council for Science Engineering and Technology EMPOWER fellowship	Irish Research Council for Science Engineering and Technology EMPOWER fellowship	The authors thank S. Hillyard, I. Robertson, M. Bellgrove, E. Lalor and J. Balsters for helpful comments, and P. Collins, E. Lacey, C. Devine and D. Allen for their assistance with data collection. This work was supported by an Irish Research Council for Science Engineering and Technology EMPOWER fellowship (R.G.O.).	Bennur S, 2011, J NEUROSCI, V31, P913, DOI 10.1523/JNEUROSCI.4417-10.2011; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Di Russo F, 2007, HUM BRAIN MAPP, V28, P323, DOI 10.1002/hbm.20276; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Donner TH, 2009, CURR BIOL, V19, P1581, DOI 10.1016/j.cub.2009.07.066; Fitzgerald JK, 2011, NAT NEUROSCI, V14, P1075, DOI 10.1038/nn.2878; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Green DM., 1966, SIGNAL DETECTION THE; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; HILLYARD SA, 1971, SCIENCE, V172, P1357, DOI 10.1126/science.172.3990.1357; Ho TC, 2009, J NEUROSCI, V29, P8675, DOI 10.1523/JNEUROSCI.5984-08.2009; Horwitz GD, 2004, J NEUROPHYSIOL, V91, P2281, DOI 10.1152/jn.00872.2003; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Hunt LT, 2012, NAT NEUROSCI, V15, P470, DOI 10.1038/nn.3017; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kopp B., 2007, COGNITIVE SCI, V2, P113; Mars RB, 2008, J NEUROSCI, V28, P12539, DOI 10.1523/JNEUROSCI.2925-08.2008; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; O'Connell RG, 2009, J NEUROSCI, V29, P8604, DOI 10.1523/JNEUROSCI.5967-08.2009; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Philiastides MG, 2006, J NEUROSCI, V26, P8965, DOI 10.1523/JNEUROSCI.1655-06.2006; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Ratcliff R, 2009, P NATL ACAD SCI USA, V106, P6539, DOI 10.1073/pnas.0812589106; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Rorie AE, 2005, TRENDS COGN SCI, V9, P41, DOI 10.1016/j.tics.2004.12.007; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; SMITH PL, 1988, J MATH PSYCHOL, V32, P135, DOI 10.1016/0022-2496(88)90043-0; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Tosoni A, 2008, NAT NEUROSCI, V11, P1446, DOI 10.1038/nn.2221; Verleger R, 2005, J PSYCHOPHYSIOL, V19, P165, DOI 10.1027/0269-8803.19.3.165; WOODS DL, 1980, SCIENCE, V207, P655, DOI 10.1126/science.7352278	38	387	388	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1729	+		10.1038/nn.3248	http://dx.doi.org/10.1038/nn.3248			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23103963				2022-12-17	WOS:000311706700020
J	Olsson, A; Phelps, EA				Olsson, Andreas; Phelps, Elizabeth A.			Social learning of fear	NATURE NEUROSCIENCE			English	Review							FACIAL EXPRESSIONS; RELEVANT STIMULI; CONDITIONED FEAR; NEURAL SYSTEMS; ELECTRODERMAL RESPONSES; POTENTIATED STARTLE; PERSPECTIVE-TAKING; AVOIDANCE-BEHAVIOR; PREFRONTAL CORTEX; LATERAL AMYGDALA	Research across species highlights the critical role of the amygdala in fear conditioning. However, fear conditioning, involving direct aversive experience, is only one means by which fears can be acquired. Exploiting aversive experiences of other individuals through social fear learning is less risky. Behavioral research provides important insights into the workings of social fear learning, and the neural mechanisms are beginning to be understood. We review research suggesting that an amygdala-centered model of fear conditioning can help to explain social learning of fear through observation and instruction. We also describe how observational and instructed fear is distinguished by involvement of additional neural systems implicated in social-emotional behavior, language and explicit memory, and propose a modified conditioning model to account for social fear learning. A better understanding of social fear learning promotes integration of biological principles of learning with cultural evolution.	Columbia Univ, Dept Psychol, New York, NY 10027 USA; NYU, Dept Psychol, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	Columbia University; New York University; New York University	Olsson, A (corresponding author), Columbia Univ, Dept Psychol, New York, NY 10027 USA.	aolsson@psych.columbia.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062104] Funding Source: NIH RePORTER; NIMH NIH HHS [MH62104] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amaral D.G., 1986, Advances in Experimental Medicine and Biology, V203, P3; Amaral DG, 2003, ANN NY ACAD SCI, V1000, P337, DOI 10.1196/annals.1280.015; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; [Anonymous], 1927, CONDITIONAL REFLEXES; BANDURA A, 1968, J PERS SOC PSYCHOL, V8, P99, DOI 10.1037/h0025260; Bandura A., 1977, SOCIAL LEARNING THEO; Barton RA, 2003, P ROY SOC B-BIOL SCI, V270, P539, DOI 10.1098/rspb.2002.2276; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Beer JS, 2003, J PERS SOC PSYCHOL, V85, P594, DOI 10.1037/0022-3514.85.4.594; BENNET G, 1993, ANN LEARN BEHAV, V21, P214; BERGER SM, 1962, PSYCHOL REV, V69, P450, DOI 10.1037/h0046466; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; COOK EW, 1986, J ABNORM PSYCHOL, V95, P195, DOI 10.1037/0021-843X.95.3.195; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Curio E., 1988, P75; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Ekman P., 1982, EMOTION HUMAN FACE; EVERITT B J, 1992, P401; Field AP, 2001, BEHAV RES THER, V39, P1259, DOI 10.1016/S0005-7967(00)00080-2; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gazzaniga M, 1978, THE INTEGRATED MIND; Gerull FC, 2002, BEHAV RES THER, V40, P279, DOI 10.1016/S0005-7967(01)00013-4; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; GRILLON C, 1991, PSYCHOPHYSIOLOGY, V28, P588, DOI 10.1111/j.1469-8986.1991.tb01999.x; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Hauser MD, 2003, P ROY SOC B-BIOL SCI, V270, P2363, DOI 10.1098/rspb.2003.2509; Hauser MD., 1996, EVOLUTION COMMUNICAT; HEYES CM, 1993, BEHAV BRAIN SCI, V16, P524, DOI 10.1017/S0140525X00031393; Hooker CI, 2006, J NEUROSCI, V26, P8915, DOI 10.1523/JNEUROSCI.3048-05.2006; HOPKINS DA, 1978, EXP BRAIN RES, V32, P529; HUGDAHL K, 1977, J EXP PSYCHOL-HUM L, V3, P608, DOI 10.1037/0278-7393.3.5.608; HYGGE S, 1978, J PERS SOC PSYCHOL, V36, P271, DOI 10.1037/0022-3514.36.3.271; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; JOHN ER, 1968, SCIENCE, V159, P1489, DOI 10.1126/science.159.3822.1489; Kavaliers M, 2001, BEHAV NEUROSCI, V115, P661, DOI 10.1037/0735-7044.115.3.661; Keller M, 2004, EUR J NEUROSCI, V20, P3433, DOI 10.1111/j.1460-9568.2004.03812.x; Kim H, 2004, J COGNITIVE NEUROSCI, V16, P1730, DOI 10.1162/0898929042947865; King NJ, 1998, BEHAV RES THER, V36, P297, DOI 10.1016/S0005-7967(98)00015-1; Kosslyn SM, 2003, PSYCHOL BULL, V129, P723, DOI 10.1037/0033-2909.129.5.723; LaBar KS, 2005, BEHAV NEUROSCI, V119, P677, DOI 10.1037/0735-7044.119.3.677; LABAR KS, 1995, J NEUROSCI, V15, P6846; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; LANZETTA JT, 1989, J PERS SOC PSYCHOL, V56, P543, DOI 10.1037/0022-3514.56.4.543; LANZETTA JT, 1980, J PERS SOC PSYCHOL, V39, P1081, DOI 10.1037/h0077713; Ledoux JE, 2001, AM J PSYCHIAT, V158, P1953, DOI 10.1176/appi.ajp.158.12.1953; LEDOUX JE, 1990, J NEUROSCI, V10, P1043; MASSERMAN JH, 1964, AM J PSYCHIAT, V121, P584, DOI 10.1176/ajp.121.6.584; Mineka S, 2006, AM PSYCHOL, V61, P10, DOI 10.1037/0003-066X.61.1.10; MINEKA S, 1993, J EXP PSYCHOL GEN, V122, P23, DOI 10.1037/0096-3445.122.1.23; MINEKA S, 1984, J ABNORM PSYCHOL, V93, P355, DOI 10.1037/0021-843X.93.4.355; Mitchell JP, 2002, P NATL ACAD SCI USA, V99, P15238, DOI 10.1073/pnas.232395699; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Munksgaard L, 2001, APPL ANIM BEHAV SCI, V73, P15, DOI 10.1016/S0168-1591(01)00119-8; MYERS RE, 1973, BRAIN RES, V64, P257, DOI 10.1016/0006-8993(73)90182-0; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; OHMAN A, 1993, J ABNORM PSYCHOL, V102, P121; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Olsson A, 2005, SCIENCE, V309, P785, DOI 10.1126/science.1113551; Olsson A, 2004, PSYCHOL SCI, V15, P822, DOI 10.1111/j.0956-7976.2004.00762.x; Olsson A, 2007, SOC COGN AFFECT NEUR, V2, P3, DOI 10.1093/scan/nsm005; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; PLOTKIN HC, 1981, BEHAV BRAIN SCI, V4, P225, DOI 10.1017/S0140525X00008566; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; PRICE JL, 1981, J NEUROSCI, V1, P1242; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Quirk GJ, 2006, BIOL PSYCHIAT, V60, P337, DOI 10.1016/j.biopsych.2006.03.010; RACHMAN S, 1976, BEHAV RES THER, V14, P437, DOI 10.1016/0005-7967(76)90090-5; Robbins TW, 2005, J COMP NEUROL, V493, P140, DOI 10.1002/cne.20717; ROLLS ET, 1994, EXP BRAIN RES, V101, P473; ROLLS ET, 1999, BRAIN EMOTION; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Ross RS, 2006, J NEUROSCI, V26, P4852, DOI 10.1523/JNEUROSCI.0659-06.2006; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Schneider M, 2005, NEUROPSYCHOPHARMACOL, V30, P944, DOI 10.1038/sj.npp.1300634; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shi CJ, 1999, J NEUROSCI, V19, P420, DOI 10.1523/JNEUROSCI.19-01-00420.1999; SIMON H, 1979, BRAIN RES, V178, P17, DOI 10.1016/0006-8993(79)90085-4; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Squires AS, 2006, NEUROBIOL LEARN MEM, V85, P95, DOI 10.1016/j.nlm.2005.08.012; Thorpe, 1963, LEARNING INSTINCT AN; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; VAUGHAN KB, 1980, J PERS SOC PSYCHOL, V38, P909, DOI 10.1037/0022-3514.38.6.909; Whalen PJ, 1998, J NEUROSCI, V18, P411; White DJ, 1998, ANIM LEARN BEHAV, V26, P433, DOI 10.3758/BF03199236; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Young M P, 1994, Rev Neurosci, V5, P227; ZAJONC RB, 1965, SCIENCE, V149, P269, DOI 10.1126/science.149.3681.269	100	387	392	3	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1095	1102		10.1038/nn1968	http://dx.doi.org/10.1038/nn1968			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	205VZ	17726475				2022-12-17	WOS:000249144000007
J	Cavanagh, JF; Wiecki, TV; Cohen, MX; Figueroa, CM; Samanta, J; Sherman, SJ; Frank, MJ				Cavanagh, James F.; Wiecki, Thomas V.; Cohen, Michael X.; Figueroa, Christina M.; Samanta, Johan; Sherman, Scott J.; Frank, Michael J.			Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold	NATURE NEUROSCIENCE			English	Article							DEEP BRAIN-STIMULATION; BASAL GANGLIA; PREFRONTAL CORTEX; DYNAMICS; MODEL; SELECTION; HORSES; MONKEY; HOLD	It takes effort and time to tame one's impulses. Although medial prefrontal cortex (mPFC) is broadly implicated in effortful control over behavior, the subthalamic nucleus (STN) is specifically thought to contribute by acting as a brake on cortico-striatal function during decision conflict, buying time until the right decision can be made. Using the drift diffusion model of decision making, we found that trial-to-trial increases in mPFC activity (EEG theta power, 4-8 Hz) were related to an increased threshold for evidence accumulation (decision threshold) as a function of conflict. Deep brain stimulation of the STN in individuals with Parkinson's disease reversed this relationship, resulting in impulsive choice. In addition, intracranial recordings of the STN area revealed increased activity (2.5-5 Hz) during these same high-conflict decisions. Activity in these slow frequency bands may reflect a neural substrate for cortico-basal ganglia communication regulating decision processes.	[Cavanagh, James F.; Wiecki, Thomas V.; Figueroa, Christina M.; Frank, Michael J.] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA; [Cohen, Michael X.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Cohen, Michael X.] Univ Arizona, Dept Physiol, Tucson, AZ USA; [Samanta, Johan; Sherman, Scott J.] Univ Arizona, Dept Neurol, Tucson, AZ USA; [Samanta, Johan] Banner Good Samaritan Med Ctr, Phoenix, AZ USA; [Frank, Michael J.] Brown Univ, Dept Psychiat, Providence, RI 02912 USA; [Frank, Michael J.] Brown Inst Brain Sci, Providence, RI USA	Brown University; University of Amsterdam; University of Arizona; University of Arizona; Banner Research; Banner Health; Brown University; Brown University	Cavanagh, JF (corresponding author), Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA.	jim.f.cav@gmail.com; michael_frank@brown.edu	Cavanagh, James F/I-5222-2015; Cohen, Michael X/H-8748-2019; Cohen, Michael/A-3092-2016	Cohen, Michael X/0000-0002-1879-3593; Cohen, Michael/0000-0002-1879-3593; Cavanagh, James/0000-0003-2428-3562	Michael J. Fox Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019118] Funding Source: NIH RePORTER	Michael J. Fox Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors express their gratitude to T. Norton and his surgical staff for their support during the intraoperative recording sessions, L. Trujillo for a review of permutation methods, E.J. Wagenmakers for consultation on Bayesian data analysis, J.J.B. Allen and E. F. Martino for laboratory resources that facilitated some data acquisition and analyses, and K. Carlisle for help with subject recruitment. This project was funded by a grant from the Michael J. Fox Foundation to M. J. F.	[Anonymous], 2006, ADV NEURAL INFORM PR; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Bogacz R, 2007, NEURAL COMPUT, V19, P442, DOI 10.1162/neco.2007.19.2.442; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Cavanagh JF, 2010, NEUROIMAGE, V49, P3198, DOI 10.1016/j.neuroimage.2009.11.080; Cavanagh JF, 2009, J NEUROSCI, V29, P98, DOI 10.1523/JNEUROSCI.4137-08.2009; Cohen MX, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00030; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fleming SM, 2010, P NATL ACAD SCI USA, V107, P6005, DOI 10.1073/pnas.0910380107; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Forstmann BU, 2010, P NATL ACAD SCI USA, V107, P15916, DOI 10.1073/pnas.1004932107; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2006, NEURAL NETWORKS, V19, P1120, DOI 10.1016/j.neunet.2006.03.006; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Gelman A., 2003, BAYESIAN DATA ANAL, DOI DOI 10.1201/9780429258411; Halbig TD, 2009, EUR J NEUROL, V16, P493, DOI 10.1111/j.1468-1331.2008.02509.x; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Humphries MD, 2006, J NEUROSCI, V26, P12921, DOI 10.1523/JNEUROSCI.3486-06.2006; Hutchison WD, 1998, ANN NEUROL, V44, P622, DOI 10.1002/ana.410440407; Inase M, 1999, BRAIN RES, V833, P191, DOI 10.1016/S0006-8993(99)01531-0; Isoda M, 2008, J NEUROSCI, V28, P7209, DOI 10.1523/JNEUROSCI.0487-08.2008; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Kayser J, 2006, CLIN NEUROPHYSIOL, V117, P348, DOI 10.1016/j.clinph.2005.08.034; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Neubert FX, 2010, P NATL ACAD SCI USA, V107, P13240, DOI 10.1073/pnas.1000674107; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Takada M, 2001, EUR J NEUROSCI, V14, P1633, DOI 10.1046/j.0953-816x.2001.01789.x; Tass P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016009; Thobois S, 2007, J CEREBR BLOOD F MET, V27, P1173, DOI 10.1038/sj.jcbfm.9600425; Vandekerckhove J, 2011, PSYCHOL METHODS, V16, P44, DOI 10.1037/a0021765; Voss A, 2008, J MATH PSYCHOL, V52, P1, DOI 10.1016/j.jmp.2007.09.005; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931	37	386	390	13	113	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1462	U140		10.1038/nn.2925	http://dx.doi.org/10.1038/nn.2925			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	841NI	21946325	Green Accepted			2022-12-17	WOS:000296518600023
J	Yeo, GSH; Hung, CCC; Rochford, J; Keogh, J; Gray, J; Sivaramakrishnan, S; O'Rahilly, S; Farooqi, IS				Yeo, GSH; Hung, CCC; Rochford, J; Keogh, J; Gray, J; Sivaramakrishnan, S; O'Rahilly, S; Farooqi, IS			A de novo mutation affecting human TrkB associated with severe obesity and developmental delay	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIC FACTOR; RECEPTOR GENE; MELANOCORTIN-4 RECEPTOR; AUTOPHOSPHORYLATION; ROLES; MICE; BDNF	An 8-year-old male with a complex developmental syndrome and severe obesity was heterozygous for a de novo missense mutation resulting in a Y722C substitution in the neurotrophin receptor TrkB. This mutation markedly impaired receptor autophosphorylation and signaling to MAP kinase. Mutation of NTRK2, which encodes TrkB, seems to result in a unique human syndrome of hyperphagic obesity. The associated impairment in memory, learning and nociception seen in the proband reflects the crucial role of TrkB in the human nervous system.	Addenbrookes Hosp, Cambridge Inst Med Res, Univ Dept Clin Biochem, Cambridge CB2 2XY, England; Castleford & Normanton Dist Hosp, Castleford WF10 5LT, Yorks, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	O'Rahilly, S (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Univ Dept Clin Biochem, Cambridge CB2 2XY, England.	sorahill@hgmp.mrc.ac.uk	O'Rahilly, Stephen/ABF-6509-2020; Farooqi, Ismaa Sadaf/AAZ-3046-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Yeo, Giles See How/0000-0001-8823-3615; Farooqi, Sadaf/0000-0001-7609-3504; Rochford, Justin/0000-0002-5020-4939	Wellcome Trust [068086] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Donovan MJ, 2000, DEVELOPMENT, V127, P4531; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Elliot C. D., 1996, BRIT ABILITY SCALES, V2; Erickson JT, 1996, J NEUROSCI, V16, P5361; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; GUITON M, 1994, J BIOL CHEM, V269, P30370; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; McCarty JH, 1998, ONCOGENE, V16, P1691, DOI 10.1038/sj.onc.1201688; O'Rahilly S, 2003, ENDOCRINOLOGY, V144, P3757, DOI 10.1210/en.2003-0373; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Ultsch MH, 1999, J MOL BIOL, V290, P149, DOI 10.1006/jmbi.1999.2816; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073	15	386	401	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1187	1189		10.1038/nn1336	http://dx.doi.org/10.1038/nn1336			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15494731				2022-12-17	WOS:000224749400009
J	Washbourne, P; Thompson, PM; Carta, M; Costa, ET; Mathews, JR; Lopez-Bendito, G; Molnar, Z; Becher, MW; Valenzuela, CF; Partridge, LD; Wilson, MC				Washbourne, P; Thompson, PM; Carta, M; Costa, ET; Mathews, JR; Lopez-Bendito, G; Molnar, Z; Becher, MW; Valenzuela, CF; Partridge, LD; Wilson, MC			Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; FROG NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; SYNAPTIC VESICLES; TETANUS TOXIN; NEUROTRANSMITTER SECRETION; CLOSTRIDIAL NEUROTOXINS; MEMBRANE-FUSION; GROWTH CONES; EXOCYTOSIS	Axon outgrowth during development and neurotransmitter release depends on exocytotic mechanisms, although what protein machinery is common to or differentiates these processes remains unclear. Here we show that the neural t-SNARE (target-membrane-associated-soluble N-ethylmaleimide fusion protein attachment protein (SNAP) receptor) SNAP-25 is not required for nerve growth or stimulus-independent neurotransmitter release, but is essential for evoked synaptic transmission at neuromuscular junctions and central synapses. These results demonstrate that the development of neurotransmission requires the recruitment of a specialized SNARE core complex to meet the demands of regulated exocytosis.	Univ New Mexico, Hlth Sci Ctr, Dept Neurosci, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA; Univ Oxford, Dept Human Anat & Genet, Oxford OX1 3QX, England	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of Oxford	Wilson, MC (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Neurosci, Albuquerque, NM 87131 USA.		Molnar, Zoltan/J-7281-2012; Carta, Mauro/AAV-3451-2021; Lopez-Bendito, Guillermina/E-4028-2014	Molnar, Zoltan/0000-0002-6852-6004; Carta, Mauro/0000-0003-0706-9687; Partridge, Linda/0000-0001-9615-0094; Lopez-Bendito, Guillermina/0000-0002-8965-6836; Carta, Mario/0000-0003-1225-2742	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048989] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH048989, MH 4-8989] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AITKEN PG, 1995, J NEUROSCI METH, V59, P139, DOI 10.1016/0165-0270(94)00204-T; BARK IC, 1993, J MOL BIOL, V233, P67, DOI 10.1006/jmbi.1993.1485; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; Brunger AT, 2000, CURR OPIN NEUROBIOL, V10, P293, DOI 10.1016/S0959-4388(00)00098-2; Capogna M, 1997, J NEUROSCI, V17, P7190; CAPOGNA M, 1996, J NEUROPHYSIOL, V76, P149; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; Chen D, 1999, BRAIN RES, V831, P11, DOI 10.1016/S0006-8993(99)01371-2; Coco S, 1999, J NEUROSCI, V19, P9803; Costa ET, 2000, ALCOHOL CLIN EXP RES, V24, P220, DOI 10.1097/00000374-200002000-00013; Deitcher DL, 1998, J NEUROSCI, V18, P2028; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HESS DT, 1992, J NEUROSCI, V12, P4634; HEUSER JE, 1981, J CELL BIOL, V88, P564, DOI 10.1083/jcb.88.3.564; Hua SY, 1998, J NEUROPHYSIOL, V80, P3233, DOI 10.1152/jn.1998.80.6.3233; Katz B., 1969, RELEASE NEURAL TRANS; Lane SR, 1997, J NEUROCHEM, V69, P1864; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Mehta PP, 1996, P NATL ACAD SCI USA, V93, P10471, DOI 10.1073/pnas.93.19.10471; Morihara T, 1999, NEUROSCIENCE, V91, P695, DOI 10.1016/S0306-4522(98)00671-X; OSENSAND A, 1993, NATURE, V364, P445, DOI 10.1038/364445a0; OsenSand A, 1996, J COMP NEUROL, V367, P222, DOI 10.1002/(SICI)1096-9861(19960401)367:2<222::AID-CNE5>3.0.CO;2-7; PELLEGRINI LL, 1995, EMBO J, V14, P4705, DOI 10.1002/j.1460-2075.1995.tb00152.x; PLOMP JJ, 1992, J PHYSIOL-LONDON, V458, P487, DOI 10.1113/jphysiol.1992.sp019429; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Veit M, 1996, FEBS LETT, V385, P119, DOI 10.1016/0014-5793(96)00362-6; Verderio C, 1999, J NEUROSCI, V19, P6723, DOI 10.1523/JNEUROSCI.19-16-06723.1999; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Washbourne P, 2001, BIOCHEM J, V357, P625, DOI 10.1042/0264-6021:3570625; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; Zakharenko S, 1999, J CELL BIOL, V144, P507, DOI 10.1083/jcb.144.3.507	48	386	398	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					19	26		10.1038/nn783	http://dx.doi.org/10.1038/nn783			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11753414				2022-12-17	WOS:000173031800010
J	Kouneiher, F; Charron, S; Koechlin, E				Kouneiher, Frederique; Charron, Sylvain; Koechlin, Etienne			Motivation and cognitive control in the human prefrontal cortex	NATURE NEUROSCIENCE			English	Article							MEDIAL FRONTAL-CORTEX; ANTERIOR CINGULATE CORTEX; CONFLICT DETECTION; DECISION-MAKING; ERROR; ORGANIZATION; REWARD; FMRI; SUPPLEMENTARY; MECHANISMS	The prefrontal cortex (PFC) subserves cognitive control, that is, the ability to select thoughts or actions in relation to internal goals. Little is known, however, about how the PFC combines motivation and the selection processes underlying cognitive control. We used functional magnetic resonance imaging in humans and found that the medial and lateral PFC have a parallel hierarchical organization from posterior to anterior regions for motivating and selecting behaviors, respectively. Moreover, using functional connectivity analyses, we found that functional interactions in this parallel system from medial to lateral PFC regions convey motivational incentives on the basis of rewards/penalties regulating the differential engagement of lateral PFC regions in top-down selection. Our results indicate that motivation is a dissociable function, reveal how the PFC integrates motivation and cognitive control in the service of decision-making, and have major implications for current theories of prefrontal executive function.	[Kouneiher, Frederique; Charron, Sylvain; Koechlin, Etienne] Univ Paris 06, INSERM, Ctr Neuroimaging Res, Ecole Normale Super, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite	Koechlin, E (corresponding author), Univ Paris 06, INSERM, Ctr Neuroimaging Res, Ecole Normale Super, Paris, France.	etienne.koechlin@upmc.fr	Winwood, Peter/A-6363-2008; Koechlin, Etienne/E-5061-2016; Koechlin, Etienne/AAF-5717-2021	Koechlin, Etienne/0000-0002-6514-9311; Koechlin, Etienne/0000-0002-6514-9311; Charron, Sylvain/0000-0001-9511-9693	European Young Investigator Award; Bettencourt-Schueller Foundation	European Young Investigator Award; Bettencourt-Schueller Foundation	We thank J.- L. Anton, B. Nazarian and M. Roth at the Magnetic Resonance Imaging Center in Hospital La Timone for MRI facilities and technical assistance. We also thank C. Summerfield and E. Procyk for helpful comments on an earlier version of the manuscript. This work was supported by a European Young Investigator Award and a Prize from the Bettencourt- Schueller Foundation to E. K.	Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; BADRE D, 2008, TRENDS COGN IN PRESS; Bartels A, 2008, TRENDS NEUROSCI, V31, P444, DOI 10.1016/j.tins.2008.06.004; Beck RC., 2004, MOTIVATION THEORIES; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Campos M, 2005, J NEUROPHYSIOL, V94, P1325, DOI 10.1152/jn.00022.2005; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Duffy E., 1962, ACTIVATION BEHAV; Friston KJ, 2007, SYNTHESE, V159, P417, DOI 10.1007/s11229-007-9237-y; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Hertz J., 1991, INTRO THEORY NEURAL, DOI DOI 10.1201/9780429499661; Hester R, 2007, COGN AFFECT BEHAV NE, V7, P317, DOI 10.3758/CABN.7.4.317; Hull C. L, 1943, PRINCIPLES BEHAV; Hyafil A, 2009, J NEUROSCI, V29, P5135, DOI 10.1523/JNEUROSCI.2828-08.2009; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kennerley SW, 2004, J NEUROPHYSIOL, V91, P978, DOI 10.1152/jn.00651.2003; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mueller RO., 1996, BASIC PRINCIPLES STR; Nachev P, 2006, CURR OPIN NEUROL, V19, P586, DOI 10.1097/01.wco.0000247609.36482.ae; Penny WD, 2004, NEUROIMAGE, V23, pS264, DOI 10.1016/j.neuroimage.2004.07.041; Pochon JB, 2002, P NATL ACAD SCI USA, V99, P5669, DOI 10.1073/pnas.082111099; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Rushworth MFS, 2007, CURR OPIN NEUROBIOL, V17, P220, DOI 10.1016/j.conb.2007.03.001; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Rushworth MFS, 2003, J COGNITIVE NEUROSCI, V15, P338, DOI 10.1162/089892903321593072; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Shima K, 1998, J NEUROPHYSIOL, V80, P3247, DOI 10.1152/jn.1998.80.6.3247; Sohn MH, 2007, P NATL ACAD SCI USA, V104, P10330, DOI 10.1073/pnas.0703225104; Stephan KE, 2004, J ANAT, V205, P443, DOI 10.1111/j.0021-8782.2004.00359.x; Stephan KE, 2003, SCIENCE, V301, P384, DOI 10.1126/science.1086025; Sumner P, 2007, NEURON, V54, P697, DOI 10.1016/j.neuron.2007.05.016; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Ullsperger M, 2004, CORTEX, V40, P593, DOI 10.1016/S0010-9452(08)70155-2	48	385	393	1	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2009	12	7					939	U167		10.1038/nn.2321	http://dx.doi.org/10.1038/nn.2321			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	462OA	19503087				2022-12-17	WOS:000267362900023
J	Berndt, A; Yizhar, O; Gunaydin, LA; Hegemann, P; Deisseroth, K				Berndt, Andre; Yizhar, Ofer; Gunaydin, Lisa A.; Hegemann, Peter; Deisseroth, Karl			Bi-stable neural state switches	NATURE NEUROSCIENCE			English	Article							LIGHT-INDUCED ACTIVATION; IN-VIVO; ANGSTROM RESOLUTION; EXPRESSING CHANNELRHODOPSIN-2; GLUTAMATE-RECEPTOR; STRUCTURAL-CHANGES; DROSOPHILA LARVAE; NEURONAL-ACTIVITY; TRANSGENIC MICE; EXCITABLE CELLS	Here we describe bi-stable channelrhodopsins that convert a brief pulse of light into a stable step in membrane potential. These molecularly engineered probes nevertheless retain millisecond-scale temporal precision. Photocurrents can be precisely initiated and terminated with different colors of light, but operate at vastly longer time scales than conventional channelrhodopsins as a result of modification at the C128 position that extends the lifetime of the open state. Because of their enhanced kinetic stability, these step-function tools are also effectively responsive to light at orders of magnitude lower intensity than wild-type channelrhodopsins. These molecules therefore offer important new capabilities for a broad range of in vivo applications.	[Berndt, Andre; Hegemann, Peter] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Yizhar, Ofer; Gunaydin, Lisa A.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Gunaydin, Lisa A.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Clark Ctr W083, Stanford, CA 94305 USA	Humboldt University of Berlin; Stanford University; Stanford University; Stanford University	Hegemann, P (corresponding author), Humboldt Univ, Inst Biol, Invalidenstr 42, D-10115 Berlin, Germany.	hegemape@rz.hu-berlin.de; deissero@stanford.edu	YIZHAR, OFER/AAV-8497-2021	Yizhar, Ofer/0000-0003-4228-1448; Berndt, Andre/0000-0003-4758-5598	Leibniz Graduate School; European Molecular Biology Organization; Stanford Bio-X; Deutsche Forschungsgemeinschaft [SFB498]; California Institute of Regenerative Medicine; McKnight and Wallace H. Coulter Foundations; National Science Foundation; US National Institute of Mental Health; US National Institute on Drug Abuse; US National Institutes of Health; Kinetics and Keck Foundations	Leibniz Graduate School; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Stanford Bio-X; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); McKnight and Wallace H. Coulter Foundations; National Science Foundation(National Science Foundation (NSF)); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kinetics and Keck Foundations	A. B. is supported by a Leibniz Graduate School fellowship, O. Y. by an European Molecular Biology Organization long-term postdoctoral fellowship and L. A. G. by a Stanford Bio-X Graduate Fellowship. P. H. is supported by the Deutsche Forschungsgemeinschaft (SFB498 and CoE: Unifying concepts in Catalysis). K. D. is supported by the California Institute of Regenerative Medicine, the McKnight and Wallace H. Coulter Foundations, the National Science Foundation, the US National Institute of Mental Health, the US National Institute on Drug Abuse, the US National Institutes of Health Pioneer Award, and the Kinetics and Keck Foundations.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Campagnola L, 2008, J NEUROSCI METH, V169, P27, DOI 10.1016/j.jneumeth.2007.11.012; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Facciotti MT, 2001, BIOPHYS J, V81, P3442, DOI 10.1016/S0006-3495(01)75976-0; FARAH N, 2007, C P IEEE ENG MED BIO, P6369; FLITSCH SL, 1989, BIOCHEMISTRY-US, V28, P7800, DOI 10.1021/bi00445a041; Goto Y, 2001, J NEUROSCI, V21, P4498, DOI 10.1523/JNEUROSCI.21-12-04498.2001; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; Hegemann P, 2008, ANNU REV PLANT BIOL, V59, P167, DOI 10.1146/annurev.arplant.59.032607.092847; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; Kalaidzidis IV, 1998, FEBS LETT, V427, P59, DOI 10.1016/S0014-5793(98)00394-9; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Lanyi JK, 2003, J MOL BIOL, V328, P439, DOI 10.1016/S0022-2836(03)00263-8; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Miesenbock G, 2005, ANNU REV NEUROSCI, V28, P533, DOI 10.1146/annurev.neuro.28.051804.101610; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; OESTERHELT D, 1985, EMBO J, V4, P2351, DOI 10.1002/j.1460-2075.1985.tb03938.x; Patzelt H, 2002, P NATL ACAD SCI USA, V99, P9765, DOI 10.1073/pnas.132253899; Peralavarez-Marin A, 2004, J BIOL CHEM, V279, P16403, DOI 10.1074/jbc.M313988200; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Schobert B, 2003, J MOL BIOL, V330, P553, DOI 10.1016/S0022-2836(03)00576-X; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wanko M, 2008, J PHYS CHEM B, V112, P11468, DOI 10.1021/jp802409k; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988; Zhao SL, 2008, BRAIN CELL BIOL, V36, P141, DOI 10.1007/s11068-008-9034-7	50	385	426	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2009	12	2					229	234		10.1038/nn.2247	http://dx.doi.org/10.1038/nn.2247			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	404VV	19079251				2022-12-17	WOS:000263182000024
J	Munzberg, H; Myers, MG				Munzberg, H; Myers, MG			Molecular and anatomical determinants of central leptin resistance	NATURE NEUROSCIENCE			English	Review							HYPOTHALAMIC ARCUATE NUCLEUS; TYROSINE PHOSPHORYLATION; INSULIN-RESISTANCE; DIABETES-MELLITUS; SIGNAL TRANSDUCER; GENE-EXPRESSION; ENERGY-BALANCE; POMC NEURONS; RECEPTOR; ACTIVATION	The increasing incidence of obesity in developed nations is an ever-growing challenge to health care, promoting diabetes and other diseases. The hormone leptin, which is derived from adipose tissue, regulates feeding and energy expenditure. Most forms of obesity are associated with diminished responsiveness to the appetite-suppressing effects of leptin. Here we review the mechanisms by which leptin activates intracellular signals, the roles of these signals in leptin action in vivo, and mechanisms that may attenuate leptin signaling, limiting its action in obese individuals. We highlight data regarding the expression of SOCS3 (a potential mediator of leptin resistance) in the arcuate nucleus of the hypothalamus.	Univ Michigan, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Div Endocrinol Diabet & Metab, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Myers, MG (corresponding author), Univ Michigan, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	mgmyers@umich.edu	Muenzberg-Gruening, Heike/N-1978-2017					Argetsinger LS, 2004, MOL CELL BIOL, V24, P4955, DOI 10.1128/MCB.24.11.4955-4967.2004; ARGETSINGER LS, 1995, J BIOL CHEM, V270, P14685, DOI 10.1074/jbc.270.24.14685; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Banks WA, 2004, PEPTIDES, V25, P331, DOI 10.1016/j.peptides.2004.02.014; Bates SH, 2005, CELL METAB, V1, P169, DOI 10.1016/j.cmet.2005.02.001; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bates SH, 2004, DIABETES, V53, P3067, DOI 10.2337/diabetes.53.12.3067; Bates SH, 2003, TRENDS ENDOCRIN MET, V14, P447, DOI 10.1016/j.tem.2003.10.003; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bjorbaek C, 2001, J BIOL CHEM, V276, P4747, DOI 10.1074/jbc.M007439200; BJORKHOLM JE, 1998, INTEL TECHNOL J Q, V3, P1; Burcelin R, 1999, DIABETES, V48, P1264, DOI 10.2337/diabetes.48.6.1264; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Butler AA, 2002, NEUROPEPTIDES, V36, P77, DOI 10.1054/npep.2002.0890; Carpino N, 2002, MOL CELL BIOL, V22, P7491, DOI 10.1128/MCB.22.21.7491-7500.2002; Cheng N, 2002, MOL CANCER RES, V1, P2; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; DUNN SL, 2004, MOL ENDOCRINOL; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Feener EP, 2004, MOL CELL BIOL, V24, P4968, DOI 10.1128/MCB.24.11.4968-4978.2004; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; HOWARD JK, 2004, NAT MED; Hu LM, 1998, NEUROENDOCRINOLOGY, V68, P77, DOI 10.1159/000054353; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717; Kloek C, 2002, J BIOL CHEM, V277, P41547, DOI 10.1074/jbc.M205148200; KRISCH B, 1978, CELL TISSUE RES, V192, P327; Kurzer JH, 2004, MOL CELL BIOL, V24, P4557, DOI 10.1128/MCB.24.10.4557-4570.2004; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Levin BE, 2004, AM J PHYSIOL-REG I, V286, pR143, DOI 10.1152/ajpregu.00393.2003; Licinio J, 2004, P NATL ACAD SCI USA, V101, P4531, DOI 10.1073/pnas.0308767101; Liu LS, 1998, J BIOL CHEM, V273, P31160, DOI 10.1074/jbc.273.47.31160; Mantzoros CS, 2000, J CLIN ENDOCR METAB, V85, P4000, DOI 10.1210/jc.85.11.4000; MORI H, 2004, NAT MED; Morton GJ, 2003, ENDOCRINOLOGY, V144, P2016, DOI 10.1210/en.2002-0115; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; MUNZBERG H, 2004, ENDOCRINOLOGY; Niswender KD, 2003, DIABETES, V52, P227, DOI 10.2337/diabetes.52.2.227; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Peruzzo B, 2000, EXP BRAIN RES, V132, P10, DOI 10.1007/s002219900289; Rothstein SI, 2002, BEHAV ECOL, V13, P1, DOI 10.1093/beheco/13.1.1; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; SASAKI A, 2000, J BIOL CHEM; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093; Tups A, 2004, ENDOCRINOLOGY, V145, P1185, DOI 10.1210/en.2003-1382; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; White DW, 1997, J BIOL CHEM, V272, P4065, DOI 10.1074/jbc.272.7.4065; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101	64	384	404	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					566	570		10.1038/nn1454	http://dx.doi.org/10.1038/nn1454			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15856064				2022-12-17	WOS:000228895100014
J	Mednick, S; Nakayama, K; Stickgold, R				Mednick, S; Nakayama, K; Stickgold, R			Sleep-dependent learning: a nap is as good as a night	NATURE NEUROSCIENCE			English	Article							DISCRIMINATION; IMPROVEMENT	The learning of perceptual skills has been shown in some cases to depend on the plasticity of the visual cortex(1) and to require post-training nocturnal sleep(2). We now report that sleep-dependent learning of a texture discrimination task can be accomplished in humans by brief (60-90 min) naps containing both slow-wave sleep (SWS) and rapid eye movement (REM) sleep. This nap-dependent learning closely resembled that previously reported for an 8-h night of sleep in terms of magnitude, sleep-stage dependency and retinotopic specificity, and it was additive to subsequent sleep-dependent improvement, such that performance over 24 h showed as much learning as is normally seen after twice that length of time. Thus, from the perspective of behavioral improvement, a nap is as good as a night of sleep for learning on this perceptual task.	Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Mental Hlth Ctr, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School	Mednick, S (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	smednick@post.harvard.edu		mednick, sara/0000-0002-0906-3097	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS026985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011744] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 11744] Funding Source: Medline; NIMH NIH HHS [MH 48832] Funding Source: Medline; NINDS NIH HHS [NS 26985] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Dinges D., 1989, SLEEP ALERTNESS CHRO; FAHLE M, 1995, VISION RES, V35, P3003, DOI 10.1016/0042-6989(95)00044-Z; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Mednick SC, 2002, NAT NEUROSCI, V5, P677, DOI 10.1038/nn864; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Takahashi M, 2000, SLEEP, V23, P813; Watanabe T, 2002, NAT NEUROSCI, V5, P1003, DOI 10.1038/nn915; ZOHARY E, 1994, SCIENCE, V263, P1289, DOI 10.1126/science.8122114	13	384	395	0	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					697	698		10.1038/nn1078	http://dx.doi.org/10.1038/nn1078			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	694NJ	12819785				2022-12-17	WOS:000183780400015
J	Filosa, JA; Bonev, AD; Straub, SV; Meredith, AL; Wilkerson, MK; Aldrich, RW; Nelson, MT				Filosa, Jessica A.; Bonev, Adrian D.; Straub, Stephen V.; Meredith, Andrea L.; Wilkerson, M. Keith; Aldrich, Richard W.; Nelson, Mark T.			Local potassium signaling couples neuronal activity to vasodilation in the brain	NATURE NEUROSCIENCE			English	Article							CEREBRAL-BLOOD-FLOW; ARTERIAL SMOOTH-MUSCLE; K+ CHANNELS; ASTROCYTE ENDFEET; NEURAL ACTIVITY; GLIAL-CELLS; RAT; STIMULATION; MEMBRANE; OPENER	The mechanisms by which active neurons, via astrocytes, rapidly signal intracerebral arterioles to dilate remain obscure. Here we show that modest elevation of extracellular potassium ( K+) activated inward rectifier K+ ( Kir) channels and caused membrane potential hyperpolarization in smooth muscle cells ( SMCs) of intracerebral arterioles and, in cortical brain slices, induced Kir-dependent vasodilation and suppression of SMC intracellular calcium ( Ca2+) oscillations. Neuronal activation induced a rapid ( < 2 s latency) vasodilation that was greatly reduced by Kir channel blockade and completely abrogated by concurrent cyclooxygenase inhibition. Astrocytic endfeet exhibited large-conductance, Ca2+-sensitive K+ ( BK) channel currents that could be activated by neuronal stimulation. Blocking BK channels or ablating the gene encoding these channels prevented neuronally induced vasodilation and suppression of arteriolar SMC Ca2+, without affecting the astrocytic Ca2+ elevation. These results support the concept of intercellular K+ channel-to-K+ channel signaling, through which neuronal activity in the form of an astrocytic Ca2+ signal is decoded by astrocytic BK channels, which locally release K+ into the perivascular space to activate SMC Kir channels and cause vasodilation.	Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA; Univ Cincinnati, Dept Psychiat, Cincinnati, OH 45237 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	University of Vermont; University System of Ohio; University of Cincinnati; Howard Hughes Medical Institute; Stanford University; Stanford University	Nelson, MT (corresponding author), Univ Vermont, Coll Med, Dept Pharmacol, 89 Beaumont Ave, Burlington, VT 05405 USA.	Mark.Nelson@uvm.edu	Filosa, Jessica Andrea/ABG-4524-2020	Filosa, Jessica Andrea/0000-0001-7536-2039; Meredith, Andrea/0000-0003-1061-2302; Nelson, Mark/0000-0002-6608-8784	NHLBI NIH HHS [HL07944, HL63722, HL44455] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044455, R01HL063722] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bradley KK, 1999, J PHYSIOL-LONDON, V515, P639, DOI 10.1111/j.1469-7793.1999.639ab.x; Brown LA, 2002, AUTON NEUROSCI-BASIC, V95, P137, DOI 10.1016/S1566-0702(01)00395-2; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Cheney JA, 2001, J CEREBR BLOOD F MET, V21, P396, DOI 10.1097/00004647-200104000-00008; Filosa JA, 2004, CIRC RES, V95, pE73, DOI 10.1161/01.RES.0000148636.60732.2e; Gebremedhin D, 2003, J NEUROSCI, V23, P1678; Gribkoff VK, 2001, NAT MED, V7, P471, DOI 10.1038/86546; HEURTEAUX C, 1993, P NATL ACAD SCI USA, V90, P9431, DOI 10.1073/pnas.90.20.9431; Horiuchi T, 2002, STROKE, V33, P2692, DOI 10.1161/01.STR.0000034791.52151.6B; Horiuchi T, 2001, STROKE, V32, P218, DOI 10.1161/01.STR.32.1.218; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P199, DOI 10.1111/j.1469-7793.1998.199br.x; Knot HJ, 1996, J PHYSIOL-LONDON, V492, P419, DOI 10.1113/jphysiol.1996.sp021318; KUFFLER SW, 1966, J NEUROPHYSIOL, V29, P768; KUSCHINSKY W, 1972, CIRC RES, V31, P240, DOI 10.1161/01.RES.31.2.240; LANGTON PD, 1991, AM J PHYSIOL, V260, P927; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; MCCARRON JG, 1990, AM J PHYSIOL, V259, pH902, DOI 10.1152/ajpheart.1990.259.3.H902; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; NELSON MT, 1990, AM J PHYSIOL, V259, pC3; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; NELSON MT, 1995, AM J PHYSIOL, V268, P799; NEWMAN EA, 1984, NATURE, V309, P155, DOI 10.1038/309155a0; NEWMAN EA, 1986, SCIENCE, V233, P453, DOI 10.1126/science.3726539; Nilsson Holger, 2003, Mol Interv, V3, P79, DOI 10.1124/mi.3.2.79; Park L, 2004, J CEREBR BLOOD F MET, V24, P334, DOI 10.1097/01.WCB.0000105800.49957.1E; Price DL, 2002, BRAIN RES, V956, P183, DOI 10.1016/S0006-8993(02)03266-3; QUAYLE JM, 1993, AM J PHYSIOL, V265, pC1363, DOI 10.1152/ajpcell.1993.265.5.C1363; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; Rossi DJ, 2006, NAT NEUROSCI, V9, P159, DOI 10.1038/nn0206-159; Roy C S, 1890, J Physiol, V11, P85; Silva AC, 2000, J CEREBR BLOOD F MET, V20, P201, DOI 10.1097/00004647-200001000-00025; Silva AC, 1999, J CEREBR BLOOD F MET, V19, P871, DOI 10.1097/00004647-199908000-00006; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Simard M, 2003, J NEUROSCI, V23, P9254; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	44	383	391	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1397	1403		10.1038/nn1779	http://dx.doi.org/10.1038/nn1779			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17013381				2022-12-17	WOS:000242403800017
J	Stickgold, R; Walker, MP				Stickgold, Robert; Walker, Matthew P.			Sleep-dependent memory triage: evolving generalization through selective processing	NATURE NEUROSCIENCE			English	Review							MEDIAL TEMPORAL-LOBE; EYE-MOVEMENT SLEEP; REM-SLEEP; EMOTIONAL MEMORY; FALSE MEMORIES; ENHANCES MEMORY; CONSOLIDATION; EXPERIENCE; FUTURE; BRAIN	The brain does not retain all the information it encodes in a day. Much is forgotten, and of those memories retained, their subsequent evolution can follow any of a number of pathways. Emerging data makes clear that sleep is a compelling candidate for performing many of these operations. But how does the sleeping brain know which information to preserve and which to forget? What should sleep do with that information it chooses to keep? For information that is retained, sleep can integrate it into existing memory networks, look for common patterns and distill overarching rules, or simply stabilize and strengthen the memory exactly as it was learned. We suggest such 'memory triage' lies at the heart of a sleep-dependent memory processing system that selects new information, in a discriminatory manner, and assimilates it into the brain's vast armamentarium of evolving knowledge, helping guide each organism through its own, unique life.	[Stickgold, Robert] Beth Israel Deaconess Med Ctr, Ctr Sleep & Cognit, Boston, MA 02215 USA; [Stickgold, Robert] Harvard Univ, Sch Med, Boston, MA USA; [Walker, Matthew P.] Univ Calif Berkeley, Dept Psychol, Sleep & Neuroimaging Lab, Berkeley, CA 94720 USA; [Walker, Matthew P.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Stickgold, R (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Sleep & Cognit, Boston, MA 02215 USA.	rstickgo@bidmc.harvard.edu; mpwalker@berkeley.edu			US National Institutes of Health [MH48832, MH92638, AG031164, MH093537, DA031939]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092638, R01MH048832, R01MH093537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA031939] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Support provided by US National Institutes of Health grants MH48832 and MH92638 (R.S.) and AG031164, MH093537 and DA031939 (M.P.W.). We thank E. Robertson, J. Chamberlain, M. Tucker, E. Wamsley, J. Saletin and I. Nieuwenhuis for discussions on these concepts and comments on this manuscript.	Anderson MC, 2012, NEBR SYM MOTIV, V58, P53, DOI 10.1007/978-1-4614-1195-6_3; Atienza M, 2008, J SLEEP RES, V17, P285, DOI 10.1111/j.1365-2869.2008.00661.x; Baran B, 2012, J NEUROSCI, V32, P1035, DOI 10.1523/JNEUROSCI.2532-11.2012; Born J, 2004, TRENDS COGN SCI, V8, P242, DOI 10.1016/j.tics.2004.04.010; Brawn TP, 2010, J NEUROSCI, V30, P13977, DOI 10.1523/JNEUROSCI.3295-10.2010; Buckmaster CA, 2004, J NEUROSCI, V24, P9811, DOI 10.1523/JNEUROSCI.1532-04.2004; Cai DJ, 2009, P NATL ACAD SCI USA, V106, P10130, DOI 10.1073/pnas.0900271106; Darsaud A, 2011, J COGNITIVE NEUROSCI, V23, P26, DOI 10.1162/jocn.2010.21448; Diekelmann S, 2010, BEHAV BRAIN RES, V208, P425, DOI 10.1016/j.bbr.2009.12.021; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Djonlagic I, 2009, LEARN MEMORY, V16, P751, DOI 10.1101/lm.1634509; Durrant SJ, 2011, NEUROPSYCHOLOGIA, V49, P1322, DOI 10.1016/j.neuropsychologia.2011.02.015; Dusek JA, 1997, P NATL ACAD SCI USA, V94, P7109, DOI 10.1073/pnas.94.13.7109; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Ellenbogen JM, 2007, P NATL ACAD SCI USA, V104, P7723, DOI 10.1073/pnas.0700094104; Fenn KM, 2009, LEARN MEMORY, V16, P509, DOI 10.1101/lm.1500808; Fischer S, 2011, J SLEEP RES, V20, P267, DOI 10.1111/j.1365-2869.2010.00881.x; Fischer S, 2009, J EXP PSYCHOL LEARN, V35, P1586, DOI 10.1037/a0017256; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frey S, 1997, NEUROSCI RES, V28, P285, DOI 10.1016/S0168-0102(97)00048-5; Gaskell MG, 2003, COGNITION, V89, P105, DOI 10.1016/S0010-0277(03)00070-2; GIUDITTA A, 1995, BEHAV BRAIN RES, V69, P157, DOI 10.1016/0166-4328(95)00012-I; Gluck MA, 2002, LEARN MEMORY, V9, P408, DOI 10.1101/lm.45202; Gomez RL, 2006, PSYCHOL SCI, V17, P670, DOI 10.1111/j.1467-9280.2006.01764.x; Grosmark AD, 2012, NEURON, V75, P1001, DOI 10.1016/j.neuron.2012.08.015; HASSELMO ME, 1993, TRENDS NEUROSCI, V16, P218, DOI 10.1016/0166-2236(93)90159-J; Hu P, 2006, PSYCHOL SCI, V17, P891, DOI 10.1111/j.1467-9280.2006.01799.x; Hupbach A, 2009, DEVELOPMENTAL SCI, V12, P1007, DOI 10.1111/j.1467-7687.2009.00837.x; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; Knowlton B J, 1994, Learn Mem, V1, P106; Knutson B, 2005, NEURON, V45, P331, DOI 10.1016/j.neuron.2005.01.020; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lewis PA, 2011, NEUROPSYCHOLOGIA, V49, P2619, DOI 10.1016/j.neuropsychologia.2011.05.009; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MEDNICK SA, 1962, PSYCHOL REV, V69, P220, DOI 10.1037/h0048850; Mednick SC, 2011, TRENDS NEUROSCI, V34, P504, DOI 10.1016/j.tins.2011.06.003; Nishida M, 2009, CEREB CORTEX, V19, P1158, DOI 10.1093/cercor/bhn155; Payne JD, 2008, PSYCHOL SCI, V19, P781, DOI 10.1111/j.1467-9280.2008.02157.x; Payne JD, 2011, J COGNITIVE NEUROSCI, V23, P1285, DOI 10.1162/jocn.2010.21526; Payne JD, 2009, NEUROBIOL LEARN MEM, V92, P327, DOI 10.1016/j.nlm.2009.03.007; Piaget J., 1952, ORIGIN INTELLIGENCE; Pilzecker, 1900, Z PSYCHOL, V1, P1; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; Rauchs G, 2011, J NEUROSCI, V31, P2563, DOI 10.1523/JNEUROSCI.3972-10.2011; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Saletin Jared M, 2012, Front Neurol, V3, P59, DOI 10.3389/fneur.2012.00059; Saletin JM, 2011, CEREB CORTEX, V21, P2534, DOI 10.1093/cercor/bhr034; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schacter DL, 2009, PHILOS T R SOC B, V364, P1245, DOI 10.1098/rstb.2008.0308; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Shimamura AP, 2011, COGN AFFECT BEHAV NE, V11, P277, DOI 10.3758/s13415-011-0031-4; Smith C, 2003, SLEEP, V26, P185; SMITH C, 1974, BRAIN RES, V77, P221, DOI 10.1016/0006-8993(74)90786-0; SQUIRE LR, 1975, SCIENCE, V187, P77, DOI 10.1126/science.1109228; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Stickgold R, 1999, J COGNITIVE NEUROSCI, V11, P182, DOI 10.1162/089892999563319; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; Tamminen J, 2010, J NEUROSCI, V30, P14356, DOI 10.1523/JNEUROSCI.3028-10.2010; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; van Dongen EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043426; van Kesteren MTR, 2012, TRENDS NEUROSCI, V35, P211, DOI 10.1016/j.tins.2012.02.001; Wagner U, 2001, LEARN MEMORY, V8, P112, DOI 10.1101/lm.36801; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, COGNITIVE BRAIN RES, V14, P317, DOI 10.1016/S0926-6410(02)00134-9; Wamsley EJ, 2010, LEARN MEMORY, V17, P332, DOI 10.1101/lm.1828310; Wamsley EJ, 2010, CURR BIOL, V20, P850, DOI 10.1016/j.cub.2010.03.027; Wang G, 2011, TRENDS NEUROSCI, V34, P452, DOI 10.1016/j.tins.2011.07.005; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wylie GR, 2008, CEREB CORTEX, V18, P670, DOI 10.1093/cercor/bhm101; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007	76	382	387	5	222	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					139	145		10.1038/nn.3303	http://dx.doi.org/10.1038/nn.3303			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	080RE	23354387	Green Accepted			2022-12-17	WOS:000314260200009
J	Dupret, D; O'Neill, J; Pleydell-Bouverie, B; Csicsvari, J				Dupret, David; O'Neill, Joseph; Pleydell-Bouverie, Barty; Csicsvari, Jozsef			The reorganization and reactivation of hippocampal maps predict spatial memory performance	NATURE NEUROSCIENCE			English	Article							NMDA-RECEPTOR BLOCKADE; PLACE CELLS; NEURONAL ENSEMBLES; CONSOLIDATION; SLEEP; PATTERNS; TRACE; RAT; TASK; IMPAIRMENT	The hippocampus is an important brain circuit for spatial memory and the spatially selective spiking of hippocampal neuronal assemblies is thought to provide a mnemonic representation of space. We found that remembering newly learnt goal locations required NMDA receptor-dependent stabilization and enhanced reactivation of goal-related hippocampal assemblies. During spatial learning, place-related firing patterns in the CA1, but not CA3, region of the rat hippocampus were reorganized to represent new goal locations. Such reorganization did not occur when goals were marked by visual cues. The stabilization and successful retrieval of these newly acquired CA1 representations of behaviorally relevant places was NMDAR dependent and necessary for subsequent memory retention performance. Goal-related assembly patterns associated with sharp wave/ripple network oscillations, during both learning and subsequent rest periods, predicted memory performance. Together, these results suggest that the reorganization and reactivation of assembly firing patterns in the hippocampus represent the formation and expression of new spatial memory traces.	[Dupret, David; O'Neill, Joseph; Pleydell-Bouverie, Barty; Csicsvari, Jozsef] Univ Oxford, Dept Pharmacol, Anat Neuropharmacol Unit, MRC, Oxford OX1 3QT, England	University of Oxford	Dupret, D (corresponding author), Univ Oxford, Dept Pharmacol, Anat Neuropharmacol Unit, MRC, S Parks Rd, Oxford OX1 3QT, England.	david.dupret@pharm.ox.ac.uk; jozsef.csicsvari@pharm.ox.ac.uk		Dupret, David/0000-0002-0040-1766	Medical Research Council; Institut de France-Fondation Louis D.; International Brain Research Organization; Saint Edmund Hall College, University of Oxford; Medical Research Council [MC_U138169944, MC_U138197111] Funding Source: researchfish; MRC [MC_U138169944, MC_U138197111] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institut de France-Fondation Louis D.; International Brain Research Organization; Saint Edmund Hall College, University of Oxford; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J.N.P. Rawlins and D. M. Bannerman for discussions about the behavioral procedures; J.R. Huxter and K. Allen for discussions about data analysis and the manuscript; P. Somogyi, M. Capogna, C. Lever, O. Paulsen and T. Bienvenu for comments on a previous version of the manuscript and N. Campo-Urriza for technical assistance. This work was supported by the Medical Research Council. D. D. was successively funded by fellowships from the Institut de France-Fondation Louis D. and the International Brain Research Organization (Research Fellowship), and currently holds a Junior Research Fellowship in Neurosciences from Saint Edmund Hall College, University of Oxford.	[Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cheng S, 2008, NEURON, V57, P303, DOI 10.1016/j.neuron.2007.11.035; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Gerrard JL, 2008, J NEUROSCI, V28, P7883, DOI 10.1523/JNEUROSCI.1265-08.2008; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; GLICKMAN SE, 1961, PSYCHOL BULL, V58, P218, DOI 10.1037/h0044212; Hok V, 2007, J NEUROSCI, V27, P472, DOI 10.1523/JNEUROSCI.2864-06.2007; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; King C, 1999, J PHYSIOL-LONDON, V521, P159, DOI 10.1111/j.1469-7793.1999.00159.x; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lansink CS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000173; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McDonald RJ, 2005, EUR J NEUROSCI, V22, P1201, DOI 10.1111/j.1460-9568.2005.04272.x; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1989, J NEUROSCI, V9, P4101; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Pennartz CMA, 2004, J NEUROSCI, V24, P6446, DOI 10.1523/JNEUROSCI.0575-04.2004; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Rasch B, 2007, CURR OPIN NEUROBIOL, V17, P698, DOI 10.1016/j.conb.2007.11.007; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Tatsuno M, 2006, J NEUROSCI, V26, P10727, DOI 10.1523/JNEUROSCI.3317-06.2006; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	50	382	387	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					995	U122		10.1038/nn.2599	http://dx.doi.org/10.1038/nn.2599			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20639874	Green Accepted			2022-12-17	WOS:000280400600019
J	Fuhrmann, M; Bittner, T; Jung, CKE; Burgold, S; Page, RM; Mitteregger, G; Haass, C; LaFerla, FM; Kretzschmar, H; Herms, J				Fuhrmann, Martin; Bittner, Tobias; Jung, Christian K. E.; Burgold, Steffen; Page, Richard M.; Mitteregger, Gerda; Haass, Christian; LaFerla, Frank M.; Kretzschmar, Hans; Herms, Jochen			Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease	NATURE NEUROSCIENCE			English	Article							FRACTALKINE-RECEPTOR; BRAIN-DAMAGE; IN-VIVO; BETA; INFLAMMATION; MAINTENANCE; PLAQUES; CELLS	Microglia, the immune cells of the brain, can have a beneficial effect in Alzheimer's disease by phagocytosing amyloid-beta. Two-photon in vivo imaging of neuron loss in the intact brain of living Alzheimer's disease mice revealed an involvement of microglia in neuron elimination, indicated by locally increased number and migration velocity of microglia around lost neurons. Knockout of the microglial chemokine receptor Cx3cr1, which is critical in neuron-microglia communication, prevented neuron loss.	[Fuhrmann, Martin; Bittner, Tobias; Jung, Christian K. E.; Burgold, Steffen; Mitteregger, Gerda; Kretzschmar, Hans; Herms, Jochen] Univ Munich, Ctr Neuropathol & Prion Res, Munich, Germany; [Page, Richard M.; Haass, Christian] Univ Munich, German Ctr Neurodegenerat Dis Munich, Munich, Germany; [LaFerla, Frank M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA	University of Munich; University of Munich; University of California System; University of California Irvine	Herms, J (corresponding author), Univ Munich, Ctr Neuropathol & Prion Res, Munich, Germany.	jochen.herms@med.uni-muenchen.de	Herms, Jochen/D-3518-2011; Fuhrmann, Martin/E-4565-2011; Fuhrmann, Martin/J-2707-2018	Fuhrmann, Martin/0000-0001-7672-2913	Deutsche Forschungsgemeinschaft [SFB 596, A13]; German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) [01GZ0713, 13N9268]; German Federal Ministry of Economics and Technology (Bundesministerium fur Wirtschaft und Technologie) [16IN0675]; European Union [GSK3, FP-7-223276]; NATIONAL INSTITUTE ON AGING [P01AG000538] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Economics and Technology (Bundesministerium fur Wirtschaft und Technologie)(Federal Ministry for Economic Affairs and Energy (BMWi)); European Union(European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Oddo for generously providing the 3xTg-AD mice and P. Thevnaz and E. Meijering for the development of the ImageJ plugins stackreg and MTrackJ. This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 596, A13), the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, 01GZ0713, 13N9268), the German Federal Ministry of Economics and Technology (Bundesministerium fur Wirtschaft und Technologie, 16IN0675) and the European Union (Neuro. GSK3, FP-7-223276).	Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Denes A, 2008, J CEREBR BLOOD F MET, V28, P1707, DOI 10.1038/jcbfm.2008.64; Fuhrmann M, 2007, J NEUROSCI, V27, P6224, DOI 10.1523/JNEUROSCI.5062-06.2007; Giulian D, 1996, J NEUROSCI, V16, P6021; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; London JA, 1996, P NATL ACAD SCI USA, V93, P4147, DOI 10.1073/pnas.93.9.4147; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484	15	382	393	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2010	13	4					411	413		10.1038/nn.2511	http://dx.doi.org/10.1038/nn.2511			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	575NI	20305648	Green Accepted			2022-12-17	WOS:000276073500007
J	King, T; Vera-Portocarrero, L; Gutierrez, T; Vanderah, TW; Dussor, G; Lai, J; Fields, HL; Porreca, F				King, Tamara; Vera-Portocarrero, Louis; Gutierrez, Tannia; Vanderah, Todd W.; Dussor, Gregory; Lai, Josephine; Fields, Howard L.; Porreca, Frank			Unmasking the tonic-aversive state in neuropathic pain	NATURE NEUROSCIENCE			English	Article							CLINICAL-TRIALS; MECHANISMS	Tonic pain has been difficult to demonstrate in animals. Because relief of pain is rewarding, analgesic agents that are not rewarding in the absence of pain should become rewarding only when there is ongoing pain. We used conditioned place preference to concomitantly determine the presence of tonic pain in rats and the efficacy of agents that relieve it. This provides a new approach for investigating tonic pain in animals and for evaluating the analgesic effects of drugs.	[King, Tamara; Vera-Portocarrero, Louis; Gutierrez, Tannia; Vanderah, Todd W.; Dussor, Gregory; Lai, Josephine; Porreca, Frank] Univ Arizona, Dept Pharmacol, Tucson, AZ 85721 USA; [Fields, Howard L.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA	University of Arizona; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Porreca, F (corresponding author), Univ Arizona, Dept Pharmacol, Tucson, AZ 85721 USA.	frankp@u.arizona.edu	Fields, Howard/ABG-9073-2020		NINDS NIH HHS [R01 NS066958, R01 NS066958-02] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066958] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Backonja MM, 2004, J PAIN, V5, P491, DOI 10.1016/j.jpain.2004.09.001; Boulton AJM, 2005, CLIN DIABETES, V23, P9, DOI DOI 10.2337/DIACLIN.23.1.9; Burgess SE, 2002, J NEUROSCI, V22, P5129, DOI 10.1523/JNEUROSCI.22-12-05129.2002; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Eisenach JC, 2003, PAIN, V105, P65, DOI 10.1016/S0304-3959(03)00158-1; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; Martin TJ, 2007, ANESTHESIOLOGY, V106, P312, DOI 10.1097/00000542-200702000-00020; Niikura K, 2008, NEUROSCI LETT, V435, P257, DOI 10.1016/j.neulet.2008.02.059; Rice ASC, 2008, PAIN, V139, P243, DOI 10.1016/j.pain.2008.08.017; Rowbotham MC, 2005, NEUROLOGY, V65, pS66, DOI 10.1212/WNL.65.12_suppl_4.S66; Skinner B. F., 1938, BEHAV ORGAN EXP ANAL; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Vierck CJ, 2008, PAIN, V135, P7, DOI 10.1016/j.pain.2007.12.008	15	382	390	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1364	1366		10.1038/nn.2407	http://dx.doi.org/10.1038/nn.2407			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19783992	Green Accepted			2022-12-17	WOS:000271194100006
J	Cobos, I; Calcagnotto, ME; Vilaythong, AJ; Thwin, MT; Noebels, JL; Baraban, SC; Rubenstein, JLR				Cobos, I; Calcagnotto, ME; Vilaythong, AJ; Thwin, MT; Noebels, JL; Baraban, SC; Rubenstein, JLR			Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy	NATURE NEUROSCIENCE			English	Article							MEDIAL GANGLIONIC EMINENCE; GABAERGIC NEURONS; DIVERSITY-SERIES; ADULT-MOUSE; CORTICAL INTERNEURONS; HOMEOBOX GENES; VISUAL-CORTEX; IN-VITRO; RAT; FOREBRAIN	Dlx homeodomain transcription factors are essential during embryonic development for the production of forebrain GABAergic interneurons. Here we show that Dlx1 is also required for regulating the functional longevity of cortical and hippocampal interneurons in the adult brain. We demonstrate preferential Dlx1 expression in a subset of cortical and hippocampal interneurons which, in postnatal Dlx1 mutants, show a time-dependent reduction in number. This reduction preferentially affects calretinin(+) ( bipolar cells) and somatostatin(+) subtypes ( for example, bitufted cells), whereas parvalbumin(+) subpopulations ( basket cells and chandelier cells) seem to be unaffected. Cell transplantation analysis demonstrates that interneuron loss reflects cell-autonomous functions of Dlx1. The decrease in the number of interneurons was associated with a reduction of GABA-mediated inhibitory postsynaptic current in neocortex and hippocampus in vitro and cortical dysrhythmia in vivo. Dlx1 mutant mice show generalized electrographic seizures and histological evidence of seizure-induced reorganization, linking the Dlx1 mutation to delayed-onset epilepsy associated with interneuron loss.	Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Neurol Surg, Epilepsy Res Lab, San Francisco, CA 94143 USA; Baylor Coll Med, Dept Neurol, Dev Neurogenet Lab, Houston, TX 77030 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Baylor College of Medicine	Cobos, I (corresponding author), Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA.	icobos@itsa.ucsf.edu; jlrr@itsa.ucsf.edu	calcagnotto, maria elisa/B-1645-2013; CALCAGNOTTO, MARIA ELISA/AAU-7718-2020	calcagnotto, maria elisa/0000-0001-8196-0596; CALCAGNOTTO, MARIA ELISA/0000-0001-8196-0596; Cobos, Inma/0000-0002-2043-1890; Noebels, Jeffrey/0000-0002-2887-0839; Baraban, Scott/0000-0003-1975-9781	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049428, K05MH065670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029709, R01NS040272] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24064] Funding Source: Medline; NIMH NIH HHS [R01 MH49428, K05 MH065670] Funding Source: Medline; NINDS NIH HHS [R01 NS40272, NS 29709] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alcantara S, 1998, J NEUROSCI, V18, P7779; Alifragis P, 2004, J NEUROSCI, V24, P5643, DOI 10.1523/JNEUROSCI.1245-04.2004; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Baraban SC, 2004, TRENDS NEUROSCI, V27, P135, DOI 10.1016/j.tins.2004.01.008; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cobos I, 2005, J COMP NEUROL, V483, P292, DOI 10.1002/cne.20405; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; DEFELIPE J, 1993, CEREB CORTEX, V3, P273, DOI 10.1093/cercor/3.4.273; Erbel-Sieler C, 2004, P NATL ACAD SCI USA, V101, P13648, DOI 10.1073/pnas.0405310101; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Gonchar Y, 2002, J COMP NEUROL, V443, P1, DOI 10.1002/cne.1425; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; JONES EG, 1975, J COMP NEUROL, V160, P205, DOI 10.1002/cne.901600204; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kobayashi M, 2003, J NEUROSCI, V23, P2440; KUBOTA Y, 1994, BRAIN RES, V649, P159, DOI 10.1016/0006-8993(94)91060-X; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Levitt P, 2004, TRENDS NEUROSCI, V27, P400, DOI 10.1016/j.tins.2004.05.008; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; Marin O, 2000, J NEUROSCI, V20, P6063; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Marty S, 1997, TRENDS NEUROSCI, V20, P198, DOI 10.1016/S0166-2236(96)01026-0; MCBAIN CJ, 1992, BRAIN RES, V592, P255, DOI 10.1016/0006-8993(92)91683-6; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Powell EM, 2003, J NEUROSCI, V23, P622, DOI 10.1523/JNEUROSCI.23-02-00622.2003; QIU MS, 1995, GENE DEV, V9, P2523, DOI 10.1101/gad.9.20.2523; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ramon y Cajal S, 1911, HISTOLOGY NERVOUS SY; Saino-Saito S, 2003, J COMP NEUROL, V461, P18, DOI 10.1002/cne.10611; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Stuhmer T, 2002, CEREB CORTEX, V12, P75, DOI 10.1093/cercor/12.1.75; Sussel L, 1999, DEVELOPMENT, V126, P3359; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Yun K, 2002, DEVELOPMENT, V129, P5029	49	381	390	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1059	1068		10.1038/nn1499	http://dx.doi.org/10.1038/nn1499			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16007083				2022-12-17	WOS:000230760200018
J	Hamann, S; Herman, RA; Nolan, CL; Wallen, K				Hamann, S; Herman, RA; Nolan, CL; Wallen, K			Men and women differ in amygdala response to visual sexual stimuli	NATURE NEUROSCIENCE			English	Article							BRAIN ACTIVATION; REWARD VALUE; MOTIVATION; BEHAVIOR; MECHANISMS; AROUSAL; MEMORY	Men are generally more interested in and responsive to visual sexually arousing stimuli than are women. Here we used functional magnetic resonance imaging (fMRI) to show that the amygdala and hypothalamus are more strongly activated in men than in women when viewing identical sexual stimuli. This was true even when women reported greater arousal. Sex differences were specific to the sexual nature of the stimuli, were restricted primarily to limbic regions, and were larger in the left amygdala than the right amygdala. Men and women showed similar activation patterns across multiple brain regions, including ventral striatal regions involved in reward. Our findings indicate that the amygdala mediates sex differences in responsiveness to appetitive and biologically salient stimuli; the human amygdala may also mediate the reportedly greater role of visual stimuli in male sexual behavior, paralleling prior animal findings.	Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA	Emory University; Emory University	Hamann, S (corresponding author), Emory Univ, Dept Psychol, 532 N Kilgo Circle, Atlanta, GA 30322 USA.	shamann@emory.edu						Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Arana FS, 2003, J NEUROSCI, V23, P9632; ARNOLD AP, 1984, ANNU REV NEUROSCI, V7, P413, DOI 10.1146/annurev.ne.07.030184.002213; Baird AD, 2004, ANN NEUROL, V55, P87, DOI 10.1002/ana.10997; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; Cahill L, 2001, NEUROBIOL LEARN MEM, V75, P1, DOI 10.1006/nlme.2000.3999; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Canli T, 2000, J NEUROSCI, V20; Davies A, 2001, OPT PHOTONICS NEWS, V12, P34, DOI 10.1364/OPN.12.2.000034; DOLAN RJ, 2000, SER AFFECTIVE SCI, P225; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Everitt BJ, 2003, ANN NY ACAD SCI, V985, P233; EVERITT BJ, 1990, NEUROSCI BIOBEHAV R, V14, P217, DOI 10.1016/S0149-7634(05)80222-2; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Funayama ES, 2001, J COGNITIVE NEUROSCI, V13, P721, DOI 10.1162/08989290152541395; GALLAGHER M, 2001, AMYGDALA FUNCTIONAL, P311; Garavan H, 2001, NEUROREPORT, V12, P2779, DOI 10.1097/00001756-200108280-00036; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Gur RC, 2000, BRAIN LANG, V74, P157, DOI 10.1006/brln.2000.2325; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; Herz RS, 1997, HUM NATURE-INT BIOS, V8, P275, DOI 10.1007/BF02912495; Holstege G, 2003, J NEUROSCI, V23, P9185; Kampe KKW, 2001, NATURE, V413, P589, DOI 10.1038/35098149; Karama S, 2002, HUM BRAIN MAPP, V16, P1, DOI 10.1002/hbm.10014; Laumann EO, 2000, SOCIAL ORG SXUALITY; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; Rauch SL, 1999, PSYCHIAT RES-NEUROIM, V91, P1, DOI 10.1016/S0925-4927(99)00020-7; Redoute J, 2000, HUM BRAIN MAPP, V11, P162, DOI 10.1002/1097-0193(200011)11:3<162::AID-HBM30>3.0.CO;2-A; Roselli CE, 2001, J COMP NEUROL, V439, P208, DOI 10.1002/cne.1343; Schmitt DP, 2003, J PERS SOC PSYCHOL, V85, P85, DOI 10.1037/0022-3514.85.1.85; Stoleru S, 1999, ARCH SEX BEHAV, V28, P1, DOI 10.1023/A:1018733420467; Symons D., 1979, EVOLUTION HUMAN SEXU; Talairach J., 1988, COPLANAR STEREOTAXIC	39	381	386	0	54	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					411	416		10.1038/nn1208	http://dx.doi.org/10.1038/nn1208			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15004563				2022-12-17	WOS:000220482500021
J	Polonsky, A; Blake, R; Braun, T; Heeger, DJ				Polonsky, A; Blake, R; Braun, T; Heeger, DJ			Neuronal activity in human primary visual cortex correlates with perception during binocular rivalry	NATURE NEUROSCIENCE			English	Article							NEUROMAGNETIC RESPONSES; CONSCIOUS PERCEPTION; FUNCTIONAL MRI; SUPPRESSION; MOTION; VISION; COLOR; BRAIN; SYNCHRONIZATION; ORGANIZATION	During binocular rivalry, two incompatible monocular images compete for perceptual dominance, with one pattern temporarily suppressed from conscious awareness. We measured fMRI signals in early visual cortex while subjects viewed rival dichoptic images of two different contrasts; the contrast difference served as a 'tag' for the neuronal representations of the two monocular images. Activity in primary visual cortex (V1) increased when subjects perceived the higher contrast pattern and decreased when subjects perceived the lower contrast pattern. These fluctuations in V1 activity during rivalry were about 55% as large as those evoked by alternately presenting the two monocular images without rivalry. The rivalry-related fluctuations in V1 activity were roughly equal to those observed in other visual areas (V2, V3, V3a and V4v). These results challenge the view that the neuronal mechanisms responsible for binocular rivalry occur primarily in later visual areas.	Stanford Univ, Dept Psychol, Palo Alto, CA 94303 USA; Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; Univ Plymouth, Inst Neurosci, Plymouth PL4 8AA, Devon, England	Stanford University; Vanderbilt University; University of Plymouth	Heeger, DJ (corresponding author), Stanford Univ, Dept Psychol, Jordan Hall,Bldg 420, Palo Alto, CA 94303 USA.	heeger@stanford.edu	Braun, Jochen/F-1370-2013	Braun, Jochen/0000-0002-8886-078X	NATIONAL EYE INSTITUTE [R01EY012741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008294] Funding Source: NIH RePORTER; NEI NIH HHS [R01EY12741] Funding Source: Medline; NIGMS NIH HHS [2T32GM08294] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Alais D, 1998, VISION RES, V38, P637, DOI 10.1016/S0042-6989(97)00190-9; Andrews TJ, 1999, NAT NEUROSCI, V2, P405, DOI 10.1038/8068; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; BLAKE R, 1979, J EXP PSYCHOL HUMAN, V5, P315, DOI 10.1037/0096-1523.5.2.315; BLAKE R, 1992, VISUAL NEUROSCI, V8, P469, DOI 10.1017/S0952523800004971; BLAKE R, 1974, NATURE, V249, P488, DOI 10.1038/249488a0; BLAKE R, 1979, PERCEPTION, V8, P143, DOI 10.1068/p080143; Brown RJ, 1997, VISION RES, V37, P2401, DOI 10.1016/S0042-6989(97)00045-X; Engel AK, 1999, CONSCIOUS COGN, V8, P128, DOI 10.1006/ccog.1999.0389; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Glover GH, 1999, MAGNET RESON MED, V42, P412, DOI 10.1002/(SICI)1522-2594(199908)42:2<412::AID-MRM25>3.0.CO;2-U; GROSSBERG S, 1987, PERCEPT PSYCHOPHYS, V41, P117, DOI 10.3758/BF03204875; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Lee SH, 1999, VISION RES, V39, P1447, DOI 10.1016/S0042-6989(98)00269-7; LEHMKUHLE SW, 1975, VISION RES, V15, P855, DOI 10.1016/0042-6989(75)90266-7; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 1997, THESIS BAYLOR COLL M; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Lumer ED, 1998, CEREB CORTEX, V8, P553, DOI 10.1093/cercor/8.6.553; MUELLER TJ, 1990, VISUAL NEUROSCI, V4, P63, DOI 10.1017/S0952523800002777; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; OSHEA RP, 1994, PERCEPTION, V23, P771, DOI 10.1068/p230771; OSHEA RP, 1987, VISION RES, V27, P781, DOI 10.1016/0042-6989(87)90075-7; OSHEA RP, 1981, VISION RES, V21, P801, DOI 10.1016/0042-6989(81)90177-2; Preuss TM, 1999, P NATL ACAD SCI USA, V96, P11601, DOI 10.1073/pnas.96.20.11601; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Sengpiel F, 1997, CURR BIOL, V7, pR447, DOI 10.1016/S0960-9822(06)00215-6; SENGPIEL F, 1995, VISION RES, V35, P179, DOI 10.1016/0042-6989(94)00125-6; SENGPIEL F, 1994, NATURE, V368, P847, DOI 10.1038/368847a0; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; SMITH EL, 1982, SCIENCE, V218, P802, DOI 10.1126/science.7134975; Srinivasan R, 1999, J NEUROSCI, V19, P5435; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tononi G, 1998, P NATL ACAD SCI USA, V95, P3198, DOI 10.1073/pnas.95.6.3198; Valle-Inclan F, 1999, NEUROREPORT, V10, P21, DOI 10.1097/00001756-199901180-00004; WADE NJ, 1978, VISION RES, V18, P827, DOI 10.1016/0042-6989(78)90123-2; WANDELL B, IN PRESS J COGN NEUR; WIESENFELDER H, 1991, VISION RES, V31, P1589, DOI 10.1016/0042-6989(91)90135-R; YU K, 1992, J EXP PSYCHOL HUMAN, V18, P1158, DOI 10.1037/0096-1523.18.4.1158	49	381	386	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1153	1159		10.1038/80676	http://dx.doi.org/10.1038/80676			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036274				2022-12-17	WOS:000167177600022
J	Menard, C; Pfau, ML; Hodes, GE; Kana, V; Wang, VX; Bouchard, S; Takahashi, A; Flanigan, ME; Aleyasin, H; LeClair, KB; Janssen, WG; Labonte, B; Parise, EM; Lorsch, ZS; Golden, SA; Heshmati, M; Tamminga, C; Turecki, G; Campbell, M; Fayad, ZA; Tang, CY; Merad, M; Russo, SJ				Menard, Caroline; Pfau, Madeline L.; Hodes, Georgia E.; Kana, Veronika; Wang, Victoria X.; Bouchard, Sylvain; Takahashi, Aki; Flanigan, Meghan E.; Aleyasin, Hossein; LeClair, Katherine B.; Janssen, William G.; Labonte, Benoit; Parise, Eric M.; Lorsch, Zachary S.; Golden, Sam A.; Heshmati, Mitra; Tamminga, Carol; Turecki, Gustavo; Campbell, Matthew; Fayad, Zahi A.; Tang, Cheuk Ying; Merad, Miriam; Russo, Scott J.			Social stress induces neurovascular pathology promoting depression	NATURE NEUROSCIENCE			English	Article							BLOOD-BRAIN-BARRIER; INDIVIDUAL-DIFFERENCES; SICKNESS BEHAVIOR; TRANSCRIPTOME; PERMEABILITY; RECEPTOR; CELLS; SUSCEPTIBILITY; MACROPHAGES; RESILIENCE	Studies suggest that heightened peripheral inflammation contributes to the pathogenesis of major depressive disorder. We investigated the effect of chronic social defeat stress, a mouse model of depression, on blood-brain barrier (BBB) permeability and infiltration of peripheral immune signals. We found reduced expression of the endothelial cell tight junction protein claudin-5 (Cldn5) and abnormal blood vessel morphology in nucleus accumbens (NAc) of stress-susceptible but not resilient mice. CLDN5 expression was also decreased in NAc of depressed patients. Cldn5 downregulation was sufficient to induce depression-like behaviors following subthreshold social stress whereas chronic antidepressant treatment rescued Cldn5 loss and promoted resilience. Reduced BBB integrity in NAc of stress-susceptible or mice injected with adeno-associated virus expressing shRNA against Cldn5 caused infiltration of the peripheral cytokine interleukin-6 (IL-6) into brain parenchyma and subsequent expression of depression-like behaviors. These findings suggest that chronic social stress alters BBB integrity through loss of tight junction protein Cldn5, promoting peripheral IL-6 passage across the BBB and depression.	[Menard, Caroline; Pfau, Madeline L.; Hodes, Georgia E.; Bouchard, Sylvain; Takahashi, Aki; Flanigan, Meghan E.; Aleyasin, Hossein; LeClair, Katherine B.; Janssen, William G.; Labonte, Benoit; Parise, Eric M.; Lorsch, Zachary S.; Golden, Sam A.; Heshmati, Mitra; Russo, Scott J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Menard, Caroline; Pfau, Madeline L.; Hodes, Georgia E.; Bouchard, Sylvain; Takahashi, Aki; Flanigan, Meghan E.; Aleyasin, Hossein; LeClair, Katherine B.; Janssen, William G.; Labonte, Benoit; Parise, Eric M.; Lorsch, Zachary S.; Golden, Sam A.; Heshmati, Mitra] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Kana, Veronika; Merad, Miriam] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Oncol Sci, New York, NY 10029 USA; [Kana, Veronika; Merad, Miriam] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Wang, Victoria X.; Fayad, Zahi A.; Tang, Cheuk Ying] Translat & Mol Imaging Inst Mt Sinai, Dept Radiol, New York, NY USA; [Takahashi, Aki] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Tamminga, Carol] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX USA; [Turecki, Gustavo] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Turecki, Gustavo] McGill Univ, Montreal, PQ, Canada; [Campbell, Matthew] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland; [Menard, Caroline] Univ Laval, Fac Med, Dept Psychiat & Neurosci, Quebec City, PQ, Canada; [Menard, Caroline] Univ Laval, CERVO Brain Res Ctr, Quebec City, PQ, Canada	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Tsukuba; University of Texas System; University of Texas Southwestern Medical Center Dallas; McGill University; Trinity College Dublin; Laval University; Laval University	Russo, SJ (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA.	scott.russo@mssm.edu	Hodes, Georgia/L-8022-2016; Russo, Scott/R-7107-2019; Fayad, Zahi/Z-3272-2019; Labonte, Benoit/GPF-5629-2022; Parise, Eric/AFM-9139-2022; Campbell, Matthew/AAZ-2997-2021; Menard, Caroline/AAV-4017-2020; Takahashi, Aki/AAC-9290-2021; Parise, Eric Michael/AHB-7518-2022	Hodes, Georgia/0000-0002-1551-2178; Russo, Scott/0000-0002-6470-1805; Fayad, Zahi/0000-0002-3439-7347; Labonte, Benoit/0000-0002-1251-5605; Parise, Eric/0000-0001-5364-5820; Menard, Caroline/0000-0001-8202-7378; Takahashi, Aki/0000-0001-8325-9744; Flanigan, Meghan/0000-0002-3185-7459; Tang, Cheuk Ying/0000-0002-9828-0092; Turecki, Gustavo/0000-0003-4075-2736; Kana, Veronika/0000-0002-9362-3156; Campbell, Matthew/0000-0001-5883-5041	Mental Health grants [RO1 MH090264, P50 MH096890, P50 AT008661-01, RO1 MH114882, RO1 MH104559]; NIH/NHLBI [P01 HL131478, T32 MH087004, T32 MH096678, F30 MH100835, F31 MH105217]; Janssen/IMHRO Rising Star Translational Research Award; Swiss National Science Foundation; Brain and Behavior Research Foundation NARSAD Young Investigator Award; Brain and Behavior Research Foundation NARSAD Young Investigator Grant - PS Fund; National Center for Complementary & Integrative Health [P50AT008661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH110073, R01MH090264, T32MH087004, R01MH104559, T32MH096678, R01MH114882, F31MH111108] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15K12773] Funding Source: KAKEN	Mental Health grants; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Janssen/IMHRO Rising Star Translational Research Award; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Brain and Behavior Research Foundation NARSAD Young Investigator Award; Brain and Behavior Research Foundation NARSAD Young Investigator Grant - PS Fund; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank A. Keller for advice on BBB-related studies and the Center for Comparative Medicine and Surgery housing facilities staff for their work and support. This research was supported by Mental Health grants RO1 MH090264 (S.J.R.), P50 MH096890 (S.J.R.), P50 AT008661-01 (S.J.R.), RO1 MH114882 (S.J.R.), RO1 MH104559 (S.J.R. and M.M.), NIH/NHLBI P01 HL131478 (Z.A.F.), T32 MH087004 (M.L.P., M.H. and M.F.), T32 MH096678 (M.L.P.), F30 MH100835 (M.H.) and F31 MH105217 (M.L.P.), a Janssen/IMHRO Rising Star Translational Research Award (S.J.R.), a Swiss National Science Foundation Advanced Postdoc Mobility Fellowship (V.K.) and a Brain and Behavior Research Foundation NARSAD Young Investigator Award (G.E.H.). C.M. is supported by a Brain and Behavior Research Foundation NARSAD Young Investigator Grant sponsored by the P&S Fund.	Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Barnes J, 2017, NEUROPSYCHOPHARMACOL, V42, P81, DOI 10.1038/npp.2016.169; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Blank T, 2016, IMMUNITY, V44, P901, DOI 10.1016/j.immuni.2016.04.005; Campbell M, 2008, J GENE MED, V10, P930, DOI 10.1002/jgm.1211; Campbell M, 2011, EMBO MOL MED, V3, P235, DOI 10.1002/emmm.201100126; Carney RM, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2016.181; COPPEN AJ, 1960, J NEUROL NEUROSUR PS, V23, P156, DOI 10.1136/jnnp.23.2.156; Dantzer R, 2009, IMMUNOL ALLERGY CLIN, V29, P247, DOI 10.1016/j.iac.2009.02.002; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Doyle SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007616; Esposito P, 2001, BRAIN RES, V888, P117, DOI 10.1016/S0006-8993(00)03026-2; Friedman A, 1996, NAT MED, V2, P1382, DOI 10.1038/nm1296-1382; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Golden SA, 2016, NATURE, V534, P688, DOI 10.1038/nature18601; Golden SA, 2013, NAT MED, V19, P337, DOI 10.1038/nm.3090; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Hodes GE, 2015, J NEUROSCI, V35, P16362, DOI 10.1523/JNEUROSCI.1392-15.2015; Hodes GE, 2015, NAT NEUROSCI, V18, P1386, DOI 10.1038/nn.4113; Hodes GE, 2014, P NATL ACAD SCI USA, V111, P16136, DOI 10.1073/pnas.1415191111; Huffman Jeff C, 2013, Cardiovasc Psychiatry Neurol, V2013, P695925, DOI 10.1155/2013/695925; Janssen WGM, 2005, EXP NEUROL, V191, pS28, DOI 10.1016/j.expneurol.2004.08.020; Keaney J, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500472; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kiraly DD, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.31; Maes M, 1997, CYTOKINE, V9, P853, DOI 10.1006/cyto.1997.0238; McKim D.B., 2017, MOL PSYCHIAT; Meltzer H, 2011, EUR PSYCHIAT, V26, P498, DOI 10.1016/j.eurpsy.2010.11.006; Menard C, 2016, NEUROSCIENCE, V321, P138, DOI 10.1016/j.neuroscience.2015.05.053; Menard C, 2017, NEUROPSYCHOPHARMACOL, V42, P62, DOI 10.1038/npp.2016.90; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; NIKLASSON F, 1984, BIOL PSYCHIAT, V19, P1183; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Powell ND, 2013, P NATL ACAD SCI USA, V110, P16574, DOI 10.1073/pnas.1310655110; Roszkowski M, 2016, J CEREBR BLOOD F MET, V36, P1304, DOI 10.1177/0271678X16647739; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Santha P, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00088; Seligman F, 2015, ANN NY ACAD SCI, V1345, P25, DOI 10.1111/nyas.12738; SHARMA H S, 1981, Indian Journal of Physiology and Pharmacology, V25, P111; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Walchli T, 2015, NAT PROTOC, V10, P53, DOI 10.1038/nprot.2015.002; Weber MD, 2017, NEUROPSYCHOPHARMACOL, V42, P46, DOI 10.1038/npp.2016.102; Wohleb ES, 2013, J NEUROSCI, V33, P13820, DOI 10.1523/JNEUROSCI.1671-13.2013; Wood SK, 2014, CURR NEUROPHARMACOL, V12, P205, DOI 10.2174/1570159X11666131120224413; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	52	380	390	8	161	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2017	20	12					1752	+		10.1038/s41593-017-0010-3	http://dx.doi.org/10.1038/s41593-017-0010-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FO1HT	29184215	Green Accepted			2022-12-17	WOS:000416509800014
J	Wichterle, H; Garcia-Verdugo, JM; Herrera, DG; Alvarez-Buylla, A				Wichterle, H; Garcia-Verdugo, JM; Herrera, DG; Alvarez-Buylla, A			Young neurons from medial ganglionic eminence disperse in adult and embryonic brain	NATURE NEUROSCIENCE			English	Article							NEURAL TRANSPLANTATION; STRIATAL PRECURSORS; CELL-MIGRATION; MONOCLONAL-ANTIBODY; SUBVENTRICULAR ZONE; PROGENITOR CELLS; MAMMALIAN BRAIN; CEREBRAL-CORTEX; RADIAL GLIA; FOREBRAIN	In this study, we identified neuronal precursors that can disperse through adult mammalian brain tissue. Transplanted neuronal precursors from embryonic medial ganglionic eminence (MGE), but not from lateral ganglionic eminence (LGE) or neocortex, dispersed and differentiated into neurons in multiple adult brain regions. In contrast, only LGE cells were able to migrate efficiently from the adult subventricular zone to the olfactory bulb. In embryonic brain slices, MGE cells migrated extensively toward cortex. Our results demonstrate that cells in different germinal regions have unique migratory potentials, and that adult mammalian brain can support widespread dispersion of specific populations of neuronal precursors. These findings could be useful in repair of diffuse brain damage.	Rockefeller Univ, New York, NY 10021 USA; Univ Valencia, E-46100 Burjassot, Spain; Cornell Med Ctr, New York Hosp, Dept Psychiat, New York, NY 10021 USA	Rockefeller University; University of Valencia; Cornell University; NewYork-Presbyterian Hospital	Wichterle, H (corresponding author), Rockefeller Univ, Box 23,1230 York Ave, New York, NY 10021 USA.		García-Verdugo, José Manuel/L-8421-2017	García-Verdugo, José Manuel/0000-0001-9872-6499; Alvarez-Buylla, Arturo/0000-0003-4426-8925	NICHD NIH HHS [HD32116] Funding Source: Medline; NINDS NIH HHS [NS28478] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028478, R29NS028478, R37NS028478] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALVAREZBUYLLA A, 1988, J NEUROSCI METH, V25, P165, DOI 10.1016/0165-0270(88)90155-0; ALVAREZBUYLLA A, 1987, J COMP NEUROL, V264, P159, DOI 10.1002/cne.902640203; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; ANDERSSON C, 1993, INT J DEV NEUROSCI, V11, P555, DOI 10.1016/0736-5748(93)90045-F; BJORKLUND A, 1991, TRENDS NEUROSCI, V14, P319, DOI 10.1016/0166-2236(91)90154-M; Brustle O, 1995, NEURON, V15, P1275, DOI 10.1016/0896-6273(95)90007-1; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; DEACON TW, 1994, BRAIN RES, V668, P211, DOI 10.1016/0006-8993(94)90526-6; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; FISHELL G, 1995, DEVELOPMENT, V121, P803; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; GRAYBIEL AM, 1989, J NEUROSCI, V9, P3250; Hu HY, 1996, NEURON, V16, P933, DOI 10.1016/S0896-6273(00)80116-6; Isacson O, 1997, TRENDS NEUROSCI, V20, P477, DOI 10.1016/S0166-2236(97)01081-3; KAWAMURA K, 1988, EXP BRAIN RES, V70, P477; Letinic K, 1997, J COMP NEUROL, V384, P373; Levitt P, 1997, ANNU REV NEUROSCI, V20, P1, DOI 10.1146/annurev.neuro.20.1.1; LIN RCS, 1994, NEUROSCIENCE, V60, P11, DOI 10.1016/0306-4522(94)90199-6; LINDVALL O, 1991, TRENDS NEUROSCI, V14, P376, DOI 10.1016/0166-2236(91)90167-S; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MartinezSerrano A, 1997, TRENDS NEUROSCI, V20, P530, DOI 10.1016/S0166-2236(97)01119-3; MARUSICH MF, 1994, J NEUROBIOL, V25, P143, DOI 10.1002/neu.480250206; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Olsson M, 1997, NEUROSCIENCE, V79, P57, DOI 10.1016/S0306-4522(96)00606-9; Olsson M, 1997, NEURON, V19, P761, DOI 10.1016/S0896-6273(00)80959-9; OLSSON M, 1995, NEUROSCIENCE, V69, P1169, DOI 10.1016/0306-4522(95)00325-D; OROURKE NA, 1995, DEVELOPMENT, V121, P2165; PAKZABAN P, 1993, EXP BRAIN RES, V97, P13; Peretto P, 1997, BRAIN RES BULL, V42, P9, DOI 10.1016/S0361-9230(96)00116-5; Peters E, 1991, FINE STRUCTURE NERVO; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P201, DOI 10.1016/0165-3806(84)90097-X; RAISMAN G, 1993, INT J DEV NEUROSCI, V11, P651, DOI 10.1016/0736-5748(93)90053-G; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; RAKIC P, 1969, Z ANAT ENTWICKLUNGS, V129, P53, DOI 10.1007/BF00521955; Redies C, 1996, DEV BIOL, V180, P413, DOI 10.1006/dbio.1996.0315; Rubenstein JLR, 1998, ANNU REV NEUROSCI, V21, P445, DOI 10.1146/annurev.neuro.21.1.445; Rubin BP, 1995, EUR J NEUROSCI, V7, P2524, DOI 10.1111/j.1460-9568.1995.tb01052.x; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Tamamaki N, 1997, J NEUROSCI, V17, P8313; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Zigova T, 1998, CELL TRANSPLANT, V7, P137, DOI 10.1016/S0963-6897(98)00009-8; ZIGOVA T, 1996, DEV BIOL, V173, P1	45	380	387	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					461	466		10.1038/8131	http://dx.doi.org/10.1038/8131			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321251				2022-12-17	WOS:000084609400017
J	Zhang, F; Prigge, M; Beyriere, F; Tsunoda, SP; Mattis, J; Yizhar, O; Hegemann, P; Deisseroth, K				Zhang, Feng; Prigge, Matthias; Beyriere, Florent; Tsunoda, Satoshi P.; Mattis, Joanna; Yizhar, Ofer; Hegemann, Peter; Deisseroth, Karl			Red-shifted optogenetic excitation: a tool for fast neural control derived from Volvox carteri	NATURE NEUROSCIENCE			English	Article							GREEN-ALGAE; CHANNELRHODOPSIN; CHANNEL; RHODOPSINS	The introduction of two microbial opsin- based tools, channelrhodopsin-2 (ChR2) and halorhodopsin (NpHR), to neuroscience has generated interest in fast, multimodal, cell type-specific neural circuit control. Here we describe a cation-conducting channelrhodopsin (VChR1) from Volvox carteri that can drive spiking at 589 nm, with excitation maximum red-shifted similar to 70 nm compared with ChR2. These results demonstrate fast photostimulation with yellow light, thereby defining a functionally distinct third category of microbial rhodopsin proteins.	[Prigge, Matthias; Beyriere, Florent; Tsunoda, Satoshi P.; Hegemann, Peter] Humboldt Univ, Inst Biol Expt Biophys, D-10115 Berlin, Germany; [Zhang, Feng; Mattis, Joanna; Yizhar, Ofer; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Zhang, Feng; Mattis, Joanna; Yizhar, Ofer; Deisseroth, Karl] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA	Humboldt University of Berlin; Stanford University; Stanford University	Hegemann, P (corresponding author), Humboldt Univ, Inst Biol Expt Biophys, Invalidenstr 42, D-10115 Berlin, Germany.	hegemape@rz.hu-berlin.de; deissero@stanford.edu	Macrae, Rhiannon/AAX-1536-2020; Tsunoda, Satoshi/AAN-7023-2021; YIZHAR, OFER/AAV-8497-2021	Mattis, Joanna/0000-0003-0341-1270; Beyriere, Florent/0000-0002-8367-3694; Tsunoda, Satoshi/0000-0003-3636-1521; Yizhar, Ofer/0000-0003-4228-1448	NIMH NIH HHS [R01 MH075957-01A2, R01 MH075957] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075957] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; ARAVANIS A, 2007, NEURAL ENG, V4, pS143; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; Hoffmann M, 2006, J AM CHEM SOC, V128, P10808, DOI 10.1021/ja062082i; Kloppmann E, 2005, PROTEINS, V61, P953, DOI 10.1002/prot.20744; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	15	379	443	2	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					631	633		10.1038/nn.2120	http://dx.doi.org/10.1038/nn.2120			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18432196	Green Accepted			2022-12-17	WOS:000256133700007
J	Liu, F; Day, M; Muniz, LC; Bitran, D; Arias, R; Revilla-Sanchez, R; Grauer, S; Zhang, G; Kelley, C; Pulito, V; Sung, A; Mervis, RF; Navarra, R; Hirst, WD; Reinhart, PH; Marquis, KL; Moss, SJ; Pangalos, MN; Brandon, NJ				Liu, Feng; Day, Mark; Muniz, Luis C.; Bitran, Daniel; Arias, Robert; Revilla-Sanchez, Raquel; Grauer, Steve; Zhang, Guoming; Kelley, Cody; Pulito, Virginia; Sung, Amy; Mervis, Ronald F.; Navarra, Rachel; Hirst, Warren D.; Reinhart, Peter H.; Marquis, Karen L.; Moss, Stephen J.; Pangalos, Menelas N.; Brandon, Nicholas J.			Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CA1 PYRAMIDAL CELLS; DENDRITIC SPINE DENSITY; ELEMENT-BINDING PROTEIN; SPATIAL MEMORY; INHIBITORY AVOIDANCE; MESSENGER-RNA; FEMALE MICE; RAT-BRAIN; ADULT-RAT	Estrogens have long been implicated in influencing cognitive processes, yet the molecular mechanisms underlying these effects and the roles of the estrogen receptors alpha (ER alpha) and beta (ER beta) remain unclear. Using pharmacological, biochemical and behavioral techniques, we demonstrate that the effects of estrogen on hippocampal synaptic plasticity and memory are mediated through ER beta. Selective ER beta agonists increased key synaptic proteins in vivo, including PSD-95, synaptophysin and the AMPA-receptor subunit GluR1. These effects were absent in ER beta knockout mice. In hippocampal slices, ER beta activation enhanced long-term potentiation, an effect that was absent in slices from ER beta knockout mice. ER beta activation induced morphological changes in hippocampal neurons in vivo, including increased dendritic branching and increased density of mushroom-type spines. An ER beta agonist, but not an ER alpha agonist, also improved performance in hippocampus-dependent memory tasks. Our data suggest that activation of ER beta can regulate hippocampal synaptic plasticity and improve hippocampus-dependent cognition.	[Bitran, Daniel] Coll Holy Cross, Dept Psychol, Worcester, MA 01610 USA; [Revilla-Sanchez, Raquel; Moss, Stephen J.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Mervis, Ronald F.] Univ S Florida, Ctr Excellence Aging & Brain Repair, Neurostruct Res Labs Inc, Tampa, FL 33637 USA	College of the Holy Cross; University of Pennsylvania; State University System of Florida; University of South Florida		daym1@wyeth.com; liuf2@wyeth.com		Hirst, Warren/0000-0003-0389-8891; Brandon, Nicholas/0000-0002-3917-0096	Medical Research Council Funding Source: Medline; NINDS NIH HHS [NS046478, NS048045, NS056359, P01NS054900, NS051195] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046478, P01NS054900, R01NS048045, R01NS056359, R01NS051195] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams MM, 2004, J COMP NEUROL, V474, P419, DOI 10.1002/cne.20148; Barco A, 2003, EXPERT OPIN THER TAR, V7, P101, DOI 10.1517/eott.7.1.101.21163; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boulware MI, 2005, J NEUROSCI, V25, P5066, DOI 10.1523/JNEUROSCI.1427-05.2005; Cyr M, 2001, NEUROPSYCHOPHARMACOL, V25, P242, DOI 10.1016/S0893-133X(01)00233-0; Day M, 2005, BEHAV BRAIN RES, V164, P128, DOI 10.1016/j.bbr.2005.05.011; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Frye CA, 2002, BRAIN RES, V956, P285, DOI 10.1016/S0006-8993(02)03559-X; Gazzaley AH, 1996, J NEUROSCI, V16, P6830; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Harris HA, 2003, ENDOCRINOLOGY, V144, P4241, DOI 10.1210/en.2003-0550; Herrick SP, 2006, BRAIN RES, V1121, P46, DOI 10.1016/j.brainres.2006.08.084; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kuramoto N, 2007, NEURON, V53, P233, DOI 10.1016/j.neuron.2006.12.015; Lee SJ, 2004, NEUROSCIENCE, V124, P549, DOI 10.1016/j.neuroscience.2003.11.035; Lein PJ, 2007, ENVIRON HEALTH PERSP, V115, P556, DOI 10.1289/ehp.9773; Li CJ, 2004, P NATL ACAD SCI USA, V101, P2185, DOI 10.1073/pnas.0307313101; MacLennan AH, 2006, MENOPAUSE, V13, P28, DOI 10.1097/01.gme.0000191204.38664.61; Maki PM, 2002, NEUROPSYCHOLOGIA, V40, P518, DOI 10.1016/S0028-3932(01)00126-9; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Milner TA, 2005, J COMP NEUROL, V491, P81, DOI 10.1002/cne.20724; Mitra SW, 2003, ENDOCRINOLOGY, V144, P2055, DOI 10.1210/en.2002-221069; Moriarty K, 2006, ENDOCRINOLOGY, V147, P5557, DOI 10.1210/en.2006-0729; Morrison JH, 2002, PROG BRAIN RES, V136, P467; Neigh GN, 2004, EUR J NEUROSCI, V20, P1865, DOI 10.1111/j.1460-9568.2004.03649.x; Ostlund H, 2003, ANN NY ACAD SCI, V1007, P54, DOI 10.1196/annals.1286.006; Pfaff DW, 2000, J STEROID BIOCHEM, V74, P365, DOI 10.1016/S0960-0760(00)00114-X; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Rhodes ME, 2006, NEUROBIOL LEARN MEM, V85, P183, DOI 10.1016/j.nlm.2005.10.003; Rissman EF, 2002, P NATL ACAD SCI USA, V99, P3996, DOI 10.1073/pnas.012032699; Rissman EF, 1997, HORM BEHAV, V31, P232, DOI 10.1006/hbeh.1997.1390; ROY EJ, 1977, STEROIDS, V30, P657, DOI 10.1016/0039-128X(77)90055-1; Rudick CN, 2003, ENDOCRINOLOGY, V144, P179, DOI 10.1210/en.2002-220581; Sandstrom NJ, 2001, BEHAV NEUROSCI, V115, P384, DOI 10.1037//0735-7044.115.2.384; Savonenko AV, 2003, NEUROSCIENCE, V119, P821, DOI 10.1016/S0306-4522(03)00213-6; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Smith CC, 2006, J NEUROSCI, V26, P8517, DOI 10.1523/JNEUROSCI.5279-05.2006; Wang SX, 2003, J BIOL CHEM, V278, P2713, DOI 10.1074/jbc.M208411200; Woolley CS, 1997, J NEUROSCI, V17, P1848; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; Yaffe K, 2000, LANCET, V356, P708, DOI 10.1016/S0140-6736(00)02628-3; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhou Y, 1996, ENDOCRINOLOGY, V137, P2163, DOI 10.1210/en.137.5.2163	50	379	392	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					334	343		10.1038/nn2057	http://dx.doi.org/10.1038/nn2057			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18297067				2022-12-17	WOS:000253548300017
J	Crochet, S; Petersen, CCH				Crochet, S; Petersen, CCH			Correlating whisker behavior with membrane potential in barrel cortex of awake mice	NATURE NEUROSCIENCE			English	Article							THALAMOCORTICAL SYNAPSES; SENSORY RESPONSES; IN-VIVO; SYSTEM; INHIBITION; DEPRESSION; NEURONS	To investigate synaptic events underlying sensory perception, we made whole-cell membrane potential recordings of barrel cortex neurons in awake mice while recording whisker-related behavior. During quiet periods, we recorded slow, large-amplitude membrane potential changes, which switched during whisking to small, fast fluctuations that were correlated with whisker position. Robust subthreshold responses were evoked by passive whisker stimulation during quiet behavior and by active whisker contact with an object.	Ecole Polytech Fed Lausanne, Lab Sensory Proc, Brain Mind Inst, SV BML LSENS AAB 105, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Petersen, CCH (corresponding author), Ecole Polytech Fed Lausanne, Lab Sensory Proc, Brain Mind Inst, SV BML LSENS AAB 105, Stn 15, CH-1015 Lausanne, Switzerland.	carl.petersen@epfl.ch	Petersen, Carl/M-5123-2017	Petersen, Carl/0000-0003-3344-4495; Crochet, Sylvain/0000-0002-2965-8899				Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V541, P319, DOI 10.1113/jphysiol.2002.016857; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; HENTSCHKE H, 2005, CEREB; Jones LM, 2004, SCIENCE, V304, P1986, DOI 10.1126/science.1097779; Krupa DJ, 2004, SCIENCE, V304, P1989, DOI 10.1126/science.1093318; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Mehta SB, 2004, NEURON, V41, P181, DOI 10.1016/S0896-6273(04)00002-9; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545	15	379	381	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					608	610		10.1038/nn1690	http://dx.doi.org/10.1038/nn1690			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16617340				2022-12-17	WOS:000237417200010
J	Yin, YQ; Henzl, MT; Lorber, B; Nakazawa, T; Thomas, TT; Jiang, F; Langer, R; Benowitz, LI				Yin, Yuqin; Henzl, Michael T.; Lorber, Barbara; Nakazawa, Toru; Thomas, Tommy T.; Jiang, Fan; Langer, Robert; Benowitz, Larry I.			Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells	NATURE NEUROSCIENCE			English	Article							RAT OPTIC-NERVE; CILIARY NEUROTROPHIC FACTOR; DEATH IN-VIVO; CALCIUM-BINDING; SENSORY NEURONS; GROWTH-STATE; ADULT-RATS; SURVIVAL; INJURY; INHIBITION	The optic nerve, like most mature CNS pathways, does not regenerate after injury. Through unknown mechanisms, however, macrophage activation in the eye stimulates retinal ganglion cells (RGCs) to regenerate long axons beyond the site of optic nerve injury. Here we identify the calcium (Ca2+)-binding protein oncomodulin as a potent macrophage-derived growth factor for RGCs and other neurons. Oncomodulin binds to rat RGCs with high affinity in a cyclic AMP (cAMP)-dependent manner and stimulates more extensive outgrowth than other known trophic agents. Depletion of oncomodulin from macrophage-conditioned media (MCM) eliminates the axon-promoting activity of MCM. The effects of oncomodulin involve downstream signaling via Ca2+/calmodulin kinase and gene transcription. In vivo, oncomodulin released from microspheres promotes regeneration in the mature rat optic nerve. Oncomodulin also stimulates outgrowth from peripheral sensory neurons. Thus, oncomodulin is a new growth factor for neurons of the mature central and peripheral nervous systems.	Childrens Hosp, Dept Neurosurg, Boston, MA 02115 USA; Childrens Hosp, Neurobiol Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; MIT, Dept Chem & Biomed Engn, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Missouri System; University of Missouri Columbia; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Benowitz, LI (corresponding author), Childrens Hosp, Dept Neurosurg, 300 Longwood Ave, Boston, MA 02115 USA.	larry.benowitz@childrens.harvard.edu		Lorber, Barbara/0000-0001-9986-4543; Benowitz, Larry/0000-0002-0277-7222	NEI NIH HHS [EY05690] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AGUAYO AJ, 1991, PHILOS T R SOC B, V331, P337, DOI 10.1098/rstb.1991.0025; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Berry M, 1996, J NEUROCYTOL, V25, P147, DOI 10.1007/BF02284793; BUXSER S, 1990, J BIOL CHEM, V265, P12701; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Cajal S., 1991, DEGENERATION REGENER; Cheng L, 2002, J NEUROSCI, V22, P3977, DOI 10.1523/JNEUROSCI.22-10-03977.2002; Chierzi S, 1999, J NEUROSCI, V19, P8367; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Fischer D, 2004, J NEUROSCI, V24, P1646, DOI 10.1523/JNEUROSCI.5119-03.2004; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Fischer D, 2001, EXP NEUROL, V172, P257, DOI 10.1006/exnr.2001.7822; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Fu K, 2003, J PHARM SCI, V92, P1582, DOI 10.1002/jps.10414; Gavazzi I, 1999, EUR J NEUROSCI, V11, P3405, DOI 10.1046/j.1460-9568.1999.00756.x; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; HAPAK RC, 1989, J BIOL CHEM, V264, P18751; Henzl MT, 2004, BIOCHEMISTRY-US, V43, P2747, DOI 10.1021/bi035890k; Henzl MT, 1997, HEARING RES, V106, P105, DOI 10.1016/S0378-5955(97)00005-1; Jo SA, 1999, NEUROSCIENCE, V89, P579, DOI 10.1016/S0306-4522(98)00546-6; Kermer P, 1998, J NEUROSCI, V18, P4656; Koeberle PD, 1998, VISION RES, V38, P1505, DOI 10.1016/S0042-6989(97)00364-7; Koprivica V, 2005, SCIENCE, V310, P106, DOI 10.1126/science.1115462; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Li YM, 2003, J NEUROSCI, V23, P7830; Lorber B, 2005, EUR J NEUROSCI, V21, P2029, DOI 10.1111/j.1460-9568.2005.04034.x; Lorber B, 2002, MOL CELL NEUROSCI, V21, P301, DOI 10.1006/mcne.2002.1175; LU X, 1991, J NEUROSCI, V11, P972; MACMANUS JP, 1982, ONCODEV BIOL MED, V3, P79; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; MAUNE JF, 1992, BIOCHEMISTRY-US, V31, P7779, DOI 10.1021/bi00149a006; McKinnon SJ, 2002, MOL THER, V5, P780, DOI 10.1006/mthe.2002.0608; MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Monsul NT, 2004, EXP NEUROL, V186, P124, DOI 10.1016/S0014-4886(03)00311-X; Otori Y, 1998, INVEST OPHTH VIS SCI, V39, P972; Pauls TL, 1996, BBA-GENE STRUCT EXPR, V1306, P39, DOI 10.1016/0167-4781(95)00221-9; PERNET V, 2006, BRAIN; Porter AC, 2002, BRAIN RES, V944, P82, DOI 10.1016/S0006-8993(02)02721-X; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Shen SL, 1999, NEURON, V23, P285, DOI 10.1016/S0896-6273(00)80780-1; Steinmetz MP, 2005, J NEUROSCI, V25, P8066, DOI 10.1523/JNEUROSCI.2111-05.2005; STREILEIN JW, 1992, CURR EYE RES, V11, P41, DOI 10.3109/02713689208999510; WEIBEL D, 1994, BRAIN RES, V642, P259, DOI 10.1016/0006-8993(94)90930-X; Yin YQ, 2003, J NEUROSCI, V23, P2284; Zhou Y, 2005, MOL THER, V12, P402, DOI 10.1016/j.ymthe.2005.04.004	50	378	401	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					843	852		10.1038/nn1701	http://dx.doi.org/10.1038/nn1701			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16699509				2022-12-17	WOS:000237895200025
J	Yu, X; Malenka, RC				Yu, X; Malenka, RC			beta-catenin is critical for dendritic morphogenesis	NATURE NEUROSCIENCE			English	Article							NMDA RECEPTOR; CELL-ADHESION; IN-VIVO; HIPPOCAMPAL-NEURONS; RHO GTPASES; N-CADHERIN; WNT; GROWTH; GENE; TRANSCRIPTION	Regulated growth and arborization of dendritic processes are critical to the formation of functional neuronal networks. Here we identify beta-catenin as a critical mediator of dendritic morphogenesis. We found that increasing the intracellular levels of beta-catenin and other members of the cadherin/catenin complex, namely N-cadherin and N-catenin, enhances dendritic arborization in rat hippocampal neurons, an effect that does not require Wnt/beta-catenin-dependent transcription. Conversely, proteins that sequester beta-catenin decreased dendritic branch tip number and total dendritic branch length. Enhancement of dendritic growth elicited by depolarization requires beta-catenin and increased Wnt release. These results identify Wnt/beta-catenin signaling as an important mediator of dendritic development and suggest that the intracellular level of the cadherin/catenin complex is a limiting factor during critical stages of dendritic morphogenesis.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, Palo Alto, CA 94304 USA	Stanford University	Yu, X (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, Palo Alto, CA 94304 USA.							Banker G., 1998, CULTURING NERVE CELL; Barth AIM, 1999, P NATL ACAD SCI USA, V96, P4947, DOI 10.1073/pnas.96.9.4947; Benson DL, 1998, J NEUROSCI, V18, P6892; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Brault V, 2001, DEVELOPMENT, V128, P1253; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; FUJIMORI T, 1993, MOL BIOL CELL, V4, P37, DOI 10.1091/mbc.4.1.37; Galceran J, 2000, DEVELOPMENT, V127, P469; GIESE K, 1991, GENE DEV, V5, P2567, DOI 10.1101/gad.5.12b.2567; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; KINTNER C, 1992, CELL, V69, P225, DOI 10.1016/0092-8674(92)90404-Z; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee SMK, 2000, DEVELOPMENT, V127, P457; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; MANSOUR SL, 1990, P NATL ACAD SCI USA, V87, P7688, DOI 10.1073/pnas.87.19.7688; MARETTO S, 1993, P NATL ACAD SCI USA, V100, P3299; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Montross WT, 2000, J CELL SCI, V113, P1759; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Polakis P, 2000, GENE DEV, V14, P1837; Rajan I, 1998, J NEUROSCI, V18, P7836; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Sadot E, 1998, P NATL ACAD SCI USA, V95, P15339, DOI 10.1073/pnas.95.26.15339; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; WIESCHAUS E, 1987, CELL, V49, P177, DOI 10.1016/0092-8674(87)90558-7; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wong WT, 2000, J NEUROSCI, V20, P5024; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zorn AM, 2001, CURR BIOL, V11, pR592, DOI 10.1016/S0960-9822(01)00360-8	49	378	389	0	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1169	1177		10.1038/nn1132	http://dx.doi.org/10.1038/nn1132			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14528308				2022-12-17	WOS:000186229200016
J	Clark, KB; Naritoku, DK; Smith, DC; Browning, RA; Jensen, RA				Clark, KB; Naritoku, DK; Smith, DC; Browning, RA; Jensen, RA			Enhanced recognition memory following vagus nerve stimulation in human subjects	NATURE NEUROSCIENCE			English	Article							AROUSAL-INDUCED MODULATION; VAGAL-STIMULATION; STORAGE PROCESSES; SEIZURES; LARYNGEAL; SYSTEM; SAFETY	Neuromodulators associated with arousal modulate learning and memory, but most of these substances do not freely enter the brain from the periphery. In rodents, these neuromodulators act in part by initiating neural messages that travel via the vagus nerve to the brain, and electrical stimulation of the vagus enhances memory. We now extend that finding to human verbal learning. We examined word-recognition memory in patients enrolled in a clinical study evaluating the capacity of vagus nerve stimulation to control epilepsy. Stimulation administered after learning significantly enhanced retention. These findings confirm in humans the hypothesis that vagus nerve activation modulates memory formation similarly to arousal.	So Illinois Univ, Dept Psychol, Program Biopsychol Learning & Memory, Carbondale, IL 62901 USA; So Illinois Univ, Sch Med, Dept Neurol, Springfield, IL 62794 USA; So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA; So Illinois Univ, Dept Physiol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Jensen, RA (corresponding author), So Illinois Univ, Dept Psychol, Program Biopsychol Learning & Memory, Carbondale, IL 62901 USA.	rajensen@siu.edu		Clark, Kevin/0000-0003-0544-2150				ARMOUR JA, 1977, NEURAL REGULATION HE, P159; BENMENACHEM E, 1994, EPILEPSIA, V35, P515; BROADHURST PL, 1957, J EXP PSYCHOL, V54, P345, DOI 10.1037/h0049114; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Cahill L, 1996, CURR OPIN NEUROBIOL, V6, P237, DOI 10.1016/S0959-4388(96)80078-X; CAR A, 1975, EXP BRAIN RES, V22, P197; CECHETTO DF, 1987, FASEB J, V46, P17; Clark KB, 1998, NEUROBIOL LEARN MEM, V70, P364, DOI 10.1006/nlme.1998.3863; CLARK KB, 1995, NEUROBIOL LEARN MEM, V63, P213, DOI 10.1006/nlme.1995.1024; CURRY DL, 1984, AM J PHYSIOL, V247, P827; Eysenck, 1982, ATTENTION AROUSAL, DOI [10.1007/978-3-642-68390-9, DOI 10.1007/978-3-642-68390-9]; FLOOD JF, 1987, SCIENCE, V236, P832, DOI 10.1126/science.3576201; GEORGE R, 1995, NEUROLOGY, V45, P224, DOI 10.1212/wnl.45.2.224; HEBB DO, 1955, PSYCHOL REV, V62, P243, DOI 10.1037/h0041823; Ko D, 1996, NEUROSURGERY, V39, P426, DOI 10.1097/00006123-199608000-00061; KRAHL SE, 1995, DISS ABSTR INT, V56, P559; LOCKARD JS, 1990, EPILEPSIA, V31, pS20, DOI 10.1111/j.1528-1157.1990.tb05844.x; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; MCGAUGH JL, 1989, ANNU REV NEUROSCI, V12, P255, DOI 10.1146/annurev.ne.12.030189.001351; NARITOKU DK, 1995, EPILEPSY RES, V22, P53, DOI 10.1016/0920-1211(95)00035-9; NIELSON KA, 1994, BEHAV NEURAL BIOL, V62, P190, DOI 10.1016/S0163-1047(05)80017-2; Nielson KA, 1996, NEUROBIOL LEARN MEM, V66, P133, DOI 10.1006/nlme.1996.0054; NOGUEIRA PJC, 1994, BEHAV BRAIN RES, V62, P165, DOI 10.1016/0166-4328(94)90024-8; OBRIEN JH, 1971, ELECTROEN CLIN NEURO, V31, P7, DOI 10.1016/0013-4694(71)90285-9; PAINTAL AS, 1973, PHYSIOL REV, V53, P159, DOI 10.1152/physrev.1973.53.1.159; PAIVIO A, 1968, J EXP PSYCHOL, V76, P1, DOI 10.1037/h0025327; PENRY JK, 1990, EPILEPSIA S2, V31, P40; RAMSAY RE, 1994, EPILEPSIA, V35, P627, DOI 10.1111/j.1528-1157.1994.tb02483.x; RUTECKI P, 1990, EPILEPSIA, V31, pS1, DOI 10.1111/j.1528-1157.1990.tb05843.x; TERRY RS, 1991, PACE, V14, P86, DOI 10.1111/j.1540-8159.1991.tb04052.x; WILLIAMS CL, 1993, BEHAV NEUROSCI, V107, P955, DOI 10.1037/0735-7044.107.6.955; WILLIAMS CL, 1993, PHYSIOL BEHAV, V54, P659, DOI 10.1016/0031-9384(93)90073-O; WILLIAMS CL, 1991, NEUR CONT B, V6, P467; WOODBURY DM, 1990, EPILEPSIA S2, V31, P7; WOODBURY JW, 1991, PACE, V14, P94, DOI 10.1111/j.1540-8159.1991.tb04053.x; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503; ZABARA J, 1992, EPILEPSIA, V33, P1005, DOI 10.1111/j.1528-1157.1992.tb01751.x	37	378	415	1	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					94	98		10.1038/4600	http://dx.doi.org/10.1038/4600			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	163MK	10195186				2022-12-17	WOS:000078409300019
J	Goard, M; Dan, Y				Goard, Michael; Dan, Yang			Basal forebrain activation enhances cortical coding of natural scenes	NATURE NEUROSCIENCE			English	Article							NUCLEUS BASALIS; VISUAL-CORTEX; CHOLINERGIC MODULATION; SYNAPTIC-TRANSMISSION; ACETYLCHOLINE-RELEASE; PREFRONTAL CORTEX; CEREBRAL-CORTEX; BARREL CORTEX; NEURONS; NEUROMODULATION	The nucleus basalis of the basal forebrain is an essential component of the neuromodulatory system controlling the behavioral state of an animal and it is thought to be important in regulating arousal and attention. However, the effect of nucleus basalis activation on sensory processing remains poorly understood. Using polytrode recording in rat visual cortex, we found that nucleus basalis stimulation caused prominent decorrelation between neurons and marked improvement in the reliability of neuronal responses to natural scenes. The decorrelation depended on local activation of cortical muscarinic acetylcholine receptors, whereas the increased reliability involved distributed neural circuits, as evidenced by nucleus basalis-induced changes in thalamic responses. Further analysis showed that the decorrelation and increased reliability improved cortical representation of natural stimuli in a complementary manner. Thus, the basal forebrain neuromodulatory circuit, which is known to be activated during aroused and attentive states, acts through both local and distributed mechanisms to improve sensory coding.	[Goard, Michael; Dan, Yang] Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Howard Hughes Med Inst,Div Neurobiol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Dan, Y (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Howard Hughes Med Inst,Div Neurobiol, Berkeley, CA 94720 USA.	ydan@berkeley.edu		Goard, Michael/0000-0002-5366-8501; Dan, Yang/0000-0002-3818-877X	US National Institute of Neurological Disorders and Stroke [F31NS059258]; NATIONAL EYE INSTITUTE [R01EY018861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS059258] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Blanche, D. Feldman, R. Froemke, D. Jones, D. Kleinfeld, C. Niell and A. Vahidnia for technical help and useful discussions. This work was supported by grants from the US National Institutes of Health to Y. D. and a Ruth L. Kirschstein National Research Service Award to M. G. (award number F31NS059258 from the US National Institute of Neurological Disorders and Stroke).	Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bezdudnaya T, 2006, NEURON, V49, P421, DOI 10.1016/j.neuron.2006.01.010; Blanche TJ, 2005, J NEUROPHYSIOL, V93, P2987, DOI 10.1152/jn.01023.2004; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; Castro-Alamancos MA, 2004, PROG NEUROBIOL, V74, P213, DOI 10.1016/j.pneurobio.2004.09.002; Disney AA, 2007, NEURON, V56, P701, DOI 10.1016/j.neuron.2007.09.034; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; HASSELMO ME, 1995, BEHAV BRAIN RES, V67, P1, DOI 10.1016/0166-4328(94)00113-T; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Hsieh CY, 2000, BRAIN RES, V880, P51, DOI 10.1016/S0006-8993(00)02766-9; Jones BE, 2008, ANN NY ACAD SCI, V1129, P26, DOI 10.1196/annals.1417.026; Jones BE, 2004, PROG BRAIN RES, V145, P157, DOI 10.1016/S0079-6123(03)45011-5; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kimura F, 1999, EUR J NEUROSCI, V11, P3597, DOI 10.1046/j.1460-9568.1999.00779.x; Kruglikov I, 2008, NEURON, V58, P911, DOI 10.1016/j.neuron.2008.04.024; Laplante F, 2005, NEUROSCIENCE, V132, P501, DOI 10.1016/j.neuroscience.2004.11.059; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; LEHMANN J, 1980, NEUROSCIENCE, V5, P1161, DOI 10.1016/0306-4522(80)90195-5; Lin SC, 2006, J NEUROPHYSIOL, V96, P3209, DOI 10.1152/jn.00524.2006; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; METHERATE R, 1992, J NEUROSCI, V12, P4701; METHERATE R, 1993, SYNAPSE, V14, P132, DOI 10.1002/syn.890140206; MULLER CM, 1989, BRAIN RES, V487, P335, DOI 10.1016/0006-8993(89)90837-8; Oldford E, 2003, NEUROSCIENCE, V117, P769, DOI 10.1016/S0306-4522(02)00663-2; PARENT A, 1988, J COMP NEUROL, V277, P281, DOI 10.1002/cne.902770209; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Robbins TW, 1997, BIOL PSYCHOL, V45, P57, DOI 10.1016/S0301-0511(96)05222-2; Roberts MJ, 2005, J NEUROPHYSIOL, V93, P2062, DOI 10.1152/jn.00911.2004; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; SATO H, 1987, J NEUROPHYSIOL, V58, P765, DOI 10.1152/jn.1987.58.4.765; Sherman SM, 1996, VISUAL NEUROSCI, V13, P205, DOI 10.1017/S0952523800007446; SILLITO AM, 1983, BRAIN RES, V289, P143, DOI 10.1016/0006-8993(83)90015-X; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260, DOI 10.1152/jn.1987.57.1.260; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Worgotter F, 1998, NATURE, V396, P165, DOI 10.1038/24157; Xiang ZX, 1998, SCIENCE, V281, P985, DOI 10.1126/science.281.5379.985; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zilles K, 1989, EXS, V57, P212; Zinke W, 2006, EUR J NEUROSCI, V24, P314, DOI 10.1111/j.1460-9568.2006.04882.x	50	377	383	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1444	1449		10.1038/nn.2402	http://dx.doi.org/10.1038/nn.2402			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19801988	Green Accepted, Green Submitted			2022-12-17	WOS:000271194100018
J	Fernandez, F; Morishita, W; Zuniga, E; Nguyen, J; Blank, M; Malenka, RC; Garner, CC				Fernandez, Fabian; Morishita, Wade; Zuniga, Elizabeth; Nguyen, James; Blank, Martina; Malenka, Robert C.; Garner, Craig C.			Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; TS65DN MOUSE; ABNORMALITIES; STORAGE; MICE; LTP	Ts65Dn mice, a model for Down syndrome, have excessive inhibition in the dentate gyrus, a condition that could compromise synaptic plasticity and mnemonic processing. We show that chronic systemic treatment of these mice with GABA(A) antagonists at non-epileptic doses causes a persistent post-drug recovery of cognition and long-term potentiation. These results suggest that over-inhibition contributes to intellectual disabilities associated with Down syndrome and that GABA(A) antagonists may be useful therapeutic agents for this disorder.	Stanford Univ, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94305 USA	Stanford University	Garner, CC (corresponding author), Stanford Univ, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94305 USA.	cgarner@stanford.edu		Garner, Craig/0000-0003-1970-5417; Fernandez, Fabian-Xose/0000-0002-4288-5383				Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Costa ACS, 2005, NEUROSCI LETT, V382, P317, DOI 10.1016/j.neulet.2005.03.031; Gerlai R, 1998, BEHAV BRAIN RES, V95, P91, DOI 10.1016/S0166-4328(97)00214-3; HANSON JE, IN PRESS J PHYSL LON; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Ivic L, 2003, J BIOL CHEM, V278, P49279, DOI 10.1074/jbc.M304034200; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Kurt MA, 2000, BRAIN RES, V858, P191, DOI 10.1016/S0006-8993(00)01984-3; LANDFIELD PW, 1981, SCIENCE, V214, P581, DOI 10.1126/science.6270791; LEVY S, 1953, JAMA-J AM MED ASSOC, V153, P1260, DOI 10.1001/jama.1953.02940310028007; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Nadel L, 2003, GENES BRAIN BEHAV, V2, P156, DOI 10.1034/j.1601-183X.2003.00026.x; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Seregaza Z, 2006, BEHAV GENET, V36, P387, DOI 10.1007/s10519-006-9056-9; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134	15	376	394	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					411	413		10.1038/nn1860	http://dx.doi.org/10.1038/nn1860			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17322876				2022-12-17	WOS:000245228600008
J	Stevens, CF; Zador, AM				Stevens, CF; Zador, AM			Input synchrony and the irregular firing of cortical neurons	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; NEOCORTICAL NEURONS; IN-VITRO; VARIABILITY; INTEGRATION; INHIBITION; POTENTIALS; NETWORK; SLICES; CELLS	Cortical neurons in the waking brain fire highly irregular, seemingly random, spike trains in response to constant sensory stimulation, whereas in vitro they fire regularly in response to constant current injection. To test whether, as has been suggested, this high in vivo variability could be due to the postsynaptic currents generated by independent synaptic inputs, we injected synthetic synaptic current into neocortical neurons in brain slices. We report that independent inputs cannot account for this high variability, but this variability can be explained by a simple alternative model of the synaptic drive in which inputs arrive synchronously. Our results suggest that synchrony may be important in the neural code by providing a means for encoding signals with high temporal fidelity over a population of neurons.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Sloan Ctr Theoret Neurobiol, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Zador, AM (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	zador@salk.edu		Zador, Anthony/0000-0002-8431-9136	NINDS NIH HHS [NS 12961] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012961] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; BAIR W, 1996, NEURAL COMPUT, V8, P1184; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BERMAN NJ, 1991, J PHYSIOL-LONDON, V440, P697, DOI 10.1113/jphysiol.1991.sp018731; Berretta N, 1996, J NEUROPHYSIOL, V76, P1089, DOI 10.1152/jn.1996.76.2.1089; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; BURGARD EC, 1993, J NEUROPHYSIOL, V70, P1841, DOI 10.1152/jn.1993.70.5.1841; BURNS BD, 1976, PROC R SOC SER B-BIO, V194, P211, DOI 10.1098/rspb.1976.0074; CALVIN WH, 1968, J NEUROPHYSIOL, V31, P574, DOI 10.1152/jn.1968.31.4.574; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Feller W, 2008, INTRO PROBABILITY TH, V2; GESHON ED, 1998, J NEUROPHYSIOL, V79, P1135; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; HUBBARD JI, 1968, J PHYSIOL-LONDON, V197, P639, DOI 10.1113/jphysiol.1968.sp008579; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Markram H, 1997, CEREB CORTEX, V7, P523, DOI 10.1093/cercor/7.6.523; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; NELSON JI, 1992, VISUAL NEUROSCI, V9, P21, DOI 10.1017/S0952523800006349; NELSON S, 1994, SCIENCE, V265, P74; NODA H, 1970, BRAIN RES, V18, P513, DOI 10.1016/0006-8993(70)90134-4; Nowak LG, 1997, CEREB CORTEX, V7, P487, DOI 10.1093/cercor/7.6.487; Reich DS, 1997, J NEUROPHYSIOL, V77, P2836, DOI 10.1152/jn.1997.77.5.2836; Rieke F., 1997, SPIKES EXPLORING NEU; Shadlen M N, 1995, Curr Opin Neurobiol, V5, P248, DOI 10.1016/0959-4388(95)80033-6; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; SOFTKY W, 1994, NEUROSCIENCE, V58, P13, DOI 10.1016/0306-4522(94)90154-6; Softky W R, 1995, Curr Opin Neurobiol, V5, P239, DOI 10.1016/0959-4388(95)80032-8; SOFTKY WR, 1993, J NEUROSCI, V13, P334; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Tang AC, 1997, CEREB CORTEX, V7, P502, DOI 10.1093/cercor/7.6.502; Troyer TW, 1997, NEURAL COMPUT, V9, P971, DOI 10.1162/neco.1997.9.5.971; USHER M, 1994, NEURAL COMPUT, V6, P795, DOI 10.1162/neco.1994.6.5.795; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Whittington MA, 1997, P NATL ACAD SCI USA, V94, P12198, DOI 10.1073/pnas.94.22.12198; ZADOR A, 1998, J NEUROPHYSIOL, V19, P1230; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	43	376	380	0	21	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1998	1	3					210	217		10.1038/659	http://dx.doi.org/10.1038/659			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QC	10195145				2022-12-17	WOS:000076361200011
J	Breakspear, M				Breakspear, Michael			Dynamic models of large-scale brain activity	NATURE NEUROSCIENCE			English	Review							SELF-ORGANIZED CRITICALITY; HUMAN ALPHA-RHYTHM; FUNCTIONAL CONNECTIVITY; FIELD-THEORY; DIMENSIONAL ANALYSIS; BURST SUPPRESSION; CORTICAL ACTIVITY; NETWORK STRUCTURE; CHAOTIC DYNAMICS; NEURAL ACTIVITY	Movement, cognition and perception arise from the collective activity of neurons within cortical circuits and across large-scale systems of the brain. While the causes of single neuron spikes have been understood for decades, the processes that support collective neural behavior in large-scale cortical systems are less clear and have been at times the subject of contention. Modeling large-scale brain activity with nonlinear dynamical systems theory allows the integration of experimental data from multiple modalities into a common framework that facilitates prediction, testing and possible refutation. This work reviews the core assumptions that underlie this computational approach, the methodological framework that fosters the translation of theory into the laboratory, and the emerging body of supporting evidence. While substantial challenges remain, evidence supports the view that collective, nonlinear dynamics are central to adaptive cortical activity. Likewise, aberrant dynamic processes appear to underlie a number of brain disorders.	[Breakspear, Michael] QIMR Berghofer Med Res Inst, Herston, Qld, Australia; [Breakspear, Michael] Metro North Mental Hlth Serv, Herston, Qld, Australia	QIMR Berghofer Medical Research Institute	Breakspear, M (corresponding author), QIMR Berghofer Med Res Inst, Herston, Qld, Australia.; Breakspear, M (corresponding author), Metro North Mental Hlth Serv, Herston, Qld, Australia.	michael.breakspear@qimrberghofer.edu.au	Breakspear, Michael/ABF-6302-2020	Breakspear, Michael/0000-0003-4943-3969	National Health and Medical Research Council [118153, 10371296, 1095227]; Australian Research Council [CE140100007]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	The author would like to thank J. Roberts, L. Gollo and L. Cocchi for detailed comments on the manuscript and C. Schneider, V. Nguyen, A. Perry, S. Sonkusare and M. Flynn for assistance with the figures. This manuscript was supported by the National Health and Medical Research Council (118153, 10371296, 1095227) and the Australian Research Council (CE140100007).	Abraham RH., 1983, DYNAMICS THE GEOMETR; Allen M, 2016, ELIFE, V5, DOI 10.7554/eLife.18103; Altenburg J, 2003, CLIN NEUROPHYSIOL, V114, P50, DOI 10.1016/S1388-2457(02)00322-X; AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; [Anonymous], 1997, DYNAMIC PATTERNS SEL; Aquino KM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002435; BABLOYANTZ A, 1985, PHYS LETT A, V111, P152, DOI 10.1016/0375-9601(85)90444-X; BABLOYANTZ A, 1986, P NATL ACAD SCI USA, V83, P3513, DOI 10.1073/pnas.83.10.3513; Baker AP, 2014, ELIFE, V3, DOI 10.7554/eLife.01867; Beggs JM, 2003, J NEUROSCI, V23, P11167; BEURLE RL, 1956, PHILOS T ROY SOC B, V240, P55, DOI 10.1098/rstb.1956.0012; Bojak I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041902; Bojak I., 2015, ENCY COMPUTATIONAL N; Bojak I, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00018; Breakspear M, 2003, NEUROIMAGE, V20, P466, DOI 10.1016/S1053-8119(03)00332-X; Breakspear M, 2006, CEREB CORTEX, V16, P1296, DOI 10.1093/cercor/bhj072; Breakspear M, 2005, PHILOS T R SOC B, V360, P1051, DOI 10.1098/rstb.2005.1643; Breakspear M, 2004, NEUROINFORMATICS, V2, P205, DOI 10.1385/NI:2:2:205; Breakspear M, 2004, J COMPUT NEUROSCI, V16, P49, DOI 10.1023/B:JCNS.0000004841.66897.7d; Breakspear M, 2003, NETWORK-COMP NEURAL, V14, P703, DOI 10.1088/0954-898X/14/4/305; Breakspear M, 2002, HUM BRAIN MAPP, V15, P175, DOI 10.1002/hbm.10011; Breakspear M, 2015, BRAIN, V138, DOI 10.1093/brain/awv261; Breakspear M, 2008, BRAIN IMAGING BEHAV, V2, P270, DOI 10.1007/s11682-008-9033-4; Bruns H., 1887, ACTA MATH, V11, P25, DOI [DOI 10.1007/BF02418042, DOI 10.1007/BF02612319]; Cabral J, 2014, PROG NEUROBIOL, V114, P102, DOI 10.1016/j.pneurobio.2013.12.005; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Chang C, 2009, NEUROIMAGE, V47, P1381, DOI 10.1016/j.neuroimage.2009.04.048; Ching SN, 2012, P NATL ACAD SCI USA, V109, P3095, DOI 10.1073/pnas.1121461109; Cocchi L, 2016, ELIFE, V5, DOI 10.7554/eLife.15252; Coombes S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051901; Coombes S., 2016, PREPRINT; da Silva FL, 2003, EPILEPSIA, V44, P72, DOI 10.1111/j.0013-9580.2003.12005.x; DASILVA FL, 1991, ELECTROEN CLIN NEURO, V79, P81, DOI 10.1016/0013-4694(91)90044-5; Daunizeau J, 2012, NEUROIMAGE, V62, P464, DOI 10.1016/j.neuroimage.2012.04.061; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Deco G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000092; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; El Boustani S, 2009, NEURAL COMPUT, V21, P46, DOI 10.1162/neco.2009.02-08-710; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fourcaud N, 2002, NEURAL COMPUT, V14, P2057, DOI 10.1162/089976602320264015; FREEMAN WJ, 1979, BIOL CYBERN, V33, P237, DOI 10.1007/BF00337412; Freeman WJ, 1975, MASS ACTION NERVOUS; Freyer F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002634; Freyer F, 2011, J NEUROSCI, V31, P6353, DOI 10.1523/JNEUROSCI.6693-10.2011; Freyer F, 2009, J NEUROSCI, V29, P8512, DOI 10.1523/JNEUROSCI.0754-09.2009; Friedman N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208102; Friston K, 2014, CRITICALITY IN NEURAL SYSTEMS, P191; Friston KJ, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00044; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gatlin L.L., 1972, INFORM THEORY LIVING; Gollo L. L., 2016, NEUROIMAGE; Gollo LL, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0532; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; GREGSON RAM, 1990, BIOL PSYCHOL, V31, P173, DOI 10.1016/0301-0511(90)90016-P; Haimovici A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.178101; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Haken H., 1982, SYNERGETIK EINFUHRUN; Hansen ECA, 2015, NEUROIMAGE, V105, P525, DOI 10.1016/j.neuroimage.2014.11.001; Harrison LM, 2005, PHILOS T R SOC B, V360, P1075, DOI 10.1098/rstb.2005.1648; Heitmann S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003260; Henderson JA, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.018102; HODGKIN AL, 1952, PROC R SOC SER B-BIO, V140, P177, DOI 10.1098/rspb.1952.0054; Hoel EP, 2013, P NATL ACAD SCI USA, V110, P19790, DOI 10.1073/pnas.1314922110; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Horvat S, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002512; Huys QJM, 2016, NAT NEUROSCI, V19, P404, DOI 10.1038/nn.4238; Hyett MP, 2015, JAMA PSYCHIAT, V72, P350, DOI 10.1001/jamapsychiatry.2014.2490; Iyer KK, 2015, BRAIN, V138, P2206, DOI 10.1093/brain/awv129; JANSEN BH, 1995, BIOL CYBERN, V73, P357, DOI 10.1007/BF00199471; Jirsa VK, 2017, NEUROIMAGE, V145, P377, DOI 10.1016/j.neuroimage.2016.04.049; Jirsa VK, 2010, ARCH ITAL BIOL, V148, P189; Jirsa VK, 2014, BRAIN, V137, P2210, DOI 10.1093/brain/awu133; Jirsa VK, 2011, B MATH BIOL, V73, P325, DOI 10.1007/s11538-010-9573-9; Jirsa VK, 1996, PHYS REV LETT, V77, P960, DOI 10.1103/PhysRevLett.77.960; Jirsa VK, 1997, PHYSICA D, V99, P503, DOI 10.1016/S0167-2789(96)00166-2; Kunze T, 2016, NEUROIMAGE, V140, P174, DOI 10.1016/j.neuroimage.2016.02.015; Laing C., 2010, STOCHASTIC METHODS N; Laing CR, 2016, STUD MECHANOBIOL TIS, V17, P367, DOI 10.1007/978-3-319-21296-8_14; Larter R, 1999, CHAOS, V9, P795, DOI 10.1063/1.166453; Laumann T. O., 2016, CEREB CORTEX; Leonardi N, 2015, NEUROIMAGE, V104, P430, DOI 10.1016/j.neuroimage.2014.09.007; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Liley DTJ, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00046; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Loh M, 2007, PLOS COMPUT BIOL, V3, P2255, DOI 10.1371/journal.pcbi.0030228; LOPESDAS.FH, 1974, KYBERNETIK, V15, P27, DOI 10.1007/BF00270757; Lundstrom BN, 2008, NAT NEUROSCI, V11, P1335, DOI 10.1038/nn.2212; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Marreiros AC, 2008, NEUROIMAGE, V42, P147, DOI 10.1016/j.neuroimage.2008.04.239; Mejias JF, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601335; Miller P, 2003, CEREB CORTEX, V13, P1208, DOI 10.1093/cercor/bhg101; Millman D, 2010, NAT PHYS, V6, P801, DOI 10.1038/NPHYS1757; Misic B, 2010, J NEUROPHYSIOL, V104, P2667, DOI 10.1152/jn.00648.2010; Moran RJ, 2007, NEUROIMAGE, V37, P706, DOI 10.1016/j.neuroimage.2007.05.032; Moran RJ, 2015, NEUROPSYCHOPHARMACOL, V40, P268, DOI 10.1038/npp.2014.184; Muller L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4675; Murray JD, 2014, CEREB CORTEX, V24, P859, DOI 10.1093/cercor/bhs370; Nguyen VT, 2014, J NEUROSCI, V34, P16397, DOI 10.1523/JNEUROSCI.2571-14.2014; NUNEZ P L, 1974, Mathematical Biosciences, V21, P279, DOI 10.1016/0025-5564(74)90020-0; Nunez P.L., 2006, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Omurtag A, 2000, J COMPUT NEUROSCI, V8, P51, DOI 10.1023/A:1008964915724; OSBORNE AR, 1989, PHYSICA D, V35, P357, DOI 10.1016/0167-2789(89)90075-4; Palus M, 1996, BIOL CYBERN, V75, P389, DOI 10.1007/s004220050304; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Petkov G, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00261; Phillips AJK, 2007, J BIOL RHYTHM, V22, P167, DOI 10.1177/0748730406297512; Poincare H., 1899, NUOVO CIMENTO, V10, P128, DOI DOI 10.1007/BF02742713; PRICHARD D, 1994, PHYS REV LETT, V73, P951, DOI 10.1103/PhysRevLett.73.951; PRITCHARD WS, 1995, PSYCHOPHYSIOLOGY, V32, P486, DOI 10.1111/j.1469-8986.1995.tb02100.x; PRITCHARD WS, 1992, PSYCHOPHYSIOLOGY, V29, P182, DOI 10.1111/j.1469-8986.1992.tb01683.x; RAPP PE, 1993, PHYS REV E, V47, P2289, DOI 10.1103/PhysRevE.47.2289; Rennie CJ, 2002, BIOL CYBERN, V86, P457, DOI 10.1007/s00422-002-0310-9; Roberts JA, 2016, NEUROIMAGE, V124, P379, DOI 10.1016/j.neuroimage.2015.09.009; Roberts JA, 2015, CURR OPIN NEUROBIOL, V31, P164, DOI 10.1016/j.conb.2014.10.014; Roberts JA, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00154; Roberts JA, 2014, J NEUROSCI, V34, P6557, DOI 10.1523/JNEUROSCI.4701-13.2014; Robinson PA, 2016, NEUROIMAGE, V142, P79, DOI 10.1016/j.neuroimage.2016.04.050; Robinson P.A., 2002, PHYS REV E, V65; Robinson PA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041904; Robinson PA, 1997, PHYS REV E, V56, P826, DOI 10.1103/PhysRevE.56.826; ROMBOUTS SARB, 1995, PHYS LETT A, V202, P352, DOI 10.1016/0375-9601(95)00335-Z; Rubino D, 2006, NAT NEUROSCI, V9, P1549, DOI 10.1038/nn1802; Rubinov M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002038; Ruff CC, 2006, CURR BIOL, V16, P1479, DOI 10.1016/j.cub.2006.06.057; SOONG ACK, 1989, BIOL CYBERN, V62, P55, DOI 10.1007/BF00217660; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Stam CJ, 1999, CLIN NEUROPHYSIOL, V110, P1801, DOI 10.1016/S1388-2457(99)00099-1; Stefanescu RA, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.026204; Stephan KE, 2001, PHILOS T ROY SOC B, V356, P1159, DOI 10.1098/rstb.2001.0908; Stephan KE, 2016, LANCET PSYCHIAT, V3, P84, DOI 10.1016/S2215-0366(15)00360-0; Stephan KE, 2015, NEURON, V87, P716, DOI 10.1016/j.neuron.2015.07.008; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Stephan KE, 2008, NEUROIMAGE, V42, P649, DOI 10.1016/j.neuroimage.2008.04.262; Suffczynski P, 2004, NEUROSCIENCE, V126, P467, DOI 10.1016/j.neuroscience.2004.03.014; THEILER J, 1986, PHYS REV A, V34, P2427, DOI 10.1103/PhysRevA.34.2427; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Tsuda I, 2001, BEHAV BRAIN SCI, V24, P829; Tsuda I, 2001, BEHAV BRAIN SCI, V24, P793, DOI 10.1017/S0140525X01000097; Valdes PA, 1999, BIOL CYBERN, V81, P415, DOI 10.1007/s004220050572; Valdes-Sosa PA, 2009, HUM BRAIN MAPP, V30, P2701, DOI 10.1002/hbm.20704; Nguyen VT, 2016, NEUROIMAGE, V124, P455, DOI 10.1016/j.neuroimage.2015.08.078; Wagner G, 2015, CORTEX, V66, P35, DOI 10.1016/j.cortex.2015.02.004; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Woolrich MW, 2013, NEUROIMAGE, V80, P330, DOI 10.1016/j.neuroimage.2013.03.059; Zalesky A, 2015, NEUROIMAGE, V114, P466, DOI 10.1016/j.neuroimage.2015.03.047; Zalesky A, 2014, P NATL ACAD SCI USA, V111, P10341, DOI 10.1073/pnas.1400181111	151	374	377	34	201	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2017	20	3					340	352		10.1038/nn.4497	http://dx.doi.org/10.1038/nn.4497			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EL9DU	28230845				2022-12-17	WOS:000394920400007
J	Miller, CA; Gavin, CF; White, JA; Parrish, RR; Honasoge, A; Yancey, CR; Rivera, IM; Rubio, MD; Rumbaugh, G; Sweatt, JD				Miller, Courtney A.; Gavin, Cristin F.; White, Jason A.; Parrish, R. Ryley; Honasoge, Avinash; Yancey, Christopher R.; Rivera, Ivonne M.; Rubio, Maria D.; Rumbaugh, Gavin; Sweatt, J. David			Cortical DNA methylation maintains remote memory	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; NEUROBIOLOGY; INVOLVEMENT; PLASTICITY	A behavioral memory's lifetime represents multiple molecular lifetimes, suggesting the necessity for a self-perpetuating signal. One candidate is DNA methylation, a transcriptional repression mechanism that maintains cellular memory throughout development. We found that persistent, gene-specific cortical hypermethylation was induced in rats by a single, hippocampus-dependent associative learning experience and pharmacologic inhibition of methylation 1 month after learning disrupted remote memory. We propose that the adult brain utilizes DNA methylation to preserve long-lasting memories.	[Miller, Courtney A.; Gavin, Cristin F.; White, Jason A.; Parrish, R. Ryley; Honasoge, Avinash; Yancey, Christopher R.; Rivera, Ivonne M.; Rubio, Maria D.; Rumbaugh, Gavin; Sweatt, J. David] Univ Alabama, Sch Med, Evelyn F McKnight Brain Inst, Birmingham, AL USA; [Miller, Courtney A.; Gavin, Cristin F.; White, Jason A.; Parrish, R. Ryley; Honasoge, Avinash; Yancey, Christopher R.; Rivera, Ivonne M.; Rubio, Maria D.; Rumbaugh, Gavin; Sweatt, J. David] Univ Alabama, Sch Med, Dept Neurobiol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Miller, CA (corresponding author), Scripps Inst, Dept Metab & Aging, Jupiter, FL USA.	cmiller@scripps.edu; dsweatt@nrc.uab.edu	Miller, Courtney A/E-8651-2010	Miller, Courtney A/0000-0001-8628-4902; Sweatt, J. David/0000-0003-3567-485X; Gavin, Cristin/0000-0001-7113-5015; Parrish, R Ryley/0000-0001-6798-6140	National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; National Institute on Aging; National Institute on Drug Abuse; American Health Assistance Foundation; Evelyn F. McKnight Brain Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064079, F32NS057953, T32NS061788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA024761, K99DA024761] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); American Health Assistance Foundation; Evelyn F. McKnight Brain Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors would like to thank O.S. Ahmed for technical assistance and M. Han of the UAB Genomics Core Facility. This work was supported by the National Institute of Mental Health, the National Institute of Neurological Disorders and Stroke, the National Institute on Aging, the National Institute on Drug Abuse, the American Health Assistance Foundation, the Evelyn F. McKnight Brain Research Foundation and Philip Morris.	BENVENGA MJ, 1988, PHARMACOL BIOCHEM BE, V30, P205, DOI 10.1016/0091-3057(88)90445-5; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Holliday R, 1999, J THEOR BIOL, V200, P339, DOI 10.1006/jtbi.1999.0995; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Roberson ED, 1999, LEARN MEMORY, V6, P381; Sacktor TC, 2008, PROG BRAIN RES, V169, P27, DOI 10.1016/S0079-6123(07)00002-7; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200	15	374	385	0	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					664	666		10.1038/nn.2560	http://dx.doi.org/10.1038/nn.2560			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20495557	Green Accepted			2022-12-17	WOS:000278003300008
J	Jeon, D; Kim, S; Chetana, M; Jo, D; Ruley, HE; Lin, SY; Rabah, D; Kinet, JP; Shin, HS				Jeon, Daejong; Kim, Sangwoo; Chetana, Mattu; Jo, Daewoong; Ruley, H. Earl; Lin, Shih-Yao; Rabah, Dania; Kinet, Jean-Pierre; Shin, Hee-Sup			Observational fear learning involves affective pain system and Ca(v)1.2 Ca2+ channels in ACC	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; PHASE SYNCHRONIZATION; WORKING-MEMORY; AMYGDALA; EMPATHY; BEHAVIOR; OTHERS; GENE; MICE; NEUROSCIENCE	Fear can be acquired vicariously through social observation of others suffering from aversive stimuli. We found that mice (observers) developed freezing behavior by observing other mice (demonstrators) receive repetitive foot shocks. Observers had higher fear responses when demonstrators were socially related to themselves, such as siblings or mating partners. Inactivation of anterior cingulate cortex (ACC) and parafascicular or mediodorsal thalamic nuclei, which comprise the medial pain system representing pain affection, substantially impaired this observational fear learning, whereas inactivation of sensory thalamic nuclei had no effect. The ACC neuronal activities were increased and synchronized with those of the lateral amygdala at theta rhythm frequency during this learning. Furthermore, an ACC-limited deletion of Ca(v)1.2 Ca2+ channels in mice impaired observational fear learning and reduced behavioral pain responses. These results demonstrate the functional involvement of the affective pain system and Ca(v)1.2 channels of the ACC in observational social fear.	[Jeon, Daejong; Kim, Sangwoo; Chetana, Mattu; Shin, Hee-Sup] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea; [Kim, Sangwoo; Shin, Hee-Sup] Univ Sci & Technol, Dept Neurosci, Taejon, South Korea; [Jo, Daewoong] ProCell Therapeut, ProCell R&D Ctr, Seoul, South Korea; [Ruley, H. Earl] Vanderbilt Univ, Sch Med, Dept Immunol & Microbiol, Nashville, TN 37212 USA; [Lin, Shih-Yao; Rabah, Dania; Kinet, Jean-Pierre] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Lin, Shih-Yao; Rabah, Dania; Kinet, Jean-Pierre] Harvard Univ, Sch Med, Boston, MA USA	Korea Institute of Science & Technology (KIST); Vanderbilt University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Shin, HS (corresponding author), Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea.	shin@kist.re.kr	Jeon, Daejong/C-1814-2011	Jeon, Daejong/0000-0002-6998-7603	National Honor Scientist program of Korea; Korea Institute of Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053950] Funding Source: NIH RePORTER	National Honor Scientist program of Korea; Korea Institute of Science and Technology(Korea Institute of Science & Technology (KIST)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Lee for help with Matlab analysis. This work was supported by the National Honor Scientist program of Korea and the Center of Excellence program from the Korea Institute of Science and Technology.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Apkarian AV, 2008, CURR OPIN NEUROBIOL, V18, P464, DOI 10.1016/j.conb.2008.09.012; Auvray M, 2010, NEUROSCI BIOBEHAV R, V34, P214, DOI 10.1016/j.neubiorev.2008.07.008; Bissiere S, 2008, BIOL PSYCHIAT, V63, P821, DOI 10.1016/j.biopsych.2007.10.022; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chen QL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004387; CHURCH RM, 1959, J COMP PHYSIOL PSYCH, V52, P132, DOI 10.1037/h0043531; Day M, 2002, J NEUROPHYSIOL, V87, P2490, DOI 10.1152/jn.00843.2001; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Frith CD, 2008, PHILOS T R SOC B, V363, P2033, DOI 10.1098/rstb.2008.0005; Gao YJ, 2004, PAIN, V110, P343, DOI 10.1016/j.pain.2004.04.030; Han CJ, 2003, P NATL ACAD SCI USA, V100, P13087, DOI 10.1073/pnas.2132313100; Hoffman M L, 1977, Nebr Symp Motiv, V25, P169; Hooker CI, 2006, J NEUROSCI, V26, P8915, DOI 10.1523/JNEUROSCI.3048-05.2006; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Jo DW, 2001, NAT BIOTECHNOL, V19, P929, DOI 10.1038/nbt1001-929; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; Johansen JP, 2004, NAT NEUROSCI, V7, P398, DOI 10.1038/nn1207; LaGraize SC, 2004, EXP NEUROL, V188, P139, DOI 10.1016/j.expneurol.2004.04.003; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee HJ, 2001, J NEUROSCI, V21, P4116, DOI 10.1523/JNEUROSCI.21-11-04116.2001; Liauw J, 2005, J NEUROPHYSIOL, V94, P878, DOI 10.1152/jn.01205.2004; Malin EL, 2006, P NATL ACAD SCI USA, V103, P1959, DOI 10.1073/pnas.0510890103; Meredith RM, 2007, NEURON, V54, P627, DOI 10.1016/j.neuron.2007.04.028; Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3; MILLER RE, 1959, J CLIN PSYCHOL, V15, P155, DOI 10.1002/1097-4679(195904)15:2<155::AID-JCLP2270150211>3.0.CO;2-P; MINEKA S, 1993, J EXP PSYCHOL GEN, V122, P23, DOI 10.1037/0096-3445.122.1.23; Mizuhara H, 2007, NEUROIMAGE, V36, P232, DOI 10.1016/j.neuroimage.2007.02.026; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Morrison I, 2007, NEUROIMAGE, V37, P642, DOI 10.1016/j.neuroimage.2007.03.079; Olsson A, 2004, PSYCHOL SCI, V15, P822, DOI 10.1111/j.0956-7976.2004.00762.x; Olsson A, 2007, SOC COGN AFFECT NEUR, V2, P3, DOI 10.1093/scan/nsm005; Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Raghavachari S, 2006, J NEUROPHYSIOL, V95, P1630, DOI 10.1152/jn.00409.2005; RICE GE, 1962, J COMP PHYSIOL PSYCH, V55, P123, DOI 10.1037/h0042276; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wiltgen BJ, 2007, LEARN MEMORY, V14, P313, DOI 10.1101/lm.430907	50	374	384	4	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2010	13	4					482	U105		10.1038/nn.2504	http://dx.doi.org/10.1038/nn.2504			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	575NI	20190743	Green Accepted			2022-12-17	WOS:000276073500018
J	Lee, A; Kessler, JD; Read, TA; Kaiser, C; Corbeil, D; Huttner, WB; Johnson, JE; Wechsler-Reya, RJ				Lee, A; Kessler, JD; Read, TA; Kaiser, C; Corbeil, D; Huttner, WB; Johnson, JE; Wechsler-Reya, RJ			Isolation of neural stem cells from the postnatal cerebellum	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR; BRAIN-TUMORS; MOUSE CEREBELLUM; PRECURSOR CELLS; SONIC HEDGEHOG; WHITE-MATTER; IN-VITRO; CNS; NEURONS	The cerebellum is critical for motor coordination and cognitive function and is the target of transformation in medulloblastoma, the most common malignant brain tumor in children. Although the development of granule cells, the most abundant neurons in the cerebellum, has been studied in detail, the origins of other cerebellar neurons and glia remain poorly understood. Here we show that the murine postnatal cerebellum contains multipotent neural stem cells (NSCs). These cells can be prospectively isolated based on their expression of the NSC marker prominin-1 (CD133) and their lack of markers of neuronal and glial lineages (lin(-)). Purified prominin(+)lin(-) cells form self-renewing neurospheres and can differentiate into astrocytes, oligodendrocytes and neurons in vitro. Moreover, they can generate each of these lineages after transplantation into the cerebellum. Identification of cerebellar stem cells has important implications for the understanding of cerebellar development and the origins of medulloblastoma.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA	Duke University; Max Planck Society; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wechsler-Reya, RJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	rw.reya@duke.edu	Corbeil, Denis/L-2340-2019; Corbeil, Denis/AFL-1008-2022; Corbeil, Denis/A-6519-2010; Huttner, Wieland B./P-4080-2018; Johnson, Jane/F-8881-2010	Corbeil, Denis/0000-0003-1181-3659; Hartman, Jessica/0000-0003-1578-3389; /0000-0002-8605-2746; Read, Tracy-Ann/0000-0002-5436-1296	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067916] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH067916-01A1, R01 MH067916-05, R01 MH067916, 1R01MH067916-01, R01 MH067916-03, R01 MH067916-04] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alder J, 1996, NEURON, V17, P389, DOI 10.1016/S0896-6273(00)80172-5; Altman J., 1996, DEV CEREBELLAR SYSTE; AOKI E, 1986, NEUROSCI LETT, V68, P267, DOI 10.1016/0304-3940(86)90500-8; ARUGA J, 1994, J NEUROCHEM, V63, P1880; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Cheng YH, 2001, J NEUROBIOL, V46, P220, DOI 10.1002/1097-4695(20010215)46:3<220::AID-NEU1004>3.0.CO;2-P; Corbeil D, 2001, TRAFFIC, V2, P82, DOI 10.1034/j.1600-0854.2001.020202.x; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Erlandsson A, 2001, J NEUROSCI, V21, P3483, DOI 10.1523/JNEUROSCI.21-10-03483.2001; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Galli R, 2000, DEV NEUROSCI-BASEL, V22, P86, DOI 10.1159/000017430; GAO WQ, 1994, DEVELOPMENT, V120, P1059; Geisert EE, 1996, J NEUROSCI, V16, P5478; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; HAEGEL H, 1993, J CELL BIOL, V122, P1067, DOI 10.1083/jcb.122.5.1067; HALLONET MER, 1990, DEVELOPMENT, V108, P19; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Imura T, 2003, J NEUROSCI, V23, P2824; KATSETOS CD, 1995, ARCH PATHOL LAB MED, V119, P734; Kern JK, 2002, MED HYPOTHESES, V59, P255, DOI 10.1016/S0306-9877(02)00212-8; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Maricich SM, 1999, J NEUROBIOL, V41, P281, DOI 10.1002/(SICI)1097-4695(19991105)41:2<281::AID-NEU10>3.0.CO;2-5; MARTIN P, 1995, SCHIZOPHRENIA BULL, V21, P241, DOI 10.1093/schbul/21.2.241; Milosevic A, 2002, J COMP NEUROL, V452, P192, DOI 10.1002/cne.10384; Pietsch T, 1997, CANCER RES, V57, P2085; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Rapoport M, 2000, J NEUROPSYCH CLIN N, V12, P193, DOI 10.1176/appi.neuropsych.12.2.193; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; ROSENBERG RN, 1989, NEUROL CLIN, V7, P25, DOI 10.1016/S0733-8619(18)30826-0; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Sawamoto K, 2001, J NEUROSCI, V21, P3895, DOI 10.1523/JNEUROSCI.21-11-03895.2001; Shetty AK, 1998, J NEUROBIOL, V35, P395, DOI 10.1002/(SICI)1097-4695(19980615)35:4<395::AID-NEU7>3.0.CO;2-U; SIMMONS ML, 1992, J NEUROSCI RES, V31, P646, DOI 10.1002/jnr.490310408; Singh SK, 2003, CANCER RES, V63, P5821; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Tamaki S, 2002, J NEUROSCI RES, V69, P976, DOI 10.1002/jnr.10412; THEODOSIS DT, 1991, P NATL ACAD SCI USA, V88, P5494, DOI 10.1073/pnas.88.13.5494; TUCKER RP, 1988, J NEUROSCI, V8, P4503; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; WERNECKE H, 1985, J NEUROIMMUNOL, V9, P115, DOI 10.1016/S0165-5728(85)80012-6; Wetmore C, 2003, CURR OPIN GENET DEV, V13, P34, DOI 10.1016/S0959-437X(03)00002-9; Zhang L, 1996, NEURON, V16, P47, DOI 10.1016/S0896-6273(00)80022-7; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	50	374	399	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					723	729		10.1038/nn1473	http://dx.doi.org/10.1038/nn1473			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15908947	Green Accepted			2022-12-17	WOS:000229345300011
J	Beierlein, M; Gibson, JR; Connors, BW				Beierlein, M; Gibson, JR; Connors, BW			A network of electrically coupled interneurons drives synchronized inhibition in neocortex	NATURE NEUROSCIENCE			English	Article							GABAERGIC CELL SUBTYPES; HIPPOCAMPUS IN-VITRO; RAT FRONTAL-CORTEX; CAT VISUAL-CORTEX; CORTICAL-NEURONS; CEREBRAL-CORTEX; GAP-JUNCTIONS; OSCILLATIONS; ACTIVATION; COORDINATION	The neocortex has at least two different networks of electrically coupled inhibitory interneurons: fast-spiking (FS) and low-threshold-spiking (LTS) cells. Agonists of metabotropic glutamate or acetylcholine receptors induced synchronized spiking and membrane fluctuations, with irregular or rhythmic patterns, in networks of LTS cells. LTS activity was closely correlated with inhibitory postsynaptic potentials in neighboring FS interneurons and excitatory neurons. Synchronized LTS activity required electrical synapses, but not fast chemical synapses. Tetanic stimulation of local circuitry induced effects similar to those of metabotropic agonists. We conclude that an electrically coupled network of LTS interneurons can mediate synchronized inhibition when activated by modulatory neurotransmitters.	Brown Univ, Dept Neurosci, Div Biol & Med, Providence, RI 02912 USA	Brown University	Connors, BW (corresponding author), Brown Univ, Dept Neurosci, Div Biol & Med, Box 1953, Providence, RI 02912 USA.	bwc@brown.edu	Connors, Barry/AAX-1975-2020	Beierlein, Michael/0000-0003-2210-3118; Connors, Barry/0000-0002-3739-3157	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025983, F32NS010478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012500] Funding Source: NIH RePORTER; NIDA NIH HHS [DA12500] Funding Source: Medline; NINDS NIH HHS [NS25983, NS10478] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Azouz R, 1999, J NEUROSCI, V19, P2209; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Benardo LS, 1997, J NEUROPHYSIOL, V77, P3134, DOI 10.1152/jn.1997.77.6.3134; Bennett MVL, 1997, J NEUROCYTOL, V26, P349, DOI 10.1023/A:1018560803261; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; Engel AK, 1997, CEREB CORTEX, V7, P571, DOI 10.1093/cercor/7.6.571; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Flint AC, 1999, P NATL ACAD SCI USA, V96, P12144, DOI 10.1073/pnas.96.21.12144; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gray CM, 1999, NEURON, V24, P31, DOI 10.1016/S0896-6273(00)80820-X; Hatsopoulos NG, 1998, P NATL ACAD SCI USA, V95, P15706, DOI 10.1073/pnas.95.26.15706; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; Kandler K, 1998, J NEUROSCI, V18, P1419; Kawaguchi Y, 1998, J NEUROSCI, V18, P6963; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kawaguchi Y, 1997, J NEUROPHYSIOL, V78, P1743, DOI 10.1152/jn.1997.78.3.1743; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; LYTTON WW, 1991, J NEUROPHYSIOL, V66, P1059, DOI 10.1152/jn.1991.66.3.1059; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Manor Y, 1997, J NEUROPHYSIOL, V77, P2736, DOI 10.1152/jn.1997.77.5.2736; MICHELSON HB, 1994, J PHYSIOL-LONDON, V477, P35, DOI 10.1113/jphysiol.1994.sp020169; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; SCHOLLHORN V, 1993, LECTINS BIOL BIOCH C, V8, P14; Skinner FK, 1999, J NEUROPHYSIOL, V81, P1274, DOI 10.1152/jn.1999.81.3.1274; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Steriade M, 1997, CEREB CORTEX, V7, P583, DOI 10.1093/cercor/7.6.583; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; Traub RD, 1999, FAST OSCILLATIONS CO; Van Vreeswijk C, 1994, J Comput Neurosci, V1, P313; WANG XJ, 1993, NEUROSCIENCE, V53, P899, DOI 10.1016/0306-4522(93)90474-T; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Xiang ZX, 1998, SCIENCE, V281, P985, DOI 10.1126/science.281.5379.985; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; Zhang Y, 1998, J NEUROSCI, V18, P9256	43	374	383	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					904	910		10.1038/78809	http://dx.doi.org/10.1038/78809			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966621				2022-12-17	WOS:000167177400017
J	Hamid, AA; Pettibone, JR; Mabrouk, OS; Hetrick, VL; Schmidt, R; Vander Weele, CM; Kennedy, RT; Aragona, BJ; Berke, JD				Hamid, Arif A.; Pettibone, Jeffrey R.; Mabrouk, Omar S.; Hetrick, Vaughn L.; Schmidt, Robert; Vander Weele, Caitlin M.; Kennedy, Robert T.; Aragona, Brandon J.; Berke, Joshua D.			Mesolimbic dopamine signals the value of work	NATURE NEUROSCIENCE			English	Article							NUCLEUS-ACCUMBENS DOPAMINE; REWARD-SEEKING; MATCHING BEHAVIOR; PREDICTION; DECISION; RELEASE; REPRESENTATION; MODULATION; STRIATUM; ENCODES	Dopamine cell firing can encode errors in reward prediction, providing a learning signal to guide future behavior. Yet dopamine is also a key modulator of motivation, invigorating current behavior. Existing theories propose that fast (phasic) dopamine fluctuations support learning, whereas much slower (tonic) dopamine changes are involved in motivation. We examined dopamine release in the nucleus accumbens across multiple time scales, using complementary microdialysis and voltammetric methods during adaptive decision-making. We found that minute-by-minute dopamine levels covaried with reward rate and motivational vigor. Second-by-second dopamine release encoded an estimate of temporally discounted future reward (a value function). Changing dopamine immediately altered willingness to work and reinforced preceding action choices by encoding temporal-difference reward prediction errors. Our results indicate that dopamine conveys a single, rapidly evolving decision variable, the available reward for investment of effort, which is employed for both learning and motivational functions.	[Hamid, Arif A.; Pettibone, Jeffrey R.; Hetrick, Vaughn L.; Schmidt, Robert; Vander Weele, Caitlin M.; Aragona, Brandon J.; Berke, Joshua D.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Hamid, Arif A.; Aragona, Brandon J.; Berke, Joshua D.] Univ Michigan, Neurosci Grad Program, Ann Arbor, MI 48109 USA; [Mabrouk, Omar S.; Kennedy, Robert T.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Mabrouk, Omar S.; Kennedy, Robert T.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Berke, Joshua D.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Berke, JD (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	jdberke@umich.edu	Core, Vector/CAF-4832-2022; Schmidt, Robert/H-6125-2017; Kennedy, Robert/G-9095-2016	Schmidt, Robert/0000-0002-2474-3744; Kennedy, Robert/0000-0003-2447-7471; Hamid, Arif/0000-0001-7403-0067	National Institute on Drug Abuse [DA032259, DA007281]; National Institute of Mental Health [MH093888, MH101697]; National Institute on Neurological Disorders and Stroke [NS078435, NS076401]; National Institute of Biomedical Imaging and Bioengineering [EB003320]; BrainLinks-BrainTools Cluster of Excellence - German Research Foundation (DFG) [EXC1086]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB003320, R01EB003320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH093888, R01MH101697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS076401, R01NS078435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007281, R21DA032259, T32DA007268] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); BrainLinks-BrainTools Cluster of Excellence - German Research Foundation (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank K. Berridge, T. Robinson, R. Wise, P. Redgrave, P. Dayan, D. Weissman, A. Kreitzer, N. Sanderson, D. Leventhal, S. Singh, J. Beeler, M. Walton, S. Nicola and members of the Berke laboratory for critical reading of various manuscript drafts, N. Mallet for initial assistance with viral injections, and K. Porter-Stransky for initial assistance with microdialysis procedures. Th-Cre<SUP>+</SUP> rats were developed by K. Deisseroth and I. Witten and made available for distribution through RRRC (http://www.rrrc.us). This work was supported by the National Institute on Drug Abuse (DA032259, training grant DA007281), the National Institute of Mental Health (MH093888, MH101697), the National Institute on Neurological Disorders and Stroke (NS078435, training grant NS076401), and the National Institute of Biomedical Imaging and Bioengineering (EB003320). R.S. was supported by the BrainLinks-BrainTools Cluster of Excellence funded by the German Research Foundation (DFG grant number EXC1086).	Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; Ainslie G, 2005, BEHAV BRAIN SCI, V28, P635, DOI 10.1017/S0140525X05000117; Aragona BJ, 2009, EUR J NEUROSCI, V30, P1889, DOI 10.1111/j.1460-9568.2009.07027.x; Beeler JA, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00049; Beierholm U, 2013, NEUROPSYCHOPHARMACOL, V38, P1495, DOI 10.1038/npp.2013.48; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Cagniard B, 2006, NEUROPSYCHOPHARMACOL, V31, P1362, DOI 10.1038/sj.npp.1300966; Cannon CM, 2003, J NEUROSCI, V23, P10827; Daw ND, 2006, NEURAL COMPUT, V18, P1637, DOI 10.1162/neco.2006.18.7.1637; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Dreyer JK, 2010, J NEUROSCI, V30, P14273, DOI 10.1523/JNEUROSCI.1894-10.2010; du Hoffmann J, 2014, J NEUROSCI, V34, P14349, DOI 10.1523/JNEUROSCI.3492-14.2014; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; FREED CR, 1985, SCIENCE, V229, P62, DOI 10.1126/science.4012312; Gage GJ, 2010, NEURON, V67, P466, DOI 10.1016/j.neuron.2010.06.034; Gan JO, 2010, NAT NEUROSCI, V13, P25, DOI 10.1038/nn.2460; Gershman SJ, 2014, NEURAL COMPUT, V26, P467, DOI 10.1162/NECO_a_00559; Guitart-Masip M, 2011, J COGNITIVE NEUROSCI, V23, P3933, DOI 10.1162/jocn_a_00090; Haith AM, 2012, J NEUROSCI, V32, P11727, DOI 10.1523/JNEUROSCI.0424-12.2012; Hart AS, 2014, J NEUROSCI, V34, P698, DOI 10.1523/JNEUROSCI.2489-13.2014; Heien MLAV, 2005, P NATL ACAD SCI USA, V102, P10023, DOI 10.1073/pnas.0504657102; Howe MW, 2013, NATURE, V500, P575, DOI 10.1038/nature12475; Hull CL, 1932, PSYCHOL REV, V39, P25, DOI 10.1037/h0072640; Humphries MD, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00009; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Ishiwari K, 2004, BEHAV BRAIN RES, V151, P83, DOI 10.1016/j.bbr.2003.08.007; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kacelnik A, 1997, Ciba Found Symp, V208, P51; Kile BM, 2012, ACS CHEM NEUROSCI, V3, P285, DOI 10.1021/cn200119u; Kim KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033612; Kobayashi S, 2008, J NEUROSCI, V28, P7837, DOI 10.1523/JNEUROSCI.1600-08.2008; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Leventhal DK, 2014, BASAL GANGLIA, V4, P43, DOI 10.1016/j.baga.2013.11.001; Leventhal DK, 2012, NEURON, V73, P523, DOI 10.1016/j.neuron.2011.11.032; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; MAZUR JE, 1984, J EXP PSYCHOL ANIM B, V10, P426, DOI 10.1037/0097-7403.10.4.426; McClure SM, 2003, TRENDS NEUROSCI, V26, P423, DOI 10.1016/S0166-2236(03)00177-2; Morita K, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00036; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Nagano-Saito A, 2012, J NEUROPHYSIOL, V108, P501, DOI 10.1152/jn.00592.2011; Nicola SM, 2010, J NEUROSCI, V30, P16585, DOI 10.1523/JNEUROSCI.3958-10.2010; Niv Y, 2006, ADV NEURAL INF PROCE, V18, P1019; Niyogi RK, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0969; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; RAPOPORT JL, 1980, ARCH GEN PSYCHIAT, V37, P933; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Satoh T, 2003, J NEUROSCI, V23, P9913; Schlinger HD, 2008, BEHAV ANALYST, V31, P39, DOI 10.1007/BF03392160; Schmidt R, 2013, NAT NEUROSCI, V16, P1118, DOI 10.1038/nn.3456; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Simen P, 2006, NEURAL NETWORKS, V19, P1013, DOI 10.1016/j.neunet.2006.05.038; Song P, 2012, ANAL CHEM, V84, P4659, DOI 10.1021/ac301203m; Song P, 2012, ANAL CHEM, V84, P412, DOI 10.1021/ac202794q; Steinberg EE, 2013, NAT NEUROSCI, V16, P966, DOI 10.1038/nn.3413; Stephens D.W., 1986, pi; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Tachibana Y, 2012, NEURON, V76, P826, DOI 10.1016/j.neuron.2012.09.030; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; Turner RS, 2010, CURR OPIN NEUROBIOL, V20, P704, DOI 10.1016/j.conb.2010.08.022; van der Meer MAA, 2011, CURR OPIN NEUROBIOL, V21, P387, DOI 10.1016/j.conb.2011.02.011; Venton BJ, 2002, ANAL CHEM, V74, P539, DOI 10.1021/ac010819a; Wang AY, 2013, NAT NEUROSCI, V16, P639, DOI 10.1038/nn.3377; Wardle MC, 2011, J NEUROSCI, V31, P16597, DOI 10.1523/JNEUROSCI.4387-11.2011; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028	69	373	376	3	132	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2016	19	1					117	+		10.1038/nn.4173	http://dx.doi.org/10.1038/nn.4173			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CZ7BH	26595651	Green Accepted			2022-12-17	WOS:000367254400020
J	Blakemore, SJ; Robbins, TW				Blakemore, Sarah-Jayne; Robbins, Trevor W.			Decision-making in the adolescent brain	NATURE NEUROSCIENCE			English	Review							HUMAN CORTICAL DEVELOPMENT; HUMAN PREFRONTAL CORTEX; RISK-TAKING; DEVELOPMENTAL-CHANGES; COGNITIVE CONTROL; NEURAL SYSTEMS; NEURODEVELOPMENTAL TRAJECTORIES; ORBITOFRONTAL CORTEX; PERSPECTIVE-TAKING; PREDICTION ERRORS	Adolescence is characterized by making risky decisions. Early lesion and neuroimaging studies in adults pointed to the ventromedial prefrontal cortex and related structures as having a key role in decision-making. More recent studies have fractionated decision-making processes into its various components, including the representation of value, response selection (including inter-temporal choice and cognitive control), associative learning, and affective and social aspects. These different aspects of decision-making have been the focus of investigation in recent studies of the adolescent brain. Evidence points to a dissociation between the relatively slow, linear development of impulse control and response inhibition during adolescence versus the nonlinear development of the reward system, which is often hyper-responsive to rewards in adolescence. This suggests that decision-making in adolescence may be particularly modulated by emotion and social factors, for example, when adolescents are with peers or in other affective ('hot') contexts.	[Blakemore, Sarah-Jayne] UCL, Inst Cognit Neurosci, London, England; [Robbins, Trevor W.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Robbins, Trevor W.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of London; University College London; University of Cambridge; University of Cambridge	Blakemore, SJ (corresponding author), UCL, Inst Cognit Neurosci, London, England.	s.blakemore@ucl.ac.uk	Robbins, Trevor W/A-7551-2008; Blakemore, Sarah-Jayne/A-1792-2010	Robbins, Trevor/0000-0003-0642-5977; Blakemore, Sarah-Jayne/0000-0002-1690-2805	Royal Society; Leverhulme Trust, UK; Medical Research Council; Wellcome Trust	Royal Society(Royal Society of London); Leverhulme Trust, UK(Leverhulme Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)	S.-J.B. is funded by the Royal Society and the Leverhulme Trust, UK. The Behavioural and Clinical Neuroscience Institute, Cambridge, UK is co-funded by the Medical Research Council and the Wellcome Trust. We thank S. Burnett Heyes, I. Dumontheil, A. L. Goddings, E.J. Kilford, K. Mills and N. Wright for commenting on previous versions of the manuscript, T. Wager for help with the meta-analysis using Neurosynth (http://neurosynth.org/), and L. Clark, J. Chein and L. Somerville for help with figures.	Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Baird AA, 2004, PHILOS T R SOC B, V359, P1797, DOI 10.1098/rstb.2004.1549; Ball WS, 2012, CEREB CORTEX, V22, P1, DOI 10.1093/cercor/bhr018; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bernoulli D, 1954, ECONOMETRICA, V22, P22; Billieux J, 2010, BEHAV RES THER, V48, P1085, DOI 10.1016/j.brat.2010.07.008; Bjork JM, 2004, J NEUROSCI, V24, P1793, DOI 10.1523/JNEUROSCI.4862-03.2004; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blakemore SJ, 2007, SOC COGN AFFECT NEUR, V2, P130, DOI 10.1093/scan/nsm009; Blakemore SJ, 2012, NEUROIMAGE, V61, P397, DOI 10.1016/j.neuroimage.2011.11.080; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Burnett S, 2010, COGNITIVE DEV, V25, P183, DOI 10.1016/j.cogdev.2009.11.003; Burnett S, 2009, J COGNITIVE NEUROSCI, V21, P1736, DOI 10.1162/jocn.2009.21121; Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Camille N, 2010, COGN AFFECT BEHAV NE, V10, P460, DOI 10.3758/CABN.10.4.460; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Casey BJ, 2011, P NATL ACAD SCI USA, V108, P14998, DOI 10.1073/pnas.1108561108; Cauffman E, 2010, DEV PSYCHOL, V46, P193, DOI 10.1037/a0016128; Chein J, 2011, DEVELOPMENTAL SCI, V14, pF1, DOI 10.1111/j.1467-7687.2010.01035.x; Christakou A, 2011, NEUROIMAGE, V54, P1344, DOI 10.1016/j.neuroimage.2010.08.067; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; Clark L, 2007, BIOL PSYCHIAT, V61, P1395, DOI 10.1016/j.biopsych.2006.07.020; Clark L, 2009, NEURON, V61, P481, DOI 10.1016/j.neuron.2008.12.031; Clarke HF, 2008, J NEUROSCI, V28, P10972, DOI 10.1523/JNEUROSCI.1521-08.2008; Cohen JR, 2010, NAT NEUROSCI, V13, P669, DOI 10.1038/nn.2558; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Crone EA, 2008, DEV PSYCHOPATHOL, V20, P1213, DOI 10.1017/S0954579408000588; Damasio A.R., 1994, DESCARTES ERROR EMOT; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Doremus-Fitzwater TL, 2010, BRAIN COGNITION, V72, P114, DOI 10.1016/j.bandc.2009.08.008; Dumontheil I, 2010, DEVELOPMENTAL SCI, V13, P331, DOI 10.1111/j.1467-7687.2009.00888.x; Durston S, 2006, DEVELOPMENTAL SCI, V9, P1, DOI 10.1111/j.1467-7687.2005.00454.x; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; EYSENCK SBG, 1978, PSYCHOL REP, V43, P1247, DOI 10.2466/pr0.1978.43.3f.1247; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Figner B, 2009, J EXP PSYCHOL LEARN, V35, P709, DOI 10.1037/a0014983; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Gardner M, 2005, DEV PSYCHOL, V41, P625, DOI 10.1037/0012-1649.41.4.625; Geier CF, 2010, CEREB CORTEX, V20, P1613, DOI 10.1093/cercor/bhp225; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gladwin TE, 2011, DEV COGN NEUROS-NETH, V1, P364, DOI 10.1016/j.dcn.2011.06.008; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Guroglu B, 2009, J EXP CHILD PSYCHOL, V104, P398, DOI 10.1016/j.jecp.2009.07.002; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Harbaugh WT, 2002, EXP ECON, V5, P53, DOI 10.1023/A:1016316725855; Hare TA, 2008, BIOL PSYCHIAT, V63, P927, DOI 10.1016/j.biopsych.2008.03.015; Harris JJ, 2011, DEV COGN NEUROS-NETH, V1, P199, DOI 10.1016/j.dcn.2011.04.001; Houde O, 2010, DEVELOPMENTAL SCI, V13, P876, DOI 10.1111/j.1467-7687.2009.00938.x; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Jensen K, 2007, SCIENCE, V318, P107, DOI 10.1126/science.1145850; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Levy I, 2010, J NEUROPHYSIOL, V103, P1036, DOI 10.1152/jn.00853.2009; Logan Gordon D., 1994, P189; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Moor BG, 2012, SOC COGN AFFECT NEUR, V7, P44, DOI 10.1093/scan/nsr020; Paulsen DJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00072; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Pfeifer JH, 2007, J COGNITIVE NEUROSCI, V19, P1323, DOI 10.1162/jocn.2007.19.8.1323; Pfeifer JH, 2012, TRENDS COGN SCI, V16, P322, DOI 10.1016/j.tics.2012.04.011; Pfeifer JH, 2009, CHILD DEV, V80, P1016, DOI 10.1111/j.1467-8624.2009.01314.x; Philpot RM, 2008, BEHAV NEUROSCI, V122, P861, DOI 10.1037/0735-7044.122.4.861; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; RACHLIN H, 1991, J EXP ANAL BEHAV, V55, P233, DOI 10.1901/jeab.1991.55-233; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Raznahan A, 2011, NEURON, V72, P873, DOI 10.1016/j.neuron.2011.09.028; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Rubia K, 2000, NEUROSCI BIOBEHAV R, V24, P13, DOI 10.1016/S0149-7634(99)00055-X; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Rubia K, 2006, HUM BRAIN MAPP, V27, P973, DOI 10.1002/hbm.20237; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Scheres A, 2006, NEUROPSYCHOLOGIA, V44, P2092, DOI 10.1016/j.neuropsychologia.2005.10.012; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Sebastian CL, 2012, SOC COGN AFFECT NEUR, V7, P53, DOI 10.1093/scan/nsr023; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Somerville LH, 2011, J COGNITIVE NEUROSCI, V23, P2123, DOI 10.1162/jocn.2010.21572; Somerville LH, 2010, BRAIN COGNITION, V72, P124, DOI 10.1016/j.bandc.2009.07.003; Steinberg L, 2010, ADOLESCENCE; Sturman DA, 2012, P NATL ACAD SCI USA, V109, P1719, DOI 10.1073/pnas.1114137109; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; van den Bos W, 2011, PSYCHOL SCI, V22, P60, DOI 10.1177/0956797610391102; Van Leijenhorst L, 2008, DEV NEUROPSYCHOL, V33, P179, DOI 10.1080/87565640701884287; Van Leijenhorst L, 2010, NEUROIMAGE, V51, P345, DOI 10.1016/j.neuroimage.2010.02.038; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; Wang AT, 2006, SOC COGN AFFECT NEUR, V1, P107, DOI 10.1093/scan/nsl018; Whelan R., NAT NEUROSC IN PRESS; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	100	373	382	15	272	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1184	1191		10.1038/nn.3177	http://dx.doi.org/10.1038/nn.3177			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	996GJ	22929913				2022-12-17	WOS:000308072600006
J	Ma, T; Trinh, MA; Wexler, AJ; Bourbon, C; Gatti, E; Pierre, P; Cavener, DR; Klann, E				Ma, Tao; Trinh, Mimi A.; Wexler, Alyse J.; Bourbon, Clarisse; Gatti, Evelina; Pierre, Philippe; Cavener, Douglas R.; Klann, Eric			Suppression of eIF2 alpha kinases alleviates Alzheimer's disease-related plasticity and memory deficits	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL SYNAPTIC PLASTICITY; TRANSLATIONAL CONTROL; OXIDATIVE STRESS; EIF2 KINASES; PHOSPHORYLATION; ACTIVATION; PERK; MECHANISMS; DISRUPTION; EXPRESSION	Expression of long-lasting synaptic plasticity and long-term memory requires protein synthesis, which can be repressed by phosphorylation of eukaryotic initiation factor 2 alpha-subunit (eIF2 alpha). Elevated phosphorylation of eIF2 alpha has been observed in the brains of Alzheimer's disease patients and Alzheimer's disease model mice. Therefore, we tested whether suppressing eIF2 alpha kinases could alleviate synaptic plasticity and memory deficits in Alzheimer's disease model mice. Genetic deletion of eIF2 alpha kinase PERK prevented enhanced phosphorylation of eIF2 alpha and deficits in protein synthesis, synaptic plasticity and spatial memory in mice that express familial Alzheimer's disease-related mutations in APP and PSEN1. Similarly, deletion of another eIF2 alpha kinase, GCN2, prevented impairments of synaptic plasticity and defects in spatial memory exhibited by the Alzheimer's disease model mice. Our findings implicate aberrant eIF2 alpha phosphorylation as a previously unidentified molecular mechanism underlying Alzheimer's disease-related synaptic pathophysioloy and memory dysfunction and suggest that PERK and GCN2 are potential therapeutic targets for treatment of individuals with Alzheimer's disease.	[Ma, Tao; Trinh, Mimi A.; Wexler, Alyse J.; Klann, Eric] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Bourbon, Clarisse; Gatti, Evelina; Pierre, Philippe] Univ Mediterranee, Ctr Immunol Marseille Luminy, CNRS, Unite Mixte Rech 6102, Marseille, France; [Bourbon, Clarisse; Gatti, Evelina; Pierre, Philippe] INSERM, U1104, F-13258 Marseille, France; [Bourbon, Clarisse; Gatti, Evelina; Pierre, Philippe] CNRS, Unite Mixte Rech 7280, Marseille, France; [Cavener, Douglas R.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	New York University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Klann, E (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	eklann@cns.nyu.edu	Gatti, Evelina/B-7941-2012	Gatti, Evelina/0000-0002-0667-0799; pierre, philippe/0000-0003-0863-8255	US National Institutes of Health [NS034007, NS047834]; Alzheimer's Association Investigator grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047384, R29NS034007, R01NS034007, R37NS034007, R21NS078718] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association Investigator grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the late Dr. Mark A. Smith (Case Western Reserve University) for providing postmortem Alzheimer's disease brain samples, R.C. Wek (Indiana University School of Medicine) for providing the ATF4 antibody, C.A. Hoeffer for help with the design of the mouse breeding, H. Bowling and M.V. Chao (New York University School of Medicine) for providing primary cultured neurons, E. Santini for advice on the statistical analyses for the mouse behavioral tests, Y. Chen for technical help, M. Dorsey for keeping colonies of transgenic mice, and all members of the Klann laboratory for comments on the manuscript. This work was supported by US National Institutes of Health grants NS034007 and NS047834, and Alzheimer's Association Investigator grant to E. K.	Alberini CM, 2008, NEUROBIOL LEARN MEM, V89, P234, DOI 10.1016/j.nlm.2007.08.007; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Bonda DJ, 2010, REDOX REP, V15, P161, DOI 10.1179/174329210X12650506623645; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jiang Z, 2010, J NEUROSCI, V30, P2582, DOI 10.1523/JNEUROSCI.3971-09.2010; Kim SM, 2010, NEUROSCIENCE, V169, P1831, DOI 10.1016/j.neuroscience.2010.06.016; Klann E, 2004, LEARN MEMORY, V11, P365, DOI 10.1101/lm.79004; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; KLANN E, 2007, TRANSLATIONAL CONTRO, P485; Leuba G, 2008, J ALZHEIMERS DIS, V15, P139; Li G, 2010, J CELL BIOL, V191, P1113, DOI 10.1083/jcb.201006121; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Ma T, 2012, J NEUROCHEM, V120, P140, DOI 10.1111/j.1471-4159.2011.07506.x; Ma T, 2011, J NEUROSCI, V31, P5589, DOI 10.1523/JNEUROSCI.6566-10.2011; Ma T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012845; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Paschen W, 2007, CURR PHARM DESIGN, V13, P1887; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Trinh MA, 2012, CELL REP, V1, P676, DOI 10.1016/j.celrep.2012.04.010; Tsaytler P, 2013, FEBS J, V280, P766, DOI 10.1111/j.1742-4658.2012.08535.x; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Wang SQ, 2010, J NEUROCHEM, V115, P47, DOI 10.1111/j.1471-4159.2010.06899.x; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Zhan K, 2004, GENETICS, V168, P1867, DOI 10.1534/genetics.104.031443; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	48	372	382	9	110	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1299	U185		10.1038/nn.3486	http://dx.doi.org/10.1038/nn.3486			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23933749	Green Accepted			2022-12-17	WOS:000323597500022
J	Rosso, SB; Sussman, D; Wynshaw-Boris, A; Salinas, PC				Rosso, SB; Sussman, D; Wynshaw-Boris, A; Salinas, PC			Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development	NATURE NEUROSCIENCE			English	Article							PLANAR CELL POLARITY; N-TERMINAL KINASE; SMALL GTPASES RAC; RHO-GTPASES; VERTEBRATE GASTRULATION; NEURONAL MORPHOGENESIS; TRANSDUCTION PATHWAY; ACTIN CYTOSKELETON; PYRAMIDAL NEURONS; BETA-CATENIN	Dendritic arborization is required for proper neuronal connectivity. Rho GTPases have been implicated in the regulation of dendrite development. However, the signaling pathways that impinge on these molecular switches remain poorly understood. Here we show that Wnt7b, which is expressed in the mouse hippocampus, increases dendritic branching in cultured hippocampal neurons. This effect is mimicked by the expression of Dishevelled (Dvl) and is blocked by Sfrp1, a secreted Wnt antagonist. Consistent with these findings, hippocampal neurons from mice lacking Dvl1 show reduced dendritic arborization. Activation of the canonical Wnt-Gsk3beta pathway does not affect dendritic development. In contrast, Wnt7b and Dvl activate Rac and JNK in hippocampal neurons. Dominant-negative Rac, dominant-negative JNK or inhibition of JNK blocks Dvl-mediated dendritic growth. These findings demonstrate a new function for the non-canonical Wnt pathway in dendrite development and identify Dvl as a regulator of Rho GTPases and JNK during dendritic morphogenesis.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA	University of London; University College London; University System of Maryland; University of Maryland Baltimore; University of California System; University of California San Diego	Salinas, PC (corresponding author), UCL, Dept Anat & Dev Biol, Rockefeller Bldg,Univ St, London WC1E 6BT, England.	p.salinas@ucl.ac.uk		Salinas, Patricia C./0000-0002-5748-083X	NINDS NIH HHS [R01 NS073159] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073159] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Ciani L, 2004, J CELL BIOL, V164, P243, DOI 10.1083/jcb.200309096; Coffey ET, 2000, J NEUROSCI, V20, P7602; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Guo X, 2001, J NEUROBIOL, V48, P120, DOI 10.1002/neu.1046; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Krylova O, 2000, J CELL BIOL, V151, P83, DOI 10.1083/jcb.151.1.83; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Kuwahara K, 1999, FEBS LETT, V452, P314, DOI 10.1016/S0014-5793(99)00680-8; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Lucas FR, 1998, J CELL SCI, V111, P1351; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Paglini G, 1998, J NEUROSCI, V18, P9858; Penton A, 2002, GENETICS, V161, P747; POKORNY J, 1981, BRAIN RES BULL, V7, P113, DOI 10.1016/0361-9230(81)90075-7; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; SUSSMAN DJ, 1994, DEV BIOL, V166, P73, DOI 10.1006/dbio.1994.1297; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zhurinsky J, 2000, MOL CELL BIOL, V20, P4238, DOI 10.1128/MCB.20.12.4238-4252.2000	50	372	379	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					34	42		10.1038/nn1374	http://dx.doi.org/10.1038/nn1374			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15608632				2022-12-17	WOS:000225967600013
J	Li, SM; Cullen, WK; Anwyl, R; Rowan, MJ				Li, SM; Cullen, WK; Anwyl, R; Rowan, MJ			Dopamine-dependent facilitation of LTP induction in hippocampal CA1 by exposure to spatial novelty	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; ACETYLCHOLINE-RELEASE; SYNAPTIC PLASTICITY; BRAIN TEMPERATURE; RAT HIPPOCAMPUS; MOTOR-ACTIVITY; DENTATE GYRUS; MEMORY; RECEPTORS; NEURONS	In addition to its role in memory formation, the hippocampus may act as a novelty detector. Here we investigated whether attention to novel events can promote the associative synaptic plasticity mechanisms believed to be necessary for storing those events in memory. We therefore examined whether exposure to a novel spatial environment promoted the induction of activity-dependent persistent increases in glutamatergic transmission (long-term potentiation, LTP) at CA1 synapses in the rat hippocampus. We found that brief exposure to a novel environment lowered the threshold for the induction of LTP. This facilitatory effect was present for a short period following novelty exposure but was absent in animals that explored a familiar environment. Furthermore, the facilitation was dependent on activation of D1/D5 receptors. These findings support an important role for dopamine-regulated synaptic plasticity in the storage of unpredicted information in the CA1 area.	Univ Dublin Trinity Coll, Dept Pharmacol & Therapeut, Dublin 2, Ireland; Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland; Univ Dublin Trinity Coll, Dept Physiol, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Rowan, MJ (corresponding author), Univ Dublin Trinity Coll, Dept Pharmacol & Therapeut, Biotechnol Bldg, Dublin 2, Ireland.			Rowan, Michael Joseph/0000-0002-3867-9536				Abraham WC, 2002, J NEUROSCI, V22, P9626; Acquas E, 1996, J NEUROSCI, V16, P3089; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Dong HW, 2001, BRAIN RES, V893, P1, DOI 10.1016/S0006-8993(00)03036-5; Fischer H, 2003, BRAIN RES BULL, V59, P387, DOI 10.1016/S0361-9230(02)00940-1; Frey S, 2001, J NEUROSCI, V21, P3697, DOI 10.1523/JNEUROSCI.21-10-03697.2001; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Gasbarri A, 1996, NEUROSCIENCE, V74, P1037, DOI 10.1016/0306-4522(96)00202-3; HARGREAVES EL, 1990, J NEUROSCI, V10, P1472; HERSI AI, 1995, NEUROSCIENCE, V69, P1067, DOI 10.1016/0306-4522(95)00319-E; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Ihalainen JA, 1999, NEUROSCI LETT, V277, P71, DOI 10.1016/S0304-3940(99)00840-X; Kim JH, 2001, J NEUROSCI, V21, P1327; Knight RT, 1998, REV NEUROSCIENCE, V9, P57; Kulla A, 2000, CEREB CORTEX, V10, P614, DOI 10.1093/cercor/10.6.614; Kusuki T, 1997, NEUROREPORT, V8, P2037, DOI 10.1097/00001756-199705260-00046; Lee I, 2002, NAT NEUROSCI, V5, P162, DOI 10.1038/nn790; LEUNG LS, 1980, BRAIN RES, V198, P95; LI S, 2001, BRIT J PHARM S, V34, P150; LI S, 2002, IRISH J MED SCI, V171, P172; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MOSER E, 1993, SCIENCE, V259, P1324, DOI 10.1126/science.8446900; Moser EI, 2001, CURR OPIN NEUROBIOL, V11, P745, DOI 10.1016/S0959-4388(01)00279-3; MOSER EI, 1994, LEARN MEMORY, V1, P55; Moses SN, 2002, BRAIN RES BULL, V58, P517, DOI 10.1016/S0361-9230(02)00820-1; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Oswald CJP, 2002, EUR J NEUROSCI, V15, P1983, DOI 10.1046/j.1460-9568.2002.02028.x; Otmakhova NA, 2000, J NEUROSCI, V20, P4446, DOI 10.1523/JNEUROSCI.20-12-04446.2000; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Ploghaus A, 2000, P NATL ACAD SCI USA, V97, P9281, DOI 10.1073/pnas.160266497; Sah P, 1996, J NEUROSCI, V16, P4537; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Seidenbecher T, 1997, P NATL ACAD SCI USA, V94, P1494, DOI 10.1073/pnas.94.4.1494; Swanson-Park JL, 1999, NEUROSCIENCE, V92, P485, DOI 10.1016/S0306-4522(99)00010-X; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G; VANKOV A, 1995, EUR J NEUROSCI, V7, P1180, DOI 10.1111/j.1460-9568.1995.tb01108.x; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073; Watabe AM, 2000, J NEUROSCI, V20, P5924, DOI 10.1523/JNEUROSCI.20-16-05924.2000; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0	48	372	388	1	38	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					526	531		10.1038/nn1049	http://dx.doi.org/10.1038/nn1049			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12704392				2022-12-17	WOS:000182553200020
J	Garaschuk, O; Linn, J; Eilers, J; Konnerth, A				Garaschuk, O; Linn, J; Eilers, J; Konnerth, A			Large-scale oscillatory calcium waves in the immature cortex	NATURE NEUROSCIENCE			English	Article							GLYCINE-RECEPTOR ACTIVATION; VISUAL-CORTEX; NEOCORTICAL DEVELOPMENT; NEONATAL HIPPOCAMPUS; RETINAL WAVES; GROWTH-CONE; AREA CA1; NEURONS; RAT; SYNAPSES	Two-photon imaging of large neuronal networks in cortical slices of newborn rats revealed synchronized oscillations in intracellular Ca2+ concentration. These spontaneous Ca2+ waves usually started in the posterior cortex and propagated slowly (2.1 mm per second) toward its anterior end. Ca2+ waves were associated with field-potential changes and required activation of AMPA and NMDA receptors. Although GABA(A) receptors were not involved in wave initiation, the developmental transition of GABAergic transmission from depolarizing to hyperpolarizing (around postnatal day 7) stopped the oscillatory activity. Thus we identified a type of large-scare Ca2+ wave that may regulate long-distance wiring in the immature cortex.	Tech Univ Munich, Inst Physiol, D-80802 Munich, Germany; Univ Saarland, Inst Physiol, D-66421 Homburg, Germany	Technical University of Munich; Saarland University	Konnerth, A (corresponding author), Tech Univ Munich, Inst Physiol, D-80802 Munich, Germany.	konnerth@physiol.med.tu-muenchen.de	Linn, Jennifer/AAE-1567-2021; Linn, Jennifer/H-8202-2013; Garaschuk, Olga/G-5633-2015; Eilers, Jens/E-6251-2012	Eilers, Jens/0000-0003-0497-5625; Linn, Jennifer/0000-0003-0797-2761				BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BLAKE JF, 1989, BRIT J PHARMACOL, V97, P71, DOI 10.1111/j.1476-5381.1989.tb11925.x; BLUE ME, 1983, J NEUROCYTOL, V12, P599, DOI 10.1007/BF01181526; BLUE ME, 1983, J NEUROCYTOL, V12, P697, DOI 10.1007/BF01181531; BRAITENBERG V, 1991, ANATOMY CORTEX, P141; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; DALVA MB, 1994, SCIENCE, V265, P255, DOI 10.1126/science.7912852; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 1997, NEURON, V19, P293, DOI 10.1016/S0896-6273(00)80940-X; Flint AC, 1999, P NATL ACAD SCI USA, V96, P12144, DOI 10.1073/pnas.96.21.12144; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; Galuske RAW, 1996, CEREB CORTEX, V6, P417, DOI 10.1093/cercor/6.3.417; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gu XN, 1997, DEV NEUROSCI-BASEL, V19, P33, DOI 10.1159/000111183; Hanse E, 1997, SEMIN CELL DEV BIOL, V8, P35, DOI 10.1006/scdb.1996.0119; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; JURASKA JM, 1979, J COMP NEUROL, V183, P257, DOI 10.1002/cne.901830204; Kandler K, 1998, J NEUROSCI, V18, P1419; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; KONNERTH A, 1990, TRENDS NEUROSCI, V13, P321, DOI 10.1016/0166-2236(90)90137-Y; KONNERTH A, 1984, NATURE, V307, P69, DOI 10.1038/307069a0; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; Leinekugel X, 1998, J NEUROSCI, V18, P6349; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Owens DF, 1996, J NEUROSCI, V16, P6414; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Schwartz TH, 1998, NEURON, V20, P541, DOI 10.1016/S0896-6273(00)80993-9; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; SPITZER NC, 1994, TRENDS NEUROSCI, V17, P115, DOI 10.1016/0166-2236(94)90120-1; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; WELIKY M, 1994, J NEUROSCI, V14, P7291; WILLIAMS RM, 1994, FASEB J, V8, P804, DOI 10.1096/fasebj.8.11.8070629; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8	46	372	384	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					452	459		10.1038/74823	http://dx.doi.org/10.1038/74823			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309DG	10769384				2022-12-17	WOS:000086752000013
J	Bradshaw, EM; Chibnik, LB; Keenan, BT; Ottoboni, L; Raj, T; Tang, A; Rosenkrantz, LL; Imboywa, S; Lee, M; Von Korff, A; Morris, MC; Evans, DA; Johnson, K; Sperling, RA; Schneider, JA; Bennett, DA; De Jager, PL				Bradshaw, Elizabeth M.; Chibnik, Lori B.; Keenan, Brendan T.; Ottoboni, Linda; Raj, Towfique; Tang, Anna; Rosenkrantz, Laura L.; Imboywa, Selina; Lee, Michelle; Von Korff, Alina; Morris, Martha C.; Evans, Denis A.; Johnson, Keith; Sperling, Reisa A.; Schneider, Julie A.; Bennett, David A.; De Jager, Philip L.		Alzheimer's Dis Neuroimaging Initi	CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology	NATURE NEUROSCIENCE			English	Article							GENOME-WIDE ASSOCIATION; COGNITIVE IMPAIRMENT; IDENTIFIES VARIANTS; COMMON VARIANTS; EPHA1; PET; DEMENTIA; BINDING; CD2AP; BETA	In our functional dissection of the CD33 Alzheimer's disease susceptibility locus, we found that the rs3865444(C) risk allele was associated with greater cell surface expression of CD33 in the monocytes ( t(50) = 10.06, P-joint = 1.3 x 10(-13)) of young and older individuals. It was also associated with diminished internalization of amyloid-beta 42 peptide, accumulation of neuritic amyloid pathology and fibrillar amyloid on in vivo imaging, and increased numbers of activated human microglia.	[Bradshaw, Elizabeth M.; Chibnik, Lori B.; Keenan, Brendan T.; Ottoboni, Linda; Raj, Towfique; Tang, Anna; Rosenkrantz, Laura L.; Imboywa, Selina; Lee, Michelle; Von Korff, Alina; De Jager, Philip L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Bradshaw, Elizabeth M.; Chibnik, Lori B.; Keenan, Brendan T.; Ottoboni, Linda; Raj, Towfique; Tang, Anna; Rosenkrantz, Laura L.; Imboywa, Selina; Lee, Michelle; Von Korff, Alina; De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Inst Neurosci, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [Bradshaw, Elizabeth M.; Chibnik, Lori B.; Ottoboni, Linda; Raj, Towfique; Johnson, Keith; Sperling, Reisa A.; De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA USA; [Bradshaw, Elizabeth M.; Chibnik, Lori B.; Keenan, Brendan T.; Ottoboni, Linda; Raj, Towfique; Tang, Anna; Rosenkrantz, Laura L.; Imboywa, Selina; De Jager, Philip L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Morris, Martha C.; Schneider, Julie A.; Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Evans, Denis A.] Rush Univ, Med Ctr, Rush Inst Hlth Aging, Chicago, IL 60612 USA; [Johnson, Keith; Sperling, Reisa A.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Sperling, Reisa A.] Brigham & Womens Hosp, Dept Neurol, Ctr Alzheimers Res & Treatment, Boston, MA 02115 USA; [Johnson, Keith; Sperling, Reisa A.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rush University; Rush University; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	De Jager, PL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	pdejager@partners.org	Hsiung, Robin/AAT-1661-2021; Preda, Adrian/K-8889-2013; Raj, Towfique/ABD-7620-2021; Ottoboni, Linda/AAC-4508-2022; Saykin, Andrew/A-1318-2007	Hsiung, Robin/0000-0002-8017-0856; Preda, Adrian/0000-0003-3373-2438; Ottoboni, Linda/0000-0001-5412-7785; Saykin, Andrew/0000-0002-1376-8532; Chibnik, Lori/0000-0001-6293-806X; Ponto, Laura/0000-0003-1197-6714	US National Institutes of Health [R01 AG031553, R01 AG30146, R01 AG17917, R01 AG15819, P30 AG10161, R01 AG11101]; Illinois Department of Public Health; JDRF; American Diabetes Association; Boston Area Diabetes and Endocrinology Research Center; Harvard NeuroDiscovery Center;  [R01 NS067305];  [RC2 GM093080];  [R01 AG043617]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM076321, RC2GM093080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG021886, P30AG010161, R01AG036042, R01AG011101, R01AG015819, P50AG008702, P30AG013846, P30AG008051, R01AG030146, R01AG031553, R01AG043617, R01AG017917, K25AG041906, P50AG005138] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Illinois Department of Public Health; JDRF(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); Boston Area Diabetes and Endocrinology Research Center; Harvard NeuroDiscovery Center; ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are grateful to the participants of the ROS, MAP, CHAP, Harvard Aging Brain Study (HAB) and Alzheimer's Disease Neuroimaging Initiative (ADNI) studies. Data used in preparation of this article were obtained from the ADNI database (http://adni.loni.ucla.edu/). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. We also thank the participants of the Brigham and Women's PhenoGenetic Project. This work is supported by the US National Institutes of Health (grants R01 AG031553, R01 AG30146, R01 AG17917, R01 AG15819, P30 AG10161 and R01 AG11101) and the Illinois Department of Public Health. This work was supported by grants R01 NS067305, RC2 GM093080 and R01 AG043617. E.M.B. receives support from the JDRF, American Diabetes Association, Boston Area Diabetes and Endocrinology Research Center and the Harvard NeuroDiscovery Center.	[Anonymous], 1997, Neurobiol Aging, V18, pS1; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bennett DA, 2005, NEUROLOGY, V64, P834, DOI 10.1212/01.WNL.0000152982.47274.9E; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Bienias JL, 2003, J ALZHEIMERS DIS, V5, P349, DOI 10.3233/JAD-2003-5501; Carrasquillo MM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-54; Ciaramella A, 2010, J ALZHEIMERS DIS, V19, P559, DOI 10.3233/JAD-2010-1257; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fiala M, 2007, J ALZHEIMERS DIS, V11, P457; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gomperts SN, 2008, NEUROLOGY, V71, P903, DOI 10.1212/01.wnl.0000326146.60732.d6; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hollingworth P, 2011, INT J GERIATR PSYCH, V26, P793, DOI 10.1002/gps.2628; Johnson KA, 2007, ANN NEUROL, V62, P229, DOI 10.1002/ana.21164; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Karch CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050976; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Lajaunias F, 2005, EUR J IMMUNOL, V35, P243, DOI 10.1002/eji.200425273; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Lopresti BJ, 2005, J NUCL MED, V46, P1959; Mackenzie IRA, 2000, NEUROLOGY, V55, P132, DOI 10.1212/WNL.55.1.132; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Okello A, 2009, NEUROLOGY, V73, P754, DOI 10.1212/WNL.0b013e3181b23564; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price JC, 2005, J CEREBR BLOOD F MET, V25, P1528, DOI 10.1038/sj.jcbfm.9600146; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Schneider JA, 2004, NEUROLOGY, V62, P1148, DOI 10.1212/01.WNL.0000118211.78503.F5; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Sperling RA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002609; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Wechsler D., 1987, WECHSLER MEMORY SCAL; Winblad B, 2012, LANCET NEUROL, V11, P597, DOI 10.1016/S1474-4422(12)70140-0; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	41	371	383	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					848	U92		10.1038/nn.3435	http://dx.doi.org/10.1038/nn.3435			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23708142	Green Submitted, Green Accepted			2022-12-17	WOS:000321180900016
J	Frischknecht, R; Heine, M; Perrais, D; Seidenbecher, CI; Choquet, D; Gundelfinger, ED				Frischknecht, Renato; Heine, Martin; Perrais, David; Seidenbecher, Constanze I.; Choquet, Daniel; Gundelfinger, Eckart D.			Brain extracellular matrix affects AMPA receptor lateral mobility and short-term synaptic plasticity	NATURE NEUROSCIENCE			English	Article							ACTIVITY-DEPENDENT REGULATION; PERINEURONAL NETS; DENDRITIC SPINES; GLUTAMATE RECEPTORS; SURFACE TRAFFICKING; HIPPOCAMPAL-NEURONS; RAT-BRAIN; DIFFUSION; MEMBRANE; DYNAMICS	Many synapses in the mature CNS are wrapped by a dense extracellular matrix (ECM). Using single-particle tracking and fluorescence recovery after photobleaching, we found that this net-like ECM formed surface compartments on rat primary neurons that acted as lateral diffusion barriers for AMPA-type glutamate receptors. Enzymatic removal of the ECM increased extrasynaptic receptor diffusion and the exchange of synaptic AMPA receptors. Whole-cell patch-clamp recording revealed an increased pairedpulse ratio as a functional consequence of ECM removal. These results suggest that the surface compartments formed by the ECM hinder lateral diffusion of AMPA receptors and may therefore modulate short-term synaptic plasticity.	[Heine, Martin; Perrais, David; Choquet, Daniel] Univ Bordeaux, CNRS, UMR 5091, Bordeaux, France; [Frischknecht, Renato; Seidenbecher, Constanze I.; Gundelfinger, Eckart D.] Leibniz Inst Neurobiol, Magdeburg, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Leibniz Institut fur Neurobiologie (LIN)	Choquet, D (corresponding author), Univ Bordeaux, CNRS, UMR 5091, Bordeaux, France.	dchoquet@u-bordeaux2.fr; gundelfi@ifn-magdeburg.de	Choquet, Daniel/E-4203-2013; Choquet, Daniel/GOJ-8825-2022; Perrais, David/W-9360-2019; Choquet, Daniel/K-7893-2018	Choquet, Daniel/0000-0003-4726-9763; Perrais, David/0000-0002-5878-5408; Choquet, Daniel/0000-0003-4726-9763; Seidenbecher, Constanze/0000-0002-7433-2716	Centre National de la Recherche Scientifique; Conseil Regional d'Aquitaine; Ministere de la Recherche; Fondation pour la Recherche Medicale; European Commission [CT-2005-005320]; Deutsche Forschungsgemeinschaft [GU230/5-2/5-3]; A. v. Humboldt Foundation; Max Planck Society; Swiss National Fonds	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); A. v. Humboldt Foundation(Alexander von Humboldt Foundation); Max Planck Society(Max Planck SocietyFoundation CELLEX); Swiss National Fonds(Swiss National Science Foundation (SNSF))	We thank C. Poujol and P. Legros for help with video microscopy, C. Breillat, B. Tessier and D. Bouchet for expert technical assistence, J. Falk for NrCAM and GPI-GFP constructs, M. Carta and P. Opazo for support with the slice cultures, O. Kobler for help with three-dimensional image processing, and A. Triller and A. Fejtova ' for very helpful discussions. This work was supported by grants from the Centre National de la Recherche Scientifique, the Conseil Regional d'Aquitaine, the Ministere de la Recherche, the Fondation pour la Recherche Medicale, the European Commission (CT-2005-005320), the Deutsche Forschungsgemeinschaft (GU230/5-2/5-3), a Max Planck award from the A. v. Humboldt Foundation and the Max Planck Society. During part of the work, R. F. was supported by a fellowship from the Swiss National Fonds.	Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Ashby MC, 2004, TRENDS NEUROSCI, V27, P257, DOI 10.1016/j.tins.2004.03.010; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Berardi N, 2004, NEURON, V44, P905, DOI 10.1016/S0896-6273(04)00796-2; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Bruckner G, 2004, J MOL HISTOL, V35, P115; BRUCKNER G, 1993, GLIA, V8, P183, DOI 10.1002/glia.440080306; Carulli D, 2006, J COMP NEUROL, V494, P559, DOI 10.1002/cne.20822; Celio MR, 1998, TRENDS NEUROSCI, V21, P510, DOI 10.1016/S0166-2236(98)01298-3; CELIO MR, 1994, BRAIN RES REV, V19, P128, DOI 10.1016/0165-0173(94)90006-X; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Cottrell JR, 2000, J NEUROPHYSIOL, V84, P1573, DOI 10.1152/jn.2000.84.3.1573; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Falk J, 2004, MOL BIOL CELL, V15, P4695, DOI 10.1091/mbc.E04-03-0171; Frischknecht R, 2008, J NEUROSCI, V28, P1568, DOI 10.1523/JNEUROSCI.3398-07.2008; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Groc L, 2007, J NEUROSCI, V27, P12433, DOI 10.1523/JNEUROSCI.3349-07.2007; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Harms KJ, 2005, J NEUROSCI, V25, P6379, DOI 10.1523/JNEUROSCI.0302-05.2005; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; John N, 2006, MOL CELL NEUROSCI, V31, P774, DOI 10.1016/j.mcn.2006.01.011; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Koppe G, 1997, CELL TISSUE RES, V288, P33, DOI 10.1007/s004410050790; Kusumi A, 2005, SEMIN IMMUNOL, V17, P3, DOI 10.1016/j.smim.2004.09.004; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Lochner JE, 2006, J NEUROBIOL, V66, P564, DOI 10.1002/neu.20250; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Mammen AL, 1997, J NEUROSCI, V17, P7351; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Nakamura H, 2000, J BIOL CHEM, V275, P38885, DOI 10.1074/jbc.M003875200; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Racine V, 2007, J MICROSC-OXFORD, V225, P214, DOI 10.1111/j.1365-2818.2007.01723.x; Rauch U, 2004, CELL MOL LIFE SCI, V61, P2031, DOI 10.1007/s00018-004-4043-x; Savtchenko LP, 2000, SYNAPSE, V35, P26, DOI 10.1002/(SICI)1098-2396(200001)35:1<26::AID-SYN4>3.3.CO;2-X; Sylantyev S, 2008, SCIENCE, V319, P1845, DOI 10.1126/science.1154330; Thomas P, 2005, NAT NEUROSCI, V8, P889, DOI 10.1038/nn1483; Thoumine O, 2005, BIOPHYS J, V89, pL40, DOI 10.1529/biophysj.105.071688; Triller A, 2003, BIOL CELL, V95, P465, DOI 10.1016/j.biolcel.2003.07.001; Volkmer H, 1998, J CELL BIOL, V142, P1083, DOI 10.1083/jcb.142.4.1083; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690	49	370	376	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2009	12	7					897	U115		10.1038/nn.2338	http://dx.doi.org/10.1038/nn.2338			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	462OA	19483686				2022-12-17	WOS:000267362900017
J	Yoo, SS; Hu, PT; Gujar, N; Jolesz, FA; Walker, MP				Yoo, Seung-Schik; Hu, Peter T.; Gujar, Ninad; Jolesz, Ferenc A.; Walker, Matthew P.			A deficit in the ability to form new human memories without sleep	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; DECLARATIVE MEMORY; EPISODIC MEMORY; WORKING-MEMORY; BRAIN ACTIVITY; DEPRIVATION; HIPPOCAMPUS; CONSOLIDATION; ORGANIZATION; RECOGNITION	Evidence indicates that sleep after learning is critical for the subsequent consolidation of human memory. Whether sleep before learning is equally essential for the initial formation of new memories, however, remains an open question. We report that a single night of sleep deprivation produces a significant deficit in hippocampal activity during episodic memory encoding, resulting in worse subsequent retention. Furthermore, these hippocampal impairments instantiate a different pattern of functional connectivity in basic alertness networks of the brainstem and thalamus. We also find that unique prefrontal regions predict the success of encoding for sleep-deprived individuals relative to those who have slept normally. These results demonstrate that an absence of prior sleep substantially compromises the neural and behavioral capacity for committing new experiences to memory. It therefore appears that sleep before learning is critical in preparing the human brain for next-day memory formation-a worrying finding considering society's increasing erosion of sleep time.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Sleep & Neuroimaging Lab,Dept Psychiat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Radiol, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Walker, MP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Sleep & Neuroimaging Lab,Dept Psychiat, FD Feldberg 862, Boston, MA 02115 USA.	mwalker@hms.harvard.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH069935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048242] Funding Source: NIH RePORTER; NCRR NIH HHS [RR19703] Funding Source: Medline; NIMH NIH HHS [MH69935] Funding Source: Medline; NINDS NIH HHS [NS48242] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Basheer R, 2004, PROG NEUROBIOL, V73, P379, DOI 10.1016/j.pneurobio.2004.06.004; Blumenfeld RS, 2006, J NEUROSCI, V26, P916, DOI 10.1523/JNEUROSCI.2353-05.2006; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buchel C, 1998, NEUROIMAGE, V8, P140, DOI 10.1006/nimg.1998.0351; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; Davis CJ, 2003, BRAIN RES, V973, P293, DOI 10.1016/S0006-8993(03)02508-3; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Drummond SPA, 2004, SLEEP MED REV, V8, P227, DOI 10.1016/j.smrv.2003.10.005; Drummond SPA, 2000, NATURE, V403, P655, DOI 10.1038/35001068; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gruart-Masso Agnes, 1995, Behavioural Brain Research, V72, P181, DOI 10.1016/0166-4328(96)00082-4; Guan ZW, 2004, BRAIN RES, V1018, P38, DOI 10.1016/j.brainres.2004.05.032; Gutchess AH, 2005, J COGNITIVE NEUROSCI, V17, P84, DOI 10.1162/0898929052880048; Henson RNA, 1999, J NEUROSCI, V19, P3962; HICKS RA, 1973, PSYCHOL REP, V32, P1242, DOI 10.2466/pr0.1973.32.3c.1242; Jackson O, 2004, NEUROIMAGE, V21, P456, DOI 10.1016/j.neuroimage.2003.09.050; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Macmillan N, 1991, DETECTION THEORY USE; MARR D, 1970, PROC R SOC SER B-BIO, V176, P161, DOI 10.1098/rspb.1970.0040; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McDermott CM, 2003, J NEUROSCI, V23, P9687; MCGRATH MJ, 1978, PSYCHOL BULL, V85, P24, DOI 10.1037/0033-2909.85.1.24; MORUZZI G, 1995, J NEUROPSYCH CLIN N, V7, P251; Nissen C, 2006, SLEEP, V29, P1068, DOI 10.1093/sleep/29.8.1068; Otten LJ, 2001, CEREB CORTEX, V11, P1150, DOI 10.1093/cercor/11.12.1150; PALLER KA, 1987, ELECTROEN CLIN NEURO, V67, P360, DOI 10.1016/0013-4694(87)90124-6; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; PLUMER SI, 1974, PHYSIOL BEHAV, V12, P285, DOI 10.1016/0031-9384(74)90184-X; Rugg MD, 2003, NEUROPSYCHOLOGIA, V41, P40, DOI 10.1016/S0028-3932(02)00129-X; Rugg MD, 2002, PHILOS T R SOC B, V357, P1097, DOI 10.1098/rstb.2002.1102; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Sei H, 2000, BRAIN RES, V877, P387, DOI 10.1016/S0006-8993(00)02708-6; SMITH C, 1985, NEUROSCI BIOBEHAV R, V9, P157, DOI 10.1016/0149-7634(85)90042-9; STERN WC, 1971, PHYSIOL BEHAV, V7, P345, DOI 10.1016/0031-9384(71)90312-X; VANHULZEN ZJM, 1982, PHYSIOL BEHAV, V29, P581, DOI 10.1016/0031-9384(82)90223-2; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727	49	370	380	6	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					385	392		10.1038/nn1851	http://dx.doi.org/10.1038/nn1851			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	140CM	17293859				2022-12-17	WOS:000244480300022
J	Murai, KK; Nguyen, LN; Irie, F; Yamaguchi, Y; Pasquale, EB				Murai, KK; Nguyen, LN; Irie, F; Yamaguchi, Y; Pasquale, EB			Control of hippocampal dendritic spine morphology through ephrin-A3/EphA4 signaling	NATURE NEUROSCIENCE			English	Article							EPH RECEPTORS; GLIA; INTERMEDIATE; EXPRESSION; VARIANTS; SYNAPSES; MOTILITY; NEURONS; MICE	Communication between glial cells and neurons is emerging as a critical parameter of synaptic function. However, the molecular mechanisms underlying the ability of glial cells to modify synaptic structure and physiology are poorly understood. Here we describe a repulsive interaction that regulates postsynaptic morphology through the EphA4 receptor tyrosine kinase and its ligand ephrin-A3. EphA4 is enriched on dendritic spines of pyramidal neurons in the adult mouse hippocampus, and ephrin-A3 is localized on astrocytic processes that envelop spines. Activation of EphA4 by ephrin-A3 was found to induce spine retraction, whereas inhibiting ephrin/EphA4 interactions distorted spine shape and organization in hippocampal slices. Furthermore, spine irregularities in pyramidal neurons from EphA4 knockout mice and in slices transfected with kinase-inactive EphA4 indicated that ephrin/EphA4 signaling is critical for spine morphology. Thus, our data support a model in which transient interactions between the ephrin-A3 ligand and the EphA4 receptor regulate the structure of excitatory synaptic connections through neuroglial cross-talk.	Burnham Inst, Neurobiol Program, La Jolla, CA 92037 USA; Univ Calif San Diego, Mol Pathol Program, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Pasquale, EB (corresponding author), Burnham Inst, Neurobiol Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	elenap@burnham.org			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS043029] Funding Source: NIH RePORTER; NEI NIH HHS [EY10576] Funding Source: Medline; NICHD NIH HHS [HD25938] Funding Source: Medline; NINDS NIH HHS [NS43029] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Chelly J, 1999, HUM MOL GENET, V8, P1833, DOI 10.1093/hmg/8.10.1833; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Davenport RW, 1998, J NEUROSCI, V18, P975; Dodelet VC, 1999, J BIOL CHEM, V274, P31941, DOI 10.1074/jbc.274.45.31941; Dunaevsky A, 2001, NAT NEUROSCI, V4, P685, DOI 10.1038/89460; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gerlai R, 2000, BEHAV BRAIN RES, V108, P133, DOI 10.1016/S0166-4328(99)00139-4; Gerlai R, 2001, NAT REV NEUROSCI, V2, P205, DOI 10.1038/35058582; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Korkotian E, 2000, HIPPOCAMPUS, V10, P587, DOI 10.1002/1098-1063(2000)10:5<587::AID-HIPO9>3.0.CO;2-C; Lai KO, 1999, FEBS LETT, V458, P265, DOI 10.1016/S0014-5793(99)01159-X; Mann F, 2002, NEURON, V35, P461, DOI 10.1016/S0896-6273(02)00786-9; Martone ME, 1997, BRAIN RES, V771, P238, DOI 10.1016/S0006-8993(97)00792-0; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; Murai KK, 2002, CURR BIOL, V12, P181, DOI 10.1016/S0960-9822(02)00680-2; Murai KK, 2002, NEURON, V33, P159, DOI 10.1016/S0896-6273(02)00565-2; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pasini A, 2002, BIOESSAYS, V24, P427, DOI 10.1002/bies.10085; Pasquale EB, 1997, CURR OPIN CELL BIOL, V9, P608, DOI 10.1016/S0955-0674(97)80113-5; Salzer JL, 1997, NEURON, V18, P843, DOI 10.1016/S0896-6273(00)80323-2; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Stein C A, 1993, Antisense Res Dev, V3, P19; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Yue Y, 2002, P NATL ACAD SCI USA, V99, P10777, DOI 10.1073/pnas.162354599; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhang JH, 1996, J NEUROSCI, V16, P7182	41	370	404	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					153	160		10.1038/nn994	http://dx.doi.org/10.1038/nn994			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12496762				2022-12-17	WOS:000180669100015
J	Zurborg, S; Yurgionas, B; Jira, JA; Caspani, O; Heppenstall, PA				Zurborg, Sandra; Yurgionas, Brian; Jira, Julia A.; Caspani, Ombretta; Heppenstall, Paul A.			Direct activation of the ion channel TRPA1 by Ca2+	NATURE NEUROSCIENCE			English	Article							CATION CHANNEL; CA2+-BINDING PROTEINS; COLD; SENSITIVITY; ANKTM1; TRPM5	TRPA1 is an ion channel expressed by nociceptors and activated by irritant compounds such as mustard oil. The endogenous function of TRPA1 has remained unclear, a fact highlighted by ongoing debate over its potential role as a sensor of noxious cold. Here we show that intracellular Ca2+ activates human TRPA1 via an EF-hand domain and that cold sensitivity occurs indirectly ( and nonphysiologically) through increased [Ca2+](i) during cooling in heterologous systems.	Charite Univ Med Berlin, Klin Anaesthesiol & Operat Intens Med, D-12200 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Heppenstall, PA (corresponding author), Charite Univ Med Berlin, Klin Anaesthesiol & Operat Intens Med, Campus Benjamin Franklin,Hindenburgdamm 30, D-12200 Berlin, Germany.	paul.heppenstall@charite.de	Yurgionas, Brian/AAD-3551-2019	Caspani, Ombretta/0000-0002-9700-3149				Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Nelson MR, 1998, BIOMETALS, V11, P297, DOI 10.1023/A:1009253808876; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Reid G, 2005, PFLUG ARCH EUR J PHY, V451, P250, DOI 10.1007/s00424-005-1437-z; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	15	369	383	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					277	279		10.1038/nn1843	http://dx.doi.org/10.1038/nn1843			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17259981				2022-12-17	WOS:000244480300007
J	Baker-Herman, TL; Fuller, DD; Bavis, RW; Zabka, AG; Golder, FJ; Doperalski, NJ; Johnson, RA; Watters, JJ; Mitchell, GS				Baker-Herman, TL; Fuller, DD; Bavis, RW; Zabka, AG; Golder, FJ; Doperalski, NJ; Johnson, RA; Watters, JJ; Mitchell, GS			BDNF is necessary and sufficient for spinal respiratory plasticity following intermittent hypoxia	NATURE NEUROSCIENCE			English	Article							LONG-TERM FACILITATION; TRANSIENT FOREBRAIN ISCHEMIA; NEUROTROPHIC FACTOR; GENOMIC CONSEQUENCES; PHRENIC MOTONEURONS; RECEPTOR ACTIVATION; GENE-EXPRESSION; MESSENGER-RNA; MOTOR CONTROL; NEURONS	Intermittent hypoxia causes a form of serotonin-dependent synaptic plasticity in the spinal cord known as phrenic long-term facilitation (pLTF). Here we show that increased synthesis of brain-derived neurotrophic factor (BDNF) in the spinal cord is necessary and sufficient for pLTF in adult rats. We found that intermittent hypoxia elicited serotonin-dependent increases in BDNF synthesis in ventral spinal segments containing the phrenic nucleus, and the magnitude of these BDNF increases correlated with pLTF magnitude. We used RNA interference (RNAi) to interfere with BDNF expression, and tyrosine kinase receptor inhibition to block BDNF signaling. These disruptions blocked pLTF, whereas intrathecal injection of BDNF elicited an effect similar to pLTF. Our findings demonstrate new roles and regulatory mechanisms for BDNF in the spinal cord and suggest new therapeutic strategies for treating breathing disorders such as respiratory insufficiency after spinal injury. These experiments also illustrate the potential use of RNAi to investigate functional consequences of gene expression in the mammalian nervous system in vivo.	Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA; Univ Wisconsin, Ctr Neurosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mitchell, GS (corresponding author), Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr W, Madison, WI 53706 USA.	mitchell@svm.vetmed.wisc.edu			NHLBI NIH HHS [HL 07654, HL 65383] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065383] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2003, NAT CELL BIOL, V5, P489, DOI 10.1038/ncb0603-490; Bach KB, 1998, J APPL PHYSIOL, V84, P2099, DOI 10.1152/jappl.1998.84.6.2099; Baker TL, 2001, RESP PHYSIOL, V129, P25, DOI 10.1016/S0034-5687(01)00280-8; Baker-Herman TL, 2002, J NEUROSCI, V22, P6239; Balkowiec A, 2000, J NEUROSCI, V20, P7417, DOI 10.1523/jneurosci.20-19-07417.2000; Basura GJ, 2001, EXP NEUROL, V169, P255, DOI 10.1006/exnr.2001.7682; Bavis RW, 2003, J APPL PHYSIOL, V94, P399, DOI 10.1152/japplphysiol.00374.2002; Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064; Black IB, 1999, J NEUROBIOL, V41, P108, DOI 10.1002/(SICI)1097-4695(199910)41:1<108::AID-NEU14>3.0.CO;2-U; Blitz DM, 2002, J NEUROPHYSIOL, V87, P2964, DOI 10.1152/jn.2002.87.6.2964; Bodineau L, 2001, NEUROSCIENCE, V108, P643, DOI 10.1016/S0306-4522(01)00442-0; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FELDMAN JL, 1908, ANNU REV NEUROSCI, V26, P239; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fuller DD, 2003, J NEUROSCI, V23, P2993; Fuller DD, 2001, J APPL PHYSIOL, V90, P2001, DOI 10.1152/jappl.2001.90.5.2001; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; JACKSON AB, 1994, ARCH PHYS MED REHAB, V75, P270, DOI 10.1016/0003-9993(94)90027-2; Johnson RA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-10-j0005.2000; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; Kinkead R, 1998, J NEUROSCI, V18, P8436; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; Kokaia Z, 1996, MOL BRAIN RES, V38, P139, DOI 10.1016/0169-328X(96)00002-2; Levine ES, 1998, P NATL ACAD SCI USA, V95, P10235, DOI 10.1073/pnas.95.17.10235; Li YX, 1998, J NEUROSCI, V18, P10231; Ling LM, 2001, J NEUROSCI, V21, P5381, DOI 10.1523/JNEUROSCI.21-14-05381.2001; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MANSEL JK, 1990, CHEST, V97, P1446, DOI 10.1378/chest.97.6.1446; Mitchell GS, 2003, J APPL PHYSIOL, V94, P358, DOI 10.1152/japplphysiol.00523.2002; Mitchell GS, 2001, J APPL PHYSIOL, V90, P2466, DOI 10.1152/jappl.2001.90.6.2466; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Prabhakar NR, 2001, J APPL PHYSIOL, V90, P1986, DOI 10.1152/jappl.2001.90.5.1986; Richerson GB, 2001, RESP PHYSIOL, V129, P175, DOI 10.1016/S0034-5687(01)00289-4; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; Schinder AF, 2000, NEURON, V25, P151, DOI 10.1016/S0896-6273(00)80879-X; Solomon IC, 2000, RESP PHYSIOL, V121, P101, DOI 10.1016/S0034-5687(00)00122-5; Strollo PJ, 1996, NEW ENGL J MED, V334, P99, DOI 10.1056/NEJM199601113340207; Tanaka T, 1997, J NEUROSCI, V17, P2959; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Thoenen H, 2000, PROG BRAIN RES, V128, P183; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Uchino H, 1997, J CEREBR BLOOD F MET, V17, P1303, DOI 10.1097/00004647-199712000-00005; Veasey SC, 1996, AM J RESP CRIT CARE, V153, P776, DOI 10.1164/ajrccm.153.2.8564132; VEASEY SC, 1995, J NEUROSCI, V15, P5346; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Zabka AG, 2001, J PHYSIOL-LONDON, V531, P509, DOI 10.1111/j.1469-7793.2001.0509i.x	50	369	386	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					48	55		10.1038/nn1166	http://dx.doi.org/10.1038/nn1166			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14699417				2022-12-17	WOS:000187636000012
J	Huang, JK; Jarjour, AA; Nait Oumesmar, B; Kerninon, C; Williams, A; Krezel, W; Kagechika, H; Bauer, J; Zhao, C; Baron-Van Evercooren, A; Chambon, P; Ffrench-Constant, C; Franklin, RJM				Huang, Jeffrey K.; Jarjour, Andrew A.; Nait Oumesmar, Brahim; Kerninon, Christophe; Williams, Anna; Krezel, Wojciech; Kagechika, Hiroyuki; Bauer, Julien; Zhao, Chao; Baron-Van Evercooren, Anne; Chambon, Pierre; Ffrench-Constant, Charles; Franklin, Robin J. M.			Retinoid X receptor gamma signaling accelerates CNS remyelination	NATURE NEUROSCIENCE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; THYROID-HORMONE; SPINAL-CORD; EXPRESSION; CELLS; OLIGODENDROCYTES; DIFFERENTIATION; DEMYELINATION; DISEASE	The molecular basis of CNS myelin regeneration (remyelination) is poorly understood. We generated a comprehensive transcriptional profile of the separate stages of spontaneous remyelination that follow focal demyelination in the rat CNS and found that transcripts that encode the retinoid acid receptor RXR-gamma were differentially expressed during remyelination. Cells of the oligodendrocyte lineage expressed RXR-gamma in rat tissues that were undergoing remyelination and in active and remyelinated multiple sclerosis lesions. Knockdown of RXR-gamma by RNA interference or RXR-specific antagonists severely inhibited oligodendrocyte differentiation in culture. In mice that lacked RXR-gamma, adult oligodendrocyte precursor cells efficiently repopulated lesions after demyelination, but showed delayed differentiation into mature oligodendrocytes. Administration of the RXR agonist 9-cis-retinoic acid to demyelinated cerebellar slice cultures and to aged rats after demyelination caused an increase in remyelinated axons. Our results indicate that RXR-gamma is a positive regulator of endogenous oligodendrocyte precursor cell differentiation and remyelination and might be a pharmacological target for regenerative therapy in the CNS.	[Jarjour, Andrew A.; Williams, Anna; Ffrench-Constant, Charles] Univ Edinburgh, Ctr Translat Res, Ctr Inflammat Res, Queens Med Res Inst,MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Jarjour, Andrew A.; Williams, Anna; Ffrench-Constant, Charles] Univ Edinburgh, Ctr Translat Res, Ctr Inflammat Res, Queens Med Res Inst,Multiple Sclerosis Soc, Edinburgh, Midlothian, Scotland; [Huang, Jeffrey K.; Zhao, Chao; Franklin, Robin J. M.] Univ Cambridge, MRC Ctr Stem Cell Biol & Regenerat Med, Cambridge, England; [Huang, Jeffrey K.; Zhao, Chao; Franklin, Robin J. M.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Nait Oumesmar, Brahim; Kerninon, Christophe; Baron-Van Evercooren, Anne] Ctr Rech, Inst Cerveau & Moelle Epiniere, INSERM, U975, Paris 13, France; [Nait Oumesmar, Brahim; Kerninon, Christophe; Baron-Van Evercooren, Anne] Univ Paris 06, UMR S975, Paris 13, France; [Nait Oumesmar, Brahim; Kerninon, Christophe; Baron-Van Evercooren, Anne] CNRS, UMR 7225, Paris 13, France; [Nait Oumesmar, Brahim; Kerninon, Christophe; Baron-Van Evercooren, Anne] Grp Hosp Pitie Salpetriere, AP HP, F-75634 Paris 13, France; [Krezel, Wojciech; Chambon, Pierre] Inst Genet Biol Mol & Cellulaire, Dept Cell Biol & Dev, Illkirch Graffenstaden, France; [Kagechika, Hiroyuki] Tokyo Med & Dent Univ, Grad Sch Biomed Sci, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo, Japan; [Bauer, Julien] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of Edinburgh; University of Edinburgh; University of Cambridge; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Tokyo Medical & Dental University (TMDU); University of Cambridge	Ffrench-Constant, C (corresponding author), Univ Edinburgh, Ctr Translat Res, Ctr Inflammat Res, Queens Med Res Inst,MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland.	cffc@ed.ac.uk; rjf1000@cam.ac.uk	KREZEL, Wojciech/S-8331-2019; OUMESMAR, Brahim NAIT/AAX-4135-2020; Messier, Claude/A-2322-2008; Krezel, Wojciech/I-7886-2016; Evercooren, Anne S Baron-Van/G-3632-2013; Huang, Jeffrey/J-5248-2017; Krezel, Wojciech/H-9080-2017; Oumesmar, Brahim Nait/E-5365-2017; Huang, Jeffrey K./AAH-2418-2021	OUMESMAR, Brahim NAIT/0000-0002-1646-6281; Messier, Claude/0000-0002-4791-1763; Krezel, Wojciech/0000-0003-1605-3185; Huang, Jeffrey/0000-0003-0996-9451; Krezel, Wojciech/0000-0003-1605-3185; Oumesmar, Brahim Nait/0000-0002-1646-6281; Huang, Jeffrey K./0000-0003-0996-9451; Baron-Van Evercooren, Anne/0000-0002-4150-2205; Jarjour, Andrew/0000-0002-1550-1778; Williams, Anna/0000-0002-6329-382X; Franklin, Robin/0000-0001-6522-2104; Kagechika, Hiroyuki/0000-0002-6747-1013	United Kingdom Multiple Sclerosis Society; Wellcome Trust; French Multiple Sclerosis foundation ARSEP; Biotechnology and Biological Sciences Research Council of the United Kingdom; National Multiple Sclerosis Society; AP-HP Hopital Pitie-Salpetriere, Service d'Anatomopathologie Neurologique et des Maladies du Systeme Nerveux; Multiple Sclerosis Society of Canada; Medical Research Council [G0700711B] Funding Source: researchfish	United Kingdom Multiple Sclerosis Society; Wellcome Trust(Wellcome TrustEuropean Commission); French Multiple Sclerosis foundation ARSEP; Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); AP-HP Hopital Pitie-Salpetriere, Service d'Anatomopathologie Neurologique et des Maladies du Systeme Nerveux; Multiple Sclerosis Society of Canada; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank D. Seilhean (Service d'Anatomopathologie Neurologique, G-H Pitie-Salpetriere, Paris) for classification of multiple sclerosis lesions, the French Brain Bank GIE NeuroCEB (Hopital Pitie-Salpetriere, Paris, France) and the United Kingdom Multiple Sclerosis Society Brain Bank (R. Reynolds, Imperial College, London) for multiple sclerosis tissue. All tissues were collected with the approval of the French and London Multicentre Research Ethics committees. Animal procedures were performed under a UK Home Office Project License. This work was supported by grants from the United Kingdom Multiple Sclerosis Society (R.J.M.F., C.ff.-C.), the Wellcome Trust (C.ff.-C.), the French Multiple Sclerosis foundation ARSEP (B.N.O.), the Biotechnology and Biological Sciences Research Council of the United Kingdom (C.ff.-C., J.B.), National Multiple Sclerosis Society (C.ff.-C., R.J.M.F., A.B.-V.E., B.N.O.), AP-HP Hopital Pitie-Salpetriere, Service d'Anatomopathologie Neurologique (B.N.O.) et des Maladies du Systeme Nerveux (A.B.-V.E.). A.W. holds a Wellcome Trust Intermediate Fellowship. A.A.J. holds a Fellowship from Multiple Sclerosis Society of Canada.	Almad A, 2010, J COMP NEUROL, V518, P785, DOI 10.1002/cne.22242; Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Birgbauer E, 2004, J NEUROSCI RES, V78, P157, DOI 10.1002/jnr.20248; Brown NS, 2000, J CLIN INVEST, V106, P73, DOI 10.1172/JCI9422; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Diab A, 2004, J NEUROIMMUNOL, V148, P116, DOI 10.1016/j.jneuroim.2003.11.010; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Georgiades P, 1997, DEV DYNAM, V210, P227; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Goldschmidt T, 2009, NEUROLOGY, V72, P1914, DOI 10.1212/WNL.0b013e3181a8260a; Granneman J, 1998, J NEUROSCI RES, V51, P563, DOI 10.1002/(SICI)1097-4547(19980301)51:5<563::AID-JNR3>3.0.CO;2-D; Haugen BR, 2004, ENDOCRINOLOGY, V145, P3679, DOI 10.1210/en.2003-1401; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Kagechika H, 2005, J MED CHEM, V48, P5875, DOI 10.1021/jm0581821; Klemann C, 2009, AM J PATHOL, V174, P2234, DOI 10.2353/ajpath.2009.081084; Krezel W, 1996, P NATL ACAD SCI USA, V93, P9010, DOI 10.1073/pnas.93.17.9010; Krzyzosiak A, 2010, NEURON, V66, P908, DOI 10.1016/j.neuron.2010.05.004; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Laursen LS, 2009, J NEUROSCI, V29, P9174, DOI 10.1523/JNEUROSCI.5942-08.2009; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Miller RH, 2007, NAT NEUROSCI, V10, P1351, DOI 10.1038/nn1995; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Nishimaki-Mogami T, 2008, BIOCHEM PHARMACOL, V76, P1006, DOI 10.1016/j.bcp.2008.08.005; Patani R, 2007, NEUROPATH APPL NEURO, V33, P277, DOI 10.1111/j.1365-2990.2007.00805.x; Pombo PMG, 1999, MOL BRAIN RES, V64, P92, DOI 10.1016/S0169-328X(98)00311-8; PRINEAS JW, 1979, ANN NEUROL, V5, P22, DOI 10.1002/ana.410050105; RAINE CS, 1993, J NEUROPATH EXP NEUR, V52, P199, DOI 10.1097/00005072-199305000-00003; Schrage K, 2006, EUR J NEUROSCI, V23, P285, DOI 10.1111/j.1460-9568.2005.04534.x; Sim FJ, 2002, J NEUROSCI, V22, P2451, DOI 10.1523/JNEUROSCI.22-07-02451.2002; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Takahashi B, 2002, J MED CHEM, V45, P3327, DOI 10.1021/jm0255320; Trousson A, 2009, J NEUROCHEM, V109, P945, DOI 10.1111/j.1471-4159.2009.06009.x; Wolswijk G, 1998, J NEUROSCI, V18, P601; Woodruff RH, 1999, GLIA, V25, P216, DOI 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L	40	367	394	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					45	U68		10.1038/nn.2702	http://dx.doi.org/10.1038/nn.2702			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21131950	Green Submitted, Green Accepted			2022-12-17	WOS:000285684900013
J	Fischer, M; Kaech, S; Wagner, U; Brinkhaus, H; Matus, A				Fischer, M; Kaech, S; Wagner, U; Brinkhaus, H; Matus, A			Glutamate receptors regulate actin-based plasticity in dendritic spines	NATURE NEUROSCIENCE			English	Article							EXCITATORY POSTSYNAPTIC POTENTIALS; EXPERIENCE-DEPENDENT PLASTICITY; CENTRAL-NERVOUS-SYSTEM; AMPA RECEPTORS; HIPPOCAMPAL-NEURONS; PYRAMIDAL NEURONS; CA2+ PERMEABILITY; CALCIUM CHANNELS; SINGLE SPINES; SYNAPSES	Dendritic spines at excitatory synapses undergo rapid, actin-dependent shape changes which may contribute to plasticity in brain circuits. Here we show that actin dynamics in spines are potently inhibited by activation of either AMPA or NMDA subtype glutamate receptors. Activation of either receptor type inhibited actin-based protrusive activity from the spine head. This blockade of motility caused spines to round up so that spine morphology became both more stable and more regular. Inhibition of spine motility by AMPA receptors was dependent on postsynaptic membrane depolarization and influx of Ca2+ through voltage-activated channels. In combination with previous studies, our results suggest a two-step process in which spines initially formed in response to NMDA receptor activation are subsequently stabilized by AMPA receptors.	Friedrich Miescher Inst, CH-4002 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Matus, A (corresponding author), Friedrich Miescher Inst, POB 2543, CH-4002 Basel, Switzerland.			Kaech Petrie, Stefanie/0000-0002-6246-6434				Allison DW, 1998, J NEUROSCI, V18, P2423; Avery RB, 1996, J NEUROSCI, V16, P5567; Banker G, 1991, CULTURING NERVE CELL, P251; BARTLETT WP, 1984, J NEUROSCI, V4, P1954; Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; CARLIN RK, 1983, P NATL ACAD SCI-BIOL, V80, P3517, DOI 10.1073/pnas.80.11.3517; CHOI DW, 1994, PROG BRAIN RES, V100, P47; Dailey ME, 1996, J NEUROSCI, V16, P2983; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feldman DE, 1998, NEURON, V20, P1067, DOI 10.1016/S0896-6273(00)80488-2; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Frotscher M, 1975, J Hirnforsch, V16, P443; Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; GAHWILER BH, 1984, NEUROSCIENCE, V11, P751, DOI 10.1016/0306-4522(84)90192-1; GAHWILER BH, 1991, CULTURING NERVE CELL, P379; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; GRAY EG, 1959, NATURE, V183, P1592, DOI 10.1038/1831592a0; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; Halpain S, 1998, J NEUROSCI, V18, P9835; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Kaech S, 1997, J NEUROSCI, V17, P9565; KATER SB, 1991, J NEUROSCI, V11, P891; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MARINPADILLA M, 1967, J COMP NEUROL, V131, P475, DOI 10.1002/cne.901310407; MARKRAM H, 1994, P NATL ACAD SCI USA, V91, P5207, DOI 10.1073/pnas.91.11.5207; Matus A, 1999, CURR OPIN NEUROBIOL, V9, P561, DOI 10.1016/S0959-4388(99)00018-5; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McDonough SI, 1998, MOL PHARMACOL, V54, P1080, DOI 10.1124/mol.54.6.1080; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Muller D, 1997, REV NEUROSCIENCE, V8, P77; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SPACEK J, 1983, ANAT EMBRYOL, V167, P289, DOI 10.1007/BF00298517; Svoboda K, 1999, NEURON, V22, P427, DOI 10.1016/S0896-6273(00)80698-4; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	47	367	378	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					887	894		10.1038/78791	http://dx.doi.org/10.1038/78791			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966619				2022-12-17	WOS:000167177400015
J	Prabhakaran, V; Narayanan, K; Zhao, Z; Gabrieli, JDE				Prabhakaran, V; Narayanan, K; Zhao, Z; Gabrieli, JDE			Integration of diverse information in working memory within the frontal lobe	NATURE NEUROSCIENCE			English	Article							PRIMATE PREFRONTAL CORTEX; POSITRON EMISSION TOMOGRAPHY; BRAIN ACTIVATION; FUNCTIONAL-ORGANIZATION; NEURAL SYSTEMS; PET; OBJECT; TASKS; REPRESENTATION; DISSOCIATION	Ability to integrate diverse forms of information in current thought, or working memory, is essential for human reasoning and problem solving. We used functional imaging to identify brain regions preferentially involved in maintaining integrated versus unintegrated information in working memory. For equal amounts of verbal and spatial information, activation of prefrontal cortex was greater for maintaining integrated rather than unintegrated representations. Posterior brain regions showed the opposite pattern. These results demonstrate frontal-lobe specialization in maintaining working-memory representations that integrate verbal and spatial information. The role of prefrontal cortex in integrating multiple forms of information in working memory may underlie its unique contribution to high-level cognition that demands flexible mental representations.	Stanford Univ, Program Neurosci, Stanford, CA 94305 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University; Stanford University	Prabhakaran, V (corresponding author), Stanford Univ, Program Neurosci, Jordan Hall,Bldg 420, Stanford, CA 94305 USA.	vivekpr@leland.stanford.edu	Gabrieli, John/AAJ-2869-2020	prabhakaran, vivek/0000-0002-1974-3125				Baddeley Alan, 1986, WORKING MEMORY; Baker SC, 1996, CEREB CORTEX, V6, P612, DOI 10.1093/cercor/6.4.612; Baker SC, 1996, NEUROPSYCHOLOGIA, V34, P515, DOI 10.1016/0028-3932(95)00133-6; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Cohen J D, 1994, Hum Brain Mapp, V1, P293, DOI 10.1002/hbm.460010407; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; DUNCAN J, 1995, NEUROPSYCHOLOGIA, V33, P261, DOI 10.1016/0028-3932(94)00124-8; Fiez JA, 1996, J NEUROSCI, V16, P808; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Fuster J., 2015, PREFRONTAL CORTEX; FUSTER JM, 1982, EXP NEUROL, V77, P679, DOI 10.1016/0014-4886(82)90238-2; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Goel V, 1997, NEUROREPORT, V8, P1305, DOI 10.1097/00001756-199703240-00049; Jonides J, 1997, J COGNITIVE NEUROSCI, V9, P462, DOI 10.1162/jocn.1997.9.4.462; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Logie R.H., 1991, MENTAL IMAGES HUMAN, P72; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; MCCARTHY G, 1994, P NATL ACAD SCI USA, V91, P8690, DOI 10.1073/pnas.91.18.8690; McCarthy G, 1996, CEREB CORTEX, V6, P600, DOI 10.1093/cercor/6.4.600; Owen AM, 1996, CEREB CORTEX, V6, P31, DOI 10.1093/cercor/6.1.31; Owen AM, 1998, P NATL ACAD SCI USA, V95, P7721, DOI 10.1073/pnas.95.13.7721; Owen AM, 1997, EUR J NEUROSCI, V9, P1329, DOI 10.1111/j.1460-9568.1997.tb01487.x; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P873, DOI 10.1073/pnas.90.3.873; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Prabhakaran V, 1997, COGNITIVE PSYCHOL, V33, P43, DOI 10.1006/cogp.1997.0659; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rainer G, 1998, P NATL ACAD SCI USA, V95, P15008, DOI 10.1073/pnas.95.25.15008; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Smith EE, 1998, P NATL ACAD SCI USA, V95, P876, DOI 10.1073/pnas.95.3.876; SMITH EE, 1995, J COGNITIVE NEUROSCI, V7, P337, DOI 10.1162/jocn.1995.7.3.337; Smith EE, 1996, CEREB CORTEX, V6, P11, DOI 10.1093/cercor/6.1.11; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Talairach J., 1988, COPLANAR STEREOTAXIC; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P549; Waltz JA, 1999, PSYCHOL SCI, V10, P119, DOI 10.1111/1467-9280.00118; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0	48	367	387	4	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2000	3	1					85	90		10.1038/71156	http://dx.doi.org/10.1038/71156			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	292TB	10607400				2022-12-17	WOS:000085810200017
J	Wu, JW; Hussaini, SA; Bastille, IM; Rodriguez, GA; Mrejeru, A; Rilett, K; Sanders, DW; Cook, C; Fu, HJ; Boonen, RACM; Herman, M; Nahmani, E; Emrani, S; Figueroa, YH; Diamond, MI; Clelland, CL; Wray, S; Duff, KE				Wu, Jessica W.; Hussaini, S. Abid; Bastille, Isle M.; Rodriguez, Gustavo A.; Mrejeru, Ana; Rilett, Kelly; Sanders, David W.; Cook, Casey; Fu, Hongjun; Boonen, Rick A. C. M.; Herman, Mathieu; Nahmani, Eden; Emrani, Sheina; Figueroa, Y. Helen; Diamond, Marc I.; Clelland, Catherine L.; Wray, Selina; Duff, Karen E.			Neuronal activity enhances tau propagation and tau pathology in vivo	NATURE NEUROSCIENCE			English	Article							PLURIPOTENT STEM-CELLS; ALZHEIMERS-DISEASE; MOUSE MODEL; CEREBROSPINAL-FLUID; TRANSGENIC MICE; AMYLOID-BETA; BRAIN; PROTEIN; TAUOPATHY; HYPEREXCITABILITY	Tau protein can transfer between neurons transneuronally and trans-synaptically, which is thought to explain the progressive spread of tauopathy observed in the brain of patients with Alzheimer's disease. Here we show that physiological tau released from donor cells can transfer to recipient cells via the medium, suggesting that at least one mechanism by which tau can transfer is via the extracellular space. Neuronal activity has been shown to regulate tau secretion, but its effect on tau pathology is unknown. Using optogenetic and chemogenetic approaches, we found that increased neuronal activity stimulates the release of tau in vitro and enhances tau pathology in vivo. These data have implications for disease pathogenesis and therapeutic strategies for Alzheimer's disease and other tauopathies.	[Wu, Jessica W.; Hussaini, S. Abid; Bastille, Isle M.; Rodriguez, Gustavo A.; Rilett, Kelly; Fu, Hongjun; Boonen, Rick A. C. M.; Herman, Mathieu; Nahmani, Eden; Emrani, Sheina; Figueroa, Y. Helen; Clelland, Catherine L.; Duff, Karen E.] Columbia Univ, Med Ctr, Taub Inst, New York, NY 10027 USA; [Hussaini, S. Abid; Duff, Karen E.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Mrejeru, Ana] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA; [Sanders, David W.; Diamond, Marc I.] Univ Texas Southwestern Med Ctr, Ctr Alzheimers & Neurodegenerat Dis, Dallas, TX USA; [Cook, Casey] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Wray, Selina] UCL, Dept Mol Neurosci, Inst Neurol, London, England; [Duff, Karen E.] New York State Psychiat Inst & Hosp, Dept Integrat Neurosci, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Mayo Clinic; University of London; University College London; New York State Psychiatry Institute	Duff, KE (corresponding author), Columbia Univ, Med Ctr, Taub Inst, New York, NY 10027 USA.; Duff, KE (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA.; Duff, KE (corresponding author), New York State Psychiat Inst & Hosp, Dept Integrat Neurosci, New York, NY 10032 USA.	ked2115@columbia.edu	Wray, Selina/C-3682-2009; Fu, Hongjun/ABB-3558-2021; Clelland, Catherine/AAZ-8551-2021; FU, HONGJUN/H-4498-2011; Hussaini, Abid/AAZ-2418-2020	Wray, Selina/0000-0003-3062-7050; FU, HONGJUN/0000-0001-5346-7075; Hussaini, S. Abid/0000-0002-3921-9021; Duff, Karen/0000-0002-6177-868X; Sanders, David/0000-0002-1835-6895; , Sheina/0000-0002-1235-5285; Rodriguez, Gustavo/0000-0003-1307-0297	BrightFocus Foundation; NIH/NINDS [NS081555, NS074874]; Cure Alzheimer's Fund; Parkinson's Disease Foundation; NIH/NIA [AG050425, AA19801]; NIHR Queen Square Dementia Biomedical Research Unit; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081555, R01NS074874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG050425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019801] Funding Source: NIH RePORTER	BrightFocus Foundation(BrightFocus Foundation); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Cure Alzheimer's Fund; Parkinson's Disease Foundation; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIHR Queen Square Dementia Biomedical Research Unit; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank C. Acker for help with Sandwich ELISA and P. Davies (Litwin Zucker Center for Alzheimer's Research, Feinstein Institute, New York, USA) for providing tau antibodies. We thank K. Jansen-West, E. Perkerson and L. Petrucelli (Mayo Clinic Jacksonville) for providing additional tau viruses and D. Sulzer for discussions regarding cell electrophysiology. We also thank L. Liu for assistance with mouse tissue collection, C. Profaci for assistance with optogenetic experiments and L. Shi for administrative assistance. This work was supported by a BrightFocus Foundation fellowship to J.W., NIH/NINDS grants NS081555 and NS074874 to K.E.D., Cure Alzheimer's Fund to K.E.D., the Parkinson's Disease Foundation to D.S and NIH/NIA grant AG050425 to S.A.H. and K.E.D. A.M. is supported by funds from NIH/NIA AA19801. S.W. is supported by the NIHR Queen Square Dementia Biomedical Research Unit.	Acker CM, 2013, NEUROBIOL AGING, V34, P338, DOI 10.1016/j.neurobiolaging.2012.05.010; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Barten DM, 2011, J ALZHEIMERS DIS, V24, P127, DOI 10.3233/JAD-2011-110161; Bomben V, 2014, NEUROBIOL AGING, V35, P2091, DOI 10.1016/j.neurobiolaging.2014.03.029; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Busche MA, 2015, NAT NEUROSCI, V18, P1623, DOI 10.1038/nn.4137; Busche MA, 2012, P NATL ACAD SCI USA, V109, P8740, DOI 10.1073/pnas.1206171109; Caillierez R, 2013, MOL THER, V21, P1358, DOI 10.1038/mt.2013.66; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Dujardin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100760; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hall AM, 2015, J NEUROSCI, V35, P6221, DOI 10.1523/JNEUROSCI.2552-14.2015; Harris JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045881; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kurz A, 1998, ALZ DIS ASSOC DIS, V12, P372, DOI 10.1097/00002093-199812000-00020; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Michel CH, 2014, J BIOL CHEM, V289, P956, DOI 10.1074/jbc.M113.515445; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mirbaha H, 2015, J BIOL CHEM, V290, P14893, DOI 10.1074/jbc.M115.652693; Osinde M, 2008, NEUROPATH APPL NEURO, V34, P523, DOI 10.1111/j.1365-2990.2008.00936.x; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Santa-Maria I, 2012, J BIOL CHEM, V287, P20522, DOI 10.1074/jbc.M111.323279; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Simon D, 2012, NEURODEGENER DIS, V10, P73, DOI 10.1159/000334915; Siskova Z, 2014, NEURON, V84, P1023, DOI 10.1016/j.neuron.2014.10.024; Sposito T, 2015, HUM MOL GENET, V24, P5260, DOI 10.1093/hmg/ddv246; Styren SC, 2000, J HISTOCHEM CYTOCHEM, V48, P1223, DOI 10.1177/002215540004800906; Takeda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9490; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Thom M, 2011, BRAIN, V134, P2969, DOI 10.1093/brain/awr209; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Yamada K, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0052-5; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011; YOON KW, 1993, J PHYSIOL-LONDON, V464, P423, DOI 10.1113/jphysiol.1993.sp019643; Zhu H, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu007	50	366	375	5	119	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2016	19	8					1085	+		10.1038/nn.4328	http://dx.doi.org/10.1038/nn.4328			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DS4TB	27322420	Green Submitted, Green Accepted			2022-12-17	WOS:000380773200017
J	Sherman, SM				Sherman, S. Murray			Thalamus plays a central role in ongoing cortical functioning	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; METABOTROPIC GLUTAMATE RECEPTORS; CAT VISUAL-CORTEX; RANGE CORTICOFUGAL AXONS; POSTERIOR MEDIAL NUCLEUS; CORTICOTHALAMIC PROJECTIONS; SYNAPTIC PROPERTIES; LAYER 6; SUPERIOR COLLICULUS; DISTINGUISHING DRIVERS	Several challenges to current views of thalamocortical processing are offered here. Glutamatergic pathways in thalamus and cortex are divided into two distinct classes: driver and modulator. We suggest that driver inputs are the main conduits of information and that modulator inputs modify how driver inputs are processed. Different driver sources reveal two types of thalamic relays: first order relays receive subcortical driver input (for example, retinal input to the lateral geniculate nucleus), whereas higher order relays (for example, pulvinar) receive driver input from layer 5 of cortex and participate in cortico-thalamo-cortical (or transthalamic) circuits. These transthalamic circuits represent an unappreciated aspect of cortical functioning, which I discuss here. Direct corticocortical connections are often paralleled by transthalamic ones. Furthermore, driver inputs to thalamus, both first and higher order, typically arrive via branching axons, and the transthalamic branch often innervates subcortical motor centers, leading to the suggestion that these inputs to thalamus serve as efference copies.	[Sherman, S. Murray] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	University of Chicago	Sherman, SM (corresponding author), Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA.	msherman@bsd.uchicago.edu			US National Institutes of Health [DC008794, EY022338]; NATIONAL EYE INSTITUTE [R01EY022338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008794] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants DC008794 and EY022338 from the US National Institutes of Health. I thank J. DeFelipe for providing the images used in Figure 4b, d and H. Kita for the image used in Figure 4c. I also thank R.A. Eatock, D. Freedman and P. Mason for comments on earlier drafts and R.W. Guillery for ongoing conversations with the author and contributions regarding all of the issues raised herein.	AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; Alitto HJ, 2003, CURR OPIN NEUROBIOL, V13, P440, DOI 10.1016/S0959-4388(03)00096-5; Andersen RA, 2009, NEURON, V63, P568, DOI 10.1016/j.neuron.2009.08.028; BENDER DB, 1983, BRAIN RES, V279, P258, DOI 10.1016/0006-8993(83)90188-9; Berman RA, 2010, J NEUROSCI, V30, P6342, DOI 10.1523/JNEUROSCI.6176-09.2010; Bickford ME, 2015, J NEUROSCI, V35, P10523, DOI 10.1523/JNEUROSCI.3375-14.2015; BOURASSA J, 1995, EUR J NEUROSCI, V7, P19, DOI 10.1111/j.1460-9568.1995.tb01016.x; BOURASSA J, 1995, NEUROSCIENCE, V66, P253, DOI 10.1016/0306-4522(95)00009-8; Briggs F, 2009, NEURON, V62, P135, DOI 10.1016/j.neuron.2009.02.024; BULL MS, 1984, SOMATOSENS RES, V1, P281, DOI 10.3109/07367228409144551; Casanova C, 2001, PROG BRAIN RES, V134, P71; CASANOVA C, 1993, EXP BRAIN RES, V96, P247; CHALUPA LM, 1972, EXP NEUROL, V36, P449, DOI 10.1016/0014-4886(72)90005-2; CHALUPA LM, 1980, NEUROSCI LETT, V19, P13, DOI 10.1016/0304-3940(80)90248-7; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chauveau F, 2005, BEHAV BRAIN RES, V156, P215, DOI 10.1016/j.bbr.2004.05.026; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; Covic EN, 2011, CEREB CORTEX, V21, P2425, DOI 10.1093/cercor/bhr029; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; Crabtree JW, 1998, NAT NEUROSCI, V1, P389, DOI 10.1038/1603; Crandall SR, 2015, NEURON, V86, P768, DOI 10.1016/j.neuron.2015.03.040; De Pasquale R, 2013, J NEUROPHYSIOL, V109, P2618, DOI 10.1152/jn.01083.2012; De Pasquale R, 2012, J NEUROSCI, V32, P7364, DOI 10.1523/JNEUROSCI.0090-12.2012; De Pasquale R, 2011, J NEUROSCI, V31, P16494, DOI 10.1523/JNEUROSCI.3664-11.2011; Denman DJ, 2015, J NEUROSCI, V35, P9265, DOI 10.1523/JNEUROSCI.0027-15.2015; DESCHENES M, 1994, BRAIN RES, V664, P215, DOI 10.1016/0006-8993(94)91974-7; DIAMOND ME, 1992, J COMP NEUROL, V318, P462, DOI 10.1002/cne.903180410; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Feinberg I, 1999, BRIT J PSYCHIAT, V174, P196, DOI 10.1192/bjp.174.3.196; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Ford JM, 2014, SCHIZOPHRENIA BULL, V40, P804, DOI 10.1093/schbul/sbt072; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Groh A, 2014, CEREB CORTEX, V24, P3167, DOI 10.1093/cercor/bht173; GUILLERY RW, 1957, J ANAT, V91, P91; Hall NJ, 2011, PHILOS T R SOC B, V366, P528, DOI 10.1098/rstb.2010.0248; HUBEL DH, 1979, SCI AM, V241, P150, DOI 10.1038/scientificamerican0979-150; ISU N, 1989, NEUROSCI LETT, V104, P25, DOI 10.1016/0304-3940(89)90323-6; Kelly LR, 2003, J COMP NEUROL, V464, P472, DOI 10.1002/cne.10800; Kita T, 2012, J NEUROSCI, V32, P5990, DOI 10.1523/JNEUROSCI.5717-11.2012; Kuramoto E, 2011, EUR J NEUROSCI, V33, P95, DOI 10.1111/j.1460-9568.2010.07481.x; Lam YW, 2013, NEUROSCIENCE, V242, P78, DOI 10.1016/j.neuroscience.2013.03.043; Lam YW, 2010, CEREB CORTEX, V20, P13, DOI 10.1093/cercor/bhp077; Lee CC, 2008, J NEUROPHYSIOL, V100, P317, DOI 10.1152/jn.90391.2008; Lee CC, 2012, NEUROREPORT, V23, P736, DOI 10.1097/WNR.0b013e328356c1aa; Lee CC, 2012, HEARING RES, V287, P43, DOI 10.1016/j.heares.2012.04.001; Lee CC, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00046; Lee CC, 2010, P NATL ACAD SCI USA, V107, P372, DOI 10.1073/pnas.0907873107; Lee CC, 2009, CEREB CORTEX, V19, P2281, DOI 10.1093/cercor/bhn246; LINDEN R, 1983, BRAIN RES, V272, P145, DOI 10.1016/0006-8993(83)90371-2; Liu TT, 2014, J NEUROPHYSIOL, V111, P2287, DOI 10.1152/jn.00730.2013; MATSUO S, 1994, EXP BRAIN RES, V100, P7; McFarland NR, 2002, J NEUROSCI, V22, P8117; MEANS LW, 1974, PHYSIOL BEHAV, V12, P973, DOI 10.1016/0031-9384(74)90144-9; Mitchell AS, 2015, NEUROSCI BIOBEHAV R, V54, P76, DOI 10.1016/j.neubiorev.2015.03.001; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; Petrof I, 2012, J COMP NEUROL, V520, P1678, DOI 10.1002/cne.23006; Petrof I, 2009, J NEUROSCI, V29, P7815, DOI 10.1523/JNEUROSCI.1564-09.2009; Pynn LK, 2013, VISION RES, V76, P124, DOI 10.1016/j.visres.2012.10.019; Raastad M, 2003, J PHYSIOL-LONDON, V548, P745, DOI 10.1113/jphysiol.2002.032706; RAFAL RD, 1987, P NATL ACAD SCI USA, V84, P7349, DOI 10.1073/pnas.84.20.7349; Ramon y Cajal S, 1909, HISTOLOGIE SYSTEME N; Reichova I, 2004, J NEUROPHYSIOL, V92, P2185, DOI 10.1152/jn.00322.2004; Rockland KS, 1998, J COMP NEUROL, V390, P515, DOI 10.1002/(SICI)1096-9861(19980126)390:4<515::AID-CNE5>3.0.CO;2-3; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Sakai ST, 1996, J COMP NEUROL, V368, P215, DOI 10.1002/(SICI)1096-9861(19960429)368:2<215::AID-CNE4>3.0.CO;2-6; Seidemann E, 1998, NATURE, V394, P72, DOI 10.1038/27906; Sherman S., 2013, THALAMOCORTICAL PROC; Sherman SM, 2014, NEUROSCIENTIST, V20, P136, DOI 10.1177/1073858413478490; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; SHERMAN SM, 1985, PROG PSYCHOB PHYSIOL, V11, P233; SHINODA Y, 1988, BEHAV BRAIN RES, V28, P59, DOI 10.1016/0166-4328(88)90076-9; Sirota MG, 2005, J NEUROSCI, V25, P5915, DOI 10.1523/JNEUROSCI.0489-05.2005; Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Stroh A, 2013, NEURON, V77, P1136, DOI 10.1016/j.neuron.2013.01.031; TAMAMAKI N, 1995, J COMP NEUROL, V354, P583, DOI 10.1002/cne.903540408; Theyel BB, 2010, NAT NEUROSCI, V13, P84, DOI 10.1038/nn.2449; Thomson AM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00013; TSUMOTO T, 1980, J COMP NEUROL, V193, P223, DOI 10.1002/cne.901930115; Usrey WM, 1999, J NEUROPHYSIOL, V82, P3527, DOI 10.1152/jn.1999.82.6.3527; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; Van Horn SC, 2000, J COMP NEUROL, V416, P509; VANEY DI, 1981, EXP BRAIN RES, V44, P27; Veinante P, 2000, J COMP NEUROL, V420, P233, DOI 10.1002/(SICI)1096-9861(20000501)420:2<233::AID-CNE6>3.0.CO;2-T; Veinante P, 2000, J COMP NEUROL, V424, P197, DOI 10.1002/1096-9861(20000821)424:2<197::AID-CNE1>3.0.CO;2-6; Viaene AN, 2011, P NATL ACAD SCI USA, V108, P18156, DOI 10.1073/pnas.1114828108; Viaene AN, 2011, J NEUROSCI, V31, P12738, DOI 10.1523/JNEUROSCI.1565-11.2011; Von Graefe A., 1854, ARCH OPHTHALMOL-CHIC, V1, P1, DOI [DOI 10.1007/BF02720619, 10.1007/BF02720619]; von Holst E., 1950, SELECTED PAPERS E VO; Wolpert DM, 2010, CURR BIOL, V20, pR467, DOI 10.1016/j.cub.2010.04.035; Xu XM, 2005, J NEUROPHYSIOL, V94, P2748, DOI 10.1152/jn.00354.2005	92	366	372	3	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2016	19	4					533	541		10.1038/nn.4269	http://dx.doi.org/10.1038/nn.4269			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DH6OI	27021938				2022-12-17	WOS:000372909800007
J	Abramov, E; Dolev, I; Fogel, H; Ciccotosto, GD; Ruff, E; Slutsky, I				Abramov, Efrat; Dolev, Iftach; Fogel, Hilla; Ciccotosto, Giuseppe D.; Ruff, Eyal; Slutsky, Inna			Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; ELECTROPHYSIOLOGICAL CHANGES; MICE LACKING; MOUSE MODEL; A-BETA; PROTEIN; DEFICITS; PEPTIDE; MEMORY	Accumulation of cerebral amyloid-beta peptide (A Beta) is essential for developing synaptic and cognitive deficits in Alzheimer's disease. However, the physiological functions of A beta, as well as the primary mechanisms that initiate early A beta-mediated synaptic dysfunctions, remain largely unknown. Here we examine the acute effects of endogenously released A beta peptides on synaptic transfer at single presynaptic terminals and synaptic connections in rodent hippocampal cultures and slices. Increasing extracellular A beta by inhibiting its degradation enhanced release probability, boosting ongoing activity in the hippocampal network. Presynaptic enhancement mediated by A beta was found to depend on the history of synaptic activation, with lower impact at higher firing rates. Notably, both elevation and reduction in A beta levels attenuated short-term synaptic facilitation during bursts in excitatory synaptic connections. These observations suggest that endogenous A beta peptides have a crucial role in activity-dependent regulation of synaptic vesicle release and might point to the primary pathological events that lead to compensatory synapse loss in Alzheimer's disease.	[Abramov, Efrat; Dolev, Iftach; Fogel, Hilla; Ruff, Eyal; Slutsky, Inna] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Ciccotosto, Giuseppe D.] Univ Melbourne, Dept Pathol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Ciccotosto, Giuseppe D.] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3052, Australia	Tel Aviv University; Sackler Faculty of Medicine; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Slutsky, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	islutsky@post.tau.ac.il		Slutsky, Inna/0000-0002-0700-2266	Rosalinde and Arthur Gilbert Foundation/American Federation for Aging Research research grant; Legacy Heritage Biomedical Program of the Israel Science Foundation; Israel Ministry of Health; National Institute of Psychobiology in Israel founded by the Charles E. Smith family; Center for Nanoscience and Nanotechnology of Tel Aviv University	Rosalinde and Arthur Gilbert Foundation/American Federation for Aging Research research grant; Legacy Heritage Biomedical Program of the Israel Science Foundation; Israel Ministry of Health; National Institute of Psychobiology in Israel founded by the Charles E. Smith family; Center for Nanoscience and Nanotechnology of Tel Aviv University	We thank A. Lee and M. Wilson for sharing unpublished data on 'natural' spike sequence, D. M. Holtzman for providing the HJ5.1 hybridoma cell line, A. I. Bush, R. Cappai and H. Zheng for App<SUP>-/-</SUP> mice, C. Kaether for the human APP695-YFP cDNA construct, and the members of our laboratory for comments on the manuscript. We thank A. I. Bush and E. Gazit for discussions. This work was supported by a Rosalinde and Arthur Gilbert Foundation/American Federation for Aging Research research grant (I. S.), the Legacy Heritage Biomedical Program of the Israel Science Foundation (I. S.), the Israel Ministry of Health (I. S.), the National Institute of Psychobiology in Israel founded by the Charles E. Smith family (I. S.), and the Center for Nanoscience and Nanotechnology of Tel Aviv University (I. D.).	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; De Strooper B, 2000, J CELL SCI, V113, P1857; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; DEVAULT A, 1987, EMBO J, V6, P1317, DOI 10.1002/j.1460-2075.1987.tb02370.x; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Iwata N, 2005, PHARMACOL THERAPEUT, V108, P129, DOI 10.1016/j.pharmthera.2005.03.010; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Lisman JE, 2007, NAT REV NEUROSCI, V8, P597, DOI 10.1038/nrn2191; Lou XL, 2005, NATURE, V435, P497, DOI 10.1038/nature03568; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; SCHEFF SW, 1990, NEUROBIOL AGING, V11, P29, DOI 10.1016/0197-4580(90)90059-9; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P349, DOI 10.1016/S0028-3908(98)00204-4; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Slutsky I, 2004, NEURON, V44, P835, DOI 10.1016/j.neuron.2004.11.013; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Ye CP, 2004, NEUROSCI LETT, V366, P320, DOI 10.1016/j.neulet.2004.05.060; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	50	366	379	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1567	U120		10.1038/nn.2433	http://dx.doi.org/10.1038/nn.2433			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19935655				2022-12-17	WOS:000272065600017
J	Holroyd, CB; Nieuwenhuis, S; Yeung, N; Nystrom, L; Mars, RB; Coles, MGH; Cohen, JD				Holroyd, CB; Nieuwenhuis, S; Yeung, N; Nystrom, L; Mars, RB; Coles, MGH; Cohen, JD			Dorsal anterior cingulate cortex shows fMRI response to internal and external error signals	NATURE NEUROSCIENCE			English	Article							REWARD; COGNITION; INTERFACE; DOPAMINE	In our event-related functional magnetic resonance imaging (fMRI) experiment, participants learned to select between two response options by trial-and-error, using feedback stimuli that indicated monetary gains and losses. The results of the experiment indicate that error responses and error feedback activate the same region of dorsal anterior cingulate cortex, suggesting that this region is sensitive to both internal and external sources of error information.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Free Univ Amsterdam, Dept Cognit Psychol, NL-1081 BT Amsterdam, Netherlands; Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA; FC Donders Ctr Cognit Neuroimaging, NL-6525 EK Nijmegen, Netherlands; Univ Nijmegen, Nijmegen Inst Cognit & & Informat, NL-6500 HE Nijmegen, Netherlands	Princeton University; Vrije Universiteit Amsterdam; Princeton University; Radboud University Nijmegen	Holroyd, CB (corresponding author), Princeton Univ, Dept Psychol, Green Hall, Princeton, NJ 08544 USA.	cholroyd@princeton.edu	Mars, Rogier/GWZ-9665-2022; Mars, Rogier/G-2312-2018	Mars, Rogier/0000-0001-6302-8631; Holroyd, Clay/0000-0003-3084-8574; Yeung, Nick/0000-0003-1905-2129	NIMH NIH HHS [MH63550, MH064445] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH063550, P50MH064445] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allman JM, 2001, ANN NY ACAD SCI, V935, P107, DOI 10.1111/j.1749-6632.2001.tb03476.x; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; HOLROYD CB, COGNITIVE NEUROSCIEN; Nieuwenhuis S, 2002, COGN AFFECT BEHAV NE, V2, P19, DOI 10.3758/CABN.2.1.19; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003	14	366	386	0	32	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					497	498		10.1038/nn1238	http://dx.doi.org/10.1038/nn1238			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15097995	Green Published			2022-12-17	WOS:000221101300025
J	Punzo, C; Kornacker, K; Cepko, CL				Punzo, Claudio; Kornacker, Karl; Cepko, Constance L.			Stimulation of the insulin/mTOR pathway delays cone death in a mouse model of retinitis pigmentosa	NATURE NEUROSCIENCE			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; ROD CGMP-PHOSPHODIESTERASE; HYPOXIA-INDUCIBLE FACTOR-1; RETINAL DEGENERATION; CELL-DEATH; DIFFUSIBLE FACTOR; OXIDATIVE STRESS; MICE LACKING; RD MOUSE; PHOTORECEPTOR	Retinitis pigmentosa is an incurable retinal disease that leads to blindness. One puzzling aspect concerns the progression of the disease. Although most mutations that cause retinitis pigmentosa are in rod photoreceptor - specific genes, cone photoreceptors also die as a result of such mutations. To understand the mechanism of non-autonomous cone death, we analyzed four mouse models harboring mutations in rod- specific genes. We found changes in the insulin/mammalian target of rapamycin pathway that coincided with the activation of autophagy during the period of cone death. We increased or decreased the insulin level and measured the survival of cones in one of the models. Mice that were treated systemically with insulin had prolonged cone survival, whereas depletion of endogenous insulin had the opposite effect. These data suggest that the non- autonomous cone death in retinitis pigmentosa could, at least in part, be a result of the starvation of cones.	[Punzo, Claudio; Cepko, Constance L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Kornacker, Karl] Nationwide Childrens Hosp, Res Inst, Columbus, OH 43214 USA; [Kornacker, Karl] Ohio State Univ, Columbus, OH 43214 USA; [Cepko, Constance L.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Harvard University; Harvard Medical School	Cepko, CL (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	cepko@genetics.med.harvard.edu	Punzo, Claudio/AAJ-8291-2021	Punzo, Claudio/0000-0001-5207-0041	US National Institutes of Health [RO1 EY014466]; Macular Vision Research Foundation; Foundation for Retinal Research; Howard Hughes Medical Institute; EMBO; NATIONAL EYE INSTITUTE [R01EY014466] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macular Vision Research Foundation; Foundation for Retinal Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the US National Institutes of Health (RO1 EY014466), Macular Vision Research Foundation, Foundation for Retinal Research, Howard Hughes Medical Institute, Merck and by an EMBO fellowship to C. P.	ALUBAIDI MR, 1990, J BIOL CHEM, V265, P20563; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Corrochano S, 2008, INVEST OPHTH VIS SCI, V49, P4188, DOI 10.1167/iovs.08-2182; Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x; Cuervo AM, 2000, J CELL SCI, V113, P4441; Dekanty A, 2005, J CELL SCI, V118, P5431, DOI 10.1242/jcs.02648; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; GOURAS P, 1994, VISUAL NEUROSCI, V11, P1227, DOI 10.1017/S0952523800007021; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; HARDING EF, 1984, APPL STAT-J ROY ST C, V33, P1; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; John SK, 2000, MOL VIS, V6, P204; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Komeima K, 2007, J CELL PHYSIOL, V213, P809, DOI 10.1002/jcp.21152; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Kunchithapautham K, 2007, AUTOPHAGY, V3, P433, DOI 10.4161/auto.4294; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Massey A, 2004, INT J BIOCHEM CELL B, V36, P2420, DOI 10.1016/j.biocel.2004.04.010; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mohand-Said S, 2000, ARCH OPHTHALMOL-CHIC, V118, P807, DOI 10.1001/archopht.118.6.807; Mohand-Said S, 1998, P NATL ACAD SCI USA, V95, P8357, DOI 10.1073/pnas.95.14.8357; MohandSaid S, 1997, OPHTHALMIC RES, V29, P290, DOI 10.1159/000268027; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; POITRYYAMATE CL, 1995, J NEUROSCI, V15, P5179; Punzo C, 2008, DEV DYNAM, V237, P1034, DOI 10.1002/dvdy.21500; Punzo C, 2007, INVEST OPHTH VIS SCI, V48, P849, DOI 10.1167/iovs.05-1555; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Snodderly DM, 2002, INVEST OPHTH VIS SCI, V43, P2815; Stearns G, 2007, J NEUROSCI, V27, P13866, DOI 10.1523/JNEUROSCI.3136-07.2007; Steinberg Roy H., 1994, Current Opinion in Neurobiology, V4, P515, DOI 10.1016/0959-4388(94)90052-3; Streichert LC, 1999, J NEUROBIOL, V39, P475, DOI 10.1002/(SICI)1097-4695(19990615)39:4<475::AID-NEU2>3.0.CO;2-#; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Tsacopoulos M, 1998, PROG RETIN EYE RES, V17, P429, DOI 10.1016/S1350-9462(98)00010-X; Tsang SH, 1996, SCIENCE, V272, P1026, DOI 10.1126/science.272.5264.1026; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; WOODFORD BJ, 1994, EXP EYE RES, V58, P631, DOI 10.1006/exer.1994.1058; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; YOUNG RW, 1971, J CELL BIOL, V49, P303, DOI 10.1083/jcb.49.2.303; Yu DY, 2005, EXP EYE RES, V80, P745, DOI 10.1016/j.exer.2005.01.018; Zhong H, 2000, CANCER RES, V60, P1541	50	365	375	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2009	12	1					44	52		10.1038/nn.2234	http://dx.doi.org/10.1038/nn.2234			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	388HL	19060896	Green Accepted			2022-12-17	WOS:000262010800014
J	Gais, S; Plihal, W; Wagner, U; Born, J				Gais, S; Plihal, W; Wagner, U; Born, J			Early sleep triggers memory for early visual discrimination skills	NATURE NEUROSCIENCE			English	Article							LATE NOCTURNAL SLEEP; PARADOXICAL SLEEP; REM-SLEEP; CONSOLIDATION; IMPROVEMENT; MODULATION; HYPOTHESIS; CORTEX; STATES	Improvement after practicing visual texture discrimination does not occur until several hours after practice has ended. We show that this improvement strongly depends on sleep. To specify the process responsible for sleep-related improvement, we compared the effects of 'early' and 'late' sleep, dominated respectively by slow-wave and rapid eye movement (REM) sleep. Discrimination skills significantly improved over early sleep, improved even more over a whole night's sleep, but did not improve after late sleep alone. These findings suggest that procedural memory formation is prompted by slow-wave sleep-related processes. Late REM sleep may promote memory formation at a second stage, only after periods of early sleep have occurred.	Med Univ Lubeck, Clin Neuroendocrinol, D-23538 Lubeck, Germany	University of Lubeck	Born, J (corresponding author), Med Univ Lubeck, Clin Neuroendocrinol, Ratzeburger Allee 160-Hs 23A, D-23538 Lubeck, Germany.	born@kfg.mu-luebeck.de	Born, Jan/K-2596-2016	Born, Jan/0000-0002-1847-6248				Aubrey JB, 1999, SLEEP RES ONLINE, V2, P220; BORN J, 1988, PSYCHONEUROENDOCRINO, V13, P233, DOI 10.1016/0306-4530(88)90021-2; BORN J, IN PRESS BEHAV BRAIN; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Cahill L, 1996, CURR OPIN NEUROBIOL, V6, P237, DOI 10.1016/S0959-4388(96)80078-X; CIPOLLI C, 1995, J SLEEP RES, V4, P2, DOI 10.1111/j.1365-2869.1995.tb00143.x; Edagawa Y, 1998, PROG NEURO-PSYCHOPH, V22, P983, DOI 10.1016/S0278-5846(98)00055-4; EMPSON JAC, 1970, NATURE, V227, P287, DOI 10.1038/227287a0; GIUDITTA A, 1995, BEHAV BRAIN RES, V69, P157, DOI 10.1016/0166-4328(95)00012-I; Heine R, 1914, Z PSYCHOL PHYSIOL SI, V68, P161; HENNEVIN E, 1995, BEHAV BRAIN RES, V69, P125, DOI 10.1016/0166-4328(95)00013-J; HORNE JA, 1984, BIOL PSYCHOL, V18, P165, DOI 10.1016/0301-0511(84)90001-2; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Kirkwood A, 1999, J NEUROSCI, V19, P1599; MAQUET P, 1999, SLEEP RES ONLINE, V2, P694; Marshall L, 1998, EUR J NEUROSCI, V10, P1167, DOI 10.1046/j.1460-9568.1998.00131.x; MCCORMICK DA, 1992, J CLIN NEUROPHYSIOL, V9, P212, DOI 10.1097/00004691-199204010-00004; McEwen BS, 1999, CONT ENDOCRINOL, V21, P233; ONIANI TN, 1984, PHYSIOL BEHAV, V33, P687, DOI 10.1016/0031-9384(84)90032-5; PASCUALLEONE A, 1993, ANN NEUROL, V34, P594, DOI 10.1002/ana.410340414; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; Pilzecker, 1900, Z PSYCHOL, V1, P1; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Plihal W, 1999, NEUROREPORT, V10, P2741, DOI 10.1097/00001756-199909090-00009; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; Plihal W, 1999, PSYCHONEUROENDOCRINO, V24, P313, DOI 10.1016/S0306-4530(98)00080-8; Roozendaal B, 2000, PSYCHONEUROENDOCRINO, V25, P213, DOI 10.1016/S0306-4530(99)00058-X; Schoups AA, 1996, P NATL ACAD SCI USA, V93, P7358, DOI 10.1073/pnas.93.14.7358; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; Smith C, 1996, BEHAV BRAIN RES, V78, P49, DOI 10.1016/0166-4328(95)00218-9; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; VERTES P, IN PRESS BEHAV BRAIN; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; YAROUSH R, 1971, J EXP PSYCHOL, V88, P361, DOI 10.1037/h0030914	39	365	373	6	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1335	1339		10.1038/81881	http://dx.doi.org/10.1038/81881			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	405UA	11100156	Bronze			2022-12-17	WOS:000167177900021
J	Galli, R; Borello, U; Gritti, A; Minasi, AG; Bjornson, C; Coletta, M; Mora, M; De Angelis, MGC; Fiocco, R; Cossu, G; Vescovi, AL				Galli, R; Borello, U; Gritti, A; Minasi, AG; Bjornson, C; Coletta, M; Mora, M; De Angelis, MGC; Fiocco, R; Cossu, G; Vescovi, AL			Skeletal myogenic potential of human and mouse neural stem cells	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; TURNING BRAIN; BONE-MARROW; ASTROCYTES; MUSCLE; TRANSPLANTATION; POPULATION; EXPRESSION; FOREBRAIN; NEURONS	Distinct cell lineages established early in development are usually maintained throughout adulthood. Thus, adult stem cells have been thought to generate differentiated cells specific to the tissue in which they reside. This view has been challenged; for example, neural stem cells can generate cells that normally originate from a different germ layer. Here we show that acutely isolated and clonally derived neural stem cells from mice and humans could produce skeletal myotubes in vitro and in vivo, the latter following transplantation into adult animals. Myogenic conversion in vitro required direct exposure to myoblasts, and was blocked if neural cells were clustered. Thus, a community effect between neural cells may override such myogenic induction. We conclude that neural stem cells, which generate neurons, glia and blood cells, can also produce skeletal muscle cells, and can undergo various patterns of differentiation depending on exposure to appropriate epigenetic signals in mature tissues.	Natl Neurol Inst C Besta, I-20133 Milan, Italy; HS Raffaele, Stem Cell Res Inst, I-20133 Milan, Italy; Univ Rome La Sapienza, Dept Histol & Med Embryol, Fdn Pasteur Cenci Bolognetti, I-00161 Rome, Italy; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Pavia, Dept Expt Med, I-27100 Pavia, Italy	IRCCS Istituto Neurologico Besta; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Washington; University of Washington Seattle; University of Pavia	Vescovi, AL (corresponding author), Natl Neurol Inst C Besta, Via Celoria 11, I-20133 Milan, Italy.		Vescovi, Angelo Luigi/A-4919-2015; Gritti, Angela/K-2729-2016; Borello, Ugo/M-5213-2014; Mora, Marina/J-2883-2018	Vescovi, Angelo Luigi/0000-0002-1742-4112; Gritti, Angela/0000-0002-9845-0370; Borello, Ugo/0000-0001-9812-579X; Mora, Marina/0000-0002-5765-2320; Cusella De Angelis, Maria Gabriella/0000-0003-2642-3346	Telethon [E.1246] Funding Source: Medline	Telethon(Fondazione Telethon)		Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; BERESFORD WA, 1990, CELL DIFFER DEV, V29, P81, DOI 10.1016/0922-3371(90)90026-S; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Daubas P, 2000, DEVELOPMENT, V127, P319; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Eguchi G, 1993, CURR OPIN CELL BIOL, V5, P1023, DOI 10.1016/0955-0674(93)90087-7; FAUST C, 1993, CURR OPIN GENET DEV, V3, P491, DOI 10.1016/0959-437X(93)90125-9; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Gritti A, 1999, J NEUROSCI, V19, P3287; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; KELLY R, 1995, J CELL BIOL, V129, P383, DOI 10.1083/jcb.129.2.383; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Loeffler Markus, 1997, P1, DOI 10.1016/B978-012563455-7/50002-7; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Moore MAS, 1999, NEW ENGL J MED, V341, P605, DOI 10.1056/NEJM199908193410811; PATAPOUTIAN A, 1995, DEVELOPMENT, V121, P3347; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; TAJBAKHSH S, 1994, NEURON, V13, P813, DOI 10.1016/0896-6273(94)90248-8; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998	26	365	404	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					986	991		10.1038/79924	http://dx.doi.org/10.1038/79924			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017170				2022-12-17	WOS:000167177500015
J	Kang, SH; Li, Y; Fukaya, M; Lorenzini, I; Cleveland, DW; Ostrow, LW; Rothstein, JD; Bergles, DE				Kang, Shin H.; Li, Ying; Fukaya, Masahiro; Lorenzini, Ileana; Cleveland, Don W.; Ostrow, Lyle W.; Rothstein, Jeffrey D.; Bergles, Dwight E.			Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis	NATURE NEUROSCIENCE			English	Article							MOTOR-NEURONS; SPINAL-CORD; SUPEROXIDE-DISMUTASE; PROGENITOR CELLS; TRANSGENIC MICE; IFN-GAMMA; EXPRESSION; MODEL; ALS; ASTROCYTES	Oligodendrocytes associate with axons to establish myelin and provide metabolic support to neurons. In the spinal cord of amyotrophic lateral sclerosis (ALS) mice, oligodendrocytes downregulate transporters that transfer glycolytic substrates to neurons and oligodendrocyte progenitors (NG2(+) cells) exhibit enhanced proliferation and differentiation, although the cause of these changes in oligodendroglia is unknown. We found extensive degeneration of gray matter oligodendrocytes in the spinal cord of SOD1 (G93A) ALS mice prior to disease onset. Although new oligodendrocytes were formed, they failed to mature, resulting in progressive demyelination. Oligodendrocyte dysfunction was also prevalent in human ALS, as gray matter demyelination and reactive changes in NG2(+) cells were observed in motor cortex and spinal cord of ALS patients. Selective removal of mutant SOD1 from oligodendroglia substantially delayed disease onset and prolonged survival in ALS mice, suggesting that ALS-linked genes enhance the vulnerability of motor neurons and accelerate disease by directly impairing the function of oligodendrocytes.	[Kang, Shin H.; Lorenzini, Ileana; Rothstein, Jeffrey D.; Bergles, Dwight E.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Li, Ying; Ostrow, Lyle W.; Rothstein, Jeffrey D.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Fukaya, Masahiro] Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa 228, Japan; [Lorenzini, Ileana; Ostrow, Lyle W.; Rothstein, Jeffrey D.] Johns Hopkins Univ, Sch Med, Brain Sci Inst, Baltimore, MD USA; [Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst, San Diego, CA 92103 USA	Johns Hopkins University; Johns Hopkins University; Kitasato University; Johns Hopkins University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Rothstein, JD (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	jrothstein@jhmi.edu; dbergles@jhmi.edu	Bergles, Dwight/U-8343-2019; Cleveland, Don/AAN-9783-2021	Bergles, Dwight/0000-0002-7133-7378; Ostrow, Lyle/0000-0001-7158-5243; Cleveland, Don/0000-0002-1934-3682	P2ALS; US National Institutes of Health [NS27036, NS33958, NS051509]; ALS Association [4ZMUDE]; Robert Packard Center for ALS Research at Johns Hopkins; Brain Science Institute; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036, R01NS051509, R01NS033958, R01NS027036] Funding Source: NIH RePORTER	P2ALS; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Association; Robert Packard Center for ALS Research at Johns Hopkins; Brain Science Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Ye, I. Srivastava, S. Singh and T. Le for their excellent technical support, M. Pucak for help with Imaris software operation and quantitative analysis, J. Carmen for her contributions to the Cre/lox animal study, and H. Zhang at the Johns Hopkins University School of Public Health FACS core for assistance with NG2<SUP>+</SUP> cell isolation. We thank B. Trapp (Cleveland Clinic Lerner Research Institute) for advice regarding human NG2<SUP>+</SUP> cell staining, R. Dutta (Cleveland Clinic Lerner Research Institute) for advice regarding protein extraction from human tissues and B. Popko (University of Chicago) for providing Plp1-creER mice. Human samples were provided by R. Bowser (Barrow Neurological Institute), K. Trevor (SACTL-VA Biorepository Trust), T. Hyde (Lieber Institute for Brain Development and the Johns Hopkins School of Medicine), J. Glass (Emory Alzheimer's Disease Research Center, 5P50AG025688-07), and the Johns Hopkins School of Medicine Department of Neuropathology. We thank E. Mosmiller for helping with patient demographic information. We also thank A. Agarwal and A. Langseth for critical discussions. This work was supported by grants from P<SUP>2</SUP>ALS (D.E.B. and J.D.R.), the US National Institutes of Health (NS27036 to D.W.C., NS33958 to J.D.R. and NS051509 to D.E.B.), the ALS Association (4ZMUDE to Y.L.), the Robert Packard Center for ALS Research at Johns Hopkins, and the Brain Science Institute.	Aebischer J, 2012, EUR J NEUROL, V19, P752, DOI 10.1111/j.1468-1331.2011.03623.x; Bauer J, 2002, J NEUROPATH EXP NEUR, V61, P12, DOI 10.1093/jnen/61.1.12; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bu J, 2001, GLIA, V34, P296, DOI 10.1002/glia.1063; Buntinx M, 2004, J NEUROSCI RES, V76, P834, DOI 10.1002/jnr.20118; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cosottini M, 2011, AM J NEURORADIOL, V32, P704, DOI 10.3174/ajnr.A2356; Coutts M, 2010, J NEUROTRAUM, V27, P1333, DOI 10.1089/neu.2010.1285; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Doerflinger NH, 2003, GENESIS, V35, P63, DOI 10.1002/gene.10154; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Guo FZ, 2010, J NEUROSCI, V30, P12036, DOI 10.1523/JNEUROSCI.1360-10.2010; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Higuchi M, 2005, J NEUROSCI, V25, P9434, DOI 10.1523/JNEUROSCI.2691-05.2005; Horner PJ, 2002, J NEUROCYTOL, V31, P469, DOI 10.1023/A:1025739630398; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Jamin N, 2001, EXP NEUROL, V172, P17, DOI 10.1006/exnr.2001.7752; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Komori T, 1999, BRAIN PATHOL, V9, P663; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Locatelli G, 2012, NAT NEUROSCI, V15, P543, DOI 10.1038/nn.3062; Magnus T, 2008, GLIA, V56, P200, DOI 10.1002/glia.20604; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P177, DOI 10.1097/01.jnen.0000248554.45456.58; Niebroj-Dobosz I, 2007, FOLIA NEUROPATHOL, V45, P236; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Pohl HBF, 2011, J NEUROSCI, V31, P1069, DOI 10.1523/JNEUROSCI.5035-10.2011; Pouly S, 1999, GLIA, V27, P259, DOI 10.1002/(SICI)1098-1136(199909)27:3<259::AID-GLIA7>3.0.CO;2-8; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Rinholm JE, 2011, J NEUROSCI, V31, P538, DOI 10.1523/JNEUROSCI.3516-10.2011; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rudick RA, 2009, NEW ENGL J MED, V361, P1505, DOI 10.1056/NEJMcibr0905482; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Woodruff RH, 2001, INT J DEV NEUROSCI, V19, P379, DOI 10.1016/S0736-5748(00)00083-6; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Wu Yu-Huan, 2008, P3; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	54	364	380	7	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					571	+		10.1038/nn.3357	http://dx.doi.org/10.1038/nn.3357			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23542689	Green Accepted, Green Submitted			2022-12-17	WOS:000318029300013
J	Yamashita, T; Tohyama, M				Yamashita, T; Tohyama, M			The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI	NATURE NEUROSCIENCE			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; BINDING PROTEIN-RHO; DISSOCIATION INHIBITOR; NOGO RECEPTOR; DEATH DOMAIN; AXON GROWTH; NEUROTROPHIN; P75(NTR); MYELIN; IDENTIFICATION	The neurotrophin receptor p75(NTR) is involved in the regulation of axonal elongation by neurotrophins as well as several myelin components, including Nogo, myelin-associated glycoprotein (MAG) and myelin oligodendrocyte glycoprotein (OMgp). Neurotrophins stimulate neurite outgrowth by inhibiting Rho activity, whereas myelin-derived proteins activate RhoA and thereby inhibit growth. Here we show that direct interaction of the Rho GDP dissociation inhibitor (Rho-GDI) with p75(NTR) initiates the activation of RhoA, and this interaction between p75(NTR) and Rho-GDI is strengthened by MAG or Nogo. We also found that p75(NTR) facilitates the release of prenylated RhoA from Rho-GDI. The peptide ligand that is associated with the fifth alpha helix of p75(NTR) inhibits the interaction between Rho-GDI and p75(NTR), thus silencing the action mediated by p75(NTR). This peptide has potential as a therapeutic agent against the inhibitory cues that block regeneration in the central nervous system.	Osaka Univ, Dept Anat & Neurosci, Grad Sch Med, Osaka 5650871, Japan; CREST, Kawaguchi 3320012, Japan	Osaka University; Japan Science & Technology Agency (JST)	Yamashita, T (corresponding author), Osaka Univ, Dept Anat & Neurosci, Grad Sch Med, 2-2 Yamadaoka, Osaka 5650871, Japan.	tyama@anat2.med.osaka-u.ac.jp		Yamashita, Toshihide/0000-0003-4559-7018				Bentley CA, 2000, J NEUROSCI, V20, P7706; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Davies AM, 2000, CURR BIOL, V10, pR198, DOI 10.1016/S0960-9822(00)00351-1; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; FEINSTEIN DL, 1990, FEBS LETT, V272, P7, DOI 10.1016/0014-5793(90)80437-N; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; Ilag LL, 1999, BIOCHEM BIOPH RES CO, V255, P104, DOI 10.1006/bbrc.1999.0101; KOCH G, 1991, FEBS LETT, V291, P336, DOI 10.1016/0014-5793(91)81315-Y; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; MASUDA T, 1994, J BIOL CHEM, V269, P19713; McQuillen PS, 2002, J NEUROSCI, V22, P3580; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Sasaki T, 1998, BIOCHEM BIOPH RES CO, V245, P641, DOI 10.1006/bbrc.1998.8253; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Walsh GS, 1999, J NEUROSCI, V19, P4155; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; YAKU H, 1994, BIOCHEM BIOPH RES CO, V198, P811, DOI 10.1006/bbrc.1994.1116; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9	28	364	379	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					461	467		10.1038/nn1045	http://dx.doi.org/10.1038/nn1045			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12692556				2022-12-17	WOS:000182553200012
J	de Hemptinne, C; Swann, NC; Ostrem, JL; Ryapolova-Webb, ES; San Luciano, M; Galifianakis, NB; Starr, PA				de Hemptinne, Coralie; Swann, Nicole C.; Ostrem, Jill L.; Ryapolova-Webb, Elena S.; San Luciano, Marta; Galifianakis, Nicholas B.; Starr, Philip A.			Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease	NATURE NEUROSCIENCE			English	Article							ELECTROCORTICOGRAPHIC SPECTRAL-ANALYSIS; HUMAN SUBTHALAMIC NUCLEUS; HUMAN SENSORIMOTOR CORTEX; NEURONAL OSCILLATIONS; FREQUENCY STIMULATION; MOTOR-PERFORMANCE; BASAL GANGLIA; REACTION-TIME; BETA-ACTIVITY; GAMMA-POWER	Deep brain stimulation (DBS) is increasingly applied for the treatment of brain disorders, but its mechanism of action remains unknown. Here we evaluate the effect of basal ganglia DBS on cortical function using invasive cortical recordings in Parkinson's disease (PD) patients undergoing DBS implantation surgery. In the primary motor cortex of PD patients, neuronal population spiking is excessively synchronized to the phase of network oscillations. This manifests in brain surface recordings as exaggerated coupling between the phase of the beta rhythm and the amplitude of broadband activity. We show that acute therapeutic DBS reversibly reduces phase-amplitude interactions over a similar time course as that of the reduction in parkinsonian motor signs. We propose that DBS of the basal ganglia improves cortical function by alleviating excessive beta phase locking of motor cortex neurons.	[de Hemptinne, Coralie; Swann, Nicole C.; Ryapolova-Webb, Elena S.; Starr, Philip A.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Ostrem, Jill L.; San Luciano, Marta; Galifianakis, Nicholas B.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Starr, Philip A.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	de Hemptinne, C (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	coralie.dehemptinne@ucsf.edu		San Luciano, Marta/0000-0002-9885-704X	Michael J. Fox foundation; US National Institutes of Health [R01 NS069779]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069779] Funding Source: NIH RePORTER	Michael J. Fox foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Thanks to our patients who participated in this study, to R. Steiner for programming the iPad task, to A. Kreitzer for critical review of the manuscript, to S. Miocinovic for symptom assessment, and to N. Ziman and S. Qasim for helping to collect data. This study was supported by a grant from the Michael J. Fox foundation and by US National Institutes of Health grant R01 NS069779.	Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Bronte-Stewart H, 2009, EXP NEUROL, V215, P20, DOI 10.1016/j.expneurol.2008.09.008; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Cohen MX, 2009, J COGNITIVE NEUROSCI, V21, P390, DOI 10.1162/jocn.2008.21020; Crone NE, 1998, BRAIN, V121, P2271, DOI 10.1093/brain/121.12.2271; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Crowell AL, 2012, BRAIN, V135, P615, DOI 10.1093/brain/awr332; de Hemptinne C, 2013, P NATL ACAD SCI USA, V110, P4780, DOI 10.1073/pnas.1214546110; Dejean C, 2009, CEREB CORTEX, V19, P1055, DOI 10.1093/cercor/bhn149; Eusebio A, 2011, J NEUROL NEUROSUR PS, V82, P569, DOI 10.1136/jnnp.2010.217489; Eusebio A, 2008, EXP NEUROL, V209, P125, DOI 10.1016/j.expneurol.2007.09.007; Follett KA, 2010, NEW ENGL J MED, V362, P2077, DOI 10.1056/NEJMoa0907083; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Hashimoto T, 2003, J NEUROSCI, V23, P1916; Hirschmann J, 2011, NEUROIMAGE, V55, P1159, DOI 10.1016/j.neuroimage.2010.11.063; Jacobs J, 2007, J NEUROSCI, V27, P3839, DOI 10.1523/JNEUROSCI.4636-06.2007; Koop MM, 2006, MOVEMENT DISORD, V21, P673, DOI 10.1002/mds.20796; Kuhn AA, 2008, J NEUROSCI, V28, P6165, DOI 10.1523/JNEUROSCI.0282-08.2008; Kuhn AA, 2004, BRAIN, V127, P735, DOI 10.1093/brain/awh106; Kuriakose R, 2010, CEREB CORTEX, V20, P1926, DOI 10.1093/cercor/bhp269; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Li Q, 2012, NEURON, V76, P1030, DOI 10.1016/j.neuron.2012.09.032; Little S, 2013, ANN NEUROL, V74, P449, DOI 10.1002/ana.23951; Litvak V, 2011, BRAIN, V134, P359, DOI 10.1093/brain/awq332; Lopez-Azcarate J, 2010, J NEUROSCI, V30, P6667, DOI 10.1523/JNEUROSCI.5459-09.2010; Mann JM, 2009, J NEUROL NEUROSUR PS, V80, P794, DOI 10.1136/jnnp.2008.159558; Manning JR, 2009, J NEUROSCI, V29, P13613, DOI 10.1523/JNEUROSCI.2041-09.2009; Melgari JM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00302; Miller KJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002655; Moran A, 2008, BRAIN, V131, P3395, DOI 10.1093/brain/awn270; Ozkurt TE, 2011, EXP NEUROL, V229, P324, DOI 10.1016/j.expneurol.2011.02.015; Osipova D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003990; Penny WD, 2008, J NEUROSCI METH, V174, P50, DOI 10.1016/j.jneumeth.2008.06.035; Pogosyan A, 2010, NEUROSCIENCE, V171, P245, DOI 10.1016/j.neuroscience.2010.08.068; Purzner J, 2007, J NEUROSCI, V27, P6029, DOI 10.1523/JNEUROSCI.5441-06.2007; Ray NJ, 2008, EXP NEUROL, V213, P108, DOI 10.1016/j.expneurol.2008.05.008; Rosin B, 2011, NEURON, V72, P370, DOI 10.1016/j.neuron.2011.08.023; Rossi L, 2008, BRAIN RES BULL, V76, P512, DOI 10.1016/j.brainresbull.2008.01.023; Rossi LF, 2012, SIAM REV, V54, P155, DOI 10.1137/SIREAD000054000001000155000001; Shahlaie K, 2011, NEUROSURGERY, V68, P114, DOI 10.1227/NEU.0b013e31820781bc; Starr PA, 2002, J NEUROSURG, V97, P370, DOI 10.3171/jns.2002.97.2.0370; Stoffers D, 2007, BRAIN, V130, P1847, DOI 10.1093/brain/awm034; Suffczynski P, 2014, J NEUROPHYSIOL, V112, P3001, DOI 10.1152/jn.00844.2013; Temel Y, 2006, EXP BRAIN RES, V169, P389, DOI 10.1007/s00221-005-0151-6; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Vitek JL, 2012, EXP NEUROL, V233, P581, DOI 10.1016/j.expneurol.2011.09.031; Voytek B, 2013, ANN NEUROL, V73, P1, DOI 10.1002/ana.23790; Voytek B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00191; Whitmer D, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00155; Williams D, 2005, EUR J NEUROSCI, V21, P249, DOI 10.1111/j.1460-9568.2004.03817.x; Wingeier B, 2006, EXP NEUROL, V197, P244, DOI 10.1016/j.expneurol.2005.09.016; Yanagisawa T, 2012, J NEUROSCI, V32, P15467, DOI 10.1523/JNEUROSCI.2929-12.2012; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	56	363	369	11	139	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2015	18	5					779	+		10.1038/nn.3997	http://dx.doi.org/10.1038/nn.3997			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG9LN	25867121	Green Submitted, Green Accepted			2022-12-17	WOS:000353636900027
J	Binder, JR; Liebenthal, E; Possing, ET; Medler, DA; Ward, BD				Binder, JR; Liebenthal, E; Possing, ET; Medler, DA; Ward, BD			Neural correlates of sensory and decision processes in auditory object identification	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE; REACTION-TIME; HUMAN-BRAIN; PREFRONTAL CORTEX; RHESUS-MONKEY; SPEECH; TASK; FMRI; ACTIVATION; SOUNDS	Physiological studies of auditory perception have not yet clearly distinguished sensory from decision processes. In this experiment, human participants identified speech sounds masked by varying levels of noise while blood oxygenation signals in the brain were recorded with functional magnetic resonance imaging (fMRI). Accuracy and response time were used to characterize the behavior of sensory and decision components of this perceptual system. Oxygenation signals in a cortical subregion just anterior and lateral to primary auditory cortex predicted accuracy of sound identification, whereas signals in an inferior frontal region predicted response time. Our findings provide neurophysiological evidence for a functional distinction between sensory and decision mechanisms underlying auditory object identification. The present results also indicate a link between inferior frontal lobe activation and response-selection processes during auditory perception tasks.	Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Binder, JR (corresponding author), Med Coll Wisconsin, Dept Neurol, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.	jbinder@mcw.edu	Binder, Jeff/CAJ-3303-2022; Liebenthal, Einat/AAO-9781-2020	Liebenthal, Einat/0000-0003-4917-8160; Binder, Jeffrey/0000-0002-2233-5640	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH051358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006287] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00058] Funding Source: Medline; NIDCD NIH HHS [R01 DC006287] Funding Source: Medline; NIMH NIH HHS [P01 MH51358] Funding Source: Medline; NINDS NIH HHS [R01 NS33576] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adler CM, 2001, SYNAPSE, V42, P266, DOI 10.1002/syn.1112; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Binder JR, 2001, HDB FUNCTIONAL NEURO, P187; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Burton MW, 2000, J COGNITIVE NEUROSCI, V12, P679, DOI 10.1162/089892900562309; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Davis MH, 2003, J NEUROSCI, V23, P3423; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; Fant G., 1973, SPEECH SOUNDS FEATUR; FIEZ JA, 1995, J COGNITIVE NEUROSCI, V7, P357, DOI 10.1162/jocn.1995.7.3.357; GALABURDA AM, 1983, J COMP NEUROL, V221, P169, DOI 10.1002/cne.902210206; GALABURDA AM, 1978, ARCH NEUROL-CHICAGO, V35, P812, DOI 10.1001/archneur.1978.00500360036007; Grabowski TJ., 2000, BRAIN MAPPING SYSTEM, P425, DOI [10.1016/B978-012692545-6/50016-7, DOI 10.1016/B978-012692545-6/50016-7]; GREEN DM, 1966, SIGNAL DETECTION THE; GRICE GR, 1982, J EXP PSYCHOL GEN, V111, P135, DOI 10.1037/0096-3445.111.1.135; Hall DA, 2000, HUM BRAIN MAPP, V10, P107, DOI 10.1002/1097-0193(200007)10:3<107::AID-HBM20>3.0.CO;2-8; Honey GD, 2000, NEUROIMAGE, V12, P495, DOI 10.1006/nimg.2000.0624; Horovitz SG, 2002, MAGN RESON IMAGING, V20, P319, DOI 10.1016/S0730-725X(02)00496-4; Ito SI, 2001, NEUROSCI RES, V41, P257, DOI 10.1016/S0168-0102(01)00287-5; Johnson PWM, 1997, ANN ONCOL, V8, P65, DOI 10.1023/A:1008234301024; Kaas JH, 1998, AUDIOL NEURO-OTOL, V3, P73, DOI 10.1159/000013783; Kleist K, 1962, SENSORY APHASIA AMUS; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Lewis JW, 2000, CEREB CORTEX, V10, P873, DOI 10.1093/cercor/10.9.873; Liebenthal E, 2003, J COGNITIVE NEUROSCI, V15, P549, DOI 10.1162/089892903321662930; MECKLINGER A, 1994, PSYCHOPHYSIOLOGY, V31, P23, DOI 10.1111/j.1469-8986.1994.tb01021.x; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Meyer A, 1908, J PSYCHOL NEUROL, V13, P203; Naatanen R, 2001, PSYCHOPHYSIOLOGY, V38, P1, DOI 10.1017/S0048577201000208; NORRIS D, 2000, NEW COGNITIVE NEUROS, P867; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Price CJ, 1996, BRAIN, V119, P919, DOI 10.1093/brain/119.3.919; RADEMACHER J, 1993, CEREB CORTEX, V3, P313, DOI 10.1093/cercor/3.4.313; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Talairach J., 1988, COPLANAR STEREOTAXIC; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; TAYLOR SF, 1994, NEUROPSYCHOLOGIA, V32, P249, DOI 10.1016/0028-3932(94)90010-8; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Warren JD, 2003, J NEUROSCI, V23, P5799; YELLOTT JI, 1971, J MATH PSYCHOL, V8, P159, DOI 10.1016/0022-2496(71)90011-3; Zatorre R. J., 2000, BRAIN MAPPING SYSTEM, P365; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	50	363	365	0	33	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					295	301		10.1038/nn1198	http://dx.doi.org/10.1038/nn1198			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14966525				2022-12-17	WOS:000189197900020
J	Carroll, RC; Lissin, DV; von Zastrow, M; Nicoll, RA; Malenka, RC				Carroll, RC; Lissin, DV; von Zastrow, M; Nicoll, RA; Malenka, RC			Rapid redistribution of glutamate receptors contributes to long-term depression in hippocampal cultures	NATURE NEUROSCIENCE			English	Article							MINIATURE SYNAPTIC CURRENTS; SILENT SYNAPSES; TRANSMITTER RELEASE; PYRAMIDAL CELLS; AMPA RECEPTORS; NMDA RECEPTOR; SPINAL-CORD; AREA CA1; POTENTIATION; EXPRESSION	Synaptic strength can be altered by a variety of pre- or postsynaptic modifications. Here we test the hypothesis that long-term depression (LTD) involves a decrease in the number of glutamate receptors that are clustered at individual synapses in primary cultures of hippocampal neurons. Similar to a prominent form of LTD observed in hippocampal slices, LTD in hippocampal cultures required NMDA receptor activation and was accompanied by a decrease in the amplitude and frequency of miniature excitatory postsynaptic currents. Immunocytochemical analysis revealed that induction of LTD caused a concurrent decrease in the number of AMPA receptors clustered at synapses but had no effect on synaptic NMDA receptor clusters. These results suggest that a subtype-specific redistribution of synaptic glutamate receptors contributes to NMDA receptor-dependent LTD.	Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Malenka, RC (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.							ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; Bardoni R, 1998, J NEUROSCI, V18, P6558; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Craig AM, 1998, NEURON, V21, P459, DOI 10.1016/S0896-6273(00)80555-3; DAVIES SN, 1989, NATURE, V338, P500, DOI 10.1038/338500a0; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Goda Y, 1996, NEURON, V16, P103, DOI 10.1016/S0896-6273(00)80027-6; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; Halpain S, 1998, J NEUROSCI, V18, P9835; Isaac JTR, 1996, P NATL ACAD SCI USA, V93, P8710, DOI 10.1073/pnas.93.16.8710; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Kandler K, 1998, NAT NEUROSCI, V1, P119, DOI 10.1038/368; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; LESTER RAJ, 1989, MOL PHARMACOL, V35, P565; Li P, 1998, NATURE, V393, P695, DOI 10.1038/31496; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Lissin DV, 1999, J NEUROSCI, V19, P1263; Mainen ZF, 1998, NAT NEUROSCI, V1, P579, DOI 10.1038/2812; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; NICOLL RA, IN PRESS ANN NY ACAD; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Rumpel S, 1998, J NEUROSCI, V18, P8863; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; XIAO MY, 1995, NEUROSCIENCE, V68, P625, DOI 10.1016/0306-4522(95)00173-G	50	363	375	0	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					454	460		10.1038/8123	http://dx.doi.org/10.1038/8123			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321250				2022-12-17	WOS:000084609400016
J	Samson, D; Apperly, IA; Chiavarino, C; Humphreys, GW				Samson, D; Apperly, IA; Chiavarino, C; Humphreys, GW			Left temporoparietal junction is necessary for representing someone else's belief	NATURE NEUROSCIENCE			English	Article							ASPERGER-SYNDROME; NORMAL ADULTS; FALSE BELIEF; MIND; AUTISM; TASKS; EYES	A standard view in the neuroscience literature is that the frontal lobes sustain our ability to process others' mental states such as beliefs, intentions and desires (this ability is often referred to as having 'theory of mind'). Here we report evidence from brain-damaged patients showing that, in addition to involvement of the frontal lobes, the left temporoparietal junction is necessary for reasoning about the beliefs of others.	Univ Birmingham, Sch Psychol, Behav Brain Sci Ctr, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Samson, D (corresponding author), Univ Birmingham, Sch Psychol, Behav Brain Sci Ctr, Hills Bldg, Birmingham B15 2TT, W Midlands, England.	d.samson@bham.ac.uk	Chiavarino, Claudia/T-6784-2019; Samson, Dana/A-8692-2008; Apperly, Ian/N-9165-2018	Chiavarino, Claudia/0000-0001-9475-3764; Apperly, Ian/0000-0001-9485-563X; Samson, Dana/0000-0001-7428-0031				Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1111/1469-7610.00715; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; Burgess PW., 1997, HAYLING BRIXTON TEST; Carlson SM, 1998, CHILD DEV, V69, P672, DOI 10.2307/1132197; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Kay J., 1992, PALPA PSYCHOLINGUIST; Peterson DM, 1999, MIND LANG, V14, P80, DOI 10.1111/1468-0017.00104; Riggs KJ, 1998, COGNITIVE DEV, V13, P73, DOI 10.1016/S0885-2014(98)90021-1; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942	14	362	370	2	51	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					499	500		10.1038/nn1223	http://dx.doi.org/10.1038/nn1223			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	816HP	15077111				2022-12-17	WOS:000221101300026
J	Ito, R; Robbins, TW; Everitt, BJ				Ito, R; Robbins, TW; Everitt, BJ			Differential control over cocaine-seeking behavior by nucleus accumbens core and shell	NATURE NEUROSCIENCE			English	Article							PAVLOVIAN APPROACH BEHAVIOR; KAINIC ACID LESIONS; EXCITOTOXIC LESIONS; EXTRACELLULAR DOPAMINE; BASOLATERAL AMYGDALA; INTRAVENOUS COCAINE; 2ND-ORDER SCHEDULE; CONDITIONED REINFORCEMENT; LOCOMOTOR-ACTIVITY; VENTRAL STRIATUM	Nucleus accumbens (NAc) dopamine is widely implicated in mediating the reinforcing effects of drugs of abuse. However, the precise function of the NAc itself in drug self-administration has been difficult to establish. Here we show a neural double-dissociation of the behavioral processes that underlie cocaine self-administration in rats. Whereas selective excitotoxic lesions of the NAc core had only a minor effect on the acquisition of responding for cocaine under a standard schedule of continuous reinforcement, these lesions profoundly impaired the acquisition of drug-seeking behavior that was maintained by drug-associated conditioned reinforcers and assessed using a second-order schedule of cocaine reinforcement. In contrast, selective excitotoxic lesions of the NAc shell did not impair drug self-administration or the acquisition of cocaine-seeking, but they did attenuate the psychostimulant effects of cocaine. These results further our understanding of how the NAc controls drug-seeking and drug-taking behavior.	Univ Cambridge, Dept Expt Psychol, Cambridge CB1 1BB, England	University of Cambridge	Everitt, BJ (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB1 1BB, England.	bje10@cam.ac.uk	Robbins, Trevor W/A-7551-2008; Ito, Rutsuko/E-7296-2013	Ito, Rutsuko/0000-0003-1769-5470; Robbins, Trevor/0000-0003-0642-5977; Everitt, Barry/0000-0003-4431-6536	MRC [G9537855] Funding Source: UKRI; Medical Research Council [G9537855] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alderson HL, 2001, PSYCHOPHARMACOLOGY, V153, P455, DOI 10.1007/s002130000634; ANNETT LE, 1989, BEHAV BRAIN RES, V31, P231, DOI 10.1016/0166-4328(89)90005-3; Arroyo M, 1998, PSYCHOPHARMACOLOGY, V140, P331, DOI 10.1007/s002130050774; Bradberry CW, 2000, J NEUROSCI, V20, P3874, DOI 10.1523/JNEUROSCI.20-10-03874.2000; BURNS LH, 1993, BEHAV BRAIN RES, V55, P167, DOI 10.1016/0166-4328(93)90113-5; CADOR M, 1989, NEUROSCIENCE, V30, P77, DOI 10.1016/0306-4522(89)90354-0; CAINE SB, 1994, J EXP ANAL BEHAV, V61, P213, DOI 10.1901/jeab.1994.61-213; CAINE SB, 1995, BRAIN RES, V692, P47; CAINE SB, 1992, BEHAV NEUROSCIENCE P, V2, P117; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Carlezon WA, 1996, J NEUROSCI, V16, P3112; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Cornish JL, 1999, NEUROSCIENCE, V93, P1359, DOI 10.1016/S0306-4522(99)00214-6; Dalley JW, 2002, PSYCHOPHARMACOLOGY, V161, P425, DOI 10.1007/s00213-002-1078-2; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; DICHIARA G, 1993, PSYCHOPHARMACOLOGY, V112, P398, DOI 10.1007/BF02244939; DWORKIN SI, 1988, PHARMACOL BIOCHEM BE, V29, P175, DOI 10.1016/0091-3057(88)90292-4; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Everitt BJ, 2000, PSYCHOPHARMACOLOGY, V153, P17, DOI 10.1007/s002130000566; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Haber SN, 2000, J NEUROSCI, V20, P2369; Hall J, 2001, EUR J NEUROSCI, V13, P1984, DOI 10.1046/j.0953-816x.2001.01577.x; HEIMER L, 1991, NEUROSCIENCE, V41, P89, DOI 10.1016/0306-4522(91)90202-Y; HURD YL, 1989, BRAIN RES, V498, P199, DOI 10.1016/0006-8993(89)90422-8; Hutcheson DM, 2001, PSYCHOPHARMACOLOGY, V153, P464, DOI 10.1007/s002130000635; Ito R, 2000, J NEUROSCI, V20, P7489; MALDONADOIRIZARRY CS, 1995, BRAIN RES BULL, V38, P551, DOI 10.1016/0361-9230(95)02030-2; Meil WM, 1997, BEHAV BRAIN RES, V87, P139, DOI 10.1016/S0166-4328(96)02270-X; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Parkinson JA, 2000, BEHAV NEUROSCI, V114, P42, DOI 10.1037/0735-7044.114.1.42; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PETTIT HO, 1984, PSYCHOPHARMACOLOGY, V84, P167, DOI 10.1007/BF00427441; PETTIT HO, 1989, PHARMACOL BIOCHEM BE, V34, P899, DOI 10.1016/0091-3057(89)90291-8; Pontieri FE, 1995, P NATL ACAD SCI USA, V92, P12304, DOI 10.1073/pnas.92.26.12304; PULVIRENTI L, 1992, BRAIN RES, V594, P327, DOI 10.1016/0006-8993(92)91145-5; READING PJ, 1991, BEHAV BRAIN RES, V46, P17, DOI 10.1016/S0166-4328(05)80093-2; Robbins TW, 1999, NATURE, V398, P567, DOI 10.1038/19208; ROBERTS DCS, 1977, PHARMACOL BIOCHEM BE, V6, P615, DOI 10.1016/0091-3057(77)90084-3; ROBLEDO P, 1992, ANN NY ACAD SCI, V654, P509, DOI 10.1111/j.1749-6632.1992.tb26015.x; Rodd-Henricks ZA, 2002, J PHARMACOL EXP THER, V303, P1216, DOI 10.1124/jpet.102.038950; See RE, 2002, PHARMACOL BIOCHEM BE, V71, P517, DOI 10.1016/S0091-3057(01)00682-7; STEWART J, 1984, PSYCHOL REV, V91, P251, DOI 10.1037/0033-295X.91.2.251; VOORN P, 1989, J COMP NEUROL, V289, P189, DOI 10.1002/cne.902890202; Weiss F, 2000, P NATL ACAD SCI USA, V97, P4321, DOI 10.1073/pnas.97.8.4321; Whitelaw RB, 1996, PSYCHOPHARMACOLOGY, V127, P213, DOI 10.1007/BF02805996; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; Wyvell CL, 2000, J NEUROSCI, V20, P8122; ZITO KA, 1985, PHARMACOL BIOCHEM BE, V23, P1029, DOI 10.1016/0091-3057(85)90110-8	49	362	372	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					389	397		10.1038/nn1217	http://dx.doi.org/10.1038/nn1217			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15034590				2022-12-17	WOS:000220482500018
J	Johansson, RS; Birznieks, I				Johansson, RS; Birznieks, I			First spikes in ensembles of human tactile afferents code complex spatial fingertip events	NATURE NEUROSCIENCE			English	Article							GLABROUS SKIN; HUMAN HAND; PRECISION GRIP; MECHANORECEPTIVE UNITS; CEREBRAL-CORTEX; STIMULUS LOCATION; OBJECT SHAPE; RESPONSES; DIRECTION; RECEPTORS	It is generally assumed that primary sensory neurons transmit information by their firing rates. However, during natural object manipulations, tactile information from the fingertips is used faster than can be readily explained by rate codes. Here we show that the relative timing of the first impulses elicited in individual units of ensembles of afferents reliably conveys information about the direction of fingertip force and the shape of the surface contacting the fingertip. The sequence in which different afferents initially discharge in response to mechanical fingertip events provides information about these events faster than the fastest possible rate code and fast enough to account for the use of tactile signals in natural manipulation.	Umea Univ, Dept Integrat Med Biol, Physiol Sect, SE-90187 Umea, Sweden	Umea University	Johansson, RS (corresponding author), Umea Univ, Dept Integrat Med Biol, Physiol Sect, SE-90187 Umea, Sweden.	roland.s.johansson@physiol.umu.se	Johansson, Roland S/A-5890-2009; Birznieks, Ingvars/D-4181-2012; B, Ingvars/Q-8634-2019	Johansson, Roland S/0000-0003-3288-8326; Birznieks, Ingvars/0000-0003-4916-1254; B, Ingvars/0000-0003-4916-1254				ADKINS RJ, 1966, SCIENCE, V153, P1020, DOI 10.1126/science.153.3739.1020; Adrian E.D., 1928, BASIS SENSATION; Birznieks I, 2001, J NEUROSCI, V21, P8222, DOI 10.1523/JNEUROSCI.21-20-08222.2001; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Ergenzinger ER, 1998, NAT NEUROSCI, V1, P226, DOI 10.1038/673; Gerstner W., 2002, SPIKING NEURON MODEL; GOODWIN AW, 1995, J NEUROSCI, V15, P798; HagerRoss C, 1996, EXP BRAIN RES, V110, P142; HARRIS F, 1965, NATURE, V208, P1215, DOI 10.1038/2081215a0; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Jenmalm P, 2003, EUR J NEUROSCI, V18, P164, DOI 10.1046/j.1460-9568.2003.02721.x; Jenmalm P, 1997, J NEUROSCI, V17, P4486; JOHANSSON RS, 1994, J PHYSIOL-LONDON, V481, P761, DOI 10.1113/jphysiol.1994.sp020480; Johansson RS, 1998, NOVART FDN SYMP, V218, P45; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; JOHANSSON RS, 1987, EXP BRAIN RES, V66, P141; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1992, CURR OPIN NEUROBIOL, V2, P815, DOI 10.1016/0959-4388(92)90139-C; JOHANSSON RS, 1983, TRENDS NEUROSCI, V6, P27, DOI 10.1016/0166-2236(83)90011-5; JOHANSSON RS, 1978, J PHYSIOL-LONDON, V281, P101, DOI 10.1113/jphysiol.1978.sp012411; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; JOHANSSON RS, 1980, BRAIN RES, V184, P353, DOI 10.1016/0006-8993(80)90804-5; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V297, P405, DOI 10.1113/jphysiol.1979.sp013048; JOHANSSON RS, 1992, EXP BRAIN RES, V89, P192, DOI 10.1007/BF00229016; JOHANSSON RS, 1982, BRAIN RES, V244, P17, DOI 10.1016/0006-8993(82)90899-X; KAKUDA N, 1992, NEUROSCI RES, V15, P179, DOI 10.1016/0168-0102(92)90003-U; Kennedy PM, 2002, J PHYSIOL-LONDON, V538, P995, DOI 10.1113/jphysiol.2001.013087; Macefield VG, 1996, EXP BRAIN RES, V108, P155; Maeno T, 1998, JSME INT J C-MECH SY, V41, P94, DOI 10.1299/jsmec.41.94; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Nakazawa N, 2000, BIOL CYBERN, V82, P207, DOI 10.1007/s004220050020; Nielsen J, 1997, J PHYSIOL-LONDON, V501, P473, DOI 10.1111/j.1469-7793.1997.473bn.x; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Pawluk DTV, 1999, J BIOMECH ENG-T ASME, V121, P178, DOI 10.1115/1.2835100; Petersen RS, 2001, NEURON, V32, P503, DOI 10.1016/S0896-6273(01)00481-0; PHILLIPS JR, 1992, J NEUROSCI, V12, P827; PUBOLS BH, 1982, J NEUROPHYSIOL, V47, P530, DOI 10.1152/jn.1982.47.3.530; Reich DS, 2001, J NEUROPHYSIOL, V85, P1039, DOI 10.1152/jn.2001.85.3.1039; ROLLS ET, 1994, P ROY SOC B-BIOL SCI, V257, P9, DOI 10.1098/rspb.1994.0087; Rowe MJ, 2002, BEHAV BRAIN RES, V135, P197, DOI 10.1016/S0166-4328(02)00166-3; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Thorpe S, 2001, NEURAL NETWORKS, V14, P715, DOI 10.1016/S0893-6080(01)00083-1; Trulsson M, 1997, J NEUROPHYSIOL, V77, P737, DOI 10.1152/jn.1997.77.2.737; Usrey WM, 2002, CURR OPIN NEUROBIOL, V12, P411, DOI 10.1016/S0959-4388(02)00339-2; VALLBO AB, 1968, EXP NEUROL, V21, P270, DOI 10.1016/0014-4886(68)90041-1; WESTLING G, 1987, EXP BRAIN RES, V66, P128; Zar J. H., 1996, BIOSTATISTICAL ANAL	48	362	372	2	33	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					170	177		10.1038/nn1177	http://dx.doi.org/10.1038/nn1177			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14730306				2022-12-17	WOS:000188468500015
J	Star, EN; Kwiatkowski, DJ; Murthy, VN				Star, EN; Kwiatkowski, DJ; Murthy, VN			Rapid turnover of actin in dendritic spines and its regulation by activity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; GEL-SOL TRANSFORMATION; F-ACTIN; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; SMALL GTPASES; GELSOLIN; PLASTICITY; FILAMENT; PROTEIN	Dendritic spines are motile structures that contain high concentrations of filamentous actin. Using hippocampal neurons expressing fluorescent actin and the method of fluorescence recovery after photobleaching, we found that 85+/-2% of actin in the spine was dynamic, with a turnover time of 44.2+/-4.0 s. The rapid turnover is not compatible with current models invoking a large population of stable filaments and static coupling of filaments to postsynaptic components. Low-frequency stimulation known to induce long-term depression in these neurons stabilized nearly half the dynamic actin in the spine. This effect depended on the activation of N-methyl-D-aspartate (NMDA) receptors and the influx of calcium. In neurons from mice lacking gelsolin, a calcium-dependent actin-binding protein, activity-dependent stabilization of actin was impaired. Our studies provide new information on the kinetics of actin turnover in spines, its regulation by neural activity and the mechanisms involved in this regulation.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Brigham & Womens Hosp, Div Hematol, Genet Lab, Boston, MA 02115 USA	Harvard University; Harvard University; Brigham & Women's Hospital	Murthy, VN (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.			Murthy, Venkatesh/0000-0003-2443-4252				Allison DW, 1998, J NEUROSCI, V18, P2423; Arcaro A, 1998, J BIOL CHEM, V273, P805, DOI 10.1074/jbc.273.2.805; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Azuma T, 1998, EMBO J, V17, P1362, DOI 10.1093/emboj/17.5.1362; BUBB MR, 1994, J BIOL CHEM, V269, P14869; CAJAL SRY, 1891, CELLULE, V7, P125; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; Goda Y, 1996, NEURON, V16, P103, DOI 10.1016/S0896-6273(00)80027-6; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Halpain S, 1998, J NEUROSCI, V18, P9835; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; JANMEY PA, 1985, BIOCHEMISTRY-US, V24, P3714, DOI 10.1021/bi00335a046; Kim CH, 1999, J NEUROSCI, V19, P4314; Kinosian HJ, 1998, BIOPHYS J, V75, P3101, DOI 10.1016/S0006-3495(98)77751-3; Korkotian E, 2001, NEURON, V30, P751, DOI 10.1016/S0896-6273(01)00314-2; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Matus A, 1999, CURR OPIN NEUROBIOL, V9, P561, DOI 10.1016/S0959-4388(99)00018-5; McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0; McGrath JL, 2000, P NATL ACAD SCI USA, V97, P6532, DOI 10.1073/pnas.100023397; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Segal M, 2001, PROG NEUROBIOL, V63, P61, DOI 10.1016/S0301-0082(00)00021-6; Sund SE, 2000, BIOPHYS J, V79, P1655, DOI 10.1016/S0006-3495(00)76415-0; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; WEGNER A, 1976, J MOL BIOL, V108, P139, DOI 10.1016/S0022-2836(76)80100-3; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Xia ZG, 1996, J NEUROSCI, V16, P5425; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0; YIN HL, 1981, J CELL BIOL, V91, P901, DOI 10.1083/jcb.91.3.901; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	50	362	371	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					239	246		10.1038/nn811	http://dx.doi.org/10.1038/nn811			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11850630				2022-12-17	WOS:000174146000014
J	Falck-Ytter, T; Gredeback, G; von Hofsten, C				Falck-Ytter, Terje; Gredeback, Gustaf; von Hofsten, Claes			Infants predict other people's action goals	NATURE NEUROSCIENCE			English	Article							SOCIAL COGNITION; SYSTEM	Do infants come to understand other people's actions through a mirror neuron system that maps an observed action onto motor representations of that action? We demonstrate that a specialized system for action perception guides proactive goal-directed eye movements in 12-month-old but not in 6-month-old infants, providing direct support for this view. The activation of this system requires observing an interaction between the hand of the agent and an object.	Uppsala Univ, Dept Psychol, S-75142 Uppsala, Sweden	Uppsala University	Falck-Ytter, T (corresponding author), Uppsala Univ, Dept Psychol, Box 1225, S-75142 Uppsala, Sweden.	terje.falck-ytter@psyk.uu.se	Gredebäck, Gustaf/C-1676-2009	Gredebäck, Gustaf/0000-0003-3046-0043; Falck-Ytter, Terje/0000-0001-9714-0197				BRUNER JS, 1970, MECHANISMS MOTOR SKI, P63; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gergely G, 2003, TRENDS COGN SCI, V7, P287, DOI 10.1016/S1364-6613(03)00128-1; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Land MF, 1997, PHILOS T ROY SOC B, V352, P1231, DOI 10.1098/rstb.1997.0105; Luo Y, 2005, PSYCHOL SCI, V16, P601, DOI 10.1111/j.1467-9280.2005.01582.x; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; ROSSANDER K, 2000, COGNITION, V91, P1; Sommerville JA, 2005, COGNITION, V96, pB1, DOI 10.1016/j.cognition.2004.07.004	15	361	368	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					878	879		10.1038/nn1729	http://dx.doi.org/10.1038/nn1729			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16783366				2022-12-17	WOS:000238590800012
J	Aoyama, K; Suh, SW; Hamby, AM; Liu, JL; Chan, WY; Chen, YM; Swanson, RA				Aoyama, K; Suh, SW; Hamby, AM; Liu, JL; Chan, WY; Chen, YM; Swanson, RA			Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse	NATURE NEUROSCIENCE			English	Article							GLUTAMATE TRANSPORTER EAAC1; CULTURED HIPPOCAMPAL-NEURONS; AMINO-ACID TRANSPORTER; NITRIC-OXIDE; DICARBOXYLIC AMINOACIDURIA; INTRACELLULAR GLUTATHIONE; CORTICAL-NEURONS; OXIDATIVE STRESS; CYSTEINE UPTAKE; IN-VITRO	Uptake of the neurotransmitter glutamate is effected primarily by transporters expressed on astrocytes, and downregulation of these transporters leads to seizures and neuronal death. Neurons also express a glutamate transporter, termed excitatory amino acid carrier-1 (EAAC1), but the physiological function of this transporter remains uncertain. Here we report that genetically EAAC1-null (Slc1a1(-/-)) mice have reduced neuronal glutathione levels and, with aging, develop brain atrophy and behavioral changes. EAAC1 can also rapidly transport cysteine, an obligate precursor for neuronal glutathione synthesis. Neurons in the hippocampal slices of EAAC1(-/-) mice were found to have reduced glutathione content, increased oxidant levels and increased susceptibility to oxidant injury. These changes were reversed by treating the EAAC1(-/-) mice with N-acetylcysteine, a membrane-permeable cysteine precursor. These findings suggest that EAAC1 is the primary route for neuronal cysteine uptake and that EAAC1 deficiency thereby leads to impaired neuronal glutathione metabolism, oxidative stress and age-dependent neurodegeneration.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Swanson, RA (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	ray@itsa.ucsf.edu	Liu, Jialing/A-8627-2012	Liu, Jialing/0000-0003-4420-4382; Swanson, Raymond/0000-0002-3664-5359; Aoyama, Koji/0000-0003-4752-9262				AOYAMA K, 2005, J CEREB BLOOD FLOW M, V25, P258; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Avshalumov MV, 2002, J NEUROPHYSIOL, V87, P2896, DOI 10.1152/jn.2002.87.6.2896; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Canolle B, 2004, J NEUROCHEM, V88, P1521, DOI 10.1046/j.1471-4159.2003.02301.x; Chen YM, 2003, J NEUROCHEM, V84, P1332, DOI 10.1046/j.1471-4159.2003.01630.x; Coco S, 1997, EUR J NEUROSCI, V9, P1902, DOI 10.1111/j.1460-9568.1997.tb00757.x; CORCORAN GB, 1986, J PHARMACOL EXP THER, V238, P54; Crow JP, 1997, NITRIC OXIDE-BIOL CH, V1, P145, DOI 10.1006/niox.1996.0113; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Dringen R, 1999, J NEUROSCI, V19, P562, DOI 10.1523/jneurosci.19-02-00562.1999; Dringen R, 2001, J NEUROSCI RES, V66, P1003, DOI 10.1002/jnr.10042; Gonzalez MI, 2002, MOL PHARMACOL, V62, P901, DOI 10.1124/mol.62.4.901; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Grover LM, 1999, J NEUROPHYSIOL, V81, P2814, DOI 10.1152/jn.1999.81.6.2814; Himi T, 2003, J NEURAL TRANSM, V110, P1337, DOI 10.1007/s00702-003-0049-z; Himi T, 2003, J NEUROSCI RES, V71, P679, DOI 10.1002/jnr.10510; Hochman DW, 2000, J NEUROPHYSIOL, V83, P406, DOI 10.1152/jn.2000.83.1.406; HOGG N, 1992, BIOCHEM J, V281, P419, DOI 10.1042/bj2810419; Hogg N, 1996, FEBS LETT, V382, P223, DOI 10.1016/0014-5793(96)00086-5; JAIN A, 1991, P NATL ACAD SCI USA, V88, P1913, DOI 10.1073/pnas.88.5.1913; Lantz RC, 2001, TOXICOL SCI, V60, P348, DOI 10.1093/toxsci/60.2.348; Mazor D, 1996, EUR J HAEMATOL, V57, P241; MEISTER A, 1986, J AM COLL NUTR, V5, P137; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MURPHY TH, 1990, FASEB J, V4, P1624, DOI 10.1096/fasebj.4.6.2180770; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Parsons JL, 2000, MUTAGENESIS, V15, P311, DOI 10.1093/mutage/15.4.311; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; SAGARA J, 1993, J NEUROCHEM, V61, P1672, DOI 10.1111/j.1471-4159.1993.tb09802.x; Sato H, 2002, J NEUROSCI, V22, P8028; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Shanker G, 2001, BRAIN RES, V902, P156, DOI 10.1016/S0006-8993(01)02342-3; Shashidharan P, 1997, BRAIN RES, V773, P139, DOI 10.1016/S0006-8993(97)00921-9; SMITH CP, 1994, GENOMICS, V20, P335, DOI 10.1006/geno.1994.1183; Suh SW, 2003, J NEUROSCI, V23, P10681; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Umansky V, 2000, J CELL BIOCHEM, V78, P578, DOI 10.1002/1097-4644(20000915)78:4<578::AID-JCB7>3.0.CO;2-A; Wang XF, 2000, J NEUROCHEM, V74, P1434, DOI 10.1046/j.1471-4159.2000.0741434.x; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yang YX, 2004, J NEUROCHEM, V88, P1361, DOI 10.1046/j.1471-4159.2003.02279.x; Yin HZ, 2002, J NEUROSCI, V22, P1273, DOI 10.1523/JNEUROSCI.22-04-01273.2002; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zerangue N, 1996, J PHYSIOL-LONDON, V493, P419, DOI 10.1113/jphysiol.1996.sp021393	50	361	377	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					119	126		10.1038/nn1609	http://dx.doi.org/10.1038/nn1609			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16311588				2022-12-17	WOS:000234288000025
J	Tavazoie, SF; Alvarez, VA; Ridenour, DA; Kwiatkowski, DJ; Sabatini, BL				Tavazoie, SF; Alvarez, VA; Ridenour, DA; Kwiatkowski, DJ; Sabatini, BL			Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2	NATURE NEUROSCIENCE			English	Article							TUBEROUS SCLEROSIS COMPLEX; LONG-TERM DEPRESSION; DENDRITIC SPINE MORPHOGENESIS; LHERMITTE-DUCLOS-DISEASE; CELL-GROWTH; SYNAPTIC PLASTICITY; SIGNALING PATHWAY; PRODUCT TUBERIN; ACTIN DYNAMICS; KNOCKOUT MICE	Mutations in the TSC1 or TSC2 tumor suppressor genes lead to tuberous sclerosis complex (TSC), a dominant hamartomatous disorder that often presents with mental retardation, epilepsy and autism. The etiology of these neurological symptoms is unclear and the function of the TSC pathway in neurons is unknown. We found that in post-mitotic, hippocampal pyramidal neurons of mice and rats, loss of Tsc1 or Tsc2 triggered enlargement of somas and dendritic spines and altered the properties of glutamatergic synapses. Furthermore, loss of a single copy of the Tsc1 gene was sufficient to perturb dendritic spine structure. Morphological changes required regulation of the actin-depolymerization factor cofilin at a conserved LIM-kinase phosphorylation site, the phosphorylation of which was increased by loss of Tsc2. Thus, the TSC pathway regulates growth and synapse function in neurons, and perturbations of neuronal structure and function are likely to contribute to the pathogenesis of the neurological symptoms of TSC.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu	Alvarez, Veronica A/E-9745-2015	Alvarez, Veronica A/0000-0003-2611-8675	NINDS NIH HHS [5T32 NS07484] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007484] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Benvenuto G, 2000, ONCOGENE, V19, P6306, DOI 10.1038/sj.onc.1204009; Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; Bryan B, 2004, J BIOL CHEM, V279, P45824, DOI 10.1074/jbc.M406216200; CARTER AG, 2004, NEURON; Chang HI, 1996, BIOCHEM BIOPH RES CO, V223, P324, DOI 10.1006/bbrc.1996.0893; Dijkhuizen PA, 2005, J NEUROBIOL, V62, P278, DOI 10.1002/neu.20100; Dong JX, 2004, GENE DEV, V18, P2479, DOI 10.1101/gad.1240504; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; Gomez M. R., 1999, TUBEROUS SCLEROSIS C; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Hengstschlager M, 2003, BIOCHEM BIOPH RES CO, V312, P676, DOI 10.1016/j.bbrc.2003.10.170; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Li Y, 2002, J BIOL CHEM, V277, P44593, DOI 10.1074/jbc.C200510200; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Mashimo J, 1997, CANCER LETT, V113, P213, DOI 10.1016/S0304-3835(97)04700-9; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Meng YH, 2003, REV NEUROSCIENCE, V14, P233; Nufer O, 2003, CURR BIOL, V13, pR391, DOI 10.1016/S0960-9822(03)00318-X; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Ramesh V, 2003, BIOCHEM SOC T, V31, P579, DOI 10.1042/bst0310579; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sepp T, 1996, J MED GENET, V33, P962, DOI 10.1136/jmg.33.11.962; SHEPHERD CW, 1995, AM J NEURORADIOL, V16, P149; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tassabehji M, 1996, NAT GENET, V13, P272, DOI 10.1038/ng0796-272; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	50	361	374	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1727	1734		10.1038/nn1566	http://dx.doi.org/10.1038/nn1566			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16286931				2022-12-17	WOS:000233576200022
J	Pasupathy, A; Connor, CE				Pasupathy, A; Connor, CE			Population coding of shape in area V4	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL NEURONS; INFEROTEMPORAL CORTEX; 3-DIMENSIONAL SHAPES; OBJECT RECOGNITION; VISUAL-CORTEX; MACAQUE; REPRESENTATION; FEATURES; SELECTIVITY; MONKEY	Shape is represented in the visual system by patterns of activity across populations of neurons. We studied the population code for shape in area V4 of macaque monkeys, which is part of the ventral (object-related) pathway in primate visual cortex. We have previously found that many macaque V4 neurons are tuned for the curvature and object-centered position of boundary fragments (such as 'concavity on the right'). Here we tested the hypothesis that populations of such cells represent complete shapes as aggregates of boundary fragments. To estimate the population representation of a given shape, we scaled each cell's tuning peak by its response to that shape, summed across cells and smoothed. The resulting population response surface contained 3-8 peaks that represented major boundary features and could be used to reconstruct (approximately) the original shape. This exemplifies how a multi-peaked neural population response can represent a complex stimulus in terms of its constituent elements.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21218 USA; MIT, Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA	Johns Hopkins University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Johns Hopkins University	Connor, CE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21218 USA.							Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Bartels RH, 1987, INTRO SPLINES USE CO; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; DESIMONE R, 1984, J NEUROSCI, V4, P2051; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; DICKINSON SJ, 1992, CVGIP-IMAG UNDERSTAN, V55, P130, DOI 10.1016/1049-9660(92)90013-S; Edelman S, 2000, SPATIAL VISION, V13, P255, DOI 10.1163/156856800741072; Edelman S., 1999, REPRESENTATION RECOG; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; GATTASS R, 1988, J NEUROSCI, V8, P1831; GOCHIN PM, 1994, J NEUROPHYSIOL, V71, P2325, DOI 10.1152/jn.1994.71.6.2325; Hanazawa A, 2001, J NEUROSCI, V21, P4490, DOI 10.1523/JNEUROSCI.21-12-04490.2001; HOFFMAN DD, 1984, COGNITION, V18, P65, DOI 10.1016/0010-0277(84)90022-2; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Lewis JE, 1998, NATURE, V391, P76, DOI 10.1038/34172; MARDIA KV, 1976, BIOMETRIKA, V63, P403, DOI 10.2307/2335637; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; MILNER PM, 1974, PSYCHOL REV, V81, P521, DOI 10.1037/h0037149; MOUNTCASTLE VB, 1995, CEREB CORTEX, V5, P377, DOI 10.1093/cercor/5.5.377; Olson CR, 1996, CURR OPIN NEUROBIOL, V6, P165, DOI 10.1016/S0959-4388(96)80069-9; Op de Beeck H, 2001, NAT NEUROSCI, V4, P1244, DOI 10.1038/nn767; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Rolls ET, 1997, EXP BRAIN RES, V114, P149, DOI 10.1007/PL00005615; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; SUTHERLAND NS, 1968, PROC R SOC SER B-BIO, V171, P297, DOI 10.1098/rspb.1968.0072; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P549; Wang Y, 2000, NAT NEUROSCI, V3, P807, DOI 10.1038/77712; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577; ZEKI SM, 1973, BRAIN RES, V53, P422, DOI 10.1016/0006-8993(73)90227-8; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017; [No title captured]; [No title captured]	49	361	365	0	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1332	1338		10.1038/nn972	http://dx.doi.org/10.1038/nn972			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12426571				2022-12-17	WOS:000179447500017
J	Montmayeur, JP; Liberles, SD; Matsunami, H; Buck, LB				Montmayeur, JP; Liberles, SD; Matsunami, H; Buck, LB			A candidate taste receptor gene near a sweet taste locus	NATURE NEUROSCIENCE			English	Article							PUTATIVE PHEROMONE RECEPTORS; METABOTROPIC GLUTAMATE-RECEPTOR; CROSS-ADAPTATION; MULTIGENE FAMILY; INBRED STRAINS; MICE; TRANSDUCTION; MOUSE; RESPONSES; SACCHARIN	The mechanisms underlying sweet taste in mammals have been elusive. Although numerous studies have implicated G proteins in sweet taste detection, the expected G protein-coupled receptors have not been found. Here we describe a candidate taste receptor gene, T1r3, that is located at or near the mouse Sac locus, a genetic locus that controls the detection of certain sweet tastants. T1R3 differs in amino acid sequence in mouse strains with different Sac phenotypes ('tasters' versus 'nontasters'). In addition, a perfect correlation exists between two different T1r3 alleles and Sac phenotypes in recombinant inbred mouse strains. The T1r3 gene is expressed in a subset of taste cells in circumvallate, foliate and fungiform taste papillae. In circumvallate and foliate papillae, most T1r3-expressing cells also express a gene encoding a related receptor, T1R2 raising the possibility that these cells recognize more than one ligand, or that the two receptors function as heterodimers.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Buck, LB (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA.	lbuck@hms.harvard.edu	Montmayeur, Jean-Pierre R/A-5723-2009	Montmayeur, Jean-Pierre/0000-0002-0942-1114; Liberles, Stephen/0000-0002-2177-9741				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Bachmanov AA, 1997, MAMM GENOME, V8, P545, DOI 10.1007/s003359900500; Bai M, 1999, INT J MOL MED, V4, P115; BELKNAP JK, 1992, BEHAV GENET, V22, P81, DOI 10.1007/BF01066794; Berghard A, 1996, J NEUROSCI, V16, P909; Bernhardt SJ, 1996, J PHYSIOL-LONDON, V490, P325, DOI 10.1113/jphysiol.1996.sp021147; Blizard DA, 1999, CHEM SENSES, V24, P373, DOI 10.1093/chemse/24.4.373; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; CAPELESS CG, 1995, CHEM SENSES, V20, P291, DOI 10.1093/chemse/20.3.291; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; DANCIGER M, 1990, GENOMICS, V6, P428, DOI 10.1016/0888-7543(90)90472-7; EICHER EM, 1993, MAMM GENOME, V4, P226, DOI 10.1007/BF00417568; FAURION A, 1980, CHEM SENSES, V5, P107, DOI 10.1093/chemse/5.2.107; Frank ME, 1999, PHYSIOL BEHAV, V67, P287, DOI 10.1016/S0031-9384(99)00071-2; Froloff N, 1998, CHEM SENSES, V23, P197, DOI 10.1093/chemse/23.2.197; Froloff N, 1996, CHEM SENSES, V21, P425, DOI 10.1093/chemse/21.4.425; FULLER JL, 1974, J HERED, V65, P33, DOI 10.1093/oxfordjournals.jhered.a108452; Gilbertson TA, 2000, CURR OPIN NEUROBIOL, V10, P519, DOI 10.1016/S0959-4388(00)00118-5; Gimelbrant AA, 2001, J BIOL CHEM, V276, P7285, DOI 10.1074/jbc.M005433200; GLASER D, 1995, CHEM SENSES, V20, P573, DOI 10.1093/chemse/20.5.573; GREENFIELD AJ, 1992, MOUSE GENOME, V90, P94; Herness MS, 1999, ANNU REV PHYSIOL, V61, P873, DOI 10.1146/annurev.physiol.61.1.873; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Ishimoto H, 2000, SCIENCE, V289, P116, DOI 10.1126/science.289.5476.116; Kinnamon SC, 2000, NEURON, V25, P507, DOI 10.1016/S0896-6273(00)81054-5; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Li X, 2001, MAMM GENOME, V12, P13, DOI 10.1007/s003350010236; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; LUSH IE, 1989, GENET RES, V53, P95, DOI 10.1017/S0016672300027968; LUSH IE, 1995, GENET RES, V66, P167, DOI 10.1017/S0016672300034510; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; McCarthy LC, 1997, GENOME RES, V7, P1153, DOI 10.1101/gr.7.12.1153; Ming D, 1998, P NATL ACAD SCI USA, V95, P8933, DOI 10.1073/pnas.95.15.8933; NIMOMIYA Y, 1997, AM J PHYSIOL, V272, pR1002; Ninomiya Y, 1999, J NEUROPHYSIOL, V81, P3087, DOI 10.1152/jn.1999.81.6.3087; Nofre C, 1996, CHEM SENSES, V21, P747, DOI 10.1093/chemse/21.6.747; PELZ WE, 1973, PHYSIOL BEHAV, V10, P263, DOI 10.1016/0031-9384(73)90308-9; RAMIREZ I, 1976, PHYSIOL BEHAV, V16, P163, DOI 10.1016/0031-9384(76)90300-0; Reed DR, 2000, APPETITE, V35, P189, DOI 10.1006/appe.2000.0347; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; SCHIFFMAN SS, 1981, PHARMACOL BIOCHEM BE, V15, P377, DOI 10.1016/0091-3057(81)90266-5; TAKAHASHI K, 1993, J BIOL CHEM, V268, P19341; TONOSAKI K, 1989, COMP BIOCHEM PHYS A, V92, P181, DOI 10.1016/0300-9629(89)90149-7; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0	50	361	396	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2001	4	5					492	498		10.1038/87440	http://dx.doi.org/10.1038/87440			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NN	11319557				2022-12-17	WOS:000168412600012
J	Schikorski, T; Stevens, CF				Schikorski, T; Stevens, CF			Morphological correlates of functionally defined synaptic vesicle populations	NATURE NEUROSCIENCE			English	Article							SYNAPSES; RELEASE; BOUTONS; NEURONS; BRAIN	By combining photoconversion of FM1-43-stained vesicles and electron microscopy of hippocampal synapses, we find evidence that the population of morphologically docked synaptic vesicles corresponds to the release-ready neurotransmitter quanta. Furthermore, those synaptic vesicles that are participating in cycles of exo- and endocytosis tend to be closer to the active zone than vesicles that are being held in reserve.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Stevens, CF (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Schikorski, Thomas/0000-0003-3902-2461				Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; ROSENMUND C, 1996, NEURON, V16, P1; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; SANDELL JH, 1988, J HISTOCHEM CYTOCHEM, V36, P555, DOI 10.1177/36.5.3356898; Schikorski T, 1999, P NATL ACAD SCI USA, V96, P4107, DOI 10.1073/pnas.96.7.4107; SCHIKORSKI T, 1994, BRAIN BEHAV EVOLUT, V43, P306, DOI 10.1159/000113642; Schikorski T, 1997, J NEUROSCI, V17, P5858; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8	19	361	365	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					391	395		10.1038/86042	http://dx.doi.org/10.1038/86042			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276229				2022-12-17	WOS:000168762200019
J	Staresina, BP; Bergmann, TO; Bonnefond, M; van der Meij, R; Jensen, O; Deuker, L; Elger, CE; Axmacher, N; Fell, J				Staresina, Bernhard P.; Bergmann, Ti Ole; Bonnefond, Mathilde; van der Meij, Roemer; Jensen, Ole; Deuker, Lorena; Elger, Christian E.; Axmacher, Nikolai; Fell, Juergen			Hierarchical nesting of slow oscillations, spindles and ripples in the human hippocampus during sleep	NATURE NEUROSCIENCE			English	Article							EYE-MOVEMENT SLEEP; TEMPORAL-LOBE; BRAIN RHYTHMS; SHARP WAVES; MEMORY; FREQUENCY; EEG; COMMUNICATION; REACTIVATION; NEOCORTEX	During systems-level consolidation, mnemonic representations initially reliant on the hippocampus are thought to migrate to neocortical sites for more permanent storage, with an eminent role of sleep for facilitating this information transfer. Mechanistically, consolidation processes have been hypothesized to rely on systematic interactions between the three cardinal neuronal oscillations characterizing non-rapid eye movement (NREM) sleep. Under global control of de- and hyperpolarizing slow oscillations (SOs), sleep spindles may cluster hippocampal ripples for a precisely timed transfer of local information to the neocortex. We used direct intracranial electroencephalogram recordings from human epilepsy patients during natural sleep to test the assumption that SOs, spindles and ripples are functionally coupled in the hippocampus. Employing cross-frequency phase-amplitude coupling analyses, we found that spindles were modulated by the up-state of SOs. Notably, spindles were found to in turn cluster ripples in their troughs, providing fine-tuned temporal frames for the hypothesized transfer of hippocampal memory traces.	[Staresina, Bernhard P.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Staresina, Bernhard P.] MRC Cognit & Brain Sci Unit, Cambridge, England; [Bergmann, Ti Ole; Bonnefond, Mathilde; van der Meij, Roemer; Jensen, Ole; Deuker, Lorena] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Bergmann, Ti Ole] Univ Kiel, Inst Psychol, Kiel, Germany; [Bergmann, Ti Ole] Univ Tubingen, Dept Neurol & Stroke, Tubingen, Germany; [Bergmann, Ti Ole] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Bergmann, Ti Ole] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Elger, Christian E.; Axmacher, Nikolai; Fell, Juergen] Univ Bonn, Dept Epileptol, Bonn, Germany; [Axmacher, Nikolai] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Axmacher, Nikolai] Ruhr Univ Bochum, Inst Cognit Neurosci, Dept Neuropsychol, Bochum, Germany	University of Birmingham; Radboud University Nijmegen; University of Kiel; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Ruhr University Bochum	Staresina, BP (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	b.staresina@bham.ac.uk	Jensen, Ole/D-2120-2010; Bergmann, Til Ole/F-9453-2010; Bonnefond, Mathilde/J-7572-2012; Staresina, Bernhard P/N-4496-2014	Jensen, Ole/0000-0001-8193-8348; Bergmann, Til Ole/0000-0002-2282-6618; Staresina, Bernhard P/0000-0002-0558-9745; Axmacher, Nikolai/0000-0002-0475-6492; Deuker, Lorena/0000-0002-4939-5862	Sir Henry Wellcome Fellowship [WT089049AIA]; BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs; VICI grant from the NWO [453-09-002]; DFG [AX82/2, AX82/3, SFB1089]	Sir Henry Wellcome Fellowship; BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); VICI grant from the NWO; DFG(German Research Foundation (DFG))	The research was supported by a Sir Henry Wellcome Fellowship (WT089049AIA) to B.P.S., the BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs (T.O.B.), the VICI grant (453-09-002) from the NWO (O.J.) and the DFG grants AX82/2, AX82/3 (NA.) and SFB1089 (NA. and J.F.).	Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; Andrade KC, 2011, J NEUROSCI, V31, P10331, DOI 10.1523/JNEUROSCI.5660-10.2011; Andrillon T, 2011, J NEUROSCI, V31, P17821, DOI 10.1523/JNEUROSCI.2604-11.2011; Aru J, 2015, CURR OPIN NEUROBIOL, V31, P51, DOI 10.1016/j.conb.2014.08.002; Axmacher N, 2008, BRAIN, V131, P1806, DOI 10.1093/brain/awn103; Ayoub A, 2012, NEUROIMAGE, V59, P1491, DOI 10.1016/j.neuroimage.2011.08.023; Bergmann TO, 2012, NEUROIMAGE, V59, P2733, DOI 10.1016/j.neuroimage.2011.10.036; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; Bragin A, 1999, HIPPOCAMPUS, V9, P137; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G, 2013, NEURON, V80, P751, DOI 10.1016/j.neuron.2013.10.002; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; Clemens Z, 2007, BRAIN, V130, P2868, DOI 10.1093/brain/awm146; Cox R, 2014, J NEUROSCI, V34, P16890, DOI 10.1523/JNEUROSCI.1953-14.2014; Cox R, 2014, NEUROIMAGE, V99, P103, DOI 10.1016/j.neuroimage.2014.05.028; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Gais S, 2002, J NEUROSCI, V22, P6830; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Kramer MA, 2008, J NEUROSCI METH, V170, P352, DOI 10.1016/j.jneumeth.2008.01.020; Logothetis NK, 2012, NATURE, V491, P547, DOI 10.1038/nature11618; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; Molle M, 2011, SLEEP, V34, P1411, DOI 10.5665/SLEEP.1290; Molle M, 2009, EUR J NEUROSCI, V29, P1071, DOI 10.1111/j.1460-9568.2009.06654.x; Molle M, 2002, J NEUROSCI, V22, P10941; Ngo HVV, 2013, NEURON, V78, P545, DOI 10.1016/j.neuron.2013.03.006; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Rechtschaffen A., 1968, MANUAL STANDARDIZED, V20, P246; Sarasso S, 2014, NEUROIMAGE, V86, P425, DOI 10.1016/j.neuroimage.2013.10.031; Schabus M, 2007, P NATL ACAD SCI USA, V104, P13164, DOI 10.1073/pnas.0703084104; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Skaggs WE, 2007, J NEUROPHYSIOL, V98, P898, DOI 10.1152/jn.00401.2007; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Sullivan D, 2014, J NEUROSCI, V34, P662, DOI 10.1523/JNEUROSCI.0552-13.2014; Takeuchi S, 2015, SLEEP, V38, P1085, DOI 10.5665/sleep.4818; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; WIESER HG, 1985, ELECTROEN CLIN NEURO, V61, P314, DOI 10.1016/0013-4694(85)91098-3; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; Zsofia C, 2011, EUR J NEUROSCI, V33, P511, DOI 10.1111/j.1460-9568.2010.07505.x	50	360	364	7	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2015	18	11					1679	1686		10.1038/nn.4119	http://dx.doi.org/10.1038/nn.4119			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU8YT	26389842	Green Accepted			2022-12-17	WOS:000363830700027
J	Han, YG; Spassky, N; Romaguera-Ros, M; Garcia-Verdugo, JM; Aguilar, A; Schneider-Maunoury, S; Alvarez-Buylla, A				Han, Young-Goo; Spassky, Nathalie; Romaguera-Ros, Miriam; Garcia-Verdugo, Jose-Manuel; Aguilar, Andrea; Schneider-Maunoury, Sylvie; Alvarez-Buylla, Arturo			Hedgehog signaling and primary cilia are required for the formation of adult neural stem cells	NATURE NEUROSCIENCE			English	Article							INTRAFLAGELLAR TRANSPORT PROTEINS; DENTATE GYRUS; SONIC HEDGEHOG; KINESIN-II; REPRESSOR FUNCTIONS; KIDNEY-DISEASE; IN-VIVO; MOUSE; MOTOR; MICE	Neural stem cells that continue to produce neurons are retained in the adult hippocampal dentate gyrus. The mechanisms by which embryonic neural progenitors expand and transform into postnatal neural stem cells, an essential process for the continual production of neurons throughout life, remain unknown. We found that radial astrocytes, the postnatal progenitors in the dentate gyrus, failed to develop after embryonic ablation of ciliary genes or Smoothened (Smo), an essential component for Sonic hedgehog (Shh) signaling. Postnatal dentate neurogenesis failed in these mutant mice, and the dentate gyrus became severely hypotrophic. In contrast, expression of a constitutively active Smo (SmoM2-YFP) resulted in a marked expansion of the dentate gyrus. Double-mutant analyses suggested that both wild-type Smo and SmoM2-YFP function through the primary cilia. We conclude that Shh signaling, acting through the primary cilia, has a critical role in the expansion and establishment of postnatal hippocampal progenitors.	[Han, Young-Goo; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurol Surg, Inst Regenerat Med, San Francisco, CA 94143 USA; [Spassky, Nathalie; Aguilar, Andrea] Univ Paris 06, INSERM, Hop Piete Salpetriere, U711,IFR Neurosci, F-75013 Paris, France; [Romaguera-Ros, Miriam; Garcia-Verdugo, Jose-Manuel] Univ Valencia, Lab Morfol Celuar, Unidad Asociada, E-46100 Valencia, Spain; [Romaguera-Ros, Miriam; Garcia-Verdugo, Jose-Manuel] Ctr Invest Principle Felipe, E-46100 Valencia, Spain; [Schneider-Maunoury, Sylvie] Univ Paris 06, CNRS, UMR 7622, F-75005 Paris, France	University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Valencia; Prince Felipe Research Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, Inst Regenerat Med, San Francisco, CA 94143 USA.	abuylla@stemcell.ucsf.edu	García-Verdugo, José Manuel/L-8421-2017; Han, Young-Goo/N-2664-2018; Spassky, Nathalie/E-3932-2016; Schneider-Maunoury, Sylvie/K-6795-2017	García-Verdugo, José Manuel/0000-0001-9872-6499; Han, Young-Goo/0000-0002-4008-294X; Schneider-Maunoury, Sylvie/0000-0002-0797-4735; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Aguilar, Andrea/0000-0002-6115-0040; spassky, nathalie/0000-0003-4722-6464	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028478, R01NS028478, R29NS028478] Funding Source: NIH RePORTER; NICHD NIH HHS [HD32116] Funding Source: Medline; NIDDK NIH HHS [P30 DK063720] Funding Source: Medline; NINDS NIH HHS [NS28478] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bagri A, 2002, DEVELOPMENT, V129, P4249; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Davis EE, 2006, DEV CELL, V11, P9, DOI 10.1016/j.devcel.2006.06.009; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Doetsch F, 1997, J NEUROSCI, V17, P5046; Ferrante MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Fukuda S, 2003, J NEUROSCI, V23, P9357; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Haraguchi K, 2006, J BIOL CHEM, V281, P4094, DOI 10.1074/jbc.M507028200; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Le Bot N, 1998, J CELL BIOL, V143, P1559, DOI 10.1083/jcb.143.6.1559; Li GN, 2005, DEV NEUROSCI-BASEL, V27, P93, DOI 10.1159/000085980; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Long FX, 2001, DEVELOPMENT, V128, P5099; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Matsuura K, 2002, CELL MOTIL CYTOSKEL, V52, P195, DOI 10.1002/cm.10051; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Miller MS, 2005, MOL BIOL CELL, V16, P3810, DOI 10.1091/mbc.E05-05-0404; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Muresan V, 1999, J NEUROSCI, V19, P1027; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; RICKMANN M, 1987, J COMP NEUROL, V264, P449, DOI 10.1002/cne.902640403; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	46	360	376	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					277	284		10.1038/nn2059	http://dx.doi.org/10.1038/nn2059			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18297065				2022-12-17	WOS:000253548300010
J	Campbell, JN; Macosko, EZ; Fenselau, H; Pers, TH; Lyubetskaya, A; Tenen, D; Goldman, M; Verstegen, AMJ; Resch, JM; McCarroll, SA; Rosen, ED; Lowell, BB; Tsai, LT				Campbell, John N.; Macosko, Evan Z.; Fenselau, Henning; Pers, Tune H.; Lyubetskaya, Anna; Tenen, Danielle; Goldman, Melissa; Verstegen, Anne M. J.; Resch, Jon M.; McCarroll, Steven A.; Rosen, Evan D.; Lowell, Bradford B.; Tsai, Linus T.			A molecular census of arcuate hypothalamus and median eminence cell types	NATURE NEUROSCIENCE			English	Article							GENOME-WIDE ASSOCIATION; AGRP NEURONS; NERVOUS-SYSTEM; NUCLEUS; PROLACTIN; CIRCUIT; RAT; HORMONE; OBESITY; MICE	The hypothalamic arcuate-median eminence complex (Arc-ME) controls energy balance, fertility and growth through molecularly distinct cell types, many of which remain unknown. To catalog cell types in an unbiased way, we profiled gene expression in 20,921 individual cells in and around the adult mouse Arc-ME using Drop-seq. We identify 50 transcriptionally distinct Arc-ME cell populations, including a rare tanycyte population at the Arc-ME diffusion barrier, a new leptin-sensing neuron population, multiple agouti-related peptide (AgRP) and pro-opiomelanocortin (POMC) subtypes, and an orexigenic somatostatin neuron population. We extended Drop-seq to detect dynamic expression changes across relevant physiological perturbations, revealing cell type-specific responses to energy status, including distinct responses in AgRP and POMC neuron subtypes. Finally, integrating our data with human genome-wide association study data implicates two previously unknown neuron populations in the genetic control of obesity. This resource will accelerate biological discovery by providing insights into molecular and cell type diversity from which function can be inferred.	[Campbell, John N.; Fenselau, Henning; Lyubetskaya, Anna; Tenen, Danielle; Verstegen, Anne M. J.; Resch, Jon M.; Rosen, Evan D.; Lowell, Bradford B.; Tsai, Linus T.] Harvard Med Sch, Dept Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02115 USA; [Macosko, Evan Z.; Goldman, Melissa; McCarroll, Steven A.] Harvard Med Sch, Dept Genet, Boston, MA USA; [Macosko, Evan Z.; Goldman, Melissa; McCarroll, Steven A.] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Macosko, Evan Z.; McCarroll, Steven A.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Pers, Tune H.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Pers, Tune H.] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [McCarroll, Steven A.; Lowell, Bradford B.] Harvard Med Sch, Program Neurosci, Boston, MA 02115 USA; [McCarroll, Steven A.; Rosen, Evan D.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Novo Nordisk Foundation; University of Copenhagen; Statens Serum Institut; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Rosen, ED; Lowell, BB; Tsai, LT (corresponding author), Harvard Med Sch, Dept Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02115 USA.; Lowell, BB (corresponding author), Harvard Med Sch, Program Neurosci, Boston, MA 02115 USA.; Rosen, ED (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	erosen@bidmc.harvard.edu; blowell@bidmc.harvard.edu; ltsai@bidmc.harvard.edu	Macosko, Evan/X-4664-2019; Core, Vector/CAF-4832-2022	Pers, Tune/0000-0003-0207-4831; McCarroll, Steven/0000-0002-6954-8184; Tsai, Linus/0000-0002-0134-6949; Resch, Jon/0000-0002-5409-7771; Lyubetskaya, Anna/0000-0003-2485-3924	US National Institutes of Health [R01 DK096010, R01 DK089044, R01 DK071051, R01 DK075632, R37 DK053477, P30 DK057521, R01 DK102170, R01 DK085171, R01 DK102173, P30 DK046200, 2P30DK057521-16, F32 DK103387]; Department of Defense [W81XWH-15-1-0251]; American Heart Association [14POST20100011]; Lundbeck Foundation; Benzon Foundation; Stanley Center for Psychiatric Research; Stanley-MGH Fellowship in Psychiatric Neuroscience; Lundbeck Foundation [R190-2014-3904] Funding Source: researchfish; NNF Center for Basic Metabolic Research [Pers Group] Funding Source: researchfish; Novo Nordisk Fonden [NNF16OC0021496] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, P30DK046200, R01DK085171, R01DK089044, R37DK053477, R01DK071051, R01DK102173, F32DK103387, R01DK111401, R01DK102170, R01DK075632, R01DK096010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH094612] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); American Heart Association(American Heart Association); Lundbeck Foundation(Lundbeckfonden); Benzon Foundation; Stanley Center for Psychiatric Research; Stanley-MGH Fellowship in Psychiatric Neuroscience; Lundbeck Foundation(Lundbeckfonden); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We gratefully acknowledge Z. Yang, J. Madara and C. Wu for technical assistance, A. Garfield for editorial advice and P. Kharchenko for advice on SCDE. Quantitative PCR and confocal imaging were done at BIDMC's Molecular Medicine Core and Confocal Imaging Core, respectively. Funding was provided by US National Institutes of Health grants to B.B.L. (R01 DK096010, R01 DK089044, R01 DK071051,R01 DK075632, R37 DK053477, BNORC Transgenic Core P30 DK046200, BADERC Transgenic Core P30 DK057521), E.D.R. (R01 DK102170, R01 DK085171, R01 DK102173), E.D.R. and L.T.T. (BNORC Functional Genomics Core P30 DK046200), L.T.T. (BADERC Pilot and Feasibility grant NIH 2P30DK057521-16) and J.M.R. (F32 DK103387); a Department of Defense grant to L.T.T. (Discovery Award W81XWH-15-1-0251); an American Heart Association Postdoctoral Fellowship to J.N.C. (14POST20100011); the Lundbeck Foundation and the Benzon Foundation (T.H.P.); the Stanley Center for Psychiatric Research (S.A.M.); and the Stanley-MGH Fellowship in Psychiatric Neuroscience (E.Z.M.).	Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Asnicar MA, 2002, ENDOCRINOLOGY, V143, P3994, DOI 10.1210/en.2002-220354; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Boules Mona, 2013, Front Endocrinol (Lausanne), V4, P36, DOI 10.3389/fendo.2013.00036; Chitravanshi VC, 2013, AM J PHYSIOL-HEART C, V305, pH182, DOI 10.1152/ajpheart.00138.2013; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Demaria JE, 2000, ENDOCRINOLOGY, V141, P366, DOI 10.1210/en.141.1.366; EVERITT BJ, 1986, BRAIN RES REV, V11, P97, DOI 10.1016/S0006-8993(86)80192-5; Fenselau H, 2017, NAT NEUROSCI, V20, P42, DOI 10.1038/nn.4442; Garfield AS, 2016, NAT NEUROSCI, V19, P1628, DOI 10.1038/nn.4392; Garfield AS, 2015, NAT NEUROSCI, V18, P863, DOI 10.1038/nn.4011; Goodman T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00387; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Han SY, 2015, P NATL ACAD SCI USA, V112, P13109, DOI 10.1073/pnas.1512243112; Henry FE, 2015, ELIFE, V4, DOI 10.7554/eLife.09800; Hsueh YC, 2002, J NEUROENDOCRINOL, V14, P745, DOI 10.1046/j.1365-2826.2002.00835.x; KAHN D, 1980, ENDOCRINOLOGY, V107, P47, DOI 10.1210/endo-107-1-47; Kong D, 2012, CELL, V151, P645, DOI 10.1016/j.cell.2012.09.020; Kong WM, 2003, FASEB J, V17, P1688, DOI 10.1096/fj.02-0805fje; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Kuperman Y, 2016, CELL METAB, V23, P1185, DOI 10.1016/j.cmet.2016.04.017; Langlet F, 2013, CELL METAB, V17, P607, DOI 10.1016/j.cmet.2013.03.004; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu JX, 2001, P NATL ACAD SCI USA, V98, P8674, DOI 10.1073/pnas.141234898; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lyons DJ, 2012, J NEUROSCI, V32, P8074, DOI 10.1523/JNEUROSCI.0129-12.2012; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Marques S, 2016, SCIENCE, V352, P1326, DOI 10.1126/science.aaf6463; MOGA MM, 1994, J COMP NEUROL, V346, P137, DOI 10.1002/cne.903460110; Morgan P J, 1996, Rev Reprod, V1, P153, DOI 10.1530/revreprod/1.3.153; NISHIYAMA T, 1985, BRAIN RES, V345, P205, DOI 10.1016/0006-8993(85)90996-5; Novak CM, 2006, J NEUROENDOCRINOL, V18, P594, DOI 10.1111/j.1365-2826.2006.01454.x; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Rodriguez EM, 2010, PEPTIDES, V31, P757, DOI 10.1016/j.peptides.2010.01.003; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Sohn JW, 2011, NEURON, V71, P488, DOI 10.1016/j.neuron.2011.06.012; Takayasu S, 2006, P NATL ACAD SCI USA, V103, P7438, DOI 10.1073/pnas.0602371103; Tesfaigzi Johannes, 1999, Cell Biochemistry and Biophysics, V30, P243, DOI 10.1007/BF02738069; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; VIJAYAN E, 1979, BRAIN RES, V172, P295, DOI 10.1016/0006-8993(79)90539-0; Vimaleswaran KS, 2012, HUM MOL GENET, V21, P4537, DOI 10.1093/hmg/dds283; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022	50	359	361	3	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2017	20	3					484	496		10.1038/nn.4495	http://dx.doi.org/10.1038/nn.4495			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EL9DU	28166221	Green Accepted, Green Submitted			2022-12-17	WOS:000394920400026
J	Paz, JT; Davidson, TJ; Frechette, ES; Delord, B; Parada, I; Peng, K; Deisseroth, K; Huguenard, JR				Paz, Jeanne T.; Davidson, Thomas J.; Frechette, Eric S.; Delord, Bruno; Parada, Isabel; Peng, Kathy; Deisseroth, Karl; Huguenard, John R.			Closed-loop optogenetic control of thalamus as a tool for interrupting seizures after cortical injury	NATURE NEUROSCIENCE			English	Article							PHOTOTHROMBOTIC BRAIN INFARCTION; RELAY NEURONS; EPILEPTIFORM ACTIVITY; IN-VITRO; EPILEPSY; STROKE; RATS; EPILEPTOGENESIS; BIOCYTIN; MODEL	Cerebrocortical injuries such as stroke are a major source of disability. Maladaptive consequences can result from post-injury local reorganization of cortical circuits. For example, epilepsy is a common sequela of cortical stroke, but the mechanisms responsible for seizures following cortical injuries remain unknown. In addition to local reorganization, long-range, extra-cortical connections might be critical for seizure maintenance. In rats, we found that the thalamus, a structure that is remote from, but connected to, the injured cortex, was required to maintain cortical seizures. Thalamocortical neurons connected to the injured epileptic cortex underwent changes in HCN channel expression and became hyperexcitable. Targeting these neurons with a closed-loop optogenetic strategy revealed that reducing their activity in real-time was sufficient to immediately interrupt electrographic and behavioral seizures. This approach is of therapeutic interest for intractable epilepsy, as it spares cortical function between seizures, in contrast with existing treatments, such as surgical lesioning or drugs.	[Paz, Jeanne T.; Frechette, Eric S.; Parada, Isabel; Peng, Kathy; Huguenard, John R.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Davidson, Thomas J.; Deisseroth, Karl] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Delord, Bruno] Univ Paris 06, CNRS, Unite Mixte Rech 7222, Inst Syst Intelligents & Robot, Paris, France	Stanford University; Stanford University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Huguenard, JR (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	jtpaz@stanford.edu; john.huguenard@stanford.edu	Ritter, Stefanie L/D-9312-2012; Huguenard, John/K-6429-2019; Huguenard, John/I-5016-2012	Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191; Davidson, Thomas/0000-0003-0836-6333	US National Institute of Neurological Disorders and Stroke [K99NS078118-01, 5R01NS006477, 5R01NS034774]; Epilepsy Foundation; Berry Foundation; Howard Hughes Medical Institute; California Institute for Regenerative Medicine; US National Institutes of Health; Defence Advanced Research Projects Agency (DARPA) Reorganization and Plasticity to Accelerate Injury Recovery (REPAIR) Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS078118, R01NS034774, R01NS006477] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Epilepsy Foundation; Berry Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defence Advanced Research Projects Agency (DARPA) Reorganization and Plasticity to Accelerate Injury Recovery (REPAIR) Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Pisaturo for designing and fabricating custom electronics, A. Herbert and S. Jin for their help with animal husbandry, and K. Graber and D. Prince for discussions related to clinical aspects of post-stroke epilepsy. J.T.P. is supported by the US National Institute of Neurological Disorders and Stroke (grant K99NS078118-01) and the Epilepsy Foundation. J.R.H. is supported by grants from the US National Institute of Neurological Disorders and Stroke (5R01NS006477 and 5R01NS034774). T.J.D. is supported by a Berry Foundation Postdoctoral fellowship. K. D. is supported by the Howard Hughes Medical Institute, the California Institute for Regenerative Medicine, the US National Institutes of Health and the Defence Advanced Research Projects Agency (DARPA) Reorganization and Plasticity to Accelerate Injury Recovery (REPAIR) Program. E. S. F. is supported by a Epilepsy Foundation Postdoctoral Fellowship.	BRUEHL C, 1995, EUR J NEUROSCI, V7, P192, DOI 10.1111/j.1460-9568.1995.tb01055.x; Bryant AS, 2009, J NEUROPHYSIOL, V102, P2880, DOI 10.1152/jn.00476.2009; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Detre JA, 1996, EPILEPSIA, V37, P657, DOI 10.1111/j.1528-1157.1996.tb00630.x; Esteller R, 2001, P ANN INT IEEE EMBS, V23, P1707, DOI 10.1109/IEMBS.2001.1020545; GASTEIGER EL, 1985, EXP NEUROL, V88, P349, DOI 10.1016/0014-4886(85)90197-9; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762, DOI 10.1152/jn.1994.71.5.1762; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; HUGUENARD JR, 1994, J NEUROSCI, V14, P5485; HUGUENARD JR, 1992, J NEUROPHYSIOL, V68, P1373, DOI 10.1152/jn.1992.68.4.1373; Huguenard JR., 1997, THALAMUS, P295; Karhunen H, 2007, NEUROSCIENCE, V148, P314, DOI 10.1016/j.neuroscience.2007.05.047; Kelly Kevin M, 2007, Epilepsy Curr, V7, P159, DOI 10.1111/j.1535-7511.2007.00211.x; Kelly KM, 2001, EPILEPSY RES, V47, P189, DOI 10.1016/S0920-1211(01)00294-7; Kharlamov EA, 2003, EPILEPSY RES, V56, P185, DOI 10.1016/j.eplepsyres.2003.09.005; KOTILA M, 1992, EPILEPSIA, V33, P495, DOI 10.1111/j.1528-1157.1992.tb01698.x; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lee JC, 2009, BRAIN DEV-JPN, V31, P294, DOI 10.1016/j.braindev.2008.05.006; Loiseau P., 1997, SEIZURES EPILEPSY EL, P63; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; MONDRAGON S, 1990, EPILEPSY RES, V5, P137, DOI 10.1016/0920-1211(90)90030-Y; Paz JT, 2011, NAT NEUROSCI, V14, P1167, DOI 10.1038/nn.2896; Paz JT, 2010, J NEUROSCI, V30, P5465, DOI 10.1523/JNEUROSCI.5083-09.2010; Redecker C, 1997, EPILEPSY RES, V27, P127, DOI 10.1016/S0920-1211(97)01029-2; Reid CA, 2012, BRIT J PHARMACOL, V165, P49, DOI 10.1111/j.1476-5381.2011.01507.x; Schofield CM, 2009, P NATL ACAD SCI USA, V106, P7630, DOI 10.1073/pnas.0811326106; Tonnesen J, 2009, P NATL ACAD SCI USA, V106, P12162, DOI 10.1073/pnas.0901915106; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; TSENG GF, 1991, J NEUROSCI METH, V37, P121, DOI 10.1016/0165-0270(91)90122-G; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; WANG XJ, 1994, NEUROSCIENCE, V59, P21, DOI 10.1016/0306-4522(94)90095-7; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	34	359	372	5	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					64	U98		10.1038/nn.3269	http://dx.doi.org/10.1038/nn.3269			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23143518	Green Submitted, Green Accepted			2022-12-17	WOS:000312633900014
J	Lam, TKT; Schwartz, GJ; Rossetti, L				Lam, TKT; Schwartz, GJ; Rossetti, L			Hypothalamic sensing of fatty acids	NATURE NEUROSCIENCE			English	Review							ACTIVATED PROTEIN-KINASE; DECREASES FOOD-INTAKE; BODY-WEIGHT; SYNTHASE INHIBITOR; MALONYL-COA; GENE-EXPRESSION; INTRACEREBROVENTRICULAR INFUSION; LEPTIN ACTION; OBESE GENE; AMP-KINASE	Selective regions of the brain, including the hypothalamus, are capable of gathering information on the body's nutritional status in order to implement appropriate behavioral and metabolic responses to changes in fuel availability. This review focuses on direct metabolic signaling within the hypothalamus. There is growing evidence supporting the idea that fatty acid metabolism within discrete hypothalamic regions can function as a sensor for nutrient availability that can integrate multiple nutritional and hormonal signals.	Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Rossetti, L (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	rossetti@aecom.yu.edu			NIA NIH HHS [T32-AG023475, AG21654] Funding Source: Medline; NIDDK NIH HHS [DK47208, DK48321, DK45024, DK20541] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK048321, R29DK045024, R01DK045024, R01DK047208, R01DK048321, P60DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG023475, P01AG021654] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Air EL, 2002, NAT MED, V8, P179, DOI 10.1038/nm0202-179; Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; BEVERLY JL, 1991, AM J PHYSIOL, V261, pR339, DOI 10.1152/ajpregu.1991.261.2.R339; BRIEF DJ, 1984, BRAIN RES BULL, V12, P571, DOI 10.1016/0361-9230(84)90174-6; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Cinti S, 1997, ENDOCRINOLOGY, V138, P797, DOI 10.1210/en.138.2.797; Clegg DJ, 2002, DIABETES, V51, P3196, DOI 10.2337/diabetes.51.11.3196; COLEMAN DL, 1979, SCIENCE, V203, P663, DOI 10.1126/science.760211; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; DAVIS JD, 1981, SCIENCE, V212, P81, DOI 10.1126/science.7193909; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Gao S, 2003, P NATL ACAD SCI USA, V100, P5628, DOI 10.1073/pnas.1031698100; GIBBS J, 1973, J COMP PHYSIOL PSYCH, V84, P488, DOI 10.1037/h0034870; GOTO M, 1971, P SOC EXP BIOL MED, V136, P1294; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; HEDESKOV CJ, 1980, PHYSIOL REV, V60, P442, DOI 10.1152/physrev.1980.60.2.442; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; KANAREK RB, 1978, PHARMACOL BIOCHEM BE, V8, P615, DOI 10.1016/0091-3057(78)90397-0; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; KENNEDY GC, 1953, PROC R SOC SER B-BIO, V140, P578, DOI 10.1098/rspb.1953.0009; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Kim EK, 2002, AM J PHYSIOL-ENDOC M, V283, pE867, DOI 10.1152/ajpendo.00178.2002; KIM KH, 1989, FASEB J, V3, P2250, DOI 10.1096/fasebj.3.11.2570725; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Landree LE, 2004, J BIOL CHEM, V279, P3817, DOI 10.1074/jbc.M310991200; Lavrentyev EN, 2004, BIOCHEM BIOPH RES CO, V315, P174, DOI 10.1016/j.bbrc.2004.01.040; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; MACDONALD MJ, 1990, DIABETES, V39, P1461, DOI 10.2337/diabetes.39.12.1461; Makimura H, 2001, DIABETES, V50, P733, DOI 10.2337/diabetes.50.4.733; Matzinger D, 2000, GUT, V46, P688, DOI 10.1136/gut.46.5.689; MAYER J, 1953, NEW ENGL J MED, V249, P13, DOI 10.1056/NEJM195307022490104; MAYER J, 1953, PHYSIOL REV, V33, P472, DOI 10.1152/physrev.1953.33.4.472; MAYER J, 1955, ANN NY ACAD SCI, V63, P15, DOI 10.1111/j.1749-6632.1955.tb36543.x; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; Miller I, 2004, NEUROREPORT, V15, P925, DOI 10.1097/00001756-200404090-00038; MILLER JC, 1987, J NEUROCHEM, V49, P1507, DOI 10.1111/j.1471-4159.1987.tb01021.x; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Monnikes H, 1997, AM J PHYSIOL-REG I, V273, pR2059, DOI 10.1152/ajpregu.1997.273.6.R2059; MORAN TP, 1994, HUM-COMPUT INTERACT, V9, P1, DOI 10.1207/s15327051hci0901_1; Morgan K, 2004, J BIOL CHEM, V279, P31139, DOI 10.1074/jbc.M400458200; Neel JV, 1999, NUTR REV, V57, pS2, DOI 10.1111/j.1753-4887.1999.tb01782.x; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI200112954; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Qi KM, 2002, CURR OPIN CLIN NUTR, V5, P133, DOI 10.1097/00075197-200203000-00003; Rapoport SI, 2001, J MOL NEUROSCI, V16, P243, DOI 10.1385/JMN:16:2-3:243; Rapoport SI, 1996, LIPIDS, V31, pS97, DOI 10.1007/BF02637059; Ravussin E, 1999, INT J OBESITY, V23, P37, DOI 10.1038/sj.ijo.0800793; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Ruderman NB, 1997, ANN NY ACAD SCI, V827, P221, DOI 10.1111/j.1749-6632.1997.tb51837.x; SALADIN R, 1995, NATURE, V377, P527, DOI 10.1038/377527a0; Schwartz GJ, 1999, AM J PHYSIOL-REG I, V277, pR1144, DOI 10.1152/ajpregu.1999.277.4.R1144; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; Shimokawa T, 2002, P NATL ACAD SCI USA, V99, P66, DOI 10.1073/pnas.012606199; SMITH GP, 1969, AM J PHYSIOL, V217, P1083, DOI 10.1152/ajplegacy.1969.217.4.1083; Takahashi KA, 2004, ENDOCRINOLOGY, V145, P184, DOI 10.1210/en.2003-0337; Thupari JN, 2002, P NATL ACAD SCI USA, V99, P9498, DOI 10.1073/pnas.132128899; VANITALLIE TB, 1953, J CLIN NUTR, V1, P208; WALLS EK, 1989, PHYSIOL BEHAV, V45, P1223, DOI 10.1016/0031-9384(89)90113-3; Wang JL, 1999, NAT MED, V5, P895, DOI 10.1038/11335; Wang JL, 2001, DIABETES, V50, P2786, DOI 10.2337/diabetes.50.12.2786; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; Widdowson PS, 1997, DIABETES, V46, P1782, DOI 10.2337/diabetes.46.11.1782; WITT E, 1992, PROTEIN ENG, V5, P267, DOI 10.1093/protein/5.3.267; WOODS SC, 1984, AM J PHYSIOL, V247, pR393, DOI 10.1152/ajpregu.1984.247.2.R393; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	80	359	370	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					579	584		10.1038/nn1456	http://dx.doi.org/10.1038/nn1456			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15856066				2022-12-17	WOS:000228895100016
J	Wong, ST; Henley, JR; Kanning, KC; Huang, KH; Bothwell, M; Poo, M				Wong, ST; Henley, JR; Kanning, KC; Huang, KH; Bothwell, M; Poo, M			A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein	NATURE NEUROSCIENCE			English	Article							GROWTH CONE GUIDANCE; NERVE GROWTH; AXONAL REGENERATION; DIFFUSIBLE FACTORS; NEURITE OUTGROWTH; RHO GTPASES; INHIBITOR; COLLAPSE; IDENTIFICATION; NEUROTROPHINS	Myelin-associated glycoprotein (MAG), an inhibitor of axon regeneration, binds with high affinity to the Nogo-66 receptor (NgR). Here we report that the p75 neurotrophin receptor (p75(NTR)) is a co-receptor of NgR for MAG signaling. In cultured human embryonic kidney (HEK) cells expressing NgR, p75(NTR) was required for MAG-induced intracellular Ca2+ elevation. Co-immunoprecipitation showed an association of NgR with p75NTR that can be disrupted by an antibody against p75(NTR) (NGFR5), and extensive coexpression was observed in the developing rat nervous system. Furthermore, NGFR5 abolished MAG-induced repulsive turning of Xenopus axonal growth cones and Ca2+ elevation, both in neurons and in NgR/p75(NTR)-expressing HEK cells. Thus we conclude that p75(NTR) is a co-receptor of NgR for MAG signaling and a potential therapeutic target for promoting nerve regeneration.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of California System; University of California Berkeley; University of Washington; University of Washington Seattle	Poo, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.		Henley, John/D-7171-2011; Huang, Kuo-Hua/AAA-4107-2021	Huang, Kuo-Hua/0000-0001-6232-296X; Bothwell, Mark/0000-0001-5423-2702; Henley, John/0000-0003-1846-5941				BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Casaccia-Bonnefil P, 1998, CELL DEATH DIFFER, V5, P357, DOI 10.1038/sj.cdd.4400377; CHAO MV, 1986, SCIENCE, V232, P518, DOI 10.1126/science.3008331; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; DeBellard ME, 1996, MOL CELL NEUROSCI, V7, P89, DOI 10.1006/mcne.1996.0007; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Hutson LD, 2001, J NEUROBIOL, V49, P79, DOI 10.1002/neu.1067; Jiang H, 1997, J BIOL CHEM, V272, P6835, DOI 10.1074/jbc.272.11.6835; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; LOHOF AM, 1992, J NEUROSCI, V12, P1253; MARANO N, 1987, J NEUROCHEM, V48, P225, DOI 10.1111/j.1471-4159.1987.tb13151.x; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; McQuillen PS, 2002, J NEUROSCI, V22, P3580; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; PHAMDINH D, 1994, J NEUROCHEM, V63, P2353; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; SPITZER NC, 1976, P NATL ACAD SCI USA, V73, P1641, DOI 10.1073/pnas.73.5.1641; Tabti N, 1998, CULTURING NERVE CELL, P237; Turnley AM, 1998, NEUROREPORT, V9, P1987, DOI 10.1097/00001756-199806220-00013; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Walsh GS, 1999, J NEUROSCI, V19, P258, DOI 10.1523/JNEUROSCI.19-01-00258.1999; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wang Q, 1998, J NEUROSCI, V18, P4973; Wang XX, 2002, J NEUROSCI, V22, P5505; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; YAN Q, 1988, J NEUROSCI, V8, P3481; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	50	359	387	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1302	1308		10.1038/nn975	http://dx.doi.org/10.1038/nn975			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12426574				2022-12-17	WOS:000179447500013
J	Tong, XP; Ao, Y; Faas, GC; Nwaobi, SE; Xu, J; Haustein, MD; Anderson, MA; Mody, I; Olsen, ML; Sofroniew, MV; Khakh, BS				Tong, Xiaoping; Ao, Yan; Faas, Guido C.; Nwaobi, Sinifunanya E.; Xu, Ji; Haustein, Martin D.; Anderson, Mark A.; Mody, Istvan; Olsen, Michelle L.; Sofroniew, Michael V.; Khakh, Baljit S.			Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; RECTIFYING K+ CHANNEL; MUTANT HUNTINGTIN; TRANSGENIC MICE; NEUROLOGICAL SYMPTOMS; IN-VIVO; STRIATAL ASTROCYTES; GLUTAMATE TRANSPORT; KNOCK-OUT; EXPRESSION	Huntington's disease (HD) is characterized by striatal medium spiny neuron (MSN) dysfunction, but the underlying mechanisms remain unclear. We explored roles for astrocytes, in which mutant huntingtin is expressed in HD patients and mouse models. We found that symptom onset in R6/2 and Q175 HD mouse models was not associated with classical astrogliosis, but was associated with decreased Kir4.1 K+ channel functional expression, leading to elevated in vivo striatal extracellular K+, which increased MSN excitability in vitro. Viral delivery of Kir4.1 channels to striatal astrocytes restored Kir4.1 function, normalized extracellular K+, ameliorated aspects of MSN dysfunction, prolonged survival and attenuated some motor phenotypes in R6/2 mice. These findings indicate that components of altered MSN excitability in HD may be caused by heretofore unknown disturbances of astrocyte-mediated K+ homeostasis, revealing astrocytes and Kir4.1 channels as therapeutic targets.	[Tong, Xiaoping; Xu, Ji; Haustein, Martin D.; Mody, Istvan; Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Ao, Yan; Anderson, Mark A.; Sofroniew, Michael V.; Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Faas, Guido C.; Mody, Istvan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Nwaobi, Sinifunanya E.; Olsen, Michelle L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Alabama System; University of Alabama Birmingham	Khakh, BS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	sofroniew@mednet.ucla.edu; bkhakh@mednet.ucla.edu	Sofroniew, Michael/ABE-8857-2020; Xu, Ji/E-5986-2013	Faas, Guido/0000-0002-1339-7698; Olsen, Michelle/0000-0003-1394-664X; Tong, Xiaoping/0000-0002-0908-8091	CHDI Foundation; US National Institutes of Health [NS060677, MH104069]; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH104069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075062, R01NS060677] Funding Source: NIH RePORTER	CHDI Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank P. Kofuji (University of Minnesota) for sharing Kir4.1- GFP plasmids, R. Korsak for coordinating the genotyping, and V. Beaumont, I. Munoz-Sanjuan, M.S. Levine, C. Cepeda, E. Shigetomi, and all current and past members of the Khakh and Sofroniew laboratories for discussions. This work was supported by the CHDI Foundation (B.S.K., M.V.S., X.T., Y.A.) and the US National Institutes of Health (NS060677, MH104069 to B.S.K.).	Adermark L, 2008, NEUROCHEM INT, V52, P1365, DOI 10.1016/j.neuint.2008.02.006; Amzica F, 2002, SLEEP MED REV, V6, P139, DOI 10.1053/smrv.2001.0181; Ariano MA, 2005, J NEUROSCI RES, V80, P634, DOI 10.1002/jnr.20492; Ariano MA, 2005, J NEUROPHYSIOL, V93, P2565, DOI 10.1152/jn.00791.2004; BARRES BA, 1991, ANN NY ACAD SCI, V633, P248; BARRES BA, 1990, NEURON, V5, P527, DOI 10.1016/0896-6273(90)90091-S; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Behrens PF, 2002, BRAIN, V125, P1908, DOI 10.1093/brain/awf180; Benn CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-17; Bradford J, 2010, J BIOL CHEM, V285, P10653, DOI 10.1074/jbc.M109.083287; Bradford J, 2009, P NATL ACAD SCI USA, V106, P22480, DOI 10.1073/pnas.0911503106; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cepeda C, 2010, ASN NEURO, V2, DOI 10.1042/AN20090058; Chever O, 2010, J NEUROSCI, V30, P15769, DOI 10.1523/JNEUROSCI.2078-10.2010; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Estrada-Sanchez AM, 2012, BASAL GANGLIA, V2, P57, DOI 10.1016/j.baga.2012.04.029; Faideau M, 2010, HUM MOL GENET, V19, P3053, DOI 10.1093/hmg/ddq212; Furutani K, 2009, MOL PHARMACOL, V75, P1287, DOI 10.1124/mol.108.052936; Hall DG, 1996, J PHYS CHEM-US, V100, P7230, DOI 10.1021/jp9603039; Hamby ME, 2012, J NEUROSCI, V32, P14489, DOI 10.1523/JNEUROSCI.1256-12.2012; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Higashi K, 2001, AM J PHYSIOL-CELL PH, V281, pC922, DOI 10.1152/ajpcell.2001.281.3.C922; Hille B., 2001, ION CHANNELS EXCITAB; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667, DOI 10.1152/jn.2001.86.6.2667; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; KUFFLER SW, 1967, PROC R SOC SER B-BIO, V168, P1, DOI 10.1098/rspb.1967.0047; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Miller BR, 2008, NEUROSCIENCE, V153, P329, DOI 10.1016/j.neuroscience.2008.02.004; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Poopalasundaram S, 2000, GLIA, V30, P362, DOI 10.1002/(SICI)1098-1136(200006)30:4<362::AID-GLIA50>3.0.CO;2-4; Pouladi MA, 2013, NAT REV NEUROSCI, V14, P708, DOI 10.1038/nrn3570; Ransom BR, 2012, METHODS MOL BIOL, V814, P3, DOI 10.1007/978-1-61779-452-0_1; Rubinsztein David C, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006549; Shigetomi E, 2013, J GEN PHYSIOL, V141, P633, DOI 10.1085/jgp.201210949; Shigetomi E, 2012, NAT NEUROSCI, V15, P70, DOI 10.1038/nn.3000; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Strand AD, 2007, J NEUROSCI, V27, P11758, DOI 10.1523/JNEUROSCI.2461-07.2007; Su SW, 2007, J PHARMACOL EXP THER, V320, P573, DOI 10.1124/jpet.106.112094; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Wang CE, 2008, J CELL BIOL, V181, P803, DOI 10.1083/jcb.200710158; Xie Y, 2010, NEUROSCIENCE, V170, P992, DOI 10.1016/j.neuroscience.2010.08.034; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	49	358	369	14	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2014	17	5					694	+		10.1038/nn.3691	http://dx.doi.org/10.1038/nn.3691			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AF9DS	24686787	Green Submitted, Green Accepted			2022-12-17	WOS:000335016200013
J	Matsumoto, M; Hikosaka, O				Matsumoto, Masayuki; Hikosaka, Okihide			Representation of negative motivational value in the primate lateral habenula	NATURE NEUROSCIENCE			English	Article							MIDBRAIN DOPAMINE NEURONS; DORSAL RAPHE NUCLEUS; ORBITOFRONTAL CORTEX; MATCHING BEHAVIOR; PREFRONTAL CORTEX; AVERSIVE STIMULI; NEURAL RESPONSES; REWARD; RAT; PREDICTION	An action may lead to either a reward or a punishment. Therefore, an appropriate action needs to be chosen on the basis of the values of both expected rewards and expected punishments. To understand the underlying neural mechanisms, we conditioned monkeys using a Pavlovian procedure with two distinct contexts: one in which rewards were available and another in which punishments were feared. We found that the population of lateral habenula neurons was most strongly excited by a conditioned stimulus associated with the most unpleasant event in each context: the absence of the reward or the presence of the punishment. The population of lateral habenula neurons was also excited by the punishment itself and inhibited by the reward itself, especially when they were less predictable. These results suggest that the lateral habenula has the potential to adaptively control both reward-seeking and punishment-avoidance behaviors, presumably through its projections to dopaminergic and serotonergic systems.	[Matsumoto, Masayuki; Hikosaka, Okihide] NEI, Sensorimotor Res Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Matsumoto, M (corresponding author), NEI, Sensorimotor Res Lab, US Natl Inst Hlth, 49 Convent Dr, Bethesda, MD 20892 USA.	matsumotom@nei.nih.gov			National Institutes of Health, National Eye Institute; NATIONAL EYE INSTITUTE [ZIAEY000415] Funding Source: NIH RePORTER	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank S. Hong, M. Yasuda and E. Bromberg-Martin for valuable discussion, and M. K. Smith, J. W. McClurkin, A. M. Nichols, T. W. Ruffner, A. V. Hays and L. P. Jensen for technical assistance. This research was supported by the Intramural Research Program at the National Institutes of Health, National Eye Institute.	Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Gandhi NJ, 2005, J NEUROPHYSIOL, V93, P1718, DOI 10.1152/jn.00854.2004; Glimcher PW, 2005, ANNU REV PSYCHOL, V56, P25, DOI 10.1146/annurev.psych.55.090902.141429; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; HERKENHAM M, 1977, J COMP NEUROL, V173, P123, DOI 10.1002/cne.901730107; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Kobayashi S, 2006, NEURON, V51, P861, DOI 10.1016/j.neuron.2006.08.031; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Lecourtier L, 2008, EUR J NEUROSCI, V27, P1755, DOI 10.1111/j.1460-9568.2008.06130.x; Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Nakamura K, 2008, J NEUROSCI, V28, P5331, DOI 10.1523/JNEUROSCI.0021-08.2008; Nieuwenhuis S, 2005, NEUROIMAGE, V25, P1302, DOI 10.1016/j.neuroimage.2004.12.043; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; PARENT A, 1981, BRAIN RES BULL, V6, P23, DOI 10.1016/S0361-9230(81)80066-4; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Sallet J, 2007, COGN AFFECT BEHAV NE, V7, P327, DOI 10.3758/CABN.7.4.327; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Seymour B, 2007, NAT REV NEUROSCI, V8, P300, DOI 10.1038/nrn2119; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; SUTHERLAND RJ, 1982, NEUROSCI BIOBEHAV R, V6, P1, DOI 10.1016/0149-7634(82)90003-3; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; WANG RY, 1977, SCIENCE, V197, P89, DOI 10.1126/science.194312; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yamada H, 2004, J NEUROSCI, V24, P3500, DOI 10.1523/JNEUROSCI.0068-04.2004; Yang LM, 2008, BEHAV BRAIN RES, V188, P84, DOI 10.1016/j.bbr.2007.10.022	40	358	368	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2009	12	1					77	84		10.1038/nn.2233	http://dx.doi.org/10.1038/nn.2233			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	388HL	19043410	Green Accepted			2022-12-17	WOS:000262010800018
J	Sweeney, MD; Kisler, K; Montagne, A; Toga, AW; Zlokovic, BV				Sweeney, Melanie D.; Kisler, Kassandra; Montagne, Axel; Toga, Arthur W.; Zlokovic, Berislav V.			The role of brain vasculature in neurodegenerative disorders	NATURE NEUROSCIENCE			English	Review							CEREBRAL-BLOOD-FLOW; MILD COGNITIVE IMPAIRMENT; DIMINISHED GLUCOSE-TRANSPORT; ALZHEIMERS-DISEASE; NEUROVASCULAR DYSFUNCTION; MULTIPLE-SCLEROSIS; FUNCTIONAL HYPEREMIA; APOLIPOPROTEIN-E; P-GLYCOPROTEIN; RISK-FACTORS	Adequate supply of blood and structural and functional integrity of blood vessels are key to normal brain functioning. On the other hand, cerebral blood flow shortfalls and blood-brain barrier dysfunction are early findings in neurodegenerative disorders in humans and animal models. Here we first examine molecular definition of cerebral blood vessels, as well as pathways regulating cerebral blood flow and blood-brain barrier integrity. Then we examine the role of cerebral blood flow and blood-brain barrier in the pathogenesis of Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and multiple sclerosis. We focus on Alzheimer's disease as a platform of our analysis because more is known about neurovascular dysfunction in this disease than in other neurodegenerative disorders. Finally, we propose a hypothetical model of Alzheimer's disease biomarkers to include brain vasculature as a factor contributing to the disease onset and progression, and we suggest a common pathway linking brain vascular contributions to neurodegeneration in multiple neurodegenerative disorders.	[Sweeney, Melanie D.; Kisler, Kassandra; Montagne, Axel; Zlokovic, Berislav V.] Univ Southern Calif, Keck Sch Med, Dept Physiol & Neurosci, Los Angeles, CA 90007 USA; [Toga, Arthur W.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA USA; [Sweeney, Melanie D.; Kisler, Kassandra; Montagne, Axel] Univ Southern Calif, Keck Sch Med, Stevens Inst Neuroimaging & Informat, Lab Neuro Imaging, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California	Zlokovic, BV (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Physiol & Neurosci, Los Angeles, CA 90007 USA.	zlokovic@usc.edu	Zlokovic, Berislav/ABE-7362-2020; Montagne, Axel/AAV-4343-2020	Zlokovic, Berislav/0000-0002-6802-8232; Montagne, Axel/0000-0001-5564-985X; Kisler, Kassandra/0000-0002-4161-2498; Sweeney, Melanie/0000-0001-9009-6488	National Institutes of Health [R01AG023084, R01NS090904, R01NS034467, R01AG039452, 1R01NS100459, 5P01AG052350, 5P50AG005142]; Alzheimer's Association; Cure Alzheimer's Fund; Foundation Leducq Transatlantic Network of Excellence for the Study of Perivascular Spaces in Small Vessel Disease [16 CVD 05]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS090904, R01NS034467, R01NS100459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG039452, P50AG005142, R01AG023084, RF1AG039452, P01AG052350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Cure Alzheimer's Fund; Foundation Leducq Transatlantic Network of Excellence for the Study of Perivascular Spaces in Small Vessel Disease; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work of B.V.Z. is supported by the National Institutes of Health grants R01AG023084, R01NS090904, R01NS034467, R01AG039452, 1R01NS100459, 5P01AG052350, and 5P50AG005142, in addition to the Alzheimer's Association, Cure Alzheimer's Fund, and the Foundation Leducq Transatlantic Network of Excellence for the Study of Perivascular Spaces in Small Vessel Disease reference no. 16 CVD 05. We apologize to those authors whose excellent original papers we were not able to cite due to space limitations; instead, we sometimes cited recent reviews by leading authorities so that the reader can access all key primary papers in the field of our review.	Al-Bachari S, 2016, THESIS; Al-Bachari S, 2017, J CEREBR BLOOD F MET, V37, P3409, DOI 10.1177/0271678X16688919; Alarcon-Martinez L, 2018, ELIFE, V7, DOI 10.7554/eLife.34861; Alata W, 2015, J CEREBR BLOOD F MET, V35, P86, DOI 10.1038/jcbfm.2014.172; Alexopoulos P, 2012, EUR ARCH PSY CLIN N, V262, P69, DOI 10.1007/s00406-011-0226-2; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Arvanitakis Z, 2016, LANCET NEUROL, V15, P934, DOI 10.1016/S1474-4422(16)30029-1; Bailly M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/583931; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Beny JL, 2008, J CARDIOVASC PHARM, V51, P505, DOI 10.1097/FJC.0b013e31816d5f2f; Biesecker KR, 2016, J NEUROSCI, V36, P9435, DOI 10.1523/JNEUROSCI.1782-16.2016; Blair LJ, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0186-2; Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Brundel M, 2012, J ALZHEIMERS DIS, V31, P259, DOI 10.3233/JAD-2012-120364; Cacciottolo M, 2016, NEUROBIOL AGING, V37, P47, DOI 10.1016/j.neurobiolaging.2015.10.010; Chen JJ, 2012, NEUROIMAGE, V59, P1043, DOI 10.1016/j.neuroimage.2011.08.112; Chen Y, 2011, NEUROLOGY, V77, P1977, DOI 10.1212/WNL.0b013e31823a0ef7; Cirrito JR, 2005, J CLIN INVEST, V115, P3285, DOI 10.1172/JCI25247; Cramer SP, 2014, NEUROIMAGE-CLIN, V4, P182, DOI 10.1016/j.nicl.2013.12.001; Dai WY, 2009, RADIOLOGY, V250, P856, DOI 10.1148/radiol.2503080751; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642; Deo AK, 2014, J NUCL MED, V55, P1106, DOI 10.2967/jnumed.113.130161; Drouin-Ouellet J, 2015, ANN NEUROL, V78, P160, DOI 10.1002/ana.24406; Dumas A, 2012, ANN NEUROL, V72, P76, DOI 10.1002/ana.23566; Fernandez-Klett F, 2010, P NATL ACAD SCI USA, V107, P22290, DOI 10.1073/pnas.1011321108; Camargo CHF, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/523041; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gaitan MI, 2011, ANN NEUROL, V70, P22, DOI 10.1002/ana.22472; de Eulate RG, 2017, J ALZHEIMERS DIS, V58, P585, DOI 10.3233/JAD-161222; Gebremedhin D, 2000, CIRC RES, V87, P60, DOI 10.1161/01.RES.87.1.60; Gejl M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17718-y; Gerwien H, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8020; Hajjar I, 2015, J AM GERIATR SOC, V63, P276, DOI 10.1111/jgs.13235; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Ham JH, 2014, J NEUROL, V261, P1628, DOI 10.1007/s00415-014-7403-y; Hartmann DA, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.4.041402; Hays CC, 2016, CELL MOL NEUROBIOL, V36, P167, DOI 10.1007/s10571-015-0261-z; Hecht M, 2018, ACTA NEUROPATHOL, V135, P681, DOI 10.1007/s00401-018-1834-y; Heringa SM, 2014, J ALZHEIMERS DIS, V38, P211, DOI 10.3233/JAD-130542; Hill RA, 2015, NEURON, V87, P95, DOI 10.1016/j.neuron.2015.06.001; Hillman EMC, 2014, ANNU REV NEUROSCI, V37, P161, DOI 10.1146/annurev-neuro-071013-014111; Hojjat SP, 2016, AM J NEURORADIOL, V37, P1454, DOI 10.3174/ajnr.A4737; HORWOOD N, 1994, VIRCHOWS ARCH, V425, P69; Hu WT, 2010, NEUROLOGY, V75, P881, DOI 10.1212/WNL.0b013e3181f11e35; Iaccarino L, 2017, J ALZHEIMERS DIS, V59, P603, DOI 10.3233/JAD-170158; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Ingrisch M, 2012, INVEST RADIOL, V47, P252, DOI 10.1097/RLI.0b013e31823bfc97; Iturria-Medina Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11934; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; JAGUST WJ, 1991, J CEREBR BLOOD F MET, V11, P323, DOI 10.1038/jcbfm.1991.65; KALARIA RN, 1989, J NEUROCHEM, V53, P1083, DOI 10.1111/j.1471-4159.1989.tb07399.x; Kilbourn MR, 2017, SEMIN NUCL MED, V47, P536, DOI 10.1053/j.semnuclmed.2017.05.005; Kim JH, 2015, EUR J NEUROL, V22, P377, DOI 10.1111/ene.12584; Kisler K, 2017, NAT REV NEUROSCI, V18, P419, DOI 10.1038/nrn.2017.48; Kisler K, 2017, NAT NEUROSCI, V20, P406, DOI 10.1038/nn.4489; Kortekaas R, 2005, ANN NEUROL, V57, P176, DOI 10.1002/ana.20369; Kur J, 2014, J PHYSIOL-LONDON, V592, P491, DOI 10.1113/jphysiol.2013.267294; Kwan JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035241; Landau SM, 2010, NEUROLOGY, V75, P230, DOI 10.1212/WNL.0b013e3181e8e8b8; Landau SM, 2011, NEUROBIOL AGING, V32, P1207, DOI 10.1016/j.neurobiolaging.2009.07.002; Leeuwis AE, 2017, ALZHEIMERS DEMENT, V13, P531, DOI 10.1016/j.jalz.2016.08.013; Leijenaar Jolien F, 2017, Alzheimers Dement (Amst), V9, P76, DOI 10.1016/j.dadm.2017.10.001; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Longden TA, 2017, NAT NEUROSCI, V20, P717, DOI 10.1038/nn.4533; Ma HR, 2017, ONCOTARGET, V8, P93196, DOI 10.18632/oncotarget.21475; Mapelli L, 2017, J NEUROSCI, V37, P1340, DOI 10.1523/JNEUROSCI.2025-16.2016; Marshall O, 2016, J CEREBR BLOOD F MET, V36, P2087, DOI 10.1177/0271678X16654922; Meel-van den Abeelen ASS, 2014, CURR ALZHEIMER RES, V11, P11; Melzer TR, 2011, BRAIN, V134, P845, DOI 10.1093/brain/awq377; Michels L, 2016, J CEREBR BLOOD F MET, V36, P581, DOI 10.1177/0271678X15605847; Mishra A, 2016, NAT NEUROSCI, V19, P1619, DOI 10.1038/nn.4428; Montagne A, 2018, NAT MED, V24, P326, DOI 10.1038/nm.4482; Montagne A, 2017, J EXP MED, V214, P3151, DOI 10.1084/jem.20171406; Montagne A, 2016, ACTA NEUROPATHOL, V131, P687, DOI 10.1007/s00401-016-1570-0; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Montagne A, 2012, NEUROIMAGE, V63, P760, DOI 10.1016/j.neuroimage.2012.07.018; Mooradian AD, 1997, NEUROBIOL AGING, V18, P469, DOI 10.1016/S0197-4580(97)00111-5; Mosconi L, 2008, J NUCL MED, V49, P390, DOI 10.2967/jnumed.107.045385; Mosconi L, 2006, J NUCL MED, V47, P1778; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Mosconi L, 2013, NEUROBIOL AGING, V34, P22, DOI 10.1016/j.neurobiolaging.2012.03.002; Murphy MJ, 2012, AMYOTROPH LATERAL SC, V13, P202, DOI 10.3109/17482968.2011.625569; Nation DA, 2013, J ALZHEIMERS DIS, V36, P689, DOI 10.3233/JAD-130086; Nelson AR, 2016, BBA-MOL BASIS DIS, V1862, P887, DOI 10.1016/j.bbadis.2015.12.016; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Nikolakopoulou AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176225; Nippert AR, 2018, NEUROSCIENTIST, V24, P73, DOI 10.1177/1073858417703033; Niwa K, 2000, P NATL ACAD SCI USA, V97, P9735, DOI 10.1073/pnas.97.17.9735; Park L, 2014, STROKE, V45, P1815, DOI 10.1161/STROKEAHA.114.005179; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Piert M, 1996, J NUCL MED, V37, P201; Poliakova T, 2016, J NEUROL, V263, P1961, DOI 10.1007/s00415-016-8220-2; Protas HD, 2013, JAMA NEUROL, V70, P320, DOI 10.1001/2013.jamaneurol.286; Rabin JS, 2018, JAMA NEUROL, V75, P1124, DOI 10.1001/jamaneurol.2018.1123; Rombouts SARB, 2000, AM J NEURORADIOL, V21, P1869; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Rule RR, 2010, NEUROLOGY, V74, P821, DOI 10.1212/WNL.0b013e3181d3e2dd; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Saito S, 2016, CURR OPIN PSYCHIATR, V29, P168, DOI 10.1097/YCO.0000000000000239; Shams S, 2015, AM J NEURORADIOL, V36, P661, DOI 10.3174/ajnr.A4176; Shams S, 2016, BIOMARK MED, V10, P9, DOI 10.2217/bmm.15.101; Shih A., 2017, OPTICS BRAIN BRW3B 1; SIMPSON IA, 1994, ANN NEUROL, V35, P546, DOI 10.1002/ana.410350507; Small SA, 1999, ANN NEUROL, V45, P466, DOI 10.1002/1531-8249(199904)45:4<466::AID-ANA8>3.0.CO;2-Q; Sosa MAG, 2010, AM J PATHOL, V176, P353, DOI 10.2353/ajpath.2010.090482; Suri S, 2015, ALZHEIMERS DEMENT, V11, P648, DOI 10.1016/j.jalz.2014.05.1755; Sweeney MD, 2018, NAT REV NEUROL, V14, P133, DOI 10.1038/nrneurol.2017.188; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Sweeney MD, 2015, J CEREBR BLOOD F MET, V35, P1055, DOI 10.1038/jcbfm.2015.76; Syrimi ZJ, 2017, J NEURAL TRANSM, V124, P551, DOI 10.1007/s00702-017-1703-1; Taheri S, 2011, MAGN RESON MED, V65, P1036, DOI 10.1002/mrm.22686; Thambisetty M, 2010, ARCH NEUROL-CHICAGO, V67, P93, DOI 10.1001/archneurol.2009.913; Toledo JB, 2013, BRAIN, V136, P2697, DOI 10.1093/brain/awt188; Uetani H, 2013, AM J NEURORADIOL, V34, P984, DOI 10.3174/ajnr.A3332; Uhlirova H, 2016, ELIFE, V5, DOI [10.7554/elife.14315, 10.7554/eLife.14315]; van Assema DME, 2012, BRAIN, V135, P181, DOI 10.1093/brain/awr298; van de Haar HJ, 2017, MED PHYS, V44, P4112, DOI 10.1002/mp.12328; van de Haar HJ, 2016, RADIOLOGY, V281, P527, DOI 10.1148/radiol.2016152244; van de Haar HJ, 2016, NEUROBIOL AGING, V45, P190, DOI 10.1016/j.neurobiolaging.2016.06.006; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; Wang YS, 2016, CURR TOP DEV BIOL, V117, P113, DOI 10.1016/bs.ctdb.2015.11.028; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wei HS, 2016, NEURON, V91, P851, DOI 10.1016/j.neuron.2016.07.016; Wen PH, 2005, DEVELOPMENT, V132, P3873, DOI 10.1242/dev.01946; Wierenga CE, 2012, J CEREBR BLOOD F MET, V32, P1589, DOI 10.1038/jcbfm.2012.58; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Wirth M., 2016, J CEREB BLOOD FLOW M, DOI [10.1177/2F0271678X16641128, DOI 10.1177/2F0271678X16641128]; Yamada M, 2001, P NATL ACAD SCI USA, V98, P14096, DOI 10.1073/pnas.251542998; Yamashiro K, 2015, PARKINSONISM RELAT D, V21, P1076, DOI 10.1016/j.parkreldis.2015.06.019; Yao Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4413; Yates PA, 2014, NEUROLOGY, V82, P1266, DOI 10.1212/WNL.0000000000000285; Yezhuvath US, 2012, NEUROBIOL AGING, V33, P75, DOI 10.1016/j.neurobiolaging.2010.02.005; Yoshiura T, 2009, AM J NEURORADIOL, V30, P1388, DOI 10.3174/ajnr.A1562; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	149	357	366	20	146	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2018	21	10					1318	1331		10.1038/s41593-018-0234-x	http://dx.doi.org/10.1038/s41593-018-0234-x			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU9FY	30250261	Green Accepted			2022-12-17	WOS:000445651600007
J	Hama, H; Hioki, H; Namiki, K; Hoshida, T; Kurokawa, H; Ishidate, F; Kaneko, T; Akagi, T; Saito, T; Saido, T; Miyawaki, A				Hama, Hiroshi; Hioki, Hiroyuki; Namiki, Kana; Hoshida, Tetsushi; Kurokawa, Hiroshi; Ishidate, Fumiyoshi; Kaneko, Takeshi; Akagi, Takumi; Saito, Takashi; Saido, Takaomi; Miyawaki, Atsushi			Sca/eS: an optical clearing palette for biological imaging	NATURE NEUROSCIENCE			English	Article							SINGLE-CELL RESOLUTION; AMYLOID DEPOSITION; MOUSE MODELS; TISSUE; DISEASE; VISUALIZATION; MECHANISMS; MORPHOLOGY; PRECURSOR; BRAIN	Optical clearing methods facilitate deep biological imaging by mitigating light scattering in situ. Multi-scale high-resolution imaging requires preservation of tissue integrity for accurate signal reconstruction. However, existing clearing reagents contain chemical components that could compromise tissue structure, preventing reproducible anatomical and fluorescence signal stability. We developed Sca /eS, a sorbitol-based optical clearing method that provides stable tissue preservation for immunochemical labeling and three-dimensional (3D) signal rendering. Sca /eS permitted optical reconstructions of aged and diseased brain in Alzheimer's disease models, including mapping of 3D networks of amyloid plaques, neurons and microglia, and multi-scale tracking of single plaques by successive fluorescence and electron microscopy. Human clinical samples from Alzheimer's disease patients analyzed via reversible optical re-sectioning illuminated plaque pathogenesis in the z axis. Comparative benchmarking of contemporary clearing agents showed superior signal and structure preservation by Sca /eS. These findings suggest that Sca /eS is a simple and reproducible method for accurate visualization of biological tissue.	[Hama, Hiroshi; Namiki, Kana; Kurokawa, Hiroshi; Ishidate, Fumiyoshi; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Lab Cell Funct Dynam, Wako, Saitama, Japan; [Hioki, Hiroyuki; Kaneko, Takeshi] Kyoto Univ, Grad Sch Med, Dept Morphol Brain Sci, Sakyo Ku, Kyoto, Japan; [Hoshida, Tetsushi; Miyawaki, Atsushi] RIKEN, Biotechnol Opt Res Team, Ctr Adv Photon, Wako, Saitama, Japan; [Akagi, Takumi] RIKEN, Support Unit Anim Resources Dev, Brain Sci Inst, Wako, Saitama, Japan; [Saito, Takashi; Saido, Takaomi] RIKEN, Lab Proteolyt Neurosci, Brain Sci Inst, Wako, Saitama, Japan	RIKEN; Kyoto University; RIKEN; RIKEN; RIKEN	Miyawaki, A (corresponding author), RIKEN, Brain Sci Inst, Lab Cell Funct Dynam, Wako, Saitama, Japan.	matsushi@brain.riken.jp	Saido, Takaomi C/N-5472-2015; Hioki, Hiroyuki/J-9412-2017; Miyawaki, Atsushi/K-3569-2014; Sado, Takaomi/AAN-2759-2021; Saito, Takashi/G-2563-2015	Saido, Takaomi C/0000-0003-1970-6903; Hioki, Hiroyuki/0000-0002-0152-7854; Miyawaki, Atsushi/0000-0002-2329-3235; Sado, Takaomi/0000-0003-1970-6903; Saito, Takashi/0000-0002-9659-9251	Japan Ministry of Education, Culture, Sports, Science and Technology; Human Frontier Science Program; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and development, AMED; Grants-in-Aid for Scientific Research [15H01430] Funding Source: KAKEN	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Sakurai for general assistance, RIKEN BSI-Olympus Collaboration Center for technical support, K. Higuchi, K. Ishihara, D. Nishiwaki, Y. Ue, K. Okazaki, A. Yaguchi, Y. Sato, H. Sakuma, K. Koga and B. Zimmermann for help with acquiring and analyzing LM images, K. Okamoto-Furuta and H. Kohda (Division of Electron Microscopic Study Center for Anatomical Studies, Graduate School of Medicine, Kyoto University) for their technical assistance in EM, G. Augustine (Duke University) for the ChR2-YFP Tg mice, J.R. Sanes (Harvard University) for the YFP-H line, R. Takahashi, Dr. K. Sohya and T. Tsumoto for advice on Tg mice, and C. Yokoyama and A. Terashima for critical reading and editing of the manuscript. This work was supported in part by grants from the Japan Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research on Priority Areas, the Human Frontier Science Program, and the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and development, AMED.	Aho L, 2010, J ALZHEIMERS DIS, V20, P1015, DOI 10.3233/JAD-2010-091681; Aoyagi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116280; Chiang AS, 2002, P NATL ACAD SCI USA, V99, P37, DOI 10.1073/pnas.012318899; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Condello C, 2011, SCI REP-UK, V1, DOI 10.1038/srep00019; D'Andrea MR, 2004, NEUROBIOL AGING, V25, P675, DOI 10.1016/j.neurobiolaging.2003.12.026; Davanlou M., 2004, Image Analysis & Stereology, V23, P1, DOI 10.5566/ias.v23.p1-11; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 2007, ACTA NEUROPATHOL, V114, P551, DOI 10.1007/s00401-007-0284-8; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hou B, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00019; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kozlowski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031814; Kumar-Singh S, 2005, AM J PATHOL, V167, P527, DOI 10.1016/S0002-9440(10)62995-1; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Mrak RE, 2012, INT J ALZHEIMERS DIS, V2012, P165021, DOI DOI 10.1155/2012; Oh Kwang-Jin, 2010, Int J Alzheimers Dis, V2010, DOI 10.4061/2010/780102; Ono M, 2009, BIOORGAN MED CHEM, V17, P7002, DOI 10.1016/j.bmc.2009.08.032; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; OZAKI HS, 1992, J COMP NEUROL, V323, P81, DOI 10.1002/cne.903230107; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; Saito T, 2014, NAT NEUROSCI, V17, P661, DOI 10.1038/nn.3697; Serrano-Pozo A, 2013, J NEUROPATH EXP NEUR, V72, P462, DOI 10.1097/NEN.0b013e3182933788; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034; Thal DR, 2008, ACTA NEUROPATHOL, V115, P175, DOI 10.1007/s00401-007-0330-6; Thal DR, 2006, SCI AGING KNOWLEDGE, V2006, P1; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Torres-Platas SG, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-12; Vidal R, 2012, FASEB J, V26, P2899, DOI 10.1096/fj.12-205542; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Yoshikawa F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013932; Zhu DY, 2003, J NEUROSCI, V23, P223	39	357	372	8	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2015	18	10					1518	+		10.1038/nn.4107	http://dx.doi.org/10.1038/nn.4107			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CS2OK	26368944				2022-12-17	WOS:000361910600024
J	Clopath, C; Busing, L; Vasilaki, E; Gerstner, W				Clopath, Claudia; Buesing, Lars; Vasilaki, Eleni; Gerstner, Wulfram			Connectivity reflects coding: a model of voltage-based STDP with homeostasis	NATURE NEUROSCIENCE			English	Article							TIMING-DEPENDENT PLASTICITY; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; DENDRITIC SPIKES; INDUCTION; LTD; DEPOLARIZATION; SYNCHRONY; NETWORK; SWITCH	Electrophysiological connectivity patterns in cortex often have a few strong connections, which are sometimes bidirectional, among a lot of weak connections. To explain these connectivity patterns, we created a model of spike timing-dependent plasticity (STDP) in which synaptic changes depend on presynaptic spike arrival and the postsynaptic membrane potential, filtered with two different time constants. Our model describes several nonlinear effects that are observed in STDP experiments, as well as the voltage dependence of plasticity. We found that, in a simulated recurrent network of spiking neurons, our plasticity rule led not only to development of localized receptive fields but also to connectivity patterns that reflect the neural code. For temporal coding procedures with spatio-temporal input correlations, strong connections were predominantly unidirectional, whereas they were bidirectional under rate-coded input with spatial correlations only. Thus, variable connectivity patterns in the brain could reflect different coding principles across brain areas; moreover, our simulations suggested that plasticity is fast.	[Clopath, Claudia; Buesing, Lars; Vasilaki, Eleni; Gerstner, Wulfram] Ecole Polytech Fed Lausanne, Lab Computat Neurosci, Brain Mind Inst, Lausanne, Switzerland; [Clopath, Claudia; Buesing, Lars; Vasilaki, Eleni; Gerstner, Wulfram] Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Clopath, C (corresponding author), Ecole Polytech Fed Lausanne, Lab Computat Neurosci, Brain Mind Inst, Lausanne, Switzerland.	claudia.clopath@epfl.ch		Vasilaki, Eleni/0000-0003-3705-7070	FACETS; Swiss National Science Foundation	FACETS(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the European project FACETS and the Swiss National Science Foundation.	[Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Badel L, 2008, J NEUROPHYSIOL, V99, P656, DOI 10.1152/jn.01107.2007; Blais BS, 1998, NEURAL COMPUT, V10, P1797, DOI 10.1162/089976698300017142; Brader JM, 2007, NEURAL COMPUT, V19, P2881, DOI 10.1162/neco.2007.19.11.2881; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Clopath C, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000248; Cooper L., 2004, THEORY CORTICAL PLAS; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gerstner W., 2002, SPIKING NEURON MODEL; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Hardie J, 2009, J NEUROSCI, V29, P3233, DOI 10.1523/JNEUROSCI.6000-08.2009; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; JADHAV SP, 2009, NAT NEUROSCI; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; Kozloski J, 2008, TOPOLOGICAL EFFECTS; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Legenstein R, 2005, NEURAL COMPUT, V17, P2337, DOI 10.1162/0899766054796888; Levy N, 2001, NEURAL NETWORKS, V14, P815, DOI 10.1016/S0893-6080(01)00044-2; Lisman J, 2005, NAT NEUROSCI, V8, P839, DOI 10.1038/nn0705-839; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Lubenov EV, 2008, NEURON, V58, P118, DOI 10.1016/j.neuron.2008.01.036; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MILLER KD, 1994, J NEUROSCI, V14, P409; Morrison A, 2007, NEURAL COMPUT, V19, P1437, DOI 10.1162/neco.2007.19.6.1437; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Ngezahayo A, 2000, J NEUROSCI, V20, P2451; O'Connor DH, 2005, J NEUROPHYSIOL, V94, P1565, DOI 10.1152/jn.00047.2005; OJA E, 1982, J MATH BIOL, V15, P267, DOI 10.1007/BF00275687; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Remy S, 2007, P NATL ACAD SCI USA, V104, P17192, DOI 10.1073/pnas.0707919104; Saudargiene A, 2004, NEURAL COMPUT, V16, P595, DOI 10.1162/089976604772744929; Senn W, 2001, NEURAL COMPUT, V13, P35, DOI 10.1162/089976601300014628; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/s0896-6273(01)00542-6; Song S, 2005, PLOS BIOL, V3, P1838, DOI 10.1371/journal.pbio.0030350; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300	50	357	365	3	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					344	U19		10.1038/nn.2479	http://dx.doi.org/10.1038/nn.2479			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20098420	Green Published, Green Submitted			2022-12-17	WOS:000274860100017
J	Bibel, M; Richter, J; Schrenk, K; Tucker, KL; Staiger, V; Korte, M; Goetz, M; Barde, YA				Bibel, M; Richter, J; Schrenk, K; Tucker, KL; Staiger, V; Korte, M; Goetz, M; Barde, YA			Differentiation of mouse embryonic stem cells into a defined neuronal lineage	NATURE NEUROSCIENCE			English	Article							IN-VITRO DIFFERENTIATION; RADIAL GLIA; HIPPOCAMPAL-NEURONS; ES CELLS; DIRECTED DIFFERENTIATION; NEURAL DIFFERENTIATION; DOPAMINERGIC-NEURONS; PRECURSOR CELLS; NERVOUS-SYSTEM; EXPRESSION	Although it has long been known that cultured embryonic stem cells can generate neurons, the lineage relationships with their immediate precursors remain unclear. We report here that selection of highly proliferative stem cells followed by treatment with retinoic acid generated essentially pure precursors that markers identified as Pax-6-positive radial glial cells. As they do in vivo, these cells went on to generate neurons with remarkably uniform biochemical and electrophysiological characteristics.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Max Planck Inst Neurobiol, D-82152 Planegg Martinsried, Germany	Friedrich Miescher Institute for Biomedical Research; Max Planck Society	Barde, YA (corresponding author), Novartis Pharma AG Nervous Syst Res, CH-4002 Basel, Switzerland.	yves.barde@unibas.ch	Barde, Yves/F-6019-2011	Barde, Yves/0000-0002-7627-461X				Abe Y, 2003, J NEUROSCI, V23, P8513; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Bain G, 1996, BIOCHEM BIOPH RES CO, V223, P691, DOI 10.1006/bbrc.1996.0957; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; Chung S, 2002, EUR J NEUROSCI, V16, P1829, DOI 10.1046/j.1460-9568.2002.02255.x; Diez del Corral R, 2003, NEURON, V40, P65; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; FRAICHARD A, 1995, J CELL SCI, V108, P3181; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Gajovic S, 1997, DIFFERENTIATION, V62, P187; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kim AS, 2001, MECH DEVELOP, V103, P167, DOI 10.1016/S0925-4773(01)00342-2; KLEIN R, 1990, DEVELOPMENT, V109, P845; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li M, 2002, Methods Mol Biol, V185, P205; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; Liour SS, 2003, GLIA, V42, P109, DOI 10.1002/glia.10202; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; MURRAY P, IN PRESS P R SOC M R; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Rathjen J, 2002, DEVELOPMENT, V129, P2649; Rathjen J, 2001, CURR OPIN GENET DEV, V11, P587, DOI 10.1016/S0959-437X(00)00237-9; Renoncourt Y, 1998, MECH DEVELOP, V79, P185, DOI 10.1016/S0925-4773(98)00189-0; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Stavridis MP, 2003, BIOCHEM SOC T, V31, P45, DOI 10.1042/bst0310045; STRUBING C, 1995, MECH DEVELOP, V53, P275, DOI 10.1016/0925-4773(95)00446-8; TRAPP BD, 1994, J NEUROSCI RES, V37, P538, DOI 10.1002/jnr.490370413; Tucker KL, 1997, NUCLEIC ACIDS RES, V25, P3745, DOI 10.1093/nar/25.18.3745; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8	45	357	370	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					1003	1009		10.1038/nn1301	http://dx.doi.org/10.1038/nn1301			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15332090				2022-12-17	WOS:000223546700021
J	Himanen, JP; Chumley, MJ; Lackmann, M; Li, C; Barton, WA; Jeffrey, PD; Vearing, C; Geleick, D; Feldheim, DA; Boyd, AW; Henkemeyer, M; Nikolov, DB				Himanen, JP; Chumley, MJ; Lackmann, M; Li, C; Barton, WA; Jeffrey, PD; Vearing, C; Geleick, D; Feldheim, DA; Boyd, AW; Henkemeyer, M; Nikolov, DB			Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling	NATURE NEUROSCIENCE			English	Article							CRYSTAL-STRUCTURE; TYROSINE RESIDUES; LIGAND-BINDING; FAMILY; DOMAIN; NUK; PHOSPHORYLATION; ENDOCYTOSIS; KINASES	The interactions between Eph receptor tyrosine kinases and their ephrin ligands regulate cell migration and axon pathfinding. The EphA receptors are generally thought to become activated by ephrin-A ligands, whereas the EphB receptors interact with ephrin-B ligands. Here we show that two of the most widely studied of these molecules, EphB2 and ephrin-A5, which have never been described to interact with each other, do in fact bind one another with high affinity. Exposure of EphB2-expressing cells to ephrin-A5 leads to receptor clustering, autophosphorylation and initiation of downstream signaling. Ephrin-A5 induces EphB2-mediated growth cone collapse and neurite retraction in a model system. We further show, using X-ray crystallography, that the ephrin-A5-EphB2 complex is a heterodimer and is architecturally distinct from the tetrameric EphB2-ephrin-B2 structure. The structural data reveal the molecular basis for EphB2-ephrin-A5 signaling and provide a framework for understanding the complexities of functional interactions and crosstalk between A- and B-subclass Eph receptors and ephrins.	Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Kent Waldrep Ctr Basic Res Nerve Growth & Regener, Dallas, TX 75390 USA; Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia; Univ Calif Santa Cruz, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA; Queensland Inst Med Res, Brisbane, Qld 4029, Australia	Memorial Sloan Kettering Cancer Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Ludwig Institute for Cancer Research; University of California System; University of California Santa Cruz; QIMR Berghofer Medical Research Institute	Nikolov, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA.	dimitar@ximpact3.ski.mskcc.org	Boyd, Andrew/G-2083-2010	Henkemeyer, Mark/0000-0002-7525-1061; Jeffrey, Philip/0000-0002-4351-5341	NIMH NIH HHS [R01 MH066332, R01-MH66332] Funding Source: Medline; NINDS NIH HHS [R01-NS38486] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038486] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 1997, Cell, V90, P403; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BECKMANN MP, 1994, EMBO J, V13, P3757, DOI 10.1002/j.1460-2075.1994.tb06685.x; Bergemann AD, 1998, ONCOGENE, V16, P471, DOI 10.1038/sj.onc.1201557; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frisen J, 1999, EMBO J, V18, P5159, DOI 10.1093/emboj/18.19.5159; Gale NW, 1996, ONCOGENE, V13, P1343; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; HENKEMEYER M, 1994, ONCOGENE, V9, P1001; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Himanen JP, 2002, ACTA CRYSTALLOGR D, V58, P533, DOI 10.1107/S0907444902000264; Himanen JP, 1998, NATURE, V396, P486, DOI 10.1038/24904; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Knoll B, 2001, DEVELOPMENT, V128, P895; Koolpe M, 2002, J BIOL CHEM, V277, P46974, DOI 10.1074/jbc.M208495200; KOZLOSKY CJ, 1995, ONCOGENE, V10, P299; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lackmann M, 2000, METH MOL B, V124, P335; Lackmann M, 1998, J BIOL CHEM, V273, P20228, DOI 10.1074/jbc.273.32.20228; Mann F, 2003, J NEUROBIOL, V57, P323, DOI 10.1002/neu.10303; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Okada T, 2001, EUR J NEUROSCI, V13, P1635, DOI 10.1046/j.0953-816x.2001.01523.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasquale EB, 1997, CURR OPIN CELL BIOL, V9, P608, DOI 10.1016/S0955-0674(97)80113-5; Smith FM, 2004, J BIOL CHEM, V279, P9522, DOI 10.1074/jbc.M309326200; St John JA, 2001, DEV BRAIN RES, V126, P43, DOI 10.1016/S0165-3806(00)00136-X; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Toth J, 2001, DEV CELL, V1, P83, DOI 10.1016/S1534-5807(01)00002-8; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	42	357	373	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					501	509		10.1038/nn1237	http://dx.doi.org/10.1038/nn1237			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15107857				2022-12-17	WOS:000221101300027
J	Lieske, SP; Thoby-Brisson, M; Telgkamp, P; Ramirez, JM				Lieske, SP; Thoby-Brisson, M; Telgkamp, P; Ramirez, JM			Reconfiguration of the neural network controlling multiple breathing patterns: eupnea, sighs and gasps	NATURE NEUROSCIENCE			English	Article							PRE-BOTZINGER COMPLEX; RESPIRATORY RHYTHM GENERATION; INFANT-DEATH-SYNDROME; IN-VITRO; PREBOTZINGER COMPLEX; PROGRESSIVE ASPHYXIA; VENTILATORY ACTIVITY; AUGMENTED BREATHS; HYPOXIC RESPONSE; NEONATAL RAT	Are different forms of breathing derived from one or multiple neural networks? We demonstrate that brainstem slices containing the pre-Botzinger complex generated two rhythms when normally oxygenated, with striking similarities to eupneic ('normal') respiration and sighs. Sighs were triggered by eupneic bursts under control conditions, but not in the presence of strychnine (1 mu M). Although all neurons received synaptic inputs during both activities, the calcium channel blocker cadmium (4 mu M) selectively abolished sighs. In anoxia, sighs ceased, and eupneic activity was reconfigured into gasping, which like eupnea was insensitive to 4 mu M cadmium. This reconfiguration was accompanied by suppression of synaptic inhibition. We conclude that a single medullary network underlies multiple breathing patterns.	Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Ramirez, JM (corresponding author), Univ Chicago, Comm Neurobiol, 1027 E 57th St, Chicago, IL 60637 USA.	jramire@midway.uchicago.edu	Thoby-Brisson, Muriel/E-1167-2014	Thoby-Brisson, Muriel/0000-0003-3214-1724; Ramirez, Jan-Marino/0000-0002-5626-3999	NHLBI NIH HHS [R01-HL 60120-01A1] Funding Source: Medline; NIGMS NIH HHS [5 T32 GM07281] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARTLETT D, 1971, RESP PHYSIOL, V12, P230, DOI 10.1016/0034-5687(71)90055-7; Brockhaus J, 1998, EUR J NEUROSCI, V10, P3823, DOI 10.1046/j.1460-9568.1998.00396.x; Butera RJ, 1999, J NEUROPHYSIOL, V82, P382, DOI 10.1152/jn.1999.82.1.382; CHERNIACK NS, 1981, ACTA PHYSIOL SCAND, V111, P349, DOI 10.1111/j.1748-1716.1981.tb06747.x; Dogas Z, 1998, J NEUROPHYSIOL, V80, P2368, DOI 10.1152/jn.1998.80.5.2368; Ellenberger HH, 1999, BRAIN RES BULL, V50, P1, DOI 10.1016/S0361-9230(99)00078-7; Elsen FP, 1998, J NEUROSCI, V18, P10652; ENGLAND SJ, 1995, J APPL PHYSIOL, V78, P856, DOI 10.1152/jappl.1995.78.3.856; FUNG ML, 1994, J PHYSIOL-LONDON, V480, P597, DOI 10.1113/jphysiol.1994.sp020387; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; GRELOT L, 1997, NEURAL CONTROL RESP, P297; HADDAD GG, 1993, PROG NEUROBIOL, V40, P277, DOI 10.1016/0301-0082(93)90014-J; HAJI A, 1992, J APPL PHYSIOL, V73, P2333, DOI 10.1152/jappl.1992.73.6.2333; Huang Q, 1997, RESP PHYSIOL, V107, P111, DOI 10.1016/S0034-5687(96)02513-3; JOHNSON SM, 1994, J NEUROPHYSIOL, V72, P2598, DOI 10.1152/jn.1994.72.6.2598; KAHN A, 1988, PEDIATRICS, V82, P721; Koshiya N, 1996, J PHYSIOL-LONDON, V491, P859, DOI 10.1113/jphysiol.1996.sp021263; Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; LAWSON EE, 1977, J APPL PHYSIOL, V43, P468, DOI 10.1152/jappl.1977.43.3.468; Li YQ, 1997, J COMP NEUROL, V378, P283, DOI 10.1002/(SICI)1096-9861(19970210)378:2<283::AID-CNE10>3.0.CO;2-T; Lijowska AS, 1997, J APPL PHYSIOL, V83, P219, DOI 10.1152/jappl.1997.83.1.219; Lumsden T, 1923, J PHYSIOL-LONDON, V57, P153; MACEFIELD G, 1987, J APPL PHYSIOL, V63, P1413, DOI 10.1152/jappl.1987.63.4.1413; MARDER E, 1994, CURR BIOL, V4, P752, DOI 10.1016/S0960-9822(00)00169-X; Matsuishi T, 1997, ANN NEUROL, V42, P978, DOI 10.1002/ana.410420621; MEYRAND P, 1991, NATURE, V351, P60, DOI 10.1038/351060a0; NEUBAUER JA, 1990, J APPL PHYSIOL, V68, P441, DOI 10.1152/jappl.1990.68.2.441; Obonai T, 1996, PEDIATR NEUROL, V15, P189, DOI 10.1016/S0887-8994(96)00217-2; OREM J, 1993, J APPL PHYSIOL, V74, P761, DOI 10.1152/jappl.1993.74.2.761; Poets CF, 1999, PEDIATR RES, V45, P350, DOI 10.1203/00006450-199903000-00010; Ramirez JM, 1998, J PHYSIOL-LONDON, V507, P571, DOI 10.1111/j.1469-7793.1998.571bt.x; Ramirez JM, 1998, J PHYSIOL-LONDON, V507, P895, DOI 10.1111/j.1469-7793.1998.895bs.x; Ramirez JM, 1998, J NEUROPHYSIOL, V80, P3137, DOI 10.1152/jn.1998.80.6.3137; RAMIREZ JM, 1988, J NEUROBIOL, V19, P257, DOI 10.1002/neu.480190307; Ramirez JM, 1997, J NEUROPHYSIOL, V78, P383, DOI 10.1152/jn.1997.78.1.383; Ramirez JM, 1997, RESP PHYSIOL, V110, P71, DOI 10.1016/S0034-5687(97)00074-1; Rekling JC, 1998, ANNU REV PHYSIOL, V60, P385, DOI 10.1146/annurev.physiol.60.1.385; RICHTER DW, 1982, J EXP BIOL, V100, P93; Schmid K, 1996, BRAIN RES, V710, P150, DOI 10.1016/0006-8993(95)01380-6; SCHMIDT C, 1995, J PHYSIOL-LONDON, V483, P769, DOI 10.1113/jphysiol.1995.sp020621; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Solomon IC, 1999, J NEUROPHYSIOL, V81, P1150, DOI 10.1152/jn.1999.81.3.1150; St John WM, 1999, RESP PHYSIOL, V116, P47, DOI 10.1016/S0034-5687(99)00030-4; St-John WM, 1998, PROG NEUROBIOL, V56, P97, DOI 10.1016/S0301-0082(98)00031-8; STJOHN WM, 1989, J APPL PHYSIOL, V66, P223, DOI 10.1152/jappl.1989.66.1.223; Telgkamp P, 1999, J NEUROPHYSIOL, V82, P2163, DOI 10.1152/jn.1999.82.5.2163; Tomori Z, 1998, RESP PHYSIOL, V114, P83, DOI 10.1016/S0034-5687(98)00077-2; Wang WG, 1996, J PHYSIOL-LONDON, V490, P277, DOI 10.1113/jphysiol.1996.sp021143; WANG WG, 1993, J APPL PHYSIOL, V74, P2801, DOI 10.1152/jappl.1993.74.6.2801	49	357	361	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2000	3	6					600	607		10.1038/75776	http://dx.doi.org/10.1038/75776			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	317WG	10816317				2022-12-17	WOS:000087249500017
J	Winkler, EA; Nishida, Y; Sagare, AP; Rege, SV; Bell, RD; Perlmutter, D; Sengillo, JD; Hillman, S; Kong, P; Nelson, AR; Sullivan, JS; Zhao, Z; Meiselman, HJ; Wenby, RB; Soto, J; Abel, ED; Makshanoff, J; Zuniga, E; De Vivo, DC; Zlokovic, BV				Winkler, Ethan A.; Nishida, Yoichiro; Sagare, Abhay P.; Rege, Sanket V.; Bell, Robert D.; Perlmutter, David; Sengillo, Jesse D.; Hillman, Sara; Kong, Pan; Nelson, Amy R.; Sullivan, John S.; Zhao, Zhen; Meiselman, Herbert J.; Wenby, Rosalinda B.; Soto, Jamie; Abel, E. Dale; Makshanoff, Jacob; Zuniga, Edward; De Vivo, Darryl C.; Zlokovic, Berislav V.			GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration	NATURE NEUROSCIENCE			English	Article							BLOOD-BRAIN-BARRIER; DIMINISHED GLUCOSE-TRANSPORT; AMYLOID-BETA PEPTIDE; MOUSE MODEL; METABOLISM; EXPRESSION; PROTEIN; FLOW; HAPLOINSUFFICIENCY; NEURODEGENERATION	The glucose transporter GLUT1 at the blood-brain barrier (BBB) mediates glucose transport into the brain. Alzheimer's disease is characterized by early reductions in glucose transport associated with diminished GLUT1 expression at the BBB. Whether GLUT1 reduction influences disease pathogenesis remains, however, elusive. Here we show that GLUT1 deficiency in mice overexpressing amyloid beta-peptide (A beta) precursor protein leads to early cerebral microvascular degeneration, blood flow reductions and dysregulation and BBB breakdown, and to accelerated amyloid beta-peptide (A beta) pathology, reduced A beta clearance, diminished neuronal activity, behavioral deficits, and progressive neuronal loss and neurodegeneration that develop after initial cerebrovascular degenerative changes. We also show that GLUT1 deficiency in endothelium, but not in astrocytes, initiates the vascular phenotype as shown by BBB breakdown. Thus, reduced BBB GLUT1 expression worsens Alzheimer's disease cerebrovascular degeneration, neuropathology and cognitive function, suggesting that GLUT1 may represent a therapeutic target for Alzheimer's disease vasculo-neuronal dysfunction and degeneration.	[Winkler, Ethan A.; Sagare, Abhay P.; Rege, Sanket V.; Sengillo, Jesse D.; Kong, Pan; Nelson, Amy R.; Sullivan, John S.; Zhao, Zhen; Makshanoff, Jacob; Zuniga, Edward; Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Winkler, Ethan A.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Nishida, Yoichiro; Bell, Robert D.; Perlmutter, David; Sengillo, Jesse D.; Hillman, Sara] Univ Rochester, Sch Med & Dent, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY USA; [Nishida, Yoichiro] Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Tokyo, Japan; [Meiselman, Herbert J.; Wenby, Rosalinda B.; Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Soto, Jamie; Abel, E. Dale] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA USA; [Soto, Jamie; Abel, E. Dale] Univ Iowa, Carver Coll Med, Div Endocrinol & Metab, Iowa City, IA USA; [De Vivo, Darryl C.] Columbia Univ, Colleen Giblin Labs Pediat Neurol Res, New York, NY USA	University of Southern California; University of California System; University of California San Francisco; University of Rochester; Tokyo Medical & Dental University (TMDU); University of Southern California; University of Iowa; University of Iowa; Columbia University	Zlokovic, BV (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	zlokovic@usc.edu	zhao, zhen/A-2080-2012; Nelson, Amy R./HCH-3772-2022; Sagare, Abhay/Y-3273-2019	zhao, zhen/0000-0001-8967-5570; Nelson, Amy R./0000-0003-2025-1408; Sagare, Abhay/0000-0002-8178-3785; Abel, E. Dale/0000-0001-5290-0738	US National Institutes of Health [AG039452, AG023084, NS034467, U01 HL087947, R01DK092065]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034467, R01NS034467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG039452, R01AG039452, R01AG023084, R37AG023084] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank E. Schauwecker for most helpful discussion. This research was supported by US National Institutes of Health grants AG039452, AG023084 and NS034467 to B.V.Z. and U01 HL087947 and R01DK092065 to E.D.A.	Agarwal Neeraj, 2007, Int J Med Sci, V4, P232; Allen A, 2013, BEHAV BRAIN RES, V240, P95, DOI 10.1016/j.bbr.2012.11.025; Baskurt OK, 2009, BIORHEOLOGY, V46, P251, DOI 10.3233/BIR-2009-0536; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Benarroch EE, 2014, NEUROLOGY, V82, P1374, DOI 10.1212/WNL.0000000000000328; Bolanos JP, 2008, BBA-BIOENERGETICS, V1777, P789, DOI 10.1016/j.bbabio.2008.04.011; Choeiri C, 2005, NEUROSCIENCE, V130, P591, DOI 10.1016/j.neuroscience.2004.09.011; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Fowler SC, 2001, J NEUROSCI METH, V107, P107, DOI 10.1016/S0165-0270(01)00359-4; HORWOOD N, 1994, VIRCHOWS ARCH, V425, P69; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; JAGUST WJ, 1991, J CEREBR BLOOD F MET, V11, P323, DOI 10.1038/jcbfm.1991.65; KALARIA RN, 1989, J NEUROCHEM, V53, P1083, DOI 10.1111/j.1471-4159.1989.tb07399.x; Landau SM, 2010, NEUROLOGY, V75, P230, DOI 10.1212/WNL.0b013e3181e8e8b8; Landau SM, 2012, ANN NEUROL, V72, P578, DOI 10.1002/ana.23650; LaRue B, 2004, J NEUROSCI METH, V138, P233, DOI 10.1016/j.jneumeth.2004.04.026; Llorente-Cortes V, 2006, J MOL BIOL, V359, P950, DOI 10.1016/j.jmb.2006.04.008; Maeda K, 2000, J CEREBR BLOOD F MET, V20, P10, DOI 10.1097/00004647-200001000-00003; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Menon P, 2010, BRAIN RES, V1317, P218, DOI 10.1016/j.brainres.2009.11.084; Mooradian AD, 1997, NEUROBIOL AGING, V18, P469, DOI 10.1016/S0197-4580(97)00111-5; Mosconi L, 2005, EUR J NUCL MED MOL I, V32, P486, DOI [10.1007/s00259-008-1039-z, 10.1007/s00259-005-1762-7]; Mosconi L, 2006, J NUCL MED, V47, P1778; Mosconi L, 2013, NEUROBIOL AGING, V34, P22, DOI 10.1016/j.neurobiolaging.2012.03.002; Muneer PMA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-23; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Niwa K, 2002, NEUROBIOL DIS, V9, P61, DOI 10.1006/nbdi.2001.0460; Niwa K, 2000, P NATL ACAD SCI USA, V97, P9735, DOI 10.1073/pnas.97.17.9735; Obermoeller-McCormick LM, 2001, J CELL SCI, V114, P899; Ossenkoppele R, 2013, NEUROLOGY, V80, P359, DOI 10.1212/WNL.0b013e31827f0889; Paris D, 2004, NEUROSCI LETT, V366, P80, DOI 10.1016/j.neulet.2004.05.017; Paris Daniel, 2004, Angiogenesis, V7, P75, DOI 10.1023/B:AGEN.0000037335.17717.bf; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Pearson TS, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0342-7; Piert M, 1996, J NUCL MED, V37, P201; Protas HD, 2013, JAMA NEUROL, V70, P320, DOI 10.1001/2013.jamaneurol.286; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Schildge S, 2013, JOVE-J VIS EXP, DOI 10.3791/50079; Seidner G, 1998, NAT GENET, V18, P188, DOI 10.1038/ng0298-188; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; SIMPSON IA, 1994, ANN NEUROL, V35, P546, DOI 10.1002/ana.410350507; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Uchida Y, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-21; Ullner PM, 2009, NEUROBIOL DIS, V36, P60, DOI 10.1016/j.nbd.2009.06.014; VANNUCCI SJ, 1994, J NEUROCHEM, V62, P240; Wang D, 2006, HUM MOL GENET, V15, P1169, DOI 10.1093/hmg/ddl032; Winkler EA, 2014, BRAIN PATHOL, V24, P371, DOI 10.1111/bpa.12152; Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287; Zeller K, 1997, J CEREBR BLOOD F MET, V17, P204, DOI 10.1097/00004647-199702000-00010; Zhao Z, 2014, NEURON, V82, P728, DOI 10.1016/j.neuron.2014.05.012; Zheng PP, 2010, ANN NEUROL, V68, P835, DOI 10.1002/ana.22318; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; ZLOKOVIC BV, 1993, J BIOL CHEM, V268, P8019	63	356	369	12	133	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2015	18	4					521	+		10.1038/nn.3966	http://dx.doi.org/10.1038/nn.3966			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CE4DL	25730668	Green Accepted			2022-12-17	WOS:000351780900013
J	Han, L; Ma, C; Liu, Q; Weng, HJ; Cui, YY; Tang, ZX; Kim, YS; Nie, H; Qu, LT; Patel, KN; Li, Z; McNeil, B; He, SQ; Guan, Y; Xiao, B; LaMotte, RH; Dong, XZ				Han, Liang; Ma, Chao; Liu, Qin; Weng, Hao-Jui; Cui, Yiyuan; Tang, Zongxiang; Kim, Yushin; Nie, Hong; Qu, Lintao; Patel, Kush N.; Li, Zhe; McNeil, Benjamin; He, Shaoqiu; Guan, Yun; Xiao, Bo; LaMotte, Robert H.; Dong, Xinzhong			A subpopulation of nociceptors specifically linked to itch	NATURE NEUROSCIENCE			English	Article							DIPHTHERIA-TOXIN RECEPTOR; NEURONS; PAIN; MICE; PRURITOGENS; SENSATIONS; EXPRESSION; HISTAMINE; CAPSAICIN; RESPONSES	Itch-specific neurons have been sought for decades. The existence of such neurons has been doubted recently as a result of the observation that itch-mediating neurons also respond to painful stimuli. We genetically labeled and manipulated MrgprA3(+) neurons in the dorsal root ganglion (DRG) and found that they exclusively innervated the epidermis of the skin and responded to multiple pruritogens. Ablation of MrgprA3(+) neurons led to substantial reductions in scratching evoked by multiple pruritogens and occurring spontaneously under chronic itch conditions, whereas pain sensitivity remained intact. Notably, mice in which TRPV1 was exclusively expressed in MrgprA3(+) neurons exhibited itch, but not pain, behavior in response to capsaicin. Although MrgprA3(+) neurons were sensitive to noxious heat, activation of TRPV1 in these-neurons by noxious heat did not alter pain behavior. These data suggest that MrgprA3 defines a specific subpopulation of DRG neurons mediating itch. Our study opens new avenues for studying itch and developing anti-pruritic therapies.	[Han, Liang; Liu, Qin; Weng, Hao-Jui; Tang, Zongxiang; Kim, Yushin; Patel, Kush N.; Li, Zhe; McNeil, Benjamin; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Ma, Chao] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Anat Histol & Embryol, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China; [Ma, Chao; Nie, Hong; Qu, Lintao; LaMotte, Robert H.] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA; [Liu, Qin; Weng, Hao-Jui; Tang, Zongxiang; Patel, Kush N.; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Cui, Yiyuan; Xiao, Bo] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Nie, Hong] Jinan Univ, Coll Pharm, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou, Guangdong, Peoples R China; [He, Shaoqiu; Guan, Yun] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	Johns Hopkins University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Yale University; Howard Hughes Medical Institute; Johns Hopkins University; Sichuan University; Jinan University; Johns Hopkins University	LaMotte, RH (corresponding author), Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA.	robert.lamotte@yale.edu; xdong2@jhmi.edu		McNeil, Benjamin/0000-0001-7545-3598; Han, Liang/0000-0001-8674-6433; Weng, Hao-Jui/0000-0002-7006-7599; Xiao, Bo/0000-0002-6161-9478	US National Institutes of Health [NS054791, GM087369, NS047399, NS014624, NS070814]; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047399, R01NS014624, R01NS070814, R01NS054791] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Hawkins and the staff of Transgenic Mouse Core at Johns Hopkins University School of Medicine for assistance with BAC transgenic mouse generation. We thank D. Anderson (California Institute of Technology) and M. Zylka (University of North Carolina at Chapel Hill) for providing Mrgprd<SUP>GFP/+</SUP> mice and A. Guler (University of Washington) for providing Rosa26<SUP>Trpv1</SUP> mice. The work was supported by grants from the US National Institutes of Health to X.D. (NS054791 and GM087369), R.L. (NS047399 and NS014624) and Y.G. (NS070814). X.D. is an Early Career Scientist of the Howard Hughes Medical Institute.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Akiyama T, 2010, J NEUROPHYSIOL, V104, P2442, DOI 10.1152/jn.00563.2010; Arenkiel BR, 2008, NAT METHODS, V5, P299, DOI [10.1038/NMETH.1190, 10.1038/nmeth.1190]; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Davidson S, 2010, TRENDS NEUROSCI, V33, P550, DOI 10.1016/j.tins.2010.09.002; Di Nardo A, 1998, ACTA DERM-VENEREOL, V78, P27; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Finger Stanley, 2002, J Hist Neurosci, V11, P234, DOI 10.1076/jhin.11.3.234.10392; GREEN BG, 1990, PERCEPT PSYCHOPHYS, V48, P12, DOI 10.3758/BF03205007; Guler AD, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1749; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Johanek LM, 2008, J NEUROSCI, V28, P7659, DOI 10.1523/JNEUROSCI.1760-08.2008; Krajnik M, 2001, J PAIN SYMPTOM MANAG, V21, P151, DOI 10.1016/S0885-3924(00)00256-6; Lagerstrom MC, 2010, NEURON, V68, P529, DOI 10.1016/j.neuron.2010.09.016; LaMotte RH, 2009, J NEUROPHYSIOL, V101, P1430, DOI 10.1152/jn.91268.2008; Liu Q, 2012, J NEUROSCI, V32, P14532, DOI 10.1523/JNEUROSCI.3509-12.2012; Liu Q, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001925; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Liu Y, 2008, J NEUROSCI, V28, P125, DOI 10.1523/JNEUROSCI.4472-07.2008; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; Ma C, 2012, J NEUROPHYSIOL, V107, P357, DOI 10.1152/jn.00801.2011; Ma C, 2010, J NEUROSCI METH, V191, P60, DOI 10.1016/j.jneumeth.2010.06.010; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MCMAHON SB, 1992, TRENDS NEUROSCI, V15, P497, DOI 10.1016/0166-2236(92)90102-E; McQueen DS, 2007, BRIT J PHARMACOL, V151, P278, DOI 10.1038/sj.bjp.0707216; Miyamoto T, 2002, JPN J PHARMACOL, V88, P285, DOI 10.1254/jjp.88.285; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; Ono SJ, 2005, J ALLERGY CLIN IMMUN, V115, P118, DOI 10.1016/j.jaci.2004.10.042; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Saint-Mezard P, 2004, EUR J DERMATOL, V14, P284; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Schmelz M, 2003, J NEUROPHYSIOL, V89, P2441, DOI 10.1152/jn.01139.2002; Schmelz M, 1997, J NEUROSCI, V17, P8003; Shimada SG, 2008, PAIN, V139, P681, DOI 10.1016/j.pain.2008.08.002; Shinohara T, 2004, J BIOL CHEM, V279, P23559, DOI 10.1074/jbc.M314240200; Sikand P, 2011, PAIN, V152, P2485, DOI 10.1016/j.pain.2011.06.001; Sikand P, 2011, J NEUROSCI, V31, P7563, DOI 10.1523/JNEUROSCI.1192-11.2011; Sikand P, 2009, PAIN, V144, P66, DOI 10.1016/j.pain.2009.03.001; Skoner DR, 2001, J ALLERGY CLIN IMMUN, V108, pS2, DOI 10.1067/mai.2001.115569; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Yamaguchi T, 1999, NEUROSCI RES, V35, P77, DOI 10.1016/S0168-0102(99)00070-X; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	50	356	371	1	145	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					174	182		10.1038/nn.3289	http://dx.doi.org/10.1038/nn.3289			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	080RE	23263443	Green Accepted			2022-12-17	WOS:000314260200014
J	Gu, Y; Angelaki, DE; DeAngelis, GC				Gu, Yong; Angelaki, Dora E.; DeAngelis, Gregory C.			Neural correlates of multisensory cue integration in macaque MSTd	NATURE NEUROSCIENCE			English	Article							SUPERIOR TEMPORAL AREA; PURSUIT EYE-MOVEMENTS; OPTIC FLOW STIMULI; MOTION SIGNALS; VISUAL-MOTION; TASK STRATEGY; V2 NEURONS; MONKEY; CHOICE; MT	Human observers combine multiple sensory cues synergistically to achieve greater perceptual sensitivity, but little is known about the underlying neuronal mechanisms. We recorded the activity of neurons in the dorsal medial superior temporal (MSTd) area during a task in which trained monkeys combined visual and vestibular cues near-optimally to discriminate heading. During bimodal stimulation, MSTd neurons combined visual and vestibular inputs linearly with subadditive weights. Neurons with congruent heading preferences for visual and vestibular stimuli showed improvements in sensitivity that parallel behavioral effects. In contrast, neurons with opposite preferences showed diminished sensitivity under cue combination. Responses of congruent cells were more strongly correlated with monkeys' perceptual decisions than were responses of opposite cells, suggesting that the monkey monitored the activity of congruent cells to a greater extent during cue integration. These findings show that perceptual cue integration occurs in nonhuman primates and identify a population of neurons that may form its neural basis.	[Gu, Yong; Angelaki, Dora E.; DeAngelis, Gregory C.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [DeAngelis, Gregory C.] Univ Rochester, Dept Brain & Cognit Sci, Ctr Visual Sci, Rochester, NY 14627 USA	Washington University (WUSTL); University of Rochester	DeAngelis, GC (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	gdeangelis@cvs.rochester.edu	Krömer, Thorsten/C-2479-2009	Krömer, Thorsten/0000-0002-1398-8172; DeAngelis, Gregory/0000-0002-1635-1273	US National Institutes of Health [EY017866, EY016178]; EJLB Foundation; NATIONAL EYE INSTITUTE [R01EY016178, R01EY017866] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EJLB Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank A. Turner and E. White for monkey care and training, M.S. Banks for helpful advice, and L. Snyder, A. Pouget and R. Moreno Bote for comments on an earlier version of the manuscript. This work was supported by US National Institutes of Health grants EY017866 (to D.E.A.) and EY016178 and an EJLB Foundation grant (to G.C.D.).	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Avillac M, 2007, J NEUROSCI, V27, P1922, DOI 10.1523/JNEUROSCI.2646-06.2007; Bremmer F, 1999, ANN NY ACAD SCI, V871, P272, DOI 10.1111/j.1749-6632.1999.tb09191.x; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; DUFFY CJ, 1995, J NEUROSCI, V15, P5192; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; GREEN DM, 1966, SIGNAL DETECTION THE; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Hillis JM, 2004, J VISION, V4, P967, DOI 10.1167/4.12.1; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P621, DOI 10.1152/jn.1988.60.2.621; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; Krug K, 2004, PHILOS T R SOC B, V359, P929, DOI 10.1098/rstb.2003.1415; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Mamassian P, 2002, NEU INF PRO, P13; Molholm S, 2004, CEREB CORTEX, V14, P452, DOI 10.1093/cercor/bhh007; Nienborg H, 2007, NAT NEUROSCI, V10, P1608, DOI 10.1038/nn1991; Nienborg H, 2006, J NEUROSCI, V26, P9567, DOI 10.1523/JNEUROSCI.2256-06.2006; Page WK, 2003, J NEUROPHYSIOL, V89, P1994, DOI 10.1152/jn.00493.2002; Parker AJ, 2002, PHILOS T ROY SOC B, V357, P1053, DOI 10.1098/rstb.2002.1112; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Stanford TR, 2005, J NEUROSCI, V25, P6499, DOI 10.1523/JNEUROSCI.5095-04.2005; Stein BE., 1993, MERGING SENSES; Sugihara T, 2006, J NEUROSCI, V26, P11138, DOI 10.1523/JNEUROSCI.3550-06.2006; Takahashi K, 2007, J NEUROSCI, V27, P9742, DOI 10.1523/JNEUROSCI.0817-07.2007; TANAKA K, 1989, J NEUROPHYSIOL, V62, P642, DOI 10.1152/jn.1989.62.3.642; TANAKA K, 1993, J NEUROPHYSIOL, V69, P128, DOI 10.1152/jn.1993.69.1.128; TANAKA K, 1986, J NEUROSCI, V6, P134; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; VANESSEN DC, 1981, J COMP NEUROL, V199, P293, DOI 10.1002/cne.901990302; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wuerger SM, 2003, PERCEPT PSYCHOPHYS, V65, P1188, DOI 10.3758/BF03194844; Yuille A. L., 1996, PERCEPTION BAYESIAN, P123, DOI DOI 10.1017/CBO9780511984037.006	48	356	359	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2008	11	10					1201	1210		10.1038/nn.2191	http://dx.doi.org/10.1038/nn.2191			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	352WQ	18776893	Green Accepted			2022-12-17	WOS:000259528500018
J	Ziskin, JL; Nishiyama, A; Rubio, M; Fukaya, M; Bergles, DE				Ziskin, Jennifer L.; Nishiyama, Akiko; Rubio, Maria; Fukaya, Masahiro; Bergles, Dwight E.			Vesicular release of glutamate from unmyelinated axons in white matter	NATURE NEUROSCIENCE			English	Article							OLIGODENDROCYTE PRECURSOR CELLS; GLIAL PROGENITOR CELLS; NG2 PROTEOGLYCAN; CORPUS-CALLOSUM; SYNAPTIC-TRANSMISSION; ALPHA-LATROTOXIN; NMDA RECEPTORS; RHESUS-MONKEY; RAT CNS; ADULT	Directed fusion of transmitter-laden vesicles enables rapid intercellular signaling in the central nervous system and occurs at synapses within gray matter. Here we show that action potentials also induce the release of glutamate from axons in the corpus callosum, a white matter region responsible for interhemispheric communication. Callosal axons release glutamate by vesicular fusion, which induces quantal AMPA receptor-mediated currents in NG2(+) glial progenitors at anatomically distinct axo-glial synaptic junctions. Glutamate release from axons was facilitated by repetitive stimulation and could be inhibited through activation of metabotropic autoreceptors. Although NG2(+) cells form associations with nodes of Ranvier in white matter, measurements of conduction velocity indicated that unmyelinated fibers are responsible for glutamatergic signaling with NG2(+) glia. This activity-dependent secretion of glutamate was prevalent in the developing and mature mouse corpus callosum, indicating that axons within white matter both conduct action potentials and engage in rapid neuron-glia communication.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Univ Connecticut, Dept Neurobiol & Physiol, Storrs, CT 06269 USA; Hokkaido Univ, Dept Anat, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan	Johns Hopkins University; University of Connecticut; Hokkaido University	Bergles, DE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St,WBSB 813, Baltimore, MD 21205 USA.	dbergles@jhmi.edu	Bergles, Dwight/U-8343-2019	Bergles, Dwight/0000-0002-7133-7378	NINDS NIH HHS [NS049267, R01 NS049267, NS051509, R01 NS051509-01A1, R01 NS051509] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049267, R01NS051509] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARAM JA, 1988, J NEUROSCI METH, V23, P211, DOI 10.1016/0165-0270(88)90005-2; Barbour B, 2001, J NEUROSCI, V21, P7969, DOI 10.1523/JNEUROSCI.21-20-07969.2001; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; Butt AM, 1999, GLIA, V26, P84, DOI 10.1002/(SICI)1098-1136(199903)26:1<84::AID-GLIA9>3.0.CO;2-L; Capogna M, 1996, J NEUROPHYSIOL, V76, P3149, DOI 10.1152/jn.1996.76.5.3149; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; Clancy B, 2001, J COMP NEUROL, V434, P233, DOI 10.1002/cne.1174; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Follett PL, 2000, J NEUROSCI, V20, P9235; Fukaya M, 2000, J COMP NEUROL, V426, P572; FULTON BP, 1992, J NEUROSCI, V12, P4816; Gensert JM, 2001, J NEUROBIOL, V48, P75, DOI 10.1002/neu.1043.abs; Hanse E, 2001, J PHYSIOL-LONDON, V531, P467, DOI 10.1111/j.1469-7793.2001.0467i.x; Hassel B, 2003, J NEUROCHEM, V87, P230, DOI 10.1046/j.1471-4159.2003.01984.x; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; Huang JK, 2005, SCIENCE, V310, P1813, DOI 10.1126/science.1118313; JACOBSON S, 1974, BRAIN RES, V74, P149, DOI 10.1016/0006-8993(74)90118-8; JAHR CE, 1992, SCIENCE, V255, P470, DOI 10.1126/science.1346477; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; KRIEGLER S, 1993, J NEUROSCI, V13, P4229, DOI 10.1523/jneurosci.13-10-04229.1993; LAMANTIA AS, 1990, J COMP NEUROL, V291, P520, DOI 10.1002/cne.902910404; Lin SC, 2005, NEURON, V46, P773, DOI 10.1016/j.neuron.2005.04.025; Lin SC, 2002, J NEUROCYTOL, V31, P537, DOI 10.1023/A:1025799816285; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; MALGAROLI A, 1989, NEUROSCIENCE, V32, P393, DOI 10.1016/0306-4522(89)90088-2; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Morgenstern DA, 2003, MOL CELL NEUROSCI, V24, P787, DOI 10.1016/S1044-7431(03)00245-8; Olivares R, 2001, BRAIN BEHAV EVOLUT, V57, P98, DOI 10.1159/000047229; PRESTON RJ, 1983, EXP NEUROL, V79, P808, DOI 10.1016/0014-4886(83)90044-4; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; Stegmuller J, 2003, J BIOL CHEM, V278, P3590, DOI 10.1074/jbc.M210010200; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Tillet E, 1997, J BIOL CHEM, V272, P10769; Ughrin YM, 2003, J NEUROSCI, V23, P175; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; WESTRUM LE, 1962, J COMP NEUROL, V119, P281, DOI 10.1002/cne.901190303; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yang ZS, 2006, J NEUROSCI, V26, P3829, DOI 10.1523/JNEUROSCI.4247-05.2006; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; Yuan XQ, 1998, DEVELOPMENT, V125, P2901; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	50	356	359	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					321	330		10.1038/nn1854	http://dx.doi.org/10.1038/nn1854			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17293857	Green Accepted			2022-12-17	WOS:000244480300014
J	Klein, ME; Lioy, DT; Ma, L; Impey, S; Mandel, G; Goodman, RH				Klein, Matthew E.; Lioy, Daniel T.; Ma, Lin; Impey, Soren; Mandel, Gail; Goodman, Richard H.			Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA	NATURE NEUROSCIENCE			English	Article							RETT-SYNDROME; MICE; DUPLICATION; MATURATION; DROSOPHILA; MALES	Both increases and decreases in methyl CpG-binding protein 2 (MeCP2) levels cause neurodevelopmental defects. We found that MeCP2 translation is regulated by microRNA 132 (miR132). Block of miR132- mediated repression increased MeCP2 and brain- derived neurotrophic factor (BDNF) levels in cultured rat neurons and the loss of MeCP2 reduced BDNF and miR132 levels in vivo. This feedback loop may provide a mechanism for homeostatic control of MeCP2 expression.	Oregon Hlth & Sci Univ, Vollurn Inst, Portland, OR 97239 USA	Oregon Health & Science University	Goodman, RH (corresponding author), Oregon Hlth & Sci Univ, Vollurn Inst, L-474,3181 SW Sam Jackson Rd, Portland, OR 97239 USA.	goodmanr@ohsu.edu	klein, matthew/GPS-5798-2022					Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; Fukuda T, 2005, J NEUROPATH EXP NEUR, V64, P537, DOI 10.1093/jnen/64.6.537; Jugloff DGM, 2005, NEUROBIOL DIS, V19, P18, DOI 10.1016/j.nbd.2004.11.002; Kurreck J, 2002, NUCLEIC ACIDS RES, V30, P1911, DOI 10.1093/nar/30.9.1911; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang H, 2006, J NEUROSCI, V26, P10911, DOI 10.1523/JNEUROSCI.1810-06.2006	15	355	386	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1513	1514		10.1038/nn2010	http://dx.doi.org/10.1038/nn2010			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17994015				2022-12-17	WOS:000251172900006
J	Lu, T; Liang, L; Wang, XQ				Lu, T; Liang, L; Wang, XQ			Temporal and rate representations of time-varying signals in the auditory cortex of awake primates	NATURE NEUROSCIENCE			English	Article							COMMON MARMOSET; DISCHARGE PATTERNS; PITCH PERCEPTION; COMPLEX TONES; RESPONSES; AMPLITUDE; DISCRIMINATION; CAT; TRANSFORMATION; NEURONS	Because auditory cortical neurons have limited stimulus-synchronized responses, cortical representations of more rapidly occurring but still perceivable stimuli remain unclear. Here we show that there are two largely distinct populations of neurons in the auditory cortex of awake primates: one with stimulus-synchronized discharges that, with a temporal code, explicitly represented slowly occurring sound sequences and the other with non-stimulus-synchronized discharges that, with a rate code, implicitly represented rapidly occurring events. Furthermore, neurons of both populations displayed selectivity in their discharge rates to temporal features within a short time-window. Our results suggest that the combination of temporal and rate codes in the auditory cortex provides a possible neural basis for the wide perceptual range of temporal information.	Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, Baltimore, MD 21205 USA; First Med Univ, Pear River Hosp, Hearing Ctr, Guangzhou 510282, GuangDong Prov, Peoples R China	Johns Hopkins University	Wang, XQ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, 720 Rutland Ave,Ross 424, Baltimore, MD 21205 USA.	xwang@bme.jhu.edu			NIDCD NIH HHS [R01 DC003180, DC03180] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003180] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; AITKIN L, 1993, PROG NEUROBIOL, V41, P345, DOI 10.1016/0301-0082(93)90004-C; AITKIN LM, 1986, J COMP NEUROL, V252, P175, DOI 10.1002/cne.902520204; Akeroyd MA, 1997, J ACOUST SOC AM, V101, P430, DOI 10.1121/1.417988; Bieser A, 1996, EXP BRAIN RES, V108, P273; BROWN CH, 1986, J ACOUST SOC AM, V79, P1058, DOI 10.1121/1.393378; Cheung SW, 2001, HEARING RES, V156, P115, DOI 10.1016/S0378-5955(01)00272-6; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; EGGERMONT JJ, 1991, HEARING RES, V56, P153, DOI 10.1016/0378-5955(91)90165-6; Esser KH, 1997, P NATL ACAD SCI USA, V94, P14019, DOI 10.1073/pnas.94.25.14019; Fay RR, 1996, AUDIT NEUROSCI, V2, P377; Fitzpatrick DC, 1999, J ACOUST SOC AM, V106, P3460, DOI 10.1121/1.428199; FLANAGAN JL, 1960, J ACOUST SOC AM, V32, P1308, DOI 10.1121/1.1907900; GAESE BH, 1995, EUR J NEUROSCI, V7, P438, DOI 10.1111/j.1460-9568.1995.tb00340.x; GOLDSTEIN MH, 1959, J ACOUST SOC AM, V31, P356, DOI 10.1121/1.1907724; GREEN DM, 1973, J ACOUST SOC AM, V54, P373, DOI 10.1121/1.1913587; HEFFNER HE, 1986, J NEUROPHYSIOL, V56, P683, DOI 10.1152/jn.1986.56.3.683; Heil P, 1997, J NEUROPHYSIOL, V77, P2616, DOI 10.1152/jn.1997.77.5.2616; HIRSH IJ, 1959, J ACOUST SOC AM, V31, P759, DOI 10.1121/1.1907782; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; JOLIOT M, 1994, P NATL ACAD SCI USA, V91, P11748, DOI 10.1073/pnas.91.24.11748; JORIS PX, 1992, J ACOUST SOC AM, V91, P215, DOI 10.1121/1.402757; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Krumbholz K, 2000, J ACOUST SOC AM, V108, P1170, DOI 10.1121/1.1287843; LANGNER G, 1992, HEARING RES, V60, P115, DOI 10.1016/0378-5955(92)90015-F; Lu T, 2000, J NEUROPHYSIOL, V84, P236, DOI 10.1152/jn.2000.84.1.236; Lu T, 2001, J NEUROPHYSIOL, V85, P2364, DOI 10.1152/jn.2001.85.6.2364; MARDIA K. V., 2009, DIRECTIONAL STAT; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MILLER GA, 1948, J ACOUST SOC AM, V20, P171, DOI 10.1121/1.1906360; MOODY DB, 1994, J ACOUST SOC AM, V95, P3499, DOI 10.1121/1.409967; PATTERSON RD, 1994, J ACOUST SOC AM, V96, P1419, DOI 10.1121/1.410286; PATTERSON RD, 1994, J ACOUST SOC AM, V96, P1409, DOI 10.1121/1.410285; PHILLIPS DP, 1989, J ACOUST SOC AM, V85, P2537, DOI 10.1121/1.397748; PLOMP R, 1964, J ACOUST SOC AM, V36, P277, DOI 10.1121/1.1918946; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; RESNICK SB, 1975, J ACOUST SOC AM, V57, P1493, DOI 10.1121/1.380590; RIBAUPIERRE FD, 1972, BRAIN RES, V48, P205, DOI 10.1016/0006-8993(72)90179-5; RONKEN DA, 1970, J ACOUST SOC AM, V47, P1091, DOI 10.1121/1.1912010; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; SCHOUTEN JF, 1962, J ACOUST SOC AM, V34, P517, DOI 10.1121/1.1918160; Schulze H, 1997, J COMP PHYSIOL A, V181, P651, DOI 10.1007/s003590050147; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Steinschneider M, 1998, J ACOUST SOC AM, V104, P2935, DOI 10.1121/1.423877; WANG XQ, 1995, J NEUROPHYSIOL, V73, P1600, DOI 10.1152/jn.1995.73.4.1600; Wang XQ, 1995, J NEUROPHYSIOL, V74, P2685, DOI 10.1152/jn.1995.74.6.2685; Wang XQ, 2000, P NATL ACAD SCI USA, V97, P11843, DOI 10.1073/pnas.97.22.11843; WHITFIELD IC, 1980, J ACOUST SOC AM, V67, P644, DOI 10.1121/1.383889; ZATORRE RJ, 1988, J ACOUST SOC AM, V84, P566, DOI 10.1121/1.396834	50	355	358	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1131	1138		10.1038/nn737	http://dx.doi.org/10.1038/nn737			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	489AY	11593234				2022-12-17	WOS:000171970900017
J	Watson, FL; Heerssen, HM; Bhattacharyya, A; Klesse, L; Lin, MZ; Segal, RA				Watson, FL; Heerssen, HM; Bhattacharyya, A; Klesse, L; Lin, MZ; Segal, RA			Neurotrophins use the Erk5 pathway to mediate a retrograde survival response	NATURE NEUROSCIENCE			English	Article							TRANSCRIPTION FACTOR; SYMPATHETIC NEURONS; CELL-SURVIVAL; CREB PHOSPHORYLATION; SIGNALING PATHWAY; NERVOUS-SYSTEM; GROWTH-FACTOR; NGF; KINASE; RAS	Growth factors synthesized and released by target tissues promote survival and differentiation of innervating neurons. This retrograde signal begins when growth factors bind receptors at nerve terminals. Activated receptors are then endocytosed and transported through the axon to the cell body. Here we show that the mitogen-activated protein kinase (MAPK) signaling pathways used by neurotrophins during retrograde signaling differ from those used following direct stimulation of the cell soma. During retrograde signaling, endocytosed neurotrophin receptors (Trks) activate the extracellular signal-related protein kinase S (Erk5) pathway, leading to nuclear translocation of Erk5, phosphorylation of CREB, and enhanced neuronal survival. In contrast, Erk1/2, which mediates nuclear responses following direct cell body stimulation, does not transmit a retrograde signal. Thus, the Erk5 pathway has a unique function in retrograde signaling. Differential activation of distinct MAPK pathways may enable an individual growth factor to relay information that specifies the location and the nature of stimulation.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Childrens Hosp, Div Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Boston Children's Hospital	Segal, RA (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	rosalind_segal@dfci.harvard.edu		Bhattacharyya, Anita/0000-0002-0360-7145; Klesse, Laura/0000-0003-1323-7720; Lin, Michael/0000-0002-0492-1961	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035148] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35148] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altar CA, 1998, TRENDS NEUROSCI, V21, P433, DOI 10.1016/S0166-2236(98)01273-9; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Beattie EC, 1996, COLD SPRING HARB SYM, V61, P389; Bhattacharyya A, 1997, J NEUROSCI, V17, P7007; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; CAMPENOT RB, 1994, J NEUROBIOL, V25, P599, DOI 10.1002/neu.480250603; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chiariello M, 2000, MOL CELL BIOL, V20, P1747, DOI 10.1128/MCB.20.5.1747-1758.2000; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Delcroix JD, 1999, J NEUROSCI, V19, part. no.; EHLERS MD, 1995, J CELL BIOL, V130, P149, DOI 10.1083/jcb.130.1.149; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Fukuhara S, 2000, J BIOL CHEM, V275, P21730, DOI 10.1074/jbc.M002410200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Klesse LJ, 1998, J NEUROSCI, V18, P10420; Kohara K, 2001, SCIENCE, V291, P2419, DOI 10.1126/science.1057415; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Lom B, 1999, J NEUROSCI, V19, P9928; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Pearson G, 2001, J BIOL CHEM, V276, P7927, DOI 10.1074/jbc.M009764200; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Senger DL, 1997, J CELL BIOL, V138, P411, DOI 10.1083/jcb.138.2.411; Snider WD, 1996, MOL CELL NEUROSCI, V7, P433, DOI 10.1006/mcne.1996.0031; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Walton M, 1999, J NEUROCHEM, V73, P1836; Watson FL, 1999, J NEUROSCI, V19, P7889; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	38	355	366	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2001	4	10					981	988		10.1038/nn720	http://dx.doi.org/10.1038/nn720			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	478CR	11544482				2022-12-17	WOS:000171325800011
J	Dyer, MA; Cepko, CL				Dyer, MA; Cepko, CL			Control of Muller glial cell proliferation and activation following retinal injury	NATURE NEUROSCIENCE			English	Article							LINEAGE ANALYSIS; MICE LACKING; INHIBITORS; HISTOPATHOLOGY; HYPERPLASIA; EXPRESSION; PROGENITOR; P21(CIP1); GLIOSIS; FAMILY	Muller glial cells are the major support cell for neurons in the vertebrate retina. Following neuronal damage, Muller cells undergo reactive gliosis, which is characterized by proliferation and changes in gene expression. We have found that downregulation of the tumor supressor protein p27(Kip1) and entry into the cell cycle occurs within the first 24 hours after retinal injury. Shortly thereafter, Muller glial cells upregulate genes typical of gliosis and then downregulate cyclin D3, in concert with an exit from mitosis. Mice lacking p27(Kip1) showed a constitutive form of reactive gliosis, which leads to retinal dysplasia and vascular abnormalities reminiscent of diabetic retinopathy. We conclude that p27(Kip1) regulates Muller glial cell proliferation during reactive gliosis.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Cepko, CL (corresponding author), Harvard Univ, Sch Med, Dept Genet, 200 Longwood Ave, Boston, MA 02115 USA.	cepko@rascal.med.harvard.edu			NEI NIH HHS [EY0-8064, EY06803-02] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY006803, R01EY008064] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amin RH, 1997, INVEST OPHTH VIS SCI, V38, P36; BERGER B, 1979, CAN J OPHTHALMOL, V14, P285; BIRNBACH CD, 1994, OPHTHALMOLOGY, V101, P1211; Cepko CL, 1998, METHODS, V14, P393, DOI 10.1006/meth.1998.0594; Cepko CL, 1998, CURR TOP DEV BIOL, V36, P51; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; COGAN D G, 1971, Birth Defects Original Article Series, V7, P41; Dithmar S, 1997, KLIN MONATSBL AUGENH, V211, P338, DOI 10.1055/s-2008-1035144; Dowling J.E., 1987, RETINA APPROACHABLE; DYER MA, IN PRESS DEVELOPMENT; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Fariss RN, 2000, AM J OPHTHALMOL, V129, P215, DOI 10.1016/S0002-9394(99)00401-8; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; Foisner R, 1997, BIOESSAYS, V19, P297, DOI 10.1002/bies.950190407; Hengst L, 1998, CURR TOP MICROBIOL, V227, P25; Hjelmeland L.M., 1988, Progress in Retinal Research, V7, P259, DOI 10.1016/0278-4327(88)90011-9; HUMPHREY MF, 1993, J COMP NEUROL, V334, P545, DOI 10.1002/cne.903340404; Ide CF, 1996, PROG BRAIN RES, V108, P365, DOI 10.1016/S0079-6123(08)62552-2; Kimura H, 1999, INVEST OPHTH VIS SCI, V40, P524; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kuhrt H, 1997, J BRAIN RES, V38, P223; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Levine EM, 2000, DEV BIOL, V219, P299, DOI 10.1006/dbio.2000.9622; LI ZY, 1995, OPHTHALMOLOGY, V102, P805, DOI 10.1016/S0161-6420(95)30953-0; MacLaren RE, 1996, BRIT J OPHTHALMOL, V80, P458, DOI 10.1136/bjo.80.5.458; MADIGAN MC, 1994, RETINA-J RET VIT DIS, V14, P65, DOI 10.1097/00006982-199401000-00014; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Morrow EM, 1998, J NEUROSCI, V18, P3738; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; NORK TM, 1986, ARCH OPHTHALMOL-CHIC, V104, P1383, DOI 10.1001/archopht.1986.01050210137041; NORK TM, 1987, ARCH OPHTHALMOL-CHIC, V105, P1424; Reichenbach A, 1997, OPHTHALMIC RES, V29, P326, DOI 10.1159/000268031; RICH KA, 1995, EXP EYE RES, V61, P235, DOI 10.1016/S0014-4835(05)80043-0; Ridet JL, 1998, TRENDS NEUROSCI, V21, P80; ROBISON WG, 1990, EXP EYE RES, V50, P355, DOI 10.1016/0014-4835(90)90136-I; RUTKA JT, 1993, CANCER RES, V53, P3624; Sahel J A, 1990, Ophtalmologie, V4, P13; SAHEL JA, 1991, EXP EYE RES, V53, P657, DOI 10.1016/0014-4835(91)90226-5; Sanchez I, 1996, CURR OPIN CELL BIOL, V8, P318, DOI 10.1016/S0955-0674(96)80004-4; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Streit WJ, 2000, TOXICOL PATHOL, V28, P28, DOI 10.1177/019262330002800104; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Sueishi Katsuo, 1996, Polish Journal of Pharmacology, V48, P307; Taomoto M, 1998, GRAEF ARCH CLIN EXP, V236, P688, DOI 10.1007/s004170050142; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Unger JW, 1998, MICROSC RES TECHNIQ, V43, P24, DOI 10.1002/(SICI)1097-0029(19981001)43:1<24::AID-JEMT4>3.0.CO;2-P; Wilson JX, 1997, CAN J PHYSIOL PHARM, V75, P1149, DOI 10.1139/cjpp-75-10-11-1149; Yee Amy S., 1998, Frontiers in Bioscience, V3, pD532	49	355	362	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					873	880		10.1038/78774	http://dx.doi.org/10.1038/78774			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966617				2022-12-17	WOS:000167177400013
J	Kreiman, G; Koch, C; Fried, I				Kreiman, G; Koch, C; Fried, I			Category-specific visual responses of single neurons in the human medial temporal lobe	NATURE NEUROSCIENCE			English	Article							FUSIFORM FACE AREA; HUMAN EXTRASTRIATE CORTEX; INFEROTEMPORAL CORTEX; PERIRHINAL CORTEX; HUMAN HIPPOCAMPUS; RECOGNITION; MEMORY; AMYGDALA; OBJECT; MONKEY	The hippocampus, amygdala and entorhinal cortex receive convergent input from temporal neocortical regions specialized for processing complex visual stimuli and are important in the representation and recognition of visual images. Recording from 427 single neurons in the human hippocampus, entorhinal cortex and amygdala, we found a remarkable degree of category-specific firing of individual neurons on a trial-by-trial basis. Of the recorded neurons, 14% responded selectively to visual stimuli from different categories, including faces, natural scenes and houses, famous people and animals. Based on the firing rate of individual neurons, stimulus category could be predicted with a mean probability of error of 0.24. In the hippocampus, the proportion of neurons responding to spatial layouts was greater than to other categories. Our data provide direct support for the role of human medial temporal regions in the representation of different categories of visual stimuli.	Univ Calif Los Angeles, Sch Med, Div Neurosurg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90095 USA; CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California Institute of Technology	Fried, I (corresponding author), Univ Calif Los Angeles, Sch Med, Div Neurosurg, 740 Westwood Plaza,Box 957039, Los Angeles, CA 90095 USA.			Koch, Christof/0000-0001-6482-8067; Kreiman, Gabriel/0000-0003-3505-8475				ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; Buckley MJ, 1998, J NEUROSCI, V18, P2268; DAMASIO AR, 1990, ANNU REV NEUROSCI, V13, P89, DOI 10.1146/annurev.ne.13.030190.000513; Efron B., 1993, INTRO BOOTSTRAP; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; FRIED I, 1982, BRAIN, V105, P349, DOI 10.1093/brain/105.2.349; Fried I, 1999, J NEUROSURG, V91, P697, DOI 10.3171/jns.1999.91.4.0697; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; GREEN DM, 1966, SIGNAL DETECTION THE; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; HEIT G, 1988, NATURE, V333, P773, DOI 10.1038/333773a0; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Keeping ES, 1995, INTRO STAT INFERENCE; Klopp J, 1999, CLIN NEUROPHYSIOL, V110, P676, DOI 10.1016/S1388-2457(98)00039-X; LEONARD CM, 1985, BEHAV BRAIN RES, V15, P159, DOI 10.1016/0166-4328(85)90062-2; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; LOGOTHETIS NK, 1995, CEREB CORTEX, V3, P270; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; McNaughton BL, 1990, NEUROSCIENCE CONNECT, P1; MEUNIER M, 1993, J NEUROSCI, V13, P5418, DOI 10.1523/JNEUROSCI.13-12-05418.1993; MISHKIN M, 1978, NATURE, V273, P297, DOI 10.1038/273297a0; MIYASHITA Y, 1989, J NEUROPHYSIOL, V61, P669, DOI 10.1152/jn.1989.61.3.669; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; Ojemann GA, 1998, NEUROSCIENTIST, V4, P285, DOI 10.1177/107385849800400417; OJEMANN JG, 1992, BRAIN, V115, P1, DOI 10.1093/brain/115.1.1; PENFIELD W, 1958, ARCH NEURO PSYCHIATR, V79, P475, DOI 10.1001/archneurpsyc.1958.02340050003001; Penfield W, 1954, EPILEPSY FUNCTIONAL; Saleem KS, 1996, J NEUROSCI, V16, P4757; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; Suzuki WA, 1996, SEMIN NEUROSCI, V8, P3, DOI 10.1006/smns.1996.0002; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tong F, 2000, COGNITIVE NEUROPSYCH, V17, P257, DOI 10.1080/026432900380607; Treisman AM, 1998, CURR OPIN NEUROBIOL, V8, P218, DOI 10.1016/S0959-4388(98)80143-8; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; WARRINGTON E, 1987, BRAIN, V110, P1275; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Yakovlev V, 1998, NAT NEUROSCI, V1, P310, DOI 10.1038/1131; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555; [No title captured]	50	355	359	0	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					946	953		10.1038/78868	http://dx.doi.org/10.1038/78868			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966627				2022-12-17	WOS:000167177400023
J	Shahmoradian, SH; Lewis, AJ; Genoud, C; Hench, J; Moors, TE; Navarro, PP; Castano-Diez, D; Schweighauser, G; Graff-Meyer, A; Godie, KN; Sutterlin, R; Huisman, E; Ingrassia, A; de Gier, Y; Rozemuller, AJM; Wang, J; De Paepe, A; Erny, J; Staempfli, A; Hoernschemeyer, J; Grosseruschkamp, F; Niedieker, D; El-Mashtoly, SF; Quadri, M; Van IJcken, WFJ; Bonifati, V; Gerwert, K; Bohrmann, B; Frank, S; Britschgi, M; Stahlberg, H; Van de Berg, WDJ; Lauer, ME				Shahmoradian, Sarah H.; Lewis, Amanda J.; Genoud, Christel; Hench, Jurgen; Moors, Tim E.; Navarro, Paula P.; Castano-Diez, Daniel; Schweighauser, Gabriel; Graff-Meyer, Alexandra; Godie, Kenneth N.; Sutterlin, Rosmarie; Huisman, Evelien; Ingrassia, Angela; de Gier, Yvonne; Rozemuller, Annemieke J. M.; Wang, Jing; De Paepe, Anne; Erny, Johannes; Staempfli, Andreas; Hoernschemeyer, Joerg; Grosserueschkamp, Frederik; Niedieker, Daniel; El-Mashtoly, Samir F.; Quadri, Marialuisa; Van IJcken, Wilfred F. J.; Bonifati, Vincenzo; Gerwert, Klaus; Bohrmann, Bernd; Frank, Stephan; Britschgi, Markus; Stahlberg, Henning; Van de Berg, Wilma D. J.; Lauer, Matthias E.			Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes	NATURE NEUROSCIENCE			English	Article							ALPHA-SYNUCLEIN; NEUROFIBRILLARY PATHOLOGY; CORRELATED LIGHT; A-BETA; BODIES; DEMENTIA; IDENTIFICATION; ALZHEIMERS; MICROSCOPY; BODY	Parkinson's disease, the most common age-related movement disorder, is a progressive neurodegenerative disease with unclear etiology. Key neuropathological hallmarks are Lewy bodies and Lewy neurites: neuronal inclusions immunopositive for the protein alpha-synuclein. In-depth ultrastructural analysis of Lewy pathology is crucial to understanding pathogenesis of this disease. Using correlative light and electron microscopy and tomography on postmortem human brain tissue from Parkinson's disease brain donors, we identified alpha-synuclein immunopositive Lewy pathology and show a crowded environment of membranes therein, including vesicular structures and dysmorphic organelles. Filaments interspersed between the membranes and organelles were identifiable in many but not all alpha-synuclein inclusions. Crowding of organellar components was confirmed by stimulated emission depletion (STED)-based super-resolution microscopy, and high lipid content within alpha-synuclein immunopositive inclusions was corroborated by confocal imaging, Fourier-transform coherent anti-Stokes Raman scattering infrared imaging and lipidomics. Applying such correlative high-resolution imaging and biophysical approaches, we discovered an aggregated protein-lipid compartmentalization not previously described in the Parkinsons' disease brain.	[Shahmoradian, Sarah H.; Lewis, Amanda J.; Navarro, Paula P.; Castano-Diez, Daniel; Godie, Kenneth N.; Sutterlin, Rosmarie; Wang, Jing; Stahlberg, Henning] Univ Basel, Ctr Cellular Imaging & NanoAnalyt, Biozentrum, Basel, Switzerland; [Genoud, Christel; Graff-Meyer, Alexandra] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Hench, Jurgen; Schweighauser, Gabriel; Frank, Stephan] Univ Hosp Basel, Inst Pathol, Div Neuropathol, Basel, Switzerland; [Moors, Tim E.; Huisman, Evelien; Ingrassia, Angela; de Gier, Yvonne; Van de Berg, Wilma D. J.] Vrije Univ Amsterdam Med Ctr, Dept Anat & Neurosci, Sect Clin Neuroanat, Amsterdam Neurosci, Amsterdam, Netherlands; [Rozemuller, Annemieke J. M.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam Neurosci, Amsterdam, Netherlands; [De Paepe, Anne; Lauer, Matthias E.] Roche Innovat Ctr Basel, Lead Discovery, Roche Pharma Res & Early Dev, Basel, Switzerland; [Erny, Johannes; Staempfli, Andreas; Hoernschemeyer, Joerg] Roche Innovat Ctr Basel, Preclin CMC, Roche Pharma Res & Early Dev, Basel, Switzerland; [Grosserueschkamp, Frederik; Niedieker, Daniel; El-Mashtoly, Samir F.; Gerwert, Klaus] Ruhr Univ, Dept Biophys, Bochum, Germany; [Quadri, Marialuisa; Bonifati, Vincenzo] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Van IJcken, Wilfred F. J.] Erasmus MC, Ctr Biom, Rotterdam, Netherlands; [Bohrmann, Bernd; Britschgi, Markus] Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, Neurosci Ophthalmol & Rare Dis Discovery & Transl, Basel, Switzerland; [Shahmoradian, Sarah H.] Paul Scherrer Inst, Dept Biol & Chem, Villigen, Switzerland	University of Basel; Friedrich Miescher Institute for Biomedical Research; University of Basel; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Roche Holding; Roche Holding; Ruhr University Bochum; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Roche Holding; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Stahlberg, H (corresponding author), Univ Basel, Ctr Cellular Imaging & NanoAnalyt, Biozentrum, Basel, Switzerland.; Van de Berg, WDJ (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Anat & Neurosci, Sect Clin Neuroanat, Amsterdam Neurosci, Amsterdam, Netherlands.; Lauer, ME (corresponding author), Roche Innovat Ctr Basel, Lead Discovery, Roche Pharma Res & Early Dev, Basel, Switzerland.	henning.stahlberg@unibas.ch; wdj.vandeberg@vumc.nl; matthias.lauer@roche.com	Stahlberg, Henning/H-1868-2011; Lewis, Amanda/AAX-6703-2021; Rozemuller, Annemieke/ABA-7093-2021; El-Mashtoly, Samir/C-8761-2014; Lewis, Amanda/AAR-1507-2020; van de Berg, Wilma/AAE-7778-2021; van ijcken, willem/N-9805-2018; Grosseruschkamp, Frederik/L-1394-2018; Shahmoradian, Sarah/C-7465-2015	Stahlberg, Henning/0000-0002-1185-4592; El-Mashtoly, Samir/0000-0001-6087-8817; Lewis, Amanda/0000-0001-7257-5848; van ijcken, willem/0000-0002-0421-8301; van de Berg, Wilma/0000-0002-6175-5357; Castano-Diez, Daniel/0000-0002-0197-163X; Navarro, Paula/0000-0002-9123-1132; Grosseruschkamp, Frederik/0000-0002-0710-6014; genoud, christel/0000-0002-0933-9911; Lauer, Matthias E/0000-0003-3252-8718; Shahmoradian, Sarah/0000-0001-9752-7287	University Hospital Basel; Roche Postdoctoral Fellowship (RPF) program; Swiss National Science Foundation (SNF) [CRSII3_154461, CRSII5_177195]; Synapsis Foundation Switzerland; Stichting Parkinson Fonds, the Netherlands; foundation Heidi Seiler-Stiftung	University Hospital Basel; Roche Postdoctoral Fellowship (RPF) program; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Synapsis Foundation Switzerland; Stichting Parkinson Fonds, the Netherlands; foundation Heidi Seiler-Stiftung	We are grateful to the individuals who participated in the brain donation program and their families, making this study possible. We thank S. Ipsen from the University Hospital Basel and S. Bichet from the Friedrich Miescher Institute for training and assisting with the immunohistochemistry, A. Fecteau-LeFebvre for electron microscopy maintenance, A. Jonker for help with preparing cryostat-cut tissue sections, Prothena for providing the pSer129 11A5 antibody, Advanced Optical Microscopy Core O vertical bar 2 (www.ao2m.amsterdam) for support with STED imaging, D. Mona for help with labeling antibodies, P. Baumgartner and K. Bergmann for administrative help, and S. Muller for carefully proof-reading and editing the manuscript. S.H.S. was supported by the Roche Postdoctoral Fellowship (RPF) program; this work was in part supported by the Swiss National Science Foundation (SNF Grants no. CRSII3_154461 and CRSII5_177195), the Synapsis Foundation Switzerland, the foundation Heidi Seiler-Stiftung, and the Stichting Parkinson Fonds, the Netherlands.	Alafuzoff I, 2008, BRAIN PATHOL, V18, P484, DOI 10.1111/j.1750-3639.2008.00147.x; Alafuzoff I, 2009, ACTA NEUROPATHOL, V117, P635, DOI 10.1007/s00401-009-0523-2; Arima K, 1998, BRAIN RES, V808, P93, DOI 10.1016/S0006-8993(98)00734-3; Baker MJ, 2014, NAT PROTOC, V9, P1771, DOI 10.1038/nprot.2014.110; Bassan P, 2012, ANALYST, V137, P1370, DOI 10.1039/c2an16088a; Boassa D, 2013, J NEUROSCI, V33, P2605, DOI 10.1523/JNEUROSCI.2898-12.2013; Braak H, 1999, NEUROSCI LETT, V265, P67, DOI 10.1016/S0304-3940(99)00208-6; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Burre J, 2015, J PARKINSON DIS, V5, P699, DOI 10.3233/JPD-150642; Castano-Diez D, 2012, J STRUCT BIOL, V178, P139, DOI 10.1016/j.jsb.2011.12.017; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Eichmann C, 2016, J BIOL CHEM, V291, P8516, DOI 10.1074/jbc.M115.707968; El-Mashtoly SF, 2014, BIOPHYS J, V106, P1910, DOI 10.1016/j.bpj.2014.03.025; Ellisman MH, 2012, METHOD CELL BIOL, V111, P139, DOI 10.1016/B978-0-12-416026-2.00008-X; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Fusco G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12563; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Grassi D, 2018, P NATL ACAD SCI USA, V115, pE2634, DOI 10.1073/pnas.1713849115; Hagen WJH, 2017, J STRUCT BIOL, V197, P191, DOI 10.1016/j.jsb.2016.06.007; Hunn BHM, 2015, TRENDS NEUROSCI, V38, P178, DOI 10.1016/j.tins.2014.12.009; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; Iwatsubo T, 1996, AM J PATHOL, V148, P1517; Jellinger KA, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1016-8; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jiang ZP, 2013, J AM CHEM SOC, V135, P15970, DOI 10.1021/ja405993r; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kallenbach-Thieltges A, 2013, J BIOPHOTONICS, V6, P88, DOI 10.1002/jbio.201200132; Klein C, 2007, NEUROLOGY, V69, P2093, DOI 10.1212/01.wnl.0000271880.27321.a7; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kuusisto E, 2003, J NEUROPATH EXP NEUR, V62, P1241, DOI 10.1093/jnen/62.12.1241; Liu YL, 2009, SPINAL CORD, V47, P166, DOI 10.1038/sc.2008.90; Mahul-Mellier A.-L., 2018, MAKING LEWY BODY ROL, DOI [10.1101/500058, DOI 10.1101/500058]; Mastronarde D.N., 2003, MICROSC MICROANAL, V9, P1182, DOI [DOI 10.1017/S1431927603445911, 10.1017/S1431927603445911]; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McNaught KSP, 2002, EUR J NEUROSCI, V16, P2136, DOI 10.1046/j.1460-9568.2002.02301.x; Mizuno N, 2012, J BIOL CHEM, V287, P29301, DOI 10.1074/jbc.M112.365817; Morell P., 1999, BASIC NEUROCHEMISTRY; Nag S, 2015, ANN NEUROL, V77, P942, DOI 10.1002/ana.24388; Navarro PP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36223-4; Navarro PP, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00082; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Nuber S, 2018, NEURON, V100, P75, DOI 10.1016/j.neuron.2018.09.014; Nugent E, 2017, INTEGR BIOL-UK, V9, P206, DOI 10.1039/c6ib00206d; Olanow CW, 2004, LANCET NEUROL, V3, P496, DOI 10.1016/S1474-4422(04)00827-0; Peng C, 2018, NATURE, V557, P558, DOI 10.1038/s41586-018-0104-4; Quadri M, 2018, LANCET NEUROL, V17, P597, DOI 10.1016/S1474-4422(18)30179-0; Ryan BJ, 2015, TRENDS BIOCHEM SCI, V40, P200, DOI 10.1016/j.tibs.2015.02.003; Schie IW, 2015, ANALYST, V140, P3897, DOI 10.1039/c5an00178a; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shi Z, 2015, PHYS CHEM CHEM PHYS, V17, P15561, DOI 10.1039/c4cp05883f; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1999, PARKINSONISM RELAT D, V5, P157, DOI 10.1016/S1353-8020(99)00031-0; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Thal Dietmar R, 2006, Sci Aging Knowledge Environ, V2006, pre1, DOI 10.1126/sageke.2006.6.re1; Thal DR, 2008, ACTA NEUROPATHOL, V115, P599, DOI 10.1007/s00401-008-0366-2; Thal DR, 2000, J NEUROPATH EXP NEUR, V59, P733, DOI 10.1093/jnen/59.8.733; Viennet T, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0049-z; Wakabayashi K, 2013, MOL NEUROBIOL, V47, P495, DOI 10.1007/s12035-012-8280-y; Westphal CH, 2013, J BIOL CHEM, V288, P1829, DOI 10.1074/jbc.M112.418871; Wong YC, 2017, NAT MED, V23, P151, DOI 10.1038/nm.4269; Wrobel TP, 2013, VIB SPECTROSC, V69, P84, DOI 10.1016/j.vibspec.2013.09.008	67	354	358	15	224	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2019	22	7					1099	+		10.1038/s41593-019-0423-2	http://dx.doi.org/10.1038/s41593-019-0423-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IE8GO	31235907				2022-12-17	WOS:000472612100011
J	Wu, HG; Miyamoto, YR; Castro, LNG; Olveczky, BP; Smith, MA				Wu, Howard G.; Miyamoto, Yohsuke R.; Castro, Luis Nicolas Gonzalez; Oelveczky, Bence P.; Smith, Maurice A.			Temporal structure of motor variability is dynamically regulated and predicts motor learning ability	NATURE NEUROSCIENCE			English	Article							GANGLIA-FOREBRAIN CIRCUIT; SIGNAL-DEPENDENT NOISE; BASAL GANGLIA; INDIVIDUAL-DIFFERENCES; ADAPTATION; MODULATION; MODEL; TIME; UNCERTAINTY; PRIMITIVES	Individual differences in motor learning ability are widely acknowledged, yet little is known about the factors that underlie them. Here we explore whether movement-to-movement variability in motor output, a ubiquitous if often unwanted characteristic of motor performance, predicts motor learning ability. Surprisingly, we found that higher levels of task-relevant motor variability predicted faster learning both across individuals and across tasks in two different paradigms, one relying on reward-based learning to shape specific arm movement trajectories and the other relying on error-based learning to adapt movements in novel physical environments. We proceeded to show that training can reshape the temporal structure of motor variability, aligning it with the trained task to improve learning. These results provide experimental support for the importance of action exploration, a key idea from reinforcement learning theory, showing that motor variability facilitates motor learning in humans and that our nervous systems actively regulate it to improve learning.	[Wu, Howard G.; Miyamoto, Yohsuke R.; Castro, Luis Nicolas Gonzalez; Smith, Maurice A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Oelveczky, Bence P.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Oelveczky, Bence P.; Smith, Maurice A.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Smith, MA (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	mas@seas.harvard.edu	Castro, Luis Gonzalez/ABN-9912-2022	Castro, Luis Gonzalez/0000-0001-7699-5188; smith, maurice/0000-0003-4214-1277; Olveczky, Bence/0000-0003-2499-2705	McKnight Scholar Award; Sloan Research Fellowship; National Institute on Aging [R01 AG041878]; National Institute of Neurological Disorders and Stroke [R01 NS066408]; NATIONAL INSTITUTE ON AGING [R01AG041878] Funding Source: NIH RePORTER	McKnight Scholar Award; Sloan Research Fellowship(Alfred P. Sloan Foundation); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank G. Sing, J. Brayanov, A. Hadjiosif and L. Clark for help with the analyses and helpful discussions. We thank G. Gabriel and S. Orozco for help with experiments. This work was supported in part by the McKnight Scholar Award, a Sloan Research Fellowship, a grant from the National Institute on Aging (R01 AG041878) to M.A.S. and a McKnight Scholar Award and a grant from the National Institute of Neurological Disorders and Stroke (R01 NS066408) to B.P.O.	Ali F, 2013, NEURON, V80, P494, DOI 10.1016/j.neuron.2013.07.049; Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; [Anonymous], 2020, REINFORCEMENT LEARNI; Bays PM, 2005, EXP BRAIN RES, V163, P400, DOI 10.1007/s00221-005-2299-5; BERRY SD, 1978, SCIENCE, V200, P1298, DOI 10.1126/science.663612; Charlesworth JD, 2012, NATURE, V486, P251, DOI 10.1038/nature11078; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Conditt MA, 1999, P NATL ACAD SCI USA, V96, P11625, DOI 10.1073/pnas.96.20.11625; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Della-Maggiore V, 2009, HUM BRAIN MAPP, V30, P4048, DOI 10.1002/hbm.20828; Diedrichsen J, 2007, J NEUROSCI, V27, P6291, DOI 10.1523/JNEUROSCI.0061-07.2007; Doya K., 1995, Advances in Neural Information Processing Systems 7, P101; Fiete IR, 2007, J NEUROPHYSIOL, V98, P2038, DOI 10.1152/jn.01311.2006; Frank MJ, 2009, NAT NEUROSCI, V12, P1062, DOI 10.1038/nn.2342; Gonzales-Castro L.N., 2008, P ANN S ADV COMP MOT, V7; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Huang VS, 2011, NEURON, V70, P787, DOI 10.1016/j.neuron.2011.04.012; Joiner WM, 2008, J NEUROPHYSIOL, V100, P2948, DOI 10.1152/jn.90706.2008; Joiner WM, 2011, J NEUROPHYSIOL, V105, P45, DOI 10.1152/jn.00884.2009; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; Kaelbling LP, 1996, J ARTIF INTELL RES, V4, P237, DOI 10.1613/jair.301; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kineses ZT, 2008, NEUROIMAGE, V39, P1950, DOI 10.1016/j.neuroimage.2007.09.070; Mandelblat-Cerf Y, 2009, J NEUROSCI, V29, P15053, DOI 10.1523/JNEUROSCI.3011-09.2009; O'Sullivan I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000345; Olveczky BP, 2011, J NEUROPHYSIOL, V106, P386, DOI 10.1152/jn.00018.2011; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; Roberts S, 2006, BEHAV PROCESS, V72, P215, DOI 10.1016/j.beproc.2006.03.003; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Scheidt RA, 2000, J NEUROPHYSIOL, V84, P853, DOI 10.1152/jn.2000.84.2.853; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Sing GC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000893; Sing GC, 2009, NEURON, V64, P575, DOI 10.1016/j.neuron.2009.10.001; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Sober SJ, 2008, J NEUROSCI, V28, P10370, DOI 10.1523/JNEUROSCI.2448-08.2008; Stahlman WD, 2011, LEARN MOTIV, V42, P221, DOI 10.1016/j.lmot.2011.05.001; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; Takikawa Y, 2002, EXP BRAIN RES, V142, P284, DOI 10.1007/s00221-001-0928-1; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tomassini V, 2011, HUM BRAIN MAPP, V32, P494, DOI 10.1002/hbm.21037; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; Wagner MJ, 2008, J NEUROSCI, V28, P10663, DOI 10.1523/JNEUROSCI.5479-07.2008; Warren TL, 2011, J NEUROPHYSIOL, V106, P1806, DOI 10.1152/jn.00311.2011; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062	50	354	354	14	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2014	17	2					312	321		10.1038/nn.3616	http://dx.doi.org/10.1038/nn.3616			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AA2FH	24413700	Green Accepted			2022-12-17	WOS:000330910000027
J	Polack, PO; Friedman, J; Golshani, P				Polack, Pierre-Olivier; Friedman, Jonathan; Golshani, Peyman			Cellular mechanisms of brain state-dependent gain modulation in visual cortex	NATURE NEUROSCIENCE			English	Article							BASAL FOREBRAIN; BARREL CORTEX; GABAERGIC NEURONS; BEHAVIORAL STATE; ACETYLCHOLINE; ACTIVATION; NOREPINEPHRINE; OSCILLATIONS; SELECTIVITY; INHIBITION	Visual cortical neurons fire at higher rates to visual stimuli during locomotion than during immobility, while maintaining orientation selectivity. The mechanisms underlying this change in gain are not understood. We performed whole-cell recordings from layer 2/3 and layer 4 visual cortical excitatory neurons and from parvalbumin-positive and somatostatin-positive inhibitory neurons in mice that were free to rest or run on a spherical treadmill. We found that the membrane potential of all cell types became more depolarized and (with the exception of somatostatin-positive interneurons) less variable during locomotion. Cholinergic input was essential for maintaining the unimodal membrane potential distribution during immobility, whereas noradrenergic input was necessary for the tonic depolarization associated with locomotion. Our results provide a mechanism for how neuromodulation controls the gain and signal-to-noise ratio of visual cortical neurons during changes in the state of vigilance.	[Polack, Pierre-Olivier; Friedman, Jonathan; Golshani, Peyman] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Polack, Pierre-Olivier; Golshani, Peyman] W Los Angeles Vet Affairs Med Ctr, Dept Neurol, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Golshani, P (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	pgolshani@mednet.ucla.edu		Polack, Pierre-Olivier/0000-0003-1716-6595	US National Institutes of Health [KO8 NS0562101]; Whitehall Foundation [2012-05-83]; Veterans Affairs Merit Review Award [1I01BX001524-01A1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS056210] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001524] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; Veterans Affairs Merit Review Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	We acknowledge R. Gruver for technical assistance on visual stimulation, Z. Peng and C. Houser for histology, and D. Contreras, M. Einstein, T. Indersmitten, M. Javaherian, C. Kaba, S. Mahon, A. Silva and S. Singh for their thoughtful comments on the manuscript. This work was supported by the US National Institutes of Health (KO8 NS0562101), the Whitehall Foundation (grant 2012-05-83) and a Veterans Affairs Merit Review Award (1I01BX001524-01A1).	Alitto HJ, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00079; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bereshpolova Y, 2007, J NEUROSCI, V27, P9392, DOI 10.1523/JNEUROSCI.2218-07.2007; BERRIDGE CW, 1993, NEUROSCIENCE, V55, P381, DOI 10.1016/0306-4522(93)90507-C; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Botly LCP, 2012, CEREB CORTEX, V22, P2441, DOI 10.1093/cercor/bhr331; Buchanan JAM, 1997, BRAIN RES, V771, P63, DOI 10.1016/S0006-8993(97)00778-6; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Fellous JM, 2003, NEUROSCIENCE, V122, P811, DOI 10.1016/j.neuroscience.2003.08.027; FOOTE SL, 1980, P NATL ACAD SCI-BIOL, V77, P3033, DOI 10.1073/pnas.77.5.3033; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Haider B, 2007, J NEUROPHYSIOL, V97, P4186, DOI 10.1152/jn.01114.2006; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hasenstaub A, 2007, J NEUROSCI, V27, P9607, DOI 10.1523/JNEUROSCI.2184-07.2007; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Kawaguchi Y, 1998, J NEUROSCI, V18, P6963; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Kirkwood A, 1999, J NEUROSCI, V19, P1599; Klinkenberg I, 2011, BEHAV BRAIN RES, V221, P430, DOI 10.1016/j.bbr.2010.11.033; Langlois M, 2010, J NEUROSCI, V30, P16523, DOI 10.1523/JNEUROSCI.1109-10.2010; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MCCORMICK DA, 1993, CEREB CORTEX, V3, P387, DOI 10.1093/cercor/3.5.387; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; METHERATE R, 1992, J NEUROSCI, V12, P4701; Mueller D, 2008, J NEUROSCI, V28, P369, DOI 10.1523/JNEUROSCI.3248-07.2008; MULLER CM, 1989, BRAIN RES, V487, P335, DOI 10.1016/0006-8993(89)90837-8; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Ringach DL, 2009, CURR OPIN NEUROBIOL, V19, P439, DOI 10.1016/j.conb.2009.07.005; Ringach DL, 2002, J NEUROSCI, V22, P5639; Rodriguez R, 2010, NEUROSCIENCE, V165, P944, DOI 10.1016/j.neuroscience.2009.10.059; Sanchez-Vives MV, 2010, J NEUROPHYSIOL, V104, P1314, DOI 10.1152/jn.00178.2010; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sarter M, 2000, NEUROSCIENCE, V95, P933; SATO H, 1987, J NEUROPHYSIOL, V58, P781, DOI 10.1152/jn.1987.58.4.781; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soma S, 2012, J NEUROPHYSIOL, V107, P283, DOI 10.1152/jn.00330.2011; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; Szuts TA, 2011, NAT NEUROSCI, V14, P263, DOI 10.1038/nn.2730; WANG Z, 1993, J NEUROSCI, V13, P2199; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347	53	354	354	3	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1331	U227		10.1038/nn.3464	http://dx.doi.org/10.1038/nn.3464			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23872595	Green Accepted, Green Submitted			2022-12-17	WOS:000323597500026
J	Chiu, IM; von Hehn, CA; Woolf, CJ				Chiu, Isaac M.; von Hehn, Christian A.; Woolf, Clifford J.			Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology	NATURE NEUROSCIENCE			English	Article							GENE-RELATED PEPTIDE; ALLERGIC AIRWAY INFLAMMATION; SUBSTANCE-P; CELL-FUNCTION; INNATE IMMUNITY; DENDRITIC CELL; MICE LACKING; MAST-CELLS; T-CELLS; RECEPTOR	The peripheral nervous and immune systems are traditionally thought of as serving separate functions. The line between them is, however, becoming increasingly blurred by new insights into neurogenic inflammation. Nociceptor neurons possess many of the same molecular recognition pathways for danger as immune cells, and, in response to danger, the peripheral nervous system directly communicates with the immune system, forming an integrated protective mechanism. The dense innervation network of sensory and autonomic fibers in peripheral tissues and high speed of neural transduction allows rapid local and systemic neurogenic modulation of immunity. Peripheral neurons also seem to contribute to immune dysfunction in autoimmune and allergic diseases. Therefore, understanding the coordinated interaction of peripheral neurons with immune cells may advance therapeutic approaches to increase host defense and suppress immunopathology.	[Chiu, Isaac M.; von Hehn, Christian A.; Woolf, Clifford J.] Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Chiu, Isaac M.; von Hehn, Christian A.; Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Woolf, CJ (corresponding author), Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.	clifford.woolf@childrens.harvard.edu	Woolf, Clifford/A-9784-2010; Chiu, Isaac/R-3803-2016	Chiu, Isaac/0000-0002-0723-4841	US National Institutes of Health [2R37NS039518]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS039518, F32NS076297] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the US National Institutes of Health for support (2R37NS039518).	Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; ANSEL JC, 1993, J IMMUNOL, V150, P4478; Bessac BF, 2009, FASEB J, V23, P1102, DOI 10.1096/fj.08-117812; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Binshtok AM, 2008, J NEUROSCI, V28, P14062, DOI 10.1523/JNEUROSCI.3795-08.2008; BRAIN SD, 1989, BRIT J PHARMACOL, V97, P77, DOI 10.1111/j.1476-5381.1989.tb11926.x; Brogden KA, 2005, NAT IMMUNOL, V6, P558, DOI 10.1038/ni1209; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Cruz-Orengo L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-30; Cunin P, 2011, J IMMUNOL, V186, P4175, DOI 10.4049/jimmunol.1002535; Cyphert JM, 2009, J IMMUNOL, V182, P7430, DOI 10.4049/jimmunol.0900039; Czepielewski RS, 2012, P NATL ACAD SCI USA, V109, P547, DOI 10.1073/pnas.1110996109; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Ding WH, 2008, J IMMUNOL, V181, P6020, DOI 10.4049/jimmunol.181.9.6020; Diogenes A, 2011, J DENT RES, V90, P759, DOI 10.1177/0022034511400225; Dunzendorfer S, 1998, J LEUKOCYTE BIOL, V64, P828, DOI 10.1002/jlb.64.6.828; EDVINSSON L, 1987, J CEREBR BLOOD F MET, V7, P720, DOI 10.1038/jcbfm.1987.126; Engel MA, 2011, GASTROENTEROLOGY, V141, P1346, DOI 10.1053/j.gastro.2011.07.002; Fryer AD, 2006, J CLIN INVEST, V116, P228, DOI 10.1172/JCI25423; Ganor Y, 2003, J IMMUNOL, V170, P4362, DOI 10.4049/jimmunol.170.8.4362; HOSOI J, 1993, NATURE, V363, P159, DOI 10.1038/363159a0; Janeway CA, 1998, SEMIN IMMUNOL, V10, P349, DOI 10.1006/smim.1998.0142; Jimeno R, 2012, IMMUNOL CELL BIOL, V90, P178, DOI 10.1038/icb.2011.23; LEVINE JD, 1984, SCIENCE, V226, P547, DOI 10.1126/science.6208609; Levine JD, 2006, ANN NY ACAD SCI, V1069, P155, DOI 10.1196/annals.1351.014; Link TM, 2010, NAT IMMUNOL, V11, P232, DOI 10.1038/ni.1842; Liu T, 2010, NAT NEUROSCI, V13, P1460, DOI 10.1038/nn.2683; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Matzinger P, 2002, ANN NY ACAD SCI, V961, P341, DOI 10.1111/j.1749-6632.2002.tb03118.x; MCCORMACK DG, 1989, J APPL PHYSIOL, V67, P1265, DOI 10.1152/jappl.1989.67.3.1265; Mikami N, 2011, J IMMUNOL, V186, P6886, DOI 10.4049/jimmunol.1100028; Ostrowski SM, 2011, J INVEST DERMATOL, V131, P1530, DOI 10.1038/jid.2011.60; Qi J, 2011, J IMMUNOL, V186, P6417, DOI 10.4049/jimmunol.1001241; Razavi R, 2006, CELL, V127, P1123, DOI 10.1016/j.cell.2006.10.038; Rochlitzer S, 2011, CLIN EXP ALLERGY, V41, P1609, DOI 10.1111/j.1365-2222.2011.03822.x; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; SARIA A, 1984, BRIT J PHARMACOL, V82, P217, DOI 10.1111/j.1476-5381.1984.tb16461.x; Sauer SK, 2001, EUR J NEUROSCI, V14, P1203, DOI 10.1046/j.0953-816x.2001.01741.x; SMITH CH, 1993, J IMMUNOL, V151, P3274; Souslova V, 2000, NATURE, V407, P1015, DOI 10.1038/35039526; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Turner H., 2007, V179, P457; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Veres TZ, 2007, AM J RESP CELL MOL, V37, P553, DOI 10.1165/rcmb.2007-0087OC; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Zhang XC, 2011, PAIN, V152, P140, DOI 10.1016/j.pain.2010.10.002	50	354	363	3	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1063	1067		10.1038/nn.3144	http://dx.doi.org/10.1038/nn.3144			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22837035	Green Accepted			2022-12-17	WOS:000306844500006
J	Stamatakis, AM; Stuber, GD				Stamatakis, Alice M.; Stuber, Garret D.			Activation of lateral habenula inputs to the ventral midbrain promotes behavioral avoidance	NATURE NEUROSCIENCE			English	Article							DOPAMINE NEURONS; NUCLEUS-ACCUMBENS; TEGMENTAL AREA; GABA NEURONS; REWARD; VTA; PREDICTION; AVERSION; STIMULI	Lateral habenula (LHb) projections to the ventral midbrain, including the rostromedial tegmental nucleus (RMTg), convey negative reward-related information, but the behavioral ramifications of selective activation of this pathway remain unexplored. We found that exposure to aversive stimuli in mice increased LHb excitatory drive onto RMTg neurons. Furthermore, optogenetic activation of this pathway promoted active, passive and conditioned behavioral avoidance. Thus, activity of LHb efferents to the midbrain is aversive but can also serve to negatively reinforce behavioral responding.	[Stamatakis, Alice M.; Stuber, Garret D.] UNC, UNC Neurobiol Curriculum, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA; [Stuber, Garret D.] UNC, UNC Neurosci Ctr, Dept Psychiat, Chapel Hill, NC USA; [Stuber, Garret D.] UNC, UNC Neurosci Ctr, Dept Cellular & Mol Physiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Stuber, GD (corresponding author), UNC, UNC Neurobiol Curriculum, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA.	gstuber@med.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022; Core, Vector/CAF-4832-2022; Stuber, Garret/E-1160-2011	Stuber, Garret/0000-0003-1730-4855	Brain and Behavior Research Foundation; Foundation for Alcohol Research; Whitehall Foundation; Foundation of Hope; National Institute on Drug Abuse [DA029325, DA032750]; UNC Neurobiology Curriculum training grant [T32 NS007431]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892, T32NS007431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA029325, R01DA032750, F31DA034472] Funding Source: NIH RePORTER	Brain and Behavior Research Foundation; Foundation for Alcohol Research; Whitehall Foundation; Foundation of Hope; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); UNC Neurobiology Curriculum training grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Ung, V. Gukassyan and the UNC Neuroscience Center Microscopy Facility, and the members of the Stuber laboratory for discussion. We thank K. Deisseroth (Stanford University) for opsin constructs and the UNC Vector Core for viral packaging. We thank C. Good for sagittal slice preparation advice. This study was supported by the Brain and Behavior Research Foundation, the Foundation for Alcohol Research, the Whitehall Foundation, the Foundation of Hope and the National Institute on Drug Abuse (DA029325 and DA032750; G.D.S.). A.M.S. was supported by the UNC Neurobiology Curriculum training grant (T32 NS007431).	Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Bromberg-Martin ES, 2011, NAT NEUROSCI, V14, P1209, DOI 10.1038/nn.2902; Cunningham CL, 2006, NAT PROTOC, V1, P1662, DOI 10.1038/nprot.2006.279; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Matsui A, 2011, J NEUROSCI, V31, P17729, DOI 10.1523/JNEUROSCI.4570-11.2011; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Perrotti LI, 2005, EUR J NEUROSCI, V21, P2817, DOI 10.1111/j.1460-9568.2005.04110.x; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Stephenson-Jones M, 2012, P NATL ACAD SCI USA, V109, pE164, DOI 10.1073/pnas.1119348109; Stuber GD, 2008, ALCOHOL CLIN EXP RES, V32, P1714, DOI 10.1111/j.1530-0277.2008.00749.x; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016	20	354	366	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1105	+		10.1038/nn.3145	http://dx.doi.org/10.1038/nn.3145			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22729176	Green Accepted, Green Submitted			2022-12-17	WOS:000306844500013
J	Rust, NC; Mante, V; Simoncelli, EP; Movshon, JA				Rust, Nicole C.; Mante, Valerio; Simoncelli, Eero P.; Movshon, J. Anthony			How MT cells analyze the motion of visual patterns	NATURE NEUROSCIENCE			English	Article							CATS STRIATE CORTEX; MACAQUE V1 NEURONS; RECEPTIVE-FIELD STRUCTURE; AREA MT; COMPLEX CELLS; FUNCTIONAL ARCHITECTURE; RESPONSE PROPERTIES; SPATIAL SUMMATION; CORTICAL-NEURONS; MONKEY	Neurons in area MT ( V5) are selective for the direction of visual motion. In addition, many are selective for the motion of complex patterns independent of the orientation of their components, a behavior not seen in earlier visual areas. We show that the responses of MT cells can be captured by a linear-nonlinear model that operates not on the visual stimulus, but on the afferent responses of a population of nonlinear V1 cells. We fit this cascade model to responses of individual MT neurons and show that it robustly predicts the separately measured responses to gratings and plaids. The model captures the full range of pattern motion selectivity found in MT. Cells that signal pattern motion are distinguished by having convergent excitatory input from V1 cells with a wide range of preferred directions, strong motion opponent suppression and a tuned normalization that may reflect suppressive input from the surround of V1 cells.	NYU, Howard Hughes Med Inst, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA; Univ Zurich, Inst Neuroinformat, CH-8057 Zurich, Switzerland; Federal Inst Technol, CH-8057 Zurich, Switzerland	Howard Hughes Medical Institute; New York University; New York University; University of Zurich	Rust, NC (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rust@mit.edu		Simoncelli, Eero/0000-0002-1206-527X	NEI NIH HHS [R01 EY004440, EY02017] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY004440, R01EY002017] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Bair W, 2004, J NEUROSCI, V24, P7305, DOI 10.1523/JNEUROSCI.0554-04.2004; Britten KH, 1999, J NEUROSCI, V19, P5074; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Carandini M, 1997, J NEUROSCI, V17, P8621; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Collins CE, 2003, J NEUROSCI, V23, P2251; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; EFRON B, 1993, INTRO BOOTHSTRAP; EMERSON RC, 1992, VISION RES, V32, P203, DOI 10.1016/0042-6989(92)90130-B; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gegenfurtner KR, 1997, J NEUROPHYSIOL, V77, P1906, DOI 10.1152/jn.1997.77.4.1906; GEISLER WS, 1992, VISION RES, V32, P1409, DOI 10.1016/0042-6989(92)90196-P; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1212, DOI 10.1152/jn.1987.58.6.1212; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Lennie P, 2005, J OPT SOC AM A, V22, P2013, DOI 10.1364/JOSAA.22.002013; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; Livingstone MS, 2001, NEURON, V30, P781, DOI 10.1016/S0896-6273(01)00313-0; MANTTE V, 2000, THESIS U ZURICH; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Movshon Adelson, 1985, PATTERN RECOGNITION, V54, P117, DOI 10.1098/rstb.1998.0333; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Movshon JA, 1996, J NEUROSCI, V16, P7733; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; Pack CC, 2004, J NEUROSCI, V24, P3268, DOI 10.1523/JNEUROSCI.4387-03.2004; Pack CC, 2003, NEURON, V39, P671, DOI 10.1016/S0896-6273(03)00439-2; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Ringach DL, 1997, VISION RES, V37, P2455, DOI 10.1016/S0042-6989(96)00247-7; ROCKLAND KS, 1989, VISUAL NEUROSCI, V3, P155, DOI 10.1017/S0952523800004466; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; RODMAN HR, 1987, VISION RES, V27, P2035, DOI 10.1016/0042-6989(87)90118-0; RODMAN HR, 1989, J NEUROSCI, V9, P2033; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Sincich LC, 2004, NAT NEUROSCI, V7, P1123, DOI 10.1038/nn1318; Smith MA, 2005, NAT NEUROSCI, V8, P220, DOI 10.1038/nn1382; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Tinsley CJ, 2003, J NEUROPHYSIOL, V90, P930, DOI 10.1152/jn.00708.2002; VANDENBERG AV, 1993, EXP BRAIN RES, V96, P519, DOI 10.1007/BF00234120; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452	50	354	357	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1421	1431		10.1038/nn1786	http://dx.doi.org/10.1038/nn1786			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17041595				2022-12-17	WOS:000242403800021
J	Lin, MZ; Schnitzer, MJ				Lin, Michael Z.; Schnitzer, Mark J.			Genetically encoded indicators of neuronal activity	NATURE NEUROSCIENCE			English	Review							GREEN FLUORESCENT PROTEINS; VOLTAGE-SENSING DOMAIN; LIGHT-SHEET MICROSCOPY; CALCIUM IMAGING DATA; IN-VIVO; NEURAL ACTIVITY; ACTION-POTENTIALS; CA2+ INDICATORS; CAENORHABDITIS-ELEGANS; CELLULAR RESOLUTION	Experimental efforts to understand how the brain represents, stores and processes information require high-fidelity recordings of multiple different forms of neural activity within functional circuits. Thus, creating improved technologies for large-scale recordings of neural activity in the live brain is a crucial goal in neuroscience. Over the past two decades, the combination of optical microscopy and genetically encoded fluorescent indicators has become a widespread means of recording neural activity in nonmammalian and mammalian nervous systems, transforming brain research in the process. In this review, we describe and assess different classes of fluorescent protein indicators of neural activity. We first discuss general considerations in optical imaging and then present salient characteristics of representative indicators. Our focus is on how indicator characteristics relate to their use in living animals and on likely areas of future progress.	[Lin, Michael Z.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Lin, Michael Z.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, James H Clark Ctr, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Lin, MZ (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.; Lin, MZ (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Schnitzer, MJ (corresponding author), Stanford Univ, James H Clark Ctr, Stanford, CA 94305 USA.; Schnitzer, MJ (corresponding author), Stanford Univ, CNC Program, Stanford, CA 94305 USA.; Schnitzer, MJ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	mzlin@stanford.edu; mschnitz@stanford.edu		Lin, Michael/0000-0002-0492-1961	Defense Advanced Research Projects Agency; Rita Allen Foundation; NIH BRAIN Initiative grant [1U01NS090600]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM111003, P50GM107615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090600] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Rita Allen Foundation; NIH BRAIN Initiative grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We gratefully acknowledge research funding from the Defense Advanced Research Projects Agency (M.J.S. and M.Z.L.), the Rita Allen Foundation (M.Z.L.) and NIH BRAIN Initiative grant 1U01NS090600 (M.Z.L. and M.J.S.).	Abdelfattah AS, 2016, J NEUROSCI, V36, P2458, DOI 10.1523/JNEUROSCI.3484-15.2016; Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Ai MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138127; Akemann W, 2013, SCI REP-UK, V3, DOI 10.1038/srep02231; Akemann W, 2012, J NEUROPHYSIOL, V108, P2323, DOI 10.1152/jn.00452.2012; Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Alabi AA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013680; Badura A, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.2.025008; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Baker BJ, 2007, J NEUROSCI METH, V161, P32, DOI 10.1016/j.jneumeth.2006.10.005; Bayraktar H, 2012, PHOTOCHEM PHOTOBIOL, V88, P90, DOI 10.1111/j.1751-1097.2011.01011.x; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Berlin S, 2015, NAT METHODS, V12, P852, DOI [10.1038/NMETH.3480, 10.1038/nmeth.3480]; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Brinks D, 2015, BIOPHYS J, V109, P914, DOI 10.1016/j.bpj.2015.07.038; Broussard GJ, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00097; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Cao G, 2013, CELL, V154, P904, DOI 10.1016/j.cell.2013.07.027; Chen JL, 2013, NATURE, V499, P336, DOI 10.1038/nature12236; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chu J, 2016, NAT BIOTECHNOL, V34, P760, DOI 10.1038/nbt.3550; Cichon J, 2015, NATURE, V520, P180, DOI 10.1038/nature14251; Cranfill PJ, 2016, NAT METHODS, V13, P557, DOI [10.1038/NMETH.3891, 10.1038/nmeth.3891]; Dana H, 2016, ELIFE, V5, DOI 10.7554/eLife.12727; Diamond JS, 2005, J NEUROSCI, V25, P2906, DOI 10.1523/JNEUROSCI.5125-04.2005; Dimitrov D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000440; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Dulla C, 2008, J NEUROSCI METH, V168, P306, DOI 10.1016/j.jneumeth.2007.10.017; Dunn TW, 2016, ELIFE, V5, DOI 10.7554/eLife.12741; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Flytzanis NC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5894; Fosque BF, 2015, SCIENCE, V347, P755, DOI 10.1126/science.1260922; Gandasi NR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127801; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Gong YY, 2015, SCIENCE, V350, P1361, DOI 10.1126/science.aab0810; Gong YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4674; Gong YY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066959, 10.1371/journal.pone.0070340]; Gore BB, 2014, LEARN MEMORY, V21, P575, DOI 10.1101/lm.036079.114; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Grosenick L, 2015, NEURON, V86, P106, DOI 10.1016/j.neuron.2015.03.034; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hamel EJO, 2015, NEURON, V86, P140, DOI 10.1016/j.neuron.2015.03.055; Helassa N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15978; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; Hendel T, 2008, J NEUROSCI, V28, P7399, DOI 10.1523/JNEUROSCI.1038-08.2008; Higley MJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005686; Hikima T, 2016, BRAIN RES, V1639, P74, DOI 10.1016/j.brainres.2016.02.042; Hires SA, 2008, BRAIN CELL BIOL, V36, P69, DOI 10.1007/s11068-008-9029-4; Hires SA, 2008, P NATL ACAD SCI USA, V105, P4411, DOI 10.1073/pnas.0712008105; Hochbaum DR, 2014, NAT METHODS, V11, P825, DOI [10.1038/NMETH.3000, 10.1038/nmeth.3000]; Hoi H, 2013, J AM CHEM SOC, V135, P46, DOI 10.1021/ja310184a; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Inoue M, 2015, NAT METHODS, V12, P64, DOI [10.1038/NMETH.3185, 10.1038/nmeth.3185]; Jagadish S, 2014, NEURON, V83, P630, DOI 10.1016/j.neuron.2014.06.025; Jercog P, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021824; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Jorgenson LA, 2015, PHILOS T R SOC B, V370, P8, DOI 10.1098/rstb.2014.0164; Jung A, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.2.021012; Kavalali ET, 2014, NAT NEUROSCI, V17, P10, DOI 10.1038/nn.3578; Kawashima T, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00037; Knopfel T, 2015, CURR OPIN CHEM BIOL, V27, P75, DOI 10.1016/j.cbpa.2015.06.006; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Kolodner P, 1996, P NATL ACAD SCI USA, V93, P11618, DOI 10.1073/pnas.93.21.11618; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Lecoq J, 2014, NAT NEUROSCI, V17, P1825, DOI 10.1038/nn.3867; Leitz J, 2014, ELIFE, V3, DOI 10.7554/eLife.03658; Li HY, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00034; Li YL, 2012, NAT NEUROSCI, V15, P1047, DOI 10.1038/nn.3126; Liang RQ, 2015, ACS CHEM NEUROSCI, V6, P84, DOI 10.1021/cn500280k; Lovett-Barron M, 2014, SCIENCE, V343, P857, DOI 10.1126/science.1247485; Lutcke H, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00201; Lutcke H, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00009; Lundby A, 2010, EUR BIOPHYS J BIOPHY, V39, P1625, DOI 10.1007/s00249-010-0620-0; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Matsuda T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01398; Melom JE, 2013, J NEUROSCI, V33, P17253, DOI 10.1523/JNEUROSCI.3334-13.2013; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mishina Y, 2012, BIOPHYS J, V103, P669, DOI 10.1016/j.bpj.2012.07.031; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Miyawaki A, 2015, MOL CELL, V58, P632, DOI 10.1016/j.molcel.2015.03.002; Mues M, 2013, NAT MED, V19, P778, DOI 10.1038/nm.3180; Mutch SA, 2011, J NEUROSCI, V31, P1461, DOI 10.1523/JNEUROSCI.3805-10.2011; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Nguyen JP, 2016, P NATL ACAD SCI USA, V113, pE1074, DOI 10.1073/pnas.1507110112; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Okumoto S, 2005, P NATL ACAD SCI USA, V102, P8740, DOI 10.1073/pnas.0503274102; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Peterka DS, 2011, NEURON, V69, P9, DOI 10.1016/j.neuron.2010.12.010; Peters AJ, 2014, NATURE, V510, P263, DOI 10.1038/nature13235; Piao HH, 2015, J NEUROSCI, V35, P372, DOI 10.1523/JNEUROSCI.3008-14.2015; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Podor B, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.2.021014; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Sabatini BL, 1999, ANNU REV PHYSIOL, V61, P521, DOI 10.1146/annurev.physiol.61.1.521; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sattarzadeh A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11771; Seo J, 2016, MOL CELLS, V39, P439, DOI 10.14348/molcells.2016.0088; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Sheffield MEJ, 2015, NATURE, V517, P200, DOI 10.1038/nature13871; Shen Y, 2014, J CELL BIOL, V207, P419, DOI 10.1083/jcb.201404107; Siegel F, 2013, EXP NEUROL, V242, P27, DOI 10.1016/j.expneurol.2012.02.007; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; Sjulson L, 2007, PHYSIOLOGY, V22, P47, DOI 10.1152/physiol.00036.2006; Sofroniew NJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14472; St-Pierre F, 2015, CURR OPIN CHEM BIOL, V27, P31, DOI 10.1016/j.cbpa.2015.05.003; St-Pierre F, 2014, NAT NEUROSCI, V17, P884, DOI 10.1038/nn.3709; Stirman J.N., 2016, NAT BIOTECHNOL; Stuart GJ, 2015, NAT NEUROSCI, V18, P1713, DOI 10.1038/nn.4157; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Sun WZ, 2016, NAT NEUROSCI, V19, P308, DOI 10.1038/nn.4196; Sun XNR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3170; Susaki EA, 2016, CELL CHEM BIOL, V23, P137, DOI 10.1016/j.chembiol.2015.11.009; Tabares L, 2007, J NEUROSCI, V27, P5422, DOI 10.1523/JNEUROSCI.0670-07.2007; Theis L, 2016, NEURON, V90, P471, DOI 10.1016/j.neuron.2016.04.014; Thestrup T, 2014, NAT METHODS, V11, P175, DOI [10.1038/NMETH.2773, 10.1038/nmeth.2773]; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tomer R, 2015, CELL, V163, P1796, DOI 10.1016/j.cell.2015.11.061; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsutsui H, 2013, J PHYSIOL-LONDON, V591, P4427, DOI 10.1113/jphysiol.2013.257048; Venkatachalam V, 2016, P NATL ACAD SCI USA, V113, pE1082, DOI 10.1073/pnas.1507109113; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; Wallace DJ, 2008, NAT METHODS, V5, P797, DOI 10.1038/NMETH.1242; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang Q, 2008, STRUCTURE, V16, P1817, DOI 10.1016/j.str.2008.10.008; Wilt BA, 2013, BIOPHYS J, V104, P51, DOI 10.1016/j.bpj.2012.07.058; Xie YC, 2016, J NEUROSCI, V36, P1261, DOI 10.1523/JNEUROSCI.2744-15.2016; Yamada Y, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00018; Yang HH, 2016, CELL, V166, P245, DOI 10.1016/j.cell.2016.05.031; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; Zhou XX, 2015, FRONT MOL NEUROSCI, V8, DOI [10.3389/fnmol.2015.00037, 10.3389/fnmo1.2015.00037]; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329; Zou P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5625	144	353	363	10	190	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2016	19	9					1142	1153		10.1038/nn.4359	http://dx.doi.org/10.1038/nn.4359			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU5SA	27571193	Green Accepted			2022-12-17	WOS:000382270400010
J	Richardson, MP; Strange, BA; Dolan, RJ				Richardson, MP; Strange, BA; Dolan, RJ			Encoding of emotional memories depends on amygdala and hippocampus and their interactions	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; DECLARATIVE MEMORY; FUNCTIONAL MRI; T2 RELAXATION; FREE-RECALL; LONG-TERM; RAT; PROJECTIONS; SCLEROSIS; NEUROPATHOLOGY	We have studied patients with variable degrees of left hippocampal and amygdala pathology who performed a verbal encoding task during functional magnetic resonance imaging (fMRI) to assess the impact of pathology on emotional-memory performance and encoding-evoked activity. The severity of left hippocampal pathology predicted memory performance for neutral and emotional items alike, whereas the severity of amygdala pathology predicted memory performance for emotional items alone. Encoding-related hippocampal activity for successfully remembered emotional items correlated with the degree of left amygdala pathology. Conversely, amygdala-evoked activity with respect to subsequently remembered emotional items correlated with the degree of left hippocampal pathology. Our data indicate a reciprocal dependence between amygdala and hippocampus during the encoding of emotional memories.	Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England; Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Richardson, MP (corresponding author), Inst Neurol, Dept Clin & Expt Epilepsy, Queen Sq, London WC1N 3BG, England.	m.richardson@ion.ucl.ac.uk	Richardson, Mark P/E-5385-2010; Strange, Bryan/AAF-3805-2019; Strange, Bryan A/L-9466-2014	Richardson, Mark P/0000-0001-8925-3140; Strange, Bryan/0000-0001-6476-4091; Strange, Bryan A/0000-0001-6476-4091; Dolan, Ray/0000-0001-9356-761X				Adolphs R, 1997, LEARN MEMORY, V4, P291, DOI 10.1101/lm.4.3.291; Alkire MT, 1998, P NATL ACAD SCI USA, V95, P14506, DOI 10.1073/pnas.95.24.14506; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bartlett PA, 2002, J NEUROL NEUROSUR PS, V73, P753, DOI 10.1136/jnnp.73.6.753; Bellgowan PSF, 1998, NEUROLOGY, V51, P479, DOI 10.1212/WNL.51.2.479; Briellmann RS, 2002, NEUROLOGY, V58, P265, DOI 10.1212/WNL.58.2.265; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; CANTERAS NS, 1992, J COMP NEUROL, V324, P180, DOI 10.1002/cne.903240204; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Duncan JS, 1996, AM J NEURORADIOL, V17, P1805; DUNCAN JS, 1997, BRAIN, V120, P376; Dupont S, 2000, BRAIN, V123, P1722, DOI 10.1093/brain/123.8.1722; FRISK V, 1990, NEUROPSYCHOLOGIA, V28, P349, DOI 10.1016/0028-3932(90)90061-R; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gallagher M, 1996, CURR OPIN NEUROBIOL, V6, P221, DOI 10.1016/S0959-4388(96)80076-6; Golby AJ, 2002, EPILEPSIA, V43, P855, DOI 10.1046/j.1528-1157.2002.20501.x; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Helmstaedter C, 2001, CURR OPIN NEUROL, V14, P211, DOI 10.1097/00019052-200104000-00013; HUDSON LP, 1993, ANN NEUROL, V33, P622, DOI 10.1002/ana.410330611; Kalviainen R, 1997, NEUROLOGY, V48, P286, DOI 10.1212/WNL.48.1.286; Kilpatrick C, 1997, SEIZURE, V6, P213, DOI 10.1016/S1059-1311(97)80008-8; KRETTEK JE, 1977, J COMP NEUROL, V172, P723, DOI 10.1002/cne.901720409; LENCZ T, 1992, ANN NEUROL, V31, P629, DOI 10.1002/ana.410310610; MAREN S, 1995, J NEUROSCI, V15, P7548; McGaugh JL, 1996, P NATL ACAD SCI USA, V93, P13508, DOI 10.1073/pnas.93.24.13508; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; Phelps EA, 1997, BRAIN COGNITION, V35, P85, DOI 10.1006/brcg.1997.0929; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Richardson MP, 2003, NEUROIMAGE, V20, pS112, DOI 10.1016/j.neuroimage.2003.09.008; Richter-Levin G, 2000, MOL NEUROBIOL, V22, P11, DOI 10.1385/MN:22:1-3:011; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; SMITH ML, 1981, NEUROPSYCHOLOGIA, V19, P781, DOI 10.1016/0028-3932(81)90090-7; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Strange BA, 2000, NEUROIMAGE, V12, P425, DOI 10.1006/nimg.2000.0637; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308; VanPaesschen W, 1995, NEUROLOGY, V45, P2233; VanPaesschen W, 1997, ANN NEUROL, V42, P756, DOI 10.1002/ana.410420512; VanPaesschen W, 1997, ANN NEUROL, V41, P41, DOI 10.1002/ana.410410109; Windmann S, 2001, J COGNITIVE NEUROSCI, V13, P577, DOI 10.1162/089892901750363172; Woermann FG, 1998, J NEUROL NEUROSUR PS, V65, P656, DOI 10.1136/jnnp.65.5.656	44	353	368	1	47	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					278	285		10.1038/nn1190	http://dx.doi.org/10.1038/nn1190			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14758364	Green Published			2022-12-17	WOS:000189197900018
J	Muller, MB; Zimmermann, S; Sillaber, I; Hagemeyer, TP; Deussing, JM; Timpl, P; Kormann, MSD; Droste, SK; Kuhn, R; Reul, JMHM; Holsboer, F; Wurst, W				Muller, MB; Zimmermann, S; Sillaber, I; Hagemeyer, TP; Deussing, JM; Timpl, P; Kormann, MSD; Droste, SK; Kuhn, R; Reul, JMHM; Holsboer, F; Wurst, W			Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress	NATURE NEUROSCIENCE			English	Article							PARAVENTRICULAR NUCLEUS; MINERALOCORTICOID RECEPTOR; ANTAGONIST R121919; CHRONIC INFUSION; REDUCED ANXIETY; MICE DEFICIENT; NERVOUS-SYSTEM; MATERNAL-CARE; PITUITARY; AMYGDALA	Corticotropin-releasing hormone (CRH) is centrally involved in coordinating responses to a variety of stress-associated stimuli. Recent clinical data implicate CRH in the pathophysiology of human affective disorders. To differentiate the CNS pathways involving CRH and CRH receptor 1 (Crhr1) that modulate behavior from those that regulate neuroendocrine function, we generated a conditional knockout mouse line (Crhr1(loxP/loxP) Camk2a-cre) in which Crhr1 function is inactivated postnatally in anterior forebrain and limbic brain structures, but not in the pituitary. This leaves the hypothalamic-pituitary-adrenocortical (HPA) system intact. Crhr1(loxP/loxP) Camk2a-cre mutants showed reduced anxiety, and the basal activity of their HPA system was normal. In contrast to Crhr1 null mutants, conditional mutants were hypersensitive to stress corticotropin and corticosterone levels remained significantly elevated after stress. Our data clearly show that limbic Crhr1 modulates anxiety-related behavior and that this effect is independent of HPA system function. Furthermore, we provide evidence for a new role of limbic Crhr1 in neuroendocrine adaptation to stress.	Max Planck Inst Psychiat, D-80804 Munich, Germany; GSF Forschungszentrum, Inst Dev Genet, D-85764 Neuherberg, Germany	Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Wurst, W (corresponding author), Max Planck Inst Psychiat, Kraepelinstr 2-10, D-80804 Munich, Germany.	wurst@gsf.de	Reul, Johannes/B-4132-2019; Kühn, Ralf/U-1278-2017; Kormann, Michael SD/C-7723-2014; Deussing, Jan M/ABB-5993-2021; Müller, Marianne B./AAL-8911-2021	Reul, Johannes/0000-0002-8787-4012; Kühn, Ralf/0000-0003-1694-9803; Müller, Marianne B./0000-0002-0269-6131; Wurst, Wolfgang/0000-0003-4422-7410; Deussing, Jan/0000-0002-9329-5252				Avishai-Eliner S, 2002, TRENDS NEUROSCI, V25, P518, DOI 10.1016/S0166-2236(02)02241-5; Brunson KL, 2001, MOL PSYCHIATR, V6, P647, DOI 10.1038/sj.mp.4000942; Caldji C, 2000, BIOL PSYCHIAT, V48, P1164, DOI 10.1016/S0006-3223(00)01084-2; Chen JC, 2000, J COMP NEUROL, V420, P305, DOI 10.1002/(SICI)1096-9861(20000508)420:3<305::AID-CNE3>3.0.CO;2-8; COLE JC, 1995, PHARMACOL BIOCHEM BE, V52, P473, DOI 10.1016/0091-3057(95)00163-Q; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DEKLOET ER, 1987, PSYCHONEUROENDOCRINO, V12, P83, DOI 10.1016/0306-4530(87)90040-0; DUNN AJ, 1990, BRAIN RES REV, V15, P71, DOI 10.1016/0165-0173(90)90012-D; Gesing A, 2001, J NEUROSCI, V21, P4822, DOI 10.1523/JNEUROSCI.21-13-04822.2001; Gray TS, 1996, CRIT REV NEUROBIOL, V10, P155, DOI 10.1615/CritRevNeurobiol.v10.i2.10; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; Hascoet M, 2001, PROG NEURO-PSYCHOPH, V25, P141, DOI 10.1016/S0278-5846(00)00151-2; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; HERMAN JP, 1992, BRAIN RES, V592, P228, DOI 10.1016/0006-8993(92)91680-D; HILL DP, 1993, METHOD ENZYMOL, V225, P664; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Holsboer F, 1999, J PSYCHIATR RES, V33, P181, DOI 10.1016/S0022-3956(98)90056-5; JOELS M, 1992, TRENDS NEUROSCI, V15, P25, DOI 10.1016/0166-2236(92)90345-9; Joels M, 2001, J NEUROENDOCRINOL, V13, P657, DOI 10.1046/j.1365-2826.2001.00688.x; Keck ME, 2001, EUR J NEUROSCI, V13, P373, DOI 10.1046/j.0953-816X.2000.01383.x; Korte SM, 2001, NEUROSCI BIOBEHAV R, V25, P117, DOI 10.1016/S0149-7634(01)00002-1; Korte SM, 1996, PHARMACOL BIOCHEM BE, V54, P261, DOI 10.1016/0091-3057(95)02172-8; KRESSE A, 1995, BRAIN RES BULL, V36, P261, DOI 10.1016/0361-9230(94)00201-B; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; LIEBSCH G, 1995, REGUL PEPTIDES, V59, P229, DOI 10.1016/0167-0115(95)00099-W; Liebsch G, 1999, J PSYCHIAT RES, V33, P153, DOI 10.1016/S0022-3956(98)80047-2; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lopez JF, 1998, BIOL PSYCHIAT, V43, P547, DOI 10.1016/S0006-3223(97)00484-8; Lopez JF, 1999, BIOL PSYCHIAT, V46, P1461, DOI 10.1016/S0006-3223(99)00266-8; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Muller MB, 2000, ENDOCRINOLOGY, V141, P4262, DOI 10.1210/en.141.11.4262; OWENS MJ, 1991, PHARMACOL REV, V43, P425; Preil J, 2001, ENDOCRINOLOGY, V142, P4946, DOI 10.1210/en.142.11.4946; RAADSHEER FC, 1995, AM J PSYCHIAT, V152, P1372; RAADSHEER FC, 1994, NEUROENDOCRINOLOGY, V60, P436, DOI 10.1159/000126778; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Sillaber I, 2002, SCIENCE, V296, P931, DOI 10.1126/science.1069836; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Sola C, 1999, J NEUROSCI RES, V57, P651, DOI 10.1002/(SICI)1097-4547(19990901)57:5<651::AID-JNR7>3.0.CO;2-G; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; Zobel AW, 2000, J PSYCHIATR RES, V34, P171, DOI 10.1016/S0022-3956(00)00016-9	44	353	364	0	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1100	1107		10.1038/nn1123	http://dx.doi.org/10.1038/nn1123			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	12973355				2022-12-17	WOS:000185633600023
J	Dayan, E; Censor, N; Buch, ER; Sandrini, M; Cohen, LG				Dayan, Eran; Censor, Nitzan; Buch, Ethan R.; Sandrini, Marco; Cohen, Leonardo G.			Noninvasive brain stimulation: from physiology to network dynamics and back	NATURE NEUROSCIENCE			English	Review							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MOTOR CORTEX; THETA-BURST-STIMULATION; HIGH-FREQUENCY STIMULATION; POSTERIOR PARIETAL CORTEX; VENTRAL PREMOTOR CORTEX; CORTICAL PLASTICITY; SYNAPTIC PLASTICITY; EXCITABILITY SHIFTS; PREFRONTAL CORTEX	Noninvasive brain stimulation techniques have been widely used for studying the physiology of the CNS, identifying the functional role of specific brain structures and, more recently, exploring large-scale network dynamics. Here we review key findings that contribute to our understanding of the mechanisms underlying the physiological and behavioral effects of these techniques. We highlight recent innovations using noninvasive stimulation to investigate global brain network dynamics and organization. New combinations of these techniques, in conjunction with neuroimaging, will further advance the utility of their application.	[Dayan, Eran; Censor, Nitzan; Buch, Ethan R.; Sandrini, Marco; Cohen, Leonardo G.] NINDS, Human Cort Physiol & Neurorehabil Sect, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Buch, Ethan R.; Sandrini, Marco] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Uniformed Services University of the Health Sciences - USA	Cohen, LG (corresponding author), NINDS, Human Cort Physiol & Neurorehabil Sect, US Natl Inst Hlth, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	cohenl@ninds.nih.gov	Buch, Ethan/AAB-4549-2021; Dayan, Eran/C-3449-2009; Sandrini, Marco/J-2276-2014; Censor, Nitzan/ABC-1739-2021	Sandrini, Marco/0000-0002-1664-5722; Dayan, Eran/0000-0001-9710-9210	Intramural Research Program of the US National Institute of Neurological Disorders and Stroke (NINDS; US National Institutes of Health); US Department of Defense in the Center for Neuroscience and Regenerative Medicine; NINDS Ruth L. Kirschstein National Research Service Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003030, ZIANS002978] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institute of Neurological Disorders and Stroke (NINDS; US National Institutes of Health); US Department of Defense in the Center for Neuroscience and Regenerative Medicine(United States Department of Defense); NINDS Ruth L. Kirschstein National Research Service Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S.-L. Liew for suggestions. This work was supported by the Intramural Research Program of the US National Institute of Neurological Disorders and Stroke (NINDS; US National Institutes of Health) and by funding from US Department of Defense in the Center for Neuroscience and Regenerative Medicine to M.S. and E.R.B. N.C. was supported by an NINDS Ruth L. Kirschstein National Research Service Award.	Agostino R, 2007, EXP BRAIN RES, V180, P105, DOI 10.1007/s00221-006-0838-3; Antal A, 2004, J COGNITIVE NEUROSCI, V16, P521, DOI 10.1162/089892904323057263; Antal A, 2010, BRAIN STIMUL, V3, P230, DOI 10.1016/j.brs.2009.12.003; Avenanti A, 2007, CURR BIOL, V17, P2129, DOI 10.1016/j.cub.2007.11.045; Avenanti A, 2013, CEREB CORTEX, V23, P570, DOI 10.1093/cercor/bhs040; BARKER AT, 1985, LANCET, V1, P1106; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Bestmann S, 2008, EXP BRAIN RES, V191, P383, DOI 10.1007/s00221-008-1601-8; Bikson M, 2012, CLIN EEG NEUROSCI, V43, P176, DOI 10.1177/1550059412445138; BINDMAN LJ, 1964, J PHYSIOL-LONDON, V172, P369, DOI 10.1113/jphysiol.1964.sp007425; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Buch ER, 2011, J NEUROSCI, V31, P17669, DOI 10.1523/JNEUROSCI.1513-11.2011; Buch ER, 2010, J NEUROSCI, V30, P1395, DOI 10.1523/JNEUROSCI.4882-09.2010; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Butefisch CM, 2004, J NEUROPHYSIOL, V91, P2110, DOI 10.1152/jn.01038.2003; Cattaneo L, 2010, CEREB CORTEX, V20, P2252, DOI 10.1093/cercor/bhp291; Censor N, 2011, J PHYSIOL-LONDON, V589, P21, DOI 10.1113/jphysiol.2010.198077; Censor N, 2010, CURR BIOL, V20, P1545, DOI 10.1016/j.cub.2010.07.047; Chambers CD, 2004, NAT NEUROSCI, V7, P217, DOI 10.1038/nn1203; Chanes L, 2013, J NEUROSCI, V33, P5000, DOI 10.1523/JNEUROSCI.4401-12.2013; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Civardi C, 2001, NEUROIMAGE, V14, P1444, DOI 10.1006/nimg.2001.0918; COHEN D, 1991, J CLIN NEUROPHYSIOL, V8, P102, DOI 10.1097/00004691-199101000-00013; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Daskalakis ZJ, 2004, J PHYSIOL-LONDON, V557, P689, DOI 10.1113/jphysiol.2003.059808; Datta A, 2009, BRAIN STIMUL, V2, P201, DOI 10.1016/j.brs.2009.03.005; Davare M, 2008, J PHYSIOL-LONDON, V586, P2735, DOI 10.1113/jphysiol.2008.152603; Deng ZD, 2013, BRAIN STIMUL, V6, P1, DOI 10.1016/j.brs.2012.02.005; Di Lazzaro V, 2008, J PHYSIOL-LONDON, V586, P3871, DOI 10.1113/jphysiol.2008.152736; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Dugue L, 2011, J NEUROSCI, V31, P11889, DOI 10.1523/JNEUROSCI.1161-11.2011; Feldman DE, 2012, NEURON, V75, P556, DOI 10.1016/j.neuron.2012.08.001; Fertonani A, 2011, J NEUROSCI, V31, P15416, DOI 10.1523/JNEUROSCI.2002-11.2011; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Groppa S, 2012, HUM BRAIN MAPP, V33, P419, DOI 10.1002/hbm.21221; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hasan A, 2013, J COGNITIVE NEUROSCI, V25, P558, DOI 10.1162/jocn_a_00338; Huang YZ, 2007, CLIN NEUROPHYSIOL, V118, P1028, DOI 10.1016/j.clinph.2007.01.021; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Huerta PT, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-7; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Kadosh RC, 2010, CURR BIOL, V20, P2016, DOI 10.1016/j.cub.2010.10.007; Kim YH, 2004, NEUROSCI LETT, V367, P181, DOI 10.1016/j.neulet.2004.05.113; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Koch G, 2007, J NEUROSCI, V27, P6815, DOI 10.1523/JNEUROSCI.0598-07.2007; Koch G, 2009, J PHYSIOL-LONDON, V587, P4281, DOI 10.1113/jphysiol.2009.174086; Kuo MF, 2012, CLIN EEG NEUROSCI, V43, P192, DOI 10.1177/1550059412444975; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Mars RB, 2009, J NEUROSCI, V29, P6926, DOI 10.1523/JNEUROSCI.1396-09.2009; Miniussi C, 2008, BRAIN STIMUL, V1, P326, DOI 10.1016/j.brs.2008.07.002; Moliadze V, 2010, J PHYSIOL-LONDON, V588, P4891, DOI 10.1113/jphysiol.2010.196998; Monte-Silva K, 2011, NEUROPSYCHOPHARMACOL, V36, P2097, DOI 10.1038/npp.2011.100; Monte-Silva K, 2010, J PHYSIOL-LONDON, V588, P3415, DOI 10.1113/jphysiol.2010.190181; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Ni Z, 2011, BRAIN STIMUL, V4, P281, DOI 10.1016/j.brs.2011.01.002; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2004, EUR J NEUROSCI, V19, P2720, DOI 10.1111/j.0953-816X.2004.03398.x; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; Nitsche MA, 2012, J PHYSIOL-LONDON, V590, P4641, DOI 10.1113/jphysiol.2012.232975; O'Shea J, 2007, EUR J NEUROSCI, V26, P2085, DOI 10.1111/j.1460-9568.2007.05795.x; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; Pasley BN, 2009, NEURON, V62, P291, DOI 10.1016/j.neuron.2009.03.012; Paus T, 2005, PHILOS T R SOC B, V360, P1109, DOI 10.1098/rstb.2005.1652; Perini F, 2012, J NEUROSCI, V32, P12361, DOI 10.1523/JNEUROSCI.5864-11.2012; Plewnia C, 2013, CORTEX, V49, P1801, DOI 10.1016/j.cortex.2012.11.002; Polania R, 2012, CURR BIOL, V22, P1314, DOI 10.1016/j.cub.2012.05.021; Polania R, 2011, HUM BRAIN MAPP, V32, P1236, DOI 10.1002/hbm.21104; Ragert P, 2008, CLIN NEUROPHYSIOL, V119, P805, DOI 10.1016/j.clinph.2007.12.001; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Ridding MC, 2010, J PHYSIOL-LONDON, V588, P2291, DOI 10.1113/jphysiol.2010.190314; Rizzo V, 2009, CEREB CORTEX, V19, P907, DOI 10.1093/cercor/bhn144; Romei V, 2011, CURR BIOL, V21, P334, DOI 10.1016/j.cub.2011.01.035; Rossi S, 2001, NAT NEUROSCI, V4, P948, DOI 10.1038/nn0901-948; Rossi S, 2007, CLIN NEUROPHYSIOL, V118, P709, DOI 10.1016/j.clinph.2006.11.005; Roth Y, 2007, J CLIN NEUROPHYSIOL, V24, P31, DOI 10.1097/WNP.0b013e31802fa393; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Sandrini M, 2011, NEUROSCI BIOBEHAV R, V35, P516, DOI 10.1016/j.neubiorev.2010.06.005; Shafi MM, 2012, EUR J NEUROSCI, V35, P805, DOI 10.1111/j.1460-9568.2012.08035.x; Silvanto J, 2006, J NEUROPHYSIOL, V96, P941, DOI 10.1152/jn.00015.2006; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Sparing R, 2009, BRAIN, V132, P3011, DOI 10.1093/brain/awp154; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Thut G, 2011, CURR BIOL, V21, P1176, DOI 10.1016/j.cub.2011.05.049; UGAWA Y, 1995, ANN NEUROL, V37, P703, DOI 10.1002/ana.410370603; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Wagner T, 2009, CORTEX, V45, P1025, DOI 10.1016/j.cortex.2008.10.002; Wolters A, 2003, J NEUROPHYSIOL, V89, P2339, DOI 10.1152/jn.00900.2002; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Yuste R, 2005, NEURON, V48, P524, DOI 10.1016/j.neuron.2005.11.012; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734	100	352	362	4	126	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					838	844		10.1038/nn.3422	http://dx.doi.org/10.1038/nn.3422			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799477	Green Accepted			2022-12-17	WOS:000321180900014
J	Lobsiger, CS; Leveland, DW				Lobsiger, Christian S.; Cleveland, Don W.			Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease	NATURE NEUROSCIENCE			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; MUTANT SUPEROXIDE-DISMUTASE; ALS-LINKED SOD1; TRANSGENIC MICE; MOTOR-NEURONS; MOUSE MODEL; DOPAMINERGIC NEURODEGENERATION; PARKINSONS-DISEASE; HUNTINGTON-DISEASE; EXTEND SURVIVAL	A lesson from dominantly inherited forms of diverse neurodegenerative diseases, including amyotrophic lateral sclerosis, spinocerebellar ataxia and Huntington's disease, is that the selective dysfunction or death of the neuronal population most at risk in each disease is not mediated solely by damage from the mutant protein within the target neurons. The disease-causing toxic process, which in each case is caused by mutation in a gene that is widely or ubiquitously expressed, involves damage done by mutant proteins within the non-neuronal glial cells of the central nervous system, especially astrocytes and microglia. The disease mechanism is non-cell-autonomous, with toxicity derived from glia as a prominent contributor driving disease progression and in some instances even disease initiation.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med Neurosci, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Leveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Lobsiger, Christian/N-4369-2018; Lobsiger, Christian S/B-2720-2017; Cleveland, Don/AAN-9783-2021; Lobsiger, Christian S./AAA-5311-2019	Lobsiger, Christian S./0000-0002-4313-010X; Cleveland, Don/0000-0002-1934-3682	NINDS NIH HHS [R37 NS027036, R37 NS027036-22] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bellamy TC, 2006, CEREBELLUM, V5, P116, DOI 10.1080/14734220600724569; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bristol LA, 1996, ANN NEUROL, V39, P676, DOI 10.1002/ana.410390519; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Croisier E, 2006, ACTA NEUROPATHOL, V112, P517, DOI 10.1007/s00401-006-0119-z; Custer SK, 2006, NAT NEUROSCI, V9, P1302, DOI 10.1038/nn1750; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Garden GA, 2002, J NEUROSCI, V22, P4897, DOI 10.1523/JNEUROSCI.22-12-04897.2002; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Gowing G, 2006, J NEUROSCI, V26, P11397, DOI 10.1523/JNEUROSCI.0602-06.2006; Gu XF, 2005, NEURON, V46, P433, DOI 10.1016/j.neuron.2005.03.025; Gu XF, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-8; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Liberatore GT, 1999, NAT MED, V5, P1403; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Miller TM, 2006, P NATL ACAD SCI USA, V103, P19546, DOI 10.1073/pnas.0609411103; Miller TM, 2005, ANN NEUROL, V57, P773, DOI 10.1002/ana.20453; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Pehar M, 2004, J NEUROCHEM, V89, P464, DOI 10.1111/j.1471-4159.2004.02357.x; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Raoul C, 2006, P NATL ACAD SCI USA, V103, P6007, DOI 10.1073/pnas.0508774103; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Son M, 2001, ANN NEUROL, V50, P273, DOI 10.1002/ana.1104; Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Wang J, 2005, NEUROBIOL DIS, V20, P943, DOI 10.1016/j.nbd.2005.06.005; Weydt P, 2004, GLIA, V48, P179, DOI 10.1002/glia.20062; WU DC, 2000, P NATL ACAD SCI USA, V103, P12133; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; Yoo SY, 2003, NEURON, V37, P383, DOI 10.1016/S0896-6273(02)01190-X; Yvert G, 2000, HUM MOL GENET, V9, P2491, DOI 10.1093/hmg/9.17.2491; Yvert G, 2001, HUM MOL GENET, V10, P1679, DOI 10.1093/hmg/10.16.1679; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	50	352	363	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1355	1360		10.1038/nn1988	http://dx.doi.org/10.1038/nn1988			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17965655	Green Accepted			2022-12-17	WOS:000250508400009
J	Meshi, D; Drew, MR; Saxe, M; Ansorge, MS; David, D; Santarelli, L; Malapani, C; Moore, H; Hen, R				Meshi, Dar; Drew, Michael R.; Saxe, Michael; Ansorge, Mark S.; David, Denis; Santarelli, Luca; Malapani, Chariklia; Moore, Holly; Hen, Rene			Hippocampal neurogenesis is not required for behavioral effects of environmental enrichment	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; DENTATE GYRUS; EXPRESSION; NEURONS; MICE	Environmental enrichment increases adult hippocampal neurogenesis and alters hippocampal-dependent behavior in rodents. To investigate a causal link between these two observations, we analyzed the effect of enrichment on spatial learning and anxiety-like behavior while blocking adult hippocampal neurogenesis. We report that environmental enrichment alters behavior in mice regardless of their hippocampal neurogenic capability, providing evidence that the newborn cells do not mediate these effects of enrichment.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; New York State Psychiat Inst & Hosp, Biopsychol Unit, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; Univ Paris Sud, Fac Pharm, F-92296 Chatenay Malabry, France	Columbia University; Columbia University; New York State Psychiatry Institute; Columbia University; UDICE-French Research Universities; Universite Paris Saclay	Hen, R (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, 1051 Riverside Dr,Unit 87, New York, NY 10032 USA.	rh95@columbia.edu	ansorge, mark s/L-1360-2014; Drew, Michael R/M-4787-2016; DAVID, Denis/K-1173-2014	Drew, Michael R/0000-0002-3883-1542; DAVID, Denis/0000-0002-0506-6688; Meshi, Dar/0000-0003-0772-037X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068542, F31MH069089, T32MH018264] Funding Source: NIH RePORTER; NIMH NIH HHS [5F31MH069089-02, 5R01MH068542-03, 5T32MH018264-22] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Dupret D, 2005, EUR J NEUROSCI, V22, P778, DOI 10.1111/j.1460-9568.2005.04262.x; Elliott BM, 2005, BEHAV BRAIN RES, V165, P187, DOI 10.1016/j.bbr.2005.06.025; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Roy V, 2001, PHYSIOL BEHAV, V74, P313, DOI 10.1016/S0031-9384(01)00561-3; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558	15	352	366	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					729	731		10.1038/nn1696	http://dx.doi.org/10.1038/nn1696			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16648847				2022-12-17	WOS:000237895200009
J	Galatro, TF; Holtman, IR; Lerario, AM; Vainchtein, ID; Brouwer, N; Sola, PR; Veras, MM; Pereira, TF; Leite, REP; Moller, T; Wes, PD; Sogayar, MC; Laman, JD; den Dunnen, W; Pasqualucci, CA; Oba-Shinjo, SM; Boddeke, EWGM; Marie, SKN; Eggen, BJL				Galatro, Thais F.; Holtman, Inge R.; Lerario, Antonio M.; Vainchtein, Ilia D.; Brouwer, Nieske; Sola, Paula R.; Veras, Mariana M.; Pereira, Tulio F.; Leite, Renata E. P.; Moller, Thomas; Wes, Paul D.; Sogayar, Mari C.; Laman, Jon D.; den Dunnen, Wilfred; Pasqualucci, Carlos A.; Oba-Shinjo, Sueli M.; Boddeke, Erik W. G. M.; Marie, Suely K. N.; Eggen, Bart J. L.			Transcriptomic analysis of purified human cortical microglia reveals age-associated changes	NATURE NEUROSCIENCE			English	Article							GENE-EXPRESSION SIGNATURE; ADULT-MOUSE; HUMAN BRAIN; CELLS; REGULATOR; RECEPTOR; DISEASE; CNS; PROLIFERATION; ASTROCYTES	Microglia are essential for CNS homeostasis and innate neuroimmune function, and play important roles in neurodegeneration and brain aging. Here we present gene expression profiles of purified microglia isolated at autopsy from the parietal cortex of 39 human subjects with intact cognition. Overall, genes expressed by human microglia were similar to those in mouse, including established microglial genes CX3CR1, P2RY12 and ITGAM (CD11B). However, a number of immune genes, not identified as part of the mouse microglial signature, were abundantly expressed in human microglia, including TLR, F-c gamma and SIGLEC receptors, as well as TAL1 and IFI16, regulators of proliferation and cell cycle. Age-associated changes in human microglia were enriched for genes involved in cell adhesion, axonal guidance, cell surface receptor expression and actin (dis)assembly. Limited overlap was observed in microglial genes regulated during aging between mice and humans, indicating that human and mouse microglia age differently.	[Galatro, Thais F.; Holtman, Inge R.; Vainchtein, Ilia D.; Brouwer, Nieske; Laman, Jon D.; Boddeke, Erik W. G. M.; Eggen, Bart J. L.] Univ Groningen, Univ Med Ctr Groningen, Sect Med Physiol, Dept Neurosci, Groningen, Netherlands; [Galatro, Thais F.; Sola, Paula R.; Oba-Shinjo, Sueli M.; Marie, Suely K. N.] Univ Sao Paulo, Sch Med, Lab Mol & Cellular Biol, Dept Neurol, Sao Paulo, Brazil; [Lerario, Antonio M.] Univ Michigan, Div Metab Endocrinol & Diabet, Dept Internal Med, Ann Arbor, MI 48109 USA; [Veras, Mariana M.; Leite, Renata E. P.; Pasqualucci, Carlos A.] Univ Sao Paulo, Sch Med, Brazilian Aging Brain Study Grp, Sao Paulo, Brazil; [Pereira, Tulio F.; Sogayar, Mari C.; Marie, Suely K. N.] Univ Sao Paulo, Ctr Studies Cellular & Mol Therapy NAP NETCEM NUC, Sao Paulo, Brazil; [Pereira, Tulio F.] Univ Sao Paulo, Chem Inst, Dept Biochem, Sao Paulo, Brazil; [Moller, Thomas; Wes, Paul D.] Lundbeck Res USA, Neuroinflammat Dis Biol Unit, Paramus, NJ USA; [den Dunnen, Wilfred] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands	University of Groningen; Universidade de Sao Paulo; University of Michigan System; University of Michigan; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Groningen	Eggen, BJL (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Sect Med Physiol, Dept Neurosci, Groningen, Netherlands.	b.j.l.eggen@umcg.nl	Sogayar, Mari C/B-3980-2017; Galatro, Thais/J-7564-2016; Lerario, Antonio M/O-7241-2018; Oba-Shinjo, Sueli M./C-4017-2012; Lerario, Antonio/X-2028-2019; Holtman, Inge R./AAE-8655-2020; Galatro, Thais/C-9934-2013; Marie, Suely Kazue Nagahashi/D-1870-2012; Möller, Thomas/W-8974-2019; Veras, Mariana M/D-8575-2012	Sogayar, Mari C/0000-0003-4805-4609; Galatro, Thais/0000-0002-3811-7680; Lerario, Antonio M/0000-0002-8336-6432; Oba-Shinjo, Sueli M./0000-0002-1650-5973; Lerario, Antonio/0000-0002-8336-6432; Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Veras, Mariana M/0000-0002-8363-4329; den Dunnen, Wilfred/0000-0002-4168-1207; Vainchtein, Ilia Davidovich/0000-0003-3190-8524; Holtman, Inge R./0000-0001-9752-4756	Sao Paulo Research Foundation (FAPESP) [2013/07704-3, 2013/06315-3, 2013/02162-8, 2014-50137-5]; CAPES-NUFFIC [062/15]; Conselho Nacional de Pesquisa [CNPq 305730/2015-0]; Fundacao Faculdade de Medicina (FFM)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES-NUFFIC(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa; Fundacao Faculdade de Medicina (FFM)	We thank I. Huitinga, the director of the Netherlands Brain Bank, for the Dutch brain samples. We thank E.G. Kallas for the use of the FACS facility at School of Medicine. We thank G. Mesander, H. Moes, R.J. van der Lei and P. Ramos Costa for technical assistance with FACS, M. Meijer for confocal microscopy support, and H. van Weering for artwork. We thank I. Moretti, C. Silva, M. Molina, V. Galdeno and C.E. Brantis for assistance in laboratory work and library preparation. We thank Sao Paulo Research Foundation (FAPESP), grants 2013/07704-3, 2013/06315-3, 2013/02162-8 and 2014-50137-5, CAPES-NUFFIC (062/15), Conselho Nacional de Pesquisa (CNPq 305730/2015-0) and Fundacao Faculdade de Medicina (FFM) for financial support. We thank the Dutch MS Research Foundation and the Gemmy & Mibeth Tichelaar Foundation.	Andrews LP, 2017, IMMUNOL REV, V276, P80, DOI 10.1111/imr.12519; Askew K, 2017, CELL REP, V18, P391, DOI 10.1016/j.celrep.2016.12.041; Babraham Bioinformatics, FASTQC QUALITY CONTR; Bayes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046683; Bozek K, 2015, NEURON, V85, P695, DOI 10.1016/j.neuron.2015.01.003; Burns TC, 2015, EUR J PHARMACOL, V759, P101, DOI 10.1016/j.ejphar.2015.03.021; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585; Chen HN, 2016, SCI REP-UK, V6, DOI 10.1038/srep28902; Chen Y, 2014, CURR MED CHEM, V21, P2146, DOI 10.2174/0929867321666131228203906; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Durrenberger PF, 2010, J NEUROPATH EXP NEUR, V69, P70, DOI 10.1097/NEN.0b013e3181c7e32f; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Galatro TF, 2017, METHODS MOL BIOL, V1559, P333, DOI 10.1007/978-1-4939-6786-5_23; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; George NI, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-92; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Gurtler C, 2013, TRENDS MICROBIOL, V21, P413, DOI 10.1016/j.tim.2013.04.004; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hawrylycz M, 2015, NAT NEUROSCI, V18, P1832, DOI 10.1038/nn.4171; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Huang G, 2008, NAT GENET, V40, P51, DOI 10.1038/ng.2007.7; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Krabbe G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060921; Krensky AM, 2005, AM J TRANSPLANT, V5, P1789, DOI 10.1111/j.1600-6143.2005.00970.x; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Leitner J, 2015, J IMMUNOL, V195, P477, DOI 10.4049/jimmunol.1401917; Lenz KM, 2015, NEUROSCIENTIST, V21, P306, DOI 10.1177/1073858414536468; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Luan Y, 2008, CYTOKINE GROWTH F R, V19, P357, DOI 10.1016/j.cytogfr.2008.11.002; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Meissner TB, 2010, P NATL ACAD SCI USA, V107, P13794, DOI 10.1073/pnas.1008684107; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189; Nicolle R, 2015, BIOINFORMATICS, V31, P3066, DOI 10.1093/bioinformatics/btv305; Orre M, 2014, NEUROBIOL AGING, V35, P1, DOI 10.1016/j.neurobiolaging.2013.07.008; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Realegeno S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005705; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ryan EJ, 2002, J IMMUNOL, V169, P5638, DOI 10.4049/jimmunol.169.10.5638; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Shimokawa T, 2005, BLOOD, V106, P2534, DOI 10.1182/blood-2004-06-2413; Smith AM, 2014, TRENDS NEUROSCI, V37, P125, DOI 10.1016/j.tins.2013.12.001; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Van Eekelen JAM, 2003, NEUROSCIENCE, V122, P421, DOI 10.1016/S0306-4522(03)00571-2; Vincent C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-190; Wehrspaun CC, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.04.008; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	62	351	355	3	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2017	20	8					1162	+		10.1038/nn.4597	http://dx.doi.org/10.1038/nn.4597			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FB7CO	28671693	Green Published			2022-12-17	WOS:000406298900017
J	Rossant, C; Kadir, SN; Goodman, DFM; Schulman, J; Hunter, MLD; Saleem, AB; Grosmark, A; Belluscio, M; Denfield, GH; Ecker, AS; Tolias, AS; Solomon, S; Buzsaki, G; Carandini, M; Harris, KD				Rossant, Cyrille; Kadir, Shabnam N.; Goodman, Dan F. M.; Schulman, John; Hunter, Maximilian L. D.; Saleem, Aman B.; Grosmark, Andres; Belluscio, Mariano; Denfield, George H.; Ecker, Alexander S.; Tolias, Andreas S.; Solomon, Samuel; Buzsaki, Gyoergy; Carandini, Matteo; Harris, Kenneth D.			Spike sorting for large, dense electrode arrays	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL PYRAMIDAL CELLS; MOUSE VISUAL-CORTEX; EXTRACELLULAR RECORDINGS; DATA VISUALIZATION; ACTION-POTENTIALS; LARGE-SCALE; WAVE-FORM; IN-VIVO; UNIT; BACKPROPAGATION	Developments in microfabrication technology have enabled the production of neural electrode arrays with hundreds of closely spaced recording sites, and electrodes with thousands of sites are under development. These probes in principle allow the simultaneous recording of very large numbers of neurons. However, use of this technology requires the development of techniques for decoding the spike times of the recorded neurons from the raw data captured from the probes. Here we present a set of tools to solve this problem, implemented in a suite of practical, user-friendly, open-source software. We validate these methods on data from the cortex, hippocampus and thalamus of rat, mouse, macaque and marmoset, demonstrating error rates as low as 5%.	[Rossant, Cyrille; Kadir, Shabnam N.; Hunter, Maximilian L. D.; Harris, Kenneth D.] UCL Inst Neurol, London, England; [Rossant, Cyrille; Kadir, Shabnam N.; Hunter, Maximilian L. D.; Harris, Kenneth D.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Goodman, Dan F. M.] Univ London Imperial Coll Sci Technol & Med, Dept Elect & Elect Engn, London, England; [Schulman, John] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Saleem, Aman B.; Carandini, Matteo] UCL Inst Ophthalmol, London, England; [Grosmark, Andres; Belluscio, Mariano; Buzsaki, Gyoergy] NYU, NYU Neurosci Inst, Langone Med Ctr, New York, NY USA; [Denfield, George H.; Ecker, Alexander S.; Tolias, Andreas S.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Solomon, Samuel] UCL Inst Behav Neurosci, Dept Expt Psychol, London, England	University of London; University College London; University of London; University College London; Imperial College London; University of California System; University of California Berkeley; University of London; University College London; New York University; NYU Langone Medical Center; Baylor College of Medicine; University of London; University College London	Harris, KD (corresponding author), UCL Inst Neurol, London, England.; Harris, KD (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	kenneth.harris@ucl.ac.uk	Ecker, Alexander S/A-5184-2010; Carandini, Matteo/ABD-8296-2021	Ecker, Alexander S/0000-0003-2392-5105; Carandini, Matteo/0000-0003-4880-7682; Buzsaki, Gyorgy/0000-0002-3100-4800; Kadir, Shabnam/0000-0002-0103-9156; Goodman, Dan/0000-0003-1007-6474; Rossant, Cyrille/0000-0003-2069-9093; Saleem, Aman/0000-0002-7100-1954; Harris, Kenneth/0000-0002-5930-6456	EPSRC [K015141, I005102]; Wellcome Trust [95668, 95669, 100154]; GlaxoSmithKline/Fight for Sight chair in Visual Neuroscience; EPSRC [EP/I005102/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I005102/1] Funding Source: researchfish; NATIONAL EYE INSTITUTE [DP1EY023176, R01EY026927] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1546273] Funding Source: National Science Foundation	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); GlaxoSmithKline/Fight for Sight chair in Visual Neuroscience(GlaxoSmithKline); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank the 200+ members of the klustaviewas@groups.google.com mailing list for their feedback, bug reports and suggestions. This work was supported by EPSRC (K015141, I005102, K.D.H.) and the Wellcome Trust (95668, 95669, 100154, K.D.H., M.C.). M.C. is supported by the GlaxoSmithKline/Fight for Sight chair in Visual Neuroscience.	Ayaz A, 2013, CURR BIOL, V23, P890, DOI 10.1016/j.cub.2013.04.012; Berenyi A, 2014, J NEUROPHYSIOL, V111, P1132, DOI 10.1152/jn.00785.2013; Bouveyron C, 2014, COMPUT STAT DATA AN, V71, P52, DOI 10.1016/j.csda.2012.12.008; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Buzsaki G, 1998, J NEUROPHYSIOL, V79, P1587, DOI 10.1152/jn.1998.79.3.1587; Calabrese A, 2011, J NEUROSCI METH, V196, P159, DOI 10.1016/j.jneumeth.2010.12.002; Carlson DE, 2014, IEEE T BIO-MED ENG, V61, P41, DOI 10.1109/TBME.2013.2275751; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Csicsvari J, 2003, J NEUROPHYSIOL, V90, P1314, DOI 10.1152/jn.00116.2003; Du JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026204; Ecker AS, 2014, NEURON, V82, P235, DOI 10.1016/j.neuron.2014.02.006; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Einevoll GT, 2012, CURR OPIN NEUROBIOL, V22, P11, DOI 10.1016/j.conb.2011.10.001; Ekanadham C, 2014, J NEUROSCI METH, V222, P47, DOI 10.1016/j.jneumeth.2013.10.001; FOWLKES EB, 1983, J AM STAT ASSOC, V78, P553, DOI 10.2307/2288117; Franke F, 2010, J COMPUT NEUROSCI, V29, P127, DOI 10.1007/s10827-009-0163-5; Freeman J, 2014, NAT METHODS, V11, P941, DOI [10.1038/NMETH.3041, 10.1038/nmeth.3041]; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Kadir SN, 2014, NEURAL COMPUT, V26, P2379, DOI 10.1162/NECO_a_00661; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Marre O, 2012, J NEUROSCI, V32, P14859, DOI 10.1523/JNEUROSCI.0723-12.2012; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; Owens JD, 2008, P IEEE, V96, P879, DOI 10.1109/JPROC.2008.917757; Pillow JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062123; Quirk MC, 1999, J NEUROSCI METH, V94, P41, DOI 10.1016/S0165-0270(99)00124-7; Quirk MC, 2001, J NEUROSCI, V21, P240, DOI 10.1523/JNEUROSCI.21-01-00240.2001; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; RECCE M K, 1989, Society for Neuroscience Abstracts, V15, P1250; Rodriguez A, 2014, SCIENCE, V344, P1492, DOI 10.1126/science.1242072; Rossant C, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00036; Saleem AB, 2013, NAT NEUROSCI, V16, P1864, DOI 10.1038/nn.3567; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Shreiner D., 2013, OPENGL PROGRAMMING G; Swayne DF, 1998, J COMPUT GRAPH STAT, V7, P113, DOI 10.2307/1390772; Swindale NV, 2015, J COMPUT NEUROSCI, V38, P249, DOI 10.1007/s10827-014-0539-z; Swindale NV, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00006; The HDF Group, 2014, HIER DAT FORM VERS 5; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WISE KD, 1991, SCIENCE, V254, P1335, DOI 10.1126/science.1962192; Zeater N, 2015, CURR BIOL, V25, P3190, DOI 10.1016/j.cub.2015.10.033	48	351	352	1	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2016	19	4					634	+		10.1038/nn.4268	http://dx.doi.org/10.1038/nn.4268			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DH6OI	26974951	Green Accepted, Green Published, Green Submitted			2022-12-17	WOS:000372909800021
J	Sale, A; Maya-Vetencourt, JF; Medinin, P; Cenni, MC; Baroncelli, L; De Pasquale, R; Maffei, L				Sale, Alessandro; Maya-Vetencourt, Jose Fernando; Medinin, Paolo; Cenni, Maria Cristina; Baroncelli, Laura; De Pasquale, Roberto; Maffei, Lamberto			Environmental enrichment in adulthood promotes amblyopia recovery through a reduction of intracortical inhibition	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; VISUAL-CORTEX; CRITICAL-PERIOD; DEPRIVATION	Loss of visual acuity caused by abnormal visual experience during development (amblyopia) is an untreatable pathology in adults. We report that environmental enrichment in adult amblyopic rats restored normal visual acuity and ocular dominance. These effects were due to reduced GABAergic inhibition in the visual cortex, accompanied by increased expression of BDNF and reduced density of extra-cellular-matrix perineuronal nets, and were prevented by enhancement of inhibition through benzodiazepine cortical infusion.	Scuola Normale Super Pisa, I-56100 Pisa, Italy; CNR, Inst Neurosci, I-56100 Pisa, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Sale, A (corresponding author), Scuola Normale Super Pisa, Piazza Cavalieri 7, I-56100 Pisa, Italy.	a.sale@sns.it	Maya-Vetencourt, Jose Fernando/F-3566-2011; Baroncelli, Laura/K-5823-2016; Maya-Vetencourt, Jose Fernando/Q-6539-2019; DE PASQUALE, ROBERTO/AAE-2941-2019; Medini, Paolo/GWC-1936-2022; Sale, Alessandro/K-7760-2016	Baroncelli, Laura/0000-0001-6739-2860; Maya-Vetencourt, Jose Fernando/0000-0003-3808-8944; De Pasquale, Roberto/0000-0003-3383-7715; Sale, Alessandro/0000-0001-7608-4456				ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; Erisir A, 2003, J NEUROSCI, V23, P5208; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; Levi DM, 1997, INVEST OPHTH VIS SCI, V38, P1493; Mitchell Donald E, 2002, Clin Exp Optom, V85, P5; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Polat U, 2004, P NATL ACAD SCI USA, V101, P6692, DOI 10.1073/pnas.0401200101; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558	15	351	361	0	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					679	681		10.1038/nn1899	http://dx.doi.org/10.1038/nn1899			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17468749				2022-12-17	WOS:000246799800007
J	Golby, AJ; Gabrieli, JDE; Chiao, JY; Eberhardt, JL				Golby, AJ; Gabrieli, JDE; Chiao, JY; Eberhardt, JL			Differential responses in the fusiform region to same-race and other-race faces	NATURE NEUROSCIENCE			English	Article							HUMAN EXTRASTRIATE CORTEX; HEMISPHERIC-SPECIALIZATION; FUNCTIONAL MRI; TEMPORAL-LOBE; OWN-RACE; RECOGNITION; EXPERTISE; AMYGDALA; MEMORY; ACTIVATION	Many studies have shown that people remember faces of their own race better than faces of other races. We investigated the neural substrates of same-race memory superiority using functional MRI (fMRI). European-American (EA) and African-American (AA) males underwent fMRI while they viewed photographs of AA males, EA males and objects under intentional encoding conditions. Recognition memory was superior for same-race versus other-race faces. Individually defined areas in the fusiform region that responded preferentially to faces had greater response to same-race versus other-race faces. Across both groups, memory differences between same-race and other-race faces correlated with activation in left fusiform cortex and right parahippocampal and hippocampal areas. These results suggest that differential activation in fusiform regions contributes to same-race memory superiority.	Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University; Stanford University	Eberhardt, JL (corresponding author), Stanford Univ, Dept Radiol, Jordan Hall,Bldg 420, Stanford, CA 94305 USA.		Gabrieli, John/AAJ-2869-2020		NIMH NIH HHS [MH59940] Funding Source: Medline; NINDS NIH HHS [F32 NS010925-02, F32 NS10925-01, F32 NS010925, F32 NS010925-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010925] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], [No title captured]; ANTHONY T, 1992, PERS SOC PSYCHOL B, V18, P296, DOI 10.1177/0146167292183005; Benton A L, 1968, Trans Am Neurol Assoc, V93, P38; BRIGHAM JC, 1985, J SOC ISSUES, V41, P139, DOI 10.1111/j.1540-4560.1985.tb01133.x; BRIGHAM JC, 1978, J APPL SOC PSYCHOL, V8, P306, DOI 10.1111/j.1559-1816.1978.tb00786.x; BRUYER R, 1992, B PSYCHONOMIC SOC, V30, P501; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; Canli T, 2000, J NEUROSCI, V20; CARROO AW, 1986, PERCEPT MOTOR SKILL, V62, P135, DOI 10.2466/pms.1986.62.1.135; CHANCE JE, 1982, J PSYCHOL, V112, P29, DOI 10.1080/00223980.1982.9923531; Chance JE., 1996, PSYCHOL ISSUES EYEWI, P153; DERENZI E, 1966, NEUROLOGY, V16, P145, DOI 10.1212/WNL.16.2_Part_1.145; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; ELLINWOO.EH, 1969, PSYCHIAT QUART, V43, P622, DOI 10.1007/BF01564275; FALLSHORE M, 1995, J EXP PSYCHOL LEARN, V21, P1608, DOI 10.1037/0278-7393.21.6.1608; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; GROSS CG, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1303; Hart AJ, 2000, NEUROREPORT, V11, P2351, DOI 10.1097/00001756-200008030-00004; Haxby JV, 1996, P NATL ACAD SCI USA, V93, P922, DOI 10.1073/pnas.93.2.922; HAXBY JV, 1994, J NEUROSCI, V14, P6336; HEIT G, 1988, NATURE, V333, P773, DOI 10.1038/333773a0; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KAPUR N, 1995, CORTEX, V31, P99, DOI 10.1016/S0010-9452(13)80108-6; Katanoda K, 2000, NEUROPSYCHOLOGIA, V38, P1616, DOI 10.1016/S0028-3932(00)00069-5; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; KOSSLYN SM, 1989, J EXP PSYCHOL HUMAN, V15, P723, DOI 10.1037/0096-1523.15.4.723; Kuskowski MA, 1999, NEUROIMAGE, V9, P599, DOI 10.1006/nimg.1999.0442; Levin DT, 2000, J EXP PSYCHOL GEN, V129, P559, DOI 10.1037//0096-3445.129.4.559; Logothetis NK, 2000, SPATIAL VISION, V13, P165, DOI 10.1163/156856800741180; MacWhinney B, 1997, SPATIAL VISION, V11, P99, DOI 10.1163/156856897X00113; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P191, DOI 10.1016/0028-3932(68)90019-5; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Phelps EA, 1997, CURR BIOL, V7, pR311, DOI 10.1016/S0960-9822(06)00146-1; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Phinney J., 1992, J ADOLESCENT RES, V7, P156, DOI [10.1177/074355489272003, DOI 10.1177/074355489272003]; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; PUCE A, 1996, NEUROPHYSIOLOGY, V74, P1192; RHODES G, 1989, BRIT J PSYCHOL, V80, P313, DOI 10.1111/j.2044-8295.1989.tb02323.x; ROLLS ET, 1992, PHILOS T R SOC B, V335, P11, DOI 10.1098/rstb.1992.0002; SEECK M, 1993, ANN NEUROL, V34, P369, DOI 10.1002/ana.410340311; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Warrington E., 1967, CORTEX, V3, P317, DOI DOI 10.1016/S0010-9452(67)80020-0; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; YARMEY AD, 1971, PSYCHON SCI, V24, P286; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	49	351	358	3	51	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2001	4	8					845	850		10.1038/90565	http://dx.doi.org/10.1038/90565			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	457KY	11477432				2022-12-17	WOS:000170137300019
J	Jazayeri, M; Movshon, JA				Jazayeri, M; Movshon, JA			Optimal representation of sensory information by neural populations	NATURE NEUROSCIENCE			English	Article							VISUAL AREA MT; PERCEPTUAL DECISION; PSYCHOPHYSICAL PERFORMANCE; MOTION DIRECTION; PARIETAL CORTEX; MACAQUE MT; NEURONS; MICROSTIMULATION; DISCRIMINATION; RESPONSES	Sensory information is encoded by populations of neurons. The responses of individual neurons are inherently noisy, so the brain must interpret this information as reliably as possible. In most situations, the optimal strategy for decoding the population signal is to compute the likelihoods of the stimuli that are consistent with an observed neural response. But it has not been clear how the brain can directly compute likelihoods. Here we present a simple and biologically plausible model that can realize the likelihood function by computing a weighted sum of sensory neuron responses. The model provides the basis for an optimal decoding of sensory information. It explains a variety of psychophysical observations on detection, discrimination and identification, and it also directly predicts the relative contributions that different sensory neurons make to perceptual judgments.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Movshon, JA (corresponding author), NYU, Ctr Neural Sci, 4 Wasington Pl,Room 809, New York, NY 10003 USA.	movshon@nyu.edu			NEI NIH HHS [EY2017] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002017] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Britten KH, 1998, J NEUROPHYSIOL, V80, P762, DOI 10.1152/jn.1998.80.2.762; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Groh JM, 1997, J NEUROSCI, V17, P4312; Hill Robert E., 1992, Current Opinion in Cell Biology, V4, P967, DOI 10.1016/0955-0674(92)90126-W; Hol K, 2001, VISION RES, V41, P685, DOI 10.1016/S0042-6989(00)00314-X; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Movshon J. A., 1985, EXPT BRAIN RES S, V11, P117, DOI DOI 10.1007/978-3-662-09224-8_7.; Nichols MJ, 2002, J NEUROSCI, V22, P9530; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; REGAN D, 1985, J OPT SOC AM A, V2, P147, DOI 10.1364/JOSAA.2.000147; Roitman JD, 2002, J NEUROSCI, V22, P9475; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; SALZMAN CD, 1994, SCIENCE, V264, P231, DOI 10.1126/science.8146653; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; SEKULER R, 1977, SCIENCE, V198, P60, DOI 10.1126/science.897682; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shamir M, 2004, NEURAL COMPUT, V16, P1105, DOI 10.1162/089976604773717559; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	41	350	350	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					690	696		10.1038/nn1691	http://dx.doi.org/10.1038/nn1691			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16617339				2022-12-17	WOS:000237417200021
J	Stranahan, AM; Khalil, D; Gould, E				Stranahan, AM; Khalil, D; Gould, E			Social isolation delays the positive effects of running on adult neurogenesis	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR-I; DENTATE GYRUS; CELL-PROLIFERATION; VOLUNTARY EXERCISE; HIPPOCAMPAL NEUROGENESIS; INDUCED INCREASES; MESSENGER-RNA; STRESS; RATS; BEHAVIOR	Social isolation can exacerbate the negative consequences of stress and increase the risk of developing psychopathology. However, the influence of living alone on experiences generally considered to be beneficial to the brain, such as physical exercise, remains unknown. We report here that individual housing precludes the positive influence of short-term running on adult neurogenesis in the hippocampus of rats and, in the presence of additional stress, suppresses the generation of new neurons. Individual housing also influenced corticosterone levels-runners in both housing conditions had elevated corticosterone during the active phase, but individually housed runners had higher levels of this hormone in response to stress. Moreover, lowering corticosterone levels converted the influence of short-term running on neurogenesis in individually housed rats from negative to positive. These results suggest that, in the absence of social interaction, a normally beneficial experience can exert a potentially deleterious influence on the brain.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University	Gould, E (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	goulde@princeton.edu	Stranahan, Alexis/AAF-3559-2020; Winwood, Peter/A-6363-2008		NATIONAL INSTITUTE ON AGING [F31AG024690] Funding Source: NIH RePORTER; NIA NIH HHS [F31 AG024690-03, F31 AG024690-04, F31 AG024690, F31 AG024690-02, F31 AG024690-01] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allen DL, 2001, J APPL PHYSIOL, V90, P1900, DOI 10.1152/jappl.2001.90.5.1900; Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Ambrogini P, 2002, NEUROENDOCRINOLOGY, V76, P366, DOI 10.1159/000067581; Banasr M, 2004, NEUROPSYCHOPHARMACOL, V29, P450, DOI 10.1038/sj.npp.1300320; Bartolomucci A, 2003, PSYCHONEUROENDOCRINO, V28, P540, DOI 10.1016/S0306-4530(02)00039-2; Bjornebekk A, 2005, INT J NEUROPSYCHOPH, V8, P357, DOI 10.1017/S1461145705005122; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Cassano WJ, 2001, NEUROENDOCRINOLOGY, V74, P167, DOI 10.1159/000054683; CHALMERS DT, 1993, J NEUROSCI, V13, P914; Droste SK, 2003, ENDOCRINOLOGY, V144, P3012, DOI 10.1210/en.2003-0097; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Gomez-Merino D, 2001, NEUROSCI LETT, V301, P143, DOI 10.1016/S0304-3940(01)01626-3; GOULD E, 1992, J NEUROSCI, V12, P3642; HOFFMANN P, 1987, BEHAV NEURAL BIOL, V47, P346, DOI 10.1016/S0163-1047(87)90461-4; Holmes MM, 2004, J NEUROSCI RES, V76, P216, DOI 10.1002/jnr.20039; IVERSEN IH, 1993, J EXP ANAL BEHAV, V60, P219, DOI 10.1901/jeab.1993.60-219; Kim YP, 2004, NEUROSCI LETT, V355, P152, DOI 10.1016/j.neulet.2003.11.005; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Lopez-Lopez C, 2004, P NATL ACAD SCI USA, V101, P9833, DOI 10.1073/pnas.0400337101; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; Montaron MF, 2006, NEUROBIOL AGING, V27, P645, DOI 10.1016/j.neurobiolaging.2005.02.014; Naylor AS, 2005, J NEUROPHYSIOL, V93, P2406, DOI 10.1152/jn.01085.2004; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/S0006-8993(96)00273-9; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Perfilieva E, 2001, J CEREBR BLOOD F MET, V21, P211, DOI 10.1097/00004647-200103000-00004; Persson AI, 2004, EUR J NEUROSCI, V19, P1847, DOI 10.1111/j.1460-9568.2004.03268.x; Rhodes JS, 2003, BEHAV NEUROSCI, V117, P1006, DOI 10.1037/0735-7044.117.5.1006; Roy MP, 1998, J PERS SOC PSYCHOL, V75, P1273, DOI 10.1037/0022-3514.75.5.1273; Ruis MAW, 1999, PSYCHONEUROENDOCRINO, V24, P285, DOI 10.1016/S0306-4530(98)00050-X; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schiller L, 2003, BRAIN RES, V980, P169, DOI 10.1016/S0006-8993(03)02832-4; Seeman TE, 1996, PSYCHOSOM MED, V58, P459, DOI 10.1097/00006842-199609000-00008; Selye H., 1976, STRESS LIFE; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Weiss IC, 2004, BEHAV BRAIN RES, V152, P279, DOI 10.1016/j.bbr.2003.10.015; WEISS JM, 1971, J COMP PHYSIOL PSYCH, V77, P22, DOI 10.1037/h0031581; Westenbroek C, 2004, BRAIN RES BULL, V64, P303, DOI 10.1016/j.brainresbull.2004.08.006; Widenfalk J, 1999, NEUROSCI RES, V34, P125, DOI 10.1016/S0168-0102(99)00051-6	47	350	357	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					526	533		10.1038/nn1668	http://dx.doi.org/10.1038/nn1668			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16531997	Green Accepted			2022-12-17	WOS:000236310700020
J	Ramirez-Castillejo, C; Sanchez-Sanchez, F; Andreu-Agullo, C; Ferron, SR; Aroca-Aguilar, JD; Sanchez, P; Mira, H; Escribano, J; Farinas, I				Ramirez-Castillejo, C; Sanchez-Sanchez, F; Andreu-Agullo, C; Ferron, SR; Aroca-Aguilar, JD; Sanchez, P; Mira, H; Escribano, J; Farinas, I			Pigment epithelium-derived factor is a niche signal for neural stem cell renewal	NATURE NEUROSCIENCE			English	Article							ADULT MAMMALIAN BRAIN; IN-VIVO; GROWTH-FACTOR; FACTOR PEDF; STIMULATES NEUROGENESIS; NEUROTROPHIC ACTIVITY; ENDOTHELIAL-CELLS; SELF-RENEWAL; MOUSE BRAIN; NEURONS	Adult stem cells are characterized by self-renewal and multilineage differentiation, and these properties seem to be regulated by signals from adjacent differentiated cell types and by extracellular matrix molecules, which collectively define the stem cell "niche.'' Self-renewal is essential for the lifelong persistence of stem cells, but its regulation is poorly understood. In the mammalian brain, neurogenesis persists in two germinal areas, the subventricular zone (SVZ) and the hippocampus, where continuous postnatal neuronal production seems to be supported by neural stem cells (NSCs). Here we show that pigment epithelium-derived factor (PEDF) is secreted by components of the murine SVZ and promotes self-renewal of adult NSCs in vitro. In addition, intraventricular PEDF infusion activated slowly dividing stem cells, whereas a blockade of endogenous PEDF decreased their cycling. These data demonstrate that PEDF is a niche-derived regulator of adult NSCs and provide evidence for a role for PEDF protein in NSC maintenance.	Univ Castilla La Mancha, Fac Med, Area Genet, Albacete 02006, Spain; Univ Castilla La Mancha, Ctr Reg Invest Biomed, Albacete 02006, Spain; Univ Valencia, Dept Cellular Biol, E-46100 Burjassot, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; University of Valencia	Farinas, I (corresponding author), Univ Valencia, Fac Med, Oncol Mol Lab, E-46100 Burjassot, Spain.	isabel.farinas@uv.es	Aroca-Aguilar, J.Daniel/B-7842-2008; Ramirez-Castillejo, Carmen/S-7276-2019; Escribano, Julio/D-9742-2015; Aroca-Aguilar, Jose Daniel/R-5513-2019; Ferrón, Sacri R./I-2958-2015; Sánchez-Gómez, Pilar/K-8256-2014; Farinas, Isabel/L-7118-2014	Aroca-Aguilar, J.Daniel/0000-0001-6487-1612; Ramirez-Castillejo, Carmen/0000-0002-1877-3381; Escribano, Julio/0000-0002-8919-8134; Aroca-Aguilar, Jose Daniel/0000-0001-6487-1612; Ferrón, Sacri R./0000-0003-0854-8575; Sánchez-Gómez, Pilar/0000-0002-0709-4973; Farinas, Isabel/0000-0003-2903-4960; Mira, Helena/0000-0001-8574-9544				Alberdi E, 1999, J BIOL CHEM, V274, P31605, DOI 10.1074/jbc.274.44.31605; Aparicio S, 2005, BIOCHEM BIOPH RES CO, V326, P387, DOI 10.1016/j.bbrc.2004.11.041; Araki T, 1998, J NEUROSCI RES, V53, P7, DOI 10.1002/(SICI)1097-4547(19980701)53:1<7::AID-JNR2>3.3.CO;2-H; BECERRA SP, 1995, J BIOL CHEM, V270, P25992, DOI 10.1074/jbc.270.43.25992; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bilak MM, 2002, J NEUROSCI, V22, P9378; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Craig CG, 1996, J NEUROSCI, V16, P2649; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Ferron S, 2004, DEVELOPMENT, V131, P4059, DOI 10.1242/dev.01215; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kozaki K, 1998, J BIOL CHEM, V273, P15125, DOI 10.1074/jbc.273.24.15125; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Mercier F, 2002, J COMP NEUROL, V451, P170, DOI 10.1002/cne.10342; Meyer C, 2002, J BIOL CHEM, V277, P45400, DOI 10.1074/jbc.M208339200; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Morshead CM, 1998, DEVELOPMENT, V125, P2251; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ortego J, 1996, INVEST OPHTH VIS SCI, V37, P2759; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Pignolo RJ, 2003, J CELL PHYSIOL, V195, P12, DOI 10.1002/jcp.10212; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Sugita Y, 1997, J NEUROSCI RES, V49, P710, DOI 10.1002/(SICI)1097-4547(19970915)49:6<710::AID-JNR5>3.0.CO;2-A; Tombran-Tink J, 2003, NAT REV NEUROSCI, V4, P628, DOI 10.1038/nrn1176; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	46	350	382	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					331	339		10.1038/nn1657	http://dx.doi.org/10.1038/nn1657			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16491078				2022-12-17	WOS:000235645600012
J	Nassar, MR; Rumsey, KM; Wilson, RC; Parikh, K; Heasly, B; Gold, JI				Nassar, Matthew R.; Rumsey, Katherine M.; Wilson, Robert C.; Parikh, Kinjan; Heasly, Benjamin; Gold, Joshua I.			Rational regulation of learning dynamics by pupil-linked arousal systems	NATURE NEUROSCIENCE			English	Article							ADAPTIVE GAIN; HUMAN BRAIN; UNCERTAINTY; NOREPINEPHRINE; NEUROMODULATION; NORADRENALINE; RESPONSES; DIAMETER; STIMULUS	The ability to make inferences about the current state of a dynamic process requires ongoing assessments of the stability and reliability of data generated by that process. We found that these assessments, as defined by a normative model, were reflected in nonluminance-mediated changes in pupil diameter of human subjects performing a predictive-inference task. Brief changes in pupil diameter reflected assessed instabilities in a process that generated noisy data. Baseline pupil diameter reflected the reliability with which recent data indicate the current state of the data-generating process and individual differences in expectations about the rate of instabilities. Together these pupil metrics predicted the influence of new data on subsequent inferences. Moreover, a task- and luminance-independent manipulation of pupil diameter predictably altered the influence of new data. Thus, pupil-linked arousal systems can help to regulate the influence of incoming data on existing beliefs in a dynamic environment.	[Nassar, Matthew R.; Rumsey, Katherine M.; Parikh, Kinjan; Heasly, Benjamin; Gold, Joshua I.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Wilson, Robert C.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	University of Pennsylvania; Princeton University	Gold, JI (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.	jigold@mail.med.upenn.edu	nassar, matthew r/H-4663-2019	nassar, matthew r/0000-0002-5397-535X	US National Institutes of Health [R01 EY015260, F31 MH093099, T90 DA22763]; McKnight Endowment Fund for Neuroscience; Burroughs-Wellcome Fund; Sloan Foundation; NATIONAL EYE INSTITUTE [R01EY015260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH093904, F31MH093099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022763] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Endowment Fund for Neuroscience; Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Cohen, S. du Lac, L. Ding, Y. Li and J. Nassar for helpful comments. This work was supported by the US National Institutes of Health (R01 EY015260, F31 MH093099 and T90 DA22763), the McKnight Endowment Fund for Neuroscience, the Burroughs-Wellcome Fund and the Sloan Foundation.	Adams R.P., 2007, BAYESIAN ONLINE CHAN; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; ASTONJONES G, 1986, SCIENCE, V234, P734, DOI 10.1126/science.3775363; AstonJones G, 1997, NEUROSCIENCE, V80, P697, DOI 10.1016/S0306-4522(97)00060-2; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Einhauser W, 2008, P NATL ACAD SCI USA, V105, P1704, DOI 10.1073/pnas.0707727105; Fearnhead P, 2007, J ROY STAT SOC B, V69, P589, DOI 10.1111/j.1467-9868.2007.00601.x; FRIEDMAN D, 1973, ELECTROEN CLIN NEURO, V34, P475, DOI 10.1016/0013-4694(73)90065-5; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Granholm E, 2004, INT J PSYCHOPHYSIOL, V52, P1, DOI 10.1016/j.ijpsycho.2003.12.001; HAKEREM G, 1964, ANN NY ACAD SCI, V105, P820, DOI 10.1111/j.1749-6632.1964.tb42965.x; HARLEY CW, 1987, PROG NEURO-PSYCHOPH, V11, P419, DOI 10.1016/0278-5846(87)90015-7; Jepma M, 2011, J COGNITIVE NEUROSCI, V23, P1587, DOI 10.1162/jocn.2010.21548; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Krugel LK, 2009, P NATL ACAD SCI USA, V106, P17951, DOI 10.1073/pnas.0905191106; KRUGMAN HE, 1964, J MARKETING RES, V1, P15, DOI 10.2307/3150372; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Nassar MR, 2010, J NEUROSCI, V30, P12366, DOI 10.1523/JNEUROSCI.0822-10.2010; Nieuwenhuis S, 2011, PSYCHOPHYSIOLOGY, V48, P162, DOI 10.1111/j.1469-8986.2010.01057.x; Preuschoff K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00115; Raisig S, 2010, INT J PSYCHOPHYSIOL, V76, P1, DOI 10.1016/j.ijpsycho.2010.01.006; RICHER F, 1987, PSYCHOPHYSIOLOGY, V24, P258, DOI 10.1111/j.1469-8986.1987.tb00291.x; SARA SJ, 1994, BRAIN RES BULL, V35, P457, DOI 10.1016/0361-9230(94)90159-7; Schmidt H.S., 1982, SLEEPING WAKING DISO, P127; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Tully K, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-15; Van Olst E.H., 1979, ORIENTING REFLEX HUM, P521; Wilson RC, 2010, NEURAL COMPUT, V22, P2452, DOI 10.1162/NECO_a_00007; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	34	348	351	3	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					1040	1046		10.1038/nn.3130	http://dx.doi.org/10.1038/nn.3130			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	966EE	22660479	Green Accepted			2022-12-17	WOS:000305819600023
J	Favaro, R; Valotta, M; Ferri, ALM; Latorre, E; Mariani, J; Giachino, C; Lancini, C; Tosetti, V; Ottolenghi, S; Taylor, V; Nicolis, SK				Favaro, Rebecca; Valotta, Menella; Ferri, Anna L. M.; Latorre, Elisa; Mariani, Jessica; Giachino, Claudio; Lancini, Cesare; Tosetti, Valentina; Ottolenghi, Sergio; Taylor, Verdon; Nicolis, Silvia K.			Hippocampal development and neural stem cell maintenance require Sox2-dependent regulation of Shh	NATURE NEUROSCIENCE			English	Article							ADULT-MOUSE BRAIN; SONIC-HEDGEHOG; SELF-RENEWAL; SUBVENTRICULAR ZONE; IN-VIVO; SOX2; EXPRESSION; MICE; PLURIPOTENCY; MUTATIONS	Neural stem cells (NSCs) are controlled by diffusible factors. The transcription factor Sox2 is expressed by NSCs and Sox2 mutations in humans cause defects in the brain and, in particular, in the hippocampus. We deleted Sox2 in the mouse embryonic brain. At birth, the mice showed minor brain defects; shortly afterwards, however, NSCs and neurogenesis were completely lost in the hippocampus, leading to dentate gyrus hypoplasia. Deletion of Sox2 in adult mice also caused hippocampal neurogenesis loss. The hippocampal developmental defect resembles that caused by late sonic hedgehog (Shh) loss. In mutant mice, Shh and Wnt3a were absent from the hippocampal primordium. A SHH pharmacological agonist partially rescued the hippocampal defect. Chromatin immunoprecipitation identified Shh as a Sox2 target. Sox2-deleted NSCs did not express Shh in vitro and were rapidly lost. Their replication was partially rescued by the addition of SHH and was almost fully rescued by conditioned medium from normal cells. Thus, NSCs control their status, at least partly, through Sox2-dependent autocrine mechanisms.	[Favaro, Rebecca; Valotta, Menella; Ferri, Anna L. M.; Latorre, Elisa; Mariani, Jessica; Lancini, Cesare; Tosetti, Valentina; Ottolenghi, Sergio; Nicolis, Silvia K.] Univ Milan, Dept Biotechnol & Biosci, Milan, Italy; [Giachino, Claudio; Taylor, Verdon] Max Planck Inst Immunobiol, Dept Mol Embryol, D-7800 Freiburg, Germany	University of Milan; University of Milano-Bicocca; Max Planck Society	Nicolis, SK (corresponding author), Univ Milan, Dept Biotechnol & Biosci, Milan, Italy.	silvia.nicolis@unimib.it	tosetti, valentina/B-6811-2013; Ferri, Luca Angelo/AAC-5890-2022	Ferri, Luca Angelo/0000-0001-9031-6284; Taylor, Verdon/0000-0003-3497-5976; NICOLIS, SILVIA KIRSTEN/0000-0003-0378-3808; Latorre, Elisa/0000-0002-8297-1219; Favaro, Rebecca/0000-0002-6195-5711; GIACHINO, Claudio/0000-0002-8332-0899	Telethon [GGP05122]; European Economic Community; Fondazione Cariplo; Associazione Italiana Ricerca sul Cancro; Fondazione Banca del Monte di Lombardia; Ministero Istruzione Universita e Ricerca; Max Planck Gesellschaft	Telethon(Fondazione Telethon); European Economic Community; Fondazione Cariplo(Fondazione Cariplo); Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Banca del Monte di Lombardia; Ministero Istruzione Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); Max Planck Gesellschaft(Max Planck Society)	We thank G. Deh and S. Zangrossi for the pcnB. Tn10 recA. cat C5507 E. coli C strain, S. Dymecki for the pLM- FLRT- 3 vector and the FLPeR mouse strain, R. Klein through Jackson Laboratories for the nestin- cre mouse strain, P. Chambon for the creERT2 gene, Curis for the 1.2 SHH agonist18, S. Lugert for help with the Notch pathway expression studies, J. Cozzi and GenOway for help with ES cell targeting, C. Tiveron and Layline Genomics for blastocyst injections, C. Tiveron and L. Tatangelo for Sox2- creERT2 pronuclear injections, R. Caccia for help with in situ hybridization, E. Bagnaresi and A. Marinelli for help with constructs, A. Ronchi for advice on EMSAs and ChIP and D. Santoni for animal care. The monoclonal antibody to SHH developed by T. M. Jessell was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the US National Institute of Child Health and Human Development and maintained by the University of Iowa. This work was supported by Telethon ( GGP05122), the European Economic Community ( STEMBRIDGE), Fondazione Cariplo, Associazione Italiana Ricerca sul Cancro, Fondazione Banca del Monte di Lombardia, the Ministero Istruzione Universita e Ricerca ( Cofin) and FAR 20047 grants to S. K. N., and by the Max Planck Gesellschaft through V. Taylor.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Akagi K, 1997, NUCLEIC ACIDS RES, V25, P1766, DOI 10.1093/nar/25.9.1766; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Balordi F, 2007, J NEUROSCI, V27, P5936, DOI 10.1523/JNEUROSCI.1040-07.2007; Cavallaro M, 2008, DEVELOPMENT, V135, P541, DOI 10.1242/dev.010801; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; CONLON RA, 1993, METHOD ENZYMOL, V225, P373; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Gritti A, 1996, J NEUROSCI, V16, P1091; Jeong YS, 2006, DEVELOPMENT, V133, P761, DOI 10.1242/dev.02239; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee SMK, 2000, DEVELOPMENT, V127, P457; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Medina DL, 2004, EMBO J, V23, P3803, DOI 10.1038/sj.emboj.7600399; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Miyagi S, 2008, FEBS LETT, V582, P2811, DOI 10.1016/j.febslet.2008.07.011; Nyfeler Y, 2005, EMBO J, V24, P3504, DOI 10.1038/sj.emboj.7600816; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Palma V, 2004, DEVELOPMENT, V131, P337, DOI 10.1242/dev.00930; Riquelme PA, 2008, PHILOS T R SOC B, V363, P123, DOI 10.1098/rstb.2006.2016; Roelink H, 2000, CURR BIOL, V10, pR279, DOI 10.1016/S0960-9822(00)00407-3; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schmitz M, 2007, BRIT J CANCER, V96, P1293, DOI 10.1038/sj.bjc.6603696; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Sisodiya SM, 2006, EPILEPSIA, V47, P534, DOI 10.1111/j.1528-1167.2006.00464.x; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005; Weber P, 2001, EUR J NEUROSCI, V14, P1777, DOI 10.1046/j.0953-816x.2001.01803.x; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Zappone MV, 2000, DEVELOPMENT, V127, P2367	47	348	363	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1248	U62		10.1038/nn.2397	http://dx.doi.org/10.1038/nn.2397			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19734891				2022-12-17	WOS:000270170200013
J	Leung, KM; van Horck, FPG; Lin, AC; Allison, R; Standart, N; Holt, CE				Leung, Kin-Mei; van Horck, Francisca P. G.; Lin, Andrew C.; Allison, Rachel; Standart, Nancy; Holt, Christine E.			Asymmetrical beta-actin mRNA translation in growth cones mediates attractive turning to netrin-1	NATURE NEUROSCIENCE			English	Article							LOCAL TRANSLATION; PROTEIN-SYNTHESIS; VG1 RBP; LOCALIZATION; GUIDANCE; MECHANISMS; TRANSPORT; COLLAPSE; PHOSPHORYLATION; TRANSCRIPTION	Local protein synthesis regulates the turning of growth cones to guidance cues, yet little is known about which proteins are synthesized or how they contribute to directional steering. Here we show that beta-actin mRNA resides in Xenopus laevis retinal growth cones where it binds to the RNA-binding protein Vg1RBP. Netrin-1 induces the movement of Vg1RBP granules into filopodia, suggesting that it may direct the localization and translation of mRNAs in growth cones. Indeed, a gradient of netrin-1 activates a translation initiation regulator, eIF-4E-binding protein 1 (4EBP), asymmetrically and triggers a polarized increase in beta-actin translation on the near side of the growth cone before growth cone turning. Inhibition of beta-actin translation abolishes both the asymmetric rise in beta-actin and attractive, but not repulsive, turning. Our data suggest that newly synthesized beta-actin, concentrated near sites of signal reception, provides the directional bias for polymerizing actin in the direction of an attractive stimulus.	Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; Univ Cambridge, Dept Biochem, Cambridge CB2 3DY, England	University of Cambridge; University of Cambridge	Holt, CE (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England.	ceh@mole.bio.cam.ac.uk	Allison, Rachel J/D-1275-2013	Allison, Rachel J/0000-0002-2446-8455; Holt, Christine Elizabeth/0000-0003-2829-121X; Lin, Andrew/0000-0001-6310-9765	Biotechnology and Biological Sciences Research Council [BB/C514766/1] Funding Source: Medline; Wellcome Trust [070568] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Bassell GJ, 1998, J NEUROSCI, V18, P251; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; Chang P, 2004, MOL BIOL CELL, V15, P4669, DOI 10.1091/mbc.E04-03-0265; Condeelis J, 2005, BIOL CELL, V97, P97; de Heredia ML, 2004, CURR OPIN CELL BIOL, V16, P80, DOI 10.1016/j.ceb.2003.11.002; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Eng H, 1999, J NEUROSCI, V19, P1; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gingras AC, 2001, GENE DEV, V15, P2852; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Hansen WJ, 1999, J CELL BIOL, V145, P265, DOI 10.1083/jcb.145.2.265; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; Kloc M, 2002, CELL, V108, P533, DOI 10.1016/S0092-8674(02)00651-7; Kuhn TB, 1999, J NEUROSCI, V19, P1965; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Oleynikov Y, 2003, CURR BIOL, V13, P199, DOI 10.1016/S0960-9822(03)00044-7; Ooashi N, 2005, J CELL BIOL, V170, P1159, DOI 10.1083/jcb.200503157; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Shestakova EA, 2001, P NATL ACAD SCI USA, V98, P7045, DOI 10.1073/pnas.121146098; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; SUNDELL CL, 1991, SCIENCE, V253, P1275, DOI 10.1126/science.1891715; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yaniv K, 2003, DEVELOPMENT, V130, P5649, DOI 10.1242/dev.00810; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yisraeli JK, 2005, BIOL CELL, V97, P87; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zhang HL, 1999, J CELL BIOL, V147, P59, DOI 10.1083/jcb.147.1.59; Zhang QH, 1999, MECH DEVELOP, V88, P101, DOI 10.1016/S0925-4773(99)00162-8; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501	50	348	354	0	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1247	1256		10.1038/nn1775	http://dx.doi.org/10.1038/nn1775			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16980963	Green Accepted			2022-12-17	WOS:000241493900018
J	Ngo-Anh, TJ; Bloodgood, BL; Lin, M; Sabatini, BL; Maylie, J; Adelman, JP				Ngo-Anh, TJ; Bloodgood, BL; Lin, M; Sabatini, BL; Maylie, J; Adelman, JP			SK channels and NMDA receptors form a Ca2+-mediated feedback loop in dendritic spines	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; CA2+-ACTIVATED K+ CHANNELS; HIPPOCAMPAL PYRAMIDAL NEURONS; POTASSIUM CHANNELS; SYNAPTIC PLASTICITY; CALCIUM-CHANNELS; RAT HIPPOCAMPUS; TIME COURSE; AREA CA1; CA2+	Small-conductance Ca2+-activated K+ channels (SK channels) influence the induction of synaptic plasticity at hippocampal CA3-CA1 synapses. We find that in mice, SK channels are localized to dendritic spines, and their activity reduces the amplitude of evoked synaptic potentials in an NMDA receptor (NMDAR)-dependent manner. Using combined two-photon laser scanning microscopy and two-photon laser uncaging of glutamate, we show that SK channels regulate NMDAR-dependent Ca2+ influx within individual spines. SK channels are tightly coupled to synaptically activated Ca2+ sources, and their activity reduces the amplitude of NMDAR-dependent Ca2+ transients. These effects are mediated by a feedback loop within the spine head; during an excitatory postsynaptic potential (EPSP), Ca2+ influx opens SK channels that provide a local shunting current to reduce the EPSP and promote rapid Mg2+ block of the NMDAR. Thus, blocking SK channels facilitates the induction of long-term potentiation by enhancing NMDAR-dependent Ca2+ signals within dendritic spines.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97239 USA	Oregon Health & Science University; Harvard University; Harvard Medical School; Oregon Health & Science University	Adelman, JP (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	adelman@ohsu.edu		Bloodgood, Brenda/0000-0002-4797-9119				ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; Behnisch T, 1998, NEUROSCI LETT, V253, P91, DOI 10.1016/S0304-3940(98)00612-0; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Goslin K., 1998, CULTURING NERVE CELL, P339; HABERMANN E, 1984, PHARMACOL THERAPEUT, V25, P255, DOI 10.1016/0163-7258(84)90046-9; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Hirschberg B, 1998, J GEN PHYSIOL, V111, P565, DOI 10.1085/jgp.111.4.565; Hirschberg B, 1999, BIOPHYS J, V77, P1905, DOI 10.1016/S0006-3495(99)77032-3; Isaacson JS, 2001, NEURON, V31, P1027, DOI 10.1016/S0896-6273(01)00428-7; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Kampa BM, 2004, J PHYSIOL-LONDON, V556, P337, DOI 10.1113/jphysiol.2003.058842; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Lee WS, 2003, J BIOL CHEM, V278, P25940, DOI 10.1074/jbc.M302091200; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LORENZON NM, 1992, J NEUROPHYSIOL, V67, P350, DOI 10.1152/jn.1992.67.2.350; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Naraghi M, 1997, J NEUROSCI, V17, P6961; Paul K, 2003, NEUROSCI LETT, V348, P180, DOI 10.1016/S0304-3940(03)00747-X; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Popescu G, 2004, NATURE, V430, P790, DOI 10.1038/nature02775; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; SAH P, 1991, NEURON, V7, P257, DOI 10.1016/0896-6273(91)90264-Z; Shah MM, 2002, J NEUROPHYSIOL, V87, P2983, DOI 10.1152/jn.2002.87.6.2983; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; ZHANG L, 1995, J PHYSIOL-LONDON, V488, P661, DOI 10.1113/jphysiol.1995.sp020998; ZORUMSKI CF, 1989, NEUROSCI LETT, V99, P293, DOI 10.1016/0304-3940(89)90462-X	43	348	354	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					642	649		10.1038/nn1449	http://dx.doi.org/10.1038/nn1449			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15852011				2022-12-17	WOS:000228895100025
J	Sincich, LC; Park, KF; Wohlgemuth, MJ; Horton, JC				Sincich, LC; Park, KF; Wohlgemuth, MJ; Horton, JC			Bypassing V1: a direct geniculate input to area MT	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; MIDDLE TEMPORAL AREA; MACAQUE MONKEY; SUPERIOR COLLICULUS; STRIATE CORTEX; KONIOCELLULAR PATHWAY; RESPONSE PROPERTIES; INFERIOR PULVINAR; PRESTRIATE CORTEX; DIRECT PROJECTION	Thalamic nuclei are thought to funnel sensory information to the brain's primary cortical areas, which in turn transmit signals afresh to higher cortical areas. Here we describe a direct projection in the macaque monkey from the lateral geniculate nucleus (LGN) to the motion-selective middle temporal area (MT or V5), a cortical area not previously considered 'primary'. The constituent neurons are mostly koniocellular, send virtually no collateral axons to primary visual cortex (V1) and equal about 10% of the V1 population innervating MT. This pathway could explain the persistence of motion sensitivity in subjects following injury to V1, suggesting more generally that residual perception after damage in a primary area may arise from sparse thalamic input to 'secondary' cortical areas.	Univ Calif San Francisco, Beckman Vis Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sincich, LC (corresponding author), Univ Calif San Francisco, Beckman Vis Ctr, 10 Koret Way, San Francisco, CA 94143 USA.	sincich@itsa.ucsf.edu		Wohlgemuth, Melville/0000-0003-4779-4154; Horton, Jonathan/0000-0002-3952-435X				BARBUR JL, 1993, BRAIN, V116, P1293, DOI 10.1093/brain/116.6.1293; BECKERS G, 1995, BRAIN, V118, P49, DOI 10.1093/brain/118.1.49; BENEVENTO LA, 1981, J COMP NEUROL, V203, P455, DOI 10.1002/cne.902030309; BENEVENTO LA, 1982, BRAIN RES, V252, P161, DOI 10.1016/0006-8993(82)90991-X; BULLIER J, 1983, EXP BRAIN RES, V53, P168; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Collins CE, 2003, J NEUROSCI, V23, P2251; COWEY A, 1995, NATURE, V373, P247, DOI 10.1038/373247a0; CRAGG BG, 1969, VISION RES, V9, P733, DOI 10.1016/0042-6989(69)90011-X; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; Cropper SJ, 1996, NATURE, V379, P72, DOI 10.1038/379072a0; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FRIES W, 1981, PROC R SOC SER B-BIO, V213, P73, DOI 10.1098/rspb.1981.0054; GIRARD P, 1992, J NEUROPHYSIOL, V67, P1437, DOI 10.1152/jn.1992.67.6.1437; HARTING JK, 1991, J COMP NEUROL, V304, P275, DOI 10.1002/cne.903040210; Hendry SHC, 2000, ANNU REV NEUROSCI, V23, P127, DOI 10.1146/annurev.neuro.23.1.127; HENDRY SHC, 1994, SCIENCE, V264, P575, DOI 10.1126/science.8160015; HORTON JC, 1984, PHILOS T ROY SOC B, V304, P199, DOI 10.1098/rstb.1984.0021; HUMPHREY NK, 1967, NATURE, V215, P595, DOI 10.1038/215595a0; LYSAKOWSKI A, 1988, EXP BRAIN RES, V69, P651; MALPELI JG, 1975, J COMP NEUROL, V161, P569, DOI 10.1002/cne.901610407; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; MAUNSELL JHR, 1990, J NEUROSCI, V10, P3323; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nowak LG, 1997, CEREBR CORT, V12, P205; NOWAK LG, 1995, VISUAL NEUROSCI, V12, P371, DOI 10.1017/S095252380000804X; RAIGUEL SE, 1989, BRAIN RES, V493, P155, DOI 10.1016/0006-8993(89)91010-X; Riddoch G, 1917, BRAIN, V40, P15, DOI 10.1093/brain/40.1.15; RODMAN HR, 1989, J NEUROSCI, V9, P2033; RODMAN HR, 1990, J NEUROSCI, V10, P1154; Rodman HR, 2001, J COMP NEUROL, V431, P168, DOI 10.1002/1096-9861(20010305)431:2<168::AID-CNE1063>3.0.CO;2-N; SAITO H, 1989, EXP BRAIN RES, V75, P1; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Seidemann E, 1999, NEURON, V24, P911, DOI 10.1016/S0896-6273(00)81038-7; SHIPP S, 1989, EUR J NEUROSCI, V1, P309, DOI 10.1111/j.1460-9568.1989.tb00798.x; Sincich LC, 2003, J NEUROSCI, V23, P5684; Sorenson KM, 1999, NEUROREPORT, V10, P3295, DOI 10.1097/00001756-199911080-00009; Stepniewska I, 1999, EUR J NEUROSCI, V11, P469, DOI 10.1046/j.1460-9568.1999.00461.x; Stepniewska I, 2000, VISUAL NEUROSCI, V17, P529, DOI 10.1017/S0952523800174048; Stoerig P, 1997, BRAIN, V120, P535, DOI 10.1093/brain/120.3.535; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; UNGERLEIDER LG, 1979, J COMP NEUROL, V188, P347, DOI 10.1002/cne.901880302; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; YOSHIDA K, 1981, NEUROSCI LETT, V22, P103, DOI 10.1016/0304-3940(81)90071-9; YUKIE M, 1981, J COMP NEUROL, V201, P81, DOI 10.1002/cne.902010107; YUKIE M, 1985, BRAIN RES, V346, P383, DOI 10.1016/0006-8993(85)90875-3; Zeki S, 1998, BRAIN, V121, P25, DOI 10.1093/brain/121.1.25; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0; ZEKI SM, 1969, BRAIN RES, V13, P197, DOI 10.1016/0006-8993(69)90282-0	50	348	350	1	42	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1123	1128		10.1038/nn1318	http://dx.doi.org/10.1038/nn1318			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15378066				2022-12-17	WOS:000224156900022
J	Kheirbek, MA; Klemenhagen, KC; Sahay, A; Hen, R				Kheirbek, Mazen A.; Klemenhagen, Kristen C.; Sahay, Amar; Hen, Rene			Neurogenesis and generalization: a new approach to stratify and treat anxiety disorders	NATURE NEUROSCIENCE			English	Review							ADULT HIPPOCAMPAL NEUROGENESIS; POSTTRAUMATIC-STRESS-DISORDER; ENHANCED SYNAPTIC PLASTICITY; LEARNING-THEORY PERSPECTIVE; SPATIAL-PATTERN SEPARATION; IDENTICAL-TWINS DISCORDANT; NEWLY GENERATED NEURONS; DENTATE GYRUS; GRANULE CELLS; VENTRAL HIPPOCAMPUS	Although an influence of adult neurogenesis in mediating some of the effects of antidepressants has received considerable attention in recent years, much less is known about how alterations in this form of plasticity may contribute to psychiatric disorders such as anxiety and depression. One way to begin to address this question is to link the functions of adult-born hippocampal neurons with specific endophenotypes of these disorders. Recent studies have implicated adult-born hippocampal neurons in pattern separation, a process by which similar experiences or events are transformed into discrete, non-overlapping representations. Here we propose that impaired pattern separation underlies the overgeneralization often seen in anxiety disorders, specifically post-traumatic stress disorder and panic disorder, and therefore represents an endophenotype for these disorders. The development of new, pro-neurogenic compounds may therefore have therapeutic potential for patients who display pattern separation deficits.	[Kheirbek, Mazen A.; Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Kheirbek, Mazen A.; Hen, Rene] Columbia Univ, Dept Psychiat, New York, NY USA; [Kheirbek, Mazen A.; Hen, Rene] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA; [Klemenhagen, Kristen C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Sahay, Amar] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Sahay, Amar] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Sahay, Amar] Harvard Stem Cell Inst, Boston, MA USA; [Sahay, Amar] Harvard Univ, Sch Med, Boston, MA USA; [Hen, Rene] Columbia Univ, Dept Pharmacol, New York, NY USA	Columbia University; Columbia University; New York State Psychiatry Institute; Washington University (WUSTL); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Columbia University	Hen, R (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10027 USA.	sahay.amar@mgh.harvard.edu; rh95@columbia.edu	Kheirbek, Mazen A/J-3656-2015; Sahay, Amar/J-3696-2014	Kheirbek, Mazen A/0000-0001-9157-7363; 	US National Institute of Mental Health [1F32MH092101-01A1, 1K01MH099371-01, 4R00MH086615-03]; Sackler Institute Award; NARSAD Young Investigator Award; Ellison Medical Foundation New Scholar in Aging; Whitehall Foundation; NARSAD; New York Stem Cell Initiative; US National Institutes of Health [R01 MH068542]; Hope for Depression Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH086615, K01MH099371, F32MH092101, R37MH068542, R01MH068542] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sackler Institute Award; NARSAD Young Investigator Award(NARSAD); Ellison Medical Foundation New Scholar in Aging(Lawrence Ellison Foundation); Whitehall Foundation; NARSAD(NARSAD); New York Stem Cell Initiative; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope for Depression Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank L. Drew for comments on the manuscript. The authors are supported by US National Institute of Mental Health grants 1F32MH092101-01A1 and 1K01MH099371-01; a Sackler Institute Award and a NARSAD Young Investigator Award (M. A. K.); US National Institute of Mental Health grant 4R00MH086615-03, the Ellison Medical Foundation New Scholar in Aging and the Whitehall Foundation (A. S.); and NARSAD, the New York Stem Cell Initiative, US National Institutes of Health grant R01 MH068542, and Hope for Depression Research Foundation grants (R.H.).	Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Alvarez RP, 2008, J NEUROSCI, V28, P6211, DOI 10.1523/JNEUROSCI.1246-08.2008; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Banasr M, 2006, BIOL PSYCHIAT, V59, P1087, DOI 10.1016/j.biopsych.2005.11.025; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Bienvenu TCM, 2012, NEURON, V74, P1059, DOI 10.1016/j.neuron.2012.04.022; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Bouton ME, 2001, PSYCHOL REV, V108, P4, DOI 10.1037//0033-295X.108.1.4; Brohawn KH, 2010, BIOL PSYCHIAT, V68, P1023, DOI 10.1016/j.biopsych.2010.07.018; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Cohen LJ, 1996, J NEUROPSYCH CLIN N, V8, P82; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; Czerniawski J, 2012, HIPPOCAMPUS, V22, P1528, DOI 10.1002/hipo.20992; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Davis M, 2006, BIOL PSYCHIAT, V60, P369, DOI 10.1016/j.biopsych.2006.03.084; DeCarolis NA, 2010, NEUROPHARMACOLOGY, V58, P884, DOI 10.1016/j.neuropharm.2009.12.013; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Dranovsky A, 2011, NEURON, V70, P908, DOI 10.1016/j.neuron.2011.05.022; DuPont RL, 1996, ANXIETY, V2, P167, DOI 10.1002/(SICI)1522-7154(1996)2:4<167::AID-ANXI2>3.0.CO;2-L; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fenton AA, 2007, SCIENCE, V315, P947, DOI 10.1126/science.1139146; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Gilbertson MW, 2007, BIOL PSYCHIAT, V62, P513, DOI 10.1016/j.biopsych.2006.12.023; Gilbertson MW, 2010, J CLIN PSYCHIAT, V71, P1324, DOI 10.4088/JCP.10m06121blu; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Guo WX, 2011, NAT MED, V17, P559, DOI 10.1038/nm.2336; Hayes JP, 2011, J PSYCHIATR RES, V45, P660, DOI 10.1016/j.jpsychires.2010.10.007; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Huff NC, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00075; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P1064, DOI 10.1002/hipo.20464; Hunsaker MR, 2008, NEUROBIOL LEARN MEM, V89, P61, DOI 10.1016/j.nlm.2007.08.016; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Irle E, 2010, J PSYCHIATR NEUROSCI, V35, P126, DOI 10.1503/jpn.090041; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; JUNG MW, 1994, J NEUROSCI, V14, P7347; Karl A, 2006, BIOL PSYCHOL, V71, P123, DOI 10.1016/j.biopsycho.2005.03.004; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kheirbek MA, 2012, J NEUROSCI, V32, P8696, DOI 10.1523/JNEUROSCI.1692-12.2012; Kim J, 2011, HIPPOCAMPUS, V21, P609, DOI 10.1002/hipo.20784; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Lacefield CO, 2012, HIPPOCAMPUS, V22, P106, DOI 10.1002/hipo.20860; Lacy JW, 2011, LEARN MEMORY, V18, P15, DOI [10.1101/lm.1971110, 10.1101/lm.1971111]; Lau JYF, 2010, NEUROIMAGE, V53, P952, DOI 10.1016/j.neuroimage.2009.11.026; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lisman J, 2011, J PHYSIOL-LONDON, V589, P1905, DOI 10.1113/jphysiol.2010.201137; Lissek S, 2008, AM J PSYCHIAT, V165, P124, DOI 10.1176/appi.ajp.2007.06091513; Lissek S, 2010, AM J PSYCHIAT, V167, P47, DOI 10.1176/appi.ajp.2009.09030410; Luo AH, 2011, SCIENCE, V333, P353, DOI 10.1126/science.1204622; Maren S, 2004, BEHAV NEUROSCI, V118, P97, DOI 10.1037/0735-7044.118.1.97; MAREN S, 1995, J NEUROSCI, V15, P7548; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Milad MR, 2012, ANNU REV PSYCHOL, V63, P129, DOI 10.1146/annurev.psych.121208.131631; Mineka S, 2006, AM PSYCHOL, V61, P10, DOI 10.1037/0003-066X.61.1.10; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; PATTON PE, 1995, HIPPOCAMPUS, V5, P245, DOI 10.1002/hipo.450050402; Peri T, 2000, BIOL PSYCHIAT, V47, P512, DOI 10.1016/S0006-3223(99)00144-4; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; Rolls ET, 2007, LEARN MEMORY, V14, P714, DOI 10.1101/lm.631207; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schloesser RJ, 2010, MOL PSYCHIATR, V15, P1152, DOI 10.1038/mp.2010.34; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Sierra A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00047; Singer BH, 2011, P NATL ACAD SCI USA, V108, P5437, DOI 10.1073/pnas.1015425108; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Sodic L, 2007, CROAT MED J, V48, P140; Stark SM, 2010, LEARN MEMORY, V17, P284, DOI 10.1101/lm.1768110; Surget A, 2011, MOL PSYCHIATR, V16, P1177, DOI 10.1038/mp.2011.48; Suthana N, 2011, HIPPOCAMPUS, V21, P694, DOI 10.1002/hipo.20833; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Treves A, 2008, NEUROSCIENCE, V154, P1155, DOI 10.1016/j.neuroscience.2008.04.073; Tronel S, 2012, HIPPOCAMPUS, V22, P292, DOI 10.1002/hipo.20895; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wang S.H., 2012, HIPPOCAMPUS; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205; WOLPE J, 1988, BEHAV RES THER, V26, P441, DOI 10.1016/0005-7967(88)90138-6	98	347	369	4	125	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1613	1620		10.1038/nn.3262	http://dx.doi.org/10.1038/nn.3262			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23187693	Green Accepted			2022-12-17	WOS:000311706700005
J	Garcia-Alias, G; Barkhuysen, S; Buckle, M; Fawcett, JW				Garcia-Alias, Guillermo; Barkhuysen, Stanley; Buckle, Miranda; Fawcett, James W.			Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation	NATURE NEUROSCIENCE			English	Article							SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; IMPROVES FUNCTIONAL RECOVERY; SENSORIMOTOR CORTEX LESIONS; FORELIMB MOTOR FUNCTION; CORTICOSPINAL TRACT; SYNAPTIC PLASTICITY; PYRAMIDAL TRACT; BRAIN-INJURY; ADULT RATS	Chondroitinase ABC treatment promotes spinal cord plasticity. We investigated whether chondroitinase-induced plasticity combined with physical rehabilitation promotes recovery of manual dexterity in rats with cervical spinal cord injuries. Rats received a C4 dorsal funiculus cut followed by chondroitinase ABC or penicillinase as a control. They were assigned to two alternative rehabilitation procedures, the first reinforcing skilled reaching and the second reinforcing general locomotion. Chondroitinase treatment enhanced sprouting of corticospinal axons independently of the rehabilitation regime. Only the rats receiving the combination of chondroitinase and specific rehabilitation showed improved manual dexterity. Rats that received general locomotor rehabilitation were better at ladder walking, but had worse skilled-reaching abilities than rats that received no treatment. Our results indicate that chondroitinase treatment opens a window during which rehabilitation can promote recovery. However, only the trained skills are improved and other functions may be negatively affected.	[Garcia-Alias, Guillermo; Barkhuysen, Stanley; Buckle, Miranda; Fawcett, James W.] Univ Cambridge, Dept Clin Neurosci, Ctr Brain Repair, Cambridge, England	University of Cambridge	Fawcett, JW (corresponding author), Univ Cambridge, Dept Clin Neurosci, Ctr Brain Repair, Cambridge, England.	jf108@cam.ac.uk	Garcia-Alias, Guillermo/AAB-8595-2021	Fawcett, James/0000-0002-7990-4568; Buckle, Miranda/0000-0002-6722-7125	Medical Research Council; Wellcome Trust; Christopher and Dana Reeve Foundation Consortium; EU Framework 6 Network of Excellence NeuroNE; Henry Smith Charity and Action Medical Research; Medical Research Council [G9828345, G0701518] Funding Source: researchfish; MRC [G9828345, G0701518] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Christopher and Dana Reeve Foundation Consortium; EU Framework 6 Network of Excellence NeuroNE; Henry Smith Charity and Action Medical Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge key advice and assistance from H. Steenson in animal care and testing. This work was funded by grants from the Medical Research Council, The Wellcome Trust, The Christopher and Dana Reeve Foundation Consortium, The EU Framework 6 Network of Excellence NeuroNE, the Henry Smith Charity and Action Medical Research.	Adkins DL, 2008, EXP NEUROL, V212, P14, DOI 10.1016/j.expneurol.2008.01.031; Allred RP, 2008, EXP NEUROL, V210, P172, DOI 10.1016/j.expneurol.2007.10.010; Anderson KD, 2005, EXP NEUROL, V194, P161, DOI 10.1016/j.expneurol.2005.02.006; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Anderson KD, 2007, EXP NEUROL, V206, P318, DOI 10.1016/j.expneurol.2007.05.024; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Beazley LD, 2003, J NEUROTRAUM, V20, P1263, DOI 10.1089/089771503770802925; Benowitz LI, 1999, P NATL ACAD SCI USA, V96, P13486, DOI 10.1073/pnas.96.23.13486; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Blochlinger S, 2001, J COMP NEUROL, V433, P426, DOI 10.1002/cne.1150; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; Cho SH, 2007, NEUROSCI LETT, V426, P123, DOI 10.1016/j.neulet.2007.08.049; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; de Leon RD, 1998, J NEUROPHYSIOL, V79, P1329, DOI 10.1152/jn.1998.79.3.1329; de Leon RD, 1998, J NEUROPHYSIOL, V80, P83; Dobkin B, 2006, NEUROLOGY, V66, P484, DOI 10.1212/01.wnl.0000202600.72018.39; Dunlop SA, 2008, TRENDS NEUROSCI, V31, P410, DOI 10.1016/j.tins.2008.05.004; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Freund P, 2007, J COMP NEUROL, V502, P644, DOI 10.1002/cne.21321; Galtrey CM, 2008, EUR J NEUROSCI, V27, P1373, DOI 10.1111/j.1460-9568.2008.06108.x; Galtrey CM, 2007, BRAIN, V130, P926, DOI 10.1093/brain/awl372; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Garcia-Alias G., 2006, SOC NEUR ABSTR; Garcia-Alias G, 2008, EXP NEUROL, V210, P331, DOI 10.1016/j.expneurol.2007.11.002; Girgis J, 2007, BRAIN, V130, P2993, DOI 10.1093/brain/awm245; Grill R, 1997, J NEUROSCI, V17, P5560; HOVDA DA, 1984, BRAIN RES, V298, P358, DOI 10.1016/0006-8993(84)91437-9; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kwok JCF, 2008, RESTOR NEUROL NEUROS, V26, P131; Lemon RN, 2005, MUSCLE NERVE, V32, P261, DOI 10.1002/mus.20333; Lin R, 2008, J NEUROCHEM, V104, P400, DOI 10.1111/j.1471-4159.2007.05066.x; Maier IC, 2006, PHILOS T R SOC B, V361, P1611, DOI 10.1098/rstb.2006.1890; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; McKenna JE, 1999, J NEUROSCI, V19, P1885; Petruska JC, 2007, J NEUROSCI, V27, P4460, DOI 10.1523/JNEUROSCI.2302-06.2007; Pettersson LG, 2007, ACTA PHYSIOL, V189, P141, DOI 10.1111/j.1748-1716.2006.01650.x; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Plunet WT, 2008, EXP NEUROL, V213, P28, DOI 10.1016/j.expneurol.2008.04.011; Ramanathan D, 2006, P NATL ACAD SCI USA, V103, P11370, DOI 10.1073/pnas.0601065103; Ribotta MGY, 2000, J NEUROSCI, V20, P5144; Starkey ML, 2005, EXP NEUROL, V195, P524, DOI 10.1016/j.expneurol.2005.06.017; Steward O, 2004, J COMP NEUROL, V472, P463, DOI 10.1002/cne.20090; WHISHAW IQ, 1993, BEHAV BRAIN RES, V56, P59, DOI 10.1016/0166-4328(93)90022-I; Whishaw IQ, 1998, BEHAV BRAIN RES, V93, P167, DOI 10.1016/S0166-4328(97)00152-6; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095; Yamamoto M, 2009, BRAIN RES, V1265, P47, DOI 10.1016/j.brainres.2009.02.019; Ying Z, 2005, EXP NEUROL, V193, P411, DOI 10.1016/j.expneurol.2005.01.015	49	347	352	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1145	U16		10.1038/nn.2377	http://dx.doi.org/10.1038/nn.2377			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19668200				2022-12-17	WOS:000269317300016
J	Dellisanti, CD; Yao, Y; Stroud, JC; Wang, ZZ; Chen, L				Dellisanti, Cosma D.; Yao, Yun; Stroud, James C.; Wang, Zuo-Zhong; Chen, Lin			Crystal structure of the extracellular domain of nAChR alpha 1 bound to alpha-bungarotoxin at 1.94 A resolution	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; LIGAND-BINDING DOMAIN; CYS-LOOP RECEPTORS; ESCHERICHIA-COLI; GATING MECHANISM; AGONIST BINDING; PICHIA-PASTORIS; PROTEIN; SUBUNIT; CHANNEL	We determined the crystal structure of the extracellular domain of the mouse nicotinic acetylcholine receptor (nAChR) alpha 1 subunit bound to alpha-bungarotoxin at 1.94 angstrom resolution. This structure is the first atomic-resolution view of a nAChR subunit extracellular domain, revealing receptor-specific features such as the main immunogenic region (MIR), the signature Cys-loop and the N-linked carbohydrate chain. The toxin binds to the receptor through extensive protein-protein and protein-sugar interactions. To our surprise, the structure showed a well-ordered water molecule and two hydrophilic residues deep in the core of the a1 subunit. The two hydrophilic core residues are highly conserved in nAChRs, but correspond to hydrophobic residues in the nonchannel homolog acetylcholine-binding proteins. We carried out site-directed mutagenesis and electrophysiology analyses to assess the functional role of the glycosylation and the hydrophilic core residues. Our structural and functional studies show essential features of the nAChR and provide new insights into the gating mechanism.	Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; Univ So Calif, Norris Canc Ctr, Los Angeles, CA 90089 USA; Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; Univ Calif Los Angeles, Inst Genom & Proteom, Dept Energy, Los Angeles, CA 90095 USA	University of Southern California; University of Southern California; University of Southern California; University of California System; University of California Los Angeles	Chen, L (corresponding author), Univ So Calif, 1050 Childs Way,RIH201, Los Angeles, CA 90089 USA.	zzwang@usc.edu; linchen@usc.edu	chen, Lin/A-3392-2008; Stroud, James C/B-3230-2012	chen, Lin/0000-0003-4798-6199; Stroud, James C/0000-0003-0850-4812	NHLBI NIH HHS [R01 HL076334] Funding Source: Medline; NIGMS NIH HHS [R01 GM077320, R01 GM064642] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077320, R01GM064642] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexeev T, 1999, EUR J BIOCHEM, V259, P310, DOI 10.1046/j.1432-1327.1999.00041.x; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; CHANGEUX JP, 1970, P NATL ACAD SCI USA, V67, P1241, DOI 10.1073/pnas.67.3.1241; Chen DN, 1998, J NEUROCHEM, V70, P349; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; daCosta CJB, 2005, BIOPHYS J, V88, P1755, DOI 10.1529/biophysj.104.052944; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Gehle VM, 1997, MOL BRAIN RES, V45, P219, DOI 10.1016/S0169-328X(96)00256-2; GRINNA LS, 1989, YEAST, V5, P107, DOI 10.1002/yea.320050206; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; GULLICK WJ, 1983, BIOCHEMISTRY-US, V22, P3312, DOI 10.1021/bi00283a003; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Harel M, 2001, NEURON, V32, P265, DOI 10.1016/S0896-6273(01)00461-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Karlin A, 2004, NEURON, V41, P841, DOI 10.1016/S0896-6273(04)00151-5; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Konstantakaki M, 2007, BIOCHEM BIOPH RES CO, V359, P413, DOI 10.1016/j.bbrc.2007.05.126; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; MATTHEWS BW, 1993, ANNU REV BIOCHEM, V62, P139, DOI 10.1146/annurev.bi.62.070193.001035; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; NEUMANN D, 1986, P NATL ACAD SCI USA, V83, P9250, DOI 10.1073/pnas.83.23.9250; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Psaridi-Linardaki L, 2002, J BIOL CHEM, V277, P26980, DOI 10.1074/jbc.M110731200; Qasba PK, 2000, CARBOHYD POLYM, V41, P293, DOI 10.1016/S0144-8617(99)00148-4; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Samson AO, 2002, NEURON, V35, P319, DOI 10.1016/S0896-6273(02)00773-0; Sine SM, 2002, J NEUROBIOL, V53, P431, DOI 10.1002/neu.10139; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Sullivan DA, 2000, J BIOL CHEM, V275, P12651, DOI 10.1074/jbc.275.17.12651; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Tsouloufis T, 2000, INT IMMUNOL, V12, P1255, DOI 10.1093/intimm/12.9.1255; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; Wang T, 2003, PROTEIN EXPRES PURIF, V30, P140, DOI 10.1016/S1046-5928(03)00098-6; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; YAO J, 1994, J MOL BIOL, V243, P736, DOI 10.1016/0022-2836(94)90044-2; Yao Y, 2002, J BIOL CHEM, V277, P12613, DOI 10.1074/jbc.M108845200	50	347	354	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					953	962		10.1038/nn1942	http://dx.doi.org/10.1038/nn1942			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17643119				2022-12-17	WOS:000248357500009
J	Walton, ME; Devlin, JT; Rushworth, MFS				Walton, ME; Devlin, JT; Rushworth, MFS			Interactions between decision making and performance monitoring within prefrontal cortex	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; HUMAN FRONTAL-LOBE; ORBITOFRONTAL CORTEX; MOTOR AREAS; REWARD; OPTIMIZATION; SELECTION; FMRI; REGISTRATION; CONNECTIONS	Our ability to judge the consequences of our actions is central to rational decision making. A large body of evidence implicates primate prefrontal regions in the regulation of this ability. It has proven extremely difficult, however, to separate functional areas in the frontal lobes. Using functional magnetic resonance imaging, we demonstrate complementary and reciprocal roles for the human orbitofrontal (OFC) and dorsal anterior cingulate cortices (ACd) in monitoring the outcome of behavior. Activation levels in these regions were negatively correlated, with activation increasing in the ACd and decreasing in the OFC when the selected response was the result of the participant's own decision. The pattern was reversed when the selected response was guided by the experimenter rather than the participant. These results indicate that the neural mechanisms underlying the way we assess the consequences of choices differ depending on whether we are told what to do or are able to exercise our volition.	John Radcliffe Hosp, Oxford Ctr Funct Magnet Resonance Imaging Brain, Oxford OX3 9DU, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford; University of Oxford	Walton, ME (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	mark.walton@psy.ox.ac.uk	Devlin, Joseph T/C-1525-2008	Rushworth, Matthew/0000-0002-5578-9884; Devlin, Joseph/0000-0001-9737-3070				BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; Chiavaras MM, 2000, J COMP NEUROL, V422, P35; DUM RP, 1991, J NEUROSCI, V11, P667; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Ferry AT, 2000, J COMP NEUROL, V425, P447, DOI 10.1002/1096-9861(20000925)425:3<447::AID-CNE9>3.0.CO;2-V; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston K.J., 1994, HUMAN BRAIN MAPPING, V1, P210; FRITH CD, 1991, P ROY SOC B-BIOL SCI, V244, P241, DOI 10.1098/rspb.1991.0077; Frith CD, 2000, BRAIN RES REV, V31, P357, DOI 10.1016/S0165-0173(99)00052-1; Hadland KA, 2003, J NEUROPHYSIOL, V89, P1161, DOI 10.1152/jn.00634.2002; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Koski L, 2000, EXP BRAIN RES, V133, P55, DOI 10.1007/s002210000400; Kremer S, 2001, J NEUROL NEUROSUR PS, V70, P264, DOI 10.1136/jnnp.70.2.264; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Morecraft RJ, 1998, BRAIN RES BULL, V45, P209, DOI 10.1016/S0361-9230(97)00344-4; Nobre AC, 1999, NAT NEUROSCI, V2, P11, DOI 10.1038/4513; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, J NEUROSCI, V23, P7931; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; Petrides M, 2002, P NATL ACAD SCI USA, V99, P5649, DOI 10.1073/pnas.072092299; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Saxena S, 1998, BRIT J PSYCHIAT, V173, P26; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; THALER D, 1995, EXP BRAIN RES, V102, P445; Toni I, 2001, EXP BRAIN RES, V141, P359, DOI 10.1007/s002210100877; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Wilson JL, 2002, NEUROIMAGE, V17, P967, DOI 10.1006/nimg.2002.1172; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931	50	347	351	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1259	1265		10.1038/nn1339	http://dx.doi.org/10.1038/nn1339			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15494729				2022-12-17	WOS:000224749400019
J	Cohen, JD; Botvinick, M; Carter, CS				Cohen, JD; Botvinick, M; Carter, CS			Anterior cingulate and prefrontal cortex: who's in control?	NATURE NEUROSCIENCE			English	News Item							PERFORMANCE; BEHAVIOR	A sophisticated study of error-related brain potentials in patients with prefrontal lesions addresses how we monitor performance and adjust cognitive control based on task demands.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Cohen, JD (corresponding author), Princeton Univ, Dept Psychol, Green Hall, Princeton, NJ 08544 USA.	jdc@princeton.edu						Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; BRAVER TS, UNPUB; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; COHEN JD, 1992, AM J PSYCHOL, V105, P239, DOI 10.2307/1423029; Falkenstein M, 1995, EEG CL N SU, P287; Gehring WJ, 1995, EEG CL N SU, P261; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Kahneman D., 1973, ATTENTION EFFORT; KIMBERG DY, 1993, J EXP PSYCHOL GEN, V122, P411, DOI 10.1037/0096-3445.122.4.411; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; MACDONALD AH, UNPUB; MACDONALD AW, 1999, SOC NEUR ABSTR, V25, P2167; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549	18	347	356	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					421	423		10.1038/74783	http://dx.doi.org/10.1038/74783			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	309DG	10769376				2022-12-17	WOS:000086752000006
J	Chang, EF; Rieger, JW; Johnson, K; Berger, MS; Barbaro, NM; Knight, RT				Chang, Edward F.; Rieger, Jochem W.; Johnson, Keith; Berger, Mitchel S.; Barbaro, Nicholas M.; Knight, Robert T.			Categorical speech representation in human superior temporal gyrus	NATURE NEUROSCIENCE			English	Article							PERCEPTUAL MAGNET; AUDITORY-CORTEX; LOBE; ACTIVATION; NONSPEECH; LANGUAGE; SOUNDS; CONSONANTS	Speech perception requires the rapid and effortless extraction of meaningful phonetic information from a highly variable acoustic signal. A powerful example of this phenomenon is categorical speech perception, in which a continuum of acoustically varying sounds is transformed into perceptually distinct phoneme categories. We found that the neural representation of speech sounds is categorically organized in the human posterior superior temporal gyrus. Using intracranial high-density cortical surface arrays, we found that listening to synthesized speech stimuli varying in small and acoustically equal steps evoked distinct and invariant cortical population response patterns that were organized by their sensitivities to critical acoustic features. Phonetic category boundaries were similar between neurometric and psychometric functions. Although speech-sound responses were distributed, spatially discrete cortical loci were found to underlie specific phonetic discrimination. Our results provide direct evidence for acoustic-to-higher order phonetic level encoding of speech sounds in human language receptive cortex.	[Chang, Edward F.; Berger, Mitchel S.; Barbaro, Nicholas M.; Knight, Robert T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Chang, Edward F.; Rieger, Jochem W.; Knight, Robert T.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Rieger, Jochem W.] Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany; [Johnson, Keith] Univ Calif Berkeley, Dept Linguist, Berkeley, CA 94720 USA; [Knight, Robert T.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; Otto von Guericke University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Chang, EF (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	changed@neurosurg.ucsf.edu; jochem.rieger@med.ovgu.de	Johnson, Keith/AAM-6322-2020	Johnson, Keith/0000-0002-2569-8121; Rieger, Jochem/0000-0003-0955-2306	US National Institutes of Health [NS21135, PO4813, F32NS061552, K99NS065120, FKZ-MK48-2009/003, RI1511/1-3]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS065120, R01NS021135, R00NS065120, F32NS061552] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the four individuals who participated in this experiment and to A. Flinker for help with data acquisition. This research was supported by US National Institutes of Health grants NS21135 (R. T. K.), PO4813 (R. T. K.), F32NS061552 (E. F. C.), K99NS065120 (E. F. C.), FKZ-MK48-2009/003 (J.W.R.) and RI1511/1-3 (J.W.R.).	Benson RR, 2006, NEUROIMAGE, V31, P342, DOI 10.1016/j.neuroimage.2005.11.029; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; BLUMSTEIN SE, 1980, J ACOUST SOC AM, V67, P648, DOI 10.1121/1.383890; Blumstein SE, 2005, J COGNITIVE NEUROSCI, V17, P1353, DOI 10.1162/0898929054985473; BOATMAN D, 1995, BRAIN LANG, V51, P269, DOI 10.1006/brln.1995.1061; CREUTZFELDT O, 1989, EXP BRAIN RES, V77, P451, DOI 10.1007/BF00249600; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Desai R, 2008, J COGNITIVE NEUROSCI, V20, P1174, DOI 10.1162/jocn.2008.20081; Diehl RL, 2004, ANNU REV PSYCHOL, V55, P149, DOI 10.1146/annurev.psych.55.090902.142028; Edwards E, 2010, NEUROIMAGE, V50, P291, DOI 10.1016/j.neuroimage.2009.12.035; HAGLUND MM, 1994, NEUROSURGERY, V34, P567, DOI 10.1227/00006123-199404000-00001; Harnad Stevan, 1987, CATEGORICAL PERCEPTI; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Howard MA, 2000, J COMP NEUROL, V416, P79, DOI 10.1002/(SICI)1096-9861(20000103)416:1<79::AID-CNE6>3.0.CO;2-2; IVERSON P, 1995, J ACOUST SOC AM, V97, P553, DOI 10.1121/1.412280; Iverson P, 2000, PERCEPT PSYCHOPHYS, V62, P874, DOI 10.3758/BF03206929; Jancke L, 2002, NEUROIMAGE, V15, P733, DOI 10.1006/nimg.2001.1027; Koh KM, 2007, J MACH LEARN RES, V8, P1519; Kruskal JosephB., 1978, MULTIDIMENSIONAL SCA, DOI [10.4135/9781412985130, DOI 10.4135/9781412985130]; Liberman AM, 2000, TRENDS COGN SCI, V4, P187, DOI 10.1016/S1364-6613(00)01471-6; LIBERMAN AM, 1957, J EXP PSYCHOL, V54, P358, DOI 10.1037/h0044417; LIBERMAN AM, 1989, SCIENCE, V243, P489, DOI 10.1126/science.2643163; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; Liebenthal E, 2005, CEREB CORTEX, V15, P1621, DOI 10.1093/cercor/bhi040; MERZENICH MM, 1973, BRAIN RES, V50, P275, DOI 10.1016/0006-8993(73)90731-2; MILLER GA, 1955, J ACOUST SOC AM, V27, P338, DOI 10.1121/1.1907526; Penfield W, 1954, EPILEPSY FUNCTIONAL; Perkell J.S., 1986, INVARIANCE VARIABILI; Raizada RDS, 2007, NEURON, V56, P726, DOI 10.1016/j.neuron.2007.11.001; Scott SK, 2004, COGNITION, V92, P13, DOI 10.1016/j.cognition.2002.12.002; SHEPARD RN, 1980, SCIENCE, V210, P390, DOI 10.1126/science.210.4468.390; Uppenkamp S, 2006, NEUROIMAGE, V31, P1284, DOI 10.1016/j.neuroimage.2006.01.004; Vihman M.M., 1996, PHONOLOGICAL DEV ORI; Vouloumanos A, 2001, J COGNITIVE NEUROSCI, V13, P994, DOI 10.1162/089892901753165890; Whalen DH, 2006, J ACOUST SOC AM, V119, P575, DOI 10.1121/1.2139627	35	346	353	4	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1428	U169		10.1038/nn.2641	http://dx.doi.org/10.1038/nn.2641			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20890293	Green Submitted, Green Accepted			2022-12-17	WOS:000283658200025
J	Dean, I; Harper, NS; McAlpine, D				Dean, I; Harper, NS; McAlpine, D			Neural population coding of sound level adapts to stimulus statistics	NATURE NEUROSCIENCE			English	Article							AUDITORY-NERVE FIBERS; RATE-INTENSITY FUNCTIONS; SHORT-TERM ADAPTATION; CONTRAST GAIN-CONTROL; DYNAMIC-RANGE; GUINEA-PIG; INFERIOR COLLICULUS; CORTICAL-NEURONS; NOISE; CATS	Mammals can hear sounds extending over a vast range of sound levels with remarkable accuracy. How auditory neurons code sound level over such a range is unclear; firing rates of individual neurons increase with sound level over only a very limited portion of the full range of hearing. We show that neurons in the auditory midbrain of the guinea pig adjust their responses to the mean, variance and more complex statistics of sound level distributions. We demonstrate that these adjustments improve the accuracy of the neural population code close to the region of most commonly occurring sound levels. This extends the range of sound levels that can be accurately encoded, fine-tuning hearing to the local acoustic environment.	UCL, Dept Physiol, London WC1E 6BT, England; UCL, Ear Inst, London WC1E 6BT, England; UCL, Ctr Math & Phys Life Sci & Expt Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Dean, I (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	i.dean@ucl.ac.uk		Harper, Nicol/0000-0002-7851-4840; McAlpine, David/0000-0001-5467-6725	Medical Research Council [G0300417] Funding Source: Medline; RNID [G16] Funding Source: Medline; MRC [G0300417] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RNID; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aubin T, 1998, P ROY SOC B-BIOL SCI, V265, P1665, DOI 10.1098/rspb.1998.0486; AVAN P, 1992, HEARING RES, V59, P59, DOI 10.1016/0378-5955(92)90102-S; Boyev KP, 2002, JARO, V3, P362, DOI 10.1007/s101620020044; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; CARMEL PW, 1963, J NEUROPHYSIOL, V26, P598, DOI 10.1152/jn.1963.26.4.598; Colburn HS, 2003, JARO, V4, P294, DOI 10.1007/s10162-002-1090-6; COSTALUPES JA, 1984, J NEUROPHYSIOL, V51, P1326, DOI 10.1152/jn.1984.51.6.1326; Dayan P., 2001, THEORETICAL NEUROSCI; DiMatteo I, 2001, BIOMETRIKA, V88, P1055, DOI 10.1093/biomet/88.4.1055; EVANS EF, 1980, EXP BRAIN RES, V40, P115; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; GIBSON DJ, 1985, J NEUROPHYSIOL, V53, P940, DOI 10.1152/jn.1985.53.4.940; HOUTSMA AJM, 1980, J ACOUST SOC AM, V68, P807, DOI 10.1121/1.384819; Ingham NJ, 2004, J NEUROPHYSIOL, V91, P632, DOI 10.1152/jn.00779.2003; JOHNSON DH, 1976, BIOPHYS J, V16, P719, DOI 10.1016/S0006-3495(76)85724-4; Kirk EC, 2003, JARO-J ASSOC RES OTO, V4, P445, DOI 10.1007/s10162-002-3013-y; Kvale MN, 2004, J NEUROPHYSIOL, V91, P604, DOI 10.1152/jn.00484.2003; MAY BJ, 1992, J NEUROPHYSIOL, V68, P1589, DOI 10.1152/jn.1992.68.5.1589; NUTTALL AL, 1974, J ACOUST SOC AM, V56, P1239, DOI 10.1121/1.1903414; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; PHILLIPS DP, 1986, J ACOUST SOC AM, V80, P177, DOI 10.1121/1.394178; Popelar J, 2003, PHYSIOL RES, V52, P615; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; REES A, 1988, J ACOUST SOC AM, V83, P1488, DOI 10.1121/1.395904; SACHS MB, 1974, J ACOUST SOC AM, V56, P1835, DOI 10.1121/1.1903521; Shapley R., 1984, PROG RETIN RES, V3, P263, DOI [10.1016/0278-4327(84)90011-7, DOI 10.1016/0278-4327(84)90011-7]; SIMMONS JA, 1971, SCIENCE, V171, P212, DOI 10.1126/science.171.3967.212; SMITH RL, 1980, HEARING RES, V2, P123, DOI 10.1016/0378-5955(80)90034-9; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; VIEMEISTER NF, 1974, J ACOUST SOC AM, V56, P1594, DOI 10.1121/1.1903483; VIEMEISTER NF, 1988, HEARING RES, V34, P267, DOI 10.1016/0378-5955(88)90007-X; VIEMEISTER NF, 1983, SCIENCE, V221, P1206, DOI 10.1126/science.6612337; WESTERMAN LA, 1984, HEARING RES, V15, P249, DOI 10.1016/0378-5955(84)90032-7; WINTER IM, 1991, J ACOUST SOC AM, V90, P1958, DOI 10.1121/1.401675; YATES GK, 1985, HEARING RES, V17, P1, DOI 10.1016/0378-5955(85)90124-8	36	346	357	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1684	1689		10.1038/nn1541	http://dx.doi.org/10.1038/nn1541			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16286934				2022-12-17	WOS:000233576200016
J	Baillet, S				Baillet, Sylvain			Magnetoencephalography for brain electrophysiology and imaging	NATURE NEUROSCIENCE			English	Review							INTERICTAL EPILEPTIFORM ACTIVITY; SPONTANEOUS FLUCTUATIONS; FUNCTIONAL CONNECTIVITY; PREOPERATIVE EVALUATION; CORTICAL OSCILLATIONS; OBJECT RECOGNITION; EVOKED RESPONSES; SIMULTANEOUS MEG; VISUAL-CORTEX; COMBINING MEG	We review the aspects that uniquely characterize magnetoencephalography (MEG) among the techniques available to explore and resolve brain function and dysfunction. While emphasizing its specific strengths in terms of millisecond source imaging, we also identify and discuss current practical challenges, in particular in signal extraction and interpretation. We also take issue with some perceived disadvantages of MEG, including the misconception that the technique is redundant with electroencephalography. Overall, MEG contributes uniquely to our deeper comprehension of both regional and large-scale brain dynamics: from the functions of neural oscillations and the nature of event-related brain activation, to the mechanisms of functional connectivity between regions and the emergence of modes of network communication in brain systems. We expect MEG to play an increasing and pivotal role in the elucidation of these grand mechanistic principles of cognitive, systems and clinical neuroscience.	[Baillet, Sylvain] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada	McGill University	Baillet, S (corresponding author), McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada.	sylvain.baillet@mcgill.ca	Baillet, Sylvain/AAF-6512-2019	Baillet, Sylvain/0000-0002-6762-5713	Killam Foundation; Fonds de Recherche du Quebec-Sante; National Science and Engineering Research Council of Canada; NIH [2R01EB009048-05]; Brain Canada Foundation	Killam Foundation; Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Canada Foundation	The author is grateful to P. Albouy and P. Donhauser for suggestions concerning the manuscript. S.B. is supported by the Killam Foundation, a Senior-Researcher grant from the Fonds de Recherche du Quebec-Sante, a Discovery Grant from the National Science and Engineering Research Council of Canada, NIH grant 2R01EB009048-05 and a Platform Support Grant from the Brain Canada Foundation.	Alem O, 2014, J NEUROSCI, V34, P14324, DOI 10.1523/JNEUROSCI.3495-14.2014; Anderson CT, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0446-8; Arnal LH, 2012, TRENDS COGN SCI, V16, P390, DOI 10.1016/j.tics.2012.05.003; Attal Y, 2009, IRBM, V30, P133, DOI 10.1016/j.irbm.2009.01.005; Attal Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059856; Baillet S, 2001, PHYS MED BIOL, V46, P77, DOI 10.1088/0031-9155/46/1/306; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Baillet S, 1999, IEEE T BIO-MED ENG, V46, P522, DOI 10.1109/10.759053; Baillet S, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/972050; Baldauf D, 2014, SCIENCE, V344, P424, DOI 10.1126/science.1247003; Balderston NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096803; Barkley GL, 2004, CLIN NEUROPHYSIOL, V115, P1001, DOI 10.1016/j.clinph.2003.12.011; Baumgartner C, 2004, CLIN NEUROPHYSIOL, V115, P1010, DOI 10.1016/j.clinph.2003.12.010; Berman JL, 2016, AM J NEURORADIOL, V37, P1178, DOI 10.3174/ajnr.A4687; Boas DA, 2014, NEUROIMAGE, V85, P1, DOI 10.1016/j.neuroimage.2013.11.033; Bourguignon M, 2013, HUM BRAIN MAPP, V34, P314, DOI 10.1002/hbm.21442; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G., 2006, RHYTHMS BRAIN; Buzsaki G, 2013, NEURON, V80, P751, DOI 10.1016/j.neuron.2013.10.002; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Cheung MJ, 2016, NEUROIMAGE, V124, P181, DOI 10.1016/j.neuroimage.2015.08.045; Cho JH, 2015, NEUROIMAGE, V110, P60, DOI 10.1016/j.neuroimage.2015.01.043; Cichy RM, 2016, CEREB CORTEX, V26, P3563, DOI 10.1093/cercor/bhw135; Cichy RM, 2016, SCI REP-UK, V6, DOI 10.1038/srep27755; Cichy RM, 2015, NEUROIMAGE, V121, P193, DOI 10.1016/j.neuroimage.2015.07.011; Cichy RM, 2014, NAT NEUROSCI, V17, P455, DOI 10.1038/nn.3635; Cimatti Z, 2007, BRAIN, V130, P198, DOI 10.1093/brain/awl259; Coffey EBJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11070; COHEN D, 1972, SCIENCE, V175, P664, DOI 10.1126/science.175.4022.664; COHEN D, 1968, SCIENCE, V161, P784, DOI 10.1126/science.161.3843.784; Connolly AT, 2012, BRAIN STIMUL, V5, P616, DOI 10.1016/j.brs.2011.11.006; Cornwell BR, 2012, HIPPOCAMPUS, V22, P1848, DOI 10.1002/hipo.22019; Cornwell BR, 2008, BRAIN RES, V1244, P103, DOI 10.1016/j.brainres.2008.09.068; Cottereau B, 2011, NEUROIMAGE, V54, P1919, DOI 10.1016/j.neuroimage.2010.10.004; da Silva FL, 2013, NEURON, V80, P1112, DOI 10.1016/j.neuron.2013.10.017; Dabek J, 2016, NEUROIMAGE, V127, P484, DOI 10.1016/j.neuroimage.2015.11.023; Dalal SS, 2009, NEUROIMAGE, V45, P1289, DOI 10.1016/j.neuroimage.2009.01.017; de Hemptinne C, 2013, P NATL ACAD SCI USA, V110, P4780, DOI 10.1073/pnas.1214546110; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Deo RC, 2015, CIRCULATION, V132, P1920, DOI 10.1161/CIRCULATIONAHA.115.001593; Ding N, 2016, NAT NEUROSCI, V19, P158, DOI 10.1038/nn.4186; Doelling KB, 2015, P NATL ACAD SCI USA, V112, pE6233, DOI 10.1073/pnas.1508431112; Dumas T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074145; Ebersole JS, 2010, J CLIN NEUROPHYSIOL, V27, P360, DOI 10.1097/WNP.0b013e318201ffc4; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Espy M, 2013, J MAGN RESON, V228, P1, DOI 10.1016/j.jmr.2012.11.030; Fedele T, 2015, PHYSIOL MEAS, V36, P357, DOI 10.1088/0967-3334/36/2/357; Feynman R. P., 2010, FEYNMAN LECT PHYS, V2; Fiederer LDJ, 2016, NEUROIMAGE, V128, P193, DOI 10.1016/j.neuroimage.2015.12.041; Florin E, 2015, NEUROIMAGE, V111, P26, DOI 10.1016/j.neuroimage.2015.01.054; Florin E, 2014, NEUROIMAGE, V88, P54, DOI 10.1016/j.neuroimage.2013.10.028; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Friston KJ, 2009, PHILOS T R SOC B, V364, P1211, DOI 10.1098/rstb.2008.0300; Garces P, 2016, HUM BRAIN MAPP, V37, P20, DOI 10.1002/hbm.22995; Gardner D, 2003, NEUROINFORMATICS, V1, P289, DOI 10.1385/NI:1:3:289; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Gmann G. E., 2010, MEG INTRO METHODS, P437; Gorgolewski KJ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002506; Gramfort A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/923703; Gross J, 2013, NEUROIMAGE, V65, P349, DOI 10.1016/j.neuroimage.2012.10.001; Gullmar D, 2010, NEUROIMAGE, V51, P145, DOI 10.1016/j.neuroimage.2010.02.014; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hanley CJ, 2016, NEUROIMAGE, V140, P20, DOI 10.1016/j.neuroimage.2015.12.021; Hari R, 2012, NEUROIMAGE, V61, P386, DOI 10.1016/j.neuroimage.2011.11.074; Hillebrand A, 2002, NEUROIMAGE, V16, P638, DOI 10.1006/nimg.2002.1102; Hirschmann J, 2011, NEUROIMAGE, V55, P1159, DOI 10.1016/j.neuroimage.2010.11.063; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Jensen O, 2014, TRENDS NEUROSCI, V37, P357, DOI 10.1016/j.tins.2014.04.001; Jerbi K, 2007, P NATL ACAD SCI USA, V104, P7676, DOI 10.1073/pnas.0609632104; Kaiser D, 2016, J NEUROSCI, V36, P10522, DOI 10.1523/JNEUROSCI.1385-16.2016; Kharkar S, 2015, EPILEPSY BEHAV, V46, P19, DOI 10.1016/j.yebeh.2014.11.029; King JR, 2014, TRENDS COGN SCI, V18, P203, DOI 10.1016/j.tics.2014.01.002; Klamer S, 2015, BRAIN TOPOGR, V28, P87, DOI 10.1007/s10548-014-0405-3; Koelewijn L, 2013, NEUROIMAGE, V79, P295, DOI 10.1016/j.neuroimage.2013.04.108; Kuhl PK, 2014, P NATL ACAD SCI USA, V111, P11238, DOI 10.1073/pnas.1410963111; Landau AN, 2015, CURR BIOL, V25, P2332, DOI 10.1016/j.cub.2015.07.048; Lanfer B, 2012, NEUROIMAGE, V62, P418, DOI 10.1016/j.neuroimage.2012.05.006; Leahy RM, 1998, ELECTROEN CLIN NEURO, V107, P159, DOI 10.1016/S0013-4694(98)00057-1; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Meyer SS, 2017, J NEUROSCI METH, V276, P38, DOI 10.1016/j.jneumeth.2016.11.009; Michalareas G, 2016, NEURON, V89, P384, DOI 10.1016/j.neuron.2015.12.018; Michel CM, 2012, NEUROIMAGE, V61, P371, DOI 10.1016/j.neuroimage.2011.12.039; Mollo G, 2016, CORTEX, V74, P262, DOI 10.1016/j.cortex.2015.10.021; Murakami H., 2016, BRAIN, V2016; Murakami S, 2006, J PHYSIOL-LONDON, V575, P925, DOI 10.1113/jphysiol.2006.105379; Muthukumaraswamy SD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00138; Myers NE, 2015, ELIFE, V4, DOI 10.7554/eLife.09000; Nasiotis K, 2017, NEUROIMAGE, V145, P107, DOI 10.1016/j.neuroimage.2016.10.017; Nichols BN, 2015, NEUROPSYCHOL REV, V25, P356, DOI 10.1007/s11065-015-9293-x; Niedermeyer E., 1999, ELECTROEN CLIN NEURO, V4th; Niso G, 2016, NEUROIMAGE, V124, P1182, DOI 10.1016/j.neuroimage.2015.04.028; Nissen IA, 2016, EPILEPSY RES, V124, P23, DOI 10.1016/j.eplepsyres.2016.05.002; Nooner KB, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00152; Okada Y, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4962020; Okazaki YO, 2015, NEUROIMAGE, V107, P323, DOI 10.1016/j.neuroimage.2014.12.014; Oswal A, 2016, J NEUROSCI METH, V261, P29, DOI 10.1016/j.jneumeth.2015.11.029; Oswal A, 2013, NEUROIMAGE, V70, P132, DOI 10.1016/j.neuroimage.2012.12.041; Ozkurt TE, 2011, J NEUROSCI METH, V201, P438, DOI 10.1016/j.jneumeth.2011.08.014; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Park H.-D., 2014, BIOL SCI, V369; Park HD, 2014, NAT NEUROSCI, V17, P612, DOI 10.1038/nn.3671; Parkkonen L, 2009, HUM BRAIN MAPP, V30, P1772, DOI 10.1002/hbm.20788; Port Russell G., 2015, Yale Journal of Biology and Medicine, V88, P25; Pursiainen S, 2012, PHYS MED BIOL, V57, P999, DOI 10.1088/0031-9155/57/4/999; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Ramirez RR, 2011, NEUROIMAGE, V56, P78, DOI 10.1016/j.neuroimage.2011.02.002; Roberts TPL, 2010, AUTISM RES, V3, P8, DOI 10.1002/aur.111; Roux F, 2013, J NEUROSCI, V33, P17827, DOI 10.1523/JNEUROSCI.5778-12.2013; Ruhnau P, 2016, SCI REP-UK, V6, DOI 10.1038/srep27138; Sacchet MD, 2015, J NEUROSCI, V35, P2074, DOI 10.1523/JNEUROSCI.1292-14.2015; Savukov IM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.123001; Schnitzler A, 2006, J PHYSIOLOGY-PARIS, V99, P3, DOI 10.1016/j.jphysparis.2005.06.010; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Schroeder CE, 2010, CURR OPIN NEUROBIOL, V20, P172, DOI 10.1016/j.conb.2010.02.010; Schurger A, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-122; Sharon D, 2007, NEUROIMAGE, V36, P1225, DOI 10.1016/j.neuroimage.2007.03.066; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Sitaram R., 2016, NAT REV NEUROSCI; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tallon-Baudry C, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00397; Tan HRM, 2015, NEUROIMAGE, V122, P417, DOI 10.1016/j.neuroimage.2015.07.055; Taylor JR, 2017, NEUROIMAGE, V144, P262, DOI 10.1016/j.neuroimage.2015.09.018; The AAN Board of Directors, 2009, MAGN MEG MOD POL TEC; Troebinger L, 2014, NEUROIMAGE, V102, P885, DOI 10.1016/j.neuroimage.2014.07.015; Tuch DS, 2001, P NATL ACAD SCI USA, V98, P11697, DOI 10.1073/pnas.171473898; Turner R, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0349; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Vicente R, 2008, P NATL ACAD SCI USA, V105, P17157, DOI 10.1073/pnas.0809353105; Vorwerk J, 2014, NEUROIMAGE, V100, P590, DOI 10.1016/j.neuroimage.2014.06.040; Weiner Michael W, 2013, Alzheimers Dement, V9, pe111, DOI [10.1016/j.jalz.2011.09.172, 10.1016/j.jalz.2013.05.1769]; Whitham EM, 2008, CLIN NEUROPHYSIOL, V119, P1166, DOI 10.1016/j.clinph.2008.01.024; Williams MA, 2010, CURR OPIN PSYCHIATR, V23, P273, DOI 10.1097/YCO.0b013e328338621d; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	142	345	351	21	175	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2017	20	3					327	339		10.1038/nn.4504	http://dx.doi.org/10.1038/nn.4504			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EL9DU	28230841	Green Submitted			2022-12-17	WOS:000394920400006
J	Freeman, J; Simoncelli, EP				Freeman, Jeremy; Simoncelli, Eero P.			Metamers of the ventral stream	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; OBJECT RECOGNITION; AREA V2; NEURONS; SELECTIVITY; MODEL; REPRESENTATION; INTEGRATION; ATTENTION; MASKING	The human capacity to recognize complex visual patterns emerges in a sequence of brain areas known as the ventral stream, beginning with primary visual cortex (V1). We developed a population model for mid-ventral processing, in which nonlinear combinations of V1 responses are averaged in receptive fields that grow with eccentricity. To test the model, we generated novel forms of visual metamers, stimuli that differ physically but look the same. We developed a behavioral protocol that uses metameric stimuli to estimate the receptive field sizes in which the model features are represented. Because receptive field sizes change along the ventral stream, our behavioral results can identify the visual area corresponding to the representation. Measurements in human observers implicate visual area V2, providing a new functional account of neurons in this area. The model also explains deficits of peripheral vision known as crowding, and provides a quantitative framework for assessing the capabilities and limitations of everyday vision.	[Freeman, Jeremy; Simoncelli, Eero P.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Simoncelli, Eero P.] NYU, Courant Inst Math Sci, New York, NY USA; [Simoncelli, Eero P.] NYU, Howard Hughes Med Inst, New York, NY USA	New York University; New York University; Howard Hughes Medical Institute; New York University	Freeman, J (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	freeman@cns.nyu.edu		Simoncelli, Eero/0000-0002-1206-527X	National Science Foundation; Howard Hughes Medical Institute	National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We would like to thank R. Rosenholtz for early inspiration and discussions regarding the relationship between texture and crowding, N. Rust for discussions about the nature of information represented in the ventral stream, C. Anderson for discussions about the scaling of receptive fields with eccentricity, M. Landy, A. Girshick and R. Goris for advice on experimental design, C. Ekanadham and U. Rajashaker for advice on the model and analysis, and D. Ganguli, D. Heeger, J. McDermott, E. Merriam and C. Ziemba for comments on the initial manuscript. This work was supported by a National Science Foundation Graduate Student Fellowship to J. F. and a Howard Hughes Medical Institute Investigatorship to E.P.S.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Anzai A, 2007, NAT NEUROSCI, V10, P1313, DOI 10.1038/nn1975; Balas B, 2008, PATTERN RECOGN, V41, P972, DOI 10.1016/j.patcog.2007.08.007; Balas B, 2009, J VISION, V9, DOI [10.1167/9.2.16, 10.1167/9.12.13]; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Chen XD, 2007, P NATL ACAD SCI USA, V104, P19120, DOI 10.1073/pnas.0706938104; Chung STL, 2007, VISION RES, V47, P3150, DOI 10.1016/j.visres.2007.08.017; David SV, 2006, J NEUROPHYSIOL, V96, P3492, DOI 10.1152/jn.00575.2006; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; GATTASS R, 1988, J NEUROSCI, V8, P1831; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; GEIGER G, 1992, COGNITIVE BRAIN RES, V1, P39, DOI 10.1016/0926-6410(92)90004-B; Graham N., 1989, VISUAL PATTERN ANAL; GRANLUND GH, 1978, COMPUT VISION GRAPH, V8, P155, DOI 10.1016/0146-664X(78)90047-3; Greenwood JA, 2009, P NATL ACAD SCI USA, V106, P13130, DOI 10.1073/pnas.0901352106; Hegde J, 2000, J NEUROSCI, V20, part. no.; HUBEL DH, 1982, NATURE, V299, P515, DOI 10.1038/299515a0; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Julesz B, 1962, IRE T INFORM THEOR, V8, P84, DOI [10.1109/TIT.1962.1057698, DOI 10.1109/TIT.1962.1057698]; Koenderink J. J., 1997, Algebraic Frames for the Perception-Action Cycle. International Workshop, AFPAC'97. Proceedings, P66, DOI 10.1007/BFb0017861; Kovesi P, 2000, PSYCHOL RES-PSYCH FO, V64, P136, DOI 10.1007/s004260000024; LeCun Yann, 1990, ADV NEURAL INFORM PR, P396, DOI DOI 10.1111/DSU.12130; Lettvin JY, 1976, SCIENCES, V16, P10, DOI [10.1002/j.2326-1951.1976.tb01231.x, DOI 10.1002/J.2326-1951.1976.TB01231.X]; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; MACMILLAN NA, 1977, PSYCHOL REV, V84, P452, DOI 10.1037/0033-295X.84.5.452; Martelli M, 2009, J VISION, V9, DOI 10.1167/9.4.14; Parkes L, 2001, NAT NEUROSCI, V4, P739, DOI 10.1038/89532; Pelli DG, 2008, NAT NEUROSCI, V11, P1129, DOI 10.1038/nn.2187; Pelli DG, 2007, J VISION, V7, DOI 10.1167/7.2.20; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Portilla J, 2000, INT J COMPUT VISION, V40, P49, DOI 10.1023/A:1026553619983; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rodionova EI, 2004, EXP BRAIN RES, V158, P373, DOI 10.1007/s00221-004-1967-1; Rolls E. T., 2009, OBJECT CATEGORIZATIO, P257, DOI [10.1017/CBO9780511635465.015, DOI 10.1017/CB09780511635465.015]; Rust NC, 2005, NAT NEUROSCI, V8, P1647, DOI 10.1038/nn1606; SCHALL JD, 1986, BRAIN RES, V368, P18, DOI 10.1016/0006-8993(86)91037-1; Schmid AM, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.015.2009; Scolari M, 2007, J VISION, V7, DOI 10.1167/7.2.7; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Shushruth S, 2009, J NEUROPHYSIOL, V102, P2069, DOI 10.1152/jn.00512.2009; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TOWNSEND JT, 1971, PERCEPT PSYCHOPHYS, V10, P375, DOI 10.3758/BF03207464; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Wandell B.A., 1995, FDN VISION; Willmore BDB, 2010, J NEUROSCI, V30, P2102, DOI 10.1523/JNEUROSCI.4099-09.2010; Yeshurun Y, 2010, J VISION, V10, DOI 10.1167/10.10.16; Zoccolan D, 2007, J NEUROSCI, V27, P12292, DOI 10.1523/JNEUROSCI.1897-07.2007	50	345	349	2	59	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1195	U130		10.1038/nn.2889	http://dx.doi.org/10.1038/nn.2889			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21841776	Green Accepted			2022-12-17	WOS:000294284900021
J	Golarai, G; Ghahremani, DG; Whitfield-Gabrieli, S; Reiss, A; Eberhardt, JL; Gabrieli, JDE; Grill-Spector, K				Golarai, Golijeh; Ghahremani, Dara G.; Whitfield-Gabrieli, S.; Reiss, Allan; Eberhardt, Jennifer L.; Gabrieli, John D. E.; Grill-Spector, Kalanit			Differential development of high-level visual cortex correlates with category-specific recognition memory	NATURE NEUROSCIENCE			English	Article							FUSIFORM FACE AREA; HUMAN EXTRASTRIATE CORTEX; OBJECT-PROCESSING STAGES; OTHER-RACE FACES; BRAIN ACTIVITY; PERCEPTION; FMRI; ACTIVATION; EXPERTISE; CHILDREN	High-level visual cortex in humans includes functionally defined regions that preferentially respond to objects, faces and places. It is unknown how these regions develop and whether their development relates to recognition memory. We used functional magnetic resonance imaging to examine the development of several functionally defined regions including object ( lateral occipital complex, LOC)-, face ('fusiform face area', FFA; superior temporal sulcus, STS)- and place ('parahippocampal place area', PPA)-selective cortices in children (ages 7 - 11), adolescents (12 - 16) and adults. Right FFA and left PPA volumes were substantially larger in adults than in children. This development occurred by expansion of FFA and PPA into surrounding cortex and was correlated with improved recognition memory for faces and places, respectively. In contrast, LOC and STS volumes and object-recognition memory remained constant across ages. Thus, the ventral stream undergoes a prolonged maturation that varies temporally across functional regions, is determined by brain region rather than stimulus category, and is correlated with the development of category-specific recognition memory.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; Stanford Univ, Program Neurosci, Stanford, CA 94305 USA	Stanford University; University of California System; University of California Los Angeles; Harvard University; Massachusetts Institute of Technology (MIT); Stanford University; Stanford University	Golarai, G (corresponding author), Stanford Univ, Dept Psychol, Jordan Hall Bldg 420, Stanford, CA 94305 USA.	ggolarai@psych.stanford.edu	Gabrieli, John/AAJ-2869-2020	Grill-Spector, Kalanit/0000-0002-5404-9606	NEI NIH HHS [R21 EY017741, 1R21EY017741] Funding Source: Medline; NIDA NIH HHS [R21 DA015893, 5R21DA15893] Funding Source: Medline; NIMH NIH HHS [T32 MH019908, T32 MH19908, R21 MH066747, 1R21MH66747] Funding Source: Medline; NATIONAL EYE INSTITUTE [R21EY017741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019908, R21MH066747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA015893] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Anastasi JS, 2005, PSYCHON B REV, V12, P1043, DOI 10.3758/BF03206441; Aylward EH, 2005, J COGNITIVE NEUROSCI, V17, P308, DOI 10.1162/0898929053124884; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; CAREY S, 1980, DEV PSYCHOL, V16, P257, DOI 10.1037/0012-1649.16.4.257; CHANCE JE, 1982, J PSYCHOL, V112, P29, DOI 10.1080/00223980.1982.9923531; Conner IP, 2004, J VISION, V4, P509, DOI 10.1167/4.6.10; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; de Haan M, 1999, DEV PSYCHOL, V35, P1113, DOI 10.1037/0012-1649.35.4.1113; DERENZI E, 1994, NEUROPSYCHOLOGIA, V32, P893, DOI 10.1016/0028-3932(94)90041-8; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Duvernoy HM, 1999, HUMAN BRAIN; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2006, NEUROPSYCHOLOGIA, V44, P1145, DOI 10.1016/j.neuropsychologia.2005.10.009; Gathers AD, 2004, NEUROREPORT, V15, P1549, DOI 10.1097/01.wnr.0000133299.84901.86; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gauthier I, 2000, TRENDS COGN SCI, V4, P1, DOI 10.1016/S1364-6613(99)01416-3; GILBERT C, 1973, NEUROPSYCHOLOGIA, V11, P355, DOI 10.1016/0028-3932(73)90049-3; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; GOREN CC, 1975, PEDIATRICS, V56, P544; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Grill-Spector K, 2006, NAT NEUROSCI, V9, P1177, DOI 10.1038/nn1745; Haslinger B, 2004, HUM BRAIN MAPP, V22, P206, DOI 10.1002/hbm.20028; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Huettel SA, 2001, NEUROIMAGE, V13, P161, DOI 10.1006/nimg.2000.0675; JENKINS WM, 1990, NEUROPSYCHOLOGIA, V28, P573, DOI 10.1016/0028-3932(90)90035-M; JOHNSON MH, 1991, COGNITION, V40, P1, DOI 10.1016/0010-0277(91)90045-6; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Kronbichler M, 2004, NEUROIMAGE, V21, P946, DOI 10.1016/j.neuroimage.2003.10.021; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Nichols EA, 2006, HIPPOCAMPUS, V16, P604, DOI 10.1002/hipo.20190; Ranganath C, 2004, COGNITIVE BRAIN RES, V20, P37, DOI 10.1016/j.cogbrainres.2003.11.017; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Tarr MJ, 2000, NAT NEUROSCI, V3, P764, DOI 10.1038/77666; Thomason ME, 2005, NEUROIMAGE, V25, P824, DOI 10.1016/j.neuroimage.2004.12.026; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P454, DOI 10.1006/nimg.2001.0979; Weisberg J, 2007, CEREB CORTEX, V17, P513, DOI 10.1093/cercor/bhj176; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7; Yue XM, 2006, VISION RES, V46, P3802, DOI 10.1016/j.visres.2006.06.017	50	345	350	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					512	522		10.1038/nn1865	http://dx.doi.org/10.1038/nn1865			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	150PL	17351637	Green Accepted			2022-12-17	WOS:000245228600023
J	Cichy, RM; Pantazis, D; Oliva, A				Cichy, Radoslaw Martin; Pantazis, Dimitrios; Oliva, Aude			Resolving human object recognition in space and time	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL CORTEX; HUMAN EXTRASTRIATE CORTEX; HUMAN VISUAL-CORTEX; FUSIFORM FACE AREA; BRAIN ACTIVITY; HUMAN-BODY; PERCEPTION; FMRI; MEG; CATEGORY	A comprehensive picture of object processing in the human brain requires combining both spatial and temporal information about brain activity. Here we acquired human magnetoencephalography (MEG) and functional magnetic resonance imaging (fMRI) responses to 92 object images. Multivariate pattern classification applied to MEG revealed the time course of object processing: whereas individual images were discriminated by visual representations early, ordinate and superordinate category levels emerged relatively late. Using representational similarity analysis, we combined human fMRI and MEG to show content-specific correspondence between early MEG responses and primary visual cortex (V1), and later MEG responses and inferior temporal (IT) cortex. We identified transient and persistent neural activities during object processing with sources in V1 and IT. Finally, we correlated human MEG signals to single-unit responses in monkey IT. Together, our findings provide an integrated space-and time-resolved view of human object categorization during the first few hundred milliseconds of vision.	[Cichy, Radoslaw Martin; Oliva, Aude] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Pantazis, Dimitrios] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Cichy, RM (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rmcichy@mit.edu	Pantazis, Dimitrios/GXG-1897-2022	Pantazis, Dimitrios/0000-0001-8246-8878; Cichy, Radoslaw/0000-0003-4190-6071	US National Eye Institute [EY020484]; US National Science Foundation [BCS-1134780]; Humboldt Scholarship; NATIONAL EYE INSTITUTE [R01EY020484] Funding Source: NIH RePORTER	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US National Science Foundation(National Science Foundation (NSF)); Humboldt Scholarship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by US National Eye Institute grant EY020484 (to A.O.), US National Science Foundation grant BCS-1134780 (to D. P.) and a Humboldt Scholarship (to R. M. C.), and was conducted at the Athinoula A. Martinos Imaging Center at the McGovern Institute for Brain Research, Massachusetts Institute of Technology.	ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Benson NC, 2012, CURR BIOL, V22, P2081, DOI 10.1016/j.cub.2012.09.014; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Brincat SL, 2006, NEURON, V49, P17, DOI 10.1016/j.neuron.2005.11.026; Carlson T, 2013, J VISION, V13, DOI 10.1167/13.10.1; Carlson TA, 2011, J VISION, V11, DOI 10.1167/11.10.9; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Debener S, 2006, TRENDS COGN SCI, V10, P558, DOI 10.1016/j.tics.2006.09.010; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Edelman S, 1998, BEHAV BRAIN SCI, V21, P449, DOI 10.1017/S0140525X98001253; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Freiwald WA, 2010, SCIENCE, V330, P845, DOI 10.1126/science.1194908; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Hari R, 2012, NEUROIMAGE, V61, P386, DOI 10.1016/j.neuroimage.2011.11.074; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Jeffreys DA, 1996, VIS COGN, V3, P1, DOI 10.1080/713756729; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kiani R, 2007, J NEUROPHYSIOL, V97, P4296, DOI 10.1152/jn.00024.2007; Kourtzi Z, 2011, ANNU REV NEUROSCI, V34, P45, DOI 10.1146/annurev-neuro-060909-153218; Kravitz DJ, 2013, TRENDS COGN SCI, V17, P26, DOI 10.1016/j.tics.2012.10.011; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Kruskal J.B., 1978, U PAPER SERIES QUANT; Liu HS, 2009, NEURON, V62, P281, DOI 10.1016/j.neuron.2009.02.025; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Luck S. J., 2005, INTRO EVENT RELATED; Mack ML, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00165; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; Milner D., 2006, VISUAL BRAIN ACTION, DOI [10.1093/acprof:oso/9780198524724.001.0001, DOI 10.1093/ACPROF:OSO/9780198524724.001.0001]; Mormann F, 2008, J NEUROSCI, V28, P8865, DOI 10.1523/JNEUROSCI.1640-08.2008; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Sadeh B, 2010, HUM BRAIN MAPP, V31, P1490, DOI 10.1002/hbm.20952; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; SHEPARD RN, 1980, SCIENCE, V210, P390, DOI 10.1126/science.210.4468.390; Stekelenburg JJ, 2004, NEUROREPORT, V15, P777, DOI 10.1097/00001756-200404090-00007; Sugase-Miyamoto Y, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00141; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Thierry G, 2006, NEUROIMAGE, V32, P871, DOI 10.1016/j.neuroimage.2006.03.060; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tong F, 2012, ANNU REV PSYCHOL, V63, P483, DOI 10.1146/annurev-psych-120710-100412; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P549; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880	54	344	346	11	128	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2014	17	3					455	462		10.1038/nn.3635	http://dx.doi.org/10.1038/nn.3635			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AB8CA	24464044	Green Accepted			2022-12-17	WOS:000332016500020
J	O'Hagan, R; Chalfie, M; Goodman, MB				O'Hagan, R; Chalfie, M; Goodman, MB			The MEC-4 DEG/ENaC channel of Caenorhabditis elegans touch receptor neurons transduces mechanical signals	NATURE NEUROSCIENCE			English	Article							C-ELEGANS; MECHANOSENSORY TRANSDUCTION; SUBUNIT; PROTEIN; LOCALIZATION; MICROTUBULES; SENSITIVITY; LOCOMOTION; MUTATIONS; SENSATION	Transformation of mechanical energy into ionic currents is essential for touch, hearing and nociception. Although DEG/ENaC proteins are believed to form sensory mechanotransduction channels, the evidence for this role remains indirect. By recording from C. elegans touch receptor neurons in vivo, we found that external force evokes rapidly activating mechanoreceptor currents (MRCs) carried mostly by Na+ and blocked by amiloride-characteristics consistent with direct mechanical gating of a DEG/ENaC channel. Like mammalian Pacinian corpuscles, these neurons depolarized with both positive and negative changes in external force but not with sustained force. Null mutations in the DEG/ENaC gene mec-4 and in the accessory ion channel subunit genes mec-2 and mec-6 eliminated MRCs. In contrast, the genetic elimination of touch neuron-specific microtubules reduced, but did not abolish, MRCs. Our findings link the application of external force to the activation of a molecularly defined metazoan sensory transduction channel.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Columbia University; Stanford University	Chalfie, M (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	mc21@columbia.edu; mbgoodman@stanford.edu	Goodman, Miriam B./H-3036-2019; O'Hagan, Robert/AAE-9789-2020	Goodman, Miriam B./0000-0002-5810-1272; O'Hagan, Robert/0000-0001-7580-1441	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047715] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM20997, R37 GM030997] Funding Source: Medline; NINDS NIH HHS [R01 NS047715-01A1, R01 NS047715] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; ALVAREZBUYLLA R, 1953, AM J PHYSIOL, V172, P237, DOI 10.1152/ajplegacy.1952.172.1.237; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1982, J CELL BIOL, V93, P15, DOI 10.1083/jcb.93.1.15; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; DIAMOND J, 1958, J PHYSIOL-LONDON, V142, P382, DOI 10.1113/jphysiol.1958.sp006024; Drummond HA, 2000, BRAIN RES, V884, P1, DOI 10.1016/S0006-8993(00)02831-6; Ernstrom GG, 2002, ANNU REV GENET, V36, P411, DOI 10.1146/annurev.genet.36.061802.101708; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; Goodman MB, 2000, J NEUROSCI METH, V100, P13, DOI 10.1016/S0165-0270(00)00224-7; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; GRAY JAB, 1953, J PHYSIOL-LONDON, V122, P610, DOI 10.1113/jphysiol.1953.sp005025; Hardie RC, 2001, J EXP BIOL, V204, P3403; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Hoger U, 1997, J NEUROPHYSIOL, V78, P2079, DOI 10.1152/jn.1997.78.4.2079; Hong K, 2000, J NEUROSCI, V20, P2575; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Johnston D., 1995, FDN CELLULAR NEUROPH; JUUSOLA M, 1994, J NEUROPHYSIOL, V72, P3026, DOI 10.1152/jn.1994.72.6.3026; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Mello C, 1995, METHOD CELL BIOL, V48, P451; OTTOSON D, 1964, J PHYSIOL-LONDON, V171, P109, DOI 10.1113/jphysiol.1964.sp007365; PLASTERK RHA, 1995, CAENORHABDITIS ELEGA, P59; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Rankin CH, 2000, J NEUROSCI, V20, P4337; Roza C, 2004, J PHYSIOL-LONDON, V558, P659, DOI 10.1113/jphysiol.2004.066001; SAVAGE C, 1989, GENE DEV, V3, P870, DOI 10.1101/gad.3.6.870; SAVAGE C, 1994, J CELL SCI, V107, P2165; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; WICKS SR, 1995, J NEUROSCI, V15, P2434, DOI 10.1523/JNEUROSCI.15-03-02434.1995; ZHANG S, 2004, IN PRESS CURR BIOL; Zhang Y, 2002, NATURE, V418, P331, DOI 10.1038/nature00891	40	344	359	2	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					43	50		10.1038/nn1362	http://dx.doi.org/10.1038/nn1362			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15580270				2022-12-17	WOS:000225967600014
J	Taubenfeld, SM; Milekic, MH; Monti, B; Alberini, CM				Taubenfeld, SM; Milekic, MH; Monti, B; Alberini, CM			The consolidation of new but not reactivated memory requires hippocampal C/EBP beta	NATURE NEUROSCIENCE			English	Article							ELEMENT-BINDING PROTEIN; RETROGRADE-AMNESIA; AMYGDALA; CREB; GENES; RECONSOLIDATION; TRANSCRIPTION; NEUROBIOLOGY; NEUROSCIENCE; INVOLVEMENT	Long-term memory formation consists of multiple phases. A new memory is initially labile and sensitive to disruption by a variety of interfering events or agents. To become stable, this new memory undergoes a process known as consolidation, which, in the case of declarative memories, occurs within the medial temporal lobes and requires gene expression. When recalled, memories re-enter a new phase of vulnerability and seem to require a reconsolidation process in order to be maintained. Here we show that consolidation but not reconsolidation of inhibitory avoidance memory requires the expression of the transcription factor CCAAT enhancer binding protein beta (C/EBP beta) in the hippocampus. Furthermore, in the same region, de novo protein synthesis is not essential for memory reconsolidation. C/EBP beta is an evolutionarily conserved genetic marker that has a selective role in the consolidation of new but not reactivated memories in the hippocampus.	CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA; Brown Univ, Dept Neurosci, Providence, RI 02912 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Brown University	Alberini, CM (corresponding author), CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, 1 Gustave L Levy Pl,Box 1218, New York, NY 10029 USA.	cristina.alberini@inka.mssm.edu	Monti, Barbara/AAG-1258-2021	Monti, Barbara/0000-0003-0330-482X				Alberini CM, 1999, J EXP BIOL, V202, P2887; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Davis M, 1997, J NEUROPSYCH CLIN N, V9, P382; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; Gerlai R, 2000, REV NEUROSCIENCE, V11, P15; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Guzowski JF, 2000, J NEUROSCI, V20, P3993; HOOPER ML, 1994, NEUROSCIENCE, V63, P917, DOI 10.1016/0306-4522(94)90559-2; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; JUDGE ME, 1982, PHYSIOL BEHAV, V28, P585, DOI 10.1016/0031-9384(82)90034-8; Lamprecht R, 1997, J NEUROSCI, V17, P8443; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; MACTUTUS CF, 1979, SCIENCE, V204, P1319, DOI 10.1126/science.572083; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Ogawa S, 1998, CHEM SENSES, V23, P249, DOI 10.1093/chemse/23.2.249; Pall M, 1997, EMBO J, V16, P5273, DOI 10.1093/emboj/16.17.5273; Quevedo J, 1999, LEARN MEMORY, V6, P600, DOI 10.1101/lm.6.6.600; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Swank MW, 2000, NEUROREPORT, V11, P1625, DOI 10.1097/00001756-200006050-00006; Taubenfeld SM, 1999, NAT NEUROSCI, V2, P309, DOI 10.1038/7217; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; Tischmeyer W, 1999, CELL MOL LIFE SCI, V55, P564, DOI 10.1007/s000180050315; Widnell KL, 1996, J PHARMACOL EXP THER, V276, P306; Wilensky AE, 2000, J NEUROSCI, V20, P7059, DOI 10.1523/JNEUROSCI.20-18-07059.2000; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	37	344	350	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2001	4	8					813	818		10.1038/90520	http://dx.doi.org/10.1038/90520			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	457KY	11477427				2022-12-17	WOS:000170137300014
J	Choi, YB; Tenneti, L; Le, DA; Ortiz, J; Bai, G; Chen, HSV; Lipton, SA				Choi, YB; Tenneti, L; Le, DA; Ortiz, J; Bai, G; Chen, HSV; Lipton, SA			Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation	NATURE NEUROSCIENCE			English	Article							NITRIC-OXIDE SYNTHASE; METHYL-D-ASPARTATE; GLUTAMATE-RECEPTOR; REDOX MODULATION; SMOOTH-MUSCLE; INDUCED BLOCKADE; N-GLYCOSYLATION; NEUROTOXICITY; ACTIVATION; RELEASE	Several ion channels are thought to be directly modulated by nitric-oxide (NO), but the molecular basis of this regulation is unclear. Here we show that the NMDA receptor (NMDAR)-associated ion channel was modulated not only by exogenous NO but also by endogenous NO. Site-directed mutagenesis identified a critical cysteine residue (Cys 399) on the NR2A subunit whose S-nitrosylation (NO+ transfer) under physiological conditions underlies this modulation. In cell systems expressing NMDARs with mutant NR2A subunits in which this single cysteine was replaced by an alanine, the effect of endogenous NO was lost. Thus endogenous S-nitrosylation can regulate ion channel activity.	Brigham & Womens Hosp, Cerebrovasc & Neurosci Res Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Lipton, SA (corresponding author), Burnham Inst, Del E Webb Ctr Neurosci & Aging Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		le, da/GSI-8607-2022	Lipton, Stuart/0000-0002-3490-1259	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009024, R01EY005477] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY09024, R01 EY05477] Funding Source: Medline; NICHD NIH HHS [P01 HD29587] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adamson DC, 1996, SCIENCE, V274, P1917, DOI 10.1126/science.274.5294.1917; Aizenman E, 1999, BRIT J PHARMACOL, V126, P296, DOI 10.1038/sj.bjp.0702295; Aizenman E, 1998, PROG BRAIN RES, V118, P53; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; BOLOTINA VM, 1994, NATURE, V368, P520; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Bredt DS, 1992, NEURON, V8, P3; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Broillet MC, 1996, NEURON, V16, P377, DOI 10.1016/S0896-6273(00)80055-0; Campbell DL, 1996, J GEN PHYSIOL, V108, P277, DOI 10.1085/jgp.108.4.277; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Dawson D. M., 1993, International Journal of Robotics & Automation, V8, P13; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; DINGLEDINE R, 1990, TRENDS PHARMACOL SCI, V11, P334, DOI 10.1016/0165-6147(90)90238-4; FAGNI L, 1995, MOL PHARMACOL, V47, P1239; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GASTON B, 1994, J PHARMACOL EXP THER, V268, P978; HOLLAND A, 1994, ENVIRON VALUE, V3, P1; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; HOYT KR, 1992, BRAIN RES, V592, P310, DOI 10.1016/0006-8993(92)91690-G; KENDRICK KM, 1996, EUR J NEUROSCI, V8, P1619; Koh SD, 1995, J PHYSIOL-LONDON, V489, P735, DOI 10.1113/jphysiol.1995.sp021087; KOIVISTO A, 1995, J PHYSIOL-LONDON, V486, P59, DOI 10.1113/jphysiol.1995.sp020790; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; KURENNY DE, 1994, NEURON, V13, P315, DOI 10.1016/0896-6273(94)90349-2; Lander HM, 1997, J BIOL CHEM, V272, P4323, DOI 10.1074/jbc.272.7.4323; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Lipton SA, 1998, PROG BRAIN RES, V118, P73; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; MANZONI O, 1993, J NEUROCHEM, V61, P368, DOI 10.1111/j.1471-4159.1993.tb03580.x; MANZONI O, 1992, NEURON, V8, P653, DOI 10.1016/0896-6273(92)90087-T; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; OMEROVIC A, 1995, J RECEPT SIGNAL TR R, V15, P811, DOI 10.3109/10799899509049859; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; STAMLER JS, 1996, METHODS NITRIC OXIDE, P521; Sucher NJ, 1996, TRENDS PHARMACOL SCI, V17, P348, DOI 10.1016/S0165-6147(96)10046-8; SULLIVAN JM, 1994, NEURON, V13, P929, DOI 10.1016/0896-6273(94)90258-5; Takeuchi T, 1996, BRIT J PHARMACOL, V117, P1204, DOI 10.1111/j.1476-5381.1996.tb16717.x; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Yuan XJ, 1996, P NATL ACAD SCI USA, V93, P10489, DOI 10.1073/pnas.93.19.10489	50	344	357	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2000	3	1					15	21		10.1038/71090	http://dx.doi.org/10.1038/71090			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TB	10607390				2022-12-17	WOS:000085810200007
J	Khan, UA; Liu, L; Provenzano, FA; Berman, DE; Profaci, CP; Sloan, R; Mayeux, R; Duff, KE; Small, SA				Khan, Usman A.; Liu, Li; Provenzano, Frank A.; Berman, Diego E.; Profaci, Caterina P.; Sloan, Richard; Mayeux, Richard; Duff, Karen E.; Small, Scott A.			Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease	NATURE NEUROSCIENCE			English	Article							CEREBRAL BLOOD-VOLUME; AMYLOID-BETA-PEPTIDE; CELLULAR PROPERTIES; PRINCIPAL NEURONS; BRAIN; TAU; MEMORY; RAT; REPRESENTATION; DECLINE	The entorhinal cortex has been implicated in the early stages of Alzheimer's disease, which is characterized by changes in the tau protein and in the cleaved fragments of the amyloid precursor protein (APP). We used a high-resolution functional magnetic resonance imaging (fMRI) variant that can map metabolic defects in patients and mouse models to address basic questions about entorhinal cortex pathophysiology. The entorhinal cortex is divided into functionally distinct regions, the medial entorhinal cortex (MEG) and the lateral entorhinal cortex (LEG), and we exploited the high-resolution capabilities of the fMRI variant to ask whether either of them was affected in patients with preclinical Alzheimer's.disease. Next, we imaged three mouse models of disease to clarify how tau and APP relate to entorhinal cortex dysfunction and to determine whether the entorhinal cortex can act as a source of dysfunction observed in other cortical areas. We found that the LEC was affected in preclinical disease, that LEC dysfunction could spread to the parietal cortex during preclinical disease and that APP expression potentiated tau toxicity in driving LEG dysfunction, thereby helping to explain regional vulnerability in the disease.	[Khan, Usman A.; Liu, Li; Provenzano, Frank A.; Berman, Diego E.; Profaci, Caterina P.; Mayeux, Richard; Duff, Karen E.; Small, Scott A.] Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA; [Khan, Usman A.; Provenzano, Frank A.; Mayeux, Richard; Small, Scott A.] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA; [Khan, Usman A.] Suny Downstate Med Ctr, Program Neural & Behav Sci, Brooklyn, NY 11203 USA; [Liu, Li; Berman, Diego E.; Profaci, Caterina P.; Duff, Karen E.] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY USA; [Sloan, Richard] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Small, Scott A.] Columbia Univ, Coll Phys & Surg, Dept Radiol, New York, NY USA	Columbia University; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Columbia University; Columbia University; Columbia University	Duff, KE (corresponding author), Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.	ked2115@columbia.edu; sas68@columbia.edu		Profaci, Caterina Pearsall/0000-0002-4073-2164; Duff, Karen/0000-0002-6177-868X	US National Institutes of Health [AG034618, AG025161, AG07232, AG037212, NS074874, HL094423]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037212, R01AG025161, P01AG007232, P50AG008702, R01AG034618] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by US National Institutes of Health grants AG034618 and AG025161 to S.A.S., AG07232 and AG037212 to R.M., NS074874 to K.E.D., and HL094423 to R.S.	Albert MS, 1997, PHILOS T ROY SOC B, V352, P1703, DOI 10.1098/rstb.1997.0152; BELLIVEAU JW, 1991, SCIENCE, V254, P716, DOI 10.1126/science.1948051; Braak H, 2012, ALZHEIMERS DEMENT, V8, P227, DOI 10.1016/j.jalz.2012.01.011; Brickman AM, 2011, HIPPOCAMPUS, V21, P923, DOI 10.1002/hipo.20840; Canto CB, 2012, HIPPOCAMPUS, V22, P1256, DOI 10.1002/hipo.20997; Canto CB, 2012, HIPPOCAMPUS, V22, P1277, DOI 10.1002/hipo.20993; Canto Cathrin B., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/381243; Das U, 2013, NEURON, V79, P447, DOI 10.1016/j.neuron.2013.05.035; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Desikan RS, 2012, ARCH NEUROL-CHICAGO, V69, P709, DOI 10.1001/archneurol.2011.3354; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; GomezIsla T, 1996, J NEUROSCI, V16, P4491; GONZALEZ RG, 1995, AM J NEURORADIOL, V16, P1763; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; HEVNER RF, 1992, J COMP NEUROL, V326, P451, DOI 10.1002/cne.903260310; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jicha GA, 1999, J NEUROSCI RES, V55, P713, DOI 10.1002/(SICI)1097-4547(19990315)55:6<713::AID-JNR6>3.0.CO;2-G; KAGEYAMA GH, 1982, NEUROSCIENCE, V7, P2337, DOI 10.1016/0306-4522(82)90199-3; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Lin WL, 1999, JMRI-J MAGN RESON IM, V9, P44, DOI 10.1002/(SICI)1522-2586(199901)9:1<44::AID-JMRI6>3.0.CO;2-7; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Meguro K, 1999, BRAIN, V122, P1519, DOI 10.1093/brain/122.8.1519; Moreno H, 2007, ARCH NEUROL-CHICAGO, V64, P1467, DOI 10.1001/archneur.64.10.1467; Moreno H, 2006, NMR BIOMED, V19, P535, DOI 10.1002/nbm.1022; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Olsen RK, 2009, J NEUROSCI, V29, P11880, DOI 10.1523/JNEUROSCI.2245-09.2009; PETERSEN RC, 1992, NEUROLOGY, V42, P396, DOI 10.1212/WNL.42.2.396; RAICHLE ME, 1983, ANNU REV NEUROSCI, V6, P249, DOI 10.1146/annurev.ne.06.030183.001341; Sabuncu MR, 2009, LECT NOTES COMPUT SC, V5761, P565, DOI 10.1007/978-3-642-04268-3_70; Schon K, 2004, J NEUROSCI, V24, P11088, DOI 10.1523/JNEUROSCI.3807-04.2004; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Small SA, 2004, P NATL ACAD SCI USA, V101, P7181, DOI 10.1073/pnas.0400285101; Solodkin A, 1996, J COMP NEUROL, V365, P610; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Stranahan AM, 2011, CEREB CORTEX, V21, P392, DOI 10.1093/cercor/bhq106; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Tsao A, 2013, CURR BIOL, V23, P399, DOI 10.1016/j.cub.2013.01.036; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Yasuda M, 2006, NEURON, V50, P309, DOI 10.1016/j.neuron.2006.03.035; Young BJ, 1997, J NEUROSCI, V17, P5183	42	343	345	6	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2014	17	2					304	311		10.1038/nn.3606	http://dx.doi.org/10.1038/nn.3606			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AA2FH	24362760	Green Accepted			2022-12-17	WOS:000330910000026
J	Law, CT; Gold, JI				Law, Chi-Tat; Gold, Joshua I.			Neural correlates of perceptual learning in a sensory-motor, but not a sensory, cortical area	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; PRIMARY VISUAL-CORTEX; PARIETAL CORTEX; RESPONSES; DECISION; MOTION; DISCRIMINATION; REPRESENTATION; NEURONS; PLASTICITY	This study aimed to identify neural mechanisms that underlie perceptual learning in a visual-discrimination task. We trained two monkeys (Macaca mulatta) to determine the direction of visual motion while we recorded from their middle temporal area (MT), which in trained monkeys represents motion information that is used to solve the task, and lateral intraparietal area (LIP), which represents the transformation of motion information into a saccadic choice. During training, improved behavioral sensitivity to weak motion signals was accompanied by changes in motion-driven responses of neurons in LIP, but not in MT. The time course and magnitude of the changes in LIP correlated with the changes in behavioral sensitivity throughout training. Thus, for this task, perceptual learning does not appear to involve improvements in how sensory information is represented in the brain, but rather how the sensory representation is interpreted to form the decision that guides behavior.	[Law, Chi-Tat; Gold, Joshua I.] Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Gold, JI (corresponding author), Univ Penn, 116 Johnson Pavilion,3610 Hamilton Walk, Philadelphia, PA 19104 USA.	jigold@mail.med.upenn.edu			NEI NIH HHS [R01 EY015260, R01 EY015260-03, R01-EY015260, T32 EY007035, T32-EY007035, R01 EY015260-04, R01 EY015260-02, R01 EY015260-01A1] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY007035, R01EY015260] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; BALL K, 1982, SCIENCE, V218, P697, DOI 10.1126/science.7134968; Bao SW, 2004, NAT NEUROSCI, V7, P974, DOI 10.1038/nn1293; Blake DT, 2006, NEURON, V52, P371, DOI 10.1016/j.neuron.2006.08.009; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; Dosher BA, 1999, VISION RES, V39, P3197, DOI 10.1016/S0042-6989(99)00059-0; Eckhoff P, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/1/015006; Fine I, 2002, J VISION, V2, P190, DOI 10.1167/2.2.5; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Furmanski CS, 2004, CURR BIOL, V14, P573, DOI 10.1016/j.cub.2004.03.032; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Gold JI, 2003, J NEUROSCI, V23, P632, DOI 10.1523/JNEUROSCI.23-02-00632.2003; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Grunewald A, 1999, J NEUROPHYSIOL, V82, P330, DOI 10.1152/jn.1999.82.1.330; HALL G, 1991, PERCEPTUAL ASSOCIATI; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Liu ZL, 2000, VISION RES, V40, P97, DOI 10.1016/S0042-6989(99)00140-6; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Mollon JD, 1996, SPATIAL VISION, V10, P51, DOI 10.1163/156856896X00051; Movshon JA, 1996, J NEUROSCI, V16, P7733; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Pleger B, 2003, NEURON, V40, P643, DOI 10.1016/S0896-6273(03)00677-9; Raiguel S, 2006, J NEUROSCI, V26, P6589, DOI 10.1523/JNEUROSCI.0457-06.2006; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; Roitman JD, 2002, J NEUROSCI, V22, P9475; SAARINEN J, 1995, VISION RES, V35, P519, DOI 10.1016/0042-6989(94)00141-8; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783, DOI 10.1152/jn.1999.81.4.1783; Sereno AB, 2006, J NEUROPHYSIOL, V95, P1078, DOI 10.1152/jn.00431.2005; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Vaina LM, 1998, P NATL ACAD SCI USA, V95, P12657, DOI 10.1073/pnas.95.21.12657; VANESSEN DC, 2004, VISUAL NEUROSCIENCES, P507; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; ZOHARY E, 1994, SCIENCE, V263, P1289, DOI 10.1126/science.8122114	50	343	349	4	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					505	513		10.1038/nn2070	http://dx.doi.org/10.1038/nn2070			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18327253	Green Accepted			2022-12-17	WOS:000254359300023
J	Kukley, M; Capetillo-Zarate, E; Dietrich, D				Kukley, Maria; Capetillo-Zarate, Estibaliz; Dietrich, Dirk			Vesicular glutamate release from axons in white matter	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; FROG NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; CORPUS-CALLOSUM; GLIAL-CELLS; MOLECULAR-MECHANISMS; PRESYNAPTIC CALCIUM; ELECTRICAL-ACTIVITY; HIPPOCAMPAL SLICES; TERM DEPRESSION	Vesicular release of neurotransmitter is the universal output signal of neurons in the brain. It is generally believed that fast transmitter release is restricted to nerve terminals that contact postsynaptic cells in the gray matter. Here we show in the rat brain that the neurotransmitter glutamate is also released at discrete sites along axons in white matter in the absence of neurons and nerve terminals. The propagation of single action potentials along axons leads to rapid vesicular release of glutamate, which is detected by ionotropic glutamate receptors on local oligodendrocyte precursor cells. Axonal release of glutamate is reliable, involves highly localized calcium microdomain signaling and is strongly calcium cooperative, similar to vesicle fusion at synapses. This axonal transmitter release represents a widespread mechanism for high-fidelity, activity-dependent signaling at the axon-glia interface in white matter.	Univ Clin Bonn, Dept Neurosurg, D-53105 Bonn, Germany; Univ Clin Bonn, Dept Neuropathol, D-53105 Bonn, Germany	University of Bonn; University of Bonn	Kukley, M (corresponding author), Univ Clin Bonn, Dept Neurosurg, Sigmund Freud Str 25, D-53105 Bonn, Germany.	maria.kukley@gmx.de; dirk.dietrich@ukb.uni-bonn.de	Kukley, Maria/I-4064-2017; Capetillo-Zarate, Estibaliz/Z-5772-2019; Messier, Claude/A-2322-2008	Kukley, Maria/0000-0002-4567-1241; Capetillo-Zarate, Estibaliz/0000-0002-8416-0495; Messier, Claude/0000-0002-4791-1763				Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441, DOI 10.1146/annurev.neuro.13.1.441; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; BERGER T, 1991, J NEUROSCI, V11, P3008; BJARTMAR C, 1994, GLIA, V11, P235, DOI 10.1002/glia.440110304; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Coggan JS, 2005, SCIENCE, V309, P446, DOI 10.1126/science.1108239; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Dietrich D, 2003, NEURON, V39, P483, DOI 10.1016/S0896-6273(03)00430-6; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Hille B., 1992, IONIC CHANNELS EXCIT; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; JACOBSON S, 1974, BRAIN RES, V74, P149, DOI 10.1016/0006-8993(74)90118-8; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; KRIEGLER S, 1993, J NEUROSCI, V13, P4229, DOI 10.1523/jneurosci.13-10-04229.1993; Li S, 1999, J Neurosci, V19, pRC16; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Meinrenken CJ, 2003, J PHYSIOL-LONDON, V547, P665, DOI 10.1113/jphsiol.2002.032714; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Naraghi M, 1997, CELL CALCIUM, V22, P255, DOI 10.1016/S0143-4160(97)90064-6; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; Pyle JL, 1999, NEURON, V24, P803, DOI 10.1016/S0896-6273(00)81028-4; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; Riederer BM, 2004, EUR J NEUROSCI, V19, P2039, DOI 10.1111/j.1460-9568.2004.03305.x; Rosenmund C, 2003, CURR OPIN NEUROBIOL, V13, P509, DOI 10.1016/j.conb.2003.09.011; Sabatini BL, 1998, BIOPHYS J, V74, P1549, DOI 10.1016/S0006-3495(98)77867-1; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Spacek J, 2004, J NEUROSCI, V24, P4233, DOI 10.1523/JNEUROSCI.0287-04.2004; Stanton PK, 2003, J NEUROSCI, V23, P5936; Steinhauser C, 1996, TRENDS NEUROSCI, V19, P339, DOI 10.1016/0166-2236(96)10043-6; Stricker C, 2003, J NEUROSCI METH, V130, P159, DOI 10.1016/j.jneumeth.2003.09.021; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; Taschenberger H, 2005, J PHYSIOL-LONDON, V568, P513, DOI 10.1113/jphysiol.2005.093468; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; VANDERKLOOT W, 1988, J PHYSIOL-LONDON, V402, P595, DOI 10.1113/jphysiol.1988.sp017224; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; Zhen M, 2004, CURR OPIN NEUROBIOL, V14, P280, DOI 10.1016/j.conb.2004.05.013	50	342	348	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					311	320		10.1038/nn1850	http://dx.doi.org/10.1038/nn1850			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17293860				2022-12-17	WOS:000244480300013
J	Virginio, C; MacKenzie, A; Rassendren, FA; North, RA; Surprenant, A				Virginio, C; MacKenzie, A; Rassendren, FA; North, RA; Surprenant, A			Pore dilation of neuronal P2X receptor channels	NATURE NEUROSCIENCE			English	Article							GATED ION CHANNELS; ATP RECEPTOR; P-2X RECEPTOR; EXTRACELLULAR ATP; SENSORY NEURONS; PATCH-CLAMP; PURINOCEPTOR; RELEASE; NODOSE; CELLS	P2X receptors are ligand-gated ion channels activated by the binding of extracellular adenosine 5'-triphosphate (ATP). Brief (< 1 s) applications of ATP to nodose ganglion neurons or to cells transfected with P2X(2) or P2X(4) receptor cDNAs induce the opening of a channel selectively permeable to small cations within milliseconds. We now show that, during longer ATP application (10-60 s), the channel also becomes permeable to much larger cations such as N-methyl-D-glucamine and the propidium analog YO-PRO-1. This effect is enhanced in P2X(2) receptors carrying point mutations in the second transmembrane segment. Progressive dilation of the ion-conducting pathway during prolonged activation reveals a mechanism by which ionotropic receptors may alter neuronal function.	Univ Sheffield, Inst Mol Physiol, Sheffield S10 2TN, S Yorkshire, England; GlaxoWellcome, Geneva Biomed Res Inst, Geneva, Switzerland	University of Sheffield; GlaxoSmithKline	Surprenant, A (corresponding author), Univ Sheffield, Inst Mol Physiol, Sheffield S10 2TN, S Yorkshire, England.		North, Richard/GQA-6156-2022; Rassendren, Francois/AAA-6190-2021	Rassendren, Francois/0000-0003-3320-2461				BENHAM CD, 1987, NATURE, V328, P275, DOI 10.1038/328275a0; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Brandle U, 1997, FEBS LETT, V404, P294, DOI 10.1016/S0014-5793(97)00128-2; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; CLEMENTS JD, 1993, AXOBITS, V14, P9; Collo G, 1997, NEUROPHARMACOLOGY, V36, P1277, DOI 10.1016/S0028-3908(97)00140-8; Collo G, 1996, J NEUROSCI, V16, P2495; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; Egan TM, 1998, J NEUROSCI, V18, P2350; EVANS RJ, 1992, BRIT J PHARMACOL, V106, P242, DOI 10.1111/j.1476-5381.1992.tb14323.x; EVANS RJ, 1995, MOL PHARMACOL, V48, P178; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; EVANS RJ, 1992, NATURE, V357, P503, DOI 10.1038/357503a0; Evans RJ, 1996, SEMIN NEUROSCI, V8, P217, DOI 10.1006/smns.1996.0028; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; GarciaGuzman M, 1997, MOL PHARMACOL, V51, P109, DOI 10.1124/mol.51.1.109; GILL CH, 1995, BRIT J PHARMACOL, V114, P1211, DOI 10.1111/j.1476-5381.1995.tb13335.x; Gu JGG, 1997, NATURE, V389, P749, DOI 10.1038/39639; HARDEN TK, 1998, P2 NUCLEOTIDE RECEPT, P109; Humphreys BD, 1998, MOL PHARMACOL, V54, P22, DOI 10.1124/mol.54.1.22; KHAKH BS, 1995, J PHYSIOL-LONDON, V484, P385, DOI 10.1113/jphysiol.1995.sp020672; Khakh BS, 1998, MOL PHARMACOL, V54, P372, DOI 10.1124/mol.54.2.372; Le KT, 1998, NEUROSCIENCE, V83, P177, DOI 10.1016/S0306-4522(97)00365-5; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Li CY, 1998, BRIT J PHARMACOL, V123, P1, DOI 10.1038/sj.bjp.0701599; Li CY, 1997, J NEUROPHYSIOL, V77, P3391, DOI 10.1152/jn.1997.77.6.3391; NEHER E, 1992, METHOD ENZYMOL, V207, P123; North RA, 1996, SEMIN NEUROSCI, V8, P187; North RA, 1997, CURR OPIN NEUROBIOL, V7, P346, DOI 10.1016/S0959-4388(97)80062-1; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Simon J, 1997, MOL PHARMACOL, V52, P237, DOI 10.1124/mol.52.2.237; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; TIAIRI A, IN PRESS BIOCHEMISTR; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Virginio C, 1998, J PHYSIOL-LONDON, V510, P27, DOI 10.1111/j.1469-7793.1998.027bz.x	37	342	344	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					315	321		10.1038/7225	http://dx.doi.org/10.1038/7225			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200GV	10204537				2022-12-17	WOS:000080532000009
J	Vialou, V; Robison, AJ; LaPlant, QC; Covington, HE; Dietz, DM; Ohnishi, YN; Mouzon, E; Rush, AJ; Watts, EL; Wallace, DL; Iniguez, SD; Ohnishi, YH; Steiner, MA; Warren, BL; Krishnan, V; Bolanos, CA; Neve, RL; Ghose, S; Berton, O; Tamminga, CA; Nestler, EJ				Vialou, Vincent; Robison, Alfred J.; LaPlant, Quincey C.; Covington, Herbert E., III; Dietz, David M.; Ohnishi, Yoshinori N.; Mouzon, Ezekiell; Rush, Augustus J., III; Watts, Emily L.; Wallace, Deanna L.; Iniguez, Sergio D.; Ohnishi, Yoko H.; Steiner, Michel A.; Warren, Brandon L.; Krishnan, Vaishnav; Bolanos, Carlos A.; Neve, Rachael L.; Ghose, Subroto; Berton, Olivier; Tamminga, Carol A.; Nestler, Eric J.			Delta FosB in brain reward circuits mediates resilience to stress and antidepressant responses	NATURE NEUROSCIENCE			English	Article							SOCIAL DEFEAT STRESS; NUCLEUS-ACCUMBENS NEURONS; VENTRAL TEGMENTAL AREA; CHROMATIN REGULATION; EXCITATORY SYNAPSES; SYNAPTIC PLASTICITY; BEHAVIORAL DEFICITS; GENE-EXPRESSION; AMPA RECEPTORS; MESSENGER-RNA	In contrast with the many studies of stress effects on the brain, relatively little is known about the molecular mechanisms of resilience, the ability of some individuals to escape the deleterious effects of stress. We found that the transcription factor Delta FosB mediates an essential mechanism of resilience in mice. Induction of Delta FosB in the nucleus accumbens, an important brain reward-associated region, in response to chronic social defeat stress was both necessary and sufficient for resilience. Delta FosB induction was also required for the standard antidepressant fluoxetine to reverse behavioral pathology induced by social defeat. Delta FosB produced these effects through induction of the GluR2 AMPA glutamate receptor subunit, which decreased the responsiveness of nucleus accumbens neurons to glutamate, and through other synaptic proteins. Together, these findings establish a previously unknown molecular pathway underlying both resilience and antidepressant action.	[Vialou, Vincent; Robison, Alfred J.; LaPlant, Quincey C.; Covington, Herbert E., III; Dietz, David M.; Ohnishi, Yoshinori N.; Mouzon, Ezekiell; Watts, Emily L.; Ohnishi, Yoko H.; Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA; [Rush, Augustus J., III; Wallace, Deanna L.; Krishnan, Vaishnav; Ghose, Subroto; Berton, Olivier; Tamminga, Carol A.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Rush, Augustus J., III; Wallace, Deanna L.; Krishnan, Vaishnav; Ghose, Subroto; Berton, Olivier; Tamminga, Carol A.] Univ Texas SW Med Ctr Dallas, Ctr Basic Neurosci, Dallas, TX 75390 USA; [Iniguez, Sergio D.; Warren, Brandon L.; Bolanos, Carlos A.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Steiner, Michel A.] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Neve, Rachael L.] MIT, Cambridge, MA 02139 USA	Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; State University System of Florida; Florida State University; Max Planck Society; Massachusetts Institute of Technology (MIT)	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA.	eric.nestler@mssm.edu	Yan, Shuo/B-8381-2009; Robison, Alfred J/P-8521-2018; Dietz, David/J-9458-2015; Ghose, Subroto/J-6732-2016; vialou, vincent/F-2968-2013; Iniguez, Sergio D/J-2410-2015; Dietz, David/AAW-4574-2021	Robison, Alfred J/0000-0002-4150-9570; Dietz, David/0000-0002-6927-9236; vialou, vincent/0000-0002-8212-751X; Iniguez, Sergio D/0000-0001-5748-4219; Dietz, David/0000-0002-6927-9236; Krishnan, Vaishnav/0000-0002-2847-0069	National Institute of Mental Health; AstraZeneca; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051399, P50MH066172] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AstraZeneca(AstraZeneca); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Institute of Mental Health and by a research alliance with AstraZeneca. We thank P. McKinnon and H. Russell for the SC1 cDNA; and I. Maze, R. Oosting, S. Gautron and D. Vialou for discussion and comments on the manuscript.	Anderson SM, 2008, NAT NEUROSCI, V11, P344, DOI 10.1038/nn2054; Becker C, 2001, J NEUROSCI, V21, P262, DOI 10.1523/JNEUROSCI.21-01-00262.2001; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Campioni MR, 2009, J NEUROPHYSIOL, V101, P3192, DOI 10.1152/jn.91111.2008; Chen JS, 1998, MOL PHARMACOL, V54, P495, DOI 10.1124/mol.54.3.495; Churchill L, 1999, J NEUROCHEM, V72, P2397, DOI 10.1046/j.1471-4159.1999.0722397.x; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; De Kloet ER, 2004, ANN NY ACAD SCI, V1018, P1, DOI 10.1196/annals.1296.001; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; HANEY M, 1995, BRAIN RES, V698, P46, DOI 10.1016/0006-8993(95)00788-R; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Kollack-Walker S, 1999, J NEUROENDOCRINOL, V11, P547; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Koolhaas JM, 1997, NEUROSCI BIOBEHAV R, V21, P775, DOI 10.1016/S0149-7634(96)00057-7; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lively S, 2008, J NEUROSCI RES, V86, P2895, DOI 10.1002/jnr.21735; Martinez M, 2002, STRESS, V5, P3, DOI 10.1080/102538902900012369; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Nestler EJ, 2008, PHILOS T R SOC B, V363, P3245, DOI 10.1098/rstb.2008.0067; Nikulina EM, 2008, EUR J NEUROSCI, V27, P2272, DOI 10.1111/j.1460-9568.2008.06176.x; Nikulina EM, 2004, NEUROSCIENCE, V123, P857, DOI 10.1016/j.neuroscience.2003.10.029; Peakman MC, 2003, BRAIN RES, V970, P73, DOI 10.1016/S0006-8993(03)02230-3; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Rada P, 2003, NEUROSCIENCE, V119, P557, DOI 10.1016/S0306-4522(03)00162-3; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Reynolds SM, 2003, EUR J NEUROSCI, V17, P2187, DOI 10.1046/j.1460-9568.2003.02642.x; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Rygula R, 2005, BEHAV BRAIN RES, V162, P127, DOI 10.1016/j.bbr.2005.03.009; Rygula R, 2006, BEHAV BRAIN RES, V174, P188, DOI 10.1016/j.bbr.2006.07.017; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Taha SA, 2006, J NEUROSCI, V26, P217, DOI 10.1523/JNEUROSCI.3227-05.2006; Tidey JW, 1997, PSYCHOPHARMACOLOGY, V130, P203, DOI 10.1007/s002130050230; Todtenkopf MS, 2006, J NEUROSCI, V26, P11665, DOI 10.1523/JNEUROSCI.3070-06.2006; TORNATZKY W, 1993, PHYSIOL BEHAV, V53, P983, DOI 10.1016/0031-9384(93)90278-N; Tremblay LK, 2005, ARCH GEN PSYCHIAT, V62, P1228, DOI 10.1001/archpsyc.62.11.1228; Vythilingam M, 2009, PSYCHIAT RES-NEUROIM, V172, P75, DOI 10.1016/j.pscychresns.2008.06.008; Wallace DL, 2009, NAT NEUROSCI, V12, P200, DOI 10.1038/nn.2257; Wilkinson MB, 2009, J NEUROSCI, V29, P7820, DOI 10.1523/JNEUROSCI.0932-09.2009; Yehuda R, 2006, ANN NY ACAD SCI, V1071, P379, DOI 10.1196/annals.1364.028	50	341	346	3	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					745	U126		10.1038/nn.2551	http://dx.doi.org/10.1038/nn.2551			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20473292	Green Accepted			2022-12-17	WOS:000278003300020
J	Meyer-Lindenberg, A; Kohn, PD; Kolachana, B; Kippenhan, S; McInerney-Leo, A; Nussbaum, R; Weinberger, DR; Berman, KF				Meyer-Lindenberg, A; Kohn, PD; Kolachana, B; Kippenhan, S; McInerney-Leo, A; Nussbaum, R; Weinberger, DR; Berman, KF			Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; MESSENGER-RNA; SCHIZOPHRENIA; EXPRESSION; SYSTEMS; CORTEX; MEMORY	Using multimodal neuroimaging in humans, we demonstrate specific interactions between prefrontal activity and midbrain dopaminergic synthesis. A common V(108/158)M substitution in the gene for catecholamine-O-methyltransferase (COMT), an important enzyme regulating prefrontal dopamine turnover, predicted reduced dopamine synthesis in midbrain and qualitatively affected the interaction with prefrontal cortex. These data implicate a dopaminergic tuning mechanism in prefrontal cortex and suggest a systems-level mechanism for cognitive and neuropsychiatric associations with COMT.	NIMH, Sect Integrat Neuroimaging, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; NHGRI, Genet Dis Res Branch, NIH, DHHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Meyer-Lindenberg, A (corresponding author), NIMH, Sect Integrat Neuroimaging, NIH, Dept Hlth & Human Serv, 9000 Rockville Pike, Bethesda, MD 20892 USA.	andreasml@nih.gov	McInerney-Leo, Aideen M/D-8302-2016; McInerney-Leo, Aideen M/E-1788-2018; Meyer-Lindenberg, Andreas/H-1076-2011	McInerney-Leo, Aideen M/0000-0002-0059-5732; Meyer-Lindenberg, Andreas/0000-0001-5619-1123	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002717, ZIAMH002716, Z01MH002717, Z01MH002716, Z01MH002867] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akil M, 2003, J NEUROSCI, V23, P2008; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; GJEDDE A, 1991, P NATL ACAD SCI USA, V88, P2721, DOI 10.1073/pnas.88.7.2721; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; GRACE AA, 1993, J NEURAL TRANSM-GEN, V91, P111, DOI 10.1007/BF01245228; Matsumoto M, 2003, NEUROSCIENCE, V116, P127, DOI 10.1016/S0306-4522(02)00556-0; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; MEADORWOODRUFF JH, 1994, P NATL ACAD SCI USA, V91, P8297, DOI 10.1073/pnas.91.17.8297; Meyer-Lindenberg A, 2002, NAT NEUROSCI, V5, P267, DOI 10.1038/nn804; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Sesack SR, 2003, ANN NY ACAD SCI, V1003, P36, DOI 10.1196/annals.1300.066; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0	15	341	349	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					594	596		10.1038/nn1438	http://dx.doi.org/10.1038/nn1438			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15821730				2022-12-17	WOS:000228895100019
J	Platt, ML; Huettel, SA				Platt, Michael L.; Huettel, Scott A.			Risky business: the neuroeconomics of decision making under uncertainty	NATURE NEUROSCIENCE			English	Review							NEURAL BASIS; PROSPECT-THEORY; REWARD; DOPAMINE; PREFERENCES; ACTIVATION; PARIETAL; CORTEX; GAINS; PREDICTION	Many decisions involve uncertainty, or imperfect knowledge about how choices lead to outcomes. Colloquial notions of uncertainty, particularly when describing a decision as 'risky', often carry connotations of potential danger as well. Gambling on a long shot, whether a horse at the racetrack or a foreign oil company in a hedge fund, can have negative consequences, but the impact of uncertainty on decision making extends beyond gambling. Indeed, uncertainty in some form pervades nearly all our choices in daily life. Stepping into traffic to hail a cab, braving an ice storm to be the first at work, or dating the boss's son or daughter also offer potentially great windfalls, at the expense of surety. We continually face trade-offs between options that promise safety and others that offer an uncertain potential for jackpot or bust. When mechanisms for dealing with uncertain outcomes fail, as in mental disorders such as problem gambling or addiction, the results can be disastrous. Thus, understanding decision making-indeed, understanding behavior itself-requires knowing how the brain responds to and uses information about uncertainty.	[Platt, Michael L.; Huettel, Scott A.] Duke Univ, Ctr Neuroecon Studies, Durham, NC 27708 USA	Duke University	Platt, ML (corresponding author), Duke Univ, Ctr Neuroecon Studies, Room B243F LSRC Bldg, Durham, NC 27708 USA.	platt@neuro.duke.edu			NATIONAL EYE INSTITUTE [R01EY013496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070685, R01MH071817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS041328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG030771] Funding Source: NIH RePORTER; NEI NIH HHS [EY-13496, R01 EY013496, R01 EY013496-07] Funding Source: Medline; NIA NIH HHS [R21 AG030771, R21 AG030771-02] Funding Source: Medline; NIMH NIH HHS [R01 MH070685, MH-070685, R01 MH071817, MH-71817] Funding Source: Medline; NINDS NIH HHS [P01 NS041328-080003, P01 NS041328] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Azim E, 2005, P NATL ACAD SCI USA, V102, P16496, DOI 10.1073/pnas.0408456102; Bateson M, 1997, ANIM BEHAV, V53, P1129, DOI 10.1006/anbe.1996.0388; BERNOULLI D, 2005, COMMENTARII ACAD SCI, V5, P175; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Bontempo RN, 1997, RISK ANAL, V17, P479, DOI 10.1111/j.1539-6924.1997.tb00888.x; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; CAMERER C, 1992, J RISK UNCERTAINTY, V5, P325, DOI 10.1007/BF00122575; Camerer C.F., 1981, CHOICES VALUES FRAME, P288; CARACO T, 1981, BEHAV ECOL SOCIOBIOL, V8, P213, DOI 10.1007/BF00299833; Cardinal RN, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-37; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Dean HL, 2004, J NEUROPHYSIOL, V92, P3056, DOI 10.1152/jn.00691.2003; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Dodd ML, 2005, ARCH NEUROL-CHICAGO, V62, P1377, DOI 10.1001/archneur.62.9.noc50009; Driver-Dunckley E, 2003, NEUROLOGY, V61, P422, DOI 10.1212/01.WNL.0000076478.45005.EC; Elliott R, 1998, NEUROIMAGE, V8, P17, DOI 10.1006/nimg.1998.0344; ELLSBERG D, 1961, Q J ECON, V75, P643, DOI 10.2307/1884324; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fiorillo CD, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-7; Ghirardato P, 2004, J ECON THEORY, V118, P133, DOI 10.1016/j.jet.2003.12.004; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Gilby IC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1771, DOI 10.1007/s00265-007-0410-6; Hayden BY, 2007, CURR BIOL, V17, P49, DOI 10.1016/j.cub.2006.10.055; Hsee CK, 1999, J BEHAV DECIS MAKING, V12, P165, DOI 10.1002/(SICI)1099-0771(199906)12:2<165::AID-BDM316>3.0.CO;2-N; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kacelnik A, 1996, AM ZOOL, V36, P402; Kacelnik A, 1997, Ciba Found Symp, V208, P51; KACELNIK A, 1997, CIBA F SYMP, V208, P67; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kalenscher T, 2007, CURR BIOL, V17, pR58, DOI 10.1016/j.cub.2006.12.016; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Lohrenz T, 2007, P NATL ACAD SCI USA, V104, P9493, DOI 10.1073/pnas.0608842104; MacCrimmon KR., 1986, TAKING RISKS MANAGEM; Mazur J.E., 1987, QUANTITATIVE ANAL BE, V5, P55; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; MCNAMARA JM, 1986, AM NAT, V127, P358, DOI 10.1086/284489; Meyer G, 2000, BIOL PSYCHIAT, V48, P948, DOI 10.1016/S0006-3223(00)00888-X; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Niv Y, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-6; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Olson CR, 1996, J NEUROPHYSIOL, V76, P3285, DOI 10.1152/jn.1996.76.5.3285; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Paulus MP, 2001, NEUROIMAGE, V13, P91, DOI 10.1006/nimg.2000.0667; PAULUS MP, 2007, BIOL PSYCHIAT, DOI DOI 10.1016/J.BI0PSYCH.2007.09.007); POST T, IN PRESS AM EC REV; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Rachlin H, 2000, SCI SELF CONTROL; Rustichini A, 2005, GAME ECON BEHAV, V52, P257, DOI 10.1016/j.geb.2004.08.005; Samuelson PA, 1948, ECONOMICA-NEW SER, V15, P243, DOI 10.2307/2549561; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schubotz RI, 2002, NEUROIMAGE, V16, P920, DOI 10.1006/nimg.2002.1183; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Seymour B, 2007, J NEUROSCI, V27, P4826, DOI 10.1523/JNEUROSCI.0400-07.2007; SLOVIC P, 1964, PSYCHOL BULL, V61, P220, DOI 10.1037/h0043608; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Smith K, 2002, MANAGE SCI, V48, P711, DOI 10.1287/mnsc.48.6.711.194; Stephens D.W., 1986, pi; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; TVERSKY A, 1995, PSYCHOL REV, V102, P269, DOI 10.1037/0033-295X.102.2.269; Venkatraman V, 2007, SLEEP, V30, P603, DOI 10.1093/sleep/30.5.603; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Volz KG, 2004, NEUROIMAGE, V21, P848, DOI 10.1016/j.neuroimage.2003.10.028; Volz KG, 2003, NEUROIMAGE, V19, P271, DOI 10.1016/S1053-8119(03)00122-8; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414	81	340	342	3	121	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					398	403		10.1038/nn2062	http://dx.doi.org/10.1038/nn2062			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	279MM	18368046	Green Accepted			2022-12-17	WOS:000254359300008
J	Di Castro, MA; Chuquet, J; Liaudet, N; Bhaukaurally, K; Santello, M; Bouvier, D; Tiret, P; Volterra, A				Di Castro, Maria Amalia; Chuquet, Julien; Liaudet, Nicolas; Bhaukaurally, Khaleel; Santello, Mirko; Bouvier, David; Tiret, Pascale; Volterra, Andrea			Local Ca2+ detection and modulation of synaptic release by astrocytes	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; IN-SITU; HIPPOCAMPAL ASTROCYTES; POSTSYNAPTIC CURRENTS; GLUTAMATE EXOCYTOSIS; DENDRITIC SPINES; GRANULE CELLS; PLASTICITY; STIMULATION; TRANSMISSION	Astrocytes communicate with synapses by means of intracellular calcium ([Ca2+](i)) elevations, but local calcium dynamics in astrocytic processes have never been thoroughly investigated. By taking advantage of high-resolution two-photon microscopy, we identify the characteristics of local astrocyte calcium activity in the adult mouse hippocampus. Astrocytic processes showed intense activity, triggered by physiological transmission at neighboring synapses. They encoded synchronous synaptic events generated by sparse action potentials into robust regional (similar to 12 mu m) [Ca2+](i) elevations. Unexpectedly, they also sensed spontaneous synaptic events, producing highly confined (similar to 4 mu m), fast (millisecond-scale) miniature Ca2+ responses. This Ca2+ activity in astrocytic processes is generated through GTP- and inositol-1,4,5-trisphosphate-dependent signaling and is relevant for basal synaptic function. Thus, buffering astrocyte [Ca2+](i) or blocking a receptor mediating local astrocyte Ca2+ signals decreased synaptic transmission reliability in minimal stimulation experiments. These data provide direct evidence that astrocytes are integrated in local synaptic functioning in adult brain.	[Di Castro, Maria Amalia; Chuquet, Julien; Liaudet, Nicolas; Bhaukaurally, Khaleel; Santello, Mirko; Bouvier, David; Tiret, Pascale; Volterra, Andrea] Univ Lausanne, Dept Cell Biol & Morphol, Lausanne, Switzerland	University of Lausanne	Volterra, A (corresponding author), Univ Lausanne, Dept Cell Biol & Morphol, Lausanne, Switzerland.	andrea.volterra@unil.ch	Di Castro, Maria Amalia/AGY-9938-2022; Santello, Mirko/F-9007-2014; Chuquet, Julien/AAH-1615-2021; Bouvier, David S./E-3999-2014	Di Castro, Maria Amalia/0000-0001-7480-1087; Santello, Mirko/0000-0002-7709-4127; Bouvier, David S./0000-0002-8630-1044; Volterra, Andrea/0000-0003-1069-1602; Liaudet, Nicolas/0000-0002-0749-5857	Swiss National Science Foundation [3100A0-100850, 3100A0-120398]; MBF Foundation, Triesen; LI/Synapsis Foundation, Zurich; Swiss National Science Foundation National Center of Competence in Research; University of Lausanne Faculty of Biology and Medicine	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); MBF Foundation, Triesen; LI/Synapsis Foundation, Zurich; Swiss National Science Foundation National Center of Competence in Research; University of Lausanne Faculty of Biology and Medicine	We thank P. Bezzi for experiments in cultured astrocytes and critical comments, K. D. McCarthy (University of North Carolina, Chapel Hill) and P. G. Haydon (Tufts University) for providing Itpr2<SUP>-/-</SUP> mice, H. Kettenmann (Max Delbruck Center) for providing GFAP-EGFP mice, V. Crunelli, R. Schneggenburger and F. Helmchen for suggestions, and T. Oertner for critical reading of a previous manuscript version. This work was supported by grants from Swiss National Science Foundation (3100A0-100850 and 3100A0-120398) to A. V.; J.C. received a postdoctoral fellowship from MBF Foundation, Triesen, LI/Synapsis Foundation, Zurich; P. T., from Swiss National Science Foundation National Center of Competence in Research 'Synapsy'. M. S. received a University of Lausanne Faculty of Biology and Medicine PhD fellowship.	Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; BERGERSEN LH, CEREB CORTE IN PRESS; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Chao TI, 2002, TRIPARTITE SYNAPSE G, P3; Colonnese MT, 2005, J NEUROSCI, V25, P1291, DOI 10.1523/JNEUROSCI.4063-04.2005; Doengi M, 2009, P NATL ACAD SCI USA, V106, P17570, DOI 10.1073/pnas.0809513106; Domercq M, 2006, J BIOL CHEM, V281, P30684, DOI 10.1074/jbc.M606429200; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Golovina VA, 2005, J PHYSIOL-LONDON, V564, P737, DOI 10.1113/jphysiol.2005.085035; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Ikeda K, 2009, P NATL ACAD SCI USA, V106, P2945, DOI 10.1073/pnas.0811017106; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Liu YB, 1996, J NEUROPHYSIOL, V76, P1074, DOI 10.1152/jn.1996.76.2.1074; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Matyash V, 2001, MOL CELL NEUROSCI, V18, P664, DOI 10.1006/mcne.2001.1047; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Min MY, 1998, P NATL ACAD SCI USA, V95, P4702, DOI 10.1073/pnas.95.8.4702; Mori M, 2001, J PHYSIOL-LONDON, V535, P115, DOI 10.1111/j.1469-7793.2001.t01-1-00115.x; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Nolte C, 2001, GLIA, V33, P72; Palygin O, 2010, CELL CALCIUM, V48, P225, DOI 10.1016/j.ceca.2010.09.004; Pankratov Y, 2007, J GEN PHYSIOL, V129, P257, DOI 10.1085/jgp.200609693; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Soler-Llavina GJ, 2006, NAT NEUROSCI, V9, P798, DOI 10.1038/nn1698; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Trommald M, 1997, J COMP NEUROL, V377, P15, DOI 10.1002/(SICI)1096-9861(19970106)377:1<15::AID-CNE3>3.0.CO;2-M; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Wang SY, 2003, CELL SIGNAL, V15, P151, DOI 10.1016/S0898-6568(02)00085-2; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Witcher MR, 2007, GLIA, V55, P13, DOI 10.1002/glia.20415; Wu JQ, 2001, J PHYSIOL-LONDON, V533, P745, DOI 10.1111/j.1469-7793.2001.t01-1-00745.x; YASUDA R, 2004, SCI STKE, V219, P15, DOI DOI 10.1126/STKE.2192004P15; Zhou M, 2006, J NEUROPHYSIOL, V95, P134, DOI 10.1152/jn.00570.2005; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	50	339	339	0	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1276	U87		10.1038/nn.2929	http://dx.doi.org/10.1038/nn.2929			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21909085				2022-12-17	WOS:000295254200016
J	Li, W; Piech, V; Gilbert, CD				Li, W; Piech, V; Gilbert, CD			Perceptual learning and top-down influences in primary visual cortex	NATURE NEUROSCIENCE			English	Article							PRIMARY AUDITORY-CORTEX; ORIENTATION DISCRIMINATION; RECEPTIVE-FIELD; VERNIER ACUITY; ATTENTION; V1; IMPROVEMENT; NEURONS; REPRESENTATION; MECHANISMS	Neuronal responses at early stages in visual cortical processing, including those in primary visual cortex (V1), are subject to the influences of visual context, experience and attention. Here we show that for monkeys trained in a shape discrimination task, V1 neurons took on novel functional properties related to the attributes of the trained shapes. Furthermore, these properties depended on the perceptual task being performed; neurons responded very differently to an identical visual stimulus under different visual discrimination tasks. These top-down influences were seen from the very beginning and throughout the entire time course of the neural responses. Information theoretic analysis showed that neurons carried more information about a stimulus attribute when the animals were performing a task related to that attribute. Our findings suggest that the output from V1 reflects both sensory and behavioral context.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Gilbert, CD (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	gilbert@rockefeller.edu	Li, Wu/AHA-4320-2022; Li, Wu/G-9415-2011	Li, Wu/0000-0002-2175-4579	NEI NIH HHS [EY07968, R01 EY007968] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007968] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BALL K, 1982, SCIENCE, V218, P697, DOI 10.1126/science.7134968; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; Crist RE, 1997, J NEUROPHYSIOL, V78, P2889, DOI 10.1152/jn.1997.78.6.2889; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; FENDICK M, 1983, VISION RES, V23, P145, DOI 10.1016/0042-6989(83)90137-2; Finney DJ, 1952, PROBIT ANAL STAT TRE; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; LAMME VAF, 1995, J NEUROSCI, V15, P1605; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; Li W, 2000, J NEUROPHYSIOL, V83, P941, DOI 10.1152/jn.2000.83.2.941; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MCKEE SP, 1978, PERCEPT PSYCHOPHYS, V24, P258, DOI 10.3758/BF03206097; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; NELSON JI, 1978, BRAIN RES, V139, P359, DOI 10.1016/0006-8993(78)90937-X; Panzeri S, 1996, NETWORK-COMP NEURAL, V7, P87, DOI [10.1088/0954-898X/7/1/006, 10.1080/0954898X.1996.11978656]; POGGIO GF, 1995, CEREB CORTEX, V5, P193, DOI 10.1093/cercor/5.3.193; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; RAMACHANDRAN VS, 1973, PERCEPTION, V2, P371, DOI 10.1068/p020371; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; SAARINEN J, 1995, VISION RES, V35, P519, DOI 10.1016/0042-6989(94)00141-8; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; Sigman M, 2000, NAT NEUROSCI, V3, P264, DOI 10.1038/72979; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; VOGELS R, 1985, VISION RES, V25, P1679, DOI 10.1016/0042-6989(85)90140-3; Weinberger NM, 1998, AUDIOL NEURO-OTOL, V3, P145, DOI 10.1159/000013787	43	339	347	4	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					651	657		10.1038/nn1255	http://dx.doi.org/10.1038/nn1255			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15156149	Green Accepted			2022-12-17	WOS:000221640300020
J	Lee, DK; Itti, L; Koch, C; Braun, J				Lee, DK; Itti, L; Koch, C; Braun, J			Attention activates winner-take-all competition among visual filters	NATURE NEUROSCIENCE			English	Article							CONTRAST DISCRIMINATION; SELECTIVE ATTENTION; HUMAN-VISION; SPATIAL-FREQUENCY; SIMPLE CELLS; AREAS V1; CORTEX; MECHANISMS; SEARCH; MODEL	Shifting attention away from a visual stimulus reduces, but does not abolish, visual discrimination performance. This residual vision with 'poor' attention can be compared to normal vision with 'full' attention to reveal how attention alters visual perception. We report large differences between residual and normal visual thresholds for discriminating the orientation or spatial frequency of simple patterns, and smaller differences for discriminating contrast. A computational model, in which attention activates a winner-take-all competition among overlapping visual filters, quantitatively accounts for all observations. Our model predicts that the effects of attention on visual cortical neurons include increased contrast gain as well as sharper tuning to orientation and spatial frequency.	CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Braun, J (corresponding author), CALTECH, Pasadena, CA 91125 USA.		Braun, Jochen/F-1370-2013	Braun, Jochen/0000-0002-8886-078X; Koch, Christof/0000-0001-6482-8067				BONNEL AM, 1994, PERCEPT PSYCHOPHYS, V55, P162, DOI 10.3758/BF03211664; BOWNE SF, 1990, VISION RES, V30, P449, DOI 10.1016/0042-6989(90)90086-Z; BRAUN J, 1994, J NEUROSCI, V14, P554; Braun J, 1998, NATURE, V393, P424, DOI 10.1038/30875; Braun J, 1998, PERCEPT PSYCHOPHYS, V60, P1, DOI 10.3758/BF03211915; BRAUN J, 1990, PERCEPT PSYCHOPHYS, V48, P45, DOI 10.3758/BF03205010; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carandini M, 1997, J NEUROSCI, V17, P8621; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; DeValois RL, 1988, SPATIAL VISION; DOSHER BA, 1998, HDB PERCEPTION COGNI, P201; DUNCAN J, 1994, NATURE, V369, P313, DOI 10.1038/369313a0; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; Foley JM, 1998, J OPT SOC AM A, V15, P1036, DOI 10.1364/JOSAA.15.001036; FOLEY JM, 1994, J OPT SOC AM A, V11, P1710, DOI 10.1364/JOSAA.11.001710; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; ITTI L, 1997, ADV NEURAL INFORMATI, V9, P173; Lee DK, 1997, VISION RES, V37, P2409, DOI 10.1016/S0042-6989(97)00055-2; LEE DK, IN PRESS PERCEPT PSY, V61; LEGGE GE, 1980, J OPT SOC AM, V70, P1458, DOI 10.1364/JOSA.70.001458; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Morgan MJ, 1998, Q J EXP PSYCHOL-A, V51, P347, DOI 10.1080/713755766; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; MUELLER HJ, 1987, PERCEPT PSYCHOPHYS, V42, P383; NACHMIAS J, 1974, VISION RES, V14, P1039, DOI 10.1016/0042-6989(74)90175-8; Niebur E, 1994, J Comput Neurosci, V1, P141, DOI 10.1007/BF00962722; PALMER J, 1995, CURR DIR PSYCHOL SCI, V4, P118, DOI 10.1111/1467-8721.ep10772534; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Pashler H., 1997, PSYCHOL ATTENTION; Pouget A, 1998, NEURAL COMPUT, V10, P373, DOI 10.1162/089976698300017809; Press W. H., 2007, NUMERICAL RECIPES C, V3rd; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Solomon JA, 1997, J OPT SOC AM A, V14, P2443, DOI 10.1364/JOSAA.14.002443; SOMERS DC, 1995, J NEUROSCI, V15, P5448; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; TREISMAN A, 1988, PSYCHOL REV, V12, P97; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; TSOTSOS JK, 1995, ARTIF INTELL, V78, P507, DOI 10.1016/0004-3702(95)00025-9; Tyler CW, 1997, SPATIAL VISION, V10, P369, DOI 10.1163/156856897X00294; Wilson H. R., 1990, VISUAL PERCEPTION NE, P231, DOI DOI 10.1016/B978-0-12-657675-7.50016-8; WILSON HR, 1980, BIOL CYBERN, V38, P171, DOI 10.1007/BF00337406; WILSON HR, 1993, VISION RES, V33, P1133, DOI 10.1016/0042-6989(93)90248-U; Wilson HR, 1997, PERCEPTION, V26, P939, DOI 10.1068/p260939; Yeshurun Y, 1999, VISION RES, V39, P293, DOI 10.1016/S0042-6989(98)00114-X; Zenger B, 1996, VISION RES, V36, P2497, DOI 10.1016/0042-6989(95)00303-7	50	339	353	0	25	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					375	381		10.1038/7286	http://dx.doi.org/10.1038/7286			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	200GV	10204546				2022-12-17	WOS:000080532000018
J	Noseda, R; Kainz, V; Jakubowski, M; Gooley, JJ; Saper, CB; Digre, K; Burstein, R				Noseda, Rodrigo; Kainz, Vanessa; Jakubowski, Moshe; Gooley, Joshua J.; Saper, Clifford B.; Digre, Kathleen; Burstein, Rami			A neural mechanism for exacerbation of headache by light	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; CUTANEOUS ALLODYNIA; NOCICEPTIVE NEURONS; NON-CONE; NON-ROD; MELANOPSIN; STIMULATION; MIGRAINE; CORTEX; PROJECTIONS	The perception of migraine headache, which is mediated by nociceptive signals transmitted from the cranial dura mater to the brain, is uniquely exacerbated by exposure to light. We found that exacerbation of migraine headache by light is prevalent among blind individuals who maintain non-image-forming photoregulation in the face of massive rod/cone degeneration. Using single-unit recording and neural tract tracing in the rat, we identified dura-sensitive neurons in the posterior thalamus whose activity was distinctly modulated by light and whose axons projected extensively across layers I-V of somatosensory, visual and associative cortices. The cell bodies and dendrites of such dura/light-sensitive neurons were apposed by axons originating from retinal ganglion cells (RGCs), predominantly from intrinsically photosensitive RGCs, the principle conduit of non-image-forming photoregulation. We propose that photoregulation of migraine headache is exerted by a non-image-forming retinal pathway that modulates the activity of dura-sensitive thalamocortical neurons.	[Noseda, Rodrigo; Kainz, Vanessa; Jakubowski, Moshe; Burstein, Rami] Harvard Univ, Sch Med, Dept Anesthesia, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Gooley, Joshua J.; Saper, Clifford B.] Harvard Univ, Sch Med, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Saper, Clifford B.; Burstein, Rami] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Digre, Kathleen] Univ Utah, Moran Eye Ctr, Dept Neurol & Ophthalmol, Salt Lake City, UT USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah	Burstein, R (corresponding author), Harvard Univ, Sch Med, Dept Anesthesia, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	rburstei@bidmc.harvard.edu	Noseda, Rodrigo/AAN-1761-2020	Noseda, Rodrigo/0000-0002-9641-4691; Jakubowski, Moshe/0000-0001-5245-1258	US National Institutes of Health [NS-051484, NS-035611]; Research to Prevent Blindness; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033987, P01NS035611, R01NS051484] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Friedman, A. Recober, M. Carmen-Wilson and A. Mauskop for sharing their blind migraine patients, and L. Villanueva and J.-F. Bernard for teaching us the juxtacellular labeling technique. This research was supported by US National Institutes of Health grants NS-051484 and NS-035611. K.D. was supported in part by an unrestricted grant from Research to Prevent Blindness.	Aurora SK, 1999, HEADACHE, V39, P469, DOI 10.1046/j.1526-4610.1999.3907469.x; Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.3.CO;2-E; Burstein R, 2000, BRAIN, V123, P1703, DOI 10.1093/brain/123.8.1703; Burstein R, 1998, J NEUROPHYSIOL, V79, P964, DOI 10.1152/jn.1998.79.2.964; Burstein R, 2004, ANN NEUROL, V55, P27, DOI 10.1002/ana.10785; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DAVIS KD, 1988, BRAIN RES, V454, P89, DOI 10.1016/0006-8993(88)90806-2; Donchin O, 1998, NATURE, V395, P274, DOI 10.1038/26220; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gauriau C, 2004, J NEUROSCI, V24, P752, DOI 10.1523/JNEUROSCI.3272-03.2004; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hannibal J, 2004, INVEST OPHTH VIS SCI, V45, P4202, DOI 10.1167/iovs.04-0313; Hannibal J, 2004, CELL TISSUE RES, V316, P99, DOI 10.1007/s00441-004-0858-x; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; HERKENHAM M, 1980, SCIENCE, V207, P532, DOI 10.1126/science.7352263; INGVAR M, 1999, TXB PAIN, P215; Kawasaki A, 2002, J NEURO-OPHTHALMOL, V22, P3, DOI 10.1097/00041327-200203000-00002; KLEIN DC, 1972, SCIENCE, V177, P532, DOI 10.1126/science.177.4048.532; LAMONTE M, 1995, HEADACHE, V35, P520, DOI 10.1111/j.1526-4610.1995.hed3509520.x; LEBENSOHN JE, 1951, AM J OPHTHALMOL, V34, P1294, DOI 10.1016/0002-9394(51)91866-1; Living E., 1873, MEGRIM SICK HEADACHE; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; LOWEL S, 1992, SCIENCE, V255, P209, DOI 10.1126/science.1372754; Lowenfeld I., 1993, DAZZLING SYNDROME; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Malick A, 2001, P NATL ACAD SCI USA, V98, P9930, DOI 10.1073/pnas.171616898; MARKOWITZ S, 1988, CEPHALALGIA, V8, P83, DOI 10.1046/j.1468-2982.1988.0802083.x; MILLER NR, 1985, WALSH HOYTS CLIN NEU, V2, P1099; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Penfield W, 1940, ARCH NEURO PSYCHIATR, V44, P43, DOI 10.1001/archneurpsyc.1940.02280070051003; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; SELBY G, 1960, J NEUROL NEUROSUR PS, V23, P23, DOI 10.1136/jnnp.23.1.23; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Strassman AM, 1996, NATURE, V384, P560, DOI 10.1038/384560a0; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; VALENSTEIN E, 1987, BRAIN, V110, P1631, DOI 10.1093/brain/110.6.1631; WELTY TE, 1990, CLIN PHARMACY, V9, P35; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Yamamura H, 1999, J NEUROPHYSIOL, V81, P479, DOI 10.1152/jn.1999.81.2.479; ZAGAMI AS, 1990, EXP BRAIN RES, V81, P552, DOI 10.1007/BF02423504	50	338	360	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					239	U128		10.1038/nn.2475	http://dx.doi.org/10.1038/nn.2475			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20062053	Green Accepted			2022-12-17	WOS:000273985800020
J	Zhong, ZH; Deane, R; Ali, Z; Parisi, M; Shapovalov, Y; O'Banion, MK; Stojanovic, K; Sagare, A; Boillee, S; Cleveland, DW; Zlokovic, BV				Zhong, Zhihui; Deane, Rashid; Ali, Zarina; Parisi, Margaret; Shapovalov, Yuriy; O'Banion, M. Kerry; Stojanovic, Konstantin; Sagare, Abhay; Boillee, Severine; Cleveland, Don W.; Zlokovic, Berislav V.			ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SUPEROXIDE-DISMUTASE; DISEASE; MICE; PROGRESSION; MICROGLIA; ONSET	We report here that amyotrophic lateral sclerosis-linked superoxide dismutase 1 (SOD1) mutants with different biochemical characteristics disrupted the blood-spinal cord barrier in mice by reducing the levels of the tight junction proteins ZO-1, occludin and claudin-5 between endothelial cells. This resulted in microhemorrhages with release of neurotoxic hemoglobin-derived products, reductions in microcirculation and hypoperfusion. SOD1 mutant-mediated endothelial damage accumulated before motor neuron degeneration and the neurovascular inflammatory response occurred, indicating that it was a central contributor to disease initiation.	[Zhong, Zhihui; Deane, Rashid; Ali, Zarina; Parisi, Margaret; Stojanovic, Konstantin; Sagare, Abhay; Zlokovic, Berislav V.] Univ Rochester, Med Ctr, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY 14642 USA; [Zhong, Zhihui; Deane, Rashid; Ali, Zarina; Parisi, Margaret; Stojanovic, Konstantin; Sagare, Abhay; Zlokovic, Berislav V.] Univ Rochester, Med Ctr, Dept Neurosurg, Rochester, NY 14642 USA; [Zhong, Zhihui; Deane, Rashid; Ali, Zarina; Parisi, Margaret; Stojanovic, Konstantin; Sagare, Abhay; Zlokovic, Berislav V.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Shapovalov, Yuriy; O'Banion, M. Kerry] Univ Rochester, Med Ctr, Dept Neurobiol & Anat, Rochester, NY 14642 USA; [Boillee, Severine; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Boillee, Severine; Cleveland, Don W.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Boillee, Severine; Cleveland, Don W.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zlokovic, BV (corresponding author), Univ Rochester, Med Ctr, Ctr Neurodegenerat & Vasc Brain Disorders, Kornberg Med Res Bldg,601 Elmwood Ave,Box 670, Rochester, NY 14642 USA.	berislav_zlokovic@urmc.rochester.edu	Boillee, Severine/J-4027-2017; Sagare, Abhay/Y-3273-2019; Cleveland, Don/AAN-9783-2021	Sagare, Abhay/0000-0002-8178-3785; BOILLEE, Severine/0000-0001-5518-9005; Cleveland, Don/0000-0002-1934-3682; O'Banion, M. Kerry/0000-0003-1246-3363	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036, R37NS034467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023084] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL063290-01, R01 HL063290, HL63290] Funding Source: Medline; NIA NIH HHS [R37 AG023084, R37 AG023084-01A1] Funding Source: Medline; NINDS NIH HHS [R01 NS034467, R37 NS34467, R37 NS034467-10, R37 NS027036, R37 NS27036, R37 NS034467] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Brettschneider J, 2006, NEUROLOGY, V66, P852, DOI 10.1212/01.wnl.0000203120.85850.54; Garbuzova-Davis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001205; Garbuzova-Davis S, 2007, BRAIN RES, V1157, P126, DOI 10.1016/j.brainres.2007.04.044; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lobsiger CS, 2007, P NATL ACAD SCI USA, V104, P7319, DOI 10.1073/pnas.0702230104; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Regan RF, 1998, J NEUROTRAUM, V15, P645, DOI 10.1089/neu.1998.15.645; Sargsyan SA, 2005, GLIA, V51, P241, DOI 10.1002/glia.20210; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	15	338	356	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					420	422		10.1038/nn2073	http://dx.doi.org/10.1038/nn2073			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18344992	Green Accepted			2022-12-17	WOS:000254359300012
J	Nir, Y; Mukamel, R; Dinstein, I; Privman, E; Harel, M; Fisch, L; Gelbard-Sagiv, H; Kipervasser, S; Andelman, F; Neufeld, MY; Kramer, U; Arieli, A; Fried, I; Malach, R				Nir, Yuval; Mukamel, Roy; Dinstein, Ilan; Privman, Eran; Harel, Michal; Fisch, Lior; Gelbard-Sagiv, Hagar; Kipervasser, Svetlana; Andelman, Fani; Neufeld, Miri Y.; Kramer, Uri; Arieli, Amos; Fried, Itzhak; Malach, Rafael			Interhemispheric correlations of slow spontaneous neuronal fluctuations revealed in human sensory cortex	NATURE NEUROSCIENCE			English	Article							RESTING-STATE NETWORKS; HUMAN AUDITORY-CORTEX; MONKEY VISUAL-CORTEX; FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; CORTICAL RESPONSES; HZ OSCILLATION; FMRI; DYNAMICS; SINGLE	Animal studies have shown robust electrophysiological activity in the sensory cortex in the absence of stimuli or tasks. Similarly, recent human functional magnetic resonance imaging (fMRI) revealed widespread, spontaneously emerging cortical fluctuations. However, it is unknown what neuronal dynamics underlie this spontaneous activity in the human brain. Here we studied this issue by combining bilateral single-unit, local field potentials (LFPs) and intracranial electrocorticography (ECoG) recordings in individuals undergoing clinical monitoring. We found slow (<0.1 Hz, following 1/f-like profiles) spontaneous fluctuations of neuronal activity with significant interhemispheric correlations. These fluctuations were evident mainly in neuronal firing rates and in gamma (40-100 Hz) LFP power modulations. Notably, the interhemispheric correlations were enhanced during rapid eye movement and stage 2 sleep. Multiple intracranial ECoG recordings revealed clear selectivity for functional networks in the spontaneous gamma LFP power modulations. Our results point to slow spontaneous modulations in firing rate and gamma LFP as the likely correlates of spontaneous fMRI fluctuations in the human sensory cortex.	[Nir, Yuval; Harel, Michal; Fisch, Lior; Gelbard-Sagiv, Hagar; Arieli, Amos; Malach, Rafael] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Mukamel, Roy; Fried, Itzhak] Univ Calif Los Angeles, David Geffen Sch Med, Div Neurosurg, Los Angeles, CA 90095 USA; [Mukamel, Roy; Fried, Itzhak] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Dinstein, Ilan] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Privman, Eran] Tel Aviv Univ, Sackler Fac Exact Sci, Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Kipervasser, Svetlana; Neufeld, Miri Y.; Kramer, Uri; Fried, Itzhak] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Kipervasser, Svetlana; Neufeld, Miri Y.] Tel Aviv Med Ctr & Sch Med, Dept Neurol, Electroencephalog & Epilepsy Unit, IL-64239 Tel Aviv, Israel; [Andelman, Fani; Kramer, Uri; Fried, Itzhak] Tel Aviv Med Ctr & Sch Med, Funct Neurosurg Unit, IL-64239 Tel Aviv, Israel	Weizmann Institute of Science; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; New York University; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Malach, R (corresponding author), Weizmann Inst Sci, Dept Neurobiol, 240 Herzl St, IL-76100 Rehovot, Israel.	rafi.malach@weizmann.ac.il	Dinstein, Ilan/L-3325-2016; Dinstein, Ilan/AAW-4400-2020; Galbard-Sagiv, Hagar/J-8482-2014; Mukamel, Roy/AAV-2900-2021	Dinstein, Ilan/0000-0001-8106-5209; Dinstein, Ilan/0000-0001-8106-5209; Galbard-Sagiv, Hagar/0000-0003-0379-3854; Mukamel, Roy/0000-0001-9359-8950; Nir, Yuval/0000-0002-5433-6349	Israel Science Foundation, Minerva and Benoziyo Center; US-Israel Binational Science Foundation; Human Frontier Science Program Organization; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033221] Funding Source: NIH RePORTER	Israel Science Foundation, Minerva and Benoziyo Center(Israel Science Foundation); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Human Frontier Science Program Organization(Human Frontier Science Program); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the participants for volunteering to take part in the study; A. D. Ekstrom, E. Isham, E. Ho, T. A. Fields, and E. Behnke for technical assistance at UCLA; C. Wilson and J. Ogren for help with sleep recordings and staging; D. Yossef, S. Nagar, R. Cohen, C. Yosef, G. Yehezkel and the EEG technicians for assistance at the Tel Aviv Medical Center; and R. Paz and E. Schneidman for helpful discussions and feedback. This study was funded by the Israel Science Foundation, Minerva and Benoziyo Center grants to R. Malach, a US-Israel Binational Science Foundation grant to I. F. and R. Malach and a Human Frontier Science Program Organization fellowship to R. Mukamel.	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Barbour DL, 2003, J NEUROSCI, V23, P7194, DOI 10.1523/JNEUROSCI.23-18-07194.2003; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bitterman Y, 2008, NATURE, V451, P197, DOI 10.1038/nature06476; Cordes D, 2002, MAGN RESON IMAGING, V20, P305, DOI 10.1016/S0730-725X(02)00503-9; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Fishbein I, 2007, CEREB CORTEX, V17, P1292, DOI 10.1093/cercor/bhl037; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Golland Y, 2008, NEUROPSYCHOLOGIA, V46, P540, DOI 10.1016/j.neuropsychologia.2007.10.003; Golland Y, 2007, CEREB CORTEX, V17, P766, DOI 10.1093/cercor/bhk030; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Johnston JM, 2008, J NEUROSCI, V28, P6453, DOI 10.1523/JNEUROSCI.0573-08.2008; Kanwisher N, 2001, COGNITION, V79, P89, DOI 10.1016/S0010-0277(00)00125-6; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Laureys S, 2007, CURR OPIN NEUROL, V20, P609, DOI 10.1097/WCO.0b013e3282f1d6dd; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mitra PP, 1997, MAGNET RESON MED, V37, P511, DOI 10.1002/mrm.1910370407; MOREL A, 1993, J COMP NEUROL, V335, P437, DOI 10.1002/cne.903350312; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Nelken I, 2004, CURR OPIN NEUROBIOL, V14, P474, DOI 10.1016/j.conb.2004.06.005; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Nir Y, 2008, NAT NEUROSCI, V11, P523, DOI 10.1038/nn0508-523; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Nir Y, 2006, NEUROIMAGE, V30, P1313, DOI 10.1016/j.neuroimage.2005.11.018; Phan ML, 2007, J NEUROPHYSIOL, V97, P1726, DOI 10.1152/jn.00698.2006; Privman E, 2007, J NEUROSCI, V27, P6234, DOI 10.1523/JNEUROSCI.4627-06.2007; Rechtschaffen A., 1968, MANUAL STANDARDIZED, V20, P246; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TSODYKS MV, 1995, NETWORK-COMP NEURAL, V6, P111, DOI 10.1088/0954-898X/6/2/001; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258	50	337	340	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2008	11	9					1100	1108		10.1038/nn.2177	http://dx.doi.org/10.1038/nn.2177			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	341NA	19160509	Green Accepted			2022-12-17	WOS:000258720000021
J	Wang, SSH; Denk, W; Hausser, M				Wang, SSH; Denk, W; Hausser, M			Coincidence detection in single dendritic spines mediated by calcium release	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; CEREBELLAR PURKINJE NEURONS; PARALLEL FIBER SYNAPSES; CLIMBING FIBER; INOSITOL TRISPHOSPHATE; ACTION-POTENTIALS; CELL DENDRITES; CA2+; RECEPTORS; ACTIVATION	Cerebellar long-term depression (LTD) is a calcium-dependent process in which coincident activity of parallel fiber (PF) and climbing fiber (CF) synapses causes a long-lasting decrease in PF synaptic strength onto Purkinje cells. Here we show that pairing CF activation with bursts of PF activity triggers large (>10 muM) calcium signals in Purkinje cell dendrites. When PFs are densely activated, signals span whole dendritic branchlets and are mediated by voltage-dependent calcium entry. When PFs are sparsely activated, however, signals are restricted to single spines and blocked by metabotropic glutamate receptor antagonists. Single-spine signals and sparse-stimulation LTD are also blocked by thapsigargin, indicating that calcium must be released from stores. Single-spine signals and sparse-stimulation LTD are greatest when PF activation precedes the CF activation within 50-200 ms. This timing rule matches the properties of several forms of motor learning, providing a link between behavior and functional properties of cerebellar synaptic plasticity.	Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany; UCL, Dept Physiol, London WC1E 6BT, England; Bell Labs, Lucent Technol, Biol Computat Res Dept, Murray Hill, NJ 07974 USA	Max Planck Society; University of London; University College London; Alcatel-Lucent; Lucent Technologies; AT&T	Hausser, M (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	winfried_denk@mpimf-heidelberg.mpg.de; m.hausser@ucl.ac.uk	Hausser, Michael/AAW-6827-2020; denk, winfried/I-6627-2012	Hausser, Michael/0000-0002-2673-8957; 				Atluri PP, 1996, J NEUROSCI, V16, P5661; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; Blackstone C, 1999, CELL CALCIUM, V26, P181, DOI 10.1054/ceca.1999.0071; BROWN TH, 1990, ANNU REV NEUROSCI, V13, P475, DOI 10.1146/annurev.neuro.13.1.475; CALLAWAY JC, 1995, J NEUROSCI, V15, P2777; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Daniel H, 1998, TRENDS NEUROSCI, V21, P401, DOI 10.1016/S0166-2236(98)01304-6; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; Eilers J, 1997, LEARN MEMORY, V4, P159, DOI 10.1101/lm.4.1.159; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; EKEROT CF, 1989, NEUROSCI RES, V6, P264, DOI 10.1016/0168-0102(89)90065-5; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; GORMEZANO I, 1983, PROGR PSYCHOBIOLOGY, P197; HARTELL NA, 1994, NEUROREPORT, V5, P913, DOI 10.1097/00001756-199404000-00015; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; HEMART N, 1995, EUR J NEUROSCI, V7, P45, DOI 10.1111/j.1460-9568.1995.tb01019.x; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; Ito M, 1990, Neuroreport, V1, P129; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; KHODAKHAH K, 1995, J PHYSIOL-LONDON, V487, P343, DOI 10.1113/jphysiol.1995.sp020884; Khodakhah K, 1997, P NATL ACAD SCI USA, V94, P14009, DOI 10.1073/pnas.94.25.14009; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Mauk MD, 1998, NEURON, V20, P359, DOI 10.1016/S0896-6273(00)80978-2; MERRILL EG, 1978, J PHYSIOL-LONDON, V284, P127, DOI 10.1113/jphysiol.1978.sp012531; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Nakazawa K, 1997, LEARN MEMORY, V3, P578, DOI 10.1101/lm.3.6.578; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; Raymond JL, 1998, J NEUROSCI, V18, P9112; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; SCHREURS BG, 1993, BRAIN RES, V631, P235, DOI 10.1016/0006-8993(93)91540-9; Schreurs BG, 1996, J NEUROPHYSIOL, V75, P1051, DOI 10.1152/jn.1996.75.3.1051; Schulman H, 1999, CALCIUM AS A CELLULAR REGULATOR, P311; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; Tank DW, 1995, J NEUROSCI, V15, P7940; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Vos BP, 1999, J NEUROSCI, V19; WALTON PD, 1991, J CELL BIOL, V113, P1145, DOI 10.1083/jcb.113.5.1145; Wang SSH, 2000, P NATL ACAD SCI USA, V97, P8635, DOI 10.1073/pnas.130414597; WANG SSH, 1995, J GEN PHYSIOL, V105, P149, DOI 10.1085/jgp.105.1.149; Yuste R, 1999, J NEUROSCI, V19, P1976; Zhao MD, 1996, BIOPHYS J, V70, P896, DOI 10.1016/S0006-3495(96)79633-9	50	337	340	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1266	1273		10.1038/81792	http://dx.doi.org/10.1038/81792			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100147	Bronze			2022-12-17	WOS:000167177900012
J	Bourinet, E; Soong, TW; Sutton, K; Slaymaker, S; Mathews, E; Monteil, A; Zamponi, GW; Nargeot, J; Snutch, TP				Bourinet, E; Soong, TW; Sutton, K; Slaymaker, S; Mathews, E; Monteil, A; Zamponi, GW; Nargeot, J; Snutch, TP			Splicing of alpha(1A) subunit gene generates phenotypic variants of P- and Q-type calcium channels	NATURE NEUROSCIENCE			English	Article							OMEGA-AGA-IVA; CA2+ CHANNELS; MOLECULAR DETERMINANTS; FUNCTIONAL EXPRESSION; SYNAPTIC TRANSMISSION; GATING MODIFIER; SCORPION TOXIN; K+ CHANNELS; NEURONS; ACTIVATION	P-type and Q-type calcium channels mediate neurotransmitter release at many synapses in the mammalian nervous system. The or,, calcium channel has been implicated in the etiologies of conditions such as episodic ataxia, epilepsy and familial migraine, and shares several properties with native P- and Q-type channels. However, the exact relationship between alpha(1A) and P- and Q-type channels is unknown. Here we report that alternative splicing of the alpha(1A) subunit gene results in channels with distinct kinetic, pharmacological and modulatory properties. Overall, the results indicate that alternative splicing of the alpha(1A) gene generates P-type and Q-type channels as well as multiple phenotypic variants.	Univ British Columbia, Biotechnol Lab, Vancouver, BC V6T 1W5, Canada; CNRS, UPR 1142, IGH, Montpellier, France; Univ Calgary, Dept Pharmacol, Calgary, AB, Canada	University of British Columbia; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Calgary	Snutch, TP (corresponding author), Univ British Columbia, Biotechnol Lab, Vancouver, BC V6T 1W5, Canada.		Snutch, Terrance P/L-3464-2019; Monteil, Arnaud/G-3113-2012	Snutch, Terrance P/0000-0001-5182-1296; Monteil, Arnaud/0000-0003-1632-7318; Zamponi, Gerald W./0000-0002-0644-9066; Soong, Tuck Wah/0000-0002-0876-0325; Nargeot, Joel/0000-0003-2893-5636; bourinet, emmanuel/0000-0001-8021-0419				BABITCH J, 1990, NATURE, V346, P321, DOI 10.1038/346321b0; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Berrow NS, 1997, EUR J NEUROSCI, V9, P739, DOI 10.1111/j.1460-9568.1997.tb01422.x; Bourinet E, 1996, J NEUROSCI, V16, P4983; Brody DL, 1997, J PHYSIOL-LONDON, V499, P637, DOI 10.1113/jphysiol.1997.sp021956; BULLER AL, 1990, J MEMBRANE BIOL, V115, P179, DOI 10.1007/BF01869456; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Herlitze S, 1997, P NATL ACAD SCI USA, V94, P1512, DOI 10.1073/pnas.94.4.1512; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Lee JH, 1999, J NEUROSCI, V19, P1912; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Ligon B, 1998, J BIOL CHEM, V273, P13905, DOI 10.1074/jbc.273.22.13905; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; MCCLESKEY EW, 1991, CURR TOP MEMBR, V39, P295; McDonough SI, 1997, BIOPHYS J, V72, P2117, DOI 10.1016/S0006-3495(97)78854-4; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; NAKAI J, 1994, P NATL ACAD SCI USA, V91, P1014, DOI 10.1073/pnas.91.3.1014; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; PRAGNELL M, 1994, NATURE, V368, P68; RANDALL A, 1995, J NEUROSCI, V15, P2995; REGEHR WG, 1994, NEURON, V12, P605, DOI 10.1016/0896-6273(94)90216-X; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; SATHER WA, 1993, NEURON, V11, P291, DOI 10.1016/0896-6273(93)90185-T; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; STEA A, 1995, NEURON, V15, P929, DOI 10.1016/0896-6273(95)90183-3; STEA A, 1995, HDB RECEPTORS CHANNE, P113; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; TANAKA I, 1990, J VAC SCI TECHNOL A, V8, P567, DOI 10.1116/1.576389; Tottene A, 1996, J NEUROSCI, V16, P6353; TURNER TJ, 1992, SCIENCE, V258, P310, DOI 10.1126/science.1357749; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WILLIAMS ME, 1994, J BIOL CHEM, V269, P22347; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; YU ASL, 1992, P NATL ACAD SCI USA, V89, P10494, DOI 10.1073/pnas.89.21.10494; Zamponi GW, 1998, CURR OPIN NEUROBIOL, V8, P351, DOI 10.1016/S0959-4388(98)80060-3; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	50	337	355	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					407	415		10.1038/8070	http://dx.doi.org/10.1038/8070			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321243				2022-12-17	WOS:000084609400009
J	Polania, R; Nitsche, MA; Ruff, CC				Polania, Rafael; Nitsche, Michael A.; Ruff, Christian C.			Studying and modifying brain function with non-invasive brain stimulation	NATURE NEUROSCIENCE			English	Review							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MOTOR CORTEX; THETA-BURST-STIMULATION; MEP AMPLITUDE-MODULATION; RANDOM NOISE STIMULATION; SPATIAL WORKING-MEMORY; HEALTHY-HUMAN SUBJECTS; ELECTRICAL-STIMULATION; VISUAL-CORTEX; EXCITABILITY CHANGES	In the past three decades, our understanding of brain-behavior relationships has been significantly shaped by research using non-invasive brain stimulation (NIBS) techniques. These methods allow non-invasive and safe modulation of neural processes in the healthy brain, enabling researchers to directly study how experimentally altered neural activity causally affects behavior. This unique property of NIBS methods has, on the one hand, led to groundbreaking findings on the brain basis of various aspects of behavior and has raised interest in possible clinical and practical applications of these methods. On the other hand, it has also triggered increasingly critical debates about the properties and possible limitations of these methods. In this review, we discuss these issues, clarify the challenges associated with the use of currently available NIBS techniques for basic research and practical applications, and provide recommendations for studies using NIBS techniques to establish brain-behavior relationships.	[Polania, Rafael; Ruff, Christian C.] Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, SNS Lab, Zurich, Switzerland; [Nitsche, Michael A.] TU Dortmund, Dept Psychol & Neurosci, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Nitsche, Michael A.] Univ Med Hosp Bergmannsheil, Dept Neurol, Bochum, Germany	University of Zurich; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Ruhr University Bochum	Polania, R; Ruff, CC (corresponding author), Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, SNS Lab, Zurich, Switzerland.	rafael.polania@econ.uzh.ch; christian.ruff@econ.uzh.ch	Nitsche, Michael A/B-6755-2012; Ruff, Christian/N-9552-2016	Ruff, Christian/0000-0002-3964-2364; Polania, Rafael/0000-0002-6176-6806	EC; FET [686764-LUMINOUS]; German ministry of Research and Education (GCBS) [01EE1403C]; German ministry of Research and Education (TRAINSTIM) [01GQ1424E]; Deutsche Forschungsgemeinschaft - Germany [SFB 1280]; Swiss National Science Foundation [105314_152891, 100019L_173248]; ERC consolidator grant (BRAINCODES)	EC(European CommissionEuropean Commission Joint Research Centre); FET; German ministry of Research and Education (GCBS); German ministry of Research and Education (TRAINSTIM); Deutsche Forschungsgemeinschaft - Germany(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ERC consolidator grant (BRAINCODES)	Michael A. Nitsche receives support by the EC Horizon 2020 Program, FET Grant, 686764-LUMINOUS, grants from the German ministry of Research and Education (GCBS grant 01EE1403C, TRAINSTIM grant 01GQ1424E), and by a grant from the Deutsche Forschungsgemeinschaft - Germany (SFB 1280 Extinction Learning). Christian C. Ruff is supported by the Swiss National Science Foundation (grants 105314_152891 and 100019L_173248) and by an ERC consolidator grant (BRAINCODES).	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Albouy P, 2017, NEURON, V94, P193, DOI 10.1016/j.neuron.2017.03.015; Alekseichuk I, 2016, CURR BIOL, V26, P1513, DOI 10.1016/j.cub.2016.04.035; Ali MM, 2013, J NEUROSCI, V33, P11262, DOI 10.1523/JNEUROSCI.5867-12.2013; AMASSIAN VE, 1989, ELECTROEN CLIN NEURO, V74, P458, DOI 10.1016/0168-5597(89)90036-1; Amedi A, 2004, NAT NEUROSCI, V7, P1266, DOI 10.1038/nn1328; [Anonymous], 2017, Nat Commun, V8, P14748, DOI 10.1038/ncomms14748; Antal A, 2015, BRAIN STIMUL, V8, P846, DOI 10.1016/j.brs.2015.05.010; Antal A, 2004, J COGNITIVE NEUROSCI, V16, P521, DOI 10.1162/089892904323057263; Antal A, 2014, NEUROIMAGE, V85, P1040, DOI 10.1016/j.neuroimage.2012.10.026; Antal A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00317; Ashbridge E, 1997, NEUROPSYCHOLOGIA, V35, P1121, DOI 10.1016/S0028-3932(97)00003-1; Bachinger M, 2017, J NEUROSCI, V37, P4766, DOI 10.1523/JNEUROSCI.1756-16.2017; Barron HC, 2016, NEURON, V90, P191, DOI 10.1016/j.neuron.2016.02.031; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Beharelle AR, 2015, J NEUROSCI, V35, P14544, DOI 10.1523/JNEUROSCI.2322-15.2015; Berenyi A, 2012, SCIENCE, V337, P735, DOI 10.1126/science.1223154; Blankenburg F, 2010, CEREB CORTEX, V20, P2702, DOI 10.1093/cercor/bhq015; Bolognini N, 2011, HUM BRAIN MAPP, V32, P2104, DOI 10.1002/hbm.21172; Bolzoni F, 2013, J PHYSIOL-LONDON, V591, P3381, DOI 10.1113/jphysiol.2012.244764; Buch ER, 2017, CLIN NEUROPHYSIOL, V128, P589, DOI 10.1016/j.clinph.2017.01.004; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cabrera LY, 2014, BRAIN TOPOGR, V27, P33, DOI 10.1007/s10548-013-0296-8; Cecere R, 2015, CURR BIOL, V25, P231, DOI 10.1016/j.cub.2014.11.034; Chaieb L, 2014, NEUROGENETICS, V15, P1, DOI 10.1007/s10048-014-0393-1; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Chipchase L, 2012, CLIN NEUROPHYSIOL, V123, P1698, DOI 10.1016/j.clinph.2012.05.003; Datta A, 2009, BRAIN STIMUL, V2, P201, DOI 10.1016/j.brs.2009.03.005; DAY BL, 1989, BRAIN, V112, P649, DOI 10.1093/brain/112.3.649; DAY BL, 1989, J PHYSIOL-LONDON, V412, P449, DOI 10.1113/jphysiol.1989.sp017626; Du XM, 2014, J MOTOR BEHAV, V46, P39, DOI 10.1080/00222895.2013.850401; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Feredoes E, 2011, P NATL ACAD SCI USA, V108, P17510, DOI 10.1073/pnas.1106439108; Fertonani A, 2011, J NEUROSCI, V31, P15416, DOI 10.1523/JNEUROSCI.2002-11.2011; Fitz NS, 2015, J MED ETHICS, V41, P410, DOI 10.1136/medethics-2013-101458; Fresnoza S, 2014, J NEUROSCI, V34, P2744, DOI 10.1523/JNEUROSCI.3655-13.2014; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Gamboa OL, 2010, EXP BRAIN RES, V204, P181, DOI 10.1007/s00221-010-2293-4; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Gentner R, 2008, CEREB CORTEX, V18, P2046, DOI 10.1093/cercor/bhm239; Gerloff C, 1997, BRAIN, V120, P1587, DOI 10.1093/brain/120.9.1587; Grossman N, 2017, CELL, V169, P1029, DOI 10.1016/j.cell.2017.05.024; Hallett M, 2001, BRAIN RES REV, V36, P169, DOI 10.1016/S0165-0173(01)00092-3; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hanslmayr S, 2014, CURR BIOL, V24, P904, DOI 10.1016/j.cub.2014.03.007; Hill CA, 2017, NAT NEUROSCI, V20, P1142, DOI 10.1038/nn.4602; Holland R, 2011, CURR BIOL, V21, P1403, DOI 10.1016/j.cub.2011.07.021; Horvath JC, 2015, BRAIN STIMUL, V8, P535, DOI 10.1016/j.brs.2015.01.400; Horvath JC, 2015, NEUROPSYCHOLOGIA, V66, P213, DOI 10.1016/j.neuropsychologia.2014.11.021; Huang YZ, 2007, CLIN NEUROPHYSIOL, V118, P1028, DOI 10.1016/j.clinph.2007.01.021; Huang Y, 2017, ELIFE, V6, DOI 10.7554/eLife.18834; Huys QJM, 2016, NAT NEUROSCI, V19, P404, DOI 10.1038/nn.4238; Joundi RA, 2012, CURR BIOL, V22, P403, DOI 10.1016/j.cub.2012.01.024; Kadosh RC, 2012, CURR BIOL, V22, pR108, DOI 10.1016/j.cub.2012.01.013; Kadosh RC, 2010, CURR BIOL, V20, P2016, DOI 10.1016/j.cub.2010.10.007; Kanai R, 2008, CURR BIOL, V18, P1839, DOI 10.1016/j.cub.2008.10.027; Kar K, 2017, J NEUROSCI, V37, P2325, DOI 10.1523/JNEUROSCI.2266-16.2016; Kar K, 2012, J NEUROPHYSIOL, V108, P2173, DOI 10.1152/jn.00505.2012; Katz LN, 2016, NATURE, V535, P285, DOI 10.1038/nature18617; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Koch G, 2009, BEHAV BRAIN RES, V202, P147, DOI 10.1016/j.bbr.2009.03.023; Kuo HI, 2013, BRAIN STIMUL, V6, P644, DOI 10.1016/j.brs.2012.09.010; Lefaucheur JP, 2017, CLIN NEUROPHYSIOL, V128, P56, DOI 10.1016/j.clinph.2016.10.087; Legon W, 2014, NAT NEUROSCI, V17, P322, DOI 10.1038/nn.3620; Lin CH, 2012, NEUROIMAGE, V62, P2007, DOI 10.1016/j.neuroimage.2012.05.015; Lomber SG, 1999, J NEUROSCI METH, V86, P179, DOI 10.1016/S0165-0270(98)00165-4; Lopez-Alonso V, 2014, BRAIN STIMUL, V7, P372, DOI 10.1016/j.brs.2014.02.004; Lustenberger C, 2016, CURR BIOL, V26, P2127, DOI 10.1016/j.cub.2016.06.044; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Marechal MA, 2017, P NATL ACAD SCI USA, V114, P4360, DOI 10.1073/pnas.1614912114; MERTON PA, 1980, NATURE, V285, P227, DOI 10.1038/285227a0; Minami S, 2017, CURR BIOL, V27, P2344, DOI 10.1016/j.cub.2017.06.033; Miniussi C, 2013, NEUROSCI BIOBEHAV R, V37, P1702, DOI 10.1016/j.neubiorev.2013.06.014; Moisa M, 2016, J NEUROSCI, V36, P12053, DOI 10.1523/JNEUROSCI.2044-16.2016; Monte-Silva K, 2013, BRAIN STIMUL, V6, P424, DOI 10.1016/j.brs.2012.04.011; Monte-Silva K, 2011, NEUROPSYCHOPHARMACOL, V36, P2097, DOI 10.1038/npp.2011.100; Morbidi F, 2007, J NEUROSCI METH, V162, P293, DOI 10.1016/j.jneumeth.2006.12.013; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Ngo HVV, 2013, NEURON, V78, P545, DOI 10.1016/j.neuron.2013.03.006; Nitsche MA, 2006, EUR J NEUROSCI, V23, P1651, DOI 10.1111/j.1460-9568.2006.04676.x; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P600, DOI 10.1016/S1388-2457(02)00412-1; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; Nitsche MA, 2015, BRAIN STIMUL, V8, P666, DOI 10.1016/j.brs.2015.03.008; Nitsche MA, 2012, J PHYSIOL-LONDON, V590, P4641, DOI 10.1113/jphysiol.2012.232975; Noury N, 2017, NEUROIMAGE, V158, P406, DOI 10.1016/j.neuroimage.2017.07.010; Noury N, 2016, NEUROIMAGE, V140, P99, DOI 10.1016/j.neuroimage.2016.03.065; Oliveri M, 2001, CEREB CORTEX, V11, P606, DOI 10.1093/cercor/11.7.606; Opitz A, 2017, P NATL ACAD SCI USA, V114, P5243, DOI 10.1073/pnas.1617024114; Opitz A, 2013, NEUROIMAGE, V81, P253, DOI 10.1016/j.neuroimage.2013.04.067; Ozen S, 2010, J NEUROSCI, V30, P11476, DOI 10.1523/JNEUROSCI.5252-09.2010; Parazzini M, 2017, IEEE T BIO-MED ENG, V64, P184, DOI 10.1109/TBME.2016.2553177; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; PASCUALLEONE A, 1991, NEUROLOGY, V41, P697, DOI 10.1212/WNL.41.5.697; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Philiastides MG, 2011, CURR BIOL, V21, P980, DOI 10.1016/j.cub.2011.04.034; Plewnia C, 2007, HUM BRAIN MAPP, V28, P238, DOI 10.1002/hbm.20270; Polania R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9090; Polania R, 2014, NEURON, V82, P709, DOI 10.1016/j.neuron.2014.03.014; Polania R, 2012, HUM BRAIN MAPP, V33, P2499, DOI 10.1002/hbm.21380; Polania R, 2012, CURR BIOL, V22, P1314, DOI 10.1016/j.cub.2012.05.021; Polania R, 2011, HUM BRAIN MAPP, V32, P1236, DOI 10.1002/hbm.21104; Poreisz C, 2007, BRAIN RES BULL, V72, P208, DOI 10.1016/j.brainresbull.2007.01.004; Rahman A, 2017, J PHYSIOL-LONDON, V595, P3535, DOI 10.1113/JP273005; Reardon S, 2016, NATURE, V531, P283, DOI 10.1038/nature.2016.19534; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Ridding MC, 2010, J PHYSIOL-LONDON, V588, P2291, DOI 10.1113/jphysiol.2010.190314; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Romei V, 2012, CURR BIOL, V22, P807, DOI 10.1016/j.cub.2012.03.025; Romei V, 2011, CURR BIOL, V21, P334, DOI 10.1016/j.cub.2011.01.035; Rose NS, 2016, SCIENCE, V354, P1136, DOI 10.1126/science.aah7011; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Roth Y, 2002, J CLIN NEUROPHYSIOL, V19, P361, DOI 10.1097/00004691-200208000-00008; Roth Y, 2007, J CLIN NEUROPHYSIOL, V24, P31, DOI 10.1097/WNP.0b013e31802fa393; Ruff CC, 2013, SCIENCE, V342, P482, DOI 10.1126/science.1241399; Saiote C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059669; Santarnecchi E, 2013, CURR BIOL, V23, P1449, DOI 10.1016/j.cub.2013.06.022; Saturnino GB, 2017, NEUROIMAGE, V163, P68, DOI 10.1016/j.neuroimage.2017.09.024; Schmidt F.L., 2014, METHODS META ANAL CO; Schwiedrzik CM, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.006.2009; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Silvanto J, 2005, NAT NEUROSCI, V8, P143, DOI 10.1038/nn1379; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Simonsohn U, 2014, PERSPECT PSYCHOL SCI, V9, P666, DOI 10.1177/1745691614553988; Sparing R, 2009, BRAIN, V132, P3011, DOI 10.1093/brain/awp154; Stagg CJ, 2011, CURR BIOL, V21, P480, DOI 10.1016/j.cub.2011.01.069; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Strang S, 2015, SOC COGN AFFECT NEUR, V10, P790, DOI 10.1093/scan/nsu114; Strube W, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12884; Tarapore PE, 2013, NEUROIMAGE, V82, P260, DOI 10.1016/j.neuroimage.2013.05.018; Tehovnik EJ, 2006, J NEUROPHYSIOL, V96, P512, DOI 10.1152/jn.00126.2006; Terney D, 2008, J NEUROSCI, V28, P14147, DOI 10.1523/JNEUROSCI.4248-08.2008; Thielscher A, 2011, NEUROIMAGE, V54, P234, DOI 10.1016/j.neuroimage.2010.07.061; Thirugnanasambandam N, 2011, RESTOR NEUROL NEUROS, V29, P311, DOI 10.3233/RNN-2011-0601; Thut G, 2011, CURR BIOL, V21, P1176, DOI 10.1016/j.cub.2011.05.049; Trepel C, 2000, SYNAPSE, V35, P120, DOI 10.1002/(SICI)1098-2396(200002)35:2<120::AID-SYN4>3.0.CO;2-6; Tufail Y, 2010, NEURON, V66, P681, DOI 10.1016/j.neuron.2010.05.008; Ueyama E, 2011, PSYCHIAT CLIN NEUROS, V65, P77, DOI 10.1111/j.1440-1819.2010.02170.x; van der Groen O, 2016, J NEUROSCI, V36, P5289, DOI 10.1523/JNEUROSCI.4519-15.2016; Violante IR, 2017, ELIFE, V6, DOI [10.7554/elife.22001.001, 10.7554/eLife.22001]; Vlachos A, 2012, J NEUROSCI, V32, P17514, DOI 10.1523/JNEUROSCI.0409-12.2012; Wang JX, 2014, SCIENCE, V345, P1054, DOI 10.1126/science.1252900; Wiethoff S, 2014, BRAIN STIMUL, V7, P468, DOI 10.1016/j.brs.2014.02.003; Woods AJ, 2016, CLIN NEUROPHYSIOL, V127, P1031, DOI 10.1016/j.clinph.2015.11.012; Wurzman R, 2016, ANN NEUROL, V80, P1, DOI 10.1002/ana.24689	150	336	341	27	237	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2018	21	2					174	187		10.1038/s41593-017-0054-4	http://dx.doi.org/10.1038/s41593-017-0054-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FV0TB	29311747	Green Published, Green Accepted			2022-12-17	WOS:000424269900008
J	Pagnoni, G; Zink, CF; Montague, PR; Berns, GS				Pagnoni, G; Zink, CF; Montague, PR; Berns, GS			Activity in human ventral striatum locked to errors of reward prediction	NATURE NEUROSCIENCE			English	Article							RESPONSES; DOPAMINE; SYSTEMS		Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	Emory University; Baylor College of Medicine	Pagnoni, G (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.		anand, amit/A-7222-2009; Pagnoni, Giuseppe/F-3398-2015	Pagnoni, Giuseppe/0000-0002-8272-8091	NIDA NIH HHS [DA11723, DA00367] Funding Source: Medline; NIMH NIH HHS [MH61010] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011723] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Duvernoy HM, 1999, HUMAN BRAIN; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Spanagel R, 1999, TRENDS NEUROSCI, V22, P521, DOI 10.1016/S0166-2236(99)01447-2; WARD BD, 2001, AFNI 3DDECONVOLVE DO	13	336	337	2	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					97	98		10.1038/nn802	http://dx.doi.org/10.1038/nn802			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11802175				2022-12-17	WOS:000173558400008
J	Arnsten, AFT				Arnsten, Amy F. T.			Stress weakens prefrontal networks: molecular insults to higher cognition	NATURE NEUROSCIENCE			English	Review							SPATIAL WORKING-MEMORY; TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; SCHIZOPHRENIA 1 DISC1; ALZHEIMERS-DISEASE; LOCUS-COERULEUS; GRAY-MATTER; TYROSINE-HYDROXYLASE; BASOLATERAL AMYGDALA; PYRAMIDAL NEURONS	A variety of cognitive disorders are worsened by stress exposure and involve dysfunction of the newly evolved prefrontal cortex (PFC). Exposure to acute, uncontrollable stress increases catecholamine release in PFC, reducing neuronal firing and impairing cognitive abilities. High levels of noradrenergic alpha 1-adrenoceptor and dopaminergic D1 receptor stimulation activate feedforward calcium-protein kinase C and cyclic AMP-protein kinase A signaling, which open potassium channels to weaken synaptic efficacy in spines. In contrast, high levels of catecholamines strengthen the primary sensory cortices, amygdala and striatum, rapidly flipping the brain from reflective to reflexive control of behavior. These mechanisms are exaggerated by chronic stress exposure, where architectural changes lead to persistent loss of PFC function. Understanding these mechanisms has led to the successful translation of prazosin and guanfacine for treating stress-related disorders. Dysregulation of stress signaling pathways by genetic insults likely contributes to PFC deficits in schizophrenia, while age-related insults initiate interacting vicious cycles that increase vulnerability to Alzheimer's degeneration.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA	Yale University	Arnsten, AFT (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA.	amy.arnsten@yale.edu			US National institutes of Health [DP1AG047744-01, R01AG043430-01A1, RO1MH100064-01A1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043430, DP1AG047744] Funding Source: NIH RePORTER	US National institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Gratitude to S. Katrancha tor discussions regarding spine dynamics. A.F.T.A. is supported by a US National institutes of Health Director's Pioneer Award DP1AG047744-01, R01AG043430-01A1 and RO1MH100064-01A1.	Acin-Perez R, 2011, CELL METAB, V13, P712, DOI 10.1016/j.cmet.2011.03.024; Altmann A, 2014, ANN NEUROL, V75, P563, DOI 10.1002/ana.24135; Ansell EB, 2012, BIOL PSYCHIAT, V72, P57, DOI 10.1016/j.biopsych.2011.11.022; Arion D, 2015, MOL PSYCHIATR, V20, P1397, DOI 10.1038/mp.2014.171; Arnsten AFT, 1999, BIOL PSYCHIAT, V45, P26, DOI 10.1016/S0006-3223(98)00296-0; Arnsten AFT, 1998, ARCH GEN PSYCHIAT, V55, P362, DOI 10.1001/archpsyc.55.4.362; Arnsten AFT, 1998, SCIENCE, V280, P1711, DOI 10.1126/science.280.5370.1711; Arnsten AFT, 2015, NEUROBIOL STRESS, V1, P89, DOI 10.1016/j.ynstr.2014.10.002; Arnsten AFT, 2012, NEURON, V76, P223, DOI 10.1016/j.neuron.2012.08.038; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Bachmann Verena A, 2013, Small GTPases, V4, P247, DOI 10.4161/sgtp.27281; Bangasser DA, 2012, CELL MOL NEUROBIOL, V32, P709, DOI 10.1007/s10571-012-9824-4; Barsegyan A, 2010, P NATL ACAD SCI USA, V107, P16655, DOI 10.1073/pnas.1011975107; Bebbington PE, 1998, PSYCHOL MED, V28, P9, DOI 10.1017/S0033291797006077; Bethea CL, 2013, NEUROBIOL DIS, V50, P96, DOI 10.1016/j.nbd.2012.10.009; Bhalla A, 2012, NEUROBIOL DIS, V47, P126, DOI 10.1016/j.nbd.2012.03.030; Birnbaum S, 1999, BIOL PSYCHIAT, V46, P1266, DOI 10.1016/S0006-3223(99)00138-9; Birnbaum SG, 2004, SCIENCE, V306, P882, DOI 10.1126/science.1100021; Bissette G, 2003, NEUROPSYCHOPHARMACOL, V28, P1328, DOI 10.1038/sj.npp.1300191; Black JE, 2004, AM J PSYCHIAT, V161, P742, DOI 10.1176/appi.ajp.161.4.742; Bloss EB, 2011, J NEUROSCI, V31, P7831, DOI 10.1523/JNEUROSCI.0839-11.2011; Blumberg HP, 2006, BIOL PSYCHIAT, V59, P611, DOI 10.1016/j.biopsych.2005.08.031; Bonini JS, 2005, PHARMACOL BIOCHEM BE, V80, P63, DOI 10.1016/j.pbb.2004.10.008; Breslau N, 2009, TRAUMA VIOLENCE ABUS, V10, P198, DOI 10.1177/1524838009334448; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bussiere T, 2003, J COMP NEUROL, V463, P281, DOI 10.1002/cne.10760; Caetano MS, 2012, J NEUROSCI, V32, P3765, DOI 10.1523/JNEUROSCI.6011-11.2012; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Cahill L, 1996, CURR OPIN NEUROBIOL, V6, P237, DOI 10.1016/S0959-4388(96)80078-X; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; Cam JA, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-8; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Cannon TD, 2005, ARCH GEN PSYCHIAT, V62, P1205, DOI 10.1001/archpsyc.62.11.1205; Cannon TD, 2015, BIOL PSYCHIAT, V77, P147, DOI 10.1016/j.biopsych.2014.05.023; Carlyle BC, 2014, P NATL ACAD SCI USA, V111, P5036, DOI 10.1073/pnas.1322360111; Chandler DJ, 2014, P NATL ACAD SCI USA, V111, P6816, DOI 10.1073/pnas.1320827111; Childress AC, 2012, DRUGS, V72, P309, DOI 10.2165/11599580-000000000-00000; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Connor DF, 2013, J CHILD ADOL PSYCHOP, V23, P244, DOI 10.1089/cap.2012.0119; Datta D, 2015, CEREB CORTEX, V25, P2295, DOI 10.1093/cercor/bhu040; DeBock F, 2003, EUR J NEUROSCI, V17, P1411, DOI 10.1046/j.1460-9568.2003.02544.x; Deng XD, 2011, AM J MED GENET B, V156B, P850, DOI 10.1002/ajmg.b.31233; DEUTCH AY, 1990, PROG BRAIN RES, V85, P367; Doens D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-48; Dumitriu D, 2010, J NEUROSCI, V30, P7507, DOI 10.1523/JNEUROSCI.6410-09.2010; El-Hassar L, 2014, BIOL PSYCHIAT, V76, P476, DOI 10.1016/j.biopsych.2013.12.019; Elliott AE, 2008, NEUROBIOL LEARN MEM, V90, P616, DOI 10.1016/j.nlm.2008.06.012; Elston GN, 2006, ANAT REC PART A, V288A, P26, DOI 10.1002/ar.a.20278; ENGBERG G, 1991, N-S ARCH PHARMACOL, V343, P472; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Fan Y, 2013, SYNAPSE, V67, P300, DOI 10.1002/syn.21641; Ferry B, 1999, J NEUROSCI, V19, P5119; Fox H, 2015, J PSYCHOPHARMACOL, V29, P312, DOI 10.1177/0269881114562464; Gartner M, 2014, PSYCHONEUROENDOCRINO, V43, P105, DOI 10.1016/j.psyneuen.2014.02.009; Gamo NJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.104; Gamo NJ, 2015, BIOL PSYCHIAT, V78, P860, DOI 10.1016/j.biopsych.2015.01.009; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; Gilabert-Juan J, 2013, BRAIN STRUCT FUNCT, V218, P1591, DOI 10.1007/s00429-012-0479-1; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; GLASS DC, 1971, J EXP SOC PSYCHOL, V7, P244, DOI 10.1016/0022-1031(71)90070-9; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Goldstein LE, 1996, J NEUROSCI, V16, P4787; Grundemann D, 1998, NAT NEUROSCI, V1, P349, DOI 10.1038/1557; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Gyoneva S, 2013, J BIOL CHEM, V288, P15291, DOI 10.1074/jbc.M113.458901; Hains AB, 2015, NEUROBIOL STRESS, V2, P1, DOI 10.1016/j.ynstr.2015.01.001; Hains AB, 2009, P NATL ACAD SCI USA, V106, P17957, DOI 10.1073/pnas.0908563106; Hammen C, 1997, AM J PSYCHIAT, V154, P856; Hayashi-Takagi A, 2014, P NATL ACAD SCI USA, V111, P6461, DOI 10.1073/pnas.1321109111; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Hermans EJ, 2011, SCIENCE, V334, P1151, DOI 10.1126/science.1209603; Hill JJ, 2006, MOL PSYCHIATR, V11, P557, DOI 10.1038/sj.mp.4001792; Ide M, 2010, BIOL PSYCHIAT, V68, P25, DOI 10.1016/j.biopsych.2010.02.016; Johansson L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003142; Katiyar S, 2009, EMBO REP, V10, P866, DOI 10.1038/embor.2009.93; Kauser H, 2013, NEUROSCIENCE, V254, P110, DOI 10.1016/j.neuroscience.2013.09.023; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kim P, 2013, P NATL ACAD SCI USA, V110, P18442, DOI 10.1073/pnas.1308240110; Kirkpatrick B, 2006, J COMP NEUROL, V497, P436, DOI 10.1002/cne.21007; Kobori N, 2011, NEUROSCIENCE, V172, P293, DOI 10.1016/j.neuroscience.2010.10.048; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Kodama T, 2014, BEHAV BRAIN RES, V266, P104, DOI 10.1016/j.bbr.2014.02.009; Kritzer MF, 1998, J COMP NEUROL, V395, P1; Kuhn S, 2013, BIOL PSYCHIAT, V73, P70, DOI 10.1016/j.biopsych.2012.06.029; LEWIS DA, 1987, J NEUROSCI, V7, P1799; Licznerski P, 2013, NEUROSCIENCE, V251, P33, DOI 10.1016/j.neuroscience.2012.09.057; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; MacKenzie KF, 2011, BIOCHEM J, V435, P755, DOI 10.1042/BJ20101184; Matuszewich L, 2014, BEHAV PHARMACOL, V25, P557, DOI 10.1097/FBP.0000000000000061; Mazure C, 1995, DOES STRESS CAUSE PS; Mckee SA, 2015, J PSYCHOPHARMACOL, V29, P300, DOI 10.1177/0269881114562091; MELIA KR, 1992, J NEUROCHEM, V58, P494, DOI 10.1111/j.1471-4159.1992.tb09748.x; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000536; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Miner LH, 2006, J NEUROSCI, V26, P1571, DOI 10.1523/JNEUROSCI.4450-05.2006; MINOR TR, 1984, J EXP PSYCHOL ANIM B, V10, P543, DOI 10.1037/0097-7403.10.4.543; Mizoguchi K, 2000, J NEUROSCI, V20, P1568; Morrow BA, 2004, BRAIN RES, V1027, P173, DOI 10.1016/j.brainres.2004.08.057; MOURADIAN RD, 1991, BRAIN RES, V546, P83, DOI 10.1016/0006-8993(91)91162-T; Murphy BL, 1996, P NATL ACAD SCI USA, V93, P1325, DOI 10.1073/pnas.93.3.1325; NAKANE H, 1994, AM J PHYSIOL-REG I, V267, pR1559, DOI 10.1152/ajpregu.1994.267.6.R1559; Nestler EJ, 1999, BIOL PSYCHIAT, V46, P1131, DOI 10.1016/S0006-3223(99)00158-4; Okawa Y, 2003, FEBS LETT, V535, P183, DOI 10.1016/S0014-5793(02)03883-8; Olver JS, 2015, STRESS HEALTH, V31, P115, DOI 10.1002/smi.2533; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Opler LA, 2016, CNS SPECTRUMS, V21, P12, DOI 10.1017/S1092852914000686; Ota KT, 2014, NAT MED, V20, P535, DOI 10.1038/nm.3513; Paspalas CD, 2013, CEREB CORTEX, V23, P1643, DOI 10.1093/cercor/bhs152; PEARSON RCA, 1985, P NATL ACAD SCI USA, V82, P4531, DOI 10.1073/pnas.82.13.4531; Qin SZ, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00016; Qin SZ, 2009, BIOL PSYCHIAT, V66, P25, DOI 10.1016/j.biopsych.2009.03.006; Radley JJ, 2005, EXP NEUROL, V196, P199, DOI 10.1016/j.expneurol.2005.07.008; RAKIC P, 1994, PROG BRAIN RES, V102, P227; Ramos BP, 2005, BIOL PSYCHIAT, V58, P894, DOI 10.1016/j.biopsych.2005.05.022; Raune D, 2009, EPIDEMIOL PSICHIAT S, V18, P221, DOI 10.1017/S1121189X00000506; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Rodrigues SM, 2009, ANNU REV NEUROSCI, V32, P289, DOI 10.1146/annurev.neuro.051508.135620; Savitz JB, 2014, NEUROSCI BIOBEHAV R, V42, P132, DOI 10.1016/j.neubiorev.2014.02.008; Schwabe L, 2012, J NEUROSCI, V32, P10146, DOI 10.1523/JNEUROSCI.1304-12.2012; Sciolino NR, 2015, NEUROPHARMACOLOGY, V89, P255, DOI 10.1016/j.neuropharm.2014.09.029; Seib LM, 2003, NEUROSCI LETT, V337, P29, DOI 10.1016/S0304-3940(02)01287-9; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; Shansky Rebecca M, 2006, Behav Brain Funct, V2, P8, DOI 10.1186/1744-9081-2-8; Shansky RM, 2009, CEREB CORTEX, V19, P2479, DOI 10.1093/cercor/bhp003; Shansky RM, 2004, MOL PSYCHIATR, V9, P531, DOI 10.1038/sj.mp.4001435; Sinha R, 2004, ANN NY ACAD SCI, V1032, P254, DOI 10.1196/annals.1314.032; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Soares JM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.59; Spyrka J, 2011, BRAIN RES BULL, V85, P363, DOI 10.1016/j.brainresbull.2011.05.008; Szeszko PR, 2008, BIOL PSYCHOL, V79, P103, DOI 10.1016/j.biopsycho.2007.10.011; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Una GL, 2015, PSYCHONEUROENDOCRINO, V51, P101, DOI 10.1016/j.psyneuen.2014.09.020; Van Bockstaele EJ, 1998, J NEUROENDOCRINOL, V10, P743, DOI 10.1046/j.1365-2826.1998.00254.x; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Vyas A, 2002, J NEUROSCI, V22, P6810; Wang M, 2004, SCIENCE, V303, P853, DOI 10.1126/science.1091162; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Wang M, 2013, NEURON, V77, P736, DOI 10.1016/j.neuron.2012.12.032; WATERHOUSE BD, 1980, EXP NEUROL, V69, P30, DOI 10.1016/0014-4886(80)90141-7; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Wilson RS, 2006, NEUROEPIDEMIOLOGY, V27, P143, DOI 10.1159/000095761; Yajima R, 2015, BIOCHEM BIOPH RES CO, V456, P482, DOI 10.1016/j.bbrc.2014.11.111; Yamada K, 2003, EXP BRAIN RES, V152, P52, DOI 10.1007/s00221-003-1519-0; Yanagawa Y, 2014, IMMUNOL LETT, V158, P109, DOI 10.1016/j.imlet.2013.12.015; Yang Y, 2013, P NATL ACAD SCI USA, V110, P12078, DOI 10.1073/pnas.1307849110; Zahrt J, 1997, J NEUROSCI, V17, P8528	150	335	345	7	123	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2015	18	10					1376	1385		10.1038/nn.4087	http://dx.doi.org/10.1038/nn.4087			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CS2OK	26404712	Green Accepted			2022-12-17	WOS:000361910600006
J	Barry, C; Hayman, R; Burgess, N; Jeffery, KJ				Barry, Caswell; Hayman, Robin; Burgess, Neil; Jeffery, Kathryn J.			Experience-dependent rescaling of entorhinal grids	NATURE NEUROSCIENCE			English	Article							PATH-INTEGRATION; PLACE FIELDS; CORTEX; HIPPOCAMPUS; REPRESENTATION; CELLS; MODEL; MAP	The firing pattern of entorhinal 'grid cells' is thought to provide an intrinsic metric for space. We report a strong experience-dependent environmental influence: the spatial scales of the grids (which are aligned and have fixed relative sizes within each animal) vary parametrically with changes to a familiar environment's size and shape. Thus grid scale reflects an interaction between intrinsic, path-integrative calculation of location and learned associations to the external environment.	UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Dept Anat, London WC1E 6BT, England; UCL, Dept Psychol, London WC1H 0AP, England	University of London; University College London; University of London; University College London; University of London; University College London	Barry, C (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.		Jeffery, Kathryn J/C-2409-2008; Burgess, Neil/B-2420-2009	Jeffery, Kathryn J/0000-0002-9495-0378; Burgess, Neil/0000-0003-0646-6584; Hayman, Robin/0000-0003-1075-0430	Medical Research Council [G0501672] Funding Source: Medline; MRC [G0501672] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barry C, 2006, REV NEUROSCIENCE, V17, P71; BROOKINGS T, 2006, PREPINT; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Gorchetchnikov A, 2007, NEURAL NETWORKS, V20, P182, DOI 10.1016/j.neunet.2006.11.007; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Kloosterman F, 2004, HIPPOCAMPUS, V14, P1026, DOI 10.1002/hipo.20022; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572	15	335	340	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					682	684		10.1038/nn1905	http://dx.doi.org/10.1038/nn1905			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17486102				2022-12-17	WOS:000246799800008
J	Isoda, M; Hikosaka, O				Isoda, Masaki; Hikosaka, Okihide			Switching from automatic to controlled action by monkey medial frontal cortex	NATURE NEUROSCIENCE			English	Article							PRESUPPLEMENTARY MOTOR AREA; SUPPLEMENTARY EYE FIELD; MEMORY-GUIDED SACCADES; NEURONAL-ACTIVITY; ELECTRICAL-STIMULATION; MACAQUE MONKEY; SUBTHALAMIC NUCLEUS; RESPONSE-CONFLICT; BASAL GANGLIA; PRE-SMA	Human behavior is mostly composed of habitual actions that require little conscious control. Such actions may become invalid if the environment changes, at which point individuals need to switch behavior by overcoming habitual actions that are otherwise triggered automatically. It is unknown how the brain controls this type of behavioral switching. Here we show that the presupplementary motor area ( pre- SMA) in the medial frontal cortex has a function in switching from automatic to volitionally controlled action in rhesus macaque monkeys. We found that a group of pre- SMA neurons was selectively activated when subjects successfully switched to a controlled alternative action. Electrical stimulation in the pre- SMA replaced automatic incorrect responses with slower correct responses. A further test suggested that the pre- SMA enabled switching by first suppressing an automatic unwanted action and then boosting a controlled desired action. Our data suggest that the pre- SMA resolves response conflict so that the desired action can be selected.	NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Isoda, M (corresponding author), NEI, Sensorimotor Res Lab, NIH, 49 Convent Dr, Bethesda, MD 20892 USA.	isodam@nei.nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL EYE INSTITUTE [ZIAEY000415, Z01EY000415] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Burman DD, 1997, J NEUROPHYSIOL, V77, P2252, DOI 10.1152/jn.1997.77.5.2252; Ding L, 2006, J NEUROSCI, V26, P6695, DOI 10.1523/JNEUROSCI.0836-06.2006; DOVE E, 2000, BRAIN RES COGN BRAIN, V9, P103; Fujii N, 2002, J NEUROPHYSIOL, V87, P2158, DOI 10.1152/jn.00867.2001; Garavan H, 2003, NEUROIMAGE, V20, P1132, DOI 10.1016/S1053-8119(03)00334-3; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1993, EXP BRAIN RES, V95, P457; HUERTA MF, 1987, J COMP NEUROL, V265, P332, DOI 10.1002/cne.902650304; Husain M, 2003, NAT NEUROSCI, V6, P117, DOI 10.1038/nn1005; Inase M, 1999, BRAIN RES, V833, P191, DOI 10.1016/S0006-8993(99)01531-0; Isoda M, 2005, J NEUROPHYSIOL, V93, P3016, DOI 10.1152/jn.01176.2004; Izawa Y, 2004, J NEUROPHYSIOL, V92, P2248, DOI 10.1152/jn.01021.2003; Izawa Y, 2004, J NEUROPHYSIOL, V92, P2261, DOI 10.1152/jn.00085.2004; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; LOGAN GD, 1980, COGNITIVE PSYCHOL, V12, P523, DOI 10.1016/0010-0285(80)90019-5; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; LUPPINO G, 1991, J COMP NEUROL, V311, P466; Matsuzaka Y, 1996, J NEUROPHYSIOL, V76, P2327, DOI 10.1152/jn.1996.76.4.2327; MATSUZAKA Y, 1992, J NEUROPHYSIOL, V68, P653, DOI 10.1152/jn.1992.68.3.653; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Nakamura K, 1998, J NEUROPHYSIOL, V80, P2671, DOI 10.1152/jn.1998.80.5.2671; Nambu A, 2000, J NEUROPHYSIOL, V84, P289, DOI 10.1152/jn.2000.84.1.289; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; PARENT A, 1984, BRAIN RES, V303, P385, DOI 10.1016/0006-8993(84)91224-1; PARTHASARATHY HB, 1992, J NEUROSCI, V12, P4468; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; Schneider W, 2003, COGNITIVE SCI, V27, P525, DOI 10.1016/S0364-0213(03)00011-9; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Shima K, 1996, P NATL ACAD SCI USA, V93, P8694, DOI 10.1073/pnas.93.16.8694; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; Stuphorn V, 2006, NAT NEUROSCI, V9, P925, DOI 10.1038/nn1714; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Wang Y, 2005, NEUROSCI RES, V53, P1, DOI 10.1016/j.neures.2005.05.005; Yamamoto J, 2004, BRAIN, V127, P873, DOI 10.1093/brain/awh110; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931; [No title captured]	49	335	340	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					240	248		10.1038/nn1830	http://dx.doi.org/10.1038/nn1830			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17237780				2022-12-17	WOS:000244175200019
J	Truccolo, W; Donoghue, JA; Hochberg, LR; Eskandar, EN; Madsen, JR; Anderson, WS; Brown, EN; Halgren, E; Cash, SS				Truccolo, Wilson; Donoghue, Jacob A.; Hochberg, Leigh R.; Eskandar, Emad N.; Madsen, Joseph R.; Anderson, William S.; Brown, Emery N.; Halgren, Eric; Cash, Sydney S.			Single-neuron dynamics in human focal epilepsy	NATURE NEUROSCIENCE			English	Article							HUMAN LIMBIC NEURONS; EPILEPTIFORM ACTIVITY; ENTORHINAL CORTEX; SPIKING ACTIVITY; FIRING PATTERNS; SEIZURES; BRAIN; TERMINATION; INITIATION; ENSEMBLE	Epileptic seizures are traditionally characterized as the ultimate expression of monolithic, hypersynchronous neuronal activity arising from unbalanced runaway excitation. Here we report the first examination of spike train patterns in large ensembles of single neurons during seizures in persons with epilepsy. Contrary to the traditional view, neuronal spiking activity during seizure initiation and spread was highly heterogeneous, not hypersynchronous, suggesting complex interactions among different neuronal groups even at the spatial scale of small cortical patches. In contrast to earlier stages, seizure termination is a nearly homogenous phenomenon followed by an almost complete cessation of spiking across recorded neuronal ensembles. Notably, even neurons outside the region of seizure onset showed significant changes in activity minutes before the seizure. These findings suggest a revision of current thinking about seizure mechanisms and point to the possibility of seizure prevention based on spiking activity in neocortical neurons.	[Truccolo, Wilson; Donoghue, Jacob A.; Hochberg, Leigh R.; Cash, Sydney S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Truccolo, Wilson; Donoghue, Jacob A.; Hochberg, Leigh R.; Eskandar, Emad N.; Madsen, Joseph R.; Anderson, William S.; Brown, Emery N.; Cash, Sydney S.] Harvard Univ, Sch Med, Boston, MA USA; [Truccolo, Wilson] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Truccolo, Wilson; Hochberg, Leigh R.] Brown Univ, Inst Brain Sci, Providence, RI 02912 USA; [Truccolo, Wilson; Hochberg, Leigh R.] Rehabil Res & Dev Serv, Dept Vet Affairs, Providence, RI USA; [Hochberg, Leigh R.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Eskandar, Emad N.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Eskandar, Emad N.] Massachusetts Gen Hosp, Nayef Al Rodhan Labs Cellular Neurosurg & Neurosu, Boston, MA 02114 USA; [Madsen, Joseph R.] Childrens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Madsen, Joseph R.; Anderson, William S.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Brown, Emery N.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Brown, Emery N.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Brown, Emery N.] MIT, Div Hlth Sci & Technol, Harvard Massachusetts Inst Technol, Cambridge, MA 02139 USA; [Halgren, Eric] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Halgren, Eric] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Halgren, Eric] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Brown University; Brown University; Brown University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Truccolo, W (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.	wilson_truccolo@brown.edu	Hochberg, Leigh/R-6872-2019	Hochberg, Leigh/0000-0003-0261-2273; Anderson, William/0000-0003-0958-050X	CIMIT; US National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) [NS062092]; NIH-NINDS [5K01NS057389]; NIH [NS018741, DP1OD003646]; NINDS [K08NS066099-01A1]; US National Eye Institute [EY017658]; US National Institute on Drug Abuse [NS063249]; US National Science Foundation [IOB 0645886]; Howard Hughes Medical Institute; Klingenstein Foundation; US Department of Veterans Affairs; Doris Duke Charitable Foundation; Massachusetts General Hospital-Deane Institute for Integrated Research on Atrial Fibrillation and Stroke; NIH-NIDCD [R01DC009899]; NATIONAL EYE INSTITUTE [R01EY017658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K01NS057389, R01NS018741, K08NS066099, R01NS062092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009899] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003646] Funding Source: NIH RePORTER	CIMIT; US National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Klingenstein Foundation(Klingenstein Philanthropies); US Department of Veterans Affairs(US Department of Veterans Affairs); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Massachusetts General Hospital-Deane Institute for Integrated Research on Atrial Fibrillation and Stroke; NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank the patients who participated in this study, as well as the nursing and physician staff at each facility. We also thank A. M. Chan, C.J. Keller, A. Dykstra and J.E. Cormier for technical assistance, and J.P. Donoghue and K.J. Staley for critical reading of the manuscript. This research is funded by a CIMIT grant and US National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) NS062092 to S. S. C.; an NIH-NINDS Career Award (5K01NS057389) to W. T.; NIH NS018741 to E. H.; NINDS K08NS066099-01A1 to W. S. A.; US National Eye Institute EY017658, US National Institute on Drug Abuse NS063249, US National Science Foundation IOB 0645886, Howard Hughes Medical Institute and the Klingenstein Foundation to E.N.E.; NIH Director's Pioneer Award DP1OD003646 to E.N.B.; US Department of Veterans Affairs Career Development Transition Award, Doris Duke Charitable Foundation-Clinical Scientist Development Award, Massachusetts General Hospital-Deane Institute for Integrated Research on Atrial Fibrillation and Stroke, and NIH-NIDCD R01DC009899 to L. R. H. The contents do not represent the views of the Department of Veterans Affairs or the United States government.	Amritkar RE, 2009, INT J BIFURCAT CHAOS, V19, P4263, DOI 10.1142/S0218127409025353; Amritkar RE, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.258102; BABB TL, 1987, ELECTROEN CLIN NEURO, V66, P467, DOI 10.1016/0013-4694(87)90093-9; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bikson M, 2003, J NEUROPHYSIOL, V90, P2402, DOI 10.1152/jn.00467.2003; Bower MR, 2008, J NEUROPHYSIOL, V99, P2431, DOI 10.1152/jn.01369.2007; Bragin A, 1999, EPILEPSIA, V40, P127, DOI 10.1111/j.1528-1157.1999.tb02065.x; Bragin A, 1997, J NEUROSCI, V17, P2567; Buckmaster PS, 2004, COMPARATIVE MED, V54, P473; CONNORS BW, 1984, NATURE, V310, P685, DOI 10.1038/310685a0; Cymerblit-Sabba A, 2010, J NEUROSCI, V30, P1619, DOI 10.1523/JNEUROSCI.5078-09.2010; da Silva FHL, 2003, IEEE T BIO-MED ENG, V50, P540, DOI 10.1109/TBME.2003.810703; DELGADOESCUETA AV, 1983, EPILEPSY, P295; Engel AK, 2005, NAT REV NEUROSCI, V6, P35, DOI 10.1038/nrn1585; Engel Jr J, 1983, CLIN NEUROSCIENCES, P1349; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; HALGREN E, 1977, EPILEPSIA, V18, P89, DOI 10.1111/j.1528-1157.1977.tb05590.x; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Jacobs MP, 2009, EPILEPSY BEHAV, V14, P438, DOI 10.1016/j.yebeh.2009.02.036; Jefferys JGR, 2003, EPILEPSIA, V44, P44, DOI 10.1111/j.0013-9580.2003.12004.x; Jiruska P, 2010, J NEUROSCI, V30, P5690, DOI 10.1523/JNEUROSCI.0535-10.2010; Keller CJ, 2010, BRAIN, V133, P1668, DOI 10.1093/brain/awq112; Kim SP, 2008, J NEURAL ENG, V5, P455, DOI 10.1088/1741-2560/5/4/010; Lado FA, 2008, EPILEPSIA, V49, P1651, DOI 10.1111/j.1528-1167.2008.01669.x; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; MATSUMOTO H, 1964, EXP NEUROL, V9, P305, DOI 10.1016/0014-4886(64)90026-3; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Penfield W, 1954, EPILEPSY FUNCTIONAL; Pinto DJ, 2005, J NEUROSCI, V25, P8131, DOI 10.1523/JNEUROSCI.2278-05.2005; Santhanam G, 2007, IEEE T BIO-MED ENG, V54, P2037, DOI 10.1109/TBME.2007.895753; SAWA M, 1968, ELECTROEN CLIN NEURO, V24, P146, DOI 10.1016/0013-4694(68)90120-X; Schevon CA, 2008, J CLIN NEUROPHYSIOL, V25, P321, DOI 10.1097/WNP.0b013e31818e8010; Schwartzkroin Philip A., 1993, P83; Staba RJ, 2002, J NEUROSCI, V22, P5694; TREIMAN DM, 2001, TREATMENT EPILEPSY P, P681; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Truccolo W, 2008, J NEUROSCI, V28, P1163, DOI 10.1523/JNEUROSCI.4415-07.2008; Truccolo W, 2010, NAT NEUROSCI, V13, P105, DOI 10.1038/nn.2455; Ulbert T, 2004, EPILEPSIA, V45, P48, DOI 10.1111/j.0013-9580.2004.04011.x; WYLER AR, 1982, ANN NEUROL, V11, P301, DOI 10.1002/ana.410110311; Yaari Y, 2002, BRAIN PATHOL, V12, P234; Ziburkus J, 2006, J NEUROPHYSIOL, V95, P3948, DOI 10.1152/jn.01378.2005	42	334	338	3	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					635	U130		10.1038/nn.2782	http://dx.doi.org/10.1038/nn.2782			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21441925	Green Published, Green Accepted			2022-12-17	WOS:000289886600020
J	DeBruyne, JP; Weaver, DR; Reppert, SM				DeBruyne, Jason P.; Weaver, David R.; Reppert, Steven M.			CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clock	NATURE NEUROSCIENCE			English	Article							EXPRESSION; MAMMALS; MICE	Heterodimers of CLOCK and BMAL1, bHLH-PAS transcription factors, are believed to be the major transcriptional regulators of the circadian clock mechanism in mammals. However, a recent study shows that CLOCK-deficient mice continue to exhibit robust behavioral and molecular rhythms. Here we report that the transcription factor NPAS2 ( MOP4) is able to functionally substitute for CLOCK in the master brain clock in mice to regulate circadian rhythmicity.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	steven.reppert@umassmed.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Weaver, David/0000-0001-7941-6719; DeBruyne, Jason/0000-0001-9803-9568	NIGMS NIH HHS [F32 GM074277-02, F32 GM074277] Funding Source: Medline; NINDS NIH HHS [R01 NS056125-02, R01 NS047141, R01 NS056125, R01 NS047141-05, R01 NS056125-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056125, R01NS047141] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Green CB, 2003, SCIENCE, V301, P319, DOI 10.1126/science.1087824; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Shearman LP, 1999, NEUROSCIENCE, V89, P387, DOI 10.1016/S0306-4522(98)00325-X; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	13	334	350	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					543	545		10.1038/nn1884	http://dx.doi.org/10.1038/nn1884			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17417633	Green Published, Green Accepted			2022-12-17	WOS:000245948000007
J	Lu, L; Hope, BT; Dempsey, J; Liu, SY; Bossert, JM; Shaham, Y				Lu, L; Hope, BT; Dempsey, J; Liu, SY; Bossert, JM; Shaham, Y			Central amygdala ERK signaling pathway is critical to incubation of cocaine craving	NATURE NEUROSCIENCE			English	Article							MESOLIMBIC DOPAMINE SYSTEM; VENTRAL TEGMENTAL AREA; MAP KINASE CASCADE; EXCITOTOXIC LESIONS; SEEKING BEHAVIOR; BASOLATERAL AMYGDALA; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; REGULATED KINASE; PROTEIN-KINASE	Using a rat model of craving and relapse, we have previously found time-dependent increases in cue-induced cocaine seeking over the first months of withdrawal from cocaine, suggesting that drug craving incubates over time. Here, we explored the role of the amygdala extracellular signal-regulated kinase (ERK) signaling pathway in this incubation. Cocaine seeking induced by exposure to cocaine cues was substantially higher after 30 withdrawal days than after 1 withdrawal day. Exposure to these cues increased ERK phosphorylation in the central, but not the basolateral, amygdala after 30 d, but not 1 d, of withdrawal. After 30 d of withdrawal from cocaine, inhibition of central, but not basolateral, amygdala ERK phosphorylation decreased cocaine seeking. After 1 d of withdrawal, stimulation of central amygdala ERK phosphorylation increased cocaine seeking. Results suggest that the incubation of cocaine craving is mediated by time-dependent increases in the responsiveness of the central amygdala ERK pathway to cocaine cues.	NIDA, NIH, Dept HHS, Intramural Res Program,Behav Neurosci Branch, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Shaham, Y (corresponding author), NIDA, NIH, Dept HHS, Intramural Res Program,Behav Neurosci Branch, 5500 Nathan Shock Dr, Baltimore, MD 21224 USA.	yshaham@intra.nida.nih.gov	shaham, yavin/G-1306-2014; Hope, Bruce T/A-9223-2010	Hope, Bruce T/0000-0001-5804-7061	NATIONAL INSTITUTE ON DRUG ABUSE [Z01DA000434, ZIADA000434] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Berhow MT, 1996, J NEUROSCI, V16, P4707; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; BURNS LH, 1993, BEHAV BRAIN RES, V55, P167, DOI 10.1016/0166-4328(93)90113-5; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Davis M, 2003, ANN NY ACAD SCI, V985, P218; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Everitt BJ, 2002, J NEUROSCI, V22, P3312; EYSENCK HJ, 1968, BEHAV RES THER, V6, P309, DOI 10.1016/0005-7967(68)90064-8; FIORE RS, 1993, J NEUROCHEM, V61, P1626, DOI 10.1111/j.1471-4159.1993.tb09796.x; Gallagher M, 1996, CURR OPIN NEUROBIOL, V6, P221, DOI 10.1016/S0959-4388(96)80076-6; GAWIN FH, 1986, ARCH GEN PSYCHIAT, V43, P107; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Grimm JW, 2003, J NEUROSCI, V23, P742; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Hayes RJ, 2003, PSYCHOPHARMACOLOGY, V168, P75, DOI 10.1007/s00213-002-1328-3; Holland PC, 2003, EUR J NEUROSCI, V17, P1680, DOI 10.1046/j.1460-9568.2003.02585.x; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Licata SC, 2003, J NEUROCHEM, V85, P14, DOI 10.1046/j.1471-4159.2003.01662.x; Lu KT, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0005.2001; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Lu L, 2004, NEUROPHARMACOLOGY, V47, P214, DOI 10.1016/j.neuropharm.2004.06.027; Lu L, 2004, PSYCHOPHARMACOLOGY, V176, P101, DOI 10.1007/s00213-004-1860-4; Lu L, 2003, J NEUROCHEM, V85, P1604, DOI 10.1046/j.1471-4159.2003.01824.x; Neisewander JL, 2000, J NEUROSCI, V20, P798, DOI 10.1523/JNEUROSCI.20-02-00798.2000; Nestler EJ, 2002, NEUROBIOL LEARN MEM, V78, P637, DOI 10.1006/nlme.2002.4084; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; OBrien CP, 1997, SCIENCE, V278, P66, DOI 10.1126/science.278.5335.66; OVERTON DA, 1974, FED PROC, V33, P1800; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Robledo P, 1996, BEHAV NEUROSCI, V110, P981, DOI 10.1037/0735-7044.110.5.981; Schafe GE, 2000, J NEUROSCI, V20, P8177; See RE, 2002, PHARMACOL BIOCHEM BE, V71, P517, DOI 10.1016/S0091-3057(01)00682-7; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Shalev U, 2002, PHARMACOL REV, V54, P1, DOI 10.1124/pr.54.1.1; Stewart J, 2004, NEBR SYM MOTIV, V50, P197; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Valjent E, 2000, J NEUROSCI, V20, P8701; Whitelaw RB, 1996, PSYCHOPHARMACOLOGY, V127, P213, DOI 10.1007/BF02805996; WISE RA, 1992, SYNAPSE, V10, P247, DOI 10.1002/syn.890100307; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006	50	334	340	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					212	219		10.1038/nn1383	http://dx.doi.org/10.1038/nn1383			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	892GN	15657599				2022-12-17	WOS:000226638200021
J	Lu, WY; Xiong, ZG; Lei, S; Orser, BA; Dudek, E; Browning, MD; MacDonald, JF				Lu, WY; Xiong, ZG; Lei, S; Orser, BA; Dudek, E; Browning, MD; MacDonald, JF			G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; MUSCARINIC ACETYLCHOLINE-RECEPTOR; CA1 HIPPOCAMPAL-NEURONS; D-ASPARTATE RECEPTORS; TYROSINE KINASE; GLUTAMATE RECEPTORS; MAP KINASE; ACTIVATION; CURRENTS; PYK2	The N-methyl-D-aspartate (NMDA) receptor contributes to synaptic plasticity in the central nervous system and is both serine-threonine and tyrosine phosphorylated. In CA1 pyramidal neurons of the hippocampus, activators of protein kinase C (PKC) as well as the G-protein-coupled receptor ligands muscarine and lysophosphatidic acid enhanced NMDA-evoked currents. Unexpectedly, this effect was blocked by inhibitors of tyrosine kinases, including a Src required sequence and an antibody selective for Src itself. In neurons from mice lacking c-Src, PKC-dependent upregulation was absent. Thus, G-protein-coupled receptors can regulate NMDA receptor function indirectly through a PKC-dependent activation of the non-receptor tyrosine kinase (Src) signaling cascade.	Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Pharmacol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Anaesthesia, Toronto, ON M5S 1A8, Canada; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Program Neurosci, Denver, CO 80262 USA	University of Toronto; University of Toronto; University of Toronto; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	MacDonald, JF (corresponding author), Univ Toronto, Dept Physiol, Med Sci Bldg, Toronto, ON M5S 1A8, Canada.		Lu, Wei-Yang/K-4404-2013					Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BENARI Y, 1992, TRENDS NEUROSCI, V15, P333, DOI 10.1016/0166-2236(92)90049-E; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CONSTANTINEPATON M, 1990, COLD SPRING HARB SYM, V55, P431; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Felsch JS, 1998, P NATL ACAD SCI USA, V95, P5051, DOI 10.1073/pnas.95.9.5051; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; HEMMINGS HCJ, 1997, REGULATORY PROTEIN M, P121; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Igishi T, 1998, BIOCHEM BIOPH RES CO, V244, P5, DOI 10.1006/bbrc.1998.8208; KELSO SR, 1992, J PHYSIOL-LONDON, V449, P705, DOI 10.1113/jphysiol.1992.sp019110; Kojima N, 1997, P NATL ACAD SCI USA, V94, P4761, DOI 10.1073/pnas.94.9.4761; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Levey AI, 1996, P NATL ACAD SCI USA, V93, P13541, DOI 10.1073/pnas.93.24.13541; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; MACDONALD JF, 1989, J PHYSIOL-LONDON, V414, P17, DOI 10.1113/jphysiol.1989.sp017674; Marino MJ, 1998, P NATL ACAD SCI USA, V95, P11465, DOI 10.1073/pnas.95.19.11465; MARKRAM H, 1992, J PHYSIOL-LONDON, V457, P491, DOI 10.1113/jphysiol.1992.sp019389; ODELL TJ, 1992, COLD SPRING HARB SYM, V57, P517, DOI 10.1101/SQB.1992.057.01.057; PARFITT KD, 1993, J PHYSIOL-LONDON, V471, P245, DOI 10.1113/jphysiol.1993.sp019900; ROCHE S, 1995, SCIENCE, V269, P1567, DOI 10.1126/science.7545311; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; WANG LY, 1995, J PHYSIOL-LONDON, V486, P83, DOI 10.1113/jphysiol.1995.sp020792; WANG LY, 1994, NATURE, V369, P230, DOI 10.1038/369230a0; Wheal HV, 1998, PROG NEUROBIOL, V55, P611, DOI 10.1016/S0301-0082(98)00026-4; Xiong ZG, 1998, MOL PHARMACOL, V54, P1055, DOI 10.1124/mol.54.6.1055; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zheng F, 1998, NAT NEUROSCI, V1, P185, DOI 10.1038/634; ZUKIN RS, 1995, TRENDS NEUROSCI, V18, P306, DOI 10.1016/0166-2236(95)93920-S	36	334	344	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					331	338		10.1038/7243	http://dx.doi.org/10.1038/7243			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200GV	10204539				2022-12-17	WOS:000080532000011
J	Benard, G; Massa, F; Puente, N; Lourenco, J; Bellocchio, L; Soria-Gomez, E; Matias, I; Delamarre, A; Metna-Laurent, M; Cannich, A; Hebert-Chatelain, E; Mulle, C; Ortega-Gutierrez, S; Martin-Fontecha, M; Klugmann, M; Guggenhuber, S; Lutz, B; Gertsch, J; Chaouloff, F; Lopez-Rodriguez, ML; Grandes, P; Rossignol, R; Marsicano, G				Benard, Giovanni; Massa, Federico; Puente, Nagore; Lourenco, Joana; Bellocchio, Luigi; Soria-Gomez, Edgar; Matias, Isabel; Delamarre, Anna; Metna-Laurent, Mathilde; Cannich, Astrid; Hebert-Chatelain, Etienne; Mulle, Christophe; Ortega-Gutierrez, Silvia; Martin-Fontecha, Mar; Klugmann, Matthias; Guggenhuber, Stephan; Lutz, Beat; Gertsch, Juerg; Chaouloff, Francis; Lopez-Rodriguez, Maria Luz; Grandes, Pedro; Rossignol, Rodrigue; Marsicano, Giovanni			Mitochondrial CB1 receptors regulate neuronal energy metabolism	NATURE NEUROSCIENCE			English	Article							CANNABINOID RECEPTOR; COMPLEX-I; ENDOCANNABINOID SYSTEM; PHOSPHORYLATION; PHARMACOLOGY; HIPPOCAMPUS; INHIBITION; TRANSPORT; OXIDASE	The mammalian brain is one of the organs with the highest energy demands, and mitochondria are key determinants of its functions. Here we show that the type-1 cannabinoid receptor (CB1) is present at the membranes of mouse neuronal mitochondria (mtCB(1)), where it directly controls cellular respiration and energy production. Through activation of mtCB(1) receptors, exogenous cannabinoids and in situ endocannabinoids decreased cyclic AMP concentration, protein kinase A activity, complex I enzymatic activity and respiration in neuronal mitochondria. In addition, intracellular CB1 receptors and mitochondria, mechanisms contributed to endocannabinoid-dependent depolarization-induced suppression of inhibition in the hippocampus. Thus, mtCB(1) receptors directly modulate neuronal energy metabolism, revealing a new mechanism of action of G protein-coupled receptor signaling in the brain.	[Benard, Giovanni; Massa, Federico; Lourenco, Joana; Bellocchio, Luigi; Soria-Gomez, Edgar; Matias, Isabel; Delamarre, Anna; Metna-Laurent, Mathilde; Cannich, Astrid; Hebert-Chatelain, Etienne; Chaouloff, Francis; Marsicano, Giovanni] INSERM, U862, Neuroctr Magendie, Bordeaux, France; [Benard, Giovanni; Rossignol, Rodrigue] Univ Bordeaux, EA 4576, Bordeaux, France; [Benard, Giovanni; Massa, Federico; Lourenco, Joana; Bellocchio, Luigi; Soria-Gomez, Edgar; Matias, Isabel; Delamarre, Anna; Metna-Laurent, Mathilde; Cannich, Astrid; Hebert-Chatelain, Etienne; Mulle, Christophe; Chaouloff, Francis; Rossignol, Rodrigue; Marsicano, Giovanni] Univ Bordeaux, Neuroctr Magendie, U862, Bordeaux, France; [Puente, Nagore; Grandes, Pedro] Univ Basque Country, Fac Med & Dent, Dept Neurosci, UPV EHU, Leioa, Spain; [Lourenco, Joana; Mulle, Christophe] Ctr Natl Rech Sci, Lab Physiol Cellulaire Synapse, UMR 5091, Bordeaux, France; [Ortega-Gutierrez, Silvia; Martin-Fontecha, Mar; Lopez-Rodriguez, Maria Luz] Univ Complutense, Dept Organ Chem, E-28040 Madrid, Spain; [Klugmann, Matthias; Guggenhuber, Stephan; Lutz, Beat] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, Mainz, Germany; [Klugmann, Matthias] Univ New S Wales, Sch Med Sci, Dept Physiol, Sydney, NSW, Australia; [Gertsch, Juerg] Inst Biochem & Mol Med, Bern, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; University of Basque Country; Centre National de la Recherche Scientifique (CNRS); Complutense University of Madrid; Johannes Gutenberg University of Mainz; University of New South Wales Sydney	Marsicano, G (corresponding author), INSERM, U862, Neuroctr Magendie, Bordeaux, France.	giovanni.marsicano@inserm.fr	Lutz, Beat/AAG-4538-2022; Grandes, Pedro/AAA-1627-2019; Marsicano, Giovanni/I-9603-2016; Soria-Gomez, Edgar/AAH-3567-2019; Massa, Federico/C-5697-2011; Lutz, Beat/AFK-6229-2022; Rossignol, Rodrigue/K-7821-2014; Ortega-Gutierrez, Silvia/ABC-7653-2021; Bénard, Giovanni/M-3485-2014; Puente, Nagore/H-7054-2015; Grandes, Pedro/H-7494-2015; Ortega-Gutierrez, Silvia/I-1935-2017; Martin-Fontecha, Mar/D-3428-2014; , Ivan/D-6804-2012; LOPEZ-RODRIGUEZ, MARIA L./S-6342-2016; Chaouloff, Francis/N-7003-2017	Soria-Gomez, Edgar/0000-0002-1361-5915; Massa, Federico/0000-0002-9427-3418; Bénard, Giovanni/0000-0003-0036-9425; Puente, Nagore/0000-0003-0866-5747; Grandes, Pedro/0000-0003-3947-4230; Ortega-Gutierrez, Silvia/0000-0002-0257-6754; Martin-Fontecha, Mar/0000-0002-4848-0109; , Ivan/0000-0002-3108-058X; Gertsch, Jurg/0000-0003-0978-1555; Mulle, Christophe/0000-0003-2709-6615; LOPEZ-RODRIGUEZ, MARIA L./0000-0001-8607-1085; Delamarre, Anna/0000-0002-5916-7433; Chaouloff, Francis/0000-0001-9036-4067; Marsicano, Giovanni/0000-0003-3804-1951	AVENIR/INSERM; INSERM-Agence Nationale de la Recherche [ANR-09RDPOC-006-01]; European Union (REPROBESITY) [HEALTH-F2-2008-223713]; European Research Council (ENDOFOOD) [ERC-2010-StG-260515]; Fondation pour la Recherche Medicate; Region Aquitaine; Fyssen Foundation; University of Bordeaux; Red de Trastornos Adictivos, Instituto de Salud Carlos III [RD07/0001/2001]; Basque Country Government [GIC07/70-IT-432-07]; University of the Basque Country UPV/EHU [UFI11/41]; Comunidad de Madrid [S2010/BMD-2353]; MICINN [SAF2009-07065, SAF2010-22198-C02-01]; Ramon y Cajal program; Deutsche Forschungsgemeinschaft [FOR926]; CONACyT	AVENIR/INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); INSERM-Agence Nationale de la Recherche(Institut National de la Sante et de la Recherche Medicale (Inserm)French National Research Agency (ANR)); European Union (REPROBESITY); European Research Council (ENDOFOOD)(European Research Council (ERC)); Fondation pour la Recherche Medicate(Fondation pour la Recherche Medicale); Region Aquitaine(Region Nouvelle-Aquitaine); Fyssen Foundation; University of Bordeaux; Red de Trastornos Adictivos, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Basque Country Government(Basque Government); University of the Basque Country UPV/EHU; Comunidad de Madrid(Comunidad de Madrid); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Ramon y Cajal program(Spanish Government); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	We thank D. Gonzales, N. Aubailly and all the personnel of the Animal Facility of the NeuroCentre Magendie for mouse care and genotyping; all the members of G.M.'s laboratory for discussions; and A. Bacci, D. Cota, M. Guzman, U. Pagotto, P.V. Piazza and C. Wotjak for critically reading the manuscript. Supported by AVENIR/INSERM (G.M.), INSERM-Agence Nationale de la Recherche (Retour Post-Doc ANR-09RDPOC-006-01 (G.B.), European Union 7th Framework Program (REPROBESITY, HEALTH-F2-2008-223713, G.M. and B.L.), European Research Council (ENDOFOOD, ERC-2010-StG-260515, G.M.), Fondation pour la Recherche Medicate (G.M. and M.M.-L.), Region Aquitaine (G.M.), Fyssen Foundation (E.S.-G.), University of Bordeaux (J.L.), Red de Trastornos Adictivos, Instituto de Salud Carlos III (RD07/0001/2001, P.G.), Basque Country Government (GIC07/70-IT-432-07, PG.), University of the Basque Country UPV/EHU (UFI11/41, P.G.), Comunidad de Madrid (S2010/BMD-2353, M.L.L.-R.), MICINN (SAF2009-07065, PG.; SAF2010-22198-C02-01, M.L.L.-R.), Ramon y Cajal program (S.O.-G.), Deutsche Forschungsgemeinschaft (FOR926, B.L.) and CONACyT (E.S.-G.).	Acin-Perez R, 2011, J BIOL CHEM, V286, P30423, DOI 10.1074/jbc.M111.266379; Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Andreeva AV, 2008, FASEB J, V22, P2821, DOI 10.1096/fj.07-104224; Aquila S, 2010, ANAT REC, V293, P298, DOI 10.1002/ar.21042; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; BARTOVA A, 1976, J BIOL CHEM, V251, P5002; Bellocchio L, 2010, NAT NEUROSCI, V13, P281, DOI 10.1038/nn.2494; Belous AE, 2006, J CELL BIOCHEM, V99, P1165, DOI 10.1002/jcb.20985; Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Costa C, 2008, J NEUROSCI, V28, P8040, DOI 10.1523/JNEUROSCI.1947-08.2008; Gomes I, 2010, AAPS J, V12, P658, DOI 10.1208/s12248-010-9217-x; Guggenhuber S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015707; Gulyas AI, 2004, EUR J NEUROSCI, V20, P441, DOI 10.1111/j.1460-9568.2004.03428.x; Heimann AS, 2007, P NATL ACAD SCI USA, V104, P20588, DOI 10.1073/pnas.0706980105; Helling S, 2008, MOL CELL PROTEOMICS, V7, P1714, DOI 10.1074/mcp.M800137-MCP200; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kilbride SM, 2008, J NEUROCHEM, V106, P826, DOI 10.1111/j.1471-4159.2008.05441.x; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Lyssand JS, 2007, FEBS LETT, V581, P5765, DOI 10.1016/j.febslet.2007.11.044; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; Marsicano G, 2006, J Endocrinol Invest, V29, P27; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Marsicano Giovanni, 2008, P161, DOI 10.1007/978-0-387-74349-3_10; MARTIN BR, 1986, PHARMACOL REV, V38, P45; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Nicholls D., 2002, BIOENERGETICS, V3; Papa S, 2006, IUBMB LIFE, V58, P173, DOI 10.1080/15216540500494516; Pertwee RG, 1999, CURR MED CHEM, V6, P635; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Rozenfeld R, 2008, FASEB J, V22, P2311, DOI 10.1096/fj.07-102731; Ryu H, 2005, P NATL ACAD SCI USA, V102, P13915, DOI 10.1073/pnas.0502878102; Tedesco L, 2010, DIABETES, V59, P2826, DOI 10.2337/db09-1881; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	37	333	340	3	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					558	564		10.1038/nn.3053	http://dx.doi.org/10.1038/nn.3053			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22388959				2022-12-17	WOS:000302114500015
J	Boccara, CN; Sargolini, F; Thoresen, VH; Solstad, T; Witter, MP; Moser, EI; Moser, MB				Boccara, Charlotte N.; Sargolini, Francesca; Thoresen, Veslemoy Hult; Solstad, Trygve; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt			Grid cells in pre- and parasubiculum	NATURE NEUROSCIENCE			English	Article							MEDIAL ENTORHINAL CORTEX; MEMBRANE-POTENTIAL OSCILLATIONS; SPATIAL REPRESENTATION SYSTEM; FREELY MOVING RATS; LAYER-II; RETROHIPPOCAMPAL REGION; HIPPOCAMPAL-FORMATION; PATH-INTEGRATION; DIRECTION CELLS; COGNITIVE MAP	Allocentric space is mapped by a widespread brain circuit of functionally specialized cell types located in interconnected subregions of the hippocampal-parahippocampal cortices. Little is known about the neural architectures required to express this variety of firing patterns. In rats, we found that one of the cell types, the grid cell, was abundant not only in medial entorhinal cortex (MEC), where it was first reported, but also in pre- and parasubiculum. The proportion of grid cells in pre- and parasubiculum was comparable to deep layers of MEC. The symmetry of the grid pattern and its relationship to the theta rhythm were weaker, especially in presubiculum. Pre- and parasubicular grid cells intermingled with head-direction cells and border cells, as in deep MEC layers. The characterization of a common pool of space-responsive cells in architecturally diverse subdivisions of parahippocampal cortex constrains the range of mechanisms that might give rise to their unique functional discharge phenotypes.	[Boccara, Charlotte N.; Sargolini, Francesca; Thoresen, Veslemoy Hult; Solstad, Trygve; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, MTFS, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway; [Boccara, Charlotte N.; Sargolini, Francesca; Thoresen, Veslemoy Hult; Solstad, Trygve; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, MTFS, Ctr Biol Memory, N-7034 Trondheim, Norway; [Sargolini, Francesca] Univ Aix Marseille 1, CNRS, UMR Pole 3C 6155, Lab Neurobiol Cognit, Marseille, France	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, MTFS, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway.	edvard.moser@ntnu.no	Boccara, Charlotte/AAP-8625-2020	Sargolini, Francesca/0000-0002-5038-3746	Kavli Foundation; Norwegian Research Council	Kavli Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission)	We thank R. Skjerpeng for programming, D. Derdikman for help with code, J. Ainge for donating an implanted rat, and A. M. Amundgard, I. Hammer, K. Haugen, K. Jenssen and H. Waade for technical assistance. This work was supported by the Kavli Foundation and a Centre of Excellence grant from the Norwegian Research Council.	ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Cacucci F, 2004, J NEUROSCI, V24, P8265, DOI 10.1523/JNEUROSCI.2635-04.2004; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; Dhillon A, 2000, NEUROSCIENCE, V99, P413, DOI 10.1016/S0306-4522(00)00225-6; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Fricker D, 2009, J PHYSIOL-LONDON, V587, P4249, DOI 10.1113/jphysiol.2009.175349; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Funahashi M, 1997, J PHYSIOL-LONDON, V501, P387, DOI 10.1111/j.1469-7793.1997.387bn.x; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Glasgow SD, 2008, J NEUROPHYSIOL, V100, P2746, DOI 10.1152/jn.90351.2008; Glasgow SD, 2007, J NEUROPHYSIOL, V97, P3868, DOI 10.1152/jn.01306.2006; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Hargreaves EL, 2007, HIPPOCAMPUS, V17, P826, DOI 10.1002/hipo.20316; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; Hasselmo ME, 2008, HIPPOCAMPUS, V18, P1213, DOI 10.1002/hipo.20512; Klink R, 1997, HIPPOCAMPUS, V7, P571; KOHLER C, 1986, J COMP NEUROL, V246, P149, DOI 10.1002/cne.902460202; KOHLER C, 1985, J COMP NEUROL, V236, P504, DOI 10.1002/cne.902360407; Kumar SS, 2007, J NEUROSCI, V27, P1239, DOI 10.1523/JNEUROSCI.3182-06.2007; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; Ranck J.B., 1985, ELECT ACTIVITY ARCHI, P217; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Savelli F, 2008, HIPPOCAMPUS, V18, P1270, DOI 10.1002/hipo.20511; Sharp PE, 1996, CEREB CORTEX, V6, P238, DOI 10.1093/cercor/6.2.238; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; Taube JS, 1995, HIPPOCAMPUS, V5, P569, DOI 10.1002/hipo.450050608; TAUBE JS, 1990, J NEUROSCI, V10, P420; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; VANGROEN T, 1990, BRAIN RES, V518, P227, DOI 10.1016/0006-8993(90)90976-I; Whitlock JR, 2008, P NATL ACAD SCI USA, V105, P14755, DOI 10.1073/pnas.0804216105; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; Witter M. P., 2004, RAT NERVOUS SYSTEM, V3rd, P637; WOUTERLOOD FG, 1995, J NEUROCYTOL, V24, P135, DOI 10.1007/BF01181556; Yoshida M, 2009, J NEUROSCI, V29, P4945, DOI 10.1523/JNEUROSCI.5154-08.2009	50	333	338	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					987	U112		10.1038/nn.2602	http://dx.doi.org/10.1038/nn.2602			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20657591				2022-12-17	WOS:000280400600018
J	Lo, CC; Wang, XJ				Lo, Chung-Chuan; Wang, Xiao-Jing			Cortico-basal ganglia circuit mechanism for a decision threshold in reaction time tasks	NATURE NEUROSCIENCE			English	Article							SACCADIC EYE-MOVEMENTS; MONKEY SUPERIOR COLLICULUS; NIGRA PARS RETICULATA; PERCEPTUAL DECISION; SENSORY STIMULI; CAUDATE NEURONS; REWARD; BRAIN; DOPAMINE; MODULATION	Growing evidence from primate neurophysiology and modeling indicates that in reaction time tasks, a perceptual choice is made when the firing rate of a selective cortical neural population reaches a threshold. This raises two questions: what is the neural substrate of the threshold and how can it be adaptively tuned according to behavioral demands? Using a biophysically based network model of spiking neurons, we show that local dynamics in the superior colliculus gives rise to an all-or-none burst response that signals threshold crossing in upstream cortical neurons. Furthermore, the threshold level depends only weakly on the efficacy of the cortico-collicular pathway. In contrast, the threshold and the rate of reward harvest are sensitive to, and hence can be optimally tuned by, the strength of cortico-striatal synapses, which are known to be modifiable by dopamine-dependent plasticity. Our model provides a framework to describe the main computational steps in a reaction time task and suggests that separate brain pathways are critical to the detection and adjustment of a decision threshold.	Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02254 USA	Brandeis University	Wang, XJ (corresponding author), Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02254 USA.	xjwang@brandeis.edu	Lo, Chung-Chuan/C-3951-2008; Wang, Xiao-Jing/D-2722-2009	Lo, Chung-Chuan/0000-0001-7737-7250; 	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062349] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 062349] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Behan M, 2002, J COMP NEUROL, V452, P334, DOI 10.1002/cne.10378; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Brown E, 2005, INT J BIFURCAT CHAOS, V15, P803, DOI 10.1142/S0218127405012478; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; Gruber AJ, 2003, J NEUROPHYSIOL, V90, P1095, DOI 10.1152/jn.00618.2002; Hall WC, 2003, SUPERIOR COLLICULUS; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1230; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P780, DOI 10.1152/jn.1989.61.4.780; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; HOUK JC, 1998, MODEL INFORMATION PR; Jiang H, 2003, NATURE, V423, P982, DOI 10.1038/nature01698; Kawagoe R, 2004, J NEUROPHYSIOL, V91, P1013, DOI 10.1152/jn.00721.2003; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Luce R. D., 1986, RESPONSE TIMES; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Munoz DP, 2000, CAN J PHYSIOL PHARM, V78, P934, DOI 10.1139/cjpp-78-11-934; Munoz DP, 1998, J NEUROPHYSIOL, V79, P1193, DOI 10.1152/jn.1998.79.3.1193; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Pettit DL, 1999, J NEUROPHYSIOL, V81, P1424, DOI 10.1152/jn.1999.81.3.1424; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; Reddi BAJ, 2003, J NEUROPHYSIOL, V90, P3538, DOI 10.1152/jn.00689.2002; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Roitman JD, 2002, J NEUROSCI, V22, P9475; Saito Y, 2004, J NEUROPHYSIOL, V92, P3500, DOI 10.1152/jn.00033.2004; Saito Y, 2003, J NEUROSCI, V23, P5854; Saito Y, 1999, J NEUROPHYSIOL, V82, P754, DOI 10.1152/jn.1999.82.2.754; Sato M, 2002, J NEUROSCI, V22, P2363, DOI 10.1523/JNEUROSCI.22-06-02363.2002; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Scudder CA, 2002, EXP BRAIN RES, V142, P439, DOI 10.1007/s00221-001-0912-9; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Soltani A, 2006, J NEUROSCI, V26, P3731, DOI 10.1523/JNEUROSCI.5159-05.2006; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1403, DOI 10.1152/jn.00740.2003; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; WICKENS J, 1997, NETWORK COMP NEURAL, V8, P77; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006	50	333	338	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					956	963		10.1038/nn1722	http://dx.doi.org/10.1038/nn1722			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16767089				2022-12-17	WOS:000238590800023
J	Trevisani, M; Smart, D; Gunthorpe, MJ; Tognetto, M; Barbieri, M; Campi, B; Amadesi, S; Gray, J; Jerman, JC; Brough, SJ; Owen, D; Smith, GD; Randall, AD; Harrison, S; Bianchi, A; Davis, JB; Geppetti, P				Trevisani, M; Smart, D; Gunthorpe, MJ; Tognetto, M; Barbieri, M; Campi, B; Amadesi, S; Gray, J; Jerman, JC; Brough, SJ; Owen, D; Smith, GD; Randall, AD; Harrison, S; Bianchi, A; Davis, JB; Geppetti, P			Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; CAPSAICIN RECEPTOR; SENSORY NEURONS; PAIN; BRADYKININ; CHANNEL; HEAT; SENSITIZATION; CAPSAZEPINE; ANANDAMIDE	The vanilloid receptor-1 (VR1) is a heat-gated ion channel that is responsible for the burning sensation elicited by capsaicin. A similar sensation is reported by patients with esophagitis when they consume alcoholic beverages or are administered alcohol by injection as a medical treatment. We report here that ethanol activates primary sensory neurons, resulting in neuropeptide release or plasma extravasation in the esophagus, spinal cord or skin. Sensory neurons from trigeminal or dorsal root ganglia as well as VR1-expressing HEK293 cells responded to ethanol in a concentration-dependent and capsazepine-sensitive fashion. Ethanol potentiated the response of VR1 to capsaicin, protons and heat and lowered the threshold for heat activation of VR1 from similar to42degreesC to similar to34degreesC. This provides a likely mechanistic explanation for the ethanol-induced sensory responses that occur at body temperature and for the sensitivity of inflamed tissues to ethanol, such as might be found in esophagitis, neuralgia or wounds.	GlaxoSmithKline, Neurol CEDD, Harlow CM19 5AW, Essex, England; Univ Ferrara, Headache Ctr, Dept Expt & Clin Med, I-44100 Ferrara, Italy; Univ Catania, Dept Pharmacol, I-95123 Catania, Italy; GlaxoSmithKline, Discovery Res, Harlow CM19 5AW, Essex, England	GlaxoSmithKline; University of Ferrara; University of Catania; GlaxoSmithKline	Davis, JB (corresponding author), GlaxoSmithKline, Neurol CEDD, 3rd Ave, Harlow CM19 5AW, Essex, England.		Geppetti, Pierangelo/AHA-7897-2022; barbieri, mario/AAJ-1477-2021	barbieri, mario/0000-0001-9074-764X; Randall, Andrew/0000-0001-8852-3671				BEVAN S, 1992, BRIT J PHARMACOL, V107, P544, DOI 10.1111/j.1476-5381.1992.tb12781.x; BOLANOWSKI SJ, 1995, J PERIODONTAL RES, V30, P192, DOI 10.1111/j.1600-0765.1995.tb01273.x; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Docherty RJ, 1997, BRIT J PHARMACOL, V121, P1461, DOI 10.1038/sj.bjp.0701272; FARDY MJ, 1994, BRIT J ORAL MAX SURG, V32, P387, DOI 10.1016/0266-4356(94)90031-0; Forman SA, 1999, MOL PHARMACOL, V55, P102, DOI 10.1124/mol.55.1.102; Hayes P, 2000, PAIN, V88, P205, DOI 10.1016/S0304-3959(00)00353-5; HOLZER P, 1991, PHARMACOL REV, V43, P143; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Liang YF, 2001, J PHYSIOL-LONDON, V532, P229, DOI 10.1111/j.1469-7793.2001.0229g.x; Nagy I, 1999, J NEUROSCI, V19, P10647, DOI 10.1523/JNEUROSCI.19-24-10647.1999; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; SARIA A, 1983, N-S ARCH PHARMACOL, V324, P212, DOI 10.1007/BF00503897; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Smid SD, 1998, NEUROGASTROENT MOTIL, V10, P403; Stubbs CD, 1999, ALCOHOL CLIN EXP RES, V23, P1552; Tognetto M, 2001, J NEUROSCI, V21, P1104; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Wick MJ, 1998, P NATL ACAD SCI USA, V95, P6504, DOI 10.1073/pnas.95.11.6504; Yiangou Y, 2001, LANCET, V357, P1338, DOI 10.1016/S0140-6736(00)04503-7; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	24	333	353	1	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					546	551		10.1038/nn852	http://dx.doi.org/10.1038/nn852			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	11992116				2022-12-17	WOS:000175874600014
J	Zhang, LI; Bao, SW; Merzenich, MM				Zhang, LI; Bao, SW; Merzenich, MM			Persistent and specific influences of early acoustic environments on primary auditory cortex	NATURE NEUROSCIENCE			English	Article							CORTICAL PLASTICITY; NEURONAL-ACTIVITY; RECEPTIVE-FIELDS; VISUAL-CORTEX; REPRESENTATION; EXPERIENCE; SYSTEM; ADULT; RAT; DRIVEN	This study demonstrates that the adult form of 'tonotopic maps' of sound frequency in the rat primary auditory cortex (A1) arises from parallel developmental processes involving two cortical zones: the progressive differentiation and refinement of selectively tone-responsive receptive fields within an initially broadly-tuned posterior zone, and the progressive loss of tone-evoked, short-latency response over an initially large, very broadly tuned anterior zone. The formation of tonotopic maps in A1 was specifically influenced by a rat pup's early acoustic environments. Exposure to pulsed tones resulted in accelerated emergence and an expansion of A1 representations of those specific tone frequencies, as well as a deteriorated tonotopicity and broader-than-normal receptive fields. Thus, auditory experiences during early postnatal development are important in shaping the functional development of auditory cortical representations of specific acoustic environments.	Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Zhang, LI (corresponding author), Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	lizhang@phy.ucsf.edu			NINDS NIH HHS [NS-10414, NS-34835] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS034835] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; BLATCHLEY BJ, 1987, DEV BRAIN RES, V32, P75, DOI 10.1016/0165-3806(87)90140-4; BRUGGE JF, 1988, HEARING RES, V34, P127, DOI 10.1016/0378-5955(88)90100-1; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CLOPTON BM, 1976, J NEUROPHYSIOL, V39, P1081, DOI 10.1152/jn.1976.39.5.1081; CONDON CD, 1991, BEHAV NEUROSCI, V105, P416, DOI 10.1037/0735-7044.105.3.416; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Eggermont JJ, 1996, AUDIT NEUROSCI, V2, P309; EGGERMONT JJ, 1991, HEARING RES, V57, P45, DOI 10.1016/0378-5955(91)90073-I; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; Fox K, 1996, PROG BRAIN RES, V108, P219, DOI 10.1016/S0079-6123(08)62542-X; FRIAUF E, 1992, EUR J NEUROSCI, V4, P798, DOI 10.1111/j.1460-9568.1992.tb00190.x; FROST DO, 1990, ANN NY ACAD SCI, V608, P92, DOI 10.1111/j.1749-6632.1990.tb48893.x; Gao E, 1998, P NATL ACAD SCI USA, V95, P12663, DOI 10.1073/pnas.95.21.12663; Gao EQ, 2000, P NATL ACAD SCI USA, V97, P8081, DOI 10.1073/pnas.97.14.8081; HARRISON RV, 1993, ACTA OTO-LARYNGOL, V113, P296, DOI 10.3109/00016489309135812; HEIL P, 1992, J COMP NEUROL, V322, P548, DOI 10.1002/cne.903220409; HORIKAWA J, 1988, P JPN ACAD B-PHYS, V64, P260, DOI 10.2183/pjab.64.260; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; KING AJ, 1988, NATURE, V332, P73, DOI 10.1038/332073a0; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Penn AA, 1999, PEDIATR RES, V45, P447, DOI 10.1203/00006450-199904010-00001; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; POON PWF, 1992, BRAIN RES, V585, P391, DOI 10.1016/0006-8993(92)91243-8; PUEL JL, 1987, BRAIN RES, V15, P179; RAJAN R, 1993, J COMP NEUROL, V338, P17, DOI 10.1002/cne.903380104; Rauschecker JP, 1999, TRENDS NEUROSCI, V22, P74, DOI 10.1016/S0166-2236(98)01303-4; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Romand R, 1997, PROG NEUROBIOL, V51, P1, DOI 10.1016/S0301-0082(96)00043-3; SALLY SL, 1988, J NEUROPHYSIOL, V59, P1627, DOI 10.1152/jn.1988.59.5.1627; SANES DH, 1983, SCIENCE, V221, P1183, DOI 10.1126/science.6612332; SANES DH, 1985, J NEUROSCI, V5, P1152; SCHMIDT JT, 1993, J NEUROBIOL, V24, P384, DOI 10.1002/neu.480240310; Sharma J, 2000, NATURE, V404, P841, DOI 10.1038/35009043; Stanton SG, 1996, AUDIT NEUROSCI, V2, P97; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; von Melchner L, 2000, NATURE, V404, P871, DOI 10.1038/35009102; WEINBERGER NM, 1995, ANNU REV NEUROSCI, V18, P129; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; ZILLES K, 1990, CEREBRAL CORTEX RAT, P77	49	333	341	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1123	1130		10.1038/nn745	http://dx.doi.org/10.1038/nn745			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	489AY	11687817				2022-12-17	WOS:000171970900016
J	Lan, JY; Skeberdis, VA; Jover, T; Grooms, SY; Lin, Y; Araneda, RC; Zheng, X; Bennett, MVL; Zukin, RS				Lan, JY; Skeberdis, VA; Jover, T; Grooms, SY; Lin, Y; Araneda, RC; Zheng, X; Bennett, MVL; Zukin, RS			Protein kinase C modulates NMDA receptor trafficking and gating	NATURE NEUROSCIENCE			English	Article							METHYL-D-ASPARTATE; LONG-TERM POTENTIATION; GLUTAMATE RECEPTORS; OPEN PROBABILITY; PYRAMIDAL CELLS; RAT HIPPOCAMPUS; XENOPUS OOCYTES; NR1 SUBUNIT; PHOSPHORYLATION; CHANNEL	Regulation of neuronal N-methyl-D-aspartate receptors (NMDARs) by protein kinases is critical in synaptic transmission. However, the molecular mechanisms underlying protein kinase C (PKC) potentiation of NMDARs are uncertain. Here we demonstrate that PKC increases NMDA channel opening rate and delivers new NMDA channels to the plasma membrane through regulated exocytosis. PKC induced a rapid delivery of functional NMDARs to the cell surface and increased surface NR1 immunofluorescence in Xenopus oocytes expressing NMDARs. PKC potentiation was inhibited by botulinum neurotoxin A and a dominant negative mutant of soluble NSF-associated protein (SNAP-25), suggesting that receptor trafficking occurs via SNARE-dependent exocytosis. In neurons, PKC induced a rapid delivery of functional NMDARs, assessed by electrophysiology, and an increase in NMDAR clusters on the surface of dendrites and dendritic spines, as indicated by immunofluorescence. Thus, PKC regulates NMDAR channel gating and trafficking in recombinant systems and in neurons, mechanisms that may be relevant to synaptic plasticity.	Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Bennett, MVL (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		Araneda, Ricardo/AAN-1051-2020; Bennett, Michael/A-6958-2009	Araneda, Ricardo/0000-0001-8728-3063; Skeberdis, Vytenis Arvydas/0000-0001-7137-3187	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020752, R01NS031282] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 07512, NS 20752, NS 31282] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ANIKSZTEJN L, 1991, EUR J PHARMACOL, V205, P327, DOI 10.1016/0014-2999(91)90921-C; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; Carroll RC, 1998, J NEUROPHYSIOL, V80, P2797, DOI 10.1152/jn.1998.80.5.2797; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chen FS, 1997, BIOCHEMISTRY-US, V36, P5719, DOI 10.1021/bi962331n; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CHEN L, 1991, NEURON, V7, P319, DOI 10.1016/0896-6273(91)90270-A; Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Filippova N, 1999, J PHYSIOL-LONDON, V518, P385, DOI 10.1111/j.1469-7793.1999.0385p.x; Gazzaley AH, 1996, J NEUROSCI, V16, P6830; Genoud S, 1999, J NEUROCHEM, V72, P1699, DOI 10.1046/j.1471-4159.1999.721699.x; GERBER G, 1989, J NEUROSCI, V9, P3606; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; Hrabetova S, 1996, J NEUROSCI, V16, P5324; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; JAHR CE, 1992, SCIENCE, V255, P470, DOI 10.1126/science.1346477; KELSO SR, 1992, J PHYSIOL-LONDON, V449, P705, DOI 10.1113/jphysiol.1992.sp019110; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MARKRAM H, 1990, NEUROSCI LETT, V113, P62, DOI 10.1016/0304-3940(90)90495-U; MORI H, 1993, NEUROREPORT, V4, P519, DOI 10.1097/00001756-199305000-00014; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Okabe S, 1999, J NEUROSCI, V19, P7781; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Pisani A, 1997, BRIT J PHARMACOL, V120, P1007, DOI 10.1038/sj.bjp.0700999; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; ROSSETTO O, 1994, NATURE, V372, P415, DOI 10.1038/372415a0; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; STRONG JA, 1987, NATURE, V325, P714, DOI 10.1038/325714a0; Sweatt JD, 1998, J NEUROCHEM, V71, P1075; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Xiong ZG, 1998, MOL PHARMACOL, V54, P1055, DOI 10.1124/mol.54.6.1055; Yamada Y, 1999, J BIOL CHEM, V274, P6647, DOI 10.1074/jbc.274.10.6647; Yao Y, 1999, CELL, V98, P475, DOI 10.1016/S0092-8674(00)81976-5; Yu SP, 1997, J PHYSIOL-LONDON, V499, P721, DOI 10.1113/jphysiol.1997.sp021964; Zampighi GA, 1999, J GEN PHYSIOL, V113, P507, DOI 10.1085/jgp.113.4.507; Zheng X, 1999, P NATL ACAD SCI USA, V96, P15262, DOI 10.1073/pnas.96.26.15262	50	333	345	1	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					382	390		10.1038/86028	http://dx.doi.org/10.1038/86028			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276228				2022-12-17	WOS:000168762200018
J	Iadecola, C; Zhang, FY; Niwa, K; Eckman, C; Turner, SK; Fischer, E; Younkin, S; Borchelt, DR; Hsiao, KK; Carlson, GA				Iadecola, C; Zhang, FY; Niwa, K; Eckman, C; Turner, SK; Fischer, E; Younkin, S; Borchelt, DR; Hsiao, KK; Carlson, GA			SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein	NATURE NEUROSCIENCE			English	Article							ALZHEIMERS-DISEASE; TRANSGENIC MICE; CHRONIC HYPERTENSION; BLOOD-FLOW; SUPEROXIDE-DISMUTASE; CALCIUM IONOPHORE; BASILAR ARTERY; MOUSE-BRAIN; ARTERIOLES; RESPONSES	Peptides derived from proteolytic processing of the beta-amyloid precursor protein (APP), including the amyloid-beta peptide, are important for the pathogenesis of Alzheimer's dementia. We found that transgenic mice overexpressing APP have a profound and selective impairment in endothelium-dependent regulation of the neocortical microcirculation. Such endothelial dysfunction was not found in transgenic mice expressing both APP and superoxide dismutase-1 (SOD1) or in APP transgenics in which SOD was topically applied to the cerebral cortex. These cerebrovascular effects of peptides derived from APP processing may contribute to the alterations in cerebral blood flow and to neuronal dysfunction in Alzheimer's dementia.	Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; Mayo Clin Jacksonville, Jacksonville, FL 32224 USA; McLaughlin Res Inst, Great Falls, MT 59405 USA; NIAID, Rocky Mt Lab, Hamilton, MT 59840 USA; Johns Hopkins Univ, Sch Med, Div Neuropathol, Baltimore, MD 21205 USA	University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; McLaughlin Research Institute for Biomedical Sciences, Inc.; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University	Iadecola, C (corresponding author), Univ Minnesota, Dept Neurol, 420 Delaware St SE, Minneapolis, MN 55455 USA.	iadec001@tc.umn.edu	Iadecola, c/ABB-8377-2020	Iadecola, Costantino/0000-0001-9797-073X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034179, R01NS034179, R01NS037853, R01NS035806] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35806, NS37853, NS34179] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Blanc EM, 1997, J NEUROCHEM, V68, P1870; Carlson GA, 1997, HUM MOL GENET, V6, P1951, DOI 10.1093/hmg/6.11.1951; Crawford F, 1998, EXP NEUROL, V150, P159, DOI 10.1006/exnr.1997.6743; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; FARACI FM, 1989, STROKE, V20, P242, DOI 10.1161/01.STR.20.2.242; HARRIS ED, 1992, J NUTR, V122, P636, DOI 10.1093/jn/122.suppl_3.636; HATAKE K, 1990, STROKE, V21, P1039, DOI 10.1161/01.STR.21.7.1039; HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270; Hock C, 1997, BRAIN RES, V755, P293, DOI 10.1016/S0006-8993(97)00122-4; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; IADECOLA C, 1990, J CEREBR BLOOD F MET, V10, P608, DOI 10.1038/jcbfm.1990.112; Jagust WJ, 1997, ANN NY ACAD SCI, V826, P254, DOI 10.1111/j.1749-6632.1997.tb48477.x; Johnson KA, 1998, NEUROLOGY, V50, P1563, DOI 10.1212/WNL.50.6.1563; Lendon CL, 1997, JAMA-J AM MED ASSOC, V277, P825, DOI 10.1001/jama.277.10.825; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; MAYHAN WG, 1990, AM J PHYSIOL, V259, pH1455, DOI 10.1152/ajpheart.1990.259.5.H1455; Mayhan WG, 1996, BRAIN RES, V738, P337, DOI 10.1016/S0006-8993(96)01000-1; MAYHAN WG, 1990, AM J PHYSIOL, V258, pH1138, DOI 10.1152/ajpheart.1990.258.4.H1138; MAYHAN WG, 1988, HYPERTENSION, V12, P556, DOI 10.1161/01.HYP.12.6.556; Mentis MJ, 1996, AM J PSYCHIAT, V153, P32; MOHAZZABH KM, 1994, AM J PHYSIOL, V266, pH2568, DOI 10.1152/ajpheart.1994.266.6.H2568; Multhaup G, 1996, SCIENCE, V271, P1406, DOI 10.1126/science.271.5254.1406; NEBOT C, 1993, ANAL BIOCHEM, V214, P442, DOI 10.1006/abio.1993.1521; ROSENBLUM WI, 1986, STROKE, V17, P494, DOI 10.1161/01.STR.17.3.494; ROSENBLUM WI, 1989, STROKE, V20, P1391, DOI 10.1161/01.STR.20.10.1391; ROSENBLUM WI, 1988, STROKE, V19, P1379, DOI 10.1161/01.STR.19.11.1379; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; Sobey CG, 1997, STROKE, V28, P2290, DOI 10.1161/01.STR.28.11.2290; Sobey CG, 1997, STROKE, V28, P837, DOI 10.1161/01.STR.28.4.837; Sobey CG, 1996, STROKE, V27, P927, DOI 10.1161/01.STR.27.5.927; Stamler JS, 1996, NATURE, V380, P108; Thomas T, 1997, NEUROREPORT, V8, P1387, DOI 10.1097/00001756-199704140-00014; Thomas T, 1996, NATURE, V380, P168, DOI 10.1038/380168a0; Wang PH, 1998, P NATL ACAD SCI USA, V95, P4556, DOI 10.1073/pnas.95.8.4556; WANG Q, 1994, J CEREBR BLOOD F MET, V14, P944, DOI 10.1038/jcbfm.1994.126; Warkentin S, 1997, DEMENT GERIATR COGN, V8, P105, DOI 10.1159/000106614; WEI EP, 1985, CIRC RES, V57, P781, DOI 10.1161/01.RES.57.5.781; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; YANG ST, 1991, HYPERTENSION, V17, P612, DOI 10.1161/01.HYP.17.5.612; Zhang FY, 1998, AM J PHYSIOL-REG I, V274, pR1704, DOI 10.1152/ajpregu.1998.274.6.R1704; Zhang FY, 1997, J NEUROSCI, V17, P7655, DOI 10.1523/jneurosci.17-20-07655.1997	46	333	346	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					157	161		10.1038/5715	http://dx.doi.org/10.1038/5715			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160LF	10195200				2022-12-17	WOS:000078231600015
J	Carlen, M; Meletis, K; Goritz, C; Darsalia, V; Evergren, E; Tanigaki, K; Amendola, M; Barnabe-Heider, F; Yeung, MSY; Naldini, L; Honjo, T; Kokaia, Z; Shupliakov, O; Cassidy, RM; Lindvall, O; Frisen, J				Carlen, Marie; Meletis, Konstantinos; Goritz, Christian; Darsalia, Vladimer; Evergren, Emma; Tanigaki, Kenji; Amendola, Mario; Barnabe-Heider, Fanie; Yeung, Maggie S. Y.; Naldini, Luigi; Honjo, Tasuku; Kokaia, Zaal; Shupliakov, Oleg; Cassidy, Robert M.; Lindvall, Olle; Frisen, Jonas			Forebrain ependymal cells are Notch-dependent and generate neuroblasts and astrocytes after stroke	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTION FACTOR HFH-4; ADULT MAMMALIAN BRAIN; RADIAL GLIAL-CELLS; IN-VIVO; RECOMBINANT ADENOVIRUS; SUBVENTRICULAR ZONE; BETA-CELLS; NEUROGENESIS	Neurons are continuously generated from stem cells in discrete regions in the adult mammalian brain. We found that ependymal cells lining the lateral ventricles were quiescent and did not contribute to adult neurogenesis under normal conditions in mice but instead gave rise to neuroblasts and astrocytes in response to stroke. Ependymal cell quiescence was actively maintained by canonical Notch signaling. Inhibition of this pathway in uninjured animals allowed ependymal cells to enter the cell cycle and produce olfactory bulb neurons, whereas forced Notch signaling was sufficient to block the ependymal cell response to stroke. Ependymal cells were depleted by stroke and failed to self-renew sufficiently to maintain their own population. Thus, although ependymal cells act as primary cells in the neural lineage to produce neurons and glial cells after stroke, they do not fulfill defining criteria for stem cells under these conditions and instead serve as a reservoir that is recruited by injury.	[Carlen, Marie; Meletis, Konstantinos; Goritz, Christian; Barnabe-Heider, Fanie; Yeung, Maggie S. Y.; Cassidy, Robert M.; Frisen, Jonas] Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Darsalia, Vladimer; Kokaia, Zaal; Lindvall, Olle] Univ Lund Hosp, Wallenberg Neurosci Ctr, SE-22184 Lund, Sweden; [Darsalia, Vladimer; Kokaia, Zaal; Lindvall, Olle] Univ Lund Hosp, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, SE-22184 Lund, Sweden; [Evergren, Emma; Shupliakov, Oleg] Karolinska Inst, Dept Neurosci, SE-17177 Stockholm, Sweden; [Tanigaki, Kenji; Honjo, Tasuku] Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; [Amendola, Mario; Naldini, Luigi] Ist Sci San Raffaele, Telethon Inst Gene Therapy, I-20132 Milan, Italy	Karolinska Institutet; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Karolinska Institutet; Kyoto University; Fondazione Telethon; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Frisen, J (corresponding author), Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se	Shupliakov, Oleg/R-9148-2016; Carlen, Marie Carlen/C-9112-2014; Kokaia, Zaal/AAL-6009-2020; amendola, mario/I-1728-2017; Göritz, Christian/AAK-5348-2021; Evergren, Emma/X-3677-2019; Naldini, Luigi/E-9083-2012; Honjo, Tasuku/N-4470-2016; Meletis, Konstantinos/ABE-6777-2020; Darsalia, Vladimer/AAF-3608-2019	Shupliakov, Oleg/0000-0001-5352-6848; Carlen, Marie Carlen/0000-0003-1658-1631; Kokaia, Zaal/0000-0003-2296-2449; amendola, mario/0000-0002-1188-8856; Göritz, Christian/0000-0003-0799-766X; Evergren, Emma/0000-0002-0775-2921; Cassidy, Robert/0000-0002-1336-7077; Meletis, Konstantinos/0000-0001-5665-4781; NALDINI, Luigi/0000-0002-7835-527X; Yeung Wong, Maggie/0000-0001-5487-780X; Darsalia, Vladimer/0000-0002-6693-934X	Telethon [TGT06D02] Funding Source: Medline	Telethon(Fondazione Telethon)		AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; BAJOCCHI G, 1993, NAT GENET, V3, P229, DOI 10.1038/ng0393-229; Barnabe-Heider F, 2008, NAT METHODS, V5, P189, DOI 10.1038/NMETH.1174; Blatt EN, 1999, AM J RESP CELL MOL, V21, P168, DOI 10.1165/ajrcmb.21.2.3691; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Consiglio A, 2004, P NATL ACAD SCI USA, V101, P14835, DOI 10.1073/pnas.0404180101; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Davidson BL, 1997, EXP NEUROL, V144, P125, DOI 10.1006/exnr.1996.6398; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dor Y, 2008, CELL, V132, P183, DOI 10.1016/j.cell.2008.01.004; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gregg C, 2003, J NEUROSCI, V23, P11587; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Lim L, 1997, P NATL ACAD SCI USA, V94, P3094, DOI 10.1073/pnas.94.7.3094; LINDVALL O, 2008, ADULT NEUROGENESIS; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mizutani K, 2005, DEVELOPMENT, V132, P1295, DOI 10.1242/dev.01693; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Ostrowski LE, 2003, MOL THER, V8, P637, DOI 10.1016/S1525-0016(03)00221-1; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Simon A, 2007, CELL, V128, P825, DOI 10.1016/j.cell.2007.02.026; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhang RL, 2007, J CEREBR BLOOD F MET, V27, P1201, DOI 10.1038/sj.jcbfm.9600430	44	332	345	2	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2009	12	3					259	267		10.1038/nn.2268	http://dx.doi.org/10.1038/nn.2268			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	410LF	19234458				2022-12-17	WOS:000263577900010
J	Slotnick, SD; Schacter, DL				Slotnick, SD; Schacter, DL			A sensory signature that distinguishes true from false memories	NATURE NEUROSCIENCE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ILLUSORY RECOGNITION MEMORY; EVENT-RELATED FMRI; EXPLICIT MEMORY; EPISODIC RETRIEVAL; PREFRONTAL CORTEX; IMPLICIT MEMORY; OLDER-ADULTS; BRAIN-AREAS; REACTIVATION	Human behavioral studies show that there is greater sensory/perceptual detail associated with true memories than false memories. We therefore hypothesized that true recognition of abstract shapes would elicit greater visual cortical activation than would false recognition. During functional magnetic resonance imaging (fMRI), participants studied exemplar shapes and later made recognition memory decisions ("old" or "new") concerning studied exemplars (old shapes), nonstudied lures (related shapes) and new shapes. Within visual processing regions, direct contrasts between true recognition ("old" response to an old shape; old-hit) and false recognition ("old" response to a related shape; related-false alarm) revealed preferential true recognition-related activity in early visual processing regions (Brodmann area (BA) 17, BA18). By comparison, both true and false recognition were associated with activity in early and late (BA19, BA37) visual processing regions, the late regions potentially supporting "old" responses, independent of accuracy. Further analyses suggested that the differential early visual processing activity reflected repetition priming, a type of implicit memory. Thus, the sensory signature that distinguishes true from false recognition may not be accessible to conscious awareness.	Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University	Slotnick, SD (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	slotnick@wjh.harvard.edu		Schacter, Daniel/0000-0002-2460-6061	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008441, R37AG008441] Funding Source: NIH RePORTER; NIA NIH HHS [AG08441] Funding Source: Medline; NIMH NIH HHS [MH-NS60941] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 1973, STAT METHODS RES WOR; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Bartlett F. C., 1932, REMEMBERING STUDY EX; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Buckner RL, 1996, J NEUROSCI, V16, P6219; Buckner RL, 1998, NEUROIMAGE, V7, P151, DOI 10.1006/nimg.1998.0327; Buckner RL, 1996, PSYCHON B REV, V3, P149, DOI 10.3758/BF03212413; Cabeza R, 2001, P NATL ACAD SCI USA, V98, P4805, DOI 10.1073/pnas.081082698; DEESE J, 1959, J EXP PSYCHOL, V58, P17, DOI 10.1037/h0046671; Dobbins IG, 2004, NATURE, V428, P316, DOI 10.1038/nature02400; Dodson CS, 2002, PSYCHOL AGING, V17, P405, DOI 10.1037//0882-7974.17.3.405; Donaldson DI, 2001, NEURON, V31, P1047, DOI 10.1016/S0896-6273(01)00429-9; Haxby JV, 1996, P NATL ACAD SCI USA, V93, P922, DOI 10.1073/pnas.93.2.922; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RNA, 2000, J COGNITIVE NEUROSCI, V12, P913, DOI 10.1162/08989290051137468; Henson RNA, 2002, CEREB CORTEX, V12, P178, DOI 10.1093/cercor/12.2.178; Konishi S, 2000, NEUROIMAGE, V12, P276, DOI 10.1006/nimg.2000.0614; Koutstaal W, 1999, COGNITIVE NEUROPSYCH, V16, P317, DOI 10.1080/026432999380816; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; Mather M, 1997, MEM COGNITION, V25, P826, DOI 10.3758/BF03211327; Norman KA, 1997, MEM COGNITION, V25, P838, DOI 10.3758/BF03211328; Nyberg L, 2001, NEUROIMAGE, V14, P521, DOI 10.1006/nimg.2001.0801; Nyberg L, 2000, P NATL ACAD SCI USA, V97, P11120, DOI 10.1073/pnas.97.20.11120; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Roediger HL, 1996, J MEM LANG, V35, P76, DOI 10.1006/jmla.1996.0005; Rugg MD, 2003, NEUROPSYCHOLOGIA, V41, P40, DOI 10.1016/S0028-3932(02)00129-X; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; Schacter DL, 1999, AM PSYCHOL, V54, P182, DOI 10.1037/0003-066X.54.3.182; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Schacter DL, 1999, J MEM LANG, V40, P1, DOI 10.1006/jmla.1998.2611; Schacter DL, 1997, NEUROIMAGE, V6, P259, DOI 10.1006/nimg.1997.0305; SCHACTER DL, 1995, NATURE, V376, P587, DOI 10.1038/376587a0; Schacter DL, 1996, NEURON, V17, P267, DOI 10.1016/S0896-6273(00)80158-0; SCHOOLER JW, 1986, J EXP PSYCHOL LEARN, V12, P171, DOI 10.1037/0278-7393.12.2.171; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Uecker A, 1997, LEARN MEMORY, V4, P337, DOI 10.1101/lm.4.4.337; UNDERWOOD BJ, 1965, J EXP PSYCHOL, V70, P122, DOI 10.1037/h0022014; Vaidya CJ, 2002, NEUROPSYCHOLOGIA, V40, P2136, DOI 10.1016/S0028-3932(02)00053-2; Velanova K, 2003, J NEUROSCI, V23, P8460; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Walla P, 1999, NEUROSCI LETT, V269, P129, DOI 10.1016/S0304-3940(99)00430-9; Wheeler ME, 2003, J NEUROSCI, V23, P3869; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X	50	332	336	2	68	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					664	672		10.1038/nn1252	http://dx.doi.org/10.1038/nn1252			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	823VA	15156146				2022-12-17	WOS:000221640300022
J	Repa, JC; Muller, J; Apergis, J; Desrochers, TM; Zhou, Y; LeDoux, JE				Repa, JC; Muller, J; Apergis, J; Desrochers, TM; Zhou, Y; LeDoux, JE			Two different lateral amygdala cell populations contribute to the initiation and storage of memory	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; BASOLATERAL AMYGDALA; CONDITIONED FEAR; MEDIAL GENICULATE; AUDITORY-CORTEX; RESPONSE PROPERTIES; CONSCIOUS CATS; SPIKE TRAINS; SINGLE UNITS; RATS	Single-cell activity was recorded in the dorsal subnucleus of the lateral amygdala (LAd) of freely behaving rats during Pavlovian fear conditioning, to determine the relationship between neuronal activity and behavioral learning. Neuronal responses elicited by the conditioned stimulus typically increased before behavioral fear was evident, supporting the hypothesis that neural changes in LAd account for the conditioning of behavior. Furthermore, two types of these rapidly modified cells were found. Some, located in the dorsal tip of LAd, exhibited short-latency responses (<20 ms) that were only transiently changed. A second class of cells, most commonly found in ventral regions of LAd, had longer latency responses, but maintained enhanced responding throughout training and even through extinction. These anatomically distinct cells in LAd may be differentially involved in the initiation of learning and long-term memory storage.	NYU, Ctr Neural Sci, WM Keck Fdn Lab Neurobiol, New York, NY 10003 USA	New York University	Repa, JC (corresponding author), NYU, Ctr Neural Sci, WM Keck Fdn Lab Neurobiol, 4 Washington Pl,Room 809, New York, NY 10003 USA.		Desrochers, Theresa/A-2654-2011	Desrochers, Theresa/0000-0002-7223-0556	NIMH NIH HHS [F31 MH11659, KO2 MH00956, R01 MH46516, R37 MH38774] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH011659, R01MH046516, K02MH000956, R37MH038774] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amorapanth P, 1999, LEARN MEMORY, V6, P491, DOI 10.1101/lm.6.5.491; Armony JL, 1998, J NEUROSCI, V18, P2592; Bailey DJ, 1999, BEHAV NEUROSCI, V113, P276, DOI 10.1037/0735-7044.113.2.276; BORDI F, 1992, J NEUROSCI, V12, P2493; BORDI F, 1994, EXP BRAIN RES, V98, P275, DOI 10.1007/BF00228415; BOUTON ME, 1980, ANIM LEARN BEHAV, V8, P429, DOI 10.3758/BF03199629; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Cahill L, 1999, NEURON, V23, P227, DOI 10.1016/S0896-6273(00)80774-6; Davis M, 1997, J NEUROPSYCH CLIN N, V9, P382; Doron NN, 1999, J COMP NEUROL, V412, P383; Doron NN, 2000, J COMP NEUROL, V425, P257; EDELINE JM, 1992, BEHAV NEUROSCI, V106, P81, DOI 10.1037/0735-7044.106.1.81; Estes WK, 1941, J EXP PSYCHOL, V29, P390, DOI 10.1037/h0062283; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Fitts P.M., 1967, HUM PERFORM; FOX SE, 1981, EXP BRAIN RES, V41, P399; Gothard KM, 1996, J NEUROSCI, V16, P823; HELMSTETTER FJ, 1994, BEHAV NEUROSCI, V108, P1005, DOI 10.1037/0735-7044.108.5.1005; Hennevin E, 1998, BEHAV NEUROSCI, V112, P839, DOI 10.1037/0735-7044.112.4.839; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Ledoux J E, 1989, J Cogn Neurosci, V1, P238, DOI 10.1162/jocn.1989.1.3.238; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee H, 1998, J NEUROSCI, V18, P8444; Maren S, 2000, EUR J NEUROSCI, V12, P4047, DOI 10.1046/j.1460-9568.2000.00281.x; Maren S, 1999, TRENDS NEUROSCI, V22, P561, DOI 10.1016/S0166-2236(99)01465-4; Maren S, 1996, BEHAV NEUROSCI, V110, P1365, DOI 10.1037/0735-7044.110.6.1365; MCECHRON MD, 1995, BRAIN RES, V682, P157, DOI 10.1016/0006-8993(95)00331-J; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; Muller J, 1997, BEHAV NEUROSCI, V111, P683, DOI 10.1037/0735-7044.111.4.683; Pare D, 1996, J NEUROSCI, V16, P3334; Pare D, 2000, J NEUROSCI, V20, P2701; Paxinos G, 1986, RAT BRAIN STEREOTAXI; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Poremba A, 2001, J NEUROSCI, V21, P270, DOI 10.1523/JNEUROSCI.21-01-00270.2001; Quirk GJ, 1996, COLD SPRING HARB SYM, V61, P247; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schafe GE, 2000, J NEUROSCI, V20, P8177; Weinberger N M, 1993, Curr Opin Neurobiol, V3, P570, DOI 10.1016/0959-4388(93)90058-7; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Wilensky AE, 2000, J NEUROSCI, V20, P7059, DOI 10.1523/JNEUROSCI.20-18-07059.2000	48	332	336	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					724	731		10.1038/89512	http://dx.doi.org/10.1038/89512			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	448HK	11426229				2022-12-17	WOS:000169621300018
J	Wang, XQ; Tsai, JW; LaMonica, B; Kriegstein, AR				Wang, Xiaoqun; Tsai, Jin-Wu; LaMonica, Bridget; Kriegstein, Arnold R.			A new subtype of progenitor cell in the mouse embryonic neocortex	NATURE NEUROSCIENCE			English	Article							RADIAL GLIAL-CELLS; MAMMALIAN NEUROEPITHELIAL CELLS; NEURAL STEM; CORTICAL NEUROGENESIS; ASYMMETRIC INHERITANCE; NEURONAL MIGRATION; RNA INTERFERENCE; CORTEX; DIVISION; EVOLUTION	A hallmark of mammalian brain evolution is cortical expansion, which reflects an increase in the number of cortical neurons established by the progenitor cell subtypes present and the number of their neurogenic divisions. Recent studies have revealed a new class of radial glia-like (oRG) progenitor cells in the human brain, which reside in the outer subventricular zone. Expansion of the subventricular zone and appearance of oRG cells may have been essential evolutionary steps leading from lissencephalic to gyrencephalic neocortex. Here we show that oRG-like progenitor cells are present in the mouse embryonic neocortex. They arise from asymmetric divisions of radial glia and undergo self-renewing asymmetric divisions to generate neurons. Moreover, mouse oRG cells undergo mitotic somal translocation whereby centrosome movement into the basal process during interphase precedes nuclear translocation. Our finding of oRG cells in the developing rodent brain fills a gap in our understanding of neocortical expansion.	[Wang, Xiaoqun; Tsai, Jin-Wu; LaMonica, Bridget] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Wang, Xiaoqun; Tsai, Jin-Wu; LaMonica, Bridget; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [LaMonica, Bridget] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wang, XQ (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	wangx2@stemcell.ucsf.edu; kriegsteina@stemcell.ucsf.edu		Tsai, Jin-Wu/0000-0003-0135-759X; Ostrem, Bridget/0000-0003-2107-3930	Bernard Osher Foundation; US National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072630, R01NS035710, R01NS021223] Funding Source: NIH RePORTER	Bernard Osher Foundation; US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Alvarez-Buylla, D. Lim, C. Harwell, W. P. Ge and L. Fuentealba for comments on the manuscript and members of the Kriegstein laboratory for discussions. We thank W. Walantus and Y.Y. Wang for mouse surgery and technical support and D. V. Hansen and J.H. Lui for ideas and discussion. We thank F. Gage (Salk Institute) for GFP-retrovirus reagents. This work was supported by grants from the Bernard Osher Foundation and the US National Institute of Neurological Disorders and Stroke (to A.R.K.).	Abdel-Mannan O, 2008, BRAIN RES BULL, V75, P398, DOI 10.1016/j.brainresbull.2007.10.047; Carney RSE, 2007, BRAIN STRUCT FUNCT, V212, P37, DOI 10.1007/s00429-007-0142-4; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Cheung AFP, 2007, J ANAT, V211, P164, DOI 10.1111/j.1469-7580.2007.00769.x; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Kamei Y, 1998, GLIA, V23, P191, DOI 10.1002/(SICI)1098-1136(199807)23:3<191::AID-GLIA2>3.0.CO;2-8; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Noctor S.C., 2007, NOVART FDN SYMP, V288, P73; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2007, NOVART FDN SYMP, V288, P96; Noctor Stephen C, 2007, Novartis Found Symp, V288, P59; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107; Rakic P, 2003, GLIA, V43, P19, DOI 10.1002/glia.10244; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Walantus William, 2007, J Vis Exp, P239, DOI 10.3791/239; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435	39	331	337	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					555	U34		10.1038/nn.2807	http://dx.doi.org/10.1038/nn.2807			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21478886	Green Accepted			2022-12-17	WOS:000289886600010
J	Nader, MA; Morgan, D; Gage, HD; Nader, SH; Calhoun, TL; Buchheimer, N; Ehrenkaufer, R; Mach, RH				Nader, Michael A.; Morgan, Drake; Gage, H. Donald; Nader, Susan H.; Calhoun, Tonya L.; Buchheimer, Nancy; Ehrenkaufer, Richard; Mach, Robert H.			PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys	NATURE NEUROSCIENCE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ENDOGENOUS DOPAMINE; NONHUMAN-PRIMATES; VERTICAL SHIFTS; BINDING-SITES; IN-VIVO; DRUG; ADDICTION; MODEL; STRESS	Dopamine neurotransmission is associated with high susceptibility to cocaine abuse. Positron emission tomography was used in 12 rhesus macaques to determine if dopamine D2 receptor availability was associated with the rate of cocaine reinforcement, and to study changes in brain dopaminergic function during maintenance of and abstinence from cocaine. Baseline D2 receptor availability was negatively correlated with rates of cocaine self-administration. D2 receptor availability decreased by 15-20% within 1 week of initiating self-administration and remained reduced by similar to 20% during 1 year of exposure. Long-term reductions in D2 receptor availability were observed, with decreases persisting for up to 1 year of abstinence in some monkeys. These data provide evidence for a predisposition to self-administer cocaine based on D2 receptor availability, and demonstrate that the brain dopamine system responds rapidly following cocaine exposure. Individual differences in the rate of recovery of D2 receptor function during abstinence were noted.	Wake Forest Univ, Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Radiol, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University	Nader, MA (corresponding author), Wake Forest Univ, Sch Med, Dept Physiol & Pharmacol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	mnader@wfubmc.edu	Morgan, Drake/F-6664-2012; Morgan, Drake/A-6373-2008		NIDA NIH HHS [DA 14637, DA 08468] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008468, R01DA014637] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Blum K, 1996, AM SCI, V84, P132; Bradberry CW, 2000, J NEUROSCI, V20, P7109, DOI 10.1523/JNEUROSCI.20-18-07109.2000; Calabresi P, 1997, NEUROSCIENCE, V78, P39; Czoty PW, 2005, SYNAPSE, V58, P215, DOI 10.1002/syn.20200; Dackis C, 2005, NAT NEUROSCI, V8, P1431, DOI 10.1038/nn1105-1431; DEWEY SL, 1995, J NEUROSCI, V15, P821; DEWEY SL, 1992, J NEUROSCI, V12, P3773; Goeders NE, 2002, J PHARMACOL EXP THER, V301, P785, DOI 10.1124/jpet.301.3.785; Griffiths R.R., 1980, ADV SUBSTANC ABUSE, P1; Grigson PS, 2002, BEHAV NEUROSCI, V116, P321, DOI 10.1037/0735-7044.116.2.321; Hietala J, 1997, PSYCHOPHARMACOLOGY, V132, P361, DOI 10.1007/s002130050356; KALIVAS PW, 1989, BIOL PSYCHIAT, V25, P913, DOI 10.1016/0006-3223(89)90271-0; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Laruelle M, 1997, NEUROPSYCHOPHARMACOL, V17, P162, DOI 10.1016/S0893-133X(97)00043-2; Leshner AI, 2000, AM J MED GENET, V96, P590, DOI 10.1002/1096-8628(20001009)96:5<590::AID-AJMG2>3.0.CO;2-2; Leshner AI, 1997, SCIENCE, V278, P45, DOI 10.1126/science.278.5335.45; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Mach RH, 1996, SYNAPSE, V24, P322, DOI 10.1002/(SICI)1098-2396(199612)24:4<322::AID-SYN2>3.0.CO;2-F; Mach RH, 1997, PHARMACOL BIOCHEM BE, V57, P477, DOI 10.1016/S0091-3057(96)00449-2; MACH RH, 1993, NUCL MED BIOL, V20, P777, DOI 10.1016/0969-8051(93)90165-Q; MACH RH, 1993, J MED CHEM, V36, P3707, DOI 10.1021/jm00075a028; MADRAS BK, 1989, J PHARMACOL EXP THER, V251, P131; Martin CR, 2003, NAT REV DRUG DISCOV, V2, P29, DOI 10.1038/nrd988; Mello NK, 1996, NEUROPSYCHOPHARMACOL, V14, P375, DOI 10.1016/0893-133X(95)00274-H; MINTUN MA, 1984, ANN NEUROL, V15, P217, DOI 10.1002/ana.410150302; Moore RJ, 1998, SYNAPSE, V30, P88, DOI 10.1002/(SICI)1098-2396(199809)30:1<88::AID-SYN11>3.0.CO;2-L; Morgan M., 2002, QUALITATIVE RES, V2, P5, DOI [DOI 10.1177/1468794102002001636, 10.1177/1468794102002001636]; Nader MA, 2005, AM J PSYCHIAT, V162, P1473, DOI 10.1176/appi.ajp.162.8.1473; Nader MA, 1999, NEUROPSYCHOPHARMACOL, V21, P589, DOI 10.1016/S0893-133X(98)00101-8; Nader MA, 2002, NEUROPSYCHOPHARMACOL, V27, P35, DOI 10.1016/S0893-133X(01)00427-4; O'Brien MS, 2005, NEUROPSYCHOPHARMACOL, V30, P1006, DOI 10.1038/sj.npp.1300681; Piazza PV, 1998, TRENDS PHARMACOL SCI, V19, P67, DOI 10.1016/S0165-6147(97)01115-2; Piazza PV, 2000, J NEUROSCI, V20, P4226; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; REITH MEA, 1980, LIFE SCI, V27, P1055, DOI 10.1016/0024-3205(80)90029-6; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; SPEALMAN RD, 1978, ANNU REV PHARMACOL, V18, P313, DOI 10.1146/annurev.pa.18.040178.001525; *US DEP HHS, 2004, 2003 NAT SURV DRUG U; *US DEP HHS, 2002, EM DEP TRENDS DRUG A; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Volkow ND, 1999, AM J PSYCHIAT, V156, P1440; VOLKOW ND, 1993, SYNAPSE, V14, P169, DOI 10.1002/syn.890140210; VOLKOW ND, 1990, AM J PSYCHIAT, V147, P719; WOOLVERTON WL, 1990, MODERN METHODS PHARM, V6, P165; World Health Organization, 2004, NEUR PSYCH SUBST US; Zernig G, 2004, PSYCHOPHARMACOLOGY, V171, P349, DOI 10.1007/s00213-003-1601-0	47	331	336	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1050	1056		10.1038/nn1737	http://dx.doi.org/10.1038/nn1737			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16829955				2022-12-17	WOS:000240080300018
J	Swadlow, HA; Gusev, AG				Swadlow, HA; Gusev, AG			The impact of 'bursting' thalamic impulses at a neocortical synapse	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE NEURONS; FUNCTIONAL-ORGANIZATION; INHIBITORY INTERNEURONS; CAT; CELLS; NUCLEUS; RABBIT; ELECTROPHYSIOLOGY; TRANSMISSION; INFORMATION	Considerable effort has gone into understanding the mechanisms underlying high-frequency 'bursting' of thalamocortical impulses, their sensory information content and their involvement in perception. However, little is known about the influence of such impulses on their cortical targets. Here we follow bursting thalamic impulses to their terminus at the thalamocortical synapse of the awake rabbit, and examine their influence on a class of somatosensory cortical neurons. We show that thalamic bursts potently activate cortical circuits. Initial impulses of each burst have a greatly enhanced ability to elicit cortical action potentials, and later impulses in the burst further raise the probability of eliciting spikes. In some cases, multiple cortical spikes result from a single burst. Moreover, we show that the interval preceding each burst is crucial for generating the enhanced cortical response. The powerful activation of neocortex by thalamocortical bursts is fully consistent with an involvement of these impulses in perceptual/attentional processes.	Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; Russian Acad Med Sci, Moscow Brain Res Inst, Moscow 103064, Russia	University of Connecticut; Russian Academy of Medical Sciences	Swadlow, HA (corresponding author), Univ Connecticut, Dept Psychol, 406 Babbidge Rd, Storrs, CT 06269 USA.	swadlow@psych.psy.uconn.edu			NIMH NIH HHS [MH-59322] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH059322] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AGMON A, 1992, J NEUROSCI, V12, P319; Biesold, 1990, BRAIN CHOLINERGIC SY, P3; COENEN AML, 1972, EXP BRAIN RES, V14, P227, DOI 10.1007/BF00816160; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; ECKHORN R, 1993, J NEUROSCI METH, V49, P175, DOI 10.1016/0165-0270(93)90121-7; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; GREEN JD, 1954, J NEUROPHYSIOL, V17, P533, DOI 10.1152/jn.1954.17.6.533; Guido W, 1998, VISUAL NEUROSCI, V15, P231, DOI 10.1017/S0952523898152033; GUIDO W, 1995, J NEUROPHYSIOL, V74, P1782, DOI 10.1152/jn.1995.74.4.1782; KRAMIS R, 1975, EXP NEUROL, V49, P58, DOI 10.1016/0014-4886(75)90195-8; LEVICK WR, 1972, INVEST OPHTH VISUAL, V11, P302; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; LU SM, 1992, J NEUROPHYSIOL, V68, P2185, DOI 10.1152/jn.1992.68.6.2185; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MCCORMICK DA, 1990, NEUROSCIENCE, V39, P103, DOI 10.1016/0306-4522(90)90225-S; METHERATE R, 1993, SYNAPSE, V14, P132, DOI 10.1002/syn.890140206; MUKHERJEE P, 1995, J NEUROPHYSIOL, V74, P1222, DOI 10.1152/jn.1995.74.3.1222; Ramcharan EJ, 2000, J NEUROPHYSIOL, V84, P1982, DOI 10.1152/jn.2000.84.4.1982; Ramcharan EJ, 2000, VISUAL NEUROSCI, V17, P55, DOI 10.1017/S0952523800171056; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; REITBOECK HJ, 1983, J NEUROSCI METH, V8, P249, DOI 10.1016/0165-0270(83)90038-9; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; SHERMAN SM, 1986, EXP BRAIN RES, V63, P1; SILLITO AM, 1983, BRAIN RES, V289, P143, DOI 10.1016/0006-8993(83)90015-X; SIMONS LH, 1989, CONSERV BIOL, V3, P11, DOI 10.1111/j.1523-1739.1989.tb00218.x; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; SWADLOW HA, 1995, J NEUROPHYSIOL, V73, P1584, DOI 10.1152/jn.1995.73.4.1584; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; WEYAND TG, IN PRESS J NEUROPHYS	34	331	339	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					402	408		10.1038/86054	http://dx.doi.org/10.1038/86054			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276231				2022-12-17	WOS:000168762200021
J	Super, H; Spekreijse, H; Lamme, VAF				Super, H; Spekreijse, H; Lamme, VAF			Two distinct modes of sensory processing observed in monkey primary visual cortex (V1)	NATURE NEUROSCIENCE			English	Article							MACAQUE MONKEY; NEURONAL RESPONSES; DYNAMICS; DECISION; STIMULI; FIGURE; NEUROPHYSIOLOGY; ORIENTATION; SENSITIVITY; MECHANISMS	Even salient sensory stimuli are sometimes not detected. What goes wrong in the brain in that case? Here we show that a late (> 100-ms) component of the neural activity in the primary visual cortex of the monkey is selectively suppressed when stimuli are not seen. As there is evidence that this activity depends on feedback from extrastriate areas, these findings suggest a specific role for recurrent processing when stimuli are reaching a perceptual level. Further results show that this perceptual level is situated between purely sensory and decision or motor stages of processing.	Univ Amsterdam, Acad Med Ctr, Dept Visual Syst Anal, Grad Sch Neurosci, NL-1100 AA Amsterdam, Netherlands; Netherlands Ophthalm Res Inst, NL-1105 BA Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Lamme, VAF (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Visual Syst Anal, Grad Sch Neurosci, POB 12011, NL-1100 AA Amsterdam, Netherlands.			Super, Hans/0000-0001-9328-0096				ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Block N, 1996, TRENDS NEUROSCI, V19, P456, DOI 10.1016/S0166-2236(96)20049-9; BOUR LJ, 1984, IEEE T BIO-MED ENG, V31, P419, DOI 10.1109/TBME.1984.325281; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; GILBERT CD, 1993, CEREB CORTEX, V3, P373, DOI 10.1093/cercor/3.5.373; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; GREEN DM, 1966, SIGNAL DETECTION THE; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Lamme VAF, 1999, CEREB CORTEX, V9, P406, DOI 10.1093/cercor/9.4.406; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Lamme VAF, 1998, P NATL ACAD SCI USA, V95, P3263, DOI 10.1073/pnas.95.6.3263; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Leon MI, 1998, NEURON, V21, P669, DOI 10.1016/S0896-6273(00)80584-X; MOORE T, 1995, P NATL ACAD SCI USA, V92, P8215, DOI 10.1073/pnas.92.18.8215; Nothdurft HC, 1999, VISUAL NEUROSCI, V16, P15, DOI 10.1017/S0952523899156189; NOTHDURFT HC, 1985, VISION RES, V25, P551, DOI 10.1016/0042-6989(85)90159-2; Payne BR, 1996, TRENDS NEUROSCI, V19, P535, DOI 10.1016/S0166-2236(96)10061-8; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Pollen DA, 1999, CEREB CORTEX, V9, P4, DOI 10.1093/cercor/9.1.4; ROCK I, 1992, COGNITIVE PSYCHOL, V24, P501; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; SALIN PA, 1995, PHYSIOL REV, V75, P107, DOI 10.1152/physrev.1995.75.1.107; Schall JD, 1998, CURR OPIN NEUROBIOL, V8, P211, DOI 10.1016/S0959-4388(98)80142-6; SCHILLER PH, 1979, J NEUROPHYSIOL, V42, P1124, DOI 10.1152/jn.1979.42.4.1124; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shadlen MN, 1996, J NEUROSCI, V16, P1486; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; THOMPSON P, 1983, DISASTERS, V7, P2; Vidyasagar TR, 1998, NEUROREPORT, V9, P1947, DOI 10.1097/00001756-199806220-00006; Zipser K, 1996, J NEUROSCI, V16, P7376	36	331	335	0	36	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					304	310		10.1038/85170	http://dx.doi.org/10.1038/85170			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224548				2022-12-17	WOS:000167178300019
J	Liao, DH; Zhang, XQ; O'Brien, R; Ehlers, MD; Huganir, RL				Liao, DH; Zhang, XQ; O'Brien, R; Ehlers, MD; Huganir, RL			Regulation of morphological postsynaptic silent synapses in developing hippocampal neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; GLUTAMATE RECEPTORS; MOSSY FIBER; SPINAL NEURONS; DENTATE GYRUS; CELL-CULTURE; NMDA; RESPONSES; LIGHT; LTP	Many excitatory synapses are thought to be postsynaptically 'silent', possessing functional NMDA but lacking functional AMPA glutamate receptors. The acquisition of AMPA receptors at silent synapses may be important in synaptic plasticity and neuronal development. Here we characterize a possible morphological correlate of silent synapses in cultured hippocampal neurons. Initially, most excitatory synapses contained NMDA receptors, but only a few contained detectable AMPA receptors. Synapses progressively acquired AMPA receptors as the cultures matured. AMPA receptor blockade increased the number, size and fluorescent intensity of AMPA receptor clusters and rapidly induced the appearance of AMPA receptors at 'silent' synapses. In contrast, NMDA receptor blockade increased the size, intensity and number of NMDA receptor clusters and decreased the number of AMPA receptor clusters, resulting in an increase in the proportion of 'silent' synapses. These results suggest that the number of silent synapses is regulated during development and by changes in synaptic activity.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.							AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Baranes D, 1996, P NATL ACAD SCI USA, V93, P4706, DOI 10.1073/pnas.93.10.4706; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Ehlers MD, 1996, CURR OPIN CELL BIOL, V8, P484, DOI 10.1016/S0955-0674(96)80024-X; Feldman DE, 1998, NEURON, V20, P1067, DOI 10.1016/S0896-6273(00)80488-2; Goslin K., 1991, CULTURING NERVE CELL, P251; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Mammen AL, 1997, J NEUROSCI, V17, P7351; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Rao A, 1998, J NEUROSCI, V18, P1217; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	38	331	344	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					37	43		10.1038/4540	http://dx.doi.org/10.1038/4540			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195178				2022-12-17	WOS:000078409300011
J	Shepherd, JD; Bear, MF				Shepherd, Jason D.; Bear, Mark F.			New views of Arc, a master regulator of synaptic plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; OCULAR DOMINANCE PLASTICITY; MOUSE VISUAL-CORTEX; AMPA RECEPTOR TRAFFICKING; MESSENGER-RNA; PROTEIN EXPRESSION; MEMORY CONSOLIDATION; ANGELMAN SYNDROME; DENDRITIC SPINE	Many proteins have been implicated in synaptic and experience-dependent plasticity. However, few demonstrate the exquisite regulation of expression and breadth of functional importance as the immediate early gene product Arc. Here we review and attempt to synthesize the disparate views of Arc in neuronal function. The main conclusion garnered from this body of work is that Arc is a critical effector molecule downstream of many molecular signaling pathways and that dysregulation of Arc expression can have dire consequences for normal brain function.	[Shepherd, Jason D.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Shepherd, JD (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	jshephe@mit.edu; mbear@mit.edu	Shepherd, Jason/N-8555-2018	Shepherd, Jason/0000-0001-7384-8289; Bear, Mark/0000-0002-9903-2541	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS076364] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [K99 NS076364] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams JP, 2009, NEUROREPORT, V20, P1429, DOI 10.1097/WNR.0b013e3283311db6; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Chen TJ, 2009, J NEUROSCI RES, V87, P2297, DOI 10.1002/jnr.22057; Cho KKA, 2009, P NATL ACAD SCI USA, V106, P5377, DOI 10.1073/pnas.0808104106; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Dickey CA, 2004, J NEUROCHEM, V88, P434, DOI 10.1046/j.1471-4159.2003.02185.x; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gao M, 2010, J NEUROSCI, V30, P7168, DOI 10.1523/JNEUROSCI.1067-10.2010; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; McCurry CL, 2010, NAT NEUROSCI, V13, P450, DOI 10.1038/nn.2508; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Panja D, 2009, J BIOL CHEM, V284, P31498, DOI 10.1074/jbc.M109.056077; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ploski JE, 2008, J NEUROSCI, V28, P12383, DOI 10.1523/JNEUROSCI.1662-08.2008; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Sharma N, 2010, NEURON, V67, P422, DOI 10.1016/j.neuron.2010.07.018; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Smith GB, 2009, PHILOS T R SOC B, V364, P357, DOI 10.1098/rstb.2008.0198; Smith-Hicks C, 2010, NAT NEUROSCI, V13, P1082, DOI 10.1038/nn.2611; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Tzingounis AV, 2006, NEURON, V52, P403, DOI 10.1016/j.neuron.2006.10.016; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; Venkitaramani DV, 2007, J NEUROSCI, V27, P11832, DOI 10.1523/JNEUROSCI.3478-07.2007; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327	50	330	344	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					279	284		10.1038/nn.2708	http://dx.doi.org/10.1038/nn.2708			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21278731	Green Accepted			2022-12-17	WOS:000287650100005
J	Grandjean, D; Sander, D; Pourtois, G; Schwartz, S; Seghier, ML; Scherer, KR; Vuilleumier, P				Grandjean, D; Sander, D; Pourtois, G; Schwartz, S; Seghier, ML; Scherer, KR; Vuilleumier, P			The voices of wrath: brain responses to angry prosody in meaningless speech	NATURE NEUROSCIENCE			English	Article							EVENT-RELATED FMRI; CORTEX; ATTENTION; EMOTION	We report two functional magnetic resonance imaging experiments showing enhanced responses in human middle superior temporal sulcus for angry relative to neutral prosody. This emotional enhancement was voice specific, unrelated to isolated acoustic amplitude or frequency cues in angry prosody, and distinct from any concomitant task-related attentional modulation. Attention and emotion seem to have separate effects on stimulus processing, reflecting a fundamental principle of human brain organization shared by voice and face perception.	Univ Geneva, Dept Psychol, Geneva Emot Res Grp, CH-1205 Geneva, Switzerland; Univ Geneva, Ctr Med Univ, Dept Neurol, Lab Neurol & Imaging Cognit, CH-1211 Geneva 4, Switzerland; Univ Geneva, Ctr Med Univ, Dept Neurosci, CH-1211 Geneva 4, Switzerland; Univ Hosp Geneva, Dept Radiol, CH-1211 Geneva 14, Switzerland; Univ Geneva, Dept Psychol, CH-1205 Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Grandjean, D (corresponding author), Univ Geneva, Dept Psychol, Geneva Emot Res Grp, Bd Pont Arve 40, CH-1205 Geneva, Switzerland.	Didier.Grandjean@pse.unige.ch	Vuilleumier, Patrik/AAJ-1839-2021; Seghier, Mohamed L/C-6314-2009; Seghier, Mohamed/O-8634-2019	Vuilleumier, Patrik/0000-0002-8198-9214; Seghier, Mohamed L/0000-0002-1146-8800; Seghier, Mohamed/0000-0002-1146-8800; Grandjean, Didier/0000-0001-6125-4520; Pourtois, Gilles/0000-0002-5109-2801; Sander, David/0000-0003-1266-9361; Schwartz, Sophie/0000-0001-7718-4053				Armony JL, 2002, NEUROPSYCHOLOGIA, V40, P817, DOI 10.1016/S0028-3932(01)00178-6; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; Hadjikhani N, 2003, CURR BIOL, V13, P2201, DOI 10.1016/S0960-9822(03)00891-1; Kriegstein KV, 2004, NEUROIMAGE, V22, P948, DOI 10.1016/j.neuroimage.2004.02.020; Mitchell RLC, 2003, NEUROPSYCHOLOGIA, V41, P1410, DOI 10.1016/S0028-3932(03)00017-4; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Taylor SF, 1998, NEUROIMAGE, V8, P188, DOI 10.1006/nimg.1998.0356; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2	12	330	334	0	39	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					145	146		10.1038/nn1392	http://dx.doi.org/10.1038/nn1392			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15665880				2022-12-17	WOS:000226638200011
J	van den Top, M; Lee, K; Whyment, AD; Blanks, AM; Spanswick, D				van den Top, M; Lee, K; Whyment, AD; Blanks, AM; Spanswick, D			Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus	NATURE NEUROSCIENCE			English	Article							VASOPRESSIN RELEASE; NEUROPEPTIDE-Y; FOOD-INTAKE; SATED RATS; GHRELIN; CHANNELS	The hypothalamic arcuate nucleus (ARC) integrates and responds to satiety and hunger signals and forms the origins of the central neural response to perturbations in energy balance. Here we show that rat ARC neurons containing neuropeptide Y (NPY) and agouti-related protein (AgRP), which are conditional pacemakers, are activated by orexigens and inhibited by the anorexigen leptin. We propose a neuron-specific signaling mechanism through which central and peripheral signals engage the central neural anabolic drive.	Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Spanswick, D (corresponding author), Univ Warwick, Dept Biol Sci, Gibbet Hill Campus, Coventry CV4 7AL, W Midlands, England.	D.C.Spanswick@warwick.ac.uk	Blanks, Andrew/J-6461-2012	Blanks, Andrew/0000-0003-1073-6081				BICKNELL RJ, 1981, NEUROENDOCRINOLOGY, V33, P295, DOI 10.1159/000123248; Burdakov D, 2003, J NEUROSCI, V23, P4951; CHRONWALL BM, 1985, PEPTIDES, V6, P1, DOI 10.1016/0196-9781(85)90128-7; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cummings DE, 2003, ANNU REV MED, V54, P453, DOI 10.1146/annurev.med.54.101601.152403; Dube MG, 2000, PEPTIDES, V21, P1557, DOI 10.1016/S0196-9781(00)00311-9; DUTTON A, 1979, J PHYSIOL-LONDON, V290, P433, DOI 10.1113/jphysiol.1979.sp012781; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Jain MR, 2000, REGUL PEPTIDES, V87, P19, DOI 10.1016/S0167-0115(99)00102-0; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; POULAIN DA, 1982, NEUROSCIENCE, V7, P773, DOI 10.1016/0306-4522(82)90044-6; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; Wang LX, 2002, NEUROSCI LETT, V325, P47; Yamanaka A, 2000, BRAIN RES, V859, P404, DOI 10.1016/S0006-8993(00)02043-6	15	330	333	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					493	494		10.1038/nn1226	http://dx.doi.org/10.1038/nn1226			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15097991				2022-12-17	WOS:000221101300023
J	Zhang, PS; Kishimoto, Y; Grammatikakis, I; Gottimukkala, K; Cutler, RG; Zhang, SL; Abdelmohsen, K; Bohr, VA; Sen, JM; Gorospe, M; Mattson, MP				Zhang, Peisu; Kishimoto, Yuki; Grammatikakis, Ioannis; Gottimukkala, Kamalvishnu; Cutler, Roy G.; Zhang, Shiliang; Abdelmohsen, Kotb; Bohr, Vilhelm A.; Sen, Jyoti Misra; Gorospe, Myriam; Mattson, Mark P.			Senolytic therapy alleviates A beta-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer's disease model	NATURE NEUROSCIENCE			English	Article							MICROGLIA; AUTOPHAGY; BIOMARKER; CULTURE; LINEAGE; BIOLOGY; LIFE	Neuritic plaques, a pathological hallmark in Alzheimer's disease (AD) brains, comprise extracellular aggregates of amyloid-beta (A beta) peptide and degenerating neurites that accumulate autolysosomes. We found that, in the brains of patients with AD and in AD mouse models, A beta plaque-associated Olig2- and NG2-expressing oligodendrocyte progenitor cells (OPCs), but not astrocytes, microglia, or oligodendrocytes, exhibit a senescence-like phenotype characterized by the upregulation of p21/CDKN1A, p16/INK4/CDKN2A proteins, and senescence-associated beta-galactosidase activity. Molecular interrogation of the A beta plaque environment revealed elevated levels of transcripts encoding proteins involved in OPC function, replicative senescence, and inflammation. Direct exposure of cultured OPCs to aggregating A beta triggered cell senescence. Senolytic treatment of AD mice selectively removed senescent cells from the plaque environment, reduced neuroinflammation, lessened A beta load, and ameliorated cognitive deficits. Our findings suggest a role for A beta-induced OPC cell senescence in neuroinflammation and cognitive deficits in AD, and a potential therapeutic benefit of senolytic treatments.	[Zhang, Peisu; Kishimoto, Yuki; Cutler, Roy G.; Mattson, Mark P.] NIA, Lab Neurosci, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Grammatikakis, Ioannis; Abdelmohsen, Kotb; Gorospe, Myriam] NIA, Lab Genet & Genom, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Gottimukkala, Kamalvishnu; Sen, Jyoti Misra] NIA, Lab Clin Invest, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Zhang, Shiliang] NIDA, Electron Microscopy Core, Intramural Res Program, NIH, Baltimore, MD USA; [Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Sen, Jyoti Misra] Johns Hopkins Univ, Sch Med, Dept Med, Immunol Program, Baltimore, MD 21205 USA; [Mattson, Mark P.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins University	Zhang, PS; Mattson, MP (corresponding author), NIA, Lab Neurosci, Intramural Res Program, NIH, Baltimore, MD 21224 USA.; Mattson, MP (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	zhangpei@mail.nih.gov; mark.mattson@nih.gov	Bohr, Vilhelm/AAP-5931-2020; Gorospe, Myriam/Y-3613-2019; Abdelmohsen, Kotb/AAX-4191-2020	Abdelmohsen, Kotb/0000-0001-6240-5810	National Institute on Aging (NIA); National Institute on Drug Abuse; NIA [P30-AG0-28383]; NATIONAL INSTITUTE ON AGING [ZIAAG000735, ZIAAG000393, ZIAAG000518] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank N. Sah, J. Tian, and R. Munk for technical support. We thank D. Baker at the Mayo Clinic for his valuable advice about the use of senolytic agents in vivo. This research was supported by the Intramural Research Programs of the National Institute on Aging (NIA) and the National Institute on Drug Abuse, and by an NIA grant supporting the University of Kentucky Alzheimer's Disease Research Center (no. P30-AG0-28383).	Antel JP, 2019, J NEUROIMMUNOL, V331, P28, DOI 10.1016/j.jneuroim.2018.03.006; Baker DJ, 2018, J CLIN INVEST, V128, P1208, DOI 10.1172/JCI95145; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Barrachina M, 2006, NEUROPATH APPL NEURO, V32, P505, DOI 10.1111/j.1365-2990.2006.00756.x; Bhat R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045069; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Bussian TJ, 2018, NATURE, V562, P578, DOI 10.1038/s41586-018-0543-y; Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659; Chinta SJ, 2018, CELL REP, V22, P930, DOI 10.1016/j.celrep.2017.12.092; Clemente D, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00268; Condello C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7176; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Farr JN, 2017, NAT MED, V23, P1072, DOI 10.1038/nm.4385; Faucher P, 2016, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00245; Geha S, 2010, BRAIN PATHOL, V20, P399, DOI 10.1111/j.1750-3639.2009.00295.x; Gowrishankar S, 2015, P NATL ACAD SCI USA, V112, pE3699, DOI 10.1073/pnas.1510329112; Jennings AR, 2015, BRAIN PATHOL, V25, P517, DOI 10.1111/bpa.12193; Jiang P, 2013, STEM CELLS, V31, P2620, DOI 10.1002/stem.1515; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kashiwaya Y, 2013, NEUROBIOL AGING, V34, P1530, DOI 10.1016/j.neurobiolaging.2012.11.023; Kurz DJ, 2000, J CELL SCI, V113, P3613; LeBrasseur NK, 2015, NESTLE NUTR WORKS SE, V83, P11, DOI 10.1159/000382054; Malm TM, 2015, NEUROTHERAPEUTICS, V12, P81, DOI 10.1007/s13311-014-0316-8; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Meijer DH, 2012, NAT REV NEUROSCI, V13, P819, DOI 10.1038/nrn3386; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Musi N, 2018, AGING CELL, V17, DOI 10.1111/acel.12840; Neumann Bjoern, 2016, Front Biosci (Schol Ed), V8, P29; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Piechota M, 2016, ONCOTARGET, V7, P81099, DOI 10.18632/oncotarget.12752; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Sykora P, 2015, NUCLEIC ACIDS RES, V43, P943, DOI 10.1093/nar/gku1356; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9; Yang LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep35460; Zhan XH, 2015, J ALZHEIMERS DIS, V44, P1213, DOI 10.3233/JAD-142013; Zhang PS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9888; Zhang RL, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00201; Zhang SL, 2015, NAT NEUROSCI, V18, P386, DOI 10.1038/nn.3945; Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344	47	329	342	18	156	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2019	22	5					719	+		10.1038/s41593-019-0372-9	http://dx.doi.org/10.1038/s41593-019-0372-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HU8SN	30936558	Green Accepted			2022-12-17	WOS:000465560800009
J	Lunnon, K; Smith, R; Hannon, E; De Jager, PL; Srivastava, G; Volta, M; Troakes, C; Al-Sarraj, S; Burrage, J; Macdonald, R; Condliffe, D; Harries, LW; Katsel, P; Haroutunian, V; Kaminsky, Z; Joachim, C; Powell, J; Lovestone, S; Bennett, DA; Schalkwyk, LC; Mill, J				Lunnon, Katie; Smith, Rebecca; Hannon, Eilis; De Jager, Philip L.; Srivastava, Gyan; Volta, Manuela; Troakes, Claire; Al-Sarraj, Safa; Burrage, Joe; Macdonald, Ruby; Condliffe, Daniel; Harries, Lorna W.; Katsel, Pavel; Haroutunian, Vahram; Kaminsky, Zachary; Joachim, Catharine; Powell, John; Lovestone, Simon; Bennett, David A.; Schalkwyk, Leonard C.; Mill, Jonathan			Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease	NATURE NEUROSCIENCE			English	Article							ALLELE-SPECIFIC METHYLATION; BLOOD; EXPRESSION; DIAGNOSIS; SUSCEPTIBILITY; GENES; LOCI	Alzheimer's disease (AD) is a chronic neurodegenerative disorder that is characterized by progressive neuropathology and cognitive decline. We performed a cross-tissue analysis of methylomic variation in AD using samples from four independent human post-mortem brain cohorts. We identified a differentially methylated region in the ankyrin 1 (ANK1) gene that was associated with neuropathology in the entorhinal cortex, a primary site of AD manifestation. This region was confirmed as being substantially hypermethylated in two other cortical regions (superior temporal gyrus and prefrontal cortex), but not in the cerebellum, a region largely protected from neurodegeneration in AD, or whole blood obtained pre-mortem from the same individuals. Neuropathology-associated ANK1 hypermethylation was subsequently confirmed in cortical samples from three independent brain cohorts. This study represents, to the best of our knowledge, the first epigenome-wide association study of AD employing a sequential replication design across multiple tissues and highlights the power of this approach for identifying methylomic variation associated with complex disease.	[Lunnon, Katie; Hannon, Eilis; Burrage, Joe; Macdonald, Ruby; Harries, Lorna W.; Mill, Jonathan] Univ Exeter, Sch Med, Exeter, Devon, England; [Smith, Rebecca; Volta, Manuela; Troakes, Claire; Al-Sarraj, Safa; Condliffe, Daniel; Powell, John; Lovestone, Simon; Schalkwyk, Leonard C.; Mill, Jonathan] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [De Jager, Philip L.; Srivastava, Gyan] Brigham & Womens Hosp, Dept Neurol, Inst Neurosci, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [De Jager, Philip L.; Srivastava, Gyan] Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA; [De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA USA; [De Jager, Philip L.; Srivastava, Gyan] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Katsel, Pavel; Haroutunian, Vahram] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Haroutunian, Vahram] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Haroutunian, Vahram] JJ Peters Virginia Med Ctr, Bronx, NY USA; [Kaminsky, Zachary] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Kaminsky, Zachary] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Joachim, Catharine] Univ Oxford, John Radcliffe Hosp, Dept Neuropathol, Oxford OX3 9DU, England; [Lovestone, Simon] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA	University of Exeter; University of London; King's College London; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Oxford; University of Oxford; Rush University	Mill, J (corresponding author), Univ Exeter, Sch Med, Exeter, Devon, England.	j.mill@exeter.ac.uk	Mill, Jonathan/B-5678-2014; Lunnon, Katie/C-4638-2012; Schalkwyk, Leonard C/A-2150-2010; Troakes, Claire/K-4346-2015; Powell, John F/G-4412-2011; Smith, Rebecca G/C-1978-2012; Mill, Jonathan S/B-3276-2010; Hannon, Eilis/T-1349-2019; Volta, Manuela/D-2147-2012	Mill, Jonathan/0000-0003-1115-3224; Lunnon, Katie/0000-0001-7570-6065; Schalkwyk, Leonard C/0000-0001-7030-5756; Powell, John F/0000-0001-6124-439X; Smith, Rebecca G/0000-0001-9264-1056; Mill, Jonathan S/0000-0003-1115-3224; Hannon, Eilis/0000-0001-6840-072X; Volta, Manuela/0000-0001-8468-0346; Lovestone, Simon/0000-0003-0473-4565; Harries, Lorna/0000-0001-7791-8061; Troakes, Claire/0000-0002-1790-7376; Macdonald, Ruby/0000-0002-1344-3826	Alzheimer's Research UK; US National Institutes of Health [R01 AG036039, AG02219, AG05138, MH064673, R01 AG036042, R01AG036836, R01 AG17917, R01 AG15819, R01 AG032990, R01 AG18023, RC2 AG036547, P30 AG10161, P50 AG016574, U01 ES017155, KL2 RR024151, K25 AG041906-01]; NIHR Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and University of Oxford; Department of Veterans Affairs VISN3 MIRECC; MRC [G1100695, MR/L022656/1] Funding Source: UKRI; Medical Research Council [G1100695, MR/L022656/1] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005138, R01AG036836, K25AG041906, R01AG036039, R01AG015819, R01AG018023, P01AG002219, P30AG010161, R01AG017917] Funding Source: NIH RePORTER	Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHR Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and University of Oxford; Department of Veterans Affairs VISN3 MIRECC(US Department of Veterans Affairs); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Sloan for technical support and I. Bodi and A. King for neuropathological diagnosis of cases. We also thank the Oxford Project to Investigate Memory and Ageing (OPTIMA), the National Institute for Health (NIHR) Biomedical Research Unit in Dementia in the South London and Maudsley NHS Foundation Trust (SLaM), Brains for Dementia Research (Alzheimer Brain Bank, UK), and the donors and families who made this research possible. Blood samples from the London cohort were collected as part of the Alzheimer's Research UK funded study "Biomarkers of AD Neurodegeneration". This work was funded by US National Institutes of Health grant R01 AG036039 to J.M. and an Equipment Grant from Alzheimer's Research UK. The Oxford Brain Bank is supported in part by the NIHR Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and University of Oxford. Brain banking and neuropathology assessments for the Mount Sinai cohort was supported by US National Institutes of Health grants AG02219, AG05138 and MH064673, and the Department of Veterans Affairs VISN3 MIRECC. Replication work in Boston was supported by US National Institutes of Health grants: R01 AG036042, R01AG036836, R01 AG17917, R01 AG15819, R01 AG032990, R01 AG18023, RC2 AG036547, P30 AG10161, P50 AG016574, U01 ES017155, KL2 RR024151 and K25 AG041906-01.	Alanentalo T, 2006, GENE EXPR PATTERNS, V6, P162, DOI 10.1016/j.modgep.2005.06.012; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Boiko T, 2007, J NEUROSCI, V27, P590, DOI 10.1523/JNEUROSCI.4302-06.2007; Booij BB, 2011, J ALZHEIMERS DIS, V23, P109, DOI 10.3233/JAD-2010-101518; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Chapuis J, 2011, HUM MOL GENET, V20, P2026, DOI 10.1093/hmg/ddr085; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Esiri M M, 1993, J Neural Transm Suppl, V39, P25; Fehlbaum-Beurdeley P, 2012, J ALZHEIMERS DIS, V32, P169, DOI 10.3233/JAD-2012-120637; Fehlbaum-Beurdeley P, 2010, ALZHEIMERS DEMENT, V6, P25, DOI 10.1016/j.jalz.2009.07.001; Guintivano J, 2013, EPIGENETICS-US, V8, P290, DOI 10.4161/epi.23924; Harder MN, 2013, J CLIN ENDOCR METAB, V98, pE801, DOI 10.1210/jc.2012-4169; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Haroutunian V, 1998, ARCH NEUROL-CHICAGO, V55, P1185, DOI 10.1001/archneur.55.9.1185; Hooper C, 2008, BIOMARK INSIGHTS, V3, P317; Imamura M, 2012, HUM MOL GENET, V21, P3042, DOI 10.1093/hmg/dds113; Knapp M., 2007, DEMENTIAL UK FULL RE; KORDELI E, 1991, J CELL BIOL, V114, P1243, DOI 10.1083/jcb.114.6.1243; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Laumet G, 2010, J ALZHEIMERS DIS, V20, P1181, DOI 10.3233/JAD-2010-100126; Lovestone S, 2010, NAT MED, V16, P1371, DOI 10.1038/nm1210-1371b; Lunnon K, 2013, AM J MED GENET B, V162, P789, DOI 10.1002/ajmg.b.32201; Lunnon K, 2013, J ALZHEIMERS DIS, V33, P737, DOI 10.3233/JAD-2012-121363; Lunnon K, 2012, J ALZHEIMERS DIS, V30, P685, DOI 10.3233/JAD-2012-111592; Meaburn EL, 2010, EPIGENETICS-US, V5, P578, DOI 10.4161/epi.5.7.12960; Mill J, 2013, NAT REV GENET, V14, P585, DOI 10.1038/nrg3405; Murphy TM, 2014, LANCET, V383, P1952, DOI 10.1016/S0140-6736(14)60269-5; Nelson SB, 2005, J HISTOCHEM CYTOCHEM, V53, P787, DOI 10.1369/jhc.5B6619.2005; Pedersen BS, 2012, BIOINFORMATICS, V28, P2986, DOI 10.1093/bioinformatics/bts545; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Rye PD, 2011, J ALZHEIMERS DIS, V23, P121, DOI 10.3233/JAD-2010-101521; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Wenk GL, 2003, J CLIN PSYCHIAT, V64, P7; Wu ZC, 2011, BRAIN RES, V1374, P129, DOI 10.1016/j.brainres.2010.12.036	38	329	332	4	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2014	17	9					1164	1170		10.1038/nn.3782	http://dx.doi.org/10.1038/nn.3782			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AO2DJ	25129077	Green Submitted, Green Accepted			2022-12-17	WOS:000341125400009
J	Blinder, P; Tsai, PS; Kaufhold, JP; Knutsen, PM; Suhl, H; Kleinfeld, D				Blinder, Pablo; Tsai, Philbert S.; Kaufhold, John P.; Knutsen, Per M.; Suhl, Harry; Kleinfeld, David			The cortical angiome: an interconnected vascular network with noncolumnar patterns of blood flow	NATURE NEUROSCIENCE			English	Article							CEREBRAL-CORTEX; FUNCTIONAL ARCHITECTURE; PENETRATING ARTERIOLES; NEURONAL-ACTIVITY; INTRINSIC SIGNAL; VISUAL-CORTEX; LASER-PULSES; BRAIN; OCCLUSION; MICROVASCULATURE	What is the nature of the vascular architecture in the cortex that allows the brain to meet the energy demands of neuronal computations? We used high-throughput histology to reconstruct the complete angioarchitecture and the positions of all neuronal somata of multiple cubic millimeter regions of vibrissa primary sensory cortex in mouse. Vascular networks were derived from the reconstruction. In contrast with the standard model of cortical columns that are tightly linked with the vascular network, graph-theoretical analyses revealed that the subsurface microvasculature formed interconnected loops with a topology that was invariant to the position and boundary of columns. Furthermore, the calculated patterns of blood flow in the networks were unrelated to location of columns. Rather, blood sourced by penetrating arterioles was effectively drained by the penetrating venules to limit lateral perfusion. This analysis provides the underpinning to understand functional imaging and the effect of penetrating vessels strokes on brain viability.	[Blinder, Pablo; Tsai, Philbert S.; Knutsen, Per M.; Suhl, Harry; Kleinfeld, David] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Kaufhold, John P.] Sci Applicat Int Corp Intelligent Syst Div, Arlington, VA USA; [Kleinfeld, David] Univ Calif San Diego, Sect Neurobiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Science Applications International Corporation (SAIC); University of California System; University of California San Diego	Kleinfeld, D (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	dk@physics.ucsd.edu	Blinder, Pablo/GQI-2237-2022; Blinder, Pablo/D-2472-2009; Blinder, Pablo/AAX-7980-2020	Blinder, Pablo/0000-0002-4042-214X; Kaufhold, John/0000-0002-2236-7909	Israeli Science Foundation (Bikura fellowship); US National Institutes of Health [EB003832, MH085499, MH072570, OD006831]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH072570, R01MH085499] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006831] Funding Source: NIH RePORTER	Israeli Science Foundation (Bikura fellowship); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Lee for assistance in the analysis of the surface vasculature, J.D. Driscoll for assistance with the imaging acquisition software, N. Nishimura and C.B. Schaffer for sharing their data logs, S. Chien, W. Denk, P.J. Drew, A.L. Fairhall, B. Friedman, R.D. Frostig, H.J. Karten, H.S. Seung, T.W. Secomb, A.Y. Shih and B. Weber for critical discussions. This work was supported by the Israeli Science Foundation (Bikura fellowship to P.B.) and the US National Institutes of Health (grants EB003832, MH085499, MH072570 and OD006831).	Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Blinder P, 2010, P NATL ACAD SCI USA, V107, P12670, DOI 10.1073/pnas.1007239107; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boas DA, 2008, NEUROIMAGE, V40, P1116, DOI 10.1016/j.neuroimage.2007.12.061; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; Brundel M, 2012, J CEREBR BLOOD F MET, V32, P425, DOI 10.1038/jcbfm.2011.200; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Chen-Bee CH, 2007, J NEUROSCI, V27, P4572, DOI 10.1523/JNEUROSCI.0326-07.2007; Cserti J, 2000, AM J PHYS, V68, P896, DOI 10.1119/1.1285881; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Derdikman D, 2003, J NEUROSCI, V23, P3100; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Emmenlauer M, 2009, J MICROSC-OXFORD, V233, P42, DOI 10.1111/j.1365-2818.2008.03094.x; Eppihimer MJ, 1996, MICROVASC RES, V51, P187, DOI 10.1006/mvre.1996.0020; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; GRINVALD A, 1991, P NATL ACAD SCI USA, V88, P11559, DOI 10.1073/pnas.88.24.11559; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Guibert R, 2010, J CEREBR BLOOD F MET, V30, P1860, DOI 10.1038/jcbfm.2010.105; Hirsch S, 2012, J CEREBR BLOOD F MET, V32, P952, DOI 10.1038/jcbfm.2012.39; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Nguyen J, 2011, J CEREBR BLOOD F MET, V31, P2243, DOI 10.1038/jcbfm.2011.95; Kaufhold JP, 2012, MED IMAGE ANAL, V16, P1241, DOI 10.1016/j.media.2012.06.004; Kim T, 2011, J CEREBR BLOOD F MET, V31, P1211, DOI 10.1038/jcbfm.2010.226; Kleinfeld David, 2011, Front Neuroenergetics, V3, P1, DOI 10.3389/fnene.2011.00001; Kohn A, 2000, NEUROSCIENCE, V95, P51; Lauwers F, 2008, NEUROIMAGE, V39, P936, DOI 10.1016/j.neuroimage.2007.09.024; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; MAYHAN WG, 1986, CIRC RES, V59, P216, DOI 10.1161/01.RES.59.2.216; Mchedlishvili G., 1963, ARTERIAL BEHAV BLOOD; NAKAI K, 1981, STROKE, V12, P653, DOI 10.1161/01.STR.12.5.653; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ., 2010, NETWORKS INTRO OXFOR; Nguyen QT, 2006, J NEUROSCI METH, V156, P351, DOI 10.1016/j.jneumeth.2006.03.001; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Nishimura N, 2007, P NATL ACAD SCI USA, V104, P365, DOI 10.1073/pnas.0609551104; Nishimura N, 2010, J CEREBR BLOOD F MET, V30, P1914, DOI 10.1038/jcbfm.2010.157; Oraevsky AA, 1996, IEEE J SEL TOP QUANT, V2, P801, DOI 10.1109/2944.577302; PRIES AR, 1990, CIRC RES, V67, P826, DOI 10.1161/01.RES.67.4.826; Risser L, 2009, INT J DEV NEUROSCI, V27, P185, DOI 10.1016/j.ijdevneu.2008.10.006; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Shih AY, 2013, NAT NEUROSCI, V16, P55, DOI 10.1038/nn.3278; Shih AY, 2009, J CEREBR BLOOD F MET, V29, P738, DOI 10.1038/jcbfm.2008.166; Sirotin YB, 2009, P NATL ACAD SCI USA, V106, P18390, DOI 10.1073/pnas.0905509106; Smith EE, 2012, LANCET NEUROL, V11, P272, DOI 10.1016/S1474-4422(11)70307-6; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Tsai PS, 2003, NEURON, V39, P27, DOI 10.1016/S0896-6273(03)00370-2; Vazquez AL, 2012, J CEREBR BLOOD F MET, V32, P745, DOI 10.1038/jcbfm.2011.198; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weber B, 2008, CEREB CORTEX, V18, P2318, DOI 10.1093/cercor/bhm259; Woolsey TA, 1996, CEREB CORTEX, V6, P647, DOI 10.1093/cercor/6.5.647; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Wu FY, 2004, J PHYS A-MATH GEN, V37, P6653, DOI 10.1088/0305-4470/37/26/004; Zhang SX, 2007, PLOS BIOL, V5, P1152, DOI 10.1371/journal.pbio.0050119	60	329	340	1	71	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					889	U150		10.1038/nn.3426	http://dx.doi.org/10.1038/nn.3426			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23749145	Green Accepted			2022-12-17	WOS:000321180900022
J	Galarreta, M; Hestrin, S				Galarreta, M; Hestrin, S			Frequency-dependent synaptic depression and the balance of excitation and inhibition in the neocortex	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; PYRAMIDAL NEURONS; RELEASE PROBABILITY; STRIATE CORTEX; RAT NEOCORTEX; CELL SYNAPSES; GAIN-CONTROL; INTERNEURONS; TRANSMISSION; CONNECTIONS	The stability of cortical neuron activity in vivo suggests that the firing rates of both excitatory and inhibitory neurons are dynamically adjusted. Using dual recordings from excitatory pyramidal neurons and inhibitory fast-spiking neurons in neocortical slices, we report that sustained activation by trains of several hundred presynaptic spikes resulted in much stronger depression of synaptic currents at excitatory synapses than at inhibitory ones. The steady-state synaptic depression was frequency dependent and reflected presynaptic function. These results suggest that inhibitory terminals of fast-spiking cells are better equipped to support prolonged transmitter release at a high frequency compared with excitatory ones. This difference in frequency-dependent depression could produce a relative increase in the impact of inhibition during periods of high global activity and promote the stability of cortical circuits.	Univ Tennessee, Dept Anat & Neurobiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Hestrin, S (corresponding author), Univ Tennessee, Dept Anat & Neurobiol, 855 Monroe Ave, Memphis, TN 38163 USA.		Hestrin, Shaul/F-4410-2010					Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ABELES M, 1991, CORTICONICS NEUROL C; Azouz R, 1997, CEREB CORTEX, V7, P534, DOI 10.1093/cercor/7.6.534; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Chance FS, 1998, J NEUROSCI, V18, P4785; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Douglas RJ, 1996, J NEUROCYTOL, V25, P893, DOI 10.1007/BF02284849; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; GUTNICK MJ, 1982, J NEUROPHYSIOL, V48, P1321, DOI 10.1152/jn.1982.48.6.1321; Hawken MJ, 1996, VISUAL NEUROSCI, V13, P477, DOI 10.1017/S0952523800008154; HUBEL DH, 1959, J PHYSIOL-LONDON, V147, P226, DOI 10.1113/jphysiol.1959.sp006238; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Katz B., 1966, NERVE MUSCLE SYNAPSE; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V69, P416, DOI 10.1152/jn.1993.69.2.416; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Larkman AU, 1997, J PHYSIOL-LONDON, V505, P457, DOI 10.1111/j.1469-7793.1997.457bb.x; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MOSHON JA, 1978, J PHYSIOL-LONDON, V283, P101; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; PORTER JT, IN PRESS EUR J NEURO; Pouzat C, 1997, J NEUROSCI, V17, P9104; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SILVA LR, 1991, SCIENCE, V251, P432, DOI 10.1126/science.1824881; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; SOMERS DC, 1995, J NEUROSCI, V15, P5448; SOMOGYI P, 1983, NEUROSCIENCE, V10, P261, DOI 10.1016/0306-4522(83)90133-1; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; TAKAHASHI M, 1995, J NEUROSCI, V15, P5693; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tarczy-Hornoch K, 1998, J PHYSIOL-LONDON, V508, P351, DOI 10.1111/j.1469-7793.1998.351bq.x; THOMSON AM, 1993, NEUROSCIENCE, V54, P347, DOI 10.1016/0306-4522(93)90257-G; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; Thomson AM, 1996, J PHYSIOL-LONDON, V496, P81, DOI 10.1113/jphysiol.1996.sp021667; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Wang C, 1998, NEURON, V21, P155, DOI 10.1016/S0896-6273(00)80523-1; White E.L., 1989, CORTICAL CIRCUITS, DOI [10.1007/978-1-4684-8721-3, DOI 10.1007/978-1-4684-8721-3]; Wu LG, 1998, BIOPHYS J, V74, P3003, DOI 10.1016/S0006-3495(98)78007-5; ZHANG S, 1994, J PHYSIOL-LONDON, V480, P123, DOI 10.1113/jphysiol.1994.sp020346; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305	50	329	337	2	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					587	594		10.1038/2822	http://dx.doi.org/10.1038/2822			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146NL	10196566				2022-12-17	WOS:000077437100014
J	Berke, JD				Berke, Joshua D.			What does dopamine mean?	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS DOPAMINE; TONICALLY ACTIVE NEURONS; REWARD PREDICTION ERROR; MEDIUM SPINY NEURONS; PHASIC DOPAMINE; MESOLIMBIC DOPAMINE; MIDBRAIN DOPAMINE; CHOLINERGIC INTERNEURONS; PARKINSONS-DISEASE	Dopamine is a critical modulator of both learning and motivation. This presents a problem: how can target cells know whether increased dopamine is a signal to learn or to move? It is often presumed that motivation involves slow ('tonic') dopamine changes, while fast ('phasic')dopamine fluctuations convey reward prediction errors for learning. Yet recent studies have shown that dopamine conveys motivational value and promotes movement even on subsecond timescales. Here I describe an alternative account of how dopamine regulates ongoing behavior. Dopamine release related to motivation is rapidly and locally sculpted by receptors on dopamine terminals, independently from dopamine cell firing. Target neurons abruptly switch between learning and performance modes, with striatal cholinergic interneurons providing one candidate switch mechanism. The behavioral impact of dopamine varies by subregion, but in each case dopamine provides a dynamic estimate of whether it is worth expending a limited internal resource, such as energy, attention, or time.	[Berke, Joshua D.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Berke, Joshua D.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Berke, Joshua D.] Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Berke, JD (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.; Berke, JD (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.; Berke, JD (corresponding author), Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94143 USA.	joshua.berke@ucsf.edu			National Institute on Neurological Disorders and Stroke; National Institute of Mental Health, and the National Institute on Drug Abuse; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA045783] Funding Source: NIH RePORTER	National Institute on Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health, and the National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)NIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	I thank the many colleagues who provided insightful comments on earlier text drafts, including K. Berridge, P. Dayan, B. Knutson, J. Beeler, P. Redgrave, J. Lisman, and J. Goldberg. I regret that space limitations precluded discussion of many important prior studies. Essential support was provided by the National Institute on Neurological Disorders and Stroke, the National Institute of Mental Health, and the National Institute on Drug Abuse.	Aarts E, 2010, NEUROPSYCHOPHARMACOL, V35, P1943, DOI 10.1038/npp.2010.68; Anderson BA, 2016, CURR BIOL, V26, P550, DOI 10.1016/j.cub.2015.12.062; Aragona BJ, 2008, J NEUROSCI, V28, P8821, DOI 10.1523/JNEUROSCI.2225-08.2008; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; Beeler JA, 2012, CELL REP, V2, P1747, DOI 10.1016/j.celrep.2012.11.014; Beeler JA, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00049; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; BERRIDGE KC, 1989, BEHAV NEUROSCI, V103, P36, DOI 10.1037/0735-7044.103.1.36; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Brown HD, 2011, EUR J NEUROSCI, V34, P1997, DOI 10.1111/j.1460-9568.2011.07914.x; Brown MTC, 2012, NATURE, V492, P452, DOI 10.1038/nature11657; Cachope R, 2012, CELL REP, V2, P33, DOI 10.1016/j.celrep.2012.05.011; Cagniard B, 2006, NEURON, V51, P541, DOI 10.1016/j.neuron.2006.07.026; Chatham CH, 2014, NEURON, V81, P930, DOI 10.1016/j.neuron.2014.01.002; Cohen JY, 2015, ELIFE, V4, DOI 10.7554/eLife.06346; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cousins MS, 1996, BEHAV BRAIN RES, V74, P189, DOI 10.1016/0166-4328(95)00151-4; da Silva JA, 2018, NATURE, V554, P244, DOI 10.1038/nature25457; Dodson PD, 2016, P NATL ACAD SCI USA, V113, pE2180, DOI 10.1073/pnas.1515941113; du Hoffmann J, 2014, J NEUROSCI, V34, P14349, DOI 10.1523/JNEUROSCI.3492-14.2014; Eban-Rothschild A, 2016, NAT NEUROSCI, V19, P1356, DOI 10.1038/nn.4377; Eshel N, 2016, NAT NEUROSCI, V19, P479, DOI 10.1038/nn.4239; Ferenczi EA, 2016, SCIENCE, V351, DOI 10.1126/science.aac9698; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Floresco SB, 1998, EUR J NEUROSCI, V10, P1241, DOI 10.1046/j.1460-9568.1998.00133.x; Franklin NT, 2015, ELIFE, V4, DOI 10.7554/eLife.12029; FREED CR, 1985, SCIENCE, V229, P62, DOI 10.1126/science.4012312; Gonon F, 2000, PROG BRAIN RES, V125, P291; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Grace AA, 2016, NAT REV NEUROSCI, V17, P524, DOI 10.1038/nrn.2016.57; Haber SN, 2000, J NEUROSCI, V20, P2369; Hamid AA, 2016, NAT NEUROSCI, V19, P117, DOI 10.1038/nn.4173; Hart AS, 2014, J NEUROSCI, V34, P698, DOI 10.1523/JNEUROSCI.2489-13.2014; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Howe MW, 2016, NATURE, V535, P505, DOI 10.1038/nature18942; Howe MW, 2013, NATURE, V500, P575, DOI 10.1038/nature12475; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Jedrzejewska-Szmek J, 2017, EUR J NEUROSCI, V45, P1044, DOI 10.1111/ejn.13287; Jones JL, 2010, BIOL PSYCHIAT, V67, P737, DOI 10.1016/j.biopsych.2009.11.006; KELLY PH, 1976, NATURE, V263, P695, DOI 10.1038/263695a0; Kim CK, 2016, NAT METHODS, V13, P325, DOI [10.1038/NMETH.3770, 10.1038/nmeth.3770]; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Leventhal DK, 2014, BASAL GANGLIA, V4, P43, DOI 10.1016/j.baga.2013.11.001; Manohar SG, 2015, CURR BIOL, V25, P1707, DOI 10.1016/j.cub.2015.05.038; MARSHALL JF, 1976, J COMP PHYSIOL PSYCH, V90, P536, DOI 10.1037/h0077230; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Mazzoni P, 2007, J NEUROSCI, V27, P7105, DOI 10.1523/JNEUROSCI.0264-07.2007; McClure SM, 2003, TRENDS NEUROSCI, V26, P423, DOI 10.1016/S0166-2236(03)00177-2; Menegas W, 2017, ELIFE, V6, DOI 10.7554/eLife.21886; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morales M, 2017, NAT REV NEUROSCI, V18, P73, DOI 10.1038/nrn.2016.165; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Moyer JT, 2007, J NEUROPHYSIOL, V98, P3731, DOI 10.1152/jn.00335.2007; Nair AG, 2015, J NEUROSCI, V35, P14017, DOI 10.1523/JNEUROSCI.0730-15.2015; Nicola SM, 2010, J NEUROSCI, V30, P16585, DOI 10.1523/JNEUROSCI.3958-10.2010; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Nougaret S, 2015, J NEUROSCI, V35, P15214, DOI 10.1523/JNEUROSCI.0039-15.2015; Owesson-White CA, 2012, J NEUROCHEM, V121, P252, DOI 10.1111/j.1471-4159.2012.07677.x; Parker NF, 2016, NAT NEUROSCI, V19, P845, DOI 10.1038/nn.4287; Pasquereau B, 2015, J NEUROPHYSIOL, V113, P1110, DOI 10.1152/jn.00401.2014; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Poulin JF, 2014, CELL REP, V9, P930, DOI 10.1016/j.celrep.2014.10.008; Rabinovich MI, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000072; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Redish AD, 2016, NAT REV NEUROSCI, V17, P147, DOI 10.1038/nrn.2015.30; Sacks O., 1973, AWAKENINGS; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Satoh T, 2003, J NEUROSCI, V23, P9913; SCHULTZ W, 1990, J NEUROPHYSIOL, V63, P607, DOI 10.1152/jn.1990.63.3.607; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SCHULTZ W, 1986, J NEUROPHYSIOL, V56, P1439, DOI 10.1152/jn.1986.56.5.1439; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Shen WX, 2015, NEURON, V88, P762, DOI 10.1016/j.neuron.2015.10.039; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Shiner T, 2012, BRAIN, V135, P1871, DOI 10.1093/brain/aws083; Soares S, 2016, SCIENCE, V354, P1273, DOI 10.1126/science.aah5234; Steinberg EE, 2013, NAT NEUROSCI, V16, P966, DOI 10.1038/nn.3413; Stocco A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00018; STRECKER RE, 1983, BRAIN RES, V260, P317, DOI 10.1016/0006-8993(83)90688-1; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Syed ECJ, 2016, NAT NEUROSCI, V19, P34, DOI 10.1038/nn.4187; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; Thura D, 2017, NEURON, V95, P1160, DOI 10.1016/j.neuron.2017.07.039; Turner RS, 2010, CURR OPIN NEUROBIOL, V20, P704, DOI 10.1016/j.conb.2010.08.022; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P95; Wassum KM, 2012, BIOL PSYCHIAT, V71, P846, DOI 10.1016/j.biopsych.2011.12.019; Westbrook A, 2016, NEURON, V89, P695, DOI [10.1016/j.neuron.2015.12.029, 10.1016/j.neuron.2016.07.020]; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wunderlich K, 2012, NEURON, V75, P418, DOI 10.1016/j.neuron.2012.03.042; Wyvell CL, 2000, J NEUROSCI, V20, P8122; Yagishita S, 2014, SCIENCE, V345, P1616, DOI 10.1126/science.1255514; Yamanaka K, 2018, J NEURAL TRANSM, V125, P501, DOI 10.1007/s00702-017-1713-z; Yapo C, 2017, J PHYSIOL-LONDON, V595, P7451, DOI 10.1113/JP274475	100	328	332	39	301	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2018	21	6					787	793		10.1038/s41593-018-0152-y	http://dx.doi.org/10.1038/s41593-018-0152-y			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GH2LE	29760524	Green Accepted			2022-12-17	WOS:000433232600005
J	Misonou, H; Mohapatra, DP; Park, EW; Leung, V; Zhen, DK; Misonou, K; Anderson, AE; Trimmer, JS				Misonou, H; Mohapatra, DP; Park, EW; Leung, V; Zhen, DK; Misonou, K; Anderson, AE; Trimmer, JS			Regulation of ion channel localization and phosphorylation by neuronal activity	NATURE NEUROSCIENCE			English	Article							KV2.1 K+ CHANNEL; NEOCORTICAL PYRAMIDAL NEURONS; GATED POTASSIUM CHANNELS; RAT HIPPOCAMPAL-NEURONS; MAMMALIAN BRAIN; ALPHA-SUBUNITS; RECEPTOR; IDENTIFICATION; ACTIVATION; BINDING	Voltage-dependent Kv2.1 K+ channels, which mediate delayed rectifier Kv currents (I-K), are expressed in large clusters on the somata and dendrites of principal pyramidal neurons, where they regulate neuronal excitability. Here we report activity-dependent changes in the localization and biophysical properties of Kv2.1. In the kainate model of continuous seizures in rat, we find a loss of Kv2.1 clustering in pyramidal neurons in vivo. Biochemical analysis of Kv2.1 in the brains of these rats shows a marked dephosphorylation of Kv2.1. In cultured rat hippocampal pyramidal neurons, glutamate stimulation rapidly causes dephosphorylation of Kv2.1, translocation of Kv2.1 from clusters to a more uniform localization, and a shift in the voltage-dependent activation of I-K. An influx of Ca2+ leading to calcineurin activation is both necessary and sufficient for these effects. Our finding that neuronal activity modifies the phosphorylation state, localization and function of Kv2.1 suggests an important link between excitatory neurotransmission and the intrinsic excitability of pyramidal neurons.	Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA; SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; Baylor Coll Med, Cain Fdn Lab, Houston, TX 77030 USA	University of California System; University of California Davis; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Baylor College of Medicine	Misonou, H (corresponding author), Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA.	hmisono@ucdavis.edu	Mohapatra, Durga/M-2133-2017; Durga, Mohapatra/B-3620-2008	Mohapatra, Durga/0000-0001-5016-1281; Misono, Hiroaki/0000-0001-5892-1804	NINDS NIH HHS [NS42225, NS39943] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042225, R01NS039943] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antonucci DE, 2001, NEUROSCIENCE, V108, P69, DOI 10.1016/S0306-4522(01)00476-6; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P611, DOI 10.1111/j.1469-7793.2000.t01-2-00611.x; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Colbert CM, 1999, J NEUROSCI, V19, P8163; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Deisseroth K, 2002, NEURON, V34, P179, DOI 10.1016/S0896-6273(02)00664-5; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; Du J, 2000, J PHYSIOL-LONDON, V522, P19, DOI 10.1111/j.1469-7793.2000.t01-2-00019.xm; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hausser M, 2004, NAT NEUROSCI, V7, P98, DOI 10.1038/nn0204-98; Kang J, 2000, J NEUROPHYSIOL, V83, P70, DOI 10.1152/jn.2000.83.1.70; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; Leonard AS, 2003, P NATL ACAD SCI USA, V100, P2029, DOI 10.1073/pnas.252782799; Levitan IB, 1999, ADV SEC MESS PHOSPH, V33, P3; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Malin SA, 2002, J NEUROSCI, V22, P10094; Martina M, 1998, J NEUROSCI, V18, P8111; MISONOU H, IN PRESS CRIT REV BI; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Murakoshi H, 1997, MOL PHARMACOL, V52, P821, DOI 10.1124/mol.52.5.821; Pal S, 2003, J NEUROSCI, V23, P4798; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; Scannevin RH, 1996, J CELL BIOL, V135, P1619, DOI 10.1083/jcb.135.6.1619; SHI GY, 1994, J BIOL CHEM, V269, P23204; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Sun DA, 2001, STROKE, V32, P2344, DOI 10.1161/hs1001.097242; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; WESTON JE, 1981, SOLID STATE IONICS, V2, P347, DOI 10.1016/0167-2738(81)90038-2	40	328	341	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					711	718		10.1038/nn1260	http://dx.doi.org/10.1038/nn1260			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15195093				2022-12-17	WOS:000222274400012
J	Semyanov, A; Walker, MC; Kullmann, DM				Semyanov, A; Walker, MC; Kullmann, DM			GABA uptake regulates cortical excitability via cell type-specific tonic inhibition	NATURE NEUROSCIENCE			English	Article							CEREBELLAR GRANULE CELLS; TEMPORAL-LOBE EPILEPSY; RAT-BRAIN-SLICES; HIPPOCAMPAL-NEURONS; SYNAPTIC INHIBITION; PERSISTENT ACTIVATION; RECEPTOR CHANNELS; PYRAMIDAL NEURONS; DELTA-SUBUNIT; HIGH-AFFINITY	GABA(A) receptors can mediate both 'phasic' synaptic inhibition and a persistent 'tonic' form of signaling. We show that, in the presence of intact GABA uptake, guinea pig hippocampal interneurons, but not pyramidal cells, express a tonic GABA(A) receptor-mediated conductance. This conductance was pharmacologically distinct from spontaneous inhibitory postsynaptic currents (IPSCs). Inhibiting GABA uptake resulted in the expression of a comparable GABA(A) receptor-mediated tonic conductance in pyramidal cells. Reducing the tonic conductance in interneurons enhanced their excitability and the inhibitory drive to pyramidal cells. These results point to a role for cell type-dependent tonic inhibition in regulating cortical excitability.	UCL, Dept Clin & Expt Epilepsy, Neurol Inst, London WC1N 3BG, England	University of London; University College London	Kullmann, DM (corresponding author), UCL, Dept Clin & Expt Epilepsy, Neurol Inst, Queen Sq, London WC1N 3BG, England.	d.kullmann@ion.ucl.ac.uk	Semyanov, Alexey/A-7654-2010; Kullmann, Dimitri M/A-3162-2009; Walker, Matthew C/C-1577-2008	Semyanov, Alexey/0000-0002-6800-0942; Kullmann, Dimitri M/0000-0001-6696-3545; Walker, Matthew C/0000-0002-0812-0352				Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; Birnir B, 2000, J MEMBRANE BIOL, V174, P21, DOI 10.1007/s002320001028; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; CELIO MR, 1993, HIPPOCAMPUS, V3, P55; Chiu CS, 2002, J NEUROSCI, V22, P10251; COLLINGRIDGE GL, 1984, J PHYSIOL-LONDON, V356, P551, DOI 10.1113/jphysiol.1984.sp015482; CURMI JP, 1993, J MEMBRANE BIOL, V136, P273; DE KONINCK Y, 1994, J NEUROPHYSIOL, V71, P1318, DOI 10.1152/jn.1994.71.4.1318; Demarque M, 2002, NEURON, V36, P1051, DOI 10.1016/S0896-6273(02)01053-X; DILLON GH, 1995, BRIT J PHARMACOL, V115, P539, DOI 10.1111/j.1476-5381.1995.tb16368.x; Draguhn A, 1996, J NEUROPHYSIOL, V76, P3983, DOI 10.1152/jn.1996.76.6.3983; DURING MJ, 1995, NATURE, V376, P174, DOI 10.1038/376174a0; Eghbali M, 1997, NATURE, V388, P71, DOI 10.1038/40404; Engel D, 1998, J PHYSIOL-LONDON, V512, P643, DOI 10.1111/j.1469-7793.1998.643bd.x; Frahm C, 2001, DEV BRAIN RES, V132, P1, DOI 10.1016/S0165-3806(01)00288-7; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; HAMANN M, 1988, BRAIN RES, V442, P287, DOI 10.1016/0006-8993(88)91514-4; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; LERMA J, 1986, BRAIN RES, V384, P145, DOI 10.1016/0006-8993(86)91230-8; Liu QY, 2000, J NEUROPHYSIOL, V84, P1392, DOI 10.1152/jn.2000.84.3.1392; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; NEWLAND CF, 1992, J PHYSIOL-LONDON, V447, P191, DOI 10.1113/jphysiol.1992.sp018998; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Overstreet LS, 2001, J NEUROPHYSIOL, V86, P596, DOI 10.1152/jn.2001.86.2.596; Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210; RADIAN R, 1990, J NEUROSCI, V10, P1319; Ribak CE, 1996, J COMP NEUROL, V367, P595, DOI 10.1002/(SICI)1096-9861(19960415)367:4<595::AID-CNE9>3.0.CO;2-#; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; SAXENA NC, 1994, J NEUROSCI, V14, P7077; Semyanov A, 2000, NEURON, V25, P663, DOI 10.1016/S0896-6273(00)81068-5; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Vizi ES, 1999, NEUROCHEM INT, V34, P407, DOI 10.1016/S0197-0186(99)00047-9; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Wingrove PB, 1997, MOL PHARMACOL, V52, P874, DOI 10.1124/mol.52.5.874; Wisden W, 2002, NEUROPHARMACOLOGY, V43, P530, DOI 10.1016/S0028-3908(02)00151-X; WOODSON W, 1989, J COMP NEUROL, V280, P254, DOI 10.1002/cne.902800207; Yan XX, 1997, DEV BRAIN RES, V99, P1, DOI 10.1016/S0165-3806(96)00192-7; Yeung JYT, 2003, MOL PHARMACOL, V63, P2, DOI 10.1124/mol.63.1.2	45	328	335	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					484	490		10.1038/nn1043	http://dx.doi.org/10.1038/nn1043			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12679782				2022-12-17	WOS:000182553200015
J	Gao, Q; Yuan, BB; Chess, A				Gao, Q; Yuan, BB; Chess, A			Convergent projections of Drosophila olfactory neurons to specific glomeruli in the antennal lobe	NATURE NEUROSCIENCE			English	Article							PUTATIVE PHEROMONE RECEPTORS; ODORANT RECEPTORS; MULTIGENE FAMILY; GENE-EXPRESSION; MELANOGASTER; ORGANIZATION; MAP; INFORMATION; EPITHELIUM; MAMMALS	Candidate Drosophila olfactory receptors (ORs) provide molecular tools to investigate how the organization of the Drosophila olfactory system determines the coding of olfactory stimuli. Neurons in the third antennal segment and maxillary palp appear to express different ORs. Individual olfactory neurons send axonal projections to glomeruli in the antennal lobe. Using transgenic flies, we provide evidence that the neurons expressing a given OR gene, which have cell bodies distributed among neurons expressing other ORs, converge in their projections to topographically fixed glomeruli in the antennal lobe. This convergence allows for the formation of an odotopic map in the antennal robe whose organization could provide a basis for olfactory discrimination in Drosophila.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Chess, A (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.							Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; CHARRO MJ, 1994, J COMP PHYSIOL A, V175, P761; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Ebrahimi FAW, 1998, CURR OPIN NEUROBIOL, V8, P453, DOI 10.1016/S0959-4388(98)80031-7; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; HAFEN E, 1986, DROSOPHILA PRACTICAL, P139; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Ito K, 1998, LEARN MEMORY, V5, P52; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Laissue PP, 1999, J COMP NEUROL, V405, P543; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; NEF P, 1992, P NATL ACAD SCI USA, V89, P8948, DOI 10.1073/pnas.89.19.8948; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Smith DP, 1996, CURR OPIN NEUROBIOL, V6, P500, DOI 10.1016/S0959-4388(96)80056-0; STOCKER RF, 1983, CELL TISSUE RES, V232, P237, DOI 10.1007/BF00213783; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; STROTMANN J, 1992, NEUROREPORT, V3, P1053, DOI 10.1097/00001756-199212000-00005; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6	38	328	331	4	29	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					780	785		10.1038/77680	http://dx.doi.org/10.1038/77680			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903570				2022-12-17	WOS:000167177300012
J	Xu, F; Gainetdinov, RR; Wetsel, WC; Jones, SR; Bohn, LM; Miller, GW; Wang, YM; Caron, MG				Xu, F; Gainetdinov, RR; Wetsel, WC; Jones, SR; Bohn, LM; Miller, GW; Wang, YM; Caron, MG			Mice lacking the norepinephrine transporter ave supersensitive to psychostimulants	NATURE NEUROSCIENCE			English	Article							CONDITIONED PLACE PREFERENCE; VENTRAL TEGMENTAL AREA; DOPAMINE-TRANSPORTER; KNOCKOUT MICE; COCAINE; NORADRENALINE; RAT; RELEASE; AMPHETAMINE; DEPRESSION	The action of norepinephrine (NE) is terminated, in part, by its uptake into presynaptic noradrenergic neurons by the plasma-membrane NE transporter (NET), which is a target for antidepressants and psychostimulants. Disruption of the NET gene in mice prolonged the clearance of NE and elevated extracellular levels of this catecholamine. In a classical test for antidepressant drugs, the NET-deficient (NET-/-) animals behaved like antidepressant-treated wild-type mice. Mutants were hyper-responsive to locomotor stimulation by cocaine or amphetamine. These responses were accompanied by dopamine D-2/D-3 receptor supersensitivity. Thus altering NET expression significantly modulates midbrain dopaminergic function, an effect that may be an important component of the actions of antidepressants and psychostimulants.	Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med Endocrinol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Caron, MG (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Cell Biol, Durham, NC 27710 USA.		Bohn, Laura/A-4412-2008; Bohn, Laura M/A-7483-2014; Jones, Sara R/K-4816-2014; Gainetdinov, Raul R/G-5875-2011	Bohn, Laura M/0000-0002-6474-8179; Jones, Sara R/0000-0002-3424-7576; Gainetdinov, Raul R/0000-0003-2951-6038	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH040159, P50MH040159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-36015] Funding Source: Medline; NIMH NIH HHS [MH-40159] Funding Source: Medline; NINDS NIH HHS [NS-19576] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Axelrod J, 1969, Prog Brain Res, V31, P21; BACKSTROM IT, 1989, J NEUROCHEM, V52, P1099, DOI 10.1111/j.1471-4159.1989.tb01853.x; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; CARR GD, 1989, NEUROPHARMACOLOGICAL, P265; Cragg SJ, 1997, J NEUROPHYSIOL, V77, P863, DOI 10.1152/jn.1997.77.2.863; FELDMAN RS, 1992, PRINCIPLES NEUROPSYC, P324; Fritz JD, 1998, J NEUROCHEM, V70, P2241; Gainetdinov RR, 1998, BRAIN RES REV, V26, P148, DOI 10.1016/S0165-0173(97)00063-5; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GIROS B, 1994, J BIOL CHEM, V269, P15985; GIROS B, 1993, TRENDS PHARMACOL SCI, V14, P43, DOI 10.1016/0165-6147(93)90029-J; Gong WH, 1996, BRAIN RES, V707, P64, DOI 10.1016/0006-8993(95)01222-2; GRENHOFF J, 1989, EUR J PHARMACOL, V165, P11, DOI 10.1016/0014-2999(89)90765-6; HORNIG A, 1997, DEPRESSION NEUROBIOL; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; KROBERT KA, 1994, J NEUROCHEM, V62, P2233; Leonard BE, 1997, J PSYCHOPHARMACOL, V11, pS39; LINDVALL O, 1983, CHEM NEUROANATOMY, P229; MANN JJ, 1995, CLIN NEUROPHARMACOL, V18, pS57; Markou A, 1998, NEUROPSYCHOPHARMACOL, V18, P135, DOI 10.1016/S0893-133X(97)00113-9; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; PALIJ P, 1992, BRAIN RES, V587, P137, DOI 10.1016/0006-8993(92)91438-K; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; REITH MEA, 1997, NEUROTRANSMITTER TRA, P345; Richelson E, 1996, J CLIN PSYCHOPHARM, V16, pS1, DOI 10.1097/00004714-199606002-00001; Rinken A, 1999, BIOCHEM PHARMACOL, V57, P155, DOI 10.1016/S0006-2952(98)00287-1; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; ROSSETTI ZL, 1991, EUR J PHARMACOL, V201, P243, DOI 10.1016/0014-2999(91)90353-R; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699; SPYRAKI C, 1981, EUR J PHARMACOL, V74, P195, DOI 10.1016/0014-2999(81)90531-8; STERU L, 1987, PROG NEURO-PSYCHOPH, V11, P659; Wang YM, 1997, NEURON, V19, P1285, DOI 10.1016/S0896-6273(00)80419-5; WILLNER P, 1995, CLIN NEUROPHARMACOL, V18, pS49; Willner P, 1997, INT CLIN PSYCHOPHARM, V12, pS7, DOI 10.1097/00004850-199707003-00002; Yavich L, 1997, EUR J PHARMACOL, V339, P113, DOI 10.1016/S0014-2999(97)01375-7	40	328	334	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					465	471		10.1038/74839	http://dx.doi.org/10.1038/74839			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309DG	10769386				2022-12-17	WOS:000086752000015
J	Huang, YF; Myers, SJ; Dingledine, R				Huang, YF; Myers, SJ; Dingledine, R			Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes	NATURE NEUROSCIENCE			English	Article							RESTRICTIVE SILENCER FACTOR; SODIUM-CHANNEL GENE; TARGET GENES; IN-VIVO; EXPRESSION; ACETYLATION; COMPLEX; CHROMATIN; GLUTAMATE; NUCLEOSOME	Many genes whose expression is restricted to neurons in the brain contain a silencer element (RE1/NRSE) that limits transcription in nonneuronal cells by binding the transcription factor REST (also named NRSF or XBR). Although two independent domains of REST are known to confer repression, the mechanisms of transcriptional repression by REST remain obscure. We provide multiple lines of evidence that the N-terminal domain of REST represses transcription of the GluR2 and type II sodium-channel genes by recruiting the corepressor Sin3A and histone deacetylase (HDAC) to the promoter region in nonneuronal cells. These results identify a general mechanism for controlling the neuronal expression pattern of a specific set of genes via the RE1 silencer element.	Emory Univ, Sch Med, Dept Pharmacol & Biochem, Cell & Dev Biol Grad Program, Atlanta, GA 30322 USA	Emory University	Dingledine, R (corresponding author), Emory Univ, Sch Med, Dept Pharmacol & Biochem, Cell & Dev Biol Grad Program, Atlanta, GA 30322 USA.		dingledine, Ray/F-5173-2011	Dingledine, Ray/0000-0001-7128-4520	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036604] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36604] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ashraf SI, 1998, CURR BIOL, V8, pR683, DOI 10.1016/S0960-9822(98)70435-X; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; COUSENS LS, 1979, J BIOL CHEM, V254, P1716; Dingledine R, 1999, PHARMACOL REV, V51, P7; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; FRIEDMAN LK, 1994, J NEUROSCI, V14, P2697; Gray SG, 1998, BIOCHEM BIOPH RES CO, V245, P423, DOI 10.1006/bbrc.1998.8449; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Imhof A, 1998, CURR BIOL, V8, pR422, DOI 10.1016/S0960-9822(98)70268-4; Kadosh D, 1998, MOL CELL BIOL, V18, P5121, DOI 10.1128/MCB.18.9.5121; Kallunki P, 1998, P NATL ACAD SCI USA, V95, P3233, DOI 10.1073/pnas.95.6.3233; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Leichter M, 1999, EUR J NEUROSCI, V11, P1937, DOI 10.1046/j.1460-9568.1999.00617.x; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; Myers SJ, 1998, J NEUROSCI, V18, P6723; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Palm K, 1998, J NEUROSCI, V18, P1280; PELLEGRINIGIAMPIETRO DE, 1992, P NATL ACAD SCI USA, V89, P10499, DOI 10.1073/pnas.89.21.10499; POLLARD H, 1993, NEUROSCIENCE, V57, P545, DOI 10.1016/0306-4522(93)90004-Y; PRINCE HK, 1995, J NEUROCHEM, V64, P462; SATO K, 1993, NEUROSCIENCE, V52, P515, DOI 10.1016/0306-4522(93)90403-3; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; TapiaRamirez J, 1997, P NATL ACAD SCI USA, V94, P1177, DOI 10.1073/pnas.94.4.1177; Thiel G, 1998, J BIOL CHEM, V273, P26891, DOI 10.1074/jbc.273.41.26891; Timmusk T, 1999, J BIOL CHEM, V274, P1078; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; VanLint C, 1996, GENE EXPRESSION, V5, P245; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	50	328	334	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1999	2	10					867	872		10.1038/13165	http://dx.doi.org/10.1038/13165			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FE	10491605				2022-12-17	WOS:000083883200010
J	Bushara, KO; Weeks, RA; Ishii, K; Catalan, MJ; Tian, B; Rauschecker, JP; Hallett, M				Bushara, KO; Weeks, RA; Ishii, K; Catalan, MJ; Tian, B; Rauschecker, JP; Hallett, M			Modality-specific frontal and parietal areas for auditory and visual spatial localization in humans	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; WORKING-MEMORY; SOUND-LOCALIZATION; VISUOSPATIAL ATTENTION; PREFRONTAL CORTEX; PET; NEURONS; NEGLECT; MONKEY; MECHANISMS	Although the importance of the posterior parietal and prefrontal regions in spatial localization of visual stimuli is well established, their role in auditory space perception is less clear. Using positron emission tomography (PET) during auditory and visual spatial localization in the same subjects, modality-specific areas were identified in the superior parietal lobule, middle temporal and lateral prefrontal cortices. These findings suggest that, similar to the visual system, the hierarchical organization of the auditory system extends beyond the temporal lobe to include areas in the posterior parietal and prefrontal regions specialized in auditory spatial processing. Our results may explain the dissociation of visual and auditory spatial localization deficits following lesions involving these regions.	NINDS, Human Motor Control Sect, Med Neurol Branch, NIH, Bethesda, MD 20892 USA; Georgetown Univ, Med Ctr, Inst Cognit & Computat Sci, Washington, DC 20007 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute of Neurological Disorders & Stroke (NINDS); Georgetown University	Hallett, M (corresponding author), NINDS, Human Motor Control Sect, Med Neurol Branch, NIH, Bldg 10,Room 5N226,10 Center MSC 1428, Bethesda, MD 20892 USA.		Rauschecker, Josef P/A-4120-2013	Rauschecker, Josef P./0000-0003-4353-9084	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002669, Z01NS002669] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHISSAR M, 1992, J NEUROPHYSIOL, V67, P203, DOI 10.1152/jn.1992.67.1.203; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; AZUMA M, 1984, BRAIN RES, V298, P343, DOI 10.1016/0006-8993(84)91434-3; BENDER MB, 1965, BRAIN, V88, P675, DOI 10.1093/brain/88.4.675; Blauert J., 1983, SPATIAL HEARING PSYC; Brugge JF, 1996, J NEUROSCI, V16, P4420; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; CRANFORD J, 1971, SCIENCE, V172, P286, DOI 10.1126/science.172.3980.286; DERENZI E, 1984, NEUROPSYCHOLOGIA, V22, P733; DERENZI E, 1989, J NEUROL NEUROSUR PS, V52, P613, DOI 10.1136/jnnp.52.5.613; FARAH MJ, 1989, NEUROPSYCHOLOGIA, V27, P461, DOI 10.1016/0028-3932(89)90051-1; Fink GR, 1997, BRAIN, V120, P2013, DOI 10.1093/brain/120.11.2013; Friston KJ, 1997, HUM BRAIN MAPP, V5, P133, DOI 10.1002/(SICI)1097-0193(1997)5:2<133::AID-HBM7>3.0.CO;2-4; Griffiths TD, 1998, NAT NEUROSCI, V1, P74, DOI 10.1038/276; Harrington DL, 1998, J NEUROSCI, V18, P1085; HAXBY JV, 1994, J NEUROSCI, V14, P6336; HEFFNER H, 1975, J NEUROPHYSIOL, V38, P1340, DOI 10.1152/jn.1975.38.6.1340; HEILMAN KM, 1971, ARCH NEUROL-CHICAGO, V24, P323, DOI 10.1001/archneur.1971.00480340055005; HERSCOVITCH P, 1983, J NUCL MED, V24, P782; JENKINS WM, 1984, J NEUROPHYSIOL, V52, P819, DOI 10.1152/jn.1984.52.5.819; JERGER J, 1972, J SPEECH HEAR DISORD, V37, P523, DOI 10.1044/jshd.3704.523; KING AJ, 1983, J PHYSIOL-LONDON, V342, P361, DOI 10.1113/jphysiol.1983.sp014856; KNUDSEN EI, 1978, SCIENCE, V200, P795, DOI 10.1126/science.644324; Lacquaniti F, 1997, NEUROIMAGE, V5, P129, DOI 10.1006/nimg.1996.0254; Maquet P, 1996, NEUROIMAGE, V3, P119, DOI 10.1006/nimg.1996.0014; Mazzoni P, 1996, J NEUROPHYSIOL, V75, P1233, DOI 10.1152/jn.1996.75.3.1233; MCCARTHY G, 1994, P NATL ACAD SCI USA, V91, P8690, DOI 10.1073/pnas.91.18.8690; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; MILNER A, 1997, NEGLECT EXTINCTION C; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; RUSSO GS, 1994, J NEUROPHYSIOL, V71, P1250, DOI 10.1152/jn.1994.71.3.1250; SANCHEZLONGO LP, 1958, NEUROLOGY, V8, P119, DOI 10.1212/WNL.8.2.119; Soroker N, 1997, NEUROPSYCHOLOGIA, V35, P249, DOI 10.1016/S0028-3932(96)00038-3; Stricanne B, 1996, J NEUROPHYSIOL, V76, P2071, DOI 10.1152/jn.1996.76.3.2071; Sweeney JA, 1996, J NEUROPHYSIOL, V75, P454, DOI 10.1152/jn.1996.75.1.454; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; VAADIA E, 1989, BRAIN BEHAV EVOLUT, V33, P127, DOI 10.1159/000115914; WARD LM, 1994, CAN J EXP PSYCHOL, V48, P242, DOI 10.1037/1196-1961.48.2.242; WATSON RT, 1994, ARCH NEUROL-CHICAGO, V51, P1014, DOI 10.1001/archneur.1994.00540220060015; WEEKS R, IN PRESS NEUROSCI LE; WEGENER J G, 1973, Journal of Auditory Research, V13, P191; WENZEL EM, 1993, J ACOUST SOC AM, V94, P111, DOI 10.1121/1.407089; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P858, DOI 10.1121/1.397557; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; YOUNG AW, 1992, BRAIN, V115, P51, DOI 10.1093/brain/115.1.51; Zatorre RJ, 1998, P NATL ACAD SCI USA, V95, P3172, DOI 10.1073/pnas.95.6.3172	50	328	332	0	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1999	2	8					759	766		10.1038/11239	http://dx.doi.org/10.1038/11239			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	259FA	10412067				2022-12-17	WOS:000083882800017
J	Ballas, N; Lioy, DT; Grunseich, C; Mandel, G				Ballas, Nurit; Lioy, Daniel T.; Grunseich, Christopher; Mandel, Gail			Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology	NATURE NEUROSCIENCE			English	Article							CPG-BINDING PROTEIN-2; RETT-SYNDROME; MOUSE MODEL; DNA METHYLATION; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; BDNF TRANSCRIPTION; MOTOR-NEURONS; ALS MICE; MECP2	The neurodevelopmental disorder Rett syndrome (RTT) is caused by sporadic mutations in the transcriptional factor methyl-CpG-binding protein 2 (MeCP2). Although it is thought that the primary cause of RTT is cell autonomous, resulting from a lack of functional MeCP2 in neurons, whether non-cell autonomous factors contribute to the disease is unknown. We found that the loss of MeCP2 occurs not only in neurons but also in glial cells of RTT brains. Using an in vitro co-culture system, we found that mutant astrocytes from a RTT mouse model, and their conditioned medium, failed to support normal dendritic morphology of either wild-type or mutant hippocampal neurons. Our studies suggest that astrocytes in the RTT brain carrying MeCP2 mutations have a non-cell autonomous effect on neuronal properties, probably as a result of aberrant secretion of soluble factor(s).	[Ballas, Nurit; Grunseich, Christopher; Mandel, Gail] SUNY Stony Brook, Dept Neurobiol & Behav, Howard Hughes Med Inst, Stony Brook, NY 11794 USA; [Ballas, Nurit] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Lioy, Daniel T.; Mandel, Gail] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Lioy, Daniel T.; Mandel, Gail] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Ballas, N (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Howard Hughes Med Inst, Stony Brook, NY 11794 USA.	nballas@notes.cc.sunysb.edu			International Rett Syndrome Foundation; US National Institutes of Health grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056503] Funding Source: NIH RePORTER	International Rett Syndrome Foundation; US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank J. Levine and L. Evans for providing the enriched glial cultures for the initial immunostaining analysis; P. Brehm, R. Goodman, T. Reese and G. Banker for valuable discussions about the results; and D. D. Lu and R. Spektor for technical assistance. This work was supported in part by a grant from the International Rett Syndrome Foundation to N. B. and a US National Institutes of Health grant to G. M. and N. B. G. M. is an Investigator of the Howard Hughes Medical Institute.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; Armstrong DD, 2005, J CHILD NEUROL, V20, P747, DOI 10.1177/08830738050200082401; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; BELICHENKO PV, 1994, NEUROREPORT, V5, P1509, DOI 10.1097/00001756-199407000-00025; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chandler SP, 1999, BIOCHEMISTRY-US, V38, P7008, DOI 10.1021/bi990224y; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Colantuoni C, 2001, NEUROBIOL DIS, V8, P847, DOI 10.1006/nbdi.2001.0428; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; HANEFELD F, 1995, NEUROPEDIATRICS, V26, P126, DOI 10.1055/s-2007-979742; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; JELLINGER K, 1988, ACTA NEUROPATHOL, V76, P142, DOI 10.1007/BF00688098; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jung BP, 2003, J NEUROBIOL, V55, P86, DOI 10.1002/neu.10201; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; KITT CA, 1995, NEUROPEDIATRICS, V26, P114, DOI 10.1055/s-2007-979739; Kriaucionis S, 2003, HUM MOL GENET, V12, pR221, DOI 10.1093/hmg/ddg286; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Maragakis NJ, 2001, ARCH NEUROL-CHICAGO, V58, P365, DOI 10.1001/archneur.58.3.365; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Saywell W, 2006, BIOCHEM BIOPH RES CO, V340, P776, DOI 10.1016/j.bbrc.2005.12.080; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Thatcher KN, 2006, EPIGENETICS-US, V1, P24; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Viola A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000157; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yang ZS, 2005, J NEUROSCI METH, V149, P50, DOI 10.1016/j.jneumeth.2005.05.003; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	50	327	340	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2009	12	3					311	317		10.1038/nn.2275	http://dx.doi.org/10.1038/nn.2275			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	410LF	19234456	Green Accepted			2022-12-17	WOS:000263577900016
J	Bellone, C; Luscher, C				Bellone, C; Luscher, C			Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; MESOLIMBIC DOPAMINE SYSTEM; DOMAIN-CONTAINING PROTEIN; KINASE-C-ALPHA; SYNAPTIC PLASTICITY; INDUCED POTENTIATION; SUBUNIT COMPOSITION; LTP INDUCTION; NEURONS; SENSITIZATION	Drugs of abuse induce long-lasting changes in neural circuits that may underlie core components of addiction. Here we focus on glutamatergic synapses onto dopamine (DA) neurons of the ventral tegmental area (VTA). Using an 'ex vivo' approach in mice, we show that a single injection of cocaine caused strong rectification and conferred sensitivity to the polyamine Joro spider toxin (JST) of AMPAR-mediated excitatory postsynaptic currents (AMPAR EPSCs), indicating the recruitment of receptors that lack GluR2. This qualitative change in transmission was paralleled by an increase in the AMPAR: NMDAR ratio and was prevented by interfering with the protein interacting with C kinase-1 (PICK1) in vivo. Activation of metabotropic glutamate receptors (mGluR1s) by intraperitoneal injection of a positive modulator depotentiated synapses and abolished rectification in slices of cocaine-treated mice, revealing a mechanism to reverse cocaine-induced synaptic plasticity in vivo.	Univ Geneva, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; Univ Geneva, Neurol Clin, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Dept Basic Neurosci, 1 Michel Servet, CH-1211 Geneva, Switzerland.	Christian.Luscher@medecine.unige.ch	Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; bellone, camilla/0000-0002-6774-6275				Andrasfalvy BK, 2004, J PHYSIOL-LONDON, V559, P543, DOI 10.1113/jphysiol.2004.065219; Bellone C, 2005, EUR J NEUROSCI, V21, P1280, DOI 10.1111/j.1460-9568.2005.03979.x; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Carlezon WA, 2002, TRENDS NEUROSCI, V25, P610, DOI 10.1016/S0166-2236(02)02289-0; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chiamulera C, 2001, NAT NEUROSCI, V4, P873, DOI 10.1038/nn0901-873; Chung HJ, 2000, J NEUROSCI, V20, P7258; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dong Y, 2004, P NATL ACAD SCI USA, V101, P14282, DOI 10.1073/pnas.0401553101; Faleiro LJ, 2004, NEUROPSYCHOPHARMACOL, V29, P2115, DOI 10.1038/sj.npp.1300495; Fiorillo CD, 1998, NATURE, V394, P78, DOI 10.1038/27919; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Hartmann B, 2004, NEURON, V44, P637, DOI 10.1016/j.neuron.2004.10.029; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; Kauer JA, 2004, ANNU REV PHYSIOL, V66, P447, DOI 10.1146/annurev.physiol.66.032102.112534; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Knoflach F, 2001, P NATL ACAD SCI USA, V98, P13402, DOI 10.1073/pnas.231358298; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Luscher C, 2001, TRENDS NEUROSCI, V24, P665, DOI 10.1016/S0166-2236(00)01959-7; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; NISHIOKA N S, 1987, Lasers in Medical Science, V2, P21, DOI 10.1007/BF02594126; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rozov A, 1998, J PHYSIOL-LONDON, V511, P361, DOI 10.1111/j.1469-7793.1998.361bh.x; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; SCHENK S, 1994, BRAIN RES, V659, P17, DOI 10.1016/0006-8993(94)90858-3; Schwarze SR, 2000, TRENDS PHARMACOL SCI, V21, P45, DOI 10.1016/S0165-6147(99)01429-7; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Szumlinski KK, 2003, ANN NY ACAD SCI, V1003, P468, DOI 10.1196/annals.1300.055; Tanaka H, 2000, BRAIN RES, V886, P190, DOI 10.1016/S0006-8993(00)02951-6; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Thomas MJ, 2003, PHILOS T ROY SOC B, V358, P815, DOI 10.1098/rstb.2002.1236; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Washburn MS, 1997, J NEUROSCI, V17, P9393; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3	50	327	337	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					636	641		10.1038/nn1682	http://dx.doi.org/10.1038/nn1682			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16582902				2022-12-17	WOS:000237417200014
J	Ling, DSF; Benardo, LS; Serrano, PA; Blace, N; Kelly, MT; Crary, JF; Sacktor, TC				Ling, DSF; Benardo, LS; Serrano, PA; Blace, N; Kelly, MT; Crary, JF; Sacktor, TC			Protein kinase M zeta is necessary and sufficient for LTP maintenance	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; ACTIVATION; MECHANISMS; INDUCTION; CELLS		SUNY Downstate Med Ctr, Dept Physiol, Brooklyn, NY 11203 USA; SUNY Downstate Med Ctr, Dept Pharmacol, Brooklyn, NY 11203 USA; SUNY Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Sacktor, TC (corresponding author), SUNY Downstate Med Ctr, Dept Physiol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.			Blace, Nancy/0000-0002-6174-6004				Bortolotto ZA, 2000, EUR J NEUROSCI, V12, P4055, DOI 10.1046/j.1460-9568.2000.00291.x; DENNY JB, 1990, BRAIN RES, V534, P201, DOI 10.1016/0006-8993(90)90130-4; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; Fukunaga K, 2000, J NEUROCHEM, V74, P807, DOI 10.1046/j.1471-4159.2000.740807.x; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MCGLYNN E, 1992, J CELL BIOCHEM, V49, P239, DOI 10.1002/jcb.240490306; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Otmakhov N, 1997, J NEUROSCI, V17, P5357; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; SCHWARTZ JH, 1987, ANNU REV NEUROSCI, V10, P459; Shirke AM, 1997, J NEUROPHYSIOL, V78, P2682, DOI 10.1152/jn.1997.78.5.2682; Thompson LJ, 1996, J BIOL CHEM, V271, P15045, DOI 10.1074/jbc.271.25.15045	15	327	345	0	41	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					295	296		10.1038/nn829	http://dx.doi.org/10.1038/nn829			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11914719				2022-12-17	WOS:000174606900006
J	McAlpine, D; Jiang, D; Palmer, AR				McAlpine, D; Jiang, D; Palmer, AR			A neural code for low-frequency sound localization in mammals	NATURE NEUROSCIENCE			English	Article							MEDIAL SUPERIOR OLIVE; ANTEROVENTRAL COCHLEAR NUCLEUS; INFERIOR COLLICULUS NEURONS; INTERAURAL PHASE DISPARITY; OWL TYTO-ALBA; BARN OWL; BINAURAL INTERACTION; DIRECTIONAL HEARING; RESPONSE PROPERTIES; CHANGING FREQUENCY	We report a systematic relationship between sound-frequency tuning and sensitivity to interaural time delays for neurons in the midbrain nucleus of the inferior colliculus; neurons with relatively low best frequencies (BFs) showed response peaks at long delays, whereas neurons with relatively high BFs showed response peaks at short delays. The consequence of this relationship is that the steepest region of the function relating discharge rate to interaural time delay (ITD) fell close to midline for all neurons irrespective of BF. These data provide support for a processing of the output of coincidence detectors subserving low-frequency sound localization in which the location of a sound source is determined by the activity in two broad, hemispheric spatial channels, rather than numerous channels tuned to discrete spatial positions.	Univ Nottingham, MRC, Inst Hearing Res, Nottingham NG7 2RD, England; UCL, Dept Physiol, London WC1E 6BT, England	University of Nottingham; University of London; University College London	McAlpine, D (corresponding author), Univ Nottingham, MRC, Inst Hearing Res, Sci Rd, Nottingham NG7 2RD, England.	d.mcalpine@ucl.ac.uk		McAlpine, David/0000-0001-5467-6725; Palmer, Alan/0000-0001-5893-4525				Batra R, 1997, J NEUROPHYSIOL, V78, P1222, DOI 10.1152/jn.1997.78.3.1222; Beckius GE, 1999, J NEUROSCI, V19, P3146; CARR CE, 1990, J NEUROSCI, V10, P3227; COLBURN HS, 1978, J ACOUST SOC AM, V64, P95, DOI 10.1121/1.381960; COLES RB, 1988, J COMP PHYSIOL A, V163, P117, DOI 10.1007/BF00612002; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; Delgutte B, 1999, J NEUROPHYSIOL, V81, P2833, DOI 10.1152/jn.1999.81.6.2833; DOMINTZ RH, 1977, J ACOUST SOC AM, V61, P1586; ELVERLAND HH, 1978, EXP BRAIN RES, V32, P117; Fitzpatrick DC, 1997, NATURE, V388, P871, DOI 10.1038/42246; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; JENKINS WM, 1982, J NEUROPHYSIOL, V47, P987, DOI 10.1152/jn.1982.47.6.987; Jiang D, 1997, J NEUROSCI, V17, P9331; JORIS PX, 1994, J NEUROPHYSIOL, V71, P1022, DOI 10.1152/jn.1994.71.3.1022; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; KUWADA S, 1987, J NEUROPHYSIOL, V57, P1338, DOI 10.1152/jn.1987.57.5.1338; KUWADA S, 1997, BINAURAL SPATIAL HEA, P399; McAlpine D, 1998, J NEUROSCI, V18, P6026; McAlpine D, 1996, HEARING RES, V97, P136, DOI 10.1016/0378-5955(96)00068-8; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; OLSEN JF, 1989, J NEUROSCI, V9, P2591; PALMER AR, 1992, PROCESSING COMPLEX S, P415; PHILLIPS DP, 1985, ANNU REV PSYCHOL, V36, P245; Shackleton TM, 2000, HEARING RES, V149, P199, DOI 10.1016/S0378-5955(00)00187-8; SHAMMA SA, 1989, J ACOUST SOC AM, V86, P989, DOI 10.1121/1.398734; SMITH PH, 1993, J COMP NEUROL, V331, P245, DOI 10.1002/cne.903310208; Spitzer MW, 1998, J NEUROPHYSIOL, V80, P3062, DOI 10.1152/jn.1998.80.6.3062; SPITZER MW, 1995, J NEUROPHYSIOL, V73, P1668, DOI 10.1152/jn.1995.73.4.1668; Stern R. M., 1996, BINAURAL SPATIAL HEA, P499; Stevens SS, 1936, AM J PSYCHOL, V48, P297, DOI 10.2307/1415748; STILLMAN RD, 1971, EXP NEUROL, V32, P404, DOI 10.1016/0014-4886(71)90007-0; Strutt J., 1907, PHILOS MAG, V13, P214, DOI [DOI 10.1080/14786440709463595, 10.1080/14786440709463595]; TAKAHASHI T, 1984, J NEUROSCI, V4, P1781; TAKAHASHI T, 1986, J NEUROSCI, V6, P3413; van BERGEIJK WILLEM A., 1962, JOUR ACOUSTICAL SOC AMER, V34, P1431, DOI 10.1121/1.1918364; von Bekesy G, 1930, PHYS Z, V31, P824; WAGNER H, 1987, J NEUROSCI, V7, P3105; WENSTRUP JJ, 1986, J NEUROSCI, V6, P964; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P868, DOI 10.1121/1.397558; YIN TCT, 1987, J NEUROPHYSIOL, V58, P562, DOI 10.1152/jn.1987.58.3.562; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465; YIN TCT, 1986, J NEUROPHYSIOL, V55, P280, DOI 10.1152/jn.1986.55.2.280; YIN TCT, 1983, J NEUROPHYSIOL, V50, P1020, DOI 10.1152/jn.1983.50.4.1020; ZWISLOCKI J, 1956, J ACOUST SOC AM, V28, P866	44	327	332	2	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					396	401		10.1038/86049	http://dx.doi.org/10.1038/86049			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276230				2022-12-17	WOS:000168762200020
J	Steinhauer, K; Alter, K; Friederici, AD				Steinhauer, K; Alter, K; Friederici, AD			Brain potentials indicate immediate use of prosodic cues in natural speech processing	NATURE NEUROSCIENCE			English	Article							EYE-MOVEMENTS; GARDEN-PATH; SENTENCES; COMPREHENSION; INFORMATION; ATTACHMENT; LANGUAGE; CONTEXT	Spoken language, in contrast to written text, provides prosodic information such as rhythm, pauses, accents, amplitude and pitch variations. However, little is known about when and how these features are used by the listener to interpret the speech signal. Here we use event-related brain potentials (ERP) to demonstrate that intonational phrasing guides the initial analysis of sentence structure. Our finding of a positive shift in the ERP at intonational phrase boundaries suggests a specific on-line brain response to prosodic processing. Additional ERP components indicate that a false prosodic boundary is sufficient to mislead the listener's sentence processor. Thus, the application of ERP measures is a promising approach for revealing the time course and neural basis of prosodic information processing.	Max Planck Inst Cognit Neurosci, Dept Neuropsychol, D-04303 Leipzig, Germany	Max Planck Society	Steinhauer, K (corresponding author), Max Planck Inst Cognit Neurosci, Dept Neuropsychol, POB 500 355, D-04303 Leipzig, Germany.	steinhau@cns.mpg.de	Steinhauer, Karsten/B-2863-2008; lee, yujun/P-6069-2014	lee, yujun/0000-0002-5821-7355; Alter, Kai/0000-0003-4575-9494				ALTMANN GTM, 1992, J MEM LANG, V31, P685, DOI 10.1016/0749-596X(92)90035-V; BADER M, IN PRESS REANALYSIS; Beckman ME, 1996, LANG COGNITIVE PROC, V11, P17, DOI 10.1080/016909696387213; Blumstein Sheila E., 1995, P915; Cutler A, 1997, LANG SPEECH, V40, P141, DOI 10.1177/002383099704000203; Fodor JD, 1998, J PSYCHOLINGUIST RES, V27, P285, DOI 10.1023/A:1023258301588; FRAZIER L, 1987, ATTENTION PERFORM, V12, P559; Friederici AD, 1998, BIOL PSYCHOL, V47, P193, DOI 10.1016/S0301-0511(97)00033-1; FRIEDERICI AD, 1995, BRAIN LANG, V50, P259, DOI 10.1006/brln.1995.1048; FRIEDERICI AD, IN PRESS MEM COGN; FRIEDMAN D, 1975, ELECTROEN CLIN NEURO, V38, P255, DOI 10.1016/0013-4694(75)90246-1; GERNSBACHER MA, 1995, COGNITIVE PSYCHOL, V29, P24, DOI 10.1006/cogp.1995.1011; Hagoort P., 1995, HDB NEUROPSYCHOL, V10, P105; Halle Morris, 1987, AN ESSAY ON STRESS; HOLCOMB PJ, 1991, PSYCHOBIOLOGY, V19, P286; Hopf JM, 1998, J COGNITIVE NEUROSCI, V10, P264, DOI 10.1162/089892998562690; Huynh H., 1970, J AM STAT ASSOC, V65, P1582, DOI DOI 10.1080/01621459.1970.10481187; Keppel G., 1991, DESIGN ANAL RES HDB, DOI DOI 10.1126/scitranslmed.aat8806; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M., 1994, HDB PSYCHOLINGUISTIC, P83, DOI DOI 10.1016/8978-012369374-7/50018-3; MARSLENWILSON WD, 1992, Q J EXP PSYCHOL-A, V45, P73, DOI 10.1080/14640749208401316; NESPOR M, 1986, PROSODIC PHONOLOGY; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OSTERHOUT L, 1993, LANG COGNITIVE PROC, V8, P413, DOI 10.1080/01690969308407584; OSTERHOUT L, 1994, J EXP PSYCHOL LEARN, V20, P786, DOI 10.1037/0278-7393.20.4.786; OSTERHOUT L, 1998, IN PRESS LANG COGN P; Osterhout L, 1995, ELECTROPHYSIOLOGY MI; Regan D., 1989, HUMAN BRAIN ELECTROP; ROSLER F, 1993, J COGNITIVE NEUROSCI, V5, P345, DOI 10.1162/jocn.1993.5.3.345; Rossi FMV, 1997, MOL BIOL CELL, V8, P699; Selkirk E.O., 1984, PHONOLOGY SYNTAX REL; Stirling L, 1996, LANG COGNITIVE PROC, V11, P193, DOI 10.1080/016909696387268; SWAAB TY, 1996, FUNCTIONAL LOCUS COM; TARABAN R, 1988, J MEM LANG, V27, P597, DOI 10.1016/0749-596X(88)90011-3; VANPETTEN C, 1991, MEM COGNITION, V19, P95, DOI 10.3758/BF03198500; WARREN P, 1995, LANG COGNITIVE PROC, V10, P457, DOI 10.1080/01690969508407112	37	327	338	7	50	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					191	196		10.1038/5757	http://dx.doi.org/10.1038/5757			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	160LF	10195205				2022-12-17	WOS:000078231600020
J	Tsai, JW; Bremner, KH; Vallee, RB				Tsai, Jin-Wu; Bremner, K. Helen; Vallee, Richard B.			Dual subcellular roles for LIS1 and dynein in radial neuronal migration in live brain tissue	NATURE NEUROSCIENCE			English	Article							CYTOPLASMIC DYNEIN; BINDING PROTEIN; CENTROSOME; MYOSIN; ORGANIZATION; CDC42; MOVEMENT; DYNACTIN; DIVISION; MOTILITY	During brain development, neural precursor cells migrate along radial glial fibers to populate the neocortex. RNA interference (RNAi) of the lissencephaly gene LIS1 (also known as PAFAH1b1) inhibits somal movement but not process extension of neural precursors in live brain slices. Here we report imaging of the subcellular events accompanying neural precursor migration and the effects of LIS1, cytoplasmic dynein and myosin II inhibition. Centrosomes move continuously and often far in advance of nuclei, which show extreme saltatory behavior. LIS1 and dynein RNAi inhibit centrosomal and nuclear movement independently, whereas myosin II inhibition blocks only nuclear translocation. Imaging of the microtubule end-binding protein 3 (EB3) reveals a centrosome-centered array of microtubules in live neural precursors under all conditions examined. Dynein is concentrated both at a swelling in the leading process reported to initiate each migratory cycle and in the soma. Thus, dynein pulls on the microtubule network from the swelling. The nucleus is transported along the trailing microtubules by dynein assisted by myosin II.	Columbia Univ, Coll Phys & Surg, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Vallee, RB (corresponding author), Columbia Univ, Coll Phys & Surg, Integrated Program Cellular Mol & Biophys Studies, 630 W 168th St, New York, NY 10032 USA.	rv2025@columbia.edu	Tsai, Jin W/A-6428-2009	Tsai, Jin-Wu/0000-0003-0135-759X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047434, R01GM047434] Funding Source: NIH RePORTER; NICHD NIH HHS [HD40182] Funding Source: Medline; NIGMS NIH HHS [GM47434] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abal M, 2002, J CELL BIOL, V159, P731, DOI 10.1083/jcb.200207076; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Contreras A, 2003, MOL CELL BIOL, V23, P8626, DOI 10.1128/MCB.23.23.8626-8636.2003; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Firtel RA, 2000, CURR OPIN GENET DEV, V10, P421, DOI 10.1016/S0959-437X(00)00107-6; Fuchs JL, 2004, CELL BIOL INT, V28, P111, DOI 10.1016/j.cellbi.2003.11.008; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; JACOBS JR, 1986, J CELL BIOL, V103, P895, DOI 10.1083/jcb.103.3.895; Kato M, 2003, HUM MOL GENET, V12, pR89, DOI 10.1093/hmg/ddg086; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; McManus MF, 2004, AM J PATHOL, V165, P775, DOI 10.1016/S0002-9440(10)63340-8; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Morris R, 2000, NAT CELL BIOL, V2, pE201, DOI 10.1038/35041123; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Rakic P, 1996, P NATL ACAD SCI USA, V93, P9218, DOI 10.1073/pnas.93.17.9218; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Stepanova T, 2003, J NEUROSCI, V23, P2655; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; White RA, 2000, MICROSC RES TECHNIQ, V49, P451, DOI 10.1002/(SICI)1097-0029(20000601)49:5<451::AID-JEMT7>3.0.CO;2-9; Xie ZG, 2004, CELL CYCLE, V3, P108	38	326	329	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					970	979		10.1038/nn1934	http://dx.doi.org/10.1038/nn1934			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17618279				2022-12-17	WOS:000248357500011
J	Hess, ME; Hess, S; Meyer, KD; Verhagen, LAW; Koch, L; Bronneke, HS; Dietrich, MO; Jordan, SD; Saletore, Y; Elemento, O; Belgardt, BF; Franz, T; Horvath, TL; Ruther, U; Jaffrey, SR; Kloppenburg, P; Bruning, JC				Hess, Martin E.; Hess, Simon; Meyer, Kate D.; Verhagen, Linda A. W.; Koch, Linda; Broenneke, Hella S.; Dietrich, Marcelo O.; Jordan, Sabine D.; Saletore, Yogesh; Elemento, Olivier; Belgardt, Bengt F.; Franz, Thomas; Horvath, Tamas L.; Ruether, Ulrich; Jaffrey, Samie R.; Kloppenburg, Peter; Bruening, Jens C.			The fat mass and obesity associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry	NATURE NEUROSCIENCE			English	Article							SUBSTANTIA-NIGRA; D2 RECEPTORS; MICE LACKING; ADDICTION; COCAINE; REWARD; BRAIN; RNA; CHILDHOOD; NEURONS	Dopaminergic (DA) signaling governs the control of complex behaviors, and its deregulation has been implicated in a wide range of diseases. Here we demonstrate that inactivation of the Fto gene, encoding a nucleic acid demethylase, impairs dopamine receptor type 2 (D2R) and type 3 (D3R) (collectively, 'D2-like receptor')-dependent control of neuronal activity and behavioral responses. Conventional and DA neuron-specific Fto knockout mice show attenuated activation of G protein-coupled inwardly-rectifying potassium (GIRK) channel conductance by cocaine and quinpirole. Impaired D2-like receptor-mediated autoinhibition results in attenuated quinpirole-mediated reduction of locomotion and an enhanced sensitivity to the locomotor-and reward-stimulatory actions of cocaine. Analysis of global N-6-methyladenosine (m(6)A) modification of mRNAs using methylated RNA immunoprecipitation coupled with next-generation sequencing in the midbrain and striatum of Fto-deficient mice revealed increased adenosine methylation in a subset of mRNAs important for neuronal signaling, including many in the DA signaling pathway. Several proteins encoded by these mRNAs had altered expression levels. Collectively, FTO regulates the demethylation of specific mRNAs in vivo, and this activity relates to the control of DA transmission.	[Hess, Martin E.; Verhagen, Linda A. W.; Broenneke, Hella S.; Bruening, Jens C.] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Hess, Martin E.; Verhagen, Linda A. W.; Koch, Linda; Broenneke, Hella S.; Jordan, Sabine D.; Belgardt, Bengt F.; Bruening, Jens C.] Univ Cologne, Inst Genet, Dept Mouse Genet & Metab, Cologne, Germany; [Hess, Martin E.; Hess, Simon; Verhagen, Linda A. W.; Koch, Linda; Broenneke, Hella S.; Jordan, Sabine D.; Belgardt, Bengt F.; Kloppenburg, Peter; Bruening, Jens C.] Ctr Mol Med Cologne, Cologne, Germany; [Hess, Martin E.; Hess, Simon; Verhagen, Linda A. W.; Koch, Linda; Broenneke, Hella S.; Jordan, Sabine D.; Belgardt, Bengt F.; Kloppenburg, Peter; Bruening, Jens C.] Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Hess, Martin E.; Verhagen, Linda A. W.; Koch, Linda; Broenneke, Hella S.; Jordan, Sabine D.; Belgardt, Bengt F.; Bruening, Jens C.] Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med, Cologne, Germany; [Hess, Simon; Kloppenburg, Peter] Univ Cologne, Inst Zool, Cologne, Germany; [Meyer, Kate D.; Jaffrey, Samie R.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Broenneke, Hella S.] CECAD, Mouse Phenotyping Facil, Cologne, Germany; [Dietrich, Marcelo O.; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA; [Dietrich, Marcelo O.; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Dietrich, Marcelo O.; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Saletore, Yogesh; Elemento, Olivier] Cornell Univ, Weill Med Coll, Inst Computat Biomed, New York, NY 10021 USA; [Franz, Thomas] Max Planck Inst Biol Ageing, Cologne, Germany; [Ruether, Ulrich] Univ Dusseldorf, Inst Anim Dev & Mol Biol, D-40225 Dusseldorf, Germany	Max Planck Society; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Cornell University; University of Cologne; Yale University; Yale University; Yale University; Cornell University; Max Planck Society; Heinrich Heine University Dusseldorf	Bruning, JC (corresponding author), Max Planck Inst Neurol Res, Gleueler Str 50, D-50931 Cologne, Germany.	bruening@nf.mpg.de	Dietrich, Marcelo/A-9928-2009	Dietrich, Marcelo/0000-0001-9781-2221; Jaffrey, Samie/0000-0003-3615-6958; Meyer, Kate/0000-0001-7197-4054; Belgardt, Bengt-Frederik/0000-0003-4537-9002; Koch, Linda/0000-0002-2943-1993	US National Institutes of Health [R01 NS056306]; Deutsche Forschungsgemeinschaft [Br1492-7/1, KL 762/2-2]; Kompetenznetz Adipositas (Competence Network for Obesity); German Federal Ministry of Education and Research (FKZ) [01GI1122A]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056306] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Kompetenznetz Adipositas (Competence Network for Obesity); German Federal Ministry of Education and Research (FKZ)(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Alber, B. Hampel, H. Wratil and Y. Masekowitz for excellent technical assistance. We also thank C. Mason for assistance with MeRIP-Seq peak calling. We thank the European Conditional Mouse Mutagenesis Program (EUCOMM) for providing mice with knock in of the beta-galactosidase gene into the Fto gene and N.G. Larsson (Max Planck Institute for Biology of Ageing, Cologne, Germany) for providing Dat-Cre mice. This work was supported by US National Institutes of Health grant R01 NS056306 (S. R. J.), the Deutsche Forschungsgemeinschaft (Br1492-7/1 to J. C. B. and KL 762/2-2 to P. K.) and the Kompetenznetz Adipositas (Competence Network for Obesity) funded by the German Federal Ministry of Education and Research (FKZ: 01GI1122A to J.C.B.).	Anzalone A, 2012, J NEUROSCI, V32, P9023, DOI 10.1523/JNEUROSCI.0918-12.2012; Bello EP, 2011, NAT NEUROSCI, V14, P1033, DOI 10.1038/nn.2862; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Cheung MK, 2013, INT J OBESITY, V37, P744, DOI 10.1038/ijo.2012.77; Choudhry Z, 2013, OBESITY, V21, pE738, DOI 10.1002/oby.20444; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; Diaz-Torga G, 2002, ENDOCRINOLOGY, V143, P1270, DOI 10.1210/en.143.4.1270; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Garcia-Tornadu I, 2010, FRONT HORM RES, V38, P59, DOI 10.1159/000318495; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Gulati P, 2013, P NATL ACAD SCI USA, V110, P2557, DOI 10.1073/pnas.1222796110; Ho AJ, 2010, P NATL ACAD SCI USA, V107, P8404, DOI 10.1073/pnas.0910878107; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Klockener T, 2011, NAT NEUROSCI, V14, P911, DOI 10.1038/nn.2847; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; LACEY MG, 1989, J NEUROSCI, V9, P1233; LACEY MG, 1988, J PHYSIOL-LONDON, V401, P437, DOI 10.1113/jphysiol.1988.sp017171; Le Foll B, 2009, BEHAV PHARMACOL, V20, P1, DOI 10.1097/FBP.0b013e3283242f05; McTaggart JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027968; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Richards CD, 1997, NEUROSCIENCE, V80, P545, DOI 10.1016/S0306-4522(97)00093-6; Seeman P, 2006, EXPERT OPIN THER TAR, V10, P515, DOI 10.1517/14728222.10.4.515; Sibley DR, 1999, ANNU REV PHARMACOL, V39, P313, DOI 10.1146/annurev.pharmtox.39.1.313; Sobczyk-Kopciol A, 2011, ADDICTION, V106, P739, DOI 10.1111/j.1360-0443.2010.03248.x; Takigawa T, 1999, J PHYSIOL-LONDON, V517, P385, DOI 10.1111/j.1469-7793.1999.0385t.x; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wardle J, 2009, INT J OBESITY, V33, P42, DOI 10.1038/ijo.2008.174; Yeo GSH, 2012, J NEUROENDOCRINOL, V24, P393, DOI 10.1111/j.1365-2826.2011.02254.x	41	325	337	3	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1042	U96		10.1038/nn.3449	http://dx.doi.org/10.1038/nn.3449			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23817550				2022-12-17	WOS:000322323000014
J	Day, JJ; Sweatt, JD				Day, Jeremy J.; Sweatt, J. David			DNA methylation and memory formation	NATURE NEUROSCIENCE			English	Article							BDNF GENE; SYNAPTIC PLASTICITY; CHROMATIN-STRUCTURE; ADULT NEUROGENESIS; MOLECULAR TURNOVER; DEMETHYLATION; TRANSCRIPTION; EPIGENETICS; REPAIR; 5-HYDROXYMETHYLCYTOSINE	Memory formation and storage require long-lasting changes in memory-related neuronal circuits. Recent evidence indicates that DNA methylation may serve as a contributing mechanism in memory formation and storage. These emerging findings suggest a role for an epigenetic mechanism in learning and long-term memory maintenance and raise apparent conundrums and questions. For example, it is unclear how DNA methylation might be reversed during the formation of a memory, how changes in DNA methylation alter neuronal function to promote memory formation, and how DNA methylation patterns differ between neuronal structures to enable both consolidation and storage of memories. Here we evaluate the existing evidence supporting a role for DNA methylation in memory, discuss how DNA methylation may affect genetic and neuronal function to contribute to behavior, propose several future directions for the emerging subfield of neuroepigenetics, and begin to address some of the broader implications of this work.	[Sweatt, J. David] Univ Alabama, Dept Neurobiol, Birmingham, AL USA; Univ Alabama, Evelyn F McKnight Brain Inst, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sweatt, JD (corresponding author), Univ Alabama, Dept Neurobiol, Birmingham, AL USA.	dsweatt@uab.edu	Day, Jeremy/AAW-2464-2020	Day, Jeremy/0000-0002-7361-3399; Sweatt, J. David/0000-0003-3567-485X	NIDA NIH HHS [F32 DA029419-01A1, F32 DA029419] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA029419] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Barrett RM, 2008, LEARN MEMORY, V15, P460, DOI 10.1101/lm.917508; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Brown SE, 2008, NEUROSCI LETT, V440, P49, DOI 10.1016/j.neulet.2008.05.028; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Graff J, 2008, BEHAV BRAIN RES, V192, P70, DOI 10.1016/j.bbr.2008.01.021; Holliday R, 1999, J THEOR BIOL, V200, P339, DOI 10.1006/jtbi.1999.0995; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Lubin FD, 2007, NEURON, V55, P942, DOI 10.1016/j.neuron.2007.07.039; Ma DKK, 2009, CELL CYCLE, V8, P1526, DOI 10.4161/cc.8.10.8500; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mammen AL, 1997, J NEUROSCI, V17, P7351; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Miller CA, 2008, NEUROBIOL LEARN MEM, V89, P599, DOI 10.1016/j.nlm.2007.07.016; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Niehrs C, 2009, DIFFERENTIATION, V77, P1, DOI 10.1016/j.diff.2008.09.004; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Razin A, 1981, Prog Nucleic Acid Res Mol Biol, V25, P33, DOI 10.1016/S0079-6603(08)60482-1; Roberson ED, 2001, REV NEUROSCIENCE, V12, P41; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Sananbenesi F, 2009, BIOL CHEM, V390, P1145, DOI 10.1515/BC.2009.131; Santos KF, 2005, BRAZ J MED BIOL RES, V38, P1531, DOI 10.1590/S0100-879X2005001000010; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Swank MW, 2001, J NEUROSCI, V21, P3383, DOI 10.1523/JNEUROSCI.21-10-03383.2001; Szyf M, 2009, ANNU REV PHARMACOL, V49, P243, DOI 10.1146/annurev-pharmtox-061008-103102; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wolffe AP, 1999, P NATL ACAD SCI USA, V96, P5894, DOI 10.1073/pnas.96.11.5894; Wood MA, 2006, LEARN MEMORY, V13, P241, DOI 10.1101/lm.278206; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100	50	325	338	2	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1319	1323		10.1038/nn.2666	http://dx.doi.org/10.1038/nn.2666			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20975755	Green Accepted			2022-12-17	WOS:000283658200008
J	Shen, SM; Sandoval, J; Swiss, VA; Li, JD; Dupree, J; Franklin, RJM; Casaccia-Bonnefil, P				Shen, Siming; Sandoval, Juan; Swiss, Victoria A.; Li, Jiadong; Dupree, Jeff; Franklin, Robin J. M.; Casaccia-Bonnefil, Patrizia			Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; OLIGODENDROCYTE PROGENITOR DIFFERENTIATION; HISTONE DEACETYLASE ACTIVITY; MULTIPLE-SCLEROSIS; INDUCED DEMYELINATION; CNS DEMYELINATION; GENE-EXPRESSION; ADULT CNS; PRECURSOR CELLS; STEM-CELLS	The efficiency of remyelination decreases with age, but the molecular mechanisms responsible for this decline remain only partially understood. In this study, we show that remyelination is regulated by age-dependent epigenetic control of gene expression. In demyelinated young brains, new myelin synthesis is preceded by downregulation of oligodendrocyte differentiation inhibitors and neural stem cell markers, and this is associated with recruitment of histone deacetylases (HDACs) to promoter regions. In demyelinated old brains, HDAC recruitment is inefficient, and this allows the accumulation of transcriptional inhibitors and prevents the subsequent surge in myelin gene expression. Defective remyelination can be recapitulated in vivo in mice receiving systemic administration of pharmacological HDAC inhibitors during cuprizone treatment and is consistent with in vitro results showing defective differentiation of oligodendrocyte progenitors after silencing specific HDAC isoforms. Thus, we suggest that inefficient epigenetic modulation of the oligodendrocyte differentiation program contributes to the age-dependent decline in remyelination efficiency.	[Shen, Siming; Sandoval, Juan; Swiss, Victoria A.; Li, Jiadong; Casaccia-Bonnefil, Patrizia] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; [Dupree, Jeff] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Franklin, Robin J. M.] Univ Cambridge, Cambridge Ctr Brain Repair, Cambridge CB3 0ES, England; [Franklin, Robin J. M.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	Rutgers State University New Brunswick; Rutgers State University Medical Center; Virginia Commonwealth University; University of Cambridge; University of Cambridge	Casaccia-Bonnefil, P (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	patrizia.casaccia@mssm.edu	sandoval, juan/M-4593-2015; Messier, Claude/A-2322-2008	sandoval, juan/0000-0002-5100-973X; Messier, Claude/0000-0002-4791-1763; Franklin, Robin/0000-0001-6522-2104	US National Institutes of Health National Institute of Neurological Disorders and Stroke [NS042925, NS52738]; National Multiple Sclerosis Society [NMSS RG-3957]; MS Research Foundation; Research into Ageing; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042925, R37NS042925, R01NS052738] Funding Source: NIH RePORTER	US National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); MS Research Foundation; Research into Ageing; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from US National Institutes of Health National Institute of Neurological Disorders and Stroke (NS042925 and NS52738 to P. C.-B.), the National Multiple Sclerosis Society (NMSS RG-3957 P. C.-B.), the MS Research Foundation (to P. C.-B.) and Research into Ageing (to R. J. M. F.). We thank J. Williamson for superb assistance with electron microscopy and acknowledge C. Ghiani (University of California Los Angeles) for the gift of the microglial BV-2 cell line.	Albert M, 2007, BRAIN PATHOL, V17, P129, DOI 10.1111/j.1750-3639.2006.00043.x; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; BLAKEMORE WF, 1973, J NEUROL SCI, V20, P73, DOI 10.1016/0022-510X(73)90119-6; Camelo S, 2005, J NEUROIMMUNOL, V164, P10, DOI 10.1016/j.jneuroim.2005.02.022; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Charles P, 2002, BRAIN, V125, P1972, DOI 10.1093/brain/awf216; Chen PS, 2007, NEUROSCIENCE, V149, P203, DOI 10.1016/j.neuroscience.2007.06.053; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Dubois-Dalcq M, 2005, NEURON, V48, P9, DOI 10.1016/j.neuron.2005.09.004; Dupree JL, 1998, MICROSC RES TECHNIQ, V41, P431, DOI 10.1002/(SICI)1097-0029(19980601)41:5<431::AID-JEMT9>3.0.CO;2-S; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Gokhan S, 2005, J NEUROSCI, V25, P8311, DOI 10.1523/JNEUROSCI.1850-05.2005; He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029; Hinks GL, 2000, MOL CELL NEUROSCI, V16, P542, DOI 10.1006/mcne.2000.0897; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Irvine KA, 2006, J NEUROIMMUNOL, V175, P69, DOI 10.1016/j.jneuroim.2006.03.002; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Kondo T, 2000, DEVELOPMENT, V127, P2989; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Li WW, 2006, EXP NEUROL, V202, P250, DOI 10.1016/j.expneurol.2006.05.012; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Liu AX, 2007, J NEUROSCI, V27, P7339, DOI 10.1523/JNEUROSCI.1226-07.2007; Liu AX, 2006, EMBO J, V25, P4833, DOI 10.1038/sj.emboj.7601352; Liu AX, 2003, GLIA, V44, P264, DOI 10.1002/glia.10290; Lyssiotis CA, 2007, P NATL ACAD SCI USA, V104, P14982, DOI 10.1073/pnas.0707044104; Marin-Husstege M, 2002, J NEUROSCI, V22, P10333; Marks PA, 2001, CLIN CANCER RES, V7, P759; Mason JL, 2001, NEUROPATH APPL NEURO, V27, P50, DOI 10.1046/j.0305-1846.2001.00301.x; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Miller RH, 2007, NAT NEUROSCI, V10, P1351, DOI 10.1038/nn1995; Natarajan C, 2002, J IMMUNOL, V168, P6506, DOI 10.4049/jimmunol.168.12.6506; O'Leary MT, 2002, MOL CELL NEUROSCI, V19, P32, DOI 10.1006/mcne.2001.1062; Patani R, 2007, NEUROPATH APPL NEURO, V33, P277, DOI 10.1111/j.1365-2990.2007.00805.x; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Shen SM, 2008, NEUROBIOL AGING, V29, P452, DOI 10.1016/j.neurobiolaging.2006.10.026; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Shields SA, 1999, GLIA, V28, P77, DOI 10.1002/(SICI)1098-1136(199910)28:1<77::AID-GLIA9>3.0.CO;2-F; Sim FJ, 2002, J NEUROSCI, V22, P2451, DOI 10.1523/JNEUROSCI.22-07-02451.2002; Stidworthy MF, 2004, BRAIN, V127, P1928, DOI 10.1093/brain/awh217; Tang DG, 2000, J CELL BIOL, V148, P971, DOI 10.1083/jcb.148.5.971; Wolswijk G, 1998, PROG BRAIN RES, V117, P233; Woodruff RH, 1999, NEUROPATH APPL NEURO, V25, P226; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Zhao C, 2005, J ANAT, V207, P251, DOI 10.1111/j.1469-7580.2005.00456.x; Zhao C, 2006, NEUROBIOL AGING, V27, P1298, DOI 10.1016/j.neurobiolaging.2005.06.008	49	325	332	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2008	11	9					1024	1034		10.1038/nn.2172	http://dx.doi.org/10.1038/nn.2172			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	341NA	19160500	Green Accepted			2022-12-17	WOS:000258720000012
J	Bielle, F; Griveau, A; Narboux-Neme, N; Vigneau, S; Sigrist, M; Arber, S; Wassef, M; Pierani, A				Bielle, F; Griveau, A; Narboux-Neme, N; Vigneau, S; Sigrist, M; Arber, S; Wassef, M; Pierani, A			Multiple origins of Cajal-Retzius cells at the borders of the developing pallium	NATURE NEUROSCIENCE			English	Article							DEVELOPING CEREBRAL-CORTEX; MESSENGER-RNA EXPRESSION; SPINAL-CORD; GANGLIONIC EMINENCE; NEURONAL MIGRATION; MARGINAL ZONE; HIPPOCAMPAL CONNECTIONS; MAMMALIAN TELENCEPHALON; HOMEOBOX GENE; MOUSE	Cajal-Retzius cells are critical in cortical lamination, but very little is known about their origin and development. The homeodomain transcription factor Dbx1 is expressed in restricted progenitor domains of the developing pallium: the ventral pallium (VP) and the septum. Using genetic tracing and ablation experiments in mice, we show that two subpopulations of Reelin(+) Cajal-Retzius cells are generated from Dbx1-expressing progenitors. VP- and septum-derived Reelin(+) neurons differ in their onset of appearance, migration routes, destination and expression of molecular markers. Together with reported data supporting the generation of Reelin(+) cells in the cortical hem, our results show that Cajal-Retzius cells are generated at least at three focal sites at the borders of the developing pallium and are redistributed by tangential migration. Our data also strongly suggest that distinct Cajal-Retzius subtypes exist and that their presence in different territories of the developing cortex might contribute to region-specific properties.	Ecole Normale Super, CNRS, UMR 8542, F-75005 Paris, France; Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland; Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; University of Basel; Friedrich Miescher Institute for Biomedical Research; Columbia University; Howard Hughes Medical Institute	Pierani, A (corresponding author), Ecole Normale Super, CNRS, UMR 8542, 46 Rue Ulm, F-75005 Paris, France.	pierani@biologie.ens.fr	Pierani, Alessandra/O-6136-2017; Vigneau, Sébastien/B-2842-2008	Pierani, Alessandra/0000-0002-4872-4791; Bielle, Franck/0000-0001-6564-6388; Arber, Silvia/0000-0002-6261-250X; Vigneau, Sebastien/0000-0002-9091-2067; Narboux-Neme, Nicolas/0000-0002-3791-7459				Aboitiz F, 2002, BRAZ J MED BIOL RES, V35, P1455, DOI 10.1590/S0100-879X2002001200006; Alcantara S, 1998, J NEUROSCI, V18, P7779; Ang ESBC, 2003, J NEUROSCI, V23, P5805; Borrell V, 1999, J NEUROSCI, V19, P1345; Campbell K, 2003, CURR OPIN NEUROBIOL, V13, P50, DOI 10.1016/S0959-4388(03)00009-6; Cohen-Tannoudji M, 1998, MOL CELL BIOL, V18, P1444, DOI 10.1128/MCB.18.3.1444; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; LU S, 1992, P NATL ACAD SCI USA, V89, P8053, DOI 10.1073/pnas.89.17.8053; LU SW, 1994, MECH DEVELOP, V47, P187, DOI 10.1016/0925-4773(94)90089-2; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8; Medina L, 2004, J COMP NEUROL, V474, P504, DOI 10.1002/cne.20141; Meyer G, 2004, J NEUROSCI, V24, P9878, DOI 10.1523/JNEUROSCI.3060-04.2004; Meyer G, 1999, EUR J NEUROSCI, V11, P3937, DOI 10.1046/j.1460-9568.1999.00818.x; Meyer G, 1999, CEREB CORTEX, V9, P765, DOI 10.1093/cercor/9.8.765; Meyer G, 1998, J COMP NEUROL, V397, P493; Meyer G, 2002, J NEUROSCI, V22, P4973, DOI 10.1523/JNEUROSCI.22-12-04973.2002; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Schiffmann SN, 1997, EUR J NEUROSCI, V9, P1055, DOI 10.1111/j.1460-9568.1997.tb01456.x; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Shinozaki K, 2002, DEVELOPMENT, V129, P3479; Shoji H, 1996, MECH DEVELOP, V56, P25, DOI 10.1016/0925-4773(96)00509-6; Super H, 2000, CEREB CORTEX, V10, P602, DOI 10.1093/cercor/10.6.602; Takiguchi-Hayashi K, 2004, J NEUROSCI, V24, P2286, DOI 10.1523/JNEUROSCI.4671-03.2004; Tamamaki N, 1997, J NEUROSCI, V17, P8313; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; WILKINSON DG, 1989, DEVELOPMENT, V106, P465; Yun K, 2001, DEVELOPMENT, V128, P193; Zecevic N, 2001, J NEUROSCI, V21, P5607, DOI 10.1523/JNEUROSCI.21-15-05607.2001; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	48	325	332	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1002	1012		10.1038/nn1511	http://dx.doi.org/10.1038/nn1511			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16041369				2022-12-17	WOS:000230760200011
J	Avillac, M; Deneve, S; Olivier, E; Pouget, A; Duhamel, JR				Avillac, M; Deneve, S; Olivier, E; Pouget, A; Duhamel, JR			Reference frames for representing visual and tactile locations in parietal cortex	NATURE NEUROSCIENCE			English	Article							VENTRAL INTRAPARIETAL AREA; PRIMATE SUPERIOR COLLICULUS; EYE POSITION; RECEPTIVE-FIELDS; MACAQUE; NEURONS; RESPONSES; GAZE; SPACE; CONNECTIONS	The ventral intraparietal area (VIP) receives converging inputs from visual, somatosensory, auditory and vestibular systems that use diverse reference frames to encode sensory information. A key issue is how VIP combines those inputs together. We mapped the visual and tactile receptive fields of multimodal VIP neurons in macaque monkeys trained to gaze at three different stationary targets. Tactile receptive fields were found to be encoded into a single somatotopic, or head-centered, reference frame, whereas visual receptive fields were widely distributed between eye-to head-centered coordinates. These findings are inconsistent with a remapping of all sensory modalities in a common frame of reference. Instead, they support an alternative model of multisensory integration based on multidirectional sensory predictions (such as predicting the location of a visual stimulus given where it is felt on the skin and vice versa). This approach can also explain related findings in other multimodal areas.	CNRS, Inst Cognit Sci, F-69675 Bron, France; Catholic Univ Louvain, Neurophysiol Lab, B-1200 Brussels, Belgium; Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	Centre National de la Recherche Scientifique (CNRS); Universite Catholique Louvain; University of Rochester	Duhamel, JR (corresponding author), CNRS, Inst Cognit Sci, 67 Blvd Pinel, F-69675 Bron, France.	duhamel@isc.cnrs.fr	Duhamel, Jean-René/M-4723-2017	Duhamel, Jean-René/0000-0003-0210-1027; AVILLAC, Marie/0000-0002-1003-8251; Pouget, Alexandre/0000-0003-3054-6365				ANDERSEN RA, 1983, J NEUROSCI, V3, P532; ANDERSEN RA, 1995, CEREB CORTEX, V5, P457, DOI 10.1093/cercor/5.5.457; BAIZER JS, 1993, VISUAL NEUROSCI, V10, P59, DOI 10.1017/S0952523800003229; Ben Hamed S, 2001, EXP BRAIN RES, V140, P127, DOI 10.1007/s002210100785; BOUSSAOUD D, 1993, EXP BRAIN RES, V93, P423; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Bremmer F, 1999, NEUROREPORT, V10, P873, DOI 10.1097/00001756-199903170-00037; Bremmer F, 2002, EUR J NEUROSCI, V16, P1569, DOI 10.1046/j.1460-9568.2002.02206.x; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; BULLIER J, 1995, CURR OPIN NEUROBIOL, V5, P497, DOI 10.1016/0959-4388(95)80011-5; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Cooke DF, 2003, P NATL ACAD SCI USA, V100, P6163, DOI 10.1073/pnas.1031751100; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; FOGASSI L, 1992, EXP BRAIN RES, V89, P686, DOI 10.1007/BF00229894; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; GALLETTI C, 1989, J NEUROSCI, V9, P1112; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; GARDNER EP, 1984, ELECTROEN CLIN NEURO, V58, P537, DOI 10.1016/0013-4694(84)90044-0; GENTILUCCI M, 1983, EXP BRAIN RES, V50, P464; Graziano Michael S. A., 1995, P1021; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Groh JM, 2001, NEURON, V29, P509, DOI 10.1016/S0896-6273(01)00222-7; HYVARINEN J, 1981, BRAIN RES, V206, P287, DOI 10.1016/0006-8993(81)90533-3; JAY MF, 1984, NATURE, V309, P345, DOI 10.1038/309345a0; JAY MF, 1987, J NEUROPHYSIOL, V57, P35, DOI 10.1152/jn.1987.57.1.35; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; LYNCH JC, 1985, J COMP NEUROL, V235, P241, DOI 10.1002/cne.902350207; Neppi-Modona M, 2004, CURR BIOL, V14, P1174, DOI 10.1016/j.cub.2004.06.047; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Raiguel SE, 1999, J NEUROPHYSIOL, V82, P1944, DOI 10.1152/jn.1999.82.4.1944; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; Rosenbluth D, 2002, NEURON, V33, P143, DOI 10.1016/S0896-6273(01)00559-1; RUSSO GS, 1994, J NEUROPHYSIOL, V71, P1250, DOI 10.1152/jn.1994.71.3.1250; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Schlack A, 2005, J NEUROSCI, V25, P4616, DOI 10.1523/JNEUROSCI.0455-05.2005; Schlack A, 2002, EUR J NEUROSCI, V16, P1877, DOI 10.1046/j.1460-9568.2002.02251.x; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Squatrito S, 1996, VISUAL NEUROSCI, V13, P385, DOI 10.1017/S0952523800007628; Stein BE., 1993, MERGING SENSES; Stricanne B, 1996, J NEUROPHYSIOL, V76, P2071, DOI 10.1152/jn.1996.76.3.2071; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	49	325	329	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					941	949		10.1038/nn1480	http://dx.doi.org/10.1038/nn1480			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15951810				2022-12-17	WOS:000230137100022
J	van Schie, HT; Mars, RB; Coles, MGH; Bekkering, H				van Schie, HT; Mars, RB; Coles, MGH; Bekkering, H			Modulation of activity in medial frontal and motor cortices during error observation	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; EVENT-RELATED FMRI; NEURAL SYSTEM; HAND ACTIONS; MECHANISMS; REWARD; IMITATION; SELECTION; PSYCHOPHYSIOLOGY; DISSOCIATION	We used measures of the human event-related brain potential (ERP) to investigate the neural mechanisms underlying error processing during action observation. Participants took part in two conditions, a task execution condition and a task observation condition. We found that activity in both the medial frontal cortex and the motor cortices, as measured via the error-related negativity and the lateralized readiness potential, respectively, was modulated by the correctness of observed behavior. These data suggest that similar neural mechanisms are involved in monitoring one's own actions and the actions of others.	Univ Nijmegen, Nijmegen Inst Cognit & Informat, NL-6500 HE Nijmegen, Netherlands; FC Donders Ctr Cognit Neuroimaging, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	van Schie, HT (corresponding author), Univ Nijmegen, Nijmegen Inst Cognit & Informat, Box 9104, NL-6500 HE Nijmegen, Netherlands.	h.vanschie@nici.kun.nl	Mars, Rogier/GWZ-9665-2022; Bekkering, Harold/A-6357-2009; Mars, Rogier/G-2312-2018; van Schie, Hein T/D-2281-2010	Mars, Rogier/0000-0001-6302-8631; 				Babiloni C, 2002, NEUROIMAGE, V17, P559, DOI 10.1006/nimg.2002.1192; Baldissera F, 2001, EUR J NEUROSCI, V13, P190, DOI 10.1046/j.0953-816x.2000.01368.x; Bekkering H, 2000, Q J EXP PSYCHOL-A, V53, P153, DOI 10.1080/027249800390718; Blandin Y, 2000, Q J EXP PSYCHOL-A, V53, P846, DOI 10.1080/027249800410571; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; COLES MGH, 1989, PSYCHOPHYSIOLOGY, V26, P251, DOI 10.1111/j.1469-8986.1989.tb01916.x; Coles MGH, 2001, BIOL PSYCHOL, V56, P173, DOI 10.1016/S0301-0511(01)00076-X; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Falkenstein M., 1990, PSYCHOPHYSIOL BRAIN, V12, P192; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hadland KA, 2003, J NEUROPHYSIOL, V89, P1161, DOI 10.1152/jn.00634.2002; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Holroyd C., 2004, ERRORS CONFLICTS BRA, P211; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; HOLROYD CB, COGNITIVE NEUROSCIEN; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1017/S0048577200990231; Leuthold H, 2002, BIOL PSYCHOL, V60, P173, DOI 10.1016/S0301-0511(02)00032-7; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Miller J, 1996, ACTA PSYCHOL, V94, P189, DOI 10.1016/0001-6918(95)00046-1; Miltner W., 2004, ERRORS CONFLICTS BRA, P124; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Petrosini L, 2003, BRAIN RES REV, V42, P252, DOI 10.1016/S0165-0173(03)00176-0; Piaget J., 1962, PLAY DREAMS IMITATIO; Posner MI, 1998, ATTENTIVE BRAIN, P401; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; SCHERG M, 1996, BESA BRAIN ELECT SOU; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; WASSERMAN S, 1989, PSYCHOPHYSIOLOGY, V26, P208, DOI 10.1111/j.1469-8986.1989.tb03159.x	40	325	327	2	35	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					549	554		10.1038/nn1239	http://dx.doi.org/10.1038/nn1239			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	816HP	15107858				2022-12-17	WOS:000221101300033
J	Ffytche, DH; Howard, RJ; Brammer, MJ; David, A; Woodruff, P; Williams, S				Ffytche, DH; Howard, RJ; Brammer, MJ; David, A; Woodruff, P; Williams, S			The anatomy of conscious vision: an fMRI study of visual hallucinations	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL NEUROANATOMY; CORTICAL RESPONSE; BRAIN ACTIVITY; CORTEX; SCHIZOPHRENIA; STIMULATION; PERCEPTION; FACE	Despite recent advances in functional neuroimaging, the apparently simple question of how and where we see-the neurobiology of visual consciousness-continues to challenge neuroscientists. Without a method to differentiate neural processing specific to consciousness from unconscious afferent sensory signals, the issue has been difficult to resolve experimentally. Here we use functional magnetic resonance imaging (fMRI) to study patients with the Charles Bonnet syndrome, for whom visual perception and sensory input have become dissociated. We found that hallucinations of color, faces, textures and objects correlate with cerebral activity in ventral extrastriate visual cortex, that the content of the hallucinations reflects the functional specializations of the region and that patients who hallucinate have increased ventral extrastriate activity, which persists between hallucinations.	Inst Psychiat, London SE5 8AF, England	University of London; King's College London	Ffytche, DH (corresponding author), Inst Psychiat, De Crespigny Pk,Denmark Hill, London SE5 8AF, England.		Brammer, Michael J/B-7128-2012; Williams, Steve C/D-6979-2011; Woodruff, Peter WR/B-5998-2009; Howard, Robert/E-4890-2010; ffytche, Dominic/ABD-8214-2021; David, Anthony/O-1750-2019; David, Anthony S/C-1315-2011	Brammer, Michael J/0000-0001-9800-2052; Williams, Steve C/0000-0003-4299-1941; David, Anthony/0000-0003-0967-774X; David, Anthony S/0000-0003-0967-774X; opoku, anita/0000-0001-7243-8157; Howard, Robert/0000-0002-3071-2338; ffytche, Dominic/0000-0002-4214-9642	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brammer MJ, 1997, MAGN RESON IMAGING, V15, P763, DOI 10.1016/S0730-725X(97)00135-5; Bullmore E, 1996, MAGN RESON MED, V35, P261, DOI 10.1002/mrm.1910350219; Crick F, 1998, CEREB CORTEX, V8, P97, DOI 10.1093/cercor/8.2.97; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; DEMORSIER G, 1936, SCHWEIZ MED WOCHENSC, V66, P700; Ffytche DH, 1996, BRAIN, V119, P1971, DOI 10.1093/brain/119.6.1971; Ffytche DH, 1996, NEUROIMAGE, V3, P104, DOI 10.1006/nimg.1996.0012; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; HOLROYD S, 1992, AM J PSYCHIAT, V149, P1701; HOWARD R, 1995, LANCET, V345, P70, DOI 10.1016/S0140-6736(95)91198-7; Howard RJ, 1998, NEUROREPORT, V9, P1019, DOI 10.1097/00001756-199804200-00012; Kanwisher N, 1996, COGNITIVE BRAIN RES, V5, P55, DOI 10.1016/S0926-6410(96)00041-9; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KOLMEL HW, 1985, J NEUROL NEUROSUR PS, V48, P29, DOI 10.1136/jnnp.48.1.29; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; LEPORE FE, 1990, NEUROLOGY, V40, P444, DOI 10.1212/WNL.40.3_Part_1.444; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; PENFIELD W, 1980, CEREBRAL CORTEX MAN; Puce A, 1996, J NEUROSCI, V16, P5205; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; SILBERSWEIG DA, 1995, NATURE, V378, P176, DOI 10.1038/378176a0; Talairach J., 1988, COPLANAR STEREOTAXIC; Teunisse RJ, 1996, LANCET, V347, P794, DOI 10.1016/S0140-6736(96)90869-7; Woodruff PWR, 1997, AM J PSYCHIAT, V154, P1676, DOI 10.1176/ajp.154.12.1676; ZEKI S, 1991, J NEUROSCI, V11, P641; Zeki S, 1998, BRAIN, V121, P25, DOI 10.1093/brain/121.1.25; Zeki S., 1993, VISION BRAIN	29	325	331	1	73	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					738	742		10.1038/3738	http://dx.doi.org/10.1038/3738			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196592				2022-12-17	WOS:000077323400020
J	Fischer, J; Whitney, D				Fischer, Jason; Whitney, David			Serial dependence in visual perception	NATURE NEUROSCIENCE			English	Article							TILTED LINES; POP-OUT; ADAPTATION; ATTENTION; SEARCH; MOTION; HYSTERESIS; MECHANISMS; BLINDNESS; CONTRAST	Visual input often arrives in a noisy and discontinuous stream, owing to head and eye movements, occlusion, lighting changes, and many other factors. Yet the physical world is generally stable; objects and physical characteristics rarely change spontaneously. How then does the human visual system capitalize on continuity in the physical environment over time? We found that visual perception in humans is serially dependent, using both prior and present input to inform perception at the present moment. Using an orientation judgment task, we found that, even when visual input changed randomly over time, perceived orientation was strongly and systematically biased toward recently seen stimuli. Furthermore, the strength of this bias was modulated by attention and tuned to the spatial and temporal proximity of successive stimuli. These results reveal a serial dependence in perception characterized by a spatiotemporally tuned, orientation-selective operator-which we call a continuity field-that may promote visual stability over time.	[Fischer, Jason; Whitney, David] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Fischer, Jason] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Fischer, Jason] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Whitney, David] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Whitney, David] Univ Calif Berkeley, Vis Sci Grp, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; University of California System; University of California Berkeley	Fischer, J (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	jason_f@mit.edu			US National Institutes of Health [EY018216]; National Science Foundation [1245461]; NATIONAL EYE INSTITUTE [R01EY018216] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Shankey for assistance with data collection, and G. Maus, S. Teng and E. Whitney for comments on the manuscript. This work was supported in part by grants from the US National Institutes of Health (EY018216) and the National Science Foundation (1245461) to D. W.	Brascamp JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001497; Chopin A, 2012, CURR BIOL, V22, P622, DOI 10.1016/j.cub.2012.02.021; Clifford CWG, 2001, VISION RES, V41, P151, DOI 10.1016/S0042-6989(00)00248-0; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Fang F, 2005, NEURON, V45, P793, DOI 10.1016/j.neuron.2005.01.037; FENDER D, 1967, J OPT SOC AM, V57, P819, DOI 10.1364/JOSA.57.000819; Fiser J, 2002, J EXP PSYCHOL LEARN, V28, P458, DOI 10.1037//0278-7393.28.3.458; Geyer T, 2006, PERCEPT PSYCHOPHYS, V68, P736, DOI 10.3758/BF03193697; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Gibson JJ, 1937, J EXP PSYCHOL, V20, P553, DOI 10.1037/h0057585; Hancock S, 2008, J VISION, V8, DOI 10.1167/8.7.11; HOCK HS, 1993, J EXP PSYCHOL HUMAN, V19, P63, DOI 10.1037/0096-1523.19.1.63; Holmes DJ, 2006, VISION RES, V46, P665, DOI 10.1016/j.visres.2005.05.023; KAHNEMAN D, 1992, COGNITIVE PSYCHOL, V24, P175, DOI 10.1016/0010-0285(92)90007-O; Kahneman D., 1984, VARIETIES ATTENTION, P29; Kanai R, 2006, P ROY SOC B-BIOL SCI, V273, P1217, DOI 10.1098/rspb.2005.3430; Kang MS, 2011, PSYCHON B REV, V18, P860, DOI 10.3758/s13423-011-0126-5; Kim N, 1999, J EXP PSYCHOL HUMAN, V25, P715, DOI 10.1037/0096-1523.25.3.715; Knapen T, 2010, J VISION, V10, DOI 10.1167/10.1.8; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Kristjansson A, 2002, COGNITION, V85, P37, DOI 10.1016/S0010-0277(02)00074-4; Kristjansson A, 2006, VISION RES, V46, P2554, DOI 10.1016/j.visres.2006.01.015; Kristjansson A, 2010, ATTEN PERCEPT PSYCHO, V72, P5, DOI 10.3758/APP.72.1.5; Magnussen S, 1999, PSYCHOL RES-PSYCH FO, V62, P81, DOI 10.1007/s004260050043; MAGNUSSEN S, 1991, VISION RES, V31, P1213, DOI 10.1016/0042-6989(91)90046-8; MALJKOVIC V, 1994, MEM COGNITION, V22, P657, DOI 10.3758/BF03209251; Maljkovic V, 1996, PERCEPT PSYCHOPHYS, V58, P977, DOI 10.3758/BF03206826; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; Maus GW, 2013, CURR BIOL, V23, pR438, DOI 10.1016/j.cub.2013.03.024; MITCHELL DE, 1976, VISION RES, V16, P609, DOI 10.1016/0042-6989(76)90007-9; NEISSER U, 1975, COGNITIVE PSYCHOL, V7, P480, DOI 10.1016/0010-0285(75)90019-5; Noles NS, 2005, PERCEPT PSYCHOPHYS, V67, P324, DOI 10.3758/BF03206495; Palmer S.E., 1999, VISION SCI PHOTONS P; Rensink RA, 2000, VIS COGN, V7, P127, DOI 10.1080/135062800394720; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Ringach DL, 2002, J NEUROSCI, V22, P5639; Ross H. E., 1998, PERCEPTUAL CONSTANCY, P499; Sasaki Y, 2010, NAT REV NEUROSCI, V11, P53, DOI 10.1038/nrn2737; SHAFFER LH, 1978, Q J EXP PSYCHOL, V30, P333, DOI 10.1080/14640747808400680; Simons DJ, 1999, PERCEPTION, V28, P1059, DOI 10.1068/p2952; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Spivey MJ, 2000, PERCEPT PSYCHOPHYS, V62, P1525, DOI 10.3758/BF03212153; Sterzer P, 2008, CURR BIOL, V18, pR697, DOI 10.1016/j.cub.2008.06.021; Stocker A. A., 2006, ADV NEURAL INF PROCE, V18, P1291; Swets J. A., 1961, INFORM THEORY, P221; TREISMAN A, 1983, B PSYCHONOMIC SOC, V21, P354; Webster M. A., 2003, VISUAL NEUROSCIENCES, V2, P936; Whitney D, 2002, TRENDS COGN SCI, V6, P211, DOI 10.1016/S1364-6613(02)01887-9; WILLIAMS D, 1986, NATURE, V324, P253, DOI 10.1038/324253a0; WING AM, 1973, PERCEPT PSYCHOPHYS, V14, P5, DOI 10.3758/BF03198607; WOLFE JM, 1984, VISION RES, V24, P471, DOI 10.1016/0042-6989(84)90044-0	52	324	325	9	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2014	17	5					738	+		10.1038/nn.3689	http://dx.doi.org/10.1038/nn.3689			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	AF9DS	24686785	Green Accepted, Green Submitted			2022-12-17	WOS:000335016200019
J	Dickendesher, TL; Baldwin, KT; Mironova, YA; Koriyama, Y; Raiker, SJ; Askew, KL; Wood, A; Geoffroy, CG; Zheng, BH; Liepmann, CD; Katagiri, Y; Benowitz, LI; Geller, HM; Giger, RJ				Dickendesher, Travis L.; Baldwin, Katherine T.; Mironova, Yevgeniya A.; Koriyama, Yoshiki; Raiker, Stephen J.; Askew, Kim L.; Wood, Andrew; Geoffroy, Cedric G.; Zheng, Binhai; Liepmann, Claire D.; Katagiri, Yasuhiro; Benowitz, Larry I.; Geller, Herbert M.; Giger, Roman J.			NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; CORTICOSPINAL TRACT REGENERATION; SPINAL-CORD-INJURY; AXON REGENERATION; NOGO-66 RECEPTOR; NEURITE GROWTH; OPTIC-NERVE; FUNCTIONAL RECEPTOR; RECOVERY	In the adult mammalian CNS, chondroitin sulfate proteoglycans (CSPGs) and myelin-associated inhibitors (MAIs) stabilize neuronal structure and restrict compensatory sprouting following injury. The Nogo receptor family members NgR1 and NgR2 bind to MAIs and have been implicated in neuronal inhibition. We found that NgR1 and NgR3 bind with high affinity to the glycosaminoglycan moiety of proteoglycans and participate in CSPG inhibition in cultured neurons. Nogo receptor triple mutants (Ngr1(-/-); Ngr2(-/-); Ngr3(-/-); which are also known as Rtn4r, Rtn4rI2 and Rtn4rI1, respectively), but not single mutants, showed enhanced axonal regeneration following retro-orbital optic nerve crush injury. The combined loss of Ngr1 and Ngr3 (Ngr1(-/-); Ngr3(-/-)), but not Ngr1 and Ngr2 (Ngr1(-/-); Ngr2(-/-)), was sufficient to mimic the triple mutant regeneration phenotype. Regeneration in Ngr1(-/-); Ngr3(-/-) mice was further enhanced by simultaneous ablation of Rptp sigma (also known as Ptprs), a known CSPG receptor. Collectively, our results identify NgR1 and NgR3 as CSPG receptors, suggest that there is functional redundancy among CSPG receptors, and provide evidence for shared mechanisms of MAI and CSPG inhibition.	[Dickendesher, Travis L.; Giger, Roman J.] Univ Michigan, Sch Med, Neurosci Program, Ann Arbor, MI 48109 USA; [Dickendesher, Travis L.; Baldwin, Katherine T.; Mironova, Yevgeniya A.; Raiker, Stephen J.; Giger, Roman J.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA; [Baldwin, Katherine T.; Mironova, Yevgeniya A.; Giger, Roman J.] Univ Michigan, Sch Med, Cellular & Mol Biol Program, Ann Arbor, MI USA; [Koriyama, Yoshiki; Benowitz, Larry I.] Harvard Univ, Childrens Hosp, Sch Med, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Koriyama, Yoshiki; Benowitz, Larry I.] Harvard Univ, Childrens Hosp, Sch Med, Lab Neurosci Res Neurosurg, Boston, MA 02115 USA; [Koriyama, Yoshiki; Benowitz, Larry I.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Raiker, Stephen J.] Univ Rochester, Sch Med & Dent, Dept Biomed Genet, Rochester, NY USA; [Askew, Kim L.; Wood, Andrew] Pfizer Global Res & Dev, Neurosci Res Unit, Groton, CT USA; [Geoffroy, Cedric G.; Zheng, Binhai] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Liepmann, Claire D.; Katagiri, Yasuhiro; Geller, Herbert M.] NHLBI, Dev Neurobiol Sect, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Benowitz, Larry I.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Giger, Roman J.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of Rochester; Pfizer; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Harvard Medical School; University of Michigan System; University of Michigan	Giger, RJ (corresponding author), Univ Michigan, Sch Med, Neurosci Program, Ann Arbor, MI 48109 USA.	rgiger@umich.edu	Koriyama, Yoshiki/AAA-1830-2022; geoffroy, cedric/AAK-5855-2020	Baldwin, Katherine/0000-0002-4423-5712; Koriyama, Yoshiki/0000-0001-8777-329X; Geller, Herbert/0000-0002-7048-6144; Benowitz, Larry/0000-0002-0277-7222	Neuroscience Training Grant [T32EY017878]; University of Michigan; Cellular and Molecular Biology Training Grant [T32GM007315]; National Research Service Award Ruth Kirschstein Fellowship [F31NS061589]; New York State Spinal Cord Injury Research Program; Dr. Miriam and Sheldon G. Adelson Medical Foundation on Neural Repair and Rehabilitation; US Department of Veterans Affairs [1I0IRX000229-01]; National Institute of Neurological Disorders and Stroke [R56NSO47333]; National Eye Institute; NATIONAL EYE INSTITUTE [T32EY017878] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054734, T32NS007489, T32NS076401, R56NS047333, F31NS061589, R01NS047333] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000229] Funding Source: NIH RePORTER	Neuroscience Training Grant; University of Michigan(University of Michigan System); Cellular and Molecular Biology Training Grant; National Research Service Award Ruth Kirschstein Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Spinal Cord Injury Research Program; Dr. Miriam and Sheldon G. Adelson Medical Foundation on Neural Repair and Rehabilitation; US Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	We thank M. Tremblay for Rptp sigma<SUP>-/-</SUP> mice, M. Greenberg for Ngr3<SUP>-/-</SUP> mice, B. Pierchala for p75<SUP>NTR-/-</SUP> mice, B. Bates, D. Howland and M.L. Mercado for their assistance in the generation and initial analysis of Ngr1<SUP>-/-</SUP>; Ngr2<SUP>-/-</SUP>; Ngr3<SUP>-/-</SUP> mice, U. Rutishauser for Endo-N, D. Figge and Y. Yasui for assistance in ELISA binding assays, Y. Yin for training in optic nerve surgery, Y. Duan for generation of the RPTP sigma(Igl-3)-Fc construct,). Barbieri for technical assistance and M.M. Zaleska for project administration. This work was supported by Neuroscience Training Grant T32EY017878 and the University of Michigan Rackham Merit Fellowship (T.L.D.), Cellular and Molecular Biology Training Grant T32GM007315 (K.T.B. and Y.A.M.), National Research Service Award Ruth Kirschstein Fellowship F31NS061589 (S.J.R.), the New York State Spinal Cord Injury Research Program, the Dr. Miriam and Sheldon G. Adelson Medical Foundation on Neural Repair and Rehabilitation, the US Department of Veterans Affairs (1I0IRX000229-01), the National Institute of Neurological Disorders and Stroke (R56NSO47333, R.J.G.) and the National Eye Institute (L.I.B.).	Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Cafferty WBJ, 2010, J NEUROSCI, V30, P6825, DOI 10.1523/JNEUROSCI.6239-09.2010; Chivatakarn O, 2007, J NEUROSCI, V27, P7117, DOI 10.1523/JNEUROSCI.1541-07.2007; Fischer D, 2004, J NEUROSCI, V24, P1646, DOI 10.1523/JNEUROSCI.5119-03.2004; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fry EJ, 2010, GLIA, V58, P423, DOI 10.1002/glia.20934; Fujita Y, 2011, EMBO J, V30, P1389, DOI 10.1038/emboj.2011.55; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Karlen A, 2009, P NATL ACAD SCI USA, V106, P20476, DOI 10.1073/pnas.0905390106; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Lee HJ, 2008, J NEUROSCI, V28, P2753, DOI 10.1523/JNEUROSCI.5586-07.2008; Lee JK, 2010, NEURON, V66, P663, DOI 10.1016/j.neuron.2010.05.002; Leibinger M, 2009, J NEUROSCI, V29, P14334, DOI 10.1523/JNEUROSCI.2770-09.2009; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Niederost BP, 1999, J NEUROSCI, V19, P8979, DOI 10.1523/JNEUROSCI.19-20-08979.1999; Ohlsson M, 2004, RESTOR NEUROL NEUROS, V22, P1; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Powell EM, 2001, GLIA, V33, P288, DOI 10.1002/1098-1136(20010315)33:4<288::AID-GLIA1027>3.0.CO;2-R; Raiker SJ, 2010, J NEUROSCI, V30, P12432, DOI 10.1523/JNEUROSCI.0895-10.2010; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Sapieha PS, 2005, MOL CELL NEUROSCI, V28, P625, DOI 10.1016/j.mcn.2004.10.011; Schweigreiter R, 2004, MOL CELL NEUROSCI, V27, P163, DOI 10.1016/j.mcn.2004.06.004; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Shypitsyna A, 2011, MOL BIOL EVOL, V28, P1363, DOI 10.1093/molbev/msq313; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Williams G, 2008, J BIOL CHEM, V283, P16641, DOI 10.1074/jbc.M802067200; Winzeler AM, 2011, J NEUROSCI, V31, P6481, DOI 10.1523/JNEUROSCI.3004-10.2011; Yamashita T, 2005, MOL NEUROBIOL, V32, P105, DOI 10.1385/MN:32:2:105; Yin YQ, 2009, P NATL ACAD SCI USA, V106, P19587, DOI 10.1073/pnas.0907085106; Zagrebelsky M, 2010, J NEUROSCI, V30, P13220, DOI 10.1523/JNEUROSCI.1044-10.2010; Zhang L, 2011, J GENET GENOMICS, V38, P515, DOI 10.1016/j.jgg.2011.10.001; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102	48	324	333	5	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					703	712		10.1038/nn.3070	http://dx.doi.org/10.1038/nn.3070			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22406547	Green Accepted, Green Submitted			2022-12-17	WOS:000303270200014
J	Lorincz, A; Notomi, T; Tamas, G; Shigemoto, R; Nusser, Z				Lorincz, A; Notomi, T; Tamas, G; Shigemoto, R; Nusser, Z			Polarized and compartment-dependent distribution of HCN1 in pyramidal cell dendrites	NATURE NEUROSCIENCE			English	Article							HYPERPOLARIZATION-ACTIVATED CHANNEL; CYCLIC-NUCLEOTIDE; RAT HIPPOCAMPUS; GLUTAMATE RECEPTORS; GABA(A) RECEPTORS; I-H; ACTION-POTENTIALS; APICAL DENDRITE; CATION CHANNELS; CA2+ CHANNELS	An ion channel's function depends largely on its location and density on neurons. Here we used high-resolution immunolocalization to determine the subcellular distribution of the hyperpolarization-activated and cyclic-nucleotide-gated channel subunit 1 (HCN1) in rat brain. Light microscopy revealed graded HCN1 immunoreactivity in apical dendrites of hippocampal, subicular and neocortical layer-5 pyramidal cells. Quantitative comparison of immunogold densities showed a 60-fold increase from somatic to distal apical dendritic membranes. Distal dendritic shafts had 16 times more HCN1 labeling than proximal dendrites of similar diameters. At the same distance from the soma, the density of HCN1 was significantly higher in dendritic shafts than in spines. Our results reveal the complex cell surface distribution of voltage-gated ion-channels, and predict its role in increasing the computational power of single neurons via subcellular domain and input-specific mechanisms.	Hungarian Acad Sci, Inst Expt Med, Lab Cellular Neurophysiol, H-1083 Budapest, Hungary; Univ Szeged, Dept Comparat Physiol, H-6726 Szeged, Hungary; Grad Univ Adv Studies, Sch Life Sci, Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi, Japan; Japan Sci & Technol Corp, CREST, Okazaki, Aichi 4448585, Japan	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Szeged University; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST)	Nusser, Z (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Cellular Neurophysiol, Szigony St 43, H-1083 Budapest, Hungary.		Tamas, Gabor/AAG-9305-2020; Nusser, Zoltan/K-8587-2014; Shigemoto, Ryuichi/E-3628-2013	Tamas, Gabor/0000-0002-7905-6001; Shigemoto, Ryuichi/0000-0001-8761-9444; Nusser, Zoltan/0000-0001-7004-4111				BAUDE A, 1995, NEUROSCIENCE, V69, P1031, DOI 10.1016/0306-4522(95)00350-R; Bender RA, 2001, NEUROSCIENCE, V106, P689, DOI 10.1016/S0306-4522(01)00314-1; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; BISCHOFBERGER J, 1995, J PHYSIOL-LONDON, V487, P305, DOI 10.1113/jphysiol.1995.sp020881; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; Colbert CM, 1996, J NEUROSCI, V16, P6676; Conti F, 1999, TRENDS NEUROSCI, V22, P451, DOI 10.1016/S0166-2236(99)01445-9; Craig AM, 2001, NAT NEUROSCI, V4, P569, DOI 10.1038/88388; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fritschy JM, 1998, J COMP NEUROL, V390, P194; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; Monteggia LM, 2000, MOL BRAIN RES, V81, P129, DOI 10.1016/S0169-328X(00)00155-8; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; NUSSER Z, 1995, EUR J NEUROSCI, V7, P630, DOI 10.1111/j.1460-9568.1995.tb00667.x; Nyiri G, 2001, EUR J NEUROSCI, V13, P428, DOI 10.1046/j.1460-9568.2001.01407.x; Ottersen OP, 1997, EUR J NEUROSCI, V9, P2219, DOI 10.1111/j.1460-9568.1997.tb01640.x; Petralia RS, 1998, CELL BIOL INT, V22, P603, DOI 10.1006/cbir.1998.0385; Rubio ME, 1997, NEURON, V18, P939, DOI 10.1016/S0896-6273(00)80333-5; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Schwindt PC, 1997, J NEUROPHYSIOL, V78, P187, DOI 10.1152/jn.1997.78.1.187; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Sloviter RS, 2001, J COMP NEUROL, V430, P283; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; SOMOGYI P, 1998, PRECISION VARIABILIT, P82; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; Stuart G, 1998, J NEUROSCI, V18, P3501; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tsubokawa H, 1999, J PHYSIOL-LONDON, V517, P135, DOI 10.1111/j.1469-7793.1999.0135z.x; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	48	324	329	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1185	1193		10.1038/nn962	http://dx.doi.org/10.1038/nn962			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12389030				2022-12-17	WOS:000178884600022
J	Hagell, P; Piccini, P; Bjorklund, A; Brundin, P; Rehncrona, S; Widner, H; Crabb, L; Pavese, N; Oertel, WH; Quinn, N; Brooks, DJ; Lindvall, O				Hagell, P; Piccini, P; Bjorklund, A; Brundin, P; Rehncrona, S; Widner, H; Crabb, L; Pavese, N; Oertel, WH; Quinn, N; Brooks, DJ; Lindvall, O			Dyskinesias following neural transplantation in Parkinson's disease	NATURE NEUROSCIENCE			English	Article							DOPAMINE NEURONS		Wallenberg Neurosci Ctr, Sect Restorat Neurol, SE-22184 Lund, Sweden; Wallenberg Neurosci Ctr, Div Neurobiol, SE-22184 Lund, Sweden; Wallenberg Neurosci Ctr, Sect Neuronal Survival, SE-22184 Lund, Sweden; Univ Hosp, Dept Clin Neurosci, Div Neurol, SE-22185 Lund, Sweden; Univ Hosp, Dept Clin Neurosci, Div Neurosurg, SE-22185 Lund, Sweden; Hammersmith Hosp, Imperial Coll, Fac Med, MRC,Clin Sci Ctr, London W12 0NN, England; Hammersmith Hosp, Imperial Coll, Fac Med, Div Neurosci, London W12 0NN, England; Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; Univ Marburg, Dept Neurol, DE-35033 Marburg, Germany	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Imperial College London; Imperial College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Philipps University Marburg	Lindvall, O (corresponding author), Wallenberg Neurosci Ctr, Sect Restorat Neurol, SE-22184 Lund, Sweden.	olle.lindvall@neurol.lu.se	Hagell, Peter/G-9559-2014; Hagell, Peter/F-5915-2010; Björklund, Anders/ABA-1326-2020	Hagell, Peter/0000-0003-2174-372X; Hagell, Peter/0000-0003-2174-372X; Pavese, Nicola/0000-0002-6801-6194; Brooks, David/0000-0003-2602-2518; Piccini, Paola/0000-0003-4162-6141; Bjorklund, Anders/0000-0002-5676-6203	MRC [MC_U120036861] Funding Source: UKRI; Medical Research Council [MC_U120036861] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		BOYCE S, 1990, CLIN NEUROPHARMACOL, V13, P448, DOI 10.1097/00002826-199010000-00006; Cubo E, 2001, ARCH NEUROL-CHICAGO, V58, P1379, DOI 10.1001/archneur.58.9.1379; Fahn S., 1987, RECENT DEV PARKINSON, P153; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Hagell P, 1999, MOVEMENT DISORD, V14, P448, DOI 10.1002/1531-8257(199905)14:3<448::AID-MDS1010>3.0.CO;2-0; Hauser RA, 1999, ARCH NEUROL-CHICAGO, V56, P179, DOI 10.1001/archneur.56.2.179; LANGSTON JW, 1992, MOVEMENT DISORD, V7, P2, DOI 10.1002/mds.870070103; Lee CS, 2000, BRAIN, V123, P1365, DOI 10.1093/brain/123.7.1365; LINDVALL O, 1989, ARCH NEUROL-CHICAGO, V46, P615, DOI 10.1001/archneur.1989.00520420033021; Lindvall O, 2000, Prog Brain Res, V127, P299; LUQUIN MR, 1992, MOVEMENT DISORD, V7, P117, DOI 10.1002/mds.870070204; Nutt JG, 2000, ANN NEUROL, V47, pS160; WIDNER H, 1992, NEW ENGL J MED, V327, P1556, DOI 10.1056/NEJM199211263272203	13	324	341	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					627	628		10.1038/nn863	http://dx.doi.org/10.1038/nn863			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12042822	Green Published			2022-12-17	WOS:000176414300009
J	Bayes, A; van de Lagemaat, LN; Collins, MO; Croning, MDR; Whittle, IR; Choudhary, JS; Grant, SGN				Bayes, Alex; van de Lagemaat, Louie N.; Collins, Mark O.; Croning, Mike D. R.; Whittle, Ian R.; Choudhary, Jyoti S.; Grant, Seth G. N.			Characterization of the proteome, diseases and evolution of the human postsynaptic density	NATURE NEUROSCIENCE			English	Article							PHENOTYPE ONTOLOGY; SCHIZOPHRENIA; TOOL	We isolated the postsynaptic density from human neocortex (hPSD) and identified 1,461 proteins. hPSD mutations cause 133 neurological and psychiatric diseases and were enriched in cognitive, affective and motor phenotypes underpinned by sets of genes. Strong protein sequence conservation in mammalian lineages, particularly in hub proteins, indicates conserved function and organization in primate and rodent models. The hPSD is an important structure for nervous system disease and behavior.	[Bayes, Alex; van de Lagemaat, Louie N.; Croning, Mike D. R.; Grant, Seth G. N.] Wellcome Trust Sanger Inst, Genes Cognit Programme, Hinxton, Cambs, England; [Whittle, Ian R.] Univ Edinburgh, Div Clin Neurosci, Edinburgh, Midlothian, Scotland	Wellcome Trust Sanger Institute; University of Edinburgh	Grant, SGN (corresponding author), Wellcome Trust Sanger Inst, Genes Cognit Programme, Hinxton, Cambs, England.	sg3@sanger.ac.uk	Collins, Mark/AAB-7484-2021; Bayés, Àlex/H-2854-2015; whittle, ian/AAX-7309-2021; Choudhary, Jyoti/S-1232-2017; Collins, Mark/A-3752-2012	Collins, Mark/0000-0002-7656-4975; Bayés, Àlex/0000-0002-5265-6306; Choudhary, Jyoti/0000-0003-0881-5477; Grant, Seth/0000-0001-8732-8735	EMBO; European Commission; Wellcome Trust; Scottish Higher Education Funding Council; Medical Research Council; US National Institutes of Health; Melville Trust; MRC [G0802238] Funding Source: UKRI; Medical Research Council [G0802238] Funding Source: researchfish; Chief Scientist Office [CZB/4/486] Funding Source: researchfish	EMBO(European Molecular Biology Organization (EMBO)); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome Trust); Scottish Higher Education Funding Council; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melville Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	We thank C.P. Ponting, P.J. Brophy, R.A.W. Frank, N.H. Komiyama, M.V. Kopanitsa, T.J. Ryan and members of the Genes to Cognition Programme for critical comments on the manuscript and for discussions. We thank the tissue donors, without whom this study would have been impossible. A.B. is supported by EMBO and the European Commission. L.N.v.L., M.O.C., M.D.R.C., J.S.C. and S.G.N.G. are supported by the Wellcome Trust. I.R.W. is supported by Scottish Higher Education Funding Council and by grants from the Medical Research Council, the US National Institutes of Health and the Melville Trust.	Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; Fraser HB, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-11; Harris LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003964; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Miao HX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002847; Pocklington AJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100041; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7; Wang HY, 2007, PLOS BIOL, V5, P335, DOI 10.1371/journal.pbio.0050013; Wang HX, 2006, J PROTEOME RES, V5, P361, DOI 10.1021/pr0503681; Winter EE, 2004, GENOME RES, V14, P54, DOI 10.1101/gr.1924004	14	323	325	1	37	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					19	21		10.1038/nn.2719	http://dx.doi.org/10.1038/nn.2719			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21170055	Green Accepted			2022-12-17	WOS:000285684900007
J	Konen, CS; Kastner, S				Konen, Christina S.; Kastner, Sabine			Two hierarchically organized neural systems for object information in human visual cortex	NATURE NEUROSCIENCE			English	Article							LATERAL OCCIPITAL COMPLEX; POSTERIOR PARIETAL CORTEX; TOPOGRAPHIC MAPS; AREA V4; SHAPE; REPRESENTATION; ATTENTION; NEURONS; MONKEY; SPACE	The primate visual system is broadly organized into two segregated processing pathways, a ventral stream for object vision and a dorsal stream for space vision. Here, evidence from functional brain imaging in humans demonstrates that object representations are not confined to the ventral pathway, but can also be found in several areas along the dorsal pathway. In both streams, areas at intermediate processing stages in extrastriate cortex (V4, V3A, MT and V7) showed object-selective but viewpoint- and size-specific responses. In contrast, higher-order areas in lateral occipital and posterior parietal cortex (LOC, IPS1 and IPS2) responded selectively to objects independent of image transformations. Contrary to the two-pathways hypothesis, our findings indicate that basic object information related to shape, size and viewpoint may be represented similarly in two parallel and hierarchically organized neural systems in the ventral and dorsal visual pathways.	[Konen, Christina S.; Kastner, Sabine] Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA; [Konen, Christina S.] Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08540 USA; [Kastner, Sabine] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08540 USA	Princeton University; Princeton University; Princeton University	Konen, CS (corresponding author), Princeton Univ, Dept Psychol, Green Hall, Princeton, NJ 08540 USA.	ckonen@princeton.edu		Kastner, Sabine/0000-0002-9742-965X	NEI NIH HHS [R01 EY017699] Funding Source: Medline; NIMH NIH HHS [R01 MH64043, P50 MH-62196] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH062196, R01MH064043] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andersen RA, 1997, PHILOS T ROY SOC B, V352, P1421, DOI 10.1098/rstb.1997.0128; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Craighero L, 1996, NEUROREPORT, V8, P347, DOI 10.1097/00001756-199612200-00068; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; DESIMONE R, 1985, VISION RES, V25, P441, DOI 10.1016/0042-6989(85)90069-0; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; Gallant JL, 1996, J NEUROPHYSIOL, V76, P2718, DOI 10.1152/jn.1996.76.4.2718; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Huk AC, 2002, J NEUROSCI, V22, P7195; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; Kanwisher N, 1996, COGNITIVE BRAIN RES, V5, P55, DOI 10.1016/S0926-6410(96)00041-9; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kastner S, 2007, J NEUROPHYSIOL, V97, P3494, DOI 10.1152/jn.00010.2007; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Kourtzi Z, 2002, NAT NEUROSCI, V5, P17, DOI 10.1038/nn780; Kourtzi Z, 2003, CEREB CORTEX, V13, P911, DOI 10.1093/cercor/13.9.911; Lehky SR, 2007, J NEUROPHYSIOL, V97, P307, DOI 10.1152/jn.00168.2006; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Nakamura H, 2001, J NEUROSCI, V21, P8174, DOI 10.1523/JNEUROSCI.21-20-08174.2001; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Riesenhuber M, 2002, CURR OPIN NEUROBIOL, V12, P162, DOI 10.1016/S0959-4388(02)00304-5; Sakata H, 1998, PHILOS T ROY SOC B, V353, P1363, DOI 10.1098/rstb.1998.0290; Sakata Hideo, 2003, Adv Neurol, V93, P121; Sawamura H, 2005, J NEUROSCI, V25, P4294, DOI 10.1523/JNEUROSCI.0377-05.2005; Schluppeck D, 2005, J NEUROPHYSIOL, V94, P1372, DOI 10.1152/jn.01290.2004; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; Swisher JD, 2007, J NEUROSCI, V27, P5326, DOI 10.1523/JNEUROSCI.0991-07.2007; Ungerleider L.G., 1982, ANAL VISUAL BEHAV; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839	50	323	327	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					224	231		10.1038/nn2036	http://dx.doi.org/10.1038/nn2036			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18193041				2022-12-17	WOS:000252712100017
J	Takano, T; Tian, GF; Peng, WG; Lou, NH; Lovatt, D; Hansen, AJ; Kasischke, KA; Nedergaard, M				Takano, Takahiro; Tian, Guo-Feng; Peng, Weiguo; Lou, Nanhong; Lovatt, Ditte; Hansen, Anker J.; Kasischke, Karl A.; Nedergaard, Maiken			Cortical spreading depression causes and coincides with tissue hypoxia	NATURE NEUROSCIENCE			English	Article							CEREBRAL-BLOOD-FLOW; TRANSGENIC MICE; VISUAL-CORTEX; MIGRAINE; BRAIN; ISCHEMIA; DEPOLARIZATION; MECHANISMS; HYPEREMIA; HEADACHE	Cortical spreading depression (CSD) is a self-propagating wave of cellular depolarization that has been implicated in migraine and in progressive neuronal injury after stroke and head trauma. Using two-photon microscopic NADH imaging and oxygen sensor microelectrodes in live mouse cortex, we find that CSD is linked to severe hypoxia and marked neuronal swelling that can last up to several minutes. Changes in dendritic structures and loss of spines during CSD are comparable to those during anoxic depolarization. Increasing O-2 availability shortens the duration of CSD and improves local redox state. Our results indicate that tissue hypoxia associated with CSD is caused by a transient increase in O-2 demand exceeding vascular O-2 supply.	Univ Rochester, Med Ctr, Dept Neurosurg, Ctr Aging & Dev Biol, Rochester, NY 14642 USA; Novo Nordisk AS, Discovery, DK-2760 Malov, Denmark	University of Rochester; Novo Nordisk	Takano, T (corresponding author), Univ Rochester, Med Ctr, Dept Neurosurg, Ctr Aging & Dev Biol, 601 Elmwood Ave,Box 645, Rochester, NY 14642 USA.	takahiro_takano@urmc.rochester.edu		Takano, Takahiro/0000-0002-6235-6673; Kasischke, Karl/0000-0003-0582-4319	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038073, R29NS030007, R01NS030007] Funding Source: NIH RePORTER; NINDS NIH HHS [NS38073, NS30007] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akin R, 2005, TURKISH J PEDIATR, V47, P150; Ayata C, 2006, ANN NEUROL, V59, P652, DOI 10.1002/ana.20778; Ayata C, 2004, J CEREBR BLOOD F MET, V24, P1172, DOI 10.1097/01.WCB.0000137057.92786.F3; Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Calandre EP, 2002, CEPHALALGIA, V22, P291, DOI 10.1046/j.1468-2982.2002.00370.x; Capobianco DJ, 2006, SEMIN NEUROL, V26, P242, DOI 10.1055/s-2006-939925; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; FABRICIUS M, 1993, BRAIN RES, V602, P350, DOI 10.1016/0006-8993(93)90701-N; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gorji A, 2001, BRAIN RES REV, V38, P33, DOI 10.1016/S0165-0173(01)00081-9; GRAFSTEIN B, 1956, J NEUROPHYSIOL, V19, P154, DOI 10.1152/jn.1956.19.2.154; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; HANSEN AJ, 1988, NEUROCHEM PATHOL, V9, P195; HANSEN AJ, 1980, ACTA PHYSIOL SCAND, V109, P1, DOI 10.1111/j.1748-1716.1980.tb06557.x; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Martins-Ferreira H, 2000, BRAIN RES REV, V32, P215, DOI 10.1016/S0165-0173(99)00083-1; Mayevsky A, 1998, ACT NEUR S, V71, P78; MAYEVSKY A, 1983, ADV EXP MED BIOL, V159, P129; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; MAYEVSKY A, 1982, BRAIN RES, V236, P93, DOI 10.1016/0006-8993(82)90037-3; MAYEVSKY A, 1991, J CEREBR BLOOD F MET, V11, P829, DOI 10.1038/jcbfm.1991.142; MAYEVSKY A, 1980, J NEUROSCI RES, V5, P173, DOI 10.1002/jnr.490050302; McKendrick AM, 2004, INVEST OPHTH VIS SCI, V45, P1061, DOI 10.1167/iovs.03-0936; Meyer JS, 2000, HEADACHE, V40, P638, DOI 10.1046/j.1526-4610.2000.040008638.x; NEDERGAARD M, 1988, ACTA NEUROL SCAND, V77, P81, DOI 10.1111/j.1600-0404.1988.tb05878.x; NEDERGAARD M, 1993, J CEREBR BLOOD F MET, V13, P568, DOI 10.1038/jcbfm.1993.74; NEDERGAARD M, 1986, J CEREBR BLOOD F MET, V6, P607, DOI 10.1038/jcbfm.1986.108; NICHOLSON C, 1978, ARZNEIMITTEL-FORSCH, V28-1, P874; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Riva D, 2006, CEPHALALGIA, V26, P596, DOI 10.1111/j.1468-2982.2006.01072.x; Schulte ML, 2006, NEUROSCI LETT, V394, P63, DOI 10.1016/j.neulet.2005.10.008; Shepherd AJ, 2005, CEPHALALGIA, V25, P412, DOI 10.1111/j.1468-2982.2004.00831.x; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Strong AJ, 2005, ADV TECH STAND NEUR, V30, P3, DOI 10.1007/3-211-27208-9_1; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Takano T, 2005, P NATL ACAD SCI USA, V102, P16466, DOI 10.1073/pnas.0506382102; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Tomita M, 2005, J CEREBR BLOOD F MET, V25, P742, DOI 10.1038/sj.jcbfm.9600074; Umegaki M, 2005, J NEUROSCI, V25, P1387, DOI 10.1523/JNEUROSCI.4182-04.2005; Van Harreveld A, 1970, J Neurobiol, V2, P13, DOI 10.1002/neu.480020103; VANHARREVELD A, 1957, AM J PHYSIOL, V101, P233; Waldie KE, 2002, NEUROLOGY, V59, P904, DOI 10.1212/WNL.59.6.904; Yenice O, 2007, EYE, V21, P218, DOI 10.1038/sj.eye.6702251	50	323	330	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					754	762		10.1038/nn1902	http://dx.doi.org/10.1038/nn1902			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17468748				2022-12-17	WOS:000246799800018
J	Aragona, BJ; Liu, Y; Yu, YJ; Curtis, JT; Detwiler, JM; Insel, TR; Wang, ZX				Aragona, BJ; Liu, Y; Yu, YJ; Curtis, JT; Detwiler, JM; Insel, TR; Wang, ZX			Nucleus accumbens dopamine differentially mediates the formation and maintenance of monogamous pair bonds	NATURE NEUROSCIENCE			English	Article							FEMALE PRAIRIE VOLES; COCAINE-SEEKING BEHAVIOR; MICROTUS-OCHROGASTER; PARTNER PREFERENCES; SOCIAL-ORGANIZATION; MOLECULAR-MECHANISMS; DRUG-ADDICTION; D-2 RECEPTORS; MALE-RATS; VASOPRESSIN	The involvement of dopamine within the nucleus accumbens in the formation and maintenance of pair bonds was assessed in a series of experiments using the monogamous prairie vole. We show that dopamine transmission that promotes pair bond formation occurs within the rostral shell of the nucleus accumbens, but not in its core or caudal shell. Within this specific brain region, D1- and D2-like receptor activation produced opposite effects: D1-like activation prevented pair bond formation, whereas D2-like activation facilitated it. After extended cohabitation with a female, male voles showed behavior indicative of pair bond maintenance-namely, selective aggression towards unfamiliar females. These voles also showed a significant upregulation in nucleus accumbens D1- like receptors, and blockade of these receptors abolished selective aggression. Thus, neuroplastic reorganization of the nucleus accumbens dopamine system is responsible for the enduring nature of monogamous pair bonding. Finally, we show that this system may also contribute to species-specific social organization.	Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA; NIMH, Bethesda, MD 20892 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Aragona, BJ (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.	aragona@unc.edu	Curtis, J. Thomas/J-4193-2019		NICHD NIH HHS [HD-40722] Funding Source: Medline; NIDA NIH HHS [DA-19627] Funding Source: Medline; NIMH NIH HHS [MH-67396, MH-66734, MH-58616] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD040722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH067396, R21MH066734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019627] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aragona BJ, 2003, J NEUROSCI, V23, P3483, DOI 10.1523/jneurosci.23-08-03483.2003; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Cardinal RN, 2004, CURR OPIN NEUROBIOL, V14, P156, DOI 10.1016/j.conb.2004.03.004; Carelli RM, 2004, CURR OPIN NEUROBIOL, V14, P763, DOI 10.1016/j.conb.2004.10.001; CARTER CS, 1995, NEUROSCI BIOBEHAV R, V19, P303; Champagne FA, 2004, J NEUROSCI, V24, P4113, DOI 10.1523/JNEUROSCI.5322-03.2004; Cho MM, 1999, BEHAV NEUROSCI, V113, P1071, DOI 10.1037/0735-7044.113.5.1071; DEWSBURY DA, 1988, NEBR SYM MOTIV, V35, P1; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; EVERITT BJ, 1990, NEUROSCI BIOBEHAV R, V14, P217, DOI 10.1016/S0149-7634(05)80222-2; Eyny YS, 2003, J NEUROSCI, V23, P1584; GETZ LL, 1993, J MAMMAL, V74, P44, DOI 10.2307/1381904; GETZ LL, 1981, BEHAV ECOL SOCIOBIOL, V8, P189, DOI 10.1007/BF00299829; Gingrich B, 2000, BEHAV NEUROSCI, V114, P173, DOI 10.1037/0735-7044.114.1.173; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Ikemoto S, 1997, J NEUROSCI, V17, P8580; INSEL TR, 1994, J NEUROSCI, V14, P5381; INSEL TR, 1992, P NATL ACAD SCI USA, V89, P5981, DOI 10.1073/pnas.89.13.5981; Insel TR, 2003, PHYSIOL BEHAV, V79, P351, DOI 10.1016/S0031-9384(03)00148-3; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Kalivas PW, 2003, PSYCHOPHARMACOLOGY, V168, P44, DOI 10.1007/s00213-003-1393-2; KEBABIAN JW, 1979, NATURE, V277, P93, DOI 10.1038/277093a0; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Kelley AE, 2002, J NEUROSCI, V22, P3306; Lim MM, 2004, NATURE, V429, P754, DOI 10.1038/nature02539; Lim MM, 2004, NEUROSCIENCE, V125, P35, DOI 10.1016/j.neuroscience.2003.12.008; Liu Y, 2003, NEUROSCIENCE, V121, P537, DOI 10.1016/S0306-4522(03)00555-4; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nestler EJ, 2004, TRENDS PHARMACOL SCI, V25, P210, DOI 10.1016/j.tips.2004.02.005; Panksepp J, 2002, ADDICTION, V97, P459, DOI 10.1046/j.1360-0443.2002.00025.x; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Pizzuto T, 1998, BEHAV PROCESS, V43, P79, DOI 10.1016/S0376-6357(97)00091-0; Reynolds SM, 2003, EUR J NEUROSCI, V17, P2187, DOI 10.1046/j.1460-9568.2003.02642.x; Robinson DL, 2002, J NEUROSCI, V22, P10477; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Schuiling GA, 2003, J PSYCHOSOM OBST GYN, V24, P55, DOI 10.3109/01674820309042802; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; Ungless MA, 2004, TRENDS NEUROSCI, V27, P702, DOI 10.1016/j.tins.2004.10.001; Wang ZX, 1997, J COMP NEUROL, V378, P535; Wang ZX, 1999, BEHAV NEUROSCI, V113, P602, DOI 10.1037/0735-7044.113.3.602; Wang ZX, 1997, BRAIN RES, V767, P321, DOI 10.1016/S0006-8993(97)00617-3; WILLIAMS JR, 1992, HORM BEHAV, V26, P339, DOI 10.1016/0018-506X(92)90004-F; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Zahm DS, 2000, NEUROSCI BIOBEHAV R, V24, P85, DOI 10.1016/S0149-7634(99)00065-2	50	323	333	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					133	139		10.1038/nn1613	http://dx.doi.org/10.1038/nn1613			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16327783				2022-12-17	WOS:000234288000027
J	Wu, GY; Deisseroth, K; Tsien, RW				Wu, GY; Deisseroth, K; Tsien, RW			Spaced stimuli stabilize MAPK pathway activation and its effects on dendritic morphology	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE CASCADE; LONG-TERM FACILITATION; ELEMENT-BINDING PROTEIN; SYNAPTIC ACTIVITY; CREB PHOSPHORYLATION; DEPENDENT REGULATION; RECEPTOR ACTIVATION; SIGNALING PATHWAY; HIPPOCAMPAL SLICE; SENSORY NEURONS	Memory storage in mammalian neurons probably depends on both biochemical events and morphological alterations in dendrites. Here we report an activity-dependent stabilization of the MAP kinase (MAPK) pathway, prominent in hippocampal dendrites. The longevity of the signal in these dendrites was increased to hours when multiple spaced stimuli were used. Likewise, spaced stimuli and MAPK activation were critical for protrusion of new dendritic filopodia that also remained stable for hours. Our experiments define a new role for stimulus-specific responses of MAPK signaling in activity-dependent neuronal plasticity. The local biochemical signaling in dendrites complements MAPK signaling in gene expression. Together, these processes may support long-lasting behavioral changes.	Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University; Stanford University	Tsien, RW (corresponding author), Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.							Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bailey CH, 1997, NEURON, V18, P913, DOI 10.1016/S0896-6273(00)80331-1; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Blum S, 1999, J NEUROSCI, V19, P3535; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CHANG FLF, 1984, BRAIN RES, V309, P35, DOI 10.1016/0006-8993(84)91008-4; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; EDWARDS FA, 1995, PHYSIOL REV, V75, P759, DOI 10.1152/physrev.1995.75.4.759; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fields RD, 1997, J NEUROSCI, V17, P7252; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; HOSOKAWA T, 1995, J NEUROSCI, V15, P5560; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Mauelshagen J, 1998, LEARN MEMORY, V5, P246; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Michael D, 1998, P NATL ACAD SCI USA, V95, P1864, DOI 10.1073/pnas.95.4.1864; Murphy DD, 1997, P NATL ACAD SCI USA, V94, P1482, DOI 10.1073/pnas.94.4.1482; MURPHY TH, 1994, J NEUROSCI, V14, P1320, DOI 10.1523/JNEUROSCI.14-03-01320.1994; Raught B, 1999, INT J BIOCHEM CELL B, V31, P43, DOI 10.1016/S1357-2725(98)00131-9; Roberson ED, 1999, J NEUROSCI, V19, P4337; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Schafe GE, 1999, LEARN MEMORY, V6, P97; Schuman EM, 1999, NEURON, V23, P645, DOI 10.1016/S0896-6273(01)80023-4; Seidel MG, 1999, J BIOL CHEM, V274, P25833, DOI 10.1074/jbc.274.36.25833; Sorra KE, 1998, J COMP NEUROL, V398, P225; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	50	323	331	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					151	158		10.1038/83976	http://dx.doi.org/10.1038/83976			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175875				2022-12-17	WOS:000167178100013
J	Lee, DA; Bedont, JL; Pak, T; Wang, H; Song, J; Miranda-Angulo, A; Takiar, V; Charubhumi, V; Balordi, F; Takebayashi, H; Aja, S; Ford, E; Fishell, G; Blackshaw, S				Lee, Daniel A.; Bedont, Joseph L.; Pak, Thomas; Wang, Hong; Song, Juan; Miranda-Angulo, Ana; Takiar, Vani; Charubhumi, Vanessa; Balordi, Francesca; Takebayashi, Hirohide; Aja, Susan; Ford, Eric; Fishell, Gordon; Blackshaw, Seth			Tanycytes of the hypothalamic median eminence form a diet-responsive neurogenic niche	NATURE NEUROSCIENCE			English	Article							ENERGY-BALANCE; BRAIN; 3RD-VENTRICLE; CELLS; RAT	Adult hypothalamic neurogenesis has recently been reported, but the cell of origin and the function of these newborn neurons are unknown. Using genetic fate mapping, we found that median eminence tanycytes generate newborn neurons. Blocking this neurogenesis altered the weight and metabolic activity of adult mice. These findings reveal a previously unreported neurogenic niche in the mammalian hypothalamus with important implications for metabolism.	[Lee, Daniel A.; Bedont, Joseph L.; Pak, Thomas; Wang, Hong; Miranda-Angulo, Ana; Takiar, Vani; Charubhumi, Vanessa; Aja, Susan; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Lee, Daniel A.; Song, Juan; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA; [Song, Juan; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Miranda-Angulo, Ana] Univ Antioquia, Medellin, Colombia; [Balordi, Francesca; Fishell, Gordon] NYU, Sch Med, Smilow Res Ctr, Neurosci Program, New York, NY USA; [Balordi, Francesca; Fishell, Gordon] NYU, Sch Med, Smilow Res Ctr, Dept Cell Biol, New York, NY USA; [Takebayashi, Hirohide] Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata, Japan; [Aja, Susan] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD USA; [Ford, Eric] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Ctr High Throughput Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Universidad de Antioquia; New York University; New York University; Niigata University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Blackshaw, S (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	sblack@jhmi.edu	Takebayashi, Hirohide/AAO-1693-2020	Pak, Thomas/0000-0003-2716-1210; Fishell, Gordon/0000-0002-9640-9278; Miranda-Angulo, Ana L./0000-0003-4938-3033; Lee, Daniel/0000-0001-7411-2740	US National Institutes of Health [F31 NS063550]; NSF; Basil O'Connor Starter Scholar Award; Klingenstein Fund; NARSAD; NATIONAL EYE INSTITUTE [T32EY007143, T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS063550] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Basil O'Connor Starter Scholar Award; Klingenstein Fund(Klingenstein Philanthropies); NARSAD(NARSAD); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Nathans, S. Hattar, N. Gaiano, P. Achanta, C. Montojo, D. McClellan, T Shimogori, T. Moran, E. Newman, M. Taylor and W. Yap for comments on the manuscript. We also thank M. Bonaguidi, C. Montojo, J. Reyes, M. Armour, E. Velarde, N. Forbes-McBean, WE Han and the Johns Hopkins School of Medicine Microscope Facility for technical advice and assistance. This work was supported by US National Institutes of Health grant F31 NS063550 and an NSF Graduate Fellowship (to D.A.L.), a Basil O'Connor Starter Scholar Award and grants from the Klingenstein Fund and NARSAD (to S.B.). S.B. is a W.M. Keck Distinguished Young Scholar in Medical Research.	Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; DAVELLA D, 1994, J NEUROSURG, V81, P774, DOI 10.3171/jns.1994.81.5.0774; Ford EC, 2011, RADIAT RES, V175, P774, DOI 10.1667/RR2214.1; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; Mathew TC, 2008, ANAT HISTOL EMBRYOL, V37, P9, DOI 10.1111/j.1439-0264.2007.00786.x; Matinfar M, 2007, LECT NOTES COMPUT SC, V4792, P926; Miller I, 2004, NEUROREPORT, V15, P925, DOI 10.1097/00001756-200404090-00038; Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010; Rodriguez EM, 2005, INT REV CYTOL, V247, P89, DOI 10.1016/S0074-7696(05)47003-5; Shimogori T, 2010, NAT NEUROSCI, V13, P767, DOI 10.1038/nn.2545; Simerly RB, 2008, PHYSIOL BEHAV, V94, P79, DOI 10.1016/j.physbeh.2007.11.023; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021	15	322	331	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					700	702		10.1038/nn.3079	http://dx.doi.org/10.1038/nn.3079			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22446882	Green Accepted			2022-12-17	WOS:000303270200013
J	Bickart, KC; Wright, CI; Dautoff, RJ; Dickerson, BC; Barrett, LF				Bickart, Kevin C.; Wright, Christopher I.; Dautoff, Rebecca J.; Dickerson, Bradford C.; Barrett, Lisa Feldman			Amygdala volume and social network size in humans	NATURE NEUROSCIENCE			English	Article							BRAIN; PRIMATES	We found that amygdala volume correlates with the size and complexity of social networks in adult humans. An exploratory analysis of subcortical structures did not find strong evidence for similar relationships with any other structure, but there were associations between social network variables and cortical thickness in three cortical areas, two of them with amygdala connectivity. These findings indicate that the amygdala is important in social behavior.	[Wright, Christopher I.; Dautoff, Rebecca J.; Dickerson, Bradford C.; Barrett, Lisa Feldman] Massachusetts Gen Hosp, Psychiat Neuroimaging Res Program, Charlestown, MA 02129 USA; [Wright, Christopher I.; Dautoff, Rebecca J.; Dickerson, Bradford C.; Barrett, Lisa Feldman] Harvard Univ, Sch Med, Charlestown, MA USA; [Bickart, Kevin C.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Wright, Christopher I.; Dautoff, Rebecca J.; Dickerson, Bradford C.; Barrett, Lisa Feldman] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Dickerson, Bradford C.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Dickerson, Bradford C.] Harvard Univ, Sch Med, Boston, MA USA; [Barrett, Lisa Feldman] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Northeastern University	Barrett, LF (corresponding author), Massachusetts Gen Hosp, Psychiat Neuroimaging Res Program, Charlestown, MA 02129 USA.	l.barrett@neu.edu	Barrett, Lisa Feldman/ABC-8157-2020		US National Institutes of Health [DP1OD003312]; US National Institute on Aging [R01-AG030311, R01-AG029411, R21-AG29840]; NATIONAL INSTITUTE ON AGING [R01AG030311, R01AG029411, R21AG029840] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003312] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Michael Brickhouse for assistance with morphometric analyses. This study was supported by grants from the US National Institutes of Health Director's Pioneer Award (DP1OD003312) and the US National Institute on Aging (R01-AG030311, R01-AG029411 and R21-AG29840).	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Barger N, 2007, AM J PHYS ANTHROPOL, V134, P392, DOI 10.1002/ajpa.20684; Barton RA, 1998, P ROY SOC B-BIOL SCI, V265, P1933, DOI 10.1098/rspb.1998.0523; Barton RA., 2000, AMYGDALA FUNCTIONAL, P480; Buchanan T., 2009, HUMAN AMYGDALA, P289; Cohen Sheldon, 1997, JAMA (Journal of the American Medical Association), V277, P1940, DOI 10.1001/jama.277.24.1940; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.3.CO;2-P; Freese J. L., 2009, HUMAN AMYGDALA, P3; Gurung RAR, 2003, PSYCHOL AGING, V18, P487, DOI 10.1037/0882-7974.18.3.487; Lewis KP, 2006, J COMP PSYCHOL, V120, P31, DOI 10.1037/0735-7036.120.1.31; O'Brien LM, 2006, HARVARD REV PSYCHIAT, V14, P141, DOI 10.1080/10673220600784119; RUSSELL D, 1984, J PERS SOC PSYCHOL, V46, P1313, DOI 10.1037/0022-3514.46.6.1313; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118	15	322	323	4	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					163	164		10.1038/nn.2724	http://dx.doi.org/10.1038/nn.2724			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	711MJ	21186358	Green Published, Green Accepted			2022-12-17	WOS:000286595400012
J	Marrs, WR; Blankman, JL; Horne, EA; Thomazeau, A; Lin, YH; Coy, J; Bodor, AL; Muccioli, GG; Hu, SSJ; Woodruff, G; Fung, S; Lafourcade, M; Alexander, JP; Long, JZ; Li, WW; Xu, C; Moller, T; Mackie, K; Manzoni, OJ; Cravatt, BF; Stella, N				Marrs, William R.; Blankman, Jacqueline L.; Horne, Eric A.; Thomazeau, Aurore; Lin, Yi Hsing; Coy, Jonathan; Bodor, Agnes L.; Muccioli, Giulio G.; Hu, Sherry Shu-Jung; Woodruff, Grace; Fung, Susan; Lafourcade, Mathieu; Alexander, Jessica P.; Long, Jonathan Z.; Li, Weiwei; Xu, Cong; Moeller, Thomas; Mackie, Ken; Manzoni, Olivier J.; Cravatt, Benjamin F.; Stella, Nephi			The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors	NATURE NEUROSCIENCE			English	Article							2-ARACHIDONOYLGLYCEROL HYDROLYSIS; ENDOGENOUS CANNABINOIDS; ENDOCANNABINOID SYSTEM; ANANDAMIDE; BLOCKADE; BRAIN; MODULATION; ACID; INHIBITOR; ENZYMES	The endocannabinoid 2-arachidonoylglycerol (2-AG) regulates neurotransmission and neuroinflammation by activating CB1 cannabinoid receptors on neurons and CB2 cannabinoid receptors on microglia. Enzymes that hydrolyze 2-AG, such as monoacylglycerol lipase, regulate the accumulation and efficacy of 2-AG at cannabinoid receptors. We found that the recently described serine hydrolase alpha-beta-hydrolase domain 6 (ABHD6) also controls the accumulation and efficacy of 2-AG at cannabinoid receptors. In cells from the BV-2 microglia cell line, ABHD6 knockdown reduced hydrolysis of 2-AG and increased the efficacy with which 2-AG can stimulate CB2-mediated cell migration. ABHD6 was expressed by neurons in primary culture and its inhibition led to activity-dependent accumulation of 2-AG. In adult mouse cortex, ABHD6 was located postsynaptically and its selective inhibition allowed the induction of CB1-dependent long-term depression by otherwise subthreshold stimulation. Our results indicate that ABHD6 is a rate-limiting step of 2-AG signaling and is therefore a bona fide member of the endocannabinoid signaling system.	[Horne, Eric A.; Lin, Yi Hsing; Coy, Jonathan; Xu, Cong; Stella, Nephi] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Marrs, William R.; Fung, Susan] Univ Washington, Neurobiol & Behav Grad Program, Seattle, WA 98195 USA; [Blankman, Jacqueline L.; Alexander, Jessica P.; Long, Jonathan Z.; Li, Weiwei; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Blankman, Jacqueline L.; Alexander, Jessica P.; Long, Jonathan Z.; Li, Weiwei; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Thomazeau, Aurore; Lafourcade, Mathieu; Manzoni, Olivier J.] Equipe Physiopathol Plast Synapt, INSERM, U862, Bordeaux, France; [Bodor, Agnes L.] Univ Washington, Dept Otolaryngol, Seattle, WA 98195 USA; [Muccioli, Giulio G.] Catholic Univ Louvain, Louvain Drug Res Inst, CHAM7230, Bioanal & Pharmacol Bioact Lipids Lab, B-1200 Brussels, Belgium; [Hu, Sherry Shu-Jung; Mackie, Ken] Indiana Univ, Gill Ctr Biomol Sci, Dept Psychol & Brain Sci, Bloomington, IN USA; [Woodruff, Grace] Univ Washington, Neurobiol Undergraduate Program, Seattle, WA 98195 USA; [Moeller, Thomas] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Stella, Nephi] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Scripps Research Institute; Scripps Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Washington; University of Washington Seattle; Universite Catholique Louvain; Indiana University System; Indiana University Bloomington; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stella, N (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	nstella@uw.edu	Mackie, Ken/E-3715-2013; LI, WEWEI/F-8657-2010; Manzoni, Olivier/M-7899-2016; Lafourcade, Mathieu/GQZ-7267-2022; Mackie, Kenneth P/B-7358-2011	Mackie, Ken/0000-0001-8501-6199; Manzoni, Olivier/0000-0002-5579-6208; Muccioli, Giulio/0000-0002-1600-9259; Thomazeau, Aurore/0000-0002-7668-2867; Long, Jonathan/0000-0003-2631-7463; Lafourcade, Mathieu/0000-0001-6117-1194	National Institute on Drug Abuse [DA14486, DA26430, DA017259, DA009789, DA025285, DA026161]; National Institute of General Medical Sciences (PHS NRSA) [2T32 GM007270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025285, K05DA021696, P01DA017259, R01DA014486, R01DA026430, P01DA009789] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of General Medical Sciences (PHS NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute on Drug Abuse (DA14486 and DA26430 to N.S., DA017259, DA009789 and DA025285 to B. F. C. and DA026161 to J.L.B.) and from the National Institute of General Medical Sciences (PHS NRSA 2T32 GM007270 to W. R. M.).	Berghuis P, 2007, SCIENCE, V316, P1212, DOI 10.1126/science.1137406; BEROD A, 1981, J HISTOCHEM CYTOCHEM, V29, P844, DOI 10.1177/29.7.6167611; Bisogno T, 2009, BBA-MOL CELL BIOL L, V1791, P53, DOI 10.1016/j.bbalip.2008.10.007; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Burston JJ, 2008, J PHARMACOL EXP THER, V327, P546, DOI 10.1124/jpet.108.141382; Cabral GA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000957; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Dinh TP, 2004, MOL PHARMACOL, V66, P1260, DOI 10.1124/mol.104.002071; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fegley D, 2005, J PHARMACOL EXP THER, V313, P352, DOI 10.1124/jpet.104.078980; Gobbi G, 2005, P NATL ACAD SCI USA, V102, P18620, DOI 10.1073/pnas.0509591102; Goparaju SK, 1998, FEBS LETT, V422, P69, DOI 10.1016/S0014-5793(97)01603-7; Gulyas AI, 2004, EUR J NEUROSCI, V20, P441, DOI 10.1111/j.1460-9568.2004.03428.x; Horne EA, 2008, FUTURE LIPIDOL, V3, P435, DOI 10.2217/17460875.3.4.435; Jessani N, 2005, NAT METHODS, V2, P691, DOI 10.1038/NMETH778; KANO M, 2009, PHYSIOL REV, V309, P380; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Lafourcade M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000709; Li WW, 2007, J AM CHEM SOC, V129, P9594, DOI 10.1021/ja073650c; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Maier S, 2006, J VIROL, V80, P9761, DOI 10.1128/JVI.00665-06; Marrs W, 2007, CHEM BIOL, V14, P1309, DOI 10.1016/j.chembiol.2007.12.004; Marrs W, 2009, AAPS J, V11, P307, DOI 10.1208/s12248-009-9109-0; Miller AM, 2009, GLIA, V57, P875, DOI 10.1002/glia.20813; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; MUCCIOLI GG, 2007, ANAL BIOCHEM, V373, P220; Muccioli GG, 2007, J NEUROSCI, V27, P2883, DOI 10.1523/JNEUROSCI.4830-06.2007; Saario SM, 2005, CHEM BIOL, V12, P649, DOI 10.1016/j.chembiol.2005.04.013; Stella N, 2001, EUR J PHARMACOL, V425, P189, DOI 10.1016/S0014-2999(01)01182-7; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; STELLA N, 1995, J NEUROSCI, V15, P3307; Stella N, 2009, NEUROPHARMACOLOGY, V56, P244, DOI 10.1016/j.neuropharm.2008.07.037; Straiker A, 2006, AAPS J, V8, pE272; Walter L, 2004, J NEUROSCI, V24, P8068, DOI 10.1523/JNEUROSCI.2419-04.2004; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Witting A, 2004, P NATL ACAD SCI USA, V101, P3214, DOI 10.1073/pnas.0306707101; Yates JR, 1996, ANAL CHEM, V68, pA534, DOI 10.1021/ac962050l	42	322	330	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					951	U67		10.1038/nn.2601	http://dx.doi.org/10.1038/nn.2601			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20657592	Green Accepted			2022-12-17	WOS:000280400600013
J	Zhou, Y; Won, J; Karlsson, MG; Zhou, M; Rogerson, T; Balaji, J; Neve, R; Poirazi, P; Silva, AJ				Zhou, Yu; Won, Jaejoon; Karlsson, Mikael Guzman; Zhou, Miou; Rogerson, Thomas; Balaji, Jayaprakash; Neve, Rachael; Poirazi, Panayiota; Silva, Alcino J.			CREB regulates excitability and the allocation of memory to subsets of neurons in the amygdala	NATURE NEUROSCIENCE			English	Article							ELEMENT-BINDING PROTEIN; CONDITIONED TASTE-AVERSION; CA1 PYRAMIDAL NEURONS; LATERAL AMYGDALA; FEAR MEMORY; TRANSCRIPTION FACTORS; MAMMALIAN NEURONS; IN-VITRO; RECEPTOR; RAT	The mechanisms that determine how information is allocated to specific regions and cells in the brain are important for memory capacity, storage and retrieval, but are poorly understood. We manipulated CREB in a subset of lateral amygdala neurons in mice with a modified herpes simplex virus (HSV) and reversibly inactivated transfected neurons with the Drosophila allatostatin G protein-coupled receptor (AlstR)/ligand system. We found that inactivation of the neurons transfected with HSV-CREB during training disrupted memory for tone conditioning, whereas inactivation of a similar proportion of transfected control neurons did not. Whole-cell recordings of fluorescently tagged transfected neurons revealed that neurons with higher CREB levels are more excitable than neighboring neurons and showed larger synaptic efficacy changes following conditioning. Our findings demonstrate that CREB modulates the allocation of fear memory to specific cells in lateral amygdala and suggest that neuronal excitability is important in this process.	[Zhou, Yu; Won, Jaejoon; Karlsson, Mikael Guzman; Zhou, Miou; Rogerson, Thomas; Balaji, Jayaprakash; Silva, Alcino J.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; [Zhou, Yu; Won, Jaejoon; Karlsson, Mikael Guzman; Zhou, Miou; Rogerson, Thomas; Balaji, Jayaprakash; Silva, Alcino J.] Univ Calif Los Angeles, Semel Inst, Los Angeles, CA USA; [Zhou, Yu; Won, Jaejoon; Karlsson, Mikael Guzman; Zhou, Miou; Rogerson, Thomas; Balaji, Jayaprakash; Silva, Alcino J.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Zhou, Yu; Won, Jaejoon; Karlsson, Mikael Guzman; Zhou, Miou; Rogerson, Thomas; Balaji, Jayaprakash; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Neve, Rachael] MIT, Picower Inst, Cambridge, MA 02139 USA; [Poirazi, Panayiota] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Computat Biol Lab, Iraklion, Crete, Greece	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Massachusetts Institute of Technology (MIT); Foundation for Research & Technology - Hellas (FORTH)	Silva, AJ (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA.	silvaa@mednet.ucla.edu	Zhou, Miou/AAK-1515-2021; Silva, Alcino/ABD-7684-2021	Zhou, Miou/0000-0001-8188-7392; Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494; Poirazi, Panayiota/0000-0001-6152-595X	US National Institutes of Health [P50-MH0779720, R37-AG13622]; European Commission [PIOF-GA-2008-219622]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013622, R01AG013622] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank T. Carvalho, Y.-S. Lee, P. Golshani, D. Buonomano, B. Wiltgen, W. Tan, J. Shobe, J. Feldman and J. Guzowski for helpful advice, E. Callaway for AlstR cDNA and K. Cai for technical support. This work was supported by grants from the US National Institutes of Health (P50-MH0779720 and R37-AG13622) to A. J. S. and a Marie Curie Outgoing fellowship of the European Commission (PIOF-GA-2008-219622) to P. P.	Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Birgul N, 1999, EMBO J, V18, P5892, DOI 10.1093/emboj/18.21.5892; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Carvalho TP, 2009, NEURON, V61, P774, DOI 10.1016/j.neuron.2009.01.013; Clark MS, 2002, J NEUROSCI, V22, P4550, DOI 10.1523/JNEUROSCI.22-11-04550.2002; Dong Y, 2006, NAT NEUROSCI, V9, P475, DOI 10.1038/nn1661; Faber ESL, 2004, J NEUROSCI, V24, P3031, DOI 10.1523/JNEUROSCI.4496-03.2004; Faber ESL, 2001, J NEUROPHYSIOL, V85, P714, DOI 10.1152/jn.2001.85.2.714; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Han MH, 2006, J NEUROSCI, V26, P4624, DOI 10.1523/JNEUROSCI.4701-05.2006; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Humeau Y, 2007, J NEUROSCI, V27, P10947, DOI 10.1523/JNEUROSCI.2603-07.2007; Jancic D, 2009, CEREB CORTEX, V19, P2535, DOI 10.1093/cercor/bhp004; Josselyn SA, 2004, NEUROBIOL LEARN MEM, V82, P159, DOI 10.1016/j.nlm.2004.05.008; Karschin C, 1996, J NEUROSCI, V16, P3559; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Lamprecht R, 1997, J NEUROSCI, V17, P8443; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Liebmann L, 2008, J NEUROPHYSIOL, V99, P958, DOI 10.1152/jn.01137.2007; LIM F, 1999, CURRENT PROTOCOLS NE; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Murphy GG, 2004, CURR BIOL, V14, P1907, DOI 10.1016/j.cub.2004.10.021; Oh MM, 2009, P NATL ACAD SCI USA, V106, P1620, DOI 10.1073/pnas.0807708106; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Santini E, 2008, J NEUROSCI, V28, P4028, DOI 10.1523/JNEUROSCI.2623-07.2008; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Schafe GE, 2005, J NEUROSCI, V25, P10010, DOI 10.1523/JNEUROSCI.3307-05.2005; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Staff NP, 2003, HIPPOCAMPUS, V13, P801, DOI 10.1002/hipo.10129; STORM JF, 1990, PROG BRAIN RES, V83, P161; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Viosca J, 2009, LEARN MEMORY, V16, P193, DOI 10.1101/lm.1254209; Won J, 2008, NEUROBIOL LEARN MEM, V89, P285, DOI 10.1016/j.nlm.2007.08.017; YAMAMOTO T, 1994, BEHAV BRAIN RES, V65, P123, DOI 10.1016/0166-4328(94)90097-3	44	322	327	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1438	1443		10.1038/nn.2405	http://dx.doi.org/10.1038/nn.2405			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19783993	Green Submitted, Green Published, Green Accepted			2022-12-17	WOS:000271194100017
J	Konishi, S; Nakajima, K; Uchida, I; Kameyama, M; Nakahara, K; Sekihara, K; Miyashita, Y				Konishi, S; Nakajima, K; Uchida, I; Kameyama, M; Nakahara, K; Sekihara, K; Miyashita, Y			Transient activation of inferior prefrontal cortex during cognitive set shifting	NATURE NEUROSCIENCE			English	Article							CARD SORTING TEST; WORKING-MEMORY TASK; POSITRON EMISSION TOMOGRAPHY; PERFORMANCE; SYSTEM; AREAS; FMRI; PET; MRI	The Wisconsin Card Sorting Test, which probes the ability to shift attention from one category of stimulus attributes to another (shifting cognitive sets), is the most common paradigm used to detect human frontal lobe pathology. However, the exact relationship of this card test to prefrontal function and the precise anatomical localization of the cognitive shifts involved are controversial. By isolating shift-related signals using the temporal resolution of functional magnetic resonance imaging, we reproducibly found transient activation of the posterior part of the bilateral inferior frontal sulci, This activation was larger as the number of dimensions (relevant stimulus attributes that had to be recognized) were increased, These results suggest that the inferior frontal areas play an essential role in the flexible shifting of cognitive sets.	Univ Tokyo, Sch Med, Dept Physiol, Tokyo 113, Japan; Japan Sci & Technol Corp, Tokyo 113, Japan; Natl Inst Physiol Sci, Okazaki, Aichi 444, Japan	University of Tokyo; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Konishi, S (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Tokyo 113, Japan.	konishi@m.u-tokyo.ac.jp	Kameyama, Masashi/E-1113-2017; Miyashita, Yasushi/B-7171-2019	Kameyama, Masashi/0000-0001-9496-2590; Miyashita, Yasushi/0000-0003-3496-8637; Nakahara, Kiyoshi/0000-0001-6701-6216				Baker SC, 1996, CEREB CORTEX, V6, P612, DOI 10.1093/cercor/6.4.612; BERMAN KF, 1995, NEUROPSYCHOLOGIA, V33, P1027, DOI 10.1016/0028-3932(95)00035-2; BLAMIRE AM, 1992, P NATL ACAD SCI USA, V89, P11069, DOI 10.1073/pnas.89.22.11069; Buckner RL, 1996, J NEUROSCI, V16, P6219; Buckner RL, 1996, P NATL ACAD SCI USA, V93, P14878, DOI 10.1073/pnas.93.25.14878; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; Damasio AR, 1995, ANN NY ACAD SCI, V769, P241, DOI 10.1111/j.1749-6632.1995.tb38142.x; Dehaene S, 1996, NEUROPSYCHOLOGIA, V34, P1097, DOI 10.1016/0028-3932(96)00027-9; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; DREWE E A, 1974, Cortex, V10, P159; Fiez JA, 1996, J NEUROSCI, V16, P808; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; FUSTERJM, 1997, PREFRONTAL CORTEX; Goldman-Rakic PS, 1987, HDB PHYSL 1, V5, P373, DOI DOI 10.1002/CPHY.CP010509; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; HEATON RK, 1981, WISCONSIN CARD SORTI; HINKE RM, 1993, NEUROREPORT, V4, P675, DOI 10.1097/00001756-199306000-00018; JANOWSKY JS, 1989, BEHAV NEUROSCI, V103, P548, DOI 10.1037/0735-7044.103.3.548; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; Kim KHS, 1997, NATURE, V388, P171, DOI 10.1038/40623; Kim SG, 1997, MAGNET RESON MED, V37, P631, DOI 10.1002/mrm.1910370427; Klingberg T, 1997, CEREB CORTEX, V7, P465, DOI 10.1093/cercor/7.5.465; Konishi S, 1996, NEUROREPORT, V8, P19, DOI 10.1097/00001756-199612200-00005; Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; MCCARTHY G, 1994, P NATL ACAD SCI USA, V91, P8690, DOI 10.1073/pnas.91.18.8690; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Milner B., 1964, FRONTAL GRANULAR COR, P313; Mishkin M., 1964, FRONTAL GRANULAR COR, P219; MIYASHITA Y, 1993, ANNU REV NEUROSCI, V16, P245, DOI 10.1146/annurev.ne.16.030193.001333; MOUNTAIN MA, 1993, CLIN NEUROPSYCHOL, V7, P108, DOI 10.1080/13854049308401893; Nagahama Y, 1996, BRAIN, V119, P1667, DOI 10.1093/brain/119.5.1667; NARAYAN SM, 1994, CEREB CORTEX, V4, P195, DOI 10.1093/cercor/4.2.195; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PASSINGHAM RE, 1972, NEUROPSYCHOLOGIA, V10, P41, DOI 10.1016/0028-3932(72)90041-3; Passingham RE., 1993, FRONTAL LOBES VOLUNT; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; PETRIDES M, 1989, HDB NEUROPSYCHOLOGY, V3, P75; Prabhakaran V, 1997, COGNITIVE PSYCHOL, V33, P43, DOI 10.1006/cogp.1997.0659; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; Rosen BR, 1998, P NATL ACAD SCI USA, V95, P773, DOI 10.1073/pnas.95.3.773; SAKAI K, 1995, P ROY SOC B-BIOL SCI, V261, P89, DOI 10.1098/rspb.1995.0121; SAKAI K, 1995, MAGNET RESON MED, V33, P736, DOI 10.1002/mrm.1910330521; SAVOY RL, 1995, P SMR 3 ANN M, V450; Talairach J., 1988, COPLANAR STEREOTAXIC; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	50	322	328	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					80	84		10.1038/283	http://dx.doi.org/10.1038/283			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	127QA	10195114				2022-12-17	WOS:000076361000023
J	Tay, TL; Mai, D; Dautzenberg, J; Fernandez-Klett, F; Lin, G; Sagar; Datta, M; Drougard, A; Stempfl, T; Ardura-Fabregat, A; Staszewski, O; Margineanu, A; Sporbert, A; Steinmetz, LM; Pospisilik, JA; Jung, S; Priller, J; Grun, D; Ronneberger, O; Prinz, M				Tay, Tuan Leng; Mai, Dominic; Dautzenberg, Jana; Fernandez-Klett, Francisco; Lin, Gen; Sagar; Datta, Moumita; Drougard, Anne; Stempfl, Thomas; Ardura-Fabregat, Alberto; Staszewski, Ori; Margineanu, Anca; Sporbert, Anje; Steinmetz, Lars M.; Pospisilik, J. Andrew; Jung, Steffen; Priller, Josef; Gruen, Dominic; Ronneberger, Olaf; Prinz, Marco			A new fate mapping system reveals context-dependent random or clonal expansion of microglia	NATURE NEUROSCIENCE			English	Article							RESIDENT MICROGLIA; ADULT MICROGLIA; YOLK-SAC; IN-VIVO; MACROPHAGES; PROLIFERATION; INFLAMMATION; RESOLUTION; MONOCYTES; CELLS	Microglia constitute a highly specialized network of tissue-resident immune cells that is important for the control of tissue homeostasis and the resolution of diseases of the CNS. Little is known about how their spatial distribution is established and maintained in vivo. Here we establish a new multicolor fluorescence fate mapping system to monitor microglial dynamics during steady state and disease. Our findings suggest that microglia establish a dense network with regional differences, and the high regional turnover rates found challenge the universal concept of microglial longevity. Microglial self-renewal under steady state conditions constitutes a stochastic process. During pathology this randomness shifts to selected clonal microglial expansion. In the resolution phase, excess disease-associated microglia are removed by a dual mechanism of cell egress and apoptosis to re-establish the stable microglial network. This study unravels the dynamic yet discrete self-organization of mature microglia in the healthy and diseased CNS.	[Tay, Tuan Leng; Dautzenberg, Jana; Datta, Moumita; Ardura-Fabregat, Alberto; Staszewski, Ori; Prinz, Marco] Univ Freiburg, Inst Neuropathol, Fac Med, Freiburg, Germany; [Mai, Dominic; Ronneberger, Olaf] Univ Freiburg, Inst Comp Sci, Freiburg, Germany; [Fernandez-Klett, Francisco; Priller, Josef] Charite, Dept Neuropsychiat, Berlin, Germany; [Fernandez-Klett, Francisco; Priller, Josef] Charite, Lab Mol Psychiat, Berlin, Germany; [Lin, Gen; Steinmetz, Lars M.] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany; [Sagar; Drougard, Anne; Gruen, Dominic] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Stempfl, Thomas] Univ Regensburg, Ctr Excellence Fluorescent Bioanalyt, Regensburg, Germany; [Margineanu, Anca; Sporbert, Anje] Max Delbruck Ctr Mol Med, Adv Light Microscopy Technol Platform, Berlin, Germany; [Steinmetz, Lars M.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Steinmetz, Lars M.] Stanford Genome Technol Ctr, Palo Alto, CA USA; [Jung, Steffen] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Priller, Josef] German Ctr Neurodegenerat Dis DZNE, Cluster Excellence NeuroCure, Berlin, Germany; [Priller, Josef] BIH, Berlin, Germany; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	University of Freiburg; University of Freiburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; European Molecular Biology Laboratory (EMBL); Max Planck Society; University of Regensburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Stanford University; Stanford University; Weizmann Institute of Science; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Berlin Institute of Health; University of Freiburg	Tay, TL; Prinz, M (corresponding author), Univ Freiburg, Inst Neuropathol, Fac Med, Freiburg, Germany.; Prinz, M (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany.	tuan.leng.tay@uniklinik-freiburg.de; marco.prinz@uniklinik-freiburg.de	Jung, Steffen/K-1409-2012; Datta, Moumita/AAU-8006-2021; Priller, Josef/ABW-3835-2022	Jung, Steffen/0000-0003-4290-5716; Steinmetz, Lars/0000-0002-3962-2865; Staszewski, Ori/0000-0002-0579-6701; Margineanu, Anca/0000-0002-6634-9729; Priller, Josef/0000-0001-7596-0979; lin, gen/0000-0001-9969-8418; Tay, Tuan Leng/0000-0002-3507-6502; , Dr. Sagar/0000-0002-8657-4704	German Research Foundation (DFG) [TA1029/1-1]; Ministry of Science, Research and the Arts, Baden-Wuerttemberg (Research Seed Capital); BMBF Competence Network of Multiple Sclerosis (KKNMS); Sobek-Stiftung; DFG [SFB992, SFB1140];  [SFB/TRR167]; MRC [MC_PC_16031] Funding Source: UKRI	German Research Foundation (DFG)(German Research Foundation (DFG)); Ministry of Science, Research and the Arts, Baden-Wuerttemberg (Research Seed Capital); BMBF Competence Network of Multiple Sclerosis (KKNMS); Sobek-Stiftung; DFG(German Research Foundation (DFG)); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank H. Snippert (University Medical Center Utrecht) and H. Clevers (Hubrecht Institute) for the R26R<SUP>Confetti</SUP> mouse line, M. Follo and team at Lighthouse Fluorescence Technologies Core Facility, T. Blank for critical feedback, J. Buhrer for technical support, and CEMT, University of Freiburg for excellent animal care. T.L.T. is supported by the German Research Foundation (DFG, TA1029/1-1) and Ministry of Science, Research and the Arts, Baden-Wuerttemberg (Research Seed Capital). M.P. is supported by the BMBF Competence Network of Multiple Sclerosis (KKNMS), the Sobek-Stiftung and the DFG (SFB992, SFB1140, Reinhart-Koselleck grant). F.F.-K., J.A.P., S.J., J.P. and M.P. are supported by the SFB/TRR167 "NeuroMac".	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Cen LP, 2015, NEUROSCIENCE, V311, P56, DOI 10.1016/j.neuroscience.2015.09.067; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Emmenlauer M, 2009, J MICROSC-OXFORD, V233, P42, DOI 10.1111/j.1365-2818.2008.03094.x; Gallego BI, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-92; Gautier EL, 2013, BLOOD, V122, P2714, DOI 10.1182/blood-2013-01-478206; Ghigo C, 2013, J EXP MED, V210, P1657, DOI 10.1084/jem.20130403; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Gomez-Nicola D, 2013, J NEUROSCI, V33, P2481, DOI 10.1523/JNEUROSCI.4440-12.2013; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Hagemeyer N, 2016, EMBO J, V35, P1730, DOI 10.15252/embj.201693801; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Olmos-Alonso A, 2016, BRAIN, V139, P891, DOI 10.1093/brain/awv379; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Rahnenfuhrer J, 2016, TOPGO ENRICHMENT ANA; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Shankaran M, 2007, J NEUROSCI RES, V85, P2374, DOI 10.1002/jnr.21389; Shemer A, 2015, TRENDS IMMUNOL, V36, P614, DOI 10.1016/j.it.2015.08.003; Sheng JP, 2015, IMMUNITY, V43, P382, DOI 10.1016/j.immuni.2015.07.016; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Wieghofer P, 2015, GLIA, V63, P1, DOI 10.1002/glia.22727; Wuidart A, 2016, GENE DEV, V30, P1261, DOI 10.1101/gad.280057.116; Xu J, 2015, DEV CELL, V34, P632, DOI 10.1016/j.devcel.2015.08.018; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	52	321	322	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2017	20	6					793	+		10.1038/nn.4547	http://dx.doi.org/10.1038/nn.4547			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EV8FU	28414331				2022-12-17	WOS:000402016900009
J	Im, HI; Hollander, JA; Bali, P; Kenny, PJ				Im, Heh-In; Hollander, Jonathan A.; Bali, Purva; Kenny, Paul J.			MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212	NATURE NEUROSCIENCE			English	Article							ELEMENT-BINDING PROTEIN; MESOLIMBIC DOPAMINE SYSTEM; NUCLEUS-ACCUMBENS; RETT-SYNDROME; NEUROTROPHIC FACTOR; BRAIN; INCREASES; NEURONS; SEEKING; REWARD	The X-linked transcriptional repressor methyl CpG binding protein 2 (MeCP2), known for its role in the neurodevelopmental disorder Rett syndrome, is emerging as an important regulator of neuroplasticity in postmitotic neurons. Cocaine addiction is commonly viewed as a disorder of neuroplasticity, but the potential involvement of MeCP2 has not been explored. Here we identify a key role for MeCP2 in the dorsal striatum in the escalating cocaine intake seen in rats with extended access to the drug, a process that mimics the increasingly uncontrolled cocaine use seen in addicted humans. MeCP2 regulates cocaine intake through homeostatic interactions with microRNA-212 (miR-212) to control the effects of cocaine on striatal brain-derived neurotrophic factor (BDNF) levels. These data suggest that homeostatic interactions between MeCP2 and miR-212 in dorsal striatum may be important in regulating vulnerability to cocaine addiction.	[Im, Heh-In; Hollander, Jonathan A.; Bali, Purva; Kenny, Paul J.] Scripps Res Inst Scripps Florida, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL USA	Scripps Research Institute; State University System of Florida; University of Florida	Kenny, PJ (corresponding author), Scripps Res Inst Scripps Florida, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL USA.	pjkenny@scripps.edu			US National Institute on Drug Abuse [DA025983]; Ruth L. Kirschstein National Research Service; National Alliance for Research on Schizophrenia and Depression (NARSAD); NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025983, F32DA024932] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Xu from Georgetown University for the BDNF 3'-UTR reporter construct. This work was supported by a grant from the US National Institute on Drug Abuse to P.J.K. (DA025983); Ruth L. Kirschstein National Research Service Awards to H.-I. I. and J.A.H.; and a National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award to H.-I. I. This is manuscript number 20438 from The Scripps Research Institute.	Abuhatzira L, 2007, EPIGENETICS-US, V2, P214, DOI 10.4161/epi.2.4.5212; Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Berglind WJ, 2007, EUR J NEUROSCI, V26, P757, DOI 10.1111/j.1460-9568.2007.05692.x; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Cassel S, 2006, MOL PHARMACOL, V70, P487, DOI 10.1124/mol.106.022301; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; CHAO HT, 2008, SOC NEUR M WASH DC, P310; Choi KH, 2006, NEUROSCIENCE, V137, P373, DOI 10.1016/j.neuroscience.2005.10.049; DiNieri JA, 2009, J NEUROSCI, V29, P1855, DOI 10.1523/JNEUROSCI.5104-08.2009; Dong Y, 2006, NAT NEUROSCI, V9, P475, DOI 10.1038/nn1661; Dunn HG, 2001, BRAIN DEV-JPN, V23, pS99, DOI 10.1016/S0387-7604(01)00354-0; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fasano S, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.029.2009; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Graham DL, 2009, BIOL PSYCHIAT, V65, P696, DOI 10.1016/j.biopsych.2008.09.032; Grimm JW, 2003, J NEUROSCI, V23, P742; Hall FS, 2003, NEUROPSYCHOPHARMACOL, V28, P1485, DOI 10.1038/sj.npp.1300192; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Horger BA, 1999, J NEUROSCI, V19, P4110; Huang YH, 2008, J BIOL CHEM, V283, P2751, DOI 10.1074/jbc.M706578200; Jeanblanc J, 2009, J NEUROSCI, V29, P13494, DOI 10.1523/JNEUROSCI.2243-09.2009; Jin J, 2008, INT J DEV NEUROSCI, V26, P457, DOI 10.1016/j.ijdevneu.2008.02.009; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Kondo M, 2008, EUR J NEUROSCI, V27, P3342, DOI 10.1111/j.1460-9568.2008.06305.x; Larimore JL, 2009, NEUROBIOL DIS, V34, P199, DOI 10.1016/j.nbd.2008.12.011; Logrip ML, 2008, FASEB J, V22, P2393, DOI 10.1096/fj.07-099135; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Lu L, 2005, NAT NEUROSCI, V8, P212, DOI 10.1038/nn1383; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nelson ED, 2006, CURR BIOL, V16, P710, DOI 10.1016/j.cub.2006.02.062; Oo TF, 2009, MOL CELL NEUROSCI, V41, P440, DOI 10.1016/j.mcn.2009.04.009; Pelka GJ, 2005, GENOMICS, V85, P441, DOI 10.1016/j.ygeno.2004.12.002; Piazza PV, 2000, J NEUROSCI, V20, P4226; Russo SJ, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.059; Schoenbaum G, 2007, NAT NEUROSCI, V10, P935, DOI 10.1038/nn0807-935; Temudo T, 2008, MOVEMENT DISORD, V23, P1384, DOI 10.1002/mds.22115; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wada R, 2010, INT J CANCER, V127, P1106, DOI 10.1002/ijc.25126; Wallace DL, 2009, NAT NEUROSCI, V12, P200, DOI 10.1038/nn.2257; Walters CL, 2001, J NEUROSCI, V21, P9438, DOI 10.1523/JNEUROSCI.21-23-09438.2001; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104	50	321	345	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1120	U121		10.1038/nn.2615	http://dx.doi.org/10.1038/nn.2615			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20711185	Green Accepted			2022-12-17	WOS:000281332600018
J	Herzig, MC; Winkler, DT; Burgermeister, P; Pfeifer, M; Kohler, E; Schmidt, SD; Danner, S; Abramowski, D; Sturchler-Pierrat, C; Burki, K; van Duinen, SG; Maat-Schieman, MLC; Staufenbiel, M; Mathews, PM; Jucker, M				Herzig, MC; Winkler, DT; Burgermeister, P; Pfeifer, M; Kohler, E; Schmidt, SD; Danner, S; Abramowski, D; Sturchler-Pierrat, C; Burki, K; van Duinen, SG; Maat-Schieman, MLC; Staufenbiel, M; Mathews, PM; Jucker, M			A beta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis	NATURE NEUROSCIENCE			English	Article							DUTCH-TYPE; PRECURSOR-PROTEIN; TRANSGENIC MICE; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; MUTANT PRESENILINS; HCHWA-D; ANGIOPATHY; IMMUNIZATION; PEPTIDE	The E693Q mutation in the amyloid beta precursor protein (APP) leads to cerebral amyloid angiopathy (CAA), with recurrent cerebral hemorrhagic strokes and dementia. In contrast to Alzheimer disease ( AD), the brains of those affected by hereditary cerebral hemorrhage with amyloidosis - Dutch type (HCHWA-D) show few parenchymal amyloid plaques. We found that neuronal overexpression of human E693Q APP in mice (APPDutch mice) caused extensive CAA, smooth muscle cell degeneration, hemorrhages and neuroinflammation. In contrast, overexpression of human wild-type APP (APPwt mice) resulted in predominantly parenchymal amyloidosis, similar to that seen in AD. In APPDutch mice and HCHWA-D human brain, the ratio of the amyloid-beta40 peptide (Abeta40) to Abeta42 was significantly higher than that seen in APPwt mice or AD human brain. Genetically shifting the AbetaDutch40/AbetaDutch42 ratio toward AbetaDutch42 by crossing APPDutch mice with transgenic mice producing mutated presenilin-1 redistributed the amyloid pathology from the vasculature to the parenchyma. The understanding that different Abeta species can drive amyloid pathology in different cerebral compartments has implications for current anti-amyloid therapeutic strategies. This HCHWA-D mouse model is the first to develop robust CAA in the absence of parenchymal amyloid, highlighting the key role of neuronally produced Abeta to vascular amyloid pathology and emphasizing the differing roles of Abeta40 and Abeta42 in vascular and parenchymal amyloid pathology.	Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, D-72076 Tubingen, Germany; Univ Basel, Inst Pathol, Dept Neuropathol, CH-4003 Basel, Switzerland; NYU, Sch Med, Nathan Kline Inst, Orangeburg, NY 10962 USA; Novartis Inst Biomed Res, Nervous Syst Res, CH-4002 Basel, Switzerland; Univ Zurich, Inst Lab Anim Sci, CH-8057 Zurich, Switzerland; Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RC Leiden, Netherlands	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Basel; Nathan Kline Institute for Psychiatric Research; New York University; Novartis; University of Zurich; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Jucker, M (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, D-72076 Tubingen, Germany.	mathias.jucker@uni-tuebingen.de	Herzig, Martin/R-4601-2016; Schmidt, Stephen/AAC-6967-2019; Schmidt, Stephen/B-5398-2012	Herzig, Martin/0000-0002-0500-353X; Mathews, Paul/0000-0003-1742-7687				Bodendorf U, 2002, J NEUROCHEM, V80, P799, DOI 10.1046/j.0022-3042.2002.00770.x; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Bornebroek M, 1996, BRAIN PATHOL, V6, P111, DOI 10.1111/j.1750-3639.1996.tb00793.x; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Castano EM, 1996, J BIOL CHEM, V271, P32185, DOI 10.1074/jbc.271.50.32185; Christie R, 2001, AM J PATHOL, V158, P1065, DOI 10.1016/S0002-9440(10)64053-9; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Das P, 2001, NEUROBIOL AGING, V22, P721, DOI 10.1016/S0197-4580(01)00245-7; De Jonghe C, 1999, NEUROBIOL DIS, V6, P280, DOI 10.1006/nbdi.1999.0247; De Jonghe C, 1998, NEUROBIOL DIS, V5, P281, DOI 10.1006/nbdi.1998.0202; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; FRASER PE, 1992, BIOCHEMISTRY-US, V31, P10716, DOI 10.1021/bi00159a011; Greenberg SM, 1998, NEUROLOGY, V51, P690, DOI 10.1212/WNL.51.3.690; Greenberg SM, 2002, NEUROLOGY, V58, P1587, DOI 10.1212/WNL.58.11.1587; Haass C, 2001, NAT NEUROSCI, V4, P859, DOI 10.1038/nn0901-859; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Johnson D, 1997, EDN, V42, P94; Klafki HW, 1996, ANAL BIOCHEM, V237, P24, DOI 10.1006/abio.1996.0195; Koller MF, 2004, NEURODEGENER DIS, V1, P20, DOI 10.1159/000076666; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Maat-Schieman MLC, 2000, ACTA NEUROPATHOL, V99, P409, DOI 10.1007/s004010051143; MaatSchieman MLC, 1996, BRAIN PATHOL, V6, P115, DOI 10.1111/j.1750-3639.1996.tb00794.x; Mehta PD, 2000, ARCH NEUROL-CHICAGO, V57, P100, DOI 10.1001/archneur.57.1.100; Meyer-Luehmann M, 2003, NAT NEUROSCI, V6, P370, DOI 10.1038/nn1022; Monro OR, 2002, NEUROBIOL AGING, V23, P405, DOI 10.1016/S0197-4580(01)00317-7; Morelli L, 2003, J BIOL CHEM, V278, P23221, DOI 10.1074/jbc.M300276200; Natte R, 1999, ACTA NEUROPATHOL, V98, P577, DOI 10.1007/s004010051121; Natte R, 2001, ANN NEUROL, V50, P765, DOI 10.1002/ana.10040; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Ohsawa K, 2000, J CELL SCI, V113, P3073; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; PRELLI F, 1990, BIOCHEM BIOPH RES CO, V170, P301, DOI 10.1016/0006-291X(90)91274-V; Richards JG, 2003, J NEUROSCI, V23, P8989; Rozmahel R, 2002, NEUROBIOL AGING, V23, P187, DOI 10.1016/S0197-4580(01)00267-6; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Tsubuki S, 2003, LANCET, V361, P1957, DOI 10.1016/S0140-6736(03)13555-6; Van Dorpe J, 2000, AM J PATHOL, V157, P1283, DOI 10.1016/S0002-9440(10)64644-5; Van Nostrand WE, 1998, J NEUROCHEM, V70, P216; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; Watson DJ, 1999, BIOCHEM J, V340, P703, DOI 10.1042/0264-6021:3400703; WATTENDORFF AR, 1982, J NEUROL SCI, V55, P121, DOI 10.1016/0022-510X(82)90094-6; Weller RO, 1998, AM J PATHOL, V153, P725, DOI 10.1016/S0002-9440(10)65616-7; Winkler DT, 2001, J NEUROSCI, V21, P1619, DOI 10.1523/JNEUROSCI.21-05-01619.2001	50	321	338	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					954	960		10.1038/nn1302	http://dx.doi.org/10.1038/nn1302			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15311281	Green Accepted			2022-12-17	WOS:000223546700014
J	Jin, RS; Banke, TG; Mayer, ML; Traynelis, SF; Gouaux, E				Jin, RS; Banke, TG; Mayer, ML; Traynelis, SF; Gouaux, E			Structural basis for partial agonist action at ionotropic glutamate receptors	NATURE NEUROSCIENCE			English	Article							POTASSIUM CHANNELS I; LIGAND-BINDING CORE; AMPA RECEPTORS; HIPPOCAMPAL-NEURONS; CRYSTAL-STRUCTURES; ION-CHANNEL; ACTIVATION; GLUR2; DESENSITIZATION; KAINATE	An unresolved problem in understanding neurotransmitter receptor function concerns the mechanism(s) by which full and partial agonists elicit different amplitude responses at equal receptor occupancy. The widely held view of 'partial agonism' posits that resting and active states of the receptor are in equilibrium, and partial agonists simply do not shift the equilibrium toward the active state as efficaciously as full agonists. Here we report findings from crystallographic and electrophysiological studies of the mechanism of activation of an AMPA-subtype glutamate receptor ion channel. In these experiments, we used 5-substituted willardiines, a series of partial agonists that differ by only a single atom. Our results show that the GluR2 ligand-binding core can adopt a range of ligand-dependent conformational states, which in turn control the open probability of discrete subconductance states of the intact ion channel. Our findings thus provide a structure-based model of partial agonism.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Emory Univ, Sch Med, Dept Pharmacol, Rollins Res Ctr, Atlanta, GA 30322 USA; Natl Inst Child Hlth & Dev, Lab Cellular & Mol Neurophysiol, NIH, Bethesda, MD 20892 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; Emory University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Gouaux, E (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 650 W 168 St, New York, NY 10032 USA.		Mayer, Mark/AAE-7356-2019; Gouaux, Eric/Y-4370-2019; Jin, Rongsheng/M-7797-2013; Mayer, Mark L/H-5500-2013	Mayer, Mark/0000-0003-4378-8451; Gouaux, Eric/0000-0002-8549-2360; Jin, Rongsheng/0000-0003-0348-7363; Banke, Tue/0000-0001-8417-4400	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000707] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000707] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Brauner-Osborne H, 2000, J MED CHEM, V43, P2609, DOI 10.1021/jm000007r; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; Colquhoun David, 1995, P483; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; CULLCANDY SG, 1988, J PHYSIOL-LONDON, V400, P189, DOI 10.1113/jphysiol.1988.sp017117; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; Dingledine R, 1999, PHARMACOL REV, V51, P7; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; EVANS RH, 1980, J PHYSIOL-LONDON, V308, pP71; GMELIN R, 1961, ACTA CHEM SCAND, V15, P1188, DOI 10.3891/acta.chem.scand.15-1188; Hille B., 2001, ION CHANNELS EXCITAB; Hogner A, 2002, J MOL BIOL, V322, P93, DOI 10.1016/S0022-2836(02)00650-2; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kizelsztein P, 2000, BIOCHEMISTRY-US, V39, P12819, DOI 10.1021/bi000962i; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATNEAU DK, 1992, J NEUROSCI, V12, P595; PATNEAU DK, 1991, NEURON, V6, P785, DOI 10.1016/0896-6273(91)90175-Y; Robert A, 2001, J NEUROSCI, V21, P5574, DOI 10.1523/JNEUROSCI.21-15-05574.2001; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Schoppa NE, 1998, J GEN PHYSIOL, V111, P271, DOI 10.1085/jgp.111.2.271; Smith TC, 2000, J NEUROSCI, V20, P2073; STEPHENSON RP, 1956, BRIT J PHARM CHEMOTH, V11, P379, DOI 10.1111/j.1476-5381.1956.tb00006.x; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Traynelis SF, 1998, TRENDS NEUROSCI, V21, P137, DOI 10.1016/S0166-2236(98)01238-7; WONG LA, 1994, J NEUROSCI, V14, P3881; WYMAN J, 1951, J POLYM SCI, V7, P499, DOI 10.1002/pol.1951.120070506; ZORUMSKI CF, 1988, J NEUROSCI, V8, P4277	43	321	329	0	13	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					803	810		10.1038/nn1091	http://dx.doi.org/10.1038/nn1091			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12872125				2022-12-17	WOS:000184413700008
J	Henze, DA; Wittner, L; Buzsaki, G				Henze, DA; Wittner, L; Buzsaki, G			Single granule cells reliably discharge targets in the hippocampal CA3 network in vivo	NATURE NEUROSCIENCE			English	Article							MOSSY FIBER SYNAPSE; DENTATE GYRUS; SPIKE TRANSMISSION; UNIT-ACTIVITY; RAT; PLASTICITY; NEURONS; MEMORY; INTERNEURONS; INFORMATION	Processing of neuronal information depends on interactions between the anatomical connectivity and cellular properties of single cells. We examined how these computational building blocks work together in the intact rat hippocampus. Single spikes in dentate granule cells, controlled intracellularly, generally failed to discharge either interneurons or CA3 pyramidal cells. In contrast, trains of spikes effectively discharged both CA3 cell types. Increasing the discharge rate of the granule cell increased the discharge probability of its target neuron and decreased the delay between the onset of a granule cell train and evoked firing in postsynaptic targets. Thus, we conclude that the granule cell to CA3 synapses are 'conditional detonators,' dependent on granule cell firing pattern. In addition, we suggest that information in single granule cells is converted into a temporal delay code in target CA3 pyramidal cells and interneurons. These data demonstrate how a neural circuit of the CNS may process information.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	Wittner, Lucia/C-9386-2013	Wittner, Lucia/0000-0001-6800-0953; Buzsaki, Gyorgy/0000-0002-3100-4800	NCRR NIH HHS [5P41RR009754] Funding Source: Medline; NIMH NIH HHS [MH12403, MH54671] Funding Source: Medline; NINDS NIH HHS [NS43157, NS34994] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043157, R01NS034994] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acsady L, 1998, J NEUROSCI, V18, P3386; Alle H, 2001, P NATL ACAD SCI USA, V98, P14708, DOI 10.1073/pnas.251610898; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BOSS BD, 1985, BRAIN RES, V338, P144, DOI 10.1016/0006-8993(85)90257-4; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; CHATTARJI S, 1989, BRAIN RES, V495, P145, DOI 10.1016/0006-8993(89)91228-6; COLLIER TJ, 1982, BEHAV NEURAL BIOL, V34, P227, DOI 10.1016/S0163-1047(82)91623-5; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Doherty J, 2001, J NEUROSCI, V21, P2048, DOI 10.1523/JNEUROSCI.21-06-02048.2001; FROTSCHER M, 1994, SYNAPSE, V16, P148, DOI 10.1002/syn.890160208; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; HARRIS KD, IN PRESS NATURE; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Lorincz A, 2000, ANN NY ACAD SCI, V911, P83; LOTHMAN EW, 1992, DENTATE GYRUS ITS RO, P301; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Marshall L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0001.2002; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MODY I, 1987, J NEUROPHYSIOL, V57, P869, DOI 10.1152/jn.1987.57.3.869; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; ROLLS E, 1989, COMP NEUR S, P125; Rolls E.T., 1989, NEURAL MODELS PLASTI, P240; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; SCHARFMAN HE, 1990, NEUROSCIENCE, V37, P693, DOI 10.1016/0306-4522(90)90100-I; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SLOVITER RS, 1994, ANN NEUROL, V35, P640, DOI 10.1002/ana.410350604; TANK DW, 1987, P NATL ACAD SCI USA, V84, P1896, DOI 10.1073/pnas.84.7.1896; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Urban NN, 2001, HIPPOCAMPUS, V11, P408, DOI 10.1002/hipo.1055.abs; VANDERWOLF CH, 1988, INT REV NEUROBIOL, V30, P225; YLINEN A, 1995, J NEUROSCI, V15, P30	43	321	326	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					790	795		10.1038/nn887	http://dx.doi.org/10.1038/nn887			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12118256				2022-12-17	WOS:000177088900023
J	Thallmair, M; Metz, GAS; Z'Graggen, WJ; Raineteau, O; Kartje, GL; Schwab, ME				Thallmair, M; Metz, GAS; Z'Graggen, WJ; Raineteau, O; Kartje, GL; Schwab, ME			Neurite growth inhibitors restrict plasticity and functional recovery following corticospinal tract lesions	NATURE NEUROSCIENCE			English	Article							HEMIPLEGIC CEREBRAL-PALSY; MONOCLONAL-ANTIBODY IN-1; RAT SENSORIMOTOR CORTEX; BASILAR PONTINE NUCLEI; SPINAL-CORD; NEURONAL PLASTICITY; MOTOR PERFORMANCE; NEONATAL LESIONS; NERVOUS-SYSTEM; AXON ARBORS	Anatomical plasticity and functional recovery after lesions of the rodent corticospinal tract (CST) decrease postnatally in parallel with myelin formation. Myelin-associated neurite growth inhibitory proteins prevent regenerative fiber growth, but whether they also prevent reactive sprouting of unlesioned fibers is less clear. Here we show that after unilateral CST lesion in the adult rat brainstem, both intact and lesioned tracts show topographically appropriate sprouting after treatment with a monoclonal antibody that neutralizes these inhibitory proteins. Antibody-treated animals showed full recovery in motor and sensory tests, whereas untreated lesioned rats exhibited persistent severe deficits. Neutralization of myelin-associated neurite growth inhibitors thus restores in adults the structural plasticity and functional recovery normally found only at perinatal ages.	Univ Zurich, Brain Res Inst, CH-8029 Zurich, Switzerland; Swiss Fed Inst Technol, CH-8029 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Thallmair, M (corresponding author), Univ Zurich, Brain Res Inst, August Forel Str 1, CH-8029 Zurich, Switzerland.		Raineteau, Olivier/I-1190-2014; Schwab, Martin E/B-6818-2016	Raineteau, Olivier/0000-0003-4294-2496; Metz, Gerlinde/0000-0002-5801-7716; Z'Graggen, Werner/0000-0002-5684-4419				AKINTUNDE A, 1992, BRAIN RES, V586, P208, DOI 10.1016/0006-8993(92)91629-S; ANTAL M, 1984, J HIRNFORSCH, V25, P647; Bandtlow C, 1996, EUR J BIOCHEM, V241, P468, DOI 10.1111/j.1432-1033.1996.00468.x; BARTH TM, 1990, J NEUROSCI, V10, P3449; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Brosamle C, 1997, J COMP NEUROL, V386, P293, DOI 10.1002/(SICI)1096-9861(19970922)386:2<293::AID-CNE9>3.0.CO;2-X; CAO Y, 1994, P NATL ACAD SCI USA, V91, P9612, DOI 10.1073/pnas.91.20.9612; CARLINI EA, 1967, MED PHARMACOL EXP, V17, P534; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; CARR LJ, 1993, BRAIN, V116, P1223, DOI 10.1093/brain/116.5.1223; CASALE EJ, 1988, J COMP NEUROL, V278, P275, DOI 10.1002/cne.902780210; CASTRO AJ, 1972, BRAIN RES, V44, P313, DOI 10.1016/0006-8993(72)90305-8; CASTRO AJ, 1972, BRAIN RES, V37, P173, DOI 10.1016/0006-8993(72)90665-8; CASTRO AJ, 1983, J COMP NEUROL, V219, P112, DOI 10.1002/cne.902190111; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; ENDO K, 1973, BRAIN RES, V57, P484, DOI 10.1016/0006-8993(73)90154-6; Fagan AM, 1997, J NEUROSCI, V17, P2499; FARMER SF, 1991, NEUROLOGY, V41, P1505, DOI 10.1212/WNL.41.9.1505; FLUMERFELT BA, 1980, J ANAT, V131, P621; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Herzog A, 1997, J NEUROSCI METH, V72, P57, DOI 10.1016/S0165-0270(96)00156-2; HICKS S P, 1970, Experimental Neurology, V29, P416, DOI 10.1016/0014-4886(70)90069-5; KALIL K, 1982, J COMP NEUROL, V211, P265, DOI 10.1002/cne.902110305; KALIL K, 1979, SCIENCE, V205, P1158, DOI 10.1126/science.472734; KALIL K, 1975, BRAIN RES, V100, P170, DOI 10.1016/0006-8993(75)90254-1; KAPFHAMMER JP, 1994, J COMP NEUROL, V340, P194, DOI 10.1002/cne.903400206; KARTJETILLOTSON G, 1980, PHYSIOL BEHAV, V24, P293, DOI 10.1016/0031-9384(80)90089-X; Kennard MA, 1936, AM J PHYSIOL, V115, P138, DOI 10.1152/ajplegacy.1936.115.1.138; KUANG RZ, 1990, J COMP NEUROL, V302, P461, DOI 10.1002/cne.903020304; KUANG RZ, 1990, J COMP NEUROL, V292, P585, DOI 10.1002/cne.902920408; LEONG SK, 1973, BRAIN RES, V62, P218, DOI 10.1016/0006-8993(73)90630-6; LIANG F, 1991, J COMP NEUROL, V311, P356, DOI 10.1002/cne.903110306; MIHAILOFF GA, 1978, BRAIN RES, V145, P347, DOI 10.1016/0006-8993(78)90867-3; NAUS C, 1985, EXP BRAIN RES, V59, P365; NAUS CG, 1985, J COMP NEUROL, V239, P453, DOI 10.1002/cne.902390411; PANTO MR, 1995, J BRAIN RES, V36, P7; REH T, 1982, J COMP NEUROL, V211, P276, DOI 10.1002/cne.902110306; ROUILLER EM, 1993, SOMATOSENS MOT RES, V10, P269, DOI 10.3109/08990229309028837; ROUILLER EM, 1991, EXP NEUROL, V114, P53, DOI 10.1016/0014-4886(91)90084-P; RUBIN BP, 1994, J NEUROCYTOL, V23, P209, DOI 10.1007/BF01275525; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHNELL L, 1993, EUR J NEUROSCI, V5, P1156, DOI 10.1111/j.1460-9568.1993.tb00970.x; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Spillmann AA, 1997, EUR J NEUROSCI, V9, P549, DOI 10.1111/j.1460-9568.1997.tb01631.x; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; VALVERDE F, 1966, Z ZELLFORSCH MIK ANA, V71, P297, DOI 10.1007/BF00332585; Vanek P, 1998, EUR J NEUROSCI, V10, P45, DOI 10.1046/j.1460-9568.1998.00018.x; WHISHAW IQ, 1988, BRAIN RES, V451, P97, DOI 10.1016/0006-8993(88)90753-6; WHISHAW IQ, 1993, BEHAV BRAIN RES, V56, P59, DOI 10.1016/0166-4328(93)90022-I; WIESENDANGER R, 1982, J COMP NEUROL, V208, P227, DOI 10.1002/cne.902080303	50	321	329	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1998	1	2					124	131		10.1038/373	http://dx.doi.org/10.1038/373			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QB	10195127				2022-12-17	WOS:000076361100013
J	Louveau, A; Herz, J; Alme, MN; Salvador, AF; Dong, MQ; Viar, KE; Herod, SG; Knopp, J; Setliff', JC; Lupi, AL; Da Mesquita, S; Frost, EL; Gaultier, A; Harris, TH; Cao, R; Hu, S; Lukens, JR; Smirnov, I; Overall, CC; Oliver, G; Kipnis, J				Louveau, Antoine; Herz, Jasmin; Alme, Maria Nordheim; Salvador, Andrea Francesca; Dong, Michael Q.; Viar, Kenneth E.; Herod, S. Grace; Knopp, James; Setliff', Joshua C.; Lupi, Alexander L.; Da Mesquita, Sandro; Frost, Elizabeth L.; Gaultier, Alban; Harris, Tajie H.; Cao, Rui; Hu, Song; Lukens, John R.; Smirnov, Igor; Overall, Christopher C.; Oliver, Guillermo; Kipnis, Jonathan			CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CEREBROSPINAL-FLUID ABSORPTION; DENDRITIC CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOLOGICAL SIGNIFICANCE; INTRACRANIAL-PRESSURE; PHOTODYNAMIC THERAPY; MULTIPLE-SCLEROSIS; ENDOTHELIAL-CELLS	Neuroinflammatory diseases, such as multiple sclerosis, are characterized by invasion of the brain by autoreactive T cells. The mechanism for how T cells acquire their encephalitogenic phenotype and trigger disease remains, however, unclear. The existence of lymphatic vessels in the meninges indicates a relevant link between the CNS and peripheral immune system, perhaps affecting autoimmunity. Here we demonstrate that meningeal lymphatics fulfill two critical criteria: they assist in the drainage of cerebrospinal fluid components and enable immune cells to enter draining lymph nodes in a CCR7-dependent manner. Unlike other tissues, meningeal lymphatic endothelial cells do not undergo expansion during inflammation, and they express a unique transcriptional signature. Notably, the ablation of meningeal lymphatics diminishes pathology and reduces the inflammatory response of brain-reactive T cells during an animal model of multiple sclerosis. Our findings demonstrate that meningeal lymphatics govern inflammatory processes and immune surveillance of the CNS and pose a valuable target for therapeutic intervention.	[Louveau, Antoine; Herz, Jasmin; Alme, Maria Nordheim; Salvador, Andrea Francesca; Dong, Michael Q.; Viar, Kenneth E.; Herod, S. Grace; Knopp, James; Setliff', Joshua C.; Lupi, Alexander L.; Da Mesquita, Sandro; Frost, Elizabeth L.; Gaultier, Alban; Harris, Tajie H.; Lukens, John R.; Smirnov, Igor; Overall, Christopher C.; Kipnis, Jonathan] Univ Virginia, Ctr Brain Immunol & Glia BIG, Charlottesville, VA 22904 USA; [Louveau, Antoine; Herz, Jasmin; Alme, Maria Nordheim; Salvador, Andrea Francesca; Dong, Michael Q.; Viar, Kenneth E.; Herod, S. Grace; Knopp, James; Setliff', Joshua C.; Lupi, Alexander L.; Da Mesquita, Sandro; Frost, Elizabeth L.; Gaultier, Alban; Harris, Tajie H.; Lukens, John R.; Smirnov, Igor; Overall, Christopher C.; Kipnis, Jonathan] Univ Virginia, Dept Neurosci, Charlottesville, VA 22904 USA; [Alme, Maria Nordheim] Univ Bergen, Dept Clin Med, Bergen, Norway; [Alme, Maria Nordheim] Haukeland Hosp, Dept Neurol, Bergen, Norway; [Salvador, Andrea Francesca; Kipnis, Jonathan] Univ Virginia, Neurosci Grad Program, Charlottesville, VA 22904 USA; [Cao, Rui; Hu, Song] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22904 USA; [Oliver, Guillermo] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Kipnis, Jonathan] Johannes Gutenberg Univ Mainz, Gutenberg Res Fellowship Grp Neuroimmunol, Focus Program Translat Neurosci FTN & Immunothera, Rhine Main Neurosci Network Rmn2,Univ Med Ctr, Mainz, Germany	University of Virginia; University of Virginia; University of Bergen; University of Bergen; Haukeland University Hospital; University of Virginia; University of Virginia; Northwestern University; Feinberg School of Medicine; Johannes Gutenberg University of Mainz	Louveau, A (corresponding author), Univ Virginia, Ctr Brain Immunol & Glia BIG, Charlottesville, VA 22904 USA.; Louveau, A; Kipnis, J (corresponding author), Univ Virginia, Dept Neurosci, Charlottesville, VA 22904 USA.; Kipnis, J (corresponding author), Univ Virginia, Neurosci Grad Program, Charlottesville, VA 22904 USA.; Kipnis, J (corresponding author), Johannes Gutenberg Univ Mainz, Gutenberg Res Fellowship Grp Neuroimmunol, Focus Program Translat Neurosci FTN & Immunothera, Rhine Main Neurosci Network Rmn2,Univ Med Ctr, Mainz, Germany.	al2hk@virginia.edu; kipnis@virginia.edu	Louveau, Antoine/AAW-2944-2020; Kipnis, Jonathan/AGG-9735-2022; Cao, Rui/B-1434-2016; Hu, Song/ABD-6256-2021; Da Mesquita, Sandro/A-7365-2010	Kipnis, Jonathan/0000-0002-3714-517X; Cao, Rui/0000-0003-4444-7528; Hu, Song/0000-0002-5760-8012; Da Mesquita, Sandro/0000-0002-0786-5010; Lupi, Alexander/0000-0002-8438-5758; Knopp, James/0000-0001-7949-9374; Lukens, John/0000-0002-6795-0866	National Institutes of Health [AG034113, NS096967, HL073402]; National Multiple Sclerosis Society (NMSS); German Research Council (DFG) [CRC-TR-128, B11]; Howard Hughes Medical Institute Medical Research Fellow Program; Lymphatic Education & Research Network postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS096967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); German Research Council (DFG)(German Research Foundation (DFG)); Howard Hughes Medical Institute Medical Research Fellow Program; Lymphatic Education & Research Network postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Smith for editing the manuscript. We also thank all the members of the Kipnis lab and the members of the Center for Brain Immunology and Glia (BIG) for their valuable comments during multiple discussions of this work. This work was supported by grants from the National Institutes of Health (AG034113 and NS096967), National Multiple Sclerosis Society (NMSS), and the German Research Council (DFG; CRC-TR-128, B11) to J.K.; National Institutes of Health HL073402 to G.O.; Howard Hughes Medical Institute Medical Research Fellow Program to M.Q.D. and by Henry M. Weitzner, Edna K. Weitzner, Dorothea M. Weitzner, Morton L. Weitzner and Lymphatic Education & Research Network postdoctoral fellowship to A.L.	Absinta M, 2017, ELIFE, V6, DOI 10.7554/eLife.29738; Ajami B, 2018, NAT NEUROSCI, V21, P541, DOI 10.1038/s41593-018-0100-x; ANDRES KH, 1987, ANAT EMBRYOL, V175, P289, DOI 10.1007/BF00309843; Antila S, 2017, J EXP MED, V214, P3645, DOI 10.1084/jem.20170391; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Brinker T, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-10; Cai R, 2018, PANOPTIC VDISCO IMAG, DOI [10.1101/374785, DOI 10.1101/374785]; Castren E, 2017, MOL PSYCHIATR, V22, P1085, DOI 10.1038/mp.2017.61; Clarkson BD, 2017, SCI REP-UK, V7, DOI 10.1038/srep42856; Coles JA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003714; CSERR HF, 1992, BRAIN PATHOL, V2, P269, DOI 10.1111/j.1750-3639.1992.tb00703.x; Cursiefen C, 2011, J EXP MED, V208, P1083, DOI 10.1084/jem.20092277; CYSTER JG, 1995, J EXP MED, V182, P581, DOI 10.1084/jem.182.2.581; Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Ensari S, 2008, TURK NEUROSURG, V18, P56; FOLDI M, 1966, ACTA ANAT, V64, P498; Frye M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03959-6; Furtado GC, 2008, J IMMUNOL, V181, P4648, DOI 10.4049/jimmunol.181.7.4648; GO KG, 1986, J NEUROSURG, V65, P642, DOI 10.3171/jns.1986.65.5.0642; Guan YJ, 2011, J IMMUNOL, V187, P1289, DOI 10.4049/jimmunol.1003399; Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jeker LT, 2013, IMMUNOL REV, V253, P65, DOI 10.1111/imr.12061; Jurisic G, 2012, CIRC RES, V111, P426, DOI 10.1161/CIRCRESAHA.112.269399; Kamphorst AO, 2010, J IMMUNOL, V185, P3426, DOI 10.4049/jimmunol.1001205; KAWAJIRI H, 1983, J MAXILLOFAC SURG, V11, P42, DOI 10.1016/S0301-0503(83)80010-1; KIDA S, 1993, NEUROPATH APPL NEURO, V19, P480, DOI 10.1111/j.1365-2990.1993.tb00476.x; Kilarski WW, 2014, ANGIOGENESIS, V17, P347, DOI 10.1007/s10456-013-9365-6; Kim H, 2014, J CLIN INVEST, V124, P936, DOI 10.1172/JCI71607; Kipnis J, 2016, SCIENCE, V353, P766, DOI 10.1126/science.aag2638; Lavado A, 2007, DEV DYNAM, V236, P518, DOI 10.1002/dvdy.21024; Louveau A, 2017, J CLIN INVEST, V127, P3210, DOI 10.1172/JCI90603; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Ma QL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01484-6; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Mollanji R, 2002, AM J PHYSIOL-REG I, V282, pR1593, DOI 10.1152/ajpregu.00695.2001; Mora JR, 2005, J EXP MED, V201, P303, DOI 10.1084/jem.20041645; Ning B, 2015, SCI REP-UK, V5, DOI 10.1038/srep18775; Nowotschin S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-49; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Oshio K, 2004, FASEB J, V18, P76, DOI 10.1096/fj.04-1711fje; Phillips MJ, 1997, J PATHOL, V182, P457; Proescholdt MA, 2002, J NEUROPATH EXP NEUR, V61, P914, DOI 10.1093/jnen/61.10.914; Randolph GJ, 2017, ANNU REV IMMUNOL, V35, P31, DOI 10.1146/annurev-immunol-041015-055354; Rottman JB, 2000, EUR J IMMUNOL, V30, P2372, DOI 10.1002/1521-4141(2000)30:8<2372::AID-IMMU2372>3.0.CO;2-D; Tammela T, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001699; van Zwam M, 2009, J PATHOL, V217, P543, DOI 10.1002/path.2476; VOGH BP, 1987, J PHARMACOL EXP THER, V243, P35; Wachowska M, 2016, PHOTODIAGN PHOTODYN, V14, P57, DOI 10.1016/j.pdpdt.2016.02.004; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wu XX, 2014, J IMMUNOL, V192, P3409, DOI 10.4049/jimmunol.1302436; Yeh YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046889; Ziarek JJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah5756; Zozulya AL, 2009, J NEUROSCI, V29, P140, DOI 10.1523/JNEUROSCI.2199-08.2009	61	320	334	18	126	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2018	21	10					1380	+		10.1038/s41593-018-0227-9	http://dx.doi.org/10.1038/s41593-018-0227-9			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU9FY	30224810	Green Accepted			2022-12-17	WOS:000445651600013
J	Bassett, DS; Yang, MZ; Wymbs, NF; Grafton, ST				Bassett, Danielle S.; Yang, Muzhi; Wymbs, Nicholas F.; Grafton, Scott T.			Learning-induced autonomy of sensorimotor systems	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN NETWORKS; FUNCTIONAL CONNECTIVITY; RESTING-STATE; COGNITIVE CONTROL; TASK; RECONFIGURATION; MECHANISMS; PRINCIPLES; WAVELETS; ANATOMY	Distributed networks of brain areas interact with one another in a time-varying fashion to enable complex cognitive and sensorimotor functions. Here we used new network-analysis algorithms to test the recruitment and integration of large-scale functional neural circuitry during learning. Using functional magnetic resonance imaging data acquired from healthy human participants, we investigated changes in the architecture of functional connectivity patterns that promote learning from initial training through mastery of a simple motor skill. Our results show that learning induces an autonomy of sensorimotor systems and that the release of cognitive control hubs in frontal and cingulate cortices predicts individual differences in the rate of learning on other days of practice. Our general statistical approach is applicable across other cognitive domains and provides a key to understanding time-resolved interactions between distributed neural circuits that enable task performance.	[Bassett, Danielle S.; Yang, Muzhi] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Bassett, Danielle S.] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA; [Yang, Muzhi] Univ Penn, Appl Math & Computat Sci Grad Grp, Philadelphia, PA 19104 USA; [Wymbs, Nicholas F.; Grafton, Scott T.] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Wymbs, Nicholas F.; Grafton, Scott T.] Univ Calif Santa Barbara, Brain Imaging Ctr, Santa Barbara, CA 93106 USA; [Wymbs, Nicholas F.] Johns Hopkins Med Inst, Dept Phys Med & Rehabil, Human Brain Physiol & Stimulat Lab, Baltimore, MD 21205 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Johns Hopkins University; Johns Hopkins Medicine	Bassett, DS (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	dsb@seas.upenn.edu			John D. and Catherine T. MacArthur Foundation; Alfred P. Sloan Foundation; Army Research Laboratory [W911NF-10-2-0022]; Institute for Translational Medicine and Therapeutics; US Army Research Office [W911NF-14-1-0679]; National Institute of Mental Health [2-R01-DC-009209-11]; National Science Foundation [CRCNS BCS-1441502, BCS-1430087]; Applied Mathematics and Computational Science Graduate Program at the University of Pennsylvania; PHS [NS44393]; Institute for Collaborative Biotechnologies from the US Army Research Office [W911NF-09-0001]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009209] Funding Source: NIH RePORTER	John D. and Catherine T. MacArthur Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Institute for Translational Medicine and Therapeutics; US Army Research Office; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); Applied Mathematics and Computational Science Graduate Program at the University of Pennsylvania; PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Institute for Collaborative Biotechnologies from the US Army Research Office; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	D.S.B. acknowledges support from the John D. and Catherine T. MacArthur Foundation; the Alfred P. Sloan Foundation; the Army Research Laboratory (contract W911NF-10-2-0022); the Institute for Translational Medicine and Therapeutics; the US Army Research Office (contract W911NF-14-1-0679); the National Institute of Mental Health through award 2-R01-DC-009209-11; and National Science Foundation awards CRCNS BCS-1441502 and BCS-1430087 through the ENG, CISE and SBE directorates. M.Y. acknowledges support from the Applied Mathematics and Computational Science Graduate Program at the University of Pennsylvania. N.F.W. and S.T.G. were supported by PHS grant NS44393 and the Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the US Army Research Office. The content is solely the responsibility of the authors and does not necessarily represent the official views of any of the funding agencies. We thank D. Baker, S. Feldt Muldoon and Q. Telesford for comments on an earlier version of the manuscript, and we thank M.A. Porter and P.J. Mucha for helpful discussions.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036104; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Ajemian R, 2013, P NATL ACAD SCI USA, V110, pE5078, DOI 10.1073/pnas.1320116110; Bassett D. S., 2013, COGNITIVE NEUROSCIEN; Bassett D. S., 2010, BRAIN ANATOMY SMALL; Bassett DS, 2014, CHAOS, V24, DOI 10.1063/1.4858457; Bassett DS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003171; Bassett DS, 2013, CHAOS, V23, DOI 10.1063/1.4790830; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Beeler JA, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00134; Brammer MJ, 1998, HUM BRAIN MAPP, V6, P378, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<378::AID-HBM9>3.3.CO;2-Z; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bullmore ET, 2004, NEUROIMAGE, V23, pS234, DOI 10.1016/j.neuroimage.2004.07.012; Bullmore ET, 2003, STAT METHODS MED RES, V12, P375, DOI 10.1191/0962280203sm339ra; Calhoun VD, 2004, NEUROIMAGE, V22, P252, DOI 10.1016/j.neuroimage.2003.12.029; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Cheeran B, 2009, NEUROREHAB NEURAL RE, V23, P97, DOI 10.1177/1545968308326636; Chrysikou EG, 2014, NEUROPSYCHOLOGIA, V62, P341, DOI 10.1016/j.neuropsychologia.2013.10.021; Collins AGE, 2013, PSYCHOL REV, V120, P190, DOI 10.1037/a0030852; CROSSMAN E. R. F. W., 1959, ERGONOMICS, V2, P153, DOI 10.1080/00140135908930419; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Desmond JE, 2002, J NEUROSCI METH, V118, P115, DOI 10.1016/S0165-0270(02)00121-8; Diedrichsen J, 2011, NEUROIMAGE, V54, P1786, DOI 10.1016/j.neuroimage.2010.10.035; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Doron KW, 2012, P NATL ACAD SCI USA, V109, P18661, DOI 10.1073/pnas.1216402109; Elton A, 2014, CORTEX, V51, P56, DOI 10.1016/j.cortex.2013.10.012; Esslinger C, 2009, SCIENCE, V324, P605, DOI 10.1126/science.1167768; Fedorenko E, 2014, TRENDS COGN SCI, V18, P120, DOI 10.1016/j.tics.2013.12.006; Floyer-Lea A, 2005, J NEUROPHYSIOL, V94, P512, DOI 10.1152/jn.00717.2004; Frey SH, 2011, NEUROREHAB NEURAL RE, V25, p6S, DOI 10.1177/1545968311410940; Galea JM, 2010, J COGNITIVE NEUROSCI, V22, P1158, DOI 10.1162/jocn.2009.21259; Grafton ST, 2007, HUM MOVEMENT SCI, V26, P590, DOI 10.1016/j.humov.2007.05.009; Grafton ST, 2002, EXP BRAIN RES, V146, P369, DOI 10.1007/s00221-002-1181-y; Grinband J, 2008, NEUROIMAGE, V43, P509, DOI 10.1016/j.neuroimage.2008.07.065; Heathcote A, 2000, PSYCHON B REV, V7, P185, DOI 10.3758/BF03212979; Hermundstad AM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003591; Hermundstad AM, 2013, P NATL ACAD SCI USA, V110, P6169, DOI 10.1073/pnas.1219562110; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Honda M, 1998, BRAIN, V121, P2159, DOI 10.1093/brain/121.11.2159; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Mantzaris AV, 2013, J COMPLEX NETW, V1, P83, DOI 10.1093/comnet/cnt001; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Newell A, 1981, COGNITIVE SKILLS THE, P1; Orban P, 2010, NEUROIMAGE, V49, P694, DOI 10.1016/j.neuroimage.2009.08.055; Otto AR, 2015, J COGNITIVE NEUROSCI, V27, P319, DOI 10.1162/jocn_a_00709; Patel R, 2013, NEUROREHAB NEURAL RE, V27, P187, DOI 10.1177/1545968312461718; Percival D., 2000, CA ST PR MA; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rosenbaum DA, 2010, HUMAN MOTOR CONTROL, 2ND EDITION, P1; Rowe JB, 2012, NEUROIMAGE, V61, P464, DOI 10.1016/j.neuroimage.2011.12.042; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Sakai K, 1999, J NEUROSCI, V19, P10074; Sandrini Marco, 2013, Handb Clin Neurol, V116, P499, DOI 10.1016/B978-0-444-53497-2.00040-1; Schmidt RA., 2005, MOTOR CONTROL LEARNI; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Snoddy GS, 1926, J APPL PSYCHOL, V10, P1, DOI 10.1037/h0075814; Sporns O., 2016, NETWORKS BRAIN; Steffener J, 2010, NEUROIMAGE, V49, P2113, DOI 10.1016/j.neuroimage.2009.11.014; Stoet G, 2009, TRENDS COGN SCI, V13, P228, DOI 10.1016/j.tics.2009.02.002; Sun FT, 2007, CEREB CORTEX, V17, P1227, DOI 10.1093/cercor/bhl033; Sun FT, 2004, NEUROIMAGE, V21, P647, DOI 10.1016/j.neuroimage.2003.09.056; Thompson-Schill SL, 2009, CURR DIR PSYCHOL SCI, V18, P259, DOI 10.1111/j.1467-8721.2009.01648.x; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wig GS, 2011, ANN NY ACAD SCI, V1224, P126, DOI 10.1111/j.1749-6632.2010.05947.x; Woolrich Mark W, 2009, Neuroimage, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Xiong JH, 2009, NEUROIMAGE, V45, P75, DOI 10.1016/j.neuroimage.2008.11.016; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	85	320	320	11	110	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2015	18	5					744	+		10.1038/nn.3993	http://dx.doi.org/10.1038/nn.3993			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG9LN	25849989	Green Accepted, Green Submitted			2022-12-17	WOS:000353636900022
J	Klein, R				Klein, Ruediger			Bidirectional modulation of synaptic functions by Eph/ephrin signaling	NATURE NEUROSCIENCE			English	Review							LONG-TERM POTENTIATION; DENDRITIC SPINE MORPHOGENESIS; RECEPTOR TYROSINE KINASES; EPHB RECEPTORS; HIPPOCAMPAL-NEURONS; NMDA RECEPTOR; REVERSE SIGNALS; AXON GUIDANCE; PHOSPHORYLATION; ACTIVATION	Ephrin ligands and their cognate Eph receptors guide axons during neural development and regulate synapse formation and neuronal plasticity in the adult. Because ephrins are tethered to the plasma membrane and possess reverse signaling properties, the Eph-ephrin system can function in a bidirectional, contact-mediated fashion between two opposing cells. Eph receptors expressed on dendrites are activated by ephrins (on axons or on astrocytes) and regulate spine and synapse formation. They also participate in activity-induced long-term changes in synaptic strength such as long-term potentiation (LTP). When expressed on axon terminals, ephrins promote presynaptic differentiation and enhance neurotransmitter release, thereby supporting presynaptic forms of LTP. In some cases, Eph receptors can simply act as ligands for ephrins without any requirement for Eph receptor signaling, suggesting that the system does not always function bidirectionally.	Max Planck Inst Neurobiol, Dept Mol Neurobiol, D-82152 Munich, Germany	Max Planck Society	Klein, R (corresponding author), Max Planck Inst Neurobiol, Dept Mol Neurobiol, Klopferspitz 18, D-82152 Munich, Germany.	rklein@neuro.mpg.de	Klein, Ruediger/C-6147-2008	Klein, Ruediger/0000-0002-3109-0163				Aoto J, 2007, BRAIN RES, V1184, P72, DOI 10.1016/j.brainres.2006.11.033; Aoto J, 2007, J NEUROSCI, V27, P7508, DOI 10.1523/JNEUROSCI.0705-07.2007; Armstrong JN, 2006, J NEUROSCI, V26, P3474, DOI 10.1523/JNEUROSCI.4338-05.2006; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bourgin C, 2007, J CELL BIOL, V178, P1295, DOI 10.1083/jcb.200610139; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Bouzioukh F, 2007, J NEUROSCI, V27, P11279, DOI 10.1523/JNEUROSCI.3393-07.2007; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Deininger K, 2008, P NATL ACAD SCI USA, V105, P12539, DOI 10.1073/pnas.0801174105; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Essmann CL, 2008, NAT NEUROSCI, V11, P1035, DOI 10.1038/nn.2171; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Ghosh A, 2002, SCIENCE, V295, P449, DOI 10.1126/science.1069391; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Lauterbach J, 2006, J NEUROSCI, V26, P11575, DOI 10.1523/JNEUROSCI.2697-06.2006; Liebl DJ, 2003, J NEUROSCI RES, V71, P7, DOI 10.1002/jnr.10457; Lim BK, 2008, NAT NEUROSCI, V11, P160, DOI 10.1038/nn2033; Lim YS, 2008, NEURON, V59, P746, DOI 10.1016/j.neuron.2008.07.032; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Moeller ML, 2006, J BIOL CHEM, V281, P1587, DOI 10.1074/jbc.M511756200; MURAMATSU Y, 2003, ADV XRAY CHEM ANAL J, V34, P153; Nestor MW, 2007, J NEUROSCI, V27, P12817, DOI 10.1523/JNEUROSCI.2442-07.2007; Nishida H, 2007, J NEUROSCI, V27, P331, DOI 10.1523/JNEUROSCI.4466-06.2007; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Richter M, 2007, J NEUROSCI, V27, P14205, DOI 10.1523/JNEUROSCI.2746-07.2007; Rodenas-Ruano A, 2006, DEV BIOL, V292, P34, DOI 10.1016/j.ydbio.2006.01.004; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tolias KF, 2007, P NATL ACAD SCI USA, V104, P7265, DOI 10.1073/pnas.0702044104; Tremblay ME, 2007, J COMP NEUROL, V501, P691, DOI 10.1002/cne.21263; Yamada S, 2007, ANNU REV BIOCHEM, V76, P267, DOI 10.1146/annurev.biochem.75.103004.142811; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Zhou L, 2007, J NEUROSCI, V27, P5127, DOI 10.1523/JNEUROSCI.1170-07.2007	48	320	329	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2009	12	1					15	20		10.1038/nn.2231	http://dx.doi.org/10.1038/nn.2231			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	388HL	19029886				2022-12-17	WOS:000262010800007
J	Garriga-Canut, M; Schoenike, B; Qazi, R; Bergendahl, K; Daley, TJ; Pfender, RM; Morrison, JF; Ockuly, J; Stafstrom, C; Sutula, T; Roopra, A				Garriga-Canut, Mireia; Schoenike, Barry; Qazi, Romena; Bergendahl, Karen; Daley, Timothy J.; Pfender, Rebecca M.; Morrison, John F.; Ockuly, Jeffrey; Stafstrom, Carl; Sutula, Thomas; Roopra, Avtar			2-deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIC FACTOR; ADULT-RAT; TRANSCRIPTIONAL REPRESSION; NEURONAL GENES; DENTATE GYRUS; TARGET GENES; SPONTANEOUS SEIZURES; HISTONE DEACETYLASE; MESSENGER-RNA; BDNF	Temporal lobe epilepsy is a common form of drug-resistant epilepsy that sometimes responds to dietary manipulation such as the 'ketogenic diet'. Here we have investigated the effects of the glycolytic inhibitor 2-deoxy-D-glucose ( 2DG) in the rat kindling model of temporal lobe epilepsy. We show that 2DG potently reduces the progression of kindling and blocks seizure-induced increases in the expression of brain-derived neurotrophic factor and its receptor, TrkB. This reduced expression is mediated by the transcription factor NRSF, which recruits the NADH-binding co-repressor CtBP to generate a repressive chromatin environment around the BDNF promoter. Our results show that 2DG has anticonvulsant and antiepileptic properties, suggesting that anti-glycolytic compounds may represent a new class of drugs for treating epilepsy. The metabolic regulation of neuronal genes by CtBP will open avenues of therapy for neurological disorders and cancer.	Univ Wisconsin, Dept Neurol, Med Sci Ctr, Madison, WI 53706 USA; Aga Khan Univ, Dept Pathol & Microbiol, Karachi 74800, Pakistan	University of Wisconsin System; University of Wisconsin Madison; Aga Khan University	Roopra, A (corresponding author), Univ Wisconsin, Dept Neurol, Med Sci Ctr, Room 1715,1300 Univ Ave, Madison, WI 53706 USA.	roopra@neurology.wisc.edu			PHS HHS [R01 25020] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; Belyaev ND, 2004, J BIOL CHEM, V279, P556, DOI 10.1074/jbc.M310353200; Binder DK, 1999, J NEUROSCI, V19, P4616; Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; CHANDRAMOULI V, 1977, BIOCHIM BIOPHYS ACTA, V496, P278, DOI 10.1016/0304-4165(77)90310-5; Conner JM, 1997, J NEUROSCI, V17, P2295; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Golarai G, 1996, J NEUROPHYSIOL, V75, P343, DOI 10.1152/jn.1996.75.1.343; Gowers W., 1881, EPILEPSY OTHER CHRON; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kim JH, 2005, NAT STRUCT MOL BIOL, V12, P423, DOI 10.1038/nsmb924; KOKAIA M, 1995, EXP NEUROL, V133, P215, DOI 10.1006/exnr.1995.1024; Koyama R, 2004, J NEUROSCI, V24, P7215, DOI 10.1523/JNEUROSCI.2045-04.2004; Lahteinen S, 2002, EUR J NEUROSCI, V15, P721; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MAUE RA, 1990, NEURON, V4, P223, DOI 10.1016/0896-6273(90)90097-Y; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Mirnezami AH, 2003, CURR BIOL, V13, P1234, DOI 10.1016/S0960-9822(03)00454-8; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; MORI N, 1990, NEURON, V4, P583, DOI 10.1016/0896-6273(90)90116-W; Murray KD, 2000, J COMP NEUROL, V418, P411, DOI 10.1002/(SICI)1096-9861(20000320)418:4<411::AID-CNE4>3.0.CO;2-F; Pearse RN, 2005, BLOOD, V105, P4429, DOI 10.1182/blood-2004-08-3096; Peterson CL, 2000, FEBS LETT, V476, P68, DOI 10.1016/S0014-5793(00)01673-2; Roopra A, 2001, Mol Interv, V1, P219; Roopra A, 2000, MOL CELL BIOL, V20, P2147, DOI 10.1128/MCB.20.6.2147-2157.2000; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Sayin U, 2003, J NEUROSCI, V23, P2759; Scharfman HE, 1999, J NEUROSCI, V19, P5619; Scharfman HE, 1997, J NEUROPHYSIOL, V78, P1082, DOI 10.1152/jn.1997.78.2.1082; Sinha SR, 2005, NEUROLOGIST, V11, P161, DOI 10.1097/01.nrl.0000160818.58821.d2; Stafstrom Carl E, 2004, Epilepsy Curr, V4, P215, DOI 10.1111/j.1535-7597.2004.46001.x; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Stryer L, 2002, BIOCHEMISTRY; SUTULA T, 1986, J NEUROPHYSIOL, V56, P732, DOI 10.1152/jn.1986.56.3.732; Sutula TP, 2004, EPILEPSY RES, V60, P161, DOI 10.1016/j.eplepsyres.2004.07.001; TIMMUSK T, 1994, NEUROCHEM INT, V25, P11, DOI 10.1016/0197-0186(94)90046-9; WARBURG O, 1930, METABOLISM TUMORS; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; WICK AN, 1955, P SOC EXP BIOL MED, V89, P579; Wood IC, 2003, J MOL BIOL, V334, P863, DOI 10.1016/j.jmb.2003.10.017; Yan Q, 1997, NEUROSCIENCE, V78, P431, DOI 10.1016/S0306-4522(96)00613-6; Zhang QH, 2002, SCIENCE, V295, P1895	50	320	335	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1382	1387		10.1038/nn1791	http://dx.doi.org/10.1038/nn1791			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17041593				2022-12-17	WOS:000242403800015
J	Reddi, BAJ; Carpenter, RHS				Reddi, BAJ; Carpenter, RHS			The influence of urgency on decision time	NATURE NEUROSCIENCE			English	Article							SACCADIC EYE-MOVEMENTS; NEURAL MECHANISMS; SELECTION	A fruitful quantitative approach to understanding how the brain makes decisions has been to look at the time needed to make a decision, and how it is affected by factors such as the supply of information, or an individual's expectations. This approach has led to a model of decision-making, consistent with recent neurophysiological data, that explains the observed variability of reaction times and correctly predicts the effects of altered expectations. Can it also predict what happens when the urgency of making the response changes? We asked subjects to make eye movements to low-visibility targets either as fast or as accurately as possible, and found that the model does indeed predict the timing of their responses: the degree of urgency seems to influence the criterion level at which a decision signal triggers a response.	Univ Cambridge, Physiol Lab, Cambridge CB2 3EG, England	University of Cambridge	Carpenter, RHS (corresponding author), Univ Cambridge, Physiol Lab, Downing St, Cambridge CB2 3EG, England.			Carpenter, Roger/0000-0003-2572-1448				BECKER W, 1992, EYE MOVEMENTS, P95; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; Carpenter R. H. S., 1999, J CONSCIOUSNESS STUD, V6, P13; Carpenter R H S, 1992, EYE MOVEMENTS, P1; Carpenter R. H. S., 1981, EYE MOVEMENTS COGNIT, P237; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Carpenter RHS, 1988, MOVEMENTS EYES; CARPENTER RHS, 1994, CONT OCULAR MOTOR VE, V480, pP4; Guitton D., 1992, EYE MOVEMENTS, P244; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Kolmogorov A, 1941, ANN MATH STAT, V23, P525; Schall JD, 1998, CURR OPIN NEUROBIOL, V8, P211, DOI 10.1016/S0959-4388(98)80142-6; Schall JD, 1998, NEURAL NETWORKS, V11, P1241, DOI 10.1016/S0893-6080(98)00059-8; SPARKS DL, 1986, PHYSIOL REV, V66, P118, DOI 10.1152/physrev.1986.66.1.118; Wurtz R. H, 1989, NEUROBIOLOGY SACCADI	16	320	324	2	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					827	830		10.1038/77739	http://dx.doi.org/10.1038/77739			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903577				2022-12-17	WOS:000167177300019
J	Sober, SJ; Sabes, PN				Sober, SJ; Sabes, PN			Flexible strategies for sensory integration during motor planning	NATURE NEUROSCIENCE			English	Article							PRISM ADAPTATION; INTERMANUAL TRANSFER; POSITION-INFORMATION; REACHING MOVEMENTS; PARIETAL CORTEX; ARM MOVEMENTS; VISION; SPACE; MODEL; REPRESENTATIONS	When planning target-directed reaching movements, human subjects combine visual and proprioceptive feedback to form two estimates of the arm's position: one to plan the reach direction, and another to convert that direction into a motor command. These position estimates are based on the same sensory signals but rely on different combinations of visual and proprioceptive input, suggesting that the brain weights sensory inputs differently depending on the computation being performed. Here we show that the relative weighting of vision and proprioception depends both on the sensory modality of the target and on the information content of the visual feedback, and that these factors affect the two stages of planning independently. The observed diversity of weightings demonstrates the flexibility of sensory integration and suggests a unifying principle by which the brain chooses sensory inputs so as to minimize errors arising from the transformation of sensory signals between coordinate frames.	Univ Calif San Francisco, Dept Physiol, Wm Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sabes, PN (corresponding author), Univ Calif San Francisco, Dept Physiol, Wm Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	sabes@phy.ucsf.edu	Sabes, Philip/B-9279-2008		NEI NIH HHS [R01 EY015679-01A2, R01 EY15679-01A2, R01 EY015679] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY015679] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; ATKESON CG, 1985, J NEUROSCI, V5, P2318; CHOE CS, 1974, J EXP PSYCHOL, V102, P1076, DOI 10.1037/h0036325; COHEN MM, 1973, PERCEPT MOTOR SKILL, V37, P599, DOI 10.2466/pms.1973.37.2.599; DIZIO P, 1995, J NEUROPHYSIOL, V74, P1787, DOI 10.1152/jn.1995.74.4.1787; Efron B., 1993, INTRO BOOTSTRAP; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; GHAHRAMANI Z, 1995, THESIS MIT; GHILARDI MF, 1995, J NEUROPHYSIOL, V73, P2535, DOI 10.1152/jn.1995.73.6.2535; Good P, 2013, PERMUTATION TESTS PR; Goodbody SJ, 1999, EXP BRAIN RES, V127, P213, DOI 10.1007/s002210050791; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Jordan M. I., 1996, HDB PERCEPTION ACTIO; KALIL RE, 1966, PERCEPT MOTOR SKILL, V22, P123, DOI 10.2466/pms.1966.22.1.123; Kitazawa S, 1997, J NEUROSCI, V17, P1481; McIntyre J, 2000, NEURAL COMPUT, V12, P2823, DOI 10.1162/089976600300014746; ROSSETTI Y, 1995, J NEUROPHYSIOL, V74, P457, DOI 10.1152/jn.1995.74.1.457; Sainburg RL, 2003, J NEUROPHYSIOL, V89, P401, DOI 10.1152/jn.00243.2002; Sainburg RL, 2002, EXP BRAIN RES, V145, P437, DOI 10.1007/s00221-002-1140-7; Sober SJ, 2003, J NEUROSCI, V23, P6982, DOI 10.1523/JNEUROSCI.23-18-06982.2003; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P582, DOI 10.1152/jn.1989.62.2.582; TAUB E, 1973, SCIENCE, V180, P755, DOI 10.1126/science.180.4087.755; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; WALLACE B, 1979, PERCEPT PSYCHOPHYS, V25, P133, DOI 10.3758/BF03198799; WARREN DH, 1978, J EXP PSYCHOL HUMAN, V4, P302, DOI 10.1037/0096-1523.4.2.302; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; WELCH RB, 1979, PERCEPT PSYCHOPHYS, V25, P126, DOI 10.3758/BF03198798; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25	33	319	324	2	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					490	497		10.1038/nn1427	http://dx.doi.org/10.1038/nn1427			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15793578	Green Accepted, Green Submitted			2022-12-17	WOS:000228040400020
J	Suzuki, R; Morcuende, S; Webber, M; Hunt, SP; Dickenson, AH				Suzuki, R; Morcuende, S; Webber, M; Hunt, SP; Dickenson, AH			Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways	NATURE NEUROSCIENCE			English	Article							SUBSTANCE-P RECEPTOR; NOXIOUS INHIBITORY CONTROLS; CENTRAL-NERVOUS-SYSTEM; LAMINA I NEURONS; PAIN-CONTROL; DORSAL-HORN; 5-HT3 RECEPTORS; NEUROKININ-1 RECEPTOR; PROJECTION NEURONS; RAT	The increase in pain sensitivity that follows injury is regulated by superficially located projection neurons in the dorsal horn of the spinal cord that express the neurokinin-1 (NK1) receptor. After selective ablation of these neurons in rats, we identified changes in receptive field size, mechanical and thermal coding and central sensitization of deeper dorsal horn neurons that are important for both pain sensations and reflexes. We were able to reproduce these changes by pharmacological block of descending serotonergic facilitatory pathways. Using Fos histochemistry, we found changes in the activation of serotonergic neurons in the brainstem as well as evidence for a loss of descending control of spinal excitability. We conclude that NK1-positive spinal projection neurons, activated by primary afferent input, project to higher brain areas that control spinal excitability- and therefore pain sensitivity-primarily through descending pathways from the brainstem.	UCL, Dept Pharmacol, London WC1E 6BT, England; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Suzuki, R (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	ucklrsu@ucl.ac.uk	HUNT, STEPHEN P/C-1646-2008; Morcuende, Sara/G-8672-2015	Morcuende, Sara/0000-0003-1471-7005; Hunt, Stephen/0000-0001-9453-5505				Ali Z, 1996, NEUROSCI LETT, V208, P203, DOI 10.1016/0304-3940(95)12600-7; BASBAUM AI, 1978, ANN NEUROL, V4, P451, DOI 10.1002/ana.410040511; Bernard JF, 1998, J COMP NEUROL, V401, P429; Bernard JF, 1996, PROG BRAIN RES, V107, P243; Bester H, 2001, J NEUROSCI, V21, P1039, DOI 10.1523/JNEUROSCI.21-03-01039.2001; BOUHASSIRA D, 1992, BRAIN RES, V595, P353, DOI 10.1016/0006-8993(92)91071-L; BOWKER RM, 1983, BRAIN RES, V288, P33, DOI 10.1016/0006-8993(83)90079-3; Cheunsuang O, 2000, NEUROSCIENCE, V97, P335, DOI 10.1016/S0306-4522(00)00035-X; Chung F, 1999, EUR J ANAESTH, V16, P669, DOI 10.1046/j.1365-2346.1999.00547.x; Cui M, 1999, J PHARMACOL EXP THER, V289, P868; DEEGAN R, 1992, AM J MED SCI, V304, P373, DOI 10.1097/00000441-199212000-00009; DICKENSON AH, 1995, BRIT J ANAESTH, V75, P193, DOI 10.1093/bja/75.2.193; DING YQ, 1995, BRAIN RES, V674, P336, DOI 10.1016/0006-8993(95)00022-I; DUBNER R, 1999, PAIN S, V6, pS27; Gauriau C, 2002, EXP PHYSIOL, V87, P251, DOI 10.1113/eph8702357; Green GM, 2000, PAIN, V89, P81, DOI 10.1016/S0304-3959(00)00346-8; Herrero JF, 2000, PROG NEUROBIOL, V61, P169, DOI 10.1016/S0301-0082(99)00051-9; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Hunt SP, 2000, TRENDS PHARMACOL SCI, V21, P284, DOI 10.1016/S0165-6147(00)01496-6; Janusonis S, 2001, J COMP NEUROL, V440, P31, DOI 10.1002/cne.1368; KIA HK, 1995, NEUROREPORT, V6, P257, DOI 10.1097/00001756-199501000-00008; KIDD EJ, 1993, BRAIN RES, V612, P289, DOI 10.1016/0006-8993(93)91674-H; Laporte AM, 1996, J CHEM NEUROANAT, V11, P67, DOI 10.1016/0891-0618(96)00130-5; LIGHT AR, 1993, SOMATOSENS MOT RES, V10, P309, DOI 10.3109/08990229309028840; Lima D, 2002, PROG NEUROBIOL, V66, P81, DOI 10.1016/S0301-0082(01)00025-9; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; Marshall GE, 1996, NEUROSCIENCE, V72, P255, DOI 10.1016/0306-4522(95)00558-7; Mason P, 1997, J NEUROPHYSIOL, V77, P1087, DOI 10.1152/jn.1997.77.3.1087; McLeod AL, 1998, P NATL ACAD SCI USA, V95, P15775, DOI 10.1073/pnas.95.26.15775; Miquel MC, 2002, EUR J NEUROSCI, V15, P449, DOI 10.1046/j.0953-816x.2001.01872.x; Nichols ML, 1999, SCIENCE, V286, P1558, DOI 10.1126/science.286.5444.1558; Oyama T, 1996, NEUROSCI RES, V25, P129; Polgar E, 2002, NEUROSCIENCE, V109, P799, DOI 10.1016/S0306-4522(01)00304-9; Roila F, 1997, EUR J CANCER, V33, P1364, DOI 10.1016/S0959-8049(97)00003-8; Satoh O, 1996, BRAIN RES, V728, P27, DOI 10.1016/0006-8993(96)00371-x; SCHOUENBORG J, 1985, BRAIN RES, V328, P23, DOI 10.1016/0006-8993(85)91318-6; Suzuki R, 2000, EXP NEUROL, V163, P408, DOI 10.1006/exnr.2000.7371; TECOTT LH, 1993, P NATL ACAD SCI USA, V90, P1430, DOI 10.1073/pnas.90.4.1430; THOMPSON SWN, 1990, EUR J NEUROSCI, V2, P638, DOI 10.1111/j.1460-9568.1990.tb00453.x; Todd AJ, 2000, EUR J NEUROSCI, V12, P689, DOI 10.1046/j.1460-9568.2000.00950.x; Todd AJ, 2002, J NEUROSCI, V22, P4103, DOI 10.1523/JNEUROSCI.22-10-04103.2002; URBAN M, 1999, P NATL ACAD SCI USA, V95, P2630; Villanueva Luis, 1995, Biological Research, V28, P113; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Yu XH, 1999, J NEUROSCI, V19, P3545; Zeitz KP, 2002, J NEUROSCI, V22, P1010, DOI 10.1523/JNEUROSCI.22-03-01010.2002; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	47	319	333	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1319	1326		10.1038/nn966	http://dx.doi.org/10.1038/nn966			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12402039				2022-12-17	WOS:000179447500015
J	Llano, I; Gonzalez, J; Caputo, C; Lai, FA; Blayney, LM; Tan, YP; Marty, A				Llano, I; Gonzalez, J; Caputo, C; Lai, FA; Blayney, LM; Tan, YP; Marty, A			Presynaptic calcium stores underlie large-amplitude miniature IPSCs and spontaneous calcium transients	NATURE NEUROSCIENCE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CEREBELLAR PURKINJE-CELLS; CA2+ RELEASE CHANNELS; SYNAPTIC-TRANSMISSION; RYANODINE RECEPTOR; IMMUNOHISTOCHEMICAL LOCALIZATION; NEUROTRANSMITTER RELEASE; QUANTAL ANALYSIS; MUSCLE; TERMINALS	The cellular mechanisms responsible for large miniature currents in some brain synapses remain undefined. In Purkinje cells, we found that large-amplitude miniature inhibitory postsynaptic currents (mIPSCs) were inhibited by ryanodine or by long-term removal of extracellular Ca2+. Two-photon Ca2+ imaging revealed random, ryanodine-sensitive intracellular Ca2+ transients, spatially constrained at putative presynaptic terminals. At high concentration, ryanodine decreased action-potential-evoked rises in intracellular Ca2+. Immuno-localization showed ryanodine receptors in these terminals. Our data suggest that large mIPSCs are multivesicular events regulated by Ca2+ release from ryanodine-sensitive presynaptic Ca2+ stores.	Max Planck Inst Biophys Chem, Arbeitsgrp Zellulare Neurobiol, D-37077 Gottingen, Germany; Inst Venezolano Invest Cient, Ctr Biofis, Caracas 1020A, Venezuela; Univ Wales Coll Cardiff, Div Med Cardiol, Cardiff CF4 4XN, S Glam, Wales; Bogazici Univ, Istanbul, Turkey	Max Planck Society; Venezuelan Institute Science Research; Cardiff University; Bogazici University	Llano, I (corresponding author), Max Planck Inst Biophys Chem, Arbeitsgrp Zellulare Neurobiol, D-37077 Gottingen, Germany.	illano@gwdg.de		Lai, Tony/0000-0003-2852-8547				ANDERSON K, 1989, J BIOL CHEM, V264, P1329; Auger C, 1997, NEURON, V19, P139, DOI 10.1016/S0896-6273(00)80354-2; Bekkers John M., 1994, Current Opinion in Neurobiology, V4, P360, DOI 10.1016/0959-4388(94)90097-3; BENNETT MR, 1995, PROG NEUROBIOL, V46, P331, DOI 10.1016/0301-0082(94)00061-L; BERRIDGE MJ, 1996, RYANODINE RECEPTORS, P120; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Bureau I, 1998, J PHYSIOL-LONDON, V509, P817, DOI 10.1111/j.1469-7793.1998.817bm.x; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Forti L, 2000, J PHYSIOL-LONDON, V527, P33, DOI 10.1111/j.1469-7793.2000.00033.x; Frerking M, 1997, J NEUROPHYSIOL, V78, P1293, DOI 10.1152/jn.1997.78.3.1293; Glitsch M, 1999, J NEUROSCI, V19, P511; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; KATZ B, 1969, SHERRINGTON LECTURES, P1; Koizumi S, 1999, NEURON, V22, P125, DOI 10.1016/S0896-6273(00)80684-4; Kondo S, 1997, J PHYSIOL-LONDON, V498, P165, DOI 10.1113/jphysiol.1997.sp021849; Krizaj D, 1999, J NEUROSCI, V19, P7249, DOI 10.1523/JNEUROSCI.19-17-07249.1999; KUWAJIMA G, 1992, NEURON, V9, P1133, DOI 10.1016/0896-6273(92)90071-K; Lacampagne A, 1999, J GEN PHYSIOL, V113, P187, DOI 10.1085/jgp.113.2.187; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; LLANO I, 1994, NEURON, V12, P663, DOI 10.1016/0896-6273(94)90221-6; Llano I, 1997, J PHYSIOL-LONDON, V502, P509, DOI 10.1111/j.1469-7793.1997.509bj.x; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; Mackrill JJ, 1997, BIOCHEM J, V327, P251, DOI 10.1042/bj3270251; MACONOCHIE DJ, 1994, NEURON, V12, P61, DOI 10.1016/0896-6273(94)90152-X; MEISSNER G, 1989, J BIOL CHEM, V264, P1715; Mothet JP, 1998, J PHYSIOL-LONDON, V507, P405, DOI 10.1111/j.1469-7793.1998.405bt.x; NAKANISHI S, 1991, J NEUROSCI, V11, P2075; Narita K, 2000, J GEN PHYSIOL, V115, P519, DOI 10.1085/jgp.115.4.519; Narita K, 1998, J GEN PHYSIOL, V112, P593, DOI 10.1085/jgp.112.5.593; Niggli E, 1999, ANNU REV PHYSIOL, V61, P311, DOI 10.1146/annurev.physiol.61.1.311; Palay S.L., 1974, CEREBELLAR CORTEX CY; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; PENG YW, 1991, NEURON, V6, P525, DOI 10.1016/0896-6273(91)90055-5; Peng YY, 1996, J NEUROSCI, V16, P6703; Pouzat C, 1999, J NEUROSCI, V19, P1675; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; Rios E, 1997, ANNU REV BIOPH BIOM, V26, P47, DOI 10.1146/annurev.biophys.26.1.47; Savic N, 1998, EUR J NEUROSCI, V10, P3379, DOI 10.1046/j.1460-9568.1998.00342.x; Sellin LC, 1996, PFLUG ARCH EUR J PHY, V431, P325, DOI 10.1007/BF02207269; SHARP AH, 1993, J NEUROSCI, V13, P3051; Smith AB, 1996, J PHYSIOL-LONDON, V497, P657, DOI 10.1113/jphysiol.1996.sp021797; STELZER A, 1988, SCIENCE, V241, P339, DOI 10.1126/science.2455347; Tan YP, 1999, J PHYSIOL-LONDON, V520, P65, DOI 10.1111/j.1469-7793.1999.00065.x; Tan YP, 1999, J NEUROSCI METH, V92, P123, DOI 10.1016/S0165-0270(99)00103-X; Tunwell REA, 1996, BIOCHEM J, V318, P477, DOI 10.1042/bj3180477; Vincent P, 1996, J PHYSIOL-LONDON, V494, P183, DOI 10.1113/jphysiol.1996.sp021484; Walliser B, 1998, J EVOL ECON, V8, P67, DOI 10.1007/s001910050056; YOSHIDA S, 1994, CELL MOL NEUROBIOL, V14, P227, DOI 10.1007/BF02088322	49	319	325	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1256	1265		10.1038/81781	http://dx.doi.org/10.1038/81781			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100146	Bronze			2022-12-17	WOS:000167177900011
J	Prinz, M; Priller, J				Prinz, Marco; Priller, Josef			The role of peripheral immune cells in the CNS in steady state and disease	NATURE NEUROSCIENCE			English	Review							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PROGRESSIVE MULTIPLE-SCLEROSIS; ONSET ALZHEIMERS-DISEASE; CERVICAL LYMPH-NODES; REGULATORY T-CELLS; CYTOKINE GM-CSF; ISCHEMIC-STROKE; DENDRITIC CELLS; MYELOID CELLS	The CNS is protected by the immune system, including cells that reside directly within the CNS and help to ensure proper neural function, as well as cells that traffic into the CNS with disease. The CNS-resident immune system is comprised mainly of innate immune cells and operates under homeostatic conditions. These myeloid cells in the CNS parenchyma and at CNS-periphery interfaces are highly specialized but also extremely plastic cells that immediately react to any changes in CNS homeostasis and become reactive in the context of neurodegenerative disorders such as Alzheimer's disease or Parkinson's disease. However, when the blood-brain barrier is impaired during CNS diseases such as multiple sclerosis or altered with cerebral ischemia, peripheral adaptive and innate immune cells, including monocytes, neutrophils, T cells and B cells, can enter the CNS, where they execute distinct cell-mediated effects. On the basis of these observations, we assess strategies for targeting peripheral immune cells to reduce CNS disease burden.	[Prinz, Marco] Univ Freiburg, Inst Neurobiol, Freiburg, Germany; [Prinz, Marco] Univ Freiburg, Fac Med, Freiburg, Germany; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Priller, Josef] Charite, Dept Neuropsychiat, Berlin, Germany; [Priller, Josef] Charite, Lab Mol Psychiat, Berlin, Germany; [Priller, Josef] German Ctr Neurodegenerat Dis DZNE, NeuroCure Cluster Excellence, Berlin, Germany; [Priller, Josef] Berlin Inst Hlth, Berlin, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Berlin Institute of Health	Prinz, M (corresponding author), Univ Freiburg, Inst Neurobiol, Freiburg, Germany.; Prinz, M (corresponding author), Univ Freiburg, Fac Med, Freiburg, Germany.; Prinz, M (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany.; Priller, J (corresponding author), Charite, Dept Neuropsychiat, Berlin, Germany.; Priller, J (corresponding author), Charite, Lab Mol Psychiat, Berlin, Germany.; Priller, J (corresponding author), German Ctr Neurodegenerat Dis DZNE, NeuroCure Cluster Excellence, Berlin, Germany.; Priller, J (corresponding author), Berlin Inst Hlth, Berlin, Germany.	marco.prinz@uniklinik-freiburg.de; josef.priller@charite.de	Priller, Josef/ABW-3835-2022	Priller, Josef/0000-0001-7596-0979	BMBF competence network of multiple sclerosis (KKNMS); DFG [SFB 992, SFB 1160]; DFG (NeuroCure Cluster of Excellence) [SFB TRR43]; BIH (CRG Proteostasis); BMBF (AERIAL); DFG collaborative research center [SFB/TRR167]; MRC [MC_PC_16031] Funding Source: UKRI	BMBF competence network of multiple sclerosis (KKNMS); DFG(German Research Foundation (DFG)); DFG (NeuroCure Cluster of Excellence)(German Research Foundation (DFG)); BIH (CRG Proteostasis); BMBF (AERIAL)(Federal Ministry of Education & Research (BMBF)); DFG collaborative research center(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Dr. E Fernandez-Klett and D. Erny for the artwork. M.P. and J.P. are coordinators of the DFG-funded collaborative research center SFB/TRR167 (NeuroMac). In addition, M.P. is supported by the BMBF-funded competence network of multiple sclerosis (KKNMS) and the DFG (SFB 992, SFB 1160, Reinhart Koeselleck Grant). J.P. receives additional funding from the DFG (NeuroCure Cluster of Excellence, SFB TRR43), the BIH (CRG Proteostasis) and the BMBF (AERIAL).	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Anandasabapathy N, 2011, J EXP MED, V208, P1695, DOI 10.1084/jem.20102657; Ankeny DP, 2009, J CLIN INVEST, V119, P2990, DOI 10.1172/JCI39780; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Baruch K, 2015, EMBO J, V34, P1816, DOI 10.15252/embj.201591468; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Biber K, 2016, NAT REV DRUG DISCOV, V15, P110, DOI 10.1038/nrd.2015.14; Bielekova B, 2004, J IMMUNOL, V172, P3893, DOI 10.4049/jimmunol.172.6.3893; Bien-Ly N, 2015, NEURON, V88, P289, DOI 10.1016/j.neuron.2015.09.036; Brendecke SM, 2015, SEMIN IMMUNOPATHOL, V37, P591, DOI 10.1007/s00281-015-0520-6; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Bulloch K, 2008, J COMP NEUROL, V508, P687, DOI 10.1002/cne.21668; Chamorro A, 2012, NAT REV NEUROL, V8, P401, DOI 10.1038/nrneurol.2012.98; Chan G, 2015, NAT NEUROSCI, V18, P1556, DOI 10.1038/nn.4126; Chard DT, 2002, BRAIN, V125, P327, DOI 10.1093/brain/awf025; Clausen BH, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-46; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Croxford AL, 2015, TRENDS IMMUNOL, V36, P651, DOI 10.1016/j.it.2015.08.004; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; CSERR HF, 1992, BRAIN PATHOL, V2, P269, DOI 10.1111/j.1750-3639.1992.tb00703.x; Dando SJ, 2016, GLIA, V64, P1331, DOI 10.1002/glia.23005; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; Doyle K. P., 2016, BRAIN BEHAV IMMUN; Doyle KP, 2015, J NEUROSCI, V35, P2133, DOI 10.1523/JNEUROSCI.4098-14.2015; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Ellison D., 2004, NEUROPATHOLOGY REFER; Engel O, 2015, STROKE, V46, P3232, DOI 10.1161/STROKEAHA.115.008989; Engelhardt B., 2017, NAT IMMUNOL; Enzmann G, 2013, ACTA NEUROPATHOL, V125, P395, DOI 10.1007/s00401-012-1076-3; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Filiano AJ, 2016, NATURE, V535, P425, DOI 10.1038/nature18626; FOLDI M, 1966, ACTA ANAT, V64, P498; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Frisullo G, 2008, CYTOKINE, V44, P22, DOI 10.1016/j.cyto.2008.08.007; Fu Y, 2015, NAT REV NEUROL, V11, P524, DOI 10.1038/nrneurol.2015.144; Gabbita SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137305; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gelderblom M, 2012, BLOOD, V120, P3793, DOI 10.1182/blood-2012-02-412726; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann J, 2006, J LEUKOCYTE BIOL, V80, P797, DOI 10.1189/jlb.0306176; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Goldmann T, 2015, EMBO J, V34, P1612, DOI 10.15252/embj.201490791; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Goldmann T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/208093; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Greter M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00249; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Hagemeyer N, 2016, EMBO J, V35, P1730, DOI 10.15252/embj.201693801; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hemmer B, 2015, LANCET NEUROL, V14, P406, DOI 10.1016/S1474-4422(14)70305-9; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Henning EC, 2009, J CEREBR BLOOD F MET, V29, P1229, DOI 10.1038/jcbfm.2009.48; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Herz J, 2015, J EXP MED, V212, P1153, DOI 10.1084/jem.20142047; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Howell OW, 2015, NEUROPATH APPL NEURO, V41, P798, DOI 10.1111/nan.12199; Huang GJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000561; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Ji QY, 2013, NAT IMMUNOL, V14, P254, DOI 10.1038/ni.2513; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kamphuis W, 2016, BBA-MOL BASIS DIS, V1862, P1847, DOI 10.1016/j.bbadis.2016.07.007; Kierdorf K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058544; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Kivisakk P, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-14; Kleinschnitz C, 2013, BLOOD, V121, P679, DOI 10.1182/blood-2012-04-426734; Kleinschnitz C, 2010, BLOOD, V115, P3835, DOI 10.1182/blood-2009-10-249078; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Li PY, 2013, ANN NEUROL, V74, P458, DOI 10.1002/ana.23815; Li T, 2013, BRAIN, V136, P3578, DOI 10.1093/brain/awt287; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Louis D.N., 2016, WHO CLASSIFICATION T; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006; Magliozzi R, 2004, J NEUROIMMUNOL, V148, P11, DOI 10.1016/j.jneuroim.2003.10.056; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Meuwissen MEC, 2016, J EXP MED, V213, P1163, DOI 10.1084/jem.20151529; Meyer-Luehmann M, 2015, TRENDS NEUROSCI, V38, P659, DOI 10.1016/j.tins.2015.08.011; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Mohle L, 2016, CELL REP, V15, P1945, DOI 10.1016/j.celrep.2016.04.074; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Noster R, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008706; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Olah M, 2009, GLIA, V57, P1046, DOI 10.1002/glia.20828; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Petito CK, 1998, J NEUROPATH EXP NEUR, V57, P231, DOI 10.1097/00005072-199803000-00004; Pikor NB, 2015, IMMUNITY, V43, P1160, DOI 10.1016/j.immuni.2015.11.010; Pinheiro MAL, 2016, BBA-MOL BASIS DIS, V1862, P461, DOI 10.1016/j.bbadis.2015.10.018; Planas AM, 2012, J IMMUNOL, V188, P2156, DOI 10.4049/jimmunol.1102289; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Popescu BFG, 2012, ANNU REV PATHOL-MECH, V7, P185, DOI 10.1146/annurev-pathol-011811-132443; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prodinger C, 2011, ACTA NEUROPATHOL, V121, P445, DOI 10.1007/s00401-010-0774-y; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Ren XF, 2011, J NEUROSCI, V31, P8556, DOI 10.1523/JNEUROSCI.1623-11.2011; Replogle JM, 2015, ANN NEUROL, V77, P469, DOI 10.1002/ana.24337; Roemer C, 2015, J NEUROSCI, V35, P7777, DOI 10.1523/JNEUROSCI.1532-14.2015; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schilling M, 2005, EXP NEUROL, V196, P290, DOI 10.1016/j.expneurol.2005.08.004; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Segal BM, 2008, LANCET NEUROL, V7, P796, DOI 10.1016/S1474-4422(08)70173-X; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Shemer A, 2015, TRENDS IMMUNOL, V36, P614, DOI 10.1016/j.it.2015.08.003; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Stanley D, 2016, NAT MED, V22, P1277, DOI 10.1038/nm.4194; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Stern JNH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008879; Stroh A, 2006, NEUROIMAGE, V33, P886, DOI 10.1016/j.neuroimage.2006.07.009; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Togo T, 2002, J NEUROIMMUNOL, V124, P83, DOI 10.1016/S0165-5728(01)00496-9; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; van Zwam M, 2009, J MOL MED, V87, P273, DOI 10.1007/s00109-008-0421-4; Villares R, 2009, EUR J IMMUNOL, V39, P1671, DOI 10.1002/eji.200839123; vom Berg J, 2012, NAT MED, V18, P1812, DOI 10.1038/nm.2965; Wang YM, 2016, J EXP MED, V213, P667, DOI 10.1084/jem.20151948; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Weller R. O., 2005, Morphologie, V89, P22, DOI 10.1016/S1286-0115(05)83235-7; Whedon JM, 2009, ALTERN THER HEALTH M, V15, P54; Willing A, 2014, EUR J IMMUNOL, V44, P3119, DOI 10.1002/eji.201344160; Wolburg H, 2010, ACTA NEUROPATHOL, V119, P75, DOI 10.1007/s00401-009-0627-8; Wolf SA, 2009, FASEB J, V23, P3121, DOI 10.1096/fj.08-113944; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Xu J, 2015, DEV CELL, V34, P632, DOI 10.1016/j.devcel.2015.08.018; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046; Zenaro E, 2015, NAT MED, V21, P880, DOI 10.1038/nm.3913; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	148	318	327	10	182	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2017	20	2					136	144		10.1038/nn.4475	http://dx.doi.org/10.1038/nn.4475			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ5PU	28092660				2022-12-17	WOS:000393271000006
J	Calhoon, GG; Tye, KM				Calhoon, Gwendolyn G.; Tye, Kay M.			Resolving the neural circuits of anxiety	NATURE NEUROSCIENCE			English	Review							MEDIAL PREFRONTAL CORTEX; HIPPOCAMPAL THETA-RHYTHM; ELEVATED PLUS-MAZE; QUALITY-OF-LIFE; BASOLATERAL AMYGDALA; ANIMAL-MODELS; BED NUCLEUS; FUNCTIONAL CONNECTIVITY; CONDITIONED-RESPONSES; STRIA TERMINALIS	Although anxiety disorders represent a major societal problem demanding new therapeutic targets, these efforts have languished in the absence of a mechanistic understanding of this subjective emotional state. While it is impossible to know with certainty the subjective experience of a rodent, rodent models hold promise in dissecting well-conserved limbic circuits. The application of modern approaches in neuroscience has already begun to unmask the neural circuit intricacies underlying anxiety by allowing direct examination of hypotheses drawn from existing psychological concepts. This information points toward an updated conceptual model for what neural circuit perturbations could give rise to pathological anxiety and thereby provides a roadmap for future therapeutic development.	[Calhoon, Gwendolyn G.; Tye, Kay M.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health	Tye, KM (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	kaytye@mit.edu			JPB Foundation; PIIF; PNDRF; JFDP; Whitehall Foundation; Klingenstein Foundation; McKnight Foundation; NARSAD Young Investigator Award; Alfred P Sloan Foundation; New York Stem Cell Foundation; Whitehead Career Development Chair; US National Institutes of Health (NIH) [R01-MH102441-01]; NIH [DP2-DK-102256-01]; JFDP Postdoctoral Fellowship from the JPB Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102441] Funding Source: NIH RePORTER	JPB Foundation; PIIF; PNDRF; JFDP; Whitehall Foundation; Klingenstein Foundation(Klingenstein Philanthropies); McKnight Foundation; NARSAD Young Investigator Award(NARSAD); Alfred P Sloan Foundation(Alfred P. Sloan Foundation); New York Stem Cell Foundation; Whitehead Career Development Chair; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JFDP Postdoctoral Fellowship from the JPB Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Kinch and M. Kheirbek for corrcspcmdencc, C. Vander Weele and R. Wichmann for reading and comments on our text, and the entire Tye laboratory for discussion. K.M.T. is a New York Stem Cell Foundation - Robertson Investigator, and this work was supported by funding from the JPB Foundation, PIIF, PNDRF, JFDP, Whitehall Foundation, Klingenstein Foundation, McKnight Foundation, NARSAD Young Investigator Award, Alfred P Sloan Foundation, New York Stem Cell Foundation, Whitehead Career Development Chair, US National Institutes of Health (NIH) R01-MH102441-01 (National Institute of Mental Health) and NIH Director's New Innovator Award DP2-DK-102256-01 (National Institute of Diabetes and Digestive and Kidney Diseases). G.G.C. is supported by the JFDP Postdoctoral Fellowship from the JPB Foundation.	Adhikari A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00112; Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Allsop SA, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00241; Amaral D, 2007, HIPPOCAMPUS BOOK, P37; American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, V5th, DOI 10.1176/appi.books.9780890425596; Anderson DJ, 2014, CELL, V157, P187, DOI 10.1016/j.cell.2014.03.003; Anthony TE, 2014, CELL, V156, P522, DOI 10.1016/j.cell.2013.12.040; Arruda-Carvalho M, 2014, J NEUROSCI, V34, P15601, DOI 10.1523/JNEUROSCI.2664-14.2014; Baeg EH, 2001, CEREB CORTEX, V11, P441, DOI 10.1093/cercor/11.5.441; Balleine BW, 2005, PHYSIOL BEHAV, V86, P717, DOI 10.1016/j.physbeh.2005.08.061; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Bereza BG, 2009, CLIN THER, V31, P1279, DOI 10.1016/j.clinthera.2009.06.004; Berlin HA, 2008, MT SINAI J MED, V75, P174, DOI 10.1002/msj.20045; Borsini F, 2002, PSYCHOPHARMACOLOGY, V163, P121, DOI 10.1007/s00213-002-1155-6; Britt JP, 2012, NEURON, V76, P790, DOI 10.1016/j.neuron.2012.09.040; Brown S., 1888, PHILOS T R SOC LON B, V179, P303; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; BYRNE JH, 1978, J NEUROPHYSIOL, V41, P402, DOI 10.1152/jn.1978.41.2.402; Cai HJ, 2014, NAT NEUROSCI, V17, P1240, DOI 10.1038/nn.3767; Calhoon GG, 2013, NEURON, V78, P181, DOI 10.1016/j.neuron.2013.01.032; Carvalho MC, 2005, BRAZ J MED BIOL RES, V38, P1857, DOI 10.1590/S0100-879X2005001200014; Chang CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011971; Christianson JP, 2011, BIOL PSYCHIAT, V70, P458, DOI 10.1016/j.biopsych.2011.04.004; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Collier DA, 1996, MOL PSYCHIATR, V1, P453; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Courtin J, 2014, NATURE, V505, P92, DOI 10.1038/nature12755; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; CULLINAN WE, 1993, J COMP NEUROL, V332, P1, DOI 10.1002/cne.903320102; Darwin C., 1872, P374; Davidson JR, 2010, J PSYCHOPHARMACOL, V24, P3, DOI 10.1177/0269881108096505; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Degroot A, 2004, EUR J NEUROSCI, V20, P1059, DOI 10.1111/j.1460-9568.2004.03556.x; Degroot A, 2004, BRAIN RES, V1001, P60, DOI 10.1016/j.brainres.2003.10.065; Do-Monte FH, 2015, NATURE, V519, P460, DOI 10.1038/nature14030; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Duvarci S, 2014, NEURON, V82, P966, DOI 10.1016/j.neuron.2014.04.042; Eden AS, 2015, J NEUROSCI, V35, P6020, DOI 10.1523/JNEUROSCI.3659-14.2015; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; FILE SE, 1985, NEUROPSYCHOBIOLOGY, V13, P55, DOI 10.1159/000118163; FILE SE, 1975, PSYCHOPHARMACOLOGIA, V44, P47, DOI 10.1007/BF00421183; Fox AS, 2015, TRENDS NEUROSCI, V38, P319, DOI 10.1016/j.tins.2015.03.002; GARDNER CR, 1985, J PHARMACOL METHOD, V14, P181, DOI 10.1016/0160-5402(85)90031-2; Grace AA, 2002, PHYSIOL BEHAV, V77, P489, DOI 10.1016/S0031-9384(02)00909-5; Groenewegen HJ, 1997, J PSYCHOPHARMACOL, V11, P99, DOI 10.1177/026988119701100202; Gross J.J., 1998, REV GEN PSYCHOL, V2, P271, DOI [10.1037/1089-2680.2.3.271, DOI 10.1037/1089-2680.2.3.271, https://doi.org/10.1037/1089-2680.2.3.271]; Hall C., 1932, U CALIF PUBL PSYCHOL, V6, P1; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Henry B, 2006, J NEUROSCI, V26, P9142, DOI 10.1523/JNEUROSCI.1494-06.2006; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Herry C, 2014, NAT NEUROSCI, V17, P1644, DOI 10.1038/nn.3869; Hoffman EJ, 2008, MT SINAI J MED, V75, P248, DOI 10.1002/msj.20041; Holmes A, 2012, NAT NEUROSCI, V15, P1359, DOI 10.1038/nn.3204; Houk JC, 1995, MODELS INFORM PROCES, P249; Hubner C, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00064; Huff ML, 2013, P NATL ACAD SCI USA, V110, P3597, DOI 10.1073/pnas.1219593110; Hull C.L., 1943, PRINCIPLES BEHAV INT, DOI DOI 10.2307/1416955; Irle E, 2010, J PSYCHIATR NEUROSCI, V35, P126, DOI 10.1503/jpn.090041; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Joel D, 2002, NEURAL NETWORKS, V15, P535, DOI 10.1016/S0893-6080(02)00047-3; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Kalueff AV, 2008, NAT PROTOC, V3, P129, DOI 10.1038/nprot.2007.516; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; Kim MJ, 2011, BEHAV BRAIN RES, V223, P403, DOI 10.1016/j.bbr.2011.04.025; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Kinch MS, 2014, DRUG DISCOV TODAY, V19, P1033, DOI 10.1016/j.drudis.2014.03.018; Lecrubier Y, 2007, J CLIN PSYCHIAT, V68, P36; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LeDoux J, 2012, NEURON, V73, P653, DOI 10.1016/j.neuron.2012.02.004; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesting J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077707; Lesting J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021714; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Likhtik E, 2005, J NEUROSCI, V25, P7429, DOI 10.1523/JNEUROSCI.2314-05.2005; Likhtik E, 2015, TRENDS NEUROSCI, V38, P158, DOI 10.1016/j.tins.2014.12.007; Likhtik E, 2014, NAT NEUROSCI, V17, P106, DOI 10.1038/nn.3582; LISTER RG, 1990, PHARMACOL THERAPEUT, V46, P321, DOI 10.1016/0163-7258(90)90021-S; Livneh U, 2012, NEURON, V75, P133, DOI 10.1016/j.neuron.2012.05.016; LORENZINI CA, 1984, PHYSIOL BEHAV, V32, P687, DOI 10.1016/0031-9384(84)90327-5; MACKINTOSH NJ, 1987, BEHAV RES THER, V25, P81, DOI 10.1016/0005-7967(87)90079-9; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Maroun M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035853; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; McNaughton N, 2007, BEHAV PHARMACOL, V18, P329, DOI 10.1097/FBP.0b013e3282ee82e3; Merali Z, 2003, BIOL PSYCHIAT, V54, P552, DOI 10.1016/S0006-3223(02)01827-9; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Mondin TC, 2013, REV BRAS PSIQUIATR, V35, P347, DOI 10.1590/1516-4446-2013-1155; Mori M, 2004, NATURE, V431, P453, DOI 10.1038/nature02854; Nabavi S, 2014, NATURE, V511, P348, DOI 10.1038/nature13294; Namburi P, 2015, NATURE, V520, P675, DOI 10.1038/nature14366; Nicolas LB, 2006, EUR J PHARMACOL, V547, P106, DOI 10.1016/j.ejphar.2006.07.015; Nieh EH, 2015, CELL, V160, P528, DOI 10.1016/j.cell.2015.01.003; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Opland DM, 2010, BRAIN RES, V1350, P65, DOI 10.1016/j.brainres.2010.04.028; Orsini CA, 2015, NEUROSCI BIOBEHAV R, V58, P147, DOI 10.1016/j.neubiorev.2015.04.009; Pagotto LF, 2015, COMPR PSYCHIAT, V58, P68, DOI 10.1016/j.comppsych.2015.01.002; Panksepp J, 2005, CONSCIOUS COGN, V14, P30, DOI 10.1016/j.concog.2004.10.004; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Penzo MA, 2015, NATURE, V519, P455, DOI 10.1038/nature13978; Penzo MA, 2014, J NEUROSCI, V34, P2432, DOI 10.1523/JNEUROSCI.4166-13.2014; Phillips PEM, 2007, PSYCHOPHARMACOLOGY, V191, P483, DOI 10.1007/s00213-006-0626-6; Poulos AM, 2010, P NATL ACAD SCI USA, V107, P14881, DOI 10.1073/pnas.1005754107; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Risold PY, 1997, BRAIN RES REV, V24, P115, DOI 10.1016/S0165-0173(97)00009-X; Risold PY, 1996, SCIENCE, V272, P1484, DOI 10.1126/science.272.5267.1484; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sanchez C, 2003, EUR J PHARMACOL, V463, P133, DOI 10.1016/S0014-2999(03)01277-9; Schoenfeld TJ, 2014, J NEUROSCI, V34, P15679, DOI 10.1523/JNEUROSCI.3234-13.2014; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Senn V, 2014, NEURON, V81, P428, DOI 10.1016/j.neuron.2013.11.006; SHEPHERD JK, 1994, PSYCHOPHARMACOLOGY, V116, P56, DOI 10.1007/BF02244871; SIMIAND J, 1984, PSYCHOPHARMACOLOGY, V84, P48, DOI 10.1007/BF00432023; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Sparta DR, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00129; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Stamatakis AM, 2014, NEUROPHARMACOLOGY, V76, P320, DOI 10.1016/j.neuropharm.2013.05.046; Sternson SM, 2013, NEURON, V77, P810, DOI 10.1016/j.neuron.2013.02.018; Stujenske JM, 2014, NEURON, V83, P919, DOI 10.1016/j.neuron.2014.07.026; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Sylvers P, 2011, CLIN PSYCHOL REV, V31, P122, DOI 10.1016/j.cpr.2010.08.004; Tejeda HA, 2014, J NEUROSCI, V34, P14365, DOI 10.1523/JNEUROSCI.0837-14.2014; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; TREIT D, 1981, PHARMACOL BIOCHEM BE, V15, P619, DOI 10.1016/0091-3057(81)90219-7; Trent NL, 2010, PHYSIOL BEHAV, V101, P141, DOI 10.1016/j.physbeh.2010.04.035; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; Tye KM, 2007, J NEUROSCI, V27, P3937, DOI 10.1523/JNEUROSCI.5281-06.2007; Tye KM, 2014, NEURON, V83, P1259, DOI 10.1016/j.neuron.2014.08.022; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; U.S. Food and Drug Administration, DRUGS FDA FAD APPR D; Van de Werd HJJM, 2014, BRAIN STRUCT FUNCT, V219, P433, DOI 10.1007/s00429-013-0630-7; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Vertes RP, 1997, NEUROSCIENCE, V81, P893; Viviani D, 2011, SCIENCE, V333, P104, DOI 10.1126/science.1201043; Wang DV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018739; Witter MP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0515; Yassa MA, 2012, J PSYCHIATR RES, V46, P1045, DOI 10.1016/j.jpsychires.2012.04.013	149	318	326	10	145	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2015	18	10					1394	1404		10.1038/nn.4101	http://dx.doi.org/10.1038/nn.4101			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CS2OK	26404714	Green Submitted, Green Accepted			2022-12-17	WOS:000361910600008
J	Gilja, V; Nuyujukian, P; Chestek, CA; Cunningham, JP; Yu, BM; Fan, JM; Churchland, MM; Kaufman, MT; Kao, JC; Ryu, SI; Shenoy, KV				Gilja, Vikash; Nuyujukian, Paul; Chestek, Cindy A.; Cunningham, John P.; Yu, Byron M.; Fan, Joline M.; Churchland, Mark M.; Kaufman, Matthew T.; Kao, Jonathan C.; Ryu, Stephen I.; Shenoy, Krishna V.			A high-performance neural prosthesis enabled by control algorithm design	NATURE NEUROSCIENCE			English	Article							CORTICAL CONTROL; MOVEMENT; INTERFACES; FEEDBACK; HUMANS; CORTEX; SYSTEM	Neural prostheses translate neural activity from the brain into control signals for guiding prosthetic devices, such as computer cursors and robotic limbs, and thus offer individuals with disabilities greater interaction with the world. However, relatively low performance remains a critical barrier to successful clinical translation; current neural prostheses are considerably slower, with less accurate control, than the native arm. Here we present a new control algorithm, the recalibrated feedback intention-trained Kalman filter (ReFIT-KF) that incorporates assumptions about the nature of closed-loop neural prosthetic control. When tested in rhesus monkeys implanted with motor cortical electrode arrays, the ReFIT-KF algorithm outperformed existing neural prosthetic algorithms in all measured domains and halved target acquisition time. This control algorithm permits sustained, uninterrupted use for hours and generalizes to more challenging tasks without retraining. Using this algorithm, we demonstrate repeatable high performance for years after implantation in two monkeys, thereby increasing the clinical viability of neural prostheses.	[Gilja, Vikash] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Gilja, Vikash; Chestek, Cindy A.; Shenoy, Krishna V.] Stanford Univ, Stanford Inst Neuroinnovat & Translat Neurosci, Stanford, CA 94305 USA; [Nuyujukian, Paul; Fan, Joline M.; Shenoy, Krishna V.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Nuyujukian, Paul] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Chestek, Cindy A.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Yu, Byron M.; Churchland, Mark M.; Kaufman, Matthew T.; Shenoy, Krishna V.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Cunningham, John P.; Yu, Byron M.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Yu, Byron M.] UCL, Gatsby Computat Neurosci Unit, London, England; [Yu, Byron M.] Carnegie Mellon Univ, Dept Elect & Comp Engn, Pittsburgh, PA 15213 USA; [Yu, Byron M.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Ryu, Stephen I.] Palo Alto Med Fdn, Dept Neurosurg, Palo Alto, CA USA; [Shenoy, Krishna V.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of Cambridge; University of London; University College London; Carnegie Mellon University; Carnegie Mellon University; Palo Alto Medical Foundation Research Institute; Stanford University	Gilja, V (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.	gilja@stanford.edu	Kaufman, Matthew/AAK-2860-2020; Kaufman, Matthew T/B-6273-2014	Kaufman, Matthew/0000-0002-8072-023X; Kaufman, Matthew T/0000-0002-8072-023X; Nuyujukian, Paul/0000-0001-7778-5473	US National Defense Science and Engineering Graduate Fellowship; National Science Foundation Graduate Research Fellowships; Stanford Medical Scholars Program; Howard Hughes Medical Institute Medical Research Fellows Program; Paul and Daisy Soros Fellowship; Stanford Medical Scientist Training Program; Stanford Graduate Fellowship; Gatsby Charitable Foundation; Helen Hay Whitney postdoctoral fellowship; Burroughs Welcome Fund Career Awards in the Biomedical Sciences; Christopher and Dana Reeve Paralysis Foundation; Defense Advanced Research Projects Agency [N66001-06-C-8005, N66001-10-C-2010]; US National Institutes of Health, National Institute of Neurological Disorders and Stroke Collaborative Research in Computational Neuroscience [R01-NS054283]; National Institutes of Health Directors Pioneer Award [1DP1OD006409]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD075623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054283] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006409] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/H019472/1] Funding Source: researchfish; EPSRC [EP/H019472/1] Funding Source: UKRI	US National Defense Science and Engineering Graduate Fellowship; National Science Foundation Graduate Research Fellowships(National Science Foundation (NSF)); Stanford Medical Scholars Program; Howard Hughes Medical Institute Medical Research Fellows Program(Howard Hughes Medical Institute); Paul and Daisy Soros Fellowship; Stanford Medical Scientist Training Program; Stanford Graduate Fellowship(Stanford University); Gatsby Charitable Foundation; Helen Hay Whitney postdoctoral fellowship; Burroughs Welcome Fund Career Awards in the Biomedical Sciences(Burroughs Wellcome Fund); Christopher and Dana Reeve Paralysis Foundation; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); US National Institutes of Health, National Institute of Neurological Disorders and Stroke Collaborative Research in Computational Neuroscience; National Institutes of Health Directors Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank M. Mazariegos, J. Aguayo, W. Kalkus, S. Kang, E. Morgan and C. Sherman for surgical assistance and veterinary care, D. Haven and B. Oskotsky for information technology support, S. Eisensee, B. Davis and E. Castaneda for administrative assistance, P. Ortega for mathematical insight, and S. Stavisky for data-collection assistance. This work was supported by a US National Defense Science and Engineering Graduate Fellowship (V. G.), National Science Foundation Graduate Research Fellowships (V. G., C. A. C., J. M. F., M. T. K. and J. C. K.), Stanford Medical Scholars Program, Howard Hughes Medical Institute Medical Research Fellows Program, Paul and Daisy Soros Fellowship, Stanford Medical Scientist Training Program (P.N.), Stanford Graduate Fellowship (C. A. C., J. P. C. and J. M. F.), Gatsby Charitable Foundation (B.M.Y.), a Helen Hay Whitney postdoctoral fellowship (M. M. C.), Burroughs Welcome Fund Career Awards in the Biomedical Sciences (M. M. C. and K. V. S.), the Christopher and Dana Reeve Paralysis Foundation (S. I. R. and K. V. S.), Defense Advanced Research Projects Agency Revolutionizing Prosthetics 2009 N66001-06-C-8005, Reorganization and Plasticity to Accelerate Injury Recovery N66001-10-C-2010, US National Institutes of Health, National Institute of Neurological Disorders and Stroke Collaborative Research in Computational Neuroscience grant R01-NS054283, and National Institutes of Health Directors Pioneer Award 1DP1OD006409 (K.V.S.).	CARD SK, 1978, ERGONOMICS, V21, P601, DOI 10.1080/00140137808931762; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chase SM, 2009, NEURAL NETWORKS, V22, P1203, DOI 10.1016/j.neunet.2009.05.005; Chestek CA, 2009, IEEE ENG MED BIO, P3369, DOI 10.1109/IEMBS.2009.5332822; Chestek CA, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/045005; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; Cunningham JP, 2011, J NEUROPHYSIOL, V105, P1932, DOI 10.1152/jn.00503.2010; Fraser GW, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055004; Gage GJ, 2005, J NEURAL ENG, V2, P52, DOI 10.1088/1741-2560/2/2/006; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; Gilja V, 2011, IEEE T BIO-MED ENG, V58, P1891, DOI 10.1109/TBME.2011.2107553; Golub MD, 2012, IEEE ENG MED BIO, P1327, DOI 10.1109/EMBC.2012.6346182; Hochberg LR, 2008, NEW ENGL J MED, V359, P1175, DOI 10.1056/NEJMcibr0805122; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Judy JW, 2012, IEEE PULSE, V3, P57, DOI 10.1109/MPUL.2011.2181026; Kalaska JF, 2009, ADV EXP MED BIOL, V629, P139, DOI 10.1007/978-0-387-77064-2_8; Kaufman MT, 2010, J NEUROPHYSIOL, V104, P799, DOI 10.1152/jn.00231.2009; Kim SP, 2011, IEEE T NEUR SYS REH, V19, P193, DOI 10.1109/TNSRE.2011.2107750; Kim SP, 2008, J NEURAL ENG, V5, P455, DOI 10.1088/1741-2560/5/4/010; Li Z, 2011, NEURAL COMPUT, V23, P3162, DOI 10.1162/NECO_a_00207; McFarland DJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036007; Mulliken GH, 2008, J NEUROSCI, V28, P12913, DOI 10.1523/JNEUROSCI.1463-08.2008; Sadtler PT, 2011, I IEEE EMBS C NEUR E, P601, DOI 10.1109/NER.2011.5910620; Santhanam G, 2007, IEEE T BIO-MED ENG, V54, P2037, DOI 10.1109/TBME.2007.895753; Schalk G, 2008, J NEURAL ENG, V5, P75, DOI 10.1088/1741-2560/5/1/008; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Shpigelman L, 2009, ADV NEURAL INFORM PR, P1489; Srinivasan L, 2007, J NEUROPHYSIOL, V98, P2456, DOI 10.1152/jn.01118.2006; Suminski AJ, 2010, J NEUROSCI, V30, P16777, DOI 10.1523/JNEUROSCI.3967-10.2010; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Yu BM, 2007, J NEUROPHYSIOL, V97, P3763, DOI 10.1152/jn.00482.2006	33	318	324	5	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1752	1757		10.1038/nn.3265	http://dx.doi.org/10.1038/nn.3265			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23160043	Green Accepted			2022-12-17	WOS:000311706700023
J	Diester, I; Kaufman, MT; Mogri, M; Pashaie, R; Goo, W; Yizhar, O; Ramakrishnan, C; Deisseroth, K; Shenoy, KV				Diester, Ilka; Kaufman, Matthew T.; Mogri, Murtaza; Pashaie, Ramin; Goo, Werapong; Yizhar, Ofer; Ramakrishnan, Charu; Deisseroth, Karl; Shenoy, Krishna V.			An optogenetic toolbox designed for primates	NATURE NEUROSCIENCE			English	Article							SENSORY-MOTOR CORTEX; IN-VIVO CONTROL; OPTICAL CONTROL; MILLISECOND-TIMESCALE; ADENOASSOCIATED VIRUS; CORTICAL-NEURONS; NEURAL CIRCUITRY; NONHUMAN PRIMATE; GENE-THERAPY; MONKEY	Optogenetics is a technique for controlling subpopulations of neurons in the intact brain using light. This technique has the potential to enhance basic systems neuroscience research and to inform the mechanisms and treatment of brain injury and disease. Before launching large-scale primate studies, the method needs to be further characterized and adapted for use in the primate brain. We assessed the safety and efficiency of two viral vector systems (lentivirus and adeno-associated virus), two human promoters (human synapsin (hSyn) and human thymocyte-1 (hThy-1)) and three excitatory and inhibitory mammalian codon-optimized opsins (channelrhodopsin-2, enhanced Natronomonas pharaonis halorhodopsin and the step-function opsin), which we characterized electrophysiologically, histologically and behaviorally in rhesus monkeys (Macaca mulatta). We also introduced a new device for measuring in vivo fluorescence over time, allowing minimally invasive assessment of construct expression in the intact brain. We present a set of optogenetic tools designed for optogenetic experiments in the non-human primate brain.	[Diester, Ilka; Mogri, Murtaza; Pashaie, Ramin; Goo, Werapong; Yizhar, Ofer; Ramakrishnan, Charu; Deisseroth, Karl; Shenoy, Krishna V.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Kaufman, Matthew T.; Deisseroth, Karl; Shenoy, Krishna V.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu; shenoy@stanford.edu	Core, Vector/CAF-4832-2022; Kaufman, Matthew/AAK-2860-2020; YIZHAR, OFER/AAV-8497-2021; Kaufman, Matthew T/B-6273-2014; Diester, Ilka/D-4473-2011	Kaufman, Matthew/0000-0002-8072-023X; Kaufman, Matthew T/0000-0002-8072-023X; Ramakrishnan, Charu/0000-0002-3474-6332; Yizhar, Ofer/0000-0003-4228-1448	Human Frontier Science Program; German Academic Exchange Service Award; National Science Foundation; Bio-X; Stanford Graduate Fellowship; Stanford University; William M. Keck Foundation; Snyder Foundation; Albert Yu and Mary Bechmann Foundation; Wallace Coulter Foundation; California Institute for Regenerative Medicine; McKnight Foundation; Esther A. and Joseph Klingenstein Fund; National Institute of Mental Health; National Institute on Drug Abuse; US National Institutes of Health [1DP1OD006409]; Burroughs Wellcome Fund; US National Institutes of Health-National Institute of Neurological Disorders and Stroke [CRCNS R01-NS054283]; Defense Advanced Research Projects Agency [N66001-10-C-2010]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054283] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006409] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); German Academic Exchange Service Award(Deutscher Akademischer Austausch Dienst (DAAD)); National Science Foundation(National Science Foundation (NSF)); Bio-X; Stanford Graduate Fellowship(Stanford University); Stanford University(Stanford University); William M. Keck Foundation(W.M. Keck Foundation); Snyder Foundation; Albert Yu and Mary Bechmann Foundation; Wallace Coulter Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); McKnight Foundation; Esther A. and Joseph Klingenstein Fund; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); US National Institutes of Health-National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Vessal and A. Lilak for technical assistance during perfusions, M. Churchland for technical support during surgeries and technical discussions, S. Ryu for surgical assistance, M. Risch for veterinary care, D. Haven for technical support, S. Eisensee for administrative assistance, I. Witten for advice and members of the Deisseroth and Shenoy laboratories for discussions. I. D. is supported by a Human Frontier Science Program fellowship and a German Academic Exchange Service Award, M. T. K. by a National Science Foundation graduate fellowship, M.M. by Bio-X and a Stanford Graduate Fellowship and R. P. by a Stanford University Dean's Postdoctoral Fellowship Award. W. G. is supported by a Stanford Graduate Fellowship. O.Y. is supported by a Human Frontier Science Program fellowship. K. D. is supported by the William M. Keck Foundation, the Snyder Foundation, the Albert Yu and Mary Bechmann Foundation, the Wallace Coulter Foundation, the California Institute for Regenerative Medicine, the McKnight Foundation, the Esther A. and Joseph Klingenstein Fund, the National Science Foundation, the National Institute of Mental Health, the National Institute on Drug Abuse and a US National Institutes of Health Director's Pioneer Award. K. V. S. is supported by a Burroughs Wellcome Fund Career Award in the Biomedical Sciences, US National Institutes of Health-National Institute of Neurological Disorders and Stroke grant CRCNS R01-NS054283 and a US National Institutes of Health Director's Pioneer Award (1DP1OD006409). K. D. and K. V. S. are supported by Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery (N66001-10-C-2010).	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Adelsberger H, 2005, NAT NEUROSCI, V8, P988, DOI 10.1038/nn1502; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bogen IL, 2009, NEUROCHEM INT, V55, P13, DOI 10.1016/j.neuint.2009.02.006; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; CALVIN WH, 1976, J NEUROPHYSIOL, V39, P420, DOI 10.1152/jn.1976.39.2.420; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Chen CH, 2007, J CELL BIOCHEM, V101, P566, DOI 10.1002/jcb.21217; Christine CW, 2009, NEUROLOGY, V73, P1662, DOI 10.1212/WNL.0b013e3181c29356; Churchland MM, 2007, J NEUROPHYSIOL, V97, P348, DOI 10.1152/jn.00808.2006; Colle MA, 2010, HUM MOL GENET, V19, P147, DOI 10.1093/hmg/ddp475; Diester I, 2008, J NEUROSCI, V28, P7737, DOI 10.1523/JNEUROSCI.1347-08.2008; Disbrow E, 2003, J COMP NEUROL, V462, P382, DOI 10.1002/cne.10731; Dodiya HB, 2010, MOL THER, V18, P579, DOI 10.1038/mt.2009.216; Frigault MM, 2009, J CELL SCI, V122, P753, DOI 10.1242/jcs.033837; GILJA V, IEEE T BIOM IN PRESS; Gordon T, 2009, NEUROSURGERY, V65, pA132, DOI 10.1227/01.NEU.0000335650.09473.D3; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; HIKOSAKA O, 1983, BRAIN RES, V272, P368, DOI 10.1016/0006-8993(83)90586-3; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; HOUSER CR, 1983, J NEUROCYTOL, V12, P617, DOI 10.1007/BF01181527; JONES EG, 1994, J NEUROSCI, V14, P611; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kaufman MT, 2010, J NEUROPHYSIOL, V104, P799, DOI 10.1152/jn.00231.2009; Kim S, 2007, IEEE T NEUR SYS REH, V15, P493, DOI 10.1109/TNSRE.2007.908429; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; LEICHNETZ GR, 1986, J COMP NEUROL, V254, P460, DOI 10.1002/cne.902540403; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McFarland NR, 2009, J NEUROCHEM, V109, P838, DOI 10.1111/j.1471-4159.2009.06010.x; MCLENDON RE, 1994, BRAIN PATHOL, V4, P221, DOI 10.1111/j.1750-3639.1994.tb00837.x; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nathanson JL, 2009, NEUROSCIENCE, V161, P441, DOI 10.1016/j.neuroscience.2009.03.032; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhang JY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055007	49	318	345	1	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					387	397		10.1038/nn.2749	http://dx.doi.org/10.1038/nn.2749			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21278729	Green Accepted			2022-12-17	WOS:000287650100021
J	Ferguson, SM; Eskenazi, D; Ishikawa, M; Wanat, MJ; Phillips, PEM; Dong, Y; Roth, BL; Neumaier, JF				Ferguson, Susan M.; Eskenazi, Daniel; Ishikawa, Masago; Wanat, Matthew J.; Phillips, Paul E. M.; Dong, Yan; Roth, Bryan L.; Neumaier, John F.			Transient neuronal inhibition reveals opposing roles of indirect and direct pathways in sensitization	NATURE NEUROSCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; STRIATOPALLIDAL NEURONS; ADDICTION; DOPAMINE; PLASTICITY; EXPRESSION; D1	Dorsal striatum is important for the development of drug addiction; however, a precise understanding of the roles of striatopallidal (indirect) and striatonigral (direct) pathway neurons in regulating behaviors remains elusive. Using viral-mediated expression of an engineered G protein-coupled receptor (hM(4)D), we found that activation of hM(4)D receptors with clozapine-N-oxide (CNO) potently reduced striatal neuron excitability. When hM(4)D receptors were selectively expressed in either direct or indirect pathway neurons, CNO did not change acute locomotor responses to amphetamine, but did alter behavioral plasticity associated with repeated drug treatment. Specifically, transiently disrupting striatopallidal neuronal activity facilitated behavioral sensitization, whereas decreasing excitability of striatonigral neurons impaired its persistence. These findings suggest that acute drug effects can be parsed from the behavioral adaptations associated with repeated drug exposure and highlight the utility of this approach for deconstructing neuronal pathway contributions to behavior.	[Ferguson, Susan M.; Eskenazi, Daniel; Wanat, Matthew J.; Phillips, Paul E. M.; Neumaier, John F.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Ishikawa, Masago; Dong, Yan] Washington State Univ, Program Neurosci, Pullman, WA 99164 USA; [Wanat, Matthew J.; Phillips, Paul E. M.; Neumaier, John F.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA	University of Washington; University of Washington Seattle; Washington State University; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Neumaier, JF (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	neumaier@uw.edu	Phillips, Paul E. M./A-4463-2008; Roth, Bryan/ABE-7032-2020; Ferguson, Susan/J-5427-2013; Dong, Yan/A-4154-2016; Roth, Bryan L/F-3928-2010; Phillips, Paul/E-7813-2013	Phillips, Paul E. M./0000-0002-8749-7026; Roth, Bryan/0000-0002-0561-6520; Ferguson, Susan/0000-0002-2840-757X; Dong, Yan/0000-0003-0016-9028; Phillips, Paul/0000-0002-8749-7026; Wanat, Matthew/0000-0003-1643-6557	US National Institutes of Health [K99 DA024762, T32 GM07266, T32 GM07108, T32 AA009455, F32 DA026273, R21 DA021793, R01 DA023206, U19MH82441]; National Institute of Mental Health; National Alliance for Research on Schizophrenia and Depression Distinguished Investigator Award; Achievement Rewards for College Scientists;  [R21 DA021273]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266, T32GM007108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017204, R21DA021273, R01DA023206, F32DA026273, K99DA024762, R21DA021793] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression Distinguished Investigator Award(NARSAD); Achievement Rewards for College Scientists; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by US National Institutes of Health grants K99 DA024762 (S.M.F.), T32 GM07266 and T32 GM07108 (D.E.), T32 AA009455 and F32 DA026273 (M.J.W.), R21 DA021793 (P.E.M.P.), R01 DA023206 (Y.D.), U19MH82441 and the National Institute of Mental Health Psychoactive Drug Screening Program (B.L.R.), and R21 DA021273 (J.F.N.), an Achievement Rewards for College Scientists (D.E.), and a National Alliance for Research on Schizophrenia and Depression Distinguished Investigator Award (B.L.R.).	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Badiani A, 1999, BEHAV BRAIN RES, V103, P203, DOI 10.1016/S0166-4328(99)00041-8; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Clark JJ, 2010, NAT METHODS, V7, P126, DOI [10.1038/NMETH.1412, 10.1038/nmeth.1412]; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Harlan RE, 1998, MOL NEUROBIOL, V16, P221, DOI 10.1007/BF02741385; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Robinson TE, 2001, ADDICTION, V96, P103, DOI 10.1046/j.1360-0443.2001.9611038.x; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Smith Y, 1998, NEUROSCIENCE, V86, P353	14	318	321	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					22	24		10.1038/nn.2703	http://dx.doi.org/10.1038/nn.2703			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21131952	Green Accepted, Green Submitted			2022-12-17	WOS:000285684900008
J	Urushitani, M; Sik, A; Sakurai, T; Nukina, N; Takahashi, R; Julien, JP				Urushitani, M; Sik, A; Sakurai, T; Nukina, N; Takahashi, R; Julien, JP			Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis	NATURE NEUROSCIENCE			English	Article							MOLECULAR-WEIGHT COMPLEXES; B-LIKE IMMUNOREACTIVITY; BRAIN MICROGLIAL CELLS; MOTOR-NEURON DISEASE; AXONAL-TRANSPORT; ALZHEIMERS-DISEASE; TRANSGENIC MICE; FAMILIAL ALS; SPINAL-CORD; MOUSE MODEL	Here we report that chromogranins, components of neurosecretory vesicles, interact with mutant forms of superoxide dismutase (SOD1) that are linked to amyotrophic lateral sclerosis (ALS), but not with wild-type SOD1. This interaction was confirmed by yeast two-hybrid screen and by co-immunoprecipitation assays using either lysates from Neuro2a cells coexpressing chromogranins and SOD1 mutants or lysates from spinal cord of ALS mice. Confocal and immunoelectron microscopy revealed a partial colocalization of mutant SOD1 with chromogranins in spinal cord of ALS mice. Mutant SOD1 was also found in immuno-isolated trans-Golgi network and in microsome preparations, suggesting that it can be secreted. Indeed we report evidence that chromogranins may act as chaperone-like proteins to promote secretion of SOD1 mutants. From these results, and our finding that extracellular mutant SOD1 can trigger microgliosis and neuronal death, we propose a new ALS pathogenic model based on the toxicity of secreted SOD1 mutants.	Univ Laval, Ctr Rech, CHU Laval, Dept Anat & Physiol, Quebec City, PQ G1V 4G2, Canada; Univ Laval Robert Giffard, Dept Psychiat, Ctr Rech, Quebec City, PQ G1J 2G3, Canada; RIKEN Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan	Laval University; Laval University; RIKEN	Julien, JP (corresponding author), Univ Laval, Ctr Rech, CHU Laval, Dept Anat & Physiol, 2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.	jean-pierre.julien@crchul.ulaval.ca	Nukina, Nobuyuki/GPP-6265-2022	Urushitani, Makoto/0000-0003-2773-9836				BOOJ S, 1989, NEUROSCIENCE, V30, P479, DOI 10.1016/0306-4522(89)90267-4; CHANAT E, 1993, EMBO J, V12, P2159, DOI 10.1002/j.1460-2075.1993.tb05864.x; Ciesielski-Treska J, 1998, J BIOL CHEM, V273, P14339, DOI 10.1074/jbc.273.23.14339; Ciesielski-Treska J, 2001, J BIOL CHEM, V276, P13113, DOI 10.1074/jbc.M009711200; Cimini V, 2002, HISTOCHEM CELL BIOL, V118, P163, DOI 10.1007/s00418-002-0429-8; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Cowley DJ, 2000, J BIOL CHEM, V275, P7743, DOI 10.1074/jbc.275.11.7743; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Huh YH, 2003, J BIOL CHEM, V278, P40581, DOI 10.1074/jbc.M304942200; Jacobsson J, 2001, BRAIN, V124, P1461, DOI 10.1093/brain/124.7.1461; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kato A, 2000, BRAIN RES, V852, P444, DOI 10.1016/S0006-8993(99)02229-5; Lafon-Cazal M, 2003, J BIOL CHEM, V278, P24438, DOI 10.1074/jbc.M211980200; Li JY, 1999, EUR J NEUROSCI, V11, P528, DOI 10.1046/j.1460-9568.1999.00456.x; LI JY, 1992, J NEUROBIOL, V23, P1094, DOI 10.1002/neu.480230813; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Marksteiner J, 2000, ACTA NEUROPATHOL, V100, P205, DOI 10.1007/s004010000239; Miyakawa K, 2003, J BIOL CHEM, V278, P35718, DOI 10.1074/jbc.M300690200; Nguyen MD, 2004, J NEUROSCI, V24, P1340, DOI 10.1523/JNEUROSCI.4786-03.2004; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Parkin ET, 1999, J NEUROCHEM, V72, P1534, DOI 10.1046/j.1471-4159.1999.721534.x; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Rangon CM, 2003, NEUROREPORT, V14, P755, DOI 10.1097/00001756-200304150-00019; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rudolf R, 2001, MOL BIOL CELL, V12, P1353, DOI 10.1091/mbc.12.5.1353; SCHIFFER D, 1995, J NEUROL SCI, V129, P68, DOI 10.1016/0022-510X(95)00068-D; SHARPLESS N, 1992, VIROLOGY, V191, P813, DOI 10.1016/0042-6822(92)90257-P; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Stephens DJ, 1999, J BIOL CHEM, V274, P30080, DOI 10.1074/jbc.274.42.30080; Stieber A, 2004, J NEUROL SCI, V219, P45, DOI 10.1016/j.jns.2003.12.004; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Taupenot L, 1996, NEUROSCIENCE, V72, P377, DOI 10.1016/0306-4522(96)83172-1; Taylor DL, 2003, J NEUROSCI, V23, P2150; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Tobisawa S, 2003, BIOCHEM BIOPH RES CO, V303, P496, DOI 10.1016/S0006-291X(03)00353-X; Turner BJ, 2005, J NEUROSCI, V25, P108, DOI 10.1523/JNEUROSCI.4253-04.2005; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	47	318	342	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					108	118		10.1038/nn1603	http://dx.doi.org/10.1038/nn1603			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16369483				2022-12-17	WOS:000234288000024
J	Singer, O; Marr, RA; Rockenstein, E; Crews, L; Coufal, NG; Gage, FH; Verma, IM; Masliah, E				Singer, O; Marr, RA; Rockenstein, E; Crews, L; Coufal, NG; Gage, FH; Verma, IM; Masliah, E			Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model	NATURE NEUROSCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; CARBOXYL-TERMINAL FRAGMENT; BETA-SECRETASE ACTIVITY; IN-VIVO; RNA INTERFERENCE; LENTIVIRAL VECTOR; CLEAVING ENZYME; MICE; BRAIN; EXPRESSION	In Alzheimer disease, increased beta-secretase (BACE1) activity has been associated with neurodegeneration and accumulation of amyloid precursor protein (APP) products. Thus, inactivation of BACE1 could be important in the treatment of Alzheimer disease. In this study, we found that lowering BACE1 levels using lentiviral vectors expressing siRNAs targeting BACE1 reduced amyloid production and the neurodegenerative and behavioral deficits in APP transgenic mice, a model of Alzheimer disease. Our results suggest that lentiviral vector delivery of BACE1 siRNA can specifically reduce the cleavage of APP and neurodegeneration in vivo and indicate that this approach could have potential therapeutic value for treatment of Alzheimer disease.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego	Masliah, E (corresponding author), Univ Calif San Diego, Dept Neurosci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	verma@salk.edu; emasliah@ucsd.edu	Coufal, Nicole/ABA-9471-2021; Crews, Leslie/B-7584-2014	Crews, Leslie/0000-0003-0704-0067; Coufal, Nicole/0000-0001-6547-1733	NIA NIH HHS [AG5131, AG08514, AG18440, AG10435] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG010435, R01AG018440, P50AG005131, R37AG008514, R01AG008514, R37AG018440] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Berger-Sweeney J, 1999, MOL BRAIN RES, V66, P150, DOI 10.1016/S0169-328X(99)00014-5; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chang WP, 2004, J NEUROCHEM, V89, P1409, DOI 10.1111/j.1471-4159.2004.02452.x; Citron M, 2002, NEUROBIOL AGING, V23, P1017, DOI 10.1016/S0197-4580(02)00122-7; Davidson BL, 2004, LANCET NEUROL, V3, P145, DOI 10.1016/S1474-4422(04)00678-7; Dingwall C, 2001, J CLIN INVEST, V108, P1243, DOI 10.1172/JCI200114402; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Huse JT, 2002, J BIOL CHEM, V277, P16278, DOI 10.1074/jbc.M111141200; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kao SC, 2004, J BIOL CHEM, V279, P1942, DOI 10.1074/jbc.M309219200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim HS, 1998, NEUROREPORT, V9, P3875, DOI 10.1097/00001756-199812010-00020; Kim HS, 2000, FASEB J, V14, P1508, DOI 10.1096/fj.14.11.1508; Kitazume S, 2005, J BIOL CHEM, V280, P8589, DOI 10.1074/jbc.M409417200; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Marr RA, 2003, J NEUROSCI, V23, P1992; Masliah E, 2003, NEUROLOGY, V61, P206, DOI 10.1212/01.WNL.0000073987.79060.4B; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Miller VM, 2004, NUCLEIC ACIDS RES, V32, P661, DOI 10.1093/nar/gkh208; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; OsterGranite ML, 1996, J NEUROSCI, V16, P6732; Pfeifer A, 2000, P NATL ACAD SCI USA, V97, P12227, DOI 10.1073/pnas.220399597; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Rockenstein E, 2003, J NEURAL TRANSM, V110, P1313, DOI 10.1007/s00702-003-0025-7; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; ROCKENSTEIN E, 2005, J BIOL CHEM     0715; Rossner S, 2001, J NEUROSCI RES, V64, P437; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sinha S, 2000, ANN NY ACAD SCI, V920, P206; Song DK, 1998, J NEUROCHEM, V71, P875; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Tuszynski MH, 2003, EXPERT OPIN BIOL TH, V3, P815, DOI 10.1517/eobt.3.5.815.21228; Vassar R, 2001, J MOL NEUROSCI, V17, P157, DOI 10.1385/JMN:17:2:157; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076	49	318	416	2	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1343	1349		10.1038/nn1531	http://dx.doi.org/10.1038/nn1531			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16136043				2022-12-17	WOS:000232145900018
J	Van Hove, H; Martens, L; Scheyltjens, I; De Vlaminck, K; Antunes, ARP; De Prijck, S; Vandamme, N; De Schepper, S; Van Isterdael, G; Scott, CL; Aerts, J; Berx, G; Boeckxstaene, GE; Vandenbroucke, RE; Vereecke, L; Moechars, D; Guilliams, M; Van Ginderachter, JA; Saeys, Y; Movahedi, K				Van Hove, Hannah; Martens, Liesbet; Scheyltjens, Isabelle; De Vlaminck, Karen; Antunes, Ana Rita Pombo; De Prijck, Sofie; Vandamme, Niels; De Schepper, Sebastiaan; Van Isterdael, Gert; Scott, Charlotte L.; Aerts, Jeroen; Berx, Geert; Boeckxstaene, Guy E.; Vandenbroucke, Roosmarijn E.; Vereecke, Lars; Moechars, Diederik; Guilliams, Martin; Van Ginderachter, Jo A.; Saeys, Yvan; Movahedi, Kiavash			A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; GENE-EXPRESSION; DENDRITIC CELLS; MICROGLIA; DISEASE; IRF8; ORIGIN; PRECURSORS; CYTOSCAPE; MONOCYTES	While the roles of parenchymal microglia in brain homeostasis and disease are fairly clear, other brain-resident myeloid cells remain less well understood. By dissecting border regions and combining single-cell RNA-sequencing with high-dimensional cytometry, bulk RNA-sequencing, fate-mapping and microscopy, we reveal the diversity of non-parenchymal brain macrophages. Border-associated macrophages (BAMs) residing in the dura mater, subdural meninges and choroid plexus consisted of distinct subsets with tissue-specific transcriptional signatures, and their cellular composition changed during postnatal development. BAMs exhibited a mixed ontogeny, and subsets displayed distinct self-renewal capacity following depletion and repopulation. Single-cell and fate-mapping analysis both suggested that there is a unique microglial subset residing on the apical surface of the choroid plexus epithelium. Finally, gene network analysis and conditional deletion revealed IRF8 as a master regulator that drives the maturation and diversity of brain macrophages. Our results provide a framework for understanding host-macrophage interactions in both the healthy and diseased brain.	[Van Hove, Hannah; Scheyltjens, Isabelle; De Vlaminck, Karen; Antunes, Ana Rita Pombo; Van Ginderachter, Jo A.; Movahedi, Kiavash] VIB Ctr Inflammat Res, Myeloid Cell Immunol Lab, Brussels, Belgium; [Van Hove, Hannah; Scheyltjens, Isabelle; De Vlaminck, Karen; Antunes, Ana Rita Pombo; Van Ginderachter, Jo A.; Movahedi, Kiavash] Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium; [Martens, Liesbet; Vandamme, Niels; Saeys, Yvan] VIB Ctr Inflammat Res, Data Min & Modeling Biomed, Ghent, Belgium; [Martens, Liesbet; De Prijck, Sofie; Vandamme, Niels; Van Isterdael, Gert; Scott, Charlotte L.; Vandenbroucke, Roosmarijn E.; Guilliams, Martin] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [De Prijck, Sofie; Scott, Charlotte L.; Guilliams, Martin] VIB Ctr Inflammat Res, Lab Myeloid Cell Ontogeny & Funct Specializat, Ghent, Belgium; [Vandamme, Niels; Berx, Geert] Canc Res Inst Ghent, Ghent, Belgium; [De Schepper, Sebastiaan; Boeckxstaene, Guy E.] Katholieke Univ Leuven, Ctr Intestinal Neuroimmune Interact, Translat Res Ctr Gastrointestinal Disorders, Dept Chron Dis Metab & Ageing, Leuven, Belgium; [Van Isterdael, Gert] VIB Ctr Inflammat Res, VIB Flow Core, Ghent, Belgium; [Scott, Charlotte L.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Aerts, Jeroen; Moechars, Diederik] Dept Neurosci Janssen Res & Dev, Beerse, Belgium; [Berx, Geert] Univ Ghent, Dept Biomed Mol Biol, Mol & Cellular Oncol Lab, Ghent, Belgium; [Vandenbroucke, Roosmarijn E.] VIB Ctr Inflammat Res, Barriers Inflammat Lab, Ghent, Belgium; [Vandenbroucke, Roosmarijn E.; Vereecke, Lars] Univ Ghent, Ghent Gut Inflammat Grp, Ghent, Belgium; [Vereecke, Lars] VIB Ctr Inflammat Res, Hostmicrobiota Interact Lab, Ghent, Belgium; [Vereecke, Lars] Univ Hosp Ghent, Dept Rheumatol, Ghent, Belgium; [Saeys, Yvan] Univ Ghent, Dept Appl Math Comp Sci & Stat, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; KU Leuven; Flanders Institute for Biotechnology (VIB); Ghent University; University of Glasgow; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University Hospital; Ghent University	Movahedi, K (corresponding author), VIB Ctr Inflammat Res, Myeloid Cell Immunol Lab, Brussels, Belgium.; Movahedi, K (corresponding author), Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium.	kiavash.movahedi@vub.vib.be	Saeys, Yvan/C-1311-2009; Guilliams, Martin/N-7803-2013; Vereecke, Lars/ABH-2926-2020; Movahedi, Kiavash/AAQ-4942-2020; Van Ginderachter, Jo A/H-5473-2013; Vandenbroucke, Roosmarijn/AAC-2757-2019; Vandenbroucke, Roosmarijn/B-9419-2009	Saeys, Yvan/0000-0002-0415-1506; Guilliams, Martin/0000-0003-3525-7570; Vereecke, Lars/0000-0002-1593-862X; Movahedi, Kiavash/0000-0002-0826-4399; Van Ginderachter, Jo A/0000-0002-4442-7474; Boeckxstaens, Guy/0000-0001-8267-5797; Pombo Antunes, Ana Rita/0000-0002-6484-5593; Vandenbroucke, Roosmarijn/0000-0002-8327-620X; Scheyltjens, Isabelle/0000-0002-2260-2921; Martens, Liesbet/0000-0001-9180-7456; Elewaut, Dirk/0000-0002-7468-974X; Van Isterdael, Gert/0000-0001-6626-1316; Berx, Geert/0000-0001-5770-2458; Van Hove, Hannah/0000-0002-0412-6474	Innoviris [BB2B 2015-2]; Fonds Wetenschappelijk Onderzoek [1506316 N]; VLAIO grant [ImmCyte HBC.2016.0889]; FWO predoctoral fellowship [1163218 N]; VIB Tech Watch	Innoviris(Innoviris); Fonds Wetenschappelijk Onderzoek(FWO); VLAIO grant; FWO predoctoral fellowship; VIB Tech Watch	This work was supported by Innoviris (Attract grant No. BB2B 2015-2) and Fonds Wetenschappelijk Onderzoek (grant No. 1506316 N) to K.M. and a VLAIO grant (No. ImmCyte HBC.2016.0889) to K.M, J.A. V.G., J.A. and D.M. H. V.H. is supported by an FWO predoctoral fellowship (No. 1163218 N). Y.S. is an ISAC Marylou Ingram Scholar. We thank Y. Elkrim for technical assistance, M. Kiss for helpful discussions, VIB BioImaging Core for support regarding microscopy and VIB Tech Watch for support and funding with regard to scRNA-seq technologies.	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Ajami B, 2018, NAT NEUROSCI, V21, P541, DOI 10.1038/s41593-018-0100-x; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; BALIN BJ, 1986, J COMP NEUROL, V251, P260, DOI 10.1002/cne.902510209; Benz C, 2008, J EXP MED, V205, P1187, DOI 10.1084/jem.20072168; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Butovsky O, 2015, ANN NEUROL, V77, P75, DOI 10.1002/ana.24304; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585; Cannoodt Robrecht, 2016, BIORXIV, DOI [10.1101/079509v2, DOI 10.1101/079509V2]; Jordao MJC, 2019, SCIENCE, V363, P365, DOI 10.1126/science.aat7554; Cronk JC, 2018, J EXP MED, V215, P1627, DOI 10.1084/jem.20180247; Deczkowska A, 2018, CELL, V173, P1073, DOI 10.1016/j.cell.2018.05.003; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Hagemeyer N, 2016, EMBO J, V35, P1730, DOI 10.15252/embj.201693801; Haimon Z, 2018, NAT IMMUNOL, V19, P636, DOI 10.1038/s41590-018-0110-6; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Inoue S, 2010, GENESIS, V48, P207, DOI 10.1002/dvg.20603; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Korin B, 2017, NAT NEUROSCI, V20, P1300, DOI 10.1038/nn.4610; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Kucera Mike, 2016, F1000Res, V5, P1717; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Ling EA, 1998, MICROSC RES TECHNIQ, V41, P43, DOI 10.1002/(SICI)1097-0029(19980401)41:1<43::AID-JEMT5>3.0.CO;2-V; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lun Aaron T L, 2016, F1000Res, V5, P2122; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Masuda T, 2014, PURINERG SIGNAL, V10, P515, DOI 10.1007/s11302-014-9413-8; Masuda T, 2012, CELL REP, V1, P334, DOI 10.1016/j.celrep.2012.02.014; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mildner A, 2017, IMMUNITY, V46, P849, DOI 10.1016/j.immuni.2017.04.018; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011; NABESHIMA S, 1975, J COMP NEUROL, V164, P127, DOI 10.1002/cne.901640202; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Scott CL, 2018, IMMUNITY, V49, P312, DOI 10.1016/j.immuni.2018.07.004; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shechter R, 2013, NAT REV IMMUNOL, V13, P206, DOI 10.1038/nri3391; Sichien D, 2016, IMMUNITY, V45, P626, DOI 10.1016/j.immuni.2016.08.013; Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027/MACHINEREADABLECITATION/RIS]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Song W, 2017, ALZHEIMERS DEMENT, V13, P381, DOI 10.1016/j.jalz.2016.07.004; Tamura T, 2015, INT J HEMATOL, V101, P342, DOI 10.1007/s12185-015-1761-9; van den Brink SC, 2017, NAT METHODS, V14, P935, DOI 10.1038/nmeth.4437; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wolburg H, 2010, ACTA NEUROPATHOL, V119, P75, DOI 10.1007/s00401-009-0627-8; Wu YE, 2017, NEURON, V96, P313, DOI 10.1016/j.neuron.2017.09.026; Xu C, 2015, BIOINFORMATICS, V31, P1974, DOI 10.1093/bioinformatics/btv088; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	67	317	318	5	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2019	22	6					1021	1035		10.1038/s41593-019-0393-4	http://dx.doi.org/10.1038/s41593-019-0393-4			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HZ5HT	31061494	Green Accepted			2022-12-17	WOS:000468883100021
J	Lepore, AC; Rauck, B; Dejea, C; Pardo, AC; Rao, MS; Rothstein, JD; Maragakis, NJ				Lepore, Angelo C.; Rauck, Britta; Dejea, Christine; Pardo, Andrea C.; Rao, Mahendra S.; Rothstein, Jeffrey D.; Maragakis, Nicholas J.			Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; GLIAL-RESTRICTED PRECURSORS; TRANSGENIC RAT MODEL; STEM-CELL GRAFTS; GLUTAMATE TRANSPORTERS; MOUSE MODEL; EXTEND SURVIVAL; HNT NEURONS; ADULT RATS; ALS MODEL	Cellular abnormalities in amyotrophic lateral sclerosis (ALS) are not limited to motor neurons. Astrocyte dysfunction also occurs in human ALS and transgenic rodents expressing mutant human SOD1 protein (SOD1(G93A)). Here we investigated focal enrichment of normal astrocytes using transplantation of lineage-restricted astrocyte precursors, called glial-restricted precursors (GRPs). We transplanted GRPs around cervical spinal cord respiratory motor neuron pools, the principal cells whose dysfunction precipitates death in ALS. GRPs survived in diseased tissue, differentiated efficiently into astrocytes and reduced microgliosis in the cervical spinal cords of SOD1G93A rats. GRPs also extended survival and disease duration, attenuated motor neuron loss and slowed declines in forelimb motor and respiratory physiological functions. Neuroprotection was mediated in part by the primary astrocyte glutamate transporter GLT1. These findings indicate the feasibility and efficacy of transplantation-based astrocyte replacement and show that targeted multisegmental cell delivery to the cervical spinal cord is a promising therapeutic strategy for slowing focal motor neuron loss associated with ALS.	[Lepore, Angelo C.; Rauck, Britta; Dejea, Christine; Pardo, Andrea C.; Rothstein, Jeffrey D.; Maragakis, Nicholas J.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; [Rao, Mahendra S.] Invitrogen Corp, Carlsbad, CA USA; [Rothstein, Jeffrey D.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA	Johns Hopkins University; Thermo Fisher Scientific; Johns Hopkins University	Maragakis, NJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, 600 N Wolfe St,Meyer 6-119, Baltimore, MD 21287 USA.	nmaragak@jhmi.edu	Pardo, Andrea/B-4836-2017; rothstein, jeffrey d/C-9470-2013	Pardo, Andrea/0000-0001-7767-8539; 	Robert Packard Center for ALS Research; ALS Association; National Institutes of Health [F32-NS059155, R01-NS33958, R01-NS41680]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033958, F32NS059155, R01NS041680] Funding Source: NIH RePORTER	Robert Packard Center for ALS Research; ALS Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all members of the Maragakis and Rothstein labs for helpful discussion and K. Tanaka for providing GLT1-null mice. This work was supported by the Robert Packard Center for ALS Research (to N.J.M.), the ALS Association (to N.J.M.) and the National Institutes of Health (F32-NS059155 to A. C. L., R01-NS33958 to J.D.R. and R01-NS41680 to J.D.R. and N.J.M.).	Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696; Aebischer P, 1996, HUM GENE THER, V7, P851, DOI 10.1089/hum.1996.7.7-851; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Corti S, 2004, BRAIN, V127, P2518, DOI 10.1093/brain/awh273; Corti S, 2007, BRAIN, V130, P1289, DOI 10.1093/brain/awm043; Deshpande DM, 2006, ANN NEUROL, V60, P32, DOI 10.1002/ana.20901; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Federici T, 2006, MUSCLE NERVE, V33, P302, DOI 10.1002/mus.20439; Garbuzova-Davis S, 2001, AMYOTROPH LATERAL SC, V2, P175, DOI 10.1080/14660820152882179; Garbuzova-Davis S, 2002, EXP NEUROL, V174, P169, DOI 10.1006/exnr.2002.7860; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Harper JM, 2004, P NATL ACAD SCI USA, V101, P7123, DOI 10.1073/pnas.0401103101; Hemendinger R, 2005, EXP NEUROL, V196, P235, DOI 10.1016/j.expneurol.2005.07.025; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Kerr DA, 2003, J NEUROSCI, V23, P5131; Kiaei M, 2005, EXP NEUROL, V191, P331, DOI 10.1016/j.expneurol.2004.10.007; Klein SM, 2005, HUM GENE THER, V16, P509, DOI 10.1089/hum.2005.16.509; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Llado J, 2006, NEUROBIOL DIS, V21, P110, DOI 10.1016/j.nbd.2005.06.019; Llado J, 2004, MOL CELL NEUROSCI, V27, P322, DOI 10.1016/j.mcn.2004.07.010; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Maragakis NJ, 2004, NEUROBIOL DIS, V15, P461, DOI 10.1016/j.nbd.2003.12.007; Maragakis NJ, 2005, GLIA, V50, P145, DOI 10.1002/glia.20161; Martin LJ, 2007, J NEUROPATH EXP NEUR, V66, P1002, DOI 10.1097/nen.0b013e318158822b; Matsumoto A, 2006, J NEUROSCI RES, V83, P119, DOI 10.1002/jnr.20708; Mitsui T, 2005, EXP NEUROL, V194, P410, DOI 10.1016/j.expneurol.2005.02.022; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Rao MS, 1998, P NATL ACAD SCI USA, V95, P3996, DOI 10.1073/pnas.95.7.3996; Rao MS, 1997, DEV BIOL, V188, P48, DOI 10.1006/dbio.1997.8597; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689; Tankersley CG, 2007, J APPL PHYSIOL, V102, P926, DOI 10.1152/japplphysiol.00193.2006; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; Xu LY, 2006, TRANSPLANTATION, V82, P865, DOI 10.1097/01.tp.0000235532.00920.7a; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yan J, 2006, STEM CELLS, V24, P1976, DOI 10.1634/stemcells.2005-0518	49	317	321	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2008	11	11					1294	1301		10.1038/nn.2210	http://dx.doi.org/10.1038/nn.2210			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	366HZ	18931666	Green Accepted			2022-12-17	WOS:000260472700018
J	Matsumoto, M; Matsumoto, K; Abe, H; Tanaka, K				Matsumoto, Madoka; Matsumoto, Kenji; Abe, Hiroshi; Tanaka, Keiji			Medial prefrontal cell activity signaling prediction errors of action values	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; DOPAMINE NEURONS; REWARD PREDICTION; FRONTAL-CORTEX; MACAQUE MONKEY; NEURAL SYSTEM; BRAIN; REINFORCEMENT; PERFORMANCE; NEGATIVITY	To adapt behavior to a changing environment, one must monitor outcomes of executed actions and adjust subsequent actions accordingly. Involvement of the medial frontal cortex in performance monitoring has been suggested, but little is known about neural processes that link performance monitoring to performance adjustment. Here, we recorded from neurons in the medial prefrontal cortex of monkeys learning arbitrary action- outcome contingencies. Some cells preferentially responded to positive visual feedback stimuli and others to negative feedback stimuli. The magnitude of responses to positive feedback stimuli decreased over the course of behavioral adaptation, in correlation with decreases in the amount of prediction error of action values. Therefore, these responses in medial prefrontal cells may signal the direction and amount of error in prediction of values of executed actions to specify the adjustment in subsequent action selections.	RIKEN, Brain Sci Inst, Cognit Brain Mapping Lab, Wako, Saitama 3510198, Japan; Kyoto Univ, Inst Primate Res, Dept Behav & Brain Sci, Inuyama, Aichi 4848506, Japan; Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Meguro Ku, Tokyo 1528552, Japan; Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan	RIKEN; Kyoto University; Tokyo Institute of Technology; Saitama University	Matsumoto, K (corresponding author), RIKEN, Brain Sci Inst, Cognit Brain Mapping Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsumot@riken.jp	Tanaka, Keiji/N-5917-2015	Tanaka, Keiji/0000-0002-1910-3427; Matsumoto, Kenji/0000-0003-0883-4280				Allport GW., 1961, PATTERN GROWTH PERSO; Amiez C, 2005, EUR J NEUROSCI, V21, P3447, DOI 10.1111/j.1460-9568.2005.04170.x; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Bartholow BD, 2005, PSYCHOPHYSIOLOGY, V42, P33, DOI 10.1111/j.1469-8986.2005.00258.x; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Blatter K, 2006, EXP BRAIN RES, V168, P541, DOI 10.1007/s00221-005-0114-y; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P366, DOI 10.1002/cne.903460305; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Donkers FCL, 2005, COGNITIVE BRAIN RES, V25, P777, DOI 10.1016/j.cogbrainres.2005.09.007; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; FANTINO E, 1969, J EXP ANAL BEHAV, V12, P723, DOI 10.1901/jeab.1969.12-723; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Frank MJ, 2005, NEURON, V47, P495, DOI 10.1016/j.neuron.2005.06.020; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; LEWIS DA, 1988, BRAIN RES, V449, P225, DOI 10.1016/0006-8993(88)91040-2; Mars RB, 2005, NEUROIMAGE, V28, P1007, DOI 10.1016/j.neuroimage.2005.06.041; Maslow A. H., 1954, MOTIVATION PERSONALI; Matsumoto K, 2004, CURR OPIN NEUROBIOL, V14, P178, DOI 10.1016/j.conb.2004.03.005; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Nakamura K, 2005, J NEUROPHYSIOL, V93, P884, DOI 10.1152/jn.00305.2004; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Pailing PE, 2004, BRAIN COGNITION, V56, P215, DOI 10.1016/j.bandc.2004.06.005; Parkinson JA, 2001, J NEUROSCI, V21, P7770, DOI 10.1523/JNEUROSCI.21-19-07770.2001; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Robbins TW, 2005, J COMP NEUROL, V493, P140, DOI 10.1002/cne.20717; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; SHIMA K, 1991, J NEUROPHYSIOL, V65, P188, DOI 10.1152/jn.1991.65.2.188; Skinner B. F, 1953, SCI HUMAN BEHAV; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Ullsperger M, 2006, J COGNITIVE NEUROSCI, V18, P651, DOI 10.1162/jocn.2006.18.4.651; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Vidal F, 2003, BIOL PSYCHOL, V64, P265, DOI 10.1016/S0301-0511(03)00097-8; Walker AE, 1940, J COMP NEUROL, V73, P59, DOI 10.1002/cne.900730106; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; WILLIAMS BA, 1994, BEHAV ANALYST, V17, P261, DOI 10.1007/BF03392675; WOODWORTH RS, 1958, DYNAMICS BEHAV; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004	50	317	320	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					647	656		10.1038/nn1890	http://dx.doi.org/10.1038/nn1890			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	160NB	17450137				2022-12-17	WOS:000245948000022
J	Liu, XX; Wang, Q; Haydar, TF; Bordey, A				Liu, XX; Wang, Q; Haydar, TF; Bordey, A			Nonsynaptic GABA signaling in postnatal subventricular zone controls proliferation of GFAP-expressing progenitors	NATURE NEUROSCIENCE			English	Article							ADULT MAMMALIAN BRAIN; CENTRAL-NERVOUS-SYSTEM; OLFACTORY-BULB; NEURONAL PROGENITORS; VENTRICULAR ZONE; PRECURSOR CELLS; RAT FOREBRAIN; RADIAL GLIA; STEM-CELLS; IN-SITU	In the postnatal subventricular zone ( SVZ), local cues or signaling molecules released from neuroblasts limit the proliferation of glial fibrillary acidic protein (GFAP)-expressing progenitors thought to be stem cells. However, signals between SVZ cells have not been identified. We show that depolarization of neuroblasts induces nonsynaptic SNARE-independent GABA(A) receptor currents in GFAP-expressing cells, the time course of which depends on GABA uptake in acute mouse slices. We found that GABA(A) receptors are tonically activated in GFAP-expressing cells, consistent with the presence of spontaneous depolarizations in neuroblasts that are sufficient to induce GABA release. These data demonstrate the existence of nonsynaptic GABAergic signaling between neuroblasts and GFAP-expressing cells. Furthermore, we show that GABA(A) receptor activation in GFAP-expressing cells limits their progression through the cell cycle. Thus, as GFAP-expressing cells generate neuroblasts, GABA released from neuroblasts provides a feedback mechanism to control the proliferation of GFAP-expressing progenitors by activating GABA(A) receptors.	Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; George Washington Univ, Sch Med, Dept Pediat, Washington, DC 20010 USA; George Washington Univ, Sch Med, Dept Pharmacol, Washington, DC 20010 USA	Yale University; Yale University; George Washington University; George Washington University	Bordey, A (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, 333 Cedar St, New Haven, CT 06520 USA.	angelique.bordey@yale.edu		Haydar, Tarik/0000-0001-6772-3076	NINDS NIH HHS [R01 NS048256, R01 NS042189, NS042189, NS048256] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042189, R01NS048256] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARCIA AD, 2004, NAT NEUROSCI, V7, P1233; Barker JL, 1998, PERSPECT DEV NEUROBI, V5, P305; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; Bordey A, 2000, GLIA, V30, P27, DOI 10.1002/(SICI)1098-1136(200003)30:1<27::AID-GLIA4>3.0.CO;2-#; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; De Marchis S, 2004, EUR J NEUROSCI, V20, P1307, DOI 10.1111/j.1460-9568.2004.03584.x; Demarque M, 2002, NEURON, V36, P1051, DOI 10.1016/S0896-6273(02)01053-X; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Fueshko SM, 1998, J NEUROSCI, V18, P2560; Harks EGA, 2001, J PHARMACOL EXP THER, V298, P1033; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Haydar TF, 1999, BRAIN RES PROTOC, V4, P425, DOI 10.1016/S1385-299X(99)00033-1; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Kao HT, 1998, P NATL ACAD SCI USA, V95, P4667, DOI 10.1073/pnas.95.8.4667; Levison SW, 1997, J NEUROSCI RES, V48, P83, DOI 10.1002/(SICI)1097-4547(19970415)48:2<83::AID-JNR1>3.0.CO;2-8; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; LEVISON SW, 1993, DEVELOPMENT, V119, P611; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LOPEZCORCUERA B, 1992, J BIOL CHEM, V267, P17491; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; LUSKIN MB, 1994, CHEM SENSES, V19, P695, DOI 10.1093/chemse/19.6.695; Luskin MB, 1997, MOL CELL NEUROSCI, V8, P351, DOI 10.1006/mcne.1996.0592; Nguyen L, 2001, CELL TISSUE RES, V305, P187, DOI 10.1007/s004410000343; Nguyen L, 2003, J NEUROSCI, V23, P3278; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Pieribone VA, 2002, J COMP NEUROL, V454, P105, DOI 10.1002/cne.10417; Smith AJ, 2004, J PHARMACOL EXP THER, V311, P601, DOI 10.1124/jpet.104.070342; Stewart RR, 2002, J NEUROBIOL, V50, P305, DOI 10.1002/neu.10038; Sudhof TC, 2001, ANNU REV NEUROSCI, V24, P933, DOI 10.1146/annurev.neuro.24.1.933; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; Wang DD, 2003, J NEUROPHYSIOL, V90, P2291, DOI 10.1152/jn.01116.2002; Wang DD, 2003, J PHYSIOL-LONDON, V550, P785, DOI 10.1113/jphysiol.2003.042572; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	45	317	332	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1179	1187		10.1038/nn1522	http://dx.doi.org/10.1038/nn1522			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116450	Green Accepted			2022-12-17	WOS:000231483800017
J	Buckholtz, JW; Treadway, MT; Cowan, RL; Woodward, ND; Benning, SD; Li, R; Ansari, MS; Baldwin, RM; Schwartzman, AN; Shelby, ES; Smith, CE; Cole, D; Kessler, RM; Zald, DH				Buckholtz, Joshua W.; Treadway, Michael T.; Cowan, Ronald L.; Woodward, Neil D.; Benning, Stephen D.; Li, Rui; Ansari, M. Sib; Baldwin, Ronald M.; Schwartzman, Ashley N.; Shelby, Evan S.; Smith, Clarence E.; Cole, David; Kessler, Robert M.; Zald, David H.			Mesolimbic dopamine reward system hypersensitivity in individuals with psychopathic traits	NATURE NEUROSCIENCE			English	Article							MICE; ANTICIPATION; AGGRESSION; VIOLENCE; ALCOHOL	Psychopathy is a personality disorder that is strongly linked to criminal behavior. Using [(18)F]fallypride positron emission tomography and blood oxygen level-dependent functional magnetic resonance imaging, we found that impulsive-antisocial psychopathic traits selectively predicted nucleus accumbens dopamine release and reward anticipation-related neural activity in response to pharmacological and monetary reinforcers, respectively. These findings suggest that neurochemical and neurophysiological hyper-reactivity of the dopaminergic reward system may comprise a neural substrate for impulsive-antisocial behavior and substance abuse in psychopathy.	[Buckholtz, Joshua W.; Treadway, Michael T.; Cowan, Ronald L.; Benning, Stephen D.; Schwartzman, Ashley N.; Shelby, Evan S.; Zald, David H.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Buckholtz, Joshua W.] Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN USA; [Cowan, Ronald L.; Woodward, Neil D.; Zald, David H.] Vanderbilt Univ, Dept Psychiat, Nashville, TN USA; [Li, Rui; Ansari, M. Sib; Baldwin, Ronald M.; Smith, Clarence E.; Kessler, Robert M.] Vanderbilt Univ, Dept Radiol, Nashville, TN USA; [Cole, David] Vanderbilt Univ, Dept Psychol & Human Dev, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Buckholtz, JW (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	joshua.buckholtz@vanderbilt.edu	Zald, David H/A-1448-2011; Woodward, Neil/V-3735-2019; Buckholtz, Joshua/E-7299-2010; Woodward, Neil D/N-3365-2017; Benning, Stephen D./H-8312-2019; Treadway, Michael/O-9056-2017	Buckholtz, Joshua/0000-0002-9418-8686; Benning, Stephen D./0000-0002-0955-1592; 	National Institute on Drug Abuse [R01DA019670-04]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019670] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Knutson for kindly making the monetary incentive delay task available and C. Weiner and M. McHugo for assistance with fMRI scanning and data analysis. This research was funded by the National Institute on Drug Abuse (R01DA019670-04).	Anderson DA, 1999, J LAW ECON, V42, P611, DOI 10.1086/467436; Benning SD, 2003, PSYCHOL ASSESSMENT, V15, P340, DOI 10.1037/1040-3590.15.3.340; Blair RJR, 2008, PHILOS T R SOC B, V363, P2557, DOI 10.1098/rstb.2008.0027; Couppis MH, 2008, PSYCHOPHARMACOLOGY, V197, P449, DOI 10.1007/s00213-007-1054-y; Edens JF, 2008, BEHAV SCI LAW, V26, P529, DOI 10.1002/bsl.823; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Ferrari PF, 2003, EUR J NEUROSCI, V17, P371, DOI 10.1046/j.1460-9568.2003.02447.x; Hare RD, 2006, PSYCHIAT CLIN N AM, V29, P709, DOI 10.1016/j.psc.2006.04.007; LEWIS MH, 1994, NEUROPSYCHOPHARMACOL, V10, P115, DOI 10.1038/npp.1994.13; Neumann CS, 2008, J CONSULT CLIN PSYCH, V76, P893, DOI 10.1037/0022-006X.76.5.893; Rodriguiz RM, 2004, BEHAV BRAIN RES, V148, P185, DOI 10.1016/S0166-4328(03)00187-6; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Skeem JL, 2001, J CONSULT CLIN PSYCH, V69, P358, DOI 10.1037//0022-006X.69.3.358; SMITH SS, 1990, J ABNORM PSYCHOL, V99, P430, DOI 10.1037/0021-843X.99.4.430; Walters GD, 2003, LAW HUMAN BEHAV, V27, P541, DOI 10.1023/A:1025490207678	15	316	321	3	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2010	13	4					419	421		10.1038/nn.2510	http://dx.doi.org/10.1038/nn.2510			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	575NI	20228805	Green Published, Green Accepted			2022-12-17	WOS:000276073500010
J	Grathwohl, SA; Kalin, RE; Bolmont, T; Prokop, S; Winkelmann, G; Kaeser, SA; Odenthal, J; Radde, R; Eldh, T; Gandy, S; Aguzzi, A; Staufenbiel, M; Mathews, PM; Wolburg, H; Heppner, FL; Jucker, M				Grathwohl, Stefan A.; Kaelin, Roland E.; Bolmont, Tristan; Prokop, Stefan; Winkelmann, Georg; Kaeser, Stephan A.; Odenthal, Joerg; Radde, Rebecca; Eldh, Therese; Gandy, Sam; Aguzzi, Adriano; Staufenbiel, Matthias; Mathews, Paul M.; Wolburg, Hartwig; Heppner, Frank L.; Jucker, Mathias			Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia	NATURE NEUROSCIENCE			English	Article							TRANSGENIC MICE; PATHOLOGY; BRAIN; CELLS	In Alzheimer's disease, microglia cluster around beta-amyloid deposits, suggesting that these cells are important for amyloid plaque formation, maintenance and/or clearance. We crossed two distinct APP transgenic mouse strains with CD11b-HSVTK mice, in which nearly complete ablation of microglia was achieved for up to 4 weeks after ganciclovir application. Neither amyloid plaque formation and maintenance nor amyloid-associated neuritic dystrophy depended on the presence of microglia.	[Kaelin, Roland E.; Prokop, Stefan; Winkelmann, Georg; Heppner, Frank L.] Charite, Dept Neuropathol, D-13353 Berlin, Germany; [Grathwohl, Stefan A.; Bolmont, Tristan; Kaeser, Stephan A.; Odenthal, Joerg; Radde, Rebecca; Jucker, Mathias] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, Tubingen, Germany; [Grathwohl, Stefan A.; Bolmont, Tristan; Kaeser, Stephan A.; Odenthal, Joerg; Radde, Rebecca; Jucker, Mathias] German Ctr Neurodegenerat Dis, Tubingen, Germany; [Grathwohl, Stefan A.] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, Tubingen, Germany; [Eldh, Therese] Univ Tubingen, Dept Radiat Oncol, Tubingen, Germany; [Gandy, Sam] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Aguzzi, Adriano] Univ Zurich Hosp, Dept Pathol, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Staufenbiel, Matthias] Novartis Inst Biomed Res, Basel, Switzerland; [Mathews, Paul M.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY USA; [Mathews, Paul M.] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Wolburg, Hartwig] Univ Tubingen, Dept Pathol, Tubingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Icahn School of Medicine at Mount Sinai; University of Zurich; University Zurich Hospital; Novartis; Nathan Kline Institute for Psychiatric Research; New York University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Heppner, FL (corresponding author), Charite, Dept Neuropathol, D-13353 Berlin, Germany.	frank.heppner@charite.de; mathias.jucker@uni-tuebingen.de	Heppner, Frank/ABH-8393-2020; Kälin, Roland/AAG-9161-2020	Heppner, Frank/0000-0001-9816-8917; Prokop, Stefan/0000-0002-5633-2149; Aguzzi, Adriano/0000-0002-0344-6708; Mathews, Paul/0000-0003-1742-7687	National Institutes of Neurological Disorders and Stroke [R01 NS046006]; US National Institutes of Health [AG017617, NS045205];  [BMBF-01GI0705];  [SFB-TR43, Exc 25]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046006, R01NS045205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010491, P01AG017617] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants to M.J. (BMBF-01GI0705), F. L. H. (SFB-TR43, Exc 25 and National Institutes of Neurological Disorders and Stroke R01 NS046006) and P. M. M. (US National Institutes of Health AG017617 and NS045205).	Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; El Khoury J, 2008, TRENDS PHARMACOL SCI, V29, P626, DOI 10.1016/j.tips.2008.08.004; GRUYS E, 1979, LAB ANIM-UK, V13, P1, DOI 10.1258/002367779781071230; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Jucker M, 2008, NEURON, V59, P8, DOI 10.1016/j.neuron.2008.06.014; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484	15	316	322	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1361	1363		10.1038/nn.2432	http://dx.doi.org/10.1038/nn.2432			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19838177	Green Accepted			2022-12-17	WOS:000271194100005
J	Amodio, DM; Jost, JT; Master, SL; Yee, CM				Amodio, David M.; Jost, John T.; Master, Sarah L.; Yee, Cindy M.			Neurocognitive correlates of liberalism and conservatism	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE; ERROR-DETECTION; CONFLICT	Political scientists and psychologists have noted that, on average, conservatives show more structured and persistent cognitive styles, whereas liberals are more responsive to informational complexity, ambiguity and novelty. We tested the hypothesis that these profiles relate to differences in general neurocognitive functioning using event-related potentials, and found that greater liberalism was associated with stronger conflict-related anterior cingulate activity, suggesting greater neurocognitive sensitivity to cues for altering a habitual response pattern.	NYU, Dept Psychol, New York, NY 10003 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	New York University; University of California System; University of California Los Angeles	Amodio, DM (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	david.amodio@nyu.edu	sarinopoulos, isidoros/B-5453-2010	Jost, John/0000-0002-2844-4645				Adorno T. W., 1950, AUTHORITARIAN PERSON; Alford JR, 2005, AM POLIT SCI REV, V99, P153, DOI 10.1017/S0003055405051579; Block J, 2006, J RES PERS, V40, P734, DOI 10.1016/j.jrp.2005.09.005; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; DeHaven RN, 2005, CURR TOP MED CHEM, V5, P303, DOI 10.2174/1568026053544542; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Jost JT, 2006, AM PSYCHOL, V61, P651, DOI 10.1037/0003-066X.61.7.651; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kaplan JT, 2007, NEUROPSYCHOLOGIA, V45, P55, DOI 10.1016/j.neuropsychologia.2006.04.024; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1017/S0048577200990231; Knutson KM, 2006, SOC NEUROSCI-UK, V1, P25, DOI 10.1080/17470910600670603; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931	14	316	320	1	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1246	1247		10.1038/nn1979	http://dx.doi.org/10.1038/nn1979			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	214FG	17828253				2022-12-17	WOS:000249720800010
J	Gooley, JJ; Schomer, A; Saper, CB				Gooley, JJ; Schomer, A; Saper, CB			The dorsomedial hypothalamic nucleus is critical for the expression of food- entrainable circadian rhythms	NATURE NEUROSCIENCE			English	Article							SUPRACHIASMATIC NUCLEUS; FEEDING SCHEDULES; ANTICIPATORY ACTIVITY; EFFERENT PROJECTIONS; PREOPTIC NUCLEUS; LESIONS; RATS; ENTRAINMENT; ORGANIZATION; TEMPERATURE	Circadian rhythms of behavior and physiology can be entrained by daily cycles of restricted food availability, but the pathways that mediate food entrainment are unknown. The dorsomedial hypothalamic nucleus (DMH) is critical for the expression of circadian rhythms and receives input from systems that monitor food availability. Here we report that restricted feeding synchronized the daily rhythm of DMH activity in rats such that c-Fos expression in the DMH was highest at scheduled mealtime. During food restriction, unlesioned rats showed a marked preprandial rise in locomotor activity, body temperature and wakefulness, and these responses were blocked by cell-specific lesions in the DMH. Furthermore, the degree of food entrainment correlated with the number of remaining DMH neurons, and lesions in cell groups surrounding the DMH did not block entrainment by food. These results establish that the neurons of the DMH have a critical role in the expression of food-entrainable circadian rhythms.	Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Div Sleep Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Saper, CB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.	csaper@caregroup.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH067413] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL60292] Funding Source: Medline; NIMH NIH HHS [MH67413] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Akiyama M, 2004, EUR J NEUROSCI, V20, P3054, DOI 10.1111/j.1460-9568.2004.03749.x; Angeles-Castellanos M, 2004, AM J PHYSIOL-REG I, V286, pR158, DOI 10.1152/ajpregu.00216.2003; BOLLES RC, 1965, J COMP PHYSIOL PSYCH, V60, P290, DOI 10.1037/h0022308; BOULOS Z, 1980, BEHAV BRAIN RES, V1, P39, DOI 10.1016/S0166-4328(80)80049-0; Choi SJ, 1998, J NEUROSCI, V18, P3843; Chou TC, 2002, J NEUROSCI, V22, P977, DOI 10.1523/JNEUROSCI.22-03-00977.2002; Chou WB, 2002, ACTA PHARMACOL SIN, V23, P691; COMPERATORE CA, 1990, PHYSIOL BEHAV, V47, P671, DOI 10.1016/0031-9384(90)90076-G; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Davidson AJ, 2000, AM J PHYSIOL-REG I, V278, pR1296, DOI 10.1152/ajpregu.2000.278.5.R1296; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Elmquist JK, 1998, P NATL ACAD SCI USA, V95, P741, DOI 10.1073/pnas.95.2.741; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; FULWILER CE, 1984, BRAIN RES REV, V7, P229, DOI 10.1016/0165-0173(84)90012-2; Gooley Joshua J., 2003, Journal of Neuroscience, V23, P7093; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; INOUYE SIT, 1982, BRAIN RES, V250, P183, DOI 10.1016/0006-8993(82)90967-2; INOUYE SIT, 1982, BRAIN RES, V232, P194, DOI 10.1016/0006-8993(82)90625-4; KRIEGER DT, 1980, ENDOCRINOLOGY, V106, P649, DOI 10.1210/endo-106-3-649; KRIEGER DT, 1974, ENDOCRINOLOGY, V95, P1195, DOI 10.1210/endo-95-5-1195; KRIEGER DT, 1977, SCIENCE, V197, P398, DOI 10.1126/science.877566; Lamont EW, 2005, NEUROSCIENCE, V132, P245, DOI 10.1016/j.neuroscience.2005.01.029; Landry GJ, 2006, AM J PHYSIOL-REG I, V290, pR1527, DOI 10.1152/ajpregu.00874.2005; Lu J, 2001, J NEUROSCI, V21, P4864, DOI 10.1523/JNEUROSCI.21-13-04864.2001; Lu J, 2000, J NEUROSCI, V20, P3830, DOI 10.1523/JNEUROSCI.20-10-03830.2000; Mieda M, 2004, J NEUROSCI, V24, P10493, DOI 10.1523/JNEUROSCI.3171-04.2004; Mistlberger RE, 1999, PHYSIOL BEHAV, V66, P329, DOI 10.1016/S0031-9384(98)00311-4; MISTLBERGER RE, 1988, J BIOL RHYTHM, V3, P277, DOI 10.1177/074873048800300306; Mitchell V, 2001, J COMP NEUROL, V429, P469, DOI 10.1002/1096-9861(20010115)429:3<469::AID-CNE8>3.0.CO;2-#; MOREIRA AC, 1982, PHYSIOL BEHAV, V28, P787, DOI 10.1016/0031-9384(82)90194-9; Morrison SR, 2004, NEWS PHYSIOL SCI, V19, P67, DOI 10.1152/nips.01502.2003; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; SIMERLY RB, 1986, J COMP NEUROL, V246, P312, DOI 10.1002/cne.902460304; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; STEPHAN FK, 1983, BEHAV BRAIN RES, V7, P81, DOI 10.1016/0166-4328(83)90006-2; STEPHAN FK, 1984, PHYSIOL BEHAV, V32, P663, DOI 10.1016/0031-9384(84)90323-8; STEPHAN FK, 1981, J COMP PHYSIOL, V143, P401, DOI 10.1007/BF00609906; STEPHAN FK, 1992, PHYSIOL BEHAV, V52, P985, DOI 10.1016/0031-9384(92)90381-B; STEPHAN FK, 1989, PHYSIOL BEHAV, V46, P489, DOI 10.1016/0031-9384(89)90026-7; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Thompson RH, 1998, BRAIN RES REV, V27, P89, DOI 10.1016/S0165-0173(98)00010-1; Thompson RH, 1996, J COMP NEUROL, V376, P143, DOI 10.1002/(SICI)1096-9861(19961202)376:1<143::AID-CNE9>3.0.CO;2-3; WATTS AG, 1987, J COMP NEUROL, V258, P230, DOI 10.1002/cne.902580205; WATTS AG, 1987, J COMP NEUROL, V258, P204, DOI 10.1002/cne.902580204; Zigman JM, 2003, ENDOCRINOLOGY, V144, P3749, DOI 10.1210/en.2003-0241	50	316	324	0	29	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					398	407		10.1038/nn1651	http://dx.doi.org/10.1038/nn1651			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16491082				2022-12-17	WOS:000235645600020
J	Rushworth, MFS; Ellison, A; Walsh, V				Rushworth, MFS; Ellison, A; Walsh, V			Complementary localization and lateralization of orienting and motor attention	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; POSTERIOR PARIETAL CORTEX; POSITRON EMISSION TOMOGRAPHY; EYE-MOVEMENTS; SPATIAL REPRESENTATION; VISUOSPATIAL ATTENTION; RECEPTIVE-FIELDS; VISUAL-ATTENTION; RHESUS-MONKEY; NEURONS	It is widely agreed that the right posterior parietal cortex has a preeminent role in visuospatial and orienting attention. A number of lines of evidence suggest that although orienting and the preparation of oculomotor responses are dissociable from each other, the two are intimately related. If this is true, then it should be possible to identify other attentional mechanisms tied to other response modalities. We used repetitive transcranial magnetic stimulation (rTMS) to demonstrate the existence of a distinct anterior parietal mechanism of motor attention. The critical area for motor attention is anterior to the one concerned with orienting, and it is lateralized to the left hemisphere in humans.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Oxford Ctr Funct Magnet Resonance Imaging Brain, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Rushworth, MFS (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	matthew.rushworth@psy.ox.ac.uk		Rushworth, Matthew/0000-0002-5578-9884				Ashbridge E, 1997, NEUROPSYCHOLOGIA, V35, P1121, DOI 10.1016/S0028-3932(97)00003-1; CAVADA C, 1989, J COMP NEUROL, V287, P393, DOI 10.1002/cne.902870402; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; COLBY CL, 1995, CEREB CORTEX, V5, P470, DOI 10.1093/cercor/5.5.470; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Cracco RQ, 1999, J NEUROSCI METH, V86, P209, DOI 10.1016/S0165-0270(98)00167-8; Deiber MP, 1996, J NEUROPHYSIOL, V75, P233, DOI 10.1152/jn.1996.75.1.233; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; DUHAMEL JR, 1992, BRAIN, V115, P1387, DOI 10.1093/brain/115.5.1387; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Edgley SA, 1997, BRAIN, V120, P839, DOI 10.1093/brain/120.5.839; EIDELBERG D, 1984, ARCH NEUROL-CHICAGO, V41, P843, DOI 10.1001/archneur.1984.04050190049013; Evans A. C., 1996, P343; Ferraina S, 1997, J NEUROPHYSIOL, V77, P1034, DOI 10.1152/jn.1997.77.2.1034; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Marzi CA, 1998, EXP BRAIN RES, V118, P435, DOI 10.1007/s002210050299; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Oliveri M, 1999, BRAIN, V122, P1731, DOI 10.1093/brain/122.9.1731; PASCUALLEONE A, 1994, NEUROLOGY, V44, P494, DOI 10.1212/WNL.44.3_Part_1.494; Passingham RE, 1998, COMP NEUROPSYCHOLOGY, P271; Paus T, 1997, J NEUROSCI, V17, P3178; Paus T, 1998, J NEUROPHYSIOL, V79, P1102, DOI 10.1152/jn.1998.79.2.1102; Pisella L, 2000, NAT NEUROSCI, V3, P729, DOI 10.1038/76694; POSNER MI, 1984, J NEUROSCI, V4, P1863; POSNER MI, 1987, PSYCHOBIOLOGY, V15, P107; ROBINSON CJ, 1980, J COMP NEUROL, V192, P69, DOI 10.1002/cne.901920105; Ruohonen J, 1999, EEG CL N SU, P30; Rushworth MFS, 1997, NEUROPSYCHOLOGIA, V35, P1261, DOI 10.1016/S0028-3932(97)00050-X; Rushworth MFS, 1998, J NEUROPHYSIOL, V79, P478, DOI 10.1152/jn.1998.79.1.478; Rushworth MFS, 1997, EXP BRAIN RES, V117, P311, DOI 10.1007/s002210050225; RUSHWORTH MFS, IN PRESS J COGN NEUR; Sakata H, 1999, EXP BRAIN RES, V128, P160, DOI 10.1007/s002210050831; Schluter ND, 1998, BRAIN, V121, P785, DOI 10.1093/brain/121.5.785; SHELIGA BM, 1995, EXP BRAIN RES, V105, P261; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; STEINMETZ MA, 1995, CEREB CORTEX, V5, P448, DOI 10.1093/cercor/5.5.448; Talairach J., 1988, COPLANAR STEREOTAXIC; VONBONIN G, 1947, NEOCORTEX MACACCA MU; Walsh V, 1999, NEUROPSYCHOLOGIA, V37, P245; Walsh V, 1998, P ROY SOC B-BIOL SCI, V265, P537, DOI 10.1098/rspb.1998.0328; Walsh V, 1998, TRENDS COGN SCI, V2, P103, DOI 10.1016/S1364-6613(98)01134-6; Walsh V, 1999, NEUROPSYCHOLOGIA, V37, P125; WASSERMANN EM, 1998, ELECTROENCEPHALOGR C, V198, P1; WITELSON SF, 1992, J COMP NEUROL, V323, P326, DOI 10.1002/cne.903230303	50	316	318	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					656	661		10.1038/88492	http://dx.doi.org/10.1038/88492			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369949				2022-12-17	WOS:000169061800021
J	Smidt, MP; Asbreuk, CHJ; Cox, JJ; Chen, H; Johnson, RL; Burbach, JPH				Smidt, MP; Asbreuk, CHJ; Cox, JJ; Chen, H; Johnson, RL; Burbach, JPH			A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b	NATURE NEUROSCIENCE			English	Article							NAIL-PATELLA SYNDROME; MUTANT MICE; PARKINSONS-DISEASE; LIMB DEVELOPMENT; MOTOR-NEURONS; MIDBRAIN; DEFECTS; BRAIN; EXPRESSION; SPECIFICATION	We identified the LIM homeodomain transcription factor Lmx1b in the mesencephalic dopamine (mesDA) systems of embryos and adults. Analysis of spatiotemporal expression in Lmx1b null mutants and wild-type mice implicated a cascade involving Lmx1b in the early development of mesDA neurons. Although disruption of this cascade did not block induction of tyrosine hydroxylase (TH), a key enzyme in DA synthesis, or Nurr1, a nuclear hormone receptor, Lmx1b knockout mice failed to induce the mesDA-specific homeodomain gene Ptx3 in TH-positive neurons. Eventually, this small set of TH-positive neurons was lost during embryonic maturation. The data suggest that at least two molecular cascades operate during the specification of the mesDA system, one specifying neurotransmitter phenotype and another essential for other aspects of mesDA neuron differentiation.	Univ Utrecht, Fac Med, Dept Med Pharmacol, Rudolf Magnus Inst Neurosci,Sect Mol Neurosci, NL-3584 CG Utrecht, Netherlands; Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Utrecht University; Utrecht University Medical Center; University of Texas System; UTMD Anderson Cancer Center	Burbach, JPH (corresponding author), Univ Utrecht, Fac Med, Dept Med Pharmacol, Rudolf Magnus Inst Neurosci,Sect Mol Neurosci, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.			Smidt, Marten/0000-0002-8815-747X				Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; Chen HX, 1998, DEV GENET, V22, P314, DOI 10.1002/(SICI)1520-6408(1998)22:4<314::AID-DVG2>3.0.CO;2-9; Danielian PS, 1996, NATURE, V383, P332, DOI 10.1038/383332a0; Date I, 1996, CELL TRANSPLANT, V5, pS17, DOI 10.1016/0963-6897(96)00032-2; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; Favor J, 1996, P NATL ACAD SCI USA, V93, P13870, DOI 10.1073/pnas.93.24.13870; Grace AA, 1997, TRENDS NEUROSCI, V20, P31, DOI 10.1016/S0166-2236(96)10064-3; GRIMA B, 1985, P NATL ACAD SCI USA, V82, P617, DOI 10.1073/pnas.82.2.617; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; Hynes M, 1999, CURR OPIN NEUROBIOL, V9, P26, DOI 10.1016/S0959-4388(99)80004-X; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Kordower JH, 1996, J COMP NEUROL, V370, P203; PERLOW MJ, 1987, NEUROSURGERY, V20, P335, DOI 10.1227/00006123-198702000-00026; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Shamim H, 1999, DEVELOPMENT, V126, P945; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Tucker AS, 1999, DEVELOPMENT, V126, P221; Urbanek P, 1997, P NATL ACAD SCI USA, V94, P5703, DOI 10.1073/pnas.94.11.5703; WURST W, 1994, DEVELOPMENT, V120, P2065; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	26	316	329	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					337	341		10.1038/73902	http://dx.doi.org/10.1038/73902			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725922				2022-12-17	WOS:000087945400013
J	Hodes, GE; Kana, V; Menard, C; Merad, M; Russo, SJ				Hodes, Georgia E.; Kana, Veronika; Menard, Caroline; Merad, Miriam; Russo, Scott J.			Neuroimmune mechanisms of depression	NATURE NEUROSCIENCE			English	Review							SOCIAL DEFEAT STRESS; TOLL-LIKE RECEPTORS; MAJOR DEPRESSION; IMMUNE-SYSTEM; GLUCOCORTICOID RESISTANCE; ANTIINFLAMMATORY DRUGS; MOOD DISORDERS; ANIMAL-MODELS; KAPPA-B; BRAIN	Current diagnosis of depression is based solely on behavioral symptomatology. The available US Food and Drug Administration-approved treatments for depression have come from serendipitous discovery and are ineffective in nearly 30-50% of patients, which is thought to reflect a lack of specificity in targeting underlying pathophysiological mechanisms. Recent evidence has identified depression-related disruptions in a neuroimmune axis that interfaces the immune system and CNS to control behavior. This Review examines the evidence in patients and in animal models of depression that demonstrates how the peripheral immune system acts on the brain to alter an individual's response to stress, ultimately contributing to their vulnerability to mood disorders.	[Hodes, Georgia E.; Menard, Caroline; Russo, Scott J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Hodes, Georgia E.; Menard, Caroline; Russo, Scott J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Kana, Veronika; Merad, Miriam] Icahn Sch Med Mt Sinai, Dept Oncol Sci, Tisch Canc Inst, New York, NY 10029 USA; [Kana, Veronika; Merad, Miriam] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Russo, SJ (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA.	scutt.russo@mssm.edu	Hodes, Georgia/L-8022-2016; Russo, Scott/R-7107-2019; Menard, Caroline/AAV-4017-2020	Hodes, Georgia/0000-0002-1551-2178; Russo, Scott/0000-0002-6470-1805; Menard, Caroline/0000-0001-8202-7378; Kana, Veronika/0000-0002-9362-3156	US National Institute of Mental Health [RO1 MH090264, RO1 MH104559]; Johnson & Johnson International Mental Health Research Organization Rising Star Award; Irma T. Hirschl/Monique Weill-Caulier Trust Research Award; Brain and Behavior Research Foundation Young Investigator Award; Swiss National Science Foundation Early Postdoc Mobility fellowship; National Center for Complementary & Integrative Health [P50AT008661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090264, P50MH096890, R01MH104559] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Johnson & Johnson International Mental Health Research Organization Rising Star Award; Irma T. Hirschl/Monique Weill-Caulier Trust Research Award; Brain and Behavior Research Foundation Young Investigator Award; Swiss National Science Foundation Early Postdoc Mobility fellowship; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by US National Institute of Mental Health grants RO1 MH090264 (to S.J.R.) and RO1 MH104559 (to S.J.R. and M.M.), the Johnson & Johnson International Mental Health Research Organization Rising Star Award (to S.J.R.), an Irma T. Hirschl/Monique Weill-Caulier Trust Research Award (to S.J.R.), a Brain and Behavior Research Foundation Young Investigator Award (G.E.H.) and a Swiss National Science Foundation Early Postdoc Mobility fellowship (to V.K.).	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, V5th, DOI 10.1176/appi.books.9780890425596; Amsterdam A, 2002, BIOCHEM PHARMACOL, V64, P843, DOI 10.1016/S0006-2952(02)01147-4; Avitsur R, 2009, IMMUNOL ALLERGY CLIN, V29, P285, DOI 10.1016/j.iac.2009.02.006; Banks WA, 1995, NEUROIMMUNOMODULAT, V2, P241, DOI 10.1159/000097202; BANKS WA, 1994, NEUROSCI LETT, V179, P53, DOI 10.1016/0304-3940(94)90933-4; Baruch K, 2013, BRAIN BEHAV IMMUN, V34, P11, DOI 10.1016/j.bbi.2013.04.002; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; BLUTHE RM, 1992, BRAIN RES, V573, P318, DOI 10.1016/0006-8993(92)90779-9; Brachman RA, 2015, J NEUROSCI, V35, P1530, DOI 10.1523/JNEUROSCI.2278-14.2015; Brietzke E, 2011, MED HYPOTHESES, V76, P21, DOI 10.1016/j.mehy.2010.08.021; Bulloch K, 2008, J COMP NEUROL, V508, P687, DOI 10.1002/cne.21668; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Conversano Ciro, 2015, Hematol Rep, V7, P5632, DOI 10.4081/hr.2015.5632; Dalla C, 2010, BASIC CLIN PHARMACOL, V106, P226, DOI 10.1111/j.1742-7843.2009.00516.x; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; De Kock M, 2013, CNS NEUROSCI THER, V19, P403, DOI 10.1111/cns.12104; Diniz BS, 2013, BRIT J PSYCHIAT, V202, P329, DOI 10.1192/bjp.bp.112.118307; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Engler H, 2008, PSYCHONEUROENDOCRINO, V33, P108, DOI 10.1016/j.psyneuen.2007.10.007; Eyre HA, 2015, PROG NEURO-PSYCHOPH, V57, P11, DOI 10.1016/j.pnpbp.2014.10.003; Fenton WS, 2006, CURR OPIN PSYCHIATR, V19, P421, DOI 10.1097/01.yco.0000228765.33356.9f; Frank MG, 2007, BRAIN BEHAV IMMUN, V21, P47, DOI 10.1016/j.bbi.2006.03.005; Frank MG, 2015, BRAIN BEHAV IMMUN, V48, P1, DOI 10.1016/j.bbi.2015.03.010; Frank MG, 2013, BRAIN BEHAV IMMUN, V33, P1, DOI 10.1016/j.bbi.2013.02.004; Frank MG, 2010, BRAIN BEHAV IMMUN, V24, P19, DOI 10.1016/j.bbi.2009.07.008; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Garcia-Oscos F, 2012, BIOL PSYCHIAT, V71, P574, DOI 10.1016/j.biopsych.2011.11.018; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Gudmundsson P, 2007, AM J GERIAT PSYCHIAT, V15, P832, DOI 10.1097/JGP.0b013e3180547091; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hawkes CA, 2009, P NATL ACAD SCI USA, V106, P1261, DOI 10.1073/pnas.0805453106; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hodes GE, 2014, P NATL ACAD SCI USA, V111, P16136, DOI 10.1073/pnas.1415191111; Iyengar RL, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.02.037; Jazayeri S, 2010, PSYCHIAT RES, V178, P112, DOI 10.1016/j.psychres.2009.04.013; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Khandaker GM, 2014, JAMA PSYCHIAT, V71, P1121, DOI 10.1001/jamapsychiatry.2014.1332; Kohler O, 2014, JAMA PSYCHIAT, V71, P1381, DOI 10.1001/jamapsychiatry.2014.1611; Kollet O, 2013, LEUKEMIA, V27, P2006, DOI 10.1038/leu.2013.154; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Koo JW, 2010, P NATL ACAD SCI USA, V107, P2669, DOI 10.1073/pnas.0910658107; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2008, AM J PSYCHIAT, V165, P1109, DOI 10.1176/appi.ajp.2008.08071076; Kubera M, 2004, INT IMMUNOPHARMACOL, V4, P185, DOI 10.1016/j.intimp.2003.11.006; Langley RG, 2010, J AM ACAD DERMATOL, V63, P457, DOI 10.1016/j.jaad.2009.09.014; Leinenga G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2512; Leventopoulos M, 2007, BRAIN RES, V1142, P119, DOI 10.1016/j.brainres.2007.01.039; Limatola C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00229; Lin S, 2014, P NATL ACAD SCI USA, V111, P17224, DOI 10.1073/pnas.1413624111; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Maes M, 1997, CYTOKINE, V9, P853, DOI 10.1006/cyto.1997.0238; MAES M, 1995, PROG NEURO-PSYCHOPH, V19, P11, DOI 10.1016/0278-5846(94)00101-M; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P702, DOI 10.1016/j.pnpbp.2010.12.017; MAES M, 1995, J AFFECT DISORDERS, V34, P301, DOI 10.1016/0165-0327(95)00028-L; MAES M, 1992, J PSYCHIAT RES, V26, P125, DOI 10.1016/0022-3956(92)90004-8; Maes M, 1998, CYTOKINE, V10, P313, DOI 10.1006/cyto.1997.0290; Maes M, 2011, NEUROENDOCRINOL LETT, V32, P7; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Marino F, 2013, AMINO ACIDS, V45, P55, DOI 10.1007/s00726-011-1186-6; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Meagher MW, 2007, BRAIN BEHAV IMMUN, V21, P1083, DOI 10.1016/j.bbi.2007.05.001; Meeuwsen S, 2003, GLIA, V43, P243, DOI 10.1002/glia.10259; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miller GE, 2014, BRAIN BEHAV IMMUN, V41, P191, DOI 10.1016/j.bbi.2014.05.016; Monje FJ, 2011, J NEUROSCI, V31, P9075, DOI 10.1523/JNEUROSCI.1537-11.2011; Murrough JW, 2013, AM J PSYCHIAT, V170, P1134, DOI 10.1176/appi.ajp.2013.13030392; Nagy C, 2015, MOL PSYCHIATR, V20, P320, DOI 10.1038/mp.2014.21; Nakai A, 2014, J EXP MED, V211, P2583, DOI 10.1084/jem.20141132; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pang Y, 2001, BRAIN RES, V914, P15, DOI 10.1016/S0006-8993(01)02766-4; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pariante Carmine M, 2006, J Psychopharmacol, V20, P79, DOI 10.1177/1359786806066063; Portou MJ, 2015, VASC PHARMACOL, V71, P31, DOI 10.1016/j.vph.2015.02.007; Quan N, 2003, J NEUROIMMUNOL, V137, P51, DOI 10.1016/S0165-5728(03)00042-0; Raison CL, 2013, JAMA PSYCHIAT, V70, P31, DOI 10.1001/2013.jamapsychiatry.4; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Raz E, 2007, NAT IMMUNOL, V8, P3, DOI 10.1038/ni0107-3; Reader BF, 2015, NEUROSCIENCE, V289, P429, DOI 10.1016/j.neuroscience.2015.01.001; RENAULT PF, 1987, ARCH INTERN MED, V147, P1577, DOI 10.1001/archinte.147.9.1577; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sawicki CM, 2015, NEUROSCIENCE, V302, P151, DOI 10.1016/j.neuroscience.2014.10.004; Scheiermann C, 2015, CARDIOVASC RES, V107, P340, DOI 10.1093/cvr/cvv099; Setiawan E, 2015, JAMA PSYCHIAT, V72, P268, DOI 10.1001/jamapsychiatry.2014.2427; Shechter R, 2013, NAT REV IMMUNOL, V13, P206, DOI 10.1038/nri3391; Slattery DA, 2014, ILAR J, V55, P297, DOI 10.1093/ilar/ilu026; Sluzewska A, 1995, ANN NY ACAD SCI, V762, P474; SMITH RS, 1991, MED HYPOTHESES, V35, P298, DOI 10.1016/0306-9877(91)90272-Z; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Steiner J, 2008, J PSYCHIATR RES, V42, P151, DOI 10.1016/j.jpsychires.2006.10.013; Steiner J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-94; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Torres-Platas SG, 2014, BRAIN BEHAV IMMUN, V42, P50, DOI 10.1016/j.bbi.2014.05.007; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Tynan RJ, 2013, ACTA NEUROPATHOL, V126, P75, DOI 10.1007/s00401-013-1102-0; Varvel NH, 2012, P NATL ACAD SCI USA, V109, P18150, DOI 10.1073/pnas.1210150109; Venkiteshwaran A, 2009, MABS-AUSTIN, V1, P432, DOI 10.4161/mabs.1.5.9497; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Warner-Schmidt JL, 2011, P NATL ACAD SCI USA, V108, P9262, DOI 10.1073/pnas.1104836108; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Wohleb ES, 2013, J NEUROSCI, V33, P13820, DOI 10.1523/JNEUROSCI.1671-13.2013; Wohleb ES, 2011, J NEUROSCI, V31, P6277, DOI 10.1523/JNEUROSCI.0450-11.2011; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yang C, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu121	115	315	325	7	186	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2015	18	10					1386	1393		10.1038/nn.4113	http://dx.doi.org/10.1038/nn.4113			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CS2OK	26404713	Green Accepted			2022-12-17	WOS:000361910600007
J	Lobo, MK; Karsten, SL; Gray, M; Geschwind, DH; Yang, XW				Lobo, MK; Karsten, SL; Gray, M; Geschwind, DH; Yang, XW			FACS-array profiling of striatal projection neuron subtypes in juvenile and adult mouse brains	NATURE NEUROSCIENCE			English	Article							ZINC-FINGER PROTEIN; GENE-EXPRESSION; D2 DOPAMINE; CAENORHABDITIS-ELEGANS; CELL-DIFFERENTIATION; GANGLIA ANTIBODIES; RECEPTOR PROTEINS; TRANSGENIC MICE; TRANSCRIPTION; NEUROBIOLOGY	A major challenge in systems neuroscience is to perform precise molecular genetic analyses of a single neuronal population in the context of the complex mammalian brain. Existing technologies for profiling cell type-specific gene expression are largely limited to immature or morphologically identifiable neurons. In this study, we developed a simple method using fluorescent activated cell sorting (FACS) to purify genetically labeled neurons from juvenile and adult mouse brains for gene expression profiling. We identify and verify a new set of differentially expressed genes in the striatonigral and striatopallidal neurons, two functionally and clinically important projection neuron subtypes in the basal ganglia. We further demonstrate that Ebf1 is a lineage-specific transcription factor essential to the differentiation of striatonigral neurons. Our study provides a general approach for profiling cell type-specific gene expression in the mature mammalian brain and identifies a set of genes critical to the function and dysfunction of the striatal projection neuron circuit.	Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Program Neurogenet, Dept Neurol, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Yang, XW (corresponding author), Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.	xwyang@mednet.ucla.edu	Karsten, Stan/AAI-4076-2021; Lobo, Mary Kay/K-7734-2015	Lobo, Mary Kay/0000-0002-9419-2079; Karsten, Stanislav/0000-0001-7387-4874	NICHD NIH HHS [5T32HD007032] Funding Source: Medline; NIDA NIH HHS [P50DA05010, P50 DA005010] Funding Source: Medline; NINDS NIH HHS [NS047391, U24 NS43562, NS049501, 5T32NS048004] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS048004, R01NS049501, R21NS047391, U24NS043562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Berninsone P, 2001, P NATL ACAD SCI USA, V98, P3738, DOI 10.1073/pnas.061593098; Bond HM, 2004, BLOOD, V103, P2062, DOI 10.1182/blood-2003-07-2388; Cao YX, 2001, CURR OPIN NEUROBIOL, V11, P615, DOI 10.1016/S0959-4388(00)00258-0; Chao J, 2004, ANNU REV MED, V55, P113, DOI 10.1146/annurev.med.55.091902.103730; Church AJ, 2002, NEUROLOGY, V59, P227, DOI 10.1212/WNL.59.2.227; de Silva MG, 2003, J MED GENET, V40, P733, DOI 10.1136/jmg.40.10.733; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dougherty JD, 2005, NEURON, V45, P183, DOI 10.1016/j.neuron.2005.01.007; FISHELL G, 1991, J COMP NEUROL, V312, P33, DOI 10.1002/cne.903120104; Garel S, 1999, DEVELOPMENT, V126, P5285; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Goto S, 2001, NAT CELL BIOL, V3, P816, DOI 10.1038/ncb0901-816; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Hentges KE, 2005, ONCOGENE, V24, P1220, DOI 10.1038/sj.onc.1208243; HERSCH SM, 1995, J NEUROSCI, V15, P5222; Ince E, 1997, SYNAPSE, V27, P357, DOI 10.1002/(SICI)1098-2396(199712)27:4<357::AID-SYN9>3.0.CO;2-B; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; Kamme F, 2003, J NEUROSCI, V23, P3607; Kim K, 2005, DEV BIOL, V286, P136, DOI 10.1016/j.ydbio.2005.07.024; Kirvan CA, 2003, NAT MED, V9, P914, DOI 10.1038/nm892; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Martino D, 2004, CURR OPIN NEUROL, V17, P425, DOI 10.1097/01.wco.0000137532.76491.19; Meyer-Lindenberg A, 2002, NAT NEUROSCI, V5, P267, DOI 10.1038/nn804; Mirnics K, 2004, NAT NEUROSCI, V7, P434, DOI 10.1038/nn1230; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Prasad BC, 1998, DEVELOPMENT, V125, P1561; Rogers MA, 1998, BRAIN RES BULL, V47, P297, DOI 10.1016/S0361-9230(98)00126-9; Sabatti C, 2002, MATH BIOSCI, V176, P17, DOI 10.1016/S0025-5564(01)00102-X; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saka E, 2003, BRAIN DEV-JPN, V25, pS15, DOI 10.1016/S0387-7604(03)90002-7; SCHIFFMANN SN, 1993, J NEUROSCI, V13, P1080; Selva EM, 2001, NAT CELL BIOL, V3, P809, DOI 10.1038/ncb0901-809; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; TECOTT LH, 1989, DEV BRAIN RES, V49, P75, DOI 10.1016/0165-3806(89)90060-6; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Tsai RYL, 1997, J NEUROSCI, V17, P4159; Warming S, 2003, BLOOD, V101, P1934, DOI 10.1182/blood-2002-08-2652; Wichmann T, 2003, ANN NY ACAD SCI, V991, P199, DOI 10.1111/j.1749-6632.2003.tb07477.x; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859	50	315	322	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					443	452		10.1038/nn1654	http://dx.doi.org/10.1038/nn1654			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16491081				2022-12-17	WOS:000235645600025
J	Yamamoto, S; Kitazawa, S				Yamamoto, S; Kitazawa, S			Reversal of subjective temporal order due to arm crossing	NATURE NEUROSCIENCE			English	Article							SOMATOSENSORY TARGETS; REPRESENTATION; SPACE; MODEL; COMPATIBILITY; JUDGMENTS; SACCADES; LOCATION; SENSE; TIME	How does the brain order successive events? Here we studied whether temporal order of two stimuli delivered in rapid succession, one to each hand, is determined before or after the stimuli are localized in space. When their arms were crossed, subjects could accurately report the temporal order, even when the interval between stimuli was as short as 70 ms. In most trials, subjects could also judge temporal order when their arms were crossed, but only if given adequate time (>1 s). At moderately short intervals (<300 ms), crossing the arms caused misreporting (that is, inverting) of the temporal order. Thus, at these intervals, the determining factor of temporal order was the spatial location of the hands. We suggest that it is not until the spatial locations of the hands are taken into account that the cutaneous signals from the respective hands are ordered in time.	Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058568, Japan; Japan Sci & Technol Corp, TOREST, Kawaguchi 3320012, Japan; Univ Tsukuba, Doctoral Program Med Sci, Tsukuba, Ibaraki 3058575, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); University of Tsukuba	Kitazawa, S (corresponding author), Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058568, Japan.	kitazawa-s@aist.go.jp	Yamamoto, Shinya/S-3134-2016	Yamamoto, Shinya/0000-0002-0505-8848				ALLAN LG, 1975, PERCEPT PSYCHOPHYS, V18, P29, DOI 10.3758/BF03199363; AXELROD S, 1968, J GERONTOL, V23, P191, DOI 10.1093/geronj/23.2.191; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Cordo PJ, 2000, EXP BRAIN RES, V132, P1, DOI 10.1007/s002219900319; DASSONVILLE P, 1995, EXP BRAIN RES, V106, P434; DENNETT DC, 1992, BEHAV BRAIN SCI, V15, P183, DOI 10.1017/S0140525X00068229; Driver J, 1998, PHILOS T R SOC B, V353, P1319, DOI 10.1098/rstb.1998.0286; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; EFRON R, 1963, BRAIN, V86, P261, DOI 10.1093/brain/86.2.261; GELDARD FA, 1986, SCI AM, V255, P90, DOI 10.1038/scientificamerican0786-90; GIBBON J, 1969, SCIENCE, V165, P413, DOI 10.1126/science.165.3891.413; Graziano MSA, 1998, CURR OPIN NEUROBIOL, V8, P195, DOI 10.1016/S0959-4388(98)80140-2; GRAZIANO MSA, 1993, EXP BRAIN RES, V97, P96; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Groh JM, 1996, J NEUROPHYSIOL, V75, P439, DOI 10.1152/jn.1996.75.1.439; Groh JM, 1996, J NEUROPHYSIOL, V75, P412, DOI 10.1152/jn.1996.75.1.412; Haggard P, 2000, PERCEPT PSYCHOPHYS, V62, P363, DOI 10.3758/BF03205556; HIRSH IJ, 1961, J EXP PSYCHOL, V62, P423, DOI 10.1037/h0045283; HOCHERMAN S, 1988, EXP BRAIN RES, V73, P256; Iwamura Y, 1998, CURR OPIN NEUROBIOL, V8, P522, DOI 10.1016/S0959-4388(98)80041-X; IWAMURA Y, 1994, NATURE, V369, P554, DOI 10.1038/369554a0; JASKOWSKI P, 1991, PERCEPT PSYCHOPHYS, V50, P76, DOI 10.3758/BF03212206; Karhu J, 1999, J NEUROPHYSIOL, V81, P2017, DOI 10.1152/jn.1999.81.5.2017; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Linhart H., 1986, MODEL SELECTION; Obayashi S, 2000, NEUROREPORT, V11, P3499, DOI 10.1097/00001756-200011090-00020; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Poppel E, 1997, TRENDS COGN SCI, V1, P56, DOI 10.1016/S1364-6613(97)01008-5; SHORE DI, IN PRESS PSYCHOL SCI; SIMON JR, 1970, J EXP PSYCHOL, V86, P97, DOI 10.1037/h0029783; Simon JR., 1990, ADV PSYCHOL, P31, DOI [10.1016/s0166-4115(08)61218-2, DOI 10.1016/S0166-4115(08)61218-2]; Sternberg S., 1973, ATTENTION PERFORM, VIV, P629; ULRICH R, 1987, PERCEPT PSYCHOPHYS, V42, P224, DOI 10.3758/BF03203074; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245	36	315	319	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					759	765		10.1038/89559	http://dx.doi.org/10.1038/89559			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	448HK	11426234				2022-12-17	WOS:000169621300023
J	Koch, C; Segev, I				Koch, Christof; Segev, Idan			The role of single neurons in information processing	NATURE NEUROSCIENCE			English	Review							SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; ACTION-POTENTIALS; DENDRITIC SPINES; OBJECT APPROACH; WIDE-FIELD; COINCIDENCE; COMPUTATION; CELLS; ARCHITECTURE	Neurons carry out the many operations that extract meaningful information from sensory receptor arrays at the organism's periphery and translate these into action, imagery and memory. Within today's dominant computational paradigm, these operations, involving synapses, membrane ionic channels and changes in membrane potential, are thought of as steps in an algorithm or as computations. The role of neurons in these computations has evolved conceptually from that of a simple integrator of synaptic inputs until a threshold is reached and an output pulse is initiated, to a much more sophisticated processor with mixed analog-digital logic and highly adaptive synaptic elements.	[Koch, Christof] CALTECH, Div Biol, Computat & Neural Syst Program, Pasadena, CA 91125 USA; [Segev, Idan] Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel; [Segev, Idan] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel	California Institute of Technology; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Koch, C (corresponding author), CALTECH, Div Biol, Computat & Neural Syst Program, Pasadena, CA 91125 USA.	koch@klab.caltech.edu		Koch, Christof/0000-0001-6482-8067; Segev, Idan/0000-0001-7279-9630	NSF/ERC; NIMH; ONR; Israeli Science Foundation; BSF	NSF/ERC(European Research Council (ERC)National Science Foundation (NSF)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ONR(Office of Naval Research); Israeli Science Foundation(Israel Science Foundation); BSF(US-Israel Binational Science Foundation)	Work in the laboratories of the authors is supported by the NSF/ERC program, NIMH, ONR, Israeli Science Foundation and the BSF. We thank R. Nitzan for Fig. 2a, Y. Manor for Fig. 2b, J. Andersen for the two pyramidal cells in Fig. 2c and d, M. Rapp for Fig. 2e, B. Burke for Fig. 2f, M. Larkum for Fig. 3, F. Gabbiani for Fig. 4 and F. Gabbiani and G. Kreiman for comments.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Agmon-Snir H, 1998, NATURE, V393, P268, DOI 10.1038/30505; BELL AJ, 1992, NEURAL INFORMATION P, V4, P59; Berman NJ, 1999, J EXP BIOL, V202, P1243; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Chklovskii DB, 2000, J NEUROPHYSIOL, V83, P2113, DOI 10.1152/jn.2000.83.4.2113; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Gabbiani F, 1999, J NEUROSCI, V19, P1122; HATSOPOULOS N, 1995, SCIENCE, V270, P1000, DOI 10.1126/science.270.5238.1000; HAUSSER M, SCIENCE IN PRESS; Hertz J., 1991, INTRO THEORY NEURAL, DOI DOI 10.1201/9780429499661; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kistler WM, 2000, NEURAL COMPUT, V12, P385, DOI 10.1162/089976600300015844; KOCH C, 1982, PHILOS T R SOC B, V298, P227, DOI 10.1098/rstb.1982.0084; KOCH C, 1993, J NEUROSCI, V13, P413; KOCH C, 1995, J COMPUT NEUROSCI, V2, P63, DOI 10.1007/BF00962708; Koch C., 1992, SINGLE NEURON COMPUT, P315; Koch Christof, 1999, P1; KONISHI M, 1992, HARVEY LECT, V86, P47; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Magee J. C., 1999, DENDRITES, P139; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mainen Z, 1998, METHODS NEURONAL MOD, P171; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McCulloch W., 1943, B MATH BIOPHYS, V5, P115, DOI [10.1007/BF02478259, 10.1007/bf02478259, DOI 10.1007/BF02478259]; Mel B. W., 1999, DENDRITES, P271; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; MEL BW, 1994, NEURAL COMPUT, V6, P1031, DOI 10.1162/neco.1994.6.6.1031; Mel BW, 1998, J NEUROSCI, V18, P4325; RALL W, 1959, EXP NEUROL, V1, P491, DOI 10.1016/0014-4886(59)90046-9; RALL W, 1974, BRAIN INFORMATION SE, V3, P13; Rall W, 1987, SYNAPTIC FUNCTION PP, P605; Rall W., 1964, NEURAL THEORY MODELI; Riesenhuber M, 2000, NAT NEUROSCI, V3, P1199, DOI 10.1038/81479; ROWELL CHF, 1977, J EXP BIOL, V68, P157; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; SCHLOTTERER GR, 1977, CAN J ZOOL, V55, P1372, DOI 10.1139/z77-179; Segev I, 1998, NATURE, V393, P207, DOI 10.1038/30340; SEGEV I, 1988, J NEUROPHYSIOL, V60, P499, DOI 10.1152/jn.1988.60.2.499; Segev I, 1998, TRENDS NEUROSCI, V21, P453, DOI 10.1016/S0166-2236(98)01327-7; SHEPHERD GM, 1985, P NATL ACAD SCI USA, V82, P2192, DOI 10.1073/pnas.82.7.2192; Shepherd GM, 1996, J NEUROPHYSIOL, V75, P2197, DOI 10.1152/jn.1996.75.6.2197; Siegel M, 2000, J COMPUT NEUROSCI, V8, P161, DOI 10.1023/A:1008973215925; SOFTKY W, 1994, NEUROSCIENCE, V58, P13, DOI 10.1016/0306-4522(94)90154-6; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; YOUNG SR, 1986, J COMP NEUROL, V254, P425, DOI 10.1002/cne.902540402; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	60	315	322	2	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11		S			1171	1177		10.1038/81444	http://dx.doi.org/10.1038/81444			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V18OV	11127834				2022-12-17	WOS:000208015000009
J	Driver, J; Mattingley, JB				Driver, J; Mattingley, JB			Parietal neglect and visual awareness	NATURE NEUROSCIENCE			English	Review							VISUOSPATIAL NEGLECT; CORTEX; EXTINCTION; REPRESENTATION; MOVEMENTS; ATTENTION; LESIONS; FIELD; PERCEPTION; HEMIANOPIA	The last decade has seen a resurgence of interest in the neural correlates of conscious vision, with most discussion focused on the 'blindsight' that can follow damage to primary visual cortex, in the occipital lobe. We suggest that new insights into the neural basis of visual awareness may be gleaned from a different neuropsychological phenomenon, namely visual 'neglect' after injury to regions in the parietal lobe. Neglect provides several revealing contrasts with occipital blindsight. Here we summarise four key findings. First, unlike the deficits caused by damage to primary visual cortex, the loss of awareness in parietal neglect is characteristically not strictly retinotopic. Second, visual segmentation processes are preserved in neglect, and can influence what will reach the patient's awareness. Third, extensive unconscious processing takes place for those stimuli on the neglected side which escape awareness, including some degree of object identification. Finally, parietal damage affects initial stages of motor planning as well as perception. These findings are consistent with recent data on single-cell activity in the monkey brain. They also suggest why areas in the inferior parietal lobe may play a prominent role in visual awareness.	Univ London Univ Coll, Inst Cognit Neurosci, Dept Psychol, London WC1E 6BT, England; Monash Univ, Dept Psychol, Clayton, Vic 3168, Australia	University of London; University College London; Monash University	Driver, J (corresponding author), Univ London Univ Coll, Inst Cognit Neurosci, Dept Psychol, Alexandra House,Queen Sq, London WC1E 6BT, England.	j.driver@ucl.ac.uk	Driver, Jon/A-4779-2010; Mattingley, Jason/J-1537-2014	Mattingley, Jason/0000-0003-0929-9216	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; BAYLIS GC, 1993, J COGNITIVE NEUROSCI, V5, P453, DOI 10.1162/jocn.1993.5.4.453; COHEN A, 1995, NEUROPSYCHOLOGY, V9, P165, DOI 10.1037/0894-4105.9.2.165; CRICK F, 1995, NATURE, V377, P294, DOI 10.1038/377294a0; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; DRIVER J, 1992, NATURE, V360, P73, DOI 10.1038/360073a0; Driver J, 1995, BEHAV BRAIN RES, V71, P135, DOI 10.1016/0166-4328(95)00044-5; Driver J., 1996, CONVERGENT OPERATION, P193; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; FARAH MJ, 1997, PARIETAL LOBE CONTRI, P385; FRIEDMANHILL SR, 1995, SCIENCE, V269, P853, DOI 10.1126/science.7638604; Gaffan D, 1997, BRAIN, V120, P1647, DOI 10.1093/brain/120.9.1647; Gilchrist ID, 1996, COGNITIVE NEUROPSYCH, V13, P1223, DOI 10.1080/026432996381737; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; HALLIGAN PW, 1990, J NEUROL NEUROSUR PS, V53, P487, DOI 10.1136/jnnp.53.6.487; HEILMAN KM, 1985, NEUROLOGY, V35, P855, DOI 10.1212/WNL.35.6.855; HIRSCH J, 1995, P NATL ACAD SCI USA, V92, P6469, DOI 10.1073/pnas.92.14.6469; KARNATH HO, 1993, BRAIN, V116, P383, DOI 10.1093/brain/116.2.383; KOOISTRA CA, 1989, NEUROLOGY, V39, P1125, DOI 10.1212/WNL.39.8.1125; MARSHALL JC, 1994, NEUROPSYCHOLOGIA, V32, P1037, DOI 10.1016/0028-3932(94)90151-1; Marzi CA, 1996, NEUROPSYCHOLOGIA, V34, P9, DOI 10.1016/0028-3932(95)00059-3; Mattingley JB, 1997, SCIENCE, V275, P671, DOI 10.1126/science.275.5300.671; MATTINGLEY JB, 1995, PERCEPTION, V24, P415, DOI 10.1068/p240415; Mattingley JB, 1998, NATURE, V392, P179, DOI 10.1038/32413; MATTINGLEY JB, 1997, PARIETAL LOBE CONTRI, P309, DOI DOI 10.1007/978-3-642-60661-8_18; MCGLINCHEYBERROTH R, 1993, COGNITIVE NEUROPSYCH, V10, P79, DOI 10.1080/02643299308253457; Milner A. D., 1995, VISUAL BRAIN ACTION; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Perenin M.-T., 1997, PARIETAL LOBE CONTRI, P289; POLLEN DA, 1995, NATURE, V377, P293, DOI 10.1038/377293b0; POPPEL E, 1973, NATURE, V243, P295, DOI 10.1038/243295a0; POSNER MI, 1984, J NEUROSCI, V4, P1863; Pouget A, 1997, PHILOS T R SOC B, V352, P1449, DOI 10.1098/rstb.1997.0131; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; Von Helmholtz H., 1866, HDB PHYSIOLOGISCHEN; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; WALKER R, 1991, NEUROPSYCHOLOGIA, V29, P1019, DOI 10.1016/0028-3932(91)90065-G; Ward R., 1994, VIS COGN, V1, P101, DOI DOI 10.1080/13506289408402295; Weiskrantz L., 1986, BLINDSIGHT CASE STUD; Zeki S., 1993, VISION BRAIN; Zingerle H, 1913, MON PSYCHIATR NEUROL, V34, P13	45	315	319	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					17	22		10.1038/217	http://dx.doi.org/10.1038/217			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	127QA	10195103				2022-12-17	WOS:000076361000012
J	Hamdy, S; Rothwell, JC; Aziz, Q; Singh, KD; Thompson, DG				Hamdy, S; Rothwell, JC; Aziz, Q; Singh, KD; Thompson, DG			Long-term reorganization of human motor cortex driven by short-term sensory stimulation	NATURE NEUROSCIENCE			English	Article							MONKEYS; OUTPUT	Removal of sensory input can induce changes in cortical motor representation that reverse when sensation is restored. Here we ask whether manipulation of sensory input can induce long-term reorganization in human motor cortex that outlasts the initial conditioning. We report that for at least 30 minutes after pharyngeal stimulation, motor cortex excitability and area of representation for the pharynx increased, while esophagus representation decreased, without parallel changes in the excitability of brainstem-mediated reflexes. Therefore increased sensory input can drive long-term cross-system changes in motor areas of the cerebral cortex, which suggests that sensory stimulation might rehabilitate dysphagia, a frequent consequence of cerebral injury.	Univ Manchester, Hope Hosp, Dept Gastroenterol, Salford M6 8HD, Lancs, England; Inst Neurol, MRC, Human Movement & Balance Unit, London WC1N 3BG, England; Univ London, Royal Holloway & Bedford New Coll, Dept Psychol, Egham TW20 0EX, Surrey, England	University of Manchester; University of London; University College London; University of London; Royal Holloway University London	Thompson, DG (corresponding author), Univ Manchester, Hope Hosp, Dept Gastroenterol, Salford M6 8HD, Lancs, England.		Singh, Krish/D-1066-2009; Aziz, Qasim/AAC-4730-2020; Hamdy, Shaheen/O-5039-2014	Hamdy, Shaheen/0000-0001-9640-7427; Aziz, Qasim/0000-0002-2718-2065; Rothwell, John/0000-0003-1367-6467; Singh, Krishna/0000-0002-3094-2475	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARER DH, 1989, J NEUROL NEUROSUR PS, V52, P236, DOI 10.1136/jnnp.52.2.236; BRASILNETO JP, 1993, BRAIN, V116, P511, DOI 10.1093/brain/116.3.511; Cohen L G, 1993, Adv Neurol, V63, P187; DONOGHUE JP, 1990, EXP BRAIN RES, V79, P492; Hamdy S, 1996, NAT MED, V2, P1217, DOI 10.1038/nm1196-1217; Hamdy S, 1997, AM J PHYSIOL-GASTR L, V272, pG802, DOI 10.1152/ajpgi.1997.272.4.G802; Jean A., 1990, NEUROPHYSIOLOGY JAWS, P294; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; MANSSON I, 1974, LARYNGOSCOPE, V84, P427; Martin Ruth E., 1993, Dysphagia, V8, P195, DOI 10.1007/BF01354538; MILLER AJ, 1982, PHYSIOL REV, V62, P129, DOI 10.1152/physrev.1982.62.1.129; Nudo RJ, 1996, J NEUROSCI, V16, P785; Ridding MC, 1997, ELECTROMYOGR MOTOR C, V105, P340, DOI 10.1016/S0924-980X(97)00041-6; Rothwell JC, 1997, J NEUROSCI METH, V74, P113, DOI 10.1016/S0165-0270(97)02242-5; SANES JN, 1992, CEREB CORTEX, V2, P141, DOI 10.1093/cercor/2.2.141; Singh KD, 1997, ELECTROMYOGR MOTOR C, V105, P345, DOI 10.1016/S0924-980X(97)96699-6; SUMI T, 1972, BRAIN RES, V46, P43, DOI 10.1016/0006-8993(72)90004-2; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; Ziemann U, 1998, J NEUROSCI, V18, P1115	19	315	335	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					64	68		10.1038/264	http://dx.doi.org/10.1038/264			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QA	10195111				2022-12-17	WOS:000076361000020
J	Sharot, T; Korn, CW; Dolan, RJ				Sharot, Tali; Korn, Christoph W.; Dolan, Raymond J.			How unrealistic optimism is maintained in the face of reality	NATURE NEUROSCIENCE			English	Article							FUTURE LIFE EVENTS; PREFRONTAL CORTEX; NEURAL MECHANISMS; DECISION-MAKING; REWARD; PERCEPTIONS; CHOICE; HEALTH	Unrealistic optimism is a pervasive human trait that influences domains ranging from personal relationships to politics and finance. How people maintain unrealistic optimism, despite frequently encountering information that challenges those biased beliefs, is unknown. We examined this question and found a marked asymmetry in belief updating. Participants updated their beliefs more in response to information that was better than expected than to information that was worse. This selectivity was mediated by a relative failure to code for errors that should reduce optimism. Distinct regions of the prefrontal cortex tracked estimation errors when those called for positive update, both in individuals who scored high and low on trait optimism. However, highly optimistic individuals exhibited reduced tracking of estimation errors that called for negative update in right inferior prefrontal gyrus. These findings indicate that optimism is tied to a selective update failure and diminished neural coding of undesirable information regarding the future.	[Sharot, Tali; Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Korn, Christoph W.] Free Univ Berlin, Dept Educ & Psychol, D-1000 Berlin, Germany; [Korn, Christoph W.] Humboldt Univ, Sch Mind & Brain, Berlin, Germany	University of London; University College London; Free University of Berlin; Humboldt University of Berlin	Sharot, T (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.	t.sharot@ucl.ac.uk		Dolan, Ray/0000-0001-9356-761X; Korn, Christoph/0000-0002-8228-2624	Wellcome Trust; British Academy; German Academic Exchange Service (DAAD)	Wellcome Trust(Wellcome TrustEuropean Commission); British Academy; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	We thank S. Fleming for assistance with analysis, P. Dayan for discussion, and T. Behrens, D. Schiller, Q. Huys, J. Winston, B. De Martino, S. Fleming, S. Bengtsson, K. Wunderlich, H. Heekeren, S. Kennerley and M. Guitart-Masip for comments on a previous version of this manuscript. This study was supported by a Wellcome Trust Program grant to R. J. D., a British Academy Postdoctoral Fellowship to T. S., and a German Academic Exchange Service (DAAD) scholarship to C. W. K.	Armor D.A., 2012, HEURISTICS BIASES PS, P334, DOI [DOI 10.1017/CBO9780511808098.021, 10.1017/cbo9780511808098.021]; BAKER LA, 1993, LAW HUMAN BEHAV, V17, P439, DOI 10.1007/BF01044377; Bengtsson SL, 2009, CEREB CORTEX, V19, P797, DOI 10.1093/cercor/bhn127; Calderon TG, 1993, MIDATLANTIC J BUS, V29, P41, DOI DOI 10.1016/0001-4575(89)90024-9; CHANG EC, 2000, OPTIMISM PESSIMISM I; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Ekman, 1983, QUESTIONS EMOTIONS, P39; Gerrard Meg, 1999, Journal of the National Cancer Institute Monographs, P94; Greening SG, 2011, NEUROIMAGE, V54, P1432, DOI 10.1016/j.neuroimage.2010.09.017; Mitchell DGV, 2009, J NEUROSCI, V29, P10827, DOI 10.1523/JNEUROSCI.0963-09.2009; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Puri M, 2007, J FINANC ECON, V86, P71, DOI 10.1016/j.jfineco.2006.09.003; SCHEIER MF, 1989, J PERS SOC PSYCHOL, V57, P1024, DOI 10.1037/0022-3514.57.6.1024; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sharot T., 2011, OPTIMISM BIAS; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Shefrin H., 2010, ROUTLEDGE COMPANION; Strunk DR, 2006, BEHAV RES THER, V44, P861, DOI 10.1016/j.brat.2005.07.001; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Taylor SE, 2000, AM PSYCHOL, V55, P99, DOI 10.1037//0003-066X.55.1.99; Taylor SF, 2007, NEUROSCIENTIST, V13, P160, DOI 10.1177/1073858406298184; UBEL P, 2009, FORBES          0222; Varki A, 2009, NATURE, V460, P684, DOI 10.1038/460684c; WEINSTEIN ND, 1980, J PERS SOC PSYCHOL, V39, P806, DOI 10.1037/0022-3514.39.5.806; WEINSTEIN ND, 1995, HEALTH PSYCHOL, V14, P132, DOI 10.1037/0278-6133.14.2.132; Yeung N, 2005, CEREB CORTEX, V15, P535, DOI 10.1093/cercor/bhh153	29	314	319	5	123	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1475	U156		10.1038/nn.2949	http://dx.doi.org/10.1038/nn.2949			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	841NI	21983684	Green Accepted, Green Published			2022-12-17	WOS:000296518600025
J	Elliott, E; Ezra-Nevo, G; Regev, L; Neufeld-Cohen, A; Chen, A				Elliott, Evan; Ezra-Nevo, Gili; Regev, Limor; Neufeld-Cohen, Adi; Chen, Alon			Resilience to social stress coincides with functional DNA methylation of the Crf gene in adult mice	NATURE NEUROSCIENCE			English	Article							BRAIN; CORTICOTROPIN; ADAPTATION	DNA methylation regulates gene transcription and has been suggested to encode psychopathologies derived from early life stress. We found that methylation regulated the expression of the Crf (also known as Crh) gene and that chronic social stress in adult mice induced long-term demethylation of this genomic region. Demethylation was observed only in the subset of defeated mice that displayed social avoidance and site-specific knockdown of Crf attenuated the stress-induced social avoidance.	[Elliott, Evan; Ezra-Nevo, Gili; Regev, Limor; Neufeld-Cohen, Adi; Chen, Alon] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Chen, A (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	alon.chen@weizmann.ac.il		Ezra-Nevo, Gili/0000-0002-7617-6139; Elliott, Evan/0000-0002-1630-969X; Chen, Alon/0000-0003-3625-8233	Pratt Foundation; Israel Science Foundation; Nella and Leon Benoziyo Center for Neurosciences; Nella and Leon Benoziyo Center for Neurological Diseases; Carl and Micaela Einhorn-Dominic Brain Research Institute; Irwin Green Alzheimer's Research Fund; Gerhard and Hannah Bacharach	Pratt Foundation; Israel Science Foundation(Israel Science Foundation); Nella and Leon Benoziyo Center for Neurosciences; Nella and Leon Benoziyo Center for Neurological Diseases; Carl and Micaela Einhorn-Dominic Brain Research Institute; Irwin Green Alzheimer's Research Fund; Gerhard and Hannah Bacharach	This work was supported by Roberto and Renata Ruhman, Mark Besen and the Pratt Foundation, the Israel Science Foundation, the Legacy Heritage Biomedical Science program of the Israel Science Foundation, the Nella and Leon Benoziyo Center for Neurosciences, the Nella and Leon Benoziyo Center for Neurological Diseases, the Carl and Micaela Einhorn-Dominic Brain Research Institute, the Irwin Green Alzheimer's Research Fund, and Gerhard and Hannah Bacharach. A. C. is incumbent of the Philip Harris and Gerald Ronson Career Development Chair.	Aguilera G, 2007, STRESS, V10, P153, DOI 10.1080/10253890701391192; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; PAXINOS F, 2001, MOUSE BRAIN STEREOTA; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	15	314	321	2	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1351	1353		10.1038/nn.2642	http://dx.doi.org/10.1038/nn.2642			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20890295				2022-12-17	WOS:000283658200014
J	Corfas, G; Roy, K; Buxbaum, J				Corfas, G; Roy, K; Buxbaum, J			Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia	NATURE NEUROSCIENCE			English	Article							WHITE-MATTER; PREFRONTAL CORTEX; OLIGODENDROCYTE DEVELOPMENT; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; GABAERGIC INTERNEURONS; PSYCHIATRIC-DISORDERS; SELECTIVE ALTERATIONS; INTERSTITIAL NEURONS; NICOTINIC RECEPTORS	Schizophrenia is a devastating psychiatric disease that affects 0.5-1% of the world's adult population. The hypothesis that this disease is a developmental disorder of the nervous system with late onset of its characteristic symptoms has been gaining acceptance in past years. However, the anatomical, cellular and molecular bases of schizophrenia remain unclear. Numerous studies point to alterations in different aspects of brain development as possible causes of schizophrenia, including defects in neuronal migration, neurotransmitter receptor expression and myelination. Recently, the gene that encodes neuregulin-1 (NRG1) has been identified as a potential susceptibility gene for schizophrenia, and defects in the expression of erbB3, one of the NRG1 receptors, have been shown to occur in the prefrontal cortex of schizophrenic patients, suggesting that NRG1-erbB signaling is involved in the pathogenesis of schizophrenia. These findings open new approaches to defining the molecular and cellular basis of schizophrenia in more mechanistic terms.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; CUNY Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Neurobiol, New York, NY 10029 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Corfas, G (corresponding author), Childrens Hosp, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.	gabriel.corfas@tch.harvard.edu	Corfas, Gabriel/AAH-2378-2020; Buxbaum, Joseph D/G-6001-2010	Corfas, Gabriel/0000-0001-5412-9473; Buxbaum, Joseph/0000-0001-8898-8313	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH066392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035884] Funding Source: NIH RePORTER; NIMH NIH HHS [P50 MH066392] Funding Source: Medline; NINDS NIH HHS [R01 NS35884] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akbarian S, 1996, ARCH GEN PSYCHIAT, V53, P425; Akbarian S, 1996, J NEUROSCI, V16, P19; Anton ES, 1997, DEVELOPMENT, V124, P3501; Arnold SE, 1996, ACTA NEUROPATHOL, V92, P217, DOI 10.1007/s004010050512; Bartzokis G, 2003, BIOL PSYCHIAT, V53, P412, DOI 10.1016/S0006-3223(02)01835-8; Bartzokis G, 2002, NEUROPSYCHOPHARMACOL, V27, P672, DOI 10.1016/S0893-133X(02)00364-0; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Blum BP, 2002, INT J NEUROPSYCHOPH, V5, P159, DOI 10.1017/S1461145702002894; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Calaora V, 2001, J NEUROSCI, V21, P4740, DOI 10.1523/JNEUROSCI.21-13-04740.2001; Cannella B, 1999, J NEUROIMMUNOL, V100, P233, DOI 10.1016/S0165-5728(99)00201-5; Cannon TD, 1998, ARCH GEN PSYCHIAT, V55, P1084, DOI 10.1001/archpsyc.55.12.1084; Canoll PD, 1996, NEURON, V17, P229, DOI 10.1016/S0896-6273(00)80155-5; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; Court J, 1999, J NEUROCHEM, V73, P1590, DOI 10.1046/j.1471-4159.1999.0731590.x; Davis KL, 2003, ARCH GEN PSYCHIAT, V60, P443, DOI 10.1001/archpsyc.60.5.443; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; Fernandez PA, 2000, NEURON, V28, P81, DOI 10.1016/S0896-6273(00)00087-8; Flynn SW, 2003, MOL PSYCHIATR, V8, P811, DOI 10.1038/sj.mp.4001337; Foong J, 2002, NEUROREPORT, V13, P333, DOI 10.1097/00001756-200203040-00017; FREEDMAN R, 1995, BIOL PSYCHIAT, V38, P22, DOI 10.1016/0006-3223(94)00252-X; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Guan ZZ, 1999, NEUROREPORT, V10, P1779, DOI 10.1097/00001756-199906030-00028; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Hakola H P, 1972, Acta Psychiatr Scand Suppl, V232, P1; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; HASHIMOTO R, 2003, MOL PSYCHIATR, V21, P21; Hof PR, 2003, BIOL PSYCHIAT, V53, P1075, DOI 10.1016/S0006-3223(03)00237-3; Hof PR, 2002, NEUROCHEM RES, V27, P1193, DOI 10.1023/A:1020981510759; Huntsman MM, 1998, P NATL ACAD SCI USA, V95, P15066, DOI 10.1073/pnas.95.25.15066; Iwata N, 2004, MOL PSYCHIATR, V9, P126, DOI 10.1038/sj.mp.4001456; Konradi C, 2003, PHARMACOL THERAPEUT, V97, P153, DOI 10.1016/S0163-7258(02)00328-5; Lewis DA, 2000, NEURON, V28, P325, DOI 10.1016/S0896-6273(00)00111-2; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Liu Y, 2001, J NEUROSCI, V21, P5660, DOI 10.1523/JNEUROSCI.21-15-05660.2001; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Moises HW, 2002, BMC PSYCHIATRY, V2, DOI 10.1186/1471-244X-2-8; Okada M, 2004, HIPPOCAMPUS, V14, P337, DOI 10.1002/hipo.10185; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; Pongrac J, 2002, NEUROCHEM RES, V27, P1049, DOI 10.1023/A:1020904821237; Prevot V, 2003, J NEUROSCI, V23, P230; Rieff HI, 1999, J NEUROSCI, V19, P10757, DOI 10.1523/JNEUROSCI.19-24-10757.1999; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Rioux L, 2003, AM J PSYCHIAT, V160, P149, DOI 10.1176/appi.ajp.160.1.149; Schmucker J, 2003, GLIA, V44, P67, DOI 10.1002/glia.10275; Sklar P, 2002, ANNU REV GENOM HUM G, V3, P371, DOI 10.1146/annurev.genom.3.022502.103141; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Steiner H, 1999, EXP NEUROL, V159, P494, DOI 10.1006/exnr.1999.7163; Tang JX, 2004, MOL PSYCHIATR, V9, P11, DOI 10.1038/sj.mp.4001436; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Tsuang MT, 2001, BRIT J PSYCHIAT, V178, pS18, DOI 10.1192/bjp.178.40.s18; Uranova N, 2001, BRAIN RES BULL, V55, P597, DOI 10.1016/S0361-9230(01)00528-7; VARTANIAN T, 1994, P NATL ACAD SCI USA, V91, P11626, DOI 10.1073/pnas.91.24.11626; Vartanian T, 1999, P NATL ACAD SCI USA, V96, P731, DOI 10.1073/pnas.96.2.731; Volk DW, 2001, AM J PSYCHIAT, V158, P256, DOI 10.1176/appi.ajp.158.2.256; Volk DW, 2000, ARCH GEN PSYCHIAT, V57, P237, DOI 10.1001/archpsyc.57.3.237; Walker E, 2002, SCHIZOPHR RES, V54, P17, DOI 10.1016/S0920-9964(01)00347-4; Williams NM, 2003, MOL PSYCHIATR, V8, P485, DOI 10.1038/sj.mp.4001348; Yang JZ, 2003, MOL PSYCHIATR, V8, P706, DOI 10.1038/sj.mp.4001377; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; Zavitsanou K, 2002, NEUROPSYCHOPHARMACOL, V27, P826, DOI 10.1016/S0893-133X(02)00347-0	65	314	332	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					575	580		10.1038/nn1258	http://dx.doi.org/10.1038/nn1258			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15162166				2022-12-17	WOS:000221640300007
J	Poolos, NP; Migliore, M; Johnston, D				Poolos, NP; Migliore, M; Johnston, D			Pharmacological upregulation of h-channels reduces the excitability of pyramidal neuron dendrites	NATURE NEUROSCIENCE			English	Article							RAT HIPPOCAMPAL-NEURONS; ACTION-POTENTIALS; NA+ CHANNELS; LAMOTRIGINE INHIBITION; PACEMAKER; BACKPROPAGATION; ENHANCEMENT; ATTENUATION; MODULATION; CURRENTS	The dendrites of pyramidal neurons have markedly different electrical properties from those of the soma, owing to the non-uniform distribution of voltage-gated ion channels in dendrites. It is thus possible that drugs acting on ion channels might preferentially alter dendritic, but not somatic, excitability. Using dendritic and somatic whole-cell and cell-attached recordings in rat hippocampal slices, we found that the anticonvulsant lamotrigine selectively reduced action potential firing from dendritic depolarization, while minimally affecting firing at the soma. This regional and input-specific effect resulted from an increase in the hyperpolarization-activated cation current (I-h), a voltage-gated current present predominantly in dendrites. These results demonstrate that neuronal excitability can be altered by drugs acting selectively on dendrites, and suggest an important role for 1 h in controlling dendritic excitability and epileptogenesis.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06520 USA; CNR, Inst Adv Diagnost Methodol, I-90146 Palermo, Italy	Baylor College of Medicine; Baylor College of Medicine; Yale University; Consiglio Nazionale delle Ricerche (CNR)	Johnston, D (corresponding author), Baylor Coll Med, Div Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA.	dan@ltp.neusc.bcm.tmc.edu	Migliore, Michele/D-7448-2011	Migliore, Michele/0000-0002-7584-6292				[Anonymous], 1999, DENDRITES; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; Calabrese JR, 1999, EUR NEUROPSYCHOPHARM, V9, pS107, DOI 10.1016/S0924-977X(99)00022-X; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Colbert CM, 1997, J NEUROSCI, V17, P6512; Coulter DA, 1997, J CHILD NEUROL, V12, pS2, DOI 10.1177/0883073897012001031; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Johnston D, 2000, J PHYSIOL-LONDON, V525, P75, DOI 10.1111/j.1469-7793.2000.00075.x; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kuo CC, 1997, BRIT J PHARMACOL, V121, P1231, DOI 10.1038/sj.bjp.0701221; Lupica CR, 2001, J NEUROPHYSIOL, V86, P261, DOI 10.1152/jn.2001.86.1.261; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; MESSENHEIMER J, 1996, TREATMENT EPILEPSY P, P899; Migliore M, 1999, J COMPUT NEUROSCI, V7, P5, DOI 10.1023/A:1008906225285; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.physiol.58.1.299; Poolos NP, 1999, J NEUROSCI, V19, P5205; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Shorvon SD, 2000, HDB EPILEPSY TREATME; Stefani A, 1996, EUR J PHARMACOL, V307, P113, DOI 10.1016/0014-2999(96)00265-8; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1998, J NEUROSCI, V18, P3501; Wang SJ, 2001, NEUROREPORT, V12, P2255, DOI 10.1097/00001756-200107200-00042; WHITE HS, 1997, EPILEPSIES, V2, P1; XIE XM, 1995, PFLUG ARCH EUR J PHY, V430, P437, DOI 10.1007/BF00373920	30	314	328	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					767	774		10.1038/nn891	http://dx.doi.org/10.1038/nn891			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12118259				2022-12-17	WOS:000177088900020
J	Aarts, E; Verhage, M; Veenvliet, JV; Dolan, CV; van der Sluis, S				Aarts, Emmeke; Verhage, Matthijs; Veenvliet, Jesse V.; Dolan, Conor V.; van der Sluis, Sophie			A solution to dependency: using multilevel analysis to accommodate nested data	NATURE NEUROSCIENCE			English	Article							REGRESSION; DESIGN	In neuroscience, experimental designs in which multiple observations are collected from a single research object (for example, multiple neurons from one animal) are common: 53% of 314 reviewed papers from five renowned journals included this type of data. These so-called 'nested designs' yield data that cannot be considered to be independent, and so violate the independency assumption of conventional statistical methods such as the t test. Ignoring this dependency results in a probability of incorrectly concluding that an effect is statistically significant that is far higher (up to 80%) than the nominal a level (usually set at 5%). We discuss the factors affecting the type I error rate and the statistical power in nested data, methods that accommodate dependency between observations and ways to determine the optimal study design when data are nested. Notably, optimization of experimental designs nearly always concerns collection of more truly independent observations, rather than more observations from one research object.	[Aarts, Emmeke; Verhage, Matthijs; van der Sluis, Sophie] Vrije Univ Amsterdam, Sect Funct Genom, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands; [Verhage, Matthijs] Vrije Univ Amsterdam Med Ctr, Sect Funct Genom, Dept Clin Genet, Amsterdam, Netherlands; [Veenvliet, Jesse V.] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands; [Dolan, Conor V.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [van der Sluis, Sophie] Vrije Univ Amsterdam Med Ctr, Sect Complex Trait Genet, Dept Clin Genet, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van der Sluis, S (corresponding author), Vrije Univ Amsterdam, Sect Funct Genom, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands.	s.vander.sluis@vu.nl	Aarts, Emmeke/K-7238-2019	van der Sluis, Sophie/0000-0001-9958-7216; Aarts, Emmeke/0000-0002-2432-7564; verhage, matthijs/0000-0002-6085-7503	European Union (ERC Advanced grant) [322966, HEALTH-F2-2009-241498 EUROSPIN, HEALTH-F2-2009-242167 SynSys]; Netherlands Organization for Scientific Research [TOP 903-42-095]; European Research Council (Genetics of Mental Illness) [ERC-230374]; Netherlands Scientific Organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, gebied Maatschappij-en Gedragswetenschappen: NWO/MaGW) [VIDI-452-12-014]	European Union (ERC Advanced grant); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council (Genetics of Mental Illness)(European Research Council (ERC)); Netherlands Scientific Organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, gebied Maatschappij-en Gedragswetenschappen: NWO/MaGW)(Netherlands Organization for Scientific Research (NWO))	We are very grateful to our colleagues from the VU University/VU Medical Center Functional Genomics department for sharing their data. M.V. is supported by the European Union (ERC Advanced grant 322966; HEALTH-F2-2009-241498 EUROSPIN, and HEALTH-F2-2009-242167 SynSys) and the Netherlands Organization for Scientific Research (TOP 903-42-095). C.V.D. is supported by the European Research Council (Genetics of Mental Illness, grant number: ERC-230374). S.v.d.S. is supported by the Netherlands Scientific Organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, gebied Maatschappij-en Gedragswetenschappen: NWO/MaGW: VIDI-452-12-014).	Amiry-Moghaddam M, 2013, NAT NEUROSCI, V16, P798, DOI 10.1038/nn.3418; [Anonymous], 2013, NAT NEUROSCI, V16, P771, DOI 10.1038/nn0713-771; [Anonymous], 2013, NAT NEUROSCI, V16, P517, DOI 10.1038/nn.3391; [Anonymous], 2013, NAT NEUROSCI, V16, P1, DOI 10.1038/nn0113-1; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Czanner G, 2008, J NEUROPHYSIOL, V99, P2672, DOI 10.1152/jn.00343.2007; Galbraith S, 2010, J NEUROSCI, V30, P10601, DOI 10.1523/JNEUROSCI.0362-10.2010; Goldstein H., 2010, MULTILEVEL STAT MODE; Hox J., 2010, MULTILEVEL ANAL TECH, DOI 10.4324/9780203852279; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kramer RH, 2013, NAT NEUROSCI, V16, P816, DOI 10.1038/nn.3424; Lipsey M., 2001, PRACTICAL METAANALYS; Maas CJM, 2004, STAT NEERL, V58, P127, DOI 10.1046/j.0039-0402.2003.00252.x; Maglione M, 2013, NAT NEUROSCI, V16, P790, DOI 10.1038/nn.3403; Moerbeek M, 2003, J CLIN EPIDEMIOL, V56, P341, DOI 10.1016/S0895-4356(03)00007-6; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; Packer AM, 2013, NAT NEUROSCI, V16, P805, DOI 10.1038/nn.3427; Raudenbush SW, 1997, PSYCHOL METHODS, V2, P173, DOI 10.1037/1082-989X.2.2.173; Smith AC, 2005, J NEUROPHYSIOL, V93, P1776, DOI 10.1152/jn.00765.2004; Snijders T.A., 2011, MULTILEVEL ANAL INTR, P1; SNIJDERS TAB, 1993, J EDUC STAT, V18, P237, DOI 10.3102/10769986018003237; Tsilidis KK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001609; WALSH JE, 1947, ANN MATH STAT, V18, P88, DOI 10.1214/aoms/1177730495	24	313	319	2	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2014	17	4					491	496		10.1038/nn.3648	http://dx.doi.org/10.1038/nn.3648			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AD6XR	24671065	Bronze			2022-12-17	WOS:000333405300007
J	Semendeferi, K; Lu, A; Schenker, N; Damasio, H				Semendeferi, K; Lu, A; Schenker, N; Damasio, H			Humans and great apes share a large frontal cortex	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; VOLUMETRIC-ANALYSIS; CEREBRAL-CORTEX; BRAIN; EVOLUTION; HOMINOIDS; LOBES	Some of the outstanding cognitive capabilities of humans are commonly attributed to a disproportionate enlargement of the human frontal lobe during evolution. This claim is based primarily on comparisons between the brains of humans and of other primates, to the exclusion of most great apes. We compared the relative size of the frontal cortices in living specimens of several primate species, including all extant hominoids, using magnetic resonance imaging. Human frontal cortices were not disproportionately large in comparison to those of the great apes. We suggest that the special cognitive abilities attributed to a frontal advantage may be due to differences in individual cortical areas and to a richer interconnectivity, none of which required an increase in the overall relative size of the frontal lobe during hominid evolution.	Univ Calif San Diego, Dept Anthropol, La Jolla, CA 92093 USA; Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA	University of California System; University of California San Diego; University of Iowa	Semendeferi, K (corresponding author), Univ Calif San Diego, Dept Anthropol, La Jolla, CA 92093 USA.	ksemende@ucsd.edu	Schenker-Ahmed, Natalie M/B-7470-2011	Schenker-Ahmed, Natalie M/0000-0002-2651-1576; Semendeferi, Katerina/0000-0002-9867-9554				AIELLO LC, 1992, J HUM EVOL, V22, P127, DOI 10.1016/0047-2484(92)90034-7; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Blinkov SM, 1968, ZENTRALNERVENSYSTEM; Brodmann Karl, 1912, Anatomischer Anzeiger, V41; Buxhoeveden DP, 2001, AM J PHYS ANTHROPOL, V115, P361, DOI 10.1002/ajpa.1092; Clark DA, 2001, NATURE, V411, P189, DOI 10.1038/35075564; DAMASIO AR, 1994, DESCARTES ERROR; DAMASIO H, 1992, ARCH NEUROL-CHICAGO, V49, P137, DOI 10.1001/archneur.1992.00530260037016; de Winter W, 2001, NATURE, V409, P710, DOI 10.1038/35055547; Deacon T., 1997, SYMBOLIC SPECIES; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Frank RJ, 1997, NEUROIMAGE, V5, P13, DOI 10.1006/nimg.1996.0250; Fuster J., 2015, PREFRONTAL CORTEX; GOLDMANRAKIC PS, 1984, TRENDS NEUROSCI, V7, P425, DOI 10.1016/S0166-2236(84)80147-2; HOLLOWAY RALPH L., 1968, BRAIN RES, V7, P121, DOI 10.1016/0006-8993(68)90094-2; Jerison HJ, 1997, DEV PREFRONTAL CORTE, P9; McBride T, 1999, BRAIN BEHAV EVOLUT, V54, P159, DOI 10.1159/000006620; Nimchinsky EA, 1999, P NATL ACAD SCI USA, V96, P5268, DOI 10.1073/pnas.96.9.5268; Preuss TM, 1999, P NATL ACAD SCI USA, V96, P11601, DOI 10.1073/pnas.96.20.11601; RADINSKY L, 1974, AM J PHYS ANTHROPOL, V41, P15, DOI 10.1002/ajpa.1330410104; ROLAND PE, 1994, TRENDS NEUROSCI, V17, P458, DOI 10.1016/0166-2236(94)90131-7; Semendeferi K, 2000, J HUM EVOL, V38, P317, DOI 10.1006/jhev.1999.0381; Semendeferi K, 1997, J HUM EVOL, V32, P375, DOI 10.1006/jhev.1996.0099; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.0.CO;2-I; Semendeferi K, 1998, AM J PHYS ANTHROPOL, V106, P129, DOI 10.1002/(SICI)1096-8644(199806)106:2<129::AID-AJPA3>3.0.CO;2-L; SMITH RJ, 1994, J HUM EVOL, V26, P239, DOI 10.1006/jhev.1994.1013; UYLINGS HBM, 1990, PROG BRAIN RES, V85, P31; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197; ZILLES K, 1988, ANAT EMBRYOL, V179, P173, DOI 10.1007/BF00304699	29	313	320	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					272	276		10.1038/nn814	http://dx.doi.org/10.1038/nn814			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11850633				2022-12-17	WOS:000174146000019
J	Zhu, JJ; Esteban, JA; Hayashi, Y; Malinow, R				Zhu, JJ; Esteban, JA; Hayashi, Y; Malinow, R			Postnatal synaptic potentiation: Delivery of GluR4-containing AMPA receptors by spontaneous activity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CENTRAL GLUTAMATERGIC SYNAPSE; SILENT SYNAPSES; NETWORK OSCILLATIONS; HIPPOCAMPAL-NEURONS; EXCITATORY SYNAPSES; NMDA RECEPTOR; CA1 REGION; IN-VIVO; EXPRESSION	To examine how functional circuits are established in the brain, we studied excitatory transmission in early postnatal hippocampus. Spontaneous neural activity was sufficient to selectively deliver GluR4-containing AMPA receptors (AMPA-Rs) into synapses. This delivery allowed non-functional connections to transmit at resting potentials and required NMDA receptors (NMDA-Rs) but not CaMKII activation. Subsequently, these delivered receptors were exchanged with non-synaptic GluR2-containing AMPA-Rs in a manner requiring little neuronal activity. The enhanced transmission resulting from this delivery and subsequent exchange was maintained for at least several days and required an interaction between GluR2 and NSF. Thus, this sequence of subunit-specific trafficking events triggered by spontaneous activity in early postnatal development may be crucial for initial establishment of long-lasting functional circuitry.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; MIT, Ctr Learning & Memory, Cambridge, MA 02139 USA	Cold Spring Harbor Laboratory; Massachusetts Institute of Technology (MIT)	Malinow, R (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Hayashi, Yasunori/C-2249-2008; Esteban, Jose/L-4944-2014; Hayashi, Yasunori/AAF-1408-2019	Hayashi, Yasunori/0000-0002-7560-3004; Esteban, Jose/0000-0002-3759-3300; Hayashi, Yasunori/0000-0002-7560-3004				BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cline HT, 1996, COLD SPRING HARB SYM, V61, P95; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Dingledine R, 1999, PHARMACOL REV, V51, P7; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; Gomperts SN, 2000, J NEUROSCI, V20, P2229; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIM HG, 1995, CEREB CORTEX, V5, P148, DOI 10.1093/cercor/5.2.148; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Liao DZ, 1996, LEARN MEMORY, V3, P138, DOI 10.1101/lm.3.2-3.138; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; MALINOW R, 1999, IMAGING NEURONS LAB; Margrie TW, 1998, NAT NEUROSCI, V1, P378, DOI 10.1038/1589; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Palva JM, 2000, J NEUROSCI, V20, P1170, DOI 10.1523/JNEUROSCI.20-03-01170.2000; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Ramon y Cajal S, 1911, HISTOLOGIE SYSTEM NE; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhu JJ, 2000, J PHYSIOL-LONDON, V526, P571, DOI 10.1111/j.1469-7793.2000.00571.x	45	313	326	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1098	1106		10.1038/80614	http://dx.doi.org/10.1038/80614			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036266	Green Submitted			2022-12-17	WOS:000167177600014
J	Chuong, AS; Miri, ML; Busskamp, V; Matthews, GAC; Acker, LC; Sorensen, AT; Young, A; Klapoetke, NC; Henninger, MA; Kodandaramaiah, SB; Ogawa, M; Ramanlal, SB; Bandler, RC; Allen, BD; Forest, CR; Chow, BY; Han, X; Lin, Y; Tye, KM; Roska, B; Cardin, JA; Boyden, ES				Chuong, Amy S.; Miri, Mitra L.; Busskamp, Volker; Matthews, Gillian A. C.; Acker, Leah C.; Sorensen, Andreas T.; Young, Andrew; Klapoetke, Nathan C.; Henninger, Mike A.; Kodandaramaiah, Suhasa B.; Ogawa, Masaaki; Ramanlal, Shreshtha B.; Bandler, Rachel C.; Allen, Brian D.; Forest, Craig R.; Chow, Brian Y.; Han, Xue; Lin, Yingxi; Tye, Kay M.; Roska, Botond; Cardin, Jessica A.; Boyden, Edward S.			Noninvasive optical inhibition with a red-shifted microbial rhodopsin	NATURE NEUROSCIENCE			English	Article							OPTOGENETIC CONTROL; LIGHT; ACTIVATION; SENSITIVITY; MODULATION; BEHAVIOR; EXPORT; MICE	Optogenetic inhibition of the electrical activity of neurons enables the causal assessment of their contributions to brain functions. Red light penetrates deeper into tissue than other visible wavelengths. We present a red-shifted cruxhalorhodopsin, Jaws, derived from Haloarcula (Halobacterium) salinarum (strain Shark) and engineered to result in red light-induced photocurrents three times those of earlier silencers. Jaws exhibits robust inhibition of sensory-evoked neural activity in the cortex and results in strong light responses when used in retinas of retinitis pigmentosa model mice. We also demonstrate that Jaws can noninvasively mediate transcranial optical inhibition of neurons deep in the brains of awake mice. The noninvasive optogenetic inhibition opened up by Jaws enables a variety of important neuroscience experiments and offers a powerful general-use chloride pump for basic and applied neuroscience.	[Chuong, Amy S.; Acker, Leah C.; Klapoetke, Nathan C.; Henninger, Mike A.; Kodandaramaiah, Suhasa B.; Ogawa, Masaaki; Bandler, Rachel C.; Allen, Brian D.; Boyden, Edward S.] MIT, Media Lab, Dept Media Arts & Sci, Cambridge, MA 02139 USA; [Chuong, Amy S.; Acker, Leah C.; Sorensen, Andreas T.; Young, Andrew; Klapoetke, Nathan C.; Henninger, Mike A.; Kodandaramaiah, Suhasa B.; Ogawa, Masaaki; Lin, Yingxi; Boyden, Edward S.] MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Chuong, Amy S.; Acker, Leah C.; Klapoetke, Nathan C.; Henninger, Mike A.; Kodandaramaiah, Suhasa B.; Ogawa, Masaaki; Boyden, Edward S.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Miri, Mitra L.; Cardin, Jessica A.] Yale Univ, Yale Sch Med, Dept Neurobiol, New Haven, CT USA; [Busskamp, Volker; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland; [Busskamp, Volker] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Matthews, Gillian A. C.; Tye, Kay M.] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Kodandaramaiah, Suhasa B.; Forest, Craig R.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Ramanlal, Shreshtha B.; Han, Xue] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Chow, Brian Y.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Cardin, Jessica A.] Yale Univ, Kavli Inst Neurosci, New Haven, CT USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Yale University; Friedrich Miescher Institute for Biomedical Research; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Northwell Health; University System of Georgia; Georgia Institute of Technology; Boston University; University of Pennsylvania; Yale University	Boyden, ES (corresponding author), MIT, Media Lab, Dept Media Arts & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	esb@media.mit.edu	Busskamp, Volker/E-6339-2015; Roska, Botond/AAD-7268-2021; Sørensen, Andreas Toft/P-4745-2018; Kodandaramaiah, Suhasa/B-2844-2016	Busskamp, Volker/0000-0001-7517-8944; Sørensen, Andreas Toft/0000-0001-5887-9247; /0000-0001-9969-4281; /0000-0002-7002-1275; Klapoetke, Nathan/0000-0002-3270-1966; Kodandaramaiah, Suhasa/0000-0002-7767-2644; Ogawa, Masaaki/0000-0003-4615-8412; /0000-0001-6754-0333	Jerry and Marge Burnett; US Defense Advanced Research Projects Agency Living Foundries Program [HR0011-12-C-0068]; Harvard/MIT Joint Grants Program in Basic Neuroscience; Human Frontiers Science Program; Institution of Engineering and Technology A F Harvey Prize; MIT McGovern Institute and McGovern Institute Neurotechnology (MINT) Program; MIT Media Lab, New York Stem Cell Foundation-Robertson Investigator Award; US National Institutes of Health (NIH) Director's New Innovator award [1DP20D002002]; NIH EUREKA award [1R01NS075421]; NIH [1R01DA029639, 1RC1MH088182, 1R01NS067199]; US National Science Foundation (NSF) CAREER award [CBET 1053233]; NSF [EFRI0835878, DM40848804]; Skolkovo Institute of Science and Technology; Society for Neuroscience Research Award for Innovation in Neuroscience (RAIN); Wallace H. Coulter Foundation; NSF DGE [1122492]; Whitehall Foundation; Klingenstein Foundation; Swebelius Family Trust; Simons Foundation; Alfred P. Sloan Fellowship; NARSAD Young Investigator Award, a Smith Family Award for Excellence in Biomedical Research [NIH ROO EY018407, NIH RO1 EY022951, NIH R01 MH102365]; Human Frontier Science Program, Swiss National Science Foundation; Volkswagen Foundation fellowships; Gebert-Ruf Foundation; SNSF; European Research Council; European Union SEEBETTER, TREATRUSH, OPTONEURO; 3X3D Imaging grants; NIH Director's New Innovator Award [1DP2NS082126]; NINDS [1R01NS087950, 1R21NS078660, 1R01N5081716]; NIMH [5R00MH085944]; Pew Foundation; Alfred P. Sloan Foundation; Michael J. Fox Foundation; Brain and Research Foundation; US Defense Advanced Research Projects Agency Living Foundries; US National Science Foundation Biophotonics; Brain Research Foundation; JPB Foundation; PIIF Funding [R01-MH102441-01 (NIMH), DP2-0D017366-01]; Simons Center for the Social Brain;  [NIH RO1 MH091220-01]; Div Of Chem, Bioeng, Env, & Transp Sys [1264975] Funding Source: National Science Foundation; NATIONAL EYE INSTITUTE [R01EY022951, R01EY023173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH085944, R01MH102441, R01MH102365, RC1MH088182, R01MH091220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [DP2NS082126, R21NS078660, R01NS075421, R01NS067199, R01NS081716, R01NS087950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029639] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002002] Funding Source: NIH RePORTER	Jerry and Marge Burnett; US Defense Advanced Research Projects Agency Living Foundries Program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Harvard/MIT Joint Grants Program in Basic Neuroscience; Human Frontiers Science Program(Human Frontier Science Program); Institution of Engineering and Technology A F Harvey Prize; MIT McGovern Institute and McGovern Institute Neurotechnology (MINT) Program; MIT Media Lab, New York Stem Cell Foundation-Robertson Investigator Award; US National Institutes of Health (NIH) Director's New Innovator award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH EUREKA award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation (NSF) CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); Skolkovo Institute of Science and Technology; Society for Neuroscience Research Award for Innovation in Neuroscience (RAIN); Wallace H. Coulter Foundation; NSF DGE(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR)); Whitehall Foundation; Klingenstein Foundation(Klingenstein Philanthropies); Swebelius Family Trust; Simons Foundation; Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); NARSAD Young Investigator Award, a Smith Family Award for Excellence in Biomedical Research; Human Frontier Science Program, Swiss National Science Foundation; Volkswagen Foundation fellowships; Gebert-Ruf Foundation; SNSF(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); European Union SEEBETTER, TREATRUSH, OPTONEURO; 3X3D Imaging grants; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Pew Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Michael J. Fox Foundation; Brain and Research Foundation; US Defense Advanced Research Projects Agency Living Foundries(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); US National Science Foundation Biophotonics(National Science Foundation (NSF)); Brain Research Foundation; JPB Foundation; PIIF Funding; Simons Center for the Social Brain; ; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Juettner for help making AAV, and Y.K. Cho, D. Schmidt, F. Chen, A. Beyeler, J.M. Zhuo and R.E. Kohman for advice and discussion. A.S.C. acknowledges the Janet and Sheldon Razin '59 Fellowship of the Massachusetts Institute of Technology (MIT) McGovern Institute. E.S.B. acknowledges Jerry and Marge Burnett, the US Defense Advanced Research Projects Agency Living Foundries Program HR0011-12-C-0068, Harvard/MIT Joint Grants Program in Basic Neuroscience, Human Frontiers Science Program, Institution of Engineering and Technology A F Harvey Prize, MIT McGovern Institute and McGovern Institute Neurotechnology (MINT) Program, MIT Media Lab, New York Stem Cell Foundation-Robertson Investigator Award, US National Institutes of Health (NIH) Director's New Innovator award 1DP20D002002, NIH EUREKA award 1R01NS075421, NIH grants 1R01DA029639, 1RC1MH088182 and 1R01NS067199, US National Science Foundation (NSF) CAREER award CBET 1053233 and NSF grants EFRI0835878 and DM40848804, the Skolkovo Institute of Science and Technology, a Society for Neuroscience Research Award for Innovation in Neuroscience (RAIN) and the Wallace H. Coulter Foundation. M.L.M. acknowledges funding from NSF DGE 1122492. J.A.C. acknowledges funding from the Whitehall Foundation, the Klingenstein Foundation, the Swebelius Family Trust, the Simons Foundation, an Alfred P. Sloan Fellowship, a NARSAD Young Investigator Award, a Smith Family Award for Excellence in Biomedical Research, NIH ROO EY018407, NIH RO1 EY022951 and NIH R01 MH102365. V.B. acknowledges Human Frontier Science Program, Swiss National Science Foundation and Volkswagen Foundation fellowships. B.R. acknowledges the Gebert-Ruf Foundation, SNSF, European Research Council, and European Union SEEBETTER, TREATRUSH, OPTONEURO and 3X3D Imaging grants. X.H. acknowledges funding from an NIH Director's New Innovator Award (1DP2NS082126), the NINDS (1R01NS087950,1R21NS078660,1R01N5081716), NIMH (5R00MH085944), Pew Foundation, Alfred P. Sloan Foundation, Michael J. Fox Foundation, and Brain and Research Foundation. Y.L. acknowledges funding from NIH RO1 MH091220-01. B.Y.C. acknowledges funding from US Defense Advanced Research Projects Agency Living Foundries, the US National Science Foundation Biophotonics and the Brain Research Foundation. K.M.T. acknowledges funding from the Whitehall Foundation, Klingenstein Foundation, JPB Foundation, PIIF Funding, R01-MH102441-01 (NIMH) and DP2-0D017366-01. G.A.C.M. was supported by the Simons Center for the Social Brain.	Al-Juboori SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067626; Anikeeva P, 2012, NAT NEUROSCI, V15, P163, DOI 10.1038/nn.2992; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; Berenyi A, 2012, SCIENCE, V337, P735, DOI 10.1126/science.1223154; Busskamp V, 2011, CURR OPIN NEUROBIOL, V21, P942, DOI 10.1016/j.conb.2011.06.001; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Cardin JA, 2012, J PHYSIOL-PARIS, V106, P104, DOI 10.1016/j.jphysparis.2011.09.005; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; FARBER DB, 1994, PROG RETIN EYE RES, V13, P31, DOI 10.1016/1350-9462(94)90004-3; Giller CA, 2003, J NEUROSURG, V98, P1299, DOI 10.3171/jns.2003.98.6.1299; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HACKETT NR, 1987, J BIOL CHEM, V262, P9277; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Hira R, 2009, J NEUROSCI METH, V179, P258, DOI 10.1016/j.jneumeth.2009.02.001; Hofherr A, 2005, J CELL SCI, V118, P1935, DOI 10.1242/jcs.02322; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Ibanez-Tallon I, 2004, NEURON, V43, P305, DOI 10.1016/j.neuron.2004.07.015; Jacobs GH, 2007, SCIENCE, V315, P1723, DOI 10.1126/science.1138838; Jazayeri M, 2012, NAT NEUROSCI, V15, P1368, DOI 10.1038/nn.3210; Kramer RH, 2013, NAT NEUROSCI, V16, P816, DOI 10.1038/nn.3424; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/NMETH.1808, 10.1038/nmeth.1808]; Menzler J, 2011, J NEUROSCI, V31, P2280, DOI 10.1523/JNEUROSCI.4238-10.2011; Naarendorp F, 2010, J NEUROSCI, V30, P12495, DOI 10.1523/JNEUROSCI.2186-10.2010; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ohayon S, 2013, J NEUROSCI, V33, P16684, DOI 10.1523/JNEUROSCI.2675-13.2013; OTOMO J, 1992, J GEN MICROBIOL, V138, P1027, DOI 10.1099/00221287-138-5-1027; Paxinos G., 2019, PAXINOS FRANKLINS MO, DOI [10.3390/ijms20225729, DOI 10.3390/IJMS20225729]; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Raimondo JV, 2012, NAT NEUROSCI, V15, P1102, DOI 10.1038/nn.3143; Rudiger M, 1997, EMBO J, V16, P3813, DOI 10.1093/emboj/16.13.3813; Scott NA, 2012, PLOS ONE, V7, P176, DOI 10.1371/journal.pone.0029859; Sung CH, 2010, J CELL BIOL, V190, P953, DOI 10.1083/jcb.201006020; Tonnesen J, 2009, P NATL ACAD SCI USA, V106, P12162, DOI 10.1073/pnas.0901915106; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tsunematsu T, 2011, J NEUROSCI, V31, P10529, DOI 10.1523/JNEUROSCI.0784-11.2011; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yoder EJ, 2002, MICROSC RES TECHNIQ, V56, P304, DOI 10.1002/jemt.10002; Znamenskiy P, 2013, NATURE, V497, P482, DOI 10.1038/nature12077	50	312	324	2	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2014	17	8					1123	1129		10.1038/nn.3752	http://dx.doi.org/10.1038/nn.3752			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AM1XA	24997763	Green Accepted, Green Published, Green Submitted			2022-12-17	WOS:000339641400019
J	Girshick, AR; Landy, MS; Simoncelli, EP				Girshick, Ahna R.; Landy, Michael S.; Simoncelli, Eero P.			Cardinal rules: visual orientation perception reflects knowledge of environmental statistics	NATURE NEUROSCIENCE			English	Article							ANISOTROPY; DISCRIMINATION; INFORMATION; SELECTIVITY; INTEGRATION; MODELS	Humans are good at performing visual tasks, but experimental measurements have revealed substantial biases in the perception of basic visual attributes. An appealing hypothesis is that these biases arise through a process of statistical inference, in which information from noisy measurements is fused with a probabilistic model of the environment. However, such inference is optimal only if the observer's internal model matches the environment. We found this to be the case. We measured performance in an orientation-estimation task and found that orientation judgments were more accurate at cardinal (horizontal and vertical) orientations. Judgments made under conditions of uncertainty were strongly biased toward cardinal orientations. We estimated observers' internal models for orientation and found that they matched the local orientation distribution measured in photographs. In addition, we determined how a neural population could embed probabilistic information responsible for such biases.	[Girshick, Ahna R.; Landy, Michael S.; Simoncelli, Eero P.] NYU, Dept Psychol, New York, NY 10003 USA; [Girshick, Ahna R.; Landy, Michael S.; Simoncelli, Eero P.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Simoncelli, Eero P.] NYU, Howard Hughes Med Inst, New York, NY USA; [Simoncelli, Eero P.] NYU, Courant Inst Math Sci, New York, NY USA	New York University; New York University; Howard Hughes Medical Institute; New York University; New York University	Girshick, AR (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	ahna.girshick@gmail.com		Landy, Michael/0000-0002-2079-4552; Simoncelli, Eero/0000-0002-1206-527X	US National Institutes of Health [EY019451, EY16165]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY016165, F32EY019451] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We wish to thank D. Ganguli for helpful discussions on image statistics and population coding, T. Saarela for the monitor calibration and N. Solomon for assisting with the experiments. This work was funded by US National Institutes of Health grants EY019451 (A.R.G.) and EY16165 (M.S.L.), and the Howard Hughes Medical Institute (E.P.S.).	APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; BIRCH EE, 1983, VISION RES, V23, P1019, DOI 10.1016/0042-6989(83)90012-3; BLAKEMORE C, 1970, NATURE, V228, P477, DOI 10.1038/228477a0; Brainard DH, 2006, J VISION, V6, P1267, DOI 10.1167/6.11.10; Burge J, 2010, J NEUROSCI, V30, P7269, DOI 10.1523/JNEUROSCI.5551-09.2010; BURT PJ, 1983, IEEE T COMMUN, V31, P532, DOI 10.1109/TCOM.1983.1095851; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; Chapman B, 1998, P NATL ACAD SCI USA, V95, P2609, DOI 10.1073/pnas.95.5.2609; Cohen EH, 2007, J NEUROSCI, V27, P12540, DOI 10.1523/JNEUROSCI.4496-07.2007; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P4002, DOI 10.1073/pnas.95.7.4002; Dakin SC, 2001, J OPT SOC AM A, V18, P1016, DOI 10.1364/JOSAA.18.001016; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; El-Bizri N., 2005, ARAB SCI PHILOS, V15, P189, DOI 10.1017/S0957423905000172; Farid H, 2004, IEEE T IMAGE PROCESS, V13, P496, DOI 10.1109/TIP.2004.823819; FISCHER BJ, 2010, INT JT C NEUR NETW, P1; Furmanski CS, 2000, NAT NEUROSCI, V3, P535, DOI 10.1038/75702; Ganguli D., 2010, ADV NEURAL INFORM PR, V23; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Granlund G.H., 1995, SIGNAL PROCESSING CO; Green DM., 1966, SIGNAL DETECTION THE; Griffiths TL, 2008, CAMB HANDB PSYCHOL, P59; HELMHOLTZ H, 2000, TREATISE PHYSL OPTIC; Ho YX, 2007, J VISION, V7, DOI 10.1167/7.1.1; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Knill DC, 1996, PERCEPTION BAYESIAN; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Li BW, 2003, J NEUROPHYSIOL, V90, P204, DOI 10.1152/jn.00954.2002; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Maloney LT, 2009, VISUAL NEUROSCI, V26, P147, DOI 10.1017/S0952523808080905; Mamassian P, 2001, COGNITION, V81, pB1, DOI 10.1016/S0010-0277(01)00116-0; MAYER MJ, 1977, VISION RES, V17, P703, DOI 10.1016/S0042-6989(77)80006-0; MITCHELL DE, 1973, VISION RES, V13, P535, DOI 10.1016/0042-6989(73)90023-0; ORBAN GA, 1984, VISION RES, V24, P121, DOI 10.1016/0042-6989(84)90097-X; Ringach DL, 2002, J NEUROSCI, V22, P5639; Schwartz O, 2007, NAT REV NEUROSCI, V8, P522, DOI 10.1038/nrn2155; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Simoncelli, 2009, COGNITIVE NEUROSCIEN, VIV, P525; Simoncelli E, 1993, THESIS MIT; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Stocker AA, 2009, J VISION, V9, DOI 10.1167/9.9.9; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; SWITKES E, 1978, VISION RES, V18, P1393, DOI 10.1016/0042-6989(78)90232-8; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; TIMNEY BN, 1976, SCIENCE, V193, P699, DOI 10.1126/science.948748; Tomassini A, 2010, VISION RES, V50, P541, DOI 10.1016/j.visres.2009.12.005; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	50	312	312	2	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					926	U156		10.1038/nn.2831	http://dx.doi.org/10.1038/nn.2831			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21642976	Green Accepted			2022-12-17	WOS:000292081700022
J	Hua, JYY; Smith, SJ				Hua, JYY; Smith, SJ			Neural activity and the dynamics of central nervous system development	NATURE NEUROSCIENCE			English	Review							LATERAL GENICULATE-NUCLEUS; DENDRITES IN-VIVO; SYNAPTIC PLASTICITY; PRESYNAPTIC TERMINALS; HIPPOCAMPAL-NEURONS; RECEPTOR ACTIVATION; RETINOTECTAL AXONS; ZEBRAFISH EMBRYOS; PROTEIN-SYNTHESIS; BRANCH DYNAMICS	Recent imaging studies show that the formation of neural connections in the central nervous system is a highly dynamic process. The iterative formation and elimination of synapses and neuronal branches result in the formation of a much larger number of trial connections than is maintained in the mature brain. Neural activity modulates development through biasing this process of formation and elimination, promoting the formation and stabilization of appropriate synaptic connections on the basis of functional activity patterns.	Stanford Univ, Beckman Ctr B141, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Smith, SJ (corresponding author), Stanford Univ, Beckman Ctr B141, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	sjsmith@stanford.edu						Ahmari SE, 2002, NEURON, V34, P333, DOI 10.1016/S0896-6273(02)00685-2; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Brenman JE, 1997, CURR OPIN NEUROBIOL, V7, P374, DOI 10.1016/S0959-4388(97)80065-7; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Cajal R., 1899, TEXTURA SISTEMA NERV; CAMPBELL G, 1992, J NEUROSCI, V12, P1847; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Collin C, 2001, EUR J NEUROSCI, V13, P1273, DOI 10.1046/j.0953-816x.2001.01500.x; CREPEL F, 1971, BRAIN RES, V35, P272, DOI 10.1016/0006-8993(71)90617-2; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Dailey ME, 1996, J NEUROSCI, V16, P2983; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gallo G, 1997, J NEUROSCI, V17, P5445; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GAZE RM, 1974, PROC R SOC SER B-BIO, V185, P301, DOI 10.1098/rspb.1974.0021; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HAMOS JE, 1987, J COMP NEUROL, V259, P165, DOI 10.1002/cne.902590202; Hashimoto K, 2003, NEURON, V38, P785, DOI 10.1016/S0896-6273(03)00298-8; Horch HW, 1999, NEURON, V23, P353; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUTTENLOCHER PR, 1982, NEUROSCI LETT, V33, P247, DOI 10.1016/0304-3940(82)90379-2; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; JACKSON H, 1982, J NEUROSCI, V2, P1736; Johns DC, 1999, J NEUROSCI, V19, P1691; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; KAETHNER RJ, 1992, J NEUROSCI, V12, P3257, DOI 10.1523/JNEUROSCI.12-08-03257.1992; Kaethner RJ, 1997, J NEUROBIOL, V32, P627, DOI 10.1002/(SICI)1097-4695(19970605)32:6<627::AID-NEU7>3.0.CO;2-1; Kantor DB, 2003, NEURON, V38, P849, DOI 10.1016/S0896-6273(03)00364-7; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; Luthi A, 2001, NAT NEUROSCI, V4, P1102, DOI 10.1038/nn744; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rajan I, 1998, J NEUROSCI, V18, P7836; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Renteria RC, 1996, J NEUROBIOL, V29, P415; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Schmidt JT, 2004, J NEUROBIOL, V58, P328, DOI 10.1002/neu.10286; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Tashiro A, 2003, NEURON, V38, P773, DOI 10.1016/S0896-6273(03)00299-X; Tavazoie SF, 2000, NAT NEUROSCI, V3, P608, DOI 10.1038/75786; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; VAUGHN JE, 1988, SYNAPSE, V2, P69, DOI 10.1002/syn.890020110; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; WEISEL TN, 1982, NATURE, V299, P583; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wong WT, 2001, NAT NEUROSCI, V4, P351, DOI 10.1038/85987; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zhu JJ, 2002, NAT NEUROSCI, V5, P513, DOI 10.1038/nn0602-850; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Ziv NE, 2001, CURR OPIN NEUROBIOL, V11, P536, DOI 10.1016/S0959-4388(00)00246-4	89	312	329	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					327	332		10.1038/nn1218	http://dx.doi.org/10.1038/nn1218			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15048120				2022-12-17	WOS:000220482500007
J	Gervais, H; Belin, P; Boddaert, N; Leboyer, M; Coez, A; Sfaello, I; Barthelemy, C; Brunelle, F; Samson, Y; Zilbovicius, M				Gervais, H; Belin, P; Boddaert, N; Leboyer, M; Coez, A; Sfaello, I; Barthelemy, C; Brunelle, F; Samson, Y; Zilbovicius, M			Abnormal cortical voice processing in autism	NATURE NEUROSCIENCE			English	Article							ASPERGER-SYNDROME; AUDITORY-CORTEX; INDIVIDUALS; CHILDREN; SPEECH; MIND	Impairments in social interaction are a key feature of autism and are associated with atypical social information processing. Here we report functional magnetic resonance imaging (fMRI) results showing that individuals with autism failed to activate superior temporal sulcus (STS) voice-selective regions in response to vocal sounds, whereas they showed a normal activation pattern in response to nonvocal sounds. These findings suggest abnormal cortical processing of socially relevant auditory information in autism.	CEA, Serv Hosp Frederic Joliot, ERM 0205,INSERM, DRM,DSV, F-91406 Orsay, France; Univ Montreal, Ctr Rech Neuropsychol & Cognit, Montreal, PQ, Canada; Univ Montreal, Ctr Rech, Inst Univ Geriatrie Montreal, Montreal, PQ, Canada; AP HP, Serv Radiol Pediat, F-75015 Paris, France; Hop Henri Mondor, Psychiat Serv, AP HP, F-94000 Creteil, France; CHU Bretonneau, INSERM, Unite 619, F-37000 Tours, France; Grp Hosp Pitie Salpetriere, Serv Urgences Cerevrovasc, AP HP, F-75013 Paris, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite de Montreal; Universite de Montreal; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Zilbovicius, M (corresponding author), CEA, Serv Hosp Frederic Joliot, ERM 0205,INSERM, DRM,DSV, 4 Pl Gen Leclerc, F-91406 Orsay, France.	zilbo@shfj.cea.fr	samson, yves/C-5647-2013; Leboyer, Marion/AAW-3648-2021; Belin, Pascal/C-6247-2009; boddaert, nathalie/GWV-2865-2022	Leboyer, Marion/0000-0001-5473-3697; Belin, Pascal/0000-0002-7578-6365; samson, yves/0000-0002-8080-1427; boddaert, nathalie/0000-0003-0991-7774				Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; American Psychiatric Association, 2000, DIAGN STAT MAN; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Belin P, 1999, NEUROIMAGE, V10, P417, DOI 10.1006/nimg.1999.0480; Bonnel A, 2003, J COGNITIVE NEUROSCI, V15, P226, DOI 10.1162/089892903321208169; BOUCHER J, 1992, J CHILD PSYCHOL PSYC, V33, P843, DOI 10.1111/j.1469-7610.1992.tb01960.x; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Ceponiene R, 2003, P NATL ACAD SCI USA, V100, P5567, DOI 10.1073/pnas.0835631100; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; FRITH U, 1994, COGNITION, V50, P115, DOI 10.1016/0010-0277(94)90024-8; Kanner L, 1943, NERV CHILD, V2, P217; KLIN A, 1991, J AUTISM DEV DISORD, V21, P29, DOI 10.1007/BF02206995; Pierce K, 2001, BRAIN, V124, P2059, DOI 10.1093/brain/124.10.2059; Rutherford MD, 2002, J AUTISM DEV DISORD, V32, P189, DOI 10.1023/A:1015497629971; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331	15	311	316	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					801	802		10.1038/nn1291	http://dx.doi.org/10.1038/nn1291			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15258587				2022-12-17	WOS:000222930800008
J	Frick, A; Magee, J; Johnston, D				Frick, A; Magee, J; Johnston, D			LTP is accompanied by an enhanced local excitability of pyramidal neuron dendrites	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; ACTIVITY-DEPENDENT ATTENUATION; EPSP-SPIKE POTENTIATION; RAT HIPPOCAMPAL SLICES; K+ CHANNELS; NA+ CHANNELS; POTASSIUM CHANNELS; ACTIVE DENDRITES; CA2+ CHANNELS; PLASTICITY	The propagation and integration of signals in the dendrites of pyramidal neurons is regulated, in part, by the distribution and biophysical properties of voltage-gated ion channels. It is thus possible that any modification of these channels in a specific part of the dendritic tree might locally alter these signaling processes. Using dendritic and somatic whole-cell recordings, combined with calcium imaging in rat hippocampal slices, we found that the induction of long-term potentiation (LTP) was accompanied by a local increase in dendritic excitability that was dependent on the activation of NMDA receptors. These changes favored the back-propagation of action potentials into this dendritic region with a subsequent boost in the Ca2+ influx. Dendritic cell-attached patch recordings revealed a hyperpolarized shift in the inactivation curve of transient, A-type K+ currents that can account for the enhanced excitability. These results suggest an important mechanism associated with LTP for shaping signal processing and controlling dendritic function.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Marine Biol Lab, Woods Hole, MA 02543 USA; Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA	Baylor College of Medicine; Marine Biological Laboratory - Woods Hole; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Johnston, D (corresponding author), Baylor Coll Med, Div Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA.	dan@mossy.bcm.tmc.edu						ABRAHAM WC, 1987, J PHYSIOL-LONDON, V394, P367, DOI 10.1113/jphysiol.1987.sp016875; Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; ALKON DL, 1982, SCIENCE, V215, P693, DOI 10.1126/science.7058334; Alonso G, 1997, NEUROSCIENCE, V77, P617; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; Colbert CM, 1999, J NEUROSCI, V19, P8163; Colbert CM, 1998, J NEUROPHYSIOL, V79, P491, DOI 10.1152/jn.1998.79.1.491; Colbert CM, 1997, J NEUROSCI, V17, P6512; Frick A, 2003, J NEUROSCI, V23, P3243; Gasparini S, 2002, J PHYSIOL-LONDON, V541, P665, DOI 10.1113/jphysiol.2002.020503; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; JESTER JM, 1995, J PHYSIOL-LONDON, V484, P689, DOI 10.1113/jphysiol.1995.sp020696; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Johnston D, 1999, CURR OPIN NEUROBIOL, V9, P288, DOI 10.1016/S0959-4388(99)80042-7; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Linden DJ, 1999, NEURON, V22, P661, DOI 10.1016/S0896-6273(00)80726-6; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Magee J. C., 1999, DENDRITES, P139; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MIYAKAWA H, 1992, NEURON, V9, P1163, DOI 10.1016/0896-6273(92)90074-N; Muller W, 2002, J NEUROPHYSIOL, V87, P2990, DOI 10.1152/jn.00790.2001; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Quirk MC, 2001, J NEUROSCI, V21, P240, DOI 10.1523/JNEUROSCI.21-01-00240.2001; Ramakers GMJ, 2002, P NATL ACAD SCI USA, V99, P10144, DOI 10.1073/pnas.152620399; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Schrader LA, 2002, MOL NEUROBIOL, V25, P51; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Staff NP, 2003, HIPPOCAMPUS, V13, P801, DOI 10.1002/hipo.10129; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; TAUBE JS, 1988, J NEUROSCI, V8, P1632; Tsubokawa H, 2000, J NEUROSCI, V20, P4878; Tsubokawa H, 1997, J NEUROSCI, V17, P5782; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	50	311	314	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					126	135		10.1038/nn1178	http://dx.doi.org/10.1038/nn1178			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14730307				2022-12-17	WOS:000188468500010
J	Aizman, O; Brismar, H; Uhlen, P; Zettergren, E; Levey, AI; Forssberg, H; Greengard, P; Aperia, A				Aizman, O; Brismar, H; Uhlen, P; Zettergren, E; Levey, AI; Forssberg, H; Greengard, P; Aperia, A			Anatomical and physiological evidence for D-1 and D-2 dopamine receptor colocalization in neostriatal neurons	NATURE NEUROSCIENCE			English	Article							STRIATAL NEURONS; GENE-EXPRESSION; BASAL GANGLIA; HELA-CELLS; RAT; NA,K-ATPASE; ISOFORMS; LOCALIZATION; DARPP-32; SODIUM	Despite the importance of dopamine signaling, it remains unknown if the two major subclasses of dopamine receptors exist on the same or distinct populations of neurons. Here we used confocal microscopy to demonstrate that virtually all striatal neurons, both in vitro and in vivo, contained dopamine receptors of both classes. We also provide functional evidence for such colocalization: in essentially all neurons examined, fenoldopam, an agonist of the D-1 subclass of receptors, inhibited both the Na+/K+ pump and tetrodotoxin (TTX)-sensitive sodium channels, and quinpirole, an agonist of the Dr subclass of receptors, activated TTX-sensitive sodium channels. Thus D-1 and D-2 classes of ligands may functionally interact in virtually all dopamine-responsive neurons within the basal ganglia.	Astrid Lindgren Childrens Hosp, Karolinska Inst, Dept Woman & Child Hlth, S-17176 Stockholm, Sweden; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	Karolinska Institutet; Emory University; Rockefeller University	Aperia, A (corresponding author), Astrid Lindgren Childrens Hosp, Karolinska Inst, Dept Woman & Child Hlth, Q2-09, S-17176 Stockholm, Sweden.		Brismar, Hjalmar/E-8524-2011; Forssberg, Hans/A-2944-2009; Levey, Allan/F-2104-2011	Brismar, Hjalmar/0000-0003-0578-4003; Levey, Allan/0000-0002-3153-502X; Uhlen, Per/0000-0003-1446-1062; Forssberg, Hans/0000-0003-2069-6618	NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH040899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 10044] Funding Source: Medline; NIMH NIH HHS [MH40899] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDERSON KD, 1991, BRAIN RES, V568, P235, DOI 10.1016/0006-8993(91)91403-N; Belusa R, 1997, J BIOL CHEM, V272, P20179, DOI 10.1074/jbc.272.32.20179; BLOCH B, 1994, TRENDS NEUROSCI, V17, P3, DOI 10.1016/0166-2236(94)90023-X; BOCKAERT J, 1986, J PHYSIOLOGY PARIS, V81, P219; Borin ML, 1997, AM J PHYSIOL-CELL PH, V272, pC428, DOI 10.1152/ajpcell.1997.272.2.C428; BORIN ML, 1993, AM J PHYSIOL, V264, pC1513, DOI 10.1152/ajpcell.1993.264.6.C1513; Castellanos FX, 1997, CLIN PEDIATR, V36, P381, DOI 10.1177/000992289703600702; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; Chase TN, 1998, NEUROLOGY, V51, pS30, DOI 10.1212/WNL.51.2_Suppl_2.S30; Egan MF, 1997, CURR OPIN NEUROBIOL, V7, P701, DOI 10.1016/S0959-4388(97)80092-X; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1994, TRENDS NEUROSCI, V17, P2, DOI 10.1016/0166-2236(94)90022-1; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; Grace A A, 1998, Adv Pharmacol, V42, P655; HEMMINGS HC, 1986, J NEUROSCI, V6, P1469; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; JOHNSON SW, 1992, SCIENCE, V258, P665, DOI 10.1126/science.1329209; Knable MB, 1997, J PSYCHOPHARMACOL, V11, P123, DOI 10.1177/026988119701100205; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; LEMOINE C, 1995, J COMP NEUROL, V355, P418, DOI 10.1002/cne.903550308; LEMOINE C, 1991, P NATL ACAD SCI USA, V88, P4205, DOI 10.1073/pnas.88.10.4205; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; OCONNELL DP, 1995, AM J PHYSIOL-RENAL, V268, pF1185, DOI 10.1152/ajprenal.1995.268.6.F1185; OUIMET CC, 1990, J NEUROCYTOL, V19, P39, DOI 10.1007/BF01188438; Peng L, 1997, J NEUROSCI, V17, P3488; PIETRINI G, 1992, P NATL ACAD SCI USA, V89, P8414, DOI 10.1073/pnas.89.18.8414; SATOH H, 1994, AM J PHYSIOL, V266, pH568, DOI 10.1152/ajpheart.1994.266.2.H568; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; SURMEIER DJ, 1994, TRENDS NEUROSCI, V17, P4, DOI 10.1016/0166-2236(94)90024-8; SURMEIER DJ, 1992, P NATL ACAD SCI USA, V89, P10178, DOI 10.1073/pnas.89.21.10178; SURMEIER DJ, 1993, TRENDS NEUROSCI, V16, P299, DOI 10.1016/0166-2236(93)90103-S; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Swanson J, 1998, CURR OPIN NEUROBIOL, V8, P263, DOI 10.1016/S0959-4388(98)80150-5; Yu XM, 1998, NATURE, V396, P469, DOI 10.1038/24877; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E; Zahler R, 1997, J GEN PHYSIOL, V110, P201, DOI 10.1085/jgp.110.2.201	37	311	323	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					226	230		10.1038/72929	http://dx.doi.org/10.1038/72929			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TE	10700253				2022-12-17	WOS:000085810500010
J	Hayashi-Takagi, A; Takaki, M; Graziane, N; Seshadri, S; Murdoch, H; Dunlop, AJ; Makino, Y; Seshadri, AJ; Ishizuka, K; Srivastava, DP; Xie, Z; Baraban, JM; Houslay, MD; Tomoda, T; Brandon, NJ; Kamiya, A; Yan, Z; Penzes, P; Sawa, A				Hayashi-Takagi, Akiko; Takaki, Manabu; Graziane, Nick; Seshadri, Saurav; Murdoch, Hannah; Dunlop, Allan J.; Makino, Yuichi; Seshadri, Anupamaa J.; Ishizuka, Koko; Srivastava, Deepak P.; Xie, Zhong; Baraban, Jay M.; Houslay, Miles D.; Tomoda, Toshifumi; Brandon, Nicholas J.; Kamiya, Atsushi; Yan, Zhen; Penzes, Peter; Sawa, Akira			Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1	NATURE NEUROSCIENCE			English	Article							CORTICAL PYRAMIDAL NEURONS; NMDA RECEPTOR ACTIVATION; DENDRITIC SPINES; EXCITATORY SYNAPSES; PLASTICITY; SUSCEPTIBILITY; ARCHITECTURE; DENSITY; COMPLEX; PROTEIN	Synaptic spines are dynamic structures that regulate neuronal responsiveness and plasticity. We examined the role of the schizophrenia risk factor DISC1 in the maintenance of spine morphology and function. We found that DISC1 anchored Kalirin-7 (Kal-7), regulating access of Kal-7 to Rac1 and controlling the duration and intensity of Rac1 activation in response to NMDA receptor activation in both cortical cultures and rat brain in vivo. These results explain why Rac1 and its activator (Kal-7) serve as important mediators of spine enlargement and why constitutive Rac1 activation decreases spine size. This mechanism likely underlies disturbances in glutamatergic neurotransmission that have been frequently reported in schizophrenia that can lead to alteration of dendritic spines with consequential major pathological changes in brain function. Furthermore, the concept of a signalosome involving disease-associated factors, such as DISC1 and glutamate, may well contribute to the multifactorial and polygenetic characteristics of schizophrenia.	[Hayashi-Takagi, Akiko; Takaki, Manabu; Seshadri, Saurav; Seshadri, Anupamaa J.; Ishizuka, Koko; Kamiya, Atsushi; Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Graziane, Nick; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA; [Murdoch, Hannah; Dunlop, Allan J.; Houslay, Miles D.] Univ Glasgow, Fac Biomed & Life Sci, Glasgow, Lanark, Scotland; [Makino, Yuichi; Baraban, Jay M.; Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Srivastava, Deepak P.; Xie, Zhong; Penzes, Peter] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Tomoda, Toshifumi] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA USA; [Brandon, Nicholas J.] Pfizer, Princeton, NJ USA	Johns Hopkins University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Glasgow; Johns Hopkins University; Northwestern University; Feinberg School of Medicine; City of Hope; Beckman Research Institute of City of Hope; Pfizer	Sawa, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA.	asawa1@jhmi.edu	Houslay, Miles D/A-6825-2011; Houslay, Miles/AAM-5281-2020; Xie, Zhong/B-6829-2011; kamiya, atsushi/L-8550-2016; Penzes, Peter/L-3987-2016; Takaki, Manabu/AFK-8037-2022	Xie, Zhong/0000-0002-8348-4455; kamiya, atsushi/0000-0002-4274-5567; Penzes, Peter/0000-0001-5449-1640; Takaki, Manabu/0000-0002-7371-2821; Houslay, Miles/0000-0002-3826-8091; Baraban, Jay/0000-0002-8165-2638; Brandon, Nicholas/0000-0002-3917-0096; Graziane, Nicholas/0000-0002-7055-7029; Seshadri, Anupamaa/0000-0001-8432-7518; Srivastava, Deepak Prakash/0000-0001-6512-9065	US National Institutes of Health [MH-084018, MH-069853, MH-088753, MH-071316, MH-084233, NS-048911]; Stanley; Cure Huntington's Disease Initiative; HighQ; S R Foundation; RUSK; National Alliance for Research on Schizophrenia and Depression; National Alliance for Autism Research; Medical Research Council [G0600765]; European Union [LSHB-CT-2006-037189]; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH084018, R01MH071316, R01MH069853, R01MH084233, RC1MH088753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048911] Funding Source: NIH RePORTER; MRC [G0600765] Funding Source: UKRI	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley; Cure Huntington's Disease Initiative; HighQ; S R Foundation; RUSK; National Alliance for Research on Schizophrenia and Depression(NARSAD); National Alliance for Autism Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Y. Lema and P. Talalay for help with manuscript preparation, A. Gruber, P. O'Donnell, P. F. Worley, R. L. Huganir, J.D. Rothstein, N. Shahani, H. Ujike, S. Kuroda, H. Bito and M. Nuriya for scientific discussions and J. Gogos, R. A. Cerione, H. Cline and A. Jeromin for providing us with reagents. This work was supported by grants from the US National Institutes of Health (MH-084018, MH-069853 and MH-088753 to A. S., MH-071316 to P. P., and MH-084233 and NS-048911 to Z.Y.), as well as by grants from Stanley (A. S.), Cure Huntington's Disease Initiative (A. S.), HighQ (A. S.), S & R Foundation (A. S.), RUSK (A. S.), National Alliance for Research on Schizophrenia and Depression (A. S., A.H.-T., A. K. and P. P.), National Alliance for Autism Research (P. P.), Uehara (A.H.-T. and M. T.), Medical Research Council (G0600765 to M. D. H.) and the European Union (LSHB-CT-2006-037189 to M. D. H.).	Blanpied TA, 2008, P NATL ACAD SCI USA, V105, P12587, DOI 10.1073/pnas.0711669105; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Cahill ME, 2009, P NATL ACAD SCI USA, V106, P13058, DOI 10.1073/pnas.0904636106; CAI X, J BIOL CHEM, V277, P36553; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Cannon TD, 2005, ARCH GEN PSYCHIAT, V62, P1205, DOI 10.1001/archpsyc.62.11.1205; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Garey LJ, 1998, J NEUROL NEUROSUR PS, V65, P446, DOI 10.1136/jnnp.65.4.446; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Goff DC, 2001, AM J PSYCHIAT, V158, P1367, DOI 10.1176/appi.ajp.158.9.1367; Harrison PJ, 2006, MOL PSYCHIATR, V11, P981, DOI 10.1038/sj.mp.4001886; Hashimoto R, 2007, DRUG TODAY, V43, P645, DOI 10.1358/dot.2007.43.9.1088821; Hill JJ, 2006, MOL PSYCHIATR, V11, P557, DOI 10.1038/sj.mp.4001792; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Ishizuka K, 2007, MOL PSYCHIATR, V12, P897, DOI 10.1038/sj.mp.4002024; Ishizuka K, 2006, BIOL PSYCHIAT, V59, P1189, DOI 10.1016/j.biopsych.2006.03.065; Jaaro-Peled H, 2009, TRENDS NEUROSCI, V32, P485, DOI 10.1016/j.tins.2009.05.007; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kirkpatrick B, 2006, J COMP NEUROL, V497, P436, DOI 10.1002/cne.21007; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Kvajo M, 2008, P NATL ACAD SCI USA, V105, P7076, DOI 10.1073/pnas.0802615105; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Ma XM, 2008, J NEUROSCI, V28, P711, DOI 10.1523/JNEUROSCI.5283-07.2008; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McCullumsmith RE, 2004, INT REV NEUROBIOL, V59, P19; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; McGlashan TH, 1996, SCHIZOPHRENIA BULL, V22, P201, DOI 10.1093/schbul/22.2.201; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Mirnics K, 2001, TRENDS NEUROSCI, V24, P479, DOI 10.1016/S0166-2236(00)01862-2; Moghaddam B, 2003, NEURON, V40, P881, DOI 10.1016/S0896-6273(03)00757-8; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Pilowsky LS, 2006, MOL PSYCHIATR, V11, P118, DOI 10.1038/sj.mp.4001751; Rabiner CA, 2005, NEUROSCIENTIST, V11, P148, DOI 10.1177/1073858404271250; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Steen RG, 2005, NEUROPSYCHOPHARMACOL, V30, P1949, DOI 10.1038/sj.npp.1300850; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005	50	310	315	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					327	U12		10.1038/nn.2487	http://dx.doi.org/10.1038/nn.2487			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20139976	Green Published, Green Accepted			2022-12-17	WOS:000274860100014
J	Niell, CM; Meyer, MP; Smith, SJ				Niell, CM; Meyer, MP; Smith, SJ			In vivo imaging of synapse formation on a growing dendritic arbor	NATURE NEUROSCIENCE			English	Article							POSTSYNAPTIC SPECIALIZATION; HIPPOCAMPAL-NEURONS; ZEBRAFISH EMBRYOS; NMDA RECEPTOR; SYNAPTOGENESIS; DYNAMICS; GROWTH; RECRUITMENT; PLASTICITY; FILOPODIA	The form of a neuron's dendritic arbor determines the set of axons with which it may form synaptic contacts, thus establishing connectivity within neural circuits. However, the dynamic relationship between dendrite growth and synaptogenesis is not well understood. To observe both processes simultaneously, we performed long-term imaging of non-spiny dendritic arbors expressing a fluorescent postsynaptic marker protein as they arborized within the optic tectum of live zebrafish larvae. Our results indicate that almost all synapses form initially on newly extended dendritic filopodia. A fraction of these nascent synapses are maintained, which in turn stabilizes the subset of filopodia on which they form. Stabilized filopodia mature into dendritic branches, and successive iterations of this process result in growth and branching of the arbor. These findings support a `synaptotropic model' in which synapse formation can direct dendrite arborization.	Stanford Univ, Beckman Ctr, Program Neurosci, Stanford, CA 94305 USA; Stanford Univ, Beckman Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Smith, SJ (corresponding author), Stanford Univ, Beckman Ctr, Program Neurosci, Stanford, CA 94305 USA.	sjsmith@stanford.edu	Meyer, Martin/C-5472-2009	Meyer, Martin/0000-0001-8337-630X	NINDS NIH HHS [NS043461] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043461] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Banker G., 1998, CULTURING NERVE CELL; Bresler T, 2001, MOL CELL NEUROSCI, V18, P149, DOI 10.1006/mcne.2001.1012; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Douglas R., 1990, VISUAL SYSTEM FISH, DOI [10.1007/978-94-009-0411-8, DOI 10.1007/978-94-009-0411-8]; Dunaevsky A, 2003, TRENDS NEUROSCI, V26, P155, DOI 10.1016/S0166-2236(03)00028-6; Ebihara T, 2003, J NEUROSCI, V23, P2170; Fiala JC, 1998, J NEUROSCI, V18, P8900; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Furrer MP, 2003, NAT NEUROSCI, V6, P223, DOI 10.1038/nn1017; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Gleason MR, 2003, NAT NEUROSCI, V6, P217, DOI 10.1038/nn1011; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Jan YN, 2001, GENE DEV, V15, P2627, DOI 10.1101/gad.916501; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Kaethner RJ, 1997, J NEUROBIOL, V32, P627, DOI 10.1002/(SICI)1097-4695(19970605)32:6<627::AID-NEU7>3.0.CO;2-1; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; McGee AW, 2003, CURR OPIN NEUROBIOL, V13, P111, DOI 10.1016/S0959-4388(03)00008-4; MEEK J, 1981, J COMP NEUROL, V199, P175, DOI 10.1002/cne.901990203; Micheva KD, 2001, J CELL BIOL, V154, P355, DOI 10.1083/jcb.200102098; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Prange O, 2001, J NEUROSCI, V21, P9325, DOI 10.1523/JNEUROSCI.21-23-09325.2001; Rao A, 1998, J NEUROSCI, V18, P1217; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Tashiro A, 2003, NEURON, V38, P773, DOI 10.1016/S0896-6273(03)00299-X; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; VAUGHN JE, 1988, SYNAPSE, V2, P69, DOI 10.1002/syn.890020110; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Westerfield M, 1993, ZEBRAFISH BOOK; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wong WT, 2001, NAT NEUROSCI, V4, P351, DOI 10.1038/85987; Wong WT, 2000, CURR OPIN NEUROBIOL, V10, P118, DOI 10.1016/S0959-4388(99)00059-8; Wu GY, 1999, J NEUROSCI, V19, P4472; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	50	310	318	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					254	260		10.1038/nn1191	http://dx.doi.org/10.1038/nn1191			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14758365				2022-12-17	WOS:000189197900015
J	Flavahan, WA; Wu, QL; Hitomi, M; Rahim, N; Kim, Y; Sloan, AE; Weil, RJ; Nakano, I; Sarkaria, JN; Stringer, BW; Day, BW; Li, MZ; Lathia, JD; Rich, JN; Hjelmeland, AB				Flavahan, William A.; Wu, Qiulian; Hitomi, Masahiro; Rahim, Nasiha; Kim, Youngmi; Sloan, Andrew E.; Weil, Robert J.; Nakano, Ichiro; Sarkaria, Jann N.; Stringer, Brett W.; Day, Bryan W.; Li, Meizhang; Lathia, Justin D.; Rich, Jeremy N.; Hjelmeland, Anita B.			Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake	NATURE NEUROSCIENCE			English	Article							INTEGRATED GENOMIC ANALYSIS; GENE-EXPRESSION; STEM-CELLS; GLIOMA; CANCER; GLIOBLASTOMA; GLUT3; IDH1; CARCINOMA; SURVIVAL	Like all cancers, brain tumors require a continuous source of energy and molecular resources for new cell production. In normal brain, glucose is an essential neuronal fuel, but the blood-brain barrier limits its delivery. We now report that nutrient restriction contributes to tumor progression by enriching for brain tumor initiating cells (BTICs) owing to preferential BTIC survival and to adaptation of non-BTICs through acquisition of BTIC features. BTICs outcompete for glucose uptake by co-opting the high affinity neuronal glucose transporter, type 3 (Glut3, SLC2A3). BTICs preferentially express Glut3, and targeting Glut3 inhibits BTIC growth and tumorigenic potential. Glut3, but not Glut1, correlates with poor survival in brain tumors and other cancers; thus, tumor initiating cells may extract nutrients with high affinity. As altered metabolism represents a cancer hallmark, metabolic reprogramming may maintain the tumor hierarchy and portend poor prognosis.	[Flavahan, William A.; Lathia, Justin D.; Rich, Jeremy N.; Hjelmeland, Anita B.] Case Western Reserve Univ, Cleveland Clin, Dept Mol Med, Lerner Coll Med, Cleveland, OH 44106 USA; [Flavahan, William A.; Wu, Qiulian; Hitomi, Masahiro; Rahim, Nasiha; Kim, Youngmi; Lathia, Justin D.; Rich, Jeremy N.; Hjelmeland, Anita B.] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Lerner Res Inst, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Dept Neurol Surg, Cleveland, OH USA; [Sloan, Andrew E.] Univ Hosp Cleveland, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Dept Translat Neurosci, Cleveland, OH USA; [Weil, Robert J.] Cleveland Clin, Neurol Inst, Dept Neurosurg, Cleveland, OH 44106 USA; [Weil, Robert J.] Cleveland Clin, Burkhardt Brain Tumor & Neurooncol Ctr, Neurol Inst, Cleveland, OH 44106 USA; [Nakano, Ichiro] Ohio State Univ, Med Ctr, Dardinger Lab Neurosci, Dept Neurol Surg, Columbus, OH 43210 USA; [Sarkaria, Jann N.] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA; [Stringer, Brett W.; Day, Bryan W.] Queensland Inst Med Res, Brain Canc Res Unit, Brisbane, Qld 4006, Australia; [Stringer, Brett W.; Day, Bryan W.] Queensland Inst Med Res, Res Unit, Leukaemia Fdn, Brisbane, Qld 4006, Australia; [Li, Meizhang; Lathia, Justin D.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Ohio State University; Mayo Clinic; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; Cleveland Clinic Foundation	Rich, JN (corresponding author), Case Western Reserve Univ, Cleveland Clin, Dept Mol Med, Lerner Coll Med, Cleveland, OH 44106 USA.	richj@ccf.org	Sloan, Andrew/AAE-9842-2020; Day, Bryan/AAV-6170-2020; Nakano, Ichiro/AAR-9562-2020; Day, Bryan/O-4469-2015; Stringer, Brett/GZB-1390-2022; Lathia, Justin/AHB-8296-2022; Rich, Jeremy/AAM-1445-2021; Nakano, Ichiro/F-2076-2014	Nakano, Ichiro/0000-0002-0916-3207; Nakano, Ichiro/0000-0002-6734-3468; Hjelmeland, Anita/0000-0003-2200-3248; Day, Bryan/0000-0002-8948-9089; Stringer, Brett/0000-0003-4552-9736	NATIONAL CANCER INSTITUTE [R01CA151522, R01CA116257, K99CA157948, U01CA137443, UM1CA137443, R01CA154130, P30CA016058, R01CA169117, R01CA116659, K08CA101954, R00CA157948, R42CA128269, R01CA129958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063971] Funding Source: NIH RePORTER; NCI NIH HHS [CA101954, R01 CA154130, CA137443, U01 CA137443, R01 CA129958, P30 CA016058, CA151522, R01 CA116257, CA116659, CA154130, CA116257, R01 CA116659, K99 CA157948, K08 CA101954, UM1 CA137443, R01 CA151522, R00 CA157948, CA129958, R01 CA169117, CA128269, R42 CA128269, CA157948] Funding Source: Medline; NINDS NIH HHS [NS063971, R01 NS063971] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baer S, 2002, LARYNGOSCOPE, V112, P393, DOI 10.1097/00005537-200202000-00034; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BOADO RJ, 1994, MOL BRAIN RES, V27, P51, DOI 10.1016/0169-328X(94)90183-X; BURGESS EA, 1962, CANCER RES, V22, P581; Charnley N, 2008, ONCOL REP, V20, P537, DOI 10.3892/or_00000039; Chen YJ, 2013, ENDOCRINOLOGY, V154, P1598, DOI 10.1210/en.2012-2076; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chung JK, 2004, NUCL MED COMMUN, V25, P11, DOI 10.1097/00006231-200401000-00003; Derr RL, 2009, J CLIN ONCOL, V27, P1082, DOI 10.1200/JCO.2008.19.1098; FELLOWS LK, 1993, BRAIN RES, V604, P225, DOI 10.1016/0006-8993(93)90373-U; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hjelmeland AB, 2011, CELL DEATH DIFFER, V18, P829, DOI 10.1038/cdd.2010.150; Laks DR, 2009, STEM CELLS, V27, P980, DOI 10.1002/stem.15; Lathia JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024807; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Loncaster JA, 2001, CANCER RES, V61, P6394; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Mathews EH, 2011, MED HYPOTHESES, V76, P157, DOI 10.1016/j.mehy.2010.09.006; NAGAMATSU S, 1993, J NEUROCHEM, V61, P2048, DOI 10.1111/j.1471-4159.1993.tb07441.x; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Novakovic B, 2013, J NUTR BIOCHEM, V24, P282, DOI 10.1016/j.jnutbio.2012.06.006; Nutt CL, 2003, CANCER RES, V63, P1602; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peters A, 2004, NEUROSCI BIOBEHAV R, V28, P143, DOI 10.1016/j.neubiorev.2004.03.002; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Ayala FRR, 2010, MOLECULES, V15, P2374, DOI 10.3390/molecules15042374; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0; Younes M, 1997, ANTICANCER RES, V17, P2747; Younes M, 1997, CANCER-AM CANCER SOC, V80, P1046, DOI 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	52	309	316	1	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1373	+		10.1038/nn.3510	http://dx.doi.org/10.1038/nn.3510			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23995067	Green Accepted			2022-12-17	WOS:000324795300009
J	Crunelli, V; Hughes, SW				Crunelli, Vincenzo; Hughes, Stuart W.			The slow (< 1 Hz) rhythm of non-REM sleep: a dialogue between three cardinal oscillators	NATURE NEUROSCIENCE			English	Review							LATERAL GENICULATE-NUCLEUS; LOW-FREQUENCY RHYTHMS; NEURONS-IN-VITRO; RAT THALAMOCORTICAL NEURONS; WAVE SLEEP; NEOCORTICAL NETWORKS; CEREBRAL-CORTEX; K-COMPLEX; CORTICOTHALAMIC NETWORKS; CELLULAR MECHANISMS	The slow (<1 Hz) rhythm, the most important electroencephalogram ( EEG) signature of non-rapid eye movement (NREM) sleep, is generally viewed as originating exclusively from neocortical networks. Here we argue that the full manifestation of this fundamental sleep oscillation in a corticothalamic module requires the dynamic interaction of three cardinal oscillators: one predominantly synaptically based cortical oscillator and two intrinsic, conditional thalamic oscillators. The functional implications of this hypothesis are discussed in relation to other EEG features of NREM sleep, with respect to coordinating activities in local and distant neuronal assemblies and in the context of facilitating cellular and network plasticity during slow-wave sleep.	[Crunelli, Vincenzo; Hughes, Stuart W.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales	Cardiff University	Crunelli, V (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	crunelli@cardiff.ac.uk	Crunelli, Vincenzo/A-7258-2010	Crunelli, Vincenzo/0000-0001-7154-9752; Hughes, Stuart/0000-0003-0423-777X	Wellcome Trust [71436, 78311, 78403]	Wellcome Trust(Wellcome TrustEuropean Commission)	Our work in this area is supported by the Wellcome Trust ( grants 71436, 78311 and 78403).	Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; Amzica F, 2002, SLEEP MED REV, V6, P139, DOI 10.1053/smrv.2001.0181; Amzica F, 1998, NEUROSCIENCE, V82, P671; Amzica F, 1997, NEUROLOGY, V49, P952, DOI 10.1212/WNL.49.4.952; AMZICA F, 1995, J NEUROSCI, V15, P4658; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Beierlein M, 2002, J NEUROSCI, V22, P9885; Blethyn KL, 2006, J NEUROSCI, V26, P2474, DOI 10.1523/JNEUROSCI.3607-05.2006; Bokor H, 2005, NEURON, V45, P929, DOI 10.1016/j.neuron.2005.01.048; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Contreras D, 1997, NEUROSCIENCE, V76, P25; Contreras D, 1997, NEUROSCIENCE, V76, P11; Contreras D, 1996, J PHYSIOL-LONDON, V490, P159, DOI 10.1113/jphysiol.1996.sp021133; CONTRERAS D, 1995, J NEUROSCI, V15, P604; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Cox CL, 2003, J NEUROSCI, V23, P7642; Cox CL, 2000, NEURON, V27, P597, DOI 10.1016/S0896-6273(00)00069-6; Crunelli V, 2005, J PHYSIOL-LONDON, V562, P121, DOI 10.1113/jphysiol.2004.076273; Crunelli V, 2006, CELL CALCIUM, V40, P175, DOI 10.1016/j.ceca.2006.04.022; Cueni L, 2008, NAT NEUROSCI, V11, P683, DOI 10.1038/nn.2124; Cunningham MO, 2006, P NATL ACAD SCI USA, V103, P5597, DOI 10.1073/pnas.0600604103; Czarnecki A, 2007, J PHYSIOL-LONDON, V578, P471, DOI 10.1113/jphysiol.2006.123588; Dang-Vu TT, 2008, P NATL ACAD SCI USA, V105, P15160, DOI 10.1073/pnas.0801819105; De Gennaro L, 2003, SLEEP MED REV, V7, P423, DOI 10.1053/smrv.2002.0252; De Gennaro L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002483; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Destexhe A, 2007, TRENDS NEUROSCI, V30, P334, DOI 10.1016/j.tins.2007.04.006; Doi A, 2007, EUR J NEUROSCI, V26, P2565, DOI 10.1111/j.1460-9568.2007.05885.x; Godwin DW, 1996, J NEUROSCI, V16, P8181; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hill S, 2005, J NEUROPHYSIOL, V93, P1671, DOI 10.1152/jn.00915.2004; Hoffman KL, 2007, J NEUROSCI, V27, P11838, DOI 10.1523/JNEUROSCI.3501-07.2007; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Hughes SW, 2004, NEURON, V42, P253, DOI 10.1016/S0896-6273(04)00191-6; Hughes SW, 2002, NEUROSCIENCE, V110, P395, DOI 10.1016/S0306-4522(01)00577-2; Hughes SW, 2002, NEURON, V33, P947, DOI 10.1016/S0896-6273(02)00623-2; Hughes SW, 1999, J PHYSIOL-LONDON, V517, P805, DOI 10.1111/j.1469-7793.1999.0805s.x; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; JONES EG, 2008, THALAMUS; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Krueger JM, 2008, NAT REV NEUROSCI, V9, P910, DOI 10.1038/nrn2521; Le Bon-Jegoa M, 2007, FRONT NEUROSCI-SWITZ, V1, P123, DOI 10.3389/neuro.01.1.1.009.2007; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Lorincz ML, 2009, NEURON, V63, P683, DOI 10.1016/j.neuron.2009.08.012; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Massimini M, 2003, J NEUROPHYSIOL, V89, P1205, DOI 10.1152/jn.00373.2002; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; Mehta MR, 2007, NAT NEUROSCI, V10, P13, DOI 10.1038/nn0107-13; Mena-Segovia J, 2008, J PHYSIOL-LONDON, V586, P2947, DOI 10.1113/jphysiol.2008.153874; METHERATE R, 1992, J NEUROSCI, V12, P4701; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Molle M, 2002, J NEUROSCI, V22, P10941; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Puig MV, 2008, P NATL ACAD SCI USA, V105, P8428, DOI 10.1073/pnas.0712219105; Reig R, 2006, CEREB CORTEX, V16, P688, DOI 10.1093/cercor/bhj014; Rigas P, 2007, J NEUROSCI, V27, P4261, DOI 10.1523/JNEUROSCI.0003-07.2007; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Siegel JM, 2008, TRENDS NEUROSCI, V31, P208, DOI 10.1016/j.tins.2008.02.001; Simon NR, 2000, BRAIN RES, V860, P64, DOI 10.1016/S0006-8993(00)01974-0; SIMON NR, 2003, SLEEP RES ONLINE, V5, P105; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; SOLTESZ I, 1992, J PHYSIOL-LONDON, V457, P257, DOI 10.1113/jphysiol.1992.sp019377; Steriade M, 1998, J NEUROSCI, V18, P6425; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; STERIADE M, 1993, J NEUROSCI, V13, P3284; Steriade M, 1997, CEREB CORTEX, V7, P583, DOI 10.1093/cercor/7.6.583; STERIADE M, 1993, J NEUROSCI, V13, P3266; Steriade M, 1996, J NEUROSCI, V16, P2788; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3253; Steriade M., 1993, ELECTROENCEPHALOGRAP, P27; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Timofeev I, 1996, J NEUROPHYSIOL, V76, P4152, DOI 10.1152/jn.1996.76.6.4152; Tononi G, 2006, NEURON, V52, P748, DOI 10.1016/j.neuron.2006.11.014; Toth TI, 1998, NEUROSCIENCE, V87, P519, DOI 10.1016/S0306-4522(98)00118-3; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; Turner JP, 2000, NEUROSCIENCE, V100, P493, DOI 10.1016/S0306-4522(00)00280-3; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Williams SR, 1997, J PHYSIOL-LONDON, V505, P689, DOI 10.1111/j.1469-7793.1997.689ba.x; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; Yuste R, 2005, NAT REV NEUROSCI, V6, P477, DOI 10.1038/nrn1686; Zhu L, 2006, NEUROSCIENCE, V141, P621, DOI 10.1016/j.neuroscience.2006.04.069	100	309	309	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					10	18		10.1038/nn.2445	http://dx.doi.org/10.1038/nn.2445			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	19966841	Green Accepted			2022-12-17	WOS:000273056300006
J	Gao, ZL; Ure, K; Ables, JL; Lagace, DC; Nave, KA; Goebbels, S; Eisch, AJ; Hsieh, J				Gao, Zhengliang; Ure, Kerstin; Ables, Jessica L.; Lagace, Diane C.; Nave, Klaus-Armin; Goebbels, Sandra; Eisch, Amelia J.; Hsieh, Jenny			Neurod1 is essential for the survival and maturation of adult-born neurons	NATURE NEUROSCIENCE			English	Article							TRANSCRIPTION FACTOR; NEUROGENESIS; DIFFERENTIATION; MORPHOGENESIS; CELLS; GENE; MICE	The transcriptional program that controls adult neurogenesis is unknown. We generated mice with an inducible stem cell-specific deletion of Neurod1, resulting in substantially fewer newborn neurons in the hippocampus and olfactory bulb. Thus, Neurod1 is cell-intrinsically required for the survival and maturation of adult-born neurons.	[Gao, Zhengliang; Ure, Kerstin; Hsieh, Jenny] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Gao, Zhengliang; Ure, Kerstin; Hsieh, Jenny] Univ Texas SW Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; [Ables, Jessica L.; Eisch, Amelia J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Lagace, Diane C.] Univ Ottawa, Ctr Stroke Recovery, Dept Cellular & Mol Med, Ottawa, ON K1N 6N5, Canada; [Lagace, Diane C.] Univ Ottawa, Ctr Stroke Recovery, Heart & Stroke Fdn, Ottawa, ON K1N 6N5, Canada; [Nave, Klaus-Armin; Goebbels, Sandra] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Ottawa; University of Ottawa; Max Planck Society	Hsieh, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	jenny.hsieh@utsouthwestern.edu	Nave, Klaus-Armin/C-8883-2011	Ables, Jessica L./0000-0003-1818-3506; Eisch, Amelia/0000-0001-6476-5385	Epilepsy Foundation; US National Institutes of Health training; Texas Advanced Research Program [3594-0029-2007, 10019-0013-2006]; Ellison Medical Foundation [AG-NS-0371-06]; Welch Foundation [I-1660]; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA023555, R21DA023701, R01DA016765] Funding Source: NIH RePORTER	Epilepsy Foundation; US National Institutes of Health training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Advanced Research Program; Ellison Medical Foundation(Lawrence Ellison Foundation); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank L. Zhang, J. Ma and Y. Jiang for technical assistance and S. Goetsch for artwork. We also thank J. Johnson, C.-L. Zhang and J. Schneider for helpful comments on the manuscript. This work was supported in part by the Epilepsy Foundation ( Z. G.), a US National Institutes of Health training grant ( K. U.), the Texas Advanced Research Program ( grant numbers 3594-0029-2007 and 10019-0013-2006), the Ellison Medical Foundation ( grant number AG-NS-0371-06) and the Welch Foundation ( grant number I-1660, J. H.).	Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Gage FH, 2008, ADULT NEUROGENESIS; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Goebbels S, 2005, GENESIS, V42, P247, DOI 10.1002/gene.20138; Guillemot F, 2007, PROG NEUROBIOL, V83, P37, DOI 10.1016/j.pneurobio.2007.02.009; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; Schwab MH, 2000, J NEUROSCI, V20, P3714, DOI 10.1523/JNEUROSCI.20-10-03714.2000; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037	13	309	319	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1090	1092		10.1038/nn.2385	http://dx.doi.org/10.1038/nn.2385			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19701197	Green Accepted			2022-12-17	WOS:000269317300008
J	Koelsch, S; Kasper, E; Sammler, D; Schulze, K; Gunter, T; Friederici, AD				Koelsch, S; Kasper, E; Sammler, D; Schulze, K; Gunter, T; Friederici, AD			Music, language and meaning: brain signatures of semantic processing	NATURE NEUROSCIENCE			English	Article							SENTENCES; WORD; FMRI; COMPREHENSION; COMMUNICATION; PERFORMANCE; EMOTIONS; CONTEXT	Semantics is a key feature of language, but whether or not music can activate brain mechanisms related to the processing of semantic meaning is not known. We compared processing of semantic meaning in language and music, investigating the semantic priming effect as indexed by behavioral measures and by the N400 component of the event-related brain potential (ERP) measured by electroencephalography (EEG). Human subjects were presented visually with target words after hearing either a spoken sentence or a musical excerpt. Target words that were semantically unrelated to prime sentences elicited a larger N400 than did target words that were preceded by semantically related sentences. In addition, target words that were preceded by semantically unrelated musical primes showed a similar N400 effect, as compared to target words preceded by related musical primes. The N400 priming effect did not differ between language and music with respect to time course, strength or neural generators. Our results indicate that both music and language can prime the meaning of a word, and that music can, as language, determine physiological indices of semantic processing.	Max Planck Inst Human Cognit & Brain Sci, D-04103 Leipzig, Germany	Max Planck Society	Koelsch, S (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Stephanstr 1A, D-04103 Leipzig, Germany.	koelsch@cns.mpg.de	Koelsch, Stefan/AAV-1556-2020; Schulze, Katrin/A-7385-2010; Sammler, Daniela/V-9044-2019	Sammler, Daniela/0000-0001-7458-0229				Baumgaertner A, 2002, NEUROIMAGE, V16, P736, DOI 10.1006/nimg.2002.1134; Bernstein L, 1981, UNANSWERED QUESTION; Busnel RG, 1976, WHISTLED LANGUAGES; Cowan GM, 1948, LANGUAGE, V24, P280, DOI 10.2307/410362; Crystal D., 1995, CAMBRIDGE ENCY LANGU; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Friederici AD, 2000, CEREB CORTEX, V10, P698, DOI 10.1093/cercor/10.7.698; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; FRIEDERICI AD, 1998, LANGUAGE COMPREHENSI; Halgren E, 2002, NEUROIMAGE, V17, P1101, DOI 10.1006/nimg.2002.1268; Helenius P, 1998, BRAIN, V121, P1133, DOI 10.1093/brain/121.6.1133; Hevner K, 1937, AM J PSYCHOL, V49, P621, DOI 10.2307/1416385; JONES MR, 1992, COGNITIVE BASES MUSI; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Juslin PN, 2000, J EXP PSYCHOL HUMAN, V26, P1797, DOI 10.1037//0096-1523.26.6.1797; Kellenbach ML, 2000, COGNITIVE BRAIN RES, V10, P67, DOI 10.1016/S0926-6410(00)00023-9; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; Krumhansl CL, 1996, MUSIC PERCEPT, V13, P401; Kuperberg GR, 2000, J COGNITIVE NEUROSCI, V12, P321, DOI 10.1162/089892900562138; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Meyer L., 1956, EMOTION MEANING MUSI; Ni W, 2000, J COGNITIVE NEUROSCI, V12, P120, DOI 10.1162/08989290051137648; OSTERHOUT L, 1995, ELECTROPHYSIOLOGY MI, P192; Peirce C. S., 1994, MASTERS; PINKER S, 1997, HOW MIND WORKS; Price CJ, 1997, J COGNITIVE NEUROSCI, V9, P727, DOI 10.1162/jocn.1997.9.6.727; RAFFMANN D, 1993, LANGUAGE MUSIC MIND; Seboek T., 1976, SPEECH SURROGATES DR; Swain J., 1997, MUSICAL LANGUAGES; Talairach J., 1988, COPLANAR STEREOTAXIC; Zbikowski Lawrence M., 2002, CONCEPTUALIZING MUSI	32	309	323	6	135	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					302	307		10.1038/nn1197	http://dx.doi.org/10.1038/nn1197			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology	777UU	14983184				2022-12-17	WOS:000189197900021
J	Shigetomi, E; Tong, XP; Kwan, KY; Corey, DP; Khakh, BS				Shigetomi, Eiji; Tong, Xiaoping; Kwan, Kelvin Y.; Corey, David P.; Khakh, Baljit S.			TRPA1 channels regulate astrocyte resting calcium and inhibitory synapse efficacy through GAT-3	NATURE NEUROSCIENCE			English	Article							GABA TRANSPORTERS; NEURAL ACTIVITY; GLIAL-CELLS; CA2+ ENTRY; ACTIVATION; RELEASE; MICE; CONTRIBUTES; EXCITATION; INDICATORS	Astrocytes contribute to the formation and function of synapses and are found throughout the brain, where they show intracellular store-mediated Ca(2+) signals. Here, using a membrane-tethered, genetically encoded calcium indicator (Lck-GCaMP3), we report the serendipitous discovery of a new type of Ca(2+) signal in rat hippocampal astrocyte-neuron cocultures. We found that Ca(2+) fluxes mediated by transient receptor potential A1 (TRPA1) channels gave rise to frequent and highly localized 'spotty' Ca(2+) microdomains near the membrane that contributed appreciably to resting Ca(2+) in astrocytes. Mechanistic evaluations in brain slices showed that decreases in astrocyte resting Ca(2+) concentrations mediated by TRPA1 channels decreased interneuron inhibitory synapse efficacy by reducing GABA transport by GAT-3, thus elevating extracellular GABA. Our data show how a transmembrane Ca(2+) source (TRPA1) targets a transporter (GAT-3) in astrocytes to regulate inhibitory synapses.	[Shigetomi, Eiji; Tong, Xiaoping; Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Kwan, Kelvin Y.; Corey, David P.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Khakh, BS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	bkhakh@mednet.ucla.edu	SHIGETOMI, EIJI/I-2372-2012	Corey, David/0000-0003-4497-6016; Tong, Xiaoping/0000-0002-0908-8091; Kwan, Kelvin/0000-0002-8617-5543; Shigetomi, Eiji/0000-0002-5267-6155	US National Institutes of Health National Institute of Neurological Disorders and Stroke [NS060677]; Whitehall Foundation [NS071292, NS063186]; Stein-Oppenheimer Endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071292, R01NS060677, R21NS063186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000304] Funding Source: NIH RePORTER	US National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Whitehall Foundation; Stein-Oppenheimer Endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors are indebted to T.J. O'Dell and M. V. Sofroniew for discussions during the course of these experiments. The authors are grateful to E. Toulme for assistance with western blots, to M. Hamby for tips on astrocyte-enriched cultures and to S. Kracun for molecular biology help and discussions. Thanks to M. Nedergaard for discussions during the early stages of this project. Special thanks to members of the Astrocyte Biology and Biophysics Affinity Group at UCLA for discussions. Thanks to A. Patapoutian (mouse TRPA1; The Scripps Research Institute), D. Julius (rat TRPA1; University of California San Francisco) and Y. Gwack (mCherry; University of California Los Angeles) for sharing plasmids. Thanks to N. Brecha (University of California Los Angeles) for GAT-1 and GAT-3 antibodies. Our work was supported mainly by US National Institutes of Health National Institute of Neurological Disorders and Stroke grant NS060677 and partly by grants NS071292 and NS063186, the Whitehall Foundation and a Stein-Oppenheimer Endowment Award (to B. S. K.).	Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bomben VC, 2011, J CELL PHYSIOL, V226, P1879, DOI 10.1002/jcp.22518; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chen J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-3; Chiu CS, 2002, J NEUROSCI, V22, P10251; Clapham D. E., 2009, ENCY NEUROSCIENCE, P1109; Deken SL, 2003, J NEUROSCI, V23, P1563; Everaerts W, 2011, CURR BIOL, V21, P316, DOI 10.1016/j.cub.2011.01.031; Garcia-Anoveros J., 2007, V179, P347; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Golovina VA, 2005, J PHYSIOL-LONDON, V564, P737, DOI 10.1113/jphysiol.2005.085035; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Grimaldi M, 2003, J NEUROSCI, V23, P4737; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hill K, 2009, CELL CALCIUM, V45, P155, DOI 10.1016/j.ceca.2008.08.001; Hires SA, 2008, BRAIN CELL BIOL, V36, P69, DOI 10.1007/s11068-008-9029-4; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lee S, 2010, SCIENCE, V330, P790, DOI 10.1126/science.1184334; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Malarkey EB, 2008, GLIA, V56, P821, DOI 10.1002/glia.20656; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Moss FJ, 2009, J GEN PHYSIOL, V134, P489, DOI 10.1085/jgp.200910314; Nilius B, 2011, J PHYSIOL-LONDON, V589, P1543, DOI 10.1113/jphysiol.2010.200717; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Overstreet LS, 2000, J NEUROSCI, V20, P7914; Reeves AMB, 2011, J NEUROSCI, V31, P9353, DOI 10.1523/JNEUROSCI.0127-11.2011; Ribak CE, 1996, J COMP NEUROL, V367, P595, DOI 10.1002/(SICI)1096-9861(19960415)367:4<595::AID-CNE9>3.0.CO;2-#; Shigetomi E, 2009, J VIS EXP, V26, P1142; Shigetomi E, 2008, J NEUROSCI, V28, P6659, DOI 10.1523/JNEUROSCI.1717-08.2008; Shigetomi E, 2010, NEURON GLIA BIOL, V6, P183, DOI 10.1017/S1740925X10000219; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Shirakawa H, 2010, J NEUROSCI, V30, P13116, DOI 10.1523/JNEUROSCI.1890-10.2010; Soeller C, 2004, PROG BIOPHYS MOL BIO, V85, P141, DOI 10.1016/j.pbiomolbio.2003.12.006; Song IS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1377; SONTHEIMER H, 1994, GLIA, V11, P156, DOI 10.1002/glia.440110210; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wang D, 2005, J BIOL CHEM, V280, P18703, DOI 10.1074/jbc.M500381200; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	50	308	317	2	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					70	U215		10.1038/nn.3000	http://dx.doi.org/10.1038/nn.3000			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22158513	Green Accepted			2022-12-17	WOS:000298414400016
J	Lomber, SG; Meredith, MA; Kral, A				Lomber, Stephen G.; Meredith, M. Alex; Kral, Andrej			Cross-modal plasticity in specific auditory cortices underlies visual compensations in the deaf	NATURE NEUROSCIENCE			English	Article							DORSAL ZONE; REVERSIBLE DEACTIVATION; COOLING DEACTIVATION; DISCRIMINATION TASK; DOUBLE DISSOCIATION; CONGENITALLY BLIND; SOUND LOCALIZATION; MOVEMENT DETECTION; PARIETAL CORTEX; WHITE CATS	When the brain is deprived of input from one sensory modality, it often compensates with supranormal performance in one or more of the intact sensory systems. In the absence of acoustic input, it has been proposed that cross-modal reorganization of deaf auditory cortex may provide the neural substrate mediating compensatory visual function. We tested this hypothesis using a battery of visual psychophysical tasks and found that congenitally deaf cats, compared with hearing cats, have superior localization in the peripheral field and lower visual movement detection thresholds. In the deaf cats, reversible deactivation of posterior auditory cortex selectively eliminated superior visual localization abilities, whereas deactivation of the dorsal auditory cortex eliminated superior visual motion detection. Our results indicate that enhanced visual performance in the deaf is caused by cross-modal reorganization of deaf auditory cortex and it is possible to localize individual visual functions in discrete portions of reorganized auditory cortex.	[Lomber, Stephen G.] Univ Western Ontario, Dept Psychol, Dept Physiol & Pharmacol, Ctr Brain & Mind, London, ON, Canada; [Meredith, M. Alex] Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, Richmond, VA USA; [Kral, Andrej] Hannover Med Sch, Inst Audioneurotechnol, Dept Expt Otol, Hannover, Germany	Western University (University of Western Ontario); Virginia Commonwealth University; Hannover Medical School	Lomber, SG (corresponding author), Univ Western Ontario, Dept Psychol, Dept Physiol & Pharmacol, Ctr Brain & Mind, London, ON, Canada.	steve.lomber@uwo.ca	Lomber, Stephen/B-6820-2015	Lomber, Stephen/0000-0002-3001-7909; Kral, Andrej/0000-0002-7762-4642; Meredith, M Alex/0000-0002-8081-6901	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Deutsche Forschungsgemeinschaft; US National Institutes of Health	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. D. Corneil, M. A. Goodale, W. A. Roberts, D. F. Sherry, B. Timney and J. Snow for helpful discussions and comments on the project and manuscript. We thank A. J. McMillan and A. Carrasco for preparing all of the figures and for help with the preparation of the manuscript. We also thank A. J. McMillan for assistance with the fabrication of the cooling loops, surgical implantations and care of the animals. J. G. Mellott graciously assisted with the histological processing of the brains. We gratefully acknowledge the support of the Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Deutsche Forschungsgemeinschaft and the US National Institutes of Health.	Auer ET, 2007, NEUROREPORT, V18, P645, DOI 10.1097/WNR.0b013e3280d943b9; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Bavelier D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-17-j0001.2000; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Berkley M.A., 1970, ANIMAL PSYCHOPHYSICS, P231; Bosworth RG, 2002, BRAIN COGNITION, V49, P152, DOI 10.1006/brcg.2001.1497; BROSS M, 1979, PERCEPT MOTOR SKILL, V48, P187, DOI 10.2466/pms.1979.48.1.187; Brozinsky CJ, 2004, COGNITIVE BRAIN RES, V21, P1, DOI 10.1016/j.cogbrainres.2004.05.002; Carrasco A, 2009, J NEUROSCI, V29, P14323, DOI 10.1523/JNEUROSCI.2905-09.2009; Collignon O, 2009, EXP BRAIN RES, V192, P343, DOI 10.1007/s00221-008-1553-z; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; Finney EM, 2001, COGNITIVE BRAIN RES, V11, P171, DOI 10.1016/S0926-6410(00)00082-3; GUILLERY RW, 1981, INVEST OPHTH VIS SCI, V21, P27; HALL SE, 1991, BEHAV BRAIN RES, V44, P1, DOI 10.1016/S0166-4328(05)80233-5; He JF, 1997, J NEUROSCI, V17, P2615; Heid S, 1998, HEARING RES, V115, P101, DOI 10.1016/S0378-5955(97)00182-2; KNIGHT PL, 1977, BRAIN RES, V130, P447, DOI 10.1016/0006-8993(77)90108-1; Kral A, 2003, EXP BRAIN RES, V153, P605, DOI 10.1007/s00221-003-1609-z; Kral A, 2002, CEREB CORTEX, V12, P797, DOI 10.1093/cercor/12.8.797; Kral A, 2006, PROG BRAIN RES, V157, P283, DOI 10.1016/S0079-6123(06)57018-9; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; LEVICK WR, 1980, VISION RES, V20, P1001, DOI 10.1016/0042-6989(80)90083-8; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lomber SG, 1999, J NEUROSCI METH, V86, P179, DOI 10.1016/S0165-0270(98)00165-4; Lomber SG, 2001, PROG BRAIN RES, V134, P265; Lomber SG, 2001, VISUAL NEUROSCI, V18, P487, DOI 10.1017/S0952523801183148; Lomber SG, 2008, NAT NEUROSCI, V11, P609, DOI 10.1038/nn.2108; Malhotra S, 2008, J NEUROPHYSIOL, V99, P1628, DOI 10.1152/jn.01228.2007; Malhotra S, 2007, J NEUROPHYSIOL, V97, P26, DOI 10.1152/jn.00720.2006; Mellott JG, 2010, HEARING RES, V267, P119, DOI 10.1016/j.heares.2010.04.003; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; MIDDLEBROOKS JC, 1983, J NEUROSCI, V3, P203; NEVILLE HJ, 1987, BRAIN RES, V405, P268, DOI 10.1016/0006-8993(87)90296-4; Nishimura H, 1999, NATURE, V397, P116, DOI 10.1038/16376; PALMER LA, 1978, J COMP NEUROL, V177, P237, DOI 10.1002/cne.901770205; PASTERNAK T, 1980, J COMP PHYSIOL PSYCH, V94, P943, DOI 10.1037/h0077806; Petitto LA, 2000, P NATL ACAD SCI USA, V97, P13961, DOI 10.1073/pnas.97.25.13961; Ptito M, 2005, BRAIN, V128, P606, DOI 10.1093/brain/awh380; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; REYNOLDS HN, 1993, AM J PSYCHOL, V106, P523, DOI 10.2307/1422967; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Stecker GC, 2005, J NEUROPHYSIOL, V94, P1267, DOI 10.1152/jn.00104.2005; STEWART DL, 1970, EXP NEUROL, V28, P525, DOI 10.1016/0014-4886(70)90190-1; SUR M, 1988, SCIENCE, V242, P1437, DOI 10.1126/science.2462279; Voss P, 2008, NEUROIMAGE, V40, P746, DOI 10.1016/j.neuroimage.2007.12.020; Weeks R, 2000, J NEUROSCI, V20, P2664; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Yang XF, 2006, NEUROBIOL DIS, V23, P637, DOI 10.1016/j.nbd.2006.05.006	50	308	314	3	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1421	U163		10.1038/nn.2653	http://dx.doi.org/10.1038/nn.2653			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20935644				2022-12-17	WOS:000283658200024
J	Ortinski, PI; Dong, JH; Mungenast, A; Yue, CY; Takano, H; Watson, DJ; Haydon, PG; Coulter, DA				Ortinski, Pavel I.; Dong, Jinghui; Mungenast, Alison; Yue, Cuiyong; Takano, Hajime; Watson, Deborah J.; Haydon, Philip G.; Coulter, Douglas A.			Selective induction of astrocytic gliosis generates deficits in neuronal inhibition	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; NEUROTRANSMITTER GABA SYNTHESIS; GLUTAMATE-GLUTAMINE CYCLE; RAT HIPPOCAMPAL-NEURONS; SYNAPTIC-TRANSMISSION; NEUROLOGICAL DISORDERS; AREA CA1; BRAIN; SYNTHETASE; SUSCEPTIBILITY	Reactive astrocytosis develops in many neurologic diseases, including epilepsy. Astrocytotic contributions to pathophysiology are poorly understood. Studies examining this are confounded by comorbidities accompanying reactive astrocytosis. We found that high-titer transduction of astrocytes with enhanced green fluorescent protein (eGFP) via adeno-associated virus induced reactive astrocytosis without altering the intrinsic properties or anatomy of neighboring neurons. We examined the consequences of selective astrocytosis induction on synaptic transmission in mouse CA1 pyramidal neurons. Neurons near eGFP-labeled reactive astrocytes had reduced inhibitory, but not excitatory, synaptic currents. This inhibitory postsynaptic current (IPSC) erosion resulted from a failure of the astrocytic glutamate-glutamine cycle. Reactive astrocytes downregulated expression of glutamine synthetase. Blockade of this enzyme normally induces rapid synaptic GABA depletion. In astrocytotic regions, residual inhibition lost sensitivity to glutamine synthetase blockade, whereas exogenous glutamine administration enhanced IPSCs. Astrocytosis-mediated deficits in inhibition triggered glutamine-reversible hyperexcitability in hippocampal circuits. Thus, reactive astrocytosis could generate local synaptic perturbations, leading to broader functional deficits associated with neurologic disease.	[Ortinski, Pavel I.; Yue, Cuiyong; Takano, Hajime; Coulter, Douglas A.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Dong, Jinghui; Mungenast, Alison; Haydon, Philip G.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Watson, Deborah J.] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Coulter, Douglas A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Coulter, Douglas A.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Tufts University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Coulter, DA (corresponding author), Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA.	coulterd@email.chop.edu	Takano, Hajime/AAD-4589-2019; Ortinski, Pavel/N-7195-2017	Ortinski, Pavel/0000-0003-0814-4490; Coulter, Douglas/0000-0002-1486-119X; Takano, Hajime/0000-0003-3033-2412; Mungenast, Alison/0000-0003-1020-0471	US National Institutes of Health [P01 NS054900, P20 MH071705, P01NS054900, R01NS054770, R01NS037585, R01NS040978]; Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH071705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040978, R01NS054770, R01NS038572, P01NS054900, R01NS037585] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health grants P01 NS054900 and P20 MH071705 to D. A. C., P01NS054900, R01NS054770 and R01NS037585 to P. G. H., R01NS040978 to D. J.W. and by an Epilepsy Foundation Research Fellowship to P.I.O.	Ang CW, 2006, J NEUROSCI, V26, P11850, DOI 10.1523/JNEUROSCI.2354-06.2006; Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Barberis A, 2004, EUR J NEUROSCI, V20, P1803, DOI 10.1111/j.1460-9568.2004.03624.x; Binder DK, 2006, GLIA, V54, P358, DOI 10.1002/glia.20394; Burrone J, 2006, NAT PROTOC, V1, P2970, DOI 10.1038/nprot.2006.449; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cameron H.A., 2006, CURRENT PROTOCOLS NE; Chaudhry FA, 2002, J CELL BIOL, V157, P349, DOI 10.1083/jcb.200201070; Cohen AS, 2000, J NEUROPHYSIOL, V84, P2465, DOI 10.1152/jn.2000.84.5.2465; Reis RAD, 2008, NEUROCHEM RES, V33, P1466, DOI 10.1007/s11064-008-9604-1; Eid T, 2004, LANCET, V363, P28, DOI 10.1016/S0140-6736(03)15166-5; Eid T, 2008, EPILEPSIA, V49, P42, DOI 10.1111/j.1528-1167.2008.01492.x; Fricke MN, 2007, J NEUROCHEM, V102, P1895, DOI 10.1111/j.1471-4159.2007.04649.x; Galic MA, 2008, J NEUROSCI, V28, P6904, DOI 10.1523/JNEUROSCI.1901-08.2008; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Jakubs K, 2008, J NEUROSCI, V28, P12477, DOI 10.1523/JNEUROSCI.3240-08.2008; Kam K, 2007, J NEUROSCI, V27, P9192, DOI 10.1523/JNEUROSCI.1198-07.2007; Liang SL, 2006, J NEUROSCI, V26, P8537, DOI 10.1523/JNEUROSCI.0329-06.2006; Mozrzymas JW, 2007, J PHYSIOL-LONDON, V585, P29, DOI 10.1113/jphysiol.2007.143602; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Ortinski PI, 2004, J NEUROPHYSIOL, V92, P1718, DOI 10.1152/jn.00243.2004; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Robinson SR, 2001, J NEUROSCI RES, V66, P972, DOI 10.1002/jnr.10057; Rosati A, 2009, J NEURO-ONCOL, V93, P319, DOI 10.1007/s11060-008-9794-z; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Steffens M, 2005, NEUROCHEM INT, V47, P379, DOI 10.1016/j.neuint.2005.06.001; Sun HY, 2005, J PHYSIOL-LONDON, V568, P815, DOI 10.1113/jphysiol.2005.093948; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Tilleux S, 2007, J NEUROSCI RES, V85, P2059, DOI 10.1002/jnr.21325; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004	37	308	314	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					584	U93		10.1038/nn.2535	http://dx.doi.org/10.1038/nn.2535			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20418874	Green Accepted			2022-12-17	WOS:000277065700016
J	Buckner, RL; Kelley, WM; Petersen, SE				Buckner, RL; Kelley, WM; Petersen, SE			Frontal cortex contributes to human memory formation	NATURE NEUROSCIENCE			English	Review							MEDIAL TEMPORAL-LOBE; EPISODIC MEMORY; HIPPOCAMPAL-FORMATION; ALZHEIMERS-DISEASE; PREFRONTAL CORTEX; NONVERBAL MEMORY; FUNCTIONAL MRI; BRAIN ACTIVITY; RETRIEVAL; RECOGNITION	The contribution of medial temporal lobe structures to memory is well established. However recent brain-imaging studies have indicated that frontal cortex may also be involved in human memory formation. Specific frontal areas are recruited during a variety of procedures that promote memory formation, and the laterality of these areas is influenced by the type of information contained in the memory. Imaging methods that capture momentary changes in brain activity have further shown that the likelihood of memory formation correlates with the level of activity in these areas. These results, taken in the context of other studies, suggest that memory formation depends on joint participation of frontal and medial temporal lobe structures.	Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Washington Univ, Dept Radiol, St Louis, MO 63130 USA; Washington Univ, Dept Neurol, St Louis, MO 63130 USA; Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Buckner, RL (corresponding author), Washington Univ, Dept Psychol, Campus Box 1125,1 Brookings Dr, St Louis, MO 63130 USA.	rbuckner@artsci.wustl.edu	Petersen, Steve/ABF-1368-2020		NIMH NIH HHS [MH57506-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057506] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buckner RL, 1998, P NATL ACAD SCI USA, V95, P891, DOI 10.1073/pnas.95.3.891; Buckner RL, 1996, P NATL ACAD SCI USA, V93, P14878, DOI 10.1073/pnas.93.25.14878; BUCKNER RL, 1995, HDB NEUROPSYCHOLOGY, V10, P439; Cohen N.J., 1993, MEMORY AMNESIA HIPPO, DOI DOI 10.1136/JNNP.58.1.128-A; Cohen NJ, 1999, HIPPOCAMPUS, V9, P83, DOI 10.1002/(SICI)1098-1063(1999)9:1<83::AID-HIPO9>3.0.CO;2-7; CORKIN S, 1984, SEMIN NEUROL, V4, P249, DOI 10.1055/s-2008-1041556; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; DEMB JB, 1995, J NEUROSCI, V15, P5870; Dolan RJ, 1997, NATURE, V388, P582, DOI 10.1038/41561; FABIANI M, 1986, PSYCHOPHYSIOLOGY, V23, P298, DOI 10.1111/j.1469-8986.1986.tb00636.x; Fuster J.M., 1989, PREFRONTAL CORTEX; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; GAZZANIGA MS, 1983, ANN NEUROL, V13, P536, DOI 10.1002/ana.410130511; Goldman-Rakic PS, 1987, HDB PHYSL 1, V5, P373, DOI DOI 10.1002/CPHY.CP010509; GRADY CL, 1995, SCIENCE, V269, P218, DOI 10.1126/science.7618082; Haxby JV, 1996, P NATL ACAD SCI USA, V93, P922, DOI 10.1073/pnas.93.2.922; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Kapur S, 1996, COGNITIVE BRAIN RES, V4, P243, DOI 10.1016/S0926-6410(96)00058-4; KAPUR S, 1994, P NATL ACAD SCI USA, V91, P2008, DOI 10.1073/pnas.91.6.2008; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Kim SG, 1997, MAGNET RESON MED, V37, P631, DOI 10.1002/mrm.1910370427; Martin A, 1997, HIPPOCAMPUS, V7, P587, DOI 10.1002/(SICI)1098-1063(1997)7:6<587::AID-HIPO1>3.0.CO;2-C; MILNER B, 1972, NEUROPSYCHOLOGIA, V10, P1, DOI 10.1016/0028-3932(72)90038-3; MILNER B, 1985, HUM NEUROBIOL, V4, P137; MILNER B, 1982, PHILOS T R SOC B, V298, P211, DOI 10.1098/rstb.1982.0083; MOSCOVITCH M, 1992, J COGNITIVE NEUROSCI, V4, P257, DOI 10.1162/jocn.1992.4.3.257; Murray EA, 1996, SEMIN NEUROSCI, V8, P13, DOI 10.1006/smns.1996.0003; PAIVIO A, 1973, COGNITIVE PSYCHOL, V5, P176, DOI 10.1016/0010-0285(73)90032-7; Paivio A, 1986, MENTAL REPRESENTATIO; PALLER KA, 1990, J EXP PSYCHOL LEARN, V16, P1021, DOI 10.1037/0278-7393.16.6.1021; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; RIEGE WH, 1980, BRAIN LANG, V10, P60, DOI 10.1016/0093-934X(80)90038-3; Rugg M.D., 1995, OX PSYCH S, P133; SAMUEL W, 1994, NEUROLOGY, V44, P2081, DOI 10.1212/WNL.44.11.2081; Schacter D. L., 1994, MEMORY SYSTEMS 1994; SCHACTER DL, 1987, PSYCHOBIOLOGY, V15, P21; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; SHIMAMURA AP, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P173; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Stuss DT., 1986, FRONTAL LOBES; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Wagner AD, 1998, NEUROREPORT, V9, P3711, DOI 10.1097/00001756-199811160-00026; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; WHITEHOUSE PJ, 1981, BRAIN LANG, V14, P315, DOI 10.1016/0093-934X(81)90083-3; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	55	308	314	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					311	314		10.1038/7221	http://dx.doi.org/10.1038/7221			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	200GV	10204536				2022-12-17	WOS:000080532000008
J	Moussawi, K; Pacchioni, A; Moran, M; Olive, MF; Gass, JT; Lavin, A; Kalivas, PW				Moussawi, Khaled; Pacchioni, Alejandra; Moran, Megan; Olive, M. Foster; Gass, Justin T.; Lavin, Antonieta; Kalivas, Peter W.			N-Acetylcysteine reverses cocaine-induced metaplasticity	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; RAT NUCLEUS-ACCUMBENS; EXCITATORY SYNAPTIC-TRANSMISSION; LONG-TERM DEPRESSION; INDUCED DRUG-SEEKING; GROUP-II; PREFRONTAL CORTEX; IN-VIVO; BEHAVIORAL SENSITIZATION; HEROIN SEEKING	Cocaine addiction is characterized by an impaired ability to develop adaptive behaviors that can compete with cocaine seeking, implying a deficit in the ability to induce plasticity in cortico-accumbens circuitry crucial for regulating motivated behavior. We found that rats withdrawn from cocaine self-administration had a marked in vivo deficit in the ability to develop long-term potentiation (LTP) and long-term depression (LTD) in the nucleus accumbens core subregion after stimulation of the prefrontal cortex. N-acetylcysteine (NAC) treatment prevents relapse in animal models and craving in humans by activating cystine-glutamate exchange and thereby stimulating extrasynaptic metabotropic glutamate receptors (mGluR). NAC treatment of rats restored the ability to induce LTP and LTD by indirectly stimulating mGluR2/3 and mGluR5, respectively. Our findings show that cocaine self-administration induces metaplasticity that inhibits further induction of synaptic plasticity, and this impairment can be reversed by NAC, a drug that also prevents relapse.	[Moussawi, Khaled; Pacchioni, Alejandra; Moran, Megan; Lavin, Antonieta; Kalivas, Peter W.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Olive, M. Foster; Gass, Justin T.] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Kalivas, PW (corresponding author), Med Univ S Carolina, Dept Neurosci, 173 Ashley Ave BSB410, Charleston, SC 29425 USA.	kalivasp@musc.edu	Moussawi, Khaled/AGZ-6981-2022; Pacchioni, Alejandra/AAP-5594-2020	Pacchioni, Alejandra/0000-0002-1665-6157; Olive, Foster/0000-0002-2517-0351; Moussawi, Khaled/0000-0001-6378-0428	US Public Health Service [DA03906, DA12513, DA015369, DA024355]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024355, R37DA003906, P50DA015369, R01DA003906, R01DA012513] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank F. Thiels (University of Pittsburgh) for invaluable advice on field recording. This research was supported by US Public Health Service grants DA03906, DA12513, DA015369 and DA024355.	Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Backstrom P, 2006, NEUROPSYCHOPHARMACOL, V31, P778, DOI 10.1038/sj.npp.1300845; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Bamford NS, 2008, NEURON, V58, P89, DOI 10.1016/j.neuron.2008.01.033; Baptista MAS, 2004, J NEUROSCI, V24, P4723, DOI 10.1523/JNEUROSCI.0176-04.2004; Bossert JM, 2006, NEUROPSYCHOPHARMACOL, V31, P2197, DOI 10.1038/sj.npp.1300977; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Chiamulera C, 2001, NAT NEUROSCI, V4, P873, DOI 10.1038/nn0901-873; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; De Roo M, 2008, PROG BRAIN RES, V169, P199, DOI 10.1016/S0079-6123(07)00011-8; Finch DM, 1996, HIPPOCAMPUS, V6, P495; Fourgeaud L, 2004, J NEUROSCI, V24, P6939, DOI 10.1523/JNEUROSCI.0671-04.2004; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Goto Y, 2005, NEURON, V47, P255, DOI 10.1016/j.neuron.2005.06.017; Grover LM, 1999, J NEUROPHYSIOL, V82, P2956, DOI 10.1152/jn.1999.82.6.2956; Grueter BA, 2005, NEUROPSYCHOPHARMACOL, V30, P1302, DOI 10.1038/sj.npp.1300672; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; Kau KS, 2008, NEUROSCIENCE, V155, P530, DOI 10.1016/j.neuroscience.2008.06.010; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; LaLumiere RT, 2008, J NEUROSCI, V28, P3170, DOI 10.1523/JNEUROSCI.5129-07.2008; LaRowe SD, 2007, AM J PSYCHIAT, V164, P1115, DOI 10.1176/appi.ajp.164.7.1115; Lavin A, 2005, J NEUROSCI, V25, P5013, DOI 10.1523/JNEUROSCI.0557-05.2005; Lindsley CW, 2004, J MED CHEM, V47, P5825, DOI 10.1021/jm049400d; Losonczy A, 2003, J NEUROPHYSIOL, V89, P1910, DOI 10.1152/jn.00842.2002; Madayag A, 2007, J NEUROSCI, V27, P13968, DOI 10.1523/JNEUROSCI.2808-07.2007; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin M, 2006, NAT NEUROSCI, V9, P868, DOI 10.1038/nn1713; McFarland K, 2003, J NEUROSCI, V23, P3531; McGeehan AJ, 2003, SYNAPSE, V47, P240, DOI 10.1002/syn.10166; Mendelson JH, 1996, NEW ENGL J MED, V334, P965, DOI 10.1056/NEJM199604113341507; Mitrano DA, 2007, J COMP NEUROL, V500, P788, DOI 10.1002/cne.21214; Montaron MF, 1996, NEUROSCIENCE, V71, P371, DOI 10.1016/0306-4522(95)00455-6; Moran MM, 2005, J NEUROSCI, V25, P6389, DOI 10.1523/JNEUROSCI.1007-05.2005; Nicola SM, 1996, J NEUROSCI, V16, P1591; PENNARTZ CMA, 1990, BRAIN RES, V529, P30, DOI 10.1016/0006-8993(90)90808-O; PENNARTZ CMA, 1993, EUR J NEUROSCI, V5, P107, DOI 10.1111/j.1460-9568.1993.tb00475.x; Peters J, 2006, PSYCHOPHARMACOLOGY, V186, P143, DOI 10.1007/s00213-006-0372-9; Pierce RC, 1996, J NEUROSCI, V16, P1550; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Robinson R, 2004, HIGH EDUC, V47, P1, DOI 10.1023/B:HIGH.0000009803.70418.9c; Rozas C, 2001, J NEUROSCI, V21, P6791, DOI 10.1523/JNEUROSCI.21-17-06791.2001; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Suto N, 2003, NEUROPSYCHOPHARMACOL, V28, P629, DOI 10.1038/sj.npp.1300075; Toda S, 2006, J NEUROSCI, V26, P1579, DOI 10.1523/JNEUROSCI.4132-05.2006; van Dongen YC, 2008, BRAIN STRUCT FUNCT, V213, P129, DOI 10.1007/s00429-008-0173-5; West AR, 2002, J PHARMACOL EXP THER, V301, P867, DOI 10.1124/jpet.301.3.867; Wu JQ, 2004, NEUROPHARMACOLOGY, V46, P311, DOI 10.1016/j.neuropharm.2003.09.014; Yin HH, 2006, BEHAV BRAIN RES, V166, P189, DOI 10.1016/j.bbr.2005.07.012; Zhou WH, 2008, BIOL PSYCHIAT, V63, P338, DOI 10.1016/j.biopsych.2007.06.008	50	307	310	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2009	12	2					182	189		10.1038/nn.2250	http://dx.doi.org/10.1038/nn.2250			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	404VV	19136971	Green Accepted			2022-12-17	WOS:000263182000019
J	Wang, Y; Markram, H; Goodman, PH; Berger, TK; Ma, JY; Goldman-Rakic, PS				Wang, Y; Markram, H; Goodman, PH; Berger, TK; Ma, JY; Goldman-Rakic, PS			Heterogeneity in the pyramidal network of the medial prefrontal cortex	NATURE NEUROSCIENCE			English	Article							SHORT-TERM PLASTICITY; IN-VITRO; PERSISTENT ACTIVITY; SYNAPTIC-TRANSMISSION; EXCITATORY SYNAPSES; WORKING-MEMORY; VISUAL-CORTEX; RAT NEOCORTEX; PAIRED-PULSE; FRONTAL-LOBE	The prefrontal cortex is specially adapted to generate persistent activity that outlasts stimuli and is resistant to distractors, presumed to be the basis of working memory. The pyramidal network that supports this activity is unknown. Multineuron patch-clamp recordings in the ferret medial prefrontal cortex showed a heterogeneity of synapses interconnecting distinct subnetworks of different pyramidal cells. One subnetwork was similar to the pyramidal network commonly found in primary sensory areas, consisting of accommodating pyramidal cells interconnected with depressing synapses. The other subnetwork contained complex pyramidal cells with dual apical dendrites displaying nonaccommodating discharge patterns; these cells were hyper-reciprocally connected with facilitating synapses displaying pronounced synaptic augmentation and post-tetanic potentiation. These cellular, synaptic and network properties could amplify recurrent interactions between pyramidal neurons and support persistent activity in the prefrontal cortex.	Tufts Univ, Caritas St Elizabeths Med Ctr, Div Neurol Res, Boston, MA 02135 USA; Ecole Polytech Fed Lausanne, Brain & Mind Inst, CH-1015 Lausanne, Switzerland; Univ Nevada, Dept Internal Med, Reno, NV 89557 USA; Univ Nevada, Biomed Engn Program, Reno, NV 89557 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	St. Elizabeth's Medical Center; Tufts University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Yale University	Wang, Y (corresponding author), Tufts Univ, Caritas St Elizabeths Med Ctr, Div Neurol Res, Boston, MA 02135 USA.	yun.wang@tufts.edu						Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Douglas RJ, 1996, J NEUROCYTOL, V25, P893, DOI 10.1007/BF02284849; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Elston GN, 2003, CEREB CORTEX, V13, P1124, DOI 10.1093/cercor/bhg093; Fisher SA, 1997, TRENDS NEUROSCI, V20, P170, DOI 10.1016/S0166-2236(96)01001-6; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gao WJ, 2001, P NATL ACAD SCI USA, V98, P295, DOI 10.1073/pnas.011524298; GIGUERE M, 1988, J COMP NEUROL, V277, P195, DOI 10.1002/cne.902770204; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GoldmanRakic PS, 1995, ANN NY ACAD SCI, V769, P71, DOI 10.1111/j.1749-6632.1995.tb38132.x; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hempel CM, 2000, J NEUROPHYSIOL, V83, P3031, DOI 10.1152/jn.2000.83.5.3031; Kalisman N, 2005, P NATL ACAD SCI USA, V102, P880, DOI 10.1073/pnas.0407088102; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 1999, P NATL ACAD SCI USA, V96, P14600, DOI 10.1073/pnas.96.25.14600; Magee JC, 1998, J NEUROSCI, V18, P7613; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Markram H, 1997, CEREB CORTEX, V7, P523, DOI 10.1093/cercor/7.6.523; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MASON A, 1991, J NEUROSCI, V11, P72; McCormick DA, 2001, NAT NEUROSCI, V4, P113, DOI 10.1038/83917; Mercer A, 2005, CEREB CORTEX, V15, P1485, DOI 10.1093/cercor/bhi027; Miller EK, 1996, J NEUROSCI, V16, P5154; Mongillo G, 2003, EUR J NEUROSCI, V18, P2011, DOI 10.1046/j.1460-9568.2003.02908.x; Reyes A, 1999, J NEUROSCI, V19, P3827; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rhodes PA, 2001, J PHYSIOL-LONDON, V536, P167, DOI 10.1111/j.1469-7793.2001.00167.x; Tarczy-Hornoch K, 1999, CEREB CORTEX, V9, P833, DOI 10.1093/cercor/9.8.833; THOMSON AM, 1993, NEUROSCIENCE, V54, P347, DOI 10.1016/0306-4522(93)90257-G; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Varela JA, 1997, J NEUROSCI, V17, P7926; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; WEST DC, CEREB CORTEX, V16, P200; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	44	307	308	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					534	542		10.1038/nn1670	http://dx.doi.org/10.1038/nn1670			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16547512				2022-12-17	WOS:000236310700021
J	Woods, C; Montcouquiol, M; Kelley, MW				Woods, C; Montcouquiol, M; Kelley, MW			Math1 regulates development of the sensory epithelium in the mammalian cochlea	NATURE NEUROSCIENCE			English	Article							HAIR CELL-DIFFERENTIATION; INNER-EAR DEVELOPMENT; MIND-BOMB MUTANT; GAMMA-SECRETASE; ORGAN DEVELOPMENT; EXPRESSION; NOTCH; ZEBRAFISH; CORTI; PROTEINS	The transcription factor Math1 (encoded by the gene Atoh1, also called Math1) is required for the formation of mechanosensory hair cells in the inner ear; however, its specific molecular role is unknown. Here we show that absence of Math1 in mice results in a complete disruption of formation of the sensory epithelium of the cochlea, including the development of both hair cells and associated supporting cells. In addition, ectopic expression of Math1 in nonsensory regions of the cochlea is sufficient to induce the formation of sensory clusters that contain both hair cells and supporting cells. The formation of these clusters is dependent on inhibitory interactions mediated, most probably, through the Notch pathway, and on inductive interactions that recruit cells to develop as supporting cells through a pathway independent of Math1. These results show that Math1 functions in the developing cochlea to initiate both inductive and inhibitory signals that regulate the overall formation of the sensory epithelia.	NIDCD, Sect Dev Neurosci, NIH, Porter Neurosci Res Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Kelley, MW (corresponding author), NIDCD, Sect Dev Neurosci, NIH, Porter Neurosci Res Ctr, Bldg 35, Bethesda, MD 20892 USA.	kelleymt@nidcd.nih.gov	montcouquiol, mireille/L-6199-2017	montcouquiol, mireille/0000-0001-8739-6519	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000059, Z01DC000059] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adam J, 1998, DEVELOPMENT, V125, P4645; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bianchi LM, 1999, ANAT RECORD, V256, P64, DOI 10.1002/(SICI)1097-0185(19990901)256:1<64::AID-AR8>3.0.CO;2-H; Bryant J, 2002, BRIT MED BULL, V63, P39, DOI 10.1093/bmb/63.1.39; CernudaCernuda R, 1996, MICROSC RES TECHNIQ, V34, P302, DOI 10.1002/(SICI)1097-0029(19960701)34:4<302::AID-JEMT3>3.0.CO;2-Q; Chen P, 2002, DEVELOPMENT, V129, P2495; Chen P, 1999, DEVELOPMENT, V126, P1581; Cheng HT, 2003, DEVELOPMENT, V130, P5031, DOI 10.1242/dev.00697; Cole LK, 2000, J COMP NEUROL, V424, P509, DOI 10.1002/1096-9861(20000828)424:3<509::AID-CNE8>3.0.CO;2-Q; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Coppens AG, 2001, DEV BRAIN RES, V126, P191, DOI 10.1016/S0165-3806(00)00153-X; CORWIN JT, 1991, CIBA F SYMP, V160, P103; El-Amraoui A, 2001, HEARING RES, V158, P151, DOI 10.1016/S0378-5955(01)00312-4; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; GOODYEAR R, 1995, J COMP NEUROL, V351, P81, DOI 10.1002/cne.903510108; Haddon C, 1999, J NEUROCYTOL, V28, P837, DOI 10.1023/A:1007013904913; Haddon C, 1998, DEVELOPMENT, V125, P4637; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Helms AW, 2000, DEVELOPMENT, V127, P1185; KELLEY MW, 1995, J NEUROSCI, V15, P3013; Kelley MW, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P137; KELLEY MW, 1993, DEVELOPMENT, V119, P1041; Kimberly WT, 2003, J NEUROSCI RES, V74, P353, DOI 10.1002/jnr.10736; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Lanford RJ, 2000, JARO-J ASSOC RES OTO, V1, P161, DOI 10.1007/sl01620010023; LEWIS J, 1991, CIBA F SYMP, V160, P25, DOI 10.4171/RMI/104; Lin MH, 2003, DEV BIOL, V263, P343, DOI 10.1016/j.ydbio.2003.07.007; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; MATTIONI T, 1994, METHOD CELL BIOL, V43, P335; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; Montcouquiol M, 2003, J NEUROSCI, V23, P9469; Morrow M, 2001, J AM COLL SURGEONS, V192, P1, DOI 10.1016/S1072-7515(00)00747-X; Morsli H, 1998, J NEUROSCI, V18, P3327; Mueller KL, 2002, J NEUROSCI, V22, P9368; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; Picard Didier, 1994, Current Opinion in Biotechnology, V5, P511, DOI 10.1016/0958-1669(94)90066-3; Rau A, 1999, J COMP NEUROL, V405, P271; Riley BB, 1999, DEVELOPMENT, V126, P5669; Rio C, 2002, J COMP NEUROL, V442, P156, DOI 10.1002/cne.10085; Rubel EW, 1978, HDB SENSORY PHYSL, VIX, P135, DOI [10.1007/978-3-642-66880-7_5, DOI 10.1007/978-3-642-66880-7_5]; Shailam R, 1999, J NEUROCYTOL, V28, P809, DOI 10.1023/A:1007009803095; VONBARTHELD CS, 1991, DEVELOPMENT, V113, P455; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zheng JL, 2000, DEVELOPMENT, V127, P4551; Zine A, 2000, DEVELOPMENT, V127, P3373; Zine A, 2001, J NEUROSCI, V21, P4712, DOI 10.1523/JNEUROSCI.21-13-04712.2001	46	307	329	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1310	1318		10.1038/nn1349	http://dx.doi.org/10.1038/nn1349			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15543141				2022-12-17	WOS:000225353900011
J	Schwamborn, JC; Puschel, AW				Schwamborn, JC; Puschel, AW			The sequential activity of the GTPases Rap1B and Cdc42 determines neuronal polarity	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL-NEURONS; CELL POLARITY; RHO-GTPASES; ESTABLISHMENT; GROWTH; AXON; RAC; NEURITOGENESIS; BREAKING; PROTEIN	The establishment of a polarized morphology is an essential step in the differentiation of neurons with a single axon and multiple dendrites. In cultured rat hippocampal neurons, one of several initially indistinguishable neurites is selected to become the axon. Both phosphatidylinositol 3,4,5-trisphosphate and the evolutionarily conserved Par complex ( comprising Par3, Par6 and an atypical PKC (aPKC) such as PKClambda or PKCzeta) are involved in axon specification. However, the initial signals that establish cellular asymmetry and the pathways that subsequently translate it into structural changes remain to be elucidated. Here we show that localization of the GTPase Rap1B to the tip of a single neurite is a decisive step in determining which neurite becomes the axon. Using GTPase mutants and RNA interference, we found that Rap1B is necessary and sufficient to initiate the development of axons upstream of Cdc42 and the Par complex.	Univ Munster, Inst Allgemeine Zool & Genet, Mol Biol Abt, D-48149 Munster, Germany	University of Munster	Puschel, AW (corresponding author), Univ Munster, Inst Allgemeine Zool & Genet, Mol Biol Abt, Schlosspl 5, D-48149 Munster, Germany.	apuschel@uni-muenster.de	Schwamborn, Jens C/F-9395-2011	Schwamborn, Jens C/0000-0003-4496-0559				Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; Bradke F, 2000, CURR BIOL, V10, P1467, DOI 10.1016/S0960-9822(00)00807-1; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Caron E, 2003, J CELL SCI, V116, P435, DOI 10.1242/jcs.00238; Caviston JP, 2002, P NATL ACAD SCI USA, V99, P12185, DOI 10.1073/pnas.182370299; Chant T, 1999, ANNU REV CELL DEV BI, V15, P365, DOI 10.1146/annurev.cellbio.15.1.365; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Park HO, 2002, J BIOL CHEM, V277, P26721, DOI 10.1074/jbc.C200245200; Pruyne D, 2000, J CELL SCI, V113, P365; Rolls MM, 2003, NATURE, V421, P905, DOI 10.1038/421905a; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Sohrmann M, 2003, TRENDS CELL BIOL, V13, P526, DOI 10.1016/j.tcb.2003.08.006; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Tsygankova OM, 2001, MOL CELL BIOL, V21, P1921, DOI 10.1128/MCB.21.6.1921-1929.2001; Tu SS, 2002, BIOCHEMISTRY-US, V41, P12350, DOI 10.1021/bi026167h; Washbourne P, 2002, CURR OPIN NEUROBIOL, V12, P566, DOI 10.1016/S0959-4388(02)00365-3; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x	37	307	312	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					923	929		10.1038/nn1295	http://dx.doi.org/10.1038/nn1295			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15286792				2022-12-17	WOS:000223546700010
J	Grundemann, D; Schechinger, B; Rappold, GA; Schomig, E				Grundemann, D; Schechinger, B; Rappold, GA; Schomig, E			Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter	NATURE NEUROSCIENCE			English	Article							NORADRENALINE; CELLS; EXPRESSION; GENE; RAT		Univ Heidelberg, Dept Pharmacol, D-69120 Heidelberg, Germany; Univ Heidelberg, Dept Human Genet, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Schomig, E (corresponding author), Univ Heidelberg, Dept Pharmacol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.		Gründemann, Dirk/AAD-2217-2022					Borowsky B, 1995, INT REV NEUROBIOL, V38, P139, DOI 10.1016/S0074-7742(08)60526-7; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; Eisenhofer G, 1996, N-S ARCH PHARMACOL, V354, P287; Grundemann D, 1997, J BIOL CHEM, V272, P10408; IVERSEN LL, 1965, BRIT J PHARM CHEMOTH, V25, P18, DOI 10.1111/j.1476-5381.1965.tb01753.x; IVERSEN LL, 1965, BRIT J PHARM CHEMOTH, V24, P387, DOI 10.1111/j.1476-5381.1965.tb01726.x; KARHUNEN T, 1994, J HISTOCHEM CYTOCHEM, V42, P1079, DOI 10.1177/42.8.8027527; LUO DF, 1995, AM J HUM GENET, V57, P911; MARK A, 1996, J HYPERTENS, V14, P159; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; Russ H, 1996, EUR J NEUROSCI, V8, P1256, DOI 10.1111/j.1460-9568.1996.tb01294.x; Schomig E, 1998, FEBS LETT, V425, P79, DOI 10.1016/S0014-5793(98)00203-8; SCHOMIG E, 1990, N-S ARCH PHARMACOL, V341, P404; SCHULTEIS G, 1994, NATURE, V371, P108, DOI 10.1038/371108a0; Trendelenburg U, 1988, HDB EXP PHARM, P279	15	307	313	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					349	351		10.1038/1557	http://dx.doi.org/10.1038/1557			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QE	10196521				2022-12-17	WOS:000076361400009
J	Johnson, JO; Pioro, EP; Boehringer, A; Chia, R; Feit, H; Renton, AE; Pliner, HA; Abramzon, Y; Marangi, G; Winborn, BJ; Gibbs, JR; Nalls, MA; Morgan, S; Shoai, M; Hardy, J; Pittman, A; Orrell, RW; Malaspina, A; Sidle, KC; Fratta, P; Harms, MB; Baloh, RH; Pestronk, A; Weihl, CC; Rogaeva, E; Zinman, L; Drory, VE; Borghero, G; Mora, G; Calvo, A; Rothstein, JD; Drepper, C; Sendtner, M; Singleton, AB; Taylor, JP; Cookson, MR; Restagno, G; Sabatelli, M; Bowser, R; Chio, A; Traynor, BJ				Johnson, Janel O.; Pioro, Erik P.; Boehringer, Ashley; Chia, Ruth; Feit, Howard; Renton, Alan E.; Pliner, Hannah A.; Abramzon, Yevgeniya; Marangi, Giuseppe; Winborn, Brett J.; Gibbs, J. Raphael; Nalls, Michael A.; Morgan, Sarah; Shoai, Maryam; Hardy, John; Pittman, Alan; Orrell, Richard W.; Malaspina, Andrea; Sidle, Katie C.; Fratta, Pietro; Harms, Matthew B.; Baloh, Robert H.; Pestronk, Alan; Weihl, Conrad C.; Rogaeva, Ekaterina; Zinman, Lorne; Drory, Vivian E.; Borghero, Giuseppe; Mora, Gabriele; Calvo, Andrea; Rothstein, Jeffrey D.; Drepper, Carsten; Sendtner, Michael; Singleton, Andrew B.; Taylor, J. Paul; Cookson, Mark R.; Restagno, Gabriella; Sabatelli, Mario; Bowser, Robert; Chio, Adriano; Traynor, Bryan J.		ITALSGEN	Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis	NATURE NEUROSCIENCE			English	Article							DOMINANT DISTAL MYOPATHY; NUCLEAR-MATRIX; PROTEIN; ALS; COMPLEXES	MATR3 is an RNA- and DNA-binding protein that interacts with TDP-43, a disease protein linked to amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. Using exome sequencing, we identified mutations in MATR3 in ALS kindreds. We also observed MATR3 pathology in ALS-affected spinal cords with and without MATR3 mutations. Our data provide more evidence supporting the role of aberrant RNA processing in motor neuron degeneration.	[Johnson, Janel O.; Renton, Alan E.; Pliner, Hannah A.; Abramzon, Yevgeniya; Marangi, Giuseppe; Traynor, Bryan J.] NIA, Neuromuscular Dis Res Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Pioro, Erik P.] Cleveland Clin, Neurol Inst, Neuromuscular Ctr, Dept Neurol, Cleveland, OH 44106 USA; [Boehringer, Ashley; Bowser, Robert] Barrow Neurol Inst, Div Neurol, Phoenix, AZ 85013 USA; [Chia, Ruth; Cookson, Mark R.] NIA, Cell Biol & Gene Express Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Feit, Howard] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Marangi, Giuseppe] Univ Cattolica Sacro Cuore, Inst Med Genet, I-00168 Rome, Italy; [Winborn, Brett J.; Taylor, J. Paul] St Jude Childrens Res Hosp, Dept Cell & Mol Biol, Memphis, TN 38105 USA; [Gibbs, J. Raphael] NIA, Computat Biol Core, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Gibbs, J. Raphael; Morgan, Sarah; Shoai, Maryam; Hardy, John; Pittman, Alan] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Gibbs, J. Raphael; Morgan, Sarah; Shoai, Maryam; Hardy, John; Pittman, Alan] UCL, Inst Neurol, Reta Lila Weston Labs, London, England; [Nalls, Michael A.; Singleton, Andrew B.] NIA, Mol Genet Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Orrell, Richard W.] UCL, Inst Neurol, Dept Clin Neurosci, London, England; [Malaspina, Andrea] Queen Mary Univ London, North East London & Essex Reg Motor Neuron Dis Ca, Blizard Inst, Ctr Neurosci & Trauma, London, England; [Fratta, Pietro] UCL, Dept Neurodegenerat Dis, London, England; [Harms, Matthew B.; Pestronk, Alan; Weihl, Conrad C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Baloh, Robert H.] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA; [Rogaeva, Ekaterina] Univ Toronto, Dept Med, Div Neurol, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Zinman, Lorne] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Internal Med, Div Neurol, Toronto, ON, Canada; [Drory, Vivian E.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, IL-69978 Tel Aviv, Israel; [Borghero, Giuseppe] Azienda Univ Osped Cagliari, Dept Neurol, Cagliari, Italy; [Borghero, Giuseppe] Univ Cagliari, Cagliari, Italy; [Mora, Gabriele] Salvatore Maugeri Fdn, ALS Ctr, Milan, Italy; [Calvo, Andrea; Chio, Adriano] Univ Turin, Rita Levi Montalcini Dept Neurosci, Turin, Italy; [Rothstein, Jeffrey D.; Traynor, Bryan J.] Johns Hopkins Univ, Dept Neurol, Brain Sci Inst, Baltimore, MD 21218 USA; [Drepper, Carsten; Sendtner, Michael] Univ Wurzburg, Inst Clin Neurobiol, D-97070 Wurzburg, Germany; [Drepper, Carsten] Univ Wurzburg, Dept Child & Adolescent Psychiat, D-97070 Wurzburg, Germany; [Restagno, Gabriella] Azienda Sanit Osped Osped Infantile Regina Marghe, Dept Clin Pathol, Mol Genet Unit, Turin, Italy; [Sabatelli, Mario] Catholic Univ, Neurol Inst, Rome, Italy; [Sabatelli, Mario] Insieme Contro Malattie Motoneurone Assoc ALS Res, Rome, Italy	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Cleveland Clinic Foundation; Barrow Neurological Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Henry Ford Health System; Henry Ford Hospital; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; University of London; Queen Mary University London; University of London; University College London; Washington University (WUSTL); Cedars Sinai Medical Center; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of Cagliari; Azienda Ospedaliero-Universitaria di Cagliari; University of Cagliari; Istituti Clinici Scientifici Maugeri IRCCS; University of Turin; Johns Hopkins University; University of Wurzburg; University of Wurzburg; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Traynor, BJ (corresponding author), NIA, Neuromuscular Dis Res Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	traynorb@mail.nih.gov	Mandrioli, Jessica/K-7235-2016; Sendtner, Michael/J-1542-2012; QUATTRONE, Aldo/A-6734-2016; Chio, Adriano/K-3425-2016; Gibbs, J. Raphael/A-3984-2010; Sander-Effron, Samuel/AAX-2231-2020; Spataro, Rossella/B-3656-2016; Battistini, Stefania/N-2596-2015; Morgan, Sarah/E-9782-2013; LOGROSCINO, GIANCARLO/K-5148-2016; Mora, Gabriele/Z-2346-2019; Drepper, Carsten/GSN-2009-2022; Hardy, John/C-2451-2009; lauria, giuseppe/AAN-5371-2020; Pittman, Alan M/D-6231-2012; Ricci, Claudia/I-8202-2018; Resource Center, NINDS Human Genetics/AGF-2474-2022; Sendtner, Michael/M-8137-2014; Mancardi, Giovanni Luigi/K-8656-2016; Singleton, Andrew B/C-3010-2009; Pittman, Alan/AAP-2534-2020; Taylor, J. Paul/N-2482-2018; Chia, Ruth/AAF-4900-2021; Aktipi, Kalliopi Marinou/AAB-8246-2020; Gambardella, Antonio/F-5295-2012; Pioro, Erik P/AAZ-5318-2020; Lunetta, Christian/K-9214-2016; CALVO, Andrea/K-4141-2016; Colletti, Tiziana/K-2195-2018; Floris, Gianluca/AAD-2113-2022; Fratta, Pietro/G-1296-2019; Cookson, Mark/AAW-2516-2021; Luigetti, Marco ML/J-2782-2018; caponnetto, claudia/K-3728-2018; Pliner, Hannah Andersen/F-3608-2015; Marangi, Giuseppe/K-5341-2016; Conforti, Francesca Luisa/K-8877-2016	Mandrioli, Jessica/0000-0002-9244-9782; Sendtner, Michael/0000-0002-4737-2974; QUATTRONE, Aldo/0000-0003-2001-957X; Chio, Adriano/0000-0001-9579-5341; Gibbs, J. Raphael/0000-0002-6985-0658; Spataro, Rossella/0000-0002-8910-3131; Battistini, Stefania/0000-0003-2887-7624; Morgan, Sarah/0000-0002-1734-4710; LOGROSCINO, GIANCARLO/0000-0003-0423-3242; Mora, Gabriele/0000-0002-8388-2373; Hardy, John/0000-0002-3122-0423; lauria, giuseppe/0000-0001-9773-020X; Pittman, Alan M/0000-0002-8112-2987; Ricci, Claudia/0000-0002-2431-0308; Sendtner, Michael/0000-0002-4737-2974; Mancardi, Giovanni Luigi/0000-0001-8427-118X; Pittman, Alan/0000-0002-8112-2987; Taylor, J. Paul/0000-0002-5794-0349; Chia, Ruth/0000-0002-4709-7423; Aktipi, Kalliopi Marinou/0000-0003-3384-0367; Gambardella, Antonio/0000-0001-7384-3074; Pioro, Erik P/0000-0002-0737-6065; Lunetta, Christian/0000-0002-4788-1875; CALVO, Andrea/0000-0002-5122-7243; Fratta, Pietro/0000-0002-8762-8188; Cookson, Mark/0000-0002-1058-3831; Luigetti, Marco ML/0000-0001-7539-505X; Zollino, Marcella/0000-0003-4871-9519; Lattante, Serena/0000-0003-2891-0340; Renton, Alan E./0000-0001-6702-8268; caponnetto, claudia/0000-0002-5547-3900; Pugliatti, Maura/0000-0001-9396-8683; Colletti, Tiziana/0000-0001-5620-0747; Solinas, Giuliana/0000-0003-2174-0983; Drepper, Carsten/0000-0002-7883-6479; fratta, pietro/0000-0002-7554-1632; Pliner, Hannah Andersen/0000-0003-1484-6501; Simone, Isabella Laura/0000-0002-7429-3091; Shoai, Maryam/0000-0003-2499-8533; Sabatelli, Mario/0000-0001-6635-4985; Marangi, Giuseppe/0000-0002-6898-8882; Conforti, Francesca Luisa/0000-0001-8364-1783; Traynor, Bryan/0000-0003-0527-2446; FLORIS, Gianluca/0000-0001-8821-123X	Intramural Research Programs of the US National Institutes of Health (NIH); National Institute on Aging [Z01-AG000949-02]; NINDS; Packard Center for ALS Research at Johns Hopkins; ALS Association; Ontario Research Fund; UK MND Association [11/6075]; Medical Research Council (MRC) UK; Wellcome Trust/MRC Joint Call in Neurodegeneration Award [WT089698]; MRC Neuromuscular Centre; UK National Institute for Health Research Biomedical Research Unit; Biomedical Research Centre; MRC/Motor Neuron Disease Association Lady Edith Wolfson fellowship; AriSLA-Italian Research Foundation for Amyotrophic Lateral Sclerosis; Italian Health Ministry; Fondazione Vialli e Mauro Onlus; Federazione Italiana Giuoco Calcio; Compagnia di San Paolo; European Community [259867]; EuroMOTOR; German Federal Ministry of Education and Research (BMBF); German Network for Motoneuron Disease [TP4]; NIH [NS061867]; Adelis Foundation; MRC [G1000287, MC_G1000735] Funding Source: UKRI; Medical Research Council [MC_G1000735, G1000287] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061867, R56NS061867, R01NS085207, K08NS075094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000933, Z01AG000949, ZIAAG000947, ZIAAG000958, K02AG042095] Funding Source: NIH RePORTER	Intramural Research Programs of the US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Packard Center for ALS Research at Johns Hopkins; ALS Association; Ontario Research Fund; UK MND Association; Medical Research Council (MRC) UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust/MRC Joint Call in Neurodegeneration Award(Wellcome TrustUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Neuromuscular Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute for Health Research Biomedical Research Unit; Biomedical Research Centre; MRC/Motor Neuron Disease Association Lady Edith Wolfson fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AriSLA-Italian Research Foundation for Amyotrophic Lateral Sclerosis; Italian Health Ministry(Ministry of Health, Italy); Fondazione Vialli e Mauro Onlus; Federazione Italiana Giuoco Calcio; Compagnia di San Paolo(Compagnia di San Paolo); European Community(European Commission); EuroMOTOR; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Network for Motoneuron Disease; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Adelis Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	DNA samples for this study were obtained in part from the National Institute of Neurological Disorders and Stroke (NINDS) repository at the Coriell Cell Repositories (http://www. coriell. org/). We thank the patients and research subjects who contributed samples for this study. This work was supported in part by the Intramural Research Programs of the US National Institutes of Health (NIH), National Institute on Aging (Z01-AG000949-02) and NINDS. The work was also supported by the Packard Center for ALS Research at Johns Hopkins (B.J.T.), ALS Association (B.J.T., A. Chio), Ontario Research Fund (E.R.), UK MND Association (J. H., R.W.O. grant 11/6075), Medical Research Council (MRC) UK (J. H.), Wellcome Trust/MRC Joint Call in Neurodegeneration Award (J. H., grant WT089698), MRC Neuromuscular Centre (J.H.), UK National Institute for Health Research Biomedical Research Unit (J.H.), Biomedical Research Centre (A. Pittman), MRC/Motor Neuron Disease Association Lady Edith Wolfson fellowship (P.F.), AriSLA-Italian Research Foundation for Amyotrophic Lateral Sclerosis (A. Chio, B.J.T.), Italian Health Ministry (Ricerca Sanitaria Finalizzata 2007, A. Chio), Fondazione Vialli e Mauro Onlus (A. Chio), Federazione Italiana Giuoco Calcio (A. Chio, M. Sabatelli, B.J.T.), Compagnia di San Paolo (A. Chio, G.R.), Adelis Foundation (V.E.D.), European Community's Health Seventh Framework Programme (FP7/2007-2013) under grant agreements 259867 (A. Chio, M. Sendtner, C.D.), EuroMOTOR (M. Sendtner), German Federal Ministry of Education and Research (BMBF) (M. Sendtner), German Network for Motoneuron Disease (M. Sendtner, grant TP4) and NIH grant NS061867 (R.B.).	Aliaga L, 2013, HUM MOL GENET, V22, P4293, DOI 10.1093/hmg/ddt279; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P310, DOI 10.3109/17482960802566824; Cookson MR, 2012, BIOCHEM SOC T, V40, P1070, DOI 10.1042/BST20120165; Eisen A, 2012, J NEUROL NEUROSUR PS, V83, P399, DOI 10.1136/jnnp-2011-301456; Feit H, 1998, AM J HUM GENET, V63, P1732, DOI 10.1086/302166; Giordano G, 2005, J NEUROCHEM, V94, P808, DOI 10.1111/j.1471-4159.2005.03235.x; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Ma H, 1999, J CELL BIOL, V146, P531, DOI 10.1083/jcb.146.3.531; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Salton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023882; Senderek J, 2009, AM J HUM GENET, V84, P511, DOI 10.1016/j.ajhg.2009.03.006; van Blitterswijk M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060788; Weihl CC, 2008, J NEUROL NEUROSUR PS, V79, P1186, DOI 10.1136/jnnp.2007.131334; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4	17	306	314	0	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2014	17	5					664	+		10.1038/nn.3688	http://dx.doi.org/10.1038/nn.3688			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AF9DS	24686783	Green Accepted			2022-12-17	WOS:000335016200008
J	Pinto, L; Goard, MJ; Estandian, D; Xu, M; Kwan, AC; Lee, SH; Harrison, TC; Feng, GP; Dan, Y				Pinto, Lucas; Goard, Michael J.; Estandian, Daniel; Xu, Min; Kwan, Alex C.; Lee, Seung-Hee; Harrison, Thomas C.; Feng, Guoping; Dan, Yang			Fast modulation of visual perception by basal forebrain cholinergic neurons	NATURE NEUROSCIENCE			English	Article							NUCLEUS BASALIS; SPATIAL ATTENTION; GAIN MODULATION; BARREL CORTEX; BRAIN-STEM; STATE; PROJECTIONS; MECHANISMS; TRANSMISSION; STIMULATION	The basal forebrain provides the primary source of cholinergic input to the cortex, and it has a crucial function in promoting wakefulness and arousal. However, whether rapid changes in basal forebrain neuron spiking in awake animals can dynamically influence sensory perception is unclear. Here we show that basal forebrain cholinergic neurons rapidly regulate cortical activity and visual perception in awake, behaving mice. Optogenetic activation of the cholinergic neurons or their V1 axon terminals improved performance of a visual discrimination task on a trial-by-trial basis. In V1, basal forebrain activation enhanced visual responses and desynchronized neuronal spiking; these changes could partly account for the behavioral improvement. Conversely, optogenetic basal forebrain inactivation decreased behavioral performance, synchronized cortical activity and impaired visual responses, indicating the importance of cholinergic activity in normal visual processing. These results underscore the causal role of basal forebrain cholinergic neurons in fast, bidirectional modulation of cortical processing and sensory perception.	[Pinto, Lucas; Goard, Michael J.; Estandian, Daniel; Xu, Min; Kwan, Alex C.; Lee, Seung-Hee; Harrison, Thomas C.; Dan, Yang] Univ Calif Berkeley, Howard Hughes Med Inst, Div Neurobiol, Dept Mol & Cell Biol,Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Feng, Guoping] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT)	Pinto, L (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Div Neurobiol, Dept Mol & Cell Biol,Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	lucaspinto@berkeley.edu; ydan@berkeley.edu	Feng, Guoping/Y-2827-2019; Xu, Min/AGD-5135-2022	Xu, Min/0000-0002-6936-7543; Dan, Yang/0000-0002-3818-877X; Goard, Michael/0000-0002-5366-8501; Kwan, Alex/0000-0003-2169-1667	US National Institutes of Health [R01 EY018861]; National Science Foundation [22250400-42533]; National Institute of Mental Health [RC1-MH088434]; Ruth L. Kirschstein National Research Service Award [F31NS059258]; National Institute of Neurological Disorders and Stroke; NATIONAL EYE INSTITUTE [R01EY018861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS059258, F31NS084696] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H.J. Alitto for helpful discussions, and E. Rothenberg, J. Cox, G. Pho, S. Zhang, J. Jin, S. Harding-Forrester, C. Oldfield, Y.-C. Kuo, C. Niell, M. Stryker and M. Sur for technical assistance. This work was supported by US National Institutes of Health grant R01 EY018861, National Science Foundation grant 22250400-42533 (Y.D.), National Institute of Mental Health grant RC1-MH088434 (G.F.) and a Ruth L. Kirschstein National Research Service Award (F31NS059258) from the National Institute of Neurological Disorders and Stroke (M.J.G.).	Bauer M, 2012, CURR BIOL, V22, P397, DOI 10.1016/j.cub.2012.01.022; Bezdudnaya T, 2006, NEURON, V49, P421, DOI 10.1016/j.neuron.2006.01.010; Boynton GM, 2009, VISION RES, V49, P1129, DOI 10.1016/j.visres.2008.11.001; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; Chiba AA, 1999, NEUROREPORT, V10, P3119, DOI 10.1097/00001756-199909290-00044; Chubykin AA, 2013, NEURON, V77, P723, DOI 10.1016/j.neuron.2012.12.039; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Disney AA, 2007, NEURON, V56, P701, DOI 10.1016/j.neuron.2007.09.034; Froemke RC, 2013, NAT NEUROSCI, V16, P79, DOI 10.1038/nn.3274; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Guillem K, 2011, SCIENCE, V333, P888, DOI 10.1126/science.1207079; Hasenstaub A, 2007, J NEUROSCI, V27, P9607, DOI 10.1523/JNEUROSCI.2184-07.2007; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; Kalmbach A, 2012, J NEUROPHYSIOL, V107, P2008, DOI 10.1152/jn.00870.2011; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kuo MC, 2009, NEUROSCIENCE, V163, P430, DOI 10.1016/j.neuroscience.2009.06.026; Laplante F, 2005, NEUROSCIENCE, V132, P501, DOI 10.1016/j.neuroscience.2004.11.059; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; Ma M, 2012, J NEUROSCI, V32, P10105, DOI 10.1523/JNEUROSCI.0058-12.2012; Marguet SL, 2011, J NEUROSCI, V31, P6414, DOI 10.1523/JNEUROSCI.5773-10.2011; METHERATE R, 1993, SYNAPSE, V14, P132, DOI 10.1002/syn.890140206; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; PARENT A, 1988, J COMP NEUROL, V277, P281, DOI 10.1002/cne.902770209; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; PRICE JL, 1983, BRAIN RES, V269, P352, DOI 10.1016/0006-8993(83)90145-2; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Rokem A, 2010, NEUROPSYCHOPHARMACOL, V35, P2538, DOI 10.1038/npp.2010.118; RYE DB, 1984, NEUROSCIENCE, V13, P627, DOI 10.1016/0306-4522(84)90083-6; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Sarter M, 2009, NAT REV NEUROSCI, V10, P383, DOI 10.1038/nrn2635; SATO H, 1987, J NEUROPHYSIOL, V58, P765, DOI 10.1152/jn.1987.58.4.765; SILLITO AM, 1983, BRAIN RES, V289, P143, DOI 10.1016/0006-8993(83)90015-X; Thiele A, 2012, J NEUROSCI, V32, P16602, DOI 10.1523/JNEUROSCI.0554-12.2012; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; Worgotter F, 1998, NATURE, V396, P165, DOI 10.1038/24157; Xu SJ, 2012, NAT NEUROSCI, V15, P449, DOI 10.1038/nn.3036; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; Zaborszky L, 2003, FRONT BIOSCI-LANDMRK, V8, pD1146, DOI 10.2741/1112; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	48	306	306	2	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1857	1863		10.1038/nn.3552	http://dx.doi.org/10.1038/nn.3552			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24162654	Green Submitted, Green Accepted			2022-12-17	WOS:000327416800024
J	Darnell, JC; Klann, E				Darnell, Jennifer C.; Klann, Eric			The translation of translational control by FMRP: therapeutic targets for FXS	NATURE NEUROSCIENCE			English	Review							FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; LONG-TERM DEPRESSION; P70 S6 KINASE; MOUSE MODEL; SYNAPTIC PLASTICITY; DENDRITIC SPINES; RNA-BINDING; DEPENDENT REGULATION; GABA(A) RECEPTOR	De novo protein synthesis is necessary for long-lasting modifications in synaptic strength and dendritic spine dynamics that underlie cognition. Fragile X syndrome (FXS), characterized by intellectual disability and autistic behaviors, holds promise for revealing the molecular basis for these long-term changes in neuronal function. Loss of function of the fragile X mental retardation protein (FMRP) results in defects in synaptic plasticity and cognition in many models of the disease. FMRP is a polyribosome-associated RNA-binding protein that regulates the synthesis of a set of plasticity-reated proteins by stalling ribosomal translocation on target mRNAs. The recent identification of mRNA targets of FMRP and its upstream regulators, and the use of small molecules to stall ribosomes in the absence of FMRP, have the potential to be translated into new therapeutic avenues for the treatment of FXS.	[Darnell, Jennifer C.] Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA; [Klann, Eric] NYU, Ctr Neural Sci, New York, NY 10003 USA	Rockefeller University; New York University	Klann, E (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	darneje@mail.rockefeller.edu; eklann@cns.nyu.edu			US National Institutes of Health [HD040647, NS047384]; US Department of Defense [W81-XWH-11-1-0389]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047384] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health grants HD040647 (J.C.D.) and NS047384 (E.K.), and Congressionally Directed Medical Research Program Award W81-XWH-11-1-0389 from the US Department of Defense (E.K.).	Adusei DC, 2010, NEUROPHARMACOLOGY, V59, P167, DOI 10.1016/j.neuropharm.2010.05.002; Akins MR, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.017.2009; Antar LN, 2006, MOL CELL NEUROSCI, V32, P37, DOI 10.1016/j.mcn.2006.02.001; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Berry-Kravis E, 2009, J MED GENET, V46, P266, DOI 10.1136/jmg.2008.063701; Berry-Kravis EM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004214; BERRYKRAVIS E, 1993, AM J MED GENET, V45, P81, DOI 10.1002/ajmg.1320450120; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Bilousova TV, 2009, J MED GENET, V46, P94, DOI 10.1136/jmg.2008.061796; Bolduc FV, 2008, NAT NEUROSCI, V11, P1143, DOI 10.1038/nn.2175; Budkevich TV, 2008, NUCLEIC ACIDS RES, V36, P4736, DOI 10.1093/nar/gkn424; Christie SB, 2009, J NEUROSCI, V29, P1514, DOI 10.1523/JNEUROSCI.3937-08.2009; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Cruz-Martin A, 2010, J NEUROSCI, V30, P7793, DOI 10.1523/JNEUROSCI.0577-10.2010; D'Hulst C, 2006, BRAIN RES, V1121, P238, DOI 10.1016/j.brainres.2006.08.115; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012344; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Deng PY, 2011, J NEUROSCI, V31, P10971, DOI 10.1523/JNEUROSCI.2021-11.2011; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; El Idrissi A, 2005, NEUROSCI LETT, V377, P141, DOI 10.1016/j.neulet.2004.11.087; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Gatto CL, 2009, MOL NEUROBIOL, V39, P107, DOI 10.1007/s12035-009-8057-0; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Goebel-Goody SM, 2012, GENES BRAIN BEHAV, V11, P586, DOI 10.1111/j.1601-183X.2012.00781.x; Gross C, 2012, MOL MED, V18, P336, DOI 10.2119/molmed.2011.00363; Gross C, 2010, J NEUROSCI, V30, P10624, DOI 10.1523/JNEUROSCI.0402-10.2010; Guo WX, 2012, HUM MOL GENET, V21, P681, DOI 10.1093/hmg/ddr501; Hanson JE, 2007, J NEUROSCI, V27, P4014, DOI 10.1523/JNEUROSCI.4717-06.2007; Harlow EG, 2010, NEURON, V65, P385, DOI 10.1016/j.neuron.2010.01.024; Henderson C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004218; Heulens I, 2012, BEHAV BRAIN RES, V229, P244, DOI 10.1016/j.bbr.2012.01.031; Hoeffer CA, 2012, GENES BRAIN BEHAV, V11, P332, DOI 10.1111/j.1601-183X.2012.00768.x; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kelley DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000931; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Klann E, 2004, LEARN MEMORY, V11, P365, DOI 10.1101/lm.79004; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Klann E, 2008, NEUROBIOL LEARN MEM, V89, P247, DOI 10.1016/j.nlm.2007.08.009; Krueger DD, 2011, P NATL ACAD SCI USA, V108, P2587, DOI 10.1073/pnas.1013855108; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Lee HY, 2011, NEURON, V72, P630, DOI 10.1016/j.neuron.2011.09.033; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Li JX, 2002, MOL CELL NEUROSCI, V19, P138, DOI 10.1006/mcne.2001.1085; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009; Mines MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009706; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Neves-Pereira M, 2009, J MED GENET, V46, P759, DOI 10.1136/jmg.2009.066852; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; Osterweil EK, 2013, NEURON, V77, P243, DOI 10.1016/j.neuron.2012.01.034; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Pan F, 2010, P NATL ACAD SCI USA, V107, P17768, DOI 10.1073/pnas.1012496107; Paribello C, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-91; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Qin M, 2005, J NEUROSCI, V25, P5087, DOI 10.1523/JNEUROSCI.0093-05.2005; Ramos A, 2003, RNA, V9, P293, DOI 10.1261/rna.2168503; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Romanelli A, 1999, MOL CELL BIOL, V19, P2921; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; Schutt J, 2009, J BIOL CHEM, V284, P25479, DOI 10.1074/jbc.M109.042663; Sebeo J, 2009, J NEUROSCI, V29, P9778, DOI 10.1523/JNEUROSCI.2613-09.2009; Shanks NF, 2012, CELL REP, V1, P590, DOI 10.1016/j.celrep.2012.05.004; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Siller SS, 2011, DIS MODEL MECH, V4, P673, DOI 10.1242/dmm.008045; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Strumbos JG, 2010, J NEUROSCI, V30, P10263, DOI 10.1523/JNEUROSCI.1125-10.2010; Suvrathan A, 2010, P NATL ACAD SCI USA, V107, P11591, DOI 10.1073/pnas.1002262107; Till SM, 2012, HUM MOL GENET, V21, P2143, DOI 10.1093/hmg/dds030; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zang JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000758; Zhang J, 2009, J NEUROPHYSIOL, V101, P2572, DOI 10.1152/jn.90558.2008; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	97	306	311	4	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1530	1536		10.1038/nn.3379	http://dx.doi.org/10.1038/nn.3379			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	23584741	Green Accepted			2022-12-17	WOS:000326205700008
J	Anastassiou, CA; Perin, R; Markram, H; Koch, C				Anastassiou, Costas A.; Perin, Rodrigo; Markram, Henry; Koch, Christof			Ephaptic coupling of cortical neurons	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL PYRAMIDAL CELLS; APPLIED ELECTRIC-FIELDS; THETA OSCILLATIONS; IN-VIVO; SINGLE NEURONS; FREQUENCY; MODULATION; NETWORK; SYNCHRONIZATION; INFORMATION	The electrochemical processes that underlie neural function manifest themselves in ceaseless spatiotemporal field fluctuations. However, extracellular fields feed back onto the electric potential across the neuronal membrane via ephaptic coupling, independent of synapses. The extent to which such ephaptic coupling alters the functioning of neurons under physiological conditions remains unclear. To address this question, we stimulated and recorded from rat cortical pyramidal neurons in slices with a 12-electrode setup. We found that extracellular fields induced ephaptically mediated changes in the somatic membrane potential that were less than 0.5 mV under subthreshold conditions. Despite their small size, these fields could strongly entrain action potentials, particularly for slow (<8 Hz) fluctuations of the extracellular field. Finally, we simultaneously measured from up to four patched neurons located proximally to each other. Our findings indicate that endogenous brain activity can causally affect neural function through field effects under physiological conditions.	[Anastassiou, Costas A.; Koch, Christof] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Anastassiou, Costas A.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Perin, Rodrigo; Markram, Henry] Ecole Polytech Fed Lausanne, Lab Neural Microcircuitry, CH-1015 Lausanne, Switzerland; [Koch, Christof] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	California Institute of Technology; Imperial College London; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Korea University	Anastassiou, CA (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	costas@caltech.edu	Perin, Rodrigo/G-7691-2015	Perin, Rodrigo/0000-0001-5756-3769; Koch, Christof/0000-0001-6482-8067	Engineering Physical Sciences Research Council; Sloan-Swartz Foundation; Swiss National Science Foundation; EU Synapse; National Science Foundation; Mathers Foundation; Ministry of Education, Science and Technology [R31-10008]	Engineering Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Sloan-Swartz Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU Synapse; National Science Foundation(National Science Foundation (NSF)); Mathers Foundation; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We thank G. Buzsaki, U. Rutishauser and E. Schomburg for comments and discussions and J. Bastiaansen for assistance. This work was funded by the Engineering Physical Sciences Research Council (C.A.A.), the Sloan-Swartz Foundation (C.A.A.), the Swiss National Science Foundation (C.A.A.), EU Synapse (R.P.), the National Science Foundation (C.K. and C.A.A.), the Mathers Foundation (C.K. and C.A.A.) and the World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R31-10008, C.K.).	Anastassiou CA, 2010, J NEUROSCI, V30, P1925, DOI 10.1523/JNEUROSCI.3635-09.2010; Arvanitaki A, 1942, J NEUROPHYSIOL, V5, P89, DOI 10.1152/jn.1942.5.2.89; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; CHAN CY, 1986, J PHYSIOL-LONDON, V371, P89, DOI 10.1113/jphysiol.1986.sp015963; CHAN CY, 1988, J PHYSIOL-LONDON, V402, P751, DOI 10.1113/jphysiol.1988.sp017232; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Deans JK, 2007, J PHYSIOL-LONDON, V583, P555, DOI 10.1113/jphysiol.2007.137711; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Ghai RS, 2000, J NEUROPHYSIOL, V84, P274, DOI 10.1152/jn.2000.84.1.274; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Holt GR, 1999, J COMPUT NEUROSCI, V6, P169, DOI 10.1023/A:1008832702585; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Jacobson GA, 2005, J PHYSIOL-LONDON, V564, P145, DOI 10.1113/jphysiol.2004.080903; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; JEFFERYS JGR, 1982, NATURE, V300, P448, DOI 10.1038/300448a0; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Koch Christof, 1999, P1; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Mann EO, 2010, NEURON, V67, P3, DOI 10.1016/j.neuron.2010.06.036; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Milstein J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004338; Montoro RJ, 2004, BRAIN RES REV, V47, P216, DOI 10.1016/j.brainresrev.2004.06.009; NOEBELS JL, 1978, J NEUROPHYSIOL, V41, P1267, DOI 10.1152/jn.1978.41.5.1267; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Ozen S, 2010, J NEUROSCI, V30, P11476, DOI 10.1523/JNEUROSCI.5252-09.2010; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Pettersen KH, 2008, BIOPHYS J, V94, P784, DOI 10.1529/biophysj.107.111179; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Radman T, 2007, J NEUROSCI, V27, P3030, DOI 10.1523/JNEUROSCI.0095-07.2007; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stuart G, 2008, DENDRITES; Tabareau N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000637; TRAUB RD, 1985, NEUROSCIENCE, V14, P1033, DOI 10.1016/0306-4522(85)90274-X; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Weiss SA, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00015; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; YLINEN A, 1995, J NEUROSCI, V15, P30	50	306	311	3	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					217	U304		10.1038/nn.2727	http://dx.doi.org/10.1038/nn.2727			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21240273				2022-12-17	WOS:000286595400019
J	Leung, CT; Coulombe, PA; Reed, RR				Leung, Cheuk T.; Coulombe, Pierre A.; Reed, Randall R.			Contribution of olfactory neural stem cells to tissue maintenance and regeneration	NATURE NEUROSCIENCE			English	Article							GLOBOSE BASAL-CELLS; ADULT MAMMALIAN BRAIN; PROGENITOR CELLS; SUBVENTRICULAR ZONE; IN-VITRO; EPITHELIUM; LINEAGE; NEUROGENESIS; EXPRESSION; EPIDERMIS	The olfactory neuroepithelium undergoes continual neurogenesis and, after extensive lesions, fully regenerates to maintain sensory function. The stem cell population underlying this regenerative capacity remains elusive. Here we show that mouse horizontal basal cells (HBCs) function as adult olfactory neuroepithelium neural stem cells and examine their distinct dynamics in olfactory neuroepithelium maintenance and regeneration. Fate-mapping analysis after olfactory neuroepithelium lesioning shows that HBCs are competent to regenerate both neuronal and non-neuronal olfactory neuroepithelium lineages. HBCs serve as a reservoir of long-lived progenitors that remain largely quiescent during normal neuronal turnover or even after acute, selective loss of mature neurons. Under these conditions, previously identified progenitors are largely responsible for tissue maintenance. Yet after extensive injuries that deplete resident neuronal precursors, HBCs transiently proliferate and their progeny fully reconstitute the neuroepithelium. Our data support a new model of adult neurogenesis in which distinct cell populations mediate normal neuronal turnover and neuronal replacement upon traumatic injury.	Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Reed, RR (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, 725 N Wolfe St,PCTB 801, Baltimore, MD 21205 USA.	rreed@jhmi.edu		Leung, Cheuk/0000-0002-5838-5535				Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Beites CL, 2005, EXP CELL RES, V306, P309, DOI 10.1016/j.yexcr.2005.03.027; Bergman U, 2002, ARCH TOXICOL, V76, P104, DOI 10.1007/s00204-002-0321-2; Berton TR, 2003, ONCOGENE, V22, P5415, DOI 10.1038/sj.onc.1206825; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; CAGGIANO M, 1994, NEURON, V13, P339, DOI 10.1016/0896-6273(94)90351-4; Calof AL, 2002, MICROSC RES TECHNIQ, V58, P176, DOI 10.1002/jemt.10147; CARR VM, 1992, EXP NEUROL, V115, P55, DOI 10.1016/0014-4886(92)90221-B; Carter LA, 2004, J NEUROSCI, V24, P5670, DOI 10.1523/JNEUROSCI.0330-04.2004; Cau E, 2002, DEVELOPMENT, V129, P1871; Chen XY, 2004, J COMP NEUROL, V469, P457, DOI 10.1002/cne.11031; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GORDON MK, 1995, MOL CELL NEUROSCI, V6, P363, DOI 10.1006/mcne.1995.1028; HOLBROOK EH, 1995, J COMP NEUROL, V363, P129, DOI 10.1002/cne.903630111; Huard JMT, 1998, J COMP NEUROL, V400, P469; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jang WC, 2003, J COMP NEUROL, V460, P123, DOI 10.1002/cne.10642; Kawauchi S, 2004, DEV NEUROSCI-BASEL, V26, P166, DOI 10.1159/000082135; LEVEY MS, 1991, J NEUROSCI, V11, P3556; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; MACKAYSIM A, 1991, J NEUROSCI, V11, P979; Manglapus GL, 2004, J COMP NEUROL, V479, P216, DOI 10.1002/cne.20316; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Mitchell BD, 2004, DEV NEUROSCI-BASEL, V26, P101, DOI 10.1159/000082131; Miyawaki A, 1996, EMBO J, V15, P2050, DOI 10.1002/j.1460-2075.1996.tb00558.x; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; SCHWOB JE, 1994, CHEM SENSES, V19, P671, DOI 10.1093/chemse/19.6.671; SCHWOB JE, 1995, J COMP NEUROL, V359, P15, DOI 10.1002/cne.903590103; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sicard G, 1998, ANN NY ACAD SCI, V855, P223, DOI 10.1111/j.1749-6632.1998.tb10570.x; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8	38	306	320	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					720	726		10.1038/nn1882	http://dx.doi.org/10.1038/nn1882			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17468753				2022-12-17	WOS:000246799800014
J	Lai, SL; Lee, T				Lai, SL; Lee, T			Genetic mosaic with dual binary transcriptional systems in Drosophila	NATURE NEUROSCIENCE			English	Article							REPRESSIBLE CELL MARKER; MUSHROOM BODIES; ANTENNAL LOBE; NERVOUS-SYSTEM; MELANOGASTER; EXPRESSION; BRAIN; NEUROBLAST; ACTIVATOR; PATTERNS	MARCM (mosaic analysis with a repressible cell marker) involves specific labeling of GAL80-minus and GAL4-positive homozygous cells in otherwise heterozygous tissues. Here we demonstrate how the concurrent use of two independent binary transcriptional systems may facilitate complex MARCM studies in the Drosophila nervous system. By fusing LexA with the VP16 acidic activation domain (VP16) or the GAL4 activation domain (GAD), we obtained both GAL80-insensitive and GAL80-suppressible transcriptional factors. LexA:: VP16 can mediate MARCM-independent binary transgene induction in mosaic organisms. The incorporation of LexA:: GAD into MARCM, which we call dual-expression-control MARCM, permits the induction of distinct transgenes in different patterns among GAL80-minus cells in mosaic tissues. Lineage analysis with dual-expression-control MARCM suggested the presence of neuroglioblasts in the developing optic lobes but did not indicate the production of glia by postembryonic mushroom body neuronal precursors. In addition, dualexpression-control MARCM with a ubiquitous LexA:: GAD driver revealed many unidentified cells in the GAL4-GH146-positive projection neuron lineages.	Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Massachusetts System; University of Massachusetts Worcester	Lee, T (corresponding author), Univ Illinois, Neurosci Program, Urbana, IL 61801 USA.	Tzumin.Lee@umassmed.edu		Lai, Sen-Lin/0000-0002-7531-283X				BRAND AH, 1993, DEVELOPMENT, V118, P401; BRENT R, 1985, CELL, V43, P729, DOI 10.1016/0092-8674(85)90246-6; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Dearborn R, 2004, DEVELOPMENT, V131, P2291, DOI 10.1242/dev.01111; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; Ito K, 1997, DEVELOPMENT, V124, P761; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; MA J, 1987, CELL, V50, P137, DOI 10.1016/0092-8674(87)90670-2; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.3.CO;2-O; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Szuts D, 2000, P NATL ACAD SCI USA, V97, P5351, DOI 10.1073/pnas.97.10.5351; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; XIONG WC, 1995, NEURON, V14, P581, DOI 10.1016/0896-6273(95)90314-3; XU T, 1993, DEVELOPMENT, V117, P1223; YANG MY, 1995, NEURON, V15, P45; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2; Zhu SJ, 2003, DEVELOPMENT, V130, P2603, DOI 10.1242/dev.00466; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012; Zugates CT, 2004, CURR OPIN NEUROBIOL, V14, P647, DOI 10.1016/j.conb.2004.08.005	39	306	309	3	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					703	709		10.1038/nn1681	http://dx.doi.org/10.1038/nn1681			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16582903				2022-12-17	WOS:000237417200023
J	Fang, F; He, S				Fang, F; He, S			Cortical responses to invisible objects in the human dorsal and ventral pathways	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; BINOCULAR-RIVALRY; RECOGNITION; PERCEPTION; ACTIVATION; FMRI; SEPARATE; MOTION; AREAS	The primate visual system is believed to comprise two main pathways: a ventral pathway for conscious perception and a dorsal pathway that can process visual information and guide action without accompanying conscious knowledge. Evidence for this theory has come primarily from studies of neurological patients and animals. Using fMRI, we show here that even though observers are completely unaware of test object images owing to interocular suppression, their dorsal cortical areas demonstrate substantial activity for different types of visual objects, with stronger responses to images of tools than of human faces. This result also suggests that in binocular rivalry, substantial information in the suppressed eye can escape the interocular suppression and reach dorsal cortex.	Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	He, S (corresponding author), Univ Minnesota, Dept Psychol, 75 E River Rd, Minneapolis, MN 55455 USA.	sheng@umn.edu						Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Blake R., 2001, BRAIN MIND, V2, P5, DOI [10.1023/A:1017925416289, DOI 10.1023/A:1017925416289, https://doi.org/10.1023/A:1017925416289]; Breese BB, 1909, PSYCHOL REV, V16, P410, DOI 10.1037/h0075805; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Claeys KG, 2003, NEURON, V40, P631, DOI 10.1016/S0896-6273(03)00590-7; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Goodale MA, 2004, CURR OPIN NEUROBIOL, V14, P203, DOI 10.1016/j.conb.2004.03.002; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; HE S, 2005, BINOCULAR RIVALRY PE; James TW, 2000, CURR BIOL, V10, P1017, DOI 10.1016/S0960-9822(00)00655-2; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; Kanwisher N, 2001, HDB FUNCTIONAL NEURO, P109; Kluver H, 1938, J PSYCHOL, V5, P33; Lee SH, 2002, J VISION, V2, P618, DOI 10.1167/2.9.4; Lee SH, 2005, NAT NEUROSCI, V8, P22, DOI 10.1038/nn1365; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Milner A. D., 1995, VISUAL BRAIN ACTION; Murray SO, 2003, CEREB CORTEX, V13, P508, DOI 10.1093/cercor/13.5.508; Pasley BN, 2004, NEURON, V42, P163, DOI 10.1016/S0896-6273(04)00155-2; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Sincich LC, 2004, NAT NEUROSCI, V7, P1123, DOI 10.1038/nn1318; Talairach J., 1988, COPLANAR STEREOTAXIC; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P549; Weiskrantz L., 1997, CONSCIOUSNESS LOST F; Williams MA, 2004, J NEUROSCI, V24, P2898, DOI 10.1523/JNEUROSCI.4977-03.2004	34	306	320	5	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1380	1385		10.1038/nn1537	http://dx.doi.org/10.1038/nn1537			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16136038				2022-12-17	WOS:000232145900023
J	Seymour, B; O'Doherty, JP; Koltzenburg, M; Wiech, K; Frackowiak, R; Friston, KJ; Dolan, R				Seymour, B; O'Doherty, JP; Koltzenburg, M; Wiech, K; Frackowiak, R; Friston, KJ; Dolan, R			Opponent appetitive-aversive neural processes underlie predictive learning of pain relief	NATURE NEUROSCIENCE			English	Article							TEMPORAL DIFFERENCE MODELS; ACQUIRED MOTIVATION; NUCLEUS-ACCUMBENS; OPIOID ANALGESIA; VENTRAL STRIATUM; HUMAN BRAIN; REWARD; DOPAMINE; AMYGDALA; ANTICIPATION	Termination of a painful or unpleasant event can be rewarding. However, whether the brain treats relief in a similar way as it treats natural reward is unclear, and the neural processes that underlie its representation as a motivational goal remain poorly understood. We used fMRI ( functional magnetic resonance imaging) to investigate how humans learn to generate expectations of pain relief. Using a pavlovian conditioning procedure, we show that subjects experiencing prolonged experimentally induced pain can be conditioned to predict pain relief. This proceeds in a manner consistent with contemporary reward-learning theory ( average reward/loss reinforcement learning), reflected by neural activity in the amygdala and midbrain. Furthermore, these reward-like learning signals are mirrored by opposite aversion-like signals in lateral orbitofrontal cortex and anterior cingulate cortex. This dual coding has parallels to 'opponent process' theories in psychology and promotes a formal account of prediction and expectation during pain.	Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; CALTECH, Div Humanities & Social Sci 228 77, Pasadena, CA 91125 USA; UCL, Inst Child Hlth, London WC1N 1EH, England; Fdn Santa Lucia, Neuroimaging Lab, I-00179 Rome, Italy	University of London; University College London; California Institute of Technology; University of London; University College London; IRCCS Santa Lucia	Seymour, B (corresponding author), Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	bseymour@fil.ion.ucl.ac.uk	Koltzenburg, Martin/C-1349-2008; Friston, Karl/D-9230-2011; Frackowiak, Richard S/I-1809-2013; Frackowiak, Richard/H-4383-2011; O'Doherty, John P/F-1204-2013	Koltzenburg, Martin/0000-0001-9181-5966; Friston, Karl/0000-0001-7984-8909; Frackowiak, Richard/0000-0002-3151-822X; Seymour, Ben/0000-0003-1724-5832; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altier N, 1999, LIFE SCI, V65, P2269, DOI 10.1016/S0024-3205(99)00298-2; Beiser, 1995, MODELS INFORM PROCES, P215; Buchel C, 1998, NEUROIMAGE, V8, P140, DOI 10.1006/nimg.1998.0351; CABANAC M, 1971, SCIENCE, V173, P1103, DOI 10.1126/science.173.4002.1103; CAMERER C, IN PRESS J EC LIT; Craig ADB, 2003, TRENDS NEUROSCI, V26, P303, DOI 10.1016/S0166-2236(03)00123-1; Daw ND, 2002, NEURAL COMPUT, V14, P2567, DOI 10.1162/089976602760407973; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Dayan P., 2001, THEORETICAL NEUROSCI; DICKENSON, 1979, MECH LEARNING MOTIVA, P203; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Fields HL, 2000, PROG BRAIN RES, V122, P245; Gadd CA, 2003, J NEUROSCI, V23, P8271, DOI 10.1523/jneurosci.23-23-08271.2003; Glascher J, 2005, NEURON, V47, P295, DOI 10.1016/j.neuron.2005.06.008; GROSSBERG S, 1984, BIOL PSYCHIAT, V19, P1075; Holland PC, 2004, CURR OPIN NEUROBIOL, V14, P148, DOI 10.1016/j.conb.2004.03.007; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Johansen JP, 2004, NAT NEUROSCI, V7, P398, DOI 10.1038/nn1207; Konorski J., 1967, INTEGRATIVE ACTIVITY; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MAHADEVAN S, 1996, MACH LEARN, V22, P1; Markowitz H, 1952, J POLIT ECON, V60, P151, DOI 10.1086/257177; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Price D. D., 1999, PSYCHOL MECH PAIN AN; Rogan MT, 2005, NEURON, V46, P309, DOI 10.1016/j.neuron.2005.02.017; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Schull J., 1979, PSYCHOL LEARN MOTIV, V13, P57; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHWARTZ A, 1993, P 10 INT C MACH LEAR, P298; Setlow B, 2003, NEURON, V38, P625, DOI 10.1016/S0896-6273(03)00264-2; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Smith AJ, 2005, NEURAL COMPUT, V17, P361, DOI 10.1162/0899766053011546; SOLOMON RL, 1980, ACTA NEUROBIOL EXP, V40, P271; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; SOLOMON RL, 1980, AM PSYCHOL, V35, P691, DOI 10.1037/0003-066X.35.8.691; Stefanovic B, 2004, NEUROIMAGE, V22, P771, DOI 10.1016/j.neuroimage.2004.01.036; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tanimoto H, 2004, NATURE, V430, P983, DOI 10.1038/430983a; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Watkins LR, 1998, BEHAV NEUROSCI, V112, P360	50	306	309	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1234	1240		10.1038/nn1527	http://dx.doi.org/10.1038/nn1527			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116445	Green Published			2022-12-17	WOS:000231483800024
J	Sharot, T; Delgado, MR; Phelps, EA				Sharot, T; Delgado, MR; Phelps, EA			How emotion enhances the feeling of remembering	NATURE NEUROSCIENCE			English	Article							RECOGNITION MEMORY; EPISODIC MEMORY; HUMAN AMYGDALA; FLASHBULB MEMORIES; HIPPOCAMPUS; PARAHIPPOCAMPAL; EVENTS; RECOLLECTION; FAMILIARITY; RETRIEVAL	Studies examining memories of arousing 'real-life' events show that emotion heightens the feeling of remembering, without necessarily enhancing the objective accuracy of the memories. We measured brain activity associated with the feeling of remembering emotional and neutral photos. Subjects indicated whether recognition was accompanied by a recollection of details about the study episode ('remember') or not ('know'). 'Remember' judgments were boosted for emotional photos, but accuracy did not differ. For neutral photos, 'remember' judgments were related to enhanced activity in the parahippocampal cortex, previously related to recognition of visual details, which one might expect to supply the retrieval clues for a 'remember' judgment. In contrast, 'remember' judgments for emotional photos were associated with enhanced activity in the amygdala, suggesting that subjects rely on arousal and perceptual fluency to evaluate these memories. For the first time, we identify the neural mechanisms underlying the enhanced feeling of remembering for emotional events.	NYU, Dept Psychol, New York, NY 10003 USA	New York University	Phelps, EA (corresponding author), NYU, Dept Psychol, Room 863,6 Washington Pl, New York, NY 10003 USA.	liz.phelps@nyu.edu			NIMH NIH HHS [MH62104] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062104] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Arthurs OJ, 2003, CLIN NEUROPHYSIOL, V114, P1203, DOI 10.1016/S1388-2457(03)00080-4; BROWN R, 1977, COGNITION, V5, P73, DOI 10.1016/0010-0277(77)90018-X; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cabeza R, 2001, P NATL ACAD SCI USA, V98, P4805, DOI 10.1073/pnas.081082698; Dolan RS, 2000, NEUROIMAGE, V11, P203, DOI 10.1006/nimg.2000.0538; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Duzel E, 2003, J NEUROSCI, V23, P9439; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Glascher J, 2003, J NEUROSCI, V23, P10274; Henson RNA, 1999, J NEUROSCI, V19, P3962; James W, 1890, PRINCIPLES PSYCHOL, V1; Kohler S, 2002, HIPPOCAMPUS, V12, P718, DOI 10.1002/hipo.10077; Lang J.P., 1999, A4 U FLOR CTR RES PS; Maratos EJ, 2001, NEUROPSYCHOLOGIA, V39, P910, DOI 10.1016/S0028-3932(01)00025-2; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; NEISSER U, 1992, STUDIES FLASHBULB ME, V4, P9; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Ochsner KN, 2000, J EXP PSYCHOL GEN, V129, P242, DOI 10.1037//0096-3445.129.2.242; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; RAJARAM S, 1993, MEM COGNITION, V21, P89, DOI 10.3758/BF03211168; Slotnick SD, 2004, NAT NEUROSCI, V7, P664, DOI 10.1038/nn1252; Talarico JM, 2003, PSYCHOL SCI, V14, P455, DOI 10.1111/1467-9280.02453; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001; WINOGRAD E, 1992, STUDIES FLASHBULB ME, V4; Yates F, 1934, J ROYAL STAT SOC S, V1, P217, DOI DOI 10.2307/2983604; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 2001, NEUROREPORT, V12, P359, DOI 10.1097/00001756-200102120-00035; YONELINAS AP, 1995, J MEM LANG, V34, P622, DOI 10.1006/jmla.1995.1028	31	306	319	4	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1376	1380		10.1038/nn1353	http://dx.doi.org/10.1038/nn1353			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	874MG	15558065				2022-12-17	WOS:000225353900019
J	Groc, L; Heine, M; Cognet, L; Brickley, K; Stephenson, FA; Lounis, B; Choquet, D				Groc, L; Heine, M; Cognet, L; Brickley, K; Stephenson, FA; Lounis, B; Choquet, D			Differential activity-dependent regulation of the lateral mobilities of AMPA and NMDA receptors	NATURE NEUROSCIENCE			English	Article							TRAFFICKING; DIFFUSION	The basis for differences in activity-dependent trafficking of AMPA receptors (AMPARs) and NMDA receptors (NMDARs) remains unclear. Using single-molecule tracking, we found different lateral mobilities for AMPARs and NMDARs: changes in neuronal activity modified AMPAR but not NMDAR mobility, whereas protein kinase C activation modified both. Differences in mobility were mainly detected for extrasynaptic AMPARs, suggesting that receptor diffusion between synaptic and extrasynaptic domains is involved in plasticity processes.	Univ Bordeaux 2, CNRS, UMR 5091, F-33077 Bordeaux, France; CNRS, UMR 5798, Talence, France; Univ London, Sch Pharm, London WC1N 1AX, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite de Bordeaux; University of London; University College London; University of London School of Pharmacy	Choquet, D (corresponding author), Univ Bordeaux 2, CNRS, UMR 5091, F-33077 Bordeaux, France.	dchoquet@u-bordeaux2.fr	Choquet, Daniel/E-4203-2013; Lounis, Brahim/I-7862-2016; Choquet, Daniel/K-7893-2018; Choquet, Daniel/GOJ-8825-2022; Cognet, Laurent/F-4163-2011; Cognet, Laurent/M-4505-2019	Lounis, Brahim/0000-0001-7501-0236; Choquet, Daniel/0000-0003-4726-9763; Choquet, Daniel/0000-0003-4726-9763; Cognet, Laurent/0000-0002-3573-5387; 				Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Chung HJ, 2000, J NEUROSCI, V20, P7258; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fong DK, 2002, J NEUROSCI, V22, P2153, DOI 10.1523/JNEUROSCI.22-06-02153.2002; Racca C, 2000, J NEUROSCI, V20, P2512; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Tovar KR, 2002, NEURON, V34, P253; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	13	306	321	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					695	696		10.1038/nn1270	http://dx.doi.org/10.1038/nn1270			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15208630				2022-12-17	WOS:000222274400006
J	Zacks, JM; Braver, TS; Sheridan, MA; Donaldson, DI; Snyder, AZ; Ollinger, JM; Buckner, RL; Raichle, ME				Zacks, JM; Braver, TS; Sheridan, MA; Donaldson, DI; Snyder, AZ; Ollinger, JM; Buckner, RL; Raichle, ME			Human brain activity time-locked to perceptual event boundaries	NATURE NEUROSCIENCE			English	Article							HUMAN CEREBRAL-CORTEX; EYE; ATTENTION; BEHAVIOR; SYSTEMS; RIVALRY; AREAS	Temporal structure has a major role in human understanding of everyday events. Observers are able to segment ongoing activity into temporal parts and sub-parts that are reliable, meaningful and correlated with ecologically relevant features of the action. Here we present evidence that a network of brain regions is tuned to perceptually salient event boundaries, both during intentional event segmentation and during naive passive viewing of events. Activity within this network may provide a basis for parsing the temporally evolving environment into meaningful units.	Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Zacks, JM (corresponding author), Washington Univ, Dept Psychol, 1 Brookings Dr, St Louis, MO 63130 USA.		Zacks, Jeffrey M/E-9099-2011; Donaldson, David I/A-5249-2009	Zacks, Jeffrey M/0000-0003-1171-3690; Donaldson, David I/0000-0002-8036-3455; Braver, Todd/0000-0002-2631-3393; Sheridan, Margaret/0000-0002-8909-7501				AVRAHAMI J, 1994, COGNITION, V53, P239, DOI 10.1016/0010-0277(94)90050-7; Bonda E, 1996, J NEUROSCI, V16, P3737; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Grafman J, 1995, ANN NY ACAD SCI, V769, P337, DOI 10.1111/j.1749-6632.1995.tb38149.x; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; McDermott KB, 1999, J COGNITIVE NEUROSCI, V11, P631, DOI 10.1162/089892999563698; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Nelson K., 1986, EVENT KNOWLEDGE STRU, P21; NEWTSON D, 1976, J EXP SOC PSYCHOL, V12, P436, DOI 10.1016/0022-1031(76)90076-7; NEWTSON D, 1977, J PERS SOC PSYCHOL, V35, P847, DOI 10.1037/0022-3514.35.12.847; OLLINGER JM, 2000, FUNCTIONAL MAPPING H; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Talairach J., 1988, COPLANAR STEREOTAXIC; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; TOOTELL RBH, 1995, CEREB CORTEX, V5, P39, DOI 10.1093/cercor/5.1.39; Van Essen DC, 1998, P NATL ACAD SCI USA, V95, P788, DOI 10.1073/pnas.95.3.788; VanEssen DC, 1997, J NEUROSCI, V17, P7079; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Wynn K, 1996, PSYCHOL SCI, V7, P164, DOI 10.1111/j.1467-9280.1996.tb00350.x; Zacks JM, 2001, PSYCHOL BULL, V127, P3, DOI 10.1037//0033-2909.127.1.3; Zacks JM, 2001, J EXP PSYCHOL GEN, V130, P29, DOI 10.1037//0096-3445.130.1.29	26	306	309	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					651	655		10.1038/88486	http://dx.doi.org/10.1038/88486			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	438PG	11369948				2022-12-17	WOS:000169061800020
J	Dayan, P; Kakade, S; Montague, PR				Dayan, Peter; Kakade, Sham; Montague, P. Read			Learning and selective attention	NATURE NEUROSCIENCE			English	Review								Selective attention involves the differential processing of different stimuli, and has widespread psychological and neural consequences. Although computational modeling should offer a powerful way of linking observable phenomena at different levels, most work has focused on the relatively narrow issue of constraints on processing resources. By contrast, we consider statistical and informational aspects of selective attention, divorced from resource constraints, which are evident in animal conditioning experiments involving uncertain predictions and unreliable stimuli. Neuromodulatory systems and limbic structures are known to underlie attentional effects in such tasks.	[Dayan, Peter; Kakade, Sham] UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England; [Montague, P. Read] Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	University of London; University College London; Baylor College of Medicine	Dayan, P (corresponding author), UCL, Gatsby Computat Neurosci Unit, 17 Queen Sq, London WC1N 3AR, England.	dayan@gatsby.ucl.ac.uk		Dayan, Peter/0000-0003-3476-1839	Gatsby Charitable Foundation; National Science Foundation; NIDA	Gatsby Charitable Foundation; National Science Foundation(National Science Foundation (NSF)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	We are grateful to Nathaniel Daw, Anthony Dickinson, Alex Kacelnik, Theresa Long, Terry Sejnowski, and Rich Sutton for discussions covering many of these issues, and particularly to Nathaniel Daw for comments on an earlier version of this paper. The authors' work is funded by the Gatsby Charitable Foundation (P.D. and S.K.), the National Science Foundation (S.K.) and NIDA (P.R.M.).	ALLPORT A, 1993, ATTENTION PERFORM, V14, P183; Anderson BDO., 1979, OPTIMAL FILTERING; BALLARD DH, 1991, ARTIF INTELL, V48, P57, DOI 10.1016/0004-3702(91)90080-4; Barto A.G., 1995, MODELS INFORM PROCES; Baxter MG, 1997, J NEUROSCI, V17, P5230; Bernando J. M., 1985, BAYESIAN STATISTICS, V2, P375; BORDLEY RF, 1982, J OPER RES SOC, V33, P171, DOI 10.2307/2581301; Broadbent Donald Eric, 2013, PERCEPTION COMMUNICA; Bundesen C., 1996, CONVERGING OPERATION, P1, DOI DOI 10.1037/10187-001; COHEN JD, 1993, SCHIZOPHRENIA BULL, V19, P85, DOI 10.1093/schbul/19.1.85; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corwin JV, 1998, PSYCHOBIOLOGY, V26, P87; Dayan P, 1998, ADV NEUR IN, V10, P117; Dayan P, 1999, INT C ART NEUR NETW; Dickinson A., 1980, CONT ANIMAL LEARNING; Doya K, 1999, NEURAL NETWORKS, V12, P961, DOI 10.1016/S0893-6080(99)00046-5; Eichenbaum H, 1999, CURR BIOL, V9, pR482, DOI 10.1016/S0960-9822(99)80301-7; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; GROSSBERG S, 1982, PSYCHOL REV, V89, P529, DOI 10.1037/0033-295X.89.5.529; Han JS, 1999, BEHAV NEUROSCI, V113, P143, DOI 10.1037/0735-7044.113.1.143; Hatfield T, 1996, J NEUROSCI, V16, P5256; Holland PC, 1997, ANIM LEARN BEHAV, V25, P373, DOI 10.3758/BF03209846; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; JACOBS RA, 1991, COGNITIVE SCI, V15, P219, DOI 10.1207/s15516709cog1502_2; Kahneman D., 1973, ATTENTION EFFORT; Kakade S, 2000, ADV NEUR IN, V12, P24; Kropotov JD, 1999, INT J PSYCHOPHYSIOL, V31, P197, DOI 10.1016/S0167-8760(98)00051-8; KRUSCHKE JK, 1997, 8 AUSTR MATH PSYCH C; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Lubow R. E., 1989, LATENT INHIBITION CO; Mackintosh N. J, 1983, CONDITIONING ASS LEA; MACKINTOSH NJ, 1975, PSYCHOL REV, V82, P276, DOI 10.1037/h0076778; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Miller RR, 1989, CONT LEARNING THEORI, P61; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Neal RM., 1996, BAYESIAN LEARNING NE, P29; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; PEARCE JM, 1988, Q J EXP PSYCHOL-B, V40, P181; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1101/GR.110528.110, DOI 10.1016/J.COGPSYCH.2004.11.001]; Robbins TW, 1998, ATTENTIVE BRAIN, P189; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; SOLOMON PR, 1975, J COMP PHYSIOL PSYCH, V89, P1192, DOI 10.1037/h0077183; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1023/A:1022633531479; Sutton R.S., 1992, P 7 YAL WORKSH AD LE, P161; SWAN JA, 1988, J EXP PSYCHOL ANIM B, V14, P292, DOI 10.1037/0097-7403.14.3.292; SWAN JA, 1987, J EXP PSYCHOL ANIM B, V13, P407, DOI 10.1037/0097-7403.13.4.407; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; WEINER I, 1990, PSYCHOL BULL, V108, P442, DOI 10.1037/0033-2909.108.3.442; Wickens J. R., 1995, MODELS INFORM PROCES, P187; WILSON PN, 1992, Q J EXP PSYCHOL-B, V44B, P17	55	306	307	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11		S			1218	1223		10.1038/81504	http://dx.doi.org/10.1038/81504			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V18OV	11127841				2022-12-17	WOS:000208015000022
J	Canales, JJ; Graybiel, AM				Canales, JJ; Graybiel, AM			A measure of striatal function predicts motor stereotypy	NATURE NEUROSCIENCE			English	Article							MESSENGER-RNA EXPRESSION; RECEPTOR MUTANT MICE; GENE-EXPRESSION; C-FOS; CREB PHOSPHORYLATION; TRANSCRIPTION FACTOR; DOPAMINE-RECEPTORS; CHRONIC COCAINE; NMDA RECEPTORS; BASAL GANGLIA	To identify basal ganglia circuit dysfunctions that might produce repetitive behaviors known as motor stereotypies, we applied psychomotor stimulants and a direct dopamine receptor agonist to induce different levels of stereotypy in rats. We then used a gene induction assay to measure the functional activation of neurons in the neurochemically distinct compartments of the striatum, the striosomes and the extrastriosomal matrix. The amount by which activation in the striosomes exceeded activation in the matrix predicted the degree of motor stereotypy induced by the drug treatments. These results suggest that imbalance between compartmentally organized basal ganglia circuits may represent a neural correlate of motor stereotypy.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Graybiel, AM (corresponding author), MIT, Dept Brain & Cognit Sci, 45 Carleton St,E25-618, Cambridge, MA 02139 USA.			Canales, Juan J./0000-0003-2884-5227; Graybiel, Ann/0000-0002-4326-7720	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008037] Funding Source: NIH RePORTER; NIDA NIH HHS [R01DA08037] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ANTONY MM, 1988, OBSESSIVE COMPULSIVE, P3; AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; ARNT J, 1985, N-S ARCH PHARMACOL, V330, P97, DOI 10.1007/BF00499901; BHAT RV, 1992, J PSYCHIATR NEUROSCI, V17, P94; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Calabresi P, 1999, J NEUROSCI, V19, P2489; COSTALL B, 1976, EUR J PHARMACOL, V36, P423, DOI 10.1016/0014-2999(76)90096-0; CREESE I, 1972, NATURE-NEW BIOL, V238, P247, DOI 10.1038/newbio238247a0; Cummings JL, 1995, ANN NY ACAD SCI, V769, P1, DOI 10.1111/j.1749-6632.1995.tb38127.x; CURRAN T, 1995, J NEUROBIOL, V26, P403, DOI 10.1002/neu.480260312; Dragunow M, 1996, BEHAV GENET, V26, P293, DOI 10.1007/BF02359385; FIBIGER HC, 1973, BRIT J PHARMACOL, V47, P683, DOI 10.1111/j.1476-5381.1973.tb08194.x; Fog R, 1972, Acta Neurol Scand Suppl, V50, P3; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; Gold L H, 1989, NIDA Res Monogr, V94, P101; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; Graybiel AM, 1997, SCHIZOPHRENIA BULL, V23, P459, DOI 10.1093/schbul/23.3.459; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; Hiroi N, 1996, J COMP NEUROL, V374, P70, DOI 10.1002/(SICI)1096-9861(19961007)374:1<70::AID-CNE5>3.0.CO;2-K; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; HUGHES P, 1995, PHARMACOL REV, V47, P133; Konradi C, 1996, J NEUROSCI, V16, P4231; LAHOSTE GJ, 1993, BRAIN RES, V611, P108, DOI 10.1016/0006-8993(93)91782-N; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; Lyon M., 1975, CURRENT DEV PSYCHOPH, V2, P80; Manschrek T.C., 1986, HDB SCHIZOPHRENIA, P65; MELLO CV, 1994, J NEUROSCI, V14, P6652; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; PAUL ML, 1992, J NEUROSCI, V12, P3729, DOI 10.1523/jneurosci.12-10-03729.1992; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; Ramamoorthy S, 1999, SCIENCE, V285, P763, DOI 10.1126/science.285.5428.763; RANDRUP A, 1972, PSYCHIAT NEUROL NEUR, V75, P193; RIDLEY RM, 1994, PROG NEUROBIOL, V44, P221, DOI 10.1016/0301-0082(94)90039-6; ROBBINS TW, 1982, B BRIT PSYCHOL SOC, V35, P297; ROSEN JB, 1994, MOL BRAIN RES, V25, P168, DOI 10.1016/0169-328X(94)90295-X; Rosenberg DR, 1997, J PSYCHIATR NEUROSCI, V22, P29; SCHEELKRUGER J, 1972, EUR J PHARMACOL, V18, P63, DOI 10.1016/0014-2999(72)90132-X; Segal D S, 1980, Science, V207, P905, DOI 10.1126/science.7188815; SHARP FR, 1993, CRIT REV NEUROBIOL, V7, P205; Steiner H, 1998, EXP BRAIN RES, V123, P60, DOI 10.1007/s002210050545; TORRES G, 1993, BRAIN RES BULL, V30, P173, DOI 10.1016/0361-9230(93)90055-G; VOLKOW ND, 1991, NIDA RES MONOGR, V105, P47; WANG JQ, 1994, SYNAPSE, V18, P343, DOI 10.1002/syn.890180410; WANG JQ, 1995, BRAIN RES, V673, P262, DOI 10.1016/0006-8993(94)01422-E; WICHMANN T, NEUROSURG CLIN N AM, V9; WIRTSHAFTER D, 1994, BRAIN RES BULL, V35, P85, DOI 10.1016/0361-9230(94)90220-8; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6	49	306	308	1	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					377	383		10.1038/73949	http://dx.doi.org/10.1038/73949			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725928				2022-12-17	WOS:000087945400019
J	Obrietan, K; Impey, S; Storm, DR				Obrietan, K; Impey, S; Storm, DR			Light and circadian rhythmicity regulate MAP kinase activation in the suprachiasmatic nuclei	NATURE NEUROSCIENCE			English	Article							NMDA RECEPTOR ANTAGONISTS; EPIDERMAL GROWTH-FACTOR; DROSOPHILA PERIOD GENE; BIOLOGICAL CLOCK; C-FOS; RETINOHYPOTHALAMIC TRACT; CREB PHOSPHORYLATION; PROTEIN-KINASE; MESSENGER-RNA; PC12 CELLS	Although the circadian time-keeping properties of the suprachiasmatic nuclei (SCN) require gene expression, little is known about the signal transduction pathways that initiate transcription. Here we report that a brief exposure to light during the subjective night, but not during the subjective day, activates the p44/42 mitogen-activated protein kinase (MAPK) signaling cascade in the SCN. In addition, MAPK stimulation activates CREB (cAMP response element binding protein), indicating that potential downstream transcription factors are stimulated by the MAPK pathway in the SCN. We also observed striking circadian variations in MAPK activity within the SCN, suggesting that the MAPK cascade is involved in crock rhythmicity.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Mail Box 357280,Hlth Sci Bldg, Seattle, WA 98195 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NINDS NIH HHS [NS 20498] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; ARONIN N, 1990, P NATL ACAD SCI USA, V87, P5959, DOI 10.1073/pnas.87.15.5959; Cagampang FRA, 1998, MOL BRAIN RES, V53, P277, DOI 10.1016/S0169-328X(97)00309-4; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; COLWELL CS, 1991, BRAIN RES, V554, P105, DOI 10.1016/0006-8993(91)90177-W; COLWELL CS, 1992, J BIOL RHYTHM, V7, P125, DOI 10.1177/074873049200700204; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Ding JM, 1997, J NEUROSCI, V17, P667; Ding JM, 1998, NATURE, V394, P381, DOI 10.1038/28639; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Finkbeiner S, 1996, NEURON, V16, P233, DOI 10.1016/S0896-6273(00)80040-9; Ghosh PK, 1997, DEV BRAIN RES, V102, P1, DOI 10.1016/S0165-3806(97)00066-7; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Glaser B. G., 1965, AM BEHAV SCI, V8, P5, DOI [10.1177/000276426500800602, DOI 10.1177/000276426500800602]; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Guido ME, 1996, NEUROSCI LETT, V217, P9; Hannibal J, 1997, J NEUROSCI, V17, P2637, DOI 10.1523/jneurosci.17-07-02637.1997; Hastings MH, 1997, TRENDS NEUROSCI, V20, P459, DOI 10.1016/S0166-2236(97)01087-4; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; KALSBEEK A, 1995, BRAIN RES, V682, P75, DOI 10.1016/0006-8993(95)00324-J; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Miller JD, 1996, SLEEP, V19, P641, DOI 10.1093/sleep/19.8.641; MOFFETT JR, 1990, P NATL ACAD SCI USA, V87, P8065, DOI 10.1073/pnas.87.20.8065; NGUYEN TT, 1993, J BIOL CHEM, V268, P9803; PROSSER RA, 1994, MOL BRAIN RES, V25, P151, DOI 10.1016/0169-328X(94)90292-5; RAJU U, 1991, SCIENCE, V253, P673, DOI 10.1126/science.1871602; Rosen LB, 1996, P NATL ACAD SCI USA, V93, P1113, DOI 10.1073/pnas.93.3.1113; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; RUSAK B, 1990, SCIENCE, V248, P1237, DOI 10.1126/science.2112267; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; SEGER R, 1991, P NATL ACAD SCI USA, V88, P6142, DOI 10.1073/pnas.88.14.6142; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; WOLLNIK F, 1995, EUR J NEUROSCI, V7, P388, DOI 10.1111/j.1460-9568.1995.tb00334.x; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; YANG J, 1994, MOL CELL NEUROSCI, V5, P97, DOI 10.1006/mcne.1994.1011; Yoshitomi H, 1997, AM J PHYSIOL-ENDOC M, V272, pE769, DOI 10.1152/ajpendo.1997.272.5.E769; Yun HY, 1998, P NATL ACAD SCI USA, V95, P5773, DOI 10.1073/pnas.95.10.5773; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	50	306	311	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					693	700		10.1038/3695	http://dx.doi.org/10.1038/3695			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196585				2022-12-17	WOS:000077323400013
J	Likhtik, E; Stujenske, JM; Topiwala, MA; Harris, AZ; Gordon, JA				Likhtik, Ekaterina; Stujenske, Joseph M.; Topiwala, Mihir A.; Harris, Alexander Z.; Gordon, Joshua A.			Prefrontal entrainment of amygdala activity signals safety in learned fear and innate anxiety	NATURE NEUROSCIENCE			English	Article							CONDITIONED FEAR; PRELIMBIC CORTEX; BASOLATERAL AMYGDALA; VENTRAL HIPPOCAMPUS; EXTINCTION; EXPRESSION; RAT; MEMORY; CONSOLIDATION; OSCILLATIONS	Successfully differentiating safety from danger is an essential skill for survival. While decreased activity in the medial prefrontal cortex (mPFC) is associated with fear generalization in animals and humans, the circuit-level mechanisms used by the mPFC to discern safety are not clear. To answer this question, we recorded activity in the mPFC, basolateral amygdala (BLA) and dorsal and ventral hippocampus in mice during exposure to learned (differential fear conditioning) and innate (open field) anxiety. We found increased synchrony between the mPFC and BLA in the theta frequency range (4-12 Hz) only in animals that differentiated between averseness and safety. Moreover, during recognized safety across learned and innate protocols, BLA firing became entrained to theta input from the mPFC. These data suggest that selective tuning of BLA firing to mPFC input provides a safety-signaling mechanism whereby the mPFC taps into the microcircuitry of the amygdala to diminish fear.	[Likhtik, Ekaterina; Topiwala, Mihir A.; Harris, Alexander Z.; Gordon, Joshua A.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA; [Stujenske, Joseph M.] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY USA; [Harris, Alexander Z.] Weill Cornell Med Coll, Dept Psychiat, New York, NY USA; [Topiwala, Mihir A.; Harris, Alexander Z.; Gordon, Joshua A.] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA	Columbia University; Columbia University; Cornell University; New York State Psychiatry Institute	Gordon, JA (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA.	jg343@columbia.edu	Harris, Alexander/GPT-0688-2022	Harris, Alexander/0000-0001-9089-0366	US NIMH [R01 MH081968, P50 MH096891, F32 MH088103]; International Mental Health Research Organization; Charles H. Revson Foundation; Columbia University Medical Scientist Training Program; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015144, R01MH081968] Funding Source: NIH RePORTER	US NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); International Mental Health Research Organization; Charles H. Revson Foundation; Columbia University Medical Scientist Training Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank T. Spellman and other members of the Gordon laboratory for technical assistance and discussions. This work was supported by grants from the US NIMH to J.A.G. (R01 MH081968 and P50 MH096891) and E.L. (F32 MH088103), by the International Mental Health Research Organization (J.A.G.) and by the Charles H. Revson Foundation (E.L.). J.M.S. is supported through the Columbia University Medical Scientist Training Program.	Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; Adhikari A, 2010, J NEUROSCI METH, V191, P191, DOI 10.1016/j.jneumeth.2010.06.019; Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Amano T, 2010, NAT NEUROSCI, V13, P489, DOI 10.1038/nn.2499; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; BrinleyReed M, 1995, NEUROSCI LETT, V202, P45, DOI 10.1016/0304-3940(95)12212-5; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Busti D, 2011, J NEUROSCI, V31, P5131, DOI 10.1523/JNEUROSCI.6100-10.2011; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; Dunsmoor JE, 2009, LEARN MEMORY, V16, P460, DOI 10.1101/lm.1431609; Gazendam FJ, 2013, BIOL PSYCHOL, V92, P342, DOI 10.1016/j.biopsycho.2012.11.006; Gordon JA, 2005, J NEUROSCI, V25, P6509, DOI 10.1523/JNEUROSCI.1211-05.2005; Greenberg T, 2013, DEPRESS ANXIETY, V30, P242, DOI 10.1002/da.22016; Hauner KK, 2012, P NATL ACAD SCI USA, V109, P9203, DOI 10.1073/pnas.1205242109; Heldt SA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.101; Herry C, 2004, EUR J NEUROSCI, V20, P781, DOI 10.1111/j.1460-9568.2004.03542.x; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; Jovanovic T, 2012, NEUROPHARMACOLOGY, V62, P695, DOI 10.1016/j.neuropharm.2011.02.023; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Knapska E, 2009, LEARN MEMORY, V16, P486, DOI 10.1101/lm.1463909; Laurent V, 2009, LEARN MEMORY, V16, P520, DOI 10.1101/lm.1474609; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lesting J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021714; Likhtik E, 2005, J NEUROSCI, V25, P7429, DOI 10.1523/JNEUROSCI.2314-05.2005; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; Milad MR, 2005, P NATL ACAD SCI USA, V102, P10706, DOI 10.1073/pnas.0502441102; Narayanan NS, 2006, NEUROSCIENCE, V139, P865, DOI 10.1016/j.neuroscience.2005.11.072; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pape HC, 1998, J NEUROPHYSIOL, V79, P205, DOI 10.1152/jn.1998.79.1.205; Pare D, 2000, J NEUROSCI, V20, P2701; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Popa D, 2010, P NATL ACAD SCI USA, V107, P6516, DOI 10.1073/pnas.0913016107; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Reinecke A, 2010, DEPRESS ANXIETY, V27, P252, DOI 10.1002/da.20662; Resnik J, 2011, NAT NEUROSCI, V14, P791, DOI 10.1038/nn.2802; Sangha S, 2009, J NEUROSCI, V29, P15713, DOI 10.1523/JNEUROSCI.2620-09.2009; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sotres-Bayon F, 2012, NEURON, V76, P804, DOI 10.1016/j.neuron.2012.09.028; Truitt WA, 2009, NEUROSCIENCE, V160, P284, DOI 10.1016/j.neuroscience.2009.01.083; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106; Woodruff AR, 2007, J NEUROPHYSIOL, V98, P2956, DOI 10.1152/jn.00739.2007	47	305	312	4	118	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2014	17	1					106	113		10.1038/nn.3582	http://dx.doi.org/10.1038/nn.3582			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281DL	24241397	Green Accepted			2022-12-17	WOS:000329080000020
J	Stevenson, IH; Kording, KP				Stevenson, Ian H.; Kording, Konrad P.			How advances in neural recording affect data analysis	NATURE NEUROSCIENCE			English	Article							FIELD POTENTIALS; ENSEMBLE; PATTERNS; ARRAYS; MODEL; STATE; MOTOR	Over the last five decades, progress in neural recording techniques has allowed the number of simultaneously recorded neurons to double approximately every 7 years, mimicking Moore's law. Such exponential growth motivates us to ask how data analysis techniques are affected by progressively larger numbers of recorded neurons. Traditionally, neurons are analyzed independently on the basis of their tuning to stimuli or movement. Although tuning curve approaches are unaffected by growing numbers of simultaneously recorded neurons, newly developed techniques that analyze interactions between neurons become more accurate and more complex as the number of recorded neurons increases. Emerging data analysis techniques should consider both the computational costs and the potential for more accurate models associated with this exponential growth of the number of recorded neurons.	[Stevenson, Ian H.; Kording, Konrad P.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Stevenson, Ian H.; Kording, Konrad P.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Kording, Konrad P.] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Kording, Konrad P.] Northwestern Univ, Dept Appl Math, Chicago, IL 60611 USA	Northwestern University; Shirley Ryan AbilityLab; Northwestern University; Northwestern University	Stevenson, IH (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.	i-stevenson@northwestern.edu	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499; Stevenson, Ian/0000-0002-1428-5946	Chicago Community Trust; US National Institutes of Health [1R01NS063399, 2P01NS044393]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044393, R01NS063399] Funding Source: NIH RePORTER	Chicago Community Trust; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Thanks to A. Kohn and members of the Kohn laboratory for providing data from visual cortex (US National Institutes of Health EY016774) and N. Hatsopoulos and J. Reimer for providing data from motor cortex. All animal use procedures were approved by the institutional animal care and use committees at Albert Einstein College of Medicine and the University of Chicago, respectively. Thanks to B. Yu and J. Cunningham for providing the GPFA code and B. Yu for insightful discussions. This work was supported by the Chicago Community Trust and US National Institutes of Health grants 1R01NS063399 and 2P01NS044393.	Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Babadi B, 2010, J VISION, V10, DOI 10.1167/10.10.22; BARNA JS, 1981, ELECTROEN CLIN NEURO, V52, P494, DOI 10.1016/0013-4694(81)90035-3; Blanche TJ, 2005, J NEUROPHYSIOL, V93, P2987, DOI 10.1152/jn.01023.2004; Brette R, 2007, J COMPUT NEUROSCI, V23, P349, DOI 10.1007/s10827-007-0038-6; Brockwell AE, 2004, J NEUROPHYSIOL, V91, P1899, DOI 10.1152/jn.00438.2003; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Churchland MM, 2007, CURR OPIN NEUROBIOL, V17, P609, DOI 10.1016/j.conb.2007.11.001; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hatsopoulos N, 2004, J NEUROPHYSIOL, V92, P1165, DOI 10.1152/jn.01245.2003; Kass RE, 2005, J NEUROPHYSIOL, V94, P8, DOI 10.1152/jn.00648.2004; Kelly RC, 2007, J NEUROSCI, V27, P261, DOI 10.1523/JNEUROSCI.4906-06.2007; Kelly RC, 2010, J COMPUT NEUROSCI, V29, P567, DOI 10.1007/s10827-009-0208-9; KRUGER J, 1981, EXP BRAIN RES, V41, P191; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Maynard EM, 1999, J NEUROSCI, V19, P8083; MOORE G, 2006, UNDERSTANDING MOORES, pCH7; Moore GE, 1965, ELECTRONICS, V38, P114; Nicolelis M, 2007, METHODS NEURAL ENSEM, DOI DOI 10.1201/9781420006414; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; Okatan M, 2005, NEURAL COMPUT, V17, P1927, DOI 10.1162/0899766054322973; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; PANINSKI L, 2009, J COMPUT NEUROSCI, V29, P1; Paninski L, 2007, PROG BRAIN RES, V165, P493, DOI 10.1016/S0079-6123(06)65031-0; Papadimitriou C.H, 2003, COMPUT COMPLEX; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; Rebesco JM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00039; ROUSCHE P, 2002, IEEE T REHABIL ENG, V7, P56; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Stevenson IH, 2009, IEEE T NEUR SYS REH, V17, P203, DOI 10.1109/TNSRE.2008.2010471; Stevenson IH, 2008, CURR OPIN NEUROBIOL, V18, P582, DOI 10.1016/j.conb.2008.11.005; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Truccolo W, 2010, NAT NEUROSCI, V13, P105, DOI 10.1038/nn.2455; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Vogelstein JT, 2009, BIOPHYS J, V97, P636, DOI 10.1016/j.bpj.2008.08.005; Yu BM, 2009, J NEUROPHYSIOL, V102, P614, DOI 10.1152/jn.90941.2008	43	305	309	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					139	142		10.1038/nn.2731	http://dx.doi.org/10.1038/nn.2731			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21270781	Green Accepted			2022-12-17	WOS:000286595400008
J	Cappello, S; Attardo, A; Wu, XW; Iwasato, T; Itohara, S; Wilsch-Brauninger, M; Eilken, HM; Rieger, MA; Schroeder, TT; Huttner, WB; Brakebusch, C; Gotz, M				Cappello, Silvia; Attardo, Alessio; Wu, Xunwei; Iwasato, Takuji; Itohara, Shigeyoshi; Wilsch-Braeuninger, Michaela; Eilken, Hanna M.; Rieger, Michael A.; Schroeder, Timm T.; Huttner, Wieland B.; Brakebusch, Cord; Goetz, Magdalena			The Rho-GTPase cdc42 regulates neural progenitor fate at the apical surface	NATURE NEUROSCIENCE			English	Article							CELL-CYCLE; NEUROEPITHELIAL CELLS; SUBVENTRICULAR ZONE; RADIAL GLIA; ASYMMETRIC DISTRIBUTION; ADHERENS JUNCTIONS; BRAIN-DEVELOPMENT; LAYER NEURONS; BETA-CATENIN; MOUSE-BRAIN	Stem cell persistence into adulthood requires self-renewal from early developmental stages. In the developing mouse brain, only apical progenitors located at the ventricle are self-renewing, whereas basal progenitors gradually deplete. However, nothing is known about the mechanisms regulating the fundamental difference between these progenitors. Here we show that the conditional deletion of the small Rho-GTPase cdc42 at different stages of neurogenesis in mouse telencephalon results in an immediate increase in basal mitoses. Whereas cdc42-deficient progenitors have normal cell cycle length, orientation of cell division and basement membrane contact, the apical location of the Par complex and adherens junctions are gradually lost, leading to an increasing failure of apically directed interkinetic nuclear migration. These cells then undergo mitoses at basal positions and acquire the fate of basal progenitors. Thus, cdc42 has a crucial role at the apical pole of progenitors, thereby regulating the position of mitoses and cell fate.	GSF, Natl Res Ctr Environm & Hlth, Inst Stem Cell Res, D-85764 Munich, Germany; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Univ Copenhagen, Inst Mol Pathol, Fac Hlth Sci, DK-2100 Copenhagen, Denmark; RIKEN, Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3510198, Japan; Univ Munich, Inst Physiol, D-80336 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Max Planck Society; University of Copenhagen; RIKEN; University of Munich	Gotz, M (corresponding author), GSF, Natl Res Ctr Environm & Hlth, Inst Stem Cell Res, Ingolstadter Landstr 1, D-85764 Munich, Germany.	magdalena.goetz@gsf.de	Rieger, Michael A/L-8324-2017; Schroeder, Timm/F-8448-2010; Itohara, Shigeyoshi/I-8769-2012; Huttner, Wieland B./P-4080-2018; Cappello, Silvia/AAQ-4590-2021; Wu, Xunwei/J-9014-2018	Rieger, Michael A/0000-0002-4158-5872; Schroeder, Timm/0000-0001-9320-0252; Itohara, Shigeyoshi/0000-0002-2410-9989; Cappello, Silvia/0000-0003-1553-6775; Wu, Xunwei/0000-0002-0822-1700; Brakebusch, Cord/0000-0002-9342-1634; Attardo, Alessio/0000-0003-0665-6011				Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Czuchra A, 2005, MOL BIOL CELL, V16, P4473, DOI 10.1091/mbc.E05-01-0061; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; ETO K, 1995, DEV GROWTH DIFFER, V37, P123, DOI 10.1046/j.1440-169X.1995.t01-1-00001.x; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524; Heins N, 2001, MOL CELL NEUROSCI, V18, P485, DOI 10.1006/mcne.2001.1046; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Manabe N, 2002, DEV DYNAM, V225, P61, DOI 10.1002/dvdy.10139; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; SMART IHM, 1976, J ANAT, V121, P71; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Zhang RL, 2004, J NEUROSCI, V24, P5810, DOI 10.1523/JNEUROSCI.1109-04.2004; Zimmer C, 2004, CEREB CORTEX, V14, P1408, DOI 10.1093/cercor/bhh102	50	305	314	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1099	1107		10.1038/nn1744	http://dx.doi.org/10.1038/nn1744			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16892058				2022-12-17	WOS:000240080800010
J	Morris, G; Nevet, A; Arkadir, D; Vaadia, E; Bergman, H				Morris, Genela; Nevet, Alon; Arkadir, David; Vaadia, Eilon; Bergman, Hagai			Midbrain dopamine neurons encode decisions for future action	NATURE NEUROSCIENCE			English	Article							MATCHING BEHAVIOR; BASAL GANGLIA; REWARD; PREDICTION; REPRESENTATION; PROBABILITY; INHIBITION; MOTIVATION; SUBSTRATE; MODELS	Current models of the basal ganglia and dopamine neurons emphasize their role in reinforcement learning. However, the role of dopamine neurons in decision making is still unclear. We recorded from dopamine neurons in monkeys engaged in two types of trial: reference trials in an instructed-choice task and decision trials in a two-armed bandit decision task. We show that the activity of dopamine neurons in the decision setting is modulated according to the value of the upcoming action. Moreover, analysis of the probability matching strategy in the decision trials revealed that the dopamine population activity and not the reward during reference trials determines choice behavior. Because dopamine neurons do not have spatial or motor properties, we conclude that immediate decisions are likely to be generated elsewhere and conveyed to the dopamine neurons, which play a role in shaping long-term decision policy through dynamic modulation of the efficacy of basal ganglia synapses.	Hebrew Univ Jerusalem, ICNC, IL-91220 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Physiol, IL-91220 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Morris, G (corresponding author), Hebrew Univ Jerusalem, ICNC, POB 12272, IL-91220 Jerusalem, Israel.	genela.morris@charite.de	Vaadia, Eilon/E-9347-2011; Morris, Genela/B-7844-2008; Bergman, Hagai/AAI-4683-2021	Bergman, Hagai/0000-0002-2402-6673; Morris, Genela/0000-0002-5417-8977				Bar-Gad I, 2003, PROG NEUROBIOL, V71, P439, DOI 10.1016/j.pneurobio.2003.12.001; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Beiser, 1995, MODELS INFORM PROCES, P215; Cragg SJ, 2004, TRENDS NEUROSCI, V27, P270, DOI 10.1016/j.tins.2004.03.011; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Dommett E, 2005, SCIENCE, V307, P1476, DOI 10.1126/science.1107026; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; Gurney K, 2004, TRENDS NEUROSCI, V27, P453, DOI 10.1016/j.tins.2004.06.003; Herrnstein RJ, 1970, J EXP ANAL BEHAV, V13, P243, DOI 10.1901/jeab.1970.13-243; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Martin RF, 2000, PRIMATE BRAIN MAPS S; McClure SM, 2003, TRENDS NEUROSCI, V26, P423, DOI 10.1016/S0166-2236(03)00177-2; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Nevet A, 2004, J NEUROPHYSIOL, V92, P1973, DOI 10.1152/jn.01036.2003; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; Rummery G., 1994, ON LINE Q LEARNING U; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Sokal R.R., 1981, BIOMETRY, V2nd ed.; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; SZABO J, 1984, J COMP NEUROL, V222, P265, DOI 10.1002/cne.902220208; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Vulkan N, 2000, J ECON SURV, V14, P101, DOI 10.1111/1467-6419.00106; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Wickens JR, 2005, HAND CHEM N, V21, P199; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wolford G, 2000, J NEUROSCI, V20, part. no.	40	305	308	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1057	1063		10.1038/nn1743	http://dx.doi.org/10.1038/nn1743			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16862149				2022-12-17	WOS:000240080300019
J	Maffei, A; Nelson, SB; Turrigiano, GG				Maffei, A; Nelson, SB; Turrigiano, GG			Selective reconfiguration of layer 4 visual cortical circuitry by visual deprivation	NATURE NEUROSCIENCE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; MONOCULAR DEPRIVATION; IMMUNOREACTIVE NEURONS; NEOCORTICAL SYNAPSES; SYNAPTIC PLASTICITY; SENSORY EXPERIENCE; OCULAR DOMINANCE; NERVOUS-SYSTEM; CORTEX; INHIBITION	Visual deprivation during a developmental sensitive period markedly alters visual cortical response properties, but the changes in intracortical circuitry that underlie these effects are poorly understood. Here we use a slice preparation of rat primary visual cortex to show that 2 d of prior visual deprivation early in life increases the excitability of layer 4 circuitry. Slice recordings showed that spontaneous activity of layer 4 star pyramidal neurons increased 25-fold after 2 d of visual deprivation between postnatal days ( P) 15 and P17. This effect was mediated by increased net excitatory and decreased net inhibitory synaptic drive. Paired recordings showed that excitatory connections between star pyramidal neurons doubled in amplitude, whereas inhibitory connections decreased or increased depending on the interneuron class. These effects reversed when vision was restored. This dynamic adjustment of the excitation-inhibition balance may allow the networks within layer 4 to maintain stable levels of activity in the face of variable sensory input.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Turrigiano, GG (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.	turrigiano@brandeis.edu		Nelson, Sacha/0000-0002-0108-8599; Maffei, Arianna/0000-0001-6755-8904	NATIONAL EYE INSTITUTE [R01EY014439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016455] Funding Source: NIH RePORTER; NEI NIH HHS [EY014439] Funding Source: Medline; NIDA NIH HHS [DA16455] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; BENEVENTO LA, 1992, BRAIN RES, V572, P198, DOI 10.1016/0006-8993(92)90470-T; BENEVENTO LA, 1995, BRAIN RES, V689, P172, DOI 10.1016/0006-8993(95)00553-3; Caleo M, 1999, NEUROSCIENCE, V91, P1017, DOI 10.1016/S0306-4522(98)00682-4; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; CHUTKOW JG, 1974, NEUROLOGY, V24, P780, DOI 10.1212/WNL.24.8.780; DeFelipe J, 2002, PROG BRAIN RES, V136, P215; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; DEUCHARS J, 1995, NEUROSCIENCE, V65, P935, DOI 10.1016/0306-4522(95)00020-J; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Finnerty GT, 2000, P NATL ACAD SCI USA, V97, P12864, DOI 10.1073/pnas.230175697; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hajos F, 1997, NEUROSCI LETT, V228, P179, DOI 10.1016/S0304-3940(97)00399-6; HENDRY SHC, 1990, J NEUROSCI, V10, P2438; HENDRY SHC, 1986, NATURE, V320, P750, DOI 10.1038/320750a0; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; Martin KAC, 2002, CURR OPIN NEUROBIOL, V12, P418, DOI 10.1016/S0959-4388(02)00343-4; Maurer D, 1999, SCIENCE, V286, P108, DOI 10.1126/science.286.5437.108; MEINECKE DL, 1987, J COMP NEUROL, V261, P388, DOI 10.1002/cne.902610305; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; Morales B, 2002, J NEUROSCI, V22, P8084; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; PETERS A, 1985, J COMP NEUROL, V234, P242, DOI 10.1002/cne.902340209; PETERS A, 1985, J COMP NEUROL, V234, P218, DOI 10.1002/cne.902340208; PETERS A, 1988, J COMP NEUROL, V267, P409, DOI 10.1002/cne.902670310; REID SNM, 1991, BRAIN RES, V563, P293, DOI 10.1016/0006-8993(91)91549-G; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Shao ZW, 1996, J NEUROSCI, V16, P7353; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/s0896-6273(01)00542-6; Taha S, 2002, NEURON, V34, P425, DOI 10.1016/S0896-6273(02)00673-6; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; VANSLUYTERS RC, 1978, J PHYSIOL-LONDON, V284, P1; WORLEY PF, 1991, P NATL ACAD SCI USA, V88, P5106, DOI 10.1073/pnas.88.12.5106; ZHANG ET, 1990, J CEREBR BLOOD F MET, V10, P136, DOI 10.1038/jcbfm.1990.18; ZILLES K, 1984, J COMP NEUROL, V226, P391, DOI 10.1002/cne.902260308	50	305	311	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1353	1359		10.1038/nn1351	http://dx.doi.org/10.1038/nn1351			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15543139				2022-12-17	WOS:000225353900016
J	Beites, CL; Xie, H; Bowser, R; Trimble, WS				Beites, CL; Xie, H; Bowser, R; Trimble, WS			The septin CDCrel-1 binds syntaxin and inhibits exocytosis	NATURE NEUROSCIENCE			English	Article							CEREVISIAE CELL-CYCLE; NEUROTRANSMITTER RELEASE; MEMBRANE-FUSION; GENE-PRODUCT; SYNAPTIC VESICLES; BUDDING SITE; BUD NECK; PROTEIN; COMPLEX; LOCALIZATION	Septins are GTPases required for the completion of cytokinesis in diverse organisms, yet their roles in cytokinesis or other cellular processes remain unknown. Here we describe studies of a newly identified septin, CDCrel-1, which is predominantly expressed in the nervous system. This protein was associated with membrane fractions, and a significant fraction of the protein copurified and coprecipitated with synaptic vesicles. In detergent extracts, CDCrel-1 and another septin, Nedd5, immunoprecipitated with the SNARE protein syntaxin by directly binding to syntaxin via the SNARE interaction domain. Transfection of HIT-T15 cells with wild-type CDCrel-1 inhibited secretion, whereas GTPase dominant-negative mutants enhanced secretion. These data suggest that septins may regulate vesicle dynamics through interactions with syntaxin.	Univ Toronto, Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5G 1X8, Canada; Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Trimble, WS (corresponding author), Univ Toronto, Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.				NIA NIH HHS [AG13208] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R29AG013208] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BOWSER R, 1992, J CELL BIOL, V118, P1041, DOI 10.1083/jcb.118.5.1041; Burgess RW, 1997, J CELL BIOL, V138, P861, DOI 10.1083/jcb.138.4.861; Byers B, 1981, MOL BIOL YEAST SACCH, P59; BYERS B, 1976, J CELL BIOL, V70, P35; Caltagarone J, 1998, NEUROREPORT, V9, P2907, DOI 10.1097/00001756-199808240-00042; CHANDLER DE, 1980, J CELL BIOL, V86, P666, DOI 10.1083/jcb.86.2.666; FARES H, 1995, MOL BIOL CELL, V6, P1843, DOI 10.1091/mbc.6.12.1843; Field CM, 1996, J CELL BIOL, V133, P605, DOI 10.1083/jcb.133.3.605; FORD SK, 1991, DEV GENET, V12, P281, DOI 10.1002/dvg.1020120405; Gaisano HY, 1996, MOL BIOL CELL, V7, P2019, DOI 10.1091/mbc.7.12.2019; GAISANO HY, 1994, J BIOL CHEM, V269, P17062; HAARER BK, 1987, MOL CELL BIOL, V7, P3678, DOI 10.1128/MCB.7.10.3678; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Honer WG, 1997, NEUROSCIENCE, V78, P99, DOI 10.1016/S0306-4522(96)00489-7; HONER WG, 1993, BRAIN RES, V609, P9, DOI 10.1016/0006-8993(93)90848-H; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Huang XH, 1998, MOL ENDOCRINOL, V12, P1060, DOI 10.1210/me.12.7.1060; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; KIM HB, 1991, J CELL BIOL, V112, P535, DOI 10.1083/jcb.112.4.535; Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; McKie JM, 1997, HUM GENET, V101, P6, DOI 10.1007/s004390050576; MONCK JR, 1994, NEURON, V12, P707, DOI 10.1016/0896-6273(94)90325-5; NEUFELD TP, 1994, CELL, V77, P371, DOI 10.1016/0092-8674(94)90152-X; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; ROTHMAN JE, 1994, CURR BIOL, V4, P220, DOI 10.1016/S0960-9822(00)00051-8; SANDERS SL, 1994, CURR BIOL, V4, P907, DOI 10.1016/S0960-9822(00)00201-3; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weis WI, 1998, NATURE, V395, P328, DOI 10.1038/26354; Wheeler MB, 1996, ENDOCRINOLOGY, V137, P1340, DOI 10.1210/en.137.4.1340; XIE H, IN PRESS CELL MOTIL; Zieger B, 1997, J CLIN INVEST, V99, P520, DOI 10.1172/JCI119188	40	305	313	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					434	439		10.1038/8100	http://dx.doi.org/10.1038/8100			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321247				2022-12-17	WOS:000084609400013
J	Pouget, A; Beck, JM; Ma, WJ; Latham, PE				Pouget, Alexandre; Beck, Jeffrey M.; Ma, Wei Ji; Latham, Peter E.			Probabilistic brains: knowns and unknowns	NATURE NEUROSCIENCE			English	Review							NEURAL IMPLEMENTATION; BAYESIAN-INFERENCE; POPULATION CODES; INTEGRATION; INFORMATION; MODEL; REPRESENTATION; ORIENTATION; COMPUTATION; RESPONSES	There is strong behavioral and physiological evidence that the brain both represents probability distributions and performs probabilistic inference. Computational neuroscientists have started to shed light on how these probabilistic representations and computations might be implemented in neural circuits. One particularly appealing aspect of these theories is their generality: they can be used to model a wide range of tasks, from sensory processing to high-level cognition. To date, however, these theories have only been applied to very simple tasks. Here we discuss the challenges that will emerge as researchers start focusing their efforts on real-life computations, with a focus on probabilistic learning, structural learning and approximate inference.	[Pouget, Alexandre; Beck, Jeffrey M.] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; [Pouget, Alexandre] Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland; [Pouget, Alexandre; Latham, Peter E.] UCL, Gatsby Computat Neurosci Unit, London, England; [Ma, Wei Ji] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	University of Rochester; University of Geneva; University of London; University College London; Baylor College of Medicine	Pouget, A (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	alexandre.pouget@unige.ch		Pouget, Alexandre/0000-0003-3054-6365; Ma, Wei Ji/0000-0002-9835-9083	Gatsby Charitable Foundation; National Eye Institute grant [R01EY020958-01]; National Science Foundation [IIS-1132009, BCS0446730]; Army Research Office grant [W911NF-12-1-0262]; Multi-University Research Initiative grant [N00014-07-1-0937]; National Institute on Drug Abuse [BCS0346785]; Swiss National Fund [31003A 143707]; James S. McDonnell Foundation; NATIONAL EYE INSTITUTE [R01EY020958] Funding Source: NIH RePORTER	Gatsby Charitable Foundation; National Eye Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Science Foundation(National Science Foundation (NSF)); Army Research Office grant; Multi-University Research Initiative grant; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Swiss National Fund(Swiss National Science Foundation (SNSF)); James S. McDonnell Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	P.E.L. is supported by the Gatsby Charitable Foundation, W.J.M. by National Eye Institute grant R01EY020958-01, National Science Foundation grant IIS-1132009 (Collaborative Research in Computational Neuroscience), and Army Research Office grant W911NF-12-1-0262, and A.P. by National Science Foundation grant #BCS0446730, Multi-University Research Initiative grant #N00014-07-1-0937, National Institute on Drug Abuse grants #BCS0346785, the Swiss National Fund (31003A 143707) and a research grant from the James S. McDonnell Foundation.	Achler T, 2008, FR ART INT, V171, P15; Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Anastasio TJ, 2000, NEURAL COMPUT, V12, P1165, DOI 10.1162/089976600300015547; ANDERSON CH, 1994, COMPUTATIONAL INTELL, P213; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; [Anonymous], 2003, NEURAL ENG COMPUTATI; [Anonymous], 1993, THEORY PROBABILITY C; Ballard DH, 1997, BEHAV BRAIN SCI, V20, P723, DOI 10.1017/S0140525X97001611; Barber MJ, 2003, NEURAL COMPUT, V15, P1843, DOI 10.1162/08997660360675062; BARLOW HB, 1969, ANN NY ACAD SCI, V156, P872, DOI 10.1111/j.1749-6632.1969.tb14019.x; Bayes T., 1763, PHILOS T ROY SOC LON, V53, P370, DOI [DOI 10.1098/RSTL.1763.0053, 10.1098/rstl.1763.0053]; Beck J., 2012, ADV NEURAL INFORM PR, V25, P3059; Beck JM, 2007, NEURAL COMPUT, V19, P1344, DOI 10.1162/neco.2007.19.5.1344; Beck JM, 2012, NEURON, V74, P30, DOI 10.1016/j.neuron.2012.03.016; Beck JM, 2011, J NEUROSCI, V31, P15310, DOI 10.1523/JNEUROSCI.1706-11.2011; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Berens P, 2012, J NEUROSCI, V32, P10618, DOI 10.1523/JNEUROSCI.1335-12.2012; Bishop C., 2006, PATTERN RECOGNITION; Bogacz R, 2007, NEURAL COMPUT, V19, P442, DOI 10.1162/neco.2007.19.2.442; Bohte SM, 2007, NEURAL COMPUT, V19, P371, DOI 10.1162/neco.2007.19.2.371; Bowers JS, 2012, PSYCHOL BULL, V138, P389, DOI 10.1037/a0026450; Braun DA, 2010, BEHAV BRAIN RES, V206, P157, DOI 10.1016/j.bbr.2009.08.031; Chater N, 2006, TRENDS COGN SCI, V10, P287, DOI 10.1016/j.tics.2006.05.007; Chomsky Noam, 1965, ASPECTS THEORY SYNTA; Churchland AK, 2011, NEURON, V69, P818, DOI 10.1016/j.neuron.2010.12.037; Collins A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001293; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; Deneve S, 2007, J NEUROSCI, V27, P5744, DOI 10.1523/JNEUROSCI.3985-06.2007; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fajen BR, 2007, EXP BRAIN RES, V180, P303, DOI 10.1007/s00221-007-0859-6; Fetsch CR, 2012, NAT NEUROSCI, V15, P146, DOI 10.1038/nn.2983; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; FOLDIAK P, 1993, COMPUTATION AND NEURAL SYSTEMS, P55; Gallistel C., 2009, MEMORY COMPUTATIONAL, DOI 10.1002/9781444310498; Gigerenzer G., 1999, SIMPLE HEURISTICS MA; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Graf ABA, 2011, NAT NEUROSCI, V14, P239, DOI 10.1038/nn.2733; Griffiths TL, 2012, PSYCHOL BULL, V138, P415, DOI 10.1037/a0026884; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Hoyer PO, 2003, ADV NEURAL INFORM PR, V15, P293; Hsu AS, 2011, COGNITION, V120, P380, DOI 10.1016/j.cognition.2011.02.013; Huys QJM, 2007, NEURAL COMPUT, V19, P404, DOI 10.1162/neco.2007.19.2.404; Isope P, 2002, J NEUROSCI, V22, P9668; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Jurafsky D, 1996, COGNITIVE SCI, V20, P137, DOI 10.1207/s15516709cog2002_1; Kappen HJ, 2012, MACH LEARN, V87, P159, DOI 10.1007/s10994-012-5278-7; Kemp C, 2008, P NATL ACAD SCI USA, V105, P10687, DOI 10.1073/pnas.0802631105; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Knill DC, 1998, VISION RES, V38, P1655, DOI 10.1016/S0042-6989(97)00324-6; Knill DC, 1996, PERCEPTION BAYESIAN; Koechlin E, 1999, BIOL CYBERN, V80, P25, DOI 10.1007/s004220050502; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; Laplace P.S., 1820, THEORIE ANAL PROBABI; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Levy Roger P., 2007, ADV NEURAL INFORM PR, V19, DOI DOI 10.5555/2976456.2976563; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Ma WJ, 2011, NAT NEUROSCI, V14, P783, DOI 10.1038/nn.2814; Mach E, 1897, CONTRIBUTIONS ANAL S, P63; MacKay David JC, 2003, INFORM THEORY INFERE; MACKAY DJC, 1992, NEURAL COMPUT, V4, P415, DOI 10.1162/neco.1992.4.3.448; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Moreno-Bote R, 2011, P NATL ACAD SCI USA, V108, P12491, DOI 10.1073/pnas.1101430108; Parra LC, 2009, NEURAL COMPUT, V21, P2991, DOI 10.1162/neco.2009.04-06-184; Paulin MG, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S06; Plate TA, 2003, HOLOGRAPHIC REDUCED; POGGIO T, 1990, COLD SPRING HARB SYM, V55, P899; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Quartz SR, 1997, BEHAV BRAIN SCI, V20, P537; Rao RPN, 2004, NEURAL COMPUT, V16, P1, DOI 10.1162/08997660460733976; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; Sanger TD, 1996, J NEUROPHYSIOL, V76, P2790, DOI 10.1152/jn.1996.76.4.2790; Simard Patrice Y., 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P235, DOI 10.1007/978-3-642-35289-8_17; SMOLENSKY P, 1990, ARTIF INTELL, V46, P159, DOI 10.1016/0004-3702(90)90007-M; Stewart T., 2011, OXFORD HDB COMPOSITI; Steyvers M, 2006, TRENDS COGN SCI, V10, P327, DOI 10.1016/j.tics.2006.05.005; Stigler Stephen M., 1980, SCI SOCIAL STRUCTURE, P147, DOI [10.1111/j.2164-0947.1980.tb02775.x, DOI 10.1111/J.2164-0947.1980.TB02775.X]; Tenenbaum J. B., 2003, ADV NEURAL INFORM PR, V15, P35; Tenenbaum JB, 2006, TRENDS COGN SCI, V10, P309, DOI 10.1016/j.tics.2006.05.009; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2008, IEEE DECIS CONTR P, P4286, DOI 10.1109/CDC.2008.4739438; Toyoizumi T, 2005, P NATL ACAD SCI USA, V102, P5239, DOI 10.1073/pnas.0500495102; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Van Horn KS, 2003, INT J APPROX REASON, V34, P3, DOI 10.1016/S0888-613X(03)00051-3; vanBeers RJ, 1996, EXP BRAIN RES, V111, P253, DOI 10.1007/BF00227302; von Helmholtz H, 1891, Z PSYCHOL PHYSL SINN, V2, P1; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818	92	304	304	4	117	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1170	1178		10.1038/nn.3495	http://dx.doi.org/10.1038/nn.3495			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23955561	Green Accepted			2022-12-17	WOS:000323597500005
J	Peters, HC; Hu, H; Pongs, O; Storm, JF; Isbrandt, D				Peters, HC; Hu, H; Pongs, O; Storm, JF; Isbrandt, D			Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior	NATURE NEUROSCIENCE			English	Article							RAT HIPPOCAMPAL-NEURONS; POTASSIUM CHANNELS; PYRAMIDAL NEURONS; K+ CHANNEL; FREQUENCY PREFERENCES; NEONATAL CONVULSIONS; THETA-OSCILLATIONS; MAMMALIAN-CELLS; KCNQ2 SUBUNITS; WORKING-MEMORY	In humans, mutations in the KCNQ2 or KCNQ3 potassium-channel genes are associated with an inherited epilepsy syndrome. We have studied the contribution of KCNQ/M-channels to the control of neuronal excitability by using transgenic mice that conditionally express dominant-negative KCNQ2 subunits in brain. We show that suppression of the neuronal M current in mice is associated with spontaneous seizures, behavioral hyperactivity and morphological changes in the hippocampus. Restriction of transgene expression to defined developmental periods revealed that M-channel activity is critical to the development of normal hippocampal morphology during the first postnatal weeks. Suppression of the M current after this critical period resulted in mice with signs of increased neuronal excitability and deficits in hippocampus-dependent spatial memory. M-current-deficient hippocampal CA1 pyramidal neurons showed increased excitability, reduced spike-frequency adaptation, attenuated medium afterhyperpolarization and reduced intrinsic subthreshold theta resonance. M channels are thus critical determinants of cellular and neuronal network excitability, postnatal brain development and cognitive performance.	Zentrum Mol Neurobiol Hamburg, Inst Neurale Signalverarbeitung, D-20246 Hamburg, Germany; Univ Oslo, Dept Physiol, Inst Basic Med Sci, N-0317 Oslo, Norway; Univ Oslo, Ctr Mol Biol & Neurosci, N-0317 Oslo, Norway	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Oslo; University of Oslo	Storm, JF (corresponding author), Zentrum Mol Neurobiol Hamburg, Inst Neurale Signalverarbeitung, Martinistr 52, D-20246 Hamburg, Germany.	j.f.storm@medisin.uio.no; isbrandt@uni-hamburg.de		Isbrandt, Dirk/0000-0002-4720-1016; Hu, Hua/0000-0001-8187-4735				Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Blumcke I, 2002, BRAIN PATHOL, V12, P199; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Borgatti R, 2004, NEUROLOGY, V63, P57, DOI 10.1212/01.WNL.0000132979.08394.6D; BROWN D, 1988, TRENDS NEUROSCI, V11, P294, DOI 10.1016/0166-2236(88)90089-6; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cooper EC, 2000, P NATL ACAD SCI USA, V97, P4914, DOI 10.1073/pnas.090092797; Cooper EC, 2001, J NEUROSCI, V21, P9529, DOI 10.1523/JNEUROSCI.21-24-09529.2001; Dedek K, 2003, EPILEPSY RES, V54, P21, DOI 10.1016/S0920-1211(03)00037-8; Dedek K, 2001, P NATL ACAD SCI USA, V98, P12272, DOI 10.1073/pnas.211431298; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hadley JK, 2003, J NEUROSCI, V23, P5012; HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4; Holmes GL, 1998, NEURON, V21, P1231, DOI 10.1016/S0896-6273(00)80642-X; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P683, DOI 10.1152/jn.1996.76.2.683; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Khazipov R, 2004, EUR J NEUROSCI, V19, P590, DOI 10.1111/j.0953-816X.2003.03152.x; Lechner SG, 2003, J PHYSIOL-LONDON, V553, P789, DOI 10.1113/jphysiol.2003.052449; Leung LS, 1998, J NEUROPHYSIOL, V79, P1592, DOI 10.1152/jn.1998.79.3.1592; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; MALENKA RC, 1986, J NEUROSCI, V6, P475; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; Martire M, 2004, J NEUROSCI, V24, P592, DOI 10.1523/JNEUROSCI.3143-03.2004; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; NITECKA L, 1984, NEUROSCIENCE, V13, P1073, DOI 10.1016/0306-4522(84)90289-6; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Pike FG, 2000, J PHYSIOL-LONDON, V529, P205, DOI 10.1111/j.1469-7793.2000.00205.x; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; RYAN SG, 1991, ANN NEUROL, V29, P469, DOI 10.1002/ana.410290504; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; SCHRETER RK, 1996, PSYCHIAT PRACTICE MA, V2, P3; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; Shah MM, 2002, J PHYSIOL-LONDON, V544, P29, DOI 10.1113/jphysiol.2002.028571; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; STORM JF, 1989, J PHYSIOL-LONDON, V409, P171, DOI 10.1113/jphysiol.1989.sp017491; STORM JF, 1990, PROG BRAIN RES, V83, P161; Tremblay P, 1998, P NATL ACAD SCI USA, V95, P12580, DOI 10.1073/pnas.95.21.12580; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x; WILLIAMSON A, 1990, J NEUROPHYSIOL, V63, P72, DOI 10.1152/jn.1990.63.1.72; Yang Y, 2003, HUM MOL GENET, V12, P975, DOI 10.1093/hmg/ddg118	50	304	314	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					51	60		10.1038/nn1375	http://dx.doi.org/10.1038/nn1375			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15608631				2022-12-17	WOS:000225967600015
J	Khakh, BS; Bao, XR; Labarca, C; Lester, HA				Khakh, BS; Bao, XR; Labarca, C; Lester, HA			Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds	NATURE NEUROSCIENCE			English	Article							FAST SYNAPTIC TRANSMISSION; ATP RECEPTOR; EXTRACELLULAR K+; SENSORY NEURONS; POTASSIUM CHANGES; NERVOUS-SYSTEM; RAT; BRAIN; RELEASE; ADENOSINE	Fast synaptic transmission depends on the selective ionic permeability of transmitter-gated ion channels. Here we show changes in the ion selectivity of neuronal P2X transmitter-gated cation channels as a function of time (on the order of seconds) and previous ATP exposure. Heterologously expressed P2X2 P2X2/P2X3 and P2X4 channels as well as native neuronal P2X channels possess various combinations of mono- or biphasic responses and permeability changes, measured by NMDG(+) and fluorescent dye. Furthermore, in P2X4 receptors, this ability to alter ion selectivity can be increased or decreased by altering an amino-acid residue thought to line the ion permeation pathway, identifying a region that governs this activity-dependent change.	CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA	California Institute of Technology	Khakh, BS (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011756] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-11756] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bardoni R, 1997, J NEUROSCI, V17, P5297; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Braun N, 1998, J NEUROSCI, V18, P4891; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; BURNSTOCK G, 1972, PHARMACOL REV, V24, P509; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; Collo G, 1997, NEUROPHARMACOLOGY, V36, P1277, DOI 10.1016/S0028-3908(97)00140-8; Collo G, 1996, J NEUROSCI, V16, P2495; Cook SP, 1997, NATURE, V387, P505, DOI 10.1038/387505a0; Cunha RA, 1996, J NEUROCHEM, V67, P2180; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; Egan TM, 1998, J NEUROSCI, V18, P2350; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; EVANS RJ, 1992, NATURE, V357, P503, DOI 10.1038/357503a0; GALLIGAN JJ, 1994, J NEUROSCI, V14, P7563; Green T, 1998, NEURON, V20, P427, DOI 10.1016/S0896-6273(00)80986-1; Gu JGG, 1997, NATURE, V389, P749, DOI 10.1038/39639; Hille B., 1992, IONIC CHANNELS EXCIT; Khakh BS, 1998, MOL PHARMACOL, V54, P372, DOI 10.1124/mol.54.2.372; KIDD EJ, 1995, MOL PHARMACOL, V48, P569; KRNJEVIC K, 1982, CAN J PHYSIOL PHARM, V60, P1643, DOI 10.1139/y82-243; KRNJEVIC K, 1980, CAN J PHYSIOL PHARM, V58, P579, DOI 10.1139/y80-097; KRNJEVIC K, 1982, CAN J PHYSIOL PHARM, V60, P1658, DOI 10.1139/y82-244; Le KT, 1998, NEUROSCIENCE, V83, P177, DOI 10.1016/S0306-4522(97)00365-5; Le KT, 1998, J NEUROSCI, V18, P7152; LESTER HA, 1992, ANNU REV BIOPH BIOM, V21, P267, DOI 10.1146/annurev.bb.21.060192.001411; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Lutz PL, 1997, BRAIN RES, V769, P281, DOI 10.1016/S0006-8993(97)00719-1; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MORRIS ME, 1993, AM J PHYSIOL, V264, pR761, DOI 10.1152/ajpregu.1993.264.4.R761; Newbolt A, 1998, J BIOL CHEM, V273, P15177, DOI 10.1074/jbc.273.24.15177; NICHOLSON C, 1978, J NEUROPHYSIOL, V41, P1026, DOI 10.1152/jn.1978.41.4.1026; Nieber K, 1997, BRIT J PHARMACOL, V122, P423, DOI 10.1038/sj.bjp.0701386; North RA, 1996, CURR OPIN CELL BIOL, V8, P474, DOI 10.1016/S0955-0674(96)80023-8; PUMAIN R, 1985, J NEUROPHYSIOL, V53, P1; QUICK MW, 1994, ION CHANNELS EXCITAB, P261; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Seguela P, 1996, J NEUROSCI, V16, P448; Soto F, 1996, P NATL ACAD SCI USA, V93, P3684, DOI 10.1073/pnas.93.8.3684; Starkus JG, 1997, J GEN PHYSIOL, V110, P539, DOI 10.1085/jgp.110.5.539; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; SURPRENANT A, 1995, TRENDS NEUROSCI, V18, P224, DOI 10.1016/0166-2236(95)93907-F; TERRIAN DM, 1989, J NEUROCHEM, V53, P1390, DOI 10.1111/j.1471-4159.1989.tb08529.x; Torres GE, 1998, FEBS LETT, V425, P19, DOI 10.1016/S0014-5793(98)00179-3; Vulchanova L, 1997, NEUROPHARMACOLOGY, V36, P1229, DOI 10.1016/S0028-3908(97)00126-3; Vulchanova L, 1996, P NATL ACAD SCI USA, V93, P8063, DOI 10.1073/pnas.93.15.8063; WICRASZKO A, 1989, BRAIN RES, V485, P244	50	304	311	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					322	330		10.1038/7233	http://dx.doi.org/10.1038/7233			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200GV	10204538				2022-12-17	WOS:000080532000010
J	Somerville, LH; Heatherton, TF; Kelley, WM				Somerville, Leah H.; Heatherton, Todd F.; Kelley, William M.			Anterior cingulate cortex responds differentially to expectancy violation and social rejection	NATURE NEUROSCIENCE			English	Article								This study investigated human anterior cingulate cortex (ACC) involvement during a task that dissociated expectancy violation from social rejection. Across two studies, participants underwent functional magnetic resonance imaging while making social judgments and receiving fictitious feedback that was either positive or negative and consistent or inconsistent with their expectations. The results demonstrate that the dorsal ACC is sensitive to expectancy violations, whereas the ventral ACC is differentially responsive to social feedback.	Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; Dartmouth Coll, Ctr Cognit Neurosci, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Kelley, WM (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	william.kelley@dartmouth.edu	Heatherton, Todd F/H-5478-2011		NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH066720, R01MH059282] Funding Source: NIH RePORTER; NIMH NIH HHS [MH66720, MH59282, R21 MH066720] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; CONDON JW, 1988, J PERS SOC PSYCHOL, V54, P789, DOI 10.1037/0022-3514.54.5.789; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Newcomb T.M, 1961, ACQUAINTANCE PROCESS; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0	7	303	310	6	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1007	1008		10.1038/nn1728	http://dx.doi.org/10.1038/nn1728			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16819523				2022-12-17	WOS:000240080300012
J	Brewer, AA; Liu, JJ; Wade, AR; Wandell, BA				Brewer, AA; Liu, JJ; Wade, AR; Wandell, BA			Visual field maps and stimulus selectivity in human ventral occipital cortex	NATURE NEUROSCIENCE			English	Article							HUMAN EXTRASTRIATE CORTEX; FUSIFORM FACE AREA; HUMAN OBJECT AREAS; HUMAN COLOR-CENTER; FUNCTIONAL MRI; ORGANIZATION; BRAIN; TOPOGRAPHY; PERCEPTION; FMRI	Human visual cortex is organized into distinct visual field maps whose locations and properties provide important information about visual computations. There are two conflicting models of the organization and computational role of ventral occipital visual field maps. We report new functional MRI measurements that test these models. We also present the first coordinated measurements of visual field maps and stimulus responsivity to color, objects and faces in ventral occipital cortex. These measurements support a model that includes a hemifield map, hV4, adjacent to the central field representation of ventral V3. In addition, the measurements demonstrate a cluster of visual field maps in ventral occipital cortex ( VO cluster) anterior to hV4. We describe the organization and stimulus responsivity of two new hemifield maps, VO-1 and VO-2, within this cluster. The maps and stimulus responsivity support a general organization of visual cortex based on clusters of maps that serve distinct computational functions.	Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	Stanford University; Stanford University; The Smith-Kettlewell Eye Research Institute	Brewer, AA (corresponding author), Stanford Univ, Neurosci Program, Stanford, CA 94305 USA.	alyssa.brewer@stanford.edu	Wade, Alex/B-5473-2010	Liu, Junjie/0000-0001-5820-4266; Wade, Alexander Robert/0000-0003-4871-2747; Brewer, Alyssa/0000-0001-8820-1525	NEI NIH HHS [R01 EY03164] Funding Source: Medline; NINDS NIH HHS [F30 NS044759, 5 F30 NS44759] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY003164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS044759] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAIZER JS, 1991, J NEUROSCI, V11, P168; Bartels A, 2000, EUR J NEUROSCI, V12, P172, DOI 10.1046/j.1460-9568.2000.00905.x; Beauchamp MS, 1999, CEREB CORTEX, V9, P257, DOI 10.1093/cercor/9.3.257; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; BRAINARD DH, 1995, HDB OPTICAL SOC, V1; DAMASIO A, 1980, NEUROLOGY, V30, P1064, DOI 10.1212/WNL.30.10.1064; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Ejima Y, 2003, NEUROREPORT, V14, P1579, DOI 10.1097/00001756-200308260-00008; Engel S, 1997, NATURE, V388, P68, DOI 10.1038/40398; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; GATTASS R, 1988, J NEUROSCI, V8, P1831; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Glover GH, 1999, MAGNET RESON MED, V42, P412, DOI 10.1002/(SICI)1522-2594(199908)42:2<412::AID-MRM25>3.0.CO;2-U; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; Hasson U, 2002, NEURON, V34, P479, DOI 10.1016/S0896-6273(02)00662-1; Hasson U, 2003, NEURON, V37, P1027, DOI 10.1016/S0896-6273(03)00144-2; Ishai A, 2000, J COGNITIVE NEUROSCI, V12, P35, DOI 10.1162/089892900564055; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; Levy I, 2004, HUM BRAIN MAPP, V22, P15, DOI 10.1002/hbm.20010; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; MEADOWS JC, 1974, J NEUROL NEUROSUR PS, V37, P489, DOI 10.1136/jnnp.37.5.489; MEADOWS JC, 1974, BRAIN, V97, P615, DOI 10.1093/brain/97.1.615; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; Rosa MGP, 2005, PHILOS T R SOC B, V360, P665, DOI 10.1098/rstb.2005.1626; Sasaki Y, 2001, P NATL ACAD SCI USA, V98, P2077, DOI 10.1073/pnas.98.4.2077; SERENO MI, 1994, CEREB CORTEX, V4, P601, DOI 10.1093/cercor/4.6.601; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; Van Essen DC, 2003, VISUAL NEUROSCIENCES, V1, P507; Wade AR, 2002, PHILOS T R SOC B, V357, P963, DOI 10.1098/rstb.2002.1108; Wandell B.A., 1995, FDN VISION; Wandell BA, 2002, P IEEE, V90, P5, DOI 10.1109/5.982401; Wandell BA, 1999, ANNU REV NEUROSCI, V22, P145, DOI 10.1146/annurev.neuro.22.1.145; Wandell BA, 2005, PHILOS T R SOC B, V360, P693, DOI 10.1098/rstb.2005.1628; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; ZEKI S, 1991, J NEUROSCI, V11, P641; Zeki S, 1999, PHILOS T R SOC B, V354, P1371, DOI 10.1098/rstb.1999.0485; Zeki S, 1998, NAT NEUROSCI, V1, P335, DOI 10.1038/1537	50	303	304	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1102	1109		10.1038/nn1507	http://dx.doi.org/10.1038/nn1507			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16025108				2022-12-17	WOS:000230760200023
J	Sakai, K; Passingham, RE				Sakai, K; Passingham, RE			Prefrontal interactions reflect future task operations	NATURE NEUROSCIENCE			English	Article							FRONTAL-LOBE DAMAGE; WORKING-MEMORY; PREMOTOR CORTEX; EPISODIC MEMORY; LONDON TASK; ORGANIZATION; RETRIEVAL; DISSOCIATION; PERFORMANCE; NEURONS	When task instructions are given, the human brain establishes a task set before the task is actually performed. By introducing a delay between the instruction and the task, we have identified the neural correlates of task sets using functional magnetic resonance imaging (fMRI). Subjects were instructed to remember a sequence of positions or letters, either in the order presented or in the reverse order. Spatial or verbal processing areas were active during the delay, depending on whether positions or letters were to be remembered, whereas the anterior region of the prefrontal cortex (PFC) was active regardless of the domain of the items. Furthermore, the nature of the interaction between the anterior PFC and the domain-specific posterior prefrontal areas (superior frontal sulcus and left inferior frontal gyrus) depended on whether the items were to be remembered in the forward or backward order. Thus we have identified inter-regional interactions that reflect preparation for task performance.	Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of London; University College London; University of Oxford	Sakai, K (corresponding author), Inst Neurol, Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.							Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Baker SC, 1996, NEUROPSYCHOLOGIA, V34, P515, DOI 10.1016/0028-3932(95)00133-6; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Calton JL, 2002, NAT NEUROSCI, V5, P580, DOI 10.1038/nn862; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crammond DJ, 2000, J NEUROPHYSIOL, V84, P986, DOI 10.1152/jn.2000.84.2.986; Dagher A, 1999, BRAIN, V122, P1973, DOI 10.1093/brain/122.10.1973; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Duzel E, 1999, P NATL ACAD SCI USA, V96, P1794, DOI 10.1073/pnas.96.4.1794; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; KURATA K, 1988, EXP BRAIN RES, V69, P327; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; Leung HC, 2002, J COGNITIVE NEUROSCI, V14, P659, DOI 10.1162/08989290260045882; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Meiran N, 2000, COGNITIVE PSYCHOL, V41, P211, DOI 10.1006/cogp.2000.0736; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; Owen AM, 1999, EUR J NEUROSCI, V11, P567, DOI 10.1046/j.1460-9568.1999.00449.x; Pochon JB, 2001, CEREB CORTEX, V11, P260, DOI 10.1093/cercor/11.3.260; Postle BR, 1999, P NATL ACAD SCI USA, V96, P12959, DOI 10.1073/pnas.96.22.12959; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rogers RD, 1998, BRAIN, V121, P815, DOI 10.1093/brain/121.5.815; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; RUSHWORTH MFS, IN PRESS J COGN NEUR; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; Wylie G, 2000, PSYCHOL RES-PSYCH FO, V63, P212, DOI 10.1007/s004269900003	35	303	305	2	21	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					75	81		10.1038/nn987	http://dx.doi.org/10.1038/nn987			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12469132				2022-12-17	WOS:000180089300018
J	Beck, DM; Rees, G; Frith, CD; Lavie, N				Beck, DM; Rees, G; Frith, CD; Lavie, N			Neural correlates of change detection and change blindness	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; ACTIVATION; ATTENTION; CORTEX; PERCEPTION; RIVALRY; FACE; MT	Functional magnetic resonance imaging (fMRI) of subjects attempting to detect a visual change occurring during a screen flicker was used to distinguish the neural correlates of change detection from those of change blindness. Change detection resulted in enhanced activity in the parietal and right dorsolateral prefrontal cortex as well as category-selective regions of the extrastriate visual cortex (for example, fusiform gyrus for changing faces). Although change blindness resulted in some extrastriate activity, the dorsal activations were clearly absent. These results demonstrate the importance of parietal and dorsolateral frontal activations for conscious detection of changes in properties coded in the ventral visual pathway, and thus suggest a key involvement of dorsal-ventral interactions in visual awareness.	UCL, Dept Psychol, London WC1E 6BT, England; UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England	University of London; University College London; University of London; University College London; University of London; University College London	Beck, DM (corresponding author), UCL, Dept Psychol, Gower St, London WC1E 6BT, England.	diane.beck@ucl.ac.uk	Frith, Chris D/A-2171-2009; Rees, Geraint/C-1493-2008; Beck, Diane M/F-7536-2010	Frith, Chris D/0000-0002-8665-0690; Rees, Geraint/0000-0002-9623-7007; Beck, Diane M/0000-0001-9802-5828	Wellcome Trust [067453] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CORBETTA M, 1991, J NEUROSCI, V11, P2383; Coull JT, 1998, NEUROIMAGE, V8, P176, DOI 10.1006/nimg.1998.0354; Driver J, 1998, NAT NEUROSCI, V1, P17, DOI 10.1038/217; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Farah M.J., 1990, VISUAL AGNOSIA DISOR; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Gitelman DR, 2000, NEUROIMAGE, V11, P58, DOI 10.1006/nimg.1999.0517; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kleinschmidt A, 1998, P ROY SOC B-BIOL SCI, V265, P2427, DOI 10.1098/rspb.1998.0594; Logothetis N, 1998, CURR OPIN NEUROBIOL, V8, P536; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; MACK A, 1998, INATTENTIONAL BUSINE; MILNER D, 1955, VISUAL BRAIN ASTION; NAVON D, 1979, PSYCHOL REV, V86, P214, DOI 10.1037/0033-295X.86.3.214; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; Rees G, 1999, SCIENCE, V286, P2504, DOI 10.1126/science.286.5449.2504; Rees G, 2000, BRAIN, V123, P1624, DOI 10.1093/brain/123.8.1624; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Ro T, 2001, PSYCHOL SCI, V12, P94, DOI 10.1111/1467-9280.00317; Shulman GL, 2001, P NATL ACAD SCI USA, V98, P313, DOI 10.1073/pnas.021381198; Simons DJ, 1998, PSYCHON B REV, V5, P644, DOI 10.3758/BF03208840; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Turner R, 1998, EXP BRAIN RES, V123, P5, DOI 10.1007/s002210050538; Zeki S., 1993, VISION BRAIN	29	303	313	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					645	650		10.1038/88477	http://dx.doi.org/10.1038/88477			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	438PG	11369947				2022-12-17	WOS:000169061800019
J	Gentet, LJ; Kremer, Y; Taniguchi, H; Huang, ZJ; Staiger, JF; Petersen, CCH				Gentet, Luc J.; Kremer, Yves; Taniguchi, Hiroki; Huang, Z. Josh; Staiger, Jochen F.; Petersen, Carl C. H.			Unique functional properties of somatostatin-expressing GABAergic neurons in mouse barrel cortex	NATURE NEUROSCIENCE			English	Article							PRIMARY SOMATOSENSORY CORTEX; GREEN FLUORESCENT PROTEIN; CONTAINING INTERNEURONS; SYNAPTIC INTEGRATION; SENSORIMOTOR SYSTEM; CORTICAL-NEURONS; MARTINOTTI CELLS; PYRAMIDAL CELLS; TRANSGENIC MICE; CEREBRAL-CORTEX	Neocortical GABAergic neurons have diverse molecular, structural and electrophysiological features, but the functional correlates of this diversity are largely unknown. We found unique membrane potential dynamics of somatostatin-expressing (SOM) neurons in layer 2/3 of the primary somatosensory barrel cortex of awake behaving mice. SOM neurons were spontaneously active during periods of quiet wakefulness. However, SOM neurons hyperpolarized and reduced action potential firing in response to both passive and active whisker sensing, in contrast with all other recorded types of nearby neurons, which were excited by sensory input. Optogenetic inhibition of SOM neurons increased burst firing in nearby excitatory neurons. We hypothesize that the spontaneous activity of SOM neurons during quiet wakefulness provides a tonic inhibition to the distal dendrites of excitatory pyramidal neurons. Conversely, the inhibition of SOM cells during active cortical processing likely enhances distal dendritic excitability, which may be important for top-down computations and sensorimotor integration.	[Gentet, Luc J.; Kremer, Yves; Petersen, Carl C. H.] EPFL, Fac Life Sci, Brain Mind Inst, Lab Sensory Proc, Zurich, Switzerland; [Gentet, Luc J.] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1012 WX Amsterdam, Netherlands; [Taniguchi, Hiroki; Huang, Z. Josh] Cold Spring Harbor, Cold Spring Harbor Lab, New York, NY USA; [Staiger, Jochen F.] Univ Gottingen, Dept Neuroanat, Gottingen, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Amsterdam; Cold Spring Harbor Laboratory; University of Gottingen	Petersen, CCH (corresponding author), EPFL, Fac Life Sci, Brain Mind Inst, Lab Sensory Proc, Zurich, Switzerland.	carl.petersen@epfl.ch	Gentet, Luc/GNN-0460-2022; Petersen, Carl/M-5123-2017; Gentet, Luc J/H-5127-2017	Gentet, Luc/0000-0001-6509-1001; Petersen, Carl/0000-0003-3344-4495; Gentet, Luc J/0000-0001-6509-1001; Huang, Z. Josh/0000-0003-0592-028X; Kremer, Yves/0000-0002-2319-1394	Swiss National Science Foundation; Human Frontiers in Science Program; SystemsX.ch; Deutsche Forschungsgemeinschaft [Sta 431/8-1, 10-1]; Deutsche Forschungsgemeinschaft/Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontiers in Science Program(Human Frontier Science Program); SystemsX.ch; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft/Swiss National Science Foundation	We thank L. Looger (Howard Hughes Medical Institute, Janelia Farm) for GCaMP3 and K. Deisseroth (Stanford University) for eNpHR3.0. This work was funded by grants from the Swiss National Science Foundation (C.C.H.P.), Human Frontiers in Science Program (C.C.H.P.), SystemsX.ch (C.C.H.P.) and Deutsche Forschungsgemeinschaft (Sta 431/8-1, 10-1 to J.E.S.), and a joint Deutsche Forschungsgemeinschaft/Swiss National Science Foundation grant Bacofun (C.C.H.P. and J.E.S.).	Acsady L, 1996, NEUROSCIENCE, V73, P317, DOI 10.1016/0306-4522(95)00609-5; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Brecht M, 2007, CURR OPIN NEUROBIOL, V17, P408, DOI 10.1016/j.conb.2007.07.008; Burkhalter A, 2008, FRONT NEUROSCI-SWITZ, V2, P155, DOI 10.3389/neuro.01.026.2008; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; Curtis JC, 2009, NAT NEUROSCI, V12, P492, DOI 10.1038/nn.2283; Dalezios Y, 2002, CEREB CORTEX, V12, P961, DOI 10.1093/cercor/12.9.961; David C, 2007, EUR J NEUROSCI, V25, P2329, DOI 10.1111/j.1460-9568.2007.05496.x; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Fanselow EE, 2008, J NEUROPHYSIOL, V100, P2640, DOI 10.1152/jn.90691.2008; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Mateo C, 2011, CURR BIOL, V21, P1593, DOI 10.1016/j.cub.2011.08.028; McGarry LM, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00012; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; SOMOGYI P, 1977, BRAIN RES, V136, P345, DOI 10.1016/0006-8993(77)90808-3; Staiger JF, 2004, J COMP NEUROL, V468, P179, DOI 10.1002/cne.10953; Suzuki N, 2010, J COMP NEUROL, V518, P1670, DOI 10.1002/cne.22295; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Xu XM, 2009, J NEUROSCI, V29, P70, DOI 10.1523/JNEUROSCI.4104-08.2009	47	302	304	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					607	612		10.1038/nn.3051	http://dx.doi.org/10.1038/nn.3051			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22366760				2022-12-17	WOS:000302114500021
J	Beurg, M; Fettiplace, R; Nam, JH; Ricci, AJ				Beurg, Maryline; Fettiplace, Robert; Nam, Jong-Hoon; Ricci, Anthony J.			Localization of inner hair cell mechanotransducer channels using high-speed calcium imaging	NATURE NEUROSCIENCE			English	Article							TRANSDUCTION CHANNELS; MECHANOELECTRICAL TRANSDUCTION; FAST ADAPTATION; STEREOCILIA; CONDUCTANCE; MYOSIN-1C; CORTI; ORGAN; LINKS; SITE	Hair cells detect vibrations of their stereociliary bundle by activation of mechanically sensitive transducer channels. Although evidence suggests the transducer channels are near the stereociliary tops and are opened by force imparted by tip links connecting contiguous stereocilia, the exact channel site remains controversial. We used fast confocal imaging of fluorescence changes reflecting calcium entry during bundle stimulation to localize the channels. Calcium signals were visible in single stereocilia of rat cochlear inner hair cells and were up to tenfold larger and faster in the second and third stereociliary rows than in the tallest first row. The number of functional stereocilia was proportional to transducer current amplitude, indicating that there were about two channels per stereocilium. Comparable results were obtained in outer hair cells. The observations, supported by theoretical simulations, suggest there are no functional mechanically sensitive transducer channels in first row stereocilia and imply the channels are present only at the bottom of the tip links.	[Fettiplace, Robert; Nam, Jong-Hoon] Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA; [Beurg, Maryline] Univ Victor Segalen Bordeaux 2, Hop Pellegrin, INSERM, U587, Bordeaux, France; [Ricci, Anthony J.] Stanford Univ, Dept Otolaryngol, Stanford, CA 94305 USA; [Ricci, Anthony J.] Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	University of Wisconsin System; University of Wisconsin Madison; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Stanford University; Stanford University	Fettiplace, R (corresponding author), Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA.	fettiplace@physiology.wisc.edu; aricci@stanford.edu		Beurg, Maryline/0000-0003-3069-267X; Nam, Jong-Hoon/0000-0002-7477-5453; ricci, anthony/0000-0002-1706-8904	National Institute on Deafness and other Communication Disorders [RO1 DC03896, DC01362]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003896, R01DC001362] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Redshirt Imaging and Prairie Technologies for help in optimizing the confocal system. This work was supported by National Institute on Deafness and other Communication Disorders grants RO1 DC03896 to A.J.R. and DC01362 to R.F.	ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Beurg M, 2006, J NEUROSCI, V26, P10992, DOI 10.1523/JNEUROSCI.2188-06.2006; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; FETTIPLACE R, 2006, SPRINGER HDB AUDITOR, P154; FURNESS DN, 1989, HEARING RES, V38, P95, DOI 10.1016/0378-5955(89)90131-7; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; HARASZTOSI C, 2008, ASS RES OT ABS, V258; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1982, J NEUROSCI, V2, P1; JARAMILLO F, 1991, NEURON, V7, P409, DOI 10.1016/0896-6273(91)90293-9; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; LUMPKIN EA, 1995, P NATL ACAD SCI USA, V92, P10297, DOI 10.1073/pnas.92.22.10297; Lumpkin EA, 1998, J NEUROSCI, V18, P6300; Nam JH, 2008, BIOPHYS J, V95, P4948, DOI 10.1529/biophysj.108.138560; OHMORI H, 1985, J PHYSIOL-LONDON, V359, P189, DOI 10.1113/jphysiol.1985.sp015581; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Ricci AJ, 2003, NEURON, V40, P983, DOI 10.1016/S0896-6273(03)00721-9; ROTH B, 1992, ANAT EMBRYOL, V185, P571, DOI 10.1007/BF00185616; Stauffer EA, 2005, NEURON, V47, P541, DOI 10.1016/j.neuron.2005.07.024; Waguespack J, 2007, J NEUROSCI, V27, P13890, DOI 10.1523/JNEUROSCI.2159-07.2007; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; Wu YC, 1996, BIOPHYS J, V71, P2256, DOI 10.1016/S0006-3495(96)79429-8	23	302	308	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2009	12	5					553	558		10.1038/nn.2295	http://dx.doi.org/10.1038/nn.2295			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438SJ	19330002	Green Accepted			2022-12-17	WOS:000265575400011
J	Ying, LT; Chin, C				Ying, LT; Chin, C			Specification of ventral neuron types is mediated by an antagonistic interaction between Shh and Gli3	NATURE NEUROSCIENCE			English	Article							FLOOR PLATE DIFFERENTIATION; DEVELOPING SPINAL-CORD; CENTRAL-NERVOUS-SYSTEM; SONIC HEDGEHOG; CUBITUS-INTERRUPTUS; MOTOR-NEURONS; GENE-FUNCTION; CHICK-EMBRYO; IN-VITRO; EXPRESSION	Specification of distinct neuron types in the ventral spinal cord is thought to be mediated by a graded concentration of Sonic hedgehog (Shh), a secreted signaling protein. Shh is made in the notochord, the most ventral part of the spinal cord, and in mice lacking Shh, ventral cell types are reduced or absent. The response to Shh depends on transcription factors of the Gli family, but the detailed mechanism is not understood. Here we show that Gli3 represses ventral fates in a dose-dependent manner. Whereas Shh(-/-) mutant mice show reductions in several classes of ventral interneurons and a complete absence of motor neurons, these cell types were rescued in Shh(-/-);Gli3(-/-) double mutants. This rescue of the Shh null phenotype depended on the level of Gli3 function; a partial rescue was observed in Shh(-/-);Gli3(+/-) embryos. We propose that Shh is required to antagonize Gli3, which would otherwise repress ventral fates. Differences between rostral and caudal regions suggest that other signaling molecules-in addition to Shh-may be involved in specifying ventral fates, particularly in the caudal region of the spinal cord.	Vanderbilt Univ, Med Ctr, Dept Cell Biol, Nashville, TN 37232 USA	Vanderbilt University	Chin, C (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell Biol, B2120 MCN, Nashville, TN 37232 USA.	chin.chiang@mcmail.vanderbilt.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD073263, R01HD037489] Funding Source: NIH RePORTER; NICHD NIH HHS [HD37489, N01-HD-7-3263] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Berggren K, 1999, DEV BIOL, V210, P288, DOI 10.1006/dbio.1999.9286; BLANC PA, 1999, TRENDS GENET, V15, P458; Borycki AG, 1999, DEVELOPMENT, V126, P4053; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Burrill JD, 1997, DEVELOPMENT, V124, P4493; Buscher D, 1998, MAMM GENOME, V9, P676, DOI 10.1007/s003359900845; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Ding Q, 1998, DEVELOPMENT, V125, P2533; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; Krishnan V, 1997, SCIENCE, V278, P1947, DOI 10.1126/science.278.5345.1947; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Mansouri A, 1998, MECH DEVELOP, V78, P171, DOI 10.1016/S0925-4773(98)00168-3; Matise MP, 1998, DEVELOPMENT, V125, P2759; Matise MP, 1997, J NEUROSCI, V17, P7805; Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; OPPENHEIM RW, 1989, DEV BIOL, V133, P468, DOI 10.1016/0012-1606(89)90050-X; Park HL, 2000, DEVELOPMENT, V127, P1593; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Renoncourt Y, 1998, MECH DEVELOP, V79, P185, DOI 10.1016/S0925-4773(98)00189-0; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; Sasaki H, 1997, DEVELOPMENT, V124, P1313; SASAKI H, 1994, CELL, V76, P103, DOI 10.1016/0092-8674(94)90176-7; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Shin SH, 1999, P NATL ACAD SCI USA, V96, P2880, DOI 10.1073/pnas.96.6.2880; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Swindell EC, 1999, DEV BIOL, V216, P282, DOI 10.1006/dbio.1999.9487; Tabin CJ, 1997, TRENDS CELL BIOL, V7, P442, DOI 10.1016/S0962-8924(97)01159-8; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Theil T, 1999, DEVELOPMENT, V126, P3561; Tremblay P, 1996, DEVELOPMENT, V122, P2555; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9	49	302	308	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					979	985		10.1038/79916	http://dx.doi.org/10.1038/79916			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017169				2022-12-17	WOS:000167177500014
J	Kaufman, MT; Churchland, MM; Ryu, SI; Shenoy, KV				Kaufman, Matthew T.; Churchland, Mark M.; Ryu, Stephen I.; Shenoy, Krishna V.			Cortical activity in the null space: permitting preparation without movement	NATURE NEUROSCIENCE			English	Article							PRIMATE SPINAL INTERNEURONS; PREMOTOR CORTEX; PRIMARY MOTOR; PRIOR INFORMATION; NEURAL DYNAMICS; MUSCLE-ACTIVITY; ARM MOVEMENTS; CELL-ACTIVITY; DIRECTION; ROLES	Neural circuits must perform computations and then selectively output the results to other circuits. Yet synapses do not change radically at millisecond timescales. A key question then is: how is communication between neural circuits controlled? In motor control, brain areas directly involved in driving movement are active well before movement begins. Muscle activity is some readout of neural activity, yet it remains largely unchanged during preparation. Here we find that during preparation, while the monkey holds still, changes in motor cortical activity cancel out at the level of these population readouts. Motor cortex can thereby prepare the movement without prematurely causing it. Further, we found evidence that this mechanism also operates in dorsal premotor cortex, largely accounting for how preparatory activity is attenuated in primary motor cortex. Selective use of 'output-null' vs. 'output-potent' patterns of activity may thus help control communication to the muscles and between these brain areas.	[Kaufman, Matthew T.; Shenoy, Krishna V.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Kaufman, Matthew T.; Ryu, Stephen I.; Shenoy, Krishna V.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Kaufman, Matthew T.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Churchland, Mark M.] Columbia Univ, Med Ctr, Dept Neurosci, New York, NY USA; [Churchland, Mark M.] Columbia Univ, Med Ctr, Grossman Ctr Stat Mind, New York, NY USA; [Churchland, Mark M.] Columbia Univ, Med Ctr, David Mahoney Ctr Brain & Behav Res, New York, NY USA; [Churchland, Mark M.] Columbia Univ, Med Ctr, Kavli Inst Brain Sci, New York, NY USA; [Ryu, Stephen I.] Palo Alto Med Fdn, Dept Neurosurg, Palo Alto, CA USA; [Shenoy, Krishna V.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University; Stanford University; Cold Spring Harbor Laboratory; Columbia University; Columbia University; Columbia University; Columbia University; Palo Alto Medical Foundation Research Institute; Stanford University; Stanford University	Shenoy, KV (corresponding author), Stanford Univ, Neurosci Program, Stanford, CA 94305 USA.	shenoy@stanford.edu	Kaufman, Matthew/AAK-2860-2020; Kaufman, Matthew T/B-6273-2014	Kaufman, Matthew/0000-0002-8072-023X; Kaufman, Matthew T/0000-0002-8072-023X	US National Science Foundation graduate research fellowship; Burroughs Wellcome Fund Career Awards in the Biomedical Sciences; Christopher and Dana Reeve Foundation; US National Institutes of Health (NIH) [CRCNS R01-NS054283]; NIH Director's Pioneer Award [1DP1OD006409]; US Defense Advanced Research Projects Agency [REPAIR N66001-10-C-2010]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD075623] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY019007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054283] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006409] Funding Source: NIH RePORTER	US National Science Foundation graduate research fellowship(National Science Foundation (NSF)); Burroughs Wellcome Fund Career Awards in the Biomedical Sciences; Christopher and Dana Reeve Foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Mazariegos for expert surgical assistance and veterinary care, D. Haven for technical support and S. Eisensee for administrative support. This work was supported by a US National Science Foundation graduate research fellowship (M. T. K.), Burroughs Wellcome Fund Career Awards in the Biomedical Sciences (M. M. C., K. V. S.), the Christopher and Dana Reeve Foundation (S. I. R., K. V. S.), US National Institutes of Health (NIH) CRCNS R01-NS054283 (K. V. S.), NIH Director's Pioneer Award 1DP1OD006409 (K. V. S.) and US Defense Advanced Research Projects Agency REPAIR N66001-10-C-2010 (K.V.S.).	Afshar A, 2011, NEURON, V71, P555, DOI 10.1016/j.neuron.2011.05.047; Ames KC, 2014, NEURON, V81, P438, DOI 10.1016/j.neuron.2013.11.003; Benjamin PR, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00030; BULLOCK D, 1988, PSYCHOL REV, V95, P49, DOI 10.1037/0033-295X.95.1.49; CHENEY PD, 1980, J NEUROPHYSIOL, V44, P773, DOI 10.1152/jn.1980.44.4.773; Churchland MM, 2007, CURR OPIN NEUROBIOL, V17, P609, DOI 10.1016/j.conb.2007.11.001; Churchland MM, 2007, J NEUROPHYSIOL, V97, P4235, DOI 10.1152/jn.00095.2007; Churchland MM, 2007, J NEUROPHYSIOL, V97, P348, DOI 10.1152/jn.00808.2006; Churchland MM, 2006, J NEUROPHYSIOL, V96, P3130, DOI 10.1152/jn.00307.2006; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Cisek P, 2006, J NEUROSCI, V26, P9761, DOI 10.1523/JNEUROSCI.5605-05.2006; Cisek P, 2009, J NEUROSCI, V29, P11560, DOI 10.1523/JNEUROSCI.1844-09.2009; Crammond DJ, 2000, J NEUROPHYSIOL, V84, P986, DOI 10.1152/jn.2000.84.2.986; Ditterich J, 2006, EUR J NEUROSCI, V24, P3628, DOI 10.1111/j.1460-9568.2006.05221.x; DUM RP, 1991, J NEUROSCI, V11, P667; Dum RP, 2002, PHYSIOL BEHAV, V77, P677, DOI 10.1016/S0031-9384(02)00929-0; Duque J, 2009, CEREB CORTEX, V19, P2013, DOI 10.1093/cercor/bhn230; EVINGER C, 1982, J NEUROPHYSIOL, V47, P827, DOI 10.1152/jn.1982.47.5.827; Fetz EE, 2002, BRAIN RES REV, V40, P53, DOI 10.1016/S0165-0173(02)00188-1; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GODSCHALK M, 1985, BEHAV BRAIN RES, V18, P143, DOI 10.1016/0166-4328(85)90070-1; Graziano MSA, 2011, NEURON, V71, P387, DOI 10.1016/j.neuron.2011.07.014; Green AM, 2011, TRENDS NEUROSCI, V34, P61, DOI 10.1016/j.tins.2010.11.003; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; HOCHERMAN S, 1991, EXP BRAIN RES, V83, P285; Johnson MTV, 1999, J NEUROPHYSIOL, V81, P875, DOI 10.1152/jn.1999.81.2.875; Jun JK, 2010, J NEUROSCI, V30, P916, DOI 10.1523/JNEUROSCI.2062-09.2010; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Kaufman MT, 2013, J NEUROPHYSIOL, V110, P817, DOI 10.1152/jn.00892.2011; Kaufman MT, 2010, J NEUROPHYSIOL, V104, P799, DOI 10.1152/jn.00231.2009; Leyton ASF, 1917, Q J EXP PHYSIOL, V11, P135, DOI 10.1113/expphysiol.1917.sp000240; Machens CK, 2010, J NEUROSCI, V30, P350, DOI 10.1523/JNEUROSCI.3276-09.2010; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Messier J, 2000, J NEUROPHYSIOL, V84, P152, DOI 10.1152/jn.2000.84.1.152; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Morrow MM, 2009, ADV EXP MED BIOL, V629, P179, DOI 10.1007/978-0-387-77064-2_9; Morrow MM, 2003, J NEUROPHYSIOL, V89, P2279, DOI 10.1152/jn.00632.2002; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Prut Y, 1999, NATURE, V401, P590, DOI 10.1038/44145; RIEHLE A, 1989, J NEUROPHYSIOL, V61, P534, DOI 10.1152/jn.1989.61.3.534; RIEHLE A, 1993, BEHAV BRAIN RES, V53, P35, DOI 10.1016/S0166-4328(05)80264-5; Rivera-Alvidrez Z, 2010, IEEE ENG MED BIO, P6027, DOI 10.1109/IEMBS.2010.5627604; Schieber MH, 2007, J NEUROPHYSIOL, V97, P70, DOI 10.1152/jn.00544.2006; Shenoy KV, 2013, ANNU REV NEUROSCI, V36, P337, DOI 10.1146/annurev-neuro-062111-150509; Shenoy KV, 2011, PROG BRAIN RES, V192, P33, DOI 10.1016/B978-0-444-53355-5.00003-8; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tresch MC, 1999, NAT NEUROSCI, V2, P162, DOI 10.1038/5721; WEINRICH M, 1982, J NEUROSCI, V2, P1329; WISE SP, 1986, PROG BRAIN RES, V64, P117; Yu BM, 2009, J NEUROPHYSIOL, V102, P614, DOI 10.1152/jn.90941.2008	55	301	302	3	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2014	17	3					440	448		10.1038/nn.3643	http://dx.doi.org/10.1038/nn.3643			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AB8CA	24487233	Green Accepted			2022-12-17	WOS:000332016500018
J	Mander, BA; Rao, V; Lu, B; Saletin, JM; Lindquist, JR; Ancoli-Israel, S; Jagust, W; Walker, MP				Mander, Bryce A.; Rao, Vikram; Lu, Brandon; Saletin, Jared M.; Lindquist, John R.; Ancoli-Israel, Sonia; Jagust, William; Walker, Matthew P.			Prefrontal atrophy, disrupted NREM slow waves and impaired hippocampal-dependent memory in aging	NATURE NEUROSCIENCE			English	Article							GROWTH-HORMONE; EEG SLEEP; CONSOLIDATION; YOUNG; MEN; DYNAMICS; DECLINE; SCALE	Aging has independently been associated with regional brain atrophy, reduced slow wave activity (SWA) during non rapid eye movement (NREM) sleep and impaired long-term retention of episodic memories. However, whether the interaction of these factors represents a neuropatholgical pathway associated with cognitive decline in later life remains unknown. We found that age-related medial prefrontal cortex (mPFC) gray-matter atrophy was associated with reduced NREM SWA in older adults, the extent to which statistically mediated the impairment of overnight sleep dependent memory retention. Moreover, this memory impairment was further associated with persistent hippocampal activation and reduced task-related hippocampal-prefrontal cortex functional connectivity, potentially representing impoverished hippocampal-neocortical memory transformation. Together, these data support a model in which age-related mPFC atrophy diminishes SWA, the functional consequence of which is impaired long-term memory. Such findings suggest that sleep disruption in the elderly, mediated by structural brain changes, represents a contributing factor to age-related cognitive decline in later life	[Mander, Bryce A.; Rao, Vikram; Saletin, Jared M.; Lindquist, John R.; Walker, Matthew P.] Univ Calif Berkeley, Sleep & Neuroimaging Lab, Berkeley, CA 94720 USA; [Lu, Brandon] Calif Pacific Med Ctr, Div Pulm & Crit Care Med, San Francisco, CA USA; [Ancoli-Israel, Sonia] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Jagust, William; Walker, Matthew P.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Jagust, William] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; California Pacific Medical Center; University of California System; University of California San Diego; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mander, BA (corresponding author), Univ Calif Berkeley, Sleep & Neuroimaging Lab, Berkeley, CA 94720 USA.	bamander@berkeley.edu; mpwalker@berkeley.edu	Jagust, William/ABE-6426-2020; Rao, Vikram/J-6931-2016	Saletin, Jared/0000-0002-8547-0161; Mander, Bryce/0000-0002-0831-7980	US National Institutes of Health [R01-AG031164, R01-AG034570, R01-AG08415, F32-AG039170]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG039170, R01AG008415, R01AG034570, R01AG031164] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Belshe, M. Shatter, M. Binod, S. Bowditch, C. Dang, A. Hayenga, A. Horn, E. Hur, C. Markeley, E. Mormino, M. Nicholas, L. Zhang and A. Zhu for their assistance, A. Mander for his aid in task design, and M. Rubens and A. Gazzaley for use of their aging template brain. This work was supported by awards R01-AG031164 (M.P.W.), R01-AG034570 (W.J.), R01-AG08415 (S.A.-I.) and F32-AG039170 (B.A.M.) from the US National Institutes of Health.	Albert MS, 1997, PHILOS T ROY SOC B, V352, P1703, DOI 10.1098/rstb.1997.0152; Backhaus J, 2007, LEARN MEMORY, V14, P336, DOI 10.1101/lm.470507; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buchmann A, 2011, CEREB CORTEX, V21, P607, DOI 10.1093/cercor/bhq129; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Davis HP, 2003, CORTEX, V39, P1063, DOI 10.1016/S0010-9452(08)70878-5; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; DIJK DJ, 1989, NEUROBIOL AGING, V10, P677, DOI 10.1016/0197-4580(89)90004-3; DIJK DJ, 1993, BRAIN RES, V626, P190, DOI 10.1016/0006-8993(93)90579-C; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; MACKINNON DP, 1995, MULTIVAR BEHAV RES, V30, P41, DOI 10.1207/s15327906mbr3001_3; Mander BA, 2011, CURR BIOL, V21, pR183, DOI 10.1016/j.cub.2011.01.019; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Marzano C, 2010, J SLEEP RES, V19, P260, DOI 10.1111/j.1365-2869.2009.00776.x; MONK TH, 1989, PSYCHIAT RES, V27, P89, DOI 10.1016/0165-1781(89)90013-9; Mormino EC, 2009, BRAIN, V132, P1310, DOI 10.1093/brain/awn320; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nadel Lynn, 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/90472; Naylor E, 2000, SLEEP, V23, P87; Nelson DL, 2004, BEHAV RES METH INS C, V36, P402, DOI 10.3758/BF03195588; Otten LJ, 2007, J COGNITIVE NEUROSCI, V19, P1776, DOI 10.1162/jocn.2007.19.11.1776; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Van Cauter E, 2000, JAMA-J AM MED ASSOC, V284, P861, DOI 10.1001/jama.284.7.861; VanCauter E, 1997, J CLIN INVEST, V100, P745, DOI 10.1172/JCI119587; Vitiello MV, 2009, CURR DIR PSYCHOL SCI, V18, P316, DOI 10.1111/j.1467-8721.2009.01659.x; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Westerberg CE, 2012, J INT NEUROPSYCH SOC, V18, P490, DOI 10.1017/S135561771200001X	34	301	311	6	109	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					357	364		10.1038/nn.3324	http://dx.doi.org/10.1038/nn.3324			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23354332	Green Accepted, Green Submitted			2022-12-17	WOS:000315474800019
J	Litwin-Kumar, A; Doiron, B				Litwin-Kumar, Ashok; Doiron, Brent			Slow dynamics and high variability in balanced cortical networks with clustered connections	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; NEURAL VARIABILITY; COMPLEX NETWORKS; DECISION-MAKING; NEURONAL GROUPS; BEHAVING MICE; IN-VIVO; RESPONSES; CIRCUITS; MACAQUE	Anatomical studies demonstrate that excitatory connections in cortex are not uniformly distributed across a network but instead exhibit clustering into groups of highly connected neurons. The implications of clustering for cortical activity are unclear. We studied the effect of clustered excitatory connections on the dynamics of neuronal networks that exhibited high spike time variability owing to a balance between excitation and inhibition. Even modest clustering substantially changed the behavior of these networks, introducing slow dynamics during which clusters of neurons transiently increased or decreased their firing rate. Consequently, neurons exhibited both fast spiking variability and slow firing rate fluctuations. A simplified model shows how stimuli bias networks toward particular activity states, thereby reducing firing rate variability as observed experimentally in many cortical areas. Our model thus relates cortical architecture to the reported variability in spontaneous and evoked spiking activity.	[Litwin-Kumar, Ashok; Doiron, Brent] Ctr Neural Basis Cognit, Pittsburgh, PA USA; [Doiron, Brent] Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA; [Litwin-Kumar, Ashok] Carnegie Mellon Univ, Program Neural Computat, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Doiron, B (corresponding author), Ctr Neural Basis Cognit, Pittsburgh, PA USA.	alk@cmu.edu; bdoiron@pitt.edu		Litwin-Kumar, Ashok/0000-0003-2422-6576	US National Science Foundation [NSFDMS-1121784]; Sloan research fellowship; US National Defense Science & Engineering Graduate Fellowship program; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022762] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); Sloan research fellowship(Alfred P. Sloan Foundation); US National Defense Science & Engineering Graduate Fellowship program; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. da Silveira and H. Sompolinsky for discussions that helped shape an early version of this work. We also thank B. Yu and J. de la Rocha for comments. B.D. was supported by the US National Science Foundation (NSFDMS-1121784) and a Sloan research fellowship. A.L.-K. was supported by the US National Defense Science & Engineering Graduate Fellowship program.	ABELES M, 1995, P NATL ACAD SCI USA, V92, P8616, DOI 10.1073/pnas.92.19.8616; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Buesing L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002211; Churchland AK, 2011, NEURON, V69, P818, DOI 10.1016/j.neuron.2010.12.037; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Coombes S, 2005, BIOL CYBERN, V93, P91, DOI 10.1007/s00422-005-0574-y; Deco G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002395; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Han F, 2008, NEURON, V60, P321, DOI 10.1016/j.neuron.2008.08.026; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Izhikevich EM, 2004, CEREB CORTEX, V14, P933, DOI 10.1093/cercor/bhh053; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; London M, 2010, NATURE, V466, P123, DOI 10.1038/nature09086; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Morrison A, 2007, NEURAL COMPUT, V19, P1437, DOI 10.1162/neco.2007.19.6.1437; Oswald AMM, 2009, J NEUROSCI, V29, P10321, DOI 10.1523/JNEUROSCI.1703-09.2009; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Rajan K, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011903; Renart A, 2007, NEURAL COMPUT, V19, P1, DOI 10.1162/neco.2007.19.1.1; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Roudi Y, 2007, PLOS COMPUT BIOL, V3, P1679, DOI 10.1371/journal.pcbi.0030141; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Sompolinsky H., 2005, HOUCHES LECT 80 METH, P341; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Teich MC, 1997, J OPT SOC AM A, V14, P529, DOI 10.1364/JOSAA.14.000529; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; Vogels TP, 2005, J NEUROSCI, V25, P10786, DOI 10.1523/JNEUROSCI.3508-05.2005; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Yassin L, 2010, NEURON, V68, P1043, DOI 10.1016/j.neuron.2010.11.029; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	50	301	306	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1498	1505		10.1038/nn.3220	http://dx.doi.org/10.1038/nn.3220			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23001062	Green Accepted			2022-12-17	WOS:000310424900009
J	Frank, MJ; Doll, BB; Oas-Terpstra, J; Moreno, F				Frank, Michael J.; Doll, Bradley B.; Oas-Terpstra, Jen; Moreno, Francisco			Prefrontal and striatal dopaminergic genes predict individual differences in exploration and exploitation	NATURE NEUROSCIENCE			English	Article							MIDBRAIN DOPAMINE; DECISION-MAKING; NEUROCOMPUTATIONAL ACCOUNT; SYNAPTIC PLASTICITY; NUCLEUS-ACCUMBENS; NEURONAL-ACTIVITY; POPULATION CODES; COMT GENOTYPE; REINFORCEMENT; REWARD	The basal ganglia support learning to exploit decisions that have yielded positive outcomes in the past. In contrast, limited evidence implicates the prefrontal cortex in the process of making strategic exploratory decisions when the magnitude of potential outcomes is unknown. Here we examine neurogenetic contributions to individual differences in these distinct aspects of motivated human behavior, using a temporal decision-making task and computational analysis. We show that two genes controlling striatal dopamine function, DARPP-32 (also called PPP1R1B) and DRD2, are associated with exploitative learning to adjust response times incrementally as a function of positive and negative decision outcomes. In contrast, a gene primarily controlling prefrontal dopamine function (COMT) is associated with a particular type of 'directed exploration', in which exploratory decisions are made in proportion to Bayesian uncertainty about whether other choices might produce outcomes that are better than the status quo. Quantitative model fits reveal that genetic factors modulate independent parameters of a reinforcement learning system.	[Frank, Michael J.; Doll, Bradley B.] Brown Univ, Brown Inst Brain Sci, Dept Cognit & Linguist Sci, Providence, RI 02912 USA; [Frank, Michael J.; Doll, Bradley B.] Brown Univ, Brown Inst Brain Sci, Dept Psychol, Providence, RI 02912 USA; [Frank, Michael J.; Doll, Bradley B.] Brown Univ, Brown Inst Brain Sci, Dept Psychiat, Providence, RI 02912 USA; [Oas-Terpstra, Jen; Moreno, Francisco] Univ Arizona, Dept Psychiat, Tucson, AZ USA	Brown University; Brown University; Brown University; University of Arizona	Frank, MJ (corresponding author), Brown Univ, Brown Inst Brain Sci, Dept Cognit & Linguist Sci, Providence, RI 02912 USA.	michael_frank@brown.edu			US National Institutes of Mental Health [R01 MH080066-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080066] Funding Source: NIH RePORTER	US National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Williamson and E. Carter for help with DNA analysis and administering cognitive tasks to participants, and N. Daw, P. Dayan, and R. O'Reilly for helpful discussions. This research was supported by US National Institutes of Mental Health grant R01 MH080066-01.	Bayer HM, 2007, J NEUROPHYSIOL, V98, P1428, DOI 10.1152/jn.01140.2006; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Calabresi P, 2000, J NEUROSCI, V20, P8443, DOI 10.1523/JNEUROSCI.20-22-08443.2000; Cohen JD, 2007, PHILOS T R SOC B, V362, P933, DOI 10.1098/rstb.2007.2098; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dalley JW, 2005, P NATL ACAD SCI USA, V102, P6189, DOI 10.1073/pnas.0502080102; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayan P, 1996, MACH LEARN, V25, P5, DOI 10.1023/A:1018357105171; Depue RA, 1999, BEHAV BRAIN SCI, V22, P491; Forbes EE, 2009, MOL PSYCHIATR, V14, P60, DOI 10.1038/sj.mp.4002086; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Frank MJ, 2005, NEURON, V47, P495, DOI 10.1016/j.neuron.2005.06.020; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Gittins J. C., 1974, PROGR STAT, P241; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hirvonen M, 2005, MOL PSYCHIATR, V10, P889, DOI 10.1038/sj.mp.4001707; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Kakade S, 2002, NEURAL NETWORKS, V15, P549, DOI 10.1016/S0893-6080(02)00048-5; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Meyer-Lindenberg A, 2007, J CLIN INVEST, V117, P672, DOI 10.1172/JCI30413; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Moustafa AA, 2008, J NEUROSCI, V28, P12294, DOI 10.1523/JNEUROSCI.3116-08.2008; Nakamura K, 2006, J NEUROSCI, V26, P5360, DOI 10.1523/JNEUROSCI.4853-05.2006; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Reilly RC, 2007, BEHAV NEUROSCI, V121, P31, DOI 10.1037/0735-7044.121.1.31; OUIMET CC, 1984, J NEUROSCI, V4, P111; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rudebeck PH, 2006, NAT NEUROSCI, V9, P1161, DOI 10.1038/nn1756; Santesso DL, 2009, HUM BRAIN MAPP, V30, P1963, DOI 10.1002/hbm.20642; Satoh T, 2003, J NEUROSCI, V23, P9913; Scheres Anouk, 2006, Behav Brain Funct, V2, P35, DOI 10.1186/1744-9081-2-35; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Slifstein M, 2008, MOL PSYCHIATR, V13, P821, DOI 10.1038/mp.2008.19; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; SUTTON RS, 1990, P 7 INT C MACH LEARN, P216; Wiecki TV, 2009, PSYCHOPHARMACOLOGY, V204, P265, DOI 10.1007/s00213-008-1457-4; YE S, 2001, NUCL ACIDS RES, V29; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104	50	301	301	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					1062	U145		10.1038/nn.2342	http://dx.doi.org/10.1038/nn.2342			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19620978	Green Accepted			2022-12-17	WOS:000268396300022
J	Yang, JM; Siao, CJ; Nagappan, G; Marinic, T; Jing, DQ; McGrath, K; Chen, ZY; Mark, W; Tessarollo, L; Lee, FS; Lu, B; Hempstead, BL				Yang, Jianmin; Siao, Chia-Jen; Nagappan, Guhan; Marinic, Tina; Jing, Deqiang; McGrath, Kelly; Chen, Zhe-Yu; Mark, Willie; Tessarollo, Lino; Lee, Francis S.; Lu, Bai; Hempstead, Barbara L.			Neuronal release of proBDNF	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIC FACTOR; CORTICAL-NEURONS; RAT; BIOSYNTHESIS; ACTIVATION; EXPRESSION; P75(NTR); SORTILIN; PATHWAY; BDNF	Pro-brain-derived neurotrophic factor (proBDNF) and mature BDNF utilize distinct receptors to mediate divergent neuronal actions. Using new tools to quantitate endogenous BDNF isoforms, we found that mouse neurons secrete both proBDNF and mature BDNF. The highest levels of proBDNF and p75 were observed perinatally and declined, but were still detectable, in adulthood. Thus, BDNF actions are developmentally regulated by secretion of proBDNF or mature BDNF and by local expression of p75 and TrkB.	[Yang, Jianmin; Siao, Chia-Jen; Marinic, Tina; McGrath, Kelly; Hempstead, Barbara L.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Jing, Deqiang; Chen, Zhe-Yu; Lee, Francis S.] Weill Cornell Med Coll, Dept Psychiat, New York, NY 10065 USA; [Mark, Willie] Mem Sloan Kettering Canc Ctr, Dept Dev Biol, New York, NY 10065 USA; [Tessarollo, Lino] NCI, Frederick, MD 21702 USA; [Nagappan, Guhan; Lu, Bai] NICHHD, Bethesda, MD 20892 USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hempstead, BL (corresponding author), Weill Cornell Med Coll, Dept Med, 1300 York Ave, New York, NY 10065 USA.	blhempst@med.cornell.edu	Lu, Bai/A-4018-2012	Lu, Bai/0000-0001-5418-9759	National Institute of Neurological Disorders and Stroke [NS30687, NS52819]; National 973 Basic Research Program of China [2006CB503803, 2009CB941403]; National Institute of Child Health and Human Development; National Institute of Mental Health; NATIONAL CANCER INSTITUTE [ZIABC010391, ZIABC010390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH079513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030687, R01NS052819] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National 973 Basic Research Program of China(National Basic Research Program of China); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Teng and members of the Hempstead laboratory for their input. These studies were supported by grants from the National Institute of Neurological Disorders and Stroke (NS30687 to B. L.H. and NS52819 to F. S. L.), National 973 Basic Research Program of China (No. 2006CB503803 and 2009CB941403 to Z.-Y.C.) and the Intramural Program of the National Institute of Child Health and Human Development and the National Institute of Mental Health (to B.L.).	Adachi N, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-42; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Kolarow R, 2007, J NEUROSCI, V27, P10350, DOI 10.1523/JNEUROSCI.0692-07.2007; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Wu YJ, 2004, J NEUROSCI RES, V75, P825, DOI 10.1002/jnr.20048; Yan Q, 1997, NEUROSCIENCE, V78, P431, DOI 10.1016/S0306-4522(96)00613-6; ZHENG M, 1994, J NEUROSCI, V14, P4656	13	301	312	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2009	12	2					113	115		10.1038/nn.2244	http://dx.doi.org/10.1038/nn.2244			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	404VV	19136973	Green Accepted			2022-12-17	WOS:000263182000008
J	Susskind, JM; Lee, DH; Cusi, A; Feiman, R; Grabski, W; Anderson, AK				Susskind, Joshua M.; Lee, Daniel H.; Cusi, Andree; Feiman, Roman; Grabski, Wojtek; Anderson, Adam K.			Expressing fear enhances sensory acquisition	NATURE NEUROSCIENCE			English	Article							FACIAL EXPRESSIONS; EMOTION; AMYGDALA; RECOGNITION; ACTIVATION; ANGER; FACE; MIND	It has been proposed that facial expression production originates in sensory regulation. Here we demonstrate that facial expressions of fear are configured to enhance sensory acquisition. A statistical model of expression appearance revealed that fear and disgust expressions have opposite shape and surface reflectance features. We hypothesized that this reflects a fundamental antagonism serving to augment versus diminish sensory exposure. In keeping with this hypothesis, when subjects posed expressions of fear, they had a subjectively larger visual field, faster eye movements during target localization and an increase in nasal volume and air velocity during inspiration. The opposite pattern was found for disgust. Fear may therefore work to enhance perception, whereas disgust dampens it. These convergent results provide support for the Darwinian hypothesis that facial expressions are not arbitrary configurations for social communication, but rather, expressions may have originated in altering the sensory interface with the physical world.	[Susskind, Joshua M.; Lee, Daniel H.; Cusi, Andree; Feiman, Roman; Grabski, Wojtek; Anderson, Adam K.] Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; [Anderson, Adam K.] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON M6A 2E1, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Baycrest	Susskind, JM (corresponding author), Univ Toronto, Dept Psychol, 100 St George St, Toronto, ON M5S 3G3, Canada.	josh@aclab.ac; anderson@psych.utoronto.ca						Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Anderson AK, 2003, J NEUROSCI, V23, P5627; ANDREW RJ, 1963, SCIENCE, V142, P1034, DOI 10.1126/science.142.3595.1034; Boiten F, 1996, PSYCHOPHYSIOLOGY, V33, P123, DOI 10.1111/j.1469-8986.1996.tb02116.x; Cootes TF, 2001, IEEE T PATTERN ANAL, V23, P681, DOI 10.1109/34.927467; Dailey MN, 2002, J COGNITIVE NEUROSCI, V14, P1158, DOI 10.1162/089892902760807177; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Eibl-Eibesfeldt I., 1973, SOCIAL COMMUNICATION, P163; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Galati D, 1997, J PERS SOC PSYCHOL, V73, P1363, DOI 10.1037/0022-3514.73.6.1363; Gallese V, 2007, PHILOS T R SOC B, V362, P659, DOI 10.1098/rstb.2006.2002; Hess U, 2000, J NONVERBAL BEHAV, V24, P265, DOI 10.1023/A:1006623213355; IZARD CE, 1994, PSYCHOL BULL, V115, P288, DOI 10.1037/0033-2909.115.2.288; James W., 1884, MIND, Vos-IX, P188, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188]; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Marsh AA, 2005, EMOTION, V5, P119, DOI 10.1037/1528-3542.5.1.119; Marsh AA, 2005, PERS SOC PSYCHOL B, V31, P73, DOI 10.1177/0146167204271306; Marsh AA, 2003, PSYCHOL SCI, V14, P373, DOI 10.1111/1467-9280.24461; Paul E., 1999, HDB COGNITION EMOTIO, V98, P16, DOI [10.1017/S0140525X0800349X, DOI 10.1002/0470013494.CH3, 10.1002/0470013494.ch3]; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; Pourtois G, 2005, NEUROIMAGE, V26, P149, DOI 10.1016/j.neuroimage.2005.01.015; ROZIN P, 1987, PSYCHOL REV, V94, P23, DOI 10.1037/0033-295X.94.1.23; Scherer KR, 2001, APPRAISAL PROCESSES, P92; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; STRACK F, 1988, J PERS SOC PSYCHOL, V54, P768, DOI 10.1037/0022-3514.54.5.768; Susskind JM, 2007, NEUROPSYCHOLOGIA, V45, P152, DOI 10.1016/j.neuropsychologia.2006.05.001; TOOBY J, 1990, ETHOL SOCIOBIOL, V11, P375, DOI 10.1016/0162-3095(90)90017-Z; Tracy JL, 2004, PSYCHOL SCI, V15, P194, DOI 10.1111/j.0956-7976.2004.01503008.x; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Whalen PJ, 1998, J NEUROSCI, V18, P411; ZAJONC RB, 1985, SCIENCE, V228, P15, DOI 10.1126/science.3883492; Zelano C, 2005, NEURON, V48, P431, DOI 10.1016/j.neuron.2005.10.009	36	301	305	0	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					843	850		10.1038/nn.2138	http://dx.doi.org/10.1038/nn.2138			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	318KD	18552843				2022-12-17	WOS:000257089400022
J	Graham, DL; Edwards, S; Bachtell, RK; DiLeone, RJ; Rios, M; Self, DW				Graham, Danielle L.; Edwards, Scott; Bachtell, Ryan K.; DiLeone, Ralph J.; Rios, Maribel; Self, David W.			Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse	NATURE NEUROSCIENCE			English	Article							D-3 RECEPTOR EXPRESSION; FACTOR PROTEIN-LEVELS; FACTOR MESSENGER-RNA; NEUROTROPHIC FACTOR; SEROTONIN METABOLISM; RETROGRADE TRANSPORT; DENDRITIC SPINES; MOUSE-BRAIN; DELTA-FOSB; IN-VIVO	A single exposure to cocaine rapidly induces the brief activation of several immediate early genes, but the role of such short-term regulation in the enduring consequences of cocaine use is poorly understood. We found that 4 h of intravenous cocaine self-administration in rats induced a transient increase in brain-derived neurotrophic factor (BDNF) and activation of TrkB-mediated signaling in the nucleus accumbens (NAc). Augmenting this dynamic regulation with five daily NAc BDNF infusions caused enduring increases in cocaine self-administration, and facilitated relapse to cocaine seeking in withdrawal. In contrast, neutralizing endogenous BDNF regulation with intra-NAc infusions of antibody to BDNF subsequently reduced cocaine self-administration and attenuated relapse. Using localized inducible BDNF knockout in mice, we found that BDNF originating from NAc neurons was necessary for maintaining increased cocaine self-administration. These findings suggest that dynamic induction and release of BDNF from NAc neurons during cocaine use promotes the development and persistence of addictive behavior.	Univ Texas, SW Med Ctr, Seay Ctr Basic & Appl Res Psychiat Illness, Dept Psychiat, Dallas, TX 75390 USA; Yale Univ, Sch Med, Connecticut Mental Hlth Ctr, Dept Psychiat, New Haven, CT 06508 USA; Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Yale University; Tufts University	Self, DW (corresponding author), Univ Texas, SW Med Ctr, Seay Ctr Basic & Appl Res Psychiat Illness, Dept Psychiat, Dallas, TX 75390 USA.	david.self@utsouthwestern.edu	Graham, Danielle L/K-8459-2014; Bachtell, Ryan/H-7436-2013	Bachtell, Ryan/0000-0001-5268-5927; DiLeone, Ralph/0000-0002-4770-2590	NIDA NIH HHS [DA 10460, DA 016857, DA 18743, DA 08227] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA016857, R01DA018743, P01DA008227, R01DA010460, R29DA010460] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Ahmed SH, 2000, NEUROPSYCHOPHARMACOL, V22, P413, DOI 10.1016/S0893-133X(99)00133-5; Altar C A, 1998, Adv Pharmacol, V42, P915; ALTAR CA, 1992, P NATL ACAD SCI USA, V89, P11347, DOI 10.1073/pnas.89.23.11347; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; CASTREN E, 1995, NEUROSCIENCE, V64, P71, DOI 10.1016/0306-4522(94)00386-J; Choi KH, 2006, NEUROSCIENCE, V137, P373, DOI 10.1016/j.neuroscience.2005.10.049; Colby CR, 2003, J NEUROSCI, V23, P2488; Conner JM, 1997, J NEUROSCI, V17, P2295; DSM-IV-TR, 2000, DIAGN STAT MAN MENT, V4th; Elmer E, 1998, NEUROSCIENCE, V83, P351, DOI 10.1016/S0306-4522(97)00387-4; Filip M, 2006, BRAIN RES, V1071, P218, DOI 10.1016/j.brainres.2005.11.099; GALL CM, 1992, TRENDS PHARMACOL SCI, V13, P401, DOI 10.1016/0165-6147(92)90123-N; Grimm JW, 2003, J NEUROSCI, V23, P742; Guillin O, 2001, NATURE, V411, P86, DOI 10.1038/35075076; Hall FS, 2003, NEUROPSYCHOPHARMACOL, V28, P1485, DOI 10.1038/sj.npp.1300192; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Horger BA, 1999, J NEUROSCI, V19, P4110; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; JAFFE JH, 1989, PSYCHOPHARMACOLOGY, V97, P59, DOI 10.1007/BF00443414; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Kuppers E, 2001, NEUROREPORT, V12, P1175; Le Foll B, 2005, NEUROREPORT, V16, P175, DOI 10.1097/00001756-200502080-00022; Le YZ, 1999, ANAL BIOCHEM, V270, P334, DOI 10.1006/abio.1999.4110; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; MARTINIVERSON MT, 1994, J NEUROSCI, V14, P1262, DOI 10.1523/JNEUROSCI.14-03-01262.1994; Mattson BJ, 2005, J NEUROCHEM, V95, P1481, DOI 10.1111/j.1471-4159.2005.03500.x; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Mufson EJ, 1996, NEUROSCIENCE, V71, P179, DOI 10.1016/0306-4522(95)00431-9; MUFSON EJ, 1994, EXP NEUROL, V129, P15, DOI 10.1006/exnr.1994.1143; NAKAO N, 1995, EXP NEUROL, V131, P1, DOI 10.1016/0014-4886(95)90002-0; Narita M, 2003, NEUROSCIENCE, V119, P767, DOI 10.1016/S0306-4522(03)00099-X; Pandey SC, 2004, J NEUROSCI, V24, P5022, DOI 10.1523/JNEUROSCI.5557-03.2004; Piazza PV, 2000, J NEUROSCI, V20, P4226; Pu L, 2006, NAT NEUROSCI, V9, P605, DOI 10.1038/nn1687; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Robinson TE, 2001, SYNAPSE, V39, P257; ROBLEDO P, 1993, BEHAV BRAIN RES, V55, P159, DOI 10.1016/0166-4328(93)90112-4; SEROOGY KB, 1994, J COMP NEUROL, V342, P321, DOI 10.1002/cne.903420302; Shaw-Lutchman TZ, 2003, SYNAPSE, V48, P10, DOI 10.1002/syn.10172; Sinha R, 1999, PSYCHOPHARMACOLOGY, V142, P343, DOI 10.1007/s002130050898; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249	47	301	308	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1029	1037		10.1038/nn1929	http://dx.doi.org/10.1038/nn1929			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17618281				2022-12-17	WOS:000248357500017
J	Rubino, D; Robbins, KA; Hatsopoulos, NG				Rubino, Doug; Robbins, Kay A.; Hatsopoulos, Nicholas G.			Propagating waves mediate information transfer in the motor cortex	NATURE NEUROSCIENCE			English	Article							LOCAL-FIELD POTENTIALS; FRONTAL-LOBE INPUTS; SENSORIMOTOR CORTEX; CORTICAL PROJECTIONS; OSCILLATIONS; SYNCHRONIZATION; ACTIVATION; DYNAMICS; REPRESENTATIONS; RESPONSES	High-frequency oscillations in the beta range (10-45 Hz) are most active in motor cortex during motor preparation and are postulated to reflect the steady postural state or global attentive state of the animal. By simultaneously recording multiple local field potential signals across the primary motor and dorsal premotor cortices of monkeys (Macaca mulatta) trained to perform an instructed-delay reaching task, we found that these oscillations propagated as waves across the surface of the motor cortex along dominant spatial axes characteristic of the local circuitry of the motor cortex. Moreover, we found that information about the visual target to be reached was encoded in terms of both latency and amplitude of evoked waves at a time when the field phase-locked with respect to the target onset. These findings suggest that high-frequency oscillations may subserve intra- and intercortical information transfer during movement preparation and execution.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Univ Texas, Dept Comp Sci, San Antonio, TX 78249 USA	University of Chicago; University of Texas System	Hatsopoulos, NG (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA.	nicho@uchicago.edu			NCRR NIH HHS [2G12RR1364-06A1] Funding Source: Medline; NINDS NIH HHS [R01 NS045853, R01 NS45853-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045853] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baker SN, 1999, EXP BRAIN RES, V128, P109, DOI 10.1007/s002210050825; Cauller LJ, 1998, J COMP NEUROL, V390, P297; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; CHERVIN RD, 1988, J NEUROPHYSIOL, V60, P1695, DOI 10.1152/jn.1988.60.5.1695; Contreras D, 2001, J NEUROSCI, V21, P9403, DOI 10.1523/JNEUROSCI.21-23-09403.2001; Cover TM., 1991, ELEMENTS INFORM THEO; DELANEY KR, 1994, P NATL ACAD SCI USA, V91, P669, DOI 10.1073/pnas.91.2.669; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; Du XX, 2006, IEEE T BIO-MED ENG, V53, P1688, DOI 10.1109/TBME.2006.877796; Dum RP, 2005, J NEUROSCI, V25, P1375, DOI 10.1523/JNEUROSCI.3902-04.2005; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; FLEET DJ, 1990, INT J COMPUT VISION, V5, P77, DOI 10.1007/BF00056772; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Ghosh S, 1995, SOMATOSENS MOT RES, V12, P359, DOI 10.3109/08990229509093668; Gilbertson T, 2005, J NEUROSCI, V25, P7771, DOI 10.1523/JNEUROSCI.1762-05.2005; KURATA K, 1991, NEUROSCI RES, V12, P263, DOI 10.1016/0168-0102(91)90116-G; Lam YW, 2000, J NEUROSCI, V20, P749, DOI 10.1523/JNEUROSCI.20-02-00749.2000; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Luppino G, 2000, NEWS PHYSIOL SCI, V15, P219; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; MUAKKASSA KF, 1979, BRAIN RES, V177, P176, DOI 10.1016/0006-8993(79)90928-4; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3949, DOI 10.1152/jn.1996.76.6.3949; Muthukumaraswamy SD, 2004, CLIN NEUROPHYSIOL, V115, P1760, DOI 10.1016/j.clinph.2004.03.004; O'Leary JG, 2006, J NEUROPHYSIOL, V96, P1492, DOI 10.1152/jn.00106.2006; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Pfurtscheller G, 2005, NEUROSCI LETT, V378, P156, DOI 10.1016/j.neulet.2004.12.034; Pfurtscheller G, 2001, J CLIN NEUROPHYSIOL, V18, P559, DOI 10.1097/00004691-200111000-00006; Pfurtscheller G, 2003, CLIN NEUROPHYSIOL, V114, P1226, DOI 10.1016/S1388-2457(03)00067-1; Prechtl JC, 1997, P NATL ACAD SCI USA, V94, P7621, DOI 10.1073/pnas.94.14.7621; Robbins KA, 2004, J COMPUT NEUROSCI, V16, P267, DOI 10.1023/B:JCNS.0000025689.01581.26; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Senseman D M, 1999, J Neurosci, V19, pRC3; Senseman DM, 2002, J NEUROPHYSIOL, V87, P1499, DOI 10.1152/jn.00475.2001; Wang WX, 2005, J COMPUT NEUROSCI, V19, P263, DOI 10.1007/s10827-005-2288-5; Wu JY, 1999, J NEUROSCI, V19, P5005	38	301	303	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1549	1557		10.1038/nn1802	http://dx.doi.org/10.1038/nn1802			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115042				2022-12-17	WOS:000242404000020
J	Walter, JT; Alvina, K; Womack, MD; Chevez, C; Khodakhah, K				Walter, JT; Alvina, K; Womack, MD; Chevez, C; Khodakhah, K			Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia	NATURE NEUROSCIENCE			English	Article							CA2+-ACTIVATED K+ CHANNELS; ACTIVATED POTASSIUM CHANNELS; CALCIUM-CHANNEL; MUTANT MICE; SYNAPTIC-TRANSMISSION; ELECTRICAL-ACTIVITY; CENTRAL NEURONS; CURRENTS; PATTERNS; OUTPUT	Episodic ataxia type-2 (EA2) is caused by mutations in P/Q-type voltage-gated calcium channels that are expressed at high densities in cerebellar Purkinje cells. Because P/Q channels support neurotransmitter release at many synapses, it is believed that ataxia is caused by impaired synaptic transmission. Here we show that in ataxic P/Q channel mutant mice, the precision of Purkinje cell pacemaking is lost such that there is a significant degradation of the synaptic information encoded in their activity. The irregular pacemaking is caused by reduced activation of calcium-activated potassium (K-Ca) channels and was reversed by pharmacologically increasing their activity with 1-ethyl-2-benzimidazolinone (EBIO). Moreover, chronic in vivo perfusion of EBIO into the cerebellum of ataxic mice significantly improved motor performance. Our data support the hypothesis that the precision of intrinsic pacemaking in Purkinje cells is essential for motor coordination and suggest that K-Ca channels may constitute a potential therapeutic target in EA2.	Yeshiva Univ Albert Einstein Coll Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Khodakhah, K (corresponding author), Yeshiva Univ Albert Einstein Coll Med, 506 Kennedy Ctr,1410 Pelham Pkwy S, Bronx, NY 10461 USA.	Kkhodakh@aecom.yu.edu		Alvina, Karina/0000-0002-8369-0953	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050808] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS050808] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; Barclay J, 2001, J NEUROSCI, V21, P6095, DOI 10.1523/JNEUROSCI.21-16-06095.2001; Brodbeck J, 2002, J BIOL CHEM, V277, P7684, DOI 10.1074/jbc.M109404200; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Cingolani LA, 2002, J NEUROSCI, V22, P4456, DOI 10.1523/JNEUROSCI.22-11-04456.2002; Dove LS, 1998, J NEUROSCI, V18, P7687; Doyle JL, 1998, TRENDS GENET, V14, P92, DOI 10.1016/S0168-9525(97)01370-X; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; ECCLES JC, 1973, J PHYSIOL-LONDON, V229, P1; ECCLES JC, 1966, EXP BRAIN RES, V1, P161; ECCLES JC, 1967, EXP BRAIN RES, V3, P81; Edgerton JR, 2003, J PHYSIOL-LONDON, V548, P53, DOI 10.1113/jphysiol.2002.027854; Fletcher CF, 2001, FASEB J, V15, P1288, DOI 10.1096/fj.00-0562fje; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Gancher S T, 1986, Mov Disord, V1, P239, DOI 10.1002/mds.870010404; GRANIT R, 1956, J PHYSIOL-LONDON, V133, P520, DOI 10.1113/jphysiol.1956.sp005606; GRIGGS RC, 1995, ANN NEUROL, V37, P285, DOI 10.1002/ana.410370302; Harno H, 2004, J NEUROL, V251, P232, DOI 10.1007/s00415-004-0299-1; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Herson PS, 2003, NAT NEUROSCI, V6, P378, DOI 10.1038/nn1025; Hoebeek FE, 2005, NEURON, V45, P953, DOI 10.1016/j.neuron.2005.02.012; Ito M, 1984, CEREBELLUM NEURAL CO; JAEGER D, 1994, EXP BRAIN RES, V100, P200; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Kaunisto MA, 2004, NEUROGENETICS, V5, P69, DOI 10.1007/s10048-003-0161-0; Khavandgar S, 2005, J PHYSIOL-LONDON, V569, P545, DOI 10.1113/jphysiol.2005.098053; Lorenzon NM, 1998, J NEUROSCI, V18, P4482; Matsushita K, 2002, J NEUROSCI, V22, P4388, DOI 10.1523/JNEUROSCI.22-11-04388.2002; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Nam SC, 1997, J NEUROBIOL, V33, P18, DOI 10.1002/(SICI)1097-4695(199707)33:1<18::AID-NEU3>3.0.CO;2-G; Pedarzani P, 2001, J BIOL CHEM, V276, P9762, DOI 10.1074/jbc.M010001200; Piedras-Renteria ES, 2004, P NATL ACAD SCI USA, V101, P3609, DOI 10.1073/pnas.0308188100; Pietrobon D, 2002, MOL NEUROBIOL, V25, P31, DOI 10.1385/MN:25:1:031; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Raman IM, 1999, J NEUROSCI, V19, P1663; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Shakkottai VG, 2004, J CLIN INVEST, V113, P582, DOI 10.1172/JCI200420216; STONE TW, 1993, PHARMACOL REV, V45, P309; Suter KJ, 2004, NEUROSCIENCE, V124, P305, DOI 10.1016/j.neuroscience.2003.11.015; Swensen AM, 2003, J NEUROSCI, V23, P9650; Tricarico D, 2004, FASEB J, V18, P760, DOI 10.1096/fj.03-0722fje; Tricarico D, 2000, ANN NEUROL, V48, P304, DOI 10.1002/1531-8249(200009)48:3<304::AID-ANA4>3.0.CO;2-A; Wakamori M, 1998, J BIOL CHEM, V273, P34857, DOI 10.1074/jbc.273.52.34857; Weisz CJC, 2005, J NEUROSCI, V25, P4141, DOI 10.1523/JNEUROSCI.0098-05.2005; Womack M, 2002, J NEUROSCI, V22, P10603; Womack MD, 2004, J NEUROSCI, V24, P3511, DOI 10.1523/JNEUROSCI.0290-04.2004; Womack MD, 2003, J NEUROSCI, V23, P2600; Womack MD, 2002, EUR J NEUROSCI, V16, P1214, DOI 10.1046/j.1460-9568.2002.02171.x; Womack MD, 2004, J NEUROSCI, V24, P8818, DOI 10.1523/JNEUROSCI.2915-04.2004; YOON KW, 1993, J PHYSIOL-LONDON, V464, P423, DOI 10.1113/jphysiol.1993.sp019643	50	301	309	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					389	397		10.1038/nn1648	http://dx.doi.org/10.1038/nn1648			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16474392				2022-12-17	WOS:000235645600019
J	Wilson, SJ; Sayette, MA; Fiez, JA				Wilson, SJ; Sayette, MA; Fiez, JA			Prefrontal responses to drug cues: a neurocognitive analysis	NATURE NEUROSCIENCE			English	Article							ORBITOFRONTAL CORTEX; CIGARETTE AVAILABILITY; SMOKING OPPORTUNITY; ENVIRONMENTAL CUES; BRAIN ACTIVATION; ALCOHOL STIMULI; REACTIVITY; ADDICTION; URGE; INVOLVEMENT	The construct of craving has been central to addiction research for more than 50 years. Only recently have investigators begun to apply functional neuroimaging techniques to the study of drug cue reactivity, and a small but growing number of studies implicate a distributed system of brain regions in the pathogenesis of craving. The internal consistency of this burgeoning literature has thus far been disappointing, however, leaving open the question of which brain regions contribute to craving. Here we review neuroimaging studies of cue-elicited craving in the context of a framework drawn from behavioral research indicating that perceived drug use opportunity significantly affects responses to the presentation of drug cues. Using this framework provides a way to reconcile discrepant findings among brain-imaging studies of cue-elicited craving.	Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; Ctr Neural Basis Cognit, Pittsburgh, PA USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wilson, SJ (corresponding author), Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA.	sjwilson@pitt.edu			NCI NIH HHS [R01 CA159463] Funding Source: Medline; NIDA NIH HHS [R01 DA010605, R01DA10605, R01DA14103, R01 DA014103, R01 DA010605-09] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA159463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010605, R01DA014103] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anton RF, 1999, ALCOHOL RES HEALTH, V23, P165; BAKER TB, 1987, NEBR SYM MOTIV, V34, P257; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Bonson KR, 2002, NEUROPSYCHOPHARMACOL, V26, P376, DOI 10.1016/S0893-133X(01)00371-2; Braus DF, 2001, J NEURAL TRANSM, V108, P887, DOI 10.1007/s007020170038; Brody AL, 2002, ARCH GEN PSYCHIAT, V59, P1162, DOI 10.1001/archpsyc.59.12.1162; Carter BL, 1999, ADDICTION, V94, P327, DOI 10.1046/j.1360-0443.1999.9433273.x; Carter BL, 2001, EXP CLIN PSYCHOPHARM, V9, P183, DOI 10.1037//1064-1297.9.2.183; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Daglish MRC, 2001, AM J PSYCHIAT, V158, P1680, DOI 10.1176/appi.ajp.158.10.1680; Dols M, 2000, ADDICT BEHAV, V25, P103, DOI 10.1016/S0306-4603(98)00115-4; DROUNGAS A, 1995, ADDICT BEHAV, V20, P657, DOI 10.1016/0306-4603(95)00029-C; Drummond DC, 2000, ADDICTION, V95, pS129, DOI 10.1046/j.1360-0443.95.8s2.2.x; Due DL, 2002, AM J PSYCHIAT, V159, P954, DOI 10.1176/appi.ajp.159.6.954; Field M, 2002, PSYCHOPHARMACOLOGY, V159, P325, DOI 10.1007/s00213-001-0923-z; Franken IHA, 2003, PROG NEURO-PSYCHOPH, V27, P563, DOI 10.1016/S0278-5846(03)00081-2; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; George MS, 2001, ARCH GEN PSYCHIAT, V58, P345, DOI 10.1001/archpsyc.58.4.345; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Groenewegen HJ, 2000, PROG BRAIN RES, V126, P3; Hommer DW, 1999, ALCOHOL RES HEALTH, V23, P187; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Juliano LM, 1998, EXP CLIN PSYCHOPHARM, V6, P45, DOI 10.1037/1064-1297.6.1.45; Kilts CD, 2001, ARCH GEN PSYCHIAT, V58, P334, DOI 10.1001/archpsyc.58.4.334; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Lazev AB, 1999, EXP CLIN PSYCHOPHARM, V7, P56, DOI 10.1037/1064-1297.7.1.56; London ED, 2000, CEREB CORTEX, V10, P334, DOI 10.1093/cercor/10.3.334; Maas LC, 1998, AM J PSYCHIAT, V155, P124, DOI 10.1176/ajp.155.1.124; Meyer RE, 2000, ADDICTION, V95, pS219; MODELL JG, 1995, J NEUROPSYCH CLIN N, V7, P15; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Sayette MA, 2003, EXP CLIN PSYCHOPHARM, V11, P218, DOI 10.1037/1064-1297.11.3.218; Schneider F, 2001, AM J PSYCHIAT, V158, P1075, DOI 10.1176/appi.ajp.158.7.1075; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Sell LA, 1999, EUR J NEUROSCI, V11, P1042, DOI 10.1046/j.1460-9568.1999.00522.x; Tapert SF, 2004, ADDICT BEHAV, V29, P33, DOI 10.1016/j.addbeh.2003.07.003; Tapert SF, 2003, ARCH GEN PSYCHIAT, V60, P727, DOI 10.1001/archpsyc.60.7.727; TIFFANY ST, 1990, PSYCHOL REV, V97, P147, DOI 10.1037/0033-295X.97.2.147; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Wang GJ, 1999, LIFE SCI, V64, P775, DOI 10.1016/S0024-3205(98)00619-5; Watanabe M, 2002, J NEUROSCI, V22, P2391, DOI 10.1523/JNEUROSCI.22-06-02391.2002; Wertz JM, 2001, EXP CLIN PSYCHOPHARM, V9, P3, DOI 10.1037//1064-1297.9.1.3; Wertz JM, 2001, PSYCHOL ADDICT BEHAV, V15, P268, DOI 10.1037/0893-164X.15.3.268; Wexler BE, 2001, AM J PSYCHIAT, V158, P86, DOI 10.1176/appi.ajp.158.1.86; WILLIAMS SM, 2000, SYLVIUS FUNDAMENTALS; Wrase J, 2002, EUR PSYCHIAT, V17, P287, DOI 10.1016/S0924-9338(02)00676-4; Zinser MC, 1999, J ABNORM PSYCHOL, V108, P240, DOI 10.1037/0021-843X.108.2.240; 2002, PHARMACOL BIOCHEM BE, V71, P517	50	301	310	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					211	214		10.1038/nn1200	http://dx.doi.org/10.1038/nn1200			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	15001989	Green Accepted			2022-12-17	WOS:000189197900024
J	Gauthier, I; Curran, T; Curby, KM; Collins, D				Gauthier, I; Curran, T; Curby, KM; Collins, D			Perceptual interference supports a non-modular account of face processing	NATURE NEUROSCIENCE			English	Article							EXPERT OBJECT RECOGNITION; SELECTIVE ATTENTION; BRAIN; MECHANISMS; COMPONENT; AREA	The perception of faces and of nonface objects share common early visual processing stages. Some argue, however, that the brain eventually processes faces separately from other objects, within a domain-specific module dedicated to face perception. This apparent specialization for faces could, alternatively, result from people's expertise with this category of stimuli. Here we used behavioral and electrophysiological measures of interference to address the functional independence of face and object processing. If the expert processing of faces and cars depend on common mechanisms related to holistic perception (obligatory processing of all parts), then for human subjects who are presumed to be face experts, car perception should interfere with concurrent face perception. Furthermore, such interference should increase with greater expertise in car identification, and indeed this is what we found. Event-related potentials (ERPs) suggest that this interference arose from perceptual processes contributing to the holistic processing of both objects of expertise and faces.	Vanderbilt Univ, Vanderbilt Vis Res Ctr, Dept Psychol, Nashville, TN 37203 USA; Univ Colorado, Dept Psychol, Boulder, CO 80309 USA	Vanderbilt University; University of Colorado System; University of Colorado Boulder	Gauthier, I (corresponding author), Vanderbilt Univ, Vanderbilt Vis Res Ctr, Dept Psychol, 301 Wilson Hall, Nashville, TN 37203 USA.			Curby, Kim/0000-0001-7830-2533; Gauthier, Isabel/0000-0002-6249-4769	NEI NIH HHS [EY13441] Funding Source: Medline; NIMH NIH HHS [MH64812] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064812] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Carmel D, 2002, COGNITION, V83, P1, DOI 10.1016/S0010-0277(01)00162-7; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gauthier I, 2002, J EXP PSYCHOL HUMAN, V28, P431, DOI 10.1037//0096-1523.28.2.431; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Kanwisher N, 1997, J NEUROSCI, V17, P4302; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Moscovitch M, 1997, J COGNITIVE NEUROSCI, V9, P555, DOI 10.1162/jocn.1997.9.5.555; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion B, 2002, PSYCHOL SCI, V13, P250, DOI 10.1111/1467-9280.00446; Tanaka JW, 2001, PSYCHOL SCI, V12, P43, DOI 10.1111/1467-9280.00308; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Velleman P. F., 1981, APPL BASICS COMPUTIN; Wenger MJ, 2002, J EXP PSYCHOL LEARN, V28, P872, DOI 10.1037//0278-7393.28.5.872	20	301	306	1	25	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					428	432		10.1038/nn1029	http://dx.doi.org/10.1038/nn1029			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12627167				2022-12-17	WOS:000181833100022
J	Horch, HW; Katz, LC				Horch, HW; Katz, LC			BDNF release from single cells elicits local dendritic growth in nearby neurons	NATURE NEUROSCIENCE			English	Article							RETROGRADE AXONAL-TRANSPORT; NEUROTROPHIC FACTOR; HIPPOCAMPAL-NEURONS; TRKB RECEPTORS; FULL-LENGTH; VISUAL-CORTEX; POSTSYNAPTIC NEURONS; TRUNCATED RECEPTORS; SYMPATHETIC NEURONS; STRIATE CORTEX	In cultured neurons, the exogenous application of neurotrophins (in homogenous concentrations) alters many features of axonal and dendritic arbors. In vivo, however, release of endogenous neurotrophins from neuronal processes creates spatially heterogeneous neurotrophin distributions. To probe the consequences of such endogenous neurotrophin distribution, we produced 'donor neurons' in ferret cortex brain slices that co-expressed brain-derived neurotrophic factor (BDNF) and red fluorescent protein (RFP). Using two-photon microscopy, we analyzed their effects on 'recipient neurons' that expressed green fluorescent protein (GFP) alone. BDNF released from dendrites and cell bodies acted directly on nearby recipient neurons to increase dendritic branching in a distance-dependent manner. Three-dimensional analysis of donor and recipient dendrites indicated that the BDNF source had to be within 4.5 mum to induce dendritic growth in the recipient neuron. Thus, BDNF released from an individual cell alters the structure of nearby dendrites on an exquisitely local scale.	Duke Univ, Med Ctr, Dept Neurobiol, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute	Horch, HW (corresponding author), Bowdoin Coll, Dept Biol, 6500 Coll Stn, Brunswick, ME 04011 USA.	hhorch@bowdoin.edu			NEI NIH HHS [EY-11553] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011553] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; Aoki C, 2000, J NEUROSCI RES, V59, P454, DOI 10.1002/(SICI)1097-4547(20000201)59:3<454::AID-JNR21>3.0.CO;2-H; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; BIFFO S, 1995, DEVELOPMENT, V121, P2461; CAMPENOT RB, 1982, DEV BIOL, V93, P1, DOI 10.1016/0012-1606(82)90232-9; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; DALVA MB, 1994, SCIENCE, V265, P255, DOI 10.1126/science.7912852; DISTEFANO PS, 1992, NEURON, V8, P983, DOI 10.1016/0896-6273(92)90213-W; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Gallo G, 2000, J NEUROBIOL, V44, P159, DOI 10.1002/1097-4695(200008)44:2<159::AID-NEU6>3.0.CO;2-H; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Gordon S.., 1998, SYNAPTIC ORG BRAIN, V5; Haapasalo A, 1999, ONCOGENE, V18, P1285, DOI 10.1038/sj.onc.1202401; HENDRY IA, 1974, BRAIN RES, V68, P103, DOI 10.1016/0006-8993(74)90536-8; Horch HW, 1999, NEURON, V23, P353; Jarvis CR, 1997, J NEUROPHYSIOL, V78, P2363, DOI 10.1152/jn.1997.78.5.2363; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; KATZ LC, 1988, J NEUROSCI, V8, P3160; KATZ LC, 1987, J NEUROSCI, V7, P1223; KATZ LC, 1991, EUR J NEUROSCI, V3, P1, DOI 10.1111/j.1460-9568.1991.tb00805.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; Kohara K, 2001, SCIENCE, V291, P2419, DOI 10.1126/science.1057415; Korte M, 1996, P NATL ACAD SCI USA, V93, P12547, DOI 10.1073/pnas.93.22.12547; KOSSEL A, 1995, J NEUROSCI, V15, P3913; Kossel AH, 1997, J NEUROSCI, V17, P9634; Kryl D, 1999, J NEUROSCI, V19, P5823, DOI 10.1523/JNEUROSCI.19-14-05823.1999; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Lom B, 1999, J NEUROSCI, V19, P9928; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Murphy DD, 1998, P NATL ACAD SCI USA, V95, P11412, DOI 10.1073/pnas.95.19.11412; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; Ozdinler PH, 2001, J COMP NEUROL, V438, P377; PEICHL L, 1979, J PHYSIOL-LONDON, V291, P117, DOI 10.1113/jphysiol.1979.sp012803; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Shimada A, 1998, J NEUROSCI, V18, P8559; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Yacoubian TA, 2000, NAT NEUROSCI, V3, P342, DOI 10.1038/73911; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; Zervas M, 1999, J COMP NEUROL, V413, P429, DOI 10.1002/(SICI)1096-9861(19991025)413:3<429::AID-CNE6>3.0.CO;2-7	50	301	307	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1177	1184		10.1038/nn927	http://dx.doi.org/10.1038/nn927			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12368805				2022-12-17	WOS:000178884600021
J	Morrone, MC; Tosetti, M; Montanaro, D; Fiorentini, A; Cioni, G; Burr, DC				Morrone, MC; Tosetti, M; Montanaro, D; Fiorentini, A; Cioni, G; Burr, DC			A cortical area that responds specifically to optic flow, revealed by fMRI	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL-ANALYSIS; HEADING PERCEPTION; VISUAL-CORTEX; MST NEURONS; MOTION; MECHANISMS; SELECTIVITY; ACTIVATION; SYSTEMS; BRAIN	The continuously changing optic flow on the retina provides information about direction of heading and about the three-dimensional structure of the environment. Here we use functional magnetic resonance Imaging (fMRI) to demonstrate that an area in human cortex responds selectively to components of optic flow, such as circular and radial motion. This area is within the region commonly referrred to as V5/MT complex, but is distinct from the part of this region that responds to translation. The functional properties of these two areas of the V5/MT complex are also different; the response to optic flow was obtained only with changing flow stimuli, whereas response to translation occurred during exposure to continuous motion.	CNR, Ist Neurofisiol, I-56127 Pisa, Italy; Ist Sci Stella Maris, Pisa, Italy; Univ Pisa, Div Neuropsichiat Infantile, Pisa, Italy; Univ Florence, Dipartimento Psicol, I-50125 Florence, Italy; Univ Vita Salute San Raffaele, Fac Psicol, I-20132 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); IRCCS Fondazione Stella Maris; University of Pisa; University of Florence; Vita-Salute San Raffaele University	Morrone, MC (corresponding author), CNR, Ist Neurofisiol, Via G Moruzzi 1, I-56127 Pisa, Italy.	concetta@in.-pi.cnr.it	Cioni, Giovanni/A-4178-2015; Morrone, Maria Concetta/C-6756-2014; Montanaro, Domenico/AAB-9718-2022; Tosetti, Michela/K-5749-2016	Cioni, Giovanni/0000-0002-6526-5566; Morrone, Maria Concetta/0000-0002-1025-0316; Montanaro, Domenico/0000-0002-9895-7016; Tosetti, Michela/0000-0002-2515-7560; Burr, David/0000-0003-1541-8832				Anderson SJ, 1996, P ROY SOC B-BIOL SCI, V263, P423, DOI 10.1098/rspb.1996.0064; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Braddick OJ, 2000, CURR BIOL, V10, P731, DOI 10.1016/S0960-9822(00)00540-6; Bradley DC, 1996, SCIENCE, V273, P1544, DOI 10.1126/science.273.5281.1544; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; Burr DC, 1998, VISION RES, V38, P1731, DOI 10.1016/S0042-6989(97)00346-5; Chen W, 1998, MAGN RESON MED, V39, P89, DOI 10.1002/mrm.1910390115; CHENG K, 1995, J NEUROPHYSIOL, V74, P413, DOI 10.1152/jn.1995.74.1.413; DEJONG BM, 1994, BRAIN, V117, P1039; Duffy CJ, 1997, EXP BRAIN RES, V114, P472, DOI 10.1007/PL00005656; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Dupont P, 1997, CEREB CORTEX, V7, P283, DOI 10.1093/cercor/7.3.283; Ellermann JM, 1998, J MAGN RESON, V131, P272, DOI 10.1006/jmre.1998.1379; Gibson J.J., 1950, PERCEPTION VISUAL WO; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; HELMHOLTZ H, 1858, CRELLES J, V55, P25, DOI DOI 10.1515/CRLL.1858.55.25; Howard RJ, 1996, CURR BIOL, V6, P1015, DOI 10.1016/S0960-9822(02)00646-2; KOENDERINK JJ, 1986, VISION RES, V26, P161, DOI 10.1016/0042-6989(86)90078-7; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1308, DOI 10.1152/jn.1986.55.6.1308; MORRONE MC, 1995, NATURE, V376, P507, DOI 10.1038/376507a0; Morrone MC, 1999, CURR BIOL, V9, P763, DOI 10.1016/S0960-9822(99)80338-8; Paolini M, 2000, J NEUROPHYSIOL, V84, P730, DOI 10.1152/jn.2000.84.2.730; Previc FH, 2000, EXP BRAIN RES, V131, P393, DOI 10.1007/s002219900298; QIAN N, 1994, J NEUROSCI, V14, P7367; REGAN D, 1979, SCIENCE, V205, P311, DOI 10.1126/science.451604; ROYDEN CS, 1992, NATURE, V360, P583, DOI 10.1038/360583a0; SAITO H, 1986, J NEUROSCI, V6, P145; Smith AT, 1998, J NEUROSCI, V18, P3816; Snowden RJ, 1996, J COGNITIVE NEUROSCI, V8, P435, DOI 10.1162/jocn.1996.8.5.435; TALAIRACH J, 1988, STEREOTACTIC COPOLAN; TANAKA K, 1989, J NEUROPHYSIOL, V62, P642, DOI 10.1152/jn.1989.62.3.642; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tootell RBH, 1997, J NEUROSCI, V17, P7060; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Xiong JH, 1995, HUM BRAIN MAPP, V3, P287, DOI 10.1002/hbm.460030404	37	300	304	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1322	1328		10.1038/81860	http://dx.doi.org/10.1038/81860			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100154	Bronze			2022-12-17	WOS:000167177900019
J	Stalnaker, TA; Cooch, NK; Schoenbaum, G				Stalnaker, Thomas A.; Cooch, Nisha K.; Schoenbaum, Geoffrey			What the orbitofrontal cortex does not do	NATURE NEUROSCIENCE			English	Review							VENTROMEDIAL PREFRONTAL CORTEX; DOPAMINE NEURONS ENCODE; FRONTAL-LOBE DAMAGE; VENTRAL TEGMENTAL AREA; DECISION-MAKING; BASOLATERAL AMYGDALA; REWARD VALUE; REINFORCER DEVALUATION; RHESUS-MONKEYS; ECONOMIC VALUE	The number of papers about the orbitofrontal cortex (OFC) has grown from 1 per month in 1987 to a current rate of over 50 per month. This publication stream has implicated the OFC in nearly every function known to cognitive neuroscience and in most neuropsychiatric diseases. However, new ideas about OFC function are typically based on limited data sets and often ignore or minimize competing ideas or contradictory findings. Yet true progress in our understanding of an area's function comes as much from invalidating existing ideas as proposing new ones. Here we consider the proposed roles for OFC, critically examining the level of support for these claims and highlighting the data that call them into question.	[Stalnaker, Thomas A.; Cooch, Nisha K.; Schoenbaum, Geoffrey] US Natl Inst Hlth, Natl Inst Drug Abuse Intramural Res Program, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Schoenbaum, G (corresponding author), US Natl Inst Hlth, Natl Inst Drug Abuse Intramural Res Program, Baltimore, MD 21224 USA.	geoffrey.schoenbaum@nih.gov		Schoenbaum, Geoffrey/0000-0001-8180-0701	National Institute on Drug Abuse; National Institute of Mental Health; National Institute on Aging; National Institute on Drug Abuse at the Intramural Research Program; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000587] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Drug Abuse at the Intramural Research Program; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors would like to thank C. Padoa-Schioppa, J. Wallis and P. Rudebeck for critical readings of earlier versions. This work was supported by grants to G.S. from the National Institute on Drug Abuse, the National Institute of Mental Health and the National Institute on Aging while G.S. was employed at the University of Maryland, Baltimore, and by funding from the National Institute on Drug Abuse at the Intramural Research Program. The opinions expressed in this article are the authors' own and do not reflect the view of the US National Institutes of Health, the Department of Health and Human Services, or the United States government.	Abe H, 2011, NEURON, V70, P731, DOI 10.1016/j.neuron.2011.03.026; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1675, DOI 10.1016/S0028-3932(02)00015-5; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1690, DOI 10.1016/S0028-3932(02)00016-7; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 2001, Semin Clin Neuropsychiatry, V6, P205, DOI 10.1053/scnp.2001.22927; Bechara A, 1999, J NEUROSCI, V19, P5473; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bissonette GB, 2008, J NEUROSCI, V28, P11124, DOI 10.1523/JNEUROSCI.2820-08.2008; Blanchard T.C., NEURON IN PRESS; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; Burke KA, 2008, NATURE, V454, P340, DOI 10.1038/nature06993; Burke KA, 2009, EUR J NEUROSCI, V30, P1941, DOI 10.1111/j.1460-9568.2009.06992.x; Cai XY, 2012, J NEUROSCI, V32, P3791, DOI 10.1523/JNEUROSCI.3864-11.2012; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Camille N, 2011, J NEUROSCI, V31, P7527, DOI 10.1523/JNEUROSCI.6527-10.2011; Chudasama Y, 2007, CEREB CORTEX, V17, P1154, DOI 10.1093/cercor/bhl025; Chudasama Y, 2003, J NEUROSCI, V23, P8771; Cohen J.Y., 2012, NATURE IN PRESS; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1659, DOI 10.1152/jn.1996.75.4.1659; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1673, DOI 10.1152/jn.1996.75.4.1673; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayan P, 2006, NEURAL NETWORKS, V19, P1153, DOI 10.1016/j.neunet.2006.03.002; DEACON TW, 1983, J COMP NEUROL, V220, P168, DOI 10.1002/cne.902200205; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Esber GR, 2011, P ROY SOC B-BIOL SCI, V278, P2553, DOI 10.1098/rspb.2011.0836; Fellows LK, 2007, ANN NY ACAD SCI, V1121, P421, DOI 10.1196/annals.1401.023; Fellows LK, 2007, CEREB CORTEX, V17, P2669, DOI 10.1093/cercor/bhl176; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Ferrier D, 1876, FUNCTIONS BRAIN; Gallagher M, 1999, J NEUROSCI, V19, P6610; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Gremel CM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3264; GROENEWEGEN HJ, 1990, PROG BRAIN RES, V85, P95; Hall, 1982, QUANTITATIVE ANAL BE, V3, P241; Harlow JM, 1993, HIST PSYCHIATR, V4, P274, DOI [10.1177/0957154X9300401407, DOI 10.1300/J233V04N01_06]; Hornak J, 2004, J COGNITIVE NEUROSCI, V16, P463, DOI 10.1162/089892904322926791; Hosokawa T, 2013, J NEUROSCI, V33, P17385, DOI 10.1523/JNEUROSCI.2221-13.2013; Huys QJM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002410; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Izquierdo A. D., 2000, SOC NEUR ABSTR, V26, P978; Izquierdo A, 2012, PSYCHOPHARMACOLOGY, V219, P607, DOI 10.1007/s00213-011-2579-7; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; Jones JL, 2012, SCIENCE, V338, P953, DOI 10.1126/science.1227489; Kazama A, 2009, J NEUROSCI, V29, P2794, DOI 10.1523/JNEUROSCI.4655-08.2009; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Kennerley SW, 2009, EUR J NEUROSCI, V29, P2061, DOI 10.1111/j.1460-9568.2009.06743.x; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kim J, 2005, NEUROBIOL LEARN MEM, V83, P125, DOI 10.1016/j.nlm.2004.10.003; Klein-Flugge M.C., 2013, J NEUROSCI, V33, P3202; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lak A, 2014, NEURON, V84, P190, DOI 10.1016/j.neuron.2014.08.039; LANG PJ, 1994, PSYCHOL REV, V101, P211, DOI 10.1037/0033-295X.101.2.211; Leathers ML, 2012, SCIENCE, V338, P132, DOI 10.1126/science.1226405; Lebreton M, 2009, NEURON, V64, P431, DOI 10.1016/j.neuron.2009.09.040; Levy DJ, 2012, CURR OPIN NEUROBIOL, V22, P1027, DOI 10.1016/j.conb.2012.06.001; Levy DJ, 2011, J NEUROSCI, V31, P14693, DOI 10.1523/JNEUROSCI.2218-11.2011; Louie K, 2011, J NEUROSCI, V31, P10627, DOI 10.1523/JNEUROSCI.1237-11.2011; Machado CJ, 2007, EUR J NEUROSCI, V25, P2885, DOI 10.1111/j.1460-9568.2007.05525.x; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; Maunsell JHR, 2004, TRENDS COGN SCI, V8, P261, DOI 10.1016/j.tics.2004.04.003; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; McDannald MA, 2005, J NEUROSCI, V25, P4626, DOI 10.1523/JNEUROSCI.5301-04.2005; McDannald MA, 2014, ELIFE, V3, DOI 10.7554/eLife.02653; McDannald MA, 2012, EUR J NEUROSCI, V35, P991, DOI 10.1111/j.1460-9568.2011.07982.x; McDannald MA, 2011, J NEUROSCI, V31, P2700, DOI 10.1523/JNEUROSCI.5499-10.2011; McNamee D, 2013, NAT NEUROSCI, V16, P479, DOI 10.1038/nn.3337; Meunier M, 1997, NEUROPSYCHOLOGIA, V35, P999, DOI 10.1016/S0028-3932(97)00027-4; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Morrison SE, 2011, NEURON, V71, P1127, DOI 10.1016/j.neuron.2011.07.016; Nobre AC, 1999, NAT NEUROSCI, V2, P11, DOI 10.1038/4513; Noonan MP, 2012, EUR J NEUROSCI, V35, P997, DOI 10.1111/j.1460-9568.2012.08023.x; O'Doherty J, 2000, NEUROREPORT, V11, P893, DOI 10.1097/00001756-200003200-00046; O'Doherty JP, 2014, NEUROSCI BIOBEHAV R, V43, P259, DOI 10.1016/j.neubiorev.2014.03.027; O'Neill M, 2010, NEURON, V68, P789, DOI 10.1016/j.neuron.2010.09.031; Ogawa M, 2013, NEURON, V77, P251, DOI 10.1016/j.neuron.2012.11.006; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Ostlund SB, 2007, J NEUROSCI, V27, P4819, DOI 10.1523/JNEUROSCI.5443-06.2007; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; Padoa-Schioppa C, 2013, NEURON, V80, P1322, DOI 10.1016/j.neuron.2013.09.013; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Padoa-Schioppa C, 2009, J NEUROSCI, V29, P14004, DOI 10.1523/JNEUROSCI.3751-09.2009; Pais-Vieira M, 2007, NEUROSCIENCE, V145, P225, DOI 10.1016/j.neuroscience.2006.11.058; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Pearson JM, 2014, NEURON, V82, P950, DOI 10.1016/j.neuron.2014.04.037; Pickens CL, 2005, BEHAV NEUROSCI, V119, P317, DOI 10.1037/0735-7044.119.1.317; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Popper Karl., 1934, LOGIK FORSCHUNG; RESCORLA RA, 1988, AM PSYCHOL, V43, P151, DOI 10.1037/0003-066X.43.3.151; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1101/GR.110528.110, DOI 10.1016/J.COGPSYCH.2004.11.001]; Riceberg JS, 2012, J NEUROSCI, V32, P16402, DOI 10.1523/JNEUROSCI.0776-12.2012; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rolls ET, 1996, PHILOS T ROY SOC B, V351, P1433, DOI 10.1098/rstb.1996.0128; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1970, DOI 10.1152/jn.1996.75.5.1970; Rudebeck PH, 2008, J NEUROSCI, V28, P8338, DOI 10.1523/JNEUROSCI.2272-08.2008; Rudebeck PH, 2013, NAT NEUROSCI, V16, P1140, DOI 10.1038/nn.3440; Rudebeck PH, 2011, ANN NY ACAD SCI, V1239, P1, DOI 10.1111/j.1749-6632.2011.06267.x; Rudebeck PH, 2011, J NEUROSCI, V31, P10569, DOI 10.1523/JNEUROSCI.0091-11.2011; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schoenbaum G, 2002, NEUROREPORT, V13, P885, DOI 10.1097/00001756-200205070-00030; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; SCHOENBAUM G, 2002, NEUROPSYCHOLOGY MEMO, P463; Schoenbaum G, 2011, ANN NY ACAD SCI, V1239, P87, DOI 10.1111/j.1749-6632.2011.06210.x; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Stalnaker TA, 2006, EUR J NEUROSCI, V24, P2643, DOI 10.1111/j.1460-9568.2006.05128.x; Stalnaker TA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4926; Steiner AP, 2014, NAT NEUROSCI, V17, P995, DOI 10.1038/nn.3740; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1023/A:1022633531479; Takahashi YK, 2013, NEURON, V80, P507, DOI 10.1016/j.neuron.2013.08.008; Takahashi YK, 2011, NAT NEUROSCI, V14, P1590, DOI 10.1038/nn.2957; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; Thorndike EL, 1933, SCIENCE, V77, P173, DOI 10.1126/science.77.1989.173-a; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Tobler PN, 2006, J NEUROPHYSIOL, V95, P301, DOI 10.1152/jn.00762.2005; TOLMAN EC, 1949, PSYCHOL REV, V56, P144, DOI 10.1037/h0055304; Tsuchida A, 2010, J NEUROSCI, V30, P16868, DOI 10.1523/JNEUROSCI.1958-10.2010; von Neumann John, 1947, THEORY GAMES EC BEHA; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Wallis JD, 2012, NAT NEUROSCI, V15, P13, DOI 10.1038/nn.2956; Wallis JD, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00124; Walton ME, 2011, ANN NY ACAD SCI, V1239, P14, DOI 10.1111/j.1749-6632.2011.06257.x; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Watson KK, 2012, CURR BIOL, V22, P2268, DOI 10.1016/j.cub.2012.10.016; West EA, 2013, BEHAV BRAIN RES, V246, P10, DOI 10.1016/j.bbr.2013.02.027; West EA, 2011, J NEUROSCI, V31, P15128, DOI 10.1523/JNEUROSCI.3295-11.2011; Wheeler EZ, 2008, BRAIN, V131, P1323, DOI 10.1093/brain/awn041; Wilson RC, 2014, NEURON, V81, P267, DOI 10.1016/j.neuron.2013.11.005; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004; Zeeb FD, 2013, J NEUROSCI, V33, P6434, DOI 10.1523/JNEUROSCI.3971-12.2013; Zeeb FD, 2011, J NEUROSCI, V31, P2197, DOI 10.1523/JNEUROSCI.5597-10.2011	150	299	304	1	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2015	18	5					620	627		10.1038/nn.3982	http://dx.doi.org/10.1038/nn.3982			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG9LN	25919962	Green Accepted			2022-12-17	WOS:000353636900007
J	Kennerley, SW; Behrens, TEJ; Wallis, JD				Kennerley, Steven W.; Behrens, Timothy E. J.; Wallis, Jonathan D.			Double dissociation of value computations in orbitofrontal and anterior cingulate neurons	NATURE NEUROSCIENCE			English	Article							TEMPORALLY DISCOUNTED VALUES; PREFRONTAL CORTEX; DECISION-MAKING; DOPAMINE NEURONS; ECONOMIC VALUE; INTERTEMPORAL CHOICE; REWARD PREFERENCE; SINGLE NEURONS; DISTINCT ROLES; PERFORMANCE	Damage to prefrontal cortex (PFC) impairs decision-making, but the underlying value computations that might cause such impairments remain unclear. Here we report that value computations are doubly dissociable among PFC neurons. Although many PFC neurons encoded chosen value, they used opponent encoding schemes such that averaging the neuronal population extinguished value coding. However, a special population of neurons in anterior cingulate cortex (ACC), but not in orbitofrontal cortex (OFC), multiplexed chosen value across decision parameters using a unified encoding scheme and encoded reward prediction errors. In contrast, neurons in OFC, but not ACC, encoded chosen value relative to the recent history of choice values. Together, these results suggest complementary valuation processes across PFC areas: OFC neurons dynamically evaluate current choices relative to recent choice values, whereas ACC neurons encode choice predictions and prediction errors using a common valuation currency reflecting the integration of multiple decision parameters.	[Kennerley, Steven W.; Behrens, Timothy E. J.] UCL, Inst Neurol, London, England; [Kennerley, Steven W.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Behrens, Timothy E. J.] Univ Oxford, John Radcliffe Hosp, Oxford Ctr Funct Magnet Resonance Imaging Brain F, Oxford OX3 9DU, England; [Wallis, Jonathan D.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of London; University College London; University of California System; University of California Berkeley; University of Oxford; University of California System; University of California Berkeley	Kennerley, SW (corresponding author), UCL, Inst Neurol, London, England.	s.kennerley@ucl.ac.uk	Kennerley, Steven W/E-3330-2018	Kennerley, Steven W/0000-0002-5696-7507; Wallis, Joni/0000-0001-7262-7417; Behrens, Timothy/0000-0003-0048-1177	US National Institute on Drug Abuse [R01DA19028]; US National Institute of Neurological Disorders and Stroke [P01NS040813]; US National Institute on Mental Health [F32MH081521]; Wellcome Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH081521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019028] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institute on Mental Health; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The project was funded by US National Institute on Drug Abuse grant R01DA19028, US National Institute of Neurological Disorders and Stroke grant P01NS040813 to J.W. and US National Institute on Mental Health training grant F32MH081521 to S.W.K. T.E.J.B. and S.W.K. are supported by the Wellcome Trust.	Amiez C, 2005, EUR J NEUROSCI, V21, P3447, DOI 10.1111/j.1460-9568.2005.04170.x; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bernacchia A, 2011, NAT NEUROSCI, V14, P366, DOI 10.1038/nn.2752; Buckley MJ, 2009, SCIENCE, V325, P52, DOI 10.1126/science.1172377; Cai XY, 2011, NEURON, V69, P170, DOI 10.1016/j.neuron.2010.11.041; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Fellows LK, 2006, BRAIN, V129, P944, DOI 10.1093/brain/awl017; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; Jessup RK, 2010, J NEUROSCI, V30, P3467, DOI 10.1523/JNEUROSCI.4130-09.2010; Jocham G, 2009, J NEUROSCI, V29, P7489, DOI 10.1523/JNEUROSCI.0349-09.2009; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kennerley SW, 2009, J NEUROPHYSIOL, V102, P3352, DOI 10.1152/jn.00273.2009; Kennerley SW, 2009, EUR J NEUROSCI, V29, P2061, DOI 10.1111/j.1460-9568.2009.06743.x; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Kim S, 2008, NEURON, V59, P161, DOI 10.1016/j.neuron.2008.05.010; Kobayashi S, 2010, J NEUROSCI, V30, P534, DOI 10.1523/JNEUROSCI.4009-09.2010; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Morrison SE, 2009, J NEUROSCI, V29, P11471, DOI 10.1523/JNEUROSCI.1815-09.2009; Noonan MP, 2010, P NATL ACAD SCI USA, V107, P20547, DOI 10.1073/pnas.1012246107; O'Neill M, 2010, NEURON, V68, P789, DOI 10.1016/j.neuron.2010.09.031; Oliveira FTP, 2007, J COGNITIVE NEUROSCI, V19, P1994, DOI 10.1162/jocn.2007.19.12.1994; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; Padoa-Schioppa C, 2009, J NEUROSCI, V29, P14004, DOI 10.1523/JNEUROSCI.3751-09.2009; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Prevost C, 2010, J NEUROSCI, V30, P14080, DOI 10.1523/JNEUROSCI.2752-10.2010; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Rudebeck PH, 2008, J NEUROSCI, V28, P13775, DOI 10.1523/JNEUROSCI.3541-08.2008; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Sallet J, 2007, COGN AFFECT BEHAV NE, V7, P327, DOI 10.3758/CABN.7.4.327; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Seo H, 2009, J NEUROSCI, V29, P3627, DOI 10.1523/JNEUROSCI.4726-08.2009; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; Williams ZM, 2004, NAT NEUROSCI, V7, P1370, DOI 10.1038/nn1354	50	299	303	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1581	U119		10.1038/nn.2961	http://dx.doi.org/10.1038/nn.2961			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22037498	Green Accepted			2022-12-17	WOS:000297546300019
J	Dieterich, DC; Hodas, JJL; Gouzer, G; Shadrin, IY; Ngo, JT; Triller, A; Tirrell, DA; Schuman, EM				Dieterich, Daniela C.; Hodas, Jennifer J. L.; Gouzer, Geraldine; Shadrin, Ilya Y.; Ngo, John T.; Triller, Antoine; Tirrell, David A.; Schuman, Erin M.			In situ visualization and dynamics of newly synthesized proteins in rat hippocampal neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; MAMMALIAN-CELLS; TRANSLATION MACHINERY; SYNAPTIC PLASTICITY; TETANIC STIMULATION; LATE-PHASE; KINASE-II; MEMBRANE; MEMORY; IDENTIFICATION	Protein translation has been implicated in different forms of synaptic plasticity, but direct in situ visualization of new proteins is limited to one or two proteins at a time. Here we describe a metabolic labeling approach based on incorporation of noncanonical amino acids into proteins followed by chemoselective fluorescence tagging by means of 'click chemistry'. After a brief incubation with azidohomoalanine or homopropargylglycine, a robust fluorescent signal was detected in somata and dendrites. Pulse-chase application of azidohomoalanine and homopropargylglycine allowed visualization of proteins synthesized in two sequential time periods. This technique can be used to detect changes in protein synthesis and to evaluate the fate of proteins synthesized in different cellular compartments. Moreover, using strain-promoted cycloaddition, we explored the dynamics of newly synthesized membrane proteins using single-particle tracking and quantum dots. The newly synthesized proteins showed a broad range of diffusive behaviors, as would be expected for a pool of labeled proteins that is heterogeneous.	[Dieterich, Daniela C.; Hodas, Jennifer J. L.; Shadrin, Ilya Y.; Schuman, Erin M.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Dieterich, Daniela C.] Leibniz Inst Neurobiol, Magdeburg, Germany; [Gouzer, Geraldine; Triller, Antoine] Ecole Normale Super, CNRS, INSERM, Inst Biol,U1024,UMR8197, Paris, France; [Ngo, John T.; Tirrell, David A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Schuman, Erin M.] Max Planck Inst Brain Res, D-60528 Frankfurt, Germany	California Institute of Technology; Leibniz Institut fur Neurobiologie (LIN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; California Institute of Technology; Max Planck Society	Schuman, EM (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	schumane@brain.mpg.de	Schuman, Erin M/D-6204-2011	TRILLER, Antoine/0000-0002-7530-1233; Dieterich, Daniela C./0000-0002-9880-1214; Shadrin, Ilya/0000-0002-4501-0400; Ngo, John/0000-0003-3508-1915; Gouzer, Geraldine/0000-0002-4578-6567	German Academy for Natural Scientists Leopoldina; US National Institutes of Health; Howard Hughes Medical Institute; Ministere de l'Enseignement Superieur et de la Recherche; Nationale de la Recherche MorphoSynDiff-INSERM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA020589] Funding Source: NIH RePORTER	German Academy for Natural Scientists Leopoldina; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ministere de l'Enseignement Superieur et de la Recherche; Nationale de la Recherche MorphoSynDiff-INSERM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank L. Chen for making beautiful cultured hippocampal neurons. We thank A.J. Link for discussions and help with the tag syntheses. We are grateful to O. Kobler for help with Imaris software. We are extremely grateful to both C. Bertozzi and J. Baskin for providing the difluorinated cyclooctyne-biotin and advising on its use. This work was supported by the German Academy for Natural Scientists Leopoldina (D.C.D.), the US National Institutes of Health (E.M.S. and D.A.T.), the Howard Hughes Medical Institute (E.M.S.), the Ministere de l'Enseignement Superieur et de la Recherche (G.G.) and the Nationale de la Recherche MorphoSynDiff-INSERM (A.T.).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Agard NJ, 2004, J AM CHEM SOC, V126, P15046, DOI 10.1021/ja044996f; AGRANOFF BW, 1964, SCIENCE, V146, P952, DOI 10.1126/science.146.3646.952; Alcor D, 2009, EUR J NEUROSCI, V30, P987, DOI 10.1111/j.1460-9568.2009.06927.x; Bannai H, 2006, NAT PROTOC, V1, P2628, DOI 10.1038/nprot.2006.429; Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104; Beatty KE, 2008, BIOORG MED CHEM LETT, V18, P5995, DOI 10.1016/j.bmcl.2008.08.046; Beatty KE, 2006, ANGEW CHEM INT EDIT, V45, P7364, DOI 10.1002/anie.200602114; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; FLEXNER JB, 1963, SCIENCE, V141, P57, DOI 10.1126/science.141.3575.57; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gogolla N, 2006, NAT PROTOC, V1, P1223, DOI 10.1038/nprot.2006.169; Huang T, 2006, EUR J CELL BIOL, V85, P635, DOI 10.1016/j.ejcb.2006.02.005; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Liao L, 2007, J PROTEOME RES, V6, P1059, DOI 10.1021/pr060358f; Lin MZ, 2008, P NATL ACAD SCI USA, V105, P7744, DOI 10.1073/pnas.0803060105; Link AJ, 2003, CURR OPIN BIOTECH, V14, P603, DOI 10.1016/j.copbio.2003.10.011; Link AJ, 2003, J AM CHEM SOC, V125, P11164, DOI 10.1021/ja036765z; Macchi P, 2003, MOL BIOL CELL, V14, P1570, DOI 10.1091/mbc.E02-08-0505; Manadas B, 2009, J PROTEOME RES, V8, P4536, DOI 10.1021/pr900366x; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Ouyang Y, 1997, J NEUROSCI, V17, P5416; Ouyang Y, 1999, J NEUROSCI, V19, P7823; RENNER M, 2005, NEURON IN PRESS; Renner M, 2009, J NEUROSCI, V29, P2926, DOI 10.1523/JNEUROSCI.4445-08.2009; Renner M, 2008, CURR OPIN NEUROBIOL, V18, P532, DOI 10.1016/j.conb.2008.09.009; Renner ML, 2009, NEUROPHARMACOLOGY, V56, P30, DOI 10.1016/j.neuropharm.2008.07.022; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Sajikumar S, 2007, J NEUROSCI, V27, P5068, DOI 10.1523/JNEUROSCI.4940-06.2007; Serge A, 2002, J NEUROSCI, V22, P3910, DOI 10.1523/JNEUROSCI.22-10-03910.2002; Steward O, 1997, NEURON, V18, P9, DOI 10.1016/S0896-6273(01)80041-6; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022; Villareal G, 2007, CURR BIOL, V17, P2073, DOI 10.1016/j.cub.2007.10.053; Wang DO, 2009, SCIENCE, V324, P1536, DOI 10.1126/science.1173205; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; WEILER IJ, 1994, PROG BRAIN RES, V100, P189; WHITAKER JE, 1992, ANAL BIOCHEM, V207, P267, DOI 10.1016/0003-2697(92)90011-U; Zhang ZW, 2003, BIOCHEMISTRY-US, V42, P6735, DOI 10.1021/bi0300231	48	299	306	5	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					897	U149		10.1038/nn.2580	http://dx.doi.org/10.1038/nn.2580			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20543841	Green Accepted			2022-12-17	WOS:000279173900024
J	Kim, DS; Duong, TQ; Kim, SG				Kim, DS; Duong, TQ; Kim, SG			High-resolution mapping of iso-orientation columns by fMRI	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; FUNCTIONAL-ORGANIZATION; SENSORY STIMULATION; INTRINSIC SIGNALS; OCULAR DOMINANCE; NEURONAL-ACTIVITY; STRIATE CORTEX; BRAIN ACTIVITY; BLOOD-FLOW; SELECTIVITY	Blood-oxygenation level-dependent (BOLD) functional magnetic resonance imaging (fMRI) is an important tool for localizing brain functions in vivo. However, the ability of BOLD fMRI to map cortical columnar structures is highly controversial, as the ultimate functional specificity of BOLD remains unknown. Here we report a biphasic BOLD response to visual stimulation in the primary visual cortex of cats. In functional imaging, the initial BOLD signal decrease accurately labeled individual iso-orientation columns. In contrast, the delayed positive BOLD changes indicated the pattern of overall activation in the visual cortex, but were less suited to discriminate active from inactive columns.	Univ Minnesota, Sch Med, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Kim, SG (corresponding author), Univ Minnesota, Sch Med, Ctr Magnet Resonance Res, 2021 6th St SE, Minneapolis, MN 55455 USA.		Kim, Seong-Gi/A-2691-2008; Duong, Tim/AAL-8357-2021; Kim, Dae-Shik/C-2071-2011; Duong, Timothy/B-8525-2008	Duong, Tim/0000-0001-6403-2827; 	NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH057180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038295] Funding Source: NIH RePORTER; NIMH NIH HHS [MH57180] Funding Source: Medline; NINDS NIH HHS [NS10930, NS38295] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BLASDEL GG, 1992, J NEUROSCI, V12, P3115, DOI 10.1523/JNEUROSCI.12-08-03115.1992; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Brodmann K., 1909, VERGLEICHENDE LOKALI; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DIAO YC, 1990, EXP BRAIN RES, V79, P271, DOI 10.1007/BF00608236; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; ERNST T, 1994, MAGN RESON MED, V32, P146, DOI 10.1002/mrm.1910320122; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Hu XP, 1997, MAGNET RESON MED, V37, P877, DOI 10.1002/mrm.1910370612; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Janz C, 1997, NMR BIOMED, V10, P222, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<222::AID-NBM462>3.0.CO;2-M; Jezzard P, 1997, MAGNET RESON MED, V38, P699, DOI 10.1002/mrm.1910380504; KIM DS, 1994, NATURE, V370, P370, DOI 10.1038/370370a0; KIM SG, 1993, SCIENCE, V261, P615, DOI 10.1126/science.8342027; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LEVAY S, 1991, VISION VISUAL DYSFUN, P266; LOEWEL S, 1987, Journal of Comparative Neurology, V255, P401; LOEWEL S, 1990, DEV BRAIN RES, V56, P99; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Malonek D, 1997, P NATL ACAD SCI USA, V94, P14826, DOI 10.1073/pnas.94.26.14826; Marota JJA, 1999, MAGNET RESON MED, V41, P247, DOI 10.1002/(SICI)1522-2594(199902)41:2<247::AID-MRM6>3.0.CO;2-U; Menon RS, 1997, J NEUROPHYSIOL, V77, P2780, DOI 10.1152/jn.1997.77.5.2780; MENON RS, 1995, MAGNET RESON MED, V33, P453, DOI 10.1002/mrm.1910330323; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Ogawa S, 1998, ANNU REV BIOPH BIOM, V27, P447, DOI 10.1146/annurev.biophys.27.1.447; Posner M. I., 1994, IMAGES MIND; Press W. H., 2007, NUMERICAL RECIPES C, V3rd; ROJER AS, 1990, BIOL CYBERN, V62, P381, DOI 10.1007/BF00197644; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shmuel A, 1996, J NEUROSCI, V16, P6945; Silva AC, 2000, J CEREBR BLOOD F MET, V20, P201, DOI 10.1097/00004647-200001000-00025; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Stetter M, 1999, J OPT SOC AM A, V16, P58, DOI 10.1364/JOSAA.16.000058; SWINDALE NV, 1987, J NEUROSCI, V7, P1414; TOOTELL RB, 1997, J NEUROSCI, V17, P7070; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Yacoub E, 1999, MAGNET RESON MED, V41, P1088, DOI 10.1002/(SICI)1522-2594(199906)41:6<1088::AID-MRM3>3.0.CO;2-Q	48	299	308	1	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2000	3	2					164	169		10.1038/72109	http://dx.doi.org/10.1038/72109			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TC	10649572				2022-12-17	WOS:000085810300014
J	Herzog, ED; Takahashi, JS; Block, GD				Herzog, ED; Takahashi, JS; Block, GD			Clock controls circadian period in isolated suprachiasmatic nucleus neurons	NATURE NEUROSCIENCE			English	Article							BIOLOGICAL CLOCK; IN-VITRO; RAT; PACEMAKER; RHYTHMS; GENE; TIMELESS; MUTATION; BEHAVIOR; PROTEIN	The suprachiasmatic nucleus (SCN) is the master circadian pacemaker in mammals, and one molecular regulator of circadian rhythms is the Clock gene. Here we studied the discharge patterns of SCN neurons isolated from Clock mutant mice. Long-term, multielectrode recordings showed that heterozygous Clock mutant neurons have,lengthened periods and that homozygous Clock neurons are arrhythmic, paralleling the effects on locomotor activity in the animal. In addition, cells in dispersals expressed a wider range of periods and phase relationships than cells in explants. These results suggest that the Clock gene is required for circadian rhythmicity in individual SCN cells and that a mechanism within the SCN synchronizes neurons and restricts the range of expressed circadian periods.	Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA; Northwestern Univ, Dept Neurobiol & Physiol, Howard Hughes Med Inst, Evanston, IL 60208 USA	University of Virginia; Howard Hughes Medical Institute; Northwestern University			Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Herzog, Erik/0000-0001-7209-5174				Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BLOCK GD, 1984, J COMP PHYSIOL, V155, P365, DOI 10.1007/BF00610590; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Dunlap J, 1998, SCIENCE, V280, P1548, DOI 10.1126/science.280.5369.1548; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; GROSS GW, 1994, J NEUROSCI METH, V52, P73, DOI 10.1016/0165-0270(94)90059-0; GROSS GW, 1982, J NEUROSCI METH, V5, P13, DOI 10.1016/0165-0270(82)90046-2; Herzog ED, 1997, BRAIN RES, V757, P285, DOI 10.1016/S0006-8993(97)00337-5; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; JACKLET JW, 1983, J NEUROCYTOL, V12, P673, DOI 10.1007/BF01181530; Jiang ZG, 1997, NEUROSCIENCE, V77, P1059, DOI 10.1016/S0306-4522(96)00539-8; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; LeSauter J, 1996, J BIOL RHYTHM, V11, P163, DOI 10.1177/074873049601100208; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; LOUDON ASI, 1994, ENDOCRINOLOGY, V135, P712, DOI 10.1210/en.135.2.712; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; MURAKAMI N, 1991, BRAIN RES, V545, P347, DOI 10.1016/0006-8993(91)91312-O; NIEOULLON A, 1977, NATURE, V266, P375, DOI 10.1038/266375a0; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; PROSSER RA, 1994, BRAIN RES, V643, P296, DOI 10.1016/0006-8993(94)90036-1; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; REPPERT SM, 1984, J NEUROSCI, V4, P1677; REPPERT SM, 1983, SCIENCE, V220, P969, DOI 10.1126/science.6844923; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; SCHWARTZ WJ, 1991, J BIOL RHYTHM, V6, P149, DOI 10.1177/074873049100600205; SHINOHARA K, 1995, P NATL ACAD SCI USA, V92, P7396, DOI 10.1073/pnas.92.16.7396; SIMON JL, 1995, RESAMPLING NEW STAT; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; VANDENPOL AN, 1993, NEUROSCIENCE, V56, P793, DOI 10.1016/0306-4522(93)90128-3; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; WATANABE A, 1994, BRAIN RES, V646, P161, DOI 10.1016/0006-8993(94)90071-X; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; YAMAZAKI S, IN PRESS J NEUROSCI	43	299	306	0	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					708	713		10.1038/3708	http://dx.doi.org/10.1038/3708			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196587				2022-12-17	WOS:000077323400015
J	Hofer, SB; Ko, H; Pichler, B; Vogelstein, J; Ros, H; Zeng, HK; Lein, E; Lesica, NA; Mrsic-Flogel, TD				Hofer, Sonja B.; Ko, Ho; Pichler, Bruno; Vogelstein, Joshua; Ros, Hana; Zeng, Hongkui; Lein, Ed; Lesica, Nicholas A.; Mrsic-Flogel, Thomas D.			Differential connectivity and response dynamics of excitatory and inhibitory neurons in visual cortex	NATURE NEUROSCIENCE			English	Article							IN-VIVO; CORTICAL-NEURONS; FUNCTIONAL CONNECTIVITY; GABAERGIC NEURONS; TRANSGENIC MICE; STRIATE CORTEX; BEHAVING MICE; BARREL CORTEX; SIMPLE CELLS; NETWORKS	Neuronal responses during sensory processing are influenced by both the organization of intracortical connections and the statistical features of sensory stimuli. How these intrinsic and extrinsic factors govern the activity of excitatory and inhibitory populations is unclear. Using two-photon calcium imaging in vivo and intracellular recordings in vitro, we investigated the dependencies between synaptic connectivity, feature selectivity and network activity in pyramidal cells and fast-spiking parvalbumin-expressing (PV) interneurons in mouse visual cortex. In pyramidal cell populations, patterns of neuronal correlations were largely stimulus-dependent, indicating that their responses were not strongly dominated by functionally biased recurrent connectivity. By contrast, visual stimulation only weakly modified co-activation patterns of fast-spiking PV cells, consistent with the observation that these broadly tuned interneurons received very dense and strong synaptic input from nearby pyramidal cells with diverse feature selectivities. Therefore, feedforward and recurrent network influences determine the activity of excitatory and inhibitory ensembles in fundamentally different ways.	[Hofer, Sonja B.; Ko, Ho; Pichler, Bruno; Ros, Hana; Mrsic-Flogel, Thomas D.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Vogelstein, Joshua] Johns Hopkins Univ, Baltimore, MD USA; [Zeng, Hongkui; Lein, Ed] Allen Inst Brain Sci, Seattle, WA USA; [Lesica, Nicholas A.] UCL, Ear Inst, London, England	University of London; University College London; Johns Hopkins University; Allen Institute for Brain Science; University of London; University College London	Mrsic-Flogel, TD (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	t.mrsic-flogel@ucl.ac.uk	Ko, Ho/I-7513-2016; Ko, Ho/AAH-2755-2020; Vogelstein, Joshua/AAG-5489-2019	Ko, Ho/0000-0002-0254-3274; Ko, Ho/0000-0002-0254-3274; Vogelstein, Joshua/0000-0003-2487-6237; Mrsic-Flogel, Tom/0000-0002-8947-408X; Lesica, Nicholas/0000-0001-5238-4462; Hofer, Sonja/0000-0003-4921-8521	Wellcome Trust; European Research Council; European Molecular Biology Organization; Humboldt Foundation; European Community [FP2007-2013, 223326]	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Humboldt Foundation(Alexander von Humboldt Foundation); European Community(European Commission)	We thank T. Margrie, A. Arenz and E. Rancz for help with in vivo electrophysiology, J. Sjostrom and K. Buchanan for help with in vitro electrophysiology, J. Rothman for NeuroMatic software, and M. Hubener and M. Sahani for comments on an earlier version of this manuscript. This work was supported by the Wellcome Trust (T.D.M.-F.), the European Research Council (T.D.M.-F.), the European Molecular Biology Organization (S.B.H.) and the Humboldt Foundation (S.B.H.). We also received funding from the European Community's Seventh Framework Programme (FP2007-2013) under grant agreement no. 223326 (T.D.M.-F.).	Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; Ch'ng YH, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00020; Chelaru MI, 2008, P NATL ACAD SCI USA, V105, P16344, DOI 10.1073/pnas.0807744105; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Jermakowicz WJ, 2009, J NEUROPHYSIOL, V101, P2279, DOI 10.1152/jn.91207.2008; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Liu BH, 2010, NAT NEUROSCI, V13, P89, DOI 10.1038/nn.2443; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Nowak LG, 2008, CEREB CORTEX, V18, P1058, DOI 10.1093/cercor/bhm137; Ohiorhenuan IE, 2010, NATURE, V466, P617, DOI 10.1038/nature09178; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Oswald AMM, 2009, J NEUROSCI, V29, P10321, DOI 10.1523/JNEUROSCI.1703-09.2009; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tanahira C, 2009, NEUROSCI RES, V63, P213, DOI 10.1016/j.neures.2008.12.007; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	50	298	298	2	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1045	U146		10.1038/nn.2876	http://dx.doi.org/10.1038/nn.2876			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21765421	Green Accepted			2022-12-17	WOS:000293123700019
J	Kim, WY; Wang, XS; Wu, YH; Doble, BW; Patel, S; Woodgett, JR; Snider, WD				Kim, Woo-Yang; Wang, Xinshuo; Wu, Yaohong; Doble, Bradley W.; Patel, Satish; Woodgett, James R.; Snider, William D.			GSK-3 is a master regulator of neural progenitor homeostasis	NATURE NEUROSCIENCE			English	Article							CELL SELF-RENEWAL; NERVOUS-SYSTEM; STEM-CELLS; N-MYC; NEUROGENESIS; NOTCH; DIFFERENTIATION; PROLIFERATION; KINASE; PLURIPOTENCY	The development of the brain requires the exquisite coordination of progenitor proliferation and differentiation to achieve complex circuit assembly. It has been suggested that glycogen synthase kinase 3 (GSK-3) acts as an integrating molecule for multiple proliferation and differentiation signals because of its essential role in the RTK, Wnt and Shh signaling pathways. We created conditional mutations that deleted both the. and. forms of GSK-3 in mouse neural progenitors. GSK-3 deletion resulted in massive hyperproliferation of neural progenitors along the entire neuraxis. Generation of both intermediate neural progenitors and postmitotic neurons was markedly suppressed. These effects were associated with the dysregulation of beta-catenin, Sonic Hedgehog, Notch and fibroblast growth factor signaling. Our results indicate that GSK-3 signaling is an essential mediator of homeostatic controls that regulate neural progenitors during mammalian brain development.	[Kim, Woo-Yang; Wang, Xinshuo; Wu, Yaohong; Snider, William D.] Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC 27515 USA; [Doble, Bradley W.] McMaster Univ, McMaster Stem Cell & Canc Res Inst, Hamilton, ON, Canada; [Patel, Satish; Woodgett, James R.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Patel, Satish; Woodgett, James R.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; McMaster University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Snider, WD (corresponding author), Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC 27515 USA.	wsnider@med.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022; Doble, Brad/L-7551-2016; Doble, Bradley/V-7848-2019; Woodgett, Jim/F-1087-2010	Doble, Brad/0000-0002-0260-2983; Doble, Bradley/0000-0002-0260-2983; Woodgett, Jim/0000-0003-3731-5797	US National Institutes of Health [NS050968, NS045892]; University of North Carolina Neuroscience Center; Canadian Institutes of Health Research (MOP) [74711]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892, R01NS050968] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina Neuroscience Center; Canadian Institutes of Health Research (MOP)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank F. Polleux, L. Pevny and E. Anton for valuable advice and comments on the manuscript. We are also grateful to L. Goins and A. McKell for animal care and M. Aita for technical support. This research was supported by grants from the US National Institutes of Health (NS050968 to W. D. S. and NS045892, which supports the Confocal and Multiphoton Imaging and Expression Localization Cores of University of North Carolina Neuroscience Center) and Canadian Institutes of Health Research (MOP 74711 to J.R.W.).	Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Bechard M, 2009, MOL CELL BIOL, V29, P2092, DOI 10.1128/MCB.01405-08; Bone HK, 2009, CHEM BIOL, V16, P15, DOI 10.1016/j.chembiol.2008.11.003; Calvisi DF, 2004, CARCINOGENESIS, V25, P901, DOI 10.1093/carcin/bgh083; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Corbin JG, 2008, J NEUROCHEM, V106, P2272, DOI 10.1111/j.1471-4159.2008.05522.x; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Ding Q, 1998, DEVELOPMENT, V125, P2533; Doble BW, 2009, CELL STEM CELL, V4, P98, DOI 10.1016/j.stem.2009.01.005; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gulacsi AA, 2008, NAT NEUROSCI, V11, P1383, DOI 10.1038/nn.2226; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Jin YH, 2009, MOL CELLS, V27, P15, DOI 10.1007/s10059-009-0001-7; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Knoepfler PS, 2006, CELL CYCLE, V5, P47, DOI 10.4161/cc.5.1.2292; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; Machon O, 2007, DEV BIOL, V311, P223, DOI 10.1016/j.ydbio.2007.08.038; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Uemura K, 2007, J BIOL CHEM, V282, P15823, DOI 10.1074/jbc.M610708200; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yokota Y, 2009, NEURON, V61, P42, DOI 10.1016/j.neuron.2008.10.053; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4	39	298	312	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1390	1397		10.1038/nn.2408	http://dx.doi.org/10.1038/nn.2408			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19801986	Green Accepted, Green Submitted			2022-12-17	WOS:000271194100011
J	Schulz, DJ; Goaillard, JM; Marder, E				Schulz, DJ; Goaillard, JM; Marder, E			Variable channel expression in identified single and electrically coupled neurons in different animals	NATURE NEUROSCIENCE			English	Article							ACTIVITY-DEPENDENT REGULATION; GENE-EXPRESSION; STOMATOGASTRIC GANGLION; POTASSIUM CURRENTS; SHAL GENE; I-A; NETWORK; CRAB; CONDUCTANCES; MODULATION	It is often assumed that all neurons of the same cell type have identical intrinsic properties, both within an animal and between animals. We exploited the large size and small number of unambiguously identifiable neurons in the crab stomatogastric ganglion to test this assumption at the level of channel mRNA expression and membrane currents (measured in voltage-clamp experiments). In lateral pyloric (LP) neurons, we saw strong correlations between measured current and the abundance of Shal and BK-KCa mRNAs (encoding the Shal-family voltage-gated potassium channel and large-conductance calcium-activated potassium channel, respectively). We also saw two- to fourfold interanimal variability for three potassium currents and their mRNA expression. Measurements of channel expression in the two electrically coupled pyloric dilator (PD) neurons showed significant interanimal variability, but copy numbers for IH (encoding the hyperpolarization-activated, inward-current channel) and Shal mRNA in the two PD neurons from the same crab were similar, suggesting that the regulation of some currents may be shared in electrically coupled neurons.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Schulz, DJ (corresponding author), Univ Missouri, Columbia, MO 65211 USA.	SchulzD@missouri.edu		Schulz, David/0000-0003-4532-5362	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH046742, R01MH046742, F32MH070292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS017813, R01NS017813] Funding Source: NIH RePORTER; NIMH NIH HHS [F32 MH070292, MH46742, MH70292] Funding Source: Medline; NINDS NIH HHS [NS17813, R01 NS017813] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Baro DJ, 1998, ANN NY ACAD SCI, V860, P281, DOI 10.1111/j.1749-6632.1998.tb09056.x; Baro DJ, 1997, J NEUROSCI, V17, P6597; Baro DJ, 2001, NEUROSCIENCE, V106, P419, DOI 10.1016/S0306-4522(01)00261-5; BARO DJ, 1994, RECEPTOR CHANNEL, V2, P193; Baro DJ, 1996, J NEUROSCI, V16, P1689; Baro DJ, 2000, J NEUROSCI, V20, P6619, DOI 10.1523/JNEUROSCI.20-17-06619.2000; BARO DJ, 1994, RECEPTOR CHANNEL, V2, P350; Bucher D, 2005, J NEUROSCI, V25, P1611, DOI 10.1523/JNEUROSCI.3679-04.2005; Cristobal R, 2005, MOL BRAIN RES, V133, P19, DOI 10.1016/j.molbrainres.2004.10.001; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; French LB, 2004, NEUROSCIENCE, V123, P919, DOI 10.1016/j.neuroscience.2003.08.036; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Golowasch J, 2002, J NEUROPHYSIOL, V87, P1129, DOI 10.1152/jn.00412.2001; GOLOWASCH J, 1992, J NEUROPHYSIOL, V67, P318, DOI 10.1152/jn.1992.67.2.318; Golowasch J, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0004.1999; Greenspan RJ, 2001, NAT REV GENET, V2, P383, DOI 10.1038/35072018; HARRISWARRICK RM, 1995, J NEUROPHYSIOL, V74, P1404, DOI 10.1152/jn.1995.74.4.1404; HOOPER SL, 1986, J COMP PHYSIOL A, V159, P227, DOI 10.1007/BF00612305; Kamme F, 2003, J NEUROSCI, V23, P3607; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Liss B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf088; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; Liu Z, 1998, J NEUROSCI, V18, P2309; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; Luther JA, 2003, J NEUROPHYSIOL, V90, P2720, DOI 10.1152/jn.00370.2003; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Ma'ayan A, 2005, ANNU REV BIOPH BIOM, V34, P319, DOI 10.1146/annurev.biophys.34.040204.144415; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Marder E, 2002, BIOESSAYS, V24, P1145, DOI 10.1002/bies.10185; MARDER E, 1976, J PHYSIOL-LONDON, V257, P63, DOI 10.1113/jphysiol.1976.sp011356; PALLANCK L, 1994, HUM MOL GENET, V3, P1239, DOI 10.1093/hmg/3.8.1239; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Rozen S, 2000, Methods Mol Biol, V132, P365; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; Selverston A.I., 1987, CRUSTACEAN STOMATOGA; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Thoby-Brisson M, 2002, J NEUROPHYSIOL, V88, P2942, DOI 10.1152/jn.00482.2001; TIERNEY AJ, 1992, J NEUROPHYSIOL, V67, P599, DOI 10.1152/jn.1992.67.3.599; Tietjen I, 2005, INT J DEV BIOL, V49, P201, DOI 10.1387/ijdb.041939it; Tkatch T, 2000, J NEUROSCI, V20, P579, DOI 10.1523/JNEUROSCI.20-02-00579.2000; WEIMANN JM, 1991, J NEUROPHYSIOL, V65, P111, DOI 10.1152/jn.1991.65.1.111; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	44	298	301	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					356	362		10.1038/nn1639	http://dx.doi.org/10.1038/nn1639			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16444270				2022-12-17	WOS:000235645600015
J	Mehring, C; Rickert, J; Vaadia, E; de Oliveira, SC; Aertsen, A; Rotter, S				Mehring, C; Rickert, J; Vaadia, E; de Oliveira, SC; Aertsen, A; Rotter, S			Inference of hand movements from local field potentials in monkey motor cortex	NATURE NEUROSCIENCE			English	Article							OSCILLATIONS	The spiking of neuronal populations in motor cortex provides accurate information about movement parameters. Here we show that hand movement target and velocity can be inferred from multiple local field potentials (LFPs) in single trials approximately as efficiently as from multiple single-unit activity (SUA) recorded from the same electrodes. Our results indicate that LFPs can be used as an additional signal for decoding brain activity, particularly for new neuroprosthetic applications.	Univ Freiburg, Inst Biol 3, D-79104 Freiburg, Germany; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Interdisciplinary Ctr Neural Computat, IL-91120 Jerusalem, Israel; Univ Dortmund, Inst Arbeitsphysiol, D-44139 Dortmund, Germany; Inst Frontier Areas Psychol & Mental Hlth, D-79098 Freiburg, Germany	University of Freiburg; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Dortmund University of Technology	Mehring, C (corresponding author), Univ Freiburg, Inst Biol 3, Schanzlestr 1, D-79104 Freiburg, Germany.	carsten.mehring@biologie.uni-freiburg.de	Vaadia, Eilon/E-9347-2011; Mehring, Carsten/R-8986-2019	Mehring, Carsten/0000-0001-8125-5205				Baker SN, 1999, EXP BRAIN RES, V128, P109, DOI 10.1007/s002210050825; de Oliveira SC, 2001, EUR J NEUROSCI, V14, P1881, DOI 10.1046/j.0953-816x.2001.01801.x; Donchin O, 1998, NATURE, V395, P274, DOI 10.1038/26220; Donchin O, 2001, EXP BRAIN RES, V140, P46, DOI 10.1007/s002210100784; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3949, DOI 10.1152/jn.1996.76.6.3949; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582	10	298	318	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1253	1254		10.1038/nn1158	http://dx.doi.org/10.1038/nn1158			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14634657				2022-12-17	WOS:000186725600008
J	Nichols, TE; Das, S; Eickhoff, SB; Evans, AC; Glatard, T; Hanke, M; Kriegeskorte, N; Milham, MP; Poldrack, RA; Poline, JB; Proal, E; Thirion, B; Van Essen, DC; White, T; Yeo, BTT				Nichols, Thomas E.; Das, Samir; Eickhoff, Simon B.; Evans, Alan C.; Glatard, Tristan; Hanke, Michael; Kriegeskorte, Nikolaus; Milham, Michael P.; Poldrack, Russell A.; Poline, Jean-Baptiste; Proal, Erika; Thirion, Bertrand; Van Essen, David C.; White, Tonya; Yeo, B. T. Thomas			Best practices in data analysis and sharing in neuroimaging using MRI	NATURE NEUROSCIENCE			English	Article							NEUROSCIENCE; RELIABILITY; TASK	Given concerns about the reproducibility of scientific findings, neuroimaging must define best practices for data analysis, results reporting, and algorithm and data sharing to promote transparency, reliability and collaboration. We describe insights from developing a set of recommendations on behalf of the Organization for Human Brain Mapping and identify barriers that impede these practices, including how the discipline must change to fully exploit the potential of the world's neuroimaging data.	[Nichols, Thomas E.] Univ Warwick, Coventry, W Midlands, England; [Das, Samir; Evans, Alan C.; Glatard, Tristan] McGill Univ, Montreal, PQ, Canada; [Das, Samir; Evans, Alan C.] Montreal Neurol Inst, Montreal, PQ, Canada; [Eickhoff, Simon B.] Julich Res Ctr, Inst Neurosci & Med INM 1, Julich, Germany; [Eickhoff, Simon B.] Heinrich Heine Univ Dusseldorf, Fac Med, Inst Syst Neurosci, Dusseldorf, Germany; [Glatard, Tristan] Concordia Univ, Dept Comp Sci & Software Engn, Montreal, PQ, Canada; [Hanke, Michael] Otto von Guericke Univ, Magdeburg, Germany; [Hanke, Michael] Ctr Behav Brain Sci, Magdeburg, Germany; [Kriegeskorte, Nikolaus] MRC Cognit & Brain Sci Unit, Cambridge, England; [Milham, Michael P.] Child Mind Inst, New York, NY USA; [Milham, Michael P.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; [Poldrack, Russell A.] Stanford Univ, Stanford, CA 94305 USA; [Poline, Jean-Baptiste] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Proal, Erika] NEUROingenia Clin & Res Ctr, Mexico City, DF, Mexico; [Thirion, Bertrand] Paris Saclay Univ, Inria, Paris, France; [Van Essen, David C.] Washington Univ, St Louis, MO USA; [White, Tonya] Erasmus MC, Rotterdam, Netherlands; [Yeo, B. T. Thomas] Natl Univ Singapore, Singapore, Singapore	University of Warwick; McGill University; McGill University; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Concordia University - Canada; Otto von Guericke University; Nathan Kline Institute for Psychiatric Research; Stanford University; University of California System; University of California Berkeley; Inria; UDICE-French Research Universities; Universite Paris Saclay; Washington University (WUSTL); Erasmus University Rotterdam; Erasmus MC; National University of Singapore	Nichols, TE (corresponding author), Univ Warwick, Coventry, W Midlands, England.	t.e.nichols@warwick.ac.uk	Evans, Alan C/B-2373-2013; Milham, Michael P./Y-3160-2019; White, Tonya/AAU-2226-2021; Hanke, Michael/F-1382-2013; Van Essen, David/ABA-8888-2020; Nichols, Thomas E./N-9902-2017; Yeo, B.T. Thomas/X-2860-2019; Hanke, Michael/A-7726-2013; Eickhoff, Simon B./K-2061-2013	Evans, Alan C/0000-0003-3841-6098; White, Tonya/0000-0003-0271-1896; Hanke, Michael/0000-0001-6398-6370; Nichols, Thomas E./0000-0002-4516-5103; Yeo, B.T. Thomas/0000-0002-0119-3276; Hanke, Michael/0000-0001-6398-6370; Eickhoff, Simon B./0000-0001-6363-2759; Poldrack, Russell/0000-0001-6755-0259	Wellcome Trust [100309/Z/12/Z]; NIH [R01 NS075066-01A1, R01 EB015611-01, U01 MH099059, R01 AG047596]; Singapore MOE Tier 2 [MOE2014-T2-2-016]; NUS [DPRT/944/09/14, R185000271720]; NMRC [CBRG14nov007]; NUS YIA; Deutsche Forschungsgemeinschaft (DFG) [EI 816/4-1, LA 3071/3-1, EI 816/6-1]; National Institute of Mental Health [R01-MH074457]; European Union Seventh Framework Programme (FP7) [604102]; German federal state of Saxony-Anhalt; CRCNS BMBF/NSF [01GQ1411/1429999]; UK Medical Research Council; European Research Council Starting Grant [261352]; Irving Ludmer Family Foundation; Ludmer Centre for Neuroinformatics and Mental Health; ZonMw TOP grant [91211021]; Laura and John Arnold Foundation; NIBIB [P41EB019936]; NIH-National Institute on Drug Abuse [U24DA038653]; Helmholtz Portfolio Theme 'Supercomputing and Modeling for the Human Brain'; European Regional Development Fund (ERDF); MRC [MC_U105597120] Funding Source: UKRI; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB019936, R01EB015611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH099059, R01MH074457, R01MH083320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047596] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore MOE Tier 2(Ministry of Education, Singapore); NUS(National University of Singapore); NMRC(National Medical Research Council, Singapore); NUS YIA(National University of Singapore); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); European Union Seventh Framework Programme (FP7); German federal state of Saxony-Anhalt; CRCNS BMBF/NSF; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council Starting Grant(European Research Council (ERC)); Irving Ludmer Family Foundation; Ludmer Centre for Neuroinformatics and Mental Health; ZonMw TOP grant; Laura and John Arnold Foundation; NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH-National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Helmholtz Portfolio Theme 'Supercomputing and Modeling for the Human Brain'; European Regional Development Fund (ERDF)(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	T.E.N. is supported by the Wellcome Trust (100309/Z/12/Z) and NIH (R01 NS075066-01A1, R01 EB015611-01). B.T.T.Y. is supported by Singapore MOE Tier 2 (MOE2014-T2-2-016), NUS (DPRT/944/09/14, R185000271720), NMRC (CBRG14nov007) and the NUS YIA. S.B.E. is supported by the Deutsche Forschungsgemeinschaft (DFG, EI 816/4-1, LA 3071/3-1; EI 816/6-1), the National Institute of Mental Health (R01-MH074457), the Helmholtz Portfolio Theme 'Supercomputing and Modeling for the Human Brain and the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 604102). M.H. was supported by funds from the German federal state of Saxony-Anhalt and the European Regional Development Fund (ERDF), project: Center for Behavioral Brain Sciences, and CRCNS BMBF/NSF (01GQ1411/1429999). N.K. was supported by the UK Medical Research Council and a European Research Council Starting Grant (261352). A.C.E., S.D. and T.G. are supported by the Irving Ludmer Family Foundation and the Ludmer Centre for Neuroinformatics and Mental Health. T.W. was supported by a ZonMw TOP grant (91211021). R.A.P. is supported by the Laura and John Arnold Foundation. M.P.M. is a Phyllis Green and Randolph Cowen Scholar and is supported in part by the NIH (U01 MH099059; R01 AG047596). J.-B.P. is supported by the NIBIB (P41EB019936) and by NIH-National Institute on Drug Abuse (U24DA038653), as well as by the Laura and John Arnold Foundation.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Abraham A, 2017, NEUROIMAGE, V147, P736, DOI 10.1016/j.neuroimage.2016.10.045; [Anonymous], 2014, NATURE, V515, P7, DOI 10.1038/515007a; Bennett CM, 2013, COGN AFFECT BEHAV NE, V13, P690, DOI 10.3758/s13415-013-0195-1; Boekel W, 2015, CORTEX, V66, P115, DOI 10.1016/j.cortex.2014.11.019; Brakewood B, 2013, NEUROIMAGE, V82, P671, DOI 10.1016/j.neuroimage.2013.02.040; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Glasser MF, 2016, NAT NEUROSCI, V19, P1175, DOI 10.1038/nn.4361; Goble C, 2014, IEEE INTERNET COMPUT, V18, P4, DOI 10.1109/MIC.2014.88; Gorgolewski KJ, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.44; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; ISO, 2006, 35342 ISO; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Mennes M, 2013, NEUROIMAGE, V82, P683, DOI 10.1016/j.neuroimage.2012.10.064; Nichols T.E., 2016, NEUROSCIENCE, DOI 10.1101/054262; Noble S., 2017, NEUROIMAGE, V277, P88; Owens B, 2016, SCIENCE, V351, P329, DOI 10.1126/science.351.6271.329; Peng RD, 2011, SCIENCE, V334, P1226, DOI 10.1126/science.1213847; Pernet CR, 2015, NEUROIMAGE, V119, P164, DOI 10.1016/j.neuroimage.2015.06.050; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; Salimi-Khorshidi G, 2009, NEUROIMAGE, V45, P810, DOI 10.1016/j.neuroimage.2008.12.039; Schnack HG, 2010, HUM BRAIN MAPP, V31, P1967, DOI 10.1002/hbm.20991; Waskom ML, 2014, J NEUROSCI, V34, P10743, DOI 10.1523/JNEUROSCI.5282-13.2014; Whitaker KJ, 2016, P NATL ACAD SCI USA, V113, P9105, DOI 10.1073/pnas.1601745113	24	297	299	3	75	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2017	20	3					299	303		10.1038/nn.4500	http://dx.doi.org/10.1038/nn.4500			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EL9DU	28230846	Green Accepted, Green Submitted			2022-12-17	WOS:000394920400003
J	Bai, L; Lennon, DP; Caplan, AI; DeChant, A; Hecker, J; Kranso, J; Zaremba, A; Miller, RH				Bai, Lianhua; Lennon, Donald P.; Caplan, Arnold I.; DeChant, Anne; Hecker, Jordan; Kranso, Janet; Zaremba, Anita; Miller, Robert H.			Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models	NATURE NEUROSCIENCE			English	Article							C-MET; BONE-MARROW; LIVER-REGENERATION; ENDOGENOUS REPAIR; IMMUNE-RESPONSE; TYROSINE KINASE; FACTOR RECEPTOR; SCATTER FACTOR; FACTOR GENE; CROSS-TALK	Mesenchymal stem cells (MSCs) have emerged as a potential therapy for a range of neural insults. In animal models of multiple sclerosis, an autoimmune disease that targets oligodendrocytes and myelin, treatment with human MSCs results in functional improvement that reflects both modulation of the immune response and myelin repair. Here we demonstrate that conditioned medium from human MSCs (MSC-CM) reduces functional deficits in mouse MOG(35-55)-induced experimental autoimmune encephalomyelitis (EAE) and promotes the development of oligodendrocytes and neurons. Functional assays identified hepatocyte growth factor (HGF) and its primary receptor cMet as critical in MSC-stimulated recovery in EAE, neural cell development and remyelination. Active MSC-CM contained HGF, and exogenously supplied HGF promoted recovery in EAE, whereas cMet and antibodies to HGF blocked the functional recovery mediated by HGF and MSC-CM. Systemic treatment with HGF markedly accelerated remyelination in lysolecithin-induced rat dorsal spinal cord lesions and in slice cultures. Together these data strongly implicate HGF in mediating MSC-stimulated functional recovery in animal models of multiple sclerosis.	[Bai, Lianhua; DeChant, Anne; Hecker, Jordan; Kranso, Janet; Zaremba, Anita; Miller, Robert H.] Case Western Reserve Univ, Dept Neurosci, Case Sch Med, Ctr Translat Neurosci, Cleveland, OH 44106 USA; Case Western Reserve Univ, Skeletal Res Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Miller, RH (corresponding author), Case Western Reserve Univ, Dept Neurosci, Case Sch Med, Ctr Translat Neurosci, Cleveland, OH 44106 USA.	rhm3@case.edu		Caplan, Arnold/0000-0002-8677-6621	Myelin Repair Foundation; US National Institutes of Health [NS 30800]; Virginia and David Baldwin Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030800] Funding Source: NIH RePORTER	Myelin Repair Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia and David Baldwin Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Hitomi for electron microscopy support, D. Carrino for help with fractionation, S. Miller for microfluidics and A. Kerstetter for help with cell culture. This study was supported by the Myelin Repair Foundation and US National Institutes of Health grant NS 30800 (R.H.M.) and the Virginia and David Baldwin Fund (A.I.C., D.P.L.).	Achim CL, 1997, DEV BRAIN RES, V102, P299, DOI 10.1016/S0165-3806(97)00108-9; Anan F, 2007, METABOLISM, V56, P593, DOI 10.1016/j.metabol.2007.01.003; Bai LH, 2007, NEUROCHEM RES, V32, P353, DOI 10.1007/s11064-006-9212-x; Bai LH, 2009, GLIA, V57, P1192, DOI 10.1002/glia.20841; Barhum Y, 2010, J MOL NEUROSCI, V41, P129, DOI 10.1007/s12031-009-9302-8; Ben-Hur T, 2008, ANN NY ACAD SCI, V1142, P218, DOI 10.1196/annals.1444.014; Benkhoucha M, 2010, P NATL ACAD SCI USA, V107, P6424, DOI 10.1073/pnas.0912437107; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; DIRENZO MF, 1993, ONCOGENE, V8, P219; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Futamatsu H, 2005, CIRC RES, V96, P823, DOI 10.1161/01.RES.0000163016.52653.2e; Gerdoni E, 2007, ANN NEUROL, V61, P219, DOI 10.1002/ana.21076; Ghasemlou N, 2007, GLIA, V55, P294, DOI 10.1002/glia.20449; Hayashi S, 1996, BIOCHEM BIOPH RES CO, V220, P539, DOI 10.1006/bbrc.1996.0440; ISHIKI Y, 1992, HEPATOLOGY, V16, P1227, DOI 10.1016/0270-9139(92)90019-6; Jung DI, 2009, J NEUROL SCI, V285, P67, DOI 10.1016/j.jns.2009.05.027; Karussis D, 2008, CLIN NEUROL NEUROSUR, V110, P889, DOI 10.1016/j.clineuro.2008.02.008; Kerstetter AE, 2009, EXP NEUROL, V220, P44, DOI 10.1016/j.expneurol.2009.07.010; Kitamura K, 2007, J NEUROSCI RES, V85, P2332, DOI 10.1002/jnr.21372; Koc ON, 2002, BONE MARROW TRANSPL, V30, P215, DOI 10.1038/sj.bmt.1703650; Krampera M, 2007, BONE, V40, P382, DOI 10.1016/j.bone.2006.09.006; Kuroiwa T, 2001, J CLIN INVEST, V107, P1365, DOI 10.1172/JCI11808; Lazarus HM, 2005, BIOL BLOOD MARROW TR, V11, P389, DOI 10.1016/j.bbmt.2005.02.001; Lennon DP, 2006, EXP HEMATOL, V34, P1604, DOI 10.1016/j.exphem.2006.07.014; MICHALOPOULOS GK, 1990, FASEB J, V4, P176, DOI 10.1096/fasebj.4.2.2404819; Miller RH, 2010, DIS MODEL MECH, V3, P535, DOI 10.1242/dmm.001958; Pan WH, 2006, EXP NEUROL, V201, P99, DOI 10.1016/j.expneurol.2006.03.026; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Polisetti N, 2010, MOL VIS, V16, P1227; Prineas J.W., 1985, HDB CLIN NEUROLOGY, P15; Rafei M, 2009, MOL THER, V17, P1799, DOI 10.1038/mt.2009.157; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sheth PR, 2008, BIOCHEMISTRY-US, V47, P4028, DOI 10.1021/bi701892f; Siatskas C, 2010, STEM CELL REV REP, V6, P500, DOI 10.1007/s12015-010-9173-y; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; Sulpice E, 2009, BIOL CELL, V101, P525, DOI 10.1042/BC20080221; Sun W, 2002, MOL BRAIN RES, V103, P36, DOI 10.1016/S0169-328X(02)00168-7; Tanaka F, 2008, LIFE SCI, V83, P771, DOI 10.1016/j.lfs.2008.09.016; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001; van der Horst E, 2009, NEOPLASIA, V11, P355, DOI 10.1593/neo.81536; Wang Y, 2009, AM J PHYSIOL-CELL PH, V297, pC1284, DOI 10.1152/ajpcell.00183.2009; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387; Yan HL, 2002, J NEUROSCI RES, V69, P597, DOI 10.1002/jnr.10323; Yoo SW, 2008, EXP MOL MED, V40, P387, DOI 10.3858/emm.2008.40.4.387	50	297	307	0	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					862	U86		10.1038/nn.3109	http://dx.doi.org/10.1038/nn.3109			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22610068	Green Accepted			2022-12-17	WOS:000304546700013
J	Yuste, R; Majewska, A; Holthoff, K				Yuste, R; Majewska, A; Holthoff, K			From form to function: calcium compartmentalization in dendritic spines	NATURE NEUROSCIENCE			English	Review							LASER-SCANNING MICROSCOPY; DEPENDENT PROTEIN-KINASE; LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; MEMBRANE CA2+ PUMP; NMDA RECEPTORS; HIPPOCAMPAL-NEURONS; PYRAMIDAL NEURONS; SINGLE SPINES; SYNAPTIC TRANSMISSION	Dendritic spines compartmentalize calcium, and this could be their I nain function. We review experimental work on spine calcium dynamics. Calcium influx into spines is mediated by calcium channels and by NMDA and AMPA receptors and is followed by fast diffusional equilibration within the spine head. Calcium decay kinetics are controlled by slower diffusion through the spine neck and by spine calcium pumps. Calcium release occurs in spines, although its role is controversial. Finally, the endogenous calcium buffers in spines remain unknown. Thus, spines are calcium compartments because of their morphologies and local influx and extrusion mechanisms. These studies highlight the richness and heterogeneity of pathways that regulate calcium accumulations in spines and the close relationship between the morphology and function of the spine.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Yuste, R (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave,Box 2435, New York, NY 10027 USA.			Majewska, Ania/0000-0002-2167-6849	NEI NIH HHS [EY 111787] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Airaksinen MS, 1997, P NATL ACAD SCI USA, V94, P1488, DOI 10.1073/pnas.94.4.1488; ALFORD S, 1993, J PHYSIOL-LONDON, V469, P693, DOI 10.1113/jphysiol.1993.sp019838; ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; [Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; ARIENSKAPPER CU, 1936, COMP ANATOMY NERVOUS, P73; BATINI C, 1993, NEUROREPORT, V4, P927, DOI 10.1097/00001756-199307000-00022; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; CAJAL SRY, 1891, JUN C MED VAL; COLONNIER MARC, 1968, BRAIN RES, V9, P268, DOI 10.1016/0006-8993(68)90234-5; CONNOR JA, 1986, P NATL ACAD SCI USA, V83, P6179, DOI 10.1073/pnas.83.16.6179; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; DEROBERTIS EDP, 1955, J BIOPHYS BIOCHEM CY, V1, P47, DOI 10.1083/jcb.1.1.47; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; EILERS J, 1995, P NATL ACAD SCI USA, V92, P10272, DOI 10.1073/pnas.92.22.10272; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fierro L, 1996, J PHYSIOL-LONDON, V496, P617, DOI 10.1113/jphysiol.1996.sp021713; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; FINE A, 1988, TRENDS NEUROSCI, V11, P345; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FURUICHI T, 1994, J NEUROSCI, V14, P4794; Furuichi Teiichi, 1994, Current Opinion in Neurobiology, V4, P294, DOI 10.1016/0959-4388(94)90089-2; Gabso M, 1997, NEURON, V18, P473, DOI 10.1016/S0896-6273(00)81247-7; GAMBLE E, 1987, SCIENCE, V236, P1311, DOI 10.1126/science.3495885; GONZALEZ JE, 1995, BIOPHYS J, V69, P1272, DOI 10.1016/S0006-3495(95)80029-9; GOODMAN M, IN PRESS J NEUROSCI; GRAY EG, 1959, NATURE, V183, P1592, DOI 10.1038/1831592a0; Guerini D, 1999, J BIOL CHEM, V274, P1667, DOI 10.1074/jbc.274.3.1667; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; Gyorke I, 1998, BIOPHYS J, V75, P2801, DOI 10.1016/S0006-3495(98)77723-9; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; HELMCHEN F, 1999, DENDRITES, P161; HOLMES WR, 1990, BRAIN RES, V519, P338, DOI 10.1016/0006-8993(90)90098-V; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; JAFFE DB, 1994, J NEUROBIOL, V25, P220, DOI 10.1002/neu.480250303; KOCH C, 1993, J NEUROSCI, V13, P413; KOCH K, 1999, BIOPHYSICS COMPUTATI, P280; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Korkotian E, 1998, EUR J NEUROSCI, V10, P2076, DOI 10.1046/j.1460-9568.1998.00219.x; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Kubota Y, 2000, J NEUROSCI, V20, P375, DOI 10.1523/JNEUROSCI.20-01-00375.2000; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Majewska A, 2000, J NEUROSCI, V20, P1722; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Markram H, 1998, J COMPUT NEUROSCI, V5, P331, DOI 10.1023/A:1008891229546; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARKS AR, 1989, P NATL ACAD SCI USA, V86, P8683, DOI 10.1073/pnas.86.22.8683; MILLER KK, 1991, NEUROSCIENCE, V43, P1, DOI 10.1016/0306-4522(91)90410-P; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MILLER SG, 1985, J BIOL CHEM, V260, P9039; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; MURPHY TH, 1995, NEURON, V15, P159, DOI 10.1016/0896-6273(95)90073-X; MURPHY TH, 1994, SCIENCE, V263, P529, DOI 10.1126/science.7904774; Murthy VN, 2000, P NATL ACAD SCI USA, V97, P901, DOI 10.1073/pnas.97.2.901; NABAUER M, 1989, SCIENCE, V244, P800, DOI 10.1126/science.2543067; Naraghi M, 1997, J NEUROSCI, V17, P6961; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; PALAY SANFORD L., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P193, DOI 10.1083/jcb.2.4.193; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; PETROZZINO JJ, 1995, NEURON, V14, P1223, DOI 10.1016/0896-6273(95)90269-4; Pozzo-Miller LD, 1999, J NEUROPHYSIOL, V81, P1404, DOI 10.1152/jn.1999.81.3.1404; Rall W., 1974, CELLULAR MECH SUBSER, P13; Rall W, 1988, COMPUTER SIMULATION, P26; Ramon y Cajal S, 1893, ARCH ANAT PHYSL, P319; Ramon y Cajal S S, 1888, REV TRIM HISTOL NORM, V1, P1; Regehr Wade G., 1994, Current Opinion in Neurobiology, V4, P373, DOI 10.1016/0959-4388(94)90099-X; Rose CR, 1999, PFLUG ARCH EUR J PHY, V439, P201, DOI 10.1007/s004240051145; Schikorski T, 1999, P NATL ACAD SCI USA, V96, P4107, DOI 10.1073/pnas.96.7.4107; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, V3rd Edn, P133; Shepherd GM, 1996, J NEUROPHYSIOL, V75, P2197, DOI 10.1152/jn.1996.75.6.2197; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; SOBEL EC, 1994, SCIENCE, V263, P823, DOI 10.1126/science.263.5148.823; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; STAUFFER TP, 1995, J BIOL CHEM, V270, P12184, DOI 10.1074/jbc.270.20.12184; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Tank DW, 1995, J NEUROSCI, V15, P7940; TSIEN RY, 1989, ANNU REV NEUROSCI, V12, P227, DOI 10.1146/annurev.ne.12.030189.001303; Volfovsky N, 1999, J NEUROPHYSIOL, V82, P450, DOI 10.1152/jn.1999.82.1.450; WICKENS J, 1988, PROG NEUROBIOL, V31, P507, DOI 10.1016/0301-0082(88)90013-5; WIGSTROM H, 1986, ACTA PHYSIOL SCAND, V126, P317, DOI 10.1111/j.1748-1716.1986.tb07822.x; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1999, J NEUROSCI, V19, P1976; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	99	297	300	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					653	659		10.1038/76609	http://dx.doi.org/10.1038/76609			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862697				2022-12-17	WOS:000167177200011
J	Koser, DE; Thompson, AJ; Foster, SK; Dwivedy, A; Pillai, EK; Sheridan, GK; Svoboda, H; Viana, M; Costa, LD; Guck, J; Holt, CE; Franze, K				Koser, David E.; Thompson, Amelia J.; Foster, Sarah K.; Dwivedy, Asha; Pillai, Eva K.; Sheridan, Graham K.; Svoboda, Hanno; Viana, Matheus; Costa, Luciano da F.; Guck, Jochen; Holt, Christine E.; Franze, Kristian			Mechanosensing is critical for axon growth in the developing brain	NATURE NEUROSCIENCE			English	Article							OPTIC TRACT; STIFFNESS; EXPRESSION; RIGIDITY; PIEZO1; MECHANISMS; EXTENSION; OUTGROWTH; NETRIN-1; COLLAPSE	During nervous system development, neurons extend axons along well-defined pathways. The current understanding of axon pathfinding is based mainly on chemical signaling. However, growing neurons interact not only chemically but also mechanically with their environment. Here we identify mechanical signals as important regulators of axon pathfinding. In vitro, substrate stiffness determined growth patterns of Xenopus retinal ganglion cell axons. In vivo atomic force microscopy revealed a noticeable pattern of stiffness gradients in the embryonic brain. Retinal ganglion cell axons grew toward softer tissue, which was reproduced in vitro in the absence of chemical gradients. To test the importance of mechanical signals for axon growth in vivo, we altered brain stiffness, blocked mechanotransduction pharmacologically and knocked down the mechanosensitive ion channel piezol. All treatments resulted in aberrant axonal growth and pathfinding errors, suggesting that local tissue stiffness, read out by mechanosensitive ion channels, is critically involved in instructing neuronal growth in vivo.	[Koser, David E.; Thompson, Amelia J.; Foster, Sarah K.; Dwivedy, Asha; Pillai, Eva K.; Sheridan, Graham K.; Svoboda, Hanno; Holt, Christine E.; Franze, Kristian] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Viana, Matheus; Costa, Luciano da F.] Univ Sao Paulo, Sao Carlos Inst Phys, Sao Carlos, SP, Brazil; [Guck, Jochen; Franze, Kristian] Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge, England; [Koser, David E.] Heidelberg Univ, Fac Med, Dept Clin Neurobiol, Heidelberg, Germany; [Koser, David E.] German Canc Res Ctr, Heidelberg, Germany; [Sheridan, Graham K.] Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England; [Svoboda, Hanno] Roche Innovat Ctr Basel, Basel, Switzerland; [Guck, Jochen] Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany	University of Cambridge; Universidade de Sao Paulo; University of Cambridge; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Brighton; Roche Holding; Technische Universitat Dresden	Franze, K (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.; Franze, K (corresponding author), Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge, England.	kf284@cam.ac.uk	da F. Costa, Luciano/H-5475-2011; Guck, Jochen/AAJ-9283-2021; Guck, Jochen/B-4412-2014	da F. Costa, Luciano/0000-0001-5203-4366; Guck, Jochen/0000-0002-1453-6119; Guck, Jochen/0000-0002-1453-6119; Koser, David/0000-0001-6139-3096; Franze, Kristian/0000-0002-8425-7297; , Graham/0000-0002-8493-2651; Holt, Christine Elizabeth/0000-0003-2829-121X	German National Academic Foundation; Wellcome Trust [WT085314]; Cambridge Trusts; Winston Churchill Foundation of the United States; Herchel Smith Foundation; CNPq [307333/2013-2]; NAP-PRP-USP; FAPESP [11/50761-2]; UK EPSRC BT grant; European Research Council [322817]; Alexander von Humboldt Foundation; UK BBSRC [BB/M021394/1]; Human Frontier Science Program [RGY0074/2013]; UK Medical Research Council [G1100312/1]; Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health [R21HD080585]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD080585] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/M021394/1] Funding Source: researchfish; Medical Research Council [G1100312] Funding Source: researchfish; BBSRC [BB/M021394/1] Funding Source: UKRI; MRC [G1100312] Funding Source: UKRI	German National Academic Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Cambridge Trusts; Winston Churchill Foundation of the United States; Herchel Smith Foundation; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NAP-PRP-USP; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); UK EPSRC BT grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); UK BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Human Frontier Science Program(Human Frontier Science Program); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank D. Bray, A. Reichenbach, B. Simons and S. Wolff for discussions about neuronal mechanics, K. Chalut and W Harris for feedback on the manuscript, A. Christ for an AFM data analysis code, P. Moshayedi for help with establishing PAA gels, F. Sachs (University at Buffalo, USA) for providing GsMTx4, H. Wong for extensive help in the lab and A. Winkel and R. Field (JPK) for technical help. This work was supported by the German National Academic Foundation (scholarship to D.E.K.), Wellcome Trust and Cambridge Trusts (scholarships to A.J.T.), Winston Churchill Foundation of the United States (scholarship to S.K.F.), Herchel Smith Foundation (Research Studentship to S.K.F.), CNPq 307333/2013-2 (L.d.F.C.), NAP-PRP-USP and FAPESP 11/50761-2 (L.d.F.C.), UK EPSRC BT grant (J.G.), Wellcome Trust WT085314 and the European Research Council 322817 grants (C.E.H.); an Alexander von Humboldt Foundation Feodor Lynen Fellowship (K.F.), UK BBSRC grant BB/M021394/1 (K.F.), the Human Frontier Science Program Young Investigator Grant RGY0074/2013 (K.F.), the UK Medical Research Council Career Development Award G1100312/1 (K.F.) and the Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health under Award Number R21HD080585 (K.F.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Atkinson-Leadbeater K, 2010, J NEUROSCI, V30, P685, DOI 10.1523/JNEUROSCI.4165-09.2010; Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1; Betz T, 2011, P NATL ACAD SCI USA, V108, P13420, DOI 10.1073/pnas.1106145108; Bollmann L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00363; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Erskine L, 2007, DEV BIOL, V308, P1, DOI 10.1016/j.ydbio.2007.05.013; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Franze K, 2013, ANNU REV BIOMED ENG, V15, P227, DOI 10.1146/annurev-bioeng-071811-150045; Franze K, 2013, DEVELOPMENT, V140, P3069, DOI 10.1242/dev.079145; Franze K, 2011, SOFT MATTER, V7, P3147, DOI 10.1039/c0sm01017k; Franze K, 2009, BIOPHYS J, V97, P1883, DOI 10.1016/j.bpj.2009.07.033; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Gottlieb PA, 2012, CHANNELS, V6, P214, DOI 10.4161/chan.21050; Guan W, 2003, J NEUROSCI, V23, P1781; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021; Iwashita M, 2014, DEVELOPMENT, V141, P3793, DOI 10.1242/dev.109637; Jiang FX, 2010, TISSUE ENG PT A, V16, P1873, DOI [10.1089/ten.tea.2009.0574, 10.1089/ten.TEA.2009.0574]; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; Kerstein PC, 2013, J NEUROSCI, V33, P273, DOI 10.1523/JNEUROSCI.2142-12.2013; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Koch D, 2012, BIOPHYS J, V102, P452, DOI 10.1016/j.bpj.2011.12.025; Koser DE, 2015, BIOPHYS J, V108, P2137, DOI 10.1016/j.bpj.2015.03.039; Kostic A, 2007, J CELL SCI, V120, P3895, DOI 10.1242/jcs.009852; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Majkut S, 2013, CURR BIOL, V23, P2434, DOI 10.1016/j.cub.2013.10.057; Moore SW, 2009, SCIENCE, V325, P166, DOI 10.1126/science.1173851; Moshayedi P, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194114; Pathak MM, 2014, P NATL ACAD SCI USA, V111, P16148, DOI 10.1073/pnas.1409802111; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Pogoda K, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/7/075002; Shibasaki K, 2010, J NEUROSCI, V30, P4601, DOI 10.1523/JNEUROSCI.5830-09.2010; Singh T, 2009, J PHYS CHEM B, V113, P2519, DOI 10.1021/jp809294p; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Walz A, 2002, J NEUROBIOL, V53, P330, DOI 10.1002/neu.10113; Weickenmeier J, 2016, ACTA BIOMATER, V42, P265, DOI 10.1016/j.actbio.2016.07.040; Weiss P, 1934, J EXP ZOOL, V68, P393, DOI 10.1002/jez.1400680304; Xu G, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000169; Zhang QY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06215	48	296	300	12	161	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2016	19	12					1592	1598		10.1038/nn.4394	http://dx.doi.org/10.1038/nn.4394			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED7BY	27643431	Green Accepted, Green Submitted			2022-12-17	WOS:000389011900018
J	Li, HH; Penzo, MA; Taniguchi, H; Kopec, CD; Huang, ZJ; Li, B				Li, Haohong; Penzo, Mario A.; Taniguchi, Hiroki; Kopec, Charles D.; Huang, Z. Josh; Li, Bo			Experience-dependent modification of a central amygdala fear circuit	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CENTRAL NUCLEUS; RECEPTOR TRAFFICKING; CONDITIONED FEAR; PROJECTIONS; NEURONS; RAT; EXPRESSION; COMPLEX; CONNECTIONS	The amygdala is essential for fear learning and expression. The central amygdala (CeA), once viewed as a passive relay between the amygdala complex and downstream fear effectors, has emerged as an active participant in fear conditioning. However, the mechanism by which CeA contributes to the learning and expression of fear is unclear. We found that fear conditioning in mice induced robust plasticity of excitatory synapses onto inhibitory neurons in the lateral subdivision of the CeA (CeL). This experience-dependent plasticity was cell specific, bidirectional and expressed presynaptically by inputs from the lateral amygdala. In particular, preventing synaptic potentiation onto somatostatin-positive neurons impaired fear memory formation. Furthermore, activation of these neurons was necessary for fear memory recall and was sufficient to drive fear responses. Our findings support a model in which fear conditioning-induced synaptic modifications in CeL favor the activation of somatostatin-positive neurons, which inhibit CeL output, thereby disinhibiting the medial subdivision of CeA and releasing fear expression.	[Li, Haohong; Penzo, Mario A.; Taniguchi, Hiroki; Huang, Z. Josh; Li, Bo] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Kopec, Charles D.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Cold Spring Harbor Laboratory; Princeton University	Li, B (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	bli@cshl.edu	Core, Vector/CAF-4832-2022; Penzo, Mario/AAP-8789-2021	Li, Bo/0000-0002-0154-3088; Huang, Z. Josh/0000-0003-0592-028X	US National Institutes of Health [5R01MH091903-03, 5U01MH078844-05]; Dana Foundation; National Alliance for Research on Schizophrenia and Depression; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH078844, R01MH091903] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; National Alliance for Research on Schizophrenia and Depression(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank R.H. Paik for expert technical assistance, K. Deisseroth and M. Mirrione for the initial help with optogenetic methods, M. Luo (National Institute of Biological Sciences, Beijing) and S.H. Shi (Memorial Sloan-Kettering Cancer Center) for the AAV-DIO-hM4Di-mCherry construct, W Wei for help with the focal optogenetic stimulation, A. Zador (Cold Spring Harbor Laboratory) for sharing the AAV-DIO-ChR2(H134R)-YFP and AAV-DIO-Arch-GFP viruses, A. Reid (Cold Spring Harbor Laboratory) for sharing the Ai32 mice, and K. Pradhan for advice on statistic analysis. We thank S. Shea, L. Van Aelst and R. Malinow for critical reading of the manuscript, and members of the Li laboratory for discussions. This study was supported by the US National Institutes of Health (5R01MH091903-03 to B.L. and 5U01MH078844-05 to Z.J.H.), the Dana Foundation (B.L.) and the National Alliance for Research on Schizophrenia and Depression (B.L. and Z.J.H.).	Anglada-Figueroa D, 2005, J NEUROSCI, V25, P9680, DOI 10.1523/JNEUROSCI.2600-05.2005; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; CASSELL MD, 1989, J COMP NEUROL, V281, P320, DOI 10.1002/cne.902810212; Cassell MD, 1999, ANN NY ACAD SCI, V877, P217, DOI 10.1111/j.1749-6632.1999.tb09270.x; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Davis M., 2000, AMYGDALA, P213; Dong SY, 2010, MOL BIOSYST, V6, P1376, DOI 10.1039/c002568m; Dumont EC, 2002, EUR J NEUROSCI, V15, P545, DOI 10.1046/j.0953-816x.2001.01879.x; Duvarci S, 2011, J NEUROSCI, V31, P289, DOI 10.1523/JNEUROSCI.4985-10.2011; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Fu Y, 2005, J NEUROPHYSIOL, V93, P3012, DOI 10.1152/jn.00871.2004; Goosens KA, 2003, BEHAV NEUROSCI, V117, P738, DOI 10.1037/0735-7044.117.4.738; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Lopez de Armentia M, 2007, J PHYSIOL-LONDON, V581, P961, DOI 10.1113/jphysiol.2007.101822; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; OTTERSEN OP, 1979, J COMP NEUROL, V187, P401, DOI 10.1002/cne.901870209; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; PITKANEN A, 1995, J COMP NEUROL, V356, P288, DOI 10.1002/cne.903560211; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sigurdsson T, 2007, NEUROPHARMACOLOGY, V52, P215, DOI 10.1016/j.neuropharm.2006.06.022; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; TURNER BH, 1991, J COMP NEUROL, V313, P295, DOI 10.1002/cne.903130208; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	44	296	298	3	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					332	339		10.1038/nn.3322	http://dx.doi.org/10.1038/nn.3322			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23354330	Green Accepted			2022-12-17	WOS:000315474800016
J	Parsons, RG; Ressler, KJ				Parsons, Ryan G.; Ressler, Kerry J.			Implications of memory modulation for post-traumatic stress and fear disorders	NATURE NEUROSCIENCE			English	Review							VENTROMEDIAL PREFRONTAL CORTEX; BDNF VAL66MET POLYMORPHISM; D-CYCLOSERINE; CONDITIONED FEAR; POTENTIATED STARTLE; BASOLATERAL AMYGDALA; PROTEIN-SYNTHESIS; EXPOSURE THERAPY; MOLECULAR-MECHANISMS; HIPPOCAMPAL ACTIVITY	Post-traumatic stress disorder, panic disorder and phobia manifest in ways that are consistent with an uncontrollable state of fear. Their development involves heredity, previous sensitizing experiences, association of aversive events with previous neutral stimuli, and inability to inhibit or extinguish fear after it is chronic and disabling. We highlight recent progress in fear learning and memory, differential susceptibility to disorders of fear, and how these findings are being applied to the understanding, treatment and possible prevention of fear disorders. Promising advances are being translated from basic science to the clinic, including approaches to distinguish risk versus resilience before trauma exposure, methods to interfere with fear development during memory consolidation after a trauma, and techniques to inhibit fear reconsolidation and to enhance extinction of chronic fear. It is hoped that this new knowledge will translate to more successful, neuroscientifically informed and rationally designed approaches to disorders of fear regulation.	[Parsons, Ryan G.; Ressler, Kerry J.] Emory Univ, Dept Psychiat & Behav Sci, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Ressler, Kerry J.] Howard Hughes Med Inst, Chevy Chase, MD USA	Emory University; Howard Hughes Medical Institute	Ressler, KJ (corresponding author), Emory Univ, Dept Psychiat & Behav Sci, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.	kressle@emory.edu	Ressler, Kerry J/N-8741-2018	Ressler, Kerry J/0000-0002-5158-1103; Parsons, Ryan/0000-0001-8136-9413	US National Institutes of Health [F32MH090700, R01MH071537, R01MH094757, R01MH096764]; Burroughs Wellcome Fund; US National Institutes of Health National Center for Research Resources base grant [P51RR000165]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094757, R01MH071537, F32MH090700, R01MH096764] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); US National Institutes of Health National Center for Research Resources base grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support was provided by the US National Institutes of Health (F32MH090700, R01MH071537, R01MH094757 and R01MH096764), the Burroughs Wellcome Fund and a US National Institutes of Health National Center for Research Resources base grant (P51RR000165) to Yerkes National Primate Research Center.	Alvarez RP, 2008, J NEUROSCI, V28, P6211, DOI 10.1523/JNEUROSCI.1246-08.2008; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andero R, 2012, GENES BRAIN BEHAV, V11, P503, DOI 10.1111/j.1601-183X.2012.00801.x; Andero R, 2011, AM J PSYCHIAT, V168, P163, DOI 10.1176/appi.ajp.2010.10030326; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bontempo A, 2012, J CLIN PSYCHIAT, V73, P533, DOI 10.4088/JCP.11r07356; BOUTON ME, 1983, J EXP PSYCHOL ANIM B, V9, P248, DOI 10.1037/0097-7403.9.3.248; Bremner JD, 2007, NEUROIMAG CLIN N AM, V17, P523, DOI 10.1016/j.nic.2007.07.003; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Britton JC, 2005, BIOL PSYCHIAT, V57, P832, DOI 10.1016/j.biopsych.2004.12.025; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; Cain CK, 2012, EXPERT OPIN INV DRUG, V21, P1323, DOI 10.1517/13543784.2012.704020; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; Carrion VG, 2010, J PEDIATR PSYCHOL, V35, P559, DOI 10.1093/jpepsy/jsp112; Chan Wan Yee Macy, 2010, Learn Mem, V17, P512, DOI 10.1101/lm.1912510; Cheng DT, 2006, BEHAV NEUROSCI, V120, P1187, DOI 10.1037/0735-7044.120.5.1187; Chhatwal JP, 2006, NAT NEUROSCI, V9, P870, DOI 10.1038/nn1718; Choi DC, 2010, P NATL ACAD SCI USA, V107, P2675, DOI 10.1073/pnas.0909359107; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Corcoran KA, 2005, J NEUROSCI, V25, P8978, DOI 10.1523/JNEUROSCI.2246-05.2005; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.ne.15.030192.002033; de Kleine RA, 2012, BIOL PSYCHIAT, V71, P962, DOI 10.1016/j.biopsych.2012.02.033; Drabant EM, 2009, BIOL PSYCHIAT, V65, P367, DOI 10.1016/j.biopsych.2008.09.007; Duvarci S, 2009, J NEUROSCI, V29, P10357, DOI 10.1523/JNEUROSCI.2119-09.2009; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; FALLS WA, 1992, J NEUROSCI, V12, P854; Fiorenza NG, 2011, AN ACAD BRAS CIENC, V83, P1363, DOI 10.1590/S0001-37652011000400023; Frustaci A, 2008, NEUROPSYCHOBIOLOGY, V58, P163, DOI 10.1159/000182892; GOOD AJ, 1995, BEHAV NEUROSCI, V109, P631, DOI 10.1037/0735-7044.109.4.631; Goosens KA, 2003, BEHAV NEUROSCI, V117, P738, DOI 10.1037/0735-7044.117.4.738; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Hofmann SG, 2006, ARCH GEN PSYCHIAT, V63, P298, DOI 10.1001/archpsyc.63.3.298; Holbrook TL, 2010, NEW ENGL J MED, V362, P110, DOI 10.1056/NEJMoa0903326; Hurlemann R, 2010, PSYCHOL MED, V40, P1839, DOI 10.1017/S0033291709992376; Inda MC, 2011, J NEUROSCI, V31, P1635, DOI 10.1523/JNEUROSCI.4736-10.2011; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Johansen JP, 2010, NAT NEUROSCI, V13, P979, DOI 10.1038/nn.2594; Jovanovic T, 2013, CORTEX, V49, P1884, DOI 10.1016/j.cortex.2012.08.011; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Knight DC, 2004, COGN AFFECT BEHAV NE, V4, P317, DOI 10.3758/CABN.4.3.317; Knoll AT, 2011, BIOL PSYCHIAT, V70, P425, DOI 10.1016/j.biopsych.2011.03.017; Kushner MG, 2007, BIOL PSYCHIAT, V62, P835, DOI 10.1016/j.biopsych.2006.12.020; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; LaLumiere RT, 2003, J NEUROSCI, V23, P6754; Lanuza E, 2004, NEUROSCIENCE, V125, P305, DOI 10.1016/j.neuroscience.2003.12.034; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Lin CH, 2003, MOL PHARMACOL, V63, P44, DOI 10.1124/mol.63.1.44; Mao SC, 2006, J NEUROSCI, V26, P8892, DOI 10.1523/JNEUROSCI.0365-06.2006; Maren S, 1996, BEHAV NEUROSCI, V110, P1365, DOI 10.1037/0735-7044.110.6.1365; Maren S, 2006, P NATL ACAD SCI USA, V103, P18020, DOI 10.1073/pnas.0608398103; McGhee LL, 2009, J BURN CARE RES, V30, P92, DOI 10.1097/BCR.0b013e3181921f51; McNally GP, 2003, BEHAV NEUROSCI, V117, P1292, DOI 10.1037/0735-7044.117.6.1292; McTeague LM, 2010, BIOL PSYCHIAT, V67, P346, DOI 10.1016/j.biopsych.2009.08.023; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Moriceau S, 2006, J NEUROSCI, V26, P6737, DOI 10.1523/JNEUROSCI.0499-06.2006; Muller J, 1997, BEHAV NEUROSCI, V111, P683, DOI 10.1037/0735-7044.111.4.683; Myers KM, 2006, LEARN MEMORY, V13, P216, DOI 10.1101/lm.119806; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Norberg MM, 2008, BIOL PSYCHIAT, V63, P1118, DOI 10.1016/j.biopsych.2008.01.012; Orsini CA, 2012, NEUROSCI BIOBEHAV R, V36, P1773, DOI 10.1016/j.neubiorev.2011.12.014; Otto MW, 2010, BIOL PSYCHIAT, V67, P365, DOI 10.1016/j.biopsych.2009.07.036; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Peters J, 2010, SCIENCE, V328, P1288, DOI 10.1126/science.1186909; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Quirk GJ, 2002, LEARN MEMORY, V9, P402, DOI 10.1101/lm.49602; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Rakofsky JJ, 2012, MOL PSYCHIATR, V17, P22, DOI 10.1038/mp.2011.121; RESCORLA RA, 1975, J EXP PSYCHOL-ANIM B, V104, P88, DOI 10.1037/0097-7403.1.1.88; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; Richardson R, 2004, LEARN MEMORY, V11, P510, DOI 10.1101/lm.78204; Rothbaum BO, 2012, BIOL PSYCHIAT, V72, P957, DOI 10.1016/j.biopsych.2012.06.002; Sanders MJ, 2003, NEUROBIOL LEARN MEM, V80, P123, DOI 10.1016/S1074-7427(03)00040-6; Saxe G, 2001, J AM ACAD CHILD PSY, V40, P915, DOI 10.1097/00004583-200108000-00013; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Sharp S, 2010, J TRAUMA, V68, P193, DOI 10.1097/TA.0b013e3181a8b326; Shi CJ, 1999, J NEUROSCI, V19, P420, DOI 10.1523/JNEUROSCI.19-01-00420.1999; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Steckler T, 2012, NEUROPHARMACOLOGY, V62, P617, DOI 10.1016/j.neuropharm.2011.06.012; Stein MB, 2007, J TRAUMA STRESS, V20, P923, DOI 10.1002/jts.20270; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Van't Veer A, 2012, NEUROPSYCHOPHARMACOL, V37, P2809, DOI 10.1038/npp.2012.151; Walker DL, 2002, J NEUROSCI, V22, P2343, DOI 10.1523/JNEUROSCI.22-06-02343.2002; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006	99	296	306	7	186	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					146	153		10.1038/nn.3296	http://dx.doi.org/10.1038/nn.3296			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	080RE	23354388	Green Accepted			2022-12-17	WOS:000314260200010
J	Bremer, J; Baumann, F; Tiberi, C; Wessig, C; Fischer, H; Schwarz, P; Steele, AD; Toyka, KV; Nave, KA; Weis, J; Aguzzi, A				Bremer, Juliane; Baumann, Frank; Tiberi, Cinzia; Wessig, Carsten; Fischer, Heike; Schwarz, Petra; Steele, Andrew D.; Toyka, Klaus V.; Nave, Klaus-Armin; Weis, Joachim; Aguzzi, Adriano			Axonal prion protein is required for peripheral myelin maintenance	NATURE NEUROSCIENCE			English	Article							MICE DEFICIENT; AMINO-TERMINUS; PRP; KNOCKOUT; CLEAVAGE; LACKING; DOPPEL; MOUSE; MUTATION; REVEALS	The integrity of peripheral nerves relies on communication between axons and Schwann cells. The axonal signals that ensure myelin maintenance are distinct from those that direct myelination and are largely unknown. Here we show that ablation of the prion protein PrPC triggers a chronic demyelinating polyneuropathy (CDP) in four independently targeted mouse strains. Ablation of the neighboring Prnd locus, or inbreeding to four distinct mouse strains, did not modulate the CDP. CDP was triggered by depletion of PrPC specifically in neurons, but not in Schwann cells, and was suppressed by PrPC expression restricted to neurons but not to Schwann cells. CDP was prevented by PrPC variants that undergo proteolytic amino-proximal cleavage, but not by variants that are nonpermissive for cleavage, including secreted PrPC lacking its glycolipid membrane anchor. These results indicate that neuronal expression and regulated proteolysis of PrPC are essential for myelin maintenance.	[Bremer, Juliane; Baumann, Frank; Tiberi, Cinzia; Fischer, Heike; Schwarz, Petra; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Wessig, Carsten; Toyka, Klaus V.] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Steele, Andrew D.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Weis, Joachim] Rheinisch Westfal TH Univ Aachen, Inst Neuropathol, Fac Med, Aachen, Germany	University of Zurich; University Zurich Hospital; University of Wurzburg; California Institute of Technology; Max Planck Society; RWTH Aachen University	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch	Bremer, Juliane/E-2298-2012; Baumann, Frank/F-7737-2016; Aguzzi, Adriano/A-3351-2008; Bremer, Juliane/AAH-9487-2020; Nave, Klaus-Armin/C-8883-2011; Weis, Joachim/G-1984-2014	Weis, Joachim/0000-0003-3280-6773; Aguzzi, Adriano/0000-0002-0344-6708	European Union; Novartis Foundation; Swiss National Foundation; University of Zurich; Departmental Research Fund	European Union(European Commission); Novartis Foundation(Novartis); Swiss National Foundation(Swiss National Science Foundation (SNSF)); University of Zurich; Departmental Research Fund	We thank M. Delic, R. Moos, D. Goriounov, C. Tostado, H. Mader, K. Nairz, M. Bieri, N. Wey and D. Meijer for methodological advice and technical help. G. Mallucci provided tgNFH-Cre and tgPrnp<SUP>loxP</SUP> mice, D. Meijer provided tgDhh-Cre mice, J.C. Manson provided Prnp<SUP>Edbg/Edbg</SUP> mice, J. Collinge provided Prnp<SUP>o/o</SUP> FVB mice, S. Lindquist and W. Jackson provided Prnp<SUP>GFP/GFP</SUP> mice and P. Saftig and A. Rittger provided nerves from BACE1<SUP>-/-</SUP> mice. We thank W. B. Macklin for the PLP plasmid; T. Rulicke for pronuclear injections and H. Welzl, I. Drescher and S. Wirth for help with behavioral tests. J. A. Girault and M. T. Dours-Zimmermann donated anti-paranodine/Caspr and anti-versican antibodies, respectively. We thank B. Seifert for statistical consulting. A. A. received an ERC Advanced Investigator Grant and grants from the European Union ( PRIORITY and LUPAS), the Novartis Foundation and the Swiss National Foundation. J. B. received a Career Development award from the University of Zurich. C. W. and K. V. T. were supported by the Departmental Research Fund.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Behrens A, 2002, EMBO J, V21, P3652, DOI 10.1093/emboj/cdf386; Bermingham JR, 2006, NAT NEUROSCI, V9, P76, DOI 10.1038/nn1598; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Britsch S, 2007, ADV ANAT EMBRYOL CEL, V190, P1; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Chen SZ, 2003, MOL CELL NEUROSCI, V22, P227, DOI 10.1016/S1044-7431(02)00014-3; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Genoud N, 2004, P NATL ACAD SCI USA, V101, P4198, DOI 10.1073/pnas.0400131101; Heikenwalder M, 2008, IMMUNITY, V29, P998, DOI 10.1016/j.immuni.2008.10.014; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Isaacs JD, 2006, CLIN EXP IMMUNOL, V146, P1, DOI 10.1111/j.1365-2249.2006.03194.x; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lindeboom F, 2003, NUCLEIC ACIDS RES, V31, P5405, DOI 10.1093/nar/gkg723; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Lledo PM, 1996, P NATL ACAD SCI USA, V93, P2403, DOI 10.1073/pnas.93.6.2403; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; McMahon HEM, 2001, J BIOL CHEM, V276, P2286, DOI 10.1074/jbc.M007243200; Meotti FC, 2007, BRAIN RES, V1151, P84, DOI 10.1016/j.brainres.2007.03.024; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Nazor KE, 2007, BBA-MOL BASIS DIS, V1772, P645, DOI 10.1016/j.bbadis.2007.04.004; Nico PBC, 2005, BEHAV BRAIN RES, V162, P173, DOI 10.1016/j.bbr.2005.02.003; Nishida N, 1999, LAB INVEST, V79, P689; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Prinz M, 2004, J NEUROSCI, V24, P5974, DOI 10.1523/JNEUROSCI.0122-04.2004; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; Rutishauser D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004446; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Steele AD, 2007, PRION, V1, P83, DOI 10.4161/pri.1.2.4346; Sunyach C, 2007, J BIOL CHEM, V282, P1956, DOI 10.1074/jbc.M609663200; Toni M, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/69469; Walmsley AR, 2009, MOL CELL NEUROSCI, V40, P242, DOI 10.1016/j.mcn.2008.10.012; Watt NT, 2005, BIOCHEM SOC T, V33, P1123, DOI 10.1042/BST20051123; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Zielasek J, 1996, MUSCLE NERVE, V19, P946, DOI 10.1002/(SICI)1097-4598(199608)19:8<946::AID-MUS2>3.0.CO;2-8	47	296	297	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					310	U9		10.1038/nn.2483	http://dx.doi.org/10.1038/nn.2483			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20098419				2022-12-17	WOS:000274860100012
J	Bond, AM; VanGompel, MJW; Sametsky, EA; Clark, MF; Savage, JC; Disterhoft, JF; Kohtz, JD				Bond, Allison M.; VanGompel, Michael J. W.; Sametsky, Evgeny A.; Clark, Mary F.; Savage, Julie C.; Disterhoft, John F.; Kohtz, Jhumku D.			Balanced gene regulation by an embryonic brain ncRNA is critical for adult hippocampal GABA circuitry	NATURE NEUROSCIENCE			English	Article							RETT-SYNDROME; BASAL FOREBRAIN; HOMEOBOX GENES; SONIC HEDGEHOG; CELL-MIGRATION; DLX GENES; INTERNEURON MIGRATION; HUMAN GENOME; MOUSE MODEL; NEURONS	Genomic studies demonstrate that, although the majority of the mammalian genome is transcribed, only about 2% of these transcripts are code for proteins. We investigated how the long, polyadenylated Evf2 noncoding RNA regulates transcription of the homeodomain transcription factors DLX5 and DLX6 in the developing mouse forebrain. We found that, in developing ventral forebrain, Evf2 recruited DLX and MECP2 transcription factors to important DNA regulatory elements in the Dlx5/6 intergenic region and controlled Dlx5, Dlx6 and Gad1 expression through trans and cis-acting mechanisms. Evf2 mouse mutants had reduced numbers of GABAergic interneurons in early postnatal hippocampus and dentate gyrus. Although the numbers of GABAergic interneurons and Gad1 RNA levels returned to normal in Evf2 mutant adult hippocampus, reduced synaptic inhibition occurred. These results suggest that noncoding RNA-dependent balanced gene regulation in embryonic brain is critical for proper formation of GABA-dependent neuronal circuitry in adult brain.	[Bond, Allison M.; VanGompel, Michael J. W.; Clark, Mary F.; Savage, Julie C.; Kohtz, Jhumku D.] Northwestern Univ, Childrens Mem Hosp, Dev Biol & Dept Pediat, Chicago, IL 60614 USA; [Sametsky, Evgeny A.; Disterhoft, John F.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60614 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Northwestern University; Feinberg School of Medicine	Kohtz, JD (corresponding author), Northwestern Univ, Childrens Mem Hosp, Dev Biol & Dept Pediat, Chicago, IL 60614 USA.	j-kohtz@northwestern.edu	; Bond, Alan/Y-7128-2018	Disterhoft, John/0000-0002-8817-7913; Bond, Alan/0000-0002-1113-5205	National Institute of Child Health and Human Development [RO1 HD044745, R21 HD049875]; Illinois Regenerative Medicine Institute; Illinois Excellence in Academic Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044745, R21HD049875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH047340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017139, R37AG008796] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Illinois Regenerative Medicine Institute; Illinois Excellence in Academic Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank K. Campbell for providing early passage W4 embryonic stem cells, and training and guidance in ES cell manipulation, M. Ekker for Dlx5/6 BAC, P. Lui and N. Copeland for PL253, PL452, bacterial strains and protocols for BAC recombineering, G. Taborn and P. Iannaccone for blastocyst injections, D. Eisentstat for antibody specific to DLX2, A. Joyner for the triple polyadenylation construct, J. Rubenstein for Gad1 probe, and Q. Ma for v-Glut1 probe. We thank K. Jones (Northwestern University) for establishing the conditions for embryonic tissue ChIP. This work was funded by National Institute of Child Health and Human Development grants RO1 HD044745 and R21 HD049875, the Illinois Regenerative Medicine Institute, and an Illinois Excellence in Academic Medicine grant to J. D. K.	Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; Cuzon VC, 2006, CEREB CORTEX, V16, P1377, DOI 10.1093/cercor/bhj084; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Di Cristo G, 2007, CLIN GENET, V72, P1, DOI 10.1111/j.1399-0004.2007.00822.x; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Feng J, 2004, DEVELOPMENT, V131, P4357, DOI 10.1242/dev.01301; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Gilligan P, 2002, GENE, V294, P35, DOI 10.1016/S0378-1119(02)00793-X; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Heng JIT, 2007, EUR J NEUROSCI, V26, P537, DOI 10.1111/j.1460-9568.2007.05694.x; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Kohtz JD, 2001, DEVELOPMENT, V128, P2351; Kohtz JD, 1998, DEVELOPMENT, V125, P5079; Le TN, 2007, J BIOL CHEM, V282, P19071, DOI 10.1074/jbc.M607486200; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lopez-Bendito G, 2003, CEREB CORTEX, V13, P932, DOI 10.1093/cercor/13.9.932; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Mattick JS, 2007, J EXP BIOL, V210, P1526, DOI 10.1242/jeb.005017; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Panganiban G, 2002, DEVELOPMENT, V129, P4371; PANGANIBAN G, 1995, SCIENCE, V270, P1363, DOI 10.1126/science.270.5240.1363; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; Potier B, 2006, NEUROSCIENCE, V142, P187, DOI 10.1016/j.neuroscience.2006.06.040; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Santini S, 2003, GENOME RES, V13, P1111, DOI 10.1101/gr.700503; Schule B, 2007, AM J HUM GENET, V81, P492, DOI 10.1086/520063; SHAMOVSKY I, 2006, SCI STKE, pPE40, DOI DOI 10.1126/STKE.3552006PE40; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Wichterle H, 2001, DEVELOPMENT, V128, P3759; XU C, 2009, HIPPOCAMPUS; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000; Zhou QP, 2004, NUCLEIC ACIDS RES, V32, P884, DOI 10.1093/nar/gkh233	50	296	325	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					1020	U91		10.1038/nn.2371	http://dx.doi.org/10.1038/nn.2371			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19620975	Green Accepted			2022-12-17	WOS:000268396300016
J	Li, RJ; Polat, U; Makous, W; Bavelier, D				Li, Renjie; Polat, Uri; Makous, Walter; Bavelier, Daphne			Enhancing the contrast sensitivity function through action video game training	NATURE NEUROSCIENCE			English	Article							SPATIAL-FREQUENCY; ADULTS; MASKING; CONTEXT	The contrast sensitivity function (CSF) is routinely assessed in clinical evaluation of vision and is the primary limiting factor in how well one sees. CSF improvements are typically brought about by correction of the optics of the eye with eyeglasses, contact lenses or surgery. We found that the very act of action video game playing also enhanced contrast sensitivity, providing a complementary route to eyesight improvement.	[Li, Renjie; Makous, Walter; Bavelier, Daphne] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; [Li, Renjie; Makous, Walter; Bavelier, Daphne] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA; [Polat, Uri] Tel Aviv Univ, Goldschleger Eye Res Inst, Tel Hashomer, Israel	University of Rochester; University of Rochester; Tel Aviv University	Bavelier, D (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	daphne@cvs.rochester.edu	Makous, Walter L/A-1200-2007; Li, Renjie/K-3494-2014	Bavelier, Daphne/0000-0002-5904-1240	US National Institutes of Health [EY016880]; James S. McDonnell Foundation; Office of Naval Research; Israel Science Foundation; NATIONAL EYE INSTITUTE [R01EY016880] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; Office of Naval Research(Office of Naval Research); Israel Science Foundation(Israel Science Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank C. S. Green for his invaluable help and advice throughout this project, and A. Anderson, S. Bailey, A. Katz, M. Maciejewski, A. States, P. Santos and B. Hubert-Wallander for their help in running the training studies. This work was supported in part by grants from the US National Institutes of Health (EY016880), the James S. McDonnell Foundation and the Office of Naval Research to D. B. and the Israel Science Foundation to U. P.	Achtman RL, 2008, RESTOR NEUROL NEUROS, V26, P435; Adini Y, 2002, NATURE, V415, P790, DOI 10.1038/415790a; CAMPBELL FW, 1983, BEHAV BRAIN RES, V10, P87, DOI 10.1016/0166-4328(83)90154-7; Fahle M, 2002, PERCEPTUAL LEARNING; Fiser J, 2003, VISION RES, V43, P2637, DOI 10.1016/S0042-6989(03)00441-3; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Maehara G, 2007, PERCEPT PSYCHOPHYS, V69, P1009, DOI 10.3758/BF03193939; MAYER MJ, 1983, VISION RES, V23, P547, DOI 10.1016/0042-6989(83)90130-X; Patching GR, 2005, INVEST OPHTH VIS SCI, V46, P2219, DOI 10.1167/iovs.03-1247; POLAT U, 1993, VISION RES, V33, P993, DOI 10.1016/0042-6989(93)90081-7; Sekuler R., 2000, OXFORD TXB GERIATRIC, P874; Sowden PT, 2002, VISION RES, V42, P1249, DOI 10.1016/S0042-6989(02)00019-6; Sowden PT, 2000, J EXP PSYCHOL HUMAN, V26, P379, DOI 10.1037/0096-1523.26.1.379; Weale R. A., 1992, SENESCENCE HUMAN VIS; Yu C, 2004, J VISION, V4, P169, DOI 10.1167/4.3.4	15	296	306	2	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2009	12	5					549	551		10.1038/nn.2296	http://dx.doi.org/10.1038/nn.2296			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438SJ	19330003	Green Accepted, Green Published			2022-12-17	WOS:000265575400010
J	Macknik, SL; Livingstone, MS				Macknik, SL; Livingstone, MS			Neuronal correlates of visibility and invisibility in the primate visual system	NATURE NEUROSCIENCE			English	Article							SACCADIC EYE-MOVEMENTS; MONKEY SUPERIOR COLLICULUS; STRIATE CORTEX; INFORMATION; MASKING; VISION; METACONTRAST; RESPONSES	A brief visual target stimulus may be rendered invisible if it is immediately preceded or followed by another stimulus. This class of illusions, known as visual masking, may allow insights into the neural mechanisms that underlie visual perception. We have therefore explored the temporal characteristics of masking illusions in humans, and compared them with corresponding neuronal responses in the primary visual cortex of awake and anesthetized monkeys. Stimulus parameters that in humans produce forward masking (in which the mask precedes the target) suppress the transient on-response to the target in monkey visual cortex. Those that produce backward masking (in which the mask comes after the target) inhibit the transient after-discharge, the excitatory response that occurs just after the disappearance of the target. These results suggest that, for targets that can be masked (those of short duration), the transient neuronal responses associated with onset and turning off of the target may be important in its visibility.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Macknik, SL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.		Macknik, Stephen L./H-7704-2019	Macknik, Stephen L./0000-0002-3143-9230; Livingstone, Margaret/0000-0002-1950-0123				ALPERN M, 1952, Am J Optom Arch Am Acad Optom, V29, P631; ALPERN M, 1953, J OPT SOC AM, V43, P648, DOI 10.1364/JOSA.43.000648; BREITMEYER B, 1984, VISUAL MASKING INTEG, P1; BREITMEYER BG, 1978, B PSYCHONOMIC SOC, V12, P50; BREITMEYER BG, 1976, PSYCHOL REV, V83, P1, DOI 10.1037/0033-295X.83.1.1; BRIDGEMAN B, 1975, VISION RES, V15, P91, DOI 10.1016/0042-6989(75)90065-6; BRIDGEMAN B, 1971, PSYCHOL REV, V78, P528, DOI 10.1037/h0031782; BRIDGEMAN B, 1980, BRAIN RES, V196, P347, DOI 10.1016/0006-8993(80)90400-X; Coppola D, 1996, P NATL ACAD SCI USA, V93, P8001, DOI 10.1073/pnas.93.15.8001; Day EC, 1915, AM J PHYSIOL, V38, P369, DOI 10.1152/ajplegacy.1915.38.3.369; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; EXNER S, 1868, WIENER SITZUNGBERICH, P601; FRANCIS G, 1995, ONLINE P 1996 MIDWES; HELMHOLTZ H, 1985, HELMHOLTZS TREATISE, P1; HUBEL DH, 1987, J NEUROSCI, V7, P3378; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; JUDGE SJ, 1980, J NEUROPHYSIOL, V43, P1133, DOI 10.1152/jn.1980.43.4.1133; KOLERS PA, 1960, AM J PSYCHOL, V73, P2, DOI 10.2307/1419113; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; Livingstone MS, 1996, COLD SPRING HARB SYM, V61, P27; MATIN E, 1975, PSYCHOL REV, V82, P451; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; MCFADDEN, 1973, VISION RES, V13, P185; OLSON CX, 1984, PERCEPT PSYCHOPHYS, V35, P295, DOI 10.3758/BF03206331; RICHMOND BJ, 1980, J NEUROPHYSIOL, V43, P1156, DOI 10.1152/jn.1980.43.4.1156; RIGGS LA, 1952, J OPT SOC AM, V42, P872; SCHILLER PH, 1968, VISION RES, V8, P855, DOI 10.1016/0042-6989(68)90135-1; Schiller PH, 1969, INFORMATION PROCESSI, P141; SMITH MC, 1966, CAN J PSYCHOLOGY, V20, P191, DOI 10.1037/h0082933; SPERLING G, 1965, J OPT SOC AM, V55, P541, DOI 10.1364/JOSA.55.000541; STIGLER R, 1913, 9 C INT PHYS, P78; Stigler R, 1926, HDB BIOL ARBEITSMETH, P949; TOVEE MJ, 1993, J NEUROPHYSIOL, V70, P640, DOI 10.1152/jn.1993.70.2.640; WEISSTEIN N, 1971, PERCEPT PSYCHOPHYS, V9, P275, DOI 10.3758/BF03212647; WEISSTEIN N, 1965, PSYCHON SCI, V2, P75, DOI 10.3758/BF03343337; Werner H, 1935, AM J PSYCHOL, V47, P40, DOI 10.2307/1416707; WURTZ RH, 1980, J NEUROPHYSIOL, V43, P1168, DOI 10.1152/jn.1980.43.4.1168; YARBUS AL, 1967, EYE MOVEMENTS VISON	39	296	303	0	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1998	1	2					144	149		10.1038/393	http://dx.doi.org/10.1038/393			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	127QB	10195130				2022-12-17	WOS:000076361100016
J	Greenberg, DS; Houweling, AR; Kerr, JND				Greenberg, David S.; Houweling, Arthur R.; Kerr, Jason N. D.			Population imaging of ongoing neuronal activity in the visual cortex of awake rats	NATURE NEUROSCIENCE			English	Article							WHOLE-CELL RECORDINGS; NETWORK STATES; IN-VIVO	It is unclear how the complex spatiotemporal organization of ongoing cortical neuronal activity recorded in anesthetized animals relates to the awake animal. We therefore used two-photon population calcium imaging in awake and subsequently anesthetized rats to follow action potential firing in populations of neurons across brain states, and examined how single neurons contributed to population activity. Firing rates and spike bursting in awake rats were higher, and pair-wise correlations were lower, compared with anesthetized rats. Anesthesia modulated population-wide synchronization and the relationship between firing rate and correlation. Overall, brain activity during wakefulness cannot be inferred using anesthesia.	[Greenberg, David S.; Kerr, Jason N. D.] Max Planck Inst Biol Cybernet, Network Imaging Grp, D-72076 Tubingen, Germany; [Greenberg, David S.] Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany; [Houweling, Arthur R.] Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands; [Houweling, Arthur R.] Humboldt Univ, Bernstein Ctr Computat Neurosci, D-10115 Berlin, Germany; [Kerr, Jason N. D.] Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany	Max Planck Society; Max Planck Society; Erasmus University Rotterdam; Erasmus MC; Humboldt University of Berlin; Max Planck Society	Kerr, JND (corresponding author), Max Planck Inst Biol Cybernet, Network Imaging Grp, Spemannstr 41, D-72076 Tubingen, Germany.	jason@tuebingen.mpg.de		Greenberg, David/0000-0002-8515-0459; Kerr, Jason/0000-0001-9459-883X				de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; KERR JN, 2007, NEUROSCIENCE, V27, P13316; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302	15	295	297	6	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					749	751		10.1038/nn.2140	http://dx.doi.org/10.1038/nn.2140			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18552841				2022-12-17	WOS:000257089400010
J	Kapfer, C; Glickfeld, LL; Atallah, BV; Scanziani, M				Kapfer, Christoph; Glickfeld, Lindsey L.; Atallah, Bassam V.; Scanziani, Massimo			Supralinear increase of recurrent inhibition during sparse activity in the somatosensory cortex	NATURE NEUROSCIENCE			English	Article							RAT BARREL CORTEX; CAT VISUAL-CORTEX; RECEPTIVE-FIELD PROPERTIES; IN-VIVO; INTRACELLULAR-RECORDINGS; GABAERGIC INTERNEURONS; SYNAPTIC-INTERACTIONS; PYRAMIDAL NEURONS; CORTICAL-NEURONS; NEOCORTEX	The balance between excitation and inhibition in the cortex is crucial in determining sensory processing. Because the amount of excitation varies, maintaining this balance is a dynamic process; yet the underlying mechanisms are poorly understood. We show here that the activity of even a single layer 2/3 pyramidal cell in the somatosensory cortex of the rat generates widespread inhibition that increases disproportionately with the number of active pyramidal neurons. This supralinear increase of inhibition results from the incremental recruitment of somatostatin-expressing inhibitory interneurons located in layers 2/3 and 5. The recruitment of these interneurons increases tenfold when they are excited by two pyramidal cells. A simple model demonstrates that the distribution of excitatory input amplitudes onto inhibitory neurons influences the sensitivity and dynamic range of the recurrent circuit. These data show that through a highly sensitive recurrent inhibitory circuit, cortical excitability can be modulated by one pyramidal cell.	Univ Calif San Diego, Grad Program Neurosci, Div Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Scanziani, M (corresponding author), Univ Calif San Diego, Grad Program Neurosci, Div Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	massimo@ucsd.edu		Atallah, Bassam/0000-0003-2315-7126	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070058, R01MH071401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS056529] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH071401, MH70058, MH71401, R01 MH070058] Funding Source: Medline; NINDS NIH HHS [F31 NS056529, 1-F31NS056529-01] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Biro AA, 2005, J NEUROSCI, V25, P223, DOI 10.1523/JNEUROSCI.3688-04.2005; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Carandini M, 1997, J NEUROSCI, V17, P8621; Chu ZG, 2003, J NEUROSCI, V23, P96; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P659, DOI 10.1113/jphysiol.1991.sp018730; DYKES RW, 1984, J NEUROPHYSIOL, V52, P1066, DOI 10.1152/jn.1984.52.6.1066; Fairen A., 1984, CEREB CORTEX, V1, P201; FERSTER D, 1992, J NEUROSCI, V12, P1262; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galarreta M, 2004, J NEUROSCI, V24, P9770, DOI 10.1523/JNEUROSCI.3027-04.2004; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Kyriazi HT, 1996, J NEUROPHYSIOL, V75, P547, DOI 10.1152/jn.1996.75.2.547; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Pinto DJ, 2003, CEREB CORTEX, V13, P33, DOI 10.1093/cercor/13.1.33; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rozov A, 2001, J NEUROSCI, V21, P8062, DOI 10.1523/JNEUROSCI.21-20-08062.2001; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Wilent WB, 2004, J NEUROSCI, V24, P3985, DOI 10.1523/JNEUROSCI.5782-03.2004; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	41	295	297	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					743	753		10.1038/nn1909	http://dx.doi.org/10.1038/nn1909			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17515899	Green Accepted			2022-12-17	WOS:000246799800017
J	Bissiere, S; Humeau, Y; Luthi, A				Bissiere, S; Humeau, Y; Luthi, A			Dopamine gates LTP induction in lateral amygdala by suppressing feedforward inhibition	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RAT BASOLATERAL AMYGDALA; LASTING POTENTIATION; SYNAPTIC PLASTICITY; CONSCIOUS CATS; FEAR; NEURONS; INTERNEURONS; MODULATION; RESPONSES	Fear conditioning involves the induction of long-term potentiation (LTP) of excitatory synaptic transmission in the lateral amygdala, a brain structure which is tightly controlled by GABAergic inhibition. Here we show that dopamine gates the induction of LTP in the mouse lateral amygdala by suppressing feedforward inhibition from local interneurons. Our findings provide a cellular mechanism for the dopaminergic modulation of fear conditioning and indicate that suppression of feedforward inhibition represents a key mechanism for the induction of associative synaptic plasticity in the lateral amygdala.	Univ Basel, Bioctr, Dept Pharmacol Neurobiol, CH-4056 Basel, Switzerland	University of Basel	Luthi, A (corresponding author), Univ Basel, Bioctr, Dept Pharmacol Neurobiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.	andreas.luthi@unibas.ch						Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brinley-Reed M, 1999, BRAIN RES, V850, P127, DOI 10.1016/S0006-8993(99)02112-5; Collins DR, 2000, LEARN MEMORY, V7, P97, DOI 10.1101/lm.7.2.97; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; DAVIS M, 2000, AMYGDALA, P231; El-Ghundi M, 2001, BRAIN RES, V892, P86, DOI 10.1016/S0006-8993(00)03234-0; Fi XF, 1996, SYNAPSE, V24, P115, DOI 10.1002/(SICI)1098-2396(199610)24:2<115::AID-SYN3>3.0.CO;2-I; Frohardt RJ, 2000, BEHAV NEUROSCI, V114, P227, DOI 10.1037/0735-7044.114.2.227; Greba Q, 2001, BRAIN RES, V899, P218, DOI 10.1016/S0006-8993(01)02243-0; Greba Q, 2000, BEHAV NEUROSCI, V114, P262, DOI 10.1037//0735-7044.114.2.262; Guarraci FA, 1999, BRAIN RES, V827, P28, DOI 10.1016/S0006-8993(99)01291-3; Heidbreder CA, 2000, NEUROSCIENCE, V100, P749, DOI 10.1016/S0306-4522(00)00336-5; Inglis FM, 1999, J NEUROCHEM, V72, P1088, DOI 10.1046/j.1471-4159.1999.0721088.x; Kemppainen S, 2000, J COMP NEUROL, V426, P441, DOI 10.1002/1096-9861(20001023)426:3<441::AID-CNE8>3.0.CO;2-7; Klimek V, 2002, BIOL PSYCHIAT, V52, P740, DOI 10.1016/S0006-3223(02)01383-5; Lang EJ, 1997, J NEUROPHYSIOL, V77, P341, DOI 10.1152/jn.1997.77.1.341; Lang EJ, 1998, NEUROSCIENCE, V83, P877, DOI 10.1016/S0306-4522(97)00420-X; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McDonald AJ, 2001, NEUROSCIENCE, V105, P681, DOI 10.1016/S0306-4522(01)00214-7; MCDONALD AJ, 1982, J COMP NEUROL, V212, P293, DOI 10.1002/cne.902120307; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Nader K, 1999, BEHAV NEUROSCI, V113, P891, DOI 10.1037/0735-7044.113.5.891; Pare D, 1996, J NEUROSCI, V16, P3334; Pare D, 2000, J NEUROSCI, V20, P2701; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; RAINNIE DG, 1991, J NEUROPHYSIOL, V66, P986, DOI 10.1152/jn.1991.66.3.986; RAINNIE DG, 1993, J NEUROPHYSIOL, V69, P1350, DOI 10.1152/jn.1993.69.4.1350; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rosenkranz JA, 1999, J NEUROSCI, V19, P11027, DOI 10.1523/JNEUROSCI.19-24-11027.1999; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Rosenkranz JA, 2001, J NEUROSCI, V21, P4090, DOI 10.1523/JNEUROSCI.21-11-04090.2001; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/s0896-6273(01)00542-6; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; SUGITA S, 1993, J PHYSIOL-LONDON, V460, P705, DOI 10.1113/jphysiol.1993.sp019495; Szinyei C, 2000, J NEUROSCI, V20, P8909; Tessitore A, 2002, J NEUROSCI, V22, P9099, DOI 10.1523/jneurosci.22-20-09099.2002; WASHBURN MS, 1992, J NEUROSCI, V12, P4066; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0; Yamada J, 1999, NEUROPHARMACOLOGY, V38, P1743, DOI 10.1016/S0028-3908(99)00126-4	45	295	300	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					587	592		10.1038/nn1058	http://dx.doi.org/10.1038/nn1058			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12740581				2022-12-17	WOS:000183140400015
J	Bomze, HM; Bulsara, KR; Iskandar, BJ; Caroni, P; Skene, JHP				Bomze, HM; Bulsara, KR; Iskandar, BJ; Caroni, P; Skene, JHP			Spinal axon regeneration evoked by replacing two growth cone proteins in adult neurons	NATURE NEUROSCIENCE			English	Article							PRIMARY SENSORY NEURONS; CENTRAL-NERVOUS-SYSTEM; NEURITE OUTGROWTH; PERIPHERAL-NERVE; CORTICOSPINAL TRACT; FUNCTIONAL RECOVERY; GAP-43 EXPRESSION; MESSENGER-RNAS; GANGLION-CELLS; MAMMALIAN CNS	In contrast to peripheral nerves, damaged axons in the mammalian brain and spinal cord rarely regenerate. Peripheral nerve injury stimulates neuronal expression of many genes that are not generally induced by CNS lesions, but it is not known which of these genes are required for regeneration. Here we show that co-expressing two major growth cone proteins, GAP-43 and GAP-23, can elicit long axon extension by adult dorsal root ganglion (DRG) neurons in vitro. Moreover, this expression triggers a 60-fold increase in regeneration of DRG axons in adult mice after spinal cord injury in vivo. Replacing key growth cone components, therefore, could be an effective way to stimulate regeneration of CNS axons.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Div Neurosurg, Durham, NC 27710 USA; Univ Wisconsin, Dept Neurol Surg, Madison, WI 53792 USA; Friedrich Miescher Inst, CH-4058 Basel, Switzerland	Duke University; Duke University; University of Wisconsin System; University of Wisconsin Madison; Friedrich Miescher Institute for Biomedical Research	Skene, JHP (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Bryan Res Bldg, Durham, NC 27710 USA.			Skene, Pate/0000-0003-3205-0697				AIGNER L, 1995, J CELL BIOL, V128, P647, DOI 10.1083/jcb.128.4.647; AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Buffo A, 1997, J NEUROSCI, V17, P8778; CAMPBELL G, 1991, EXP BRAIN RES, V87, P67; Caroni P, 1997, BIOESSAYS, V19, P767, DOI 10.1002/bies.950190906; Caroni P, 1997, J CELL BIOL, V136, P679, DOI 10.1083/jcb.136.3.679; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; CHONG MS, 1994, J NEUROSCI, V14, P4375; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; DOSTER SK, 1991, NEURON, V6, P1; Fernandes KJL, 1999, J COMP NEUROL, V414, P495, DOI 10.1002/(SICI)1096-9861(19991129)414:4<495::AID-CNE6>3.0.CO;2-S; Fidler PS, 1999, J NEUROSCI, V19, P8778, DOI 10.1523/JNEUROSCI.19-20-08778.1999; Frey D, 2000, J CELL BIOL, V149, P1443, DOI 10.1083/jcb.149.7.1443; FRIEDMAN B, 1985, J NEUROSCI, V5, P1616; Goldberg JL, 2000, NATURE, V403, P369, DOI 10.1038/35000309; Higo N, 1999, CEREB CORTEX, V9, P317, DOI 10.1093/cercor/9.4.317; HIMI T, 1994, BRAIN RES, V655, P177, DOI 10.1016/0006-8993(94)91612-8; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; KALIL K, 1986, J NEUROSCI, V6, P2563; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; Maekawa S, 1999, J BIOL CHEM, V274, P21369, DOI 10.1074/jbc.274.30.21369; Maier DL, 1999, P NATL ACAD SCI USA, V96, P9397, DOI 10.1073/pnas.96.16.9397; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; McNamara RK, 1997, J COMP NEUROL, V379, P48; Meiri KF, 1998, J NEUROSCI, V18, P10429; Mosevitsky MI, 1997, BIOCHIMIE, V79, P373, DOI 10.1016/S0300-9084(97)80032-6; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; NEVE RL, 1988, P NATL ACAD SCI USA, V85, P3638, DOI 10.1073/pnas.85.10.3638; Qiu J, 2000, GLIA, V29, P166, DOI 10.1002/(SICI)1098-1136(20000115)29:2<166::AID-GLIA10>3.0.CO;2-G; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; RICHARDSON PM, 1986, J NEUROCYTOL, V15, P585, DOI 10.1007/BF01611859; RICHARDSON PM, 1984, J NEUROCYTOL, V13, P165, DOI 10.1007/BF01148324; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; SCHADEN H, 1994, J NEUROBIOL, V25, P1570, DOI 10.1002/neu.480251209; SCHREYER DJ, 1993, J NEUROBIOL, V24, P959, DOI 10.1002/neu.480240709; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; SKENE JHP, 1981, J CELL BIOL, V89, P96, DOI 10.1083/jcb.89.1.96; Smith DS, 1997, J NEUROSCI, V17, P646; SO KF, 1985, BRAIN RES, V328, P349, DOI 10.1016/0006-8993(85)91047-9; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; STRITTMATTER SM, 1995, CELL, V80, P445, DOI 10.1016/0092-8674(95)90495-6; Sugiura Y, 1995, DEV BRAIN RES, V90, P73, DOI 10.1016/0165-3806(96)83488-2; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Wiederkehr A, 1997, EXP CELL RES, V236, P103, DOI 10.1006/excr.1997.3709; Zhu QZ, 1999, EXP NEUROL, V155, P228, DOI 10.1006/exnr.1998.6989	49	295	311	0	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2001	4	1					38	43		10.1038/82881	http://dx.doi.org/10.1038/82881			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UB	11135643				2022-12-17	WOS:000167178000012
J	Morris, M; Knudsen, GM; Maeda, S; Trinidad, JC; Ioanoviciu, A; Burlingame, AL; Mucke, L				Morris, Meaghan; Knudsen, Giselle M.; Maeda, Sumihiro; Trinidad, Jonathan C.; Ioanoviciu, Alexandra; Burlingame, Alma L.; Mucke, Lennart			Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice	NATURE NEUROSCIENCE			English	Article							LINKED N-ACETYLGLUCOSAMINE; PAIRED HELICAL FILAMENTS; MASS-SPECTROMETRY; O-GLCNACYLATION; PHOSPHORYLATION SITES; LYSINE METHYLATION; ENDOGENOUS TAU; MOUSE MODELS; DISEASE; BRAIN	The microtubule-associated protein tau has been implicated in the pathogenesis of Alzheimer's disease (AD) and other neurodegenerative disorders. Reducing tau levels ameliorates AD-related synaptic, network, and behavioral abnormalities in transgenic mice expressing human amyloid precursor protein (hAPP). We used mass spectrometry to characterize the post-translational modification of endogenous tau isolated from wild-type and hAPP mice. We identified seven types of tau modifications at 63 sites in wild-type mice. Wild-type and hAPP mice had similar modifications, supporting the hypothesis that neuronal dysfunction in hAPP mice is enabled by physiological forms of tau. Our findings provide clear evidence for acetylation and ubiquitination of the same lysine residues; some sites were also targeted by lysine methylation. Our findings refute the hypothesis of extensive O-linked N-acetylglucosamine (O-GlcNAc) modification of endogenous tau. The complex post-translational modification of physiological tau suggests that tau is regulated by diverse mechanisms.	[Morris, Meaghan; Maeda, Sumihiro; Mucke, Lennart] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Morris, Meaghan] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Biochem Cellular & Mol Biol Grad Program, Baltimore, MD 21205 USA; [Knudsen, Giselle M.; Trinidad, Jonathan C.; Ioanoviciu, Alexandra; Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, Mass Spectrometry Facil, San Francisco, CA 94143 USA; [Maeda, Sumihiro; Mucke, Lennart] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Mucke, L (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	lmucke@gladstone.ucsf.edu	Maeda, Sumihiro/W-9146-2019; Trinidad, Jonathan/GWR-2077-2022	Maeda, Sumihiro/0000-0002-0701-6860; Morris, Meaghan/0000-0001-5340-148X	US National Institutes of Health [NS041787, GM103481]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041787] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Finucane for help with the statistical analysis, S. Lee, W. Guo, J. Kang, X. Wang, D. Kim and G.-Q. Yu for technical assistance, S. Ordway for editorial assistance, and M. Dela Cruz and A. Cheung for administrative assistance. The study was supported by US National Institutes of Health grants to L.M. (NS041787) and to A.L.B. (GM103481).	Arnold CS, 1996, J BIOL CHEM, V271, P28741, DOI 10.1074/jbc.271.46.28741; Baker PR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008078; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Biernat J, 1999, MOL BIOL CELL, V10, P727, DOI 10.1091/mbc.10.3.727; Biggar KK, 2015, NAT REV MOL CELL BIO, V16, P5, DOI 10.1038/nrm3915; Borghgraef P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084442; Bradshaw RA, 2010, J MASS SPECTROM, V45, P1095, DOI 10.1002/jms.1786; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Chalkley RJ, 2009, P NATL ACAD SCI USA, V106, P8894, DOI 10.1073/pnas.0900288106; Chalkley RJ, 2008, MOL CELL PROTEOMICS, V7, P2386, DOI 10.1074/mcp.M800021-MCP200; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Cook C, 2014, HUM MOL GENET, V23, P104, DOI 10.1093/hmg/ddt402; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; Dawson HN, 2001, J CELL SCI, V114, P1179; Devos SL, 2013, J NEUROSCI, V33, P12887, DOI 10.1523/JNEUROSCI.2107-13.2013; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Funk KE, 2014, BIOCHEM J, V462, P77, DOI 10.1042/BJ20140372; Gheyara AL, 2014, ANN NEUROL, V76, P443, DOI 10.1002/ana.24230; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; Guan SH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010728; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Holth JK, 2013, J NEUROSCI, V33, P1651, DOI 10.1523/JNEUROSCI.3191-12.2013; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Ivanovova N, 2008, J IMMUNOL METHODS, V339, P17, DOI 10.1016/j.jim.2008.07.014; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Li ZY, 2014, NEUROBIOL AGING, V35, P2617, DOI 10.1016/j.neurobiolaging.2014.05.001; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu F, 2009, BRAIN, V132, P1820, DOI 10.1093/brain/awp099; MANDELKOW EM, 1995, NEUROBIOL AGING, V16, P355, DOI 10.1016/0197-4580(95)00025-A; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; MORISHIMAKAWASHIMA M, 1993, NEURON, V10, P1151, DOI 10.1016/0896-6273(93)90063-W; Morris M, 2013, NEUROBIOL AGING, V34, P1523, DOI 10.1016/j.neurobiolaging.2012.12.003; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Reynolds CH, 2008, J BIOL CHEM, V283, P18177, DOI 10.1074/jbc.M709715200; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Rudrabhatla P, 2011, FASEB J, V25, P3896, DOI 10.1096/fj.11-181297; Seward ME, 2013, J CELL SCI, V126, P1278, DOI 10.1242/jcs.1125880; Simon AM, 2009, NEUROBIOL DIS, V33, P369, DOI 10.1016/j.nbd.2008.11.005; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Suberbielle E, 2013, NAT NEUROSCI, V16, P613, DOI 10.1038/nn.3356; Sultan A, 2011, J BIOL CHEM, V286, P4566, DOI 10.1074/jbc.M110.199976; Tavares IA, 2013, J BIOL CHEM, V288, P15418, DOI 10.1074/jbc.M112.448183; Thomas SN, 2012, ACTA NEUROPATHOL, V123, P105, DOI 10.1007/s00401-011-0893-0; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Trinidad JC, 2005, J NEUROCHEM, V92, P1306, DOI 10.1111/j.1471-4159.2004.02943.x; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Vossel KA, 2015, J CELL BIOL, V209, P419, DOI 10.1083/jcb.201407065; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Wang ZH, 2010, MOL CELL PROTEOMICS, V9, P153, DOI 10.1074/mcp.M900268-MCP200; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/NCHEMBIO.797, 10.1038/nchembio.797]; Yuzwa SA, 2011, AMINO ACIDS, V40, P857, DOI 10.1007/s00726-010-0705-1; Zempel H, 2013, EMBO J, V32, P2920, DOI 10.1038/emboj.2013.207; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010	67	294	301	3	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2015	18	8					1183	+		10.1038/nn.4067	http://dx.doi.org/10.1038/nn.4067			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CN7HO	26192747	Green Submitted, Green Accepted			2022-12-17	WOS:000358605400021
J	Suberbielle, E; Sanchez, PE; Kravitz, AV; Wang, X; Ho, K; Eilertson, K; Devidze, N; Kreitzer, AC; Mucke, L				Suberbielle, Elsa; Sanchez, Pascal E.; Kravitz, Alexxai V.; Wang, Xin; Ho, Kaitlyn; Eilertson, Kirsten; Devidze, Nino; Kreitzer, Anatol C.; Mucke, Lennart			Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-beta	NATURE NEUROSCIENCE			English	Article							SYNTHETIC SUPEROXIDE-DISMUTASE; ALZHEIMERS-DISEASE; MOUSE MODELS; COGNITIVE IMPAIRMENTS; OXIDATIVE STRESS; HISTONE H2A.X; DAMAGE; DYSFUNCTION; REPAIR; PHOSPHORYLATION	We show that a natural behavior, exploration of a novel environment, causes DNA double-strand breaks (DSBs) in neurons of young adult wild-type mice. DSBs occurred in multiple brain regions, were most abundant in the dentate gyrus, which is involved in learning and memory, and were repaired within 24 h. Increasing neuronal activity by sensory or optogenetic stimulation increased neuronal DSBs in relevant but not irrelevant networks. Mice transgenic for human amyloid precursor protein (hAPP), which simulate key aspects of Alzheimer's disease, had increased neuronal DSBs at baseline and more severe and prolonged DSBs after exploration. Interventions that suppress aberrant neuronal activity and improve learning and memory in hAPP mice normalized their levels of DSBs. Blocking extrasynaptic NMDA-type glutamate receptors prevented amyloid-beta (A beta)-induced DSBs in neuronal cultures. Thus, transient increases in neuronal DSBs occur as a result of physiological brain activity, and A beta exacerbates DNA damage, most likely by eliciting synaptic dysfunction.	[Suberbielle, Elsa; Sanchez, Pascal E.; Kravitz, Alexxai V.; Wang, Xin; Ho, Kaitlyn; Devidze, Nino; Kreitzer, Anatol C.; Mucke, Lennart] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Suberbielle, Elsa; Sanchez, Pascal E.; Kravitz, Alexxai V.; Kreitzer, Anatol C.; Mucke, Lennart] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Eilertson, Kirsten] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Mucke, L (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA USA.	lmucke@gladstone.ucsf.edu	Suberbielle, Elsa/K-5416-2014	Suberbielle, Elsa/0000-0002-4554-471X; Eilertson, Kirsten/0000-0003-4850-1210; Kravitz, Alexxai/0000-0001-5983-0218	US National Institutes of Health [AG011385, AG022074, NS065780]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS065780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011385, R37AG011385, P01AG022074] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D.J. Selkoe (Harvard Medical School) and D.M. Walsh (Conway Institute and University College Dublin) for CHO-7PA2 cells; N. Sakane, E. Verdin and L. Verret for comments on the manuscript; H. Kassler for advice on gamma-irradiation; D. Davalos for advice on confocal imaging; D. Pathak for advice on live cell imaging; H. Solanoy, M. Thwin, C. Wang and G.-Q. Yu for technical support; A.L. Lucido for editorial review; J. Carroll, T. Roberts, G. Maki and C. Goodfellow for preparation of graphics; and M. Dela Cruz for administrative assistance. The study was supported by US National Institutes of Health grants AG011385, AG022074 and NS065780 to L.M. and a gift from the S.D. Bechtel, Jr. Foundation.	Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Bhogal N, 2009, INT J RADIAT BIOL, V85, P732, DOI 10.1080/09553000902785791; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brasnjevic I, 2008, DNA REPAIR, V7, P1087, DOI 10.1016/j.dnarep.2008.03.010; Canugovi C, 2012, P NATL ACAD SCI USA, V109, P14948, DOI 10.1073/pnas.1204156109; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Cheng JS, 2009, NAT NEUROSCI, V12, P119, DOI 10.1038/nn.2240; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Crowe SL, 2006, EUR J NEUROSCI, V23, P2351, DOI 10.1111/j.1460-9568.2006.04768.x; Crowe SL, 2011, J NEUROSCI, V31, P7648, DOI 10.1523/JNEUROSCI.0092-11.2011; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Esposito L, 2006, J NEUROSCI, V26, P5167, DOI 10.1523/JNEUROSCI.0482-06.2006; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Fernando RN, 2011, P NATL ACAD SCI USA, V108, P5837, DOI 10.1073/pnas.1014993108; Fillingham J, 2006, BIOCHEM CELL BIOL, V84, P568, DOI 10.1139/O06-072; Flint MS, 2007, PSYCHONEUROENDOCRINO, V32, P470, DOI 10.1016/j.psyneuen.2007.02.013; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Grudzenski S, 2010, P NATL ACAD SCI USA, V107, P14205, DOI 10.1073/pnas.1002213107; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Ismail IH, 2008, ENVIRON MOL MUTAGEN, V49, P73, DOI 10.1002/em.20358; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kobayashi DT, 2005, GENES BRAIN BEHAV, V4, P173, DOI 10.1111/j.1601-183X.2005.00124.x; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lange J, 2011, NATURE, V479, P237, DOI 10.1038/nature10508; Lee HG, 2009, NEUROCHEM INT, V54, P84, DOI 10.1016/j.neuint.2008.10.013; Lee SY, 2010, J BIOL CHEM, V285, P29525, DOI 10.1074/jbc.M110.127233; Li Luming, 2011, Int J Alzheimers Dis, V2011, P171464, DOI 10.4061/2011/171464; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Marchetti C, 2011, REV NEUROSCIENCE, V22, P373, DOI 10.1515/RNS.2011.035; Morelra PI, 2008, FREE RADICAL BIO MED, V44, P1493, DOI 10.1016/j.freeradbiomed.2008.01.002; Morris M, 2013, NEUROBIOL AGING, V34, P1523, DOI 10.1016/j.neurobiolaging.2012.12.003; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Pinheiro J., 2010, NLME LINEAR NONLINEA, DOI DOI 10.1371/J0URNAL.P0NE.0018860; Pong K, 2001, EXP NEUROL, V171, P84, DOI 10.1006/exnr.2001.7747; Roberson E.D., 2007, NAT REV NEUROSCI, V316, P750; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Rong YQ, 1999, P NATL ACAD SCI USA, V96, P9897, DOI 10.1073/pnas.96.17.9897; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609; Spink AJ, 2001, PHYSIOL BEHAV, V73, P731, DOI 10.1016/S0031-9384(01)00530-3; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Yang JL, 2010, J BIOL CHEM, V285, P28191, DOI 10.1074/jbc.M109.082883; Yin B, 2009, J EXP MED, V206, P2625, DOI 10.1084/jem.20091320; Zhang Y, 2000, J NEUROSCI, V20, P8384, DOI 10.1523/JNEUROSCI.20-22-08384.2000	55	293	307	2	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					613	+		10.1038/nn.3356	http://dx.doi.org/10.1038/nn.3356			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23525040	Green Submitted, Green Accepted			2022-12-17	WOS:000318029300018
J	Greka, A; Navarro, B; Oancea, E; Duggan, A; Clapham, DE				Greka, A; Navarro, B; Oancea, E; Duggan, A; Clapham, DE			TRPC5 is a regulator of hippocampal neurite length and growth cone morphology	NATURE NEUROSCIENCE			English	Article							CALCIUM TRANSIENTS; CATION CHANNEL; FUNCTIONAL-CHARACTERIZATION; NEURONAL DIFFERENTIATION; SYNAPTIC VESICLE; STATHMIN FAMILY; NERVOUS-SYSTEM; PROTEIN; CORTACTIN; RECEPTOR	Growth cone motility is regulated by both fast voltage-dependent Ca2+ channels and by unknown receptor-operated Ca2+ entry mechanisms. Transient receptor potential (TRP) homomeric TRPC5 ion channels are receptor-operated, Ca2+-permeable channels predominantly expressed in the brain. Here we show that TRPC5 is expressed in growth cones of young rat hippocampal neurons. Our results indicate that TRPC5 channel subunits interact with the growth cone-enriched protein stathmin 2, are packaged into vesicles and are carried to newly forming growth cones and synapses. Once in the growth cone, TRPC5 channels regulate neurite extension and growth-cone morphology. Dominant-negative TRPC5 expression allowed significantly longer neurites and filopodia to form. We conclude that TRPC5 channels are important components of the mechanism controlling neurite extension and growth cone morphology.	Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard MIT Div Hlth Sci & Technol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Clapham, DE (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Enders 1309,320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/R-5974-2019; Clapham, David/S-1123-2019	Clapham, David/0000-0002-4459-9428				Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Antonsson B, 1997, PROTEIN EXPRES PURIF, V9, P363, DOI 10.1006/prep.1996.0710; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BIXBY JL, 1984, DEV BIOL, V106, P89, DOI 10.1016/0012-1606(84)90065-4; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Du YR, 1998, MOL CELL BIOL, V18, P5838, DOI 10.1128/MCB.18.10.5838; Gavet O, 1998, J CELL SCI, V111, P3333; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kuhn TB, 1998, J NEUROBIOL, V37, P524, DOI 10.1002/(SICI)1097-4695(199812)37:4<524::AID-NEU3>3.0.CO;2-H; Lorenz E, 1998, MOL CELL BIOL, V18, P1652, DOI 10.1128/MCB.18.3.1652; Lutjens R, 2000, EUR J NEUROSCI, V12, P2224, DOI 10.1046/j.1460-9568.2000.00112.x; Martin TFJ, 2002, NEURON, V34, P9, DOI 10.1016/S0896-6273(02)00651-7; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Ozon S, 1998, J NEUROCHEM, V70, P2386; Ozon S, 1997, EUR J BIOCHEM, V248, P794, DOI 10.1111/j.1432-1033.1997.t01-2-00794.x; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Spitzer NC, 2000, BIOESSAYS, V22, P811; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Weed SA, 1998, J CELL SCI, V111, P2433	42	293	308	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					837	845		10.1038/nn1092	http://dx.doi.org/10.1038/nn1092			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12858178				2022-12-17	WOS:000184413700013
J	Lin, X; Antalffy, B; Kang, D; Orr, HT; Zoghbi, HY				Lin, X; Antalffy, B; Kang, D; Orr, HT; Zoghbi, HY			Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1	NATURE NEUROSCIENCE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CEREBELLAR PURKINJE-CELLS; ENDOPLASMIC-RETICULUM; MESSENGER-RNA; TRANSGENIC MICE; POLYPHOSPHATE 5-PHOSPHATASES; CARBOXYL METHYLTRANSFERASE; GLUTAMATE TRANSPORTER; INSITU HYBRIDIZATION; MOUSE-BRAIN	The expansion of an unstable CAG repeat causes spinocerebellar ataxia type 1 (SCA1) and several other neurodegenerative diseases. How polyglutamine expansions render the resulting proteins toxic to neurons, however, remains elusive. Hypothesizing that long polyglutamine tracts alter gene expression, we found certain neuronal genes involved in signal transduction and calcium homeostasis sequentially downregulated in SCA1 mice. These genes were abundant in Purkinje cells, the primary site of SCA1 pathogenesis; moreover, their downregulation was mediated by expanded ataxin-1 and occured before detectable pathology. Similar downregulation occurred in SCA1 human tissues. Altered gene expression may be the earliest mediator of polyglutamine toxicity.	Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Univ Minnesota, Inst Human Genet, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities	Zoghbi, HY (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, 1 Baylor Plaza, Houston, TX 77030 USA.			Orr, Harry/0000-0001-6118-741X; Zoghbi, Huda/0000-0002-0700-3349	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022920, R37NS027699, R01NS027699, R37NS022920] Funding Source: NIH RePORTER; NINDS NIH HHS [NS27699, NS22920] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; AKAABOUNE M, 1994, J NEUROBIOL, V25, P503, DOI 10.1002/neu.480250505; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Birnbaumer L, 1996, P NATL ACAD SCI USA, V93, P15195, DOI 10.1073/pnas.93.26.15195; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Clark HB, 1997, J NEUROSCI, V17, P7385; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; DAS S, 1995, NEURON, V14, P447, DOI 10.1016/0896-6273(95)90300-3; DESMEDT F, 1994, FEBS LETT, V347, P69, DOI 10.1016/0014-5793(94)00509-5; Doucas V, 1999, P NATL ACAD SCI USA, V96, P2627, DOI 10.1073/pnas.96.6.2627; Drayer AL, 1996, BIOCHEM SOC T, V24, P1001, DOI 10.1042/bst0241001; HRYCYNA CA, 1993, PHARMACOL THERAPEUT, V59, P281, DOI 10.1016/0163-7258(93)90071-K; Imai Y, 1997, MOL CELL BIOL, V17, P1543, DOI 10.1128/MCB.17.3.1543; INGLIS JD, 1991, GENE, V106, P213, DOI 10.1016/0378-1119(91)90201-L; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; KOO EH, 1991, NEUROBIOL AGING, V12, P495, DOI 10.1016/0197-4580(91)90079-Y; Kotera J, 1997, EUR J BIOCHEM, V249, P434, DOI 10.1111/j.1432-1033.1997.t01-1-00434.x; Liu BF, 1996, J BIOL CHEM, V271, P5536, DOI 10.1074/jbc.271.10.5536; MAILLEUX P, 1992, NEUROSCIENCE, V49, P577, DOI 10.1016/0306-4522(92)90228-T; Masuyama H, 1998, J CELL BIOCHEM, V71, P429, DOI 10.1002/(SICI)1097-4644(19981201)71:3<429::AID-JCB11>3.0.CO;2-P; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; MILLER KK, 1991, NEUROSCIENCE, V43, P1, DOI 10.1016/0306-4522(91)90410-P; Mitchell CA, 1996, BIOCHEM SOC T, V24, P994, DOI 10.1042/bst0240994; Mori Y, 1998, NEUROREPORT, V9, P507; NAKANISHI S, 1991, J NEUROSCI, V11, P2075; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Rando RR, 1996, BBA-LIPID LIPID MET, V1300, P5, DOI 10.1016/0005-2760(95)00233-2; ROSS CA, 1992, P NATL ACAD SCI USA, V89, P4265, DOI 10.1073/pnas.89.10.4265; ROUSTAN P, 1995, NEUROREPORT, V6, P1837, DOI 10.1097/00001756-199510020-00004; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Street VA, 1997, J NEUROSCI, V17, P635; TAKEI K, 1992, J NEUROSCI, V12, P489; Tanaka J, 1997, NEUROREPORT, V8, P2461, DOI 10.1097/00001756-199707280-00010; Verkhratsky A, 1998, TRENDS NEUROSCI, V21, P2, DOI 10.1016/S0166-2236(97)01156-9; VILLA A, 1992, NEUROSCIENCE, V49, P467, DOI 10.1016/0306-4522(92)90111-E; VOLPE P, 1993, COMP BIOCHEM PHYS A, V105, P205, DOI 10.1016/0300-9629(93)90196-B; Woscholski R, 1997, TRENDS BIOCHEM SCI, V22, P427, DOI 10.1016/S0968-0004(97)01120-1; Yamada K, 1996, NEUROREPORT, V7, P2013, DOI 10.1097/00001756-199608120-00032; Zhang JS, 1998, GENE DEV, V12, P1775, DOI 10.1101/gad.12.12.1775; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7; ZOGHBI HY, 1995, SEMIN CELL BIOL, V6, P29, DOI 10.1016/1043-4682(95)90012-8	47	293	301	2	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2000	3	2					157	163		10.1038/72101	http://dx.doi.org/10.1038/72101			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TC	10649571				2022-12-17	WOS:000085810300013
J	Xu, HT; Pan, F; Yang, G; Gan, WB				Xu, Hua-Tai; Pan, Feng; Yang, Guang; Gan, Wen-Biao			Choice of cranial window type for in vivo imaging affects dendritic spine turnover in the cortex	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; ADULT CORTEX; BRAIN; STABILITY; NEOCORTEX		NYU, Sch Med, Dept Physiol & Neurosci, Mol Neurobiol Program,Skirball Inst, New York, NY 10016 USA	New York University	Gan, WB (corresponding author), NYU, Sch Med, Dept Physiol & Neurosci, Mol Neurobiol Program,Skirball Inst, 540 1st Ave, New York, NY 10016 USA.	gan@saturn.med.nyu.edu		Yang, Guang/0000-0002-5739-9126				Allen NJ, 2005, CURR OPIN NEUROBIOL, V15, P542, DOI 10.1016/j.conb.2005.08.006; Bruce-Keller AJ, 1999, J NEUROSCI RES, V58, P191, DOI 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO;2-E; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Meyer MP, 2003, CURR BIOL, V13, pR180, DOI 10.1016/S0960-9822(03)00118-0; NAVARI RM, 1978, MICROVASC RES, V16, P304, DOI 10.1016/0026-2862(78)90064-X; Ottersen OP, 2002, NATURE, V420, P751, DOI 10.1038/420751a; Plock N, 2005, EUR J PHARM SCI, V25, P1, DOI 10.1016/j.ejps.2005.01.017; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Super H, 2005, PROG BRAIN RES, V147, P263, DOI 10.1016/S0079-6123(04)47020-4; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	15	292	300	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					549	551		10.1038/nn1883	http://dx.doi.org/10.1038/nn1883			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17417634				2022-12-17	WOS:000245948000009
J	Morrone, MC; Ross, J; Burr, D				Morrone, MC; Ross, J; Burr, D			Saccadic eye movements cause compression of time as well as space	NATURE NEUROSCIENCE			English	Article							VISUAL-PERCEPTION; VOLUNTARY ACTION; PARIETAL CORTEX; REPRESENTATION; ATTENTION; DURATION; LOCALIZATION; SUPPRESSION; INTEGRATION; AWARENESS	There is now considerable evidence that space is compressed when stimuli are flashed shortly before or after the onset of a saccadic eye movement. Here we report that short intervals of time between two successive perisaccadic visual (but not auditory) stimuli are also underestimated, indicating a compression of perceived time. We were even more surprised that in a critical interval before saccades, perceived temporal order is consistently reversed. The very similar time courses of spatial and temporal compression suggest that both are mediated by a common neural mechanism, probably related to the predictive shifts that occur in receptive fields of many visual areas at the time of saccades.	CNR, Ist Neurosci, I-56100 Pisa, Italy; Univ Vita Salute San Raffaele, Fac Psicol, I-20132 Milan, Italy; Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia; Univ Florence, Dipartimento Psicol, Florence, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Vita-Salute San Raffaele University; University of Western Australia; University of Florence	Burr, D (corresponding author), CNR, Ist Neurosci, Via Moruzzi 1, I-56100 Pisa, Italy.	dave@in.cnr.it	Morrone, Maria Concetta/C-6756-2014	Morrone, Maria Concetta/0000-0002-1025-0316; Burr, David/0000-0003-1541-8832				BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; Burr DC, 1996, VISION RES, V36, P2069, DOI 10.1016/0042-6989(95)00282-0; Carpenter R. H. S., 1988, MOVEMENT EYES; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; Enns JT, 1999, J GEN PSYCHOL, V126, P355, DOI 10.1080/00221309909595371; Gersch TM, 2004, VISION RES, V44, P1469, DOI 10.1016/j.visres.2003.12.014; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Henderson JM, 2003, PSYCHOL SCI, V14, P493, DOI 10.1111/1467-9280.02459; Hodinott-Hill I, 2002, CURR BIOL, V12, P1779, DOI 10.1016/S0960-9822(02)01219-8; HONDA H, 1989, PERCEPT PSYCHOPHYS, V45, P162, DOI 10.3758/BF03208051; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Kaiser M, 2004, NEURON, V41, P293, DOI 10.1016/S0896-6273(03)00849-3; Kusunoki M, 2003, J NEUROPHYSIOL, V89, P1519, DOI 10.1152/jn.00519.2002; Lappe M, 2000, NATURE, V403, P892, DOI 10.1038/35002588; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; LIBET B, 1979, BRAIN, V102, P193, DOI 10.1093/brain/102.1.193; MATIN L, 1972, HDB SENSORY PHYSIOLO, V7, P331; MCCONKIE GW, 1979, PERCEPT PSYCHOPHYS, V25, P221, DOI 10.3758/BF03202990; Morrone MC, 1997, J NEUROSCI, V17, P7941; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Niemeier M, 2003, NATURE, V422, P76, DOI 10.1038/nature01439; Park J, 2003, VISION RES, V43, P1667, DOI 10.1016/S0042-6989(03)00217-7; Park J, 2003, EXP BRAIN RES, V149, P527, DOI 10.1007/s00221-003-1376-x; REEVES A, 1986, PSYCHOL REV, V93, P180, DOI 10.1037/0033-295X.93.2.180; RIDDER WH, 1993, VISION RES, V33, P1795, DOI 10.1016/0042-6989(93)90170-2; ROSE D, 1995, PERCEPTION, V24, P1177, DOI 10.1068/p241177; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; ROSS J, 1972, 4 U W AUSTR DEP PSYC; Santoro L, 2002, VISION RES, V42, P1361, DOI 10.1016/S0042-6989(02)00056-1; Shore DI, 2001, PSYCHOL SCI, V12, P205, DOI 10.1111/1467-9280.00337; SPERLING G, 1995, PSYCHOL REV, V102, P503, DOI 10.1037/0033-295X.102.3.503; STEVENSON SB, 1986, VISION RES, V26, P1815, DOI 10.1016/0042-6989(86)90133-1; Titchener E. B., 1908, LECT ELEMENTARY PSYC, DOI 10.1037/10867-000; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; Yarrow K, 2003, CURR BIOL, V13, P1134, DOI 10.1016/S0960-9822(03)00413-5; Yarrow K, 2001, NATURE, V414, P302, DOI 10.1038/35104551	40	292	296	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					950	954		10.1038/nn1488	http://dx.doi.org/10.1038/nn1488			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15965472				2022-12-17	WOS:000230137100023
J	Whelan, R; Conrod, PJ; Poline, JB; Lourdusamy, A; Banaschewski, T; Barker, GJ; Bellgrove, MA; Buchel, C; Byrne, M; Cummins, TDR; Fauth-Buhler, M; Flor, H; Gallinat, J; Heinz, A; Ittermann, B; Mann, K; Martinot, JL; Lalor, EC; Lathrop, M; Loth, E; Nees, F; Paus, T; Rietschel, M; Smolka, MN; Spanagel, R; Stephens, DN; Struve, M; Thyreau, B; Vollstaedt-Klein, S; Robbins, TW; Schumann, G; Garavan, H				Whelan, Robert; Conrod, Patricia J.; Poline, Jean-Baptiste; Lourdusamy, Anbarasu; Banaschewski, Tobias; Barker, Gareth J.; Bellgrove, Mark A.; Buechel, Christian; Byrne, Mark; Cummins, Tarrant D. R.; Fauth-Buehler, Mira; Flor, Herta; Gallinat, Juergen; Heinz, Andreas; Ittermann, Bernd; Mann, Karl; Martinot, Jean-Luc; Lalor, Edmund C.; Lathrop, Mark; Loth, Eva; Nees, Frauke; Paus, Tomas; Rietschel, Marcella; Smolka, Michael N.; Spanagel, Rainer; Stephens, David N.; Struve, Maren; Thyreau, Benjamin; Vollstaedt-Klein, Sabine; Robbins, Trevor W.; Schumann, Gunter; Garavan, Hugh		IMAGEN Consortium	Adolescent impulsivity phenotypes characterized by distinct brain networks	NATURE NEUROSCIENCE			English	Article							RESPONSE-INHIBITION; INDIVIDUAL-DIFFERENCES; ORBITOFRONTAL CORTEX; DRUG-ADDICTION; ACTIVATION; ATOMOXETINE; CHILDHOOD; DISORDER; BEHAVIOR; AGE	The impulsive behavior that is often characteristic of adolescence may reflect underlying neurodevelopmental processes. Moreover, impulsivity is a multi-dimensional construct, and it is plausible that distinct brain networks contribute to its different cognitive, clinical and behavioral aspects. As these networks have not yet been described, we identified distinct cortical and subcortical networks underlying successful inhibitions and inhibition failures in a large sample (n = 1,896) of 14-year-old adolescents. Different networks were associated with drug use (n = 1,593) and attention-deficit hyperactivity disorder symptoms (n = 342). Hypofunctioning of a specific orbitofrontal cortical network was associated with likelihood of initiating drug use in early adolescence. Right inferior frontal activity was related to the speed of the inhibition process (n = 826) and use of illegal substances and associated with genetic variation in a norepinephrine transporter gene (n = 819). Our results indicate that both neural endophenotypes and genetic variation give rise to the various manifestations of impulsive behavior.	[Whelan, Robert; Garavan, Hugh] Univ Vermont, Dept Psychiat & Psychol, Burlington, VT 05405 USA; [Whelan, Robert; Byrne, Mark; Lalor, Edmund C.; Garavan, Hugh] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [Conrod, Patricia J.; Lourdusamy, Anbarasu; Barker, Gareth J.; Loth, Eva; Schumann, Gunter] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Conrod, Patricia J.] Univ Montreal, Dept Psychiat, CHU Ste Justine Hosp, Montreal, PQ H3C 3J7, Canada; [Poline, Jean-Baptiste; Thyreau, Benjamin] Neurospin, Commissariat Energie Atom, Gif Sur Yvette, France; [Cummins, Tarrant D. R.] Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, D-6800 Mannheim, Germany; [Bellgrove, Mark A.; Cummins, Tarrant D. R.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Bellgrove, Mark A.; Cummins, Tarrant D. R.] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia; [Buechel, Christian] Univ klinikum Hamburg Eppendorf, Hamburg, Germany; [Fauth-Buehler, Mira; Mann, Karl; Vollstaedt-Klein, Sabine] Cent Inst Mental Hlth, Dept Addict Behav & Addict Med, D-6800 Mannheim, Germany; [Flor, Herta; Nees, Frauke; Struve, Maren] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Cognit & Clin Neurosci, D-6800 Mannheim, Germany; [Gallinat, Juergen; Heinz, Andreas] Charite, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Ittermann, Bernd] Physikalisch Tech Bundesanstalt, Berlin, Germany; [Martinot, Jean-Luc] Univ Paris Sud, INSERM CEA Unit Imaging & Psychiat 1000, Inst Natl Sante & Rech Med, Orsay, France; [Martinot, Jean-Luc] Univ Paris 05, Assistance Publ Hop Paris, Dept Adolescent Psychopathol & Med, Paris, France; [Lathrop, Mark] Ctr Natl Genptypage, Evry, France; [Loth, Eva; Schumann, Gunter] MRC Social, Genet & Dev Psychiat Ctr, London, England; [Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON, Canada; [Paus, Tomas] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; [Paus, Tomas] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Rietschel, Marcella] Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, D-6800 Mannheim, Germany; [Smolka, Michael N.] Tech Univ, Dept Psychiat & Psychotherapy, Dresden, Germany; [Smolka, Michael N.] Tech Univ, Dept Psychol, Neuroimaging Ctr, Dresden, Germany; [Spanagel, Rainer] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Inst Psychopharmacol, D-6800 Mannheim, Germany; [Stephens, David N.] Univ Sussex, Dept Psychol, Brighton BN1 9RH, E Sussex, England; [Robbins, Trevor W.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [Robbins, Trevor W.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England; [IMAGEN Consortium] Kings Coll London, Inst Psychiat, London WC2R 2LS, England	University of Vermont; Trinity College Dublin; University of London; King's College London; Universite de Montreal; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Central Institute of Mental Health; University of Queensland; University of Queensland; University of Hamburg; University Medical Center Hamburg-Eppendorf; Central Institute of Mental Health; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Physikalisch-Technische Bundesanstalt (PTB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; University of London; King's College London; University of Toronto; University Toronto Affiliates; Baycrest; University of Nottingham; McGill University; Central Institute of Mental Health; Technische Universitat Dresden; Technische Universitat Dresden; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Sussex; University of Cambridge; University of Cambridge; University of London; King's College London	Whelan, R (corresponding author), Univ Vermont, Dept Psychiat & Psychol, Burlington, VT 05405 USA.	robert.whelan@uvm.edu; hugh.garavan@uvm.edu	Heinz, Andreas/ABB-7736-2020; Bellgrove, Mark/AAB-3114-2019; Lourdusamy, Anbarasu/G-3387-2011; Robbins, Trevor W/A-7551-2008; Barker, Gareth J/C-9616-2009; Whelan, Robert/E-5365-2010; Lourdusamy, Anbarasu/P-6606-2014; Conrod, Patricia J/P-4187-2018; Martinot, Jean-Luc/N-3704-2018; Nees, Frauke/AAZ-2150-2020; Schumann, Gunter/H-1013-2013; Vollstädt-Klein, Sabine/C-6744-2012; Stephens, David/G-2384-2012; Smolka, Michael/B-4865-2011; Banaschewski, Tobias/ABE-5985-2020; Cummins, Tarrant/I-3086-2014	Heinz, Andreas/0000-0001-5405-9065; Barker, Gareth J/0000-0002-5214-7421; Whelan, Robert/0000-0002-2790-7281; Vollstädt-Klein, Sabine/0000-0002-6210-672X; Smolka, Michael/0000-0001-5398-5569; Banaschewski, Tobias/0000-0003-4595-1144; Nees, Frauke/0000-0002-7796-8234; Robbins, Trevor/0000-0003-0642-5977; Bellgrove, Mark/0000-0003-0186-8349; Loth, Eva/0000-0001-9458-9167; Cummins, Tarrant/0000-0003-2324-3366; Flor, Herta/0000-0003-4809-5398; Lourdusamy, Anbarasu/0000-0002-1978-6301; Lalor, Edmund/0000-0002-2498-6631	European Community [LSHM-CT-2007-037286]; FP7 projects ADAMS [242257]; Innovative Medicine Initiative Project EU-AIMS [115300-2]; UK National Institute for Health Research Biomedical Research Centre Mental Health; Medical Research Council [93558]; Medical Research Council [G1000183B, G0901858, G0400568, G9817803B, G0001354, G0001354B] Funding Source: researchfish; MRC [G0400568, G0901858] Funding Source: UKRI	European Community(European Commission); FP7 projects ADAMS; Innovative Medicine Initiative Project EU-AIMS; UK National Institute for Health Research Biomedical Research Centre Mental Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The IMAGEN study receives research funding from the European Community's Sixth Framework Programme (LSHM-CT-2007-037286). Further support was provided by the FP7 projects ADAMS (genomic variations underlying common neuropsychiatric diseases and disease-related cognitive traits in different human populations; 242257) and the Innovative Medicine Initiative Project EU-AIMS (115300-2), as well as the UK National Institute for Health Research Biomedical Research Centre Mental Health and the Medical Research Council Programme Grant 'Developmental pathways into adolescent substance abuse' (93558).	Albrecht B, 2008, BIOL PSYCHIAT, V64, P615, DOI 10.1016/j.biopsych.2007.12.016; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Bellgrove MA, 2004, NEUROPSYCHOLOGIA, V42, P1910, DOI 10.1016/j.neuropsychologia.2004.05.007; Bevilacqua L, 2010, NATURE, V468, P1061, DOI 10.1038/nature09629; Braet W, 2009, NEUROPSYCHOLOGIA, V47, P3143, DOI 10.1016/j.neuropsychologia.2009.07.018; Chamberlain SR, 2009, BIOL PSYCHIAT, V65, P550, DOI 10.1016/j.biopsych.2008.10.014; Chamberlain SR, 2006, SCIENCE, V311, P861, DOI 10.1126/science.1121218; CHURCHILL GA, 1994, GENETICS, V138, P963; Congdon E, 2010, NEUROIMAGE, V53, P653, DOI 10.1016/j.neuroimage.2010.06.062; Crombag HS, 2005, CEREB CORTEX, V15, P341, DOI 10.1093/cercor/bhh136; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Ersche KD, 2012, SCIENCE, V335, P601, DOI 10.1126/science.1214463; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Goodman A, 2011, SOC PSYCH PSYCH EPID, V46, P521, DOI 10.1007/s00127-010-0219-x; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Goudriaan AE, 2006, ADDICTION, V101, P534, DOI 10.1111/j.1360-0443.2006.01380.x; Hibell B, 1997, 1995 ESPAD REPORT AL; Ivanov I, 2008, AM J DRUG ALCOHOL AB, V34, P239, DOI 10.1080/00952990802013334; Johnston LD, 2009, NIH PUBLICATION, VII; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Konrad K, 2010, HUM BRAIN MAPP, V31, P904, DOI 10.1002/hbm.21058; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lee SS, 2011, CLIN PSYCHOL REV, V31, P328, DOI 10.1016/j.cpr.2011.01.006; Li CSR, 2007, NEUROIMAGE, V38, P640, DOI 10.1016/j.neuroimage.2007.07.021; Li CSR, 2006, J NEUROSCI, V26, P186, DOI 10.1523/JNEUROSCI.3741-05.2006; Logan Gordon D., 1994, P189; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Monti PM, 2005, ALCOHOL CLIN EXP RES, V29, P207, DOI 10.1097/01.ALC.0000153551.11000.F3; O'Shea M, 2004, J PSYCHOPHARMACOL, V18, P502, DOI 10.1177/0269881104047277; Osborne JW., 2009, PRACT ASSESS RES EVA, V10, P1, DOI DOI 10.7275/JYJ1-4868; Overbey GA, 2011, J ATTEN DISORD, V15, P67, DOI 10.1177/1087054709347257; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Peters J, 2011, AM J PSYCHIAT, V168, P540, DOI 10.1176/appi.ajp.2010.10071024; Ramoz N, 2009, NEUROPSYCHOPHARMACOL, V34, P2135, DOI 10.1038/npp.2009.39; Robinson TE, 2001, SYNAPSE, V39, P257; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rubia K, 2005, AM J PSYCHIAT, V162, P1067, DOI 10.1176/appi.ajp.162.6.1067; Scangos KW, 2010, J NEUROSCI, V30, P1968, DOI 10.1523/JNEUROSCI.4509-09.2010; Schoenbaum G, 2008, BIOL PSYCHIAT, V63, P256, DOI 10.1016/j.biopsych.2007.06.003; Schumann G, 2010, MOL PSYCHIATR, V15, P1128, DOI 10.1038/mp.2010.4; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Tapert SF, 1999, J INT NEUROPSYCH SOC, V5, P481, DOI 10.1017/S1355617799566010; Tarter RE, 2003, AM J PSYCHIAT, V160, P1078, DOI 10.1176/appi.ajp.160.6.1078; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Zhang S, 2012, HUM BRAIN MAPP, V33, P89, DOI 10.1002/hbm.21197	55	291	293	1	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					920	U153		10.1038/nn.3092	http://dx.doi.org/10.1038/nn.3092			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22544311				2022-12-17	WOS:000304546700021
J	Freiwald, WA; Tsao, DY; Livingstone, MS				Freiwald, Winrich A.; Tsao, Doris Y.; Livingstone, Margaret S.			A face feature space in the macaque temporal lobe	NATURE NEUROSCIENCE			English	Article							MONKEY INFEROTEMPORAL CORTEX; SINGLE NEURONS; SCHEMATIC FACES; VISUAL-CORTEX; RECOGNITION; SELECTIVITY; PERCEPTION; RESPONSES; OBJECTS; IMAGES	The ability of primates to effortlessly recognize faces has been attributed to the existence of specialized face areas. One such area, the macaque middle face patch, consists almost entirely of cells that are selective for faces, but the principles by which these cells analyze faces are unknown. We found that middle face patch neurons detect and differentiate faces using a strategy that is both part based and holistic. Cells detected distinct constellations of face parts. Furthermore, cells were tuned to the geometry of facial features. Tuning was most often ramp-shaped, with a one-to-one mapping of feature magnitude to firing rate. Tuning amplitude depended on the presence of a whole, upright face and features were interpreted according to their position in a whole, upright face. Thus, cells in the middle face patch encode axes of a face space specialized for whole, upright faces.	[Freiwald, Winrich A.; Tsao, Doris Y.; Livingstone, Margaret S.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Freiwald, Winrich A.; Tsao, Doris Y.] Univ Bremen, Ctr Adv Imaging & Cognit Sci, Bremen, Germany; [Freiwald, Winrich A.; Tsao, Doris Y.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Freiwald, Winrich A.] Rockefeller Univ, New York, NY 10021 USA; [Tsao, Doris Y.] Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA	Harvard University; Harvard Medical School; University of Bremen; California Institute of Technology; Rockefeller University	Freiwald, WA (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	winrich.freiwald@googlemail.com		Livingstone, Margaret/0000-0002-1950-0123	US National Institutes of Health [EY16187]; German Science Foundation [FR 1437/3-1]; Alexander von Humboldt Foundation; NATIONAL EYE INSTITUTE [R01EY016187] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Science Foundation(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to the late D. Freeman and N. Nallasamy for stimulus programming; R. Tootell, W. Vanduffel and members of the Massachusetts General Hospital monkey fMRI group for assistance with scanning; A. Dale and A. van der Kouwe for allowing us to use their multi-echo sequence and undistortion algorithm; T. Chuprina and N. Schweers for animal care and Guerbet for providing Sinerem contrast agent. This work was sponsored by US National Institutes of Health grant EY16187 and German Science Foundation grant FR 1437/3-1. D.Y.T. was supported by a Sofja Kovalevskaja Award from the Alexander von Humboldt Foundation.	ANDERSEN RA, 1990, J NEUROSCI, V10, P1176; BARTLETT JC, 1993, COGNITIVE PSYCHOL, V25, P281, DOI 10.1006/cogp.1993.1007; BAYLIS GC, 1985, BRAIN RES, V342, P91, DOI 10.1016/0006-8993(85)91356-3; BENSON P J, 1991, European Journal of Cognitive Psychology, V3, P105, DOI 10.1080/09541449108406222; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Brincat SL, 2004, NAT NEUROSCI, V7, P880, DOI 10.1038/nn1278; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Brunswik E, 1937, Z PSYCHOL PHYSIOL SI, V142, P67; Cox D, 2004, SCIENCE, V304, P115, DOI 10.1126/science.1093110; De Baene W, 2007, J NEUROPHYSIOL, V97, P2900, DOI 10.1152/jn.00741.2006; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Eurich CW, 2000, NEURAL COMPUT, V12, P1519, DOI 10.1162/089976600300015240; Fabre-Thorpe M, 1998, NEUROREPORT, V9, P303, DOI 10.1097/00001756-199801260-00023; FRASER IH, 1990, PERCEPTION, V19, P661, DOI 10.1068/p190661; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; Galton F., 1878, J ANTHR I GREAT BRIT, V18, P97, DOI 10.2307/2841021; Grunewald A, 2004, J NEUROSCI, V24, P9185, DOI 10.1523/JNEUROSCI.1884-04.2004; Guigon E, 2003, NEURAL COMPUT, V15, P2115, DOI 10.1162/089976603322297313; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kayaert G, 2005, EUR J NEUROSCI, V22, P212, DOI 10.1111/j.1460-9568.2005.04202.x; Keysers C, 2001, J COGNITIVE NEUROSCI, V13, P90, DOI 10.1162/089892901564199; Koida K, 2007, NAT NEUROSCI, V10, P108, DOI 10.1038/nn1823; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Leopold DA, 2006, NATURE, V442, P572, DOI 10.1038/nature04951; Liu Y, 2008, J NEUROPHYSIOL, V100, P966, DOI 10.1152/jn.01354.2007; Manly Bryan F.J., 2007, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9780429329203; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; McKone E, 2005, J EXP PSYCHOL HUMAN, V31, P1181, DOI 10.1037/0096-1523.31.6.1181; Mel BW, 2000, NEURAL COMPUT, V12, P247, DOI 10.1162/089976600300015772; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; RHODES G, 1987, COGNITIVE PSYCHOL, V19, P473, DOI 10.1016/0010-0285(87)90016-8; Rhodes G, 1996, SUPERPORTRAITS CARIC; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; THOMPSON P, 1980, PERCEPTION, V9, P483, DOI 10.1068/p090483; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665; Webster MA, 1999, PSYCHON B REV, V6, P647, DOI 10.3758/BF03212974; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747; Zar, 2011, BIOSTAT ANAL; Zhang KC, 1999, NEURAL COMPUT, V11, P75, DOI 10.1162/089976699300016809; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	50	291	293	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1187	U28		10.1038/nn.2363	http://dx.doi.org/10.1038/nn.2363			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	487ZD	19668199	Green Accepted			2022-12-17	WOS:000269317300023
J	He, F; Ge, WH; Martinowich, K; Becker-Catania, S; Coskun, V; Zhu, WY; Wu, H; Castro, D; Guillemot, F; Fan, GP; de Vellis, J; Sun, YE				He, F; Ge, WH; Martinowich, K; Becker-Catania, S; Coskun, V; Zhu, WY; Wu, H; Castro, D; Guillemot, F; Fan, GP; de Vellis, J; Sun, YE			A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; LEUKEMIA INHIBITORY FACTOR; EPIDERMAL-GROWTH-FACTOR; ASTROCYTE DIFFERENTIATION; SERINE PHOSPHORYLATION; NEURONAL DIFFERENTIATION; MAXIMAL ACTIVATION; MAMMALIAN BRAIN; GLIAL IDENTITY	During development of the CNS, neurons and glia are generated in a sequential manner. The mechanism underlying the later onset of gliogenesis is poorly understood, although the cytokine-induced Jak-STAT pathway has been postulated to regulate astrogliogenesis. Here, we report that the overall activity of Jak-STAT signaling is dynamically regulated in mouse cortical germinal zone during development. As such, activated STAT1/3 and STAT-mediated transcription are negligible at early, neurogenic stages, when neurogenic factors are highly expressed. At later, gliogenic periods, decreased expression of neurogenic factors causes robust elevation of STAT activity. Our data demonstrate a positive autoregulatory loop whereby STAT1/3 directly induces the expression of various components of the Jak-STAT pathway to strengthen STAT signaling and trigger astrogliogenesis. Forced activation of Jak-STAT signaling leads to precocious astrogliogenesis, and inhibition of this pathway blocks astrocyte differentiation. These observations suggest that autoregulation of the Jak-STAT pathway controls the onset of astrogliogenesis.	Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Inst Neuropsychiat, Mental Retardat Res Ctr, Los Angeles, CA 90024 USA; Natl Inst Med Res, Div Mol Neurobiol, London NW7 1AA, England	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; MRC National Institute for Medical Research	Sun, YE (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA.	ysun@mednet.ucla.edu	Wu, Hao/G-4145-2013; Martinowich, Keri/F-9841-2012; Castro, Diogo S/I-6217-2016	Wu, Hao/0000-0002-1256-6891; Castro, Diogo S/0000-0001-8178-9565; Martinowich, Keri/0000-0002-5237-0789; Wu, Hao/0000-0003-4395-6929; Fan, Guoping/0000-0001-5235-6410	NICHD NIH HHS [HD006576, P01 HD006576] Funding Source: Medline; NIMH NIH HHS [R01 MH066196] Funding Source: Medline; NINDS NIH HHS [R01 NS044405, NS44405] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD006576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044405] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Barres BA, 2001, SCIENCE, V294, P1296, DOI 10.1126/science.1066724; Bartlett PF, 1998, IMMUNOL CELL BIOL, V76, P414, DOI 10.1046/j.1440-1711.1998.00762.x; Bayer S.A., 1991, NEOCORTICAL DEV; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bugga L, 1998, J NEUROBIOL, V36, P509, DOI 10.1002/(SICI)1097-4695(19980915)36:4<509::AID-NEU5>3.0.CO;2-#; Chambers CB, 2001, DEVELOPMENT, V128, P689; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Ge WH, 2002, J NEUROSCI RES, V69, P848, DOI 10.1002/jnr.10364; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Li WW, 1998, J NEUROSCI, V18, P8853; Mabie PC, 1999, J NEUROSCI, V19, P7077, DOI 10.1523/JNEUROSCI.19-16-07077.1999; Mattar P, 2004, DEV BIOL, V273, P373, DOI 10.1016/j.ydbio.2004.06.013; Molne M, 2000, J NEUROSCI RES, V59, P301, DOI 10.1002/(SICI)1097-4547(20000201)59:3<301::AID-JNR3>3.0.CO;2-H; Morrow T, 2001, DEVELOPMENT, V128, P3585; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; OBrien CA, 1997, J BIOL CHEM, V272, P15003, DOI 10.1074/jbc.272.23.15003; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Sun YE, 2003, SEMIN CELL DEV BIOL, V14, P161, DOI 10.1016/S1084-9521(03)00007-7; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Turnley AM, 2002, NAT NEUROSCI, V5, P1155, DOI 10.1038/nn954; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Viti J, 2003, J NEUROSCI, V23, P3385; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	49	291	300	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					616	625		10.1038/nn1440	http://dx.doi.org/10.1038/nn1440			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15852015	Green Accepted			2022-12-17	WOS:000228895100022
J	Tunik, E; Frey, SH; Grafton, ST				Tunik, E; Frey, SH; Grafton, ST			Virtual lesions of the anterior intraparietal area disrupt goal-dependent on-line adjustments of grasp	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; VISUAL GUIDANCE; HAND ACTION; NEURONS; ACTIVATION; PERTURBATION; MOVEMENTS; OBJECTS; DISCRIMINATION; MANIPULATION	Adaptive motor behavior requires efficient error detection and correction. The posterior parietal cortex is critical for on-line control of reach-to-grasp movements. Here we show a causal relationship between disruption of cortical activity within the anterior intraparietal sulcus (aIPS) by transcranial magnetic stimulation (TMS) and disruption of goal-directed prehensile actions ( either grip size or forearm rotation, depending on the task goal, with reaching preserved in either case). Deficits were elicited by applying TMS within 65 ms after object perturbation, which attributes a rapid control process on the basis of visual feedback to aIPS. No aperture deficits were produced when TMS was applied to a more caudal region within the intraparietal sulcus, to the parietooccipital complex ( putative V6, V6A) or to the hand area of primary motor cortex. We contend that aIPS is critical for dynamic error detection during goal-dependent reach-to-grasp action that is visually guided.	Dartmouth Coll, Dept Psychol & Brain Sci, Ctr Cognit Neurosci, Hanover, NH 03755 USA; Univ Oregon, Dept Psychol 1227, Eugene, OR 97403 USA	Dartmouth College; University of Oregon	Grafton, ST (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Ctr Cognit Neurosci, HB 6162 Moore Hall, Hanover, NH 03755 USA.	scott.t.grafton@dartmouth.edu	Tunik, Eugene/O-8327-2015	Tunik, Eugene/0000-0002-7497-1251	NINDS NIH HHS [NS044393] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044393] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andersen Richard A, 2003, Adv Neurol, V93, P159; Battaglini PP, 2002, EXP BRAIN RES, V144, P419, DOI 10.1007/s00221-002-1099-4; Binkofski F, 1998, NEUROLOGY, V50, P1253, DOI 10.1212/WNL.50.5.1253; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; CASTIELLO U, 1993, EXP BRAIN RES, V94, P163; CLOWER DM, 2004, CEREB CORTEX    0930, DOI DOI 10.1039/CERCOR/BHH190; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; Della-Maggiore V, 2004, J NEUROSCI, V24, P9971, DOI 10.1523/JNEUROSCI.2833-04.2004; Desmurget M, 2004, BRAIN, V127, P1755, DOI 10.1093/brain/awh206; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Foxe JJ, 2002, EXP BRAIN RES, V142, P139, DOI 10.1007/s00221-001-0906-7; GALLESE V, 1994, NEUROREPORT, V5, P1525, DOI 10.1097/00001756-199407000-00029; Galletti C, 2003, EXP BRAIN RES, V153, P158, DOI 10.1007/s00221-003-1589-z; Galletti C, 1997, EUR J NEUROSCI, V9, P410, DOI 10.1111/j.1460-9568.1997.tb01410.x; Glover S, 2005, J COGNITIVE NEUROSCI, V17, P124, DOI 10.1162/0898929052880066; Grea H, 2002, NEUROPSYCHOLOGIA, V40, P2471, DOI 10.1016/S0028-3932(02)00009-X; JEANNEROD M, 1992, ADV PSYCHOL, V87, P265; Johnson SH, 2003, PROG BRAIN RES, V142, P127; Johnson SH, 2002, NEUROIMAGE, V17, P1693, DOI 10.1006/nimg.2002.1265; JOHNSONFREY S, IN PRESS BRAIN RES C; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; MACKENZIE CL, 1994, ADV PSYCHOL, V104, P162; Marconi B, 2001, CEREB CORTEX, V11, P513, DOI 10.1093/cercor/11.6.513; Martinez A, 2001, VISION RES, V41, P1437, DOI 10.1016/S0042-6989(00)00267-4; Monzee J, 2004, J NEUROPHYSIOL, V91, P1230, DOI 10.1152/jn.01120.2002; Morand S, 2000, CEREB CORTEX, V10, P817, DOI 10.1093/cercor/10.8.817; Murata A, 1996, J NEUROPHYSIOL, V75, P2180, DOI 10.1152/jn.1996.75.5.2180; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; PAULIGNAN Y, 1991, EXP BRAIN RES, V87, P407; Pisella L, 2000, NAT NEUROSCI, V3, P729, DOI 10.1038/76694; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 2003, EXP BRAIN RES, V153, P146, DOI 10.1007/s00221-003-1588-0; Rodriguez-Fornells A, 2002, J NEUROSCI, V22, P9990; Saito DN, 2003, COGNITIVE BRAIN RES, V17, P14, DOI 10.1016/S0926-6410(03)00076-4; Sakata H, 1998, PHILOS T ROY SOC B, V353, P1363, DOI 10.1098/rstb.1998.0290; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Sakata H, 1999, EXP BRAIN RES, V128, P160, DOI 10.1007/s002210050831; Schroeder CE, 1998, CEREB CORTEX, V8, P575, DOI 10.1093/cercor/8.7.575; Shikata E, 2003, EUR J NEUROSCI, V17, P1105, DOI 10.1046/j.1460-9568.2003.02540.x; Shikata E, 2001, J NEUROPHYSIOL, V85, P1309, DOI 10.1152/jn.2001.85.3.1309; Smith MA, 2000, NATURE, V403, P544, DOI 10.1038/35000576; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Tunik E, 2004, EXP BRAIN RES, V159, P23, DOI 10.1007/s00221-004-1929-7; Tunik E, 2004, MOVEMENT DISORD, V19, P897, DOI 10.1002/mds.20138; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139	46	291	294	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					505	511		10.1038/nn1430	http://dx.doi.org/10.1038/nn1430			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15778711				2022-12-17	WOS:000228040400022
J	Leopold, DA; Wilke, M; Maier, A; Logothetis, NK				Leopold, DA; Wilke, M; Maier, A; Logothetis, NK			Stable perception of visually ambiguous patterns	NATURE NEUROSCIENCE			English	Article							BINOCULAR-RIVALRY; MOTION; MODEL; TIME	During the viewing of certain patterns, widely known as ambiguous or puzzle figures, perception lapses into a sequence of spontaneous alternations, switching every few seconds between two or more visual interpretations of the stimulus. Although their nature and origin remain topics of debate, these stochastic switches are generally thought to be the automatic and inevitable consequence of viewing a pattern without a unique solution. We report here that in humans such perceptual alternations can be slowed, and even brought to a standstill, if the visual stimulus is periodically removed from view. We also show, with a visual illusion, that this stabilizing effect hinges on perceptual disappearance rather than on actual removal of the stimulus. These findings indicate that uninterrupted subjective perception of an ambiguous pattern is required for the initiation of the brain-state changes underlying multistable vision.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	Max Planck Society	Leopold, DA (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	david.leopold@tuebingen.mpg.de	Maier, Alexander/B-7489-2009; Logothetis, Nikos/U-9282-2019	Maier, Alexander/0000-0002-7250-502X; Leopold, David/0000-0002-1345-6360				ATTNEAVE F, 1971, SCI AM, V225, P62, DOI 10.1038/scientificamerican1271-62; BLAKE R, 1990, PERCEPT PSYCHOPHYS, V48, P593, DOI 10.3758/BF03211605; Bonneh YS, 2001, NATURE, V411, P798, DOI 10.1038/35081073; BORSELLINO A, 1972, KYBERNETIK, V10, P139, DOI 10.1007/BF00290512; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Brown RJ, 1997, VISION RES, V37, P2401, DOI 10.1016/S0042-6989(97)00045-X; CARLSON VR, 1953, J EXP PSYCHOL, V45, P442, DOI 10.1037/h0054794; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Du Tour EF., 1760, MIM MATH PHYS ACAD R, V3, P514; FOX R, 1967, PERCEPT PSYCHOPHYS, V2, P432, DOI 10.3758/BF03208783; Gregory R. L., 1997, EYE BRAIN PSYCHOL SE; LEHKY SR, 1988, PERCEPTION, V17, P215, DOI 10.1068/p170215; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Miller SM, 2000, CURR BIOL, V10, P383, DOI 10.1016/S0960-9822(00)00416-4; MUELLER TJ, 1990, VISUAL NEUROSCI, V4, P63, DOI 10.1017/S0952523800002777; NAWROT M, 1989, SCIENCE, V244, P716, DOI 10.1126/science.2717948; Necker LA., 1832, LONDON EDINBURGH, V1, P329, DOI [10.1080/14786443208647909, DOI 10.1080/14786443208647909]; Pettigrew J D, 2001, BRAIN MIND, V2, P85, DOI [10.1023/A:1017929617197, DOI 10.1023/A:1017929617197]; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Rock Irvin., 1984, PERCEPTION; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Tononi G, 1998, P NATL ACAD SCI USA, V95, P3198, DOI 10.1073/pnas.95.6.3198; von Schiller P, 1933, PSYCHOL FORSCH, V17, P179; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880; WOLFE JM, 1984, VISION RES, V24, P471, DOI 10.1016/0042-6989(84)90044-0	29	291	296	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					605	609		10.1038/nn0602-851	http://dx.doi.org/10.1038/nn0602-851			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	11992115				2022-12-17	WOS:000175874600022
J	Lembo, PMC; Grazzini, E; Groblewski, T; O'Donnell, D; Roy, MO; Zhang, J; Hoffert, C; Cao, J; Schmidt, R; Pelletier, M; Labarre, M; Gosselin, M; Fortin, Y; Banville, D; Shen, SH; Strom, P; Payza, K; Dray, A; Walker, P; Ahmad, S				Lembo, PMC; Grazzini, E; Groblewski, T; O'Donnell, D; Roy, MO; Zhang, J; Hoffert, C; Cao, J; Schmidt, R; Pelletier, M; Labarre, M; Gosselin, M; Fortin, Y; Banville, D; Shen, SH; Strom, P; Payza, K; Dray, A; Walker, P; Ahmad, S			Proenkephalin A gene products activate a new family of sensory neuron-specific GPCRs	NATURE NEUROSCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; BOVINE ADRENAL-MEDULLA; PEPTIDE-E; CHROMAFFIN CELLS; OPIOID PEPTIDE; SPINAL-CORD; RAT; ENKEPHALIN; NOCICEPTORS; EXPRESSION	Several peptide fragments are produced by proteolytic cleavage of the opioid peptide precursor proenkephalin A, and among these are a number of enkephalin fragments, in particular bovine adrenal medulla peptide 22 (BAM22). These peptide products have been implicated in diverse biological functions, including analgesia. We have cloned a newly identified family of 'orphan' G protein-coupled receptors (GPCRs) and demonstrate that BAM22 and a number of its fragments bind to and activate these receptors with nanomolar affinities. This family of GPCRs is uniquely localized in the human and rat small sensory neuron, and we called this family the sensory neuron-specific G protein-coupled receptors (SNSRs). Receptors of the SNSR family are distinct from the traditional opioid receptors in their insensitivity to the classical opioid antagonist naloxone and poor activation by opioid ligands. The unique localization of SNSRs and their activation by proenkephalin A peptide fragments indicate a possible function for SNSRs in sensory neuron regulation and in the modulation of nociception.	AstraZeneca R&D Montreal, St Laurent, PQ H4S 1Z9, Canada; Biotechnol Res Inst, Pharmaceut Sector, Montreal, PQ H4P 2R2, Canada; AstraZeneca R&D Sodertalje, S-15185 Sodertalje, Sweden	AstraZeneca; National Research Council Canada; AstraZeneca	Lembo, PMC (corresponding author), AstraZeneca R&D Montreal, 7171 Frederick Banting, St Laurent, PQ H4S 1Z9, Canada.		Zhang, Ji/L-5922-2019					AHMAD S, 1998, Patent No. 9932519; BAIRD A, 1984, P SOC EXP BIOL MED, V175, P304; BOARDER MR, 1987, J NEUROCHEM, V49, P1824, DOI 10.1111/j.1471-4159.1987.tb02443.x; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; BOERSMA GJC, 1994, J NEUROENDOCRINOL, V6, P47; Cao J, 1998, J BIOL CHEM, V273, P32281, DOI 10.1074/jbc.273.48.32281; Caterina MJ, 1999, CURR OPIN NEUROBIOL, V9, P525, DOI 10.1016/S0959-4388(99)00009-4; Che FY, 2001, P NATL ACAD SCI USA, V98, P9971, DOI 10.1073/pnas.161542198; Civelli O, 2001, TRENDS NEUROSCI, V24, P230, DOI 10.1016/S0166-2236(00)01763-X; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; DAVIS TP, 1990, EUR J PHARMACOL, V191, P253, DOI 10.1016/0014-2999(90)94157-S; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; DORES RM, 1990, BRAIN BEHAV EVOLUT, V36, P80, DOI 10.1159/000115300; DRAY A, 1985, J PHARMACOL EXP THER, V235, P670; Goumon Y, 2000, J BIOL CHEM, V275, P38355, DOI 10.1074/jbc.M007557200; HARLAN RE, 1987, J COMP NEUROL, V258, P159, DOI 10.1002/cne.902580202; Henderson G, 1997, TRENDS PHARMACOL SCI, V18, P293, DOI 10.1016/S0165-6147(97)90645-3; HOLLT V, 1982, EUR J PHARMACOL, V85, P355, DOI 10.1016/0014-2999(82)90226-6; HOLLT V, 1982, LIFE SCI, V31, P1883, DOI 10.1016/0024-3205(82)90234-X; LOH YP, 1984, ANNU REV NEUROSCI, V7, P189, DOI 10.1146/annurev.ne.07.030184.001201; MANSOUR A, 1995, BRAIN RES, V700, P89, DOI 10.1016/0006-8993(95)00928-J; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; MIZUNO K, 1980, BIOCHEM BIOPH RES CO, V97, P1283, DOI 10.1016/S0006-291X(80)80005-2; PITTIUS CW, 1984, BRAIN RES, V304, P127, DOI 10.1016/0006-8993(84)90868-0; POHL M, 1994, J NEUROCHEM, V63, P1226; QUIRION R, 1983, PEPTIDES, V4, P445, DOI 10.1016/0196-9781(83)90047-5; RANG HP, 1994, TXB PAIN, P201; Rohrer DK, 1998, PHYSIOL REV, V78, P35, DOI 10.1152/physrev.1998.78.1.35; SANCHEZBLAZQUEZ P, 1984, NEUROPEPTIDES, V5, P181, DOI 10.1016/0143-4179(84)90057-X; SANCHEZBLAZQUEZ P, 1985, NEUROSCI LETT, V61, P267, DOI 10.1016/0304-3940(85)90475-6; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Stadel JM, 1997, TRENDS PHARMACOL SCI, V18, P430, DOI 10.1016/S0165-6147(97)01117-6; SWAIN MG, 1994, AM J PHYSIOL, V266, pG201, DOI 10.1152/ajpgi.1994.266.2.G201; WEIHE E, 1992, ANN ANAT, V174, P89, DOI 10.1016/S0940-9602(11)80327-4; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3	35	291	336	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					201	209		10.1038/nn815	http://dx.doi.org/10.1038/nn815			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11850634				2022-12-17	WOS:000174146000009
J	Park, J; Wetzel, I; Marriott, I; Dreau, D; D'Avanzo, C; Kim, DY; Tanzi, RE; Cho, HS				Park, Joseph; Wetzel, Isaac; Marriott, Ian; Dreau, Didier; D'Avanzo, Carla; Kim, Doo Yeon; Tanzi, Rudolph E.; Cho, Hansang			A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer's disease	NATURE NEUROSCIENCE			English	Article							AMYLOID CASCADE HYPOTHESIS; PLURIPOTENT STEM-CELLS; IFN-GAMMA PRODUCTION; MICROGLIAL ACCUMULATION; BETA; ACTIVATION; PATHOLOGY; NEURONS; INFLAMMATION; MACROPHAGES	Alzheimer's disease (AD) is characterized by beta-amyloid accumulation, phosphorylated tau formation, hyperactivation of glial cells, and neuronal loss. The mechanisms of AD pathogenesis, however, remain poorly understood, partially due to the lack of relevant models that can comprehensively recapitulate multistage intercellular interactions in human AD brains. Here we present a new three-dimensional (3D) human AD triculture model using neurons, astrocytes, and microglia in a 3D microfluidic platform. Our model provided key representative AD features: beta-amyloid aggregation, phosphorylated tau accumulation, and neuroinflammatory activity. In particular, the model mirrored microglial recruitment, neurotoxic activities such as axonal cleavage, and NO release damaging AD neurons and astrocytes. Our model will serve to facilitate the development of more precise human brain models for basic mechanistic studies in neural-glial interactions and drug discovery.	[Park, Joseph; Wetzel, Isaac; Cho, Hansang] Univ North Carolina Charlotte, Dept Mech Engn & Engn Sci, Charlotte, NC 28223 USA; [Park, Joseph; Wetzel, Isaac; Marriott, Ian; Dreau, Didier; Cho, Hansang] Univ North Carolina Charlotte, Ctr Biomed Engn & Sci, Charlotte, NC 28223 USA; [Park, Joseph; Wetzel, Isaac; Marriott, Ian; Dreau, Didier; Cho, Hansang] Univ North Carolina Charlotte, Dept Biol Sci, Charlotte, NC 28223 USA; [Park, Joseph; Wetzel, Isaac; Cho, Hansang] Univ North Carolina Charlotte, Nanoscale Sci Program, Charlotte, NC 28223 USA; [Park, Joseph; D'Avanzo, Carla; Kim, Doo Yeon; Tanzi, Rudolph E.] Harvard Med Sch, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Genet & Aging Res Unit, Charlestown, MA 02115 USA	University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte; Harvard University; Massachusetts General Hospital	Cho, HS (corresponding author), Univ North Carolina Charlotte, Dept Mech Engn & Engn Sci, Charlotte, NC 28223 USA.; Cho, HS (corresponding author), Univ North Carolina Charlotte, Ctr Biomed Engn & Sci, Charlotte, NC 28223 USA.; Cho, HS (corresponding author), Univ North Carolina Charlotte, Dept Biol Sci, Charlotte, NC 28223 USA.; Cho, HS (corresponding author), Univ North Carolina Charlotte, Nanoscale Sci Program, Charlotte, NC 28223 USA.; Kim, DY; Tanzi, RE (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Genet & Aging Res Unit, Charlestown, MA 02115 USA.	dkim@helix.mgh.harvard.edu; tanzi@helix.mgh.harvard.edu; h.cho@uncc.edu	Cho, Hansang/AAF-6294-2020; Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454; Cho, Hansang/0000-0003-1829-2462; Kim, Doo Yeon/0000-0002-6969-0340	NIH/NIA [P01 AG015379, RF1 AG048080, R01 AG014713]; Pioneering Funding Award - Cure Alzheimer's Fund (CAF); BrightFocus Foundation; Duke Energy Special Initiatives - Charlotte Research Institute; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2015R1A6A3A03019848]; NATIONAL INSTITUTE ON AGING [R01AG014713, RF1AG048080, P01AG015379] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Pioneering Funding Award - Cure Alzheimer's Fund (CAF); BrightFocus Foundation(BrightFocus Foundation); Duke Energy Special Initiatives - Charlotte Research Institute; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank L. Quinti (MGH) for sharing preliminary results regarding 3D neuron/microglia co-culture systems, M. Busche (MGH) for helpful guidance regarding the calcium imaging, S.H. Choi (MGH) for helpful discussion regarding the data interpretation, and Y.J. Kang (UNCC) for critically reviewing our manuscript. This work was supported by the NIH/NIA (P01 AG015379 and RF1 AG048080 to D.Y.K. and R.E.T.; R01 AG014713 to D.Y.K.), the Pioneering Funding Award funded by Cure Alzheimer's Fund (CAF; to H.C., D.Y.K., R.E.T.), BrightFocus Foundation (D.Y.K.), the Duke Energy Special Initiatives funded by Charlotte Research Institute (CRI; to H.C.), and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1A6A3A03019848, to J.P.).	Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Armstrong RA, 2014, FOLIA NEUROPATHOL, V52, P211, DOI 10.5114/fn.2014.45562; Baruch K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8967; Brion JP, 1998, EUR NEUROL, V40, P130, DOI 10.1159/000007969; Browne TC, 2013, J IMMUNOL, V190, P2241, DOI 10.4049/jimmunol.1200947; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cho HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01823; Choi SH, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0139-7; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Crehan H, 2013, NEUROBIOL DIS, V54, P139, DOI 10.1016/j.nbd.2013.02.003; D'Avanzo C, 2015, BIOESSAYS, V37, P1139, DOI 10.1002/bies.201500063; Dou Y, 2012, CELL RES, V22, P1022, DOI 10.1038/cr.2012.10; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Garwood CJ, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.50; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Han S, 2012, LAB CHIP, V12, P2305, DOI 10.1039/c2lc21285d; Hashioka S, 2010, J NEUROIMMUNOL, V225, P91, DOI 10.1016/j.jneuroim.2010.04.023; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Johansson JU, 2013, J NEUROSCI, V33, P16016, DOI 10.1523/JNEUROSCI.2203-13.2013; Karran E, 2016, J NEUROCHEM, V139, P237, DOI 10.1111/jnc.13632; Kim YH, 2015, NAT PROTOC, V10, P985, DOI 10.1038/nprot.2015.065; Koch P, 2012, AM J PATHOL, V180, P2404, DOI 10.1016/j.ajpath.2012.02.012; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Li SQ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0396-3; Moore S, 2015, CELL REP, V11, P689, DOI 10.1016/j.celrep.2015.03.068; Muratore CR, 2014, HUM MOL GENET, V23, P3523, DOI 10.1093/hmg/ddu064; Papageorgiou IE, 2016, P NATL ACAD SCI USA, V113, P212, DOI 10.1073/pnas.1513853113; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; de Lara MJP, 2015, J ALZHEIMERS DIS, V43, P177, DOI 10.3233/JAD-141005; Shi YC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003771; Smits HA, 2002, J NEUROIMMUNOL, V127, P160, DOI 10.1016/S0165-5728(02)00112-1; Spangenberg EE, 2016, BRAIN, V139, P1265, DOI 10.1093/brain/aww016; Sproul AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084547; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tischbirek C, 2015, P NATL ACAD SCI USA, V112, P11377, DOI 10.1073/pnas.1514209112; Tubsuwan A, 2016, STEM CELL RES, V16, P110, DOI 10.1016/j.scr.2015.12.015; White JA, 2005, NEUROBIOL DIS, V18, P459, DOI 10.1016/j.nbd.2004.12.013; Xiao BG, 1998, NEUROREPORT, V9, P1487, DOI 10.1097/00001756-199805110-00044; Xu Q, 2000, J BIOL CHEM, V275, P31770, DOI 10.1074/jbc.M002796200; Yagi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041572; Zhang ZN, 2016, P NATL ACAD SCI USA, V113, P3185, DOI 10.1073/pnas.1521255113	46	290	292	15	177	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2018	21	7					941	+		10.1038/s41593-018-0175-4	http://dx.doi.org/10.1038/s41593-018-0175-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM3EW	29950669	Green Accepted			2022-12-17	WOS:000437983900007
J	Viswanathan, A; Freeman, RD				Viswanathan, Ahalya; Freeman, Ralph D.			Neurometabolic coupling in cerebral cortex reflects synaptic more than spiking activity	NATURE NEUROSCIENCE			English	Article							RAT CEREBELLAR CORTEX; MONKEY VISUAL-CORTEX; BLOOD-FLOW; SENSORY STIMULATION; HUMAN BRAIN; TISSUE OXYGENATION; FIELD POTENTIALS; NEURAL ACTIVITY; SIGNAL; SELECTIVITY	In noninvasive neuroimaging, neural activity is inferred from local fluctuations in deoxyhemoglobin. A fundamental question of functional magnetic resonance imaging (fMRI) is whether the inferred neural activity is driven primarily by synaptic or spiking activity. The answer is critical for the interpretation of the blood oxygen level-dependent (BOLD) signal in fMRI. Here, we have used well-established visual-system circuitry to create a stimulus that elicits synaptic activity without associated spike discharge. In colocalized recordings of neural and metabolic activity in cat primary visual cortex, we observed strong coupling between local field potentials (LFPs) and changes in tissue oxygen concentration in the absence of spikes. These results imply that the BOLD signal is more closely coupled to synaptic activity.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Sch Optometry, Grp Vis Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Freeman, RD (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Sch Optometry, Grp Vis Sci, Berkeley, CA 94720 USA.	freeman@neurovision.berkeley.edu			NEI NIH HHS [EY03716, EY01175] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY003716, R01EY001175] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; Caesar K, 2003, P NATL ACAD SCI USA, V100, P16000, DOI 10.1073/pnas.2635195100; Devor A, 2003, NEURON, V39, P353, DOI 10.1016/S0896-6273(03)00403-3; Duong TQ, 2001, P NATL ACAD SCI USA, V98, P10904, DOI 10.1073/pnas.191101098; Fatt I, 1976, POLAROGRAPHIC OXYGEN; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; Hawken MJ, 1996, VISUAL NEUROSCI, V13, P477, DOI 10.1017/S0952523800008154; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Kim DS, 2004, NEUROIMAGE, V21, P876, DOI 10.1016/j.neuroimage.2003.10.018; Kim SG, 1997, J NEUROSCI METH, V74, P229, DOI 10.1016/S0165-0270(97)02252-8; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Maex R, 1996, J NEUROPHYSIOL, V75, P1515, DOI 10.1152/jn.1996.75.4.1515; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Mathiesen C, 1998, J PHYSIOL-LONDON, V512, P555, DOI 10.1111/j.1469-7793.1998.555be.x; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Offenhauser N, 2005, J PHYSIOL-LONDON, V565, P279, DOI 10.1113/jphysiol.2005.082776; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Rager G, 1998, EUR J NEUROSCI, V10, P1856, DOI 10.1046/j.1460-9568.1998.00197.x; Thompson JK, 2005, J NEUROSCI, V25, P9046, DOI 10.1523/JNEUROSCI.2127-05.2005; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Wilke M, 2006, P NATL ACAD SCI USA, V103, P17507, DOI 10.1073/pnas.0604673103; Zheng Y, 2002, NEUROIMAGE, V16, P617, DOI 10.1006/nimg.2002.1078	32	290	292	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1308	1312		10.1038/nn1977	http://dx.doi.org/10.1038/nn1977			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828254				2022-12-17	WOS:000249720800018
J	Heurteaux, C; Lucas, G; Guy, N; El Yacoubi, M; Thummler, S; Peng, XD; Noble, F; Blondeau, N; Widmann, C; Borsotto, M; Gobbi, G; Vaugeois, JM; Debonnel, G; Lazdunski, M				Heurteaux, Catherine; Lucas, Guillaume; Guy, Nicolas; El Yacoubi, Malika; Thummler, Susanne; Peng, Xiao-Dong; Noble, Florence; Blondeau, Nicolas; Widmann, Catherine; Borsotto, Marc; Gobbi, Gabriella; Vaugeois, Jean-Marie; Debonnel, Guy; Lazdunski, Michel			Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype	NATURE NEUROSCIENCE			English	Article							DOMAIN K+ CHANNELS; TAIL SUSPENSION TEST; FORCED SWIM TEST; IN-VIVO; ANTIDEPRESSANT TREATMENTS; METABOLITE NORFLUOXETINE; HIPPOCAMPAL NEUROGENESIS; LEARNED HELPLESSNESS; ARACHIDONIC-ACID; NERVOUS-SYSTEM	Depression is a devastating illness with a lifetime prevalence of up to 20%. The neurotransmitter serotonin or 5-hydroxytryptamine (5-HT) is involved in the pathophysiology of depression and in the effects of antidepressant treatments. However, molecular alterations that underlie the pathology or treatment of depression are still poorly understood. The TREK-1 protein is a background K+ channel regulated by various neurotransmitters including 5-HT. In mice, the deletion of its gene (Kcnk2, also called TREK-1) led to animals with an increased efficacy of 5-HT neurotransmission and a resistance to depression in five different models and a substantially reduced elevation of corticosterone levels under stress. TREK-1-deficient (Kcnk2(-/-)) mice showed behavior similar to that of naive animals treated with classical antidepressants such as fluoxetine. Our results indicate that alterations in the functioning, regulation or both of the TREK-1 channel may alter mood, and that this particular K+ channel may be a potential target for new antidepressants.	Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, Inst Paul Hamel, F-06560 Valbonne, France; McGill Univ, Dept Psychiat, Montreal, PQ, Canada; CNRS, Fac Med & Pharm, Unite Neuropsychopharmacol Expt, FRE 2735,IFRMP 23, F-76183 Rouen, France; CNRS, Dept Pharmacochim Mol & Struct, INSERM U266, FRE 2463,Unite Format & Rech Sci Pharmaceut & Bio, F-75270 Paris 06, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; McGill University; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Lazdunski, M (corresponding author), Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, Inst Paul Hamel, 660 Route Lucioles, F-06560 Valbonne, France.	ipmc@ipmc.cnrs.fr	Blondeau, Nicolas/T-1136-2019; Gobbi, Gabriella/I-2786-2013; Blondeau, Nicolas P/M-5002-2016; BORSOTTO, Marc/M-5096-2016; Yan, Shuo/B-8381-2009; HEURTEAUX, Catherine/M-4947-2016; Lucas, Guillaume/N-6993-2017	Gobbi, Gabriella/0000-0003-4124-9825; Blondeau, Nicolas P/0000-0001-5954-4094; BORSOTTO, Marc/0000-0002-1302-7419; HEURTEAUX, Catherine/0000-0002-9741-9777; Lucas, Guillaume/0000-0003-0647-9756; THUMMLER, Susanne/0000-0001-9993-6981; Noble, Florence/0000-0003-4497-0212; EL YACOUBI, Malika/0000-0002-1010-9179; Vaugeois, Jean-Marie/0000-0001-8296-672X				Blier P, 1999, NEUROPSYCHOPHARMACOL, V21, pS91, DOI 10.1016/S0893-133X(99)00036-6; Bolo NR, 2000, NEUROPSYCHOPHARMACOL, V23, P428, DOI 10.1016/S0893-133X(00)00116-0; CACCIA S, 1990, PSYCHOPHARMACOLOGY, V100, P509, DOI 10.1007/BF02244004; Caldarone BJ, 2000, PHARMACOL BIOCHEM BE, V66, P811, DOI 10.1016/S0091-3057(00)00271-9; Caldarone BJ, 2003, PSYCHOPHARMACOLOGY, V170, P94, DOI 10.1007/s00213-003-1518-7; Chemin J, 2003, EMBO J, V22, P5403, DOI 10.1093/emboj/cdg528; COPPEN A, 1967, BRIT J PSYCHIAT, V113, P1237, DOI 10.1192/bjp.113.504.1237; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Cryan JF, 2002, EUR J PHARMACOL, V436, P197, DOI 10.1016/S0014-2999(01)01628-4; Delgado PL, 1999, BIOL PSYCHIAT, V46, P212, DOI 10.1016/S0006-3223(99)00014-1; DESCARRIES L, 1982, J COMP NEUROL, V207, P239, DOI 10.1002/cne.902070305; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Gobbi G, 2001, J PHARMACOL EXP THER, V296, P987; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Haddjeri N, 1998, J NEUROSCI, V18, P10150; HERMANN G, 1994, J NEUROIMMUNOL, V53, P173, DOI 10.1016/0165-5728(94)90027-2; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Heuser IJE, 1996, AM J PSYCHIAT, V153, P93; KAMEYAMA T, 1985, NEUROPHARMACOLOGY, V24, P285, DOI 10.1016/0028-3908(85)90133-9; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; KARSON CN, 1993, J NEUROPSYCH CLIN N, V5, P322; Kennard LE, 2005, BRIT J PHARMACOL, V144, P821, DOI 10.1038/sj.bjp.0706068; KOMOROSKI RA, 1994, MAGNET RESON MED, V31, P204, DOI 10.1002/mrm.1910310214; LAPIN IP, 1969, LANCET, V1, P132; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Maes Michael, 1995, P933; MAIER SF, 1984, PROG NEURO-PSYCHOPH, V8, P435, DOI 10.1016/0278-5846(84)90120-9; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Maingret F, 1999, J BIOL CHEM, V274, P1381, DOI 10.1074/jbc.274.3.1381; Malberg JE, 2004, J PSYCHIATR NEUROSCI, V29, P196; Mayorga AJ, 2001, J PHARMACOL EXP THER, V298, P1101; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; Owens M J, 1996, Depress Anxiety, V4, P153, DOI 10.1002/(SICI)1520-6394(1996)4:4<153::AID-DA1>3.0.CO;2-G; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Redrobe JP, 2005, PEPTIDES, V26, P1394, DOI 10.1016/j.peptides.2005.03.029; Reyes R, 2000, NEUROSCIENCE, V95, P893; Ripoll N, 2003, BEHAV BRAIN RES, V143, P193, DOI 10.1016/S0166-4328(03)00034-2; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Xu XG, 2002, J NEUROGENET, V16, P263, DOI 10.1080/01677060216294	49	290	314	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1134	1141		10.1038/nn1749	http://dx.doi.org/10.1038/nn1749			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16906152				2022-12-17	WOS:000240080800014
J	Deneve, S; Latham, PE; Pouget, A				Deneve, S; Latham, PE; Pouget, A			Reading population codes: a neural implementation of ideal observers	NATURE NEUROSCIENCE			English	Article							PSYCHOPHYSICAL PERFORMANCE; STRIATE CORTEX; VISUAL-MOTION; RESPONSES; DISCHARGE; NEURONS; MODEL	Many sensory and motor variables are encoded in the nervous system by the activities of large populations of neurons with bell-shaped tuning curves. Extracting information from these population codes is difficult because of the noise inherent in neuronal responses. In most cases of interest, maximum likelihood (ML) is the best read-out method and would be used by an ideal observer. Using simulations and analysis, we show that a close approximation to ML can be implemented in a biologically plausible model of cortical circuitry. Our results apply to a wide range of nonlinear activation functions, suggesting that cortical areas may, in general, function as ideal observers of activity in preceding areas.	Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA	University of Rochester; University of California System; University of California Los Angeles	Pouget, A (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	alex@bcs.rochester.edu		Pouget, Alexandre/0000-0003-3054-6365				Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; BARTO A, 1989, COMP NEUR S, P73; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; CARANDINI M, 1997, J NEUROSCI, V17, P3061; David E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.5555/104279.104293; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Gershon ED, 1998, J NEUROPHYSIOL, V79, P1135, DOI 10.1152/jn.1998.79.3.1135; Hawken M.J., 1990, P103; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Li ZP, 1998, NEURAL COMPUT, V10, P903, DOI 10.1162/089976698300017557; MAUNSELL JH, 1985, J NEUROPHYSIOL, V49, P1127; MAZZONI P, 1991, P NATL ACAD SCI USA, V88, P4433, DOI 10.1073/pnas.88.10.4433; NELSON ME, 1994, NEURAL COMPUT, V6, P242, DOI 10.1162/neco.1994.6.2.242; Papoulis A., 1991, COMMUNICATIONS SIGNA, V3; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Pouget A, 1998, NEURAL COMPUT, V10, P373, DOI 10.1162/089976698300017809; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; TOLHURST DJ, 1981, EXP BRAIN RES, V41, P414; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	27	290	294	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	1999	2	8					740	745		10.1038/11205	http://dx.doi.org/10.1038/11205			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FA	10412064				2022-12-17	WOS:000083882800014
J	Higuchi, M; Iwata, N; Matsuba, Y; Sato, K; Sasamoto, K; Saido, TC				Higuchi, M; Iwata, N; Matsuba, Y; Sato, K; Sasamoto, K; Saido, TC			F-19 and H-1 MRI detection of amyloid beta plaques in vivo	NATURE NEUROSCIENCE			English	Article							TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; BRAIN; MICE; VISUALIZATION; DERIVATIVES; MICROSCOPY	Formation of senile plaques composed of amyloid beta peptide, a pathological hallmark of Alzheimer disease, in human brains precedes disease onset by many years. Noninvasive detection of such plaques could be critical in presymptomatic diagnosis and could contribute to early preventive treatment strategies. Using amyloid precursor protein (APP) transgenic mice as a model of amyloid beta amyloidosis, we demonstrate here that an intravenously administered F-19-containing amyloidophilic compound labels brain plaques and allows them to be visualized in living mice by magnetic resonance imaging ( MRI) using F-19 and H-1. Our findings provide a new direction for specific noninvasive amyloid imaging without the danger of exposure to radiation. This approach could be used in longitudinal studies in mouse models of Alzheimer disease to search for biomarkers associated with amyloid beta pathology as well as to track disease course after treatment with candidate medications.	RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan; Dojin Labs, Mashiki, Kumamoto 8612202, Japan	RIKEN	Saido, TC (corresponding author), RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan.	saido@brain.riken.jp	Sado, Takaomi/AAN-2759-2021; Saido, Takaomi C/N-5472-2015	Sado, Takaomi/0000-0003-1970-6903; Saido, Takaomi C/0000-0003-1970-6903				Alzheimers Assoc, 1998, NEUROBIOL AGING, V19, P109; Backskai BJ, 2001, NAT MED, V7, P369, DOI 10.1038/85525; Bacskai BJ, 2003, P NATL ACAD SCI USA, V100, P12462, DOI 10.1073/pnas.2034101100; Benveniste H, 1999, P NATL ACAD SCI USA, V96, P14079, DOI 10.1073/pnas.96.24.14079; GOEDERT M, 1997, MOL GENETIC BASIS NE; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Helpern JA, 2004, MAGNET RESON MED, V51, P794, DOI 10.1002/mrm.20038; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jack CR, 2004, MAGN RESON MED, V52, P1263, DOI 10.1002/mrm.20266; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Kung MP, 2002, BRAIN RES, V956, P202, DOI 10.1016/S0006-8993(02)03436-4; Lee SP, 2004, MAGN RESON MED, V52, P538, DOI 10.1002/mrm.20196; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Mathis CA, 2002, BIOORG MED CHEM LETT, V12, P295, DOI 10.1016/S0960-894X(01)00734-X; Nordberg A, 2004, LANCET NEUROL, V3, P519, DOI 10.1016/S1474-4422(04)00853-1; Okamura N, 2004, J NEUROSCI, V24, P2535, DOI 10.1523/JNEUROSCI.4456-03.2004; Poduslo JF, 2002, NEUROBIOL DIS, V11, P315, DOI 10.1006/nbdi.2002.0550; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Saido TC, 2003, ABETA METABOLISM ALZ; Sair HI, 2004, NEURORADIOLOGY, V46, P93, DOI 10.1007/s00234-003-1034-9; Sato K, 2004, EUR J MED CHEM, V39, P573, DOI 10.1016/j.ejmech.2004.02.013; SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003; Shoghi-Jadid K, 2002, AM J GERIAT PSYCHIAT, V10, P24, DOI 10.1176/appi.ajgp.10.1.24; Skovronsky DM, 2000, P NATL ACAD SCI USA, V97, P7609, DOI 10.1073/pnas.97.13.7609; Wadghiri YZ, 2003, MAGN RESON MED, V50, P293, DOI 10.1002/mrm.10529; Zhang J, 2004, MAGN RESON MED, V51, P452, DOI 10.1002/mrm.10730; Zhuang ZP, 2001, J MED CHEM, V44, P1905, DOI 10.1021/jm010045q	29	289	305	0	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					527	533		10.1038/nn1422	http://dx.doi.org/10.1038/nn1422			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15768036				2022-12-17	WOS:000228040400025
J	Kilner, JM; Vargas, C; Duval, S; Blakemore, SJ; Sirigu, A				Kilner, JM; Vargas, C; Duval, S; Blakemore, SJ; Sirigu, A			Motor activation prior to observation of a predicted movement	NATURE NEUROSCIENCE			English	Article								Previous research has shown that some of the same motor regions are activated both when performing and when observing a movement. Here we demonstrate in human subjects that such motor activity also occurs prior to observing someone else's action. This suggests that the mere knowledge of an upcoming movement is sufficient to excite one's own motor system, enabling people to anticipate, rather than react to, others' actions.	CNRS, Inst Cognit Sci, F-69675 Bron, France; UCL, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Univ Fed Rio de Janeiro, Inst Biophys, BR-21949900 Rio De Janeiro, Brazil; UCL, Inst Cognit Neurosci, London WC1N 3AR, England	Centre National de la Recherche Scientifique (CNRS); University of London; University College London; Universidade Federal do Rio de Janeiro; University of London; University College London	Sirigu, A (corresponding author), CNRS, Inst Cognit Sci, 67 Blvd Pinel, F-69675 Bron, France.	sirigu@isc.cnrs.fr	Sirigu, Angela/L-4683-2017; Blakemore, Sarah-Jayne/A-1792-2010; Kilner, James M/A-2040-2010; Vargas, Claudia D./A-1523-2016	Blakemore, Sarah-Jayne/0000-0002-1690-2805; Vargas, Claudia D./0000-0001-6202-3580; Kilner, James/0000-0002-6632-6797				Brunia CHM, 2001, INT J PSYCHOPHYSIOL, V43, P59, DOI 10.1016/S0167-8760(01)00179-9; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239	10	289	290	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1299	1301		10.1038/nn1355	http://dx.doi.org/10.1038/nn1355			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15558063				2022-12-17	WOS:000225353900009
J	Richeson, JA; Baird, AA; Gordon, HL; Heatherton, TF; Wyland, CL; Trawalter, S; Shelton, JN				Richeson, JA; Baird, AA; Gordon, HL; Heatherton, TF; Wyland, CL; Trawalter, S; Shelton, JN			An fMRI investigation of the impact of interracial contact on executive function	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; ERROR-DETECTION; INDIVIDUAL-DIFFERENCES; WORKING-MEMORY; PREJUDICE; ACTIVATION; INTERFERENCE; SUPPRESSION; INHIBITION	We investigated whether individual differences in racial bias among white participants predict the recruitment, and potential depletion, of executive attentional resources during contact with black individuals. White individuals completed an unobtrusive measure of racial bias, then interacted with a black individual, and finally completed an ostensibly unrelated Stroop color-naming test. In a separate functional magnetic resonance imaging (fMRI) session, subjects were presented with unfamiliar black male faces, and the activity of brain regions thought to be critical to executive control was assessed. We found that racial bias predicted activity in right dorsolateral prefrontal cortex (DLPFC) in response to black faces. Furthermore, activity in this region predicted Stroop interference after an actual interracial interaction, and it statistically mediated the relation between racial bias and Stroop interference. These results are consistent with a resource depletion account of the temporary executive dysfunction seen in racially biased individuals after interracial contact.	Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA	Dartmouth College; Princeton University	Richeson, JA (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, 6207 Moore Hall, Hanover, NH 03755 USA.	jriches@dartmouth.edu	Heatherton, Todd F/H-5478-2011					Banich MT, 2000, COGNITIVE BRAIN RES, V10, P1, DOI 10.1016/S0926-6410(00)00015-X; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Baumeister RF, 2000, SOC COGNITION, V18, P130, DOI 10.1521/soco.2000.18.2.130; Blascovich J, 2001, J PERS SOC PSYCHOL, V80, P253, DOI 10.1037//0022-3514.80.2.253; Brass M, 2001, NEUROIMAGE, V14, P1416, DOI 10.1006/nimg.2001.0944; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; Chee MWL, 2000, NEUROREPORT, V11, P135; Cohen JD, 2000, NAT NEUROSCI, V3, P421, DOI 10.1038/74783; Crandall CS, 2002, J PERS SOC PSYCHOL, V82, P359, DOI 10.1037//0022-3514.82.3.359; De Houwer J, 2001, J EXP SOC PSYCHOL, V37, P443, DOI 10.1006/jesp.2000.1464; de Zubicaray GI, 2000, NEUROPSYCHOLOGIA, V38, P1280, DOI 10.1016/S0028-3932(00)00033-6; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; Devine P.G., 1998, CONFRONTING RACISM P, P234; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.1.5; ENGLE RW, 1995, PSYCHOL SCI, V6, P122, DOI 10.1111/j.1467-9280.1995.tb00318.x; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; Fuster JM, 2000, BRAIN RES BULL, V52, P331, DOI 10.1016/S0361-9230(99)00258-0; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Hazeltine E, 2000, J COGNITIVE NEUROSCI, V12, P118, DOI 10.1162/089892900563984; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Karpinski A, 2001, J PERS SOC PSYCHOL, V81, P774, DOI 10.1037/0022-3514.81.5.774; Kawashima R, 1996, BRAIN RES, V728, P79, DOI 10.1016/0006-8993(96)00389-7; KIMBERG DY, 1993, J EXP PSYCHOL GEN, V122, P411, DOI 10.1037/0096-3445.122.4.411; Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; Lepore L, 1997, J PERS SOC PSYCHOL, V72, P275, DOI 10.1037/0022-3514.72.2.275; Leung HC, 2000, CEREB CORTEX, V10, P552, DOI 10.1093/cercor/10.6.552; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Milham MP, 2003, NEUROIMAGE, V18, P483, DOI 10.1016/S1053-8119(02)00050-2; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Richeson JA, 2003, PSYCHOL SCI, V14, P287, DOI 10.1111/1467-9280.03437; Shallice T, 1993, ATTENTION SELECTION, P171; Shelton JN, 2003, GROUP PROCESS INTERG, V6, P171, DOI 10.1177/1368430203006002003; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Talairach P., 1988, STEREOTACTIC COPLANA; Vohs KD, 2000, PSYCHOL SCI, V11, P249, DOI 10.1111/1467-9280.00250; von Hippel W, 2000, PERS SOC PSYCHOL B, V26, P523, DOI 10.1177/0146167200267001	45	289	293	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1323	1328		10.1038/nn1156	http://dx.doi.org/10.1038/nn1156			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	746BC	14625557				2022-12-17	WOS:000186725600018
J	Barcelo, F; Suwazono, S; Knight, RT				Barcelo, F; Suwazono, S; Knight, RT			Prefrontal modulation of visual processing in humans	NATURE NEUROSCIENCE			English	Article							EVENT-RELATED POTENTIALS; NORMAL HUMAN CORTEX; SPATIAL ATTENTION; SELECTIVE ATTENTION; NEURAL MECHANISMS; BRAIN POTENTIALS; CYTOARCHITECTONIC DEFINITION; AREAS 9; OBJECT; PET	Single neuron, evoked potential and metabolic techniques show that attention influences visual processing in extrastriate cortex. We provide anatomical, electrophysiological and behavioral evidence that prefrontal cortex regulates neuronal activity in extrastriate cortex during visual discrimination. Event-related potentials (ERPs) were recorded during a visual detection task in patients with damage in dorsolateral prefrontal cortex. Prefrontal damage reduced neuronal activity in extrastriate cortex of the lesioned hemisphere. These electrophysiological abnormalities, beginning 125 ms after stimulation and lasting for another 500 ms, were accompanied by behavioral deficits in detection ability in the contralesional hemifield. The results provide evidence for intrahemispheric prefrontal modulation of visual processing.	Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Complutense, Fac Psychol, Dept Psychobiol, Madrid 28223, Spain; Niigata Univ, Brain Res Inst, Dept Integrated Neurosci, Niigata 95021, Japan	University of California System; University of California Berkeley; Complutense University of Madrid; Niigata University	Knight, RT (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	rtknight@socrates.berkeley.edu	Barceló, Francisco/B-3629-2011	Barceló, Francisco/0000-0001-6012-7116; Suwazono, Shugo/0000-0003-1286-9718	NINDS NIH HHS [NS21135] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021135] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chao LL, 1998, J COGNITIVE NEUROSCI, V10, P167, DOI 10.1162/089892998562636; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Clark V.P., 1994, HUMAN BRAIN MAPPING, V2, P170, DOI [10.1002/hbm.460020306, DOI 10.1002/HBM.460020306]; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; CORBETTA M, 1993, J NEUROSCI, V13, P1202; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; HANSEN JC, 1980, ELECTROEN CLIN NEURO, V49, P277, DOI 10.1016/0013-4694(80)90222-9; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hillyard Steven A., 1995, P665; Karayanidis F, 1997, ELECTROEN CLIN NEURO, V103, P282, DOI 10.1016/S0013-4694(97)96077-6; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Knight RT, 1998, J CLIN NEUROPHYSIOL, V15, P3, DOI 10.1097/00004691-199801000-00003; KNIGHT RT, 1984, ELECTROEN CLIN NEURO, V59, P9, DOI 10.1016/0168-5597(84)90016-9; Knight RT, 1997, J COGNITIVE NEUROSCI, V9, P75, DOI 10.1162/jocn.1997.9.1.75; Luck SJ, 1995, BEHAV BRAIN RES, V71, P113, DOI 10.1016/0166-4328(95)00041-0; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; MCINTOSH AR, 1994, J NEUROSCI, V14, P655; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; Muller MM, 1998, NAT NEUROSCI, V1, P631, DOI 10.1038/2865; Nielsen-Bohlman L, 1999, COGNITIVE BRAIN RES, V8, P299, DOI 10.1016/S0926-6410(99)00035-X; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; RAJKOWSKA G, 1995, CEREB CORTEX, V5, P323, DOI 10.1093/cercor/5.4.323; RAJKOWSKA G, 1995, CEREB CORTEX, V5, P307, DOI 10.1093/cercor/5.4.307; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Rees G, 1997, SCIENCE, V275, P835, DOI 10.1126/science.275.5301.835; ROSAHL SK, 1995, CEREB CORTEX, V5, P123, DOI 10.1093/cercor/5.2.123; Smid HGOM, 1999, PSYCHOPHYSIOLOGY, V36, P264, DOI 10.1017/S0048577299971135; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Valdes-Sosa M, 1998, J COGNITIVE NEUROSCI, V10, P137, DOI 10.1162/089892998563743; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; Webster MJ, 1998, ATTENTIVE BRAIN, P19; Wijers AA, 1997, PSYCHOPHYSIOLOGY, V34, P553, DOI 10.1111/j.1469-8986.1997.tb01742.x; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; Woldorff MG, 1997, HUM BRAIN MAPP, V5, P280, DOI 10.1002/(SICI)1097-0193(1997)5:4<280::AID-HBM13>3.0.CO;2-I	41	289	313	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					399	403		10.1038/73975	http://dx.doi.org/10.1038/73975			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725931				2022-12-17	WOS:000087945400022
J	Lee, JLC				Lee, Jonathan L. C.			Memory reconsolidation mediates the strengthening of memories by additional learning	NATURE NEUROSCIENCE			English	Article							SPATIAL MEMORY; FEAR MEMORIES; DESTABILIZATION; CONSOLIDATION; NEUROBIOLOGY; ANISOMYCIN; RETRIEVAL	Memories are dynamic, rather than static, in nature. The reactivation of a memory through re-exposure to salient training stimuli results in its destabilization, necessitating a restabilization process known as reconsolidation, a disruption of which leads to amnesia. I found that one normal function of hippocampal memory reconsolidation in rats is to modify the strength of a contextual-fear memory as a result of further learning.	Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Lee, JLC (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	j.l.c.lee@bham.ac.uk	Lee, Jonathan LC/A-9629-2008	Lee, Jonathan LC/0000-0002-2284-2482	Royal Society	Royal Society(Royal Society of London)	I'd like to thank B.J. Everitt and D. Belin for helpful discussions, as well as Y. Pelloux and M. Wood for practical cooperation. This work was supported by a grant from the Royal Society and was conducted in the MRC/Wellcome Trust Behavioural and Clinical Neuroscience Institute, Department of Experimental Psychology at the University of Cambridge (UK).	Ben Mamou C, 2006, NAT NEUROSCI, V9, P1237, DOI 10.1038/nn1778; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Pelloux Y, 2007, PSYCHOPHARMACOLOGY, V194, P127, DOI 10.1007/s00213-007-0805-0; Rodriguez-Ortiz CJ, 2008, NEUROBIOL LEARN MEM, V89, P352, DOI 10.1016/j.nlm.2007.10.004; Rudy JW, 2006, LEARN MEMORY, V13, P1, DOI 10.1101/lm.157806; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Suzuki A, 2008, LEARN MEMORY, V15, P426, DOI 10.1101/lm.888808; Tronel S, 2005, PLOS BIOL, V3, P1630, DOI 10.1371/journal.pbio.0030293	14	288	292	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2008	11	11					1264	1266		10.1038/nn.2205	http://dx.doi.org/10.1038/nn.2205			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	366HZ	18849987	Green Submitted			2022-12-17	WOS:000260472700014
J	Ignashchenkova, A; Dicke, PW; Haarmeier, T; Thier, P				Ignashchenkova, A; Dicke, PW; Haarmeier, T; Thier, P			Neuron-specific contribution of the superior colliculus to overt and covert shifts of attention	NATURE NEUROSCIENCE			English	Article							SACCADE TARGET SELECTION; EYE-MOVEMENTS; VISUAL-ATTENTION; SPATIAL ATTENTION; LAYER CELLS; MONKEY; RESPONSES; MODULATION; ORGANIZATION; PROBABILITY	The analysis of a peripheral visual location can be improved in two ways: either by orienting one's gaze (usually by making a foveating saccade) or by 'covertly' shifting one's attention to the peripheral location without making an eye movement. The premotor theory of attention holds that saccades and spatial shifts of attention share a common functional module with a distinct neuronal basis. Using single-unit recording from the brains of trained rhesus monkeys, we investigated whether the superior colliculus, the major subcortical center for the control of saccades, is part of this shared network for attention and saccades. Here we show that a distinct type of neuron in the intermediate layer of the superior colliculus, the visuomotor neuron, which is known to be centrally involved in the preparation of saccades, is also active during covert shifts of attention.	Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cognit Neurol, D-72076 Tubingen, Germany; Univ Tubingen, Hertie Inst Clin Brain Res, Dept Gen Neurol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Thier, P (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cognit Neurol, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	thier@uni-tuebingen.de	Ignashchenkova, Alla/U-3745-2019	Ignashchenkova, Alla/0000-0002-9444-5945; Thier, Peter/0000-0001-5909-4222				Andersen R A, 1989, Rev Oculomot Res, V3, P315; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; Basso MA, 1998, J NEUROSCI, V18, P7519; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Gattass R., 1996, Revista Brasileira de Biologia, V56, P257; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P560, DOI 10.1152/jn.1972.35.4.560; GRAIGHERO L, 1999, J EXP PSYCHOL HUMAN, V25, P1673; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2527, DOI 10.1152/jn.2001.86.5.2527; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Lunenburger L, 2001, PROG BRAIN RES, V134, P109; MAYS LE, 1980, J NEUROPHYSIOL, V43, P207, DOI 10.1152/jn.1980.43.1.207; MCKEE SP, 1985, PERCEPT PSYCHOPHYS, V37, P286, DOI 10.3758/BF03211350; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; MOHLER CW, 1976, J NEUROPHYSIOL, V39, P722, DOI 10.1152/jn.1976.39.4.722; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; ROBINSON DL, 1995, J NEUROPHYSIOL, V74, P713, DOI 10.1152/jn.1995.74.2.713; SCHILLER PH, 1972, J NEUROPHYSIOL, V35, P915, DOI 10.1152/jn.1972.35.6.915; SHEPARD RN, 1986, J EXP PSYCHOL HUMAN, V12, P383, DOI 10.1037/0096-1523.12.3.383; Sparks D L, 1989, Rev Oculomot Res, V3, P213; Stuphorn V, 2000, J NEUROPHYSIOL, V83, P1283, DOI 10.1152/jn.2000.83.3.1283; TAYLOR MM, 1967, J ACOUST SOC AM, V41, P782, DOI 10.1121/1.1910407; THIER P, 1992, EUR J NEUROSCI, V4, P539, DOI 10.1111/j.1460-9568.1992.tb00904.x; Wurtz RH, 1996, INVEST OPHTH VIS SCI, V37, P2131; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P745, DOI 10.1152/jn.1976.39.4.745; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936	37	288	290	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					56	64		10.1038/nn1169	http://dx.doi.org/10.1038/nn1169			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14699418				2022-12-17	WOS:000187636000013
J	Sakai, K; Rowe, JB; Passingham, RE				Sakai, K; Rowe, JB; Passingham, RE			Active maintenance in prefrontal area 46 creates distractor-resistant memory	NATURE NEUROSCIENCE			English	Article							SPATIAL WORKING-MEMORY; DELAYED-RESPONSE PERFORMANCE; POSTERIOR PARIETAL CORTEX; EVENT-RELATED FMRI; NEURONAL-ACTIVITY; EXECUTIVE CONTROL; FRONTAL-CORTEX; FUNCTIONAL MRI; BRAIN ACTIVITY; RHESUS-MONKEY	How does the brain maintain information in working memory while challenged by incoming distractions? Using functional magnetic resonance imaging (fMRI), we measured human brain activity during the memory delay of a spatial working memory task with distraction. We found that, in the prefrontal cortex (PFC), the magnitude of activity sustained throughout the memory delay was significantly higher on correct trials than it was on error trials. By contrast, the magnitude of sustained activity in posterior areas did not differ between correct and error trials. The correlation of activity between posterior areas was, however, associated with correct memory performance after distraction. On the basis of these findings, we propose that memory representations gain resistance against distraction during a period of active maintenance within working memory. This may be mediated by interactions between prefrontal and posterior areas.	Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of London; University College London; University of Oxford	Sakai, K (corresponding author), Inst Neurol, Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.	ksakai@fil.ion.ucl.ac.uk	Tick, Beata/ABA-1728-2020; rowe, james B/C-3661-2013	rowe, james B/0000-0001-7216-8679	Wellcome Trust [077029] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; CHAO LL, 1995, NEUROREPORT, V6, P1605, DOI 10.1097/00001756-199508000-00005; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Constantinidis C, 1996, J NEUROPHYSIOL, V76, P1352, DOI 10.1152/jn.1996.76.2.1352; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; D'Esposito M, 1999, P NATL ACAD SCI USA, V96, P7514, DOI 10.1073/pnas.96.13.7514; D'Esposito M, 1999, NEUROPSYCHOLOGIA, V37, P1303, DOI 10.1016/S0028-3932(99)00021-4; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Frith C, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P549; Funahashi S, 1997, BEHAV BRAIN RES, V84, P203, DOI 10.1016/S0166-4328(96)00151-9; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; Gopher D, 2000, J EXP PSYCHOL GEN, V129, P308, DOI 10.1037/0096-3445.129.3.308; Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0; KATO M, 1995, J NEUROSCI, V15, P912; KOJIMA S, 1982, BRAIN RES, V248, P43, DOI 10.1016/0006-8993(82)91145-3; Malmo RB, 1942, J NEUROPHYSIOL, V5, P295, DOI 10.1152/jn.1942.5.4.295; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MILLER EK, 1993, J NEUROSCI, V13, P1460; Miller EK, 1996, J NEUROSCI, V16, P5154; Miyashita Y, 2000, CURR OPIN NEUROBIOL, V10, P187, DOI 10.1016/S0959-4388(00)00071-4; Owen AM, 1999, EUR J NEUROSCI, V11, P567, DOI 10.1046/j.1460-9568.1999.00449.x; Perry RJ, 2000, BRAIN, V123, P2273, DOI 10.1093/brain/123.11.2273; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Petrides M, 1998, PREFRONTAL CORTEX EX, P103; RAJKOWSKA G, 1995, CEREB CORTEX, V5, P323, DOI 10.1093/cercor/5.4.323; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rosen AC, 1999, J COGNITIVE NEUROSCI, V11, P135, DOI 10.1162/089892999563283; Rowe JB, 2001, NEUROIMAGE, V14, P77, DOI 10.1006/nimg.2001.0784; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Rubinstein JS, 2001, J EXP PSYCHOL HUMAN, V27, P763, DOI 10.1037//0096-1523.27.4.763; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Sawaguchi T, 1999, J NEUROPHYSIOL, V82, P2070, DOI 10.1152/jn.1999.82.5.2070; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3	46	288	293	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					479	484		10.1038/nn846	http://dx.doi.org/10.1038/nn846			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11953754				2022-12-17	WOS:000175272000020
J	Immke, DC; McCleskey, EW				Immke, DC; McCleskey, EW			Lactate enhances the acid-sensing Na+ channel on ischemia-sensing neurons	NATURE NEUROSCIENCE			English	Article							MYOCARDIAL-ISCHEMIA; EVOKED CURRENTS; SENSORY NEURONS; H+		Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Immke, DC (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.							Armour JA, 1999, CARDIOVASC RES, V41, P41, DOI 10.1016/S0008-6363(98)00252-1; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Benson CJ, 1999, CIRC RES, V84, P921; COBBE SM, 1980, J MOL CELL CARDIOL, V12, P745, DOI 10.1016/0022-2828(80)90077-2; COHEN RD, 1983, DIABETES, V32, P181, DOI 10.2337/diab.32.2.181; Hong JL, 1997, J PHYSIOL-LONDON, V500, P319, DOI 10.1113/jphysiol.1997.sp022023; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; Martell A. E., 1977, CRITICAL STABILITY C, V3; Pan HL, 1999, J PHYSIOL-LONDON, V518, P857, DOI 10.1111/j.1469-7793.1999.0857p.x; STAHL GL, 1992, AM J PHYSIOL, V262, pH748, DOI 10.1152/ajpheart.1992.262.3.H748; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; YAN GX, 1992, CIRC RES, V71, P460, DOI 10.1161/01.RES.71.2.460	14	288	311	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					869	870		10.1038/nn0901-869	http://dx.doi.org/10.1038/nn0901-869			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528414				2022-12-17	WOS:000170698600009
J	Aizawa, H; Wakatsuki, S; Ishii, A; Moriyama, K; Sasaki, Y; Ohashi, K; Sekine-Aizawa, Y; Sehara-Fujisawa, A; Mizuno, K; Goshima, Y; Yahara, I				Aizawa, H; Wakatsuki, S; Ishii, A; Moriyama, K; Sasaki, Y; Ohashi, K; Sekine-Aizawa, Y; Sehara-Fujisawa, A; Mizuno, K; Goshima, Y; Yahara, I			Phosphorylation of cofilin by LIM-kinase is necessary for semaphorin 3A-induced growth cone collapse	NATURE NEUROSCIENCE			English	Article							ACTIN-DEPOLYMERIZING FACTOR; RETROGRADE AXOPLASMIC-TRANSPORT; ARP2/3 COMPLEX; PROTEIN; CYTOSKELETON; FILAMENTS; DYNAMICS; FAMILY; WASP; ADF/COFILIN	Semaphorin 3A is a chemorepulsive axonal guidance molecule that depolymerizes the actin cytoskeleton and collapses growth cones of dorsal root ganglia neurons. Here we investigate! the role of LIM-kinase 1, which phosphorylates an actin-depolymerizimg protein, cofilin, in semaphorin 3A-induced growth cone collapse. Semaphorin 3A induced phosphorylation and dephosphorylation of cofilin at growth cones sequentially. A synthetic cell-permeable peptide containing a cofilin phosphorylation site inhibited LIM-kinase in vitro and in vivo, and essentially suppressed semaphorin 3A-induced growth cone collapse. A dominant-negative LIM kinase, which could not be activated by PAK or ROCK, suppressed the collapsing activity of semaphorin 3A. Phosphorylation of cofilin by LIM-kinase may be a critical signaling event in growth cone collapse by semaphorin 3A.	Tokyo Metropolitan Inst Med Sci, Dept Cell Biol, Bunkyo Ku, Tokyo 1138613, Japan; Yokohama City Univ, Sch Med, Dept Pharmacol, Yokohama, Kanagawa 2360004, Japan; Tohoku Univ, Grad Sch Sci, Inst Biol, Sendai, Miyagi 9808578, Japan; RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan	Tokyo Metropolitan Institute of Medical Science; Yokohama City University; Tohoku University; RIKEN; Japan Science & Technology Agency (JST)	Aizawa, H (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	aizawa@rr.iij4u.or.jp	Mizuno, Kensaku/G-8631-2015; Ohashi, Kazumasa/U-7028-2019; Sasaki, Yukio/P-7662-2015	Ohashi, Kazumasa/0000-0001-7617-403X; Sasaki, Yukio/0000-0001-6143-7001				Abe H, 1996, J CELL BIOL, V132, P871, DOI 10.1083/jcb.132.5.871; AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Aizawa H, 1996, J CELL BIOL, V132, P335, DOI 10.1083/jcb.132.3.335; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; BAMBURG JR, 1987, J CELL BIOL, V105, P2817, DOI 10.1083/jcb.105.6.2817; Beckerle MC, 1998, CELL, V95, P741, DOI 10.1016/S0092-8674(00)81697-9; Byk T, 1996, J NEUROSCI, V16, P688; Carlier MF, 1999, J BIOL CHEM, V274, P33827, DOI 10.1074/jbc.274.48.33827; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Edwards DC, 1999, J BIOL CHEM, V274, P11352, DOI 10.1074/jbc.274.16.11352; FAN JH, 1993, J CELL BIOL, V121, P867, DOI 10.1083/jcb.121.4.867; Goshima Y, 1999, J NEUROBIOL, V39, P579, DOI 10.1002/(SICI)1097-4695(19990615)39:4<579::AID-NEU11>3.0.CO;2-9; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Goshima Y, 1997, J NEUROBIOL, V33, P316, DOI 10.1002/(SICI)1097-4695(199709)33:3<316::AID-NEU9>3.0.CO;2-4; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; IIDA K, 1993, GENE, V124, P115; Jin Z, 1997, J NEUROSCI, V17, P6256; Kuhn TB, 1999, J NEUROSCI, V19, P1965; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Machesky LM, 1999, NAT CELL BIOL, V1, pE29, DOI 10.1038/10020; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; MINTURN JE, 1995, J NEUROSCI, V15, P6757; MOON AL, 1993, J CELL BIOL, V120, P421, DOI 10.1083/jcb.120.2.421; Moriyama K, 1999, EMBO J, V18, P6752, DOI 10.1093/emboj/18.23.6752; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Prochiantz A, 1996, CURR OPIN NEUROBIOL, V6, P629, DOI 10.1016/S0959-4388(96)80095-X; PROSCHEL C, 1995, ONCOGENE, V11, P1271; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rosenblatt J, 1998, NATURE, V393, P739, DOI 10.1038/31597; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tassabehji M, 1996, NAT GENET, V13, P272, DOI 10.1038/ng0796-272; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vastrik I, 1999, CURR BIOL, V9, P991, DOI 10.1016/S0960-9822(99)80447-3; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; YONEZAWA N, 1990, J BIOL CHEM, V265, P8382	47	288	294	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					367	373		10.1038/86011	http://dx.doi.org/10.1038/86011			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276226				2022-12-17	WOS:000168762200016
J	St-Pierre, F; Marshall, JD; Yang, Y; Gong, YY; Schnitzer, MJ; Lin, MZ				St-Pierre, Francois; Marshall, Jesse D.; Yang, Ying; Gong, Yiyang; Schnitzer, Mark J.; Lin, Michael Z.			High-fidelity optical reporting of neuronal electrical activity with an ultrafast fluorescent voltage sensor	NATURE NEUROSCIENCE			English	Article							MICROBIAL RHODOPSIN; ACTION-POTENTIALS; NEURAL ACTIVITY; PROTEIN; PROBE; MECHANISM; INTERNEURONS; INTEGRATION; INDICATORS; CIRCUITS	Accurate optical reporting of electrical activity in genetically defined neuronal populations is a long-standing goal in neuroscience. We developed Accelerated Sensor of Action Potentials 1 (ASAP1), a voltage sensor design in which a circularly permuted green fluorescent protein is inserted in an extracellular loop of a voltage-sensing domain, rendering fluorescence responsive to membrane potential. ASAP1 demonstrated on and off kinetics of similar to 2 ms, reliably detected single action potentials and subthreshold potential changes, and tracked trains of action potential waveforms up to 200 Hz in single trials. With a favorable combination of brightness, dynamic range and speed, ASAP1 enables continuous monitoring of membrane potential in neurons at kilohertz frame rates using standard epifluorescence microscopy.	[St-Pierre, Francois; Yang, Ying; Lin, Michael Z.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [St-Pierre, Francois; Yang, Ying; Lin, Michael Z.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Marshall, Jesse D.; Gong, Yiyang; Schnitzer, Mark J.] Stanford Univ, James H Clark Ctr, Stanford, CA 94305 USA; [Marshall, Jesse D.; Gong, Yiyang; Schnitzer, Mark J.] Stanford Univ, CNC Program, Palo Alto, CA 94304 USA; [Schnitzer, Mark J.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Lin, MZ (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	mzlin@stanford.edu		Gong, Yiyang/0000-0002-1855-930X; Lin, Michael/0000-0002-0492-1961; St-Pierre, Francois/0000-0001-8618-4135	DARPA; National Science Foundation [1134416]; Stanford Graduate Fellowship; Walter V. and Idun Berry Postdoctoral Fellowship; Stanford University Bio-X Interdisciplinary Initiatives Project grant; Stanford CNC Program; Howard Hughes Medical Institute; National Academy of Sciences Keck Futures Initiative; Rita Allen Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [1134416] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615] Funding Source: NIH RePORTER	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Science Foundation(National Science Foundation (NSF)); Stanford Graduate Fellowship(Stanford University); Walter V. and Idun Berry Postdoctoral Fellowship; Stanford University Bio-X Interdisciplinary Initiatives Project grant; Stanford CNC Program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Academy of Sciences Keck Futures Initiative; Rita Allen Foundation; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the following for providing rats or dissociated neurons: H. Park and Y. Geng (Stanford), M. Hintze and S. Ganesan (Stanford), and C. Ramakrishnan and H. Swanson (Stanford). We also thank X. Ding (Tsinghua University) for assistance with cloning ASAP1 variants with cpsepHluorin A227D, Y. Geng (Stanford) for providing microfluidic chambers, J. Chu (Stanford) for a purified preparation of Clover GFP, V. Pieribone (Yale University) for the generous gift of GgVSD(153Q), DrVSD(R153Q) and XIVSD(R152Q), L. Oltrogge (Stanford) for the generous gift of cpsfGFP-OPT, J. Bant (Stanford) for advice on electrophysiological recordings, and members of the Lin laboratory for comments on the manuscript. This work was supported by DARPA (M.Z.L., M.J.S.), National Science Foundation grant 1134416 (ES.-P., M.Z.L.), a Stanford Graduate Fellowship (J.D.M.), a Walter V. and Idun Berry Postdoctoral Fellowship (Y.Y.), a Stanford University Bio-X Interdisciplinary Initiatives Project grant (M.Z.L., M.J.S.), the Stanford CNC Program (YG., J.D.M., M.J.S.), the Howard Hughes Medical Institute (M.J.S.) and the National Academy of Sciences Keck Futures Initiative (Y.G., J.D.M., M.J.S.). M.Z.L. receives funding from the Rita Allen Foundation.	Akemann W, 2012, J NEUROPHYSIOL, V108, P2323, DOI 10.1152/jn.00452.2012; Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Ataka K, 2002, BIOPHYS J, V82, P509, DOI 10.1016/S0006-3495(02)75415-5; Baker BJ, 2007, J NEUROSCI METH, V161, P32, DOI 10.1016/j.jneumeth.2006.10.005; Barnett L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043454; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Cao G, 2013, CELL, V154, P904, DOI 10.1016/j.cell.2013.07.027; Castro-Alamancos MA, 2009, NEUROSCIENTIST, V15, P625, DOI 10.1177/1073858409333074; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Dimitrov D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000440; Gautam Sunita Ghimire, 2009, Front Neuroeng, V2, P14, DOI 10.3389/neuro.16.014.2009; Gong YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4674; Gong YY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066959, 10.1371/journal.pone.0070340]; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Knopfel T, 2012, NAT REV NEUROSCI, V13, P687, DOI 10.1038/nrn3293; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Li QF, 2014, NAT STRUCT MOL BIOL, V21, P244, DOI 10.1038/nsmb.2768; Lundby A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002514; Maclaurin D, 2013, P NATL ACAD SCI USA, V110, P5939, DOI 10.1073/pnas.1215595110; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Murthy VN, 2000, P NATL ACAD SCI USA, V97, P901, DOI 10.1073/pnas.97.2.901; Perron A, 2009, CHEM BIOL, V16, P1268, DOI 10.1016/j.chembiol.2009.11.014; Puig MV, 2008, P NATL ACAD SCI USA, V105, P8428, DOI 10.1073/pnas.0712219105; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; Staff NP, 2000, J NEUROPHYSIOL, V84, P2398, DOI 10.1152/jn.2000.84.5.2398; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tsutsui H, 2013, J PHYSIOL-LONDON, V591, P4427, DOI 10.1113/jphysiol.2013.257048; Zecevic D., 2003, CURR PROTOC NEUROSCI, V6; Zhou FW, 2011, CEREB CORTEX, V21, P1645, DOI 10.1093/cercor/bhq234	34	287	298	3	148	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2014	17	6					884	889		10.1038/nn.3709	http://dx.doi.org/10.1038/nn.3709			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI1TO	24755780	Green Accepted			2022-12-17	WOS:000336638000025
J	Lin, SC; Bergles, DE				Lin, SC; Bergles, DE			Synaptic signaling between GABAergic interneurons and oligodendrocyte precursor cells in the hippocampus	NATURE NEUROSCIENCE			English	Article							IDENTIFIED GLIAL-CELLS; GABA(A) RECEPTORS; PROGENITOR-CELL; GLUTAMATE-RECEPTOR; ALPHA-5 SUBUNIT; WHITE-MATTER; MICE LACKING; A RECEPTOR; CURRENTS; NEURONS	Oligodendrocyte precursor cells (OPCs) express receptors for many neurotransmitters, but the mechanisms responsible for their activation are poorly understood. We have found that quantal release of GABA from interneurons elicits GABA(A) receptor currents with rapid rise times in hippocampal OPCs. These currents did not exhibit properties of spillover transmission or release by transporters, and immunofluorescence and electron microscopy suggest that interneuronal terminals are in direct contact with OPCs, indicating that these GABA currents are generated at direct interneuron-OPC synapses. The reversal potential of OPC GABA(A) currents was -43 mV, and interneuronal firing was correlated with transient depolarizations induced by GABA(A) receptors; however, GABA application induced a transient inhibition of currents mediated by AMPA receptors in OPCs. These results indicate that OPCs are a direct target of interneuronal collaterals and that the GABA-induced Cl- flux generated by these events may influence oligodendrocyte development by regulating the efficacy of glutamatergic signaling in OPCs.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Bergles, DE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St,WBSB 813, Baltimore, MD 21205 USA.	dbergles@jhmi.edu	Messier, Claude/A-2322-2008; Bergles, Dwight/U-8343-2019	Messier, Claude/0000-0002-4791-1763; Bergles, Dwight/0000-0002-7133-7378				BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441, DOI 10.1146/annurev.neuro.13.1.441; BARRES BA, 1990, NEURON, V4, P507, DOI 10.1016/0896-6273(90)90109-S; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Burgard EC, 1996, MOL PHARMACOL, V50, P119; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Clark BA, 2002, J NEUROSCI, V22, P4428, DOI 10.1523/JNEUROSCI.22-11-04428.2002; Cohen AS, 2000, J NEUROPHYSIOL, V84, P2465, DOI 10.1152/jn.2000.84.5.2465; Collinson N, 2002, J NEUROSCI, V22, P5572; Dzubay JA, 1999, J NEUROSCI, V19, P5265; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; Follett PL, 2000, J NEUROSCI, V20, P9235; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; GILBERT P, 1984, J NEUROSCI, V4, P561; Goldstein PA, 2002, J NEUROPHYSIOL, V88, P3208, DOI 10.1152/jn.00885.2001; Hajos N, 2000, EUR J NEUROSCI, V12, P810, DOI 10.1046/j.1460-9568.2000.00964.x; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Lavoie AM, 1996, NEUROPHARMACOLOGY, V35, P1383, DOI 10.1016/S0028-3908(96)00077-9; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Levison SW, 1999, J NEUROSCI RES, V57, P435, DOI 10.1002/(SICI)1097-4547(19990815)57:4<435::AID-JNR3>3.0.CO;2-L; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; Mody I, 2001, NEUROCHEM RES, V26, P907, DOI 10.1023/A:1012376215967; MUDRICKDONNON LA, 1993, J NEUROSCI, V13, P4660; Overstreet LS, 2000, J NEUROSCI, V20, P7914; Owens DF, 1996, J NEUROSCI, V16, P6414; PASTOR A, 1995, EUR J NEUROSCI, V7, P1188, DOI 10.1111/j.1460-9568.1995.tb01109.x; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; Perrais D, 1999, J NEUROSCI, V19, P578; PITLER TA, 1992, J PHYSIOL-LONDON, V450, P127, DOI 10.1113/jphysiol.1992.sp019119; Porter JT, 1996, J NEUROSCI, V16, P5073; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Sciancalepore M, 1998, J NEUROPHYSIOL, V80, P2316, DOI 10.1152/jn.1998.80.5.2316; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; STEINHAUSER C, 1992, EUR J NEUROSCI, V4, P472, DOI 10.1111/j.1460-9568.1992.tb00897.x; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Theodosis DT, 1996, TRENDS NEUROSCI, V19, P363, DOI 10.1016/0166-2236(96)10055-2; Tillet E, 1997, J BIOL CHEM, V272, P10769; Van Damme P, 2003, J NEUROSCI, V23, P4942; VONBLANKENFELD G, 1991, EUR J NEUROSCI, V3, P310; Williamson AV, 1998, NEUROPHARMACOLOGY, V37, P859, DOI 10.1016/S0028-3908(98)00016-1; Yuan XQ, 1998, DEVELOPMENT, V125, P2901	47	287	294	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					24	32		10.1038/nn1162	http://dx.doi.org/10.1038/nn1162			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14661022				2022-12-17	WOS:000187636000009
J	Helmchen, F; Svoboda, K; Denk, W; Tank, DW				Helmchen, F; Svoboda, K; Denk, W; Tank, DW			In vivo dendritic calcium dynamics in deep-layer cortical pyramidal neurons	NATURE NEUROSCIENCE			English	Article							ACTION-POTENTIAL INITIATION; IN-VIVO; NEOCORTICAL NEURONS; APICAL DENDRITES; SENSORIMOTOR CORTEX; SYNAPTIC RESPONSES; INHIBITORY CONTROL; CA2+ CHANNELS; MOTOR CORTEX; RAT	Dendritic Ca2+ action potentials in neocortical pyramidal neurons have been characterized in brain slices, but their presence and role in the intact neocortex remain unclear. Here we used two-photon microscopy to demonstrate Ca2+ electrogenesis in apical dendrites of deep-layer pyramidal neurons of rat barrel cortex in vive. During whisker stimulation, complex spikes recorded intracellularly from distal dendrites and sharp waves in the electrocorticogram were accompanied by large dendritic [Ca2+] transients; these also occurred during bursts of action potentials recorded from somata of identified layer 5 neurons. The amplitude of the [Ca2+] transients was largest proximal to the main bifurcation, where sodium action potentials produced little Ca2+ influx. In some cases, synaptic stimulation evoked [Ca2+] transients without a concomitant action potential burst, suggesting variable coupling between dendrite and soma.	Lucent Technol, Bell Labs, Biol Computat Res Dept, Murray Hill, NJ 07974 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Alcatel-Lucent; Lucent Technologies; AT&T; Cold Spring Harbor Laboratory	Helmchen, F (corresponding author), Lucent Technol, Bell Labs, Biol Computat Res Dept, Murray Hill, NJ 07974 USA.		denk, winfried/I-6627-2012; Helmchen, Fritjof/A-6255-2008	Helmchen, Fritjof/0000-0002-8867-9569				AMITAI Y, 1993, CEREB CORTEX, V3, P26, DOI 10.1093/cercor/3.1.26; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BARANYI A, 1993, J NEUROPHYSIOL, V69, P1850, DOI 10.1152/jn.1993.69.6.1850; BERNANDER O, 1994, J NEUROPHYSIOL, V72, P2743, DOI 10.1152/jn.1994.72.6.2743; Buzsaki G, 1998, J NEUROPHYSIOL, V79, P1587, DOI 10.1152/jn.1998.79.3.1587; CAULLER LJ, 1994, J NEUROSCI, V14, P751; CHAGNACAMITAL Y, 1990, J COMP NEUROL, V296, P598, DOI 10.1002/cne.902960407; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; FRANCESCHETTI S, 1995, BRAIN RES, V696, P127, DOI 10.1016/0006-8993(95)00807-3; FRIEDMAN A, 1989, EUR J NEUROSCI, V1, P374, DOI 10.1111/j.1460-9568.1989.tb00802.x; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; HIRSCH JA, 1995, NATURE, V378, P612, DOI 10.1038/378612a0; Kandel A, 1997, J NEUROSCI, V17, P6783; KIM HG, 1995, J NEUROPHYSIOL, V74, P1810, DOI 10.1152/jn.1995.74.4.1810; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MASON A, 1990, J NEUROSCI, V10, P1415; MCCORMICK DA, 1993, CEREB CORTEX, V3, P387, DOI 10.1093/cercor/3.5.387; NUNEZ A, 1993, J NEUROPHYSIOL, V70, P418, DOI 10.1152/jn.1993.70.1.418; Pare D, 1998, NEUROSCIENCE, V84, P377, DOI 10.1016/S0306-4522(97)00530-7; Pare D, 1998, EUR J NEUROSCI, V10, P3164, DOI 10.1046/j.1460-9568.1998.00323.x; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; POCKBERGER H, 1991, BRAIN RES, V539, P181, DOI 10.1016/0006-8993(91)91619-C; REUVENI I, 1993, J NEUROSCI, V13, P4609; RHODES PA, 1994, NEURAL COMPUT, V6, P1086, DOI 10.1162/neco.1994.6.6.1086; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Schwindt PC, 1997, J NEUROPHYSIOL, V77, P2466, DOI 10.1152/jn.1997.77.5.2466; Seamans JK, 1997, J NEUROSCI, V17, P5936; SILVA LR, 1991, SCIENCE, V251, P432, DOI 10.1126/science.1824881; STAFSTROM CE, 1985, J NEUROPHYSIOL, V53, P153, DOI 10.1152/jn.1985.53.1.153; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; TSENG GF, 1993, J COMP NEUROL, V335, P92, DOI 10.1002/cne.903350107; WANG Z, 1993, J NEUROSCI, V13, P219; WONG RKS, 1978, BRAIN RES, V159, P385, DOI 10.1016/0006-8993(78)90544-9; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	50	287	291	1	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					989	996		10.1038/14788	http://dx.doi.org/10.1038/14788			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526338				2022-12-17	WOS:000083883300016
J	Vaccarino, FM; Schwartz, ML; Raballo, R; Nilsen, J; Rhee, J; Zhou, M; Doetschman, T; Coffin, JD; Wyland, JJ; Hung, YTE				Vaccarino, FM; Schwartz, ML; Raballo, R; Nilsen, J; Rhee, J; Zhou, M; Doetschman, T; Coffin, JD; Wyland, JJ; Hung, YTE			Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; PROGRAMMED CELL-DEATH; CLONAL HETEROGENEITY; PROGENITOR CELLS; CYCLE PARAMETERS; PRECURSOR CELLS; GERMINAL ZONE; MESSENGER-RNA; FGF-RECEPTOR; RAT-BRAIN	We show that fibroblast growth factor 2 (FGF2) and FGF receptors are transiently expressed by cells of the pseudostratified ventricular epithelium (PVE) during early neurogenesis. A single microinjection of FGF2 into cerebral ventricles of rat embryos at E15.5 increased the volume and total number of neurons in the adult cerebral cortex by 18% and 87%, respectively. Microinjection of FGF2, by the end of neurogenesis, at E20.5, selectively increased the number of glia. Mice lacking the FGF2 gene had fewer cortical neurons and glia at maturity. BrdU studies in FGF2-microinjected and FGF2-null animals suggested that FGF2 increases the proportion of dividing cells in the PVE without affecting the cell-cycle length. Thus, FGF2 increases the number of rounds of division of cortical progenitors.	Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; Yale Univ, Neurobiol Sect, New Haven, CT 06520 USA; Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; McLaughlin Res Inst, Great Falls, MT 59405 USA	Yale University; Yale University; University System of Ohio; University of Cincinnati; McLaughlin Research Institute for Biomedical Sciences, Inc.	Vaccarino, FM (corresponding author), Yale Univ, Ctr Child Study, 230 S Frontage Rd, New Haven, CT 06520 USA.		Nilsen, Jon/A-3082-2008	Nilsen, Jon/0000-0002-9305-7799; Vaccarino, Flora/0000-0003-2167-981X				ACKLIN SE, 1993, DEVELOPMENT, V118, P175; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; Bayer S.A., 1991, NEOCORTICAL DEV; Blaschke AJ, 1996, DEVELOPMENT, V122, P1165; BOHEN P, 1985, FEBS LETT, V185, P177; BROWN NA, 1990, POSTIMPLANTATION MAM; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Cavanagh JFR, 1997, CEREB CORTEX, V7, P293, DOI 10.1093/cercor/7.4.293; DEHAMER MK, 1994, NEURON, V13, P1083, DOI 10.1016/0896-6273(94)90047-7; Dono R, 1998, EMBO J, V17, P4213, DOI 10.1093/emboj/17.15.4213; ECKENSTEIN FP, 1994, J NEUROBIOL, V25, P1467; ENGELE J, 1992, DEV BIOL, V152, P363, DOI 10.1016/0012-1606(92)90143-5; FLORKIEWICZ RZ, 1995, J CELL PHYSIOL, V162, P388, DOI 10.1002/jcp.1041620311; FUJITA S, 1963, J COMP NEUROL, V120, P37, DOI 10.1002/cne.901200104; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GIORDANO S, 1992, DEV BIOL, V152, P293, DOI 10.1016/0012-1606(92)90136-5; KILPATRICK TJ, 1995, J NEUROSCI, V15, P3653; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; MURPHY M, 1990, J NEUROSCI RES, V25, P463, DOI 10.1002/jnr.490250404; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; ORRURTREGER A, 1991, DEVELOPMENT, V113, P1419; Ortega S, 1998, P NATL ACAD SCI USA, V95, P5672, DOI 10.1073/pnas.95.10.5672; PARTANEN J, 1993, PHILOS T R SOC B, V340, P297, DOI 10.1098/rstb.1993.0071; PATSTONE G, 1993, DEV BIOL, V155, P107, DOI 10.1006/dbio.1993.1011; POWELL PP, 1991, MOL BRAIN RES, V11, P71, DOI 10.1016/0169-328X(91)90023-Q; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; RAY J, 1995, J NEUROCHEM, V64, P503; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; Reznikov K, 1997, DEV DYNAM, V210, P328, DOI 10.1002/(SICI)1097-0177(199711)210:3<328::AID-AJA12>3.0.CO;2-6; Robel L, 1995, J NEUROSCI, V15, P7879; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; SMART I, 1961, J COMP NEUROL, V116, P325, DOI 10.1002/cne.901160306; TAKAHASHI T, 1993, J NEUROSCI, V13, P820; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Takahashi T, 1996, J NEUROSCI, V16, P6183; TAKAHASHI T, 1994, P NATL ACAD SCI USA, V91, P373; TAKAUWA N, 1993, J BIOL CHEM, V268, P138; Thomaidou D, 1997, J NEUROSCI, V17, P1075, DOI 10.1523/jneurosci.17-03-01075.1997; VACCARINO FM, 1995, CEREB CORTEX, V1, P64; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WEISE B, 1993, J NEUROSCI RES, V34, P442, DOI 10.1002/jnr.490340409; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WILLIAMS BP, 1985, DEV BIOL, V112, P126, DOI 10.1016/0012-1606(85)90126-5; ZHAN X, 1993, J BIOL CHEM, V268, P9611; Zhou M, 1998, NAT MED, V4, P201, DOI 10.1038/nm0298-201	48	287	295	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					246	253		10.1038/6350	http://dx.doi.org/10.1038/6350			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	220TX	10195217				2022-12-17	WOS:000081684500012
J	Hoekzema, E; Barba-Muller, E; Pozzobon, C; Picado, M; Lucco, F; Garcia-Garcia, D; Soliva, JC; Tobena, A; Desco, M; Crone, EA; Ballesteros, A; Carmona, S; Vilarroya, O				Hoekzema, Elseline; Barba-Muller, Erika; Pozzobon, Cristina; Picado, Marisol; Lucco, Florencio; Garcia-Garcia, David; Carlos Soliva, Juan; Tobena, Adolf; Desco, Manuel; Crone, Eveline A.; Ballesteros, Agustin; Carmona, Susanna; Vilarroya, Oscar			Pregnancy leads to long-lasting changes in human brain structure	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL NEUROGENESIS; CORTICAL THICKNESS; POSTPARTUM PERIOD; PITUITARY-GLAND; SURFACE-AREA; MOTHERHOOD; MEMORY; SPECTROSCOPY; ORGANIZATION; SENSITIVITY	Pregnancy involves radical hormone surges and biological adaptations. However, the effects of pregnancy on the human brain are virtually unknown. Here we show, using a prospective ('pre'-'post' pregnancy) study involving first-time mothers and fathers and nulliparous control groups, that pregnancy renders substantial changes in brain structure, primarily reductions in gray matter (GM) volume in regions subserving social cognition. The changes were selective for the mothers and highly consistent, correctly classifying all women as having undergone pregnancy or not in-between sessions. Interestingly, the volume reductions showed a substantial overlap with brain regions responding to the women's babies postpartum. Furthermore, the GM volume changes of pregnancy predicted measures of postpartum maternal attachment, suggestive of an adaptive process serving the transition into motherhood. Another follow-up session showed that the GM reductions endured for at least 2 years post-pregnancy. Our data provide the first evidence that pregnancy confers long-lasting changes in a woman's brain.	[Hoekzema, Elseline; Barba-Muller, Erika; Picado, Marisol; Carlos Soliva, Juan; Tobena, Adolf; Carmona, Susanna; Vilarroya, Oscar] Univ Autonoma Barcelona, Dept Psiquiatria & Med Legal, Unitat Recerca Neurociencia Cognit, Barcelona, Spain; [Hoekzema, Elseline; Crone, Eveline A.] Leiden Univ, Brain & Dev Lab, Leiden, Netherlands; [Hoekzema, Elseline; Crone, Eveline A.] Leiden Univ, LIBC, Leiden, Netherlands; [Pozzobon, Cristina; Lucco, Florencio; Ballesteros, Agustin] Inst Valenciano Infertil, Barcelona, Spain; [Garcia-Garcia, David; Desco, Manuel; Carmona, Susanna] Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Carmona, Susanna] Ctr Invest Biorned Red Salud Mental CIBERSAM, Madrid, Spain; [Vilarroya, Oscar] Fundacio IMIM, Barcelona, Spain	Autonomous University of Barcelona; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Universidad Carlos III de Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Institut Hospital del Mar d'Investigacions Mediques (IMIM)	Hoekzema, E (corresponding author), Univ Autonoma Barcelona, Dept Psiquiatria & Med Legal, Unitat Recerca Neurociencia Cognit, Barcelona, Spain.; Hoekzema, E (corresponding author), Leiden Univ, Brain & Dev Lab, Leiden, Netherlands.; Hoekzema, E (corresponding author), Leiden Univ, LIBC, Leiden, Netherlands.	elselinehoekzema@gmail.com	tobena, adolf/G-1032-2010; Desco, Manuel/AAD-7137-2019; Vilarroya, Oscar/AAH-3283-2021; Garcia-Garcia, David/I-2105-2015	Desco, Manuel/0000-0003-0989-3231; Vilarroya, Oscar/0000-0001-8285-5624; Garcia-Garcia, David/0000-0001-5224-3280; Hoekzema, Elseline/0000-0001-5814-8647; Crone, Eveline/0000-0002-7508-6078; Barba-Muller, Erika/0000-0001-7916-5390; Tobena, Adolf/0000-0001-6137-0660; Carmona, Susanna/0000-0001-5853-6527	Formacion de Profesorado Universitario (FPU) grant by the Ministerio de Educacion y Ciencia, Spanish government; Innovational Research Incentives Scheme grant of the Netherlands Organization for Scientific Research (NWO) [451-14-036]; National Council of Science and Technology of Mexico; Consejeria de Educacion, Juventud y Deporte of Comunidad de Madrid; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7)/under REA grant [291820]; Agencia de Gestic d'Ajuts Universitaris de Recerca, Generalitat de Catalunya	Formacion de Profesorado Universitario (FPU) grant by the Ministerio de Educacion y Ciencia, Spanish government(German Research Foundation (DFG)); Innovational Research Incentives Scheme grant of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Council of Science and Technology of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejeria de Educacion, Juventud y Deporte of Comunidad de Madrid; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7)/under REA grant; Agencia de Gestic d'Ajuts Universitaris de Recerca, Generalitat de Catalunya	We acknowledge the participants for their contribution to this study. We thank A. Bulbena for supporting the project, and M. Lopez, G. Pons, R. Martinez, L. Gonzalez, E. Castatio, N. Mallorqui-Bague, J. Fauquet and C. Pretus for helping with the data collection and scoring of the cognitive tests. In addition, we thank C. Phillips and J.D. Gispert for advice on the multivariate analyses, E. Marinetto and C. Falcon for advice on the FreeSurfer analyses, and J. van Hemmen and J. Bakker for discussions of the project and results. E.H. was supported by a Formacion de Profesorado Universitario (FPU) grant by the Ministerio de Educacion y Ciencia, Spanish government, and is now supported by an Innovational Research Incentives Scheme grant (Veni, 451-14-036) of the Netherlands Organization for Scientific Research (NWO), E.B.-M. by a grant from the National Council of Science and Technology of Mexico, S.C. by the Consejeria de Educacion, Juventud y Deporte of Comunidad de Madrid and the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement 291820, and M.P. by an FI grant of the Agencia de Gestic d'Ajuts Universitaris de Recerca, Generalitat de Catalunya.	Anderson MV, 2012, EVOL PSYCHOL-US, V10, P659, DOI 10.1177/147470491201000402; Anderson MV, 2011, EVOL PSYCHOL-US, V9, P47; Barha CK, 2015, NEUROBIOL AGING, V36, P2391, DOI 10.1016/j.neurobiolaging.2015.04.007; BERGLAND RM, 1968, J NEUROSURG, V28, P93, DOI 10.3171/jns.1968.28.2.0093; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Brunton PJ, 2008, NAT REV NEUROSCI, V9, P11, DOI 10.1038/nrn2280; Buckwalter J G, 2001, Prog Brain Res, V133, P303; Casey M. L., 1993, HUMAN PLACENTA, P237; Christensen H, 2010, BRIT J PSYCHIAT, V196, P126, DOI 10.1192/bjp.bp.109.068635; Comasco E, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00388; Condon JT., 1998, J REPROD INFANT PSYC, V16, P57, DOI [DOI 10.1080/02646839808404558, 10.1080/02646839808404558]; Craig MC, 2007, CLIMACTERIC, V10, P97, DOI 10.1080/13697130701598746; Erdheim J., 1909, BEITR PATHOL ANAT, V45, P1; Galea LAM, 2000, HORM BEHAV, V37, P86, DOI 10.1006/hbeh.1999.1560; Glynn LM, 2010, PSYCHONEUROENDOCRINO, V35, P1148, DOI 10.1016/j.psyneuen.2010.01.015; GONZALEZ JG, 1988, AM J MED, V85, P217, DOI 10.1016/0002-9343(88)90542-6; Henry JD, 2007, J CLIN EXP NEUROPSYC, V29, P793, DOI 10.1080/13803390701612209; Herting MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119774; Hillerer KM, 2014, HIPPOCAMPUS, V24, P673, DOI 10.1002/hipo.22258; Hillerer KM, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/574159; Holdcroft A, 2005, AM J NEURORADIOL, V26, P352; Kim P, 2010, BEHAV NEUROSCI, V124, P695, DOI 10.1037/a0020884; Kinsley CH, 2012, MINI-REV MED CHEM, V12, P1063, DOI 10.2174/138955712802762248; Kinsley CH, 2011, J NEUROENDOCRINOL, V23, P974, DOI 10.1111/j.1365-2826.2011.02194.x; Kinsley CH, 2006, HORM BEHAV, V49, P131, DOI 10.1016/j.yhbeh.2005.05.017; Kinsley Craig Howard, 2012, Curr Top Behav Neurosci, V10, P317, DOI 10.1007/7854_2011_123; Lyall AE, 2015, CEREB CORTEX, V25, P2204, DOI 10.1093/cercor/bhu027; Macbeth AH, 2010, NEUROSCI BIOBEHAV R, V34, P452, DOI 10.1016/j.neubiorev.2009.08.011; Meins E, 2001, J CHILD PSYCHOL PSYC, V42, P637, DOI 10.1111/1469-7610.00759; Nygaard GO, 2015, MULT SCLER J, V21, P402, DOI 10.1177/1352458514543811; Oatridge A, 2002, AM J NEURORADIOL, V23, P19; OSTER S, 1993, ACTA NEUROPATHOL, V85, P617, DOI 10.1007/BF00334671; Pawluski JL, 2007, NEUROSCIENCE, V149, P53, DOI 10.1016/j.neuroscience.2007.07.031; Pawluski JL, 2015, NEUROSCIENCE, V290, P379, DOI 10.1016/j.neuroscience.2015.01.048; Pawluski JL, 2012, NEUROSCIENCE, V227, P201, DOI 10.1016/j.neuroscience.2012.09.059; Pawluski JL, 2016, HORM BEHAV, V77, P86, DOI 10.1016/j.yhbeh.2015.06.004; Pearson RM, 2009, HORM BEHAV, V56, P557, DOI 10.1016/j.yhbeh.2009.09.013; Peper JS, 2011, NEUROSCIENCE, V191, P28, DOI 10.1016/j.neuroscience.2011.02.014; Peper JS, 2009, PSYCHONEUROENDOCRINO, V34, P332, DOI 10.1016/j.psyneuen.2008.09.012; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; REGEUR L, 1994, NEUROBIOL AGING, V15, P347, DOI 10.1016/0197-4580(94)90030-2; Roos A, 2011, BEHAV BRAIN RES, V222, P200, DOI 10.1016/j.bbr.2011.03.055; Rutherford JM, 2003, BJOG-INT J OBSTET GY, V110, P416, DOI 10.1016/S1470-0328(03)00916-9; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Swain JE, 2014, BRAIN RES, V1580, P78, DOI 10.1016/j.brainres.2014.03.007; Toffoletto S, 2014, PSYCHONEUROENDOCRINO, V50, P28, DOI 10.1016/j.psyneuen.2014.07.025; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	50	286	290	17	141	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2017	20	2					287	296		10.1038/nn.4458	http://dx.doi.org/10.1038/nn.4458			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ5PU	27991897	Green Submitted			2022-12-17	WOS:000393271000023
J	Mishra, A; Reynolds, JP; Chen, Y; Gourine, AV; Rusakov, DA; Attwell, D				Mishra, Anusha; Reynolds, James P.; Chen, Yang; Gourine, Alexander V.; Rusakov, Dmitri A.; Attwell, David			Astrocytes mediate neurovascular signaling to capillary pericytes but not to arterioles	NATURE NEUROSCIENCE			English	Article							NITRIC-OXIDE; PHOSPHOLIPASE A(2); BRAIN-SLICES; GLIAL-CELLS; D-SERINE; VASODILATION; RECEPTOR; EPOXYGENASE; MODULATION; REGULATORS	Active neurons increase their energy supply by dilating nearby arterioles and capillaries. This neurovascular coupling underlies blood oxygen level-dependent functional imaging signals, but its mechanism is controversial. Canonically, neurons release glutamate to activate metabotropic glutamate receptor 5 (mGluR5) on astrocytes, evoking Ca2+ release from internal stores, activating phospholipase A2 and generating vasodilatory arachidonic acid derivatives. However, adult astrocytes lack mGluR5, and knockout of the inositol 1,4,5-trisphosphate receptors that release Ca2+ from stores does not affect neurovascular coupling. We now show that buffering astrocyte Ca2+ inhibits neuronally evoked capillary dilation, that astrocyte (Ca2+](i) is raised not by release from stores but by entry through ATP-gated channels, and that Ca2+ generates arachidonic acid via phospholipase D2 and diacylglycerol kinase rather than phospholipase A2. In contrast, dilation of arterioles depends on NMDA receptor activation and Ca2+-dependent NO generation by interneurons. These results reveal that different signaling cascades regulate cerebral blood flow at the capillary and arteriole levels.	[Mishra, Anusha; Chen, Yang; Gourine, Alexander V.; Attwell, David] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Reynolds, James P.; Rusakov, Dmitri A.] UCL, Inst Neurol, London, England	University of London; University College London; University of London; University College London	Attwell, D (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	d.attwell@ucl.ac.uk	Attwell, David/ABE-6750-2020; Rusakov, Dmitri/AAH-4529-2021; Rusakov, Dmitri A/E-1987-2011; Mishra, Anusha/AAR-6128-2020	Rusakov, Dmitri/0000-0001-9539-9947; Rusakov, Dmitri A/0000-0001-9539-9947; Chen, Yang/0000-0002-5733-7523; Reynolds, James/0000-0002-1086-1424; Attwell, David/0000-0003-3618-0843; Mishra, Anusha/0000-0002-3642-5049	European Research Council; Fondation Leducq Transatlantic Network; Wellcome Trust [075232, 099222, 095064, 200893, 101896]; EU FP7 grant [ITN EXTRABRAIN 606950]; RSF grant [15-14-30000]; BBSRC [BB/J001473/1] Funding Source: UKRI; Russian Science Foundation [15-14-30000] Funding Source: Russian Science Foundation; Biotechnology and Biological Sciences Research Council [BB/J001473/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Fondation Leducq Transatlantic Network(Leducq Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); EU FP7 grant; RSF grant(Russian Science Foundation (RSF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Russian Science Foundation(Russian Science Foundation (RSF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank K. Zheng for help with two-photon microscopy, and M. Carandini, I. Christie, S. Cockcroft, M. Ford, R. Jolivet, S. Mastitskaya and S. Sullivan for comments on the manuscript. Supported by the European Research Council (BRAINPOWER to D.A. and NETSIGNAL to D.A.R.), a Fondation Leducq Transatlantic Network grant (to D.A.), a Wellcome Trust Programme Grant and Senior Investigator Award (075232 and 099222 to D.A.), a Wellcome Trust Senior Research Fellowship (095064 and 200893 to A.V.G.), a Wellcome Trust Principal Research Fellowship (101896 to D.A.R.), an EU FP7 grant (ITN EXTRABRAIN 606950 to D.A.R.) and an RSF grant (15-14-30000 to D.A.R.).	Alkayed NJ, 1996, STROKE, V27, P971, DOI 10.1161/01.STR.27.5.971; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Biesecker KR, 2016, J NEUROSCI, V36, P9435, DOI 10.1523/JNEUROSCI.1782-16.2016; Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Bonder DE, 2014, J NEUROSCI, V34, P13139, DOI 10.1523/JNEUROSCI.2591-14.2014; Butt AM, 2011, SEMIN CELL DEV BIOL, V22, P205, DOI 10.1016/j.semcdb.2011.02.023; Calcinaghi N, 2011, J CEREBR BLOOD F MET, V31, P1967, DOI 10.1038/jcbfm.2011.96; Cockcroft S, 2001, CELL MOL LIFE SCI, V58, P1674, DOI 10.1007/PL00000805; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; DUFFY S, 1995, J NEUROSCI, V15, P5535; Farooqui AA, 1997, J NEUROCHEM, V69, P889; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; Haustein MD, 2014, NEURON, V82, P413, DOI 10.1016/j.neuron.2014.02.041; Lalo U, 2006, J NEUROSCI, V26, P2673, DOI 10.1523/JNEUROSCI.4689-05.2006; Lalo U, 2008, J NEUROSCI, V28, P5473, DOI 10.1523/JNEUROSCI.1149-08.2008; Lecrux C, 2012, J CEREBR BLOOD F MET, V32, P896, DOI 10.1038/jcbfm.2012.4; Lind BL, 2013, P NATL ACAD SCI USA, V110, pE4678, DOI 10.1073/pnas.1310065110; Lindauer U, 1999, AM J PHYSIOL-HEART C, V277, pH799, DOI 10.1152/ajpheart.1999.277.2.H799; MENG W, 1995, STROKE, V26, P857, DOI 10.1161/01.STR.26.5.857; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Mishra A, 2014, NAT PROTOC, V9, P323, DOI 10.1038/nprot.2014.019; Mishra A, 2011, P NATL ACAD SCI USA, V108, P17827, DOI 10.1073/pnas.1110533108; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Nizar K, 2013, J NEUROSCI, V33, P8411, DOI 10.1523/JNEUROSCI.3285-12.2013; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Otsu Y, 2015, NAT NEUROSCI, V18, P210, DOI 10.1038/nn.3906; Panatier A, 2016, NEUROSCIENCE, V323, P29, DOI 10.1016/j.neuroscience.2015.03.063; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Reeves AMB, 2011, J NEUROSCI, V31, P9353, DOI 10.1523/JNEUROSCI.0127-11.2011; Sarri E, 2003, BIOCHEM J, V369, P319, DOI 10.1042/BJ20021347; SEIFERT G, 1995, EUR J NEUROSCI, V7, P1872, DOI 10.1111/j.1460-9568.1995.tb00708.x; Shigetomi E, 2013, J NEUROSCI, V33, P10143, DOI 10.1523/JNEUROSCI.5779-12.2013; Shigetomi E, 2013, J GEN PHYSIOL, V141, P633, DOI 10.1085/jgp.201210949; SHMIDT HHHW, 1992, CELL CALCIUM, V13, P427, DOI 10.1016/0143-4160(92)90055-W; Srinivasan R, 2015, NAT NEUROSCI, V18, P708, DOI 10.1038/nn.4001; STEPHENSON DT, 1994, BRAIN RES, V637, P97, DOI 10.1016/0006-8993(94)91221-1; Stobart JLL, 2013, P NATL ACAD SCI USA, V110, P3149, DOI 10.1073/pnas.1215929110; Sun W, 2013, SCIENCE, V339, P197, DOI 10.1126/science.1226740; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Tricoire L, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00082; Wells JA, 2015, J NEUROSCI, V35, P5284, DOI 10.1523/JNEUROSCI.3787-14.2015; WIERASZKO A, 1989, BRAIN RES, V485, P244, DOI 10.1016/0006-8993(89)90567-2; Winship IR, 2007, J NEUROSCI, V27, P6268, DOI 10.1523/JNEUROSCI.4801-06.2007; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Zhang Y, 2004, GLIA, V46, P74, DOI 10.1002/glia.10322; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zimmermann K. W., 1923, Zeitschrift Ges Anat Munchen Abt 1, V68, P29, DOI 10.1007/BF02593544; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	51	286	290	6	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2016	19	12					1619	1627		10.1038/nn.4428	http://dx.doi.org/10.1038/nn.4428			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED7BY	27775719	Green Accepted, Green Submitted			2022-12-17	WOS:000389011900021
J	Maingret, N; Girardeau, G; Todorova, R; Goutierre, M; Zugaro, M				Maingret, Nicolas; Girardeau, Gabrielle; Todorova, Ralitsa; Goutierre, Marie; Zugaro, Michael			Hippocampo-cortical coupling mediates memory consolidation during sleep	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; SLOW OSCILLATIONS; SPATIAL MEMORY; IN-VIVO; RAT; REACTIVATION; SPINDLES; STATE; REORGANIZATION; STIMULATION	Memory consolidation is thought to involve a hippocampo-cortical dialog during sleep to stabilize labile memory traces for long-term storage. However, direct evidence supporting this hypothesis is lacking. We dynamically manipulated the temporal coordination between the two structures during sleep following training on a spatial memory task specifically designed to trigger encoding, but not memory consolidation. Reinforcing the endogenous coordination between hippocampal sharp wave-ripples, cortical delta waves and spindles by timed electrical stimulation resulted in a reorganization of prefrontal cortical networks, along with subsequent increased prefrontal responsivity to the task and high recall performance on the next day, contrary to control rats, which performed at chance levels. Our results provide, to the best of our knowledge, the first direct evidence for a causal role of a hippocampo-cortical dialog during sleep in memory consolidation, and indicate that the underlying mechanism involves a fine-tuned coordination between sharp wave-ripples, delta waves and spindles.	[Maingret, Nicolas; Girardeau, Gabrielle; Todorova, Ralitsa; Goutierre, Marie; Zugaro, Michael] Coll France, Ctr Interdisciplinary Res Biol CIRB, F-75231 Paris, France; [Maingret, Nicolas; Girardeau, Gabrielle; Todorova, Ralitsa; Goutierre, Marie; Zugaro, Michael] CNRS, UMR 7241, Paris, France; [Maingret, Nicolas; Girardeau, Gabrielle; Todorova, Ralitsa; Goutierre, Marie; Zugaro, Michael] INSERM, U1050, Paris, France; [Maingret, Nicolas; Girardeau, Gabrielle; Todorova, Ralitsa; Goutierre, Marie; Zugaro, Michael] PSL Res Univ, Paris, France; [Girardeau, Gabrielle] NYU Med Ctr, Inst Neurosci, New York, NY 10016 USA	UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; New York University	Zugaro, M (corresponding author), Coll France, Ctr Interdisciplinary Res Biol CIRB, F-75231 Paris, France.; Zugaro, M (corresponding author), CNRS, UMR 7241, Paris, France.; Zugaro, M (corresponding author), INSERM, U1050, Paris, France.; Zugaro, M (corresponding author), PSL Res Univ, Paris, France.	michael.zugaro@college-de-france.fr		MAINGRET, Nicolas/0000-0002-0092-8963; Todorova, Ralitsa/0000-0003-2238-0297; Zugaro, Michael/0000-0002-6199-2635; Girardeau, Gabrielle/0000-0002-5265-9697	French Ministry of Research; Fondation pour la Recherche Medicale [FDT20150532568]; Ecole des Neurosciences de Paris Ile-de-France; LabEx MemoLife [ANR-10-LABX-54 MEMO LIFE, ANR-10-IDEX-0001-02 PSL*]	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ecole des Neurosciences de Paris Ile-de-France; LabEx MemoLife	We thank C. Drieu, V. Oberto, H.-Y. Gao, A. Cei, S. Sara, S.I. Wiener and K. Benchenane for advice and comments on the manuscript, and S. Doutremer, M.A. Thomas and Y. Dupraz for technical support. This work was supported by the French Ministry of Research (N.M.), a grant from the Fondation pour la Recherche Medicale (grant no. FDT20150532568) (N.M.), and a joint grant from Ecole des Neurosciences de Paris Ile-de-France and LabEx MemoLife (ANR-10-LABX-54 MEMO LIFE, ANR-10-IDEX-0001-02 PSL*) (R.T.).	Amzica F, 1998, NEUROSCIENCE, V82, P671; Ballarini F, 2009, P NATL ACAD SCI USA, V106, P14599, DOI 10.1073/pnas.0907078106; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; FERINO F, 1987, EXP BRAIN RES, V65, P421; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Girardeau G, 2014, J NEUROSCI, V34, P5176, DOI 10.1523/JNEUROSCI.4288-13.2014; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Johnson LA, 2010, J NEUROSCI, V30, P2650, DOI 10.1523/JNEUROSCI.1617-09.2010; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; Mednick SC, 2013, J NEUROSCI, V33, P4494, DOI 10.1523/JNEUROSCI.3127-12.2013; Ngo HVV, 2013, NEURON, V78, P545, DOI 10.1016/j.neuron.2013.03.006; Peyrache A, 2011, P NATL ACAD SCI USA, V108, P17207, DOI 10.1073/pnas.1103612108; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Phillips KG, 2012, NEURON, V76, P526, DOI 10.1016/j.neuron.2012.09.016; Rosanova M, 2005, J NEUROSCI, V25, P9398, DOI 10.1523/JNEUROSCI.2149-05.2005; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Sirota Anton, 2005, Thalamus & Related Systems, V3, P245, DOI 10.1017/S1472928807000258; Staresina BP, 2015, NAT NEUROSCI, V18, P1679, DOI 10.1038/nn.4119; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Vyazovskiy VV, 2009, J NEUROPHYSIOL, V101, P1921, DOI 10.1152/jn.91157.2008; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]	32	286	289	5	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2016	19	7					959	964		10.1038/nn.4304	http://dx.doi.org/10.1038/nn.4304			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DP8PH	27182818				2022-12-17	WOS:000378759600015
J	Williams, KW; Elmquist, JK				Williams, Kevin W.; Elmquist, Joel K.			From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior	NATURE NEUROSCIENCE			English	Review							GLUCAGON-LIKE PEPTIDE-1; NUCLEUS-TRACTUS-SOLITARIUS; LEPTIN RECEPTOR GENE; FOOD-INTAKE; PROOPIOMELANOCORTIN NEURONS; BODY-WEIGHT; ENERGY-BALANCE; GLUCOSE-HOMEOSTASIS; INSULIN SENSITIVITY; ARCUATE NUCLEUS	Over the past two centuries, prevalent models of energy and glucose homeostasis have emerged from careful anatomical descriptions in tandem with an understanding of cellular physiology. More recent technological advances have culminated in the identification of peripheral and central factors that influence neural circuits regulating metabolism. This Review highlights contributions to our understanding of peripheral and central factors regulating food intake and energy expenditure.	[Williams, Kevin W.; Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Div Hypothalam Res, Dept Internal Med, Dallas, TX 75390 USA; [Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Williams, KW (corresponding author), Univ Texas SW Med Ctr Dallas, Div Hypothalam Res, Dept Internal Med, Dallas, TX 75390 USA.	kevin.williams@utsouthwestern.edu	Williams, Kevin W/AAA-4243-2020; Williams, Kevin W/ABD-5818-2021	Williams, Kevin W/0000-0002-8434-8658; Williams, Kevin W/0000-0002-8434-8658	US National Institutes of Health [K01 DK087780, DK53301, MH61583, DK08876, DK081185, DK71320]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071320, R37DK053301, RL1DK081185, F32DK008876, K01DK087780, R01DK053301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061583] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors gratefully acknowledge M.M. Scott and L. Gautron for comments on the manuscript. This work was supported by the US National Institutes of Health (K01 DK087780 to K.W.W. and DK53301, MH61583, DK08876, DK081185 and DK71320 to J.K.E.) and by an award from the American Diabetes Association to J.K.E.	Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Arvat E, 2000, J ENDOCRINOL INVEST, V23, P493, DOI 10.1007/BF03343763; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Baldock PA, 2007, J BIOL CHEM, V282, P19092, DOI 10.1074/jbc.M700644200; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Baptista V, 2005, J NEUROPHYSIOL, V94, P2763, DOI 10.1152/jn.00351.2005; Barrera JG, 2011, NAT REV ENDOCRINOL, V7, P507, DOI 10.1038/nrendo.2011.77; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Berglund ED, 2012, J CLIN INVEST, V122, P1000, DOI 10.1172/JCI59816; Bernard C., 1855, LECONS PHYSL EXPT AP, DOI [10.5962/bhl.title.1818, DOI 10.5962/BHL.TITLE.1818]; Berthoud HR, 2008, REGUL PEPTIDES, V149, P15, DOI 10.1016/j.regpep.2007.08.024; Bingham NC, 2008, ENDOCRINOLOGY, V149, P2138, DOI 10.1210/en.2007-1200; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; COLEMAN DL, 1969, AM J PHYSIOL, V217, P1298; COLEMAN DL, 1973, DIABETOLOGIA, V9, P294, DOI 10.1007/BF01221857; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Elias CF, 2000, J COMP NEUROL, V423, P261; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fan W, 2004, NAT NEUROSCI, V7, P335, DOI 10.1038/nn1214; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; GIBBS J, 1973, J COMP PHYSIOL PSYCH, V84, P488, DOI 10.1037/h0034870; GOKE R, 1995, EUR J NEUROSCI, V7, P2294, DOI 10.1111/j.1460-9568.1995.tb00650.x; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Grill HJ, 2002, ENDOCRINOLOGY, V143, P239, DOI 10.1210/en.143.1.239; Hansotia T, 2007, J CLIN INVEST, V117, P143, DOI 10.1172/JCI25483; Hayes MR, 2010, CELL METAB, V11, P77, DOI 10.1016/j.cmet.2009.10.009; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Horvath TL, 2001, ENDOCRINOLOGY, V142, P4163, DOI 10.1210/en.142.10.4163; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; Joshi RL, 1996, EMBO J, V15, P1542, DOI 10.1002/j.1460-2075.1996.tb00498.x; Klockener T, 2011, NAT NEUROSCI, V14, P911, DOI 10.1038/nn.2847; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Luquet S, 2007, PEPTIDES, V28, P214, DOI 10.1016/j.peptides.2006.08.036; Merchenthaler I, 1999, J COMP NEUROL, V403, P261, DOI 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5; Michel MC, 1998, PHARMACOL REV, V50, P143; Moran TH, 2001, INT J OBESITY, V25, pS39, DOI 10.1038/sj.ijo.0801910; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Morton GJ, 2003, ENDOCRINOLOGY, V144, P2016, DOI 10.1210/en.2002-0115; Noble F, 1999, PHARMACOL REV, V51, P745; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Qiu J, 2010, J NEUROSCI, V30, P1560, DOI 10.1523/JNEUROSCI.4816-09.2010; Ramnanan CJ, 2012, CELL METAB, V15, P656, DOI 10.1016/j.cmet.2012.03.006; Rinaman L, 1999, AM J PHYSIOL-REG I, V277, pR582, DOI 10.1152/ajpregu.1999.277.2.R582; ROGERS RC, 1995, AM J PHYSIOL-GASTR L, V268, pG1, DOI 10.1152/ajpgi.1995.268.1.G1; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Sainsbury A, 2002, P NATL ACAD SCI USA, V99, P8938, DOI 10.1073/pnas.132043299; Schwartz GJ, 2000, NUTRITION, V16, P866, DOI 10.1016/S0899-9007(00)00464-0; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Scott MM, 2011, J CLIN INVEST, V121, P2413, DOI 10.1172/JCI43703; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Shi HF, 2008, AM J PHYSIOL-ENDOC M, V294, pE630, DOI 10.1152/ajpendo.00704.2007; Shi YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011361; Skibicka KP, 2009, ENDOCRINOLOGY, V150, P1705, DOI 10.1210/en.2008-1316; Smith GP, 2006, OBESITY, V14, p168S, DOI 10.1038/oby.2006.300; SMITH GP, 1981, SCIENCE, V213, P1036, DOI 10.1126/science.7268408; Sohn JW, 2011, NEURON, V71, P488, DOI 10.1016/j.neuron.2011.06.012; SOUTH EH, 1988, PEPTIDES, V9, P601, DOI 10.1016/0196-9781(88)90171-4; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; Sutton GM, 2006, ENDOCRINOLOGY, V147, P2183, DOI 10.1210/en.2005-1209; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; van den Pol AN, 2003, NEURON, V40, P1059, DOI 10.1016/S0896-6273(03)00809-2; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Williams KW, 2011, EUR J PHARMACOL, V660, P2, DOI 10.1016/j.ejphar.2010.11.042; Williams KW, 2010, J NEUROSCI, V30, P2472, DOI 10.1523/JNEUROSCI.3118-09.2010; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Woods SC, 2009, CELL METAB, V9, P489, DOI 10.1016/j.cmet.2009.04.007; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Wu Q, 2011, EUR J PHARMACOL, V660, P21, DOI 10.1016/j.ejphar.2010.10.110; Xu AW, 2007, ENDOCRINOLOGY, V148, P72, DOI 10.1210/en.2006-1119; Xu Y, 2010, NAT NEUROSCI, V13, P1457, DOI 10.1038/nn.2664; Xu Y, 2008, NEURON, V60, P582, DOI 10.1016/j.neuron.2008.09.033; Yeo GSH, 2012, NAT NEUROSCI, V15, P1343, DOI 10.1038/nn.3211; Zeltser LM, 2012, NAT NEUROSCI, V15, P1336, DOI 10.1038/nn.3219; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zheng HY, 2010, AM J PHYSIOL-REG I, V298, pR720, DOI 10.1152/ajpregu.00619.2009; Zigman JM, 2003, ENDOCRINOLOGY, V144, P3749, DOI 10.1210/en.2003-0241; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	100	286	290	1	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1350	1355		10.1038/nn.3217	http://dx.doi.org/10.1038/nn.3217			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	23007190	Green Accepted			2022-12-17	WOS:000309335300010
J	Antony, JM; van Marle, G; Opii, W; Butterfield, DA; Mallet, F; Yong, VW; Wallace, JL; Deacon, RM; Warren, K; Power, C				Antony, JM; van Marle, G; Opii, W; Butterfield, DA; Mallet, F; Yong, VW; Wallace, JL; Deacon, RM; Warren, K; Power, C			Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination	NATURE NEUROSCIENCE			English	Article							NITRIC-OXIDE SYNTHASE; ACTIVE MULTIPLE-SCLEROSIS; HERV-W; CEREBROSPINAL-FLUID; PRIMATE EVOLUTION; EXPRESSION; PROTEIN; ACTIVATION; VIRUS; BRAIN	Human endogenous retroviruses (HERVs) constitute 8% of the human genome and have been implicated in both health and disease. Increased HERV gene activity occurs in immunologically activated glia, although the consequences of HERV expression in the nervous system remain uncertain. Here, we report that the HERV-W encoded glycoprotein syncytin is upregulated in glial cells within acute demyelinating lesions of multiple sclerosis patients. Syncytin expression in astrocytes induced the release of redox reactants, which were cytotoxic to oligodendrocytes. Syncytin-mediated neuroinflammation and death of oligodendrocytes, with the ensuing neurobehavioral deficits, were prevented by the antioxidant ferulic acid in a mouse model of multiple sclerosis. Thus, syncytin's proinflammatory properties in the nervous system demonstrate a novel role for an endogenous retrovirus protein, which may be a target for therapeutic intervention.	Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; Univ Kentucky, Ctr Membrane Sci, Lexington, KY 40506 USA; Ecole Normale Super Lyon, IFR BioSci Lyon Gerland 128, UMR CNRS bioMerieux, F-69364 Lyon, France; Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB T2N 4N1, Canada; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Univ Alberta, Dept Med, Edmonton, AB T6G 2B7, Canada	University of Calgary; University of Kentucky; University of Kentucky; Ecole Normale Superieure de Lyon (ENS de LYON); University of Calgary; University of Oxford; University of Alberta	Power, C (corresponding author), Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada.	power@ucalgary.ca	Power, Christopher/C-7181-2013; Wallace, John/AAL-3763-2021; Antony, Joseph Mathew/W-7552-2019; Mallet, Francois/G-4812-2014	Antony, Joseph Mathew/0000-0002-5700-7719; van Marle, Guido/0000-0002-5148-6229; Yong, V. Wee/0000-0002-2600-3563; MALLET, Francois/0000-0002-1331-096X; Power, Christopher/0000-0002-5131-9711				Anlar O, 2003, Electromyogr Clin Neurophysiol, V43, P349; BANSAL R, 1989, J NEUROSCI RES, V24, P548, DOI 10.1002/jnr.490240413; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; BO L, 1994, ANN NEUROL, V36, P778, DOI 10.1002/ana.410360515; Bock M, 2000, CURR OPIN GENET DEV, V10, P651, DOI 10.1016/S0959-437X(00)00138-6; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Calabrese V, 2003, NEUROCHEM RES, V28, P1321, DOI 10.1023/A:1024984013069; Calabrese V, 2002, J NEUROSCI RES, V70, P580, DOI 10.1002/jnr.10408; Carson MJ, 2002, GLIA, V40, P218, DOI 10.1002/glia.10145; Costas J, 2002, MOL BIOL EVOL, V19, P526, DOI 10.1093/oxfordjournals.molbev.a004108; Danilov AI, 2003, J NEUROIMMUNOL, V136, P112, DOI 10.1016/S0165-5728(02)00464-2; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Guenther K, 2001, EUR J NEUROSCI, V14, P401, DOI 10.1046/j.0953-816x.2001.01645.x; Hua LWL, 2002, J NEUROCHEM, V83, P1120, DOI 10.1046/j.1471-4159.2002.01226.x; Hughes JF, 2001, NAT GENET, V29, P487, DOI 10.1038/ng775; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Johnston JB, 2001, ANN NEUROL, V50, P434, DOI 10.1002/ana.1131; Kanski J, 2002, J NUTR BIOCHEM, V13, P273, DOI 10.1016/S0955-2863(01)00215-7; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Lu FM, 2000, J NEUROL SCI, V177, P95, DOI 10.1016/S0022-510X(00)00343-9; Lynch WP, 2000, J VIROL, V74, P1558, DOI 10.1128/JVI.74.3.1558-1565.2000; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Ogiwara T, 2003, ANTICANCER RES, V23, P1317; PATY DW, 1998, MULT SCLER, P68; Power C, 1998, J VIROL, V72, P9045, DOI 10.1128/JVI.72.11.9045-9053.1998; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Power C, 2001, TRENDS NEUROSCI, V24, P162, DOI 10.1016/S0166-2236(00)01737-9; Ravikumar A., 2000, Indian Journal of Experimental Biology, V38, P438; ROSEN CL, 1989, J NEUROSCI, V9, P3371; Scott GS, 2003, GLIA, V41, P105, DOI 10.1002/glia.10137; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3; Sverdlov ED, 2000, BIOESSAYS, V22, P161, DOI 10.1002/(SICI)1521-1878(200002)22:2<161::AID-BIES7>3.0.CO;2-X; TAKACS S, 1988, SUPERCOND SCI TECH, V1, P53, DOI 10.1088/0953-2048/1/1/011; van de Lagemaat LN, 2003, TRENDS GENET, V19, P530, DOI 10.1016/j.tig.2003.08.004; van Marle G, 2003, VIROLOGY, V309, P61, DOI 10.1016/S0042-6822(02)00139-3; Wesselingh SL, 2001, CURR OPIN NEUROL, V14, P375, DOI 10.1097/00019052-200106000-00018; West MJ, 1996, J COMP NEUROL, V370, P11; YONG VW, 1997, PROTOCOLS NEURAL CEL, P81; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127	43	286	305	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1088	1095		10.1038/nn1319	http://dx.doi.org/10.1038/nn1319			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15452578				2022-12-17	WOS:000224156900018
J	Jo, YH; Schlichter, R				Jo, YH; Schlichter, R			Synaptic corelease of ATP and GABA in cultured spinal neurons	NATURE NEUROSCIENCE			English	Article							DORSAL HORN NEURONS; INTERMEDIATE LOBE CELLS; NERVOUS-SYSTEM; SUBSTANTIA-GELATINOSA; GLUTAMATE RELEASE; RECEPTORS; TRANSMISSION; CORD; LOCALIZATION; ADENOSINE	In the spinal dorsal horn (DH), transmission and modulation of peripheral nociceptive (pain-inducing) messages involve classical neurotransmitters and neuropeptides. We show that approximately half of DH neurons use ATP as a fast excitatory neurotransmitter acting at ionotropic P2X postsynaptic receptors. ATP was not codetected with glutamate but was coreleased with the inhibitory neurotransmitter GABA. Moreover, adenosine, probably generated by extracellular metabolism of ATP, finely tuned GABAergic inhibitory postsynaptic currents. Differential modulation of excitatory versus inhibitory components of this mixed cotransmission may help to explain changes in sensory message processing in the DH during mechanical hyperalgesia and neuropathic pain.	Univ Strasbourg, CNRS, Lab Neurophysiol Cellulaire & Integree, UMR 7519, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schlichter, R (corresponding author), Univ Strasbourg, CNRS, Lab Neurophysiol Cellulaire & Integree, UMR 7519, 21 Rue Descartes, Strasbourg, France.	schlichter@neurochem.u-strasbg.fr		Jo, Young-Hwan/0000-0001-6939-8000				Bardoni R, 1997, J NEUROSCI, V17, P5297; BURNSTOCK G, 1972, BRIT J PHARMACOL, V44, P451, DOI 10.1111/j.1476-5381.1972.tb07283.x; Burnstock G, 1997, NEUROPHARMACOLOGY, V36, P1127, DOI 10.1016/S0028-3908(97)00125-1; Burnstock G, 1996, CURR OPIN NEUROBIOL, V6, P526, DOI 10.1016/S0959-4388(96)80060-2; Coggeshall RE, 1997, BRAIN RES REV, V24, P28, DOI 10.1016/S0165-0173(97)00010-6; Collo G, 1996, J NEUROSCI, V16, P2495; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; EVANS RJ, 1992, NATURE, V357, P503, DOI 10.1038/357503a0; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; Feoktistov I, 1997, PHARMACOL REV, V49, P381; FYFFE REW, 1984, P NATL ACAD SCI-BIOL, V81, P6890, DOI 10.1073/pnas.81.21.6890; GALLIGAN JJ, 1994, J NEUROSCI, V14, P7563; Gu JGG, 1997, NATURE, V389, P749, DOI 10.1038/39639; HAMANN M, 1988, BRAIN RES, V442, P287, DOI 10.1016/0006-8993(88)91514-4; Hu ZH, 1997, J PHYSIOL-LONDON, V501, P67, DOI 10.1111/j.1469-7793.1997.067bo.x; JAHR CE, 1983, NATURE, V304, P730, DOI 10.1038/304730a0; Jo YH, 1998, J NEUROSCI, V18, P2377; Jo YH, 1998, J NEUROPHYSIOL, V79, P1583, DOI 10.1152/jn.1998.79.3.1583; JOHNSON MD, 1994, NEURON, V12, P433, DOI 10.1016/0896-6273(94)90283-6; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; LI J, 1995, J NEUROSCI, V15, P3357; Malcangio M, 1996, TRENDS PHARMACOL SCI, V17, P457; North RA, 1997, CURR OPIN NEUROBIOL, V7, P346, DOI 10.1016/S0959-4388(97)80062-1; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; Poisbeau P, 1996, J NEUROSCI, V16, P4835; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Ralevic V, 1998, PHARMACOL REV, V50, P413; SALTER MW, 1993, PROG NEUROBIOL, V41, P125, DOI 10.1016/0301-0082(93)90006-E; SAWYNOK J, 1993, BRAIN RES, V610, P32, DOI 10.1016/0006-8993(93)91213-C; Sulzer D, 1998, J NEUROSCI, V18, P4588, DOI 10.1523/jneurosci.18-12-04588.1998; TODD AJ, 1993, PROG NEUROBIOL, V41, P609, DOI 10.1016/0301-0082(93)90045-T; Todorov LD, 1997, NATURE, V387, P76, DOI 10.1038/387076a0; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Woolf Clifford J., 1994, Current Opinion in Neurobiology, V4, P525, DOI 10.1016/0959-4388(94)90053-1; YOSHIMURA M, 1989, J NEUROPHYSIOL, V62, P96, DOI 10.1152/jn.1989.62.1.96; ZHANG ZW, 1991, BRIT J PHARMACOL, V102, P19, DOI 10.1111/j.1476-5381.1991.tb12125.x; Zimmermann H, 1996, PROG NEUROBIOL, V49, P589, DOI 10.1016/0301-0082(96)00026-3; ZIMMERMANN H, 1994, TRENDS NEUROSCI, V17, P420, DOI 10.1016/0166-2236(94)90016-7	40	286	297	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					241	245		10.1038/6344	http://dx.doi.org/10.1038/6344			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	220TX	10195216				2022-12-17	WOS:000081684500011
J	Amano, T; Unal, CT; Pare, D				Amano, Taiju; Unal, Cagri T.; Pare, Denis			Synaptic correlates of fear extinction in the amygdala	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; CONDITIONED FEAR; POTENTIATED STARTLE; NUCLEUS; PROJECTIONS; NEURONS; EXPRESSION; MECHANISMS; PLASTICITY; RECEPTORS	Anxiety disorders such as post-traumatic stress are characterized by an impaired ability to learn that cues previously associated with danger no longer represent a threat. However, the mechanisms underlying fear extinction remain unclear. We found that fear extinction in rats was associated with increased levels of synaptic inhibition in fear output neurons of the central amygdala (CEA). This increased inhibition resulted from a potentiation of fear input synapses to GABAergic intercalated amygdala neurons that project to the CEA. Enhancement of inputs to intercalated cells required prefrontal activity during extinction training and involved an increased transmitter release probability coupled to an altered expression profile of ionotropic glutamate receptors. Overall, our results suggest that intercalated cells constitute a promising target for pharmacological treatment of anxiety disorders.	[Amano, Taiju; Unal, Cagri T.; Pare, Denis] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Pare, D (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	pare@andromeda.rutgers.edu	Ünal, Çağrı Temuçin/G-5590-2018		National Institute of Mental Health [RO1 MH083710]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083710] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health grant RO1 MH083710 to D. P.	Amorapanth P, 2000, NAT NEUROSCI, V3, P74, DOI 10.1038/71145; Anglada-Figueroa D, 2005, J NEUROSCI, V25, P9680, DOI 10.1523/JNEUROSCI.2600-05.2005; Bremner JD, 2007, PROG BRAIN RES, V167, P171, DOI 10.1016/S0079-6123(07)67012-5; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; CIOCCHI S, 2008, FENS ABSTR; Davis M., 2000, AMYGDALA, P213; FALLS WA, 1992, J NEUROSCI, V12, P854; Harris JA, 1998, PSYCHOPHARMACOLOGY, V140, P105, DOI 10.1007/s002130050745; Heidi SA, 2007, EUR J NEUROSCI, V26, P3631, DOI 10.1111/j.1460-9568.2007.05970.x; HERKENHAM M, 1982, J NEUROSCI, V2, P1129; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hobin JA, 2003, J NEUROSCI, V23, P8410; HOPKINS DA, 1978, EXP BRAIN RES, V32, P529; Jacobsen KX, 2006, NEUROSCIENCE, V141, P2007, DOI 10.1016/j.neuroscience.2006.05.054; Jungling K, 2008, NEURON, V59, P298, DOI 10.1016/j.neuron.2008.07.002; KRETTEK JE, 1978, J COMP NEUROL, V178, P255, DOI 10.1002/cne.901780205; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Lee H, 1998, J NEUROSCI, V18, P8444; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; Lin HC, 2009, BIOL PSYCHIAT, V66, P665, DOI 10.1016/j.biopsych.2009.04.003; Maren S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0001.2001; McDonald AJ, 1996, NEUROSCIENCE, V71, P55, DOI 10.1016/0306-4522(95)00417-3; Milad MR, 2008, J PSYCHIATR RES, V42, P515, DOI 10.1016/j.jpsychires.2008.01.017; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; PARE D, 1993, NEUROSCIENCE, V57, P1077, DOI 10.1016/0306-4522(93)90050-P; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; PARE D, 1993, NEUROSCIENCE, V57, P1061, DOI 10.1016/0306-4522(93)90049-L; PASCOE JP, 1985, BEHAV BRAIN RES, V16, P117, DOI 10.1016/0166-4328(85)90087-7; Petrovich GD, 1997, BRAIN RES, V763, P247, DOI 10.1016/S0006-8993(96)01361-3; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; RESCORLA RA, 1969, J COMP PHYSIOL PSYCH, V67, P504, DOI 10.1037/h0027313; ROMANSKI LM, 1993, CEREB CORTEX, V3, P515, DOI 10.1093/cercor/3.6.515; Royer S, 1999, J NEUROSCI, V19, P10575; Royer S, 2002, NEUROSCIENCE, V115, P455, DOI 10.1016/S0306-4522(02)00455-4; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Walker DL, 2002, J NEUROSCI, V22, P2343, DOI 10.1523/JNEUROSCI.22-06-02343.2002	39	285	291	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2010	13	4					489	U112		10.1038/nn.2499	http://dx.doi.org/10.1038/nn.2499			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	575NI	20208529	Green Accepted			2022-12-17	WOS:000276073500019
J	Mander, BA; Marks, SM; Vogel, JW; Rao, V; Lu, B; Saletin, JM; Ancoli-Israel, S; Jagust, WJ; Walker, MP				Mander, Bryce A.; Marks, Shawn M.; Vogel, Jacob W.; Rao, Vikram; Lu, Brandon; Saletin, Jared M.; Ancoli-Israel, Sonia; Jagust, William J.; Walker, Matthew P.			beta-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation	NATURE NEUROSCIENCE			English	Article							LESS-THAN-1 HZ OSCILLATION; ALZHEIMERS-DISEASE; COGNITIVE DECLINE; YOUNG-ADULT; IN-VIVO; SLEEP; BRAIN; SYSTEM; EEG; DEPOSITION	Independent evidence associates beta-amyloid pathology with both non-rapid eye movement (NREM) sleep disruption and memory impairment in older adults. However, whether the influence of beta-amyloid pathology on hippocampus-dependent memory is, in part, driven by impairments of NREM slow wave activity (SWA) and associated overnight memory consolidation is unknown. Here we show that beta-amyloid burden in medial prefrontal cortex (mPFC) correlates significantly with the severity of impairment in NREM SWA generation. Moreover, reduced NREM SWA generation was further associated with impaired overnight memory consolidation and impoverished hippocampal-neocortical memory transformation. Furthermore, structural equation models revealed that the association between mPFC beta-amyloid pathology and impaired hippocampus-dependent memory consolidation was not direct, but instead statistically depended on the intermediary factor of diminished NREM SWA. By linking beta-amyloid pathology with impaired NREM SWA, these data implicate sleep disruption as a mechanistic pathway through which beta-amyloid pathology may contribute to hippocampus-dependent cognitive decline in the elderly.	[Mander, Bryce A.; Rao, Vikram; Saletin, Jared M.; Walker, Matthew P.] Univ Calif Berkeley, Sleep & Neuroimaging Lab, Berkeley, CA 94720 USA; [Marks, Shawn M.; Vogel, Jacob W.; Jagust, William J.; Walker, Matthew P.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Lu, Brandon] Calif Pacific Med Ctr, Div Pulm & Crit Care Med, San Francisco, CA USA; [Ancoli-Israel, Sonia] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Jagust, William J.] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; California Pacific Medical Center; University of California System; University of California San Diego; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Mander, BA (corresponding author), Univ Calif Berkeley, Sleep & Neuroimaging Lab, Berkeley, CA 94720 USA.	bamander@berkeley.edu; mpwalker@berkeley.edu	Rao, Vikram/J-6931-2016; Jagust, William/ABE-6426-2020	Mander, Bryce/0000-0002-0831-7980; Marks, Shawn/0000-0001-9884-8461	US National Institutes of Health [R01-AG031164, R01-AG034570, F32-AG039170]; NATIONAL INSTITUTE ON AGING [R01AG031164, F32AG039170, R01AG034570] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. Baquirin, M. Belshe, M. Bhatter, M. Binod, S. Bowditch, C. Dang, J. Gupta, A. Hayenga, D. Holzman, A. Horn, E. Hur, J. Jeng, S. Kumar, J. Lindquist, C. Markeley, E. Mormino, M. Nicholas, S. Rashidi, M. Shonman, L. Zhang and A. Zhu for their assistance; A. Mander for his aid in task design; and M. Rubens and A. Gazzaley for use of their aging template brain. This work was supported by awards R01-AG031164 (M.P.W.), R01-AG034570 (W.J.J.) and F32-AG039170 (B.A.M.) from the US National Institutes of Health.	Backhaus J, 2007, LEARN MEMORY, V14, P336, DOI 10.1101/lm.470507; Boyle PA, 2013, ANN NEUROL, V74, P478, DOI 10.1002/ana.23964; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Bradshaw EM, 2013, NAT NEUROSCI, V16, P848, DOI 10.1038/nn.3435; Brett M., 2002, NEUROIMAGE, V16, P2, DOI DOI 10.1016/S1053-8119(02)90010-8; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Carrier J, 2011, EUR J NEUROSCI, V33, P758, DOI 10.1111/j.1460-9568.2010.07543.x; Cavdar S, 2008, J ANAT, V212, P249, DOI 10.1111/j.1469-7580.2008.00858.x; Chauvette S, 2012, NEURON, V75, P1105, DOI 10.1016/j.neuron.2012.08.034; Cohen DA, 2011, NAT NEUROSCI, V14, P953, DOI 10.1038/nn.2840; Cricco M, 2001, J AM GERIATR SOC, V49, P1185, DOI 10.1046/j.1532-5415.2001.49235.x; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; DIJK DJ, 1989, NEUROBIOL AGING, V10, P677, DOI 10.1016/0197-4580(89)90004-3; Elman JA, 2014, NAT NEUROSCI, V17, P1316, DOI 10.1038/nn.3806; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Hedden T, 2012, J NEUROSCI, V32, P16233, DOI 10.1523/JNEUROSCI.2462-12.2012; Hedden T, 2012, CEREB CORTEX, V22, P1038, DOI 10.1093/cercor/bhr172; Hita-Yanez E, 2013, SLEEP, V36, P1327, DOI 10.5665/sleep.2956; Jack CR, 2013, NEUROLOGY, V80, P890, DOI 10.1212/WNL.0b013e3182840bbe; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Ju YES, 2014, NAT REV NEUROL, V10, P115, DOI 10.1038/nrneurol.2013.269; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kim H, 2011, NEUROIMAGE, V54, P2446, DOI 10.1016/j.neuroimage.2010.09.045; Kline R.B., 2011, PRINCIPLES PRACTICE, V3rd; Kurup P, 2010, J NEUROSCI, V30, P5948, DOI 10.1523/JNEUROSCI.0157-10.2010; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Liguori C, 2014, JAMA NEUROL, V71, P1498, DOI 10.1001/jamaneurol.2014.2510; Lim ASP, 2013, JAMA NEUROL, V70, P1544, DOI 10.1001/jamaneurol.2013.4215; Mander BA, 2014, CEREB CORTEX, V24, P3301, DOI 10.1093/cercor/bht188; Mander BA, 2013, NAT NEUROSCI, V16, P357, DOI 10.1038/nn.3324; Mander BA, 2011, CURR BIOL, V21, pR183, DOI 10.1016/j.cub.2011.01.019; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Mormino EC, 2009, BRAIN, V132, P1310, DOI 10.1093/brain/awn320; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Oh H, 2013, J NEUROSCI, V33, P18425, DOI 10.1523/JNEUROSCI.2775-13.2013; Oh H, 2012, NEUROBIOL AGING, V33, P2746, DOI 10.1016/j.neurobiolaging.2012.02.008; Ooms S, 2014, JAMA NEUROL, V71, P971, DOI 10.1001/jamaneurol.2014.1173; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PRINZ PN, 1982, NEUROBIOL AGING, V3, P361, DOI 10.1016/0197-4580(82)90024-0; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Rechtschaffen A., 1968, MANUAL STANDARDIZED, V20, P246; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Roh JH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004291; Saletin JM, 2013, NEUROIMAGE, V83, P658, DOI 10.1016/j.neuroimage.2013.06.021; Sepulcre J, 2013, BRAIN, V136, P2239, DOI 10.1093/brain/awt146; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Spira AP, 2013, JAMA NEUROL, V70, P1537, DOI 10.1001/jamaneurol.2013.4258; Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004; Stage FK, 2004, J EDUC RES, V98, P5, DOI 10.3200/JOER.98.1.5-13; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Tan X, 2001, CLIN NEUROPHYSIOL, V112, P1540, DOI 10.1016/S1388-2457(01)00570-3; Van Cauter E, 2000, JAMA-J AM MED ASSOC, V284, P861, DOI 10.1001/jama.284.7.861; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Wechsler D., 1987, WECHSLER MEMORY SCAL; Westerberg CE, 2012, J INT NEUROPSYCH SOC, V18, P490, DOI 10.1017/S135561771200001X; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Zec RF, 1986, ARCH CLIN NEUROPSYCH, V1, P274; Zheng HY, 2012, J CLIN SLEEP MED, V8, P87, DOI 10.5664/jcsm.1670	71	284	290	5	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2015	18	7					1051	+		10.1038/nn.4035	http://dx.doi.org/10.1038/nn.4035			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CL3QU	26030850	Green Accepted, Green Submitted			2022-12-17	WOS:000356866200021
J	Kirby, BB; Takada, N; Latimer, AJ; Shin, J; Carney, TJ; Kelsh, RN; Appel, B				Kirby, Brandon B.; Takada, Norio; Latimer, Andrew J.; Shin, Jimann; Carney, Thomas J.; Kelsh, Robert N.; Appel, Bruce			In vivo time-lapse imaging shows dynamic oligodendrocyte progenitor behavior during zebrafish development	NATURE NEUROSCIENCE			English	Article							MULTIPLE-SCLEROSIS LESIONS; PRECURSOR CELL-MIGRATION; CENTRAL-NERVOUS-SYSTEM; DORSAL SPINAL-CORD; GROWTH-FACTOR; PREMYELINATING OLIGODENDROCYTES; DIFFERENTIATION; NETRIN-1; PROLIFERATION; ASTROCYTES	Myelinating oligodendrocytes arise from migratory and proliferative oligodendrocyte progenitor cells (OPCs). Complete myelination requires that oligodendrocytes be uniformly distributed and form numerous, periodically spaced membrane sheaths along the entire length of target axons. Mechanisms that determine spacing of oligodendrocytes and their myelinating processes are not known. Using in vivo time-lapse confocal microscopy, we show that zebrafish OPCs continuously extend and retract numerous filopodium-like processes as they migrate and settle into their final positions. Process remodeling and migration paths are highly variable and seem to be influenced by contact with neighboring OPCs. After laser ablation of oligodendrocyte-lineage cells, nearby OPCs divide more frequently, orient processes toward the ablated cells and migrate to fill the unoccupied space. Thus, process activity before axon wrapping might serve as a surveillance mechanism by which OPCs determine the presence or absence of nearby oligodendrocyte-lineage cells, facilitating uniform spacing of oligodendrocytes and complete myelination.	Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; Univ Bath, Dept Biol & Biochem, Ctr Regenerat Med, Bath BA2 7AY, Avon, England	Vanderbilt University; University of Bath	Appel, B (corresponding author), Vanderbilt Univ, Dept Biol Sci, 465 21st Ave S, Nashville, TN 37232 USA.	b.appel@vanderbilt.edu	Carney, Tom J/H-4389-2011; Kelsh, Robert/B-6445-2008; Messier, Claude/A-2322-2008; Appel, Bruce/X-6418-2019	Carney, Tom J/0000-0003-2371-1924; Kelsh, Robert/0000-0002-9381-0066; Messier, Claude/0000-0002-4791-1763; Appel, Bruce/0000-0003-4500-0672	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046668] Funding Source: NIH RePORTER; NINDS NIH HHS [NS046668, R01 NS046668] Funding Source: Medline; CSR NIH HHS [RG 3420] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CSR NIH HHS		Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; Baron W, 2005, GLIA, V49, P467, DOI 10.1002/glia.20132; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Benediktsson AM, 2005, J NEUROSCI METH, V141, P41, DOI 10.1016/j.jneumeth.2004.05.013; Blaschuk KL, 2000, DEVELOPMENT, V127, P1961; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cai J, 2005, NEURON, V45, P41, DOI 10.1016/j.neuron.2004.12.028; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; de Castro F, 2005, BRAIN RES REV, V49, P227, DOI 10.1016/j.brainresrev.2004.12.034; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Fogarty M, 2005, DEVELOPMENT, V132, P1951, DOI 10.1242/dev.01777; Fox MA, 2006, GLIA, V53, P563, DOI 10.1002/glia.20293; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Hardy RJ, 1996, DEV NEUROSCI-BASEL, V18, P243, DOI 10.1159/000111414; Jarjour AA, 2003, J NEUROSCI, V23, P3735; KACHAR B, 1986, CELL TISSUE RES, V244, P27; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Levine JM, 1999, EXP NEUROL, V160, P333, DOI 10.1006/exnr.1999.7224; Maeda Y, 2001, ANN NEUROL, V49, P776, DOI 10.1002/ana.1015; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Milner R, 1997, GLIA, V19, P85, DOI 10.1002/(SICI)1098-1136(199701)19:1<85::AID-GLIA9>3.0.CO;2-9; Milner R, 1997, GLIA, V21, P350; Milner R, 1996, J NEUROSCI, V16, P7240; MILNER R, 1994, DEVELOPMENT, V120, P3497; Nelson PJ, 2002, KIDNEY INT S1, V61, P99, DOI DOI 10.1046/J.1523-1755.2002.0610S1099.X; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Pfeifer T, 1997, MICROSYST TECHNOL, V3, P191, DOI 10.1007/s005420050079; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Redwine JM, 1998, J NEUROBIOL, V37, P413, DOI 10.1002/(SICI)1097-4695(19981115)37:3<413::AID-NEU7>3.0.CO;2-8; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Schmidt C, 1997, GLIA, V20, P284; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Simpson PB, 1999, GLIA, V26, P22, DOI 10.1002/(SICI)1098-1136(199903)26:1<22::AID-GLIA3>3.0.CO;2-M; Sugimoto Y, 2001, DEVELOPMENT, V128, P3321; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Tsai HH, 2006, J NEUROSCI, V26, P1913, DOI 10.1523/JNEUROSCI.3571-05.2006; Tsai HH, 2003, DEVELOPMENT, V130, P2095, DOI 10.1242/dev.00424; Vallstedt A, 2005, NEURON, V45, P55, DOI 10.1016/j.neuron.2004.12.026; van Heyningen P, 2001, CURR BIOL, V11, P232, DOI 10.1016/S0960-9822(01)00075-6; Wolswijk G, 2000, BRAIN, V123, P105, DOI 10.1093/brain/123.1.105; Wolswijk G, 1998, J NEUROSCI, V18, P601; Yue T, 2006, J NEUROSCI, V26, P1275, DOI 10.1523/JNEUROSCI.4717-05.2006; Zhang H, 2004, J CELL SCI, V117, P93, DOI 10.1242/jcs.00827; Zhang H, 1996, J NEUROSCI, V16, P6886	50	284	286	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1506	1511		10.1038/nn1803	http://dx.doi.org/10.1038/nn1803			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17099706				2022-12-17	WOS:000242404000014
J	Yao, JQ; Sasaki, Y; Wen, ZX; Bassell, GJ; Zheng, JQ				Yao, Jiaqi; Sasaki, Yukio; Wen, Zhexing; Bassell, Gary J.; Zheng, James Q.			An essential role for beta-actin mRNA localization and translation in Ca2+-dependent growth cone guidance	NATURE NEUROSCIENCE			English	Article							LOCAL PROTEIN-SYNTHESIS; NERVE GROWTH; AXON GUIDANCE; CHEMOTROPIC RESPONSES; INTRACELLULAR CALCIUM; BINDING-PROTEINS; CYTOSKELETAL; MOTILITY; FILOPODIA; TRANSPORT	Axon pathfinding requires directional responses of growth cones to extracellular cues, which have been shown to involve local synthesis of protein. The identity and functions of the locally produced proteins remain, however, unclear. Here we report that Ca2+-dependent bidirectional turning of Xenopus laevis growth cones requires localized distribution and translation of beta-actin messenger RNA. Both beta-actin mRNA and its zipcode-binding protein, ZBP1, are localized at the growth cone and become asymmetrically distributed upon local exposure to brain-derived neurotrophic factor ( BDNF). Inhibition of protein synthesis or antisense interference with beta-actin mRNA-ZBP1 binding abolishes both Ca2+-mediated attraction and repulsion. In addition, attraction involves a local increase in beta-actin, whereas repulsion is accompanied by a local decrease in beta-actin; thus, both produce a synthesis- and ZBP1 binding-dependent beta-actin asymmetry but with opposite polarities. Together with a similar asymmetry in Src activity during bidirectional responses, our findings indicate that Ca2+-dependent spatial regulation of b-actin synthesis through Src contributes to the directional motility of growth cones during guidance.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Emory University	Zheng, JQ (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	zhengjq@umdnj.edu	Wen, Zhexing/L-1228-2018; Wen, Zhexing/B-9313-2014; Sasaki, Yukio/P-7662-2015	Wen, Zhexing/0000-0002-1518-3845; Sasaki, Yukio/0000-0001-6143-7001	NICHD NIH HHS [HD46368] Funding Source: Medline; NINDS NIH HHS [R29 NS036241, NS36241] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036241, R29NS036241] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bassell GJ, 2004, CURR OPIN NEUROBIOL, V14, P574, DOI 10.1016/j.conb.2004.08.010; Bassell GJ, 1998, J NEUROSCI, V18, P251; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Guirland C, 2003, J NEUROSCI, V23, P2274; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Kalil K, 2005, CURR OPIN NEUROBIOL, V15, P521, DOI 10.1016/j.conb.2005.08.005; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; Korey CA, 2000, J NEUROBIOL, V44, P184, DOI 10.1002/1097-4695(200008)44:2<184::AID-NEU8>3.0.CO;2-N; Lee SK, 2003, J CELL SCI, V116, P4467, DOI 10.1242/jcs.00745; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Martin KC, 2004, CURR OPIN NEUROBIOL, V14, P305, DOI 10.1016/j.conb.2004.05.009; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Ming GL, 1997, J NEUROSCI, V17, P7860; Moccia R, 2003, J NEUROSCI, V23, P9409; Oleynikov Y, 2003, CURR BIOL, V13, P199, DOI 10.1016/S0960-9822(03)00044-7; PENG HB, 1991, METHOD CELL BIOL, V36, P511; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Piper M, 2005, NAT NEUROSCI, V8, P179, DOI 10.1038/nn1380; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; REHDER V, 1992, J NEUROSCI, V12, P3175, DOI 10.1523/JNEUROSCI.12-08-03175.1992; Robles E, 2005, J NEUROSCI, V25, P7669, DOI 10.1523/JNEUROSCI.2680-05.2005; Shestakova EA, 2001, P NATL ACAD SCI USA, V98, P7045, DOI 10.1073/pnas.121146098; SHUSTER CB, 1995, J CELL BIOL, V128, P837, DOI 10.1083/jcb.128.5.837; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Steward O, 2002, CELL, V110, P537, DOI 10.1016/S0092-8674(02)00934-0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Willis DE, 2006, CURR OPIN NEUROBIOL, V16, P111, DOI 10.1016/j.conb.2006.01.002; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yaniv K, 2003, DEVELOPMENT, V130, P5649, DOI 10.1242/dev.00810; Yisraeli JK, 2005, BIOL CELL, V97, P87; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zhang HL, 1999, J CELL BIOL, V147, P59, DOI 10.1083/jcb.147.1.59; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; Zheng JQ, 1996, J NEUROSCI, V16, P1140	47	284	286	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1265	1273		10.1038/nn1773	http://dx.doi.org/10.1038/nn1773			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16980965				2022-12-17	WOS:000241493900020
J	Alsina, B; Vu, T; Cohen-Cory, S				Alsina, B; Vu, T; Cohen-Cory, S			Visualizing synapse formation in arborizing optic axons in vivo: dynamics and modulation by BDNF	NATURE NEUROSCIENCE			English	Article							IN-VIVO; NEUROMUSCULAR-JUNCTIONS; HIPPOCAMPAL-NEURONS; EXCITATORY SYNAPSES; NEUROTROPHIC FACTOR; DENDRITIC GROWTH; C-ELEGANS; SYNAPTOGENESIS; PROTEIN; ARBORS	Dynamic developmental changes in axon arbor morphology may directly reflect the formation, stabilization and elimination of synapses. We used dual-color imaging to study, in the live, developing animal, the relationship between axon arborization and synapse formation at the single cell level, and to examine the participation of brain-derived neurotrophic factor (BDNF) in synaptogenesis. Green fluorescent protein (GFP)-tagged synaptobrevin II served as a marker to visualize synaptic sites in individual fluorescently labeled Xenopus optic axons. Time-lapse confocal microscopy revealed that although most synapses remain stable, synapses are also formed and eliminated as axons branch and increase their complexity. Most new branches originated at GFP-labeled synaptic sites. Increasing BDNF levels significantly increased both axon arborization and synapse number, with BDNF increasing synapse number per axon terminal. The ability to visualize central synapses in real time provides insights about the dynamic mechanisms underlying synaptogenesis, and reveals BDNF as a modulator of synaptogenesis in vivo.	Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Mental Retardat Res Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Cohen-Cory, S (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Mental Retardat Res Ctr, 760 Westwood Plaza,NPI 58-258, Los Angeles, CA 90095 USA.		Alsina, Berta/A-2632-2010	Alsina, Berta/0000-0002-6997-1249	NATIONAL EYE INSTITUTE [R01EY011912] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY011912, EY11912] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; ALDER J, 1995, J NEUROSCI, V15, P511; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; BALICEGORDON RJ, 1993, NEURON, V11, P801, DOI 10.1016/0896-6273(93)90110-D; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; CAMPBELL G, 1992, J NEUROSCI, V12, P1847; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; Cohen-Cory S, 1999, J NEUROSCI, V19, P9996; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; CONSTANTINEPATON M, 1990, COLD SPRING HARB SYM, V55, P431; Dingwell KS, 2000, J NEUROBIOL, V44, P246; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Gonzalez M, 1999, NEURON, V24, P567, DOI 10.1016/S0896-6273(00)81113-7; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KISTNER U, 1993, J BIOL CHEM, V268, P4580; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Lom B, 1999, J NEUROSCI, V19, P9928; Martinez A, 1998, J NEUROSCI, V18, P7336; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; NORDEN JJ, 1994, J COMP NEUROL, V348, P461, DOI 10.1002/cne.903480310; Pinches EM, 1998, J NEUROBIOL, V35, P426, DOI 10.1002/(SICI)1097-4695(19980615)35:4<426::AID-NEU8>3.0.CO;2-0; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; RAMOA AS, 1988, J NEUROSCI, V8, P4239; ROURKE NA, 1990, NEURON, V5, P159; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Schuman EM, 1999, CURR OPIN NEUROBIOL, V9, P105, DOI 10.1016/S0959-4388(99)80013-0; Seil FJ, 2000, J NEUROSCI, V20, P5367, DOI 10.1523/JNEUROSCI.20-14-05367.2000; Silver MA, 1999, J NEUROSCI, V19, P10829, DOI 10.1523/JNEUROSCI.19-24-10829.1999; Snider WD, 1996, MOL CELL NEUROSCI, V7, P433, DOI 10.1006/mcne.1996.0031; SOLLNER T, 1994, TRENDS NEUROSCI, V17, P344, DOI 10.1016/0166-2236(94)90178-3; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; YEN LS, 1995, J NEUROSCI, V15, P4712; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Zou DJ, 1999, J NEUROSCI, V19, P8909, DOI 10.1523/JNEUROSCI.19-20-08909.1999	50	284	298	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1093	1101		10.1038/nn735	http://dx.doi.org/10.1038/nn735			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	489AY	11593233				2022-12-17	WOS:000171970900012
J	Xu, T; Binz, T; Niemann, H; Neher, E				Xu, T; Binz, T; Niemann, H; Neher, E			Multiple kinetic components of exocytosis distinguished by neurotoxin sensitivity	NATURE NEUROSCIENCE			English	Article							ADRENAL CHROMAFFIN CELLS; READILY RELEASABLE POOL; MEMBRANE-FUSION COMPLEX; PROTEIN-KINASE-C; TETANUS TOXIN; NEUROTRANSMITTER RELEASE; CLOSTRIDIAL NEUROTOXINS; CA2+-ACTIVATED SECRETION; CATECHOLAMINE RELEASE; BOTULINUM NEUROTOXINS	The secretion of synaptic and other vesicles is a complex process involving multiple steps. Many molecular components of the secretory apparatus have been identified, but how they relate to the different stages of vesicle release is not clear. We examined this issue in adrenal chromaffin cells, where capacitance measurements and amperometry allow us to measure vesicle fusion and hormone release simultaneously. Using flash photolysis of caged intracellular calcium to induce exocytosis, we observed three distinct kinetic components to vesicle fusion, of which only two are related to catecholamine release. Intracellular dialysis with botulinum neurotoxin E, D or C1 or tetanus-toxin light chains abolishes the catecholamine-related components, but leaves the third component untouched. Botulinum neurotoxin A, which removes nine amino acids from the carboxy(C)-terminal end of SNAP-25, does not eliminate catecholamine release completely, but slows down both catecholamine-related components. Thus we assign a dual role to SNAP-25 and suggest that its nine C-terminal amino acids are directly involved in coupling the calcium sensor to the final step in exocytosis.	Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany; Med Hsch Hannover, Dept Biochem, D-30625 Hannover, Germany	Max Planck Society; Hannover Medical School	Xu, T (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, Fassberg 11, D-37077 Gottingen, Germany.		Neher, Erwin/A-2109-2013					Banerjee A, 1996, J BIOL CHEM, V271, P20223, DOI 10.1074/jbc.271.34.20223; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; BINZ T, 1994, J BIOL CHEM, V269, P1617; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; BITTNER MA, 1993, CELL MOL NEUROBIOL, V13, P649, DOI 10.1007/BF00711564; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; Capogna M, 1997, J NEUROSCI, V17, P7190; Colombo MI, 1996, J BIOL CHEM, V271, P18810, DOI 10.1074/jbc.271.31.18810; DREYER F, 1987, N-S ARCH PHARMACOL, V335, P1, DOI 10.1007/BF00165027; ELLISDAVIES GCR, 1994, P NATL ACAD SCI USA, V91, P187, DOI 10.1073/pnas.91.1.187; Foran P, 1996, BIOCHEMISTRY-US, V35, P2630, DOI 10.1021/bi9519009; FORAN P, 1995, BIOCHEMISTRY-US, V34, P5494, DOI 10.1021/bi00016a021; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; HAY JC, 1993, NATURE, V366, P572, DOI 10.1038/366572a0; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HohneZell B, 1996, FEBS LETT, V394, P109, DOI 10.1016/0014-5793(96)00931-3; HOLZ RW, 1989, J BIOL CHEM, V264, P5412; IKONEN E, 1995, CELL, V81, P571, DOI 10.1016/0092-8674(95)90078-0; Klingauf J, 1997, BIOPHYS J, V72, P674, DOI 10.1016/S0006-3495(97)78704-6; Lawrence GW, 1997, BIOCHEMISTRY-US, V36, P3061, DOI 10.1021/bi9622478; Martin TFJ, 1997, TRENDS CELL BIOL, V7, P271, DOI 10.1016/S0962-8924(97)01060-X; MCMAHON HT, 1992, J BIOL CHEM, V267, P21338; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; Moser T, 1997, J NEUROSCI, V17, P2314; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; OTTO H, 1995, BIOCHEM BIOPH RES CO, V212, P945, DOI 10.1006/bbrc.1995.2061; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Poulain B, 1996, NEUROSCIENCE, V70, P567, DOI 10.1016/0306-4522(95)00336-3; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; Weimbs T, 1997, TRENDS CELL BIOL, V7, P393, DOI 10.1016/S0962-8924(97)01130-6; Xu T, 1997, BIOPHYS J, V73, P532, DOI 10.1016/S0006-3495(97)78091-3	50	284	292	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1998	1	3					192	200		10.1038/642	http://dx.doi.org/10.1038/642			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QC	10195143	Green Published			2022-12-17	WOS:000076361200009
J	Hansen, T; Olkkonen, M; Walter, S; Gegenfurtner, KR				Hansen, Thorsten; Olkkonen, Maria; Walter, Sebastian; Gegenfurtner, Karl R.			Memory modulates color appearance	NATURE NEUROSCIENCE			English	Article							PAST EXPERIENCE; CONSTANCY; PERCEPTION	We asked human observers to adjust the color of natural fruit objects until they appeared achromatic. The objects were generally perceived to be gray when their color was shifted away from the observers' gray point in a direction opposite to the typical color of the fruit. These results show that color sensations are not determined by the incoming sensory data alone, but are significantly modulated by high-level visual memory.	Univ Giessen, D-35394 Giessen, Germany	Justus Liebig University Giessen	Gegenfurtner, KR (corresponding author), Univ Giessen, Otto Behaghel Str 10F, D-35394 Giessen, Germany.	gegenfurtner@uni-giessen.de	Olkkonen, Maria/AAW-6469-2020	Olkkonen, Maria/0000-0001-7962-2256; Sanchez-Fernandez, Gregorio Esteban/0000-0002-6059-7182; Gegenfurtner, Karl/0000-0001-5390-0684				BARTLESON CJ, 1960, J OPT SOC AM, V50, P73, DOI 10.1364/JOSA.50.000073; BOLLES RC, 1959, CAN J PSYCHOLOGY, V13, P175, DOI 10.1037/h0083774; BRUNER JS, 1951, AM J PSYCHOL, V64, P216, DOI 10.2307/1418668; DELK JL, 1965, AM J PSYCHOL, V78, P290, DOI 10.2307/1420503; Duncker K, 1939, AM J PSYCHOL, V52, P255, DOI 10.2307/1416111; FISHER SC, 1956, AM J PSYCHOL, V69, P546, DOI 10.2307/1419079; GROSSBERG S, 1980, PSYCHOL REV, V87, P1, DOI 10.1037/0033-295X.87.1.1; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Jin EW, 1996, J OPT SOC AM A, V13, P1981, DOI 10.1364/JOSAA.13.001981; Knill DC, 1996, PERCEPTION BAYESIAN; Kraft JM, 1999, P NATL ACAD SCI USA, V96, P307, DOI 10.1073/pnas.96.1.307; RAMACHANDRAN VS, 1988, NATURE, V331, P163, DOI 10.1038/331163a0; Smithson HE, 2005, PHILOS T R SOC B, V360, P1329, DOI 10.1098/rstb.2005.1633; Taylor AH, 1941, J OPT SOC AM, V31, P3, DOI 10.1364/JOSA.31.000003	14	283	285	2	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1367	1368		10.1038/nn1794	http://dx.doi.org/10.1038/nn1794			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17041591				2022-12-17	WOS:000242403800012
J	Dani, JA; Harris, RA				Dani, JA; Harris, RA			Nicotine addiction and comorbidity with alcohol abuse and mental illness	NATURE NEUROSCIENCE			English	Review							VENTRAL TEGMENTAL AREA; LONG-TERM POTENTIATION; BRAIN REWARD FUNCTION; ACETYLCHOLINE-RECEPTORS; DOPAMINE RELEASE; SYNAPTIC MECHANISMS; CHOLINERGIC MODULATION; MOLECULAR-MECHANISMS; CIGARETTE-SMOKING; DEPENDENCE	The World Health Organization estimates that one-third of the global adult population smokes. Because tobacco use is on the rise in developing countries, death resulting from tobacco use continues to rise. Nicotine, the main addictive component of tobacco, initiates synaptic and cellular changes that underlie the motivational and behavioral alterations that culminate in addiction. Nicotine addiction progresses rapidly in adolescents and is most highly expressed in vulnerable people who have psychiatric illness or other substance abuse problems.	Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Dept Neurosci, Houston, TX 77030 USA; Univ Texas, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA	Baylor College of Medicine; University of Texas System; University of Texas Austin	Dani, JA (corresponding author), Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Dept Neurosci, Houston, TX 77030 USA.	jdani@bcm.tmc.edu			NINDS NIH HHS [R01 NS021229] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021229] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adriani W, 2003, J NEUROSCI, V23, P4712; Balfour DJK, 2000, PHARMACOL BIOCHEM BE, V66, P79, DOI 10.1016/S0091-3057(00)00205-7; Balfour DJK, 2004, NICOTINE TOB RES, V6, P899, DOI 10.1080/14622200412331324965; Benowitz NL, 1999, PRIMARY CARE, V26, P611, DOI 10.1016/S0095-4543(05)70120-2; Berrendero F, 2002, J NEUROSCI, V22, P10935; Blednow YA, 2003, P NATL ACAD SCI USA, V100, P277, DOI 10.1073/pnas.012682399; Blomqvist O, 2002, ALCOHOL CLIN EXP RES, V26, P326, DOI 10.1111/j.1530-0277.2002.tb02541.x; Borghese CM, 2003, J PHARMACOL EXP THER, V307, P42, DOI 10.1124/jpet.102.053710; Butt CM, 2004, J PHARMACOL EXP THER, V308, P591, DOI 10.1124/jpet.103.059758; Butt CM, 2003, ALCOHOL CLIN EXP RES, V27, P733, DOI 10.1097/01.ALC.0000067973.41153.BC; Cardoso RA, 1999, J PHARMACOL EXP THER, V289, P774; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Clark A, 2001, NEUROPHARMACOLOGY, V41, P108, DOI 10.1016/S0028-3908(01)00037-5; Cohen C, 2005, PHARMACOL BIOCHEM BE, V81, P387, DOI 10.1016/j.pbb.2005.01.024; Corrigall W A, 1999, Nicotine Tob Res, V1, P11, DOI 10.1080/14622299050011121; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; Dani JA, 2001, NEURON, V31, P349, DOI 10.1016/S0896-6273(01)00379-8; de Fiebre N, 2002, ALCOHOL CLIN EXP RES, V26, P765, DOI 10.1097/00000374-200206000-00004; de Rover M, 2002, EUR J NEUROSCI, V16, P2279, DOI 10.1046/j.1460-9568.2002.02289.x; DEFIEBRE CM, 1987, ALCOHOL, V4, P493, DOI 10.1016/0741-8329(87)90092-9; Di Chiara G, 2000, EUR J PHARMACOL, V393, P295, DOI 10.1016/S0014-2999(00)00122-9; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; DiFranza JR, 2000, TOB CONTROL, V9, P313, DOI 10.1136/tc.9.3.313; Epping-Jordan MP, 1998, NATURE, V393, P76, DOI 10.1038/30001; Fowler JS, 1996, P NATL ACAD SCI USA, V93, P14065, DOI 10.1073/pnas.93.24.14065; Freedman R, 2001, AM J MED GENET, V105, P20, DOI 10.1002/1096-8628(20010108)105:1<20::AID-AJMG1047>3.0.CO;2-C; Garzon M, 1999, J COMP NEUROL, V410, P197, DOI 10.1002/(SICI)1096-9861(19990726)410:2<197::AID-CNE3>3.0.CO;2-D; Goeders NE, 2002, J PHARMACOL EXP THER, V301, P785, DOI 10.1124/jpet.301.3.785; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1107, DOI 10.1001/archpsyc.61.11.1107; Harris JG, 2004, NEUROPSYCHOPHARMACOL, V29, P1378, DOI 10.1038/sj.npp.1300450; HENNINGFIELD JE, 2003, TOBACCO CONTROL S1, V12, P14; HUGHES JR, 1994, ADDICTION, V89, P1461, DOI 10.1111/j.1360-0443.1994.tb03744.x; Hughes JR, 2000, ALCOHOL CLIN EXP RES, V24, P1633, DOI 10.1097/00000374-200011000-00005; John U, 2003, ADDICTION, V98, P805, DOI 10.1046/j.1360-0443.2003.00381.x; Johnson BA, 2004, ADDICT BEHAV, V29, P1465, DOI 10.1016/j.addbeh.2004.06.014; Jones S, 2005, CURR OPIN PHARMACOL, V5, P20, DOI 10.1016/j.coph.2004.08.011; Jones S, 1999, TRENDS NEUROSCI, V22, P555, DOI 10.1016/S0166-2236(99)01471-X; Kandel D, 1997, DRUG ALCOHOL DEPEN, V44, P11, DOI 10.1016/S0376-8716(96)01315-4; Karan LD, 2003, PRINCIPLES ADDICTION, P225; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P36; Kenny PJ, 2005, J NEUROSCI, V25, P6208, DOI 10.1523/JNEUROSCI.4785-04.2005; Kenny PJ, 2003, J PHARMACOL EXP THER, V306, P1068, DOI 10.1124/jpet.103.052027; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Lanca AJ, 2000, NEUROSCIENCE, V96, P735, DOI 10.1016/S0306-4522(99)00607-7; Laviolette SR, 2004, NAT REV NEUROSCI, V5, P55, DOI 10.1038/nrn1298; Laviolette SR, 2003, MOL PSYCHIATR, V8, P50, DOI 10.1038/sj.mp.4001197; Leonard S, 2001, PHARMACOL BIOCHEM BE, V70, P561, DOI 10.1016/S0091-3057(01)00677-3; Levin ED, 2003, PSYCHOPHARMACOLOGY, V169, P141, DOI 10.1007/s00213-003-1486-y; Lopez MF, 2001, ADDICT BIOL, V6, P119, DOI 10.1080/13556210020040190; Lovinger DM, 2005, NAT NEUROSCI, V8, P1471, DOI 10.1038/nn1581; MADDEN PAF, 1995, ALCOHOL CLIN EXP RES, V19, P1111, DOI 10.1111/j.1530-0277.1995.tb01588.x; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mansvelder HD, 2003, EUR J PHARMACOL, V480, P117, DOI 10.1016/j.ejphar.2003.08.099; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Mansvelder HD, 2002, NEURON, V33, P905, DOI 10.1016/S0896-6273(02)00625-6; Mansvelder HD, 2002, J NEUROBIOL, V53, P606, DOI 10.1002/neu.10148; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; McEvoy JP, 1999, AM J PSYCHIAT, V156, P1120; Nestler EJ, 2004, NEUROPHARMACOLOGY, V47, P24, DOI 10.1016/j.neuropharm.2004.06.031; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Omelchenko N, 2005, J COMP NEUROL, V483, P217, DOI 10.1002/cne.20417; Owens JC, 2003, ALCOHOL CLIN EXP RES, V27, P1867, DOI 10.1097/01.ALC.0000102700.72447.0F; Patton GC, 1998, AM J PUBLIC HEALTH, V88, P1518, DOI 10.2105/AJPH.88.10.1518; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Picciotto MR, 2002, J NEUROSCI, V22, P3338; Pidoplichko VI, 2004, LEARN MEMORY, V11, P60, DOI 10.1101/lm.70004; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; Quattrocki E, 2000, HARVARD REV PSYCHIAT, V8, P99, DOI 10.1093/hrp/8.3.99; Riala K, 2004, J ADOLESCENT HEALTH, V35, P245, DOI 10.1016/j.jadohealth.2003.08.016; Rice ME, 2004, NAT NEUROSCI, V7, P583, DOI 10.1038/nn1244; Role LW, 1996, NEURON, V16, P1077, DOI 10.1016/S0896-6273(00)80134-8; Rose JE, 1999, DRUG ALCOHOL DEPEN, V56, P99, DOI 10.1016/S0376-8716(99)00025-3; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Salas R, 2004, J NEUROSCI, V24, P10035, DOI 10.1523/JNEUROSCI.1939-04.2004; Salminen O, 2004, MOL PHARMACOL, V65, P1526, DOI 10.1124/mol.65.6.1526; Schilstrom B, 2003, INT J NEUROPSYCHOPH, V6, P1, DOI 10.1017/S1461145702003188; Schilstrom B, 1998, NEUROSCIENCE, V82, P781; Schuckit MA, 2004, ALCOHOL ALCOHOLISM, V39, P433, DOI 10.1093/alcalc/agh081; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Staley JK, 2005, ARCH GEN PSYCHIAT, V62, P877, DOI 10.1001/archpsyc.62.8.877; STOLERMAN IP, 1991, TRENDS PHARMACOL SCI, V12, P467, DOI 10.1016/0165-6147(91)90638-9; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; True WR, 1999, ARCH GEN PSYCHIAT, V56, P655, DOI 10.1001/archpsyc.56.7.655; Upadhyaya HP, 2002, J AM ACAD CHILD PSY, V41, P1294, DOI 10.1097/00004583-200211000-00010; Vastola BJ, 2002, PHYSIOL BEHAV, V77, P107, DOI 10.1016/S0031-9384(02)00818-1; Walters CL, 2005, NEURON, V46, P933, DOI 10.1016/j.neuron.2005.05.005; Wonnacott S, 2005, CURR OPIN PHARMACOL, V5, P53, DOI 10.1016/j.coph.2004.12.002; Wooltorton JRA, 2003, J NEUROSCI, V23, P3176; World Health Organization, 1997, TOB HLTH GLOB STAT R; Zhang H, 2004, NAT NEUROSCI, V7, P581, DOI 10.1038/nn1243; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	92	283	289	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1465	1470		10.1038/nn1580	http://dx.doi.org/10.1038/nn1580			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	979TB	16251989				2022-12-17	WOS:000232966600017
J	Johnson, EN; Hawken, MJ; Shapley, R				Johnson, EN; Hawken, MJ; Shapley, R			The spatial transformation of color in the primary visual cortex of the macaque monkey	NATURE NEUROSCIENCE			English	Article							STRIATE CORTEX; CONTRAST SENSITIVITY; RECEPTIVE-FIELDS; CELLS; NEURONS; ORGANIZATION; MECHANISMS; LUMINANCE; V1; ORIENTATION	Perceptually, color is used to discriminate objects by hue and to identify color boundaries. The primate retina and the lateral geniculate nucleus (LGN) have cell populations sensitive to color modulation, but the role of the primary visual cortex (V1) in color signal processing is uncertain. We reevaluated color processing in V1 by studying single-neuron responses to luminance and to equiluminant color patterns equated for cone contrast. Many neurons respond robustly to both equiluminant color and luminance modulation (color-luminance cells). Also, there are neurons that prefer luminance (luminance cells), and a few neurons that prefer color (color cells). Surprisingly, most color-luminance cells are spatial-frequency tuned, with approximately equal selectivity for chromatic and achromatic patterns. Therefore, V1 retains the color sensitivity provided by the LGN, and adds spatial selectivity for color boundaries.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Johnson, EN (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl, New York, NY 10003 USA.	zab@cns.nyu.edu			NEI NIH HHS [EY8300, P30-EY13079, EY01472] Funding Source: Medline; NIMH NIH HHS [MH12430-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008300, R01EY001472, P30EY013079] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Batschelet E., 1981, CIRCULAR STAT BIOL; Boyd JD, 1999, J COMP NEUROL, V409, P573, DOI 10.1002/(SICI)1096-9861(19990712)409:4<573::AID-CNE5>3.0.CO;2-R; BRADLEY A, 1988, VISION RES, V28, P841, DOI 10.1016/0042-6989(88)90031-4; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; COLE GR, 1990, J OPT SOC AM A, V7, P128, DOI 10.1364/JOSAA.7.000128; DEVALOIS KK, 1983, J OPT SOC AM, V73, P11, DOI 10.1364/JOSA.73.000011; DEVALOIS RL, 1988, SPATIAL VISION, P218; DEYOE EA, 1988, TRENDS NEUROSCI, V11, P219, DOI 10.1016/0166-2236(88)90130-0; DOW BM, 1974, J NEUROPHYSIOL, V37, P927, DOI 10.1152/jn.1974.37.5.927; Engel S, 1997, NATURE, V388, P68, DOI 10.1038/40398; ESTEVEZ O, 1982, VISION RES, V22, P681, DOI 10.1016/0042-6989(82)90104-3; Gegenfurtner KR, 1997, J NEUROPHYSIOL, V77, P1906, DOI 10.1152/jn.1997.77.4.1906; GOURAS P, 1974, J PHYSIOL-LONDON, V238, P583, DOI 10.1113/jphysiol.1974.sp010545; HAWKEN MJ, 1988, J NEUROSCI, V8, P3541; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; JAMESON D, 1959, J OPT SOC AM, V49, P890, DOI 10.1364/JOSA.49.000890; KAPLAN E, 1988, NEUROSCI RES, pS151, DOI 10.1016/0921-8696(88)90014-X; Kiper DC, 1997, VISUAL NEUROSCI, V14, P1061, DOI 10.1017/S0952523800011779; KRAUSKOPF J, 1963, J OPT SOC AM, V53, P741, DOI 10.1364/JOSA.53.000741; KRAUSKOPF J, 1986, VISION RES, V26, P23, DOI 10.1016/0042-6989(86)90068-4; LENNIE P, 1990, J NEUROSCI, V10, P649; Lennie P., 1999, COLOR VISION GENES P, P235; LEVENTHAL AG, 1995, J NEUROSCI, V15, P1808, DOI 10.1523/JNEUROSCI.15-03-01808.1995; LEVICK WR, 1982, J PHYSIOL-LONDON, V329, P243, DOI 10.1113/jphysiol.1982.sp014301; Levitt JB, 1996, BEHAV BRAIN RES, V76, P5, DOI 10.1016/0166-4328(95)00188-3; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; LUND JS, 1981, J COMP NEUROL, V202, P19, DOI 10.1002/cne.902020104; LUTKENHONER B, 1991, ACTA OTO-LARYNGOL, P52; MICHAEL CR, 1978, J NEUROPHYSIOL, V41, P572, DOI 10.1152/jn.1978.41.3.572; MULLEN KT, 1985, J PHYSIOL-LONDON, V359, P381, DOI 10.1113/jphysiol.1985.sp015591; REID RC, 1992, NATURE, V356, P716, DOI 10.1038/356716a0; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; SHAPLEY RM, 1999, COLOR VISION GENES P, P221; Shevell SK, 1998, VISION RES, V38, P1561, DOI 10.1016/S0042-6989(98)00006-6; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; SWITKES E, 1988, J OPT SOC AM A, V5, P1149, DOI 10.1364/JOSAA.5.001149; THORELL LG, 1984, VISION RES, V24, P751, DOI 10.1016/0042-6989(84)90216-5; TSO DY, 1988, J NEUROSCI, V8, P1712; VANDERHORST GJ, 1969, J OPT SOC AM, V59, P1482, DOI 10.1364/JOSA.59.001482; VANESSEN DC, 1986, J COMP NEUROL, V244, P451, DOI 10.1002/cne.902440405; Wallach H, 1935, PSYCHOL FORSCH, V20, P325, DOI 10.1007/BF02409790; Yarbus A. L., 1967, EYE MOVEMENTS VISION, P171; Zeki S., 1993, VISION BRAIN	44	283	286	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					409	416		10.1038/86061	http://dx.doi.org/10.1038/86061			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276232				2022-12-17	WOS:000168762200022
J	Todorov, E				Todorov, E			Direct cortical control of muscle activation in voluntary arm movements: a model	NATURE NEUROSCIENCE			English	Article							PRIMATE MOTOR CORTEX; SIMILAR HAND PATHS; REACHING MOVEMENTS; NEURAL DISCHARGE; ISOMETRIC FORCE; CELLS; TASK; NEURONS; JOINT; SPACE	What neural activity in motor cortex represents and how it controls ongoing movement remain unclear. Suggestions that cortex generates low-level muscle control are discredited by correlations with higher-level parameters of hand movement, but no coherent alternative exists. I argue that the view of low-level control is in principle correct, and that seeming contradictions result from overlooking known properties of the motor periphery. Assuming direct motor cortical activation of muscle groups and taking into account the state dependence of muscle-force production and multijoint mechanics, I show that cortical population output must correlate with hand kinematics in quantitative agreement with experimental observations. The model reinterprets the 'neural population vector' to afford unified control of posture, movement and force production.	UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England	University of London; University College London	Todorov, E (corresponding author), UCL, Gatsby Computat Neurosci Unit, 17 Queen Sq, London WC1N 3AR, England.	emo@gatsby.ucl.ac.uk						ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P164, DOI 10.1152/jn.1990.64.1.164; ASHE J, 1994, CEREB CORTEX, V4, P590, DOI 10.1093/cercor/4.6.590; BENNETT DJ, 1992, EXP BRAIN RES, V88, P433, DOI 10.1007/BF02259118; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; Bullock D, 1998, CEREB CORTEX, V8, P48, DOI 10.1093/cercor/8.1.48; CAMINITI R, 1990, J NEUROSCI, V10, P2039; Carpenter AF, 1999, SCIENCE, V283, P1752, DOI 10.1126/science.283.5408.1752; Crammond DJ, 1996, EXP BRAIN RES, V108, P45; DUM RP, 1991, J NEUROSCI, V11, P667; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Evarts EV, 1981, HDB PHYSL NERVOUS SY, VII, P1083; FETZ EE, 1992, BEHAV BRAIN SCI, V15, P679; FETZ EE, 1980, J NEUROPHYSIOL, V44, P751, DOI 10.1152/jn.1980.44.4.751; FETZ EE, 1989, PROG BRAIN RES, V80, P437; FLAMENT D, 1988, J NEUROPHYSIOL, V60, P1268, DOI 10.1152/jn.1988.60.4.1268; FU QG, 1995, J NEUROPHYSIOL, V73, P836, DOI 10.1152/jn.1995.73.2.836; FU QG, 1993, J NEUROPHYSIOL, V70, P2097, DOI 10.1152/jn.1993.70.5.2097; GALAGAN J, 1999, THESIS MIT; GEORGOPOULOS AP, 1989, SCIENCE, V243, P234, DOI 10.1126/science.2911737; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Gomi H, 1996, SCIENCE, V272, P117, DOI 10.1126/science.272.5258.117; Gottlieb GL, 1996, J NEUROPHYSIOL, V76, P3207, DOI 10.1152/jn.1996.76.5.3207; HOCHERMAN S, 1991, EXP BRAIN RES, V83, P285; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Humphrey D R, 1983, Adv Neurol, V39, P347; JOHNSON PB, 1992, CONTROL ARM MOVEMENT; JOYCE GC, 1969, J PHYSIOL-LONDON, V204, P461, DOI 10.1113/jphysiol.1969.sp008924; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; KALASKA JF, 1992, SCIENCE, V255, P1517, DOI 10.1126/science.1549781; KALASKA JF, 1989, J NEUROSCI, V9, P2080; KALASKA JF, 1992, CONTROL ARM MOVEMENT; KETTNER RE, 1988, J NEUROSCI, V8, P2938; KHATIB O, 1987, IEEE T ROBOTIC AUTOM, V3, P43, DOI 10.1109/JRA.1987.1087068; Miller LE, 1998, J NEUROPHYSIOL, V80, P59, DOI 10.1152/jn.1998.80.1.59; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; MUSSAIVALDI FA, 1988, NEUROSCI LETT, V91, P106, DOI 10.1016/0304-3940(88)90257-1; SANES JN, 1995, CAN J PHYSIOL PHARM, V73, P223, DOI 10.1139/y95-033; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; SCHWARTZ AB, 1994, SCIENCE, V265, P540, DOI 10.1126/science.8036499; Scott SH, 1997, J NEUROPHYSIOL, V77, P1016, DOI 10.1152/jn.1997.77.2.1016; Scott SH, 1997, J NEUROPHYSIOL, V77, P826, DOI 10.1152/jn.1997.77.2.826; SCOTT SH, 1995, J NEUROPHYSIOL, V73, P2563, DOI 10.1152/jn.1995.73.6.2563; Sergio LE, 1998, J NEUROPHYSIOL, V80, P1577, DOI 10.1152/jn.1998.80.3.1577; Taira M, 1996, EXP BRAIN RES, V109, P367; TANAKA S, 1994, NEUROSCI LETT, V180, P83, DOI 10.1016/0304-3940(94)90493-6; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; TSUJI T, 1995, BIOL CYBERN, V72, P475, DOI 10.1007/BF00199890; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359	50	283	300	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					391	398		10.1038/73964	http://dx.doi.org/10.1038/73964			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725930				2022-12-17	WOS:000087945400021
J	Scheetz, AJ; Nairn, AC; Constantine-Paton, M				Scheetz, AJ; Nairn, AC; Constantine-Paton, M			NMDA receptor-mediated control of protein synthesis at developing synapses	NATURE NEUROSCIENCE			English	Article							ELONGATION FACTOR-II; MESSENGER-RNA COMPETITION; D-ASPARTATE RECEPTOR; REGULATING TRANSLATION; SUPERIOR COLLICULUS; KINASE-II; CYTOPLASMIC POLYADENYLATION; SYNAPTIC PLASTICITY; RAT-BRAIN; PHOSPHORYLATION	We demonstrate a rapid and complex effect of N-methyl-D-aspartate receptor (NMDAR) activation on synaptic protein synthesis in the superior colliculi of young rats. Within minutes of receptor activation, translation of alpha Ca2+/calmodulin dependent kinase II (alpha CamK II) was increased, whereas total protein synthesis was reduced. NMDAR activation also increased phosphorylation of eukaryotic elongation factor 2 (eEF2), a process known to inhibit protein translation by reducing peptide chain elongation. Low doses of cycloheximide, which reduce elongation rate independently of eEF2 phosphorylation, decreased overall protein synthesis but increased alpha CaMK II synthesis. These observations suggest that regulation of peptide elongation via eEF2 phosphorylation can link NMDAR activation to local increases in the synthesis of specific proteins during activity-dependent synaptic change.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	Yale University; Rockefeller University	Scheetz, AJ (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 333 Cedar St,POB 208024, New Haven, CT 06520 USA.			Nairn, Angus/0000-0002-7075-0195	NATIONAL EYE INSTITUTE [R37EY006039, R01EY006039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050402] Funding Source: NIH RePORTER; NEI NIH HHS [EY 06039] Funding Source: Medline; NIGMS NIH HHS [GM 50402] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAITINGER C, 1990, J CELL BIOL, V111, P1763, DOI 10.1083/jcb.111.5.1763; BRENDLER T, 1981, J BIOL CHEM, V256, P1747; BRENDLER T, 1981, J BIOL CHEM, V256, P1755; BROCKE L, 1995, J NEUROSCI, V15, P6797; BURGIN KE, 1990, J NEUROSCI, V10, P1788; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; FEIG S, 1993, J NEUROSCI, V13, P1010; GODEFROYCOLBURN T, 1981, J BIOL CHEM, V256, P1762; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; KELLY PT, 1991, MOL NEUROBIOL, V5, P153, DOI 10.1007/BF02935544; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Leski ML, 1996, NEUROCHEM RES, V21, P681, DOI 10.1007/BF02527725; LUND RD, 1972, BRAIN RES, V42, P1, DOI 10.1016/0006-8993(72)90038-8; Marin P, 1997, J NEUROSCI, V17, P3445; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MCGREW LL, 1990, EMBO J, V9, P3743, DOI 10.1002/j.1460-2075.1990.tb07587.x; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; NAIRN AC, 1996, TRANSLATIONAL CONTRO, P295; Ouyang Y, 1999, J NEUROSCI, V19, P7823; REDPATH NT, 1989, BIOCHEM J, V262, P69, DOI 10.1042/bj2620069; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Scheetz AJ, 1997, P NATL ACAD SCI USA, V94, P14770, DOI 10.1073/pnas.94.26.14770; Scheetz AJ, 1996, J NEUROSCI, V16, P1460; Scheetz AJ, 1996, EUR J NEUROSCI, V8, P1322, DOI 10.1111/j.1460-9568.1996.tb01594.x; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shi J, 1997, J NEUROSCI, V17, P6264; SIMON DK, 1990, DEV BIOL, V137, P125, DOI 10.1016/0012-1606(90)90013-9; SIMON DK, 1992, J NEUROSCI, V12, P1212; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; Steward O, 1999, J NEUROSCI, V19, P7834; STEWARD O, 1986, J NEUROSCI, V6, P412; STEWARD O, 1991, J COMP NEUROL, V314, P545, DOI 10.1002/cne.903140311; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; WALDEN WE, 1986, BIOCHEMISTRY-US, V25, P2033, DOI 10.1021/bi00356a030; WALDEN WE, 1981, J BIOL CHEM, V256, P1739; WEILER IJ, 1993, P NATL ACAD SCI USA, V90, P7168, DOI 10.1073/pnas.90.15.7168; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3	40	283	290	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					211	216		10.1038/72915	http://dx.doi.org/10.1038/72915			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TE	10700251				2022-12-17	WOS:000085810500008
J	Srinivasan, R; Huang, BS; Venugopal, S; Johnston, AD; Chai, H; Zeng, HK; Golshani, P; Khakh, BS				Srinivasan, Rahul; Huang, Ben S.; Venugopal, Sharmila; Johnston, April D.; Chai, Hua; Zeng, Hongkui; Golshani, Peyman; Khakh, Baljit S.			Ca2+ signaling in astrocytes from Ip3r2(-/-) mice in brain slices and during startle responses in vivo	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL ASTROCYTES; RECEPTOR ACTIVATION; CORTICAL ASTROCYTES; VISUAL-CORTEX; MODULATION; PLASTICITY; GLIA; REGULATORS; PHYSIOLOGY; BEHAVIOR	Intracellular Ca2+ signaling is considered to be important for multiple astrocyte functions in neural circuits. However, mice devoid of inositol triphosphate type 2 receptors (IP3R2) reportedly lack all astrocyte Ca2+ signaling, but display no neuronal or neurovascular deficits, implying that astrocyte Ca2+ fluctuations are not involved in these functions. An assumption has been that the loss of somatic Ca2+ fluctuations also reflects a similar loss in astrocyte processes. We tested this assumption and found diverse types of Ca2+ fluctuations in astrocytes, with most occurring in processes rather than in somata. These fluctuations were preserved in Ip3r2(-/-) (also known as Itpr2(-/-)) mice in brain slices and in vivo, occurred in end feet, and were increased by G protein-coupled receptor activation and by startle-induced neuromodulatory responses. Our data reveal previously unknown Ca2+ fluctuations in astrocytes and highlight limitations of studies that used Ip3r2(-/-) mice to evaluate astrocyte contributions to neural circuit function and mouse behavior.	[Srinivasan, Rahul; Venugopal, Sharmila; Johnston, April D.; Chai, Hua; Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Huang, Ben S.; Golshani, Peyman] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA USA; [Golshani, Peyman] Univ Calif Los Angeles, David Geffen Sch Med, Integrat Ctr Learning & Memory, Los Angeles, CA 90095 USA; [Golshani, Peyman] W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Allen Institute for Brain Science; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Khakh, BS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	bkhakh@mednet.ucla.edu		Huang, Ben/0000-0003-2838-6315; Srinivasan, Rahul/0000-0003-0237-6602	US National Institutes of Health (NIH) [NS060677]; NIH [MH099559A, MH104069, MH101198-1]; CHDI Foundation; Simon's Foundation Circuits Grant; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099559, R01MH101198, DP1MH104069, R01MH105427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060677] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI Foundation; Simon's Foundation Circuits Grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are grateful to current and past members of the laboratories for discussions and comments. Thanks also to M.V. Sofroniew for sharing equipment and to J. Chen for sharing mice. Special thanks to M.D. Haustein who helped with the initial testing of GECIquant and made valuable suggestions on its development. We thank C. Octeau for comments on the paper. Most of the work was supported by the US National Institutes of Health (NIH, NS060677). B.S.K., R.S. and S.V. were also supported by NIH grants (MH099559A, MH104069) and the CHDI Foundation. P.G. and B.S.H. were supported by NIH MH101198-1 and a Simon's Foundation Circuits Grant.	Agulhon C, 2013, J PHYSIOL-LONDON, V591, P5599, DOI 10.1113/jphysiol.2013.261289; Allen NJ, 2014, ANNU REV CELL DEV BI, V30, P439, DOI 10.1146/annurev-cellbio-100913-013053; Anders S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0600; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bekar LK, 2008, CEREB CORTEX, V18, P2789, DOI 10.1093/cercor/bhn040; Bonder DE, 2014, J NEUROSCI, V34, P13139, DOI 10.1523/JNEUROSCI.2591-14.2014; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Chen NY, 2012, P NATL ACAD SCI USA, V109, pE2832, DOI 10.1073/pnas.1206557109; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Ding FF, 2013, CELL CALCIUM, V54, P387, DOI 10.1016/j.ceca.2013.09.001; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Fiacco TA, 2009, ANNU REV PHARMACOL, V49, P151, DOI 10.1146/annurev.pharmtox.011008.145602; Fossat P, 2012, CEREB CORTEX, V22, P595, DOI 10.1093/cercor/bhr130; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Haustein MD, 2014, NEURON, V82, P413, DOI 10.1016/j.neuron.2014.02.041; Jiang R, 2014, JOVE-J VIS EXP, DOI 10.3791/51972; Khakh BS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020404; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Muthukumar AK, 2014, NAT NEUROSCI, V17, P1340, DOI 10.1038/nn.3791; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Nimmerjahn A, 2009, NEURON, V62, P400, DOI 10.1016/j.neuron.2009.03.019; Nizar K, 2013, J NEUROSCI, V33, P8411, DOI 10.1523/JNEUROSCI.3285-12.2013; Otsu Y, 2015, NAT NEUROSCI, V18, P210, DOI 10.1038/nn.3906; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Paukert M, 2014, NEURON, V82, P1263, DOI 10.1016/j.neuron.2014.04.038; Perez-Alvarez A, 2014, J NEUROSCI, V34, P12738, DOI 10.1523/JNEUROSCI.2401-14.2014; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Petravicz J, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00384; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Reeves AMB, 2011, J NEUROSCI, V31, P9353, DOI 10.1523/JNEUROSCI.0127-11.2011; Shigetomi E, 2008, J NEUROSCI, V28, P6659, DOI 10.1523/JNEUROSCI.1717-08.2008; Shigetomi E, 2013, J NEUROSCI, V33, P10143, DOI 10.1523/JNEUROSCI.5779-12.2013; Shigetomi E, 2013, J GEN PHYSIOL, V141, P633, DOI 10.1085/jgp.201210949; Shigetomi E, 2012, NAT NEUROSCI, V15, P70, DOI 10.1038/nn.3000; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Sun W, 2013, SCIENCE, V339, P197, DOI 10.1126/science.1226740; Takata N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066525; Takata N, 2011, J NEUROSCI, V31, P18155, DOI 10.1523/JNEUROSCI.5289-11.2011; Thrane AS, 2012, P NATL ACAD SCI USA, V109, P18974, DOI 10.1073/pnas.1209448109; Wallraff A, 2006, J NEUROSCI, V26, P5438, DOI 10.1523/JNEUROSCI.0037-06.2006; Wang FS, 2012, P NATL ACAD SCI USA, V109, P7911, DOI 10.1073/pnas.1120380109; Wang FS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002334; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	48	282	284	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2015	18	5					708	+		10.1038/nn.4001	http://dx.doi.org/10.1038/nn.4001			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG9LN	25894291	Green Accepted, Green Submitted			2022-12-17	WOS:000353636900018
J	Lisman, JE; Fellous, JM; Wang, XJ				Lisman, JE; Fellous, JM; Wang, XJ			A role for NMDA-receptor channels in working memory	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; MODULATION; DOPAMINE; SCHIZOPHRENIA; INHIBITION; MODEL		Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02254 USA; Salk Inst Biol Sci, La Jolla, CA 92037 USA	Brandeis University; Salk Institute	Lisman, JE (corresponding author), Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02254 USA.	lisman@binah.cc.brandeis.edu	Wang, Xiao-Jing/D-2722-2009; Fellous, Jean-Marc/AAP-3117-2021					Adler CM, 1998, BIOL PSYCHIAT, V43, P811, DOI 10.1016/S0006-3223(97)00556-8; AMIT DJ, 1994, J NEUROSCI, V14, P6435; CAMPERI M, 1998, IN PRESS J COMPUTATI; CARAMANOS Z, 1994, BEHAV NEUROSCI, V108, P30, DOI 10.1037/0735-7044.108.1.30; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; DAW NW, 1993, ANNU REV NEUROSCI, V16, P207, DOI 10.1146/annurev.ne.16.030193.001231; FLOHR H, 1995, NEUROPSYCHOLOGIA, V33, P1169, DOI 10.1016/0028-3932(95)00056-9; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Grunze HCR, 1996, J NEUROSCI, V16, P2034; HANSE E, 1994, NEUROSCI RES, V20, P15, DOI 10.1016/0168-0102(94)90018-3; Javitt DC, 1996, P NATL ACAD SCI USA, V93, P11962, DOI 10.1073/pnas.93.21.11962; Jensen O, 1996, LEARN MEMORY, V3, P264, DOI 10.1101/lm.3.2-3.264; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; OLNEY JW, 1995, ARCH GEN PSYCHIAT, V52, P998; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; TSAI GC, 1995, ARCH GEN PSYCHIAT, V52, P829; Verma A, 1996, J NEUROSCI, V16, P373; WANG XJ, 1995, P NATL ACAD SCI USA, V92, P5577, DOI 10.1073/pnas.92.12.5577; Wang XJ, 1996, J NEUROSCI, V16, P6402; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0	20	282	285	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1998	1	4					273	275		10.1038/1086	http://dx.doi.org/10.1038/1086			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QD	10195158				2022-12-17	WOS:000076361300008
J	Stachenfeld, KL; Botvinick, MM; Gershman, SJ				Stachenfeld, Kimberly L.; Botvinick, Matthew M.; Gershman, Samuel J.			The hippocampus as a predictive map	NATURE NEUROSCIENCE			English	Article							PHASE PRECESSION; SPATIAL MAP; MODEL; REPRESENTATION; ORGANIZATION; ENVIRONMENT; NAVIGATION; LOCATION	A cognitive map has long been the dominant metaphor for hippocampal function, embracing the idea that place cells encode a geometric representation of space. However, evidence for predictive coding, reward sensitivity and policy dependence in place cells suggests that the representation is not purely spatial. We approach this puzzle from a reinforcement learning perspective: what kind of spatial representation is most useful for maximizing future reward? We show that the answer takes the form of a predictive representation. This representation captures many aspects of place cell responses that fall outside the traditional view of a cognitive map. Furthermore, we argue that entorhinal grid cells encode a low-dimensionality basis set for the predictive representation, useful for suppressing noise in predictions and extracting multiscale structure for hierarchical planning.	[Stachenfeld, Kimberly L.; Botvinick, Matthew M.] DeepMind, London, England; [Stachenfeld, Kimberly L.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Botvinick, Matthew M.] UCL, Gatsby Computat Neurosci Unit, London, England; [Gershman, Samuel J.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Gershman, Samuel J.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Princeton University; University of London; University College London; Harvard University; Harvard University	Stachenfeld, KL (corresponding author), DeepMind, London, England.; Stachenfeld, KL (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	stachenfeld@google.com		Gershman, Samuel/0000-0002-6546-3298	NSF Collaborative Research in Computational Neuroscience (CRCNS) Program [IIS-120 7833]; John Templeton Foundation	NSF Collaborative Research in Computational Neuroscience (CRCNS) Program; John Templeton Foundation	We are grateful to T. Behrens, I. Mommenejad, and K. Miller for helpful discussions, and to A. Mathis, H. Sanders, M. Chadwick, and D. Kumaran for comments on an earlier draft of the paper. This research was supported by the NSF Collaborative Research in Computational Neuroscience (CRCNS) Program Grant IIS-120 7833 and The John Templeton Foundation. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the funding agencies.	Alvernhe A, 2011, EUR J NEUROSCI, V33, P1696, DOI 10.1111/j.1460-9568.2011.07653.x; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Bialek W., 2012, BIOPHYSICS SEARCHING; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Bonnevie T, 2013, NAT NEUROSCI, V16, P309, DOI 10.1038/nn.3311; Buckner RL, 2010, ANNU REV PSYCHOL, V61, P27, DOI 10.1146/annurev.psych.60.110707.163508; Carpenter F, 2015, CURR BIOL, V25, P1176, DOI 10.1016/j.cub.2015.02.037; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; DAYAN P, 1993, NEURAL COMPUT, V5, P613, DOI 10.1162/neco.1993.5.4.613; Derdikman D, 2009, NAT NEUROSCI, V12, P1325, DOI 10.1038/nn.2396; Deuker L, 2016, ELIFE, V5, DOI 10.7554/eLife.16534; Dordek Y., 2015, EXTRACTING GRID CHAR; Ekstrom AD, 2001, NEURON, V31, P631, DOI 10.1016/S0896-6273(01)00401-9; Fanselow MS, 2010, TRENDS COGN SCI, V14, P7, DOI 10.1016/j.tics.2009.10.008; Foster DJ, 2000, HIPPOCAMPUS, V10, P1, DOI 10.1002/(SICI)1098-1063(2000)10:1<1::AID-HIPO1>3.0.CO;2-1; Garvert MM, 2017, ELIFE, V6, DOI 10.7554/eLife.17086; Gershman SJ, 2012, NEURAL COMPUT, V24, P1553, DOI 10.1162/NECO_a_00282; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Gustafson NJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002235; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hales JB, 2014, CELL REP, V9, P893, DOI 10.1016/j.celrep.2014.10.009; Hassabis D, 2009, PHILOS T R SOC B, V364, P1263, DOI 10.1098/rstb.2008.0296; Hasselmo ME, 2014, NEUROIMAGE, V85, P656, DOI 10.1016/j.neuroimage.2013.06.022; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Howard MW, 2005, PSYCHOL REV, V112, P75, DOI 10.1037/0033-295X.112.1.75; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Krupic J, 2015, NATURE, V518, P232, DOI 10.1038/nature14153; Krupic J, 2012, SCIENCE, V337, P853, DOI 10.1126/science.1222403; Levy WB, 2005, NEURAL NETWORKS, V18, P1242, DOI 10.1016/j.neunet.2005.08.005; Mahadevan S, 2007, J MACH LEARN RES, V8, P2169; Maurer AP, 2007, TRENDS NEUROSCI, V30, P325, DOI 10.1016/j.tins.2007.05.002; Mazumder R, 2010, J MACH LEARN RES, V11, P2287; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Momennejad I., 2017, SUCCESSOR REPRESENTT; Muller RU, 1996, J GEN PHYSIOL, V107, P663, DOI 10.1085/jgp.107.6.663; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Penny WD, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003383; Pezzulo G, 2014, TRENDS COGN SCI, V18, P647, DOI 10.1016/j.tics.2014.06.011; Ribas-Fernandes JJF, 2011, NEURON, V71, P370, DOI 10.1016/j.neuron.2011.05.042; Russek E. M., 2017, PREDICTIVE REPRESENT; Schapiro AC, 2016, HIPPOCAMPUS, V26, P3, DOI 10.1002/hipo.22523; Schlesiger MI, 2015, NAT NEUROSCI, V18, P1123, DOI 10.1038/nn.4056; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Skaggs WE, 1998, J NEUROSCI, V18, P8455; Solway A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003779; Strange BA, 2014, NAT REV NEUROSCI, V15, P655, DOI 10.1038/nrn3785; Sutton R. S., 1991, ACM SIGART B, V2, P160, DOI [10/cd8-9h, 10.1145/122344.122377]; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Weng JY, 2003, IEEE T PATTERN ANAL, V25, P1034, DOI 10.1109/TPAMI.2003.1217609; Wiltgen BJ, 2006, J NEUROSCI, V26, P5484, DOI 10.1523/JNEUROSCI.2685-05.2006; Zhang J., 2017, IEEE RSJ INT C INT R	55	281	282	16	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2017	20	11					1643	+		10.1038/nn.4650	http://dx.doi.org/10.1038/nn.4650			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FL0QV	28967910	Green Submitted			2022-12-17	WOS:000413916800025
J	Kohara, K; Pignatelli, M; Rivest, AJ; Jung, HY; Kitamura, T; Suh, J; Frank, D; Kajikawa, K; Mise, N; Obata, Y; Wickersham, IR; Tonegawa, S				Kohara, Keigo; Pignatelli, Michele; Rivest, Alexander J.; Jung, Hae-Yoon; Kitamura, Takashi; Suh, Junghyup; Frank, Dominic; Kajikawa, Koichiro; Mise, Nathan; Obata, Yuichi; Wickersham, Ian R.; Tonegawa, Susumu			Cell type-specific genetic and optogenetic tools reveal hippocampal CA2 circuits	NATURE NEUROSCIENCE			English	Article							RAT HIPPOCAMPUS; PYRAMIDAL NEURONS; SYNAPTIC PLASTICITY; DENTATE GYRUS; POSTSYNAPTIC TARGETS; DENDRITIC MORPHOLOGY; PATTERN SEPARATION; ENTORHINAL CORTEX; CEREBRAL-CORTEX; NMDA RECEPTORS	The formation and recall of episodic memory requires precise information processing by the entorhinal-hippocampal network. For several decades, the trisynaptic circuit entorhinal cortex layer II (ECII)-> dentate gyrus -> CA3 -> CA1 and the monosynaptic circuit ECIII -> CA1 have been considered the primary substrates of the network responsible for learning and memory. Circuits linked to another hippocampal region, CA2, have only recently come to light. Using highly cell type-specific transgenic mouse lines, optogenetics and patch-clamp recordings, we found that dentate gyrus cells, long believed to not project to CA2, send functional monosynaptic inputs to CA2 pyramidal cells through abundant longitudinal projections. CA2 innervated CA1 to complete an alternate trisynaptic circuit, but, unlike CA3, projected preferentially to the deep, rather than to the superficial, sublayer of CA1. Furthermore, contrary to existing knowledge, ECIII did not project to CA2. Our results allow a deeper understanding of the biology of learning and memory.	[Kohara, Keigo; Pignatelli, Michele; Rivest, Alexander J.; Jung, Hae-Yoon; Kitamura, Takashi; Suh, Junghyup; Frank, Dominic; Kajikawa, Koichiro; Tonegawa, Susumu] MIT, Dept Biol, RIKEN MIT Ctr Neural Circuit Genet Picower Inst L, Cambridge, MA 02139 USA; [Kohara, Keigo; Pignatelli, Michele; Rivest, Alexander J.; Jung, Hae-Yoon; Kitamura, Takashi; Suh, Junghyup; Frank, Dominic; Kajikawa, Koichiro; Tonegawa, Susumu] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Mise, Nathan; Obata, Yuichi] RIKEN, BioResource Ctr, Tsukuba, Ibaraki, Japan; [Wickersham, Ian R.] MIT, Genet Neuroengn Grp, Cambridge, MA 02139 USA; [Tonegawa, Susumu] MIT, Howard Hughes Med Inst, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Kohara, K (corresponding author), MIT, Dept Biol, RIKEN MIT Ctr Neural Circuit Genet Picower Inst L, Cambridge, MA 02139 USA.	keigo@mit.edu; tonegawa@mit.edu	Suh, Junghyup/AAO-8265-2020; Obata, Yuichi/A-5300-2016; 名丹, 三瀬/AAD-1036-2021	Obata, Yuichi/0000-0003-1839-4709; Pignatelli, Michele/0000-0002-4918-2066	US National Institutes of Health [R01-MH078821, P50-MH58880]; McGovern Institute Neurotechnology Program; Japanese Society for Promotion of Science; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078821, P50MH058880] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McGovern Institute Neurotechnology Program; Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank K. Rockland for helpful discussions, R. Neve for the generation of HSV, A. Burds for her support in the generation of the CA2 mouse line, A. Yoshii for helpful suggestions on PSD95 staining, K. Fuji and A. Murakami for their support in the generation of the dentate gyrus mouse line, C. Lovett, Y. Wang, W. Yu, L. Sultzman, N. Nayyar, M. Serock, C. Ragion and H. Sullivan for technical support, and T. Ryan, J.Z. Young and C. Yokoyama for comments on the manuscript. This work was supported by US National Institutes of Health grants R01-MH078821 and P50-MH58880 to S.T., by an award from the McGovern Institute Neurotechnology Program to I.R.W. and by the Japanese Society for Promotion of Science to K. Kohara.	Acsady L, 1998, J NEUROSCI, V18, P3386; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Andersen P., 2007, HIPPOCAMPUS BOOK; BANNISTER NJ, 1995, J COMP NEUROL, V360, P150, DOI 10.1002/cne.903600111; BANNISTER NJ, 1995, J COMP NEUROL, V360, P161, DOI 10.1002/cne.903600112; Bartesaghi R, 2004, HIPPOCAMPUS, V14, P948, DOI 10.1002/hipo.20011; Berzhanskaya J, 1998, J NEUROPHYSIOL, V79, P2111, DOI 10.1152/jn.1998.79.4.2111; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Caruana DA, 2012, LEARN MEMORY, V19, P391, DOI 10.1101/lm.025304.111; Cenquizca LA, 2007, BRAIN RES REV, V56, P1, DOI 10.1016/j.brainresrev.2007.05.002; Chevaleyre V, 2010, NEURON, V66, P560, DOI 10.1016/j.neuron.2010.04.013; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Cui ZZ, 2013, J COMP NEUROL, V521, P1844, DOI 10.1002/cne.23263; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; Dong HW, 2009, P NATL ACAD SCI USA, V106, P11794, DOI 10.1073/pnas.0812608106; Gonzales RB, 2001, J COMP NEUROL, V430, P357, DOI 10.1002/1096-9861(20010212)430:3<357::AID-CNE1036>3.0.CO;2-K; HAGLUND L, 1984, J COMP NEUROL, V229, P171, DOI 10.1002/cne.902290204; ISHIZUKA N, 1995, J COMP NEUROL, V362, P17, DOI 10.1002/cne.903620103; Jones MW, 2011, TRENDS NEUROSCI, V34, P526, DOI 10.1016/j.tins.2011.07.007; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; Lein ES, 2005, J COMP NEUROL, V485, P1, DOI 10.1002/cne.20426; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; MAGLOCZKY Z, 1994, HIPPOCAMPUS, V4, P322, DOI 10.1002/hipo.450040316; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Melzer S, 2012, SCIENCE, V335, P1506, DOI 10.1126/science.1217139; Mercer A, 2007, J NEUROSCI, V27, P7329, DOI 10.1523/JNEUROSCI.1829-07.2007; Mizuseki K, 2011, NAT NEUROSCI, V14, P1174, DOI 10.1038/nn.2894; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nishimura-Akiyoshi S, 2007, P NATL ACAD SCI USA, V104, P14801, DOI 10.1073/pnas.0706919104; Piskorowski RA, 2012, CELL MOL LIFE SCI, V69, P75, DOI 10.1007/s00018-011-0769-4; Ramon y Cajal S., 1897, HISTOLOGY NERVOUS SY, V1; Rollenhagen Astrid, 2010, Front Synaptic Neurosci, V2, P2, DOI 10.3389/fnsyn.2010.00002; Shinohara Y, 2012, EUR J NEUROSCI, V35, P702, DOI 10.1111/j.1460-9568.2012.07993.x; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Sun GJ, 2013, J NEUROSCI, V33, P11400, DOI 10.1523/JNEUROSCI.1374-13.2013; SWANSON LW, 1978, J COMP NEUROL, V181, P681, DOI 10.1002/cne.901810402; TAMAMAKI N, 1993, HIPPOCAMPUS, V3, P471, DOI 10.1002/hipo.450030408; TAMAMAKI N, 1988, BRAIN RES, V452, P255, DOI 10.1016/0006-8993(88)90030-3; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhao M, 2007, J NEUROSCI, V27, P12025, DOI 10.1523/JNEUROSCI.4094-07.2007	50	281	284	2	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2014	17	2					269	279		10.1038/nn.3614	http://dx.doi.org/10.1038/nn.3614			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AA2FH	24336151	Green Accepted, Green Submitted			2022-12-17	WOS:000330910000022
J	Iadecola, C; Anrather, J				Iadecola, Costantino; Anrather, Josef			Stroke research at a crossroad: asking the brain for directions	NATURE NEUROSCIENCE			English	Article							ISCHEMIC TOLERANCE; CEREBRAL-ISCHEMIA; NEUROTROPHIC FACTOR; NITRIC-OXIDE; EXERCISE; MECHANISMS; PROTECTION; NEUROPROTECTION; INJURY; NEUROBIOLOGY	Ischemic stroke remains a vexing public health problem. Although progress has been made in prevention and supportive care, efforts to protect the brain from ischemic cell death have failed. Thus, no new treatment has made it from bench to bedside since tissue plasminogen activator was introduced in 1996. The brain has a remarkable capacity for self-preservation, illustrated by the protective responses induced by ischemia, preconditioning and exercise. Here we describe the mechanisms underlying brain self-protection, with the goal of identifying features that could provide insight into stroke therapy. Unlike traditional therapeutic approaches based on counteracting selected pathways of the ischemic cascade, endogenous neuroprotection relies on coordinated neurovascular programs that support cerebral perfusion, mitigate the harmful effects of cerebral ischemia and promote tissue restoration. Learning how the brain triggers and implements these protective measures may advance our quest to treat stroke.	[Iadecola, Costantino; Anrather, Josef] Weill Cornell Med Coll, Dept Neurol & Neurosci, Div Neurobiol, New York, NY USA	Cornell University	Iadecola, C (corresponding author), Weill Cornell Med Coll, Dept Neurol & Neurosci, Div Neurobiol, New York, NY USA.	coi2001@med.cornell.edu	Iadecola, c/ABB-8377-2020	Iadecola, Costantino/0000-0001-9797-073X	US National Institutes of Health [R37-NS34179, NS35806]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035806, R37NS034179] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health grants R37-NS34179 and NS35806.	Andjelkovic AV, 2003, J CEREBR BLOOD F MET, V23, P1348, DOI 10.1097/01.WCB.0000091762.61714.FE; Bath PMW, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005207.pub3; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Digicaylioglu M, 2010, EXPERT OPIN BIOL TH, V10, P937, DOI 10.1517/14712598.2010.481435; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Dreixler JC, 2011, EXP EYE RES, V92, P521, DOI 10.1016/j.exer.2011.03.015; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Endres M, 2003, ANN NEUROL, V54, P582, DOI 10.1002/ana.10722; Fagan SC, 2011, TRANSL STROKE RES, V2, P202, DOI 10.1007/s12975-011-0072-6; Fonarow GC, 2011, CIRCULATION, V123, P750, DOI 10.1161/CIRCULATIONAHA.110.974675; Gesuete R, 2011, STROKE, V42, P1445, DOI 10.1161/STROKEAHA.110.603266; GomezPinilla F, 1997, BRAIN RES, V764, P1, DOI 10.1016/S0006-8993(97)00375-2; Greenberg David A, 2006, NeuroRx, V3, P458, DOI 10.1016/j.nurx.2006.08.003; Hachinski V, 2010, STROKE, V41, P1084, DOI 10.1161/STROKEAHA.110.586156; Hardingham GE, 2011, ANTIOXID REDOX SIGN, V14, P1421, DOI 10.1089/ars.2010.3573; Hemmen TM, 2010, STROKE, V41, P2265, DOI 10.1161/STROKEAHA.110.592295; Huang SS, 2006, CIRC J, V70, P1070, DOI 10.1253/circj.70.1070; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Johansson A, 2000, J INTERN MED, V247, P179, DOI 10.1046/j.1365-2796.2000.00600.x; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Koch S, 2011, STROKE, V42, P1387, DOI 10.1161/STROKEAHA.110.605840; Kunz A., 2008, HDB CLIN NEUROL, V92, P283, DOI 10.1016/S0072-9752(08)01914-3; Kunz A, 2007, J NEUROSCI, V27, P7083, DOI 10.1523/JNEUROSCI.1645-07.2007; Liebeskind DS, 2010, CURR OPIN NEUROL, V23, P36, DOI 10.1097/WCO.0b013e328334da32; LLorens-Martin M, 2010, MOL CELL NEUROSCI, V44, P109, DOI 10.1016/j.mcn.2010.02.006; Marsh B, 2009, J NEUROSCI, V29, P9839, DOI 10.1523/JNEUROSCI.2496-09.2009; Morris KC, 2011, J CEREBR BLOOD F MET, V31, P1003, DOI 10.1038/jcbfm.2010.229; Moskowitz MA, 2010, STROKE, V41, pS85, DOI 10.1161/STROKEAHA.110.598458; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Paschen W, 2003, J CEREBR BLOOD F MET, V23, P773, DOI 10.1097/01.WCB.0000075009.47474.F9; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen CM, 2011, J THROMB HAEMOST, V9, P404, DOI 10.1111/j.1538-7836.2010.04142.x; Rasmussen P, 2009, EXP PHYSIOL, V94, P1062, DOI 10.1113/expphysiol.2009.048512; Ren CC, 2009, BRAIN RES, V1288, P88, DOI 10.1016/j.brainres.2009.07.029; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Saxena P, 2010, J CARDIAC SURG, V25, P127, DOI 10.1111/j.1540-8191.2009.00820.x; Sharp FR, 2001, ADV EXP MED BIOL, V502, P273; Stapels M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000502; Stenzel-Poore MP, 2003, LANCET, V362, P1028, DOI 10.1016/S0140-6736(03)14412-1; Tang XN, 2010, AGEING RES REV, V9, P61, DOI 10.1016/j.arr.2009.10.002; Torres-Aleman I, 2010, DEV NEUROBIOL, V70, P384, DOI 10.1002/dneu.20778; Yenari MA, 2002, ADV EXP MED BIOL, V513, P281; Zaheer A, 2006, NEUROCHEM RES, V31, P579, DOI 10.1007/s11064-006-9049-3; Zhang F, 2011, NEUROSCIENCE, V177, P170, DOI 10.1016/j.neuroscience.2011.01.018; Zhang YH, 2007, AM J PHYSIOL-HEART C, V292, pH2573, DOI 10.1152/ajpheart.01098.2006; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460	50	281	294	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1363	1368		10.1038/nn.2953	http://dx.doi.org/10.1038/nn.2953			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	22030546	Green Accepted			2022-12-17	WOS:000296518600007
J	Nakamura, K; Morrison, SF				Nakamura, Kazuhiro; Morrison, Shaun F.			A thermosensory pathway that controls body temperature	NATURE NEUROSCIENCE			English	Article							PROSTAGLANDIN EP3 RECEPTOR; BROWN ADIPOSE-TISSUE; PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; SYMPATHETIC PREMOTOR NEURONS; PARABRACHIAL NUCLEUS; DORSOMEDIAL HYPOTHALAMUS; EFFERENT PROJECTIONS; PREOPTIC AREA; THERMOREGULATORY FUNCTIONS; EVOKED THERMOGENESIS	Defending body temperature against environmental thermal challenges is one of the most fundamental homeostatic functions that are governed by the nervous system. Here we describe a somatosensory pathway that essentially constitutes the afferent arm of the thermoregulatory reflex that is triggered by cutaneous sensation of environmental temperature changes. Using in vivo electrophysiological and anatomical approaches in the rat, we found that lateral parabrachial neurons are pivotal in this pathway by glutamatergically transmitting cutaneous thermosensory signals received from spinal somatosensory neurons directly to the thermoregulatory command center, the preoptic area. This feedforward pathway mediates not only sympathetic and shivering thermogenic responses but also metabolic and cardiac responses to skin cooling challenges. Notably, this 'thermoregulatory afferent' pathway exists in parallel with the spinothalamocortical somatosensory pathway that mediates temperature perception. These findings make an important contribution to our understanding of both the somatosensory system and thermal homeostasis-two mechanisms that are fundamental to the nervous system and to our survival.	[Nakamura, Kazuhiro; Morrison, Shaun F.] Oregon Hlth & Sci Univ, Inst Neurol Sci, Beaverton, OR 97006 USA	Oregon Health & Science University	Nakamura, K (corresponding author), Oregon Hlth & Sci Univ, Inst Neurol Sci, 505 NW 185th Ave, Beaverton, OR 97006 USA.	nakamura@ohsu.edu	Morrison, Shaun F./T-5869-2017; Nakamura, Kazuhiro/A-5431-2008	Morrison, Shaun F./0000-0002-8813-8359; Nakamura, Kazuhiro/0000-0002-6095-8996	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040987] Funding Source: NIH RePORTER; NCRR NIH HHS [RR 016858, S10 RR016858-01] Funding Source: Medline; NIDDK NIH HHS [DK 57838, R01 DK057838-07, R01 DK057838] Funding Source: Medline; NINDS NIH HHS [NS 40987, R01 NS040987-07, R01 NS040987] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERNARD JF, 1995, J COMP NEUROL, V353, P480, DOI 10.1002/cne.903530403; BESTER H, 1995, J NEUROPHYSIOL, V73, P568, DOI 10.1152/jn.1995.73.2.568; Bester H, 1997, J COMP NEUROL, V383, P245, DOI 10.1002/(SICI)1096-9861(19970707)383:3<245::AID-CNE1>3.0.CO;2-3; Bester H, 2000, J NEUROPHYSIOL, V83, P2239, DOI 10.1152/jn.2000.83.4.2239; Blomqvist A, 1996, EXP BRAIN RES, V108, P33; BOULANT JA, 1977, BRAIN RES, V120, P367, DOI 10.1016/0006-8993(77)90916-7; BOULANT JA, 1974, J PHYSIOL-LONDON, V240, P639, DOI 10.1113/jphysiol.1974.sp010627; Bratincsak A, 2005, NEUROSCIENCE, V135, P525, DOI 10.1016/j.neuroscience.2005.06.028; BROMAN J, 1992, J NEUROSCI, V12, P204; CECHETTO DF, 1985, J COMP NEUROL, V240, P153, DOI 10.1002/cne.902400205; Chen XM, 1998, J PHYSIOL-LONDON, V512, P883, DOI 10.1111/j.1469-7793.1998.883bd.x; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; CRAIG AD, 1994, NATURE, V372, P770, DOI 10.1038/372770a0; Craig AD, 2001, J NEUROPHYSIOL, V86, P856, DOI 10.1152/jn.2001.86.2.856; FEIL K, 1995, J COMP NEUROL, V353, P506, DOI 10.1002/cne.903530404; FULWILER CE, 1984, BRAIN RES REV, V7, P229, DOI 10.1016/0165-0173(84)90012-2; Gauriau C, 2004, J COMP NEUROL, V468, P24, DOI 10.1002/cne.10873; HAMMEL HT, 1968, ANNU REV PHYSIOL, V30, P641, DOI 10.1146/annurev.ph.30.030168.003233; HELLON RF, 1975, J PHYSIOL-LONDON, V248, P349, DOI 10.1113/jphysiol.1975.sp010978; Hensel H, 1981, Monogr Physiol Soc, V38, P1; HORI T, 1988, BRAIN RES BULL, V20, P879, DOI 10.1016/0361-9230(88)90105-0; HUCKABA C E, 1971, International Journal of Biometeorology, V15, P141, DOI 10.1007/BF01803888; HYLDEN JLK, 1989, NEUROSCIENCE, V28, P27, DOI 10.1016/0306-4522(89)90229-7; Johnston GAR, 1996, PHARMACOL THERAPEUT, V69, P173, DOI 10.1016/0163-7258(95)02043-8; Kobayashi A, 2003, PFLUG ARCH EUR J PHY, V446, P760, DOI 10.1007/s00424-003-1119-7; KRUKOFF TL, 1993, BRAIN RES BULL, V30, P163, DOI 10.1016/0361-9230(93)90054-F; Lazarus M, 2007, NAT NEUROSCI, V10, P1131, DOI 10.1038/nn1949; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Madden CJ, 2004, AM J PHYSIOL-REG I, V286, pR320, DOI 10.1152/ajpregu.00515.2003; Madden CJ, 2003, NEUROSCIENCE, V122, P5, DOI 10.1016/S0306-4522(03)00527-X; Morrison SF, 2000, AM J PHYSIOL-REG I, V279, pR1763, DOI 10.1152/ajpregu.2000.279.5.R1763; Morrison SR, 2004, NEWS PHYSIOL SCI, V19, P67, DOI 10.1152/nips.01502.2003; Nagashima K, 2000, AUTON NEUROSCI-BASIC, V85, P18, DOI 10.1016/S1566-0702(00)00216-2; Nakamura K, 2005, NEUROSCI RES, V51, P1, DOI 10.1016/j.neures.2004.09.007; Nakamura K, 2004, J THERM BIOL, V29, P339, DOI 10.1016/j.jtherbio.2004.08.001; Nakamura K, 2000, J COMP NEUROL, V421, P543, DOI 10.1002/(SICI)1096-9861(20000612)421:4<543::AID-CNE6>3.0.CO;2-3; Nakamura K, 2004, J NEUROSCI, V24, P5370, DOI 10.1523/JNEUROSCI.1219-04.2004; Nakamura K, 2002, J NEUROSCI, V22, P4600, DOI 10.1523/JNEUROSCI.22-11-04600.2002; Nakamura K, 2001, NEUROSCIENCE, V103, P763, DOI 10.1016/S0306-4522(01)00027-6; Nakamura K, 1999, NEUROSCI LETT, V260, P117, DOI 10.1016/S0304-3940(98)00962-8; Nakamura K, 2007, AM J PHYSIOL-REG I, V292, pR127, DOI 10.1152/ajpregu.00427.2006; Nakamura Y, 2005, EUR J NEUROSCI, V22, P3137, DOI 10.1111/j.1460-9568.2005.04515.x; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Romanovsky AA, 2007, AM J PHYSIOL-REG I, V292, pR37, DOI 10.1152/ajpregu.00668.2006; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; Saper CB, 2002, ANNU REV NEUROSCI, V25, P433, DOI 10.1146/annurev.neuro.25.032502.111311; SAPER CB, 1980, BRAIN RES, V197, P291, DOI 10.1016/0006-8993(80)91117-8; Savage MV, 1996, J APPL PHYSIOL, V80, P1249, DOI 10.1152/jappl.1996.80.4.1249; Zaretskaia MV, 2003, NEUROSCI LETT, V340, P1, DOI 10.1016/S0304-3940(03)00047-8; Zhang XJ, 2006, J NEUROSCI, V26, P5215, DOI 10.1523/JNEUROSCI.0701-06.2006	50	281	291	3	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					62	71		10.1038/nn2027	http://dx.doi.org/10.1038/nn2027			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18084288	Green Accepted			2022-12-17	WOS:000252117900013
J	Grosshans, DR; Clayton, DA; Coultrap, SJ; Browning, MD				Grosshans, DR; Clayton, DA; Coultrap, SJ; Browning, MD			LTP leads to rapid surface expression of NMDA but not AMPA receptors in adult rat CA1	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-C; TYROSINE PHOSPHORYLATION; GLUTAMATE RECEPTORS; DIFFERENTIAL DISTRIBUTION; SYNAPTIC-TRANSMISSION; SUBUNIT; NR1; TRAFFICKING; ACTIVATION	In the CA1 region of the rat hippocampus, long-term potentiation (LTP) requires the activation of NMDA receptors (NMDARs) and leads to an enhancement of AMPA receptor (AMPAR) function. In neonatal hippocampus, this increase in synaptic strength seems to be mediated by delivery of AMPARs to the synapse. Here we studied changes in surface expression of native AMPA and NMDA receptors following induction of LTP in the adult rat brain. In contrast to early postnatal rats, we find that LTP in the adult rat does not alter membrane association of AMPARs. Instead, LTP leads to rapid surface expression of NM DARs in a PKC- and Src-family-dependent manner. The present study suggests a developmental shift in the LTP-dependent trafficking of AMPA receptors. Moreover, our results indicate that insertion of NMDA receptors may be a key step in regulating synaptic plasticity.	Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Med Sci Training Program, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Program Neurosci, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Browning, MD (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, 4200 E 9th Ave Box C236, Denver, CO 80262 USA.	michael.browning@uchsc.edu			NIAAA NIH HHS [R01 AA09675] Funding Source: Medline; NIA NIH HHS [AG04418-17] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG004418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009675] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Aniksztejn L, 1995, J NEUROPHYSIOL, V74, P2349, DOI 10.1152/jn.1995.74.6.2349; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Chazot PL, 1997, J NEUROCHEM, V68, P507; DAVID V, 1993, J BIOL CHEM, V268, P9585; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Dunah AW, 2001, J NEUROSCI, V21, P5546, DOI 10.1523/JNEUROSCI.21-15-05546.2001; Gardoni F, 2001, J NEUROSCI, V21, P1501, DOI 10.1523/JNEUROSCI.21-05-01501.2001; Grosshans DR, 2001, J NEUROCHEM, V76, P737, DOI 10.1046/j.1471-4159.2001.00034.x; Hall RA, 1997, J BIOL CHEM, V272, P4135, DOI 10.1074/jbc.272.7.4135; Hall RA, 1997, NEUROSCIENCE, V78, P361, DOI 10.1016/S0306-4522(96)00525-8; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Mammen AL, 1997, J NEUROSCI, V17, P7351; MIYATANI S, 1989, SCIENCE, V245, P631, DOI 10.1126/science.2762814; Nayak A, 1998, NATURE, V394, P680, DOI 10.1038/29305; Nayak AS, 1996, P NATL ACAD SCI USA, V93, P15451, DOI 10.1073/pnas.93.26.15451; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; Okabe S, 1999, J NEUROSCI, V19, P7781; PARFITT KD, 1993, J PHYSIOL-LONDON, V471, P245, DOI 10.1113/jphysiol.1993.sp019900; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Pickard L, 2000, J NEUROSCI, V20, P7922; PORTER RM, 1993, J PATHOL, V170, P435, DOI 10.1002/path.1711700406; Racca C, 2000, J NEUROSCI, V20, P2512; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Rosenblum K, 1996, P NATL ACAD SCI USA, V93, P10457, DOI 10.1073/pnas.93.19.10457; Rosenblum K, 1997, J NEUROSCI, V17, P5129; Salter MW, 1998, BIOCHEM PHARMACOL, V56, P789, DOI 10.1016/S0006-2952(98)00124-5; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SIEGEL SJ, 1994, P NATL ACAD SCI USA, V91, P564, DOI 10.1073/pnas.91.2.564; Snell LD, 1996, MOL BRAIN RES, V40, P71; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; STONE LM, 1994, J NEUROSCI, V14, P301; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Waters J, 2000, J NEUROSCI, V20, P7863; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501	47	281	293	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					27	33		10.1038/nn779	http://dx.doi.org/10.1038/nn779			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11740502				2022-12-17	WOS:000173031800011
J	Xi, ZX; Peng, XQ; Li, X; Song, R; Zhang, HY; Liu, QR; Yang, HJ; Bi, GH; Li, J; Gardner, EL				Xi, Zheng-Xiong; Peng, Xiao-Qing; Li, Xia; Song, Rui; Zhang, Hai-Ying; Liu, Qing-Rong; Yang, Hong-Ju; Bi, Guo-Hua; Li, Jie; Gardner, Eliot L.			Brain cannabinoid CB2 receptors modulate cocaine's actions in mice	NATURE NEUROSCIENCE			English	Article							DORSAL-HORN NEURONS; PHARMACOLOGICAL CHARACTERIZATION; MOLECULAR CHARACTERIZATION; CHRONIC PAIN; RAT; EXPRESSION; DOPAMINE; AGONISTS; RESPONSES; IDENTIFICATION	The presence and function of cannabinoid CB2 receptors in the brain have been the subjects of much debate. We found that systemic, intranasal or intra-accumbens local administration of JWH133, a selective CB2 receptor agonist, dose-dependently inhibited intravenous cocaine self-administration, cocaine-enhanced locomotion, and cocaine-enhanced accumbens extracellular dopamine in wild-type and CB1 receptor knockout (CB1-/-, also known as Cnr1(-/-)) mice, but not in CB2-/-(Cnr2(-/-)) mice. This inhibition was mimicked by GW405833, another CB2 receptor agonist with a different chemical structure, and was blocked by AM630, a selective CB2 receptor antagonist. Intra-accumbens administration of JWH133 alone dose-dependently decreased, whereas intra-accumbens administration of AM630 elevated, extracellular dopamine and locomotion in wild-type and CB1-/- mice, but not in CB2-/- mice. Intra-accumbens administration of AM630 also blocked the reduction in cocaine self-administration and extracellular dopamine produced by systemic administration of JWH133. These findings suggest that brain CB2 receptors modulate cocaine's rewarding and locomotor-stimulating effects, likely by a dopamine-dependent mechanism.	[Xi, Zheng-Xiong; Peng, Xiao-Qing; Li, Xia; Song, Rui; Zhang, Hai-Ying; Liu, Qing-Rong; Yang, Hong-Ju; Bi, Guo-Hua; Li, Jie; Gardner, Eliot L.] Natl Inst Drug Abuse, Intramural Res Program, Baltimore, MD USA; [Song, Rui] Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Academy of Military Medical Sciences - China	Xi, ZX (corresponding author), Natl Inst Drug Abuse, Intramural Res Program, Baltimore, MD USA.	zxi@intra.nida.nih.gov	Liu, Qing-Rong/A-3059-2012	Liu, Qing-Rong/0000-0001-8477-6452; PENG, XIAOQING/0000-0002-7272-5428; Zhang, Haiying/0000-0003-0593-5940	National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000478, ZIADA000513] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Y. Shaham and E.A. Stein of the Intramural Research Program of the National Institute on Drug Abuse, and K. Mackie of Indiana University for their helpful comments on this manuscript. This research was supported by the Intramural Research Program of the National Institute on Drug Abuse.	Anand U, 2008, PAIN, V138, P667, DOI 10.1016/j.pain.2008.06.007; Ashton JC, 2008, CURR MED CHEM, V15, P1428, DOI 10.2174/092986708784567716; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Baek J-H, 2008, ACTA OTO-LARYNGOL, V128, P1; Bardo MT, 1998, CRIT REV NEUROBIOL, V12, P37, DOI 10.1615/CritRevNeurobiol.v12.i1-2.30; BAYEWITCH M, 1995, FEBS LETT, V375, P143, DOI 10.1016/0014-5793(95)01207-U; Beltramo M, 2006, EUR J NEUROSCI, V23, P1530, DOI 10.1111/j.1460-9568.2006.04684.x; Bingham B, 2007, BRIT J PHARMACOL, V151, P1061, DOI 10.1038/sj.bjp.0707303; Brown SM, 2002, BBA-GENE STRUCT EXPR, V1576, P255, DOI 10.1016/S0167-4781(02)00341-X; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Chin CL, 2008, BRIT J PHARMACOL, V153, P367, DOI 10.1038/sj.bjp.0707506; Costantino HR, 2007, INT J PHARMACEUT, V337, P1, DOI 10.1016/j.ijpharm.2007.03.025; Elmes SJR, 2004, EUR J NEUROSCI, V20, P2311, DOI 10.1111/j.1460-9568.2004.03690.x; Glass M, 1997, NEUROSCIENCE, V77, P299, DOI 10.1016/S0306-4522(96)00428-9; Goncalves MB, 2008, MOL CELL NEUROSCI, V38, P526, DOI 10.1016/j.mcn.2008.05.001; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Griffin G, 2000, J PHARMACOL EXP THER, V292, P886; Guindon J, 2008, BRIT J PHARMACOL, V153, P319, DOI 10.1038/sj.bjp.0707531; Haydon PG, 2009, NEUROPHARMACOLOGY, V56, P83, DOI 10.1016/j.neuropharm.2008.06.050; Huffman JW, 2005, MINI-REV MED CHEM, V5, P641, DOI 10.2174/1389557054368844; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; Jhaveri MD, 2008, EUR J NEUROSCI, V27, P1722, DOI 10.1111/j.1460-9568.2008.06162.x; Lanciego JL, 2011, J PSYCHOPHARMACOL, V25, P97, DOI 10.1177/0269881110367732; Li X, 2009, PSYCHOPHARMACOLOGY, V204, P1, DOI 10.1007/s00213-008-1432-0; Liu QR, 2009, GENES BRAIN BEHAV, V8, P519, DOI 10.1111/j.1601-183X.2009.00498.x; Mackie K, 2008, J NEUROENDOCRINOL, V20, P10, DOI 10.1111/j.1365-2826.2008.01671.x; Malan TP, 2003, CURR OPIN PHARMACOL, V3, P62, DOI 10.1016/S1471-4892(02)00004-8; Malan TP, 2001, PAIN, V93, P239, DOI 10.1016/S0304-3959(01)00321-9; Morgan NH, 2009, NEUROPHARMACOLOGY, V57, P356, DOI 10.1016/j.neuropharm.2009.07.017; Mukherjee S, 2004, EUR J PHARMACOL, V505, P1, DOI 10.1016/j.ejphar.2004.09.058; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Onaivi ES, 2006, ANN NY ACAD SCI, V1074, P514, DOI 10.1196/annals.1369.052; Parolaro D, 2008, DRUG NEWS PERSPECT, V21, P149, DOI 10.1358/dnp.2008.21.3.1203411; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; Ross RA, 2001, NEUROPHARMACOLOGY, V40, P221, DOI 10.1016/S0028-3908(00)00135-0; Sagar DR, 2005, EUR J NEUROSCI, V22, P371, DOI 10.1111/j.1460-9568.2005.04206.x; Sagredo O, 2009, GLIA, V57, P1154, DOI 10.1002/glia.20838; Schatz AR, 1997, TOXICOL APPL PHARM, V142, P278, DOI 10.1006/taap.1996.8034; Schwarting RKW, 1997, NEUROTOXICOLOGY, V18, P689; Soria G, 2005, NEUROPSYCHOPHARMACOL, V30, P1670, DOI 10.1038/sj.npp.1300707; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Thakur GA, 2005, MINI-REV MED CHEM, V5, P631, DOI 10.2174/1389557054368772; Valenzano KJ, 2005, NEUROPHARMACOLOGY, V48, P658, DOI 10.1016/j.neuropharm.2004.12.008; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Viscomi MT, 2009, J NEUROSCI, V29, P4564, DOI 10.1523/JNEUROSCI.0786-09.2009; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Xi ZX, 2008, NEUROPSYCHOPHARMACOL, V33, P1735, DOI 10.1038/sj.npp.1301552; Yao BB, 2006, BRIT J PHARMACOL, V149, P145, DOI 10.1038/sj.bjp.0706838; Zhang J, 2003, EUR J NEUROSCI, V17, P2750, DOI 10.1046/j.1460-9568.2003.02704.x; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	50	280	286	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1160	U216		10.1038/nn.2874	http://dx.doi.org/10.1038/nn.2874			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21785434	Green Accepted			2022-12-17	WOS:000294284900016
J	Fan, Y; Fricker, D; Brager, DH; Chen, XX; Lu, HC; Chitwood, RA; Johnston, D				Fan, Y; Fricker, D; Brager, DH; Chen, XX; Lu, HC; Chitwood, RA; Johnston, D			Activity-dependent decrease of excitability in rat hippocampal neurons through increases in I-h	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CA1 PYRAMIDAL NEURONS; DENDRITIC K+ CHANNELS; INTRINSIC EXCITABILITY; SYNAPTIC TRANSMISSION; LASTING POTENTIATION; CORTICAL-NEURONS; PROTEIN-KINASE; PLASTICITY; STIMULATION	Hippocampal long-term potentiation (LTP) induced by theta-burst pairing of Schaffer collateral inputs and postsynaptic firing is associated with localized increases in synaptic strength and dendritic excitability. Using the same protocol, we now demonstrate a decrease in cellular excitability that was blocked by the h-channel blocker ZD7288. This decrease was also induced by postsynaptic theta-burst firing alone, yet it was blocked by NMDA receptor antagonists, postsynaptic Ca2+ chelation, low concentrations of tetrodotoxin, omega-conotoxin MVIIC, calcium/calmodulin-dependent protein kinase II (CaMKII) inhibitors and a protein synthesis inhibitor. Increasing network activity with high extracellular K+ caused a similar reduction of cellular excitability and an increase in h-channel HCN1 protein. We propose that backpropagating action potentials open glutamate-bound NMDA receptors, resulting in an increase in I-h and a decrease in overall excitability. The occurrence of such a reduction in cellular excitability in parallel with synaptic potentiation would be a negative feedback mechanism to normalize neuronal output firing and thus promote network stability.	Univ Texas, Ctr Learning & Memory, Austin, TX 78712 USA; Univ Paris 06, INSERM, U739, F-75013 Paris, France; Baylor Coll Med, Dept Pediat, Div Neurol & Dev Neurosci, Cain Fdn Labs, Houston, TX 77030 USA	University of Texas System; University of Texas Austin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Baylor College of Medicine	Johnston, D (corresponding author), Univ Texas, Ctr Learning & Memory, 1 Univ Stn,C7000, Austin, TX 78712 USA.	djohnston@mail.clm.utexas.edu	Fricker, Desdemona/ABD-2279-2020	Fricker, Desdemona/0000-0001-7328-9480; Brager, Darrin/0000-0002-3736-0515; Chitwood, Raymond/0000-0002-2016-5238	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048432, R37MH044754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048884, F32NS011034, P01NS037444] Funding Source: NIH RePORTER; NIMH NIH HHS [MH44754, R01 MH048432, MH48432] Funding Source: Medline; NINDS NIH HHS [F32 NS011034, NS48884, NS37444] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; ANDERSEN P, 1980, J PHYSIOL-LONDON, V302, P463; Bender RA, 2001, NEUROSCIENCE, V106, P689, DOI 10.1016/S0306-4522(01)00314-1; Berger T, 2004, EUR J NEUROSCI, V20, P1688, DOI 10.1111/j.1460-9568.2004.03617.x; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cudmore RH, 2004, J NEUROPHYSIOL, V92, P341, DOI 10.1152/jn.01059.2003; Daoudal G, 2002, P NATL ACAD SCI USA, V99, P14512, DOI 10.1073/pnas.222546399; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Frick A, 2003, J NEUROSCI, V23, P3243; Ganguly K, 2000, NAT NEUROSCI, V3, P1018, DOI 10.1038/79838; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; MACCAFERRI G, 1993, J NEUROPHYSIOL, V69, P2129, DOI 10.1152/jn.1993.69.6.2129; Mackenzie PJ, 1998, J NEUROPHYSIOL, V80, P2089, DOI 10.1152/jn.1998.80.4.2089; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Marder CP, 2004, J NEUROSCI, V24, P8873, DOI 10.1523/JNEUROSCI.2661-04.2004; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Roberson ED, 1996, LEARN MEMORY, V3, P1, DOI 10.1101/lm.3.1.1; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Saar D, 2003, EUR J NEUROSCI, V17, P2727, DOI 10.1046/j.1460-9568.2003.02699.x; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; SPITZER NC, 1991, J NEUROBIOL, V22, P659, DOI 10.1002/neu.480220702; Thomas MJ, 1998, J NEUROSCI, V18, P7118, DOI 10.1523/jneurosci.18-18-07118.1998; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; Vasilyev DV, 2002, J NEUROSCI, V22, P8992; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Xu J, 2005, J NEUROSCI, V25, P1750, DOI 10.1523/JNEUROSCI.4217-04.2005; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248; Zhu JJ, 2000, J PHYSIOL-LONDON, V526, P571, DOI 10.1111/j.1469-7793.2000.00571.x	50	280	281	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1542	1551		10.1038/nn1568	http://dx.doi.org/10.1038/nn1568			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16234810				2022-12-17	WOS:000232966600029
J	Behra, M; Cousin, X; Bertrand, C; Vonesch, JL; Biellmann, D; Chatonnet, A; Strahle, U				Behra, M; Cousin, X; Bertrand, C; Vonesch, JL; Biellmann, D; Chatonnet, A; Strahle, U			Acetylcholinesterase is required for neuronal and muscular development in the zebrafish embryo	NATURE NEUROSCIENCE			English	Article							MONOCLONAL-ANTIBODIES; MUSCLE DEVELOPMENT; WILD-TYPE; EXPRESSION; CHOLINESTERASES; HINDBRAIN; IDENTIFICATION; MOTONEURONS; VERTEBRATE; OUTGROWTH	The neurotransmitter acetylcholine (ACh) has a crucial role in central and neuromuscular synapses of the cholinergic system. After release into the synaptic cleft, ACh is rapidly degraded by acetylcholinesterase (AChE). We have identified a mutation in the ache gene of the zebrafish, which abolishes ACh hydrolysis in homozygous animals completely. Embryos are initially motile but subsequently develop paralysis. Mutant embryos show defects in muscle fiber formation and innervation, and primary sensory neurons die prematurely. The neuromuscular phenotype in ache mutants is suppressed by a homozygous loss-of-function allele of the alpha-subunit of the nicotinic acetylcholine receptor (nAChR), indicating that the impairment of neuromuscular development is mediated by activation of nAChR in the mutant. Here we provide genetic evidence for non-classical functions of AChE in vertebrate development.	ULP, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, F-67404 Illkirch Graffenstaden, France; INRA, Unite Differenciat Cellulaire & Croissance, F-34060 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; INRAE	Strahle, U (corresponding author), ULP, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, BP 163,CU Strasbourg, F-67404 Illkirch Graffenstaden, France.		BERTRAND-GADAY, Christelle/ABA-8619-2021; Chatonnet, Arnaud/AAM-5569-2021; Straehle, Uwe/K-7054-2013; Chatonnet, Arnaud/E-2190-2017; Cousin, Xavier/E-2542-2013	BERTRAND-GADAY, Christelle/0000-0003-0461-2402; Chatonnet, Arnaud/0000-0002-4057-3896; Cousin, Xavier/0000-0002-8520-3610; Behra, Martine/0000-0001-8107-6565				Bertrand C, 2001, J BIOL CHEM, V276, P464, DOI 10.1074/jbc.M006308200; Buonanno A, 1999, CURR OPIN NEUROBIOL, V9, P110, DOI 10.1016/S0959-4388(99)80014-2; Coronas V, 2000, NEUROSCIENCE, V98, P213, DOI 10.1016/S0306-4522(00)00143-3; Cousin X, 1998, NUCLEIC ACIDS RES, V26, P226, DOI 10.1093/nar/26.1.226; CROW MT, 1986, DEV BIOL, V113, P238, DOI 10.1016/0012-1606(86)90126-0; Devoto SH, 1996, DEVELOPMENT, V122, P3371; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Feng GP, 1999, J CELL BIOL, V144, P1349, DOI 10.1083/jcb.144.6.1349; HANNEMAN E, 1989, J COMP NEUROL, V284, P350, DOI 10.1002/cne.902840303; HANNEMAN E, 1988, DEVELOPMENT, V103, P49; Hensey C, 1997, MECH DEVELOP, V69, P183, DOI 10.1016/S0925-4773(97)00191-3; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Koenigsberger C, 1997, J NEUROCHEM, V69, P1389; LASKOWSKI MB, 1977, EXP NEUROL, V57, P13, DOI 10.1016/0014-4886(77)90041-3; LAYER PG, 1995, PROG HISTOCHEM CYTOC, V29, P1; LAYER PG, 1990, BIOESSAYS, V12, P415, DOI 10.1002/bies.950120904; LEONARD JP, 1979, J CELL BIOL, V82, P811, DOI 10.1083/jcb.82.3.811; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; LINTON DM, 1990, DM-DIS MON, V36, P593; LIU DWC, 1992, J NEUROSCI, V12, P1859; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MILLARD CB, 1995, J NEUROCHEM, V64, P1909, DOI 10.1046/j.1471-4159.1995.64051909.x; MILLER JB, 1989, J BIOL CHEM, V264, P13122; Muller F, 1999, DEVELOPMENT, V126, P2103; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; PARNETTI L, 1995, CLIN PHARMACOKINET, V29, P110, DOI 10.2165/00003088-199529020-00005; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; Sambrock J., 2001, MOL CLONING LAB MANU, V3; Sepich DS, 1998, GENETICS, V148, P361; Silver A., 1974, BIOL CHOLINESTERASES; Simon S, 1999, J BIOL CHEM, V274, P27740, DOI 10.1074/jbc.274.39.27740; SOLNICAKREZEL L, 1994, GENETICS, V136, P1401; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Sternfeld M, 1998, J NEUROSCI, V18, P1240; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TESSIERLAVIGNE M, 1994, CURR OPIN GENET DEV, V4, P596, DOI 10.1016/0959-437X(94)90078-H; Ticho BS, 1996, MECH DEVELOP, V59, P205, DOI 10.1016/0925-4773(96)00601-6; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; WECKER L, 1986, FUND APPL TOXICOL, V6, P172, DOI 10.1016/0272-0590(86)90273-3; Weinberg ES, 1996, DEVELOPMENT, V122, P271; WESTERFIELD M, 1992, GENE DEV, V6, P591, DOI 10.1101/gad.6.4.591; WESTERFIELD M, 1990, NEURON, V4, P867, DOI 10.1016/0896-6273(90)90139-7; WESTERFIELD M, 1993, ZEBRA FISH BOOK; Williams JA, 2000, DEV BIOL, V226, P220, DOI 10.1006/dbio.2000.9860; Xie WH, 2000, J PHARMACOL EXP THER, V293, P896	50	280	289	4	30	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					111	118		10.1038/nn788	http://dx.doi.org/10.1038/nn788			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11753420				2022-12-17	WOS:000173558400012
J	Jin, X; Tecuapetla, F; Costa, RM				Jin, Xin; Tecuapetla, Fatuel; Costa, Rui M.			Basal ganglia subcircuits distinctively encode the parsing and concatenation of action sequences	NATURE NEUROSCIENCE			English	Article							DIFFERENTIAL ROLES; FOREBRAIN CIRCUIT; GLOBUS-PALLIDUS; NEURONS; MOVEMENT; CHUNKING; SPEECH; CORTEX; POPULATIONS; DOPAMINE	Chunking allows the brain to efficiently organize memories and actions. Although basal ganglia circuits have been implicated in action chunking, little is known about how individual elements are concatenated into a behavioral sequence at the neural level. Using a task in which mice learned rapid action sequences, we uncovered neuronal activity encoding entire sequences as single actions in basal ganglia circuits. In addition to neurons with activity related to the start/stop activity signaling sequence parsing, we found neurons displaying inhibited or sustained activity throughout the execution of an entire sequence. This sustained activity covaried with the rate of execution of individual sequence elements, consistent with motor concatenation. Direct and indirect pathways of basal ganglia were concomitantly active during sequence initiation, but behaved differently during sequence performance, revealing a more complex functional organization of these circuits than previously postulated. These results have important implications for understanding the functional organization of basal ganglia during the learning and execution of action sequences.	[Jin, Xin; Costa, Rui M.] NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD 20892 USA; [Jin, Xin] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Tecuapetla, Fatuel; Costa, Rui M.] Inst Gulbenkian Ciencias, Champalimaud Neurosci Programme, Lisbon, Portugal; [Tecuapetla, Fatuel; Costa, Rui M.] Champalimaud Ctr Unknown, Lisbon, Portugal	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Salk Institute; Fundacao Champalimaud; Instituto Gulbenkian de Ciencia; Fundacao Champalimaud	Jin, X (corresponding author), NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD 20892 USA.	xjin@salk.edu; rui.costa@neuro.fchampalimaud.org		Costa, Rui M./0000-0003-0495-8374; Tecuapetla, Fatuel/0000-0002-9191-6553	National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research; Champalimaud Neuroscience Programme, European Research Council [243393]; Howard Hughes Medical Institute International Early Careers Scientist Grant; Whitehall Foundation; US National Institutes of Health [NS083815]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083815, R56NS083815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000416] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research; Champalimaud Neuroscience Programme, European Research Council; Howard Hughes Medical Institute International Early Careers Scientist Grant; Whitehall Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank C. Gerfen for the D1-Cre and D2-Cre mice (US National Institutes of Health), Y. Li for the Rgs9-cre mice (University of Florida), K. Nakazawa for the Grin1<SUP>loxP/loxP</SUP> mice (US National Institutes of Health), G. Luo and A. Vaz for genotyping, and G. Cui for comments on the manuscript. This research was supported by the National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, the Champalimaud Neuroscience Programme, European Research Council grant 243393 and Howard Hughes Medical Institute International Early Careers Scientist Grant to R. M. C., the Whitehall Foundation, and US National Institutes of Health grant NS083815 to X.J.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Aldridge JW, 1998, J NEUROSCI, V18, P2777; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; BENECKE R, 1987, BRAIN, V110, P361, DOI 10.1093/brain/110.2.361; Boyd LA, 2009, NEUROBIOL LEARN MEM, V92, P35, DOI 10.1016/j.nlm.2009.02.009; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Burkhardt JM, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.028.2009; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Doupe AJ, 2005, TRENDS NEUROSCI, V28, P353, DOI 10.1016/j.tins.2005.05.005; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Fujii N, 2003, SCIENCE, V301, P1246, DOI 10.1126/science.1086872; Gallistel C. R., 1980, ORG ACTION NEW SYNTH; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gerfen CR, 2006, NAT NEUROSCI, V9, P157, DOI 10.1038/nn0206-157; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; GULLEY RL, 1971, TISSUE CELL, V3, P675, DOI 10.1016/S0040-8166(71)80013-7; Hampton CM, 2009, J NEUROPHYSIOL, V101, P3235, DOI 10.1152/jn.91089.2008; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hikosaka O, 2007, PROG BRAIN RES, V160, P209, DOI 10.1016/S0079-6123(06)60012-5; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Hikosaka O, 1998, NEUROBIOL LEARN MEM, V70, P137, DOI 10.1006/nlme.1998.3844; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; JURASKA JM, 1977, J COMP NEUROL, V172, P585, DOI 10.1002/cne.901720403; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kimura M, 1996, J NEUROPHYSIOL, V76, P3771, DOI 10.1152/jn.1996.76.6.3771; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lashley K. S., 1951, CEREBRAL MECH BEHAV; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; McHaffie JG, 2005, TRENDS NEUROSCI, V28, P401, DOI 10.1016/j.tins.2005.06.006; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/0033-295X.101.2.343; MILLHOUSE OE, 1986, J COMP NEUROL, V254, P209, DOI 10.1002/cne.902540206; Mink JW, 2003, ARCH NEUROL-CHICAGO, V60, P1365, DOI 10.1001/archneur.60.10.1365; Miyachi S, 1997, EXP BRAIN RES, V115, P1, DOI 10.1007/PL00005669; Nambu A, 1997, J COMP NEUROL, V377, P85; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Paxinos G., 2012, MOUSE BRAIN STEREOTA, V2nd; Pellegrino F, 2011, LANGUAGE, V87, P539; PHILLIPS JG, 1995, NEUROPSYCHOLOGIA, V33, P365, DOI 10.1016/0028-3932(94)00114-5; Sakai K, 2003, EXP BRAIN RES, V152, P229, DOI 10.1007/s00221-003-1548-8; Shima K, 2006, J NEUROSCI, V26, P2579, DOI 10.1523/JNEUROSCI.4161-05.2006; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Watanabe M, 2011, EUR J NEUROSCI, V33, P2070, DOI 10.1111/j.1460-9568.2011.07691.x; Wymbs NF, 2012, NEURON, V74, P936, DOI 10.1016/j.neuron.2012.03.038	50	279	282	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2014	17	3					423	430		10.1038/nn.3632	http://dx.doi.org/10.1038/nn.3632			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AB8CA	24464039	Green Accepted			2022-12-17	WOS:000332016500016
J	Ferrini, F; Trang, T; Mattioli, TAM; Laffray, S; Del'Guidice, T; Lorenzo, LE; Castonguay, A; Doyon, N; Zhang, WB; Godin, AG; Mohr, D; Beggs, S; Vandal, K; Beaulieu, JM; Cahill, CM; Salter, MW; De Koninck, Y				Ferrini, Francesco; Trang, Tuan; Mattioli, Theresa-Alexandra M.; Laffray, Sophie; Del'Guidice, Thomas; Lorenzo, Louis-Etienne; Castonguay, Annie; Doyon, Nicolas; Zhang, Wenbo; Godin, Antoine G.; Mohr, Daniela; Beggs, Simon; Vandal, Karen; Beaulieu, Jean-Martin; Cahill, Catherine M.; Salter, Michael W.; De Koninck, Yves			Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl- homeostasis	NATURE NEUROSCIENCE			English	Article							LAMINA-I NEURONS; ALTERED CHLORIDE HOMEOSTASIS; INDUCED ABNORMAL PAIN; NEUROTROPHIC FACTOR; SPINAL MICROGLIA; P2X(4) RECEPTORS; DOWN-REGULATION; ANION GRADIENT; UP-REGULATION; NERVE INJURY	A major unresolved issue in treating pain is the paradoxical hyperalgesia produced by the gold-standard analgesic morphine and other opiates. We found that hyperalgesia-inducing treatment with morphine resulted in downregulation of the K+-Cl- co-transporter KCC2, impairing Cl- homeostasis in rat spinal lamina I neurons. Restoring the anion equilibrium potential reversed the morphine-induced hyperalgesia without affecting tolerance. The hyperalgesia was also reversed by ablating spinal microglia. Morphine hyperalgesia, but not tolerance, required mu opioid receptor-dependent expression of P2X4 receptors (P2X4Rs) in microglia and mu-independent gating of the release of brain-derived neurotrophic factor (BDNF) by P2X4Rs. Blocking BDNF-TrkB signaling preserved Cl- homeostasis and reversed the hyperalgesia. Gene-targeted mice in which Bdnf was deleted from microglia did not develop hyperalgesia to morphine. However, neither morphine antinociception nor tolerance was affected in these mice. Our findings dissociate morphine-induced hyperalgesia from tolerance and suggest the microglia-to-neuron P2X4-BDNF-KCC2 pathway as a therapeutic target for preventing hyperalgesia without affecting morphine analgesia.	[Ferrini, Francesco; Laffray, Sophie; Del'Guidice, Thomas; Lorenzo, Louis-Etienne; Castonguay, Annie; Doyon, Nicolas; Godin, Antoine G.; Vandal, Karen; Beaulieu, Jean-Martin; De Koninck, Yves] Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada; [Ferrini, Francesco; Laffray, Sophie; Del'Guidice, Thomas; Lorenzo, Louis-Etienne; Castonguay, Annie; Doyon, Nicolas; Godin, Antoine G.; Beaulieu, Jean-Martin; De Koninck, Yves] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada; [Ferrini, Francesco] Univ Turin, Dept Vet Sci, Turin, Italy; [Ferrini, Francesco; Zhang, Wenbo; Mohr, Daniela; Beggs, Simon; Salter, Michael W.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Trang, Tuan; Zhang, Wenbo; Mohr, Daniela; Beggs, Simon; Salter, Michael W.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Trang, Tuan] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB, Canada; [Trang, Tuan] Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB, Canada; [Mattioli, Theresa-Alexandra M.; Cahill, Catherine M.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Cahill, Catherine M.] Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Irvine, CA USA	Laval University; Laval University; University of Turin; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Calgary; University of Calgary; Queens University - Canada; University of California System; University of California Irvine	De Koninck, Y (corresponding author), Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada.	yves.dekoninck@crulrg.ulaval.ca	Laffray, Sophie/AAA-4792-2019; Cahill, Catherine/AAA-1611-2019; Ferrini, Francesco/T-9903-2019; Beggs, Simon/AAI-4438-2021; Cahill, Catherine M/J-6524-2019; De Koninck, Yves/C-2659-2008; Lorenzo, Louis-Etienne/A-5409-2012; Beaulieu, Jean-Martin/A-7598-2008; Castonguay, Annie/E-4068-2010	Laffray, Sophie/0000-0002-1562-0304; Ferrini, Francesco/0000-0002-4779-005X; Beggs, Simon/0000-0002-1582-8391; De Koninck, Yves/0000-0002-5779-9330; Lorenzo, Louis-Etienne/0000-0002-5514-0049; Beaulieu, Jean-Martin/0000-0002-0446-7447; Mohr, Daniela/0000-0001-8129-2604; Godin, Antoine/0000-0003-2417-2563; Castonguay, Annie/0000-0001-8065-3359; Del'Guidice, Thomas/0000-0003-4969-7016	Canadian Institutes for Health Research (CIHR); Krembil Foundation; Regione Piemonte/University of Turin Fellowship Program; CIHR Fellowship program; Howard Hughes Medical Institute; Anne and Max Tanenbaum Chair Program; Canada Research Chairs Program; Fonds de la recherche en sante du Quebec Chercheur National Program; Ontario Research Fund Research Excellence Program	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Krembil Foundation; Regione Piemonte/University of Turin Fellowship Program; CIHR Fellowship program(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Anne and Max Tanenbaum Chair Program; Canada Research Chairs Program(Canada Research Chairs); Fonds de la recherche en sante du Quebec Chercheur National Program; Ontario Research Fund Research Excellence Program	We thank K. Bachand for technical assistance with behavior, F. Rassendren (INSERM) for P2rx4<SUP>-/-</SUP>mice, C.J. Evans (National Institute on Drug Abuse) for (+)naloxone and J. Vlahakis for (+)naloxone polarimetric analysis. This paper is dedicated to the memory of Karen Vandal, who passed away during the course of this study. This work was supported by Canadian Institutes for Health Research (CIHR) grants to Y.D.K., M.W.S., C.M.C. and J.-M.B., by the Krembil Foundation (Y.D.K. and M.W.S.), the Regione Piemonte/University of Turin Fellowship Program (F.F.), the CIHR Fellowship program (T.T. and L.-E.L.), the Howard Hughes Medical Institute (M.W.S.), the Anne and Max Tanenbaum Chair Program (M.W.S.), the Canada Research Chairs Program (C.M.C., J.-M.B. and M.W.S.), the Fonds de la recherche en sante du Quebec Chercheur National Program (Y.D.K.) and the Ontario Research Fund Research Excellence Program (M.W.S.).	Asiedu M, 2010, PAIN, V148, P302, DOI 10.1016/j.pain.2009.11.015; Beggs S, 2010, CURR OPIN NEUROBIOL, V20, P474, DOI 10.1016/j.conb.2010.08.005; Bekhit MH, 2010, AM J THER, V17, P498, DOI 10.1097/MJT.0b013e3181ed83a0; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Chorin E, 2011, J NEUROSCI, V31, P12916, DOI 10.1523/JNEUROSCI.2205-11.2011; Cordero-Erausquin M, 2005, J NEUROSCI, V25, P9613, DOI 10.1523/JNEUROSCI.1488-05.2005; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; De Koninck Y, 2007, CURR OPIN PHARMACOL, V7, P93, DOI 10.1016/j.coph.2006.11.005; Doyon N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002149; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Heinke B, 2011, J NEUROSCI, V31, P1313, DOI 10.1523/JNEUROSCI.4060-10.2011; Hewitt SA, 2009, NAT NEUROSCI, V12, P438, DOI 10.1038/nn.2274; Horvath RJ, 2010, PAIN, V150, P401, DOI 10.1016/j.pain.2010.02.042; Horvath RJ, 2009, J NEUROSCI, V29, P998, DOI 10.1523/JNEUROSCI.4595-08.2009; Hutchinson MR, 2011, PHARMACOL REV, V63, P772, DOI 10.1124/pr.110.004135; Keller AF, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-27; Kemp T, 1996, NEUROSCIENCE, V75, P1231, DOI 10.1016/0306-4522(96)00333-8; Knabl J, 2008, NATURE, V451, P330, DOI 10.1038/nature06493; Lee M, 2011, PAIN PHYSICIAN, V14, P145; Mannion RJ, 1999, P NATL ACAD SCI USA, V96, P9385, DOI 10.1073/pnas.96.16.9385; Mao JR, 2002, PAIN, V100, P213, DOI 10.1016/S0304-3959(02)00422-0; Mao JR, 2002, J NEUROSCI, V22, P8312; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Merighi A, 2008, PROG NEUROBIOL, V85, P297, DOI 10.1016/j.pneurobio.2008.04.004; Prescott SA, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-32; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; SJOGREN P, 1993, PAIN, V55, P93, DOI 10.1016/0304-3959(93)90188-U; Smirnov S, 1999, J NEUROSCI, V19, P9252; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Takayama N, 2005, J NEUROSCI, V25, P430, DOI 10.1523/JNEUROSCI.3170-04.2005; Trang T, 2009, J NEUROSCI, V29, P3518, DOI 10.1523/JNEUROSCI.5714-08.2009; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2010, BRAIN RES REV, V63, P222, DOI 10.1016/j.brainresrev.2009.11.003; Ulmann L, 2008, J NEUROSCI, V28, P11263, DOI 10.1523/JNEUROSCI.2308-08.2008; Vanderah TW, 2001, J NEUROSCI, V21, P279, DOI 10.1523/JNEUROSCI.21-01-00279.2001; Vargas-Perez H, 2009, SCIENCE, V324, P1732, DOI 10.1126/science.1168501; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wang Y, 2012, NAT MED, V18, P385, DOI 10.1038/nm.2633; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Xu J, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-9; Zeilhofer HU, 2012, ANNU REV PHARMACOL, V52, P111, DOI 10.1146/annurev-pharmtox-010611-134636; Zeng JS, 2006, J NEUROSCI, V26, P12033, DOI 10.1523/JNEUROSCI.2530-06.2006; Zhao J, 2006, MOL CELL NEUROSCI, V31, P539, DOI 10.1016/j.mcn.2005.11.008; Zhao P, 2007, J NEUROSCI, V27, P2357, DOI 10.1523/JNEUROSCI.0138-07.2007	50	279	289	3	117	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					183	192		10.1038/nn.3295	http://dx.doi.org/10.1038/nn.3295			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	080RE	23292683	Green Accepted, Green Submitted			2022-12-17	WOS:000314260200015
J	Kleinlogel, S; Feldbauer, K; Dempski, RE; Fotis, H; Wood, PG; Bamann, C; Bamberg, E				Kleinlogel, Sonja; Feldbauer, Katrin; Dempski, Robert E.; Fotis, Heike; Wood, Phillip G.; Bamann, Christian; Bamberg, Ernst			Ultra light-sensitive and fast neuronal activation with the Ca2+-permeable channelrhodopsin CatCh	NATURE NEUROSCIENCE			English	Article							RESTORES VISUAL RESPONSES; SURFACE-CHARGE; PHOTOCYCLE; CHANNELS; CALCIUM; BACTERIORHODOPSIN; EXPRESSION; MEMBRANE; CELLS; MICE	The light-gated cation channel channelrhodopsin-2 (ChR2) has rapidly become an important tool in neuroscience, and its use is being considered in therapeutic interventions. Although wild-type and known variant ChR2s are able to drive light-activated spike trains, their use in potential clinical applications is limited by either low light sensitivity or slow channel kinetics. We present a new variant, calcium translocating channelrhodopsin (CatCh), which mediates an accelerated response time and a voltage response that is similar to 70-fold more light sensitive than that of wild-type ChR2. CatCh's superior properties stem from its enhanced Ca2+ permeability. An increase in [Ca2+](i) elevates the internal surface potential, facilitating activation of voltage-gated Na+ channels and indirectly increasing light sensitivity. Repolarization following light-stimulation is markedly accelerated by Ca2+-dependent BK channel activation. Our results demonstrate a previously unknown principle: shifting permeability from monovalent to divalent cations to increase sensitivity without compromising fast kinetics of neuronal activation. This paves the way for clinical use of light-gated channels.	[Kleinlogel, Sonja; Feldbauer, Katrin; Dempski, Robert E.; Fotis, Heike; Wood, Phillip G.; Bamann, Christian; Bamberg, Ernst] Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany; [Bamberg, Ernst] Goethe Univ Frankfurt, Chem & Pharmaceut Sci Dept, Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt	Bamberg, E (corresponding author), Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany.	ernst.bamberg@biophys.mpg.de		Bamann, Christian/0000-0001-7473-438X	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 807]; Centre of Excellence Frankfurt Macromolecular Complexes; Federal Ministry of Education and Research of Germany [01GQ0815]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Centre of Excellence Frankfurt Macromolecular Complexes; Federal Ministry of Education and Research of Germany(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We would like to thank I. Bartnik for the preparation of the hippocampal neuron cultures, S. O'Shea for the help with the calcium imaging experiments, V. Busskamp for the support in recombinant adeno-associated virus construction, H. Biehl for excellent technical assistance, and K. Hartung, H. Spors, U. Terpitz and M. van Wyk for helpful discussions. The work was supported by grants from the Deutsche Forschungsgemeinschaft Sonderforschungsbereich 807, Centre of Excellence Frankfurt Macromolecular Complexes and the Federal Ministry of Education and Research of Germany (01GQ0815) to E.B., and by the Max Planck Society.	Allocca M, 2007, J VIROL, V81, P11372, DOI 10.1128/JVI.01327-07; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Cady C, 2001, BRAIN RES, V921, P1, DOI 10.1016/S0006-8993(01)03063-3; Caldwell JH, 2008, J BIOL CHEM, V283, P24300, DOI 10.1074/jbc.M802593200; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; Faber ESL, 2003, NEUROSCIENTIST, V9, P181, DOI 10.1177/1073858403009003011; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; HILLE B, 1975, PHILOS T R SOC B, V270, P301, DOI 10.1098/rstb.1975.0011; HILLE B, 2001, ION CHANNELS EXCITAB, P649; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Joh NH, 2009, J AM CHEM SOC, V131, P10846, DOI 10.1021/ja904711k; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; MULLER RU, 1972, J GEN PHYSIOL, V60, P285, DOI 10.1085/jgp.60.3.285; Nack M, 2010, PHOTOCH PHOTOBIO SCI, V9, P194, DOI 10.1039/b9pp00157c; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; SUBRAMANIAM S, 1991, P NATL ACAD SCI USA, V88, P6873, DOI 10.1073/pnas.88.15.6873; Subramaniam S, 1997, P NATL ACAD SCI USA, V94, P1767, DOI 10.1073/pnas.94.5.1767; Thyagarajan S, 2010, J NEUROSCI, V30, P8745, DOI 10.1523/JNEUROSCI.4417-09.2010; Weber WM, 1999, BBA-BIOMEMBRANES, V1421, P213, DOI 10.1016/S0005-2736(99)00135-2; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	30	279	302	0	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					513	U152		10.1038/nn.2776	http://dx.doi.org/10.1038/nn.2776			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21399632				2022-12-17	WOS:000288849400023
J	Korman, M; Doyon, J; Doljansky, J; Carrier, J; Dagan, Y; Karni, A				Korman, Maria; Doyon, Julien; Doljansky, Julia; Carrier, Julie; Dagan, Yaron; Karni, Avi			Daytime sleep condenses the time course of motor memory consolidation	NATURE NEUROSCIENCE			English	Article							SKILL; ACQUISITION; PLASTICITY; PERFORMANCE; ADAPTATION; SEQUENCE; PERFECT; SYSTEMS; CORTEX	Two behavioral phenomena characterize human motor memory consolidation: diminishing susceptibility to interference by a subsequent experience and the emergence of delayed, offline gains in performance. A recent model proposes that the sleep-independent reduction in interference is followed by the sleep-dependent expression of offline gains. Here, using the finger-opposition sequence-learning task, we show that an interference experienced at 2 h, but not 8 h, following the initial training prevented the expression of delayed gains at 24 h post-training. However, a 90-min nap, immediately post-training, markedly reduced the susceptibility to interference, with robust delayed gains expressed overnight, despite interference at 2 h post-training. With no interference, a nap resulted in much earlier expression of delayed gains, within 8 h post-training. These results suggest that the evolution of robustness to interference and the evolution of delayed gains can coincide immediately post-training and that both effects reflect sleep-sensitive processes.	Univ Haifa, Brain Behav Res Ctr, IL-31905 Haifa, Israel; Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; Sheba Med Ctr, Chronobiol & Sleep Lab, IL-52662 Tel Aviv, Israel	University of Haifa; Universite de Montreal; Chaim Sheba Medical Center	Korman, M (corresponding author), Univ Haifa, Brain Behav Res Ctr, IL-31905 Haifa, Israel.	mariakorman@yahoo.com	Korman, Maria/GWQ-3314-2022; Korman, Maria/N-6515-2019	Korman, Maria/0000-0003-1895-0189; Korman, Maria/0000-0003-1895-0189; Carrier, Julie/0000-0001-5311-2370				ADAMS JA, 1987, PSYCHOL BULL, V101, P41, DOI 10.1037/0033-2909.101.1.41; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Censor N, 2006, VISION RES, V46, P4071, DOI 10.1016/j.visres.2006.07.022; Cohen DA, 2005, P NATL ACAD SCI USA, V102, P18237, DOI 10.1073/pnas.0506072102; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Fischer S, 2005, J NEUROSCI, V25, P11248, DOI 10.1523/JNEUROSCI.1743-05.2005; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Goedert KM, 2002, LEARN MEMORY, V9, P279, DOI 10.1101/lm.50102; Hauptmann B, 2005, COGNITIVE BRAIN RES, V24, P181, DOI 10.1016/j.cogbrainres.2005.01.012; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Karni A, 1996, COGNITIVE BRAIN RES, V5, P39, DOI 10.1016/S0926-6410(96)00039-0; Korman M, 2005, BEHAV BRAIN SCI, V28, P74, DOI 10.1017/S0140525X05320024; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Krakauer JW, 2006, TRENDS NEUROSCI, V29, P58, DOI 10.1016/j.tins.2005.10.003; Luft AR, 2005, MOL NEUROBIOL, V32, P205, DOI 10.1385/MN:32:3:205; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Maquet P, 2003, J NEUROSCI, V23, P1432, DOI 10.1523/JNEUROSCI.23-04-01432.2003; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Nudo RJ, 1996, J NEUROSCI, V16, P785; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orban P, 2006, P NATL ACAD SCI USA, V103, P7124, DOI 10.1073/pnas.0510198103; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rauchs G, 2005, J SLEEP RES, V14, P123, DOI 10.1111/j.1365-2869.2005.00450.x; Rechtschaffen A, 1968, MANUAL STANDARIZED T; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Roth DAE, 2005, LEARN MEMORY, V12, P159, DOI 10.1101/87505; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Sosnik R, 2004, EXP BRAIN RES, V156, P422, DOI 10.1007/s00221-003-1799-4; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; Vertes RP, 2004, NEURON, V44, P135, DOI 10.1016/j.neuron.2004.08.034; Walker M. P., 2005, BEHAV BRAIN SCI, V28, P64, DOI [DOI 10.1017/S0140525X05000026, 10.1017/s0140525x05000026]; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Walker MP, 2005, CLIN SPORT MED, V24, P301, DOI 10.1016/j.csm.2004.11.002; Walker MP, 2005, BEHAV BRAIN SCI, V28, P51, DOI 10.1017/S0140525X05000026; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930	51	279	280	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1206	1213		10.1038/nn1959	http://dx.doi.org/10.1038/nn1959			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17694051				2022-12-17	WOS:000249144000024
J	Samanez-Larkin, GR; Gibbs, SEB; Khanna, K; Nielsen, L; Carstensen, LL; Knutson, B				Samanez-Larkin, Gregory R.; Gibbs, Sasha E. B.; Khanna, Kabir; Nielsen, Lisbeth; Carstensen, Laura L.; Knutson, Brian			Anticipation of monetary gain but not loss in healthy older adults	NATURE NEUROSCIENCE			English	Article							DECISION-MAKING; AGE; VISUALIZATION; COGNITION; OUTCOMES; FMRI	Although global declines in structure have been documented in the aging human brain, little is known about the functional integrity of the striatum and prefrontal cortex in older adults during incentive processing. We used event-related functional magnetic resonance imaging to determine whether younger and older adults differed in both self-reported and neural responsiveness to anticipated monetary gains and losses. The present study provides evidence for intact striatal and insular activation during gain anticipation with age, but shows a relative reduction in activation during loss anticipation. These findings suggest that there is an asymmetry in the processing of gains and losses in older adults that may have implications for decision-making.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; NIA, Bethesda, MD 20892 USA; NIH, Bethesda, MD 20892 USA; Stanford Ctr Longev, Stanford, CA 94305 USA; Stanford Univ, Inst Neurosci, Stanford, CA 94305 USA	Stanford University; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; Stanford University	Samanez-Larkin, GR (corresponding author), Stanford Univ, Dept Psychol, Bldg 420,Jordan Hall, Stanford, CA 94305 USA.	glarkin@stanford.edu	Samanez-Larkin, Gregory/A-1139-2007	Samanez-Larkin, Gregory/0000-0001-7846-3804; Knutson, Brian/0000-0002-7669-426X; carstensen, laura/0000-0002-5011-3789	NATIONAL INSTITUTE ON AGING [P30AG024957, P30AG017253, R37AG008816, R01AG008816] Funding Source: NIH RePORTER; NIA NIH HHS [P30 AG017253, AG008816, R37 AG008816-17, P30 AG017253-09, AG017253, R37 AG008816, AG024957, R01 AG008816, P30 AG024957, P30 AG024957-04] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Backman L, 2000, AM J PSYCHIAT, V157, P635; Bjork JM, 2004, J NEUROSCI, V24, P1793, DOI 10.1523/JNEUROSCI.4862-03.2004; Cabeza R., 2005, COGNITIVE NEUROSCIEN; Carstensen LL, 2006, SCIENCE, V312, P1913, DOI 10.1126/science.1127488; Carstensen LL, 2005, CURR DIR PSYCHOL SCI, V14, P117, DOI 10.1111/j.0963-7214.2005.00348.x; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; CARSTENSEN LL, 2005, HDB PSYCHOL AGING, P343; Cohen J, 2003, ANIM COGN, V6, P93, DOI 10.1007/s10071-003-0168-9; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Denburg NL, 2006, INT J PSYCHOPHYSIOL, V61, P19, DOI 10.1016/j.ijpsycho.2005.10.021; Denburg NL, 2005, NEUROPSYCHOLOGIA, V43, P1099, DOI 10.1016/j.neuropsychologia.2004.09.012; Garavan H, 2006, BRAIN RES, V1105, P130, DOI 10.1016/j.brainres.2006.03.029; Gazzaley A, 2005, COGNITIVE NEUROSCIEN, P107; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Kaasinen V, 2000, NEUROBIOL AGING, V21, P683, DOI 10.1016/S0197-4580(00)00149-4; Kennedy KM, 2005, J COGNITIVE NEUROSCI, P140; KISLEY MA, IN PRESS PSYCHOL SCI; Knight M., 2006, BIOL BASES PERSONALI, P159; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Marschner A, 2005, BRAIN RES BULL, V67, P382, DOI 10.1016/j.brainresbull.2005.06.010; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Mather M, 2004, PSYCHOL SCI, V15, P259, DOI 10.1111/j.0956-7976.2004.00662.x; Neter J., 1990, APPL LINEAR STAT MOD; Park D.C., 2000, COGNITIVE AGING PRIM, V1st; Volkow ND, 1998, AM J PSYCHIAT, V155, P344; Wood S, 2006, PSYCHOL AGING, V21, P815, DOI 10.1037/0882-7974.21.4.815	30	279	284	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					787	791		10.1038/nn1894	http://dx.doi.org/10.1038/nn1894			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	172JI	17468751	Green Accepted			2022-12-17	WOS:000246799800022
J	Nevian, T; Larkum, ME; Polsky, A; Schiller, J				Nevian, Thomas; Larkum, Matthew E.; Polsky, Alon; Schiller, Jackie			Properties of basal dendrites of layer 5 pyramidal neurons: a direct patch-clamp recording study	NATURE NEUROSCIENCE			English	Article							TIMING-DEPENDENT PLASTICITY; ACTION-POTENTIAL INITIATION; DISTAL APICAL DENDRITES; SYNAPTIC PLASTICITY; OBLIQUE DENDRITES; CALCIUM SPIKES; VISUAL-CORTEX; NMDA SPIKES; EVOKED CA2+; IN-VIVO	Basal dendrites receive the majority of synapses that contact neocortical pyramidal neurons, yet our knowledge of synaptic processing in these dendrites has been hampered by their inaccessibility for electrical recordings. A new approach to patch-clamp recordings enabled us to characterize the integrative properties of these cells. Despite the short physical length of rat basal dendrites, synaptic inputs were electrotonically remote from the soma ( > 30- fold excitatory postsynaptic potential ( EPSP) attenuation) and back- propagating action potentials were significantly attenuated. Unitary EPSPs were location dependent, reaching large amplitudes distally ( > 8 mV), yet their somatic contribution was relatively location independent. Basal dendrites support sodium and NMDA spikes, but not calcium spikes, for 75% of their length. This suggests that basal dendrites, despite their proximity to the site of action potential initiation, do not form a single basal- somatic region but rather should be considered as a separate integrative compartment favoring two integration modes: subthreshold, location- independent summation versus local amplification of incoming spatiotemporally clustered information.	Technion Israel Inst Technol, Sch Med, Dept Physiol, IL-31096 Haifa, Israel; Univ Bern, Dept Physiol, CH-3012 Bern, Switzerland; Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany	Technion Israel Institute of Technology; University of Bern; Max Planck Society	Schiller, J (corresponding author), Technion Israel Inst Technol, Sch Med, Dept Physiol, IL-31096 Haifa, Israel.	jackie@tx.technion.ac.il		Nevian, Thomas/0000-0001-9804-608X; Poleg-Polsky, Alon/0000-0003-1327-5129; Larkum, Matthew/0000-0001-9799-2656				Antic SD, 2003, J PHYSIOL-LONDON, V550, P35, DOI 10.1113/jphysiol.2002.033746; Ariav G, 2003, J NEUROSCI, V23, P7750; Bannister AP, 2005, NEUROSCI RES, V53, P95, DOI 10.1016/j.neures.2005.06.019; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Colbert CM, 1997, J NEUROSCI, V17, P6512; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hausser M, 2001, SCIENCE, V291, P138, DOI 10.1126/science.291.5501.138; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Jack J.J.B., 1975, ELECT CURRENT FLOW E; Jaffe DB, 1999, J NEUROPHYSIOL, V82, P3268, DOI 10.1152/jn.1999.82.6.3268; Kampa BM, 2006, J NEUROSCI, V26, P7424, DOI 10.1523/JNEUROSCI.3062-05.2006; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; LARKMAN AU, 1992, J COMP NEUROL, V323, P137, DOI 10.1002/cne.903230202; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2002, J NEUROSCI, V22, P6991; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Larkum ME, 1999, P NATL ACAD SCI USA, V96, P14600, DOI 10.1073/pnas.96.25.14600; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Milojkovic BA, 2005, J NEUROSCI, V25, P3940, DOI 10.1523/JNEUROSCI.5314-04.2005; Milojkovic BA, 2004, J PHYSIOL-LONDON, V558, P193, DOI 10.1113/jphysiol.2004.061416; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; RALL W, 1973, BIOPHYS J, V13, P648, DOI 10.1016/S0006-3495(73)86014-X; Rapp M, 1996, P NATL ACAD SCI USA, V93, P11985, DOI 10.1073/pnas.93.21.11985; Rathenberg J, 2003, J NEUROSCI METH, V126, P91, DOI 10.1016/S0165-0270(03)00069-4; Rhodes P, 2006, J NEUROSCI, V26, P6704, DOI 10.1523/JNEUROSCI.3791-05.2006; Rhodes PA, 2001, J PHYSIOL-LONDON, V536, P167, DOI 10.1111/j.1469-7793.2001.00167.x; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; SCHILLER J, 1995, J PHYSIOL-LONDON, V487, P583, DOI 10.1113/jphysiol.1995.sp020902; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Williams SR, 1999, J PHYSIOL-LONDON, V521, P467, DOI 10.1111/j.1469-7793.1999.00467.x; Wimmer VC, 2004, PFLUG ARCH EUR J PHY, V449, P319, DOI 10.1007/s00424-004-1327-9; ZADOR AM, 1995, J NEUROSCI, V15, P1669, DOI 10.1523/JNEUROSCI.15-03-01669.1995; Zhu JJ, 2000, J PHYSIOL-LONDON, V526, P571, DOI 10.1111/j.1469-7793.2000.00571.x	50	279	285	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					206	214		10.1038/nn1826	http://dx.doi.org/10.1038/nn1826			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17206140				2022-12-17	WOS:000244175200015
J	Ohta, H; Yamazaki, S; McMahon, DG				Ohta, H; Yamazaki, S; McMahon, DG			Constant light desynchronizes mammalian clock neurons	NATURE NEUROSCIENCE			English	Article							CIRCADIAN-RHYTHMS; INDIVIDUAL FIBROBLASTS; GENE-EXPRESSION; NUCLEUS; INVITRO	Circadian organization can be disrupted by constant light, resulting in behavioral arrhythmicity or 'splitting' of rhythms of activity and rest. By imaging molecular rhythms of individual clock neurons in explanted mouse clock nuclei, we now find that constant light desynchronizes clock neurons but does not compromise their ability to generate circadian rhythms. Cellular synchrony within clock nuclei is disrupted during arrhythmicity, whereas neurons in the left and right clock nuclei cycle in antiphase during 'splitting.'	Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	McMahon, DG (corresponding author), Vanderbilt Univ, Dept Biol Sci, VU Stn B,Box 35-1634, Nashville, TN 37235 USA.	douglas.g.mcmahon@vanderbilt.edu		Yamazaki, Shin/0000-0002-6691-1531	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063341] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH63341] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ASCHOFF J, 1976, FED PROC, V35, P2326; de la Iglesia HO, 2000, SCIENCE, V290, P799, DOI 10.1126/science.290.5492.799; Granados-Fuentes D, 2004, J NEUROSCI, V24, P615, DOI 10.1523/JNEUROSCI.4002-03.2004; MASON R, 1991, NEUROSCI LETT, V123, P160, DOI 10.1016/0304-3940(91)90920-O; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Quintero JE, 2003, J NEUROSCI, V23, P8070; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; ZLOMANCZUK P, 1991, BRAIN RES, V559, P94, DOI 10.1016/0006-8993(91)90291-3	10	279	287	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					267	269		10.1038/nn1395	http://dx.doi.org/10.1038/nn1395			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15746913				2022-12-17	WOS:000227354600008
J	Schmolesky, MT; Wang, YC; Pu, ML; Leventhal, AG				Schmolesky, MT; Wang, YC; Pu, ML; Leventhal, AG			Degradation of stimulus selectivity of visual cortical cells in senescent rhesus monkeys	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; LATERAL GENICULATE NEURONS; STRIATE CORTEX; ORIENTATION SELECTIVITY; CEREBRAL-CORTEX; DIRECTION SELECTIVITY; CONTRAST SENSITIVITY; PRIMATE RETINA; NEURAL BASES; LIFE-SPAN	Human visual function declines with age. Much of this decline is probably mediated by changes in the central visual pathways. We compared the stimulus selectivity of cells in primary visual cortex (striate cortex or V1) in young adult and very old macaque monkeys using single-neuron in vivo electrophysiology. Our results provide evidence for a significant degradation of orientation and direction selectivity in senescent animals. The decreased selectivity of cells in old animals was accompanied by increased responsiveness to all orientations and directions as well as an increase in spontaneous activity. The decreased selectivities and increased excitability of cells in old animals are consistent with an age-related degeneration of intracortical inhibition. The neural changes described here could underlie declines in visual function during senescence.	Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Leventhal, AG (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA.	audie.leventhal@m.cc.u.utah.edu		Schmolesky, Matthew/0000-0002-3536-3333	NEI NIH HHS [EY04951] Funding Source: Medline; NIA NIH HHS [AG16148] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY004951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG016148] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AHMAD A, 1993, J COMP NEUROL, V334, P631, DOI 10.1002/cne.903340410; Crook JM, 1998, EUR J NEUROSCI, V10, P2056, DOI 10.1046/j.1460-9568.1998.00218.x; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; Dustman RE, 1996, BRAIN COGNITION, V30, P109, DOI 10.1006/brcg.1996.0007; Eysel UT, 1998, NEUROSCIENCE, V84, P25, DOI 10.1016/S0306-4522(97)00378-3; FITZPATRICK D, 1987, J COMP NEUROL, V264, P73, DOI 10.1002/cne.902640107; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Kim CBY, 1997, ANAT REC, V247, P119, DOI 10.1002/(SICI)1097-0185(199701)247:1<119::AID-AR14>3.0.CO;2-S; KLINE DW, 1983, J GERONTOL, V38, P211, DOI 10.1093/geronj/38.2.211; KLINE DW, 1991, VISION VISUAL DYSFUN, V16, P150; KLINE DW, 1985, HDB PSYCHOL AGING, P296; LEVENTHAL AG, 1993, J COMP NEUROL, V338, P242, DOI 10.1002/cne.903380208; LEVENTHAL AG, 1980, J NEUROPHYSIOL, V43, P1111, DOI 10.1152/jn.1980.43.4.1111; LEVENTHAL AG, 1988, SCIENCE, V240, P66, DOI 10.1126/science.3353708; LEVENTHAL AG, 1981, SCIENCE, V213, P1139, DOI 10.1126/science.7268423; LEVENTHAL AG, 1995, J NEUROSCI, V15, P1808, DOI 10.1523/JNEUROSCI.15-03-01808.1995; MCGEER E, 1976, NEUROBIOL AGING, P389; ORBAN GA, 1991, NEURAL BASIS VISUAL, P173; ORDY JM, 1979, SENSORY SYSTEMS COMM, P13; OWSLEY C, 1987, BRIT J OPHTHALMOL, V71, P791, DOI 10.1136/bjo.71.10.791; OWSLEY C, 1981, INVEST OPHTH VIS SCI, V21, P362; PERRY VH, 1981, EXP BRAIN RES, V43, P226; PETERS A, 1993, ANAT REC, V236, P721, DOI 10.1002/ar.1092360416; Peters A, 1998, CEREB CORTEX, V8, P295, DOI 10.1093/cercor/8.4.295; PETERS A, 1991, ANAT REC, V229, P384, DOI 10.1002/ar.1092290311; Peters A, 1997, NEUROBIOL AGING, V18, P29, DOI 10.1016/S0197-4580(96)00208-4; Porciatti V, 1999, VISION RES, V39, P2157, DOI 10.1016/S0042-6989(98)00288-0; PORCIATTI V, 1992, VISION RES, V32, P1199, DOI 10.1016/0042-6989(92)90214-4; PU M, 1992, J NEUROSCI METH, V41, P45, DOI 10.1016/0165-0270(92)90122-T; Pu ML, 1999, J COMP NEUROL, V414, P267; Ross RG, 1999, BIOL PSYCHIAT, V46, P383, DOI 10.1016/S0006-3223(98)00369-2; SAMORAJSKI T, 1977, J AM GERIATR SOC, V25, P337, DOI 10.1111/j.1532-5415.1977.tb00657.x; Sato H, 1996, J PHYSIOL-LONDON, V494, P757, DOI 10.1113/jphysiol.1996.sp021530; SCHEIBEL ME, 1975, EXP NEUROL, V47, P392, DOI 10.1016/0014-4886(75)90072-2; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; SHERMAN SM, 1982, PHYSIOL REV, V62, P738, DOI 10.1152/physrev.1982.62.2.738; SILLITO AM, 1979, J PHYSIOL-LONDON, V289, P33, DOI 10.1113/jphysiol.1979.sp012723; SILLITO AM, 1977, J PHYSIOL-LONDON, V271, P699, DOI 10.1113/jphysiol.1977.sp012021; SPEAR PD, 1994, J NEUROPHYSIOL, V72, P402, DOI 10.1152/jn.1994.72.1.402; SPEAR PD, 1993, VISION RES, V33, P2589, DOI 10.1016/0042-6989(93)90218-L; TIGGES J, 1988, AM J PRIMATOL, V15, P263, DOI 10.1002/ajp.1350150308; TOMODA H, 1991, DOC OPHTHALMOL, V77, P201, DOI 10.1007/BF00161368; Tran DB, 1998, GRAEF ARCH CLIN EXP, V236, P269, DOI 10.1007/s004170050076; TRICK GL, 1986, CURR EYE RES, V5, P717, DOI 10.3109/02713688609000011; VINCENT SL, 1989, ANAT REC, V223, P329, DOI 10.1002/ar.1092230312; VOLGUSHEV M, 1993, VISUAL NEUROSCI, V10, P1151, DOI 10.1017/S0952523800010257; Walker EP., 1975, MAMMALS WORLD; WATANABE M, 1989, J COMP NEUROL, V289, P434, DOI 10.1002/cne.902890308; WESTON HC, 1948, BRIT J OPHTHALMOL, V32, P645, DOI 10.1136/bjo.32.9.645	50	279	298	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					384	390		10.1038/73957	http://dx.doi.org/10.1038/73957			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725929				2022-12-17	WOS:000087945400020
J	Gu, Y; Arruda-Carvalho, M; Wang, J; Janoschka, SR; Josselyn, SA; Frankland, PW; Ge, SY				Gu, Yan; Arruda-Carvalho, Maithe; Wang, Jia; Janoschka, Stephen R.; Josselyn, Sheena A.; Frankland, Paul W.; Ge, Shaoyu			Optical controlling reveals time-dependent roles for adult-born dentate granule cells	NATURE NEUROSCIENCE			English	Article							ENHANCED SYNAPTIC PLASTICITY; NEWLY GENERATED NEURONS; HIPPOCAMPAL NEUROGENESIS; CRITICAL PERIOD; T-TYPE; PATTERN SEPARATION; GYRUS; INVOLVEMENT; INTEGRATION; RESPONSES	Accumulating evidence suggests that global depletion of adult hippocampal neurogenesis influences its function and that the timing of the depletion affects the deficits. However, the behavioral roles of adult-born neurons during their establishment of projections to CA3 pyramidal neurons remain largely unknown. We used a combination of retroviral and optogenetic approaches to birth date and reversibly control a group of adult-born neurons in adult mice. Adult-born neurons formed functional synapses on CA3 pyramidal neurons as early as 2 weeks after birth, and this projection to the CA3 area became stable by 4 weeks in age. Newborn neurons at this age were more plastic than neurons at other stages. Notably, we found that reversibly silencing this cohort of similar to 4-week-old cells after training, but not cells of other ages, substantially disrupted retrieval of hippocampal memory. Our results identify a restricted time window for adult-born neurons essential in hippocampal memory retrieval.	[Gu, Yan; Wang, Jia; Janoschka, Stephen R.; Ge, Shaoyu] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Arruda-Carvalho, Maithe; Josselyn, Sheena A.; Frankland, Paul W.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Arruda-Carvalho, Maithe; Josselyn, Sheena A.; Frankland, Paul W.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Janoschka, Stephen R.; Ge, Shaoyu] SUNY Stony Brook, Program Neurosci, Stony Brook, NY 11794 USA; [Josselyn, Sheena A.; Frankland, Paul W.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Toronto	Ge, SY (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.	paul.frankland@sickkids.ca; sge@notes.cc.sunysb.edu	Gu, Yan/K-4702-2017; Carvalho, Maithe Arruda/AAW-2490-2021	Gu, Yan/0000-0001-5562-6279; Arruda-Carvalho, Maithe/0000-0002-7832-3729	US National Institutes of Health [NS065915]; American Heart Association [0930067N]; Feldstein Medical Foundation; State University of New York Research Excellence in Academic Health; Canadian Institutes of Health Research [MOP86762, MOP74650]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065915] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Feldstein Medical Foundation; State University of New York Research Excellence in Academic Health; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Bischofberger, G. Matthews, L. Role and H. Song for their critical comments, and Q. Xiong and J. Tucciarone for technical support. We thank the members of F. Gage's laboratory for sharing their behavioral protocols. This work was supported by US National Institutes of Health (NS065915), American Heart Association (0930067N), Feldstein Medical Foundation and State University of New York Research Excellence in Academic Health grants to S. G. and Canadian Institutes of Health Research grants to P. W. F. (MOP86762) and S. A. J. (MOP74650).	Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Arruda-Carvalho M, 2011, J NEUROSCI, V31, P15113, DOI 10.1523/JNEUROSCI.3432-11.2011; Bergquist F, 2003, NEUROSCIENCE, V120, P757, DOI 10.1016/S0306-4522(03)00385-3; BEZPROZVANNY L, 1995, MOL PHARMACOL, V48, P540; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Drew MR, 2010, BEHAV NEUROSCI, V124, P446, DOI 10.1037/a0020081; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Faulkner RL, 2008, P NATL ACAD SCI USA, V105, P14157, DOI 10.1073/pnas.0806658105; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hastings NB, 2002, J COMP NEUROL, V452, P324, DOI 10.1002/cne.10386; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kerr AM, 2008, NEURON, V57, P5, DOI 10.1016/j.neuron.2007.12.015; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kim WR, 2012, BEHAV BRAIN RES, V227, P470, DOI 10.1016/j.bbr.2011.07.012; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Marin-Burgin A, 2012, SCIENCE, V335, P1238, DOI 10.1126/science.1214956; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Teixeira CM, 2006, J NEUROSCI, V26, P7555, DOI 10.1523/JNEUROSCI.1068-06.2006; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Yoshimura Y, 2008, EUR J NEUROSCI, V28, P730, DOI 10.1111/j.1460-9568.2008.06384.x; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	42	278	284	2	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1700	+		10.1038/nn.3260	http://dx.doi.org/10.1038/nn.3260			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23143513	Green Accepted			2022-12-17	WOS:000311706700016
J	McCoy, AN; Platt, ML				McCoy, AN; Platt, ML			Risk-sensitive neurons in macaque posterior cingulate cortex	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; DECISION-MAKING; PARIETAL; EXPECTATION; UNCERTAINTY; MONKEY; REPRESENTATION; ADOLESCENCE; MOTIVATION; NETWORKS	People and animals often demonstrate strong attraction or aversion to options with uncertain or risky rewards, yet the neural substrate of subjective risk preferences has rarely been investigated. Here we show that monkeys systematically preferred the risky target in a visual gambling task in which they chose between two targets offering the same mean reward but differing in reward uncertainty. Neuronal activity in posterior cingulate cortex (CGp), a brain area linked to visual orienting and reward processing, increased when monkeys made risky choices and scaled with the degree of risk. CGp activation was better predicted by the subjective salience of a chosen target than by its actual value. These data suggest that CGp signals the subjective preferences that guide visual orienting.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Ctr Cognit Neurosci, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biol Anthropol & Anat, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Platt, ML (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	platt@neuro.duke.edu						Arnauld Antoine, 1662, ART THINKING PORT RO; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Bateson M, 2002, P NUTR SOC, V61, P509, DOI 10.1079/PNS2002181; Bateson M, 1997, ANIM BEHAV, V53, P1129, DOI 10.1006/anbe.1996.0388; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1675, DOI 10.1016/S0028-3932(02)00015-5; Berman RA, 1999, HUM BRAIN MAPP, V8, P209, DOI 10.1002/(SICI)1097-0193(1999)8:4<209::AID-HBM5>3.0.CO;2-0; BERNOUILLI D, 1758, WORKS; Bickel WK, 2004, ADDICTION, V99, P855, DOI 10.1111/j.1360-0443.2004.00733.x; CARACO T, 1983, BEHAV ECOL SOCIOBIOL, V8, P820; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Damasio A, 1995, DESCARTES ERROR EMOT; Dean HL, 2004, J NEUROPHYSIOL, V92, P3056, DOI 10.1152/jn.00691.2003; Dickhaut J, 2003, P NATL ACAD SCI USA, V100, P3536, DOI 10.1073/pnas.0530279100; Doremus TL, 2004, ANN NY ACAD SCI, V1021, P427, DOI 10.1196/annals.1308.057; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Glimcher PW, 2001, J NEUROSCI METH, V108, P131, DOI 10.1016/S0165-0270(01)00365-X; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kacelnik A, 1997, Ciba Found Symp, V208, P51; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Kelley AE, 2004, ANN NY ACAD SCI, V1021, P27, DOI 10.1196/annals.1308.003; Ladouceur R, 2003, ADDICTION, V98, P733, DOI 10.1046/j.1360-0443.2003.00412.x; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Marsh B, 2002, P NATL ACAD SCI USA, V99, P3352, DOI 10.1073/pnas.042491999; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; McCoy A, 2005, J COMP PHYSIOL A, V191, P201, DOI 10.1007/s00359-004-0565-9; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; MCGLOTHLIN WH, 1956, AM J PSYCHOL, V69, P604, DOI 10.2307/1419083; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Meyer G, 2000, BIOL PSYCHIAT, V48, P948, DOI 10.1016/S0006-3223(00)00888-X; Olson CR, 1996, J NEUROPHYSIOL, V76, P3285, DOI 10.1152/jn.1996.76.5.3285; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rescorla R. A., 1972, CLASSICAL CONDITIONI; Rode C, 1999, COGNITION, V72, P269, DOI 10.1016/S0010-0277(99)00041-4; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Schultz W, 2004, CURR OPIN NEUROBIOL, V14, P139, DOI 10.1016/j.conb.2004.03.017; Sharpe L, 2004, J GAMBL STUD, V20, P95, DOI 10.1023/B:JOGS.0000016706.96540.43; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Stephens D.W., 1986, pi; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208; Weber EU, 2004, PSYCHOL REV, V111, P430, DOI 10.1037/0033-295X.111.2.430	50	278	281	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1220	1227		10.1038/nn1523	http://dx.doi.org/10.1038/nn1523			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116449				2022-12-17	WOS:000231483800022
J	Sun, HJ; Frost, BJ				Sun, HJ; Frost, BJ			Computation of different optical variables of looming objects in pigeon nucleus rotundus neurons	NATURE NEUROSCIENCE			English	Article							ORTHOPTERAN DCMD NEURON; APPROACHING OBJECTS; MOVING-OBJECTS; FLOW-FIELD; TIME; RESPONSES; MOTION; REEVALUATION; COLLISION; EXPANSION	Three types of looming-selective neurons have been found in the nucleus rotundus of pigeons, each computing a different optical variable related to image expansion of objects approaching on a direct collision course with the bird. None of these neurons respond to simulated approach toward stationary objects. A detailed analysis of these neurons' firing pattern to approaching objects of different sizes and velocities shows that one group of neurons signals relative rate of expansion tau (tau), a second group signals absolute rate of expansion rho (rho), and a third group signals yet another optical variable eta (eta). The rho parameter is required for the computation of both tau and eta, whose respective ecological functions probably provide precise 'time-to-collision' information and 'early warning' detection for large approaching objects.	Queens Univ, Dept Psychol, Visual & Audit Neurosci Lab, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Frost, BJ (corresponding author), Queens Univ, Dept Psychol, Visual & Audit Neurosci Lab, Kingston, ON K7L 3N6, Canada.	Frost@pavlov.psyc.queensu.ca						BALL W, 1971, SCIENCE, V171, P818, DOI 10.1126/science.171.3973.818; BOWER TGR, 1970, PERCEPT PSYCHOPHYS, V9, P193; DILL LM, 1974, ANIM BEHAV, V22, P771; Frost B.J., 1994, P248; Frost BJ, 1997, FROM LIVING EYES TO SEEING MACHINES, P80; Gibson J.J., 1979, ECOLOGICAL APPROACH; Gibson JJ., 1966, SENSES CONSIDERED PE; HATSOPOULOS N, 1995, SCIENCE, V270, P1000, DOI 10.1126/science.270.5238.1000; HAYES WN, 1967, ANIM BEHAV, V15, P102, DOI 10.1016/S0003-3472(67)80018-6; Ingle DJ, 1985, BRAIN MECH SPATIAL V, P229; Lee D.N., 1985, BRAIN MECH SPATIAL V, P1, DOI 10.1007/978-94-009-5071-9_1; LEE DN, 1981, NATURE, V293, P293, DOI 10.1038/293293a0; LEE DN, 1980, PHILOS T R SOC B, V290, P169, DOI 10.1098/rstb.1980.0089; LEE DN, 1982, J EXP PSYCHOL HUMAN, V8, P448; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; LONGUETHIGGINS HC, 1980, P R SOC LOND B, V206, P358; NAKAYAMA K, 1974, PERCEPTION, V3, P63, DOI 10.1068/p030063; REGAN D, 1993, VISION RES, V33, P447, DOI 10.1016/0042-6989(93)90252-R; RIND FC, 1992, J NEUROPHYSIOL, V68, P1654, DOI 10.1152/jn.1992.68.5.1654; ROBERTSON RM, 1993, NATURWISSENSCHAFTEN, V80, P176, DOI 10.1007/BF01226378; ROY JP, 1990, NATURE, V348, P160, DOI 10.1038/348160a0; SCHIFF W, 1965, PSYCHOL MONOGR, V79, P1, DOI 10.1037/h0093887; SCHIFF W, 1962, SCIENCE, V136, P982, DOI 10.1126/science.136.3520.982; SIMMONS PJ, 1992, J NEUROPHYSIOL, V68, P1667, DOI 10.1152/jn.1992.68.5.1667; SUN HJ, 1992, EXP BRAIN RES, V91, P171; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; TRESILIAN JR, 1993, PERCEPTION, V22, P653, DOI 10.1068/p220653; TRONICK E, 1967, J COMP PHYSIOL PSYCH, V64, P529, DOI 10.1037/h0025206; WAGNER H, 1982, NATURE, V297, P147, DOI 10.1038/297147a0; WANG YC, 1993, VISUAL NEUROSCI, V10, P21, DOI 10.1017/S0952523800003199; WANG YC, 1992, NATURE, V356, P236, DOI 10.1038/356236a0; Wann JP, 1996, J EXP PSYCHOL HUMAN, V22, P1031, DOI 10.1037/0096-1523.22.4.1031; WYLIE DR, 1993, J NEUROPHYSIOL, V70, P2632, DOI 10.1152/jn.1993.70.6.2632	33	278	282	0	30	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1998	1	4					296	303		10.1038/1110	http://dx.doi.org/10.1038/1110			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QD	10195163				2022-12-17	WOS:000076361300013
J	Hawrylycz, M; Miller, JA; Menon, V; Feng, D; Dolbeare, T; Guillozet-Bongaarts, AL; Jegga, AG; Aronow, BJ; Lee, CK; Bernard, A; Glasser, MF; Dierker, DL; Menche, J; Szafer, A; Collman, F; Grange, P; Berman, KA; Mihalas, S; Yao, ZZ; Stewart, L; Barabasi, AL; Schulkin, J; Phillips, J; Ng, L; Dang, C; Haynor, DR; Jones, A; Van Essen, DC; Koch, C; Lein, E				Hawrylycz, Michael; Miller, Jeremy A.; Menon, Vilas; Feng, David; Dolbeare, Tim; Guillozet-Bongaarts, Angela L.; Jegga, Anil G.; Aronow, Bruce J.; Lee, Chang-Kyu; Bernard, Amy; Glasser, Matthew F.; Dierker, Donna L.; Menche, Joerg; Szafer, Aaron; Collman, Forrest; Grange, Pascal; Berman, Kenneth A.; Mihalas, Stefan; Yao, Zizhen; Stewart, Lance; Barabasi, Albert-Laszlo; Schulkin, Jay; Phillips, John; Ng, Lydia; Chinh Dang; Haynor, David R.; Jones, Allan; Van Essen, David C.; Koch, Christof; Lein, Ed			Canonical genetic signatures of the adult human brain	NATURE NEUROSCIENCE			English	Article							HUMAN CONNECTOME PROJECT; GENOME-WIDE ASSOCIATION; NETWORK ANALYSIS; MOUSE-BRAIN; FUNCTIONAL CONNECTIVITY; EXPRESSION PATTERNS; ALZHEIMERS-DISEASE; TRANSCRIPTOME; ORGANIZATION; GENERATION	The structure and function of the human brain are highly stereotyped, implying a conserved molecular program responsible for its development, cellular structure and function. We applied a correlation-based metric called differential stability to assess reproducibility of gene expression patterning across 132 structures in six individual brains, revealing mesoscale genetic organization. The genes with the highest differential stability are highly biologically relevant, with enrichment for brain-related annotations, disease associations, drug targets and literature citations. Using genes with high differential stability, we identified 32 anatomically diverse and reproducible gene expression signatures, which represent distinct cell types, intracellular components and/or associations with neurodevelopmental and neurodegenerative disorders. Genes in neuron-associated compared to non-neuronal networks showed higher preservation between human and mouse; however, many diversely patterned genes displayed marked shifts in regulation between species. Finally, highly consistent transcriptional architecture in neocortex is correlated with resting state functional connectivity, suggesting a link between conserved gene expression and functionally relevant circuitry.	[Hawrylycz, Michael; Miller, Jeremy A.; Menon, Vilas; Feng, David; Dolbeare, Tim; Guillozet-Bongaarts, Angela L.; Lee, Chang-Kyu; Bernard, Amy; Szafer, Aaron; Collman, Forrest; Mihalas, Stefan; Yao, Zizhen; Phillips, John; Ng, Lydia; Chinh Dang; Jones, Allan; Koch, Christof; Lein, Ed] Allen Inst Brain Sci, Seattle, WA USA; [Jegga, Anil G.; Aronow, Bruce J.] Cincinnati Childrens Hosp & Med Ctr, Div Biomed Informat, Cincinnati, OH USA; [Glasser, Matthew F.; Dierker, Donna L.; Van Essen, David C.] Washington Univ, Dept Anat & Neurobiol, St Louis, MO USA; [Menche, Joerg; Barabasi, Albert-Laszlo] Northeastern Univ, Ctr Complex Networks Res, Boston, MA 02115 USA; [Menche, Joerg; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Menche, Joerg; Barabasi, Albert-Laszlo] Cent European Univ, Ctr Network Sci, Budapest, Hungary; [Grange, Pascal] Xian Jiaotong Liverpool Univ, Dept Math Sci, Suzhou, Jiangsu, Peoples R China; [Berman, Kenneth A.] Univ Cincinnati, Dept Elect Engn & Comp Syst, Cincinnati, OH USA; [Stewart, Lance] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Barabasi, Albert-Laszlo] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Schulkin, Jay] Georgetown Univ, Dept Neurosci, Washington, DC USA; [Haynor, David R.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA	Allen Institute for Brain Science; Cincinnati Children's Hospital Medical Center; Washington University (WUSTL); Northeastern University; Northeastern University; Central European University; Xi'an Jiaotong-Liverpool University; University System of Ohio; University of Cincinnati; University of Washington; University of Washington Seattle; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Georgetown University; University of Washington; University of Washington Seattle	Hawrylycz, M (corresponding author), Allen Inst Brain Sci, Seattle, WA USA.	mikeh@alleninstitute.org; edl@alleninstitute.org	Menon, Vilas/AAG-4109-2021; Glasser, Matthew F./AAE-7291-2019; Menche, Jörg/G-3994-2015; Jegga, Anil/H-6140-2011; Grange, Pascal/I-9950-2016; Van Essen, David/ABA-8888-2020; Barabasi, Albert-Laszlo/S-6474-2017; Menche, Jörg/AAB-7008-2021	Menon, Vilas/0000-0002-4096-8601; Menche, Jörg/0000-0002-1583-6404; Jegga, Anil/0000-0002-4881-7752; Grange, Pascal/0000-0002-9621-1990; Menche, Jörg/0000-0002-1583-6404; HALDER, Rashi/0000-0002-1402-1254; Collman, Forrest/0000-0002-0280-7022; Feng, David/0000-0002-4920-8123; Koch, Christof/0000-0001-6482-8067; Bernard, Amy/0000-0003-2540-1153; Barabasi, Albert/0000-0002-4028-3522	Allen Institute for Brain Science; US National Institute of Drug Abuse [4R33DA027644]; D. Wall of Stanford University School of Medicine; NIH Blueprint for Neuroscience Research [1U54MH091657]; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA027644] Funding Source: NIH RePORTER	Allen Institute for Brain Science; US National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); D. Wall of Stanford University School of Medicine; NIH Blueprint for Neuroscience Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank the Allen Institute for Brain Science founders, Paul G. Allen and Jody Allen, for their vision, encouragement and support. Research was supported by the Allen Institute for Brain Science. We also gratefully acknowledge support from the US National Institute of Drug Abuse, grant 4R33DA027644; D. Wall of Stanford University School of Medicine; and 1U54MH091657 (NIH Blueprint for Neuroscience Research).	Bernard A, 2012, NEURON, V73, P1083, DOI 10.1016/j.neuron.2012.03.002; Bray NJ, 2002, GENES BRAIN BEHAV, V1, P187, DOI 10.1034/j.1601-183X.2002.10307.x; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Bacco F, 2012, CANCER RES, V72, P4537, DOI 10.1158/0008-5472.CAN-11-3490; French Leon, 2011, Front Neuroinform, V5, P12, DOI 10.3389/fninf.2011.00012; French L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001049; Geschwind DH, 2009, NATURE, V461, P908, DOI 10.1038/nature08537; Gratacos M, 2009, AM J MED GENET B, V150B, P808, DOI 10.1002/ajmg.b.30902; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hanashima C, 2007, J NEUROSCI, V27, P11103, DOI 10.1523/JNEUROSCI.1066-07.2007; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hosokawa M, 2003, GLIA, V42, P417, DOI 10.1002/glia.10234; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Konopka G, 2012, NEURON, V75, P601, DOI 10.1016/j.neuron.2012.05.034; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Manolio TA, 2009, ANNU REV MED, V60, P443, DOI 10.1146/annurev.med.60.061907.093117; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Morris JA, 2010, P NATL ACAD SCI USA, V107, P19049, DOI 10.1073/pnas.1003732107; Nelson TH, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-56; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Pinheiro AP, 2010, AM J MED GENET B, V153B, P1070, DOI 10.1002/ajmg.b.31082; Ponomarev I, 2012, J NEUROSCI, V32, P1884, DOI 10.1523/JNEUROSCI.3136-11.2012; Richiardi J, 2015, SCIENCE, V348, P1241, DOI 10.1126/science.1255905; Rosenmann H, 2003, NEUROSCI LETT, V336, P101, DOI 10.1016/S0304-3940(02)01218-1; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Shaw GTW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029314; Siegenthaler JA, 2008, DEV BIOL, V313, P35, DOI 10.1016/j.ydbio.2007.09.036; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Walker DG, 2008, MICROVASC RES, V75, P411, DOI 10.1016/j.mvr.2007.10.004; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	44	277	278	6	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2015	18	12					1832	1844		10.1038/nn.4171	http://dx.doi.org/10.1038/nn.4171			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX1LV	26571460	Green Submitted, Green Accepted			2022-12-17	WOS:000365458600022
J	Hunt, LT; Kolling, N; Soltani, A; Woolrich, MW; Rushworth, MFS; Behrens, TEJ				Hunt, Laurence T.; Kolling, Nils; Soltani, Alireza; Woolrich, Mark W.; Rushworth, Matthew F. S.; Behrens, Timothy E. J.			Mechanisms underlying cortical activity during value-guided choice	NATURE NEUROSCIENCE			English	Article							NEURAL REPRESENTATION; PREFRONTAL CORTEX; DECISION-MAKING; PARIETAL CORTEX; WORKING-MEMORY; NEUROBIOLOGY; TIME; CINGULATE; BEHAVIOR; DORSAL	When choosing between two options, correlates of their value are represented in neural activity throughout the brain. Whether these representations reflect activity that is fundamental to the computational process of value comparison, as opposed to other computations covarying with value, is unknown. We investigated activity in a biophysically plausible network model that transforms inputs relating to value into categorical choices. A set of characteristic time-varying signals emerged that reflect value comparison. We tested these model predictions using magnetoencephalography data recorded from human subjects performing value-guided decisions. Parietal and prefrontal signals matched closely with model predictions. These results provide a mechanistic explanation of neural signals recorded during value-guided choice and a means of distinguishing computational roles of different cortical regions whose activity covaries with value.	[Hunt, Laurence T.; Kolling, Nils; Rushworth, Matthew F. S.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Hunt, Laurence T.; Woolrich, Mark W.; Rushworth, Matthew F. S.; Behrens, Timothy E. J.] Univ Oxford, John Radcliffe Hosp, FMRIB Ctr, Oxford OX3 9DU, England; [Soltani, Alireza] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Soltani, Alireza] Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; [Woolrich, Mark W.] Warneford Hosp, Univ Dept Psychiat, Oxford Ctr Human Brain Activ OHBA, Oxford OX3 7JX, England; [Behrens, Timothy E. J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England	University of Oxford; University of Oxford; Howard Hughes Medical Institute; Stanford University; Stanford University; University of Oxford; University of London; University College London	Hunt, LT (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	lhunt@fmrib.ox.ac.uk; behrens@fmrib.ox.ac.uk	Hunt, Laurence/ABA-1691-2021	Hunt, Laurence/0000-0002-8393-8533; Rushworth, Matthew/0000-0002-5578-9884; Behrens, Timothy/0000-0003-0048-1177; Woolrich, Mark/0000-0001-8460-8854; Soltani, Alireza/0000-0003-4386-8486; Kolling, Nils/0000-0002-0283-6966	Wellcome Trust [WT088312, WT080540]; Consortium Of Neuroimagers for Non-invasive Exploration of Brain Connectivity and Tracts (CONNECT); UK Medical Research Council; UK Engineering and Physical Sciences Research Council; European Commission [238292]; MRC [G0700399, G0902373] Funding Source: UKRI; Medical Research Council [G0700399, G0902373] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Consortium Of Neuroimagers for Non-invasive Exploration of Brain Connectivity and Tracts (CONNECT); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank V. Litvak and G. Barnes for many helpful discussions, C. Stagg and K. Friston for comments on the manuscript, T. Nichols for assistance implementing four-dimensional cluster-based permutation testing, and S. Braeutigam and A. Rao for help with data collection. This work was supported by the Wellcome Trust (L. T. H., N.K., M. W. W. and T.E.J.B., grant reference numbers WT088312 and WT080540), the Consortium Of Neuroimagers for Non-invasive Exploration of Brain Connectivity and Tracts (CONNECT; L. T. H. and T.E.J.B.), the UK Medical Research Council (M. F. S. R.) and the UK Engineering and Physical Sciences Research Council (M. W. W.). The project CONNECT acknowledges the financial support of the Future and Emerging Technologies (FET) program in the Seventh Framework Program for Research of the European Commission, under FET-Open grant number 238292.	Basten U, 2010, P NATL ACAD SCI USA, V107, P21767, DOI 10.1073/pnas.0908104107; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; Blair K, 2006, J NEUROSCI, V26, P11379, DOI 10.1523/JNEUROSCI.1640-06.2006; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Cai XY, 2011, NEURON, V69, P170, DOI 10.1016/j.neuron.2010.11.041; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Fellows LK, 2006, BRAIN, V129, P944, DOI 10.1093/brain/awl017; Gershman SJ, 2009, J NEUROSCI, V29, P13524, DOI 10.1523/JNEUROSCI.2469-09.2009; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hillebrand A, 2002, NEUROIMAGE, V16, P638, DOI 10.1006/nimg.2002.1102; Hsu M, 2009, J NEUROSCI, V29, P2231, DOI 10.1523/JNEUROSCI.5296-08.2009; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Kiebel SJ, 2009, HUM BRAIN MAPP, V30, P1866, DOI 10.1002/hbm.20775; Kim S, 2011, BIOL PSYCHIAT, V69, P1140, DOI 10.1016/j.biopsych.2010.07.005; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Marinkovic K, 2004, Neurol Clin Neurophysiol, V2004, P30; Mars RB, 2011, J NEUROSCI, V31, P4087, DOI 10.1523/JNEUROSCI.5102-10.2011; Meltzer JA, 2008, CEREB CORTEX, V18, P1843, DOI 10.1093/cercor/bhm213; Milosavljevic M, 2010, JUDGM DECIS MAK, V5, P437; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Noonan MP, 2010, P NATL ACAD SCI USA, V107, P20547, DOI 10.1073/pnas.1012246107; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rolls ET, 2010, NEUROIMAGE, V53, P694, DOI 10.1016/j.neuroimage.2010.06.073; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Scheperjans F, 2008, CEREB CORTEX, V18, P846, DOI 10.1093/cercor/bhm116; Serences JT, 2008, NEURON, V60, P1169, DOI 10.1016/j.neuron.2008.10.051; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Sigman M, 2005, PLOS BIOL, V3, P334, DOI 10.1371/journal.pbio.0030037; Soltani A, 2006, J NEUROSCI, V26, P3731, DOI 10.1523/JNEUROSCI.5159-05.2006; Stephens D.W., 1986, pi; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Wong KF, 2007, FRONT COMPUT NEUROSC, V1, DOI 10.3389/neuro.10.006.2007	50	277	278	3	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					470	U169		10.1038/nn.3017	http://dx.doi.org/10.1038/nn.3017			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	899CY	22231429	Green Accepted			2022-12-17	WOS:000300793100022
J	Sanchez-Mejia, RO; Newman, JW; Toh, S; Yu, GQ; Zhou, YU; Halabisky, B; Cisse, M; Scearce-Levie, K; Cheng, IH; Gan, L; Palop, JJ; Bonventre, JV; Mucke, L				Sanchez-Mejia, Rene O.; Newman, John W.; Toh, Sandy; Yu, Gui-Qiu; Zhou, Yungui; Halabisky, Brian; Cisse, Moustapha; Scearce-Levie, Kimberly; Cheng, Irene H.; Gan, Li; Palop, Jorge J.; Bonventre, Joseph V.; Mucke, Lennart			Phospholipase A(2) reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease	NATURE NEUROSCIENCE			English	Article							AMPA RECEPTOR SUBUNITS; HIPPOCAMPAL; INVOLVEMENT; TRAFFICKING; NEURONS; BRAIN; TRANSMISSION; MECHANISMS; OLIGOMERS; CERAMIDE	Neuronal expression of familial Alzheimer's disease-mutant human amyloid precursor protein (hAPP) and hAPP-derived amyloid-beta (A beta) peptides causes synaptic dysfunction, inflammation and abnormal cerebrovascular tone in transgenic mice. Fatty acids may be involved in these processes, but their contribution to Alzheimer's disease pathogenesis is uncertain. We used a lipidomics approach to generate a broad profile of fatty acids in brain tissues of hAPP-expressing mice and found an increase in arachidonic acid and its metabolites, suggesting increased activity of the group IV isoform of phospholipase A(2) (GIVA-PLA(2)). The levels of activated GIVA-PLA(2) in the hippocampus were increased in individuals with Alzheimer's disease and in hAPP mice. A beta caused a dose-dependent increase in GIVA-PLA(2) phosphorylation in neuronal cultures. Inhibition of GIVA-PLA(2) diminished A beta-induced neurotoxicity. Genetic ablation or reduction of GIVA-PLA(2) protected hAPP mice against A beta-dependent deficits in learning and memory, behavioral alterations and premature mortality. Inhibition of GIVA-PLA(2) may be beneficial in the treatment and prevention of Alzheimer's disease.	[Sanchez-Mejia, Rene O.; Toh, Sandy; Yu, Gui-Qiu; Zhou, Yungui; Halabisky, Brian; Cisse, Moustapha; Scearce-Levie, Kimberly; Cheng, Irene H.; Gan, Li; Palop, Jorge J.; Mucke, Lennart] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Sanchez-Mejia, Rene O.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Newman, John W.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Newman, John W.] USDA, Western Human Nutr Res Ctr, Davis, CA 95616 USA; [Toh, Sandy; Mucke, Lennart] Univ Calif San Francisco, Neurosci Grad Training Program, San Francisco, CA 94143 USA; [Bonventre, Joseph V.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Mucke, Lennart] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California Davis; United States Department of Agriculture (USDA); University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California San Francisco	Mucke, L (corresponding author), Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	rene_sanchez@post.harvard.edu; lmucke@gladstone.ucsf.edu	CISSE, Moustapha/AAM-1022-2021; Palop, Jorge/AAH-9014-2020; Palop, Jorge J./D-8128-2011	CISSE, Moustapha/0000-0003-3890-9183; Palop, Jorge/0000-0001-6086-1070; Newman, John/0000-0001-9632-6571	US National Institutes of Health (NIH) [AG011385, AG022074, NS041787, AG028233]; US NIH/National Center for Research Resources [CO6RR018928]; US Department of Agriculture Agricultural Research Service [5306-51530-016-00D]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [DK 054741]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054741, R56DK054741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG011385, R21AG024447, F32AG028233, P01AG022074, R01AG011385] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Alzheimer's Disease Research Center at University of California San Francisco for postmortem brain tissues; T. Wu, A. Thwin and H. Solanoy for technical support; C. McCulloch for help with statistical analysis; G. Howard and S. Ordway for editorial review; J. Carroll and C. Goodfellow for preparation of graphics; and D. McPherson for administrative assistance. The study was supported by US National Institutes of Health (NIH) grants AG011385, AG022074 and NS041787 to L. M., AG028233 to R.O.S.-M. and US NIH/National Center for Research Resources grant CO6RR018928 to the J. David Gladstone Institutes. Additional support was provided by the US Department of Agriculture Agricultural Research Service 5306-51530-016-00D to J.W.N. and from the NIH National Institute of Diabetes and Digestive and Kidney Diseases DK 054741 to J. V. B.	Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Blanchard BJ, 2002, BIOCHEM BIOPH RES CO, V293, P1197, DOI 10.1016/S0006-291X(02)00346-7; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Brady KM, 2006, EUR J NEUROSCI, V24, P3381, DOI 10.1111/j.1460-9568.2006.05237.x; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BRORSON JR, 1995, J NEUROBIOL, V26, P325, DOI 10.1002/neu.480260305; Carter TL, 2004, EXP NEUROL, V187, P299, DOI 10.1016/j.expneurol.2003.12.010; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gattaz WF, 1996, EUR ARCH PSY CLIN N, V246, P129, DOI 10.1007/BF02189113; Gaudreault SB, 2004, J BIOL CHEM, V279, P356, DOI 10.1074/jbc.M304777200; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hwang DY, 2002, FASEB J, V16, DOI 10.1096/fj.01-0732com; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kishimoto K, 1999, NEUROSCIENCE, V92, P1061, DOI 10.1016/S0306-4522(99)00051-2; Kriem B, 2004, FASEB J, V18, P85, DOI 10.1096/fj.04-1807fje; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; Malaplate-Armand C, 2006, NEUROBIOL DIS, V23, P178, DOI 10.1016/j.nbd.2006.02.010; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mark RJ, 1997, J NEUROSCI, V17, P1046; Meilandt WJ, 2008, J NEUROSCI, V28, P5007, DOI 10.1523/JNEUROSCI.0590-08.2008; Menard C, 2005, NEUROSCI LETT, V389, P51, DOI 10.1016/j.neulet.2005.07.012; MILLER B, 1992, NATURE, V355, P722, DOI 10.1038/355722a0; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Prasad MR, 1998, NEUROCHEM RES, V23, P81, DOI 10.1023/A:1022457605436; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Rui YF, 2006, J NEUROSCI, V26, P10480, DOI 10.1523/JNEUROSCI.3231-06.2006; Sandhya TL, 1998, BRAIN RES, V788, P223, DOI 10.1016/S0006-8993(97)01552-7; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Stephenson D, 1999, GLIA, V27, P110, DOI 10.1002/(SICI)1098-1136(199908)27:2<110::AID-GLIA2>3.0.CO;2-C; Ting JT, 2007, P NATL ACAD SCI USA, V104, P353, DOI 10.1073/pnas.0608807104; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0; Yoshikawa K, 2006, J BIOL CHEM, V281, P14663, DOI 10.1074/jbc.M511089200; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	50	277	281	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2008	11	11					1311	1318		10.1038/nn.2213	http://dx.doi.org/10.1038/nn.2213			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	366HZ	18931664	Green Accepted			2022-12-17	WOS:000260472700020
J	Rouw, R; Scholte, HS				Rouw, Romke; Scholte, H. Steven			Increased structural connectivity in grapheme-color synesthesia	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; INDIVIDUAL-DIFFERENCES; VISUAL-PERCEPTION; SYNAESTHESIA; CORTEX; FMRI; ACTIVATION; MECHANISMS; CONSCIOUSNESS; IMAGES	Diffusion tensor imaging allowed us to validate for the first time the hypothesis that hyperconnectivity causes the added sensations in synesthesia. Grapheme- color synesthetes (n = 18), who experience specific colors with particular letters or numbers (for example, 'R is sky blue'), showed greater anisotropic diffusion compared with matched controls. Greater anisotropic diffusion indicates more coherent white matter. Anisotropy furthermore differentiated subtypes of grapheme-color synesthesia. Greater connectivity in the inferior temporal cortex was particularly strong for synesthetes who see synesthetic color in the outside world ('projectors') as compared with synesthetes who see the color in their 'mind's eye' only ('associators'). In contrast, greater connectivity (as compared with non-synesthetes) in the superior parietal or frontal cortex did not differentiate between subtypes of synesthesia. In conclusion, we found evidence that increased structural connectivity is associated with the presence of grapheme-color synesthesia, and has a role in the subjective nature of synesthetic color experience.	Univ Amsterdam, Dept Psychol, NL-1018 WB Amsterdam, Netherlands	University of Amsterdam	Rouw, R (corresponding author), Univ Amsterdam, Dept Psychol, Roetersstr 15, NL-1018 WB Amsterdam, Netherlands.	R.Rouw@uva.nl	Scholte, H.Steven/ABD-1737-2020	Scholte, H.Steven/0000-0002-9839-1788				BaronCohen S, 1996, PERCEPTION, V25, P1073, DOI 10.1068/p251073; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; DAY S, 2005, SYNESTHESIA PERSPECT, P11; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Dixon MJ, 2004, COGN AFFECT BEHAV NE, V4, P335, DOI 10.3758/CABN.4.3.335; Dixon MJ, 2005, NEURON, V45, P821, DOI 10.1016/j.neuron.2005.03.007; Duncan RO, 2003, NEURON, V38, P659, DOI 10.1016/S0896-6273(03)00265-4; Esterman M, 2006, J COGNITIVE NEUROSCI, V18, P1570, DOI 10.1162/jocn.2006.18.9.1570; Evans A. C., 1992, Society for Neuroscience Abstracts, V18, P408; FRIEDMANHILL SR, 1995, SCIENCE, V269, P853, DOI 10.1126/science.7638604; Grossenbacher PG, 2001, TRENDS COGN SCI, V5, P36, DOI 10.1016/S1364-6613(00)01571-0; Hubbard EM, 2005, NEURON, V48, P509, DOI 10.1016/j.neuron.2005.10.012; Hubbard EM, 2005, NEURON, V45, P975, DOI 10.1016/j.neuron.2005.02.008; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kleinschmidt A, 1998, P ROY SOC B-BIOL SCI, V265, P2427, DOI 10.1098/rspb.1998.0594; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; Mondloch CJ, 2004, COGN AFFECT BEHAV NE, V4, P133, DOI 10.3758/CABN.4.2.133; Muggleton N, 2007, NEUROPSYCHOLOGIA, V45, P1582, DOI 10.1016/j.neuropsychologia.2006.11.021; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nunn JA, 2002, NAT NEUROSCI, V5, P371, DOI 10.1038/nn818; PAULESU E, 1995, BRAIN, V118, P661, DOI 10.1093/brain/118.3.661; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Smilek D, 2001, J COGNITIVE NEUROSCI, V13, P930, DOI 10.1162/089892901753165845; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sperling JM, 2006, CORTEX, V42, P295, DOI 10.1016/S0010-9452(08)70355-1; WARD J, 2006, CORTEX, V42; Weiss PH, 2005, NEUROIMAGE, V28, P859, DOI 10.1016/j.neuroimage.2005.06.052; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	45	277	282	9	191	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					792	797		10.1038/nn1906	http://dx.doi.org/10.1038/nn1906			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17515901				2022-12-17	WOS:000246799800023
J	Persaud, N; McLeod, P; Cowey, A				Persaud, Navindra; McLeod, Peter; Cowey, Alan			Post-decision wagering objectively measures awareness	NATURE NEUROSCIENCE			English	Article							UNCONSCIOUS KNOWLEDGE; VISUAL SENSITIVITY; CORTEX; DAMAGE	The lack of an accepted measure of awareness has made claims that accurate decisions can be made without awareness controversial. Here we introduce a new objective measure of awareness, post- decision wagering. We show that participants fail to maximize cash earnings by wagering high following correct decisions in blindsight, the Iowa gambling task and an artificial grammar task. This demonstrates, without the uncertainties associated with the conventional subjective measures of awareness ( verbal reports and confidence ratings), that the participants were not aware that their decisions were correct. Post- decision wagering may be used to study the neural correlates of consciousness.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Persaud, N (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	nav.persaud@utoronto.ca			Medical Research Council [G0601975] Funding Source: Medline; MRC [G0601975] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BARBUR JL, 1980, BRAIN, V103, P905, DOI 10.1093/brain/103.4.905; BARBUR JL, 1994, PHILOS T R SOC B, V343, P157, DOI 10.1098/rstb.1994.0018; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; BLYTHE IM, 1986, NATURE, V320, P619, DOI 10.1038/320619a0; Cleeremans A, 1998, TRENDS COGN SCI, V2, P406, DOI 10.1016/S1364-6613(98)01232-7; Cowey A, 2005, PHILOS T R SOC B, V360, P1185, DOI 10.1098/rstb.2005.1658; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; Damasio A.R., 1994, DESCARTES ERROR EMOT; Dienes Z, 2005, PSYCHOL RES-PSYCH FO, V69, P338, DOI 10.1007/s00426-004-0208-3; DIENES Z, 1995, J EXP PSYCHOL LEARN, V21, P1322, DOI 10.1037/0278-7393.21.5.1322; King SM, 1996, VISUAL NEUROSCI, V13, P1, DOI 10.1017/S0952523800007082; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; REBER AS, 1969, J EXP PSYCHOL, V81, P115, DOI 10.1037/h0027454; SHANKS DR, 1994, BEHAV BRAIN SCI, V17, P367, DOI 10.1017/S0140525X00035032; Stoerig P, 2002, CEREB CORTEX, V12, P565, DOI 10.1093/cercor/12.6.565; Tunney RJ, 2003, MEM COGNITION, V31, P1060, DOI 10.3758/BF03196127; WEISKRANTZ L, 1991, BRAIN, V114, P2269, DOI 10.1093/brain/114.5.2269	18	277	281	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					257	261		10.1038/nn1840	http://dx.doi.org/10.1038/nn1840			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	135TB	17237774				2022-12-17	WOS:000244175200021
J	Murray, SO; Boyaci, H; Kersten, D				Murray, SO; Boyaci, H; Kersten, D			The representation of perceived angular size in human primary visual cortex	NATURE NEUROSCIENCE			English	Article							MOON ILLUSION; SPATIAL SUMMATION; RECEPTIVE-FIELDS; FUNCTIONAL MRI; DISTANCE; MODULATION; RETINOTOPY; PERCEPTION; VISION; SYSTEM	Two objects that project the same visual angle on the retina can appear to occupy very different proportions of the visual field if they are perceived to be at different distances. What happens to the retinotopic map in primary visual cortex (V1) during the perception of these size illusions? Here we show, using functional magnetic resonance imaging (fMRI), that the retinotopic representation of an object changes in accordance with its perceived angular size. A distant object that appears to occupy a larger portion of the visual field activates a larger area in V1 than an object of equal angular size that is perceived to be closer and smaller. These results demonstrate that the retinal size of an object and the depth information in a scene are combined early in the human visual system.	Univ Washington, Dept Psychol, Seattle, WA 98195 USA; Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities	Murray, SO (corresponding author), Univ Washington, Dept Psychol, Box 351525, Seattle, WA 98195 USA.	somurray@u.washington.edu	Boyaci, Huseyin/ABI-5769-2020	Boyaci, Huseyin/0000-0003-3168-0654	NATIONAL EYE INSTITUTE [R01EY015261, F32EY015342] Funding Source: NIH RePORTER; NEI NIH HHS [F32 EY015342, R01 EY-015261] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDERSON CH, 1987, P NATL ACAD SCI USA, V84, P6297, DOI 10.1073/pnas.84.17.6297; BARLOW HB, 1958, J PHYSIOL-LONDON, V141, P337, DOI 10.1113/jphysiol.1958.sp005978; Dobbins AC, 1998, SCIENCE, V281, P552, DOI 10.1126/science.281.5376.552; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; FOLEY JM, 1972, VISION RES, V12, P323, DOI 10.1016/0042-6989(72)90121-6; GILINSKY A S, 1955, Am J Psychol, V68, P173; Holway AH, 1941, AM J PSYCHOL, V54, P21, DOI 10.2307/1417790; JENKIN N, 1959, AM J PSYCHOL, V72, P68, DOI 10.2307/1420212; Joynson RB, 1949, Q J EXP PSYCHOL, V1, P119; KAUFMAN L, 1962, SCIENCE, V136, P953, DOI 10.1126/science.136.3520.953; Kaufman L, 2000, P NATL ACAD SCI USA, V97, P500, DOI 10.1073/pnas.97.1.500; KERSTEN D, 1984, VISION RES, V24, P1977, DOI 10.1016/0042-6989(84)90033-6; KING WL, 1962, SCIENCE, V135, P1125, DOI 10.1126/science.135.3509.1125; LARSON GW, 1996, RENDERING RADIANCE A; LEIBOWITZ H, 1969, SCIENCE, V166, P1174, DOI 10.1126/science.166.3909.1174; MARG E, 1970, EXPERIENTIA, V26, P270, DOI 10.1007/BF01900088; MCCREADY D, 1985, PERCEPT PSYCHOPHYS, V37, P323, DOI 10.3758/BF03211355; ONO H, 1966, AM J PSYCHOL, V79, P234, DOI 10.2307/1421129; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; RICHARDS W, 1968, KYBERNETIK, V4, P146, DOI 10.1007/BF00288548; RICHARDS W, 1967, NEUROPSYCHOLOGIA, V5, P63, DOI 10.1016/0028-3932(67)90051-6; ROCK I, 1962, SCIENCE, V136, P1023, DOI 10.1126/science.136.3521.1023; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TROTTER Y, 1992, SCIENCE, V257, P1279, DOI 10.1126/science.1519066; Whitney D, 2003, SCIENCE, V302, P878, DOI 10.1126/science.1087839	27	277	282	6	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					429	434		10.1038/nn1641	http://dx.doi.org/10.1038/nn1641			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16462737				2022-12-17	WOS:000235645600023
J	De Martino, B; Fleming, SM; Garrett, N; Dolan, RJ				De Martino, Benedetto; Fleming, Stephen M.; Garrett, Neil; Dolan, Raymond J.			Confidence in value-based choice	NATURE NEUROSCIENCE			English	Article							DECISION-MAKING; ORBITOFRONTAL CORTEX; FRONTOPOLAR CORTEX; FREE-ENERGY; BRAIN; COMPUTATION; PERFORMANCE; UNCERTAINTY; VALUATION; TASKS	Decisions are never perfect, with confidence in one's choices fluctuating over time. How subjective confidence and valuation of choice options interact at the level of brain and behavior is unknown. Using a dynamic model of the decision process, we show that confidence reflects the evolution of a decision variable over time, explaining the observed relation between confidence, value, accuracy and reaction time. As predicted by our dynamic model, we show that a functional magnetic resonance imaging signal in human ventromedial prefrontal cortex (vmPFC) reflects both value comparison and confidence in the value comparison process. Crucially, individuals varied in how they related confidence to accuracy, allowing us to show that this introspective ability is predicted by a measure of functional connectivity between vmPFC and rostrolateral prefrontal cortex. Our findings provide a mechanistic link between noise in value comparison and metacognitive awareness of choice, enabling us both to want and to express knowledge of what we want.	[De Martino, Benedetto; Fleming, Stephen M.; Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [De Martino, Benedetto] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Fleming, Stephen M.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Fleming, Stephen M.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of London; University College London; California Institute of Technology; New York University; University of Oxford	De Martino, B (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.	b.martino@ucl.ac.uk; fleming.sm@gmail.com		Fleming, Stephen/0000-0003-0233-4891; De Martino, Benedetto/0000-0002-3555-2732; Garrett, Neil/0000-0003-1440-472X; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust [098362/Z/12/Z, 091593/Z/10/Z]; Sir Henry Wellcome Fellowships [082674/Z/07/Z, WT096185]	Wellcome Trust(Wellcome TrustEuropean Commission); Sir Henry Wellcome Fellowships	We thank T. Fitzgerald, D. Kumaran and T. Sharot for comments on a previous draft of this manuscript, and T. Behrens and N. Daw for discussions. This work was supported by a Wellcome Trust Senior Investigator Award, 098362/Z/12/Z to R.J.D.; S. M. F. and B. D. M. are supported by Sir Henry Wellcome Fellowships (B. D. M., 082674/Z/07/Z; S. M. F., WT096185). The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust, 091593/Z/10/Z.	Bahrami B, 2010, SCIENCE, V329, P1081, DOI 10.1126/science.1185718; Basten U, 2010, P NATL ACAD SCI USA, V107, P21767, DOI 10.1073/pnas.0908104107; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; De Martino B, 2009, J NEUROSCI, V29, P3833, DOI 10.1523/JNEUROSCI.4832-08.2009; Feldman H, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00215; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Fleming SM, 2012, J NEUROSCI, V32, P6117, DOI 10.1523/JNEUROSCI.6489-11.2012; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Glascher J, 2009, NEUROINFORMATICS, V7, P73, DOI 10.1007/s12021-008-9042-x; Glimcher PW, 2005, ANNU REV PSYCHOL, V56, P25, DOI 10.1146/annurev.psych.55.090902.141429; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hunt LT, 2012, NAT NEUROSCI, V15, P470, DOI 10.1038/nn.3017; Insabato A, 2010, J NEUROPHYSIOL, V104, P539, DOI 10.1152/jn.01068.2009; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kepecs A, 2012, PHILOS T R SOC B, V367, P1322, DOI 10.1098/rstb.2012.0037; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Lau H, 2011, TRENDS COGN SCI, V15, P365, DOI 10.1016/j.tics.2011.05.009; Maniscalco B., 2010, J VIS, V10, P213, DOI DOI 10.1167/10.7.213; Pasquali A, 2010, COGNITION, V117, P182, DOI 10.1016/j.cognition.2010.08.010; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Pleskac TJ, 2010, PSYCHOL REV, V117, P864, DOI 10.1037/a0019737; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; Rolls ET, 2010, NEUROIMAGE, V53, P694, DOI 10.1016/j.neuroimage.2010.06.073; Smith DV, 2010, J NEUROSCI, V30, P2490, DOI 10.1523/JNEUROSCI.3319-09.2010; Song C, 2011, CONSCIOUS COGN, V20, P1787, DOI 10.1016/j.concog.2010.12.011; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Summerfield C, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00070; VICKERS D, 1970, Ergonomics, V13, P37, DOI 10.1080/00140137008931117; Vickers D., 1979, DECISION PROCESSES V; Yokoyama O, 2010, NEUROSCI RES, V68, P199, DOI 10.1016/j.neures.2010.07.2041	37	276	276	3	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					105	U147		10.1038/nn.3279	http://dx.doi.org/10.1038/nn.3279			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	058KZ	23222911	Green Accepted, Green Published			2022-12-17	WOS:000312633900019
J	Northoff, G; Walter, M; Schulte, RF; Beck, J; Dydak, U; Henning, A; Boeker, H; Grimm, S; Boesiger, P				Northoff, Georg; Walter, Martin; Schulte, Rolf F.; Beck, Johannes; Dydak, Ulrike; Henning, Anke; Boeker, Heinz; Grimm, Simone; Boesiger, Peter			GABA concentrations in the human anterior cingulate cortex predict negative BOLD responses in fMRI	NATURE NEUROSCIENCE			English	Article							NEURONAL-ACTIVITY; FUNCTIONAL MRI; RESTING-STATE; MODULATION; BRAIN; ATTENUATION; ANXIETY; SIGNAL	The human anterior cingulate cortex (ACC) is part of the default-mode network that shows predominant negative blood oxygen level-dependent (BOLD) responses in functional magnetic resonance imaging (fMRI). We combined fMRI during emotional processing and resting-state magnetic resonance spectroscopy measurements and observed that the concentration of GABA in the ACC specifically correlated with the amount of negative BOLD responses in the very same region. Our findings show that default-mode network negative BOLD responses during emotions are mediated by GABA.	Univ Magdeburg, Dept Psychiat, D-39120 Magdeburg, Germany; Univ Zurich, ETH Zurich, Inst Biomed Engn, CH-8092 Zurich, Switzerland; Univ Zurich, Dept Psychiat, CH-8029 Zurich, Switzerland	Otto von Guericke University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich	Northoff, G (corresponding author), Univ Magdeburg, Dept Psychiat, Leipziger Str 44, D-39120 Magdeburg, Germany.	georg.northoff@medizin.uni-magdeburg.de		Henning, Anke/0000-0002-2267-4861; Walter, Martin/0000-0001-7857-4483				Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Northoff G, 2004, HUM BRAIN MAPP, V21, P202, DOI 10.1002/hbm.20002; Northoff G, 2002, J COGNITIVE NEUROSCI, V14, P348, DOI 10.1162/089892902317361895; Pasley BN, 2007, NEUROIMAGE, V36, P269, DOI 10.1016/j.neuroimage.2006.09.015; Raichle ME, 2005, J COMP NEUROL, V493, P167, DOI 10.1002/cne.20752; Schulte RF, 2006, NMR BIOMED, V19, P255, DOI 10.1002/nbm.1026; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193	15	276	280	2	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1515	1517		10.1038/nn2001	http://dx.doi.org/10.1038/nn2001			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17982452				2022-12-17	WOS:000251172900007
J	Brenner, R; Chen, QH; Vilaythong, A; Toney, GM; Noebels, JL; Aldrich, RW				Brenner, R; Chen, QH; Vilaythong, A; Toney, GM; Noebels, JL; Aldrich, RW			BK channel beta 4 subunit reduces dentate gyrus excitability and protects against temporal lobe seizures	NATURE NEUROSCIENCE			English	Article							ACTIVATED POTASSIUM CHANNEL; CA2+-ACTIVATED K+ CHANNELS; SPIKE FREQUENCY ADAPTATION; RAT LATERAL AMYGDALA; LARGE-CONDUCTANCE; GRANULE CELLS; PYRAMIDAL CELLS; MOSSY CELLS; NEURONS; INHIBITION	Synaptic inhibition within the hippocampus dentate gyrus serves a 'low-pass filtering' function that protects against hyperexcitability that leads to temporal lobe seizures. Here we demonstrate that calcium-activated potassium (BK) channel accessory beta 4 subunits serve as key regulators of intrinsic firing properties that contribute to the low-pass filtering function of dentate granule cells. Notably, a critical b4 subunit function is to preclude BK channels from contributing to membrane repolarization and thereby broaden action potentials. Longer-duration action potentials secondarily recruit SK channels, leading to greater spike frequency adaptation and reduced firing rates. In contrast, granule cells from beta 4 knockout mice show a gain-of-function for BK channels that sharpens action potentials and supports higher firing rates. Consistent with breakdown of the dentate filter, beta 4 knockouts show distinctive seizures emanating from the temporal cortex, demonstrating a unique nonsynaptic mechanism for gate control of hippocampal synchronization leading to temporal lobe epilepsy.	Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78229 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	University of Texas System; University of Texas Health San Antonio; Baylor College of Medicine; Howard Hughes Medical Institute; Stanford University	Brenner, R (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	brennerr@uthscsa.edu; raldrich@leland.stanford.edu		Noebels, Jeffrey/0000-0002-2887-0839; Brenner, Robert/0000-0002-1036-8031	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029709] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL071645] Funding Source: Medline; NICHD NIH HHS [HD24064] Funding Source: Medline; NINDS NIH HHS [NS29709] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; BIELEFELDT K, 1993, J NEUROPHYSIOL, V70, P284, DOI 10.1152/jn.1993.70.1.284; Blank T, 2004, CNS NEUROL DISORD-DR, V3, P161, DOI 10.2174/1568007043337472; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Buhl EH, 1996, SCIENCE, V271, P369, DOI 10.1126/science.271.5247.369; Coulter DA, 2000, EPILEPSIA, V41, pS96, DOI 10.1111/j.1528-1157.2000.tb01565.x; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Engel J, 1999, BIOPHYS J, V76, P1310, DOI 10.1016/S0006-3495(99)77293-0; Faber ESL, 2003, J PHYSIOL-LONDON, V552, P483, DOI 10.1113/jphysiol.2003.050120; Faber ESL, 2002, J NEUROSCI, V22, P1618, DOI 10.1523/JNEUROSCI.22-05-01618.2002; Garcia ML, 2001, TOXICON, V39, P739, DOI 10.1016/S0041-0101(00)00214-2; Greffrath W, 2004, J NEUROENDOCRINOL, V16, P577, DOI 10.1111/j.1365-2826.2004.01204.x; Ha TS, 2004, BIOPHYS J, V86, P2871, DOI 10.1016/S0006-3495(04)74339-8; HEINEMANN U, 1992, EPILEPSY RES, P273; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Jin W, 2000, BRAIN RES, V860, P21, DOI 10.1016/S0006-8993(00)01943-0; Juhng KN, 1999, EPILEPSY RES, V34, P177, DOI 10.1016/S0920-1211(98)00111-9; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kamal A, 2003, NEUROSCIENCE, V118, P577, DOI 10.1016/S0306-4522(02)00874-6; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Lau D, 2000, J NEUROSCI, V20, P9071; Lippiat JD, 2003, J MEMBRANE BIOL, V192, P141, DOI 10.1007/s00232-002-1070-0; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; MODY I, 1992, EPILEPSY RES, P159; Mori M, 2004, NATURE, V431, P453, DOI 10.1038/nature02854; MOTT DD, 1993, J NEUROPHYSIOL, V69, P674, DOI 10.1152/jn.1993.69.3.674; Moyer JR, 1998, J NEUROSCI METH, V86, P35, DOI 10.1016/S0165-0270(98)00143-5; Nadler JV, 2003, NEUROCHEM RES, V28, P1649, DOI 10.1023/A:1026004904199; Ratzliff ADH, 2002, TRENDS NEUROSCI, V25, P140, DOI 10.1016/S0166-2236(00)02122-6; REINHART PH, 1989, NEURON, V2, P1031, DOI 10.1016/0896-6273(89)90227-4; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Sanchez M, 1996, NEUROPHARMACOLOGY, V35, P963, DOI 10.1016/0028-3908(96)00137-2; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; Sloviter RS, 2003, J COMP NEUROL, V459, P44, DOI 10.1002/cne.10630; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Stocker M, 2004, TOXICON, V43, P933, DOI 10.1016/j.toxicon.2003.12.009; Strassle BW, 2005, J COMP NEUROL, V484, P144, DOI 10.1002/cne.20443; Swensen AM, 2003, J NEUROSCI, V23, P9650; Teshima K, 2003, NEUROSCIENCE, V120, P65, DOI 10.1016/S0306-4522(03)00270-7; Tian LJ, 1998, J BIOL CHEM, V273, P13531, DOI 10.1074/jbc.273.22.13531; WANG G, 1992, PFLUG ARCH EUR J PHY, V421, P558, DOI 10.1007/BF00375051; Weiger TM, 2000, J NEUROSCI, V20, P3563, DOI 10.1523/JNEUROSCI.20-10-03563.2000; Williamson PD, 1997, EPILEPSY COMPREHENSI, P557; Yen JC, 1999, J BIOMED SCI, V6, P418, DOI 10.1007/BF02253673	49	276	285	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1752	1759		10.1038/nn1573	http://dx.doi.org/10.1038/nn1573			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16261134				2022-12-17	WOS:000233576200025
J	Tomizawa, K; Iga, N; Lu, YF; Moriwaki, A; Matsushita, M; Li, ST; Miyamoto, O; Itano, T; Matsui, H				Tomizawa, K; Iga, N; Lu, YF; Moriwaki, A; Matsushita, M; Li, ST; Miyamoto, O; Itano, T; Matsui, H			Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade	NATURE NEUROSCIENCE			English	Article							RAT-BRAIN; SYNAPTIC PLASTICITY; TERM POTENTIATION; MATERNAL-BEHAVIOR; RECEPTOR GENE; ESTROUS-CYCLE; LATE-PHASE; EXPRESSION; MOUSE; TRANSCRIPTION	Oxytocin is an essential hormone for mammalian labor and lactation. Here, we show a new function of oxytocin in causing plastic changes in hippocampal synapses during motherhood. In oxytocin-perfused hippocampal slices, one-train tetanus stimulation induced long-lasting, long-term potentiation (L-LTP) and phosphorylation of cyclic AMP-responsive element binding protein (CREB), and MAP kinase inhibitors blocked these inductions. An increase in CREB phosphorylation and L-LTP induced by one-train tetanus were observed in the multiparous mouse hippocampus without oxytocin application. Furthermore, intracerebroventricular injection of oxytocin in virgin mice improved long-term spatial learning in vivo, whereas an injection of oxytocin antagonist in multiparous mice significantly inhibited the improved spatial memory, L-LTP and CREB phosphorylation. These findings indicate that oxytocin is critically involved in improving hippocampus-dependent learning and memory during motherhood in mice.	Okayama Univ, Grad Sch Med & Dent, Dept Physiol, Okayama 7008558, Japan; Kagawa Med Univ, Dept Biol, Kagawa 7610793, Japan; Japan Sci & Technol Corp, New Technoventure Oriented Res & Dev, Prot Therapy, Okayama 7008558, Japan	Okayama University; Kagawa University; Japan Science & Technology Agency (JST)	Tomizawa, K (corresponding author), Okayama Univ, Grad Sch Med & Dent, Dept Physiol, Shikata Cho 2-5-1, Okayama 7008558, Japan.		Tomizawa, Kazuhito/F-2405-2015	Tomizawa, Kazuhito/0000-0002-5663-2627; Li, Sheng Tian/0000-0002-2836-3802				ABLE T, 1997, CELL, V88, P615; ARGIOLAS A, 1991, NEUROSCI BIOBEHAV R, V15, P217, DOI 10.1016/S0149-7634(05)80002-8; BALE TL, 1995, ENDOCRINOLOGY, V136, P27, DOI 10.1210/en.136.1.27; Bale TL, 2001, J NEUROSCI, V21, P2546, DOI 10.1523/JNEUROSCI.21-07-02546.2001; BARNES CA, 1988, TRENDS NEUROSCI, V11, P163, DOI 10.1016/0166-2236(88)90143-9; Borroni AM, 2000, J NEUROSCI, V20, P9272; Breton C, 1997, ENDOCRINOLOGY, V138, P1857, DOI 10.1210/en.138.5.1857; Diaz-Cabiale Z, 2000, BRAIN RES, V887, P421, DOI 10.1016/S0006-8993(00)03017-1; DURHAM DA, 1991, NEUROENDOCRINOLOGY, V53, P447, DOI 10.1159/000125756; FAHRBACH SE, 1985, NEUROENDOCRINOLOGY, V40, P526, DOI 10.1159/000124125; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Gainer Harold, 1994, P1099; Gass P, 1998, LEARN MEMORY, V5, P274; Grattan DR, 2002, REPRODUCTION, V123, P497, DOI 10.1530/rep.0.1230497; Guerra-Araiza C, 2000, LIFE SCI, V66, P1743, DOI 10.1016/S0024-3205(00)00497-5; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; INSEL TR, 1992, PSYCHONEUROENDOCRINO, V17, P3, DOI 10.1016/0306-4530(92)90073-G; JIRIKOWSKI GF, 1991, CELL TISSUE RES, V266, P399, DOI 10.1007/BF00318196; Kinsley CH, 1999, NATURE, V402, P137, DOI 10.1038/45957; KREMARIK P, 1993, J COMP NEUROL, V333, P343, DOI 10.1002/cne.903330304; Kubota Y, 1996, MOL CELL ENDOCRINOL, V124, P25, DOI 10.1016/S0303-7207(96)03923-8; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Masaki T, 2001, DIABETES, V50, P376, DOI 10.2337/diabetes.50.2.376; Matsushita M, 2001, J NEUROSCI, V21, P6000, DOI 10.1523/JNEUROSCI.21-16-06000.2001; Nguyen PV, 1997, LEARN MEMORY, V4, P230, DOI 10.1101/lm.4.2.230; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Olton D.S., 1983, NEUROBIOLOGY HIPPOCA, P335; PEDERSEN CA, 1994, BEHAV NEUROSCI, V108, P1163, DOI 10.1037/0735-7044.108.6.1163; PERDERSEN CA, 1988, P NATL ACAD SCI USA, V76, P6661; Pi XJ, 2002, MOL BRAIN RES, V103, P130, DOI 10.1016/S0169-328X(02)00194-8; Schulkin J, 1999, NEUROENDOCRINE REGUL, P123; SHAPIRO ML, 1992, BEHAV NEUROSCI, V106, P604, DOI 10.1037/0735-7044.106.4.604; Shapiro ML, 1999, HIPPOCAMPUS, V9, P365, DOI 10.1002/(SICI)1098-1063(1999)9:4<365::AID-HIPO4>3.3.CO;2-K; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Tomizawa K, 1996, NEUROSCIENCE, V74, P519, DOI 10.1016/0306-4522(96)00136-4; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; Vaccari C, 1998, ENDOCRINOLOGY, V139, P5015, DOI 10.1210/en.139.12.5015; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305	40	276	288	4	33	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					384	390		10.1038/nn1023	http://dx.doi.org/10.1038/nn1023			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12598900				2022-12-17	WOS:000181833100016
J	Kawasaki, H; Adolphs, R; Kaufman, O; Damasio, H; Damasio, AR; Granner, M; Bakken, H; Hori, T; Howard, MA				Kawasaki, H; Adolphs, R; Kaufman, O; Damasio, H; Damasio, AR; Granner, M; Bakken, H; Hori, T; Howard, MA			Single-neuron responses to emotional visual stimuli recorded in human ventral prefrontal cortex	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN		Univ Iowa Hosp & Clin, Dept Neurol, Div Cognit Neurosci, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Surg, Div Neurosurg, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Adolphs, R (corresponding author), Univ Iowa Hosp & Clin, Dept Neurol, Div Cognit Neurosci, 200 Hawkins Dr, Iowa City, IA 52242 USA.		Damasio, Antonio/AAD-1342-2019	Kawasaki, Hiroto/0000-0002-7688-9171; Howard, Matthew/0000-0003-3935-8889; Granner, Mark/0000-0002-7395-5575	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004290] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC004290] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Damasio A.R., 1994, DESCARTES ERROR EMOT; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Fuster J.M., 1989, PREFRONTAL CORTEX; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P51, DOI 10.1016/0928-4257(94)90093-0; Howard MA, 1996, J NEUROSURG, V84, P129, DOI 10.3171/jns.1996.84.1.0129; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; Northoff G, 2000, CEREB CORTEX, V10, P93, DOI 10.1093/cercor/10.1.93; Ojemann GA, 1998, NEUROSCIENTIST, V4, P285, DOI 10.1177/107385849800400417; ROLLS ET, 1999, BRAIN EMOTION; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372	13	276	292	1	21	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2001	4	1					15	16		10.1038/82850	http://dx.doi.org/10.1038/82850			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UB	11135639				2022-12-17	WOS:000167178000008
J	Hardy, J; Duff, K; Hardy, KG; Perez-Tur, J; Hutton, M				Hardy, J; Duff, K; Hardy, KG; Perez-Tur, J; Hutton, M			Genetic dissection of Alzheimer's disease and related dementias: Amyloid and its relationship to tau	NATURE NEUROSCIENCE			English	Review							BETA-PROTEIN-PRECURSOR; AGE-OF-ONSET; APOLIPOPROTEIN-E; TRANSGENIC MICE; SENILE PLAQUES; NEUROFIBRILLARY TANGLES; MUTANT PRESENILIN-1; TRANSFECTED CELLS; APOE GENOTYPE; IN-VIVO	Molecular genetic analysis is revealing the etiologies of Alzheimer's disease (AD) and related dementias. Here we review genetic and molecular biological evidence suggesting that the peptide A beta 42 is central to the etiology of AD. Recent data also suggests that dysfunction in the cytoskeletal protein tau is on the pathway that leads to neurodegeneration and dementia. Tau is produced either indirectly, by A beta 42, or directly, in some forms of frontotemporal dementia by mutations in tau itself. These data support and refine the amyloid cascade hypothesis for AD and suggest that understanding the causes and consquences of tau dysfunction is an important priority for dementia research.	Mayo Clin Jacksonville, Neurogenet & Transgen Labs, Jacksonville, FL 32224 USA	Mayo Clinic	Hardy, J (corresponding author), Mayo Clin Jacksonville, Neurogenet & Transgen Labs, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.		Perez-Tur, Jordi/A-2143-2010; Duff, Karen EK/C-2510-2009; Hardy, John/C-2451-2009	Perez-Tur, Jordi/0000-0002-9111-1712; Hardy, John/0000-0002-3122-0423; Duff, Karen/0000-0002-6177-868X				ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Artiga MJ, 1998, FEBS LETT, V421, P105, DOI 10.1016/S0014-5793(97)01543-3; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Braak H, 1996, NEUROSCI LETT, V210, P87, DOI 10.1016/0304-3940(96)12668-9; Bullido MJ, 1998, NAT GENET, V18, P69, DOI 10.1038/ng0198-69; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crook R, 1998, NAT MED, V4, P452, DOI 10.1038/nm0498-452; Cruz L, 1997, P NATL ACAD SCI USA, V94, P7612, DOI 10.1073/pnas.94.14.7612; Delacourte A, 1998, ANN NEUROL, V43, P193, DOI 10.1002/ana.410430209; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Foster NL, 1997, ANN NEUROL, V41, P706, DOI 10.1002/ana.410410606; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; HOULDEN H, 1993, LANCET, V342, P737; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Irizarry MC, 1997, J NEUROSCI, V17, P7053; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lambert JC, 1997, HUM MOL GENET, V6, P2151, DOI 10.1093/hmg/6.12.2151; Lambert JC, 1998, HUM MOL GENET, V7, P533, DOI 10.1093/hmg/7.3.533; Lemere CA, 1996, NAT MED, V2, P1146, DOI 10.1038/nm1096-1146; Lendon CL, 1997, HUM MUTAT, V10, P186; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Mann DMA, 1996, ANN NEUROL, V40, P149, DOI 10.1002/ana.410400205; Mehta ND, 1998, ANN NEUROL, V43, P256, DOI 10.1002/ana.410430217; PerezTur J, 1995, NEUROREPORT, V7, P297; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Reed LA, 1997, ANN NEUROL, V42, P564, DOI 10.1002/ana.410420406; ROSES AD, 1994, J NEUROPATH EXP NEUR, V53, P429, DOI 10.1097/00005072-199409000-00002; Roses AD, 1998, AM J MED GENET, V81, P49, DOI 10.1002/(SICI)1096-8628(19980207)81:1<49::AID-AJMG10>3.0.CO;2-W; ROYSTON MC, 1994, NEUROREPORT, V5, P2583, DOI 10.1097/00001756-199412000-00044; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SORBI S, 1995, ANN NEUROL, V38, P124, DOI 10.1002/ana.410380120; Spillantini MG, 1998, BRAIN PATHOL, V8, P387; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; VAN BROECKHOVEN C, 1994, NEUROSCI LETT, V169, P179, DOI 10.1016/0304-3940(94)90385-9; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977; YANG AJ, 1995, J BIOL CHEM, V270, P14786, DOI 10.1074/jbc.270.24.14786	56	276	290	0	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					355	358		10.1038/1565	http://dx.doi.org/10.1038/1565			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QE	10196523				2022-12-17	WOS:000076361400011
J	Puighermanal, E; Marsicano, G; Busquets-Garcia, A; Lutz, B; Maldonado, R; Ozaita, A				Puighermanal, Emma; Marsicano, Giovanni; Busquets-Garcia, Arnau; Lutz, Beat; Maldonado, Rafael; Ozaita, Andres			Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling	NATURE NEUROSCIENCE			English	Article							FACTOR 4E PHOSPHORYLATION; MAMMALIAN TARGET; SYNAPTIC PLASTICITY; REGULATED KINASE; ENDOCANNABINOID SYSTEM; PROTEIN-SYNTHESIS; SPATIAL MEMORY; P70S6 KINASE; TRANSLATION; RAPAMYCIN	Cognitive impairment is one of the most important negative consequences associated with cannabis consumption. We found that CB1 cannabinoid receptor (CB1R) activation transiently modulated the mammalian target of rapamycin (mTOR)/p70S6K pathway and the protein synthesis machinery in the mouse hippocampus, which correlated with the amnesic properties of delta9-tetrahydrocannabinol (THC). In addition, non-amnesic doses of either the mTOR blocker rapamycin or the protein synthesis inhibitor anisomycin abrogated the amnesic-like effects of THC, pointing to a mechanism involving new protein synthesis. Moreover, using pharmacological and genetic tools, we found that THC long-term memory deficits were mediated by CB1Rs expressed on GABAergic interneurons through a glutamatergic mechanism, as both the amnesic-like effects and p70S6K phosphorylation were reduced in GABA-CB1R knockout mice and by NMDA blockade.	[Puighermanal, Emma; Busquets-Garcia, Arnau; Maldonado, Rafael; Ozaita, Andres] Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Lab Neurofarmacol, Barcelona, Spain; [Marsicano, Giovanni] Univ Bordeaux, INSERM, NeuroCtr Magendie Endocannabinoids & Neuroadap Gr, U862, Bordeaux, France; [Lutz, Beat] Johannes Gutenberg Univ Mainz, Dept Physiol Chem, Mainz, Germany	Pompeu Fabra University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Johannes Gutenberg University of Mainz	Ozaita, A (corresponding author), Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Lab Neurofarmacol, Barcelona, Spain.	andres.ozaita@upf.edu	Maldonado, Rafael/F-5657-2014; Puighermanal, Emma/J-4426-2019; Lutz, Beat/AAG-4538-2022; Busquets-Garcia, Arnau/Y-5856-2019; Lutz, Beat/AFK-6229-2022; Busquets-Garcia, Arnau/A-7307-2018; Ozaita, Andres/H-3411-2015; Marsicano, Giovanni/I-9603-2016	Maldonado, Rafael/0000-0002-4359-8773; Puighermanal, Emma/0000-0003-4271-9104; Busquets-Garcia, Arnau/0000-0002-7100-8873; Busquets-Garcia, Arnau/0000-0002-7100-8873; Ozaita, Andres/0000-0002-2239-7403; Marsicano, Giovanni/0000-0003-3804-1951	European Commission [MIRG-6-CT-2005-014856]; NEWMOOD [LSHM-CT-2004-503474]; GENADDICT [LSHM-CT-2004-05166]; Spanish Ministry of Health [FIS PI041526]; Spanish Ministry of Science and Innovation [SAF200764062]; Generalitat de Catalunya [2005SGR00131]; ICREA Academia; Spanish Ministry of Education and Culture	European Commission(European CommissionEuropean Commission Joint Research Centre); NEWMOOD; GENADDICT; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); ICREA Academia(ICREA); Spanish Ministry of Education and Culture(Spanish Government)	We thank C. Fernandez-Avile's for expert technical assistance, J. Bertran-Gonzalez for advice in immunohistochemical techniques and the Laboratori de Neurofarmacologia for helpful discussion. This study was supported by grants from the European Commission (CANSIGWITH (MIRG-6-CT-2005-014856) to A. O. and NEWMOOD (LSHM-CT-2004-503474) and GENADDICT (LSHM-CT-2004-05166) to R. M.), the Spanish Ministry of Health (FIS PI041526) to A. O., the Spanish Ministry of Science and Innovation (Consolider-C #SAF200764062), Generalitat de Catalunya (2005SGR00131) and ICREA Academia to R. M. A. O. is a recipient of a Ramon y Cajal award from the Spanish Ministry of Education and Culture, E. P. is a recipient of a predoctoral fellowship from the Spanish Ministry of Education and Culture and A. B.-G. is a recipient of a fellowship from La Caixa.	Banko JL, 2008, PROG BRAIN RES, V169, P59, DOI 10.1016/S0079-6123(07)00004-0; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Blundell J, 2008, NEUROBIOL LEARN MEM, V90, P28, DOI 10.1016/j.nlm.2007.12.004; Bolduc FV, 2008, NAT NEUROSCI, V11, P1143, DOI 10.1038/nn.2175; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Clarke JR, 2008, NEUROBIOL LEARN MEM, V90, P374, DOI 10.1016/j.nlm.2008.04.009; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Derkinderen P, 2003, J NEUROSCI, V23, P2371; Duncan RF, 2003, BIOCHEM J, V369, P213, DOI 10.1042/BJ20020435; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; ELROYSTEIN O, 2008, TRANSLATIONAL CONTRO; FERRARI S, 1994, CRIT REV BIOCHEM MOL, V29, P385, DOI 10.3109/10409239409083485; Gelinas JN, 2007, J BIOL CHEM, V282, P27527, DOI 10.1074/jbc.M701077200; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Jaworski J, 2006, MOL NEUROBIOL, V34, P205, DOI 10.1385/MN:34:3:205; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Katona I, 2001, J NEUROSCI, V21, P9506, DOI 10.1523/JNEUROSCI.21-23-09506.2001; Katona I, 1999, J NEUROSCI, V19, P4544; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kim MH, 2009, J NEUROSCI, V29, P1586, DOI 10.1523/JNEUROSCI.4306-08.2009; Lehman JA, 2003, J BIOL CHEM, V278, P28130, DOI 10.1074/jbc.M300376200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; Ozaita A, 2007, J NEUROCHEM, V102, P1105, DOI 10.1111/j.1471-4159.2007.04642.x; Page G, 2006, NEUROCHEM INT, V49, P413, DOI 10.1016/j.neuint.2006.01.020; Pearson R B, 1995, Prog Cell Cycle Res, V1, P21; Piomelli D, 2006, CNS DRUG REV, V12, P21, DOI 10.1111/j.1527-3458.2006.00021.x; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Rubino T, 2004, MOL CELL NEUROSCI, V25, P355, DOI 10.1016/j.mcn.2003.11.003; Sekulic A, 2000, CANCER RES, V60, P3504; Straiker A, 2006, AAPS J, V8, pE272; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Takahashi KA, 2006, NEUROSCIENCE, V139, P795, DOI 10.1016/j.neuroscience.2006.01.024; Tsokas P, 2007, J NEUROSCI, V27, P5885, DOI 10.1523/JNEUROSCI.4548-06.2007; Valjent E, 2000, J NEUROSCI, V20, P8701; Varvel SA, 2005, PSYCHOPHARMACOLOGY, V179, P863, DOI 10.1007/s00213-004-2121-2; Wang XR, 2007, MOL CELL BIOL, V27, P7405, DOI 10.1128/MCB.00760-07; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wise LE, 2009, NEUROPSYCHOPHARMACOL, V34, P2072, DOI 10.1038/npp.2009.31; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	49	275	281	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1152	U18		10.1038/nn.2369	http://dx.doi.org/10.1038/nn.2369			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19648913				2022-12-17	WOS:000269317300017
J	Zalfa, F; Eleuteri, B; Dickson, KS; Mercaldo, V; De Rubeis, S; di Penta, A; Tabolacci, E; Chiurazzi, P; Neri, G; Grant, SGN; Bagni, C				Zalfa, Francesca; Eleuteri, Boris; Dickson, Kirsten S.; Mercaldo, Valentina; De Rubeis, Silvia; di Penta, Alessandra; Tabolacci, Elisabetta; Chiurazzi, Pietro; Neri, Giovanni; Grant, Seth G. N.; Bagni, Claudia			A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; NMDA RECEPTOR; ALZHEIMERS-DISEASE; BINDING PROTEINS; FMRP; TRANSLATION; MECHANISMS; SYNAPSES; MICE; IDENTIFICATION	Fragile X syndrome ( FXS) results from the loss of the fragile X mental retardation protein ( FMRP), an RNA- binding protein that regulates a variety of cytoplasmic mRNAs. FMRP regulates mRNA translation and may be important in mRNA localization to dendrites. We report a third cytoplasmic regulatory function for FMRP: control of mRNA stability. In mice, we found that FMRP binds, in vivo, the mRNA encoding PSD- 95, a key molecule that regulates neuronal synaptic signaling and learning. This interaction occurs through the 3' untranslated region of the PSD- 95 ( also known as Dlg4) mRNA, increasing message stability. Moreover, stabilization is further increased by mGluR activation. Although we also found that the PSD- 95 mRNA is synaptically localized in vivo, localization occurs independently of FMRP. Through our functional analysis of this FMRP target we provide evidence that dysregulation of mRNA stability may contribute to the cognitive impairments in individuals with FXS.	Univ Roma Tor Vergata, Dipartimento Biol, I-00133 Rome, Italy; Fdn Santa Lucia, Ist Neurosci Sperimentali, I-00143 Rome, Italy; Univ Edinburgh, Div Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland; Univ Cattolica, Ist Genet Med, I-00168 Rome, Italy; Wellcome Trust Res Labs, Sanger Inst, Hinxton CB10 1SA, Cambs, England	University of Rome Tor Vergata; IRCCS Santa Lucia; University of Edinburgh; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Wellcome Trust Sanger Institute	Bagni, C (corresponding author), Univ Roma Tor Vergata, Dipartimento Biol, Via Ric Sci 1, I-00133 Rome, Italy.	dickson.kris@gmail.com; claudia.bagni@uniroma2.it	Zalfa, Francesca/J-7759-2018; Mercaldo, Valentina/AAA-6000-2019; De Rubeis, Silvia/E-9852-2013; Chiurazzi, Pietro/J-3169-2012; TABOLACCI, Elisabetta/AAR-6538-2020	Zalfa, Francesca/0000-0002-1922-9468; De Rubeis, Silvia/0000-0001-9383-6883; TABOLACCI, Elisabetta/0000-0002-4707-2242; Bagni, Claudia/0000-0002-4419-210X; Grant, Seth/0000-0001-8732-8735	Telethon [GGP05269] Funding Source: Medline; Wellcome Trust [056523, 077155] Funding Source: Medline	Telethon(Fondazione Telethon); Wellcome Trust(Wellcome TrustEuropean Commission)		Adinolfi S, 1999, RNA, V5, P1248, DOI 10.1017/S1355838299990647; Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bencini G, 2005, BRAIN LANG, V95, P133, DOI 10.1016/j.bandl.2005.07.075; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Chen L, 2003, NEUROSCIENCE, V120, P1005, DOI 10.1016/S0306-4522(03)00406-8; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; Gabus C, 2004, NUCLEIC ACIDS RES, V32, P2129, DOI 10.1093/nar/gkh535; Gylys KH, 2004, AM J PATHOL, V165, P1809, DOI 10.1016/S0002-9440(10)63436-0; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Johnson EM, 2006, J NEUROSCI RES, V83, P929, DOI 10.1002/jnr.20806; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Loesch DZ, 2004, MENT RETARD DEV D R, V10, P31, DOI 10.1002/mrdd.20006; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ramos A, 2003, RNA, V9, P1198, DOI 10.1261/rna.5960503; REISS AL, 1994, NEUROLOGY, V44, P1317, DOI 10.1212/WNL.44.7.1317; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961; Smith CL, 2004, J NEUROBIOL, V61, P222, DOI 10.1002/neu.20038; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Tarpey P, 2004, AM J HUM GENET, V75, P318, DOI 10.1086/422703; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Tonegawa S, 1996, COLD SPRING HARB SYM, V61, P225; Toro C, 2005, SCHIZOPHR RES, V80, P323, DOI 10.1016/j.schres.2005.07.003; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; VICKERS CA, 2006, BRAIN RES; Wang HP, 2004, HUM MOL GENET, V13, P79, DOI 10.1093/hmg/ddh009; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; Zalfa F, 2005, J BIOL CHEM, V280, P33403, DOI 10.1074/jbc.M504286200; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zalfa F, 2006, CURR OPIN NEUROBIOL, V16, P265, DOI 10.1016/j.conb.2006.05.010; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zhong N, 1999, AM J MED GENET, V84, P268, DOI 10.1002/(SICI)1096-8628(19990528)84:3<268::AID-AJMG20>3.0.CO;2-#	50	275	284	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					578	587		10.1038/nn1893	http://dx.doi.org/10.1038/nn1893			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17417632	Green Published, Green Accepted			2022-12-17	WOS:000245948000014
J	Dalton, P; Doolittle, N; Nagata, H; Breslin, PAS				Dalton, P; Doolittle, N; Nagata, H; Breslin, PAS			The merging of the senses: integration of subthreshold taste and smell	NATURE NEUROSCIENCE			English	Article							CORTEX		Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Monell Chemical Senses Center	Dalton, P (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.			Breslin, Paul/0000-0001-5988-8401	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC002995, R01DC003704] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01-DC03704, R29-DC02995] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		FOWLER CA, 1991, J EXP PSYCHOL HUMAN, V17, P816, DOI 10.1037/0096-1523.17.3.816; FRANK RA, 1988, CHEM SENSES, V13, P445, DOI 10.1093/chemse/13.3.445; GIELEN SCAM, 1983, PERCEPT PSYCHOPHYS, V34, P161, DOI 10.3758/BF03211343; GUADAGNI DG, 1963, NATURE, V200, P1288, DOI 10.1038/2001288a0; KAPP B S, 1992, P229; KRUSHEL LA, 1988, J COMP NEUROL, V270, P39, DOI 10.1002/cne.902700105; MURPHY C, 1977, SENS PROCESS, V1, P204; ROLLS ET, 1994, J NEUROSCI, V14, P5437; Schifferstein HNJ, 1996, ACTA PSYCHOL, V94, P87, DOI 10.1016/0001-6918(95)00040-2; Schul R, 1996, BEHAV NEUROSCI, V110, P760; Sparks David L., 1995, P565; Stevens JC, 1997, PHYSIOL BEHAV, V62, P1137, DOI 10.1016/S0031-9384(97)00270-9; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; WETHERILL GB, 1965, BRIT J MATH STAT PSY, V18, P1, DOI 10.1111/j.2044-8317.1965.tb00689.x; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912	15	275	285	1	91	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					431	432		10.1038/74797	http://dx.doi.org/10.1038/74797			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	309DG	10769380				2022-12-17	WOS:000086752000009
J	Navratilova, E; Porreca, F				Navratilova, Edita; Porreca, Frank			Reward and motivation in pain and pain relief	NATURE NEUROSCIENCE			English	Review							ANTERIOR CINGULATE CORTEX; PLACE PREFERENCE PARADIGM; VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; ONGOING PAIN; SPINAL-CORD; NEGATIVE REINFORCEMENT; CENTRAL SENSITIZATION; ANIMAL-MODEL; DOPAMINE	Pain is fundamentally unpleasant, a feature that protects the organism by promoting motivation and learning. Relief of aversive states, including pain, is rewarding. The aversiveness of pain, as well as the reward from relief of pain, is encoded by brain reward/motivational mesocorticolimbic circuitry. In this Review, we describe current knowledge of the impact of acute and chronic pain on reward/motivation circuits gained from preclinical models and from human neuroimaging. We highlight emerging clinical evidence suggesting that anatomical and functional changes in these circuits contribute to the transition from acute to chronic pain. We propose that assessing activity in these conserved circuits can offer new outcome measures for preclinical evaluation of analgesic efficacy to improve translation and speed drug discovery. We further suggest that targeting reward/motivation circuits may provide a path for normalizing the consequences of chronic pain to the brain, surpassing symptomatic management to promote recovery from chronic pain.	[Navratilova, Edita; Porreca, Frank] Univ Arizona, Hlth Sci Ctr, Dept Pharmacol, Tucson, AZ 85721 USA	University of Arizona; University of Arizona Health Sciences	Porreca, F (corresponding author), Univ Arizona, Hlth Sci Ctr, Dept Pharmacol, Tucson, AZ 85721 USA.	frankp@email.arizona.edu			US National Institutes of Health [NS066958, DA034975]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034975] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We gratefully acknowledge comments and suggestions from I. Tracey and H. Fields. We thank P. Navratilova for help with illustrations. This work was funded by grants NS066958 and DA034975 from the US National Institutes of Health.	Altier N, 1999, LIFE SCI, V65, P2269, DOI 10.1016/S0024-3205(99)00298-2; Anderson EM, 2013, JOVE-J VIS EXP, DOI 10.3791/50336; Andreatta M, 2012, LEARN MEMORY, V19, P518, DOI 10.1101/lm.026864.112; Apkarian AV, 2011, PAIN MANAG, V1, P577, DOI 10.2217/PMT.11.53; Apkarian AV, 2013, CURR OPIN NEUROL, V26, P360, DOI 10.1097/WCO.0b013e32836336ad; Apkarian AV, 2011, PAIN, V152, pS49, DOI 10.1016/j.pain.2010.11.010; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Atlas LY, 2012, NEUROSCI LETT, V520, P140, DOI 10.1016/j.neulet.2012.03.039; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Becerra L, 2013, J NEUROPHYSIOL, V110, P1221, DOI 10.1152/jn.00284.2013; Becerra L, 2008, EUR J PAIN, V12, P866, DOI 10.1016/j.ejpain.2007.12.007; Berger JV, 2011, BRAIN RES REV, V67, P282, DOI 10.1016/j.brainresrev.2011.03.003; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Brotis AG, 2009, STEREOT FUNCT NEUROS, V87, P271, DOI 10.1159/000226669; Budygin EA, 2012, NEUROSCIENCE, V201, P331, DOI 10.1016/j.neuroscience.2011.10.056; Burgess G, 2010, J CLIN INVEST, V120, P3753, DOI 10.1172/JCI43195; BURSTEIN R, 1989, BRAIN RES, V497, P149, DOI 10.1016/0006-8993(89)90981-5; Bushnell MC, 2013, NAT REV NEUROSCI, V14, P502, DOI 10.1038/nrn3516; Chapin H, 2012, NEUROSCI LETT, V520, P174, DOI 10.1016/j.neulet.2012.02.076; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Davoody L, 2011, J PAIN, V12, P868, DOI 10.1016/j.jpain.2011.01.010; DeFelice M, 2013, ANN NEUROL, V74, P257, DOI 10.1002/ana.23922; Denk F, 2014, NAT NEUROSCI, V17, P192, DOI 10.1038/nn.3628; Denton DA, 2009, CONSCIOUS COGN, V18, P500, DOI 10.1016/j.concog.2008.06.009; Dodick DW, 2014, LANCET NEUROL, V13, P885, DOI 10.1016/S1474-4422(14)70128-0; Eippert F, 2009, SCIENCE, V326, P404, DOI 10.1126/science.1180142; Ewan EE, 2013, NEUROSCI LETT, V557, P60, DOI 10.1016/j.neulet.2013.08.018; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Fields HL, 1999, PAIN, pS61, DOI 10.1016/S0304-3959(99)00139-6; Fields HL., 2006, P 11 WORLD C PAIN, P449; FOLTZ EL, 1962, J NEUROSURG, V19, P89, DOI 10.3171/jns.1962.19.2.0089; Gear RW, 2011, EXP NEUROL, V229, P502, DOI 10.1016/j.expneurol.2011.03.021; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Gerber B, 2014, LEARN MEMORY, V21, P232, DOI 10.1101/lm.032995.113; Gjerstad AC, 2008, PEDIATRICS, V122, pE848, DOI 10.1542/peds.2007-2545; Gold MS, 2010, NAT MED, V16, P1248, DOI 10.1038/nm.2235; Harris RE, 2007, J NEUROSCI, V27, P10000, DOI 10.1523/JNEUROSCI.2849-07.2007; He Y, 2012, J PAIN, V13, P598, DOI 10.1016/j.jpain.2012.03.011; Johannes CB, 2010, J PAIN, V11, P1230, DOI 10.1016/j.jpain.2010.07.002; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; Johansen JP, 2004, NAT NEUROSCI, V7, P398, DOI 10.1038/nn1207; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kender RG, 2008, J PAIN, V9, P597, DOI 10.1016/j.jpain.2008.01.334; King CD, 2007, NEUROSCIENCE, V147, P174, DOI 10.1016/j.neuroscience.2007.04.012; King T, 2009, NAT NEUROSCI, V12, P1364, DOI 10.1038/nn.2407; LaBuda CJ, 2000, EXP NEUROL, V163, P490, DOI 10.1006/exnr.2000.7395; LaGraize SC, 2004, EXP NEUROL, V188, P139, DOI 10.1016/j.expneurol.2004.04.003; Lanz S, 2011, J NEURAL TRANSM, V118, P1139, DOI 10.1007/s00702-011-0606-9; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lee MC, 2013, BRIT J ANAESTH, V111, P64, DOI 10.1093/bja/aet174; Lee MC, 2010, CURR PAIN HEADACHE R, V14, P124, DOI 10.1007/s11916-010-0103-0; Leknes S, 2008, EUR J NEUROSCI, V28, P794, DOI 10.1111/j.1460-9568.2008.06380.x; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Leknes S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017870; Levenson RW, 2011, EMOT REV, V3, P379, DOI 10.1177/1754073911410743; Lim SL, 2011, J NEUROSCI, V31, P13214, DOI 10.1523/JNEUROSCI.1246-11.2011; Lorenz J, 2002, NEURON, V35, P383, DOI 10.1016/S0896-6273(02)00767-5; Martin TJ, 2006, PAIN, V125, P257, DOI 10.1016/j.pain.2006.05.027; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; Mohseni HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037993; Narita M, 2010, ADDICT BIOL, V15, P434, DOI 10.1111/j.1369-1600.2010.00249.x; Navratilova E, 2013, ANN NY ACAD SCI, V1282, P1, DOI 10.1111/nyas.12095; Navratilova E, 2012, P NATL ACAD SCI USA, V109, P20709, DOI 10.1073/pnas.1214605109; Neugebauer V, 2009, BRAIN RES REV, V60, P226, DOI 10.1016/j.brainresrev.2008.12.014; Noonan MP, 2010, P NATL ACAD SCI USA, V107, P20547, DOI 10.1073/pnas.1012246107; Okun A, 2012, PAIN, V153, P924, DOI 10.1016/j.pain.2012.01.022; Okun A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-4; Park HJ, 2013, ANESTH ANALG, V116, P224, DOI 10.1213/ANE.0b013e31826e1007; Porreca F, 2002, TRENDS NEUROSCI, V25, P319, DOI 10.1016/S0166-2236(02)02157-4; Qu CL, 2011, PAIN, V152, P1641, DOI 10.1016/j.pain.2011.03.002; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Redgrave P, 2008, BRAIN RES REV, V58, P322, DOI 10.1016/j.brainresrev.2007.10.007; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; Scott DJ, 2008, ARCH GEN PSYCHIAT, V65, P220, DOI 10.1001/archgenpsychiatry.2007.34; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Scott DJ, 2006, J NEUROSCI, V26, P10789, DOI 10.1523/JNEUROSCI.2577-06.2006; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Seminowicz DA, 2009, NEUROIMAGE, V47, P1007, DOI 10.1016/j.neuroimage.2009.05.068; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; Simons LE, 2014, NEUROSCI BIOBEHAV R, V39, P61, DOI 10.1016/j.neubiorev.2013.12.006; Singh Gurkirpal, 1998, American Journal of Medicine, V105, p31S, DOI 10.1016/S0002-9343(98)00072-2; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Sprenger C, 2012, CURR BIOL, V22, P1019, DOI 10.1016/j.cub.2012.04.006; SUFKA KJ, 1994, PAIN, V58, P355, DOI 10.1016/0304-3959(94)90130-9; Tracey I, 2010, NAT MED, V16, P1277, DOI 10.1038/nm.2229; Tracey I, 2009, J PAIN, V10, P1113, DOI 10.1016/j.jpain.2009.09.001; van Hecke O, 2013, BRIT J ANAESTH, V111, P13, DOI 10.1093/bja/aet123; Villemure C, 2012, PAIN RES MANAG, V17, P69, DOI 10.1155/2012/371362; Villemure C, 2009, J NEUROSCI, V29, P705, DOI 10.1523/JNEUROSCI.3822-08.2009; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Wang JY, 2003, BRAIN RES, V992, P263, DOI 10.1016/j.brainres.2003.08.059; Wanigasekera V, 2012, P NATL ACAD SCI USA, V109, P17705, DOI 10.1073/pnas.1120201109; Watson A, 2009, PAIN, V145, P24, DOI 10.1016/j.pain.2009.04.003; Wiech K, 2005, NEUROIMAGE, V27, P59, DOI 10.1016/j.neuroimage.2005.03.044; Wiech K, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00046; Wiech K, 2009, NEUROIMAGE, V47, P987, DOI 10.1016/j.neuroimage.2009.05.059; Wood PB, 2007, J PAIN, V8, P51, DOI 10.1016/j.jpain.2006.05.014; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Xie JY, 2014, PAIN, V155, P1659, DOI 10.1016/j.pain.2014.05.018; Yen CP, 2005, J CLIN NEUROSCI, V12, P886, DOI 10.1016/j.jocn.2004.11.018; Zubieta JK, 2005, J NEUROSCI, V25, P7754, DOI 10.1523/JNEUROSCI.0439-05.2005	109	274	285	11	154	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2014	17	10					1304	1312		10.1038/nn.3811	http://dx.doi.org/10.1038/nn.3811			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	AP8KD	25254980	Green Accepted			2022-12-17	WOS:000342327000008
J	Figee, M; Luigjes, J; Smolders, R; Valencia-Alfonso, CE; van Wingen, G; de Kwaasteniet, B; Mantione, M; Ooms, P; de Koning, P; Vulink, N; Levar, N; Droge, L; van den Munckhof, P; Schuurman, PR; Nederveen, A; van den Brink, W; Mazaheri, A; Vink, M; Denys, D				Figee, Martijn; Luigjes, Judy; Smolders, Ruud; Valencia-Alfonso, Carlos-Eduardo; van Wingen, Guido; de Kwaasteniet, Bart; Mantione, Mariska; Ooms, Pieter; de Koning, Pelle; Vulink, Nienke; Levar, Nina; Droge, Lukas; van den Munckhof, Pepijn; Schuurman, P. Richard; Nederveen, Aart; van den Brink, Wim; Mazaheri, Ali; Vink, Matthijs; Denys, Damiaan			Deep brain stimulation restores frontostriatal network activity in obsessive-compulsive disorder	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL CONNECTIVITY	Little is known about the underlying neural mechanism of deep brain stimulation (DBS). We found that DBS targeted at the nucleus accumbens (NAc) normalized NAc activity, reduced excessive connectivity between the NAc and prefrontal cortex, and decreased frontal low-frequency oscillations during symptom provocation in patients with obsessive-compulsive disorder. Our findings suggest that DBS is able to reduce maladaptive activity and connectivity of the stimulated region.	[Figee, Martijn; Luigjes, Judy; Smolders, Ruud; Valencia-Alfonso, Carlos-Eduardo; van Wingen, Guido; de Kwaasteniet, Bart; Mantione, Mariska; Ooms, Pieter; de Koning, Pelle; Vulink, Nienke; Levar, Nina; Droge, Lukas; van den Brink, Wim; Mazaheri, Ali; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Figee, Martijn; Luigjes, Judy; Smolders, Ruud; van Wingen, Guido; de Kwaasteniet, Bart; Levar, Nina; Nederveen, Aart] Univ Amsterdam, Acad Med Ctr, Brain Imaging Ctr, NL-1105 AZ Amsterdam, Netherlands; [Valencia-Alfonso, Carlos-Eduardo; Denys, Damiaan] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands; [van den Munckhof, Pepijn; Schuurman, P. Richard] Univ Amsterdam, Acad Med Ctr, Dept Neurosurg, NL-1105 AZ Amsterdam, Netherlands; [Nederveen, Aart] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Vink, Matthijs] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center	Figee, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.figee@amc.nl; ddenys@gmail.com	van den Munckhof, Pepijn/AAY-9259-2020; luigjes, judy/P-5161-2014; Figee, Martijn/N-5659-2019; Smolders, Ruud/H-4771-2013; de Koning, Pelle/F-2599-2013; Schuurman, Rick/ABE-9100-2021; van Wingen, Guido/AAK-8462-2021; Figee, Martijn/C-7581-2012	Figee, Martijn/0000-0003-3679-284X; Smolders, Ruud/0000-0002-1976-3775; van Wingen, Guido/0000-0003-3076-5891; Figee, Martijn/0000-0003-3679-284X; Vink, Matthijs/0000-0002-1235-8347; Vulink, Nienke/0000-0001-8991-9627; Mazaheri, Ali/0000-0001-5732-7555	Netherlands Organization for Scientific Research ZON-MW VENI program [916.66.095]; VENI grant from the Netherlands Organization for Scientific Research [016.115.196]	Netherlands Organization for Scientific Research ZON-MW VENI program; VENI grant from the Netherlands Organization for Scientific Research	This study was supported by grant 916.66.095 from the Netherlands Organization for Scientific Research ZON-MW VENI program. A.M. was supported from a VENI grant 016.115.196 from the Netherlands Organization for Scientific Research.	Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Denys D, 2010, ARCH GEN PSYCHIAT, V67, P1061, DOI 10.1001/archgenpsychiatry.2010.122; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Figee M, 2011, BIOL PSYCHIAT, V69, P867, DOI 10.1016/j.biopsych.2010.12.003; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152; Knyazev GG, 2012, NEUROSCI BIOBEHAV R, V36, P677, DOI 10.1016/j.neubiorev.2011.10.002; Kringelbach ML, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00008; Lang P.J., 2008, INT AFFECTIVE PICTUR, DOI 10.1016/j.epsr.2006.03.016; Lehman JF, 2011, J NEUROSCI, V31, P10392, DOI 10.1523/JNEUROSCI.0595-11.2011; McIntyre CC, 2010, NEUROBIOL DIS, V38, P329, DOI 10.1016/j.nbd.2009.09.022; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pogarell O, 2006, INT J PSYCHOPHYSIOL, V62, P87, DOI 10.1016/j.ijpsycho.2006.02.002; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Laere K, 2006, J NUCL MED, V47, P740	20	274	277	2	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					386	U195		10.1038/nn.3344	http://dx.doi.org/10.1038/nn.3344			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23434914				2022-12-17	WOS:000316723700006
J	Holderith, N; Lorincz, A; Katona, G; Rozsa, B; Kulik, A; Watanabe, M; Nusser, Z				Holderith, Noemi; Lorincz, Andrea; Katona, Gergely; Rozsa, Balazs; Kulik, Akos; Watanabe, Masahiko; Nusser, Zoltan			Release probability of hippocampal glutamatergic terminals scales with the size of the active zone	NATURE NEUROSCIENCE			English	Article							TRANSMITTER RELEASE; PYRAMIDAL CELLS; NERVE-TERMINALS; SINGLE SYNAPSES; FREEZE-FRACTURE; CALCIUM CURRENT; CA2+ CHANNELS; RECEPTORS; AMPA; DEPENDENCE	Cortical synapses have structural, molecular and functional heterogeneity; our knowledge regarding the relationship between their ultrastructural and functional parameters is still fragmented. Here we asked how the neurotransmitter release probability and presynaptic [Ca2+] transients relate to the ultrastructure of rat hippocampal glutamatergic axon terminals. Two-photon Ca2+ imaging derived optical quantal analysis and correlated electron microscopic reconstructions revealed a tight correlation between the release probability and the active-zone area. Peak amplitude of [Ca2+] transients in single boutons also positively correlated with the active-zone area. Freeze-fracture immunogold labeling revealed that the voltage-gated calcium channel subunit Cav2.1 and the presynaptic protein Rim 1/2 are confined to the active zone and their numbers scale linearly with the active-zone area. Gold particles labeling Cav2.1 were nonrandomly distributed in the active zones. Our results demonstrate that the numbers of several active-zone proteins, including presynaptic calcium channels, as well as the number of docked vesicles and the release probability, scale linearly with the active-zone area.	[Holderith, Noemi; Lorincz, Andrea; Nusser, Zoltan] Hungarian Acad Sci, Inst Expt Med, Lab Cellular Neurophysiol, Budapest, Hungary; [Katona, Gergely; Rozsa, Balazs] Hungarian Acad Sci, Inst Expt Med, Photon Imaging Ctr 2, Budapest, Hungary; [Kulik, Akos] Univ Freiburg, Inst Anat & Cell Biol, Dept Neuroanat, Dept Physiol 2, D-79106 Freiburg, Germany; [Kulik, Akos] Univ Freiburg, Ctr Biol Signaling Studies, D-79106 Freiburg, Germany; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Freiburg; University of Freiburg; Hokkaido University	Nusser, Z (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Cellular Neurophysiol, Budapest, Hungary.	nusser@koki.hu	Watanabe, Masahiko/S-3614-2019; Nusser, Zoltan/K-8587-2014; WATANABE, Masahiko/A-4055-2012; Balazs, Rozsa/C-6306-2015	Watanabe, Masahiko/0000-0001-5037-7138; WATANABE, Masahiko/0000-0001-5037-7138; Balazs, Rozsa/0000-0003-1427-7003; Nusser, Zoltan/0000-0001-7004-4111; Katona, Gergely/0000-0002-4173-0355	Hungarian Academy of Sciences; Wellcome Trust [083484/Z/07/Z, 090197/Z/09/Z, 094513/Z/10/Z]; European Research Council; Hungarian National Office for Research and Technology-French National Research Agency TeT Fund (NKTH-Neurogen); GOP [1.1.1-08/1-2008-0085]; Deutsche Forschungsgemeinschaft [SFB 780]	Hungarian Academy of Sciences(Hungarian Academy of Sciences); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Hungarian National Office for Research and Technology-French National Research Agency TeT Fund (NKTH-Neurogen)(French National Research Agency (ANR)); GOP; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	N.H. and A.L. are funded by Janos Bolyai Scholarships of the Hungarian Academy of Sciences. Z.N. is supported by Wellcome Trust Equipment (083484/Z/07/Z) and Project Grants (090197/Z/09/Z; 094513/Z/10/Z), a European Research Council Advanced Grant, and a Hungarian National Office for Research and Technology-French National Research Agency TeT Fund (NKTH-Neurogen). B.R. was supported by a GOP grant (1.1.1-08/1-2008-0085). A.K. is supported by a Deutsche Forschungsgemeinschaft (SFB 780) grant. We thank N. Suzuki (Mie University, Japan) for providing Cav2.1<SUP>-/-</SUP> mice, A. Unger for helping with the Cav2.1<SUP>-/-</SUP> replica labeling, E. Dobai and D. Ronaszeki for technical assistance, M. Sumegi for his help with the modeling, members of Synaptic Systems GmbH for providing the rabbit anti-Car2.1 antibody, E. Neher and M. Eyre for their comments on the manuscript, and H. Koester for helpful discussions.	Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; ATWOOD HL, 1983, CELL TISSUE RES, V231, P103; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Branco T, 2010, J STRUCT BIOL, V172, P203, DOI 10.1016/j.jsb.2009.10.014; Bucurenciu I, 2008, NEURON, V57, P536, DOI 10.1016/j.neuron.2007.12.026; Bucurenciu I, 2010, NAT NEUROSCI, V13, P19, DOI 10.1038/nn.2461; Christie JM, 2011, NAT NEUROSCI, V14, P62, DOI 10.1038/nn.2718; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; DiGregorio DA, 1999, J NEUROSCI, V19, P7846; Eggermann E, 2012, NAT REV NEUROSCI, V13, P7, DOI 10.1038/nrn3125; Fedchyshyn MJ, 2005, J NEUROSCI, V25, P4131, DOI 10.1523/JNEUROSCI.0350-05.2005; FIELDS RD, 1985, SCIENCE, V228, P197, DOI 10.1126/science.3975637; Frank T, 2009, P NATL ACAD SCI USA, V106, P4483, DOI 10.1073/pnas.0813213106; Hagiwara A, 2005, J COMP NEUROL, V489, P195, DOI 10.1002/cne.20633; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; KORN H, 1982, J NEUROPHYSIOL, V48, P679, DOI 10.1152/jn.1982.48.3.679; Kulik A, 2004, EUR J NEUROSCI, V19, P2169, DOI 10.1111/j.0953-816X.2004.03319.x; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; Liu KSY, 2011, SCIENCE, V334, P1565, DOI 10.1126/science.1212991; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; Losonczy A, 2002, J PHYSIOL-LONDON, V542, P193, DOI 10.1113/jphysiol.2002.020024; Masugi-Tokita M, 2007, CURR OPIN NEUROBIOL, V17, P387, DOI 10.1016/j.conb.2007.04.012; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Ohana O, 1998, J PHYSIOL-LONDON, V513, P135, DOI 10.1111/j.1469-7793.1998.135by.x; PROPST JW, 1987, J NEUROSCI, V7, P3654; Racca C, 2000, J NEUROSCI, V20, P2512; Reid CA, 1997, J NEUROSCI, V17, P2738; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tanaka J, 2005, J NEUROSCI, V25, P799, DOI 10.1523/JNEUROSCI.4256-04.2005; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WU LG, 1994, J NEUROSCI, V14, P5613; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001	50	274	277	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					988	997		10.1038/nn.3137	http://dx.doi.org/10.1038/nn.3137			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	966EE	22683683	Green Accepted			2022-12-17	WOS:000305819600017
J	Meyer-Lindenberg, A; Hariri, AR; Munoz, KE; Mervis, CB; Mattay, VS; Morris, CA; Berman, KF				Meyer-Lindenberg, A; Hariri, AR; Munoz, KE; Mervis, CB; Mattay, VS; Morris, CA; Berman, KF			Neural correlates of genetically abnormal social cognition in Williams syndrome	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; AMYGDALA RESPONSE; BEHAVIOR; STIMULI; ANXIETY	Williams-Beuren syndrome (WBS), caused by a microdeletion of approximately 21 genes on chromosome 7q11.23, is characterized by unique hypersociability combined with increased non-social anxiety. Using functional neuroimaging, we found reduced amygdala activation in individuals with WBS for threatening faces but increased activation for threatening scenes, relative to matched normal controls. Activation and interactions of prefrontal regions linked to amygdala, especially orbitofrontal cortex, were abnormal, suggesting a genetically controlled neural circuitry for regulating human social behavior.	NIMH, Sect Integrat Neuroimaging, NIH, US Dept HHS, Bethesda, MD 20892 USA; NIMH, Neuroimaging Core Facil, NIH, US Dept HHS, Bethesda, MD 20892 USA; NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, NIH,US Dept HHS, Bethesda, MD 20892 USA; Univ Louisville, Dept Psychol & Brain Sci, Neurodev Sci Lab, Louisville, KY 40292 USA; Univ Nevada, Sch Med, Dept Pediat, Las Vegas, NV 89102 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Louisville; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Meyer-Lindenberg, A (corresponding author), NIMH, Sect Integrat Neuroimaging, NIH, US Dept HHS, Bethesda, MD 20892 USA.	andreasml@nih.gov	Hariri, Ahmad/D-5761-2011; Meyer-Lindenberg, Andreas/H-1076-2011	Meyer-Lindenberg, Andreas/0000-0001-5619-1123	NINDS NIH HHS [R01 NS035102, NS35102] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002863, Z01MH002867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035102] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Amaral DG, 2002, BIOL PSYCHIAT, V51, P11, DOI 10.1016/S0006-3223(01)01307-5; Bellugi U, 1999, NEUROREPORT, V10, P1653, DOI 10.1097/00001756-199906030-00006; Dilger S, 2003, NEUROSCI LETT, V348, P29, DOI 10.1016/S0304-3940(03)00647-5; Dykens EM, 2003, DEV NEUROPSYCHOL, V23, P291, DOI 10.1207/S15326942DN231&2_13; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Klein-Tasman BP, 2003, DEV NEUROPSYCHOL, V23, P269, DOI 10.1207/S15326942DN231&2_12; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Meyer-Lindenberg A, 2004, NEURON, V43, P623, DOI 10.1016/j.neuron.2004.08.014; Prather MD, 2001, NEUROSCIENCE, V106, P653, DOI 10.1016/S0306-4522(01)00445-6; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Reiss AL, 2004, J NEUROSCI, V24, P5009, DOI 10.1523/JNEUROSCI.5272-03.2004; Wood JN, 2005, NEUROPSYCHOLOGIA, V43, P249, DOI 10.1016/j.neuropsychologia.2004.11.011	15	274	279	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					991	993		10.1038/nn1494	http://dx.doi.org/10.1038/nn1494			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16007084				2022-12-17	WOS:000230760200009
J	McIntyre, J; Zago, M; Berthoz, A; Lacquaniti, F				McIntyre, J; Zago, M; Berthoz, A; Lacquaniti, F			Does the brain model Newton's laws?	NATURE NEUROSCIENCE			English	Article							COORDINATION; MOVEMENT; GRAVITY; BALL; TIME		European Lab Neurosci Act, CNRS, Lab Physiol Percept & Act, F-75005 Paris, France; Coll France, F-75005 Paris, France; IRCCS, Fdn Santa Lucia, Sez Fisiol Umana, European Lab Neurosci Act, I-00179 Rome, Italy; Univ Roma Tor Vergata, Ctr Biomed Spaziale, I-00173 Rome, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France; IRCCS Santa Lucia; University of Rome Tor Vergata	McIntyre, J (corresponding author), European Lab Neurosci Act, CNRS, Lab Physiol Percept & Act, 11 Pl Marcelin Berthelot, F-75005 Paris, France.		Lacquaniti, Francesco/J-9842-2016; McIntyre, Joseph/K-6395-2015; Zago, Myrka/B-3669-2012	Lacquaniti, Francesco/0000-0003-0896-7315; McIntyre, Joseph/0000-0003-4974-4257; Zago, Myrka/0000-0001-7100-7582				COLLEWIJN H, 1972, BRAIN RES, V36, P59, DOI 10.1016/0006-8993(72)90766-4; Gibson JJ., 1966, SENSES CONSIDERED PE; HUBBARD TL, 1995, PSYCHON B REV, V2, P322, DOI 10.3758/BF03210971; Lackner JR, 2000, EXP BRAIN RES, V130, P2, DOI 10.1007/s002210050002; LACQUANITI F, 1989, J NEUROSCI, V9, P134, DOI 10.1523/JNEUROSCI.09-01-00134.1989; Lacquaniti F., 1993, MULTISENSORY CONTROL, P379, DOI [10.1093/acprof:oso/9780198547853.003.0190, DOI 10.1093/ACPROF:OSO/9780198547853.003.0190]; Lee DN, 1999, P ROY SOC B-BIOL SCI, V266, P2029, DOI 10.1098/rspb.1999.0882; LEE DN, 1983, Q J EXP PSYCHOL-A, V35, P333, DOI 10.1080/14640748308402138; LEE DN, 1980, TUTORIALS MOTOR BEHA, P281; PEPER L, 1994, J EXP PSYCHOL HUMAN, V20, P591, DOI 10.1037/0096-1523.20.3.591; Regan D, 1997, J SPORT SCI, V15, P533, DOI 10.1080/026404197366985; Rushton SK, 1999, NAT NEUROSCI, V2, P186, DOI 10.1038/5750; SAVELSBERGH GJP, 1992, EXP BRAIN RES, V89, P223; Tresilian JR, 1999, TRENDS COGN SCI, V3, P301, DOI 10.1016/S1364-6613(99)01352-2; WERKHOVEN P, 1992, VISION RES, V32, P2313, DOI 10.1016/0042-6989(92)90095-Z	15	274	279	0	33	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					693	694		10.1038/89477	http://dx.doi.org/10.1038/89477			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	448HK	11426224				2022-12-17	WOS:000169621300013
J	Amorapanth, P; LeDoux, JE; Nader, K				Amorapanth, P; LeDoux, JE; Nader, K			Different lateral amygdala outputs mediate reactions and actions elicited by a fear-arousing stimulus	NATURE NEUROSCIENCE			English	Article							PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; CENTRAL NUCLEUS; NEUROTOXIC LESIONS; PROJECTIONS; RAT; INVOLVEMENT; STARTLE	Fear-arousing stimuli elicit innate reactions and can reinforce acquisition of new responses. We tested whether mechanisms mediating these conditioned stimulus (CS) properties were isomorphic or dissociable within the amygdala. Rats trained on a fear-conditioning task (CS paired with footshock) were then trained on an escape-from-fear task (EFF) in which the CS reinforced a locomotor response terminating the CS. Lateral nucleus (LA) lesions blocked acquisition of both conditioned freezing responses and the CS's reinforcement of a new response in the EFF task. Central nucleus (CE) lesions blocked conditioned freezing but not the EFF, whereas basal nucleus (B) lesions blocked the EFF but not conditioned freezing. Thus, activation of the LA by a CS seems to trigger conditioned reactions via CE and conditioned aversion via B activation, reduction of which reinforces new actions.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Nader, K (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.			Amorapanth, Prin/0000-0002-4260-7826	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046516, R37MH038774, K02MH000956] Funding Source: NIH RePORTER; NIMH NIH HHS [MH46516, R37 MH38774, K02 MH00956] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARNARAF DG, 1992, AMYGDALA NEUROBIOLOG, P1; BLANCHARD R J, 1971, Learning and Motivation, V2, P351, DOI 10.1016/0023-9690(71)90016-6; BOLLES RC, 1980, BEHAV BRAIN SCI, V3, P291, DOI 10.1017/S0140525X0000491X; BOLLES RC, 1972, PSYCHOL REV, V79, P394, DOI 10.1037/h0033120; Cahill L, 1999, NEURON, V23, P227, DOI 10.1016/S0896-6273(00)80774-6; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; CAMPEAU S, 1995, J NEUROSCI, V15, P2301, DOI 10.1523/JNEUROSCI.15-03-02301.1995; DAVIS M, 1994, INT REV NEUROBIOL, V36, P225, DOI 10.1016/S0074-7742(08)60305-0; EVERITT B J, 1992, P401; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; FANSELOW MS, 1987, EVOLUTION LEARNING, P185; Hatfield T, 1996, J NEUROSCI, V16, P5256; HELMSTETTER FJ, 1992, BEHAV NEUROSCI, V106, P518, DOI 10.1037/0735-7044.106.3.518; KAPP BS, 1979, PHYSIOL BEHAV, V23, P1109, DOI 10.1016/0031-9384(79)90304-4; KILLCROSS AS, 1997, TRENDS COGN SCI, V1, P244; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Mackintosh N. J, 1983, CONDITIONING ASS LEA; Maren S, 1996, NEURON, V16, P237, DOI 10.1016/S0896-6273(00)80041-0; Maren S, 1998, J NEUROSCI, V18, P3088; MASCAGNI F, 1993, NEUROSCIENCE, V57, P697, DOI 10.1016/0306-4522(93)90016-9; McAllister WR, 1971, AVERSIVE CONDITION, P105; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; Miller N. E., 1951, HDB EXPT PSYCHOL, P435; MILLER NE, 1948, J EXP PSYCHOL, V38, P89, DOI 10.1037/h0058455; Mowrer OH, 1946, J COMP PSYCHOL, V39, P29, DOI 10.1037/h0060150; Mowrer Orval, 1960, LEARNING THEORY BEHA, DOI DOI 10.1037/10802-000; Nader K, 1997, TRENDS COGN SCI, V1, P241, DOI 10.1016/S1364-6613(97)01078-4; PARE D, 1995, NEUROSCIENCE, V69, P567, DOI 10.1016/0306-4522(95)00272-K; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; ROBBINS TW, 1989, NEUROSCI BIOBEHAV R, V13, P155, DOI 10.1016/S0149-7634(89)80025-9; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; ROOZENDAAL B, 1991, PHYSIOL BEHAV, V50, P777, DOI 10.1016/0031-9384(91)90017-I; TURNER BH, 1991, J COMP NEUROL, V313, P295, DOI 10.1002/cne.903130208; Walker DL, 1997, J NEUROSCI, V17, P9375	38	274	279	0	25	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2000	3	1					74	79		10.1038/71145	http://dx.doi.org/10.1038/71145			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TB	10607398				2022-12-17	WOS:000085810200015
J	Burghy, CA; Stodola, DE; Ruttle, PL; Molloy, EK; Armstrong, JM; Oler, JA; Fox, ME; Hayes, AS; Kalin, NH; Essex, MJ; Davidson, RJ; Birn, RM				Burghy, Cory A.; Stodola, Diane E.; Ruttle, Paula L.; Molloy, Erin K.; Armstrong, Jeffrey M.; Oler, Jonathan A.; Fox, Michelle E.; Hayes, Andrea S.; Kalin, Ned H.; Essex, Marilyn J.; Davidson, Richard J.; Birn, Rasmus M.			Developmental pathways to amygdala-prefrontal function and internalizing symptoms in adolescence	NATURE NEUROSCIENCE			English	Article							STRUCTURAL CONNECTIVITY; LIFE EVENTS; STRESS; CORTISOL; CORTEX; BRAIN; CHILDHOOD; DIFFICULTIES; CHILDREN; BEHAVIOR	Early life stress (ELS) and function of the hypothalamic-pituitary-adrenal axis predict later psychopathology. Animal studies and cross-sectional human studies suggest that this process might operate through amygdala-ventromedial prefrontal cortex (vmPFC) circuitry implicated in the regulation of emotion. Here we prospectively investigated the roles of ELS and childhood basal cortisol amounts in the development of adolescent resting-state functional connectivity (rs-FC), assessed by functional connectivity magnetic resonance imaging (fcMRI), in the amygdala-PFC circuit. In females only, greater ELS predicted increased childhood cortisol levels, which predicted decreased amygdala-vmPFC rs-FC 14 years later. For females, adolescent amygdala-vmPFC functional connectivity was inversely correlated with concurrent anxiety symptoms but positively associated with depressive symptoms, suggesting differing pathways from childhood cortisol levels function through adolescent amygdala-vmPFC functional connectivity to anxiety and depression. These data highlight that, for females, the effects of ELS and early HPA-axis function may be detected much later in the intrinsic processing of emotion-related brain circuits.	[Burghy, Cory A.; Stodola, Diane E.; Fox, Michelle E.; Hayes, Andrea S.; Davidson, Richard J.] Univ Wisconsin Madison, Waisman Lab Brain Imaging & Behav, Madison, WI USA; [Ruttle, Paula L.; Molloy, Erin K.; Armstrong, Jeffrey M.; Oler, Jonathan A.; Kalin, Ned H.; Essex, Marilyn J.; Davidson, Richard J.] Univ Wisconsin Madison, Dept Psychiat, Madison, WI USA; [Kalin, Ned H.; Davidson, Richard J.] Univ Wisconsin Madison, Dept Psychol, Madison, WI USA; [Birn, Rasmus M.] Univ Wisconsin Madison, Dept Med Phys, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Burghy, CA (corresponding author), Univ Wisconsin Madison, Waisman Lab Brain Imaging & Behav, Madison, WI USA.	caburghy@wisc.edu	Molloy, Erin K/AAG-4086-2021	Molloy, Erin K/0000-0001-5553-3312; Davidson, Richard/0000-0002-8506-4964; Kalin, Ned/0000-0003-1184-0868	US National Institutes of Health [P50 MH084051, R01-MH044340, P50-MH052354]; John D. and Catherine T. MacArthur Foundation Research Network on Psychopathology and Development; HealthEmotions Research Institute, Department of Psychiatry, University of Wisconsin School of Medicine and Public Health; Canadian Institutes for Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T15HL097789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH084051, P50MH052354, R01MH043454, R01MH044340] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John D. and Catherine T. MacArthur Foundation Research Network on Psychopathology and Development; HealthEmotions Research Institute, Department of Psychiatry, University of Wisconsin School of Medicine and Public Health; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by US National Institutes of Health grants P50 MH084051, R01-MH044340 and P50-MH052354; the John D. and Catherine T. MacArthur Foundation Research Network on Psychopathology and Development; and the HealthEmotions Research Institute, Department of Psychiatry, University of Wisconsin School of Medicine and Public Health. Support for P. L. R. was provided by the Canadian Institutes for Health Research post-doctoral fellowship. We thank M. Anderle, R. Fisher, L. Angelos, C. Hermes, A. Koppenhaver and C. Boldt for assistance with data collection and recruitment, and D. Jackson, J. Ollinger, G. Kirk, N. Vack, J. Koger and I. Dolski for general, technical and administrative assistance.	Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Anisman H, 1998, INT J DEV NEUROSCI, V16, P149, DOI 10.1016/S0736-5748(98)00025-2; [Anonymous], 2008, MPLUS USERS GUIDE; Barrett P, 2007, PERS INDIV DIFFER, V42, P815, DOI 10.1016/j.paid.2006.09.018; Beesdo K, 2009, ARCH GEN PSYCHIAT, V66, P275, DOI 10.1001/archgenpsychiatry.2008.545; BENTLER PM, 1987, SOCIOL METHOD RES, V16, P78, DOI 10.1177/0049124187016001004; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bourke CH, 2012, HORM BEHAV, V62, P210, DOI 10.1016/j.yhbeh.2012.02.024; Christianson John P, 2009, Stress, V12, P445, DOI 10.1080/10253890802510302; COMPAS BE, 1987, PSYCHOL BULL, V101, P393, DOI 10.1037/0033-2909.101.3.393; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Davidson RJ, 2012, NAT NEUROSCI, V15, P689, DOI 10.1038/nn.3093; Essex MJ, 2011, DEV PSYCHOPATHOL, V23, P1039, DOI 10.1017/S0954579411000484; Essex MJ, 2002, J AM ACAD CHILD PSY, V41, P588, DOI 10.1097/00004583-200205000-00017; Essex MJ, 2002, BIOL PSYCHIAT, V52, P776, DOI 10.1016/S0006-3223(02)01553-6; Gunnar M, 2007, ANNU REV PSYCHOL, V58, P145, DOI 10.1146/annurev.psych.58.110405.085605; Hakamata Y, 2009, PSYCHIAT RES-NEUROIM, V173, P206, DOI 10.1016/j.pscychresns.2008.10.002; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kim MJ, 2011, BEHAV BRAIN RES, V223, P403, DOI 10.1016/j.bbr.2011.04.025; Kim MJ, 2011, CEREB CORTEX, V21, P1667, DOI 10.1093/cercor/bhq237; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; Lui S, 2011, AM J PSYCHIAT, V168, P642, DOI 10.1176/appi.ajp.2010.10101419; Lupien SJ, 2011, P NATL ACAD SCI USA, V108, P14324, DOI 10.1073/pnas.1105371108; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; Michels N, 2012, PSYCHONEUROENDOCRINO, V37, P1506, DOI 10.1016/j.psyneuen.2012.02.004; Murgatroyd C, 2011, STRESS, V14, P581, DOI 10.3109/10253890.2011.602146; Myers-Schulz B, 2012, MOL PSYCHIATR, V17, P132, DOI 10.1038/mp.2011.88; Northoff G, 2011, NEUROSCI BIOBEHAV R, V35, P1929, DOI 10.1016/j.neubiorev.2010.12.007; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Pruessner JC, 2010, PSYCHONEUROENDOCRINO, V35, P179, DOI 10.1016/j.psyneuen.2009.02.016; Saad ZS, 2009, NEUROIMAGE, V44, P839, DOI 10.1016/j.neuroimage.2008.09.037; Sanchez MM, 2000, J NEUROSCI, V20, P4657, DOI 10.1523/JNEUROSCI.20-12-04657.2000; SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932; Schreiber JE, 2006, PSYCHONEUROENDOCRINO, V31, P1131, DOI 10.1016/j.psyneuen.2006.07.005; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Talairach J., 1988, COPLANAR STEREOTAXIC; Thomason ME, 2011, J CHILD PSYCHOL PSYC, V52, P1026, DOI 10.1111/j.1469-7610.2011.02422.x; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Veer IM, 2012, PSYCHONEUROENDOCRINO, V37, P1039, DOI 10.1016/j.psyneuen.2011.12.001; Weinstock M, 2007, NEUROCHEM RES, V32, P1730, DOI 10.1007/s11064-007-9339-4; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	47	273	280	1	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1736	+		10.1038/nn.3257	http://dx.doi.org/10.1038/nn.3257			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	045OR	23143517	Green Accepted			2022-12-17	WOS:000311706700021
J	Eisenberger, NI; Cole, SW				Eisenberger, Naomi I.; Cole, Steve W.			Social neuroscience and health: neurophysiological mechanisms linking social ties with physical health	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; AUTONOMIC ACTIVITY; FEAR EXPRESSION; BRAIN MEDIATORS; LIMBIC SYSTEM; STRESS; RESPONSES; SUPPORT; HUMANS; PAIN	Although considerable research has shown the importance of social connection for physical health, little is known about the higher-level neurocognitive processes that link experiences of social connection or disconnection with health-relevant physiological responses. Here we review the key physiological systems implicated in the link between social ties and health and the neural mechanisms that may translate social experiences into downstream health-relevant physiological responses. Specifically, we suggest that threats to social connection may tap into the same neural and physiological 'alarm system' that responds to other critical survival threats, such as the threat or experience of physical harm. Similarly, experiences of social connection may tap into basic reward-related mechanisms that have inhibitory relationships with threat-related responding. Indeed, the neurocognitive correlates of social disconnection and connection may be important mediators for understanding the relationships between social ties and health.	[Eisenberger, Naomi I.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Cole, Steve W.] Univ Calif Los Angeles, Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA; [Cole, Steve W.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Cole, Steve W.] Univ Calif Los Angeles, Cousins Ctr Psychoneuroimmunol, Semel Inst Neurosci & Human Behav, Los Angeles, CA USA; [Cole, Steve W.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Eisenberger, NI (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA.	neisenbe@ucla.edu	Carroll, Joseph/D-1158-2011	Carroll, Joseph/0000-0003-2656-1378				Atlas LY, 2010, J NEUROSCI, V30, P12964, DOI 10.1523/JNEUROSCI.0057-10.2010; Bandler R, 2000, BRAIN RES BULL, V53, P95, DOI 10.1016/S0361-9230(00)00313-0; Bonnet MP, 2008, ANESTH ANALG, V106, P1142, DOI 10.1213/ane.0b013e318165de89; Bosch JA, 2009, PSYCHOSOM MED, V71, P877, DOI 10.1097/PSY.0b013e3181baef05; Brown SL, 2003, PSYCHOL SCI, V14, P320, DOI 10.1111/1467-9280.14461; Buchanan TW, 2010, PSYCHONEUROENDOCRINO, V35, P56, DOI 10.1016/j.psyneuen.2009.09.006; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Cacioppo JT, 2009, TRENDS COGN SCI, V13, P447, DOI 10.1016/j.tics.2009.06.005; Cole SW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r189; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Delgado MR, 2006, BIOL PSYCHOL, V73, P39, DOI 10.1016/j.biopsycho.2006.01.006; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Drolet G, 2001, PROG NEURO-PSYCHOPH, V25, P729, DOI 10.1016/S0278-5846(01)00161-0; Eisenberger N.I, NAT REV NEU IN PRESS; Eisenberger NI, 2007, NEUROIMAGE, V35, P1601, DOI 10.1016/j.neuroimage.2007.01.038; Eisenberger NI, 2011, J COGNITIVE NEUROSCI, V23, P3448, DOI 10.1162/jocn_a_00027; Eisenberger NI, 2011, P NATL ACAD SCI USA, V108, P11721, DOI 10.1073/pnas.1108239108; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Finch CE, 2007, BIOL HUMAN LONGEVITY; Gianaros PJ, 2004, PSYCHOPHYSIOLOGY, V41, P521, DOI 10.1111/1469-8986.2004.00179.x; HENKE PG, 1982, NEUROSCI BIOBEHAV R, V6, P381, DOI 10.1016/0149-7634(82)90047-1; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Inagaki TK, 2012, PSYCHOSOM MED, V74, P3, DOI 10.1097/PSY.0b013e3182359335; INSEL TR, 1992, P NATL ACAD SCI USA, V89, P5981, DOI 10.1073/pnas.89.13.5981; Irwin MR, 2011, NAT REV IMMUNOL, V11, P625, DOI 10.1038/nri3042; Kross E, 2011, P NATL ACAD SCI USA, V108, P6270, DOI 10.1073/pnas.1102693108; LUNDBERG U, 1980, J PSYCHOSOM RES, V24, P125, DOI 10.1016/0022-3999(80)90033-1; Milad MR, 2007, BIOL PSYCHIAT, V62, P1191, DOI 10.1016/j.biopsych.2007.04.032; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Miller G, 2009, ANNU REV PSYCHOL, V60, P501, DOI 10.1146/annurev.psych.60.110707.163551; Miller GE, 2008, BIOL PSYCHIAT, V64, P266, DOI 10.1016/j.biopsych.2008.03.017; Mobbs D, 2010, P NATL ACAD SCI USA, V107, P20582, DOI 10.1073/pnas.1009076107; Mobbs D, 2009, J NEUROSCI, V29, P12236, DOI 10.1523/JNEUROSCI.2378-09.2009; O'Connor MF, 2008, NEUROIMAGE, V42, P969, DOI 10.1016/j.neuroimage.2008.04.256; Onoda K, 2009, SOC NEUROSCI-UK, V4, P443, DOI 10.1080/17470910902955884; Panksepp J, 2004, AFFECTIVE NEUROSCIEN; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Piferi RL, 2006, INT J PSYCHOPHYSIOL, V62, P328, DOI 10.1016/j.ijpsycho.2006.06.002; Pruessner JC, 2008, BIOL PSYCHIAT, V63, P234, DOI 10.1016/j.biopsych.2007.04.041; Slavich GM, 2010, P NATL ACAD SCI USA, V107, P14817, DOI 10.1073/pnas.1009164107; Sloan EK, 2007, J NEUROSCI, V27, P8857, DOI 10.1523/JNEUROSCI.1247-07.2007; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; THOMAS E, 1988, PSYCHOBIOLOGY, V16, P36; Uvnas-Moberg K, 1998, PSYCHONEUROENDOCRINO, V23, P819, DOI 10.1016/S0306-4530(98)00056-0; Wager TD, 2009, NEUROIMAGE, V47, P836, DOI 10.1016/j.neuroimage.2009.05.044; Wang JJ, 2005, P NATL ACAD SCI USA, V102, P17804, DOI 10.1073/pnas.0503082102; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952	49	273	275	5	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					669	674		10.1038/nn.3086	http://dx.doi.org/10.1038/nn.3086			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	932DI	22504347				2022-12-17	WOS:000303270200008
